PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Miyashita, N; Kawai, Y; Inamura, N; Tanaka, T; Akaike, H; Teranishi, H; Wakabayashi, T; Nakano, T; Ouchi, K; Okimoto, N				Miyashita, Naoyuki; Kawai, Yasuhiro; Inamura, Norikazu; Tanaka, Takaaki; Akaike, Hiroto; Teranishi, Hideto; Wakabayashi, Tokio; Nakano, Takashi; Ouchi, Kazunobu; Okimoto, Niro			Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Mycoplasma pneumoniae; Refractory pneumonia; Severe pneumonia; Interleukin 18; Lactate dehydrogenase; Steroid therapy	COMMUNITY-ACQUIRED PNEUMONIA; METHYLPREDNISOLONE PULSE THERAPY; CLINICAL-FEATURES; CHILDREN; INTERLEUKIN-18; INFECTION; EFFICACY; LUNG	Serum interleukin (IL)-18 level was thought to be a useful as a predictor of refractory or severe Mycoplasma pneumoniae pneumonia, and steroid administration is reported to be effective in this situation. The serum levels of IL-18 correlated significantly with those of lactate dehydrogenase (LDH). The purpose of this study was to set a standard for the initiation of steroid therapy in M. pneumoniae pneumonia using a simple serum marker. We analyzed 41 adolescent and adult patients with refractory or severe M. pneumoniae pneumonia who received steroid therapy, and compared them with 108 patients with M. pneumoniae pneumonia who responded to treatment promptly (control group). Serum LDH levels were significantly higher in the refractory and severe group than in the control group at the initiation of steroid therapy (723 vs 210 IU/L, respectively; p < 0.0001). From receiver operating characteristic curve analysis, we calculated serum LDH cut-off levels of 364 IU/L at initiation of steroid therapy and 302 IU/L at 1-3 days before the initiation of steroid therapy. The administration of steroids to patients in the refractory and severe group resulted in the rapid improvement of symptoms and a decrease in serum LDH levels in all patients. Serum LDH level can be used as a useful parameter to determine the initiation of steroid therapy in refractory or severe M. pneumoniae pneumonia. A serum LDH level of 302-364 IU/L seems to be an appropriate criterion for the initiation of steroid therapy. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Miyashita, Naoyuki; Kawai, Yasuhiro; Okimoto, Niro] Kawasaki Med Univ, Dept Internal Med 1, Okayama, Okayama 7008505, Japan; [Inamura, Norikazu; Tanaka, Takaaki; Akaike, Hiroto; Teranishi, Hideto; Wakabayashi, Tokio; Nakano, Takashi; Ouchi, Kazunobu] Kawasaki Med Univ, Dept Pediat, Okayama, Okayama 7008505, Japan	Miyashita, N (reprint author), Kawasaki Med Univ, Dept Internal Med 1, Kita Ku, 2-1-80 Nakasange, Okayama, Okayama 7008505, Japan.	nao@med.kawasaki-m.ac.jp			MEXT KAKENHI [19591190, 21591304]; Kawasaki Medical School [13-401, 14-402, 15-405A, 16-405M, 17-402M, 18-401, 19-402M, 20-4030]	This study was supported in part by MEXT KAKENHI (19591190 and 21591304) and Project Research Grants from Kawasaki Medical School (13-401, 14-402, 15-405A, 16-405M, 17-402M, 18-401, 19-402M, 20-4030).	Tamura A, 2008, J INFECTION, V57, P223, DOI 10.1016/j.jinf.2008.06.012; Lu AZ, 2011, PEDIATR PULM, V46, P1093, DOI 10.1002/ppul.21481; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Miyashita N, 2007, J MED MICROBIOL, V56, P1625, DOI 10.1099/jmm.0.47119-0; Oishi T, 2011, J INFECT CHEMOTHER, V17, P803, DOI 10.1007/s10156-011-0265-7; Lee KY, 2006, PEDIATR PULM, V41, P263, DOI 10.1002/ppul.20374; Tanaka H, 2002, CHEST, V121, P1493, DOI 10.1378/chest.121.5.1493; HANLEY JA, 1982, RADIOLOGY, V143, P29; Miyashita N, 2013, ANTIMICROB AGENTS CH, V57, P5181, DOI 10.1128/AAC.00737-13; Izumikawa K, 2014, J INFECT CHEMOTHER, V20, P181, DOI 10.1016/j.jiac.2013.09.009; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Shafiq M, 2013, J HOSP MED, V8, P68, DOI 10.1002/jhm.1992; Tagliabue C, 2008, J INFECT DIS, V198, P1180, DOI 10.1086/591915; Radisic M, 2000, CLIN INFECT DIS, V31, P1507, DOI 10.1086/317498; Narita M, 2000, CLIN DIAGN LAB IMMUN, V7, P909, DOI 10.1128/CDLI.7.6.909-914.2000; You SY, 2014, ALLERGY ASTHMA IMMUN, V6, P22, DOI 10.4168/aair.2014.6.1.22; Gotoh S, 2008, EUR RESPIR J, V31, P1269; Hirao S, 2011, FEMS IMMUNOL MED MIC, V62, P182, DOI 10.1111/j.1574-695X.2011.00799.x; Inamura M, 2014, J INFECT CHEMOTHER, V20, P270; Kawai Y, 2013, ANTIMICROB AGENTS CH, V57, P2252, DOI 10.1128/AAC.00048-13; Luo Z, 2013, PEDIAT PULMONOL; Miyashita Naoyuki, 2009, BMC Med Imaging, V9, P7, DOI 10.1186/1471-2342-9-7; Miyashita N, 2012, RESPIROLOGY, V17, P1073, DOI 10.1111/j.1440-1843.2012.02188.x; Miyashita N, 2011, EUR J CLIN MICROBIOL, V30, P439, DOI 10.1007/s10096-010-1107-8; National Institute of Health, MYC PNEUM PNEUM; Povoa P, 2012, CURR OPIN INFECT DIS, V25, P199, DOI 10.1097/QCO.0b013e32834f44c7; Principi N, 2013, EUR J CLIN MICROBIOL, V32, P151, DOI 10.1007/s10096-012-1747-y; Sawa T, 2013, J CLIN MICROBIOL, V51, P70, DOI 10.1128/JCM.01871-12; Shimizu T, 2011, IMMUNOLOGY, V133, P51, DOI 10.1111/j.1365-2567.2011.03408.x; The committee for the Japanese Respiratory Society Guidelines in Management of Respiratory Infections, 2006, RESPIROLOGY S3, V11, P79	30	1	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					153	160		10.1016/j.jiac.2014.10.008		8	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900001		
J	Yamada, H; Tairaku, S; Morioka, I; Sonoyama, A; Tanimura, K; Deguchi, M; Nagamata, S; Ebina, Y				Yamada, Hideto; Tairaku, Shinya; Morioka, Ichiro; Sonoyama, Ayako; Tanimura, Kenji; Deguchi, Masashi; Nagamata, Satoshi; Ebina, Yasuhiko			Nationwide survey of mother-to-child infections in Japan	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Cytomegalovirus; Parvovirus 819; Rubella virus; Toxoplasma gondii; Treponema pallidum	MANAGEMENT; PREGNANCY	Objectives: The aim of this survey study was to evaluate a state of mother-to-child infections in Japan. Methods: A nationwide survey on 2714 obstetric facilities where regular maternity checkups were carried out was conducted. A primary questionnaire assessed numbers of pregnancies including induced abortion, spontaneous abortion, still-birth as well as live-birth, which were affected by congenital infections of 6 pathogens during a year of 2011. The secondary questionnaire assessed clinical information, diagnostic modality, and the outcome for each case. The clinical features and diagnostic problems were evaluated. Results: The high reply rates for the primary (73.7%) and the secondary questionnaire (100%) were achieved. The presence of congenital infections for 34 cases with cytomegalovirus (CMV), 1 with Toxoplasma gondii, 4 with rubella virus, 5 with Treponema pallidum, 8 with herpes simplex virus, and 69 with parvovirus B19 was confirmed after questionnaire assessment. The incidence of fetal demise among pregnancies with congenital parvovirus B19 infection was up to 71.0%. Eleven mothers with hydrops fetalis received prenatal fetal therapies involving fetal blood transfusion and immunoglobulin administration, whereas only three pregnancies (27.3%) ended in live-births. Conclusions: This survey study for the first time revealed the annual frequency of pregnancies with mother-to-child infections of 6 pathogens in Japan. The results involve important information and are helpful for clinical practitioners. The majority of neonates with congenital infection of CMV or T. gondii might be undiagnosed in obstetric facilities. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Yamada, Hideto; Tairaku, Shinya; Sonoyama, Ayako; Tanimura, Kenji; Deguchi, Masashi; Nagamata, Satoshi; Ebina, Yasuhiko] Kobe Univ, Dept Obstet & Gynecol, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Morioka, Ichiro] Kobe Univ, Dept Pediat, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Yamada, H (reprint author), Kobe Univ, Dept Obstet & Gynecol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yhideto@med.kobe-u.ac.jp			Ministry of Health, Labor and Welfare of Japan [H23-Jisedai-Ippan-001]; Japan Association of Obstetricians and Gynecologists [H22, 23-Ogyah-Kenkin]	This work was supported in part by Grants-in-Aid from the Ministry of Health, Labor and Welfare of Japan (grant number; H23-Jisedai-Ippan-001) and Japan Association of Obstetricians and Gynecologists (grant number; H22, 23-Ogyah-Kenkin).	Yamada H, 2011, J CLIN MICROBIOL, V49, P2552, DOI 10.1128/JCM.02092-10; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; Enders M, 2004, PRENATAL DIAG, V24, P513, DOI 10.1002/pd.940; Gilbert RE, 1999, CONGENITAL TOXOPLASM; GUERINA NG, 1994, PEDIATR ANN, V23, P138; Kamiya K, 2013, MATERN CHILD HLTH J, P42; Koyano S, 2011, BMJ OPEN; Rodis JE, 1998, AM J OBSTET GYNECOL, V179, P985, DOI 10.1016/S0002-9378(98)70203-0; Yamada H, 2013, CONGENIT ANOM	9	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					161	164		10.1016/j.jiac.2014.10.013		4	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900002		
J	Sato, R; Suzuki, Y; Takahashi, G; Kojika, M; Inoue, Y; Endo, S				Sato, Ryo; Suzuki, Yasushi; Takahashi, Gaku; Kojika, Masahiro; Inoue, Yoshihiro; Endo, Shigeatsu			A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Urinary liver-type fatty acid-binding protein; Dip-test; Point of care testing; Enzyme-linked immunosorbent assay	EXCRETION; NEPHROPATHY; SEVERITY; DISEASE	In recent years, it has been reported that the urinary level of Liver-type fatty acid-binding protein (L-FABP) serves as a useful biomarker for diagnosing acute kidney injury (AKI) or sepsis complicated by AKI. However, because the urinary level of L-FABP is currently measured by enzyme-linked immunosorbent assay (ELISA), several days may elapse before the results of the measurement become available. We have newly developed a simplified kit, the Dip-test, for measuring the urinary level of L-FABP. The Dip-test was measured at 80 measurement points (22 points in noninfectious disease, 13 points in SIRS, 20 points in infectious disease, and 25 points in sepsis) in 20 patients. The urinary L-FABP levels as determined by ELISA in relation to the results of the Dip-test were as follows: 10.10 +/- 12.85 ng/ml in patients with a negative Dip-test ([-] group), 41.93 +/- 50.51 ng/ml in patients with a test ([] group), 70.36 +/- 73.70 ng/ml in patients with a positive test ({+] group), 1048.96 +/- 2117.68 ng/ml in patients with a 2 + test ([2+] group), and 23,571.55 +/- 21,737.45 ng/ml in patients with a 3 + test ([3+] group). The following tendency was noted: the stronger the positive Dip-test reaction, the higher the urinary L-FABP level. Multigroup comparison revealed a significant differences in the urinary L-FABP levels between the Dip-test (-) group and each of the other groups. In this study, the usefulness of the Dip-test, our newly developed simplified kit for measuring the urinary L-FABP level, is suggested. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Sato, Ryo; Suzuki, Yasushi; Takahashi, Gaku; Kojika, Masahiro; Inoue, Yoshihiro; Endo, Shigeatsu] Iwate Med Univ, Dept Crit Care Med, Sch Med, Iwate Prefectural Adv Crit Care & Emergency Ctr, Morioka, Iwate 0208505, Japan	Sato, R (reprint author), Iwate Med Univ, Dept Crit Care Med, Sch Med, Iwate Prefectural Adv Crit Care & Emergency Ctr, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	rsato@iwate-med.ac.jp					BONE RC, 1992, CRIT CARE MED, V20, P864; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kamijo A, 2004, AM J PATHOL, V165, P1243, DOI 10.1016/S0002-9440(10)63384-6; Portilla D, 2008, KIDNEY INT, V73, P465, DOI 10.1038/sj.ki.5002721; Vincent JL, 1998, CRIT CARE MED, V26, P1793; MAATMAN RGHJ, 1992, BIOCHEM J, V288, P285; Negishi K, 2009, AM J PATHOL, V174, P1154, DOI 10.2353/ajpath.2009.080644; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P2894, DOI 10.1681/ASN.2007010097; Nakamura T, 2006, AM J KIDNEY DIS, V47, P439, DOI 10.1053/j.ajkd.2005.11.006; Nakamura T, 2009, SHOCK, V31, P454, DOI 10.1097/SHK.0b013e3181891131; Hofstra JM, 2008, NEPHROL DIAL TRANSPL, V23, P3160, DOI 10.1093/ndt/gfn190; Susantitaphong P, 2013, AM J KIDNEY DIS, V61, P430, DOI 10.1053/j.ajkd.2012.10.016; Doi K, 2010, CRIT CARE MED, V38, P2037, DOI 10.1097/CCM.0b013e3181eedac0; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; Tanaka T, 2009, AM J PATHOL, V174, P1203, DOI 10.2353/ajpath.2009.080511; Norie E, 2009, AM J PHYSIOL-RENAL, V296, pF669	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					165	169		10.1016/j.jiac.2014.10.017		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900003		
J	Aoki, I; Ishikawa, K; Wakana, A; Aso, M; Yoshinori, T				Aoki, Ikuo; Ishikawa, Kensuke; Wakana, Akira; Aso, Masako; Yoshinori, Tomoko			Evaluation of the safety, tolerability, and pharmacokinetics of a single bolus injection of daptomycin in healthy Japanese subjects	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Daptomycin; Pharmacokinetics; Safety; Bolus injection; 10 s; Japanese	STAPHYLOCOCCUS-AUREUS; INFECTIONS; VOLUNTEERS	This was a phase I double-blind, randomized, placebo-controlled, 2-period, single-dose, crossover study in healthy Japanese subjects to evaluate the safety, tolerability, and pharmacokinetics of a single bolus injection of daptomycin. Twenty healthy subjects were randomized; 16 received a single intravenous (IV) administration of 6 mg/kg of daptomycin and 4 received a single intravenous administration of placebo (0.9% sodium chloride) by either bolus injection (10 s) or infusion (30 min) following an overnight fast in Periods 1 or 2. There was a minimum 5-day washout period from the administration in Period Ito the administration in Period 2. Administration of a single bolus injection of daptomycin 6 mg/kg was generally well tolerated. The geometric mean ratios (GMRs) (90% confidence intervals [Cis]) for AUC(0-infinity), AUC(0-24) h. C-max, and C-24 h of daptomycin in plasma following bolus injection over 10 s relative to IV infusion over 30 min were 1.01 (1.00, 1.03), 1.02 (1.00, 1.03), 1.50 (1.41, 1.60) and 1.05 (1.02, 1.08), respectively. Because no existing studies of this nature were available, C-max following daptomycin 6 mg/ kg/10 s multiple-dose bolus injections was simulated. It was estimated at 178 mu g/mL (upper limit) and was expected to be equal to or less than the confirmed C-max in Japanese or non-Japanese healthy subjects following single- or multiple-dose IV infusion over 30 min. From the results of this study, daptomycin multiple-dose bolus injections over 10 s are expected well tolerated and to have similar C-max values as IV infusion over 30 min, thus offering potential clinical benefit. Trial registration: Because this was a phase I trial in healthy subjects, the trial was not registered (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Aoki, Ikuo; Wakana, Akira; Yoshinori, Tomoko] Japan Dev, MSD KK, Chiyoda Ku, Tokyo 1028667, Japan; [Ishikawa, Kensuke] Japan Dev, MSD KK, Chuo Ku, Osaka 5410046, Japan; [Aso, Masako] Kitasato Univ, Kitasato Inst Hosp, Minato Ku, Tokyo 1088642, Japan	Aoki, I (reprint author), Japan Dev, MSD KK, Chiyoda Ku, Kitanomaru Sq,1-13-12 Kudan Kita, Tokyo 1028667, Japan.	ikuo.aoki@merck.com					Safdar N, 2004, ANTIMICROB AGENTS CH, V48, P63, DOI 10.1128/AAC.48.1.63-68.2004; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Benvenuto M, 2006, ANTIMICROB AGENTS CH, V50, P3245, DOI 10.1128/AAC.00247-06; Louie A, 2001, ANTIMICROB AGENTS CH, V45, P845, DOI 10.1128/AAC.45.3.845-851.2001; Aikawa N, 2013, J INFECT CHEMOTHER, V19, P447, DOI 10.1007/s10156-012-0501-9; Dvorchik BH, 2003, ANTIMICROB AGENTS CH, V47, P1318, DOI 10.1128/AAC.47.4.1318-1323.2003; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Asin E, 2012, INT J ANTIMICROB AG, V40, P313, DOI 10.1016/j.ijantimicag.2012.06.005; Canut A, 2012, EUR J CLIN MICROBIOL, V31, P2227, DOI 10.1007/s10096-012-1560-7; Chakraborty A, 2009, J ANTIMICROB CHEMOTH, V64, P151, DOI 10.1093/jac/dkp155; Cubist Pharmaceuticals, 2013, CUB PACK INS; Garrelts J C, 1992, Pharmacoeconomics, V1, P116, DOI 10.2165/00019053-199201020-00008; Hagihara M, 2012, THER CLIN RISK MANAG, V8, P79, DOI 10.2147/TCRM.S23875; Hasegawa S, 2011, ANTIBIOT CHEMOTHER, V27, P135; Novartis Europharm Ltd, 2013, CUB SUMM PROD CHAR; Steven WJ, 2008, NURS 2008 CRIT CARE, V3, P13; Tally F P, 1999, Expert Opin Investig Drugs, V8, P1223, DOI 10.1517/13543784.8.8.1223	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					170	175		10.1016/j.jiac.2014.11.001		6	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900004		
J	Mukae, H; Yatera, K; Noguchi, S; Kawanami, T; Yamasaki, K; Tokuyama, S; Inoue, N; Nishida, C; Kawanami, Y; Ogoshi, T; Orihashi, T; Yoshii, C; Ishimoto, H				Mukae, Hiroshi; Yatera, Kazuhiro; Noguchi, Shingo; Kawanami, Toshinori; Yamasaki, Kei; Tokuyama, Susumu; Inoue, Naoyuki; Nishida, Chinatsu; Kawanami, Yukiko; Ogoshi, Takaaki; Orihashi, Takeshi; Yoshii, Chiharu; Ishimoto, Hiroshi			Evaluation of a rapid immunochromatographic ODK0501 assay for detecting Streptococcus pneumoniae antigens in the sputum of pneumonia patients with positive S. pneumoniae urinary antigens	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Sputum antigen detection; ODK0501; Urinary antigen detection; Pneumococcal pneumonia; Streptococcus pneumoniae	COMMUNITY-ACQUIRED PNEUMONIA; PNEUMOCOCCAL PNEUMONIA; DIAGNOSIS	Background: A novel, rapid and noninvasive test (ODK0501, RAPIRUN (R) Streptococcus pneumoniae) uses polyclonal antibodies to detect C polysaccharide of S. pneumoniae derived from sputum samples using an immunochromatographic assay. We evaluated its usefulness in Japanese patients with pneumonia who exhibited positive urinary antigen tests for S. pneumoniae (BinaxNOW (R) S. pneumoniae). Patients and methods: Forty adult patients with pneumonia treated between May 2011 and August 2013 were enrolled. Bacterial cultures, Gram staining and ODK0501 assays of sputum as well as urinary antigen tests for S. pneumoniae using urine samples obtained from the same patients were performed upon admission, the fourth day after starting antimicrobial treatment and at the end of the antimicrobial treatment. Results: Twenty-seven of the 40 patients were positive for ODK0501, while a negative result for 001(0501 was associated with low-quality sputum samples according to the Geckler classification of sputum. The sensitivity and specificity of the ODK0501 assay in the 40 patients were 90.9% and 61.1%, respectively, based on the culture results. The results obtained with this kit were more favorable than those observed on Gram staining. The 001(0501 assay also showed a rapid reaction to the disappearance of S. pneumoniae in the sputum samples, while approximately 80% of the patients exhibited persistent positive results on the urinary antigen detection tests at the end of treatment. Conclusions: The 001(0501 test is a noninvasive, rapid and accurate tool for diagnosing respiratory infections caused by S. pneumoniae, although good quality sputum must be obtained prior to adequate treatment with antibiotics. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Mukae, Hiroshi; Yatera, Kazuhiro; Noguchi, Shingo; Kawanami, Toshinori; Yamasaki, Kei; Nishida, Chinatsu; Kawanami, Yukiko; Ogoshi, Takaaki; Orihashi, Takeshi; Ishimoto, Hiroshi] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka, Japan; [Noguchi, Shingo; Orihashi, Takeshi; Yoshii, Chiharu] Univ Occupat & Environm Hlth, Dept Resp Med, Wakamatsu Hosp, Kitakyushu, Fukuoka, Japan; [Tokuyama, Susumu; Inoue, Naoyuki] Kyushu Rosai Hosp, Dept Internal Med, Kitakyushu, Fukuoka, Japan	Mukae, H (reprint author), Univ Occupat & Environm Hlth Japan, Dept Resp Med, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	hmukae@med.uoeh-u.ac.jp			Otsuka Pharmaceutical, Co., Ltd.	Hiroshi Mukae has received honoraria and research grants fees for activities other than this study from Otsuka Pharmaceutical, Co., Ltd. The authors alone are responsible for the content and writing of the paper.	Ehara N, 2008, J MED MICROBIOL, V57, P820, DOI 10.1099/jmm.0.47793-0; Horita N, 2013, RESPIROLOGY, V18, P1177, DOI 10.1111/resp.12163; Murdoch DR, 2003, CLIN INFECT DIS, V37, P153, DOI 10.1086/375610; Marcos MA, 2003, EUR RESPIR J, V21, P209, DOI 10.1183/09031936.03.00058802; Klugman KP, 2008, CLIN INFECT DIS, V47, pS202, DOI 10.1086/591405; Blaschke AJ, 2011, CLIN INFECT DIS, V52, pS331, DOI 10.1093/cid/cir048; Kobashi Y, 2007, RESPIRATION, V74, P387, DOI 10.1159/000092547; Izumikawa K, 2009, CLIN VACCINE IMMUNOL, V16, P672, DOI 10.1128/CVI.00308-08; Musher DM, 2004, CLIN INFECT DIS, V39, P165, DOI 10.1086/421497; Priner M, 2008, J AM GERIATR SOC, V56, P170, DOI 10.1111/j.1532-5415.2007.01451.x; Monno R, 2013, J MICROBIOL METH, V92, P127, DOI 10.1016/j.mimet.2012.11.011; Committee for the Japanese Respiratory Society guidelines in management of respiratory infections, 2007, JAP RESP SOC GUID MA; Esposito S, 2004, PEDIATR INFECT DIS J, V23, P365, DOI 10.1097/00006454-200404000-00021; Fukushima K, 2013, NIHON KOKYUKI GAKKAI, V2, P343; Murdoch DR, 2003, J CLIN MICROBIOL, V41, P2271, DOI 10.1128/JCM.41.5.2271.2003; Yoshida Kanako, 2003, Nihon Kokyuki Gakkai Zasshi, V41, P521	16	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					176	181		10.1016/j.jiac.2014.11.003		6	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900005		
J	Kohno, S; Tateda, K; Mikamo, H; Kadota, J; Niki, Y; Itamura, R				Kohno, Shigeru; Tateda, Kazuhiro; Mikamo, Hiroshige; Kadota, Jun-ichi; Niki, Yoshihito; Itamura, Rio			Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: A multicenter, open-label, uncontrolled study	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Sulbactam/ampicillin; Pneumonia; Antibacterial therapy; High-dose regimen		Although sulbactam/ampicillin (SBT/ABPC) 3 g 4 times daily (QID) is widely used worldwide for patients with moderate to severe community-acquired pneumonia (CAP), the 3 g QID regimen was not available in Japan. In fact, there has been no evidence from a formal clinical study regarding the efficacy and safety of SBT/ABPC 3 g QID in these patients. We report the first results of a multicenter, unblinded, non-comparative, phase 3 study of SBT/ABPC 3 g QID in Japanese adults with moderate to severe CAP. Forty-seven subjects with moderate to severe CAP were enrolled and received SBT/ABPC 3 g QID intravenously for 3-14 days. The clinical responses assessed by the data review committee (DRC) were the primary endpoints. The secondary endpoints included the bacteriological responses assessed by the DRC. The clinical efficacy rate at the test of cure (TOC) was 94.6%. The bacterial eradication rate at TOC was 91.7%. Causative pathogens were isolated from sputum sample taken at baseline in 28 subjects (59.6%). Common causative pathogens included Streptococcus pneumoniae (14 strains), Haemophilus influenzae (9 strains), and Moraxella catart-halis (8 strains). The clinical efficacy rate and the bacterial eradication rate at TOC of the common pathogens were, respectively, 92.3% and 90.0% in subjects with S. pneumoniae, 83.3% and 75.0% in subjects with H. influenzae, and 87.5% and 87.5% in subjects with M. catarrhalis. All treatment-related adverse events were mild or moderate in severity. SBT/ABPC 3 g QID was well tolerated and demonstrated excellent clinical and bacteriological responses. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Kohno, Shigeru] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 852, Japan; [Tateda, Kazuhiro] Toho Univ, Fac Med, Dept Microbiol & Infect Dis, Tokyo, Japan; [Mikamo, Hiroshige] Aichi Med Univ, Dept Clin Infect Dis, Nagakute, Aichi, Japan; [Kadota, Jun-ichi] Oita Univ, Fac Med, Dept Resp Med & Infect Dis, Oita 87011, Japan; [Niki, Yoshihito] Showa Univ, Sch Med, Div Clin Infect Dis, Dept Med, Tokyo 142, Japan; [Itamura, Rio] Pfizer Japan Inc, Clin Res, Dev Japan, Tokyo 1518589, Japan	Itamura, R (reprint author), Pfizer Japan Inc, Clin Res, Dev Japan, Shibuya Ku, 3-22-7 Yoyogi, Tokyo 1518589, Japan.	Rio.Itamura@pfizer.com			Pfizer Japan Inc	We gratefully acknowledge the contributions of the study participants, the principal investigators listed below, and all medical personnel for this clinical study. This study was sponsored by Pfizer Japan Inc.	Jacobs MR, 2001, CLIN MICROBIOL INFEC, V7, P589, DOI 10.1046/j.1198-743x.2001.00295.x; Niki Y, 2011, J INFECT CHEMOTHER, V17, P510, DOI 10.1007/s10156-011-0214-5; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; [Anonymous], 2005, GUID US ANT AG, P10; Ishibashi Tsuneo, 1998, Japanese Journal of Antibiotics, V51, P746; Ishikawa K, 2011, J INFECT CHEMOTHER, V17, P126, DOI 10.1007/s10156-010-0174-1; Longo D, 2011, HARRISONS PRINCIPLES, V1-2; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Saito A, 1999, J INFECT CHEMOTHER, V5, P110, DOI 10.1007/s101560050020; Soto E, 2014, BRIT J CLIN PHARMACO, V77, P509, DOI 10.1111/bcp.12232	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					182	188		10.1016/j.jiac.2014.11.006		7	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900006		
J	Teranishi, H; Ohzono, N; Inamura, N; Kato, A; Wakabayashi, T; Akaike, H; Terada, K; Ouchi, K				Teranishi, Hideto; Ohzono, Nanae; Inamura, Norikazu; Kato, Atsushi; Wakabayashi, Tokio; Akaike, Hiroto; Terada, Kihei; Ouchi, Kazunobu			Detection of bacteria and fungi in blood of patients with febrile neutropenia by real-time PCR with universal primers and probes	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Febrile neutropenia; Real-time PCR assay; Blood culture; Bacteria; Fungi	BROAD-RANGE PCR; DIAGNOSIS; IDENTIFICATION; INFECTIONS; PATHOGENS; CULTURE; THERAPY; ASSAY	Febrile neutropenia is the main treatment-related cause of mortality in cancer patients. During June 2012 to April 2014, 97 blood culture samples were collected from patients receiving chemotherapy for hematological malignancy and cancer with febrile neutropenia episodes (FNEs). The samples were examined for the presence of bacteria and fungi using real-time PCR amplification and sequencing of 16S and 18S rRNA genes. Bacteria were identified in 20 of 97 samples (20.6%) by the real-time PCR assay and in 10 of 97 (10.3%) samples by blood culture. In 6 blood culture-positive samples, the real-time PCR assay detected the same type of bacteria. No fungi were detected by the real-time PCR assay or blood culture. During antibiotic therapy, all samples were negative by blood culture, but the real-time PCR assay yielded a positive result in 2 cases of 2 (100%). The bacterial DNA copy number was not well correlated with the serum C-reactive protein titer of patients with FNEs. We conclude that a real-time PCR assay could provide better detection of causative microbes' in a shorter time, and with a smaller blood sample than blood culture. Using a real-time PCR assay in combination with blood culture could improve microbiological documentation of FNEs. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Teranishi, Hideto; Ohzono, Nanae; Inamura, Norikazu; Kato, Atsushi; Wakabayashi, Tokio; Akaike, Hiroto; Terada, Kihei; Ouchi, Kazunobu] Kawasaki Med Univ, Dept Pediat, Kurashiki, Okayama, Japan	Teranishi, H (reprint author), Kawasaki Med Univ, Dept Pediat, Kurashiki, Okayama, Japan.	teranishi.h@med.kawasaki-m.ac.jp			Kawasaki Medical School	The work was supported by a Research Project Grant from Kawasaki Medical School.	Ammann RA, 2007, SUPPORT CARE CANCER, V15, P637, DOI 10.1007/s00520-007-0235-x; Einsele H, 1997, J CLIN MICROBIOL, V35, P1353; Zucol F, 2006, J CLIN MICROBIOL, V44, P2750, DOI 10.1128/JCM.00112-06; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Loeffler J, 2000, J CLIN MICROBIOL, V38, P586; Kruger W, 1999, BONE MARROW TRANSPL, V23, P589, DOI 10.1038/sj.bmt.1701614; Jordanides NE, 2005, BONE MARROW TRANSPL, V35, P389, DOI 10.1038/sj.bmt.1704768; Blijlevens NMA, 2001, CLIN MICROBIOL INFEC, V7, P47, DOI 10.1046/j.1469-0691.2001.00058.x; Freifeld AG, 2011, CLIN INFECT DIS, V52, P56; Lilienfend-Toal M, 2009, J CLIN MICROBIOL, V47, P2405; Loeffler J., 1997, Journal of Clinical Microbiology, V35, P3311; Nakamura A, 2010, J CLIN MICROBIOL, V48, P2030, DOI 10.1128/JCM.01700-09; Rastogi R, 2009, BMC MICROBIOL, V9, P1; Santolaya ME, 2011, PEDIATR INFECT DIS J, V30, P957, DOI 10.1097/INF.0b013e31822a37d7; Schabereiter-Gurtner C, 2008, J APPL MICROBIOL, V104, P1228, DOI 10.1111/j.1365-2672.2007.03648.x	15	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					189	193		10.1016/j.jiac.2014.11.008		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900007		
J	Komeda, T; Ishii, S; Itoh, Y; Ariyasu, Y; Sanekata, M; Yoshikawa, T; Shimada, J				Komeda, Takuji; Ishii, Shingo; Itoh, Yumiko; Ariyasu, Yasuyuki; Sanekata, Masaki; Yoshikawa, Takayoshi; Shimada, Jingoro			Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (II): A pediatric drug use investigation	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Influenza; Post-marketing surveillance; Peramivir; Pediatric; Safety profile; Abnormal behavior	LANINAMIVIR OCTANOATE HYDRATE; INFLUENZA-VIRUS INFECTION; EFFICACY; SURVEILLANCE; CHILDREN	Peramivir is the only intravenous formulation among anti-influenza neuraminidase inhibitors currently available. Peramivir was approved for manufacturing and marketing in Japan in January 2010. In October 2010, an additional indication for pediatric use was approved. We conducted a pediatric drug use investigation of peramivir from October 2010 to February 2012 and evaluated its real-world safety and effectiveness in pediatric patients. We collected the data of 1254 peramivir-treated pediatric patients from 161 facilities across Japan and examined the safety in 1199 patients and effectiveness in 1188 patients. In total, 245 adverse events were observed with an incidence rate of 14.01% (168/1199). Of these, 115 events were adverse drug reactions (ADRs) with an incidence rate of 7.67% (92/1199). Common ADRs were diarrhea and abnormal behavior, with incidence rates of 2.50% (30/1199) and 2.25% (27/1199), respectively. Fourteen serious ADRs were observed in 12 patients (1.00%), including 5 cases each of abnormal behavior and neutrophil count decreased. While 87.0% (100 events) of ADRs occurred within 3 days after the initiation of peramivir administration, 87.8% (101 events) resolved or improved within 7 days after onset. Multivariate analyses indicated that the presence or absence of underlying diseases/complications was significantly related to ADR incidence. With regard to effectiveness, the median time to alleviation of both influenza symptoms and fever was 3 days, including the first day of administration. Thus, this study confirms the pediatric safety of peramivir without any concerns about effectiveness under routine clinical settings. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Komeda, Takuji; Ishii, Shingo; Itoh, Yumiko; Ariyasu, Yasuyuki; Sanekata, Masaki; Yoshikawa, Takayoshi] Shionogi & Co Ltd, Pharmacovigilance, Chuo Ku, Osaka 5410045, Japan; [Shimada, Jingoro] St Marianna Univ, Sch Med, Dept Microbiol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan	Komeda, T (reprint author), Shionogi & Co Ltd, Pharmacovigilance, Chuo Ku, 1-8 Doshomachi 3 Chome, Osaka 5410045, Japan.	takuji.komeda@shionogi.co.jp			Shionogi & Co., Ltd. (Osaka, Japan)	We would like to thank the 161 medical facilities and their physicians participating in this investigation and providing valuable data. This survey was conducted with a grant from Shionogi & Co., Ltd. (Osaka, Japan).	Kohno S, 2011, ANTIMICROB AGENTS CH, V55, P2803, DOI [10.1128/AAC.01718-10, 10.1128/AAC.00360-11]; Kashiwagi S, 2012, INT J ANTIMICROB AG, V40, P381, DOI 10.1016/j.ijantimicag.2012.06.017; Peltola V, 2003, CLIN INFECT DIS, V36, P299, DOI 10.1086/345909; Hernandez J, 2010, 48 ANN M INF DIS SOC, P765; Kashiwagi S, 2013, J INFECT CHEMOTHER, V19, P223, DOI 10.1007/s10156-012-0481-9; Kohno S, 2010, ANTIMICROB AGENTS CH, V54, P4568, DOI 10.1128/AAC.00474-10; Sugaya N, 2012, ANTIMICROB AGENTS CH, V56, P369, DOI 10.1128/AAC.00132-11	7	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					194	201		10.1016/j.jiac.2014.11.009		8	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900008		
J	Nakano, R; Nakano, A; Ishii, Y; Ubagai, T; Kikuchi-Ueda, T; Kikuchi, H; Tansho-Nagakawa, S; Kamoshida, G; Mu, XQ; Ono, Y				Nakano, Ryuichi; Nakano, Akiyo; Ishii, Yoshikazu; Ubagai, Tsuneyuki; Kikuchi-Ueda, Takane; Kikuchi, Hirotoshi; Tansho-Nagakawa, Shigeru; Kamoshida, Go; Mu, Xiaoqin; Ono, Yasuo			Rapid detection of the Klebsiella pneumoniae carbapenemase (KPC) gene by loop-mediated isothermal amplification (LAMP)	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Antibiotic resistance gene; Klebsiella pneumoniae carbapenemase (KPC); Loop-mediated isothermal amplification; Rapid detection	GRAM-NEGATIVE BACTERIA; REAL-TIME PCR; BETA-LACTAMASE; ESCHERICHIA-COLI; NEW-YORK; 1ST REPORT; ENTEROBACTERIACEAE; RESISTANCE; EPIDEMIOLOGY; BLA(KPC)	Klebsiella pneumoniae carbapenemases (KPC), which are associated with resistance to carbapenem, have recently spread worldwide and have become a global concern. It is necessary to detect KPC-producing organisms in clinical settings to be able to control the spread of this resistance. We have developed a loop-mediated isothermal amplification (LAMP) method for rapid detection of KPC producers. LAMP primer sets were designed to recognize the homologous regions of bla(KPC-2) to bla(KPC-17) and could amplify bla(KPC) rapidly. The specificity and sensitivity of the primers in the LAMP reactions for bla(KPC) detection were determined. This LAMP assay was able to specifically detect KPC producers at 68 degrees C, and no cross-eactivity was observed for other types of beta-lactamase (class A, B, C, or D) producers. The detection limit for this assay was found to be 10(0) CFU per tube, in 25 mm, which was 10-fold more sensitive than a PCR assay for bla(KPC) detection. Then, the sensitivity of the LAMP reactions for bla(KPC) detection in human specimens (sputum samples, urine samples, fecal samples and blood samples) was analyzed; it was observed that the LAMP assay had almost the same sensitivity in these samples as when using purified DNA. The LAMP assay is easy to perform and rapid. It may therefore be routinely applied for detection of KPC producers in the clinical laboratory. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Nakano, Ryuichi; Nakano, Akiyo; Ubagai, Tsuneyuki; Kikuchi-Ueda, Takane; Kikuchi, Hirotoshi; Tansho-Nagakawa, Shigeru; Kamoshida, Go; Mu, Xiaoqin; Ono, Yasuo] Teikyo Univ, Sch Med, Dept Microbiol & Immunol, Itabashi Ku, Tokyo 1738605, Japan; [Ishii, Yoshikazu] Toho Univ, Sch Med, Dept Microbiol & Infect Dis, Ota Ku, Tokyo 1438540, Japan; [Mu, Xiaoqin] Genom Res Ctr, State Prov Key Labs Biomed Pharmaceut China 1, Harbin 150081, Heilongjiang Pr, Peoples R China	Nakano, R (reprint author), Teikyo Univ, Sch Med, Dept Microbiol & Immunol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	nakano@med.teikyo-u.ac.jp			Kurozumi Medical Foundation	This work was supported by the Kurozumi Medical Foundation.	Tuite N, 2014, J ANTIMICROB CHEMOTH, V69, P1729, DOI 10.1093/jac/dku083; Nijhuis R, 2013, DIAGN MICR INFEC DIS, V77, P316, DOI 10.1016/j.diagmicrobio.2013.09.007; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Manchanda V, 2011, INDIAN J MED MICROBI, V29, P249, DOI 10.4103/0255-0857.83907; Lascols C, 2012, J CLIN MICROBIOL, V50, P1632, DOI 10.1128/JCM.06115-11; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P432, DOI 10.1111/j.1469-0691.2012.03815.x; Mangold KA, 2011, J CLIN MICROBIOL, V49, P3338, DOI 10.1128/JCM.00268-11; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Bradford PA, 2004, CLIN INFECT DIS, V39, P55, DOI 10.1086/421495; Bratu S, 2005, ANTIMICROB AGENTS CH, V49, P3018, DOI 10.1128/AAC.49.7.3018-3020.2005; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Carmeli Y, 2010, CLIN MICROBIOL INFEC, V16, P102, DOI 10.1111/j.1469-0691.2009.03115.x; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Anderson KF, 2007, J CLIN MICROBIOL, V45, P2723, DOI 10.1128/JCM.00015-07; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Rapp RP, 2012, PHARMACOTHERAPY, V32, P399, DOI 10.1002/j.1875-9114.2012.01035.x; Liu W, 2012, J CLIN MICROBIOL, V50, P1580, DOI 10.1128/JCM.06647-11; Enosawa M, 2003, J CLIN MICROBIOL, V41, P4359, DOI 10.1128/JCM.41.9.4359-4365.2003; Calfee D, 2008, INFECT CONT HOSP EP, V29, P966, DOI 10.1086/590661; Hindiyeh M, 2008, J CLIN MICROBIOL, V46, P2879, DOI 10.1128/JCM.00661-08; Kurokawa H, 1999, LANCET, V354, P955, DOI 10.1016/S0140-6736(05)75707-X; Nagano N, 2013, JPN J INFECT DIS, V66, P79; Nakano Ryuichi, 2007, Journal of Infection and Chemotherapy, V13, P18, DOI 10.1007/s10156-006-0483-6; Nakano R, 2014, ANTIMICROB AGENTS CH, V58, P7611, DOI 10.1128/AAC.04265-14; Nakano R, 2012, J MED MICROBIOL, V61, P1727, DOI 10.1099/jmm.0.049726-0; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Peter H, 2012, J CLIN MICROBIOL, V50, P3990, DOI 10.1128/JCM.00990-12; Roth AL, 2012, J CLIN MICROBIOL, V50, P4183, DOI 10.1128/JCM.02194-12; Solanki R, 2013, J MED MICROBIOL, V62, P1540, DOI 10.1099/jmm.0.059907-0; Voulgari E, 2013, FUTURE MICROBIOL, V8, P27, DOI [10.2217/fmb.12.130, 10.2217/FMB.12.130]; Weisenberg SA, 2009, DIAGN MICR INFEC DIS, V64, P233, DOI 10.1016/j.diagmicrobio.2009.02.004	36	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					202	206		10.1016/j.jiac.2014.11.010		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900009		
J	Ikebe, T; Chiba, K; Shima, T; Masuda, C; Okuno, R; Ohya, H; Ogata, K; Katsukawa, C; Kawahara, R; Tominaga, K; Yabata, J; Tada, Y; Okabe, N; Watanabe, H; Chang, B; Ogawa, M; Ohnishi, M				Ikebe, Tadayoshi; Chiba, Kazuki; Shima, Tomoko; Masuda, Chieko; Okuno, Rumi; Ohya, Hitomi; Ogata, Kikuyo; Katsukawa, Chihiro; Kawahara, Ryuji; Tominaga, Kiyoshi; Yabata, Junko; Tada, Yuki; Okabe, Nobuhiko; Watanabe, Haruo; Chang, Bin; Ogawa, Michinaga; Ohnishi, Makoto		Working Grp Beta-Hemolytic	Evaluation of streptococcal toxic shock-like syndrome caused by group B streptococcus in adults in Japan between 2009 and 2013	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Group B streptococcus; Streptococcal toxic shock-like syndrome; Serotype; Antimicrobial susceptibility	GROUP-A; MACROLIDE RESISTANCE; INVASIVE INFECTIONS; NONPREGNANT ADULTS; SEQUENCE TYPE; RISK-FACTORS; DISEASE; AGALACTIAE; EPIDEMIOLOGY; SEROTYPE	Infection with Streptococcus agalactiae has long been recognized in infants. In recent years, S. agalactiae is an important cause of morbidity and mortality among adults and among those with underlying medical condition. Several cases of GBS infection and more fulminant disease similar to streptococcal toxic shock syndrome have recently been reported. We report here that 19 S. agalactiae strains were isolated from streptococcal toxic shock-like syndrome cases involving adult patients in Japan between 2009 and 2013. The average age of the patients was 66.3 years. At least one underlying disease was present in 47.4% (9/19) of the patients. The most prevalent serotype among these strains was Ib. All serotype I strains belonged to clonal complex 10 and were ciprofloxacin resistant. In contrast, all strains were susceptible to penicillin G, ampicillin, cefazolin, cefotaxime, imipenem, panipenem, and linezolid. The characteristic type distributions of streptococcal toxic shock-like syndrome isolates differed between isolates obtained from vaginal swabs of women and infants with invasive infections.. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Ikebe, Tadayoshi; Watanabe, Haruo; Chang, Bin; Ogawa, Michinaga; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo 1628640, Japan; [Chiba, Kazuki] Fukushima Inst Publ Hlth, Dept Microbiol, Fukushima 9608560, Japan; [Shima, Tomoko; Masuda, Chieko] Toyama Inst Hlth, Dept Bacteriol, Imizu, Toyama 9390363, Japan; [Okuno, Rumi] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Shinjuku Ku, Tokyo 1690073, Japan; [Ohya, Hitomi] Kanagawa Prefectural Inst Publ Hlth, Div Microbiol, Chigasaki, Kanagawa 2530087, Japan; [Ogata, Kikuyo] Oita Prefectural Inst Hlth & Environm, Microbiol Lab, Oita 8701117, Japan; [Katsukawa, Chihiro; Kawahara, Ryuji] Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Higashinari Ku, Osaka 5370025, Japan; [Tominaga, Kiyoshi; Yabata, Junko] Yamaguchi Prefectural Inst Publ Hlth & Environm, Dept Publ Hlth Sci, Yamaguchi 7530821, Japan; [Tada, Yuki; Okabe, Nobuhiko] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinjuku Ku, Tokyo 1628640, Japan	Ikebe, T (reprint author), Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	tdikebe@nih.go.jp			Ministry of Health, Labor, and Welfare [H22-013]	This work was supported by a grant from the Ministry of Health, Labor, and Welfare (H22-013).	Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Melin P, 2013, VACCINE, V31, pD31, DOI 10.1016/j.vaccine.2013.05.012; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; Lambertsen L, 2010, EUR J CLIN MICROBIOL, V29, P1071, DOI 10.1007/s10096-010-0941-z; SCHUCHAT A, 1994, EPIDEMIOL REV, V16, P374; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562; Ueno H, 2012, JPN J INFECT DIS, V65, P516; Morozumi M, 2014, EPIDEMIOL INFECT, V142, P812, DOI 10.1017/S0950268813001647; Wang H, 2013, ANTIMICROB AGENTS CH, V57, P1538, DOI 10.1128/AAC.02317-12; Tazi A, 2011, CLIN MICROBIOL INFEC, V17, P1587, DOI 10.1111/j.1469-0691.2011.03628.x; Murayama SY, 2009, ANTIMICROB AGENTS CH, V53, P2650, DOI 10.1128/AAC.01716-08; Ki M, 2012, EUR J CLIN MICROBIOL, V31, P3199, DOI 10.1007/s10096-012-1685-8; BADRI MS, 1977, J INFECT DIS, V135, P308; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Crum NF, 2003, SCAND J INFECT DIS, V35, P878, DOI 10.1080/00365540310016691; De Azavedo JCS, 1999, ANTIMICROB AGENTS CH, V43, P2144; Ekelund K, 2005, CLIN MICROBIOL INFEC, V11, P569, DOI 10.1111/j.1469-0691.2005.01169.x; JACKSON LA, 1995, ANN INTERN MED, V123, P415; Shimizu Y, 1998, KANSEN ZAS-J JPN ASS, V72, P258; Smith FR, 1938, J INFECT DIS, V62, P1062; BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					207	211		10.1016/j.jiac.2014.12.002		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900010		
J	Tojo, M; Mawatari, M; Hayakawa, K; Nagamatsu, M; Shimada, K; Mezaki, K; Sugiki, Y; Kuroda, E; Takeshita, N; Kutsuna, S; Fujiya, Y; Miyoshi-Akiyama, T; Kirikae, T; Ohmagari, N				Tojo, Masayoshi; Mawatari, Momoko; Hayakawa, Kayoko; Nagamatsu, Maki; Shimada, Kayo; Mezaki, Kazuhisa; Sugiki, Yuko; Kuroda, Emi; Takeshita, Nozomi; Kutsuna, Satoshi; Fujiya, Yoshihiro; Miyoshi-Akiyama, Tohru; Kirikae, Teruo; Ohmagari, Norio			Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Antimicrobial resistance; Carbapenemase; 16S rRNA methylase; bla(OxA-23); armA; Acinetobacter baumannii	RIBOSOMAL-RNA METHYLASE; KLEBSIELLA-PNEUMONIAE; ARMA; DISSEMINATION; CARBAPENEMASE; BLA(OXA-23); INFECTIONS; MUTATIONS; EMERGENCE; MORTALITY	We report a case of multidrug-resistant (MDR) Acinetobactor baumannii isolates obtained from a traveler returned from Brunei. Whole-genome sequencing analysis revealed that the isolates harbored b/a(OxA-23) and armA. The minimum inhibitory concentrations of antibiotics against the strain were as follows: imipenem, 32 mu g/ml; meropenem, 32 mu g/ml; ciprofloxacin, 16 mu g/ml; amilcacin, >= 1024 mu z/ml; arbekacin, >= 1024 mu g/ml; aztreonam, >= 64 mu g/ml; colistin, >= 4 mu g/ml. A. baumannii harboring both bla(OxA-23) and armA is rarely reported in Japan, and, to the best of our knowledge, this is the second report of A. baumannii harboring both resistant genes in Japan. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Tojo, Masayoshi] Univ Tsukuba, Dept Anat & Embryol, Fac Med, Ibaraki, Japan; [Tojo, Masayoshi; Mawatari, Momoko; Hayakawa, Kayoko; Nagamatsu, Maki; Takeshita, Nozomi; Kutsuna, Satoshi; Fujiya, Yoshihiro; Ohmagari, Norio] Dis Control & Prevent Ctr, Nagoya, Aichi, Japan; [Tojo, Masayoshi; Nagamatsu, Maki; Shimada, Kayo; Miyoshi-Akiyama, Tohru; Kirikae, Teruo] Dept Infect Dis, Res Inst, Tokyo, Japan; [Sugiki, Yuko; Kuroda, Emi] Natl Ctr Global Hlth & Med, Infect Control & Prevent, Tokyo 1628655, Japan	Kirikae, T (reprint author), Natl Ctr Global Hlth & Med, Dept Infect Dis, Res Inst, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	tkirikae@ri.ncgm.go.jp			Ministry of Health, Labor and Welfare of Japan [H24-Shinko-Ippan-010]	This research was supported by a grant from the Ministry of Health, Labor and Welfare of Japan (H24-Shinko-Ippan-010).	Hashimoto A, 2014, JPN J INFECT DIS, V67, P120, DOI 10.7883/yoken.67.120; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07; Vila J, 1996, ANTIMICROB AGENTS CH, V40, P491; Kwon KT, 2007, J ANTIMICROB CHEMOTH, V59, P525, DOI 10.1093/jac/dkl499; Tada T, 2013, INT J ANTIMICROB AG, V42, P372, DOI 10.1016/j.ijantimicag.2013.06.014; Doi Y, 2007, ANTIMICROB AGENTS CH, V51, P4209, DOI 10.1128/AAC.00560-07; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Karah N, 2011, J MED MICROBIOL, V60, P515, DOI 10.1099/jmm.0.028340-0; Karthikeyan K, 2010, J ANTIMICROB CHEMOTH, V65, P2253, DOI 10.1093/jac/dkq273; VILA J, 1995, ANTIMICROB AGENTS CH, V39, P1201; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Bonnin RA, 2011, ANTIMICROB AGENTS CH, V55, P2424, DOI 10.1128/AAC.01795-10; Wachino J, 2012, DRUG RESIST UPDATE, V15, P133, DOI 10.1016/j.drup.2012.05.001; Tada T, 2014, ANTIMICROB AGENTS CH, V58, P2916, DOI 10.1128/AAC.01212-13; Clinical Laboratory Standards Institute, 2009, M07A7 CLIN LAB STAND, V8th; Domingues S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002837; Hamouda A, 2004, J ANTIMICROB CHEMOTH, V54, P695, DOI 10.1093/jac/dkh368; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Kim JW, 2008, CLIN MICROBIOL INFEC, V14, P716, DOI 10.1111/j.1469-0691.2008.02022.x; Park Sunok, 2011, Osong Public Health Res Perspect, V2, P164, DOI 10.1016/j.phrp.2011.11.040; Strateva T, 2012, BRAZ J INFECT DIS, V16, P307, DOI 10.1590/S1413-86702012000300020; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97; Wang XH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-234	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					212	214		10.1016/j.jiac.2014.08.029		3	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900011		
J	Nishioka, H; Kozuki, T; Kamei, H				Nishioka, Hiroaki; Kozuki, Tomohiro; Kamei, Hiroki			Capnocytophaga canimorsus bacteremia presenting with acute cholecystitis after a dog bite	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Capnocytophaga canimorsus; Dog bite; Acute cholecystitis; Blood culture	SEPTICEMIA; MENINGITIS	Capnocytophaga canimorsus is part of normal gingival flora of dogs and cats. The organism can cause septicemia, meningitis, and endocarditis in humans after contact with dogs or cats. In spite of the frequency of gastrointestinal symptoms in C. canimorsus infection patients, specific gastrointestinal disease or clinical images have not been reported. We report a case of C. canimorsus bacteremia presenting with acute cholecystitis in elderly woman. She suffered from general fatigue and right upper abdominal pain. She had leukocytosis and abnormal liver function tests. She showed abnormal findings of the gallbladder by abdominal computed tomography and ultrasonography. She was diagnosed with acute cholecystitis without gallstones and was administered with antibiotics. C. canimorsus was isolated from blood cultures. A history of an insignificant wound secondary to a dog bite was elicited. She recovered completely with antibiotic treatment. This case revealed that C canimorsus bacteremia can be presented with acute cholecystitis, suggesting that C canimorsus could cause cholecystitis. And this cholecystitis can be treated with antibiotics without operation. Physicians seeing patients with acute cholecysitis should ask questions regarding animal contact. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Nishioka, Hiroaki; Kozuki, Tomohiro; Kamei, Hiroki] Kobe City Med Ctr Gen Hosp, Dept Gen Internal Med, Chuo Ku, Kobe, Hyogo 6500047, Japan	Nishioka, H (reprint author), Kobe City Med Ctr Gen Hosp, Dept Gen Internal Med, Chuo Ku, 2-1-1 Minami Machi, Kobe, Hyogo 6500047, Japan.	nishiokahiroaki@hotmail.com					Takada T, 2013, J HEPATO-BIL-PAN SCI, V20, P1, DOI 10.1007/s00534-012-0566-y; Pers C, 1996, CLIN INFECT DIS, V23, P71; BOBO RA, 1976, AM J CLIN PATHOL, V65, P564; Le Moal GL, 2003, CLIN INFECT DIS, V36, pE42, DOI 10.1086/345477; Lion C, 1996, EUR J EPIDEMIOL, V12, P521, DOI 10.1007/BF00144007; Nagata H, 2014, SURG INFECT, V15, P72, DOI 10.1089/sur.2012.201; Sandoe JAT, 2004, J MED MICROBIOL, V53, P245, DOI 10.1099/jmm.0.05274-0; VALTONEN M, 1995, EUR J CLIN MICROBIOL, V14, P520, DOI 10.1007/BF02113430	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					215	217		10.1016/j.jiac.2014.09.001		3	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900012		
J	Kutsuna, S; Kato, Y; Koizumi, N; Yamamoto, K; Fujiya, Y; Mawatari, M; Takeshita, N; Hayakawa, K; Kanagawa, S; Ohmagari, N				Kutsuna, Satoshi; Kato, Yasuyuki; Koizumi, Nobuo; Yamamoto, Kei; Fujiya, Yoshihiro; Mawatari, Momoko; Takeshita, Nozomi; Hayakawa, Kayoko; Kanagawa, Shuzo; Ohmagari, Norio			Travel-related leptospirosis in Japan: A report on a series of five imported cases diagnosed at the National Center for Global Health and Medicine	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Leptospirosis; Freshwater; Zoonosis; Returned travelers; Leptospira	RETURNED TRAVELERS; BRADYCARDIA; VIETNAM	Leptospirosis is one of the most common travel-related infections. We report 5 cases of travel-related leptospirosis who presented at our clinic between January 2008 and December 2013. Patients were included in the study if they presented with a clinical profile that was compatible with the disease within 21 days of their return from traveling, which were laboratory-diagnosed as leptospirosis by blood culture, rise in antibody titers in paired sera using the microscopic agglutination test (MAT), and/or DNA detection using fIaB-nested PCR. Five leptospirosis cases were evaluated, all of which contracted the disease after exposure to fresh water in Southeast Asian countries. All of the cases had fevers, headaches, conjunctival injections, and relative bradycardia. The pertinent laboratory findings included elevated C-reactive protein levels, elevated creatinine levels, and sterile pyuria. All 5 cases had serum MAT titers that increased by >= 4 times in the interval between specimens taken during the acute phase and those taken during the convalescence phase, and leptospiral DNA was detected in plasma and/or urine specimens in 4 cases. Leptospira interrogans was isolated from one patient's blood sample. Patients were treated with penicillin G, minocycline, or doxycycline. One case was cured without antibiotics. A diagnosis of leptospirosis should be considered for febrile travelers who return from Southeast Asian countries to Japan after being exposed to freshwater while traveling. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Kutsuna, Satoshi; Kato, Yasuyuki; Yamamoto, Kei; Fujiya, Yoshihiro; Mawatari, Momoko; Takeshita, Nozomi; Hayakawa, Kayoko; Kanagawa, Shuzo; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Koizumi, Nobuo] Natl Inst Infect Dis, Dept Bacteriol, Shinjuku Ku, Tokyo 1628640, Japan	Kutsuna, S (reprint author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628640, Japan.	sonare.since1192@gmail.com			Ministry of Health, Labour and Welfare, Japan [H24-shinkou-ippan-013]	This work was partly supported by funding from the Research on Emerging and Re-emerging Infectious Diseases grant by the Ministry of Health, Labour and Welfare, Japan (H24-shinkou-ippan-013).	Koizumi N, 2008, JPN J INFECT DIS, V61, P465; Jansen A, 2007, CLIN INFECT DIS, V44, pE69, DOI 10.1086/513431; Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892; Koizumi N, 2013, J MED MICROBIOL, V62, P630, DOI 10.1099/jmm.0.050039-0; Sejvar J, 2003, EMERG INFECT DIS, V9, P702; Cunha BA, 2000, CLIN MICROBIOL INFEC, V6, P633, DOI 10.1046/j.1469-0691.2000.0194f.x; Vanasco NB, 2008, ACTA TROP, V107, P255, DOI 10.1016/j.actatropica.2008.06.007; Kutsuna S, 2014, AM J TROP MED HYG, V90, P444, DOI 10.4269/ajtmh.13-0536; BERMAN SJ, 1973, ANN INTERN MED, V79, P167; Guerrant R. L., 2011, TROPICAL INFECT DIS; Infectious Disease Surveillance Center, ANN SURV DAT NOT DIS; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Leshem E, 2010, AM J TROP MED HYG, V82, P459, DOI 10.4269/ajtmh.2010.09-0239; Mishima Nobuyuki, 2013, Trop Med Health, V41, P171, DOI 10.2149/tmh.2013-04; Miyazato Kátia Eiko, 2013, Int Arch Med, V6, P23, DOI 10.1186/1755-7682-6-23; Sakamoto Mitsuo, 2005, Kansenshogaku Zasshi, V79, P294; Ostergaard L, 1996, J INFECTION, V33, P185, DOI 10.1016/S0163-4453(96)92225-2; Sakamoto M, 2001, MALAYS KANSENSHOGAKU, V75, P1057; The National Institute of Infectious Diseases, INFECT AGENTS SURVEI; Yaita K, 2013, INTERNAL MED, V52, P1439, DOI 10.2169/internalmedicine.52.0343	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					218	223		10.1016/j.jiac.2014.10.004		6	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900013		
J	Kawano, S; Maeda, T; Suzuki, T; Abe, T; Mikita, K; Hamakawa, Y; Ono, T; Sonehara, W; Miyahira, Y; Kawana, A				Kawano, Shuichi; Maeda, Takuya; Suzuki, Takefumi; Abe, Tatsuhiro; Mikita, Kei; Hamakawa, Yusuke; Ono, Takeshi; Sonehara, Wataru; Miyahira, Yasushi; Kawana, Akihiko			Loop-mediated isothermal amplification with the Procedure for Ultra Rapid Extraction kit for the diagnosis of pneumocystis pneumonia	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Pneumocystis jirovecii; Pneumocystis pneumonia; Loop-mediated isothermal amplification; Procedure for Ultra Rapid Extraction; Polymerase chain reaction	PERFORMANCE; SPECIMENS; CARINII; MALARIA; DNA; PCR	Loop-mediated isothermal amplification (LAMP) is an innovative molecular technique requiring only a heating device and isothermal conditions to amplify a specific target gene. The results of current microscopic diagnostic tools for pneumocystis pneumonia are not sufficiently consistent for detecting infection with a low-density of Pneumocystis jirovecii. Although polymerase chain reaction (PCR) is highly sensitive, it is not suitable for resource-limited facilities. LAMP is a potential diagnostic replacement for PCR in such settings but a critical disadvantage of DNA extraction was still remained. Therefore, we employed the Procedure for Ultra Rapid Extraction (PURE) kit, which uses a porous material, to isolate the DNA from clinical samples in a simple way in combination with previously reported LAMP procedure for diagnosing PCP. The detection limit of the PURE-LAMP method applied to artificial bronchoalveolar lavage fluid samples was 100 copies/tube, even with the use of massive blood-contaminated solutions. In addition, we concluded the diagnostic procedure within 1 h without the need for additional equipment. PURE-LAMP coupled with suitable primers for specific pathogens has good potential for diagnosing various infectious diseases. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Kawano, Shuichi; Maeda, Takuya; Abe, Tatsuhiro; Mikita, Kei; Hamakawa, Yusuke; Kawana, Akihiko] Natl Def Med Coll, Div Infect Dis & Pulm Med, Dept Internal Med, Tokorozawa, Saitama 3598513, Japan; [Suzuki, Takefumi; Sonehara, Wataru] Natl Def Med Coll Hosp, Dept Pharm, Saitama, Japan; [Ono, Takeshi; Miyahira, Yasushi] Natl Def Med Coll, Dept Global Infect Dis & Trop Med, Tokorozawa, Saitama 3598513, Japan	Maeda, T (reprint author), Natl Def Med Coll, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	tmaeda@ndmc.ac.jp					Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Uemura N, 2008, J MED MICROBIOL, V57, P50, DOI 10.1099/jmm.0.47216-0; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; Caliendo AM, 1998, J CLIN MICROBIOL, V36, P979; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Flori P, 2004, J MED MICROBIOL, V53, P603, DOI 10.1099/jmm.0.45528-0; Mitarai S, 2011, INT J TUBERC LUNG D, V15, P1211, DOI 10.5588/ijtld.10.0629; Asai N, 2012, J INFECT CHEMOTHER, V18, P965, DOI 10.1007/s10156-012-0415-6; Boonsarngsuk V, 2009, INT J INFECT DIS, V13, P59, DOI 10.1016/j.ijid.2008.03.027; Kawano Shuichi, 2014, J Med Case Rep, V8, P254, DOI 10.1186/1752-1947-8-254; Mikita K, 2014, PARASITOL INT, V63, P785, DOI 10.1016/j.parint.2014.07.007; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Vogel MN, 2007, BRIT J RADIOL, V80, P516, DOI 10.1259/bjr/39696316	14	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					224	226		10.1016/j.jiac.2014.09.004		3	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900014		
J	Takeda, S; Hisano, M; Komano, J; Yamamoto, H; Sago, H; Yamaguchi, K				Takeda, Satoshi; Hisano, Michi; Komano, Jun; Yamamoto, Hiroyuki; Sago, Haruhiko; Yamaguchi, Koushi			Influenza vaccination during pregnancy and its usefulness to mothers and their young infants	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Review						Pregnancy; Influenza; Vaccine; Vaccine safety; Immunogenicity; Transplacental transfer	A H1N1 2009; IMMUNIZATION PRACTICES ACIP; RESPIRATORY ILLNESS; SEASONAL INFLUENZA; ANTIBODY-RESPONSE; VIRUS INFECTION; MATERNAL IMMUNIZATION; ADVISORY-COMMITTEE; MONOVALENT VACCINE; OUTPATIENT VISITS	The current approach to protecting pregnant women from influenza infection and serious influenzarelated complications is vaccination. It is, therefore, critical to evaluate the vaccine's safety, immunogenicity, and protection efficacy during pregnancy. However, because it is affected by previous influenza vaccination or infection, the efficacy of the seasonal trivalent inactivated influenza vaccine is difficult to evaluate in pregnant women. The A/H1N1 pdm pandemic in 2009 provided us with the opportunity to evaluate the immunogenicity of the influenza vaccine unaffected by previous vaccinations or infections. Vaccination with inactivated influenza virus during pregnancy elicited neutralizing antibody titers that were sufficient and comparable to those of naturally infected individuals. Furthermore, post-pandemic surveys provided a wealth of definitive information on vaccine efficacy and safety. In addition, transplacental transfer of antibodies following vaccination protected newborn infants against influenza infection. With reports showing the effectiveness of influenza vaccine during pregnancy, it is suggested that influenza vaccination benefits both mothers and their young infants. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Takeda, Satoshi; Yamamoto, Hiroyuki] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Hisano, Michi; Sago, Haruhiko; Yamaguchi, Koushi] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal, Neonatal & Reprod Med, Setagaya Ku, Tokyo 1578535, Japan; [Komano, Jun] Osaka Prefectural Inst Publ Hlth, Div Virol, Dept Infect Dis, Higashinari Ku, Osaka 5370025, Japan	Yamaguchi, K (reprint author), Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal, Neonatal & Reprod Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	yamaguchi-k@ncchd.go.jp					ACOG Committee, 2004, OBSTET GYNECOL, V104, P1125; American College of Obstetricians and Gynecologists, 2010, OBSTET GYNECOL, V116, P1006; Parren PWHI, 2001, ADV IMMUNOL, V77, P195, DOI 10.1016/S0065-2776(01)77018-6; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Conlin AMS, 2013, OBSTET GYNECOL, V121, P511, DOI 10.1097/AOG.0b013e318280d64e; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Kharbanda EO, 2013, OBSTET GYNECOL, V122, P659, DOI 10.1097/AOG.0b013e3182a1118a; Donner B, 2010, DRUG SAFETY, V33, P631, DOI 10.2165/11536370-000000000-00000; Zuccotti G, 2010, JAMA-J AM MED ASSOC, V304, P2360, DOI 10.1001/jama.2010.1729; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; ENGLUND JA, 1993, J INFECT DIS, V168, P647; Irving WL, 2000, BRIT J OBSTET GYNAEC, V107, P1282, DOI 10.1111/j.1471-0528.2000.tb11621.x; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; DEINARD AS, 1981, AM J OBSTET GYNECOL, V140, P240; Tsuda H, 2002, AM J REPROD IMMUNOL, V48, P1, DOI 10.1034/j.1600-0897.2002.01117.x; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Grund S, 2011, J VIROL METHODS, V171, P369, DOI 10.1016/j.jviromet.2010.11.024; Saito S, 2000, J REPROD IMMUNOL, V47, P87, DOI 10.1016/S0165-0378(00)00060-7; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI [10.7326/0003-4819-156-7-201204030-00411, 10.1059/0003-4819-156-7-201204030-00411]; Oppermann M, 2012, VACCINE, V30, P4445, DOI 10.1016/j.vaccine.2012.04.081; GREENBERG M, 1958, AM J OBSTET GYNECOL, V76, P897; Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210; Nordin JD, 2013, OBSTET GYNECOL, V121, P519, DOI 10.1097/AOG.0b013e3182831b83; Abzug MJ, 2013, CLIN INFECT DIS, V56, P1488, DOI 10.1093/cid/cit057; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172; Omon E, 2011, VACCINE, V29, P9649, DOI 10.1016/j.vaccine.2011.10.034; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; Louik C, 2013, VACCINE, V31, P5033, DOI 10.1016/j.vaccine.2013.08.096; Greer LG, 2010, OBSTET GYNECOL, V115, P711, DOI 10.1097/AOG.0b013e3181d44752; Wilking AN, 2014, PEDIATR NEUROL, V51, P370, DOI 10.1016/j.pediatrneurol.2014.04.026; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094; Skowronski DM, 2009, VACCINE, V27, P4754, DOI 10.1016/j.vaccine.2009.03.079; Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3; HEINONEN OP, 1973, INT J EPIDEMIOL, V2, P229, DOI 10.1093/ije/2.3.229; Harris JW, 1919, J AMER MED ASSOC, V72, P978; Tanaka T, 2009, CAN MED ASSOC J, V181, P55, DOI 10.1503/cmaj.090866; Munoz FM, 2005, AM J OBSTET GYNECOL, V192, P1098, DOI 10.1016/j.ajog.2004.12.019; Nordin JD, 2014, J PEDIATR-US, V164, P1051, DOI 10.1016/j.jpeds.2014.01.037; France EK, 2006, ARCH PEDIAT ADOL MED, V160, P1277, DOI 10.1001/archpedi.160.12.1277; Puleston RL, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14550-01; Bednarczyk RA, 2012, AM J OBSTET GYNECOL, V207, pS38, DOI 10.1016/j.ajog.2012.07.002; Black SB, 2004, AM J PERINAT, V21, P333, DOI 10.1055/s-2004-831888; Bridges Carolyn B, 2003, MMWR Recomm Rep, V52, P1; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; Singleton J. A., 2010, Morbidity and Mortality Weekly Report, V59, P44; Centers for Disease Control and Prevention, 1995, MMWR-MORBID MORTAL W, V44, P1; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P1; Centers for Disease Control and Prevention (CDC), 2012, MMWR-MORBID MORTAL W, V61, P758; Chamber TM, 2013, VACCINE, V31, P5026; de Jong J C, 2003, Dev Biol (Basel), V115, P63; DEATHS from Asian influenza, 1958, BR MED J, V1, P915; Dunstan HJ, 2014, BJOG-INT J OBSTET GY, V121, P901, DOI 10.1111/1471-0528.12640; Fell DB, 2013, EXPERT REV VACCINES, V12, P1417, DOI 10.1586/14760584.2013.851607; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; Fisher BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033048; Fukushima W, 2012, VACCINE, V30, P7630, DOI 10.1016/j.vaccine.2012.10.027; Hardelid P, 2011, EURO SURVEILL, V16; Harper Scott A., 2004, Morbidity and Mortality Weekly Report, V53, P1; Heinonen OP, 1977, BIRTH DEFECTS DRUGS, P314; Horiya M, 2011, OBSTET GYNECOL, V118, P887, DOI 10.1097/AOG.0b013e31822e5c02; Katz J., 2009, Morbidity and Mortality Weekly Report, V58, P521; Larson L, 2010, MED DISORDERS OBSTET, V5th, P1; Lim SH, 2010, VACCINE, V28, P7455, DOI 10.1016/j.vaccine.2010.08.087; Lin SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062983; Mackenzie IS, 2011, BR J CLIN PHARM, V73, P801; Moro PL, 2013, OBSTET GYNECOL, V122, P1271, DOI 10.1097/AOG.0000000000000010; Moro PL, 2012, EXPERT REV VACCINES, V11, P911, DOI [10.1586/ERV.12.72, 10.1586/erv.12.72]; MURRAY DL, 1979, J CLIN MICROBIOL, V10, P184; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Pasternak B, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2794; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; Quach C, 2003, PEDIATRICS, V112, pE197, DOI 10.1542/peds.112.3.e197; REUMAN PD, 1987, PEDIATR INFECT DIS J, V6, P398; Saito S, 2013, AM J OBSTET GYNECOL, V209, pe1; Shaw ML, 2013, FIELDS VIROLOGY, V1, P1151; SUMAYA CV, 1979, J INFECT DIS, V140, P141; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Thompson MG, 2013, CLIN INFECT DIS, V57, P1587, DOI 10.1093/cid/cit551; Travares F, 2011, VACCINE, V29, P6358; Wollenhaupt M, 2014, PHARMACOEPIDEM DR S, V23, P1035, DOI 10.1002/pds.3673; Wright PF, 2013, FIELDS VIROLOGY, P1186; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736; Xie HY, 2013, AM J OBSTET GYNECOL, V208, pe1; Yamaguchi K, 2009, J MED VIROL, V81, P1923, DOI 10.1002/jmv.21620; Yeager DP, 1999, AM J PERINAT, V16, P283, DOI 10.1055/s-2007-993873	91	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					238	246		10.1016/j.jiac.2015.01.015		9	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900017		
J	Shiro, H; Sato, Y; Toyonaga, Y; Hanaki, H; Sunakawa, K				Shiro, Hiroyuki; Sato, Yoshitake; Toyonaga, Yoshikiyo; Hanaki, Hideaki; Sunakawa, Keisuke			Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: Evaluation of the changes in drug sensitivity of Haemophilus influenzae and patients' background factors	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Child; Infectious disease; Surveillance; Drug-resistance; Haemophilus influenzae	JAPAN 2ND REPORT; STREPTOCOCCUS-PNEUMONIAE; INFECTIOUS-DISEASES; PREVALENCE; PATHOGENS; SURVEILLANCE; ASSOCIATION; MENINGITIS; SOCIETY; VACCINE	The Drug-Resistant Pathogen Surveillance Group in Pediatric Infectious Disease has conducted surveillance of pediatric patients with respiratory tract infections, meningitis, and sepsis five times (in 2000 2001 [period 1], 2004 [period 2], 2007 [period 3], 2010 [period 4], and 2012 [period 5]). With respect to the clinically isolated Haemophilus influenzae, the drug susceptibility, the frequency of drug-resistant strains, and patients' background factors in each period have already been reported. Here we evaluate trends in the development of drug resistance in H. influenzae, and the relationship between the development of drug resistance and patients' background factors in the aforementioned five periods. H. influenzae derived from pediatric patients with respiratory tract infections that had been previously collected (period I, 448 isolates; period 2, 376 isolates; period 3, 386 isolates; period 4, 484 isolates; and period 5, 411 isolates) were analyzed. The proportions of S-lactamase-nonproducing ampicillin (ABPC)intermediate resistant (BLNAI) strains + [beta-lactamase-nonproducing ABPC-resistant (BLNAR) strains, were 28.8% in period 1, 59.3% in period 2, 61.1% in period 3,58.1% in period 4, and 63.5% in period 5, showing a rapid increase from period I to period 2 followed by an almost constant rate of approximately 60%. The proportion of g-lactamase-producing ABPC-resistant (BLPAR) strains + g-lactamase-producing clayulanic acid/amoxicillin-resistant (BLPACR) strains was 4.4% in period 3, which was somewhat low; however, there were no significant changes in the proportions of these strains, which ranged between 6.4% and 8.7% throughout the surveillance period except for period 3. The drugs whose MIC90 values against BLNAR strains were low throughout the surveillance included piperacillin (0.25 mu g/mL) and tazobactam/piperacillin (0.125-0.25 gg/mL) in the penicillins; cefditoren and ceftriaxone (0.25-0.5 ug/mL for both) in the cephems; meropenem (0.5-1 gg/mL) and tebipenem (1 n/mL) in the carbapenems; and levofloxacin, tosufloxacin, and garenoxacin (<0.061.1,g/mL for all) and norfloxacin (0.06-0.125 mu g/mL) in the quinolones. We investigated the relationship between the frequency of BLNAS strains/BLNAI + BLNAR strains and patients' background factors in each surveillance period. Significant differences were shown on age category (<3 years or >3 years) in all periods except period 4, and the presence/absence of prior administration of antimicrobial agents within one month in period 2 and period 3. In all periods, the frequency of BLNAI + BLNAR strains were higher in patients aged <3 years than in patients aged years, and were also higher in patients with presence of prior treatment than in patients without prior treatment. We consider that it is important to promote the proper use of antimicrobial agents by conducting surveillance continuously in the future to clarify the relationship between the development of drug resistance in H. influenzae and patients' background factors and provide those information to clinical setting. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.>3	[Shiro, Hiroyuki] Yokohama Rosai Hosp, Dept Pediat, Drug Resistant Pathogen Surveillance Grp Pediat I, Yokohama, Kanagawa, Japan; [Sato, Yoshitake] Ota Mem Hosp, Dept Pediat, Drug Resistant Pathogen Surveillance Grp Pediat I, Fuji Heavy Ind Hlth Insurance Soc, Ota, Gunma, Japan; [Toyonaga, Yoshikiyo] Saitama Sekishinkai Hosp, Dept Pediat, Drug Resistant Pathogen Surveillance Grp Pediat I, Sayama, Saitama, Japan; [Hanaki, Hideaki] Kitasato Univ, Kitasato Inst, Res Ctr Antiinfect Drugs, Tokyo, Japan; [Sunakawa, Keisuke] Kitasato Univ, Kitasato Inst, Drug Resistant Pathogen Surveillance Grp Pediat I, Res Org Infect Control Sci, Tokyo, Japan	Shiro, H (reprint author), Yokohama Rosai Hosp, Dept Pediat, Drug Resistant Pathogen Surveillance Grp Pediat I, Kouhoku Ku, 3211 Kozukue Cho, Yokohama, Kanagawa, Japan.	shiro@yokohamah.rofuku.go.jp			Chugai Pharmaceutical Co., Ltd; Daiichi Sankyo Co., Ltd; Dainippon Sumitomo Pharma Co., Ltd; Meiji Seika Pharma Co., Ltd; Shionogi Co., Ltd; Toyama chemical Co., Ltd.	Yoshikiyo Toyonaga, Yoshitake Sato, Hideaki Hanaki and Keisuke Sunakawa have research funds from Chugai Pharmaceutical Co., Ltd, Daiichi Sankyo Co., Ltd, Dainippon Sumitomo Pharma Co., Ltd, Meiji Seika Pharma Co., Ltd, Shionogi & Co., Ltd, and Toyama chemical Co., Ltd. Other author reports no conflict of interest.	Ubukata K, 2001, ANTIMICROB AGENTS CH, V45, P1693, DOI 10.1128/AAC.45.6.1693-1699.2001; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Hasegawa K, 2006, J ANTIMICROB CHEMOTH, V57, P1077, DOI 10.1093/jac/dk1142; Niki Y, 2011, J INFECT CHEMOTHER, V17, P510, DOI 10.1007/s10156-011-0214-5; Watanabe A, 2012, J INFECT CHEMOTHER, V18, P609, DOI 10.1007/s10156-012-0434-3; Hoshino T, 2013, J INFECT CHEMOTHER, V19, P495, DOI 10.1007/s10156-013-0591-z; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Clinical Laboratory Standards Institute, 2007, M100S17 CLIN LAB S S, pM100; Hasegawa K, 2004, ANTIMICROB AGENTS CH, V48, P1509, DOI 10.1128/AAC.48.5.1509-1514.2004; Heilmann KP, 2005, ANTIMICROB AGENTS CH, V49, P2561, DOI 10.1128/aac.49.6.2561-2564.2005; Hoshino Tadashi, 2013, Kansenshogaku Zasshi, V87, P581; Jansen WTM, 2006, J ANTIMICROB CHEMOTH, V58, P873, DOI 10.1093/jac/dkl310; Li XY, 2004, ANTIMICROB AGENTS CH, V48, P3570, DOI 10.1128/AAC.48.9.3570-3572.2004; Morikawa Y, 2004, ANTIMICROB AGENTS CH, V48, P1229, DOI 10.1128/AAC.48.4.1229-1234.2004; National Institute of Infectious Diseases, 2012, IASR INFECT AGENT SU, V33, P71; Sakata H, 2009, J INFECT CHEMOTHER, V15, P402, DOI 10.1007/s10156-009-0729-1; Sato Y, 2009, J INFECT CHEMOTHER, V15, P396, DOI 10.1007/s10156-009-0723-7; Sato Y, 2014, JPN J CHEMOTHER, V62, P118; Subcommittee of Clinical Practice Guideline for Diagnosis and Management of Acute Otitis Media in Children, 2012, AURIS NASUS LARYNX, V39, P1; Subcommittee of Clinical Practice Guideline for Diagnosis and Management of Respiratory Infectious Diseases in Children, 2011, GUID MAN RESP INF DI; Tajima T, 2013, J INFECT CHEMOTHER, V19, P510, DOI 10.1007/s10156-013-0593-x; Takakura Mariko, 2012, Jpn J Antibiot, V65, P305; Yamanaka N, 2001, JPN J CHEMOTHER, V49, P297	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					247	256		10.1016/j.jiac.2014.11.012		10	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900018		
J	Nakamura, Y; Murai, A; Mizunuma, M; Ohta, D; Kawano, Y; Matsumoto, N; Nishida, T; Ishikura, H				Nakamura, Yoshihiko; Murai, Akira; Mizunuma, Mariko; Ohta, Daiki; Kawano, Yasumasa; Matsumoto, Norihiko; Nishida, Takeshi; Ishikura, Hiroyasu			Potential use of procalcitonin as biomarker for bacterial sepsis in patients with or without acute kidney injury	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Procalcitonin; Acute kidney injury; Sepsis; Diagnosis	VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE-UNIT; ACUTE-RENAL-FAILURE; ANTIBIOTIC-THERAPY; SEPTIC SHOCK; INFECTION; GUIDELINES; MANAGEMENT; SIRS	Introduction: There are few investigations regarding the relationships between procalcitonin (PCT) and the acute kidney injury (AKI) in the diagnosis of sepsis. The purpose of this study was to clarify the diagnostic accuracy of the use of PCT levels in patients with or without AKI. Methods: This study was conducted as a single-center retrospective study. We enrolled 393 patients in whom PCT were measured on admission. We grouped the patients into non-AKI and AKI, and those with AKI were classified according to the RIFLE criteria (Risk, Injury, Failure). The patients in each group were further classified into the sepsis and the non-sepsis group. We subsequently investigated the diagnostic accuracy of the PCT for detecting sepsis in these groups. Results: The levels of PCT were significantly higher in the sepsis group than in the non-sepsis group among the non-AKI and each AKI patients (p<0.0001). The diagnostic accuracy of the POT for detecting sepsis was determined according to a ROC analysis; AUC value was 0.958 in the non-AKI group, in the Risk, Injury and Failure groups were 0.888 and 0.917, 0.857, respectively. AUC value for non-AKI group was significantly different from that of Failure group (p<0.05). Conclusions: In Failure AKI patients, the diagnostic accuracy of the PCT level is significantly lower than non-AKI patients. It is therefore suggested that we should be careful in using per value to diagnose sepsis in patients with Failure under RIFLE criteria. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Nakamura, Yoshihiko; Murai, Akira; Mizunuma, Mariko; Ohta, Daiki; Kawano, Yasumasa; Matsumoto, Norihiko; Nishida, Takeshi; Ishikura, Hiroyasu] Fukuoka Univ, Dept Emergency & Crit Care Med, Fac Med, Fukuoka 8140180, Japan	Nakamura, Y (reprint author), Fukuoka Univ, Dept Emergency & Crit Care Med, Fac Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	pdmxy827@yahoo.co.jp; akiramurai.fuk@gmail.com; numariko625@gmail.com; d-oota@fasd.or.jp; kawano0301@cis.fukuoka-u.ac.jp; noirnori107@yahoo.co.jp; bushinishitaxi007@gmail.com; ishikurah@fukuoka-u.ac.jp					Shirakawa K, 2011, CLIN CHEM LAB MED, V49, P937, DOI 10.1515/CCLM.2011.145; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Singh N, 2000, AM J RESP CRIT CARE, V162, P505; Herzum I, 2008, CURR MED CHEM, V15, P581, DOI 10.2174/092986708783769704; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.10; Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Amour J, 2008, CRIT CARE MED, V36, P1147, DOI 10.1097/CCM.0b013e3181692966; Ricci Z, 2006, NEPHROL DIAL TRANSPL, V21, P690, DOI 10.1093/ndt/gfi296; Christ-Crain M, 2005, SWISS MED WKLY, V135, P451; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bellomo R, 2004, CRIT CARE, V8, P11204; Cho Sung-Yeon, 2014, Infect Chemother, V46, P1, DOI 10.3947/ic.2014.46.1.1; Herget-Rosenthal S, 2001, NEPHROL DIAL TRANSPL, V16, P975, DOI 10.1093/ndt/16.5.975; Mehanic Snjezana, 2013, Mater Sociomed, V25, P277, DOI 10.5455/msm.2013.25.277-281; Meisner M, 2001, EUR J ANAESTH, V18, P79, DOI 10.1046/j.0265-0215.2000.00783.x; Monti G, 2007, CONTRIB NEPHROL, V156, P434; Opatrna S, 2005, PERITON DIALYSIS INT, V25, P470; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Steinbach G, 2004, WIEN KLIN WOCHENSCHR, V116, P849, DOI 10.1007/s00508-004-0279-6; Yu VL, 2004, INTENS CARE MED, V30, P735, DOI 10.1007/s00134-004-2201-0	26	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					257	263		10.1016/j.jiac.2014.12.001		7	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900019		
J	Mitsumoto, F; Murata, M; Ura, K; Takayama, K; Hiramine, S; Shimizu, M; Toyoda, K; Ogawa, E; Furusyo, N; Hayashi, J				Mitsumoto, Fujiko; Murata, Masayuki; Ura, Kazuya; Takayama, Koji; Hiramine, Satoshi; Shimizu, Motohiro; Toyoda, Kazuhiro; Ogawa, Eiichi; Furusyo, Norihiro; Hayashi, Jun			The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Hepatitis B virus; Human immunodeficiency virus; Immune reconstitution inflammatory syndrome; Hepatitis B surface antigen	TERM-FOLLOW-UP; HBEAG; HIV; LAMIVUDINE; INFECTION; COMBINATION; TENOFOVIR; DISEASE; LIVER; THAILAND	Background: Hepatic flares (HF), which reflect hepatitis B virus (HBV)-related immune reconstitution inflammatory syndrome (IRIS), frequently occur in patients with HBV and human immunodeficiency virus (HIV) coinfection after the start of antiretoroviral therapy (ART). The rate of hepatitis B envelope antigen (HBeAg) and hepatitis B surface antigen (HBsAg) loss is higher for patients with HF after the initiation of ART. Methods: We retrospectively examined the kinetics of the HBsAg and HBeAg levels of six HBV/HIV coinfected patients after the commencement of ART that included tenofovir. All were male and HBeAg positive. Results: Three patients developed HF after the initiation of ART. All subsequently lost HBeAg and one of them lost HBsAg after HF. None who did not experience HF lost HBeAg. The HBsAg and HBeAg levels remarkably decreased when HF occurred, but the decline of HBsAg was very slow in the periods before and after HF. The median decline of the HBsAg level at 48 weeks was 2.20 Log IU/mL for patients with HF, but only 1.00 Log ILI/nal for patients without HF. Little decline was seen for either group in the median decline of the HBsAg level from 48 weeks to 96 weeks, 0.28 Log IU/mL in the HF group and 0.06 Log IU/mL in the non-HF group. Conclusion: The immune reconstitution of a HBV/HIV coinfected patient plays an important role in the clearance of HBV. If HBsAg and HBeAg levels decrease rapidly when HF occurs, the hepatic flare would be due to HBV-related IRIS. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Mitsumoto, Fujiko; Murata, Masayuki; Ura, Kazuya; Takayama, Koji; Hiramine, Satoshi; Shimizu, Motohiro; Toyoda, Kazuhiro; Ogawa, Eiichi; Furusyo, Norihiro] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka 8128582, Japan; [Hayashi, Jun] Haradoi Hosp, Kyushu Gen Med Ctr, Fukuoka, Japan	Murata, M (reprint author), Kyushu Univ Hosp, Dept Gen Internal Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	mmurata@gim.med.kyushu-u.ac.jp					Piratvisuth T, 2008, HEPATOL INT, V2, P102, DOI 10.1007/s12072-007-9022-5; Thompson AJV, 2010, HEPATOLOGY, V51, P1933, DOI 10.1002/hep.23571; BODSWORTH NJ, 1991, J INFECT DIS, V163, P1138; BORTOLOTTI F, 1990, GASTROENTEROLOGY, V99, P805; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Zoutendijk R, 2012, J INFECT DIS, V206, P974, DOI 10.1093/infdis/jis439; Buster EHCJ, 2008, GASTROENTEROLOGY, V135, P459, DOI 10.1053/j.gastro.2008.05.031; Boni C, 1998, J CLIN INVEST, V102, P968, DOI 10.1172/JCI3731; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Chan HLY, 2007, CLIN GASTROENTEROL H, V5, P1462, DOI 10.1016/j.cgh.2007.09.005; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; Matthews GV, 2008, HEPATOLOGY, V48, P1062, DOI 10.1002/hep.22462; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Weber R, 2006, ARCH INTERN MED, V166, P1632; Lin SM, 2004, J VIRAL HEPATITIS, V11, P349, DOI 10.1111/j.1365-2893.2004.00512.x; Arendt E, 2012, VIRAL IMMUNOL, V25, P442, DOI 10.1089/vim.2012.0036; Avihingsanon A, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-6; de Vries-Sluijs TEMS, 2010, GASTROENTEROLOGY, V139, P1934, DOI 10.1053/j.gastro.2010.08.045; Drake A, 2004, CLIN INFECT DIS, V39, P129, DOI 10.1086/421386; Koike K, 2008, HEPATOL RES, V38, P310, DOI 10.1111/j.1872-034X.2007.00263.x; Marcellin P, 2014, J HEPATOL, V61, P1228, DOI 10.1016/j.jhep.2014.07.019; MELS GC, 1994, LIVER, V14, P175; Plaza Z, 2013, AIDS, V27, P2219, DOI 10.1097/QAD.0b013e328362fe42; Yanagimoto S, 2012, J INFECT CHEMOTHER, V18, P883, DOI 10.1007/s10156-012-0433-4; Yuen MF, 2003, GUT, V52, P416, DOI 10.1136/gut.52.3.416	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					264	271		10.1016/j.jiac.2014.12.003		8	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900020		
J	Kutsuna, S; Hayakawa, K; Kato, Y; Fujiya, Y; Mawatari, M; Takeshita, N; Kanagawa, S; Ohmagari, N				Kutsuna, Satoshi; Hayakawa, Kayoko; Kato, Yasuyuki; Fujiya, Yoshihiro; Mawatari, Momoko; Takeshita, Nozomi; Kanagawa, Shuzo; Ohmagari, Norio			Comparison of clinical characteristics and laboratory findings of malaria, dengue, and enteric fever in returning travelers: 8-year experience at a referral center in Tokyo, Japan	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Dengue fever; Malaria; Typhoid fever; Enteric fever; C-reactive protein	C-REACTIVE PROTEIN; GEOSENTINEL SURVEILLANCE; IMPORTED MALARIA; OUTBREAK; ILLNESS; MARKERS; AFRICA	Background: Without specific symptoms, diagnosis of febrile illness in returning travelers is challenging. Dengue, malaria, and enteric fever are common causes of fever in returning travelers and timely and appropriate treatment is important. However, differentiation is difficult without specific diagnostic tests. Methods: A retrospective study was conducted at the National Centre for Global Health and Medicine (NCGM) from April 2005 to March 2013. Febrile travelers returning from overseas who were diagnosed with dengue, malaria, or enteric fever were included in this study. Clinical characteristics and laboratory findings were compared for each diagnosis. Results: During the study period, 86 malaria, 85 dengue, and 31 enteric fever cases were identified. The mean age of the study cohort was 33.1 +/- 12 years and 134(66.3%) study participants were male. Asia was the most common area visited by returning travelers with fevers (89% of dengue, 18.6% of malaria, and 100% of enteric fever cases), followed by Africa (1.2% of dengue and 70.9% of malaria cases). Clinical characteristics and laboratory findings were significantly different among each group with each diagnosis. Decision tree models revealed that returning from Africa and CRP levels <10 mg/L were factors specific for diagnosis of malaria and dengue fever, respectively. Conclusion: Clinical manifestations, simple laboratory test results, and regions of travel are helpful to distinguish between dengue, malaria, and enteric fever in febrile returning travelers with non-specific symptoms. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Kutsuna, Satoshi; Hayakawa, Kayoko; Kato, Yasuyuki; Fujiya, Yoshihiro; Mawatari, Momoko; Takeshita, Nozomi; Kanagawa, Shuzo; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo 1628655, Japan	Kutsuna, S (reprint author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	sonare.since1192@gmail.com			Ministry of Health, Labour, and Welfare, Japan [H23-shinkou-ippan-006, H24-shinkou-ippan-013]	This work was partly supported by funding from the Research on Emerging and Re-emerging Infectious Diseases by the Ministry of Health, Labour, and Welfare, Japan (H23-shinkou-ippan-006 and H24-shinkou-ippan-013).	Oki M, 2013, EPIDEMIOL INFECT, V141, P2612, DOI 10.1017/S0950268813000447; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Taylor SM, 2010, JAMA-J AM MED ASSOC, V304, P2048, DOI 10.1001/jama.2010.1578; Potts JA, 2008, TROP MED INT HEALTH, V13, P1328, DOI 10.1111/j.1365-3156.2008.02151.x; Premaratna R, 2007, T ROY SOC TROP MED H, V101, P683, DOI 10.1016/j.trstmh.2007.02.006; Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; Imanishi M, 2014, AM J TROP MED HYG, V90, P945, DOI 10.4269/ajtmh.13-0497; Mizuno Y, 2012, TRAVEL MED INFECT DI, V10, P86, DOI 10.1016/j.tmaid.2012.02.005; Kutsuna S, 2014, AM J TROP MED HYG, V90, P444, DOI 10.4269/ajtmh.13-0536; Choo KE, 2001, J TROP PEDIATRICS, V47, P211, DOI 10.1093/tropej/47.4.211; Hellgren U, 2013, TRAVEL MED, V3rd, P173; HURT N, 1994, T ROY SOC TROP MED H, V88, P182, DOI 10.1016/0035-9203(94)90287-9; Infectious Disease Surveillance Center, TYPH FEV 2010; Infectious Disease Surveillance Center, ANN SURV DAT PAG 1 N; Keystone J, CDC HLTH INFORM INT, P547; Kozarsky PE, TRAVEL MED, V3rd, P1; Kruger S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-65; Kutsuna S, 2015, EMERG INFECT DIS; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Mendelson M, 2014, EMERG INFECT DIS, V20, P532, DOI 10.3201/eid2004.131128; Paul Rudrajit, 2012, Adv Biomed Res, V1, P41, DOI 10.4103/2277-9175.100140; Takasaki Tomohiko, 2011, Trop Med Health, V39, P13, DOI 10.2149/tmh.2011-S07	23	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					272	276		10.1016/j.jiac.2014.12.004		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900021		
J	Baba, H; Sato, Y; Toyonaga, Y; Hanaki, H; Sunakawa, K				Baba, Hiroaki; Sato, Yoshitake; Toyonaga, Yoshikiyo; Hanaki, Hideaki; Sunakawa, Keisuke			Nationwide survey of the development of drug resistance in the pediatric field in 2007, 2010, and 2012: Drug sensitivity of Haemophilus influenzae serotype b strain in Japan	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Child; Infectious disease; Surveillance; Haemophilus influenzae serotype b; Drug-resistance	STREPTOCOCCUS-PNEUMONIAE; 2ND REPORT; CHILDREN; DISEASES	Based on the results of surveillance in the pediatric field conducted in 2007, 2010, and 2012, we examined the frequency of Haemophilus influenzae serotype b (Hib) strains, the susceptibility for Hib strains to various types of antimicrobial agent, and the relations to patients' background factors. Among all of Haemophilus influenzae, the frequency of Hib strains was 3.6% (14/386 strains) in 2007, 4.8% (23/484 strains) in 2010, 1.2% (5/411 strains) in 2012, and decreasing in 2012. Hib strains were isolated in patients with the following infections: nine patients with respiratory tract infections (upper respiratory tract infection, bronchitis, and pneumonia), three patients with sepsis, one patient with meningitis, and one patient with purulent inflammation of a tendon sheath in 2007; 11 patients with respiratory tract infections (upper respiratory tract infection, bronchitis, and pneumonia), four patients with sepsis, and eight patients with meningitis in 2010, demonstrating a relatively high frequency in patients with invasive infections. However, in 2012, Hib strains were isolated in only four patients with respiratory tract infections (upper respiratory tract infection) and one patient with bronchial asthma. Evaluation of background factors with pediatric patients in whom Hib strains were isolated showed that approximately 70% were male; majority was children under three years of age; and higher detection rates were also related to the background of patients who were attendant to daycare center, had siblings, had received no antimicrobial agents within the previous one month before collecting specimens. Throughout the surveillance between 2007 and 2012, antimicrobial agents with all phases' MICs <= 1 mu g/mL were cefditoren, cefcapene, and cefteram in the oral beta-lactams; tazobactam/piperacillin, ceftriaxone, cefotaxime, and meropenem in the injectable beta-lactams; azithromycin in the macrolide; and levofloxacin in the quinolone. After 2010, MIC ranges were evaluated for tebipenem in the oral B-lactam (<= 0.063-0.25 mu g/mL), doripenem in the injectable beta-lactam (<= 0.063-0.5 mu g/mL), and tosufloxacin in the quinolone (<= 0.063 mu g/mL). Throughout the surveillance, Hib strains were highly susceptible to the above mentioned antimicrobial agents, and there was no significant change in the susceptibility. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Baba, Hiroaki; Sato, Yoshitake] Ota Mem Hosp, Fuji Heavy Ind Hlth Insurance Soc, Ota, Gunma, Japan; [Toyonaga, Yoshikiyo] Saitama Sekishinkai Hosp, Sayama, Saitama, Japan; [Hanaki, Hideaki] Kitasato Univ, Kitasato Inst, Res Ctr Antiinfect Drugs, Tokyo, Japan; [Sunakawa, Keisuke] Kitasato Univ, Kitasato Inst, Res Org Infect Control Sci, Tokyo, Japan	Baba, H (reprint author), Ota Mem Hosp, Fuji Heavy Ind Hlth Insurance Soc, 455-1 Oshima Cho, Ota, Gunma, Japan.	h.baba@ota-hosp.or.jp			Chugai Pharmaceutical Co., Ltd; Daiichi Sankyo Co., Ltd; Dainippon Sumitomo Pharma Co., Ltd; Meiji Seika Pharma Co., Ltd; Shionogi Co., Ltd; Toyama chemical Co., Ltd	Yoshitake Sato, Yoshikiyo Toyonaga, Hideaki Hanaki and Keisuke Sunakawa have received research funds from Chugai Pharmaceutical Co., Ltd, Daiichi Sankyo Co., Ltd, Dainippon Sumitomo Pharma Co., Ltd, Meiji Seika Pharma Co., Ltd, Shionogi & Co., Ltd, and Toyama chemical Co., Ltd. Other author reports no conflict of interest.	Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Rahman M, 2008, J INFECTION, V56, P191, DOI 10.1016/j.jinf.2007.12.008; FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382; Hoshino T, 2013, J INFECT CHEMOTHER, V19, P495, DOI 10.1007/s10156-013-0591-z; Centers for Disease Control and Prevention, 1996, MMWR-MORBID MORTAL W, V45, P901; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Clinical and Laboratory Standards Institute, 2007, M100S17 CLIN LAB STA; Hoshino Tadashi, 2013, Kansenshogaku Zasshi, V87, P581; Li XY, 2004, ANTIMICROB AGENTS CH, V48, P3570, DOI 10.1128/AAC.48.9.3570-3572.2004; National Institute of Infectious Diseases, 2012, IASR INFECT AGENT SU, V33, P71; Niki Y, 2011, INFECT CHEMOTHER, V17, P510; Okabe N, 2013, COLLECTION QUESTIONS; Sakata H, 2009, J INFECT CHEMOTHER, V15, P402, DOI 10.1007/s10156-009-0729-1; Sato Y, 2014, JPN J CHEMOTHER, V62, P118; Subcommittee of Clinical Practice Guideline for Diagnosis and Management of Acute Otitis Media in Children, 2012, AURIS NASUS LARYNX, V39, P1; Subcommittee of Clinical Practice Guideline for Diagnosis and Management of Respiratory Infectious Diseases in Children, 2011, GUID MAN RESP INF DI; Sunakawa Keisuke, 2008, Kansenshogaku Zasshi, V82, P187; Sunakawa Keisuke, 2011, Kansenshogaku Zasshi, V85, P227; Tajima T, 2013, J INFECT CHEMOTHER, V19, P510, DOI 10.1007/s10156-013-0593-x; Takakura Mariko, 2012, Jpn J Antibiot, V65, P305; Tarasi A, 1998, MICROB DRUG RESIST, V4, P301, DOI 10.1089/mdr.1998.4.301; Togashi T, 2009, CURR INFORM MATERNAL, V59, P91	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					277	283		10.1016/j.jiac.2014.12.006		7	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900022		
J	Yokoyama, Y; Matsumoto, K; Ikawa, K; Watanabe, E; Morikawa, N; Takeda, Y				Yokoyama, Yuta; Matsumoto, Kazuaki; Ikawa, Kazuro; Watanabe, Erika; Morikawa, Norifumi; Takeda, Yasuo			Population pharmacokinetic-pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: Dosing considerations for Acinetobacter baumannii infections	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Sulbactam; Actnetobacter baumannii; Population pharmacokinetics; Monte Carlo simulation; Dosing regimen	AMPICILLIN; RESISTANCE; REGIMENS; SURGERY	This study aimed to perform a pharmacokinetic (PK)-pharmacodynamic (PD) target attainment analysis of sulbactam against Acinetobacter baumannii in patients with impaired renal function. The PI( data (188 plasma samples and 27 urine samples) were modeled simultaneously. The mean population parameters were CLr (I/h) = 0.0792 x CLcr (ni/min), CLnr (I/h) = 2.35, V-c (1) = 12.2, Q (1/h) = 4.68 and V-P (1) = 4.44, where CLr and CLpr are the renal and non-renal clearances, Vc and Vp are the distribution volumes of the central and peripheral compartments and Q is intercompartmental clearance. The creatinine clearance (CLcr) was the most significant covariate. The determined MIC of sulbactam against A. baumannii clinical isolates (n = 27) was 0.75-6.0 mu g/ml with MIC50 and MIC90 of 1 and 4 ng/ml, respectively. For sulbactam regimens, a Monte Carlo simulation estimated the probabilities of attaining the bactericidal target (60% of the time above the MIC) and determined the PR PD breakpoints (the highest MICs at which the probabilities were 90% or more). In a patient with a CIcr of 15 ml/min, a regimen of 1 g twice daily achieved a 90% or more probability against the A. baumannii isolate population; however, 2 g four times daily was needed for a 90% or more probability in a patient with a CLcr of 90 ml/min. The results of the PR -PD target attainment analysis are useful when choosing the sulbactam regimen based on the CLcr of the patient and the susceptibility of A. baumannii. Registration number: UMIN000007356. (C), 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Yokoyama, Yuta; Matsumoto, Kazuaki; Watanabe, Erika; Takeda, Yasuo] Kagoshima Univ, Dept Clin Pharm & Pharmacol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Yokoyama, Yuta; Ikawa, Kazuro; Morikawa, Norifumi] Hiroshima Univ, Dept Clin Pharmacotherapy, Hiroshima 730, Japan	Takeda, Y (reprint author), 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	takeda@m.kufm.kagoshima-u.ac.jp					Martin C, 1998, ANTIMICROB AGENTS CH, V42, P1093; Oliveira MS, 2008, J ANTIMICROB CHEMOTH, V61, P1369, DOI 10.1093/jac/dkn128; Corbella X, 1998, J ANTIMICROB CHEMOTH, V42, P793, DOI 10.1093/jac/42.6.793; Fishbain J, 2010, CLIN INFECT DIS, V51, P79, DOI 10.1086/653120; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Trotman RL, 2005, CLIN INFECT DIS, V41, P1159, DOI 10.1086/444500; Yokoyama Y, 2012, J INFECT CHEMOTHER, V18, P878, DOI 10.1007/s10156-012-0431-6; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Cho N, 1988, JPN J CHEMOTHER, V36, P466; de la Pena A, 1999, INT J CLIN PHARM TH, V37, P63; Drusano GL, 2003, CLIN INFECT DIS, V36, pS42, DOI 10.1086/344653; Ikawa K, 2009, INT J ANTIMICROB AG, V33, P276, DOI 10.1016/j.ijantimicag.2008.08.031; Jaruratanasirikul S, 2013, ANTIMICROB AGENTS CH, V57, P3441, DOI 10.1128/AAC.00342-13; Kano H, 1988, JPN J CHEMOTHER, V32, P131; Ohta N, 1988, JPN J CHEMOTHER, V36, P382; Sekine O, 1988, JPN J CHEMOTHER, V36, P130; Shimooka K, 1988, JPN J CHEMOTHER, V36, P81; Sieniawski Karol, 2013, Pol Przegl Chir, V85, P483, DOI 10.2478/pjs-2013-0075; Soto E, 2014, BRIT J CLIN PHARMACO, V77, P509, DOI 10.1111/bcp.12232; Wayne PA, 2009, M7A8 CLIN LAB STAND; Yokoyama Y, 2014, INT J ANTIMICROB AG, V43, P547, DOI 10.1016/j.ijantimicag.2014.02.012; Yura J, 1988, JPN J CHEMOTHER, V36, P324	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					284	289		10.1016/j.jiac.2014.12.005		6	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900023		
J	Izawa, S; Yamaoka, M; Deguchi, T				Izawa, Shigeru; Yamaoka, Makiko; Deguchi, Takashi			Effect of urinary excretion on the bladder tissue distribution of fluoroquinolones in rats	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Bladder distribution; Urinary tract infection; Quinolones; Permeability	SIGNIFICANT ABSORPTION; TRACT-INFECTIONS; LEVOFLOXACIN; PLASMA	The purpose of this study was to evaluate which of blood or urine has the greater effect on bladder tissue concentrations of fluoroquinolones important for the treatment of urinary tract infections by measuring concentrations of fluoroquinolones in the vesical tissue (chemically and immunohistochemically) and intravesical space (chemically). Thirty-minute incubation of isolated rat bladders with fluoroquinolones showed only a 1.9-fold difference in transferability among norfloxacin, levofloxacin, ciprofloxacin and sparfloxacin. Intravesical instillation of norfloxacin and sparfloxacin in rats yielded similar vesical tissue distributions. Thus, there were no large differences in vesical tissue transfer among the four fluoroquinolones. The bladder tissue/plasma concentration ratios of norfloxacin (high urinary excretion-type) and sparfloxacin (low urinary excretion-type) at 1 h after a single oral dose (10 mg/kg) to rats were 15.4 and 1.3, respectively. The bladder tissue/plasma concentration ratios of norfloxacin after an intravenous injection (10 mg/kg) to ureter-catheterized and sham-operated rats were 1.36 and 57.8. Thus the bladder tissue distribution was significantly higher in the urine-exposed bladder. Immunohistochemical examination of the vesical tissue localization of norfloxacin in rats given a single intravenous dose revealed the presence of the drug-positive image in the cytoplasm of surface layer cells (both in umbrella and cover cells) of the bladder transitional epithelium. In conclusion, the results suggest that norfloxacin and other fluoroquinolones are excreted into urine and then transferred to the surface layer of the bladder transitional epithelium. Therefore, the urine levels have a greater effect on the vesicle tissue distribution of fluoroquinolones than the plasma levels in rats. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Izawa, Shigeru; Deguchi, Takashi] Gifu Univ, Grad Sch Med, Dept Urol, Gifu 5011193, Japan; [Izawa, Shigeru; Yamaoka, Makiko] Kyorin Pharmaceut Co Ltd, Dev Res Labs, Nogi, Tochigi 3290114, Japan	Izawa, S (reprint author), Kyorin Pharmaceut Co Ltd, Dev Res Labs, Nogi, Tochigi 3290114, Japan.	shigeru.izawa@mb.kyorin-pharm.co.jp					Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Drusano GL, 2004, J INFECT DIS, V189, P1590, DOI 10.1086/383320; Craig WA, 2001, CLIN INFECT DIS, V33, pS233, DOI 10.1086/321854; Wagenlehner FME, 2006, INT J ANTIMICROB AG, V27, P7, DOI 10.1016/j.ijantimicag.2005.09.014; AU JLS, 1991, J PHARMACOL EXP THER, V258, P357; Chuang YC, 2008, INT UROGYNECOL J, V19, P1353, DOI 10.1007/s00192-008-0650-7; COLBURN WA, 1978, J PHARM SCI, V67, P1493, DOI 10.1002/jps.2600671054; DALTON JT, 1989, J CHROMATOGR-BIOMED, V495, P330, DOI 10.1016/S0378-4347(00)82641-9; DALTON JT, 1992, J PHARMACOL EXP THER, V260, P608; Deguchi T, 2010, INT J ANTIMICROB AG, V35, P573, DOI 10.1016/j.ijantimicag.2010.02.004; Dong ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076952; Fujiwara K, 2011, YAKUGAKU ZASSHI, V131, P949; Li QH, 2002, BIOL PHARM BULL, V25, P1084, DOI 10.1248/bpb.25.1084; Matsumoto Y, 2010, UROLOGY, V75, P862, DOI 10.1016/j.urology.2009.12.013; Nagatsu Y, 1981, CHEMOTHERAPY, V29, P105; Nogawa H, 2013, EUR J PHARMACOL, V720, P29, DOI 10.1016/j.ejphar.2013.10.056; Ohara K, 2007, HISTOCHEM CELL BIOL, V127, P603, DOI 10.1007/s00418-006-0267-1; PARSONS CL, 1990, J UROLOGY, V143, P139; Rybak MJ, 2006, AM J INFECT CONTROL, V34, pS38, DOI 10.1016/j.ajic.2006.05.227; STAMEY TA, 1974, NEW ENGL J MED, V291, P1159, DOI 10.1056/NEJM197411282912204; Tringali G, 2008, PHARMACOL RES, V58, P340, DOI 10.1016/j.phrs.2008.09.008; Wagenlehner FME, 2006, ANTIMICROB AGENTS CH, V50, P3947, DOI 10.1128/AAC.00477-06; Zellenitsky SA, 2003, INT J ANTIMICROB AG, V52, P668	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					290	295		10.1016/j.jiac.2014.12.010		6	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900024		
J	Uemura, Y; Kashiwagi, T; Hara, K; Nakazono, Y; Hamada, N; Watanabe, H				Uemura, Yusaku; Kashiwagi, Takahito; Hara, Koyu; Nakazono, Yoko; Hamada, Nobuyuki; Watanabe, Hiroshi			The N-terminal fragment of PA subunit of the influenza A virus effectively inhibits ribonucleoprotein (RNP) activity via suppression of its RNP expression	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Influenza A virus; RNA polymerase; Ribonucleoprotein; PA subunit; Inhibitor	ENDONUCLEASE ACTIVITY; POLYMERASE SUBUNITS; PROMOTER-BINDING; PROTEIN; REPLICATION; REGION; DOMAIN; MODEL; SITE; PB2	The influenza RNP, which is formed from PB1, PB2, PA, NP subunits, and vRNA, is autonomously replicated and transcribed in the infected cell. The simplest method to inhibit RNP activity is to impair the formation of the RNR Thereupon we confirmed whether the peptides/fragments mimicking one of RNP components can interfere with their formation. During the process of this inhibitory study we found interesting suppression of protein expression of the RNP components by the N-terminal fragment of PA subunit. Especially, we found two residues (D108 and 1(134) on the fragment that were critical for the suppression. Furthermore, we determined the combination of three amino acids (P28, M86 and E100) on the fragment that are important for the strong suppression, and identified the minimum essential region (residues from 1 to 188) of the PA subunit that allowed its suppression. Our findings indicate that the N-terminal fragment of PA subunit may become one of candidates for an effective inhibitor of influenza RNP activity. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Uemura, Yusaku; Kashiwagi, Takahito; Hara, Koyu; Nakazono, Yoko; Hamada, Nobuyuki; Watanabe, Hiroshi] Kurume Univ, Dept Infect Control & Prevent, Sch Med, Kurume, Fukuoka 8300011, Japan	Kashiwagi, T (reprint author), Kurume Univ, Dept Infect Control & Prevent, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	takahito@med.kurume-u.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [24591590]; Ishibashi Foundation for the Promotion of Science	This study was supported by grants from the Promotion of Science and the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (C), 24591590, 2012-2014, and the Ishibashi Foundation for the Promotion of Science.	Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Desmet EA, 2013, J VIROL, V87, P3108, DOI 10.1128/JVI.02826-12; Tefsen B, 2014, J VIROL, V88, P1935, DOI 10.1128/JVI.03270-13; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; SANZEZQUERRO JJ, 1995, J VIROL, V69, P2420; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Fodor E, 2002, PERSP MED V, V7, P1; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2013, J GEN VIROL, V94, P2406, DOI 10.1099/vir.0.053959-0; Kashiwagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005473; Kashiwagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015140; Nakazono Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032634; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647; SanzEzquerro JJ, 1996, J VIROL, V70, P1905	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					296	301		10.1016/j.jiac.2014.12.007		6	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900025		
J	Oba, U; Koga, Y; Hoshina, T; Suminoe, A; Abe, K; Hayashida, M; Taguchi, T; Hara, T				Oba, Utako; Koga, Yuhki; Hoshina, Takayuki; Suminoe, Aiko; Abe, Kenji; Hayashida, Makoto; Taguchi, Tomoaki; Hara, Toshiro			An adolescent female having hepatocellular carcinoma associated with hepatitis B virus genotype H with a deletion mutation in the pre-S2 region	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Hepatitis virus B (HBV); Genotype H of HBV; Hepatocellular carcinoma; Pre-S2 region of HBV; Deletion mutant of HBV	INFECTION; PROGNOSIS; CHILDREN; MUTANTS; PATIENT; DISEASE	The genotypes of hepatitis B virus (HBV) have a distinct geographical distribution, with HBV genotype H being very rare in East Asia, including Japan. We herein report the case of a 12-year-old Japanese female with hepatocellular carcinoma (HCC) who exhibited HBV genotype H. Notably, the HBV isolated from the patient had a deletion mutation in the pre-S2 region. The genome of HBV genotype H in the patient with HCC has not been analyzed in detail. The deletion mutations in the pre-S2 region, which may play an important role in hepatocarcinogenesis in children, can also present in genotype H. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Oba, Utako; Koga, Yuhki; Hoshina, Takayuki; Suminoe, Aiko; Hara, Toshiro] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan; [Hayashida, Makoto; Taguchi, Tomoaki] Kyushu Univ, Grad Sch Med Sci, Dept Pediat Surg, Fukuoka 8128582, Japan; [Hoshina, Takayuki] Univ Occupat & Environm Hlth, Sch Med, Dept Pediat, Kitakyushu, Fukuoka 807, Japan; [Abe, Kenji] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan	Hoshina, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hoshina@pediatr.med.kyushu-u.ac.jp					Abe K, 2010, MOL DETECTION HUMAN, P847; NI YH, 1991, CANCER, V68, P1737, DOI 10.1002/1097-0142(19911015)68:8<1737::AID-CNCR2820680815>3.0.CO;2-G; Bortolotti F, 2006, HEPATOLOGY, V43, P556, DOI 10.1002/hep.21077; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059; Su IJ, 2008, J GASTROEN HEPATOL, V23, P1169, DOI 10.1111/j.1440-1746.2008.05348.x; Chen YC, 2010, HEPATOLOGY, V51, P435, DOI 10.1002/hep.23348; Zhang Q, 2011, HEPAT MON, V11, P86; Abe K, 2009, CANCER SCI, V100, P2249, DOI 10.1111/j.1349-7006.2009.01309.x; Chihara N, 2007, INTERNAL MED, V46, P1847, DOI 10.2169/internalmedicine.46.0163; Huy TTT, 2003, J CLIN MICROBIOL, V41, P5449, DOI 10.1128/JCM.41.12.5449-5455.2003; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kumagai I, 2007, J GASTROENTEROL, V42, P168, DOI 10.1007/s00535-006-1963-2; Nakajima A, 2005, JPN J INFECT DIS, V58, P244; Ohnuma H, 2005, J GEN VIROL, V86, P595, DOI 10.1099/vir.0.80732-0; Roman S, 2013, J CANC THER, V2A, P367, DOI [10.4236/jct.2013.42A044, DOI 10.4236/JCT.2013.42A044, DOI 10.4236/JCT.2013.42A044]]; Shibayama T, 2005, J MED VIROL, V76, P24, DOI 10.1002/jmv.20319	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					302	304		10.1016/j.jiac.2014.10.015		3	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900026		
J	Iwata, S; Sato, Y; Toyonaga, Y; Hanaki, H; Sunakawa, K				Iwata, Satoshi; Sato, Yoshitake; Toyonaga, Yoshikiyo; Hanaki, Hideaki; Sunakawa, Keisuke			Genetic analysis of a pediatric clinical isolate of Moraxella catarrhalis with resistance to macrolides and quinolones	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Moraxella catarrhalis; Pediatric infectious disease; Drug resistance; Susceptibility; Macrolides; Quinolones	FIELD DRUG-SENSITIVITY; JAPAN 2ND REPORT; NATIONWIDE SURVEY; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; MOLECULAR ANALYSIS; PATHOGENS; MECHANISM	During the surveillance conducted in 2012 by the Drug-resistant Pathogen Surveillance Group in Pediatric Infectious Disease, we isolated a strain of Moraxella catarrhalis that demonstrated resistance to both macrolides and quinolones from a male pediatric patient aged 1.5 years who had developed acute bronchitis. Then we evaluated the susceptibility of this strain to different types of antibacterial agents and conducted a genetic analysis. The results of the susceptibility evaluation showed that the MIC values of azithromycin, clarithromycin, and roldtamycin were >64 mu g/mL, >64 mu g/mL, and 4 mu g/mL, respectively; clearly demonstrating resistance to macrolides. The MIC values of the quinolones levofloxacin, tosufloxacin, and garenoxacin were 4 mu g/mL, 2 mu g/mL, and 1 mu g/mL, respectively; indicating decreased susceptibility. The genetic analysis of this strain revealed one mutation in 23s rRNA with a replacement of adenine by thymine at nucleotide position 2330 (A2330T) and another mutation in gyrB at nucleotide position 1481 by replacement of adenine with guanine (A1481G) that caused a substitution of the 494th asparagine acid by glycine, as being associated with the observed resistance to macrolides and quinolones, respectively. Similar to drug-resistant bacteria Streptococcus pneumoniae and Haemophilus influenzae, the prevalence of which has recently increased, the treatment of drug-resistant M. catarrhalis infections is considered difficult due to the development of resistance to different types of antibacterial agents. It is vital to maintain an unwavering focus on the trend toward an increasing number of drug-resistant M. catarrhalis strains and ensure the proper use of each antibacterial agent. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Iwata, Satoshi] Keio Univ, Dept Infect Dis, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Sato, Yoshitake] Fuji Heavy Ind Hlth Insurance Soc Ota Mem Hosp, Dept Pediat, Ota, Japan; [Toyonaga, Yoshikiyo] Saitama Sekishinkai Hosp, Dept Pediat, Sayama, Osaka, Japan; [Hanaki, Hideaki] Kitasato Univ, Kitasato Inst, Res Ctr Antiinfect Drugs, Minato Ku, Tokyo, Japan; [Sunakawa, Keisuke] Kitasato Univ, Kitasato Inst, Res Org Infect Control Sci, Minato Ku, Tokyo, Japan	Iwata, S (reprint author), Keio Univ, Dept Infect Dis, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	siwata@a8.keio.jp			Chugai Pharmaceutical Co., Ltd; Daiichi Sankyo Co., Ltd; Meiji Seika Pharma Co., Ltd; Shionogi Co., Ltd; Sumitomo Dainippon Pharma Co., Ltd; Toyama Chemical Co., Ltd	Satoshi lwata, Yoshitake Sato, Yoshikiyo Toyonaga, Hideaki Hanaki, and Keisuke Sunakawa have received research funds from Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Meiji Seika Pharma Co., Ltd., Shionogi & Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., and Toyama Chemical Co., Ltd.	Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Verduin CM, 2002, CLIN MICROBIOL REV, V15, P125, DOI 10.1128/CMR.15.1.125-144.2002; Saito R, 2012, J MED MICROBIOL, V61, P1435, DOI 10.1099/jmm.0.046706-0; Matsuoka M, 2004, ANTIMICROB AGENTS CH, V48, P4624, DOI 10.1128/AAC.48.12.4624-4630.2004; Aoike N, 2013, J CLIN MICROBIOL, V51, P1692, DOI 10.1128/JCM.03049-12; Liu YL, 2012, MICROB DRUG RESIST, V18, P417, DOI 10.1089/mdr.2011.0175; Fabrega A, 2009, MICROB BIOTECHNOL, V2, P40, DOI 10.1111/j.1751-7915.2008.00063.x; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; Hoshino T, 2013, J INFECT CHEMOTHER, V19, P495, DOI 10.1007/s10156-013-0591-z; Endo Y, 1998, Tanpakushitsu Kakusan Koso, V43, P2199; Matsuoka M, 1999, J CLIN EXP MED, V191, P1041; Nakane K, 2002, JPN J MED TECHNOL, V51, P1391; Nakane K, 2008, JPN J MED TECHNOL, V57, P915; Sakata H, 2009, J INFECT CHEMOTHER, V15, P402, DOI 10.1007/s10156-009-0729-1; Sato Y, 2009, J INFECT CHEMOTHER, V15, P396, DOI 10.1007/s10156-009-0723-7; Sato Y, 2014, JPN J CHEMOTHER, V62, P118; Shinzato T, 2008, JPN J CHEMOTHER, V56, P409; Tajima T, 2013, J INFECT CHEMOTHER, V19, P510, DOI 10.1007/s10156-013-0593-x; The committee of the guidelines for the management of respiratory infectious diseases in children, 2011, GUID MAN RESP INF DI; Ubukata K, 2008, J JPN SOC CLIN MICRO, V18, P75; Ubukata Kimiko, 2003, Journal of Infection and Chemotherapy, V9, P285, DOI 10.1007/s10156-003-0278-y; Yamada K, 2013, J JPN SOC CLIN MICRO, V23, P95; Yamada K, 2014, 25 ANN M JAP SOC CLI	23	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					308	311		10.1016/j.jiac.2014.11.002		4	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900028		
J	Fujimura, N; Obara, H; Suda, K; Takeuchi, H; Matsuda, S; Kurosawa, T; Katono, Y; Murata, M; Kishi, K; Kitagawa, Y				Fujimura, Naoki; Obara, Hideaki; Suda, Koichi; Takeuchi, Hiroya; Matsuda, Sachiko; Kurosawa, Tomoko; Katono, Yasuhiro; Murata, Mitsuru; Kishi, Kazuo; Kitagawa, Yuko			A novel rat model of incisional surgical site infection model developed using absorbable multifilament thread inoculated with Escherichia coli	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Incisional surgical site infection; Wound infection model; Aquacel Ag	WOUNDS; SYSTEM; PIGS	The development of an effective rat model of incisional surgical site infection (SSI) has so far proven difficult. In this study, we created a novel incisional SSI model and validated it in terms of both macroscopic and microscopic aspects including its response to treatment using antimicrobial wound-dressing, Aquacel Ag (R). Wounds were created on the dorsum of rats. 3-0 Vicryl (R) threads inoculated with Escherichia coil were inserted in the wound beds in the infection group (n = 6). The wounds were closed for two days to induce infection and then opened and covered with polypropylene sheets during the study. Aquacel Ag was placed under the polypropylene sheet in the infected wounds of the Aquacel Ag group rats (n = 6). The wounds in the control group (n = 6) contained sterile Vicryl thread that had not been inoculated with E. coil. The macroscopic appearance, wound area, bacterial counts, and histology of each group were evaluated. The infection group demonstrated significantly lower wound healing (p < 0.001), greater bacterial counts (median [interquartile range] ratings, 2.15 x 10(7) [0.51 x 10(7) -53.40 x 10(7)] vs 2.07 x 10(4) [0.60 x 10(4)-4.45 x 10(4)] CFU/g, respectively; p < 0.01), and severer histological inflammation (p < 0.001) than the control group. The Aquacel Ag group was only able to show significantly better wound healing than the infection group (p < 0.001). The new incisional SSI model exhibited all clinical manifestations of incisional SSI. It could be utilized to assess the effectiveness of newly developed treatments for incisional SSI. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Fujimura, Naoki; Obara, Hideaki; Suda, Koichi; Takeuchi, Hiroya; Matsuda, Sachiko; Kurosawa, Tomoko; Kitagawa, Yuko] Keio Univ, Dept Surg, Sch Med, Tokyo 1608582, Japan; [Katono, Yasuhiro; Murata, Mitsuru] Keio Univ, Lab Med, Sch Med, Tokyo 1608582, Japan; [Kishi, Kazuo] Keio Univ, Plast & Reconstruct Surg, Sch Med, Tokyo 1608582, Japan	Obara, H (reprint author), Keio Univ, Dept Surg, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	obara@z3.keio.jp					Agalar C, 2006, ANZ J SURG, V76, P387, DOI 10.1111/j.1445-2197.2006.03728.x; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Donay JL, 2007, J CLIN MICROBIOL, V45, P4088, DOI 10.1128/JCM.01847-07; Barnea Y, 2010, THER CLIN RISK MANAG, V6, P21; Asada M, 2012, WOUND REPAIR REGEN, V20, P601, DOI 10.1111/j.1524-475X.2012.00800.x; Badia JM, 1996, J SURG RES, V63, P457, DOI 10.1006/jsre.1996.0292; BUNCE C, 1992, INFECT IMMUN, V60, P2636; KAISER AB, 1992, J INFECT DIS, V166, P393; Mehta PH, 1996, ANN EMERG MED, V27, P43, DOI 10.1016/S0196-0644(96)70295-0; Ming DY, 2012, INFECT CONT HOSP EP, V33, P276, DOI 10.1086/664053; RAJU DR, 1977, SURG GYNECOL OBSTET, V144, P347; Rumbaugh KP, 2004, J SURG RES, V116, P137, DOI 10.1016/j.jss.2003.08.009; Steinstraesser L, 2006, COMPARATIVE MED, V56, P279; Tachi Masahiro, 2004, Int Wound J, V1, P49, DOI 10.1111/j.1742-481x.2004.00006.x	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	MAR-APR	2015	21	3-4					312	315		10.1016/j.jiac.2014.10.012		4	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CH6ME	WOS:000354149900029		
J	Tanaka, T; Osuka, A				Tanaka, Takayuki; Osuka, Atsuhiro			Synthesis and Characterization of Novel Fused Porphyrinoids	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Review						porphyrin; expanded porphyrin; fusion reaction; absorption spectrum; X-ray diffraction analysis; cyclic voltammetry	ABSORPTION CROSS-SECTION; NEAR-IR ABSORPTION; MESO-MESO; 2-PHOTON ABSORPTION; EXPANDED PORPHYRINS; CONJUGATED PORPHYRIN; ARRAYS; TAPES; DIMER; TETRAPHENYLPORPHYRINS	meso-meso, beta-beta, beta-beta Triply linked porphyrin arrays (porphyrin tapes) have been extensively studied in the last decade owing to their remarkable physical properties such as extremely red-shifted absorption bands reaching up to IR region and large two-photon absorption cross-sections. Recently, hybrid porphyrin tapes have emerged as novel promising molecular motifs by realizing ample chemical stabilities and good solubilities in common organic solvents. Synthesis of porphyrin-hexaphyrin hybrid tape has been also achieved and the unique property has been revealed. In other cases, various aromatic segments have been fused onto the porphyrin or hexaphyrin periphery to create fused porphyrinoids. These novel fused porphyrinoids are promising molecules as near-infrared (NIR)-absorbing dyes, pointing to future applications such as conducting wire, NIR emitter, photovoltaics, and nonlinear optical materials.	[Tanaka, Takayuki; Osuka, Atsuhiro] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan	Tanaka, T (reprint author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	taka@kuchem.kyoto-u.ac.jp; osuka@kuchem.kyoto-u.ac.jp					Anderson A, 2002, COMMENTARY, V113, P6; Susumu K, 1996, TETRAHEDRON LETT, V37, P8399, DOI 10.1016/0040-4039(96)01920-X; Nakamura Y, 2006, J AM CHEM SOC, V128, P4119, DOI 10.1021/ja057812l; Tanaka T, 2015, CHEM SOC REV, V44, P943, DOI 10.1039/c3cs60443h; LINDSEY JS, 1987, J ORG CHEM, V52, P827, DOI 10.1021/jo00381a022; Yamane O, 2004, CHEM LETT, V33, P40, DOI 10.1246/cl.2004.40; Tsuda A, 2001, J AM CHEM SOC, V123, P10304, DOI 10.1021/ja0110933; Cammidge AN, 2005, ORG LETT, V7, P3413, DOI 10.1021/ol050962g; Osuka A, 1997, ANGEW CHEM INT EDIT, V36, P135, DOI 10.1002/anie.199701351; Aratani N, 2000, ANGEW CHEM INT EDIT, V39, P1458, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1458::AID-ANIE1458>3.0.CO;2-E; Tanaka T, 2011, CHEM SCI, V2, P1414, DOI 10.1039/c1sc00228g; Nakamura Y, 2008, CHEM-EUR J, V14, P8279, DOI 10.1002/chem.200800776; Higashino T, 2013, HETEROCYCLES, V87, P31, DOI 10.3987/REV-12-757; Sakurai T, 2011, J AM CHEM SOC, V133, P6537, DOI 10.1021/ja201272t; Avlasevich Y, 2006, J MATER CHEM, V16, P1053, DOI 10.1039/b516264e; Ota K, 2014, ORG LETT, V16, P2974, DOI 10.1021/ol501115m; LINDSEY JS, 1986, TETRAHEDRON LETT, V27, P4969, DOI 10.1016/S0040-4039(00)85109-6; Davis NKS, 2008, ORG LETT, V10, P3945, DOI 10.1021/ol801500b; Diev VV, 2012, J ORG CHEM, V77, P143, DOI 10.1021/jo201490y; Pawlicki M, 2009, ANGEW CHEM INT EDIT, V48, P3244, DOI 10.1002/anie.200805257; Sessler JL, 2003, ANGEW CHEM INT EDIT, V42, P5134, DOI 10.1002/anie.200200561; Tsuda A, 2001, SCIENCE, V293, P79, DOI 10.1126/science.1059552; Davis NKS, 2010, ORG LETT, V12, P2124, DOI 10.1021/ol100619p; Ahn TK, 2006, J AM CHEM SOC, V128, P1700, DOI 10.1021/ja056773a; Ikeda T, 2009, CHEM-ASIAN J, V4, P1248, DOI 10.1002/asia.200900125; Mori H, 2013, J MATER CHEM C, V1, P2500, DOI 10.1039/c3tc00932g; Misra R, 2008, ACCOUNTS CHEM RES, V41, P265, DOI 10.1021/ar700091k; Davis NKS, 2011, J AM CHEM SOC, V133, P30, DOI 10.1021/ja109671f; Stepien M, 2011, ANGEW CHEM INT EDIT, V50, P4288, DOI 10.1002/anie.201003353; Fox S, 2006, TETRAHEDRON, V62, P10039, DOI 10.1016/j.tet.2006.08.021; Sankar J, 2008, J AM CHEM SOC, V130, P13568, DOI 10.1021/ja801983d; Shin JY, 2001, J AM CHEM SOC, V123, P7190, DOI 10.1021/ja0106624; Yorimitsu H, 2013, ASIAN J ORG CHEM, V2, P356, DOI 10.1002/ajoc.201200183; Mori H, 2015, J AM CHEM SOC, V137, P2097, DOI 10.1021/ja5130034; Aratani N, 2001, ORG LETT, V3, P4213, DOI 10.1021/ol0168110; Hong SK, 2005, J PORPHYR PHTHALOCYA, V9, P285; Ikeda T, 2006, CHEM LETT, V35, P946, DOI 10.1246/cl.2006.946; Inokuma Y, 2005, CHEM COMMUN, P3782, DOI 10.1039/b505340d; Ishida SI, 2014, ASIAN J ORG CHEM, V3, P716, DOI 10.1002/ajoc.201402023; Kadish K. M., 2010, HDB PORPHYRIN SCI, V1-20; Kadish K. M., 2003, PORPHYRIN HDB, V11-20; Kadish K M, 1999, PORPHYRIN HDB, V1; Kurotobi K, 2006, ANGEW CHEM INT EDIT, V45, P3944, DOI 10.1002/anie.200600892; Sakurai T, 2008, J AM CHEM SOC, V130, P13812, DOI 10.1021/ja8030714; Mori H, 2012, CHEM-ASIAN J, V7, P1811, DOI 10.1002/asia.201200247; Naoda K, 2012, ANGEW CHEM INT EDIT, V51, P9856, DOI 10.1002/anie.201204446; Neves MGPMS, 1999, CHEM COMMUN, P385, DOI 10.1039/a808952c; Rath H, 2009, CHEM COMMUN, P3762, DOI 10.1039/b905859a; Sato H, 2005, J AM CHEM SOC, V127, P13086, DOI 10.1021/ja052993c; Sato H, 2005, CHEM COMMUN, P2324, DOI 10.1039/b501689d; Sedghi G, 2012, ADV MATER, V24, P653, DOI 10.1002/adma.201103109; Shinokubo H, 2009, CHEM COMMUN, P1011, DOI 10.1039/b817941g; Tanaka T., 2009, CHEM-EUR J, V17, P14400; Tanaka T, 2012, CHEM-ASIAN J, V7, P889, DOI 10.1002/asia.201101039; Yamada H, 2008, CHEM COMMUN, P2957, DOI 10.1039/b719964c	55	1	1	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAR	2015	73	3					220	229				10	Chemistry, Organic	Chemistry	CH2OC	WOS:000353863500002		
J	Hashimoto, M; Murakami, T				Hashimoto, Masaru; Murakami, Takanori			Molecular Mechanism of Mycoparasitism on Apple Fruits	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Review						mycoparasitism on apple fruits; Lambertella spp.; Monilinia fructigena; lambertellols A and B; lambertellin; Lambertellin System; total synthesis; structure activity relationship; dynamic analyses of the metabolites	LAMBERTELLA-CORNI-MARIS; BIOLOGICAL-PROPERTIES; STRUCTURE ELUCIDATION; BIOSYNTHESIS; NEOLAMBERTELLIN	In the course of our mechanistic studies of mycoparasitism between Lambertella spp. (the parasite) and Monilinia fructigena (M. f., the host) on apple fruits, we isolated known lambertellin (1) and new spirobutenolides lambertellols A (2), B (3). Lambertellols were detected only when the host M. f. co-inhabited in the broth of M. f. Lambertellols 2, 3 were readily interconverted and gradually decomposed into 1. Our total syntheses enable the SAR studies to disclose that 1 should be the real active species and 2 and 3 are diffusible precursors. In order to rationally explain these observations, we performed dynamic analyses of the metabolites to disclose a novel alleropathy 'Lambertellin system' as described in this article. This mechanism also accords with the progress of 'Natsu-Nenju' disease on apple fruits, which is known to be a mysterious phyto-disease because of two unique stages of its lifecycle, anamorphic (asexual) and teleomorphic (sexual). Only organic chemistry based investigations could approach the final conclusion in this particular case.	[Hashimoto, Masaru] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan; [Murakami, Takanori] Sci Feed Lab Co Ltd, Sakura 2850043, Japan	Hashimoto, M (reprint author), Hirosaki Univ, Fac Agr & Life Sci, 3 Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	hmasaru@cc.hirosaki-u.ac.jp; t-murakami@kashiken.co.jp					Murakami T, 2004, ORG LETT, V6, P157, DOI 10.1021/ol035889d; Schuetz A, 2008, ANGEW CHEM INT EDIT, V47, P2032, DOI 10.1002/anie.200705037; ARMSTRON.JJ, 1965, J CHEM SOC, P5927, DOI 10.1039/jr9650005927; Harada Y., 1990, REP TOTTORI MYCOL I, V28, P275; Hirose A, 2014, BIOORGAN MED CHEM, V22, P2489, DOI 10.1016/j.bmc.2014.02.051; Keniry M. A., 1990, MAG RES CHEM, V29, P46; Murakami T, 2004, J AM CHEM SOC, V126, P9214, DOI 10.1021/ja048345v; Murakami T, 2005, BIOORG MED CHEM LETT, V15, P4185, DOI 10.1016/j.bmcl.2005.06.082; Murakami T, 2008, BIOORG MED CHEM LETT, V18, P4547, DOI 10.1016/j.bmcl.2008.07.032; Murakami T, 2005, BIOORG MED CHEM LETT, V15, P2587, DOI 10.1016/j.bmcl.2005.03.036; Murakami T, 2007, BIOSCI BIOTECH BIOCH, V71, P1230, DOI 10.1271/bbb.60667; Nomiya M, 2008, J ORG CHEM, V73, P5039, DOI 10.1021/jo8005478	12	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAR	2015	73	3					230	240				11	Chemistry, Organic	Chemistry	CH2OC	WOS:000353863500003		
J	Jin, TA				Jin, Tienan			Development of New Transition-Metal-Catalyzed Fullerene Functionalization	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Review						transition-metal catalysis; fullerene functionalization; fullerene monoradical; hydrofullerene; fullerene cycloadduct; single-bonded fullerene dimer; fullerene 1,4-bisadduct; organic photovoltaics	PHOTOVOLTAIC PERFORMANCES; 2+2 PHOTOCYCLOADDITION; EFFICIENT SYNTHESIS; SELECTIVE SYNTHESIS; SOLAR-CELLS; C-60; DIMERS; BUCKMINSTERFULLERENE; CYCLOADDITION; DIMERIZATION	Functional fullerenes have been used widely as excellent n-type semiconductors in solution processable organic electronics, especially as the unique electron acceptors for organic photovoltaics due to their significant increase in solubility while preserving certain electronic and optical properties of pristine fullerenes. Numerous efforts have been made to develop new fullerene functionalization. In comparison with the traditional methods, such as nucleophilic addition of organometallic reagents, cycloaddition, and addition of free radicals, the transition-metal-catalyzed fullerene functionalization has been proved to exhibit high efficiency and selectivity under mild reaction conditions as well as a high compatibility with a wide range of functional groups. We have been interested in the catalytic generation and reactivity of the fullerene radicals. The account describes our recent achievements for the synthesis of various monosubstituted hydrofullerenes, fullerene cycloadducts, single-bonded fullerene dimers, and amine-substituted 1,4-bisadducts in the presence of cobalt and copper catalysts via the formation of the fullerene monoradical as an active species.	Tohoku Univ, WPI Adv Inst Mat Sci AIMR, Aoba Ku, Sendai, Miyagi 9808577, Japan	Jin, TA (reprint author), Tohoku Univ, WPI Adv Inst Mat Sci AIMR, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	tjin@m.tohoku.ac.jp	Jin, Tienan/K-3321-2014				Lu SR, 2013, ORG LETT, V15, P4030, DOI 10.1021/ol401876n; Segura JL, 2000, CHEM SOC REV, V29, P13, DOI 10.1039/a903716k; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; He YJ, 2010, J AM CHEM SOC, V132, P1377, DOI 10.1021/ja908602j; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Matsuo Y, 2009, J AM CHEM SOC, V131, P16048, DOI 10.1021/ja9048702; Nambo M, 2009, J AM CHEM SOC, V131, P15112, DOI 10.1021/ja9071173; He YJ, 2011, PHYS CHEM CHEM PHYS, V13, P1970, DOI 10.1039/c0cp01178a; Matsuo Y, 2012, CHEM LETT, V41, P754, DOI 10.1246/cl.2012.754; Lu SR, 2012, ORG LETT, V14, P3466, DOI 10.1021/ol301435m; PRATO M, 1993, J AM CHEM SOC, V115, P1594, DOI 10.1021/ja00057a065; FAGAN PJ, 1992, J AM CHEM SOC, V114, P9697, DOI 10.1021/ja00050a081; Xiao Z, 2010, J AM CHEM SOC, V132, P12234, DOI 10.1021/ja1056399; Martin N, 2006, ANGEW CHEM INT EDIT, V45, P110, DOI 10.1002/anie.200502556; Li CZ, 2012, J MATER CHEM, V22, P4161, DOI 10.1039/c2jm15126j; Maroto EE, 2011, ANGEW CHEM INT EDIT, V50, P6060, DOI 10.1002/anie.201101246; HIRSCH A, 1991, ANGEW CHEM INT EDIT, V30, P1309, DOI 10.1002/anie.199113091; MAGGINI M, 1993, J AM CHEM SOC, V115, P9798, DOI 10.1021/ja00074a056; KRUSIC PJ, 1991, SCIENCE, V254, P1183, DOI 10.1126/science.254.5035.1183; Wienk MM, 2003, ANGEW CHEM INT EDIT, V42, P3371, DOI 10.1002/anie.200351647; HUMMELEN JC, 1995, J ORG CHEM, V60, P532, DOI 10.1021/jo00108a012; Matsuo Y, 2008, J AM CHEM SOC, V130, P15429, DOI 10.1021/ja8041299; Matsuo Y, 2008, CHEM REV, V108, P3016, DOI 10.1021/cr0684218; Lu SR, 2011, J AM CHEM SOC, V133, P12842, DOI 10.1021/ja204982w; Cheng FY, 2002, ORG LETT, V4, P2541, DOI 10.1021/ol026281s; Zhang Y, 2011, J AM CHEM SOC, V133, P8086, DOI 10.1021/ja201267t; Wang GW, 2011, CHEM COMMUN, V47, P6111, DOI 10.1039/c1cc10820d; BECKER L, 1993, J ORG CHEM, V58, P7630, DOI 10.1021/jo00079a002; BELIK P, 1993, ANGEW CHEM INT EDIT, V32, P78, DOI 10.1002/anie.199300781; Belik P., 1993, ANGEW CHEM INT EDIT, V32, P90, DOI DOI 10.1002/ANIE.199300781; BINGEL C, 1993, CHEM BER-RECL, V126, P1957, DOI 10.1002/cber.19931260829; FAGAN PJ, 1993, SCIENCE, V262, P404, DOI 10.1126/science.262.5132.404; Giacalone F, 2010, ADV MATER, V22, P4220, DOI 10.1002/adma.201000083; Hatzimarinaki M, 2005, J AM CHEM SOC, V127, P14182, DOI 10.1021/ja053431; HIRSCH A, 1993, CHEM BER-RECL, V126, P1061, DOI 10.1002/cber.19931260428; HIRSCH A, 1992, ANGEW CHEM INT EDIT, V31, P766, DOI 10.1002/anie.199207661; Isobe H, 2005, J ORG CHEM, V70, P4826, DOI 10.1021/jo050432y; Lu SR, 2013, ORG LETT, V15, P5674, DOI 10.1021/ol4026606; Lu SR, 2012, ANGEW CHEM INT EDIT, V51, P802, DOI 10.1002/anie.201107505; Lu SR, 2013, TETRAHEDRON, V69, P1302, DOI 10.1016/j.tet.2012.11.099; Matsuo Y, 2007, ANGEW CHEM INT EDIT, V46, P2844, DOI 10.1002/anie.200604839; Mori S, 2008, ORG LETT, V10, P4609, DOI 10.1021/ol801936j; MORTON JR, 1992, J AM CHEM SOC, V114, P5454, DOI 10.1021/ja00039a083; Murata Y, 2004, J AM CHEM SOC, V126, P8874, DOI 10.1021/ja047483h; Nambo M, 2007, J AM CHEM SOC, V129, P8080, DOI 10.1021/ja073042x; Osawa S, 1996, J ORG CHEM, V61, P257, DOI 10.1021/jo9511861; Si WL, 2014, ORG LETT, V16, P620, DOI 10.1021/ol403573r; Si WL, 2014, CHEM COMMUN, V50, P15730, DOI 10.1039/c4cc07780f; Tanaka T., 1999, J CHEM SOC PERK T, VI, P1671; Wakabayashi K, 2001, J AM CHEM SOC, V123, P5374, DOI 10.1021/ja0100423; WILSON SR, 1993, J AM CHEM SOC, V115, P8495, DOI 10.1021/ja00071a088; Yoshida M, 1999, TETRAHEDRON LETT, V40, P735, DOI 10.1016/S0040-4039(98)02442-3	52	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAR	2015	73	3					241	253				13	Chemistry, Organic	Chemistry	CH2OC	WOS:000353863500004		
J	Arisawa, M; Nishida, A; Shuto, S				Arisawa, Mitsuhiro; Nishida, Atsushi; Shuto, Satoshi			Design and Synthesis of Biologically Active Substituted Indole Compounds Using Enamide-ene Metathesis	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Review						ruthenium; enamide; metathesis; isomerization; multi-drug resistance	RING-CLOSING METATHESIS; NITROGEN-CONTAINING HETEROCYCLES; COX INHIBITORY-ACTIVITY; CONFORMATIONAL RESTRICTION; ANTIINFLAMMATORY AGENTS; INDOMETHACIN ANALOGS; P-GLYCOPROTEIN; RECEPTOR; CYCLOISOMERIZATION; CYCLOOXYGENASE-2	We have established aromatic enamide-ene metathesis to give highly substituted indole derivatives. This is a new method for the preparation of chiral 2-trans-cyclopropyl indoles, which successfully led to our H-4 antagonist candidates. Based on this findings, we also designed and synthesized conformationally restricted analogues and regioisomers of the nonsteroidal anti-inflammatory drug indomethacin. Evaluation of the inhibitory effects of these compounds on COX, P-glycoprotein, and multidrug-resistance indicated that NSAIDS modulation of multidrug resistant P-glycoprotein and multidrug-resistant protein-1 is not associated with COX-1 and COX-2 inhibitory activities.	[Arisawa, Mitsuhiro] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650862, Japan; Osaka Univ, Graduated Sch Pharmaceut Sci, Suita, Osaka 5650862, Japan; Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Arisawa, M (reprint author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Kita-12,Nishi-6, Sapporo, Hokkaido 0600812, Japan.	arisaw@phs.osaka-u.ac.jp; anishida@faculty.chiba-u.ac.jp; shu@pharm.hokudai.ac.jp					Terada Y, 2004, ANGEW CHEM INT EDIT, V43, P4063, DOI 10.1002/anie.200454157; Evans DA, 2006, ORG LETT, V8, P2249, DOI 10.1021/ol060576e; Mukai C, 2005, ORG LETT, V7, P5793, DOI 10.1021/ol052179u; Charette AB, 2001, J AM CHEM SOC, V123, P12168, DOI 10.1021/ja0108382; Arisawa M, 2006, J ORG CHEM, V71, P4255, DOI 10.1021/jo060308u; YU K, 1995, J BIOL CHEM, V270, P23975; Arisawa M, 2007, CHEM REC, V7, P238, DOI 10.1002/tcr.20121; YAMAMOTO H, 1968, CHEM PHARM BULL, V16, P17; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Theeraladanon C, 2005, TETRAHEDRON-ASYMMETR, V16, P827, DOI 10.1016/j.tetasy.2004.12.022; Takahashi H, 2011, ORG LETT, V13, P760, DOI 10.1021/ol103008d; Lehmann JM, 1997, J BIOL CHEM, V272, P3406; Lee S, 2007, J AM CHEM SOC, V129, P15438, DOI 10.1021/ja0767480; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Arisawa M, 2002, ANGEW CHEM INT EDIT, V41, P4732, DOI 10.1002/anie.200290031; Hoshiya N, 2013, ORG LETT, V15, P6202, DOI 10.1021/ol4030452; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; Arisawa M, 2005, HETEROCYCLES, V66, P683; Arisawa M, 2000, CHEM PHARM BULL, V48, P1593; Arisawa M, 2012, J MED CHEM, V55, P8152, DOI 10.1021/jm301084z; Arisawa M, 1997, SYNLETT, P1179; Arisawa M, 2011, ACS MED CHEM LETT, V2, P353, DOI 10.1021/ml100292y; Arisawa M, 2006, J ORGANOMET CHEM, V691, P5109, DOI 10.1016/j.jorganchem.2006.08.009; Ballou LR, 2000, P NATL ACAD SCI USA, V97, P10272, DOI 10.1073/pnas.180319297; Fraper M., 1997, BRIT J CANCER, V75, P810; HART F D, 1963, Br Med J, V2, P965; Hirai H, 2002, J IMMUNOL, V168, P981; Kazuta Y, 2003, J MED CHEM, V46, P1980, DOI 10.1021/jm020415q; Kinderman SS, 2001, ORG LETT, V3, P2045, DOI 10.1021/ol016013e; Kobayashi T, 2011, ORG BIOMOL CHEM, V9, P1219, DOI 10.1039/c0ob00597e; Loll PJ, 1996, BIOCHEMISTRY-US, V35, P7330, DOI 10.1021/bi952776w; Michalak M., 2010, SCI SYNTHESIS HOUB A, p[327, 47a]; Patel VA, 2002, J BIOL CHEM, V277, P38915, DOI 10.1074/jbc.M206855200; Rohrer SP, 1998, SCIENCE, V282, P737, DOI 10.1126/science.282.5389.737; SHEN TY, 1963, J AM CHEM SOC, V85, P488, DOI 10.1021/ja00887a038; Tanaka A, 2002, J PHARMACOL EXP THER, V300, P754, DOI 10.1124/jpet.300.3.754; Tellers DM, 2006, J AM CHEM SOC, V128, P17063, DOI 10.1021/ja0623358; Terada Y, 2006, J ORG CHEM, V71, P1269, DOI 10.1021/jo0522005; Vickers T, 2008, BIOORG MED CHEM LETT, V18, P3230, DOI 10.1016/j.bmcl.2008.04.045; Watanabe M, 2010, J MED CHEM, V53, P3585, DOI 10.1021/jm901848b; Watanabe M, 2006, J MED CHEM, V49, P5587, DOI 10.1021/jm0603318; Wey S.-J., 2007, J MED CHEM, V50, P63; Yao ML, 2000, NEW J CHEM, V24, P425, DOI 10.1039/b001051k; Yotsuji K., ADV SYNTH C IN PRESS	44	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAR	2015	73	3					254	265				12	Chemistry, Organic	Chemistry	CH2OC	WOS:000353863500005		
J	Michida, M; Imai, M				Michida, Makoto; Imai, Makoto			Development of Efficient and Scalable Synthetic Method for Renin Inhibitor	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Review						renin inhibitor; process chemistry; chiral pool; chiral auxiliary; stereoselective alkylation; bromolactonization; aziridine; nosyl group	OPTIMIZATION; DISCOVERY; DS-8108B	A process development research of renin inhibitor 1 for anti-hypertensive drug candidate is described, This compound consists of three intermediates, and especially the key intermediate is chiral lactone 3 which contains three asymmetric carbons. We developed two different approaches to construct those carbons for the synthesis of the common intermediate 9. Namely, scalable synthetic method was established from D-glucose, and 6 kg of 1 was provided for early clinical studies. Then we also developed a highly efficient alternative synthetic method of 1 for manufacturing from n-butyryl chloride 24 by using Evans stereoselective alkylation, followed by stereoselective bromolactonization as key reactions.	[Michida, Makoto; Imai, Makoto] Daiichi Sankyo Co LTD, Proc Technol Res Labs, Hiratsuka, Kanagawa 2540014, Japan	Michida, M (reprint author), Daiichi Sankyo Co LTD, Proc Technol Res Labs, 1-12-1 Shinomiya, Hiratsuka, Kanagawa 2540014, Japan.	michida.makoto.wp@daiichisankyo.co.jp; makoto.dj@daiichisankyo.co.jp					Michida M, 2013, ORG PROCESS RES DEV, V17, P1430, DOI 10.1021/op400219y; TAMARU Y, 1984, J AM CHEM SOC, V106, P1079, DOI 10.1021/ja00316a044; Tu Y, 1996, J AM CHEM SOC, V118, P9806, DOI 10.1021/ja962345g; Node M, 2001, TETRAHEDRON LETT, V42, P9207, DOI 10.1016/S0040-4039(01)02024-X; Nakamura Y, 2012, BIOORG MED CHEM LETT, V22, P4561, DOI 10.1016/j.bmcl.2012.05.092; Yamaguchi Y, 2009, BIOORG MED CHEM LETT, V19, P4863, DOI 10.1016/j.bmcl.2009.05.128; Nakamura Y, 2013, BIOORGAN MED CHEM, V21, P3175, DOI 10.1016/j.bmc.2013.03.022; BAKER SR, 1988, TETRAHEDRON LETT, V29, P991, DOI 10.1016/0040-4039(88)85316-4; Li YF, 2007, ANGEW CHEM INT EDIT, V46, P279, DOI 10.1002/anie.200601963; Nakamura Y, 2012, ACS MED CHEM LETT, V3, P754, DOI 10.1021/ml300168e; Yang K., 2003, ORG LETT, V21, P4007	11	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAR	2015	73	3					266	275				10	Chemistry, Organic	Chemistry	CH2OC	WOS:000353863500006		
J	Anzai, T; Kaminishi, M; Sato, K; Kaufman, L; Iwata, H; Nakae, D				Anzai, Takayuki; Kaminishi, Masamichi; Sato, Keizo; Kaufman, Laura; Iwata, Hijiri; Nakae, Dai			Responses to the Standard for Exchange of Nonclinical Data (SEND) in non-US countries	JOURNAL OF TOXICOLOGIC PATHOLOGY			English	Review						SEND; CDISC; FDA; INHAND; controlled terminology		The Standard for the Exchange of Nonclinical Data (SEND), adopted by the US FDA, is part of a set of regulations and guidances requiring the submission of standardized electronic study data for nonclinical and clinical data submissions. SEND is the nonclinical implementation of SDTM (Study Data Tabulation Model), the standard electronic format for clinical regulatory submissions to FDA. SEND, SDTM, and the associated Controlled Terminology have been developed by CDISC (Clinical Data Interchange Standards Consortium). In order to successfully implement SEND, interdisciplinary contributions between sponsors and CROs, need a model for task allocation. This is being undertaken by the Pharmaceutical Users Software Exchange (PhUSE). Because SEND is currently the preferred submission format of the US FDA only and will become required by it starting in December 2016, only American academic societies and companies are actively involved. An exception to this is the IN HAN D initiative, which leads the way in standardizing terminology for toxicological pathology. On the other hand, international globalization of other clinical and nonclinical practices is not feasible because there are substantial differences between the US and non-US countries in CRO involvement in drug development. Thus, non-US countries must consider and develop approaches to SEND that meet their needs. This paper summarizes the activities of the major organizations involved in SEND development and implementation, discusses the effective use of SEND, and details a compliance scheme (research material of the Showa University School of Medicine) illustrating how pharmaceutical companies can complete a large amount of work up to an FDA application with the effective utilization of CROs and solution providers.	[Anzai, Takayuki; Kaminishi, Masamichi; Sato, Keizo] Showa Univ, Sch Med, Shinagawa Ku, Tokyo 1420064, Japan; [Kaufman, Laura] PDS Life Sci, Mt Arlington, NJ 07856 USA; [Iwata, Hijiri] LunaPath LLC, Naka Ku, Hamamatsu, Shizuoka 4338114, Japan; [Nakae, Dai] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci & Food Safety, Setagaya Ku, Tokyo 1568502, Japan	Anzai, T (reprint author), Showa Univ, Sch Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1420064, Japan.	takayuki.anzai@me.com; agalennde.dai@nifty.com					Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; CDISC SDTM TEAM Clinical Data Interchange Standards Consortium (CDISC), 2013, STUD DAT TAB MOD SDT; CDISC SEND TEAM, 2014, CLIN DAT INT STAND C; CDISC website, 2014, CDISC SOL PROV CHART; Dixon D, 2014, J TOXICOL PATHOL, V27, p1S, DOI 10.1293/tox.27.1S; International Harmonization of Nomenclature and Diagnostic Criteria for Lesions in Rats and Mice INHAND, 2012, COLLABORATION FDA SE; Interorganizational SEND. (iSEND). Pharmaceutical Us-ers Software Exchange (PhUSE), 2013, SCEN GEN SEND NONCL; US Department of Health and Human Services U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Center for Biologics Evaluation and Research, 2014, GUID IND PROV REG SU; U.S. Department of Health and Human Services U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Center for Biologics Evaluation and Research. Guidance for Industry, 2014, GUID IND PR IN PRESS; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2014, GDUFA INF TECHN INF; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2014, PROV REG SUBM EL FOR	11	0	0	JAPANESE SOC TOXICOLOGIC PATHOLOGY	TOKYO	DEPT ACAD SOC, MEDICAL TRIBUNE INC, ITALIAN CULTURAL INST BLDG 8F 2-1-30, KUDAN MINAMI, CHIYODA, TOKYO, 102-0074, JAPAN	0914-9198	1881-915X		J TOXICOL PATHOL	J. Toxicol. Pathol.	SPR	2015	28	2					57	64		10.1293/tox.28.2015-0007		8	Pathology; Toxicology	Pathology; Toxicology	CH9GL	WOS:000354343900001		
J	Ohmachi, Y; Imamura, T; Ikeda, M; Shishikura, E; Kim, E; Kurihara, O; Sakai, K				Ohmachi, Yasushi; Imamura, Tomomi; Ikeda, Mizuyo; Shishikura, Eriko; Kim, Eunjoo; Kurihara, Osamu; Sakai, Kazuo			Sodium bicarbonate protects uranium-induced acute nephrotoxicity through uranium-decorporation by urinary alkalinization in rats	JOURNAL OF TOXICOLOGIC PATHOLOGY			English	Article						uranium; decorporation effect; sodium bicarbonate; urine alkalinization; rat	EFFICACY	To evaluate the effectiveness of sodium bicarbonate (SB) in removing uranium and protecting animals from uranium toxicity, we intramuscularly administered 1 mg/kg of uranyl nitrate to 8-wk-old male SD rats, and 20 min after administration of uranyl nitrate, the animals were given a single oral administration of SB at 0.1, 0.3 or 1 g/kg. The SB treatment at a dose of 0.3 g/kg or more raised the pH of the rats' urine until 4 h after treatment, and it significantly reduced the uranium amounts in the kidneys at I day after treatment. In another experiment, rats were intramuscularly administered I mg/kg of uranyl nitrate, and 20 min later, the animals were treated with sodium bicarbonate (0.1 or 1 g/kg). The rats were autopsied at 1, 3 and 7 days after uranium treatment. High-dose SB resulted in a significant increase in urinary uranium excretion in the first 24 h and a reduction of uranium deposition in the kidneys and femurs, and it also significantly suppressed uranium-induced renal toxicity, as shown by both histopathology and clinical chemistry at 3 days after uranium treatment. Low-dose SB did not show such marked effects. Our findings demonstrated that the uranium decorporation effect of sodium bicarbonate was observed at the dosage showing urine alkalinization in rats and that decorporation effect of sodium bicarbonate might be beneficial if it is administered immediately after incorporation of soluble uranium.	[Ohmachi, Yasushi; Imamura, Tomomi; Ikeda, Mizuyo; Shishikura, Eriko; Kim, Eunjoo; Kurihara, Osamu; Sakai, Kazuo] Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Res Program Radiat Dosimetry, Inage Ku, Chiba 2638555, Japan	Ohmachi, Y (reprint author), Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Res Program Radiat Dosimetry, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	y-omachi@nirs.go.jp					Durbin PW, 2008, HEALTH PHYS, V95, P465, DOI 10.1097/01.HP.0000326345.41816.c2; Kathren RL, 2008, HEALTH PHYS, V94, P170, DOI 10.1097/01.HP.0000288043.94908.1f; Fukuda S, 2008, HEMOGLOBIN, V32, P191, DOI 10.1080/03630260701727093; [Anonymous], 2005, INT AT EN AG GEN PRO; [Anonymous], 2013, AG TOX SUBST DIS REG; [Anonymous], 2005, ICRP PUBL, V96; Vicente-Vicente L, 2010, TOXICOL SCI, V118, P324, DOI 10.1093/toxsci/kfq178; [Anonymous], 2010, 161 NCRP; CHIU PJS, 1979, CLIN EXP PHARMACOL P, V6, P317, DOI 10.1111/j.1440-1681.1979.tb01253.x; Hattori S, 1987, KIDNEY DIALYSIS, V22, P335; Henge-Napoli MH, 1999, INT J RADIAT BIOL, V75, P1473; HENGENAPOLI MH, 1995, INT J RADIAT BIOL, V68, P389, DOI 10.1080/09553009514551331; International Agency for Research on Cancer (IARC), 2001, IARC MONOGRAPHS EVAL, V78; Moulin C, 1998, APPL SPECTROSC, V52, P528, DOI 10.1366/0003702981944076; Stradling GN, 2005, RADIOLOGICAL PROTECT, V4, P295, DOI 10.1007/10723325_9	15	0	0	JAPANESE SOC TOXICOLOGIC PATHOLOGY	TOKYO	DEPT ACAD SOC, MEDICAL TRIBUNE INC, ITALIAN CULTURAL INST BLDG 8F 2-1-30, KUDAN MINAMI, CHIYODA, TOKYO, 102-0074, JAPAN	0914-9198	1881-915X		J TOXICOL PATHOL	J. Toxicol. Pathol.	SPR	2015	28	2					65	71		10.1293/tox.28.2014-0041		7	Pathology; Toxicology	Pathology; Toxicology	CH9GL	WOS:000354343900002		
J	Sato, J; Yamada, N; Kobayashi, R; Tsuchitani, M; Kobayashi, Y				Sato, Junko; Yamada, Naoaki; Kobayashi, Ryosuke; Tsuchitani, Minoru; Kobayashi, Yoshiyasu			Morphometric analysis of progressive changes in hereditary cerebellar cortical degenerative disease (abiotrophy) in rabbits caused by abnormal synaptogenesis	JOURNAL OF TOXICOLOGIC PATHOLOGY			English	Article						abiotrophy; cerebellum; rabbits; morphometry	EXTERNAL GERMINAL LAYER; POSTNATAL-DEVELOPMENT; MOLECULAR LAYER; MUTANT MICE; CORTEX; RAT; MATURATION; PARALLEL; CELLS	We previously investigated rabbit hereditary cerebellar cortical degenerative disease, called cerebellar cortical abiotrophy in the veterinary field, and determined that the pathogenesis of this disease is the result of failed synaptogenesis between parallel fibers and Purkinje cells. In this study, longitudinal changes in the development and atrophy of the cerebellum of rabbits with hereditary abiotrophy after birth were morphometrically examined (postnatal day [PD] 15 and 42) using image analysis. Although development of the cerebellum in rabbits with abiotrophy was observed from PD 15 to PD 42, the growth rate of the cerebellum was less than that in normal rabbits. In rabbits with abiotrophy, the number of granular cells undergoing apoptosis was significantly higher at PD 15 and dramatically decreased at PD 42. The number of granular cells did not increase from PD 15 to 42. The synaptogenesis peak at PD 15 occurred when the largest number of apoptotic granular cells in rabbits with abiotrophy was observed. Although 26% to 36% of parallel fiber terminals formed synaptic junctions with Purkinje cell spines, the remainder did not at PD 15 and 42. The rate of failure of synaptogenesis in the present study might be specific to this case of abiotrophy. Morphometric analysis revealed detailed changes in development and atrophy in animals with postnatal cerebellar disease occurring soon after birth.	[Sato, Junko; Yamada, Naoaki; Kobayashi, Ryosuke; Tsuchitani, Minoru] LSI Medience Corp, Kamisu, Ibaraki 3140255, Japan; [Kobayashi, Yoshiyasu] Obihiro Univ Agr & Vet Med, Dept Basic Vet Med, Div Pathol Sci, Lab Vet Pathol, Obihiro, Hokkaido 0808555, Japan	Sato, J (reprint author), LSI Medience Corp, 14-1 Sunayama, Kamisu, Ibaraki 3140255, Japan.	Satou.Junko@ms.medience.co.jp					ALTMAN J, 1973, J COMP NEUROL, V149, P181, DOI 10.1002/cne.901490204; ANDERSON WA, 1986, BRAIN RES, V383, P245, DOI 10.1016/0006-8993(86)90023-5; LANDIS DMD, 1978, J COMP NEUROL, V179, P831, DOI 10.1002/cne.901790408; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; Lossi L, 2002, NEUROSCIENCE, V112, P509, DOI 10.1016/S0306-4522(02)00112-4; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; Kurihara H, 1997, J NEUROSCI, V17, P9613; Lossi L, 1995, J ANAT, V187, P709; Lossi Laura, 2002, Italian Journal of Anatomy and Embryology, V107, P117; Sato J, 2013, J VET MED SCI, V75, P445, DOI 10.1292/jvms.12-0232; Sato J, 2012, VET PATHOL, V49, P621, DOI 10.1177/0300985811402840; Summers BA, 1995, VET NEUROPATHOLOGY, P300	13	0	0	JAPANESE SOC TOXICOLOGIC PATHOLOGY	TOKYO	DEPT ACAD SOC, MEDICAL TRIBUNE INC, ITALIAN CULTURAL INST BLDG 8F 2-1-30, KUDAN MINAMI, CHIYODA, TOKYO, 102-0074, JAPAN	0914-9198	1881-915X		J TOXICOL PATHOL	J. Toxicol. Pathol.	SPR	2015	28	2					73	78		10.1293/tox.28.2014-0057		6	Pathology; Toxicology	Pathology; Toxicology	CH9GL	WOS:000354343900003		
J	Inoue, K; Morikawa, T; Takahashi, M; Yoshida, M; Ogawa, K				Inoue, Kaoru; Morikawa, Tomomi; Takahashi, Miwa; Yoshida, Midori; Ogawa, Kumiko			Obstructive nephropathy induced with DL-potassium hydrogen tartrate in F344 rats	JOURNAL OF TOXICOLOGIC PATHOLOGY			English	Article						obstructive nephropathy; rat; kidney; DL-potassium hydrogen tartrate	LESIONS	We experienced obstructive nephropathy in F344 rats treated with DL-potassium hydrogen tartrate (PHT) in a 13-week oral repeated dose toxicity study. Six-week-old male and female F344/DuCrj rats were fed a diet containing up to 2.0% PHT for 13 weeks. Microscopical findings including irregular dilation of the distal tubule lumen, foreign body giant cells, inflammatory cell infiltration, and regeneration of renal tubules were observed focally or multifocally in the renal cortex and/or medulla in the 0.5% and higher dosage groups of both sexes. The severity of these lesions increased in a dose-dependent manner. In the urinalysis, an increase in protein and white blood cells or the concentration of tartaric acid was detected in the 0.5% PHT and higher dosage groups of both sexes or males, respectively, though conventional blood biochemical analysis did not indicate failure of renal function. These results indicate that the PHT induces obstructive nephropathy in rats. There were no other treatment-related changes in other organs.	[Inoue, Kaoru; Morikawa, Tomomi; Takahashi, Miwa; Yoshida, Midori; Ogawa, Kumiko] Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo 1588501, Japan	Inoue, K (reprint author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	k-inoue@nihs.go.jp			Ministry of Health, Labour and Welfare of Japan	This work was supported by a Grant-in-Aid for Research on Food Sanitation from the Ministry of Health, Labour and Welfare of Japan. We thank Ms. Ayako Saikawa and Ms. Yoshimi Komatsu for their technical assistance in conducting the animal studies and section preparation.	Frazier KS, 2012, TOXICOL PATHOL, V40, P14, DOI 10.1177/0192623312438736; Bodansky O, 1942, J AM PHARM ASSOC, V31, P1; BURTON DS, 1979, LAB ANIM SCI, V29, P642; DOWN WH, 1977, TOXICOLOGY, V8, P333, DOI 10.1016/0300-483X(77)90081-6; Gold H, 1943, J AM PHARM ASSOC, V32, P173; Ikezaki S, 2011, J TOXICOL PATHOL, V24, P37, DOI 10.1293/tox.24.37; Ito Y, 2014, J TOXICOL PATHOL, V27, P91, DOI 10.1293/tox.2013-0059; Madheswaran R., 2009, Brazilian Journal of Veterinary Pathology, V2, P62; ROBERTSO.B, 1968, ACTA PATHOL MIC SC, V74, P305	9	0	0	JAPANESE SOC TOXICOLOGIC PATHOLOGY	TOKYO	DEPT ACAD SOC, MEDICAL TRIBUNE INC, ITALIAN CULTURAL INST BLDG 8F 2-1-30, KUDAN MINAMI, CHIYODA, TOKYO, 102-0074, JAPAN	0914-9198	1881-915X		J TOXICOL PATHOL	J. Toxicol. Pathol.	SPR	2015	28	2					89	97		10.1293/tox.28.2014-0058		9	Pathology; Toxicology	Pathology; Toxicology	CH9GL	WOS:000354343900005		
J	Sato, M; Todoriki, S; Takahashi, T; Hafez, E; Takasu, C; Uehara, H; Yamakage, K; Kondo, T; Matsumoto, K; Furuta, M; Izumi, K				Sato, Makoto; Todoriki, Setsuko; Takahashi, Tetsuyuki; Hafez, Ezar; Takasu, Chie; Uehara, Hisanori; Yamakage, Kohji; Kondo, Takashi; Matsumoto, Kozo; Furuta, Masakazu; Izumi, Keisuke			Modifications of azoxymethane-induced carcinogenesis and 90-day oral toxicities of 2-tetradecylcyclobutanone as a radiolytic product of stearic acid in F344 rats	JOURNAL OF TOXICOLOGIC PATHOLOGY			English	Article						food irradiation; 2-tetradecylcyclobutanone; 90-day oral toxicity; colon carcinogenesis	BETA-CELL APOPTOSIS; FAT-CONTAINING FOOD; IRRADIATED FOODS; 2-ALKYLCYCLOBUTANONES; 2-DODECYLCYCLOBUTANONE; MUTAGENICITY; COMPONENTS; MUTATIONS; MARKERS	A 90-day oral toxicity test in rats was performed to evaluate the toxicity of 2-tetradecylcyclobutanone (2-tDCB), a unique radiolytic product of stearic acid. Six-week-old male and female F344 rats (n=15/group) were given 2-tDCB at concentrations of 0, 12, 60 and 300 ppm in a powder diet for 13 weeks. Slight dose-dependent increases in serum total protein and albumin in male rats were found, but these changes were not considered to be a toxic effect. The fasting, but not non-fasting, blood glucose levels of the male rats in the 300 ppm group and female rats in the 60 and 300 ppm groups were lower than those of the controls. Gas chromatography-mass spectrometry analysis showed dose-dependent accumulation of 2-tDCB in adipose tissue, notably in males. Next, we performed an azoxymethane (AOM)-induced two-stage carcinogenesis study. After injection of 6-week-old male F344 rats (n=30/group) once a week for 3 weeks, the animals received 2-tDCB at concentrations of 0, 10, 50 and 250 ppm in a powder diet for 25 weeks. The incidences of colon tumors for the 2-tDCB dosages were 34%, 45%, 40% and 37%, respectively, and were not statistically significant. These data suggest that 2-tDCB shows no toxic or tumor-modifying effects under the present conditions, and that the no-observed-adverse-effect level for 2-tDCB is 300 ppm in both sexes, equivalent to 15.5 mg/kg b.w./day in males and 16.5 mg/kg b.w./day in females.	[Sato, Makoto; Takahashi, Tetsuyuki; Hafez, Ezar; Takasu, Chie; Uehara, Hisanori; Izumi, Keisuke] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol & Environm Pathol, Tokushima 7708503, Japan; [Todoriki, Setsuko] Natl Food Res Inst, Food Safety Div, Tsukuba, Ibaraki 3058642, Japan; [Yamakage, Kohji] Food & Drug Safety Ctr, Hatano Res Inst, Div Alternat Toxicol Test, Hadano, Kanagawa 2578523, Japan; [Kondo, Takashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 9300194, Japan; [Matsumoto, Kozo] Kyoto Sangyo Univ, Fac Life Sci, Dept Anim Med Sci, Kita Ku, Kyoto 6038555, Japan; [Furuta, Masakazu] Osaka Prefecture Univ, Ctr Radiat Res, Lab Quantum Beam Chem Biol, Sakai, Osaka 5998570, Japan	Izumi, K (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol & Environm Pathol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	izumi-k@tokushima-u.ac.jp			Food Safety Commission, Cabinet Office, Japan [0906]	We are grateful to Miss Hitomi Umemoto and Mrs. Megumi Sato for laboratory assistance. This work was supported in part by the Food Safety Commission, Cabinet Office, Japan (#0906). The authors declare that they have no conflicts of interest.	STEVENSON MH, 1990, NATURE, V344, P202, DOI 10.1038/344202b0; Kume T, 2009, RADIAT PHYS CHEM, V78, P222, DOI 10.1016/j.radphyschem.2008.09.009; Sommers CH, 2003, J AGR FOOD CHEM, V51, P6367, DOI 10.1021/jf030348o; Ebbesson SOE, 2010, INT J CIRCUMPOL HEAL, V69, P344; Louheranta AM, 1998, METABOLISM, V47, P529, DOI 10.1016/S0026-0495(98)90235-9; Sommers CH, 2004, J FOOD PROTECT, V67, P1293; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Gadgil P, 2004, J FOOD SCI, V69, pC713; Obana H, 2005, J AGR FOOD CHEM, V53, P6603, DOI 10.1021/jf0506636; Ashley BC, 2004, INT J HYG ENVIR HEAL, V207, P493, DOI 10.1078/1438-4639-00321; Caulfield CD, 2009, VET PATHOL, V46, P1258, DOI 10.1354/vp.08-VP-0336-C-FL; Chen SS, 2011, J AGR FOOD CHEM, V59, P78, DOI 10.1021/jf103439c; Delincee H, 2002, RADIAT PHYS CHEM, V63, P431, DOI 10.1016/S0969-806X(01)00532-1; EFSA, 2011, EFSA J, V9, P1930; Eitel K, 2002, BIOCHEM BIOPH RES CO, V299, P853, DOI 10.1016/S0006-291X(02)02752-3; Hagiwara A, 2005, FOOD CHEM TOXICOL, V43, P1297, DOI 10.1016/j.fct.2005.04.001; Hartwig A, 2007, FOOD CHEM TOXICOL, V45, P2581, DOI 10.1016/j.fct.2007.05.033; Horvatovich P, 2002, J FOOD PROTECT, V65, P1610; Knoll N, 2006, MUTAT RES-FUND MOL M, V594, P10, DOI 10.1016/j.mrfmmm.2005.07.015; LETELLIE.PR, 1972, LIPIDS, V7, P75, DOI 10.1007/BF02531273; Rao CV, 2003, NUTR CANCER, V46, P107, DOI 10.1207/S15327914NC4602_01; Raul Francis, 2002, Nutr Cancer, V44, P189, DOI 10.1207/S15327914NC4402_11; SCHUBERT J, 1969, B WORLD HEALTH ORGAN, V41, P873; Variyar PS, 2008, J AGR FOOD CHEM, V56, P11817, DOI 10.1021/jf802391z; World Health Organization, 2011, WHO TECH REP SER; World Health Organization, 1999, WHO TECH REP SER; Yu DY, 2012, APOPTOSIS, V17, P636, DOI 10.1007/s10495-012-0698-1	27	0	0	JAPANESE SOC TOXICOLOGIC PATHOLOGY	TOKYO	DEPT ACAD SOC, MEDICAL TRIBUNE INC, ITALIAN CULTURAL INST BLDG 8F 2-1-30, KUDAN MINAMI, CHIYODA, TOKYO, 102-0074, JAPAN	0914-9198	1881-915X		J TOXICOL PATHOL	J. Toxicol. Pathol.	SPR	2015	28	2					99	107		10.1293/tox.28.2015-0002		9	Pathology; Toxicology	Pathology; Toxicology	CH9GL	WOS:000354343900006		
J	Sonoda, J; Seki, Y; Hakura, A; Hosokawa, S				Sonoda, Jiro; Seki, Yuki; Hakura, Atsushi; Hosokawa, Satoru			Time course of the incidence/multiplicity and histopathological features of murine colonic dysplasia, adenoma and adenocarcinoma induced by benzo[a]pyrene and dextran sulfate sodium	JOURNAL OF TOXICOLOGIC PATHOLOGY			English	Article						benzo[a]pyrene; dextran sulfate sodium; colon; tumor; dysplastic foci; beta-catenin	ABERRANT CRYPT FOCI; POLYCYCLIC AROMATIC-HYDROCARBONS; COLITIS-ASSOCIATED NEOPLASIA; INFLAMMATORY BOWEL-DISEASE; CATENIN GENE-MUTATIONS; BETA-CATENIN; COLORECTAL-CANCER; PRENEOPLASTIC LESIONS; RAPID INDUCTION; MOUSE MODELS	Benzo[a]pyrene (BP) is mutagenic but noncarcinogenic in the murine colon. Recently, we reported rapid induction of colonic tumors by treatment of CD2F(1) mice with BP (125 mg/kg for 5 days) followed by a colitis inducer, dextran sulfate sodium (DSS) (4% in drinking water for 1 or 2 weeks). However, there are no reports on detailed time course and histopathological features of colonic proliferative lesions in this model. Here, we show the detailed time course of colonic dysplasia, adenoma and adenocarcinoma induced by treatment with BP, DSS, and a combination of the two (BP/DSS). In the colon of mice exposed to BP/DSS, 14.6 dysplastic foci per mouse were present one week after DSS treatment (week 4). The number of dysplastic foci decreased with time to 3.1 at week 9 and thereafter remained almost constant. At week 4, 1.5 adenocarcinomas were also observed, with a marked increase in numbers with time, reaching 29.3 at week 14. In contrast, the number of dysplastic foci induced by DSS alone showed a time course similar to that following BP/DSS treatment; however, only a few tumors appeared. Neither dysplastic foci nor neoplastic lesions were induced by BP only. In mice exposed to BP/DSS, beta-catenin was demonstrated immunohistochemically in the nucleus and/or cytoplasm of the tumor cells, and this translocation from the cell membrane was evident in subsets of dysplastic foci. In dysplastic foci induced by DSS alone, beta-catenin was absent in the nucleus/cytoplasm. These finding suggest that aberrant beta-catenin accumulation in dysplastic foci is associated with tumor progression in this BP/DSS model.	[Sonoda, Jiro; Seki, Yuki; Hakura, Atsushi; Hosokawa, Satoru] Eisai & Co Ltd, Biopharmaceut Assessments Core Funct Unit, Global Drug Safety, Tsukuba Drug Safety, Tsukuba, Ibaraki 3002635, Japan	Sonoda, J (reprint author), Eisai & Co Ltd, Biopharmaceut Assessments Core Funct Unit, Global Drug Safety, Tsukuba Drug Safety, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan.	j-sonoda@hhc.eisai.co.jp					Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2; Ochiai M, 2003, AM J PATHOL, V163, P1607, DOI 10.1016/S0002-9440(10)63517-1; Tanaka T, 2005, CARCINOGENESIS, V26, P229, DOI 10.1093/carcin/bgh292; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Westbrook AM, 2010, MUTAT RES-REV MUTAT, V705, P40, DOI 10.1016/j.mrrev.2010.03.001; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Harris DL, 2009, TOXICOL PATHOL, V37, P938, DOI 10.1177/0192623309351722; Suzuki R, 2006, CARCINOGENESIS, V27, P162, DOI 10.1093/carcin/bgi205; Hakura A, 2011, FOOD CHEM TOXICOL, V49, P2997, DOI 10.1016/j.fct.2011.07.057; Diggs DL, 2011, J ENVIRON SCI HEAL C, V29, P324, DOI 10.1080/10590501.2011.629974; Benford D, 2010, FOOD CHEM TOXICOL, V48, pS42, DOI 10.1016/j.fct.2009.09.039; Culp SJ, 1998, CARCINOGENESIS, V19, P117, DOI 10.1093/carcin/19.1.117; Yamada Y, 2007, CANCER SCI, V98, P6, DOI 10.1111/j.1349-7006.2006.00348.x; Heijstek MW, 2005, DIGEST SURG, V22, P16, DOI 10.1159/000085342; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Hakura A, 1998, MUTAT RES-FUND MOL M, V398, P123, DOI 10.1016/S0027-5107(97)00248-0; Leedham SJ, 2005, CELL PROLIFERAT, V38, P387, DOI 10.1111/j.1365-2184.2005.00359.x; PASCAL RR, 1994, HUM PATHOL, V25, P1160, DOI 10.1016/0046-8177(94)90032-9; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Brittan M, 2004, GUT, V53, P899, DOI 10.1136/gut.2003.025478; Hakura A, 1999, MUTAT RES-FUND MOL M, V426, P71, DOI 10.1016/S0027-5107(99)00046-9; Cooper HS, 2000, CARCINOGENESIS, V21, P757, DOI 10.1093/carcin/21.4.757; Aoki K, 2007, ONCOGENE, V26, P3511, DOI 10.1038/sj.onc.1210141; Hakura A., 2013, PYRENE CHEM PROPERTI, P43; Imai T, 2007, CARCINOGENESIS, V28, P2199, DOI 10.1093/carcin/bgm118; Kobaek-Larsen M, 2000, COMPARATIVE MED, V50, P16; MORI H, 1984, Nutrition and Cancer, V6, P92; Mori H, 2004, MUTAT RES-REV MUTAT, V566, P191, DOI 10.1016/j.mrrev.2003.08.002; Okayasu I, 2002, J GASTROEN HEPATOL, V17, P1078, DOI 10.1046/j.1440-1746.2002.02853.x; Onose J, 2003, CANCER LETT, V198, P145, DOI 10.1016/S0304-3835(03)00316-1; Smith Jason E., 2010, IARC MONOGR EVAL CAR, V1.1, P1; Suzui M, 2013, J TOXICOL PATHOL, V26, P335, DOI 10.1293/tox.2013-0028; Suzuki R, 2004, CANCER SCI, V95, P721, DOI 10.1111/j.1349-7006.2004.tb03252.x; Tanaka Takuji, 2009, J Carcinog, V8, P5; Wang JG, 2004, WORLD J GASTROENTERO, V10, P2958; WARD JM, 1974, LAB INVEST, V30, P505; Weinberg R. A., 2007, BIOL CANC; Yamada Y, 2003, CARCINOGENESIS, V24, P91, DOI 10.1093/carcin/24.1.91; Yamada Y, 2000, CANCER RES, V60, P3323; Yamada Y, 2003, CARCINOGENESIS, V24, P1015, DOI 10.1093/carcin/bgg041; Yoshimi N, 2004, CANCER SCI, V95, P792, DOI 10.1111/j.1349-7006.2004.tb02183.x	44	1	1	JAPANESE SOC TOXICOLOGIC PATHOLOGY	TOKYO	DEPT ACAD SOC, MEDICAL TRIBUNE INC, ITALIAN CULTURAL INST BLDG 8F 2-1-30, KUDAN MINAMI, CHIYODA, TOKYO, 102-0074, JAPAN	0914-9198	1881-915X		J TOXICOL PATHOL	J. Toxicol. Pathol.	SPR	2015	28	2					109	120		10.1293/tox.28.2014-0061		12	Pathology; Toxicology	Pathology; Toxicology	CH9GL	WOS:000354343900007		
J	Kobayashi, R; Kurotaki, T; Yamada, N; Kumabe, S; Doi, T; Wako, Y; Tsuchitani, M				Kobayashi, Ryosuke; Kurotaki, Tetsuro; Yamada, Naoaki; Kumabe, Shino; Doi, Takuya; Wako, Yumi; Tsuchitani, Minoru			Spontaneous and bilateral necrosis of the femoral head in a young experimental beagle dog	JOURNAL OF TOXICOLOGIC PATHOLOGY			English	Article						avascular osteonecrosis; dog; Legg-Calve-Perthes disease; necrosis of the femoral head; spontaneous lesion	CALVE-PERTHES-DISEASE; INTRACAPSULAR TAMPONADE; PATHOGENESIS	This report describes the pathological characterizations of a rare case of necrosis of the femoral head that was spontaneous, bilateral, avascular and nontraumatic. A 14-month-old beagle dog was presented with pain in the hind limbs. At necropsy, the articular surface in the bilateral femoral head was markedly irregular. There were no gross abnormalities other than in the hip joints. Microscopically, a wide range of trabecular bone necrosis localized in the subchondral area was observed in both femoral heads. In the right femoral head, fibrosis and proliferative vessels were noted in the subchondral area. The articular cartilage was thickened irregularly, but there was no evidence of cartilage necrosis. The bone marrow adjacent to the affected area showed severe depression. In the metaphysis, atrophic bone marrow, but not bone necrosis, was observed. This was a rare case of spontaneous necrosis of the femoral head in an experimental beagle dog.	[Kobayashi, Ryosuke; Kurotaki, Tetsuro; Yamada, Naoaki; Kumabe, Shino; Doi, Takuya; Wako, Yumi; Tsuchitani, Minoru] LSI Medience Corp, Dept Pathol, Kamisu, Ibaraki 3140255, Japan	Kobayashi, R (reprint author), LSI Medience Corp, Dept Pathol, 14-1 Sunayama, Kamisu, Ibaraki 3140255, Japan.	kobayashi.ryousuke@mu.medience.co.jp					HOTTENDORF GH, 1974, VET PATHOL, V11, P240; Sato J, 2012, J TOXICOL PATHOL, V25, P103, DOI 10.1293/tox.25.103; Ginja MMD, 2010, VET J, V184, P269, DOI 10.1016/j.tvjl.2009.04.009; Alpaslan AM, 2007, ARCH ORTHOP TRAUM SU, V127, P485, DOI 10.1007/s00402-007-0367-y; TAKAOKA K, 1981, ARCH ORTHOP TRAUM SU, V99, P109, DOI 10.1007/BF00389746; Carlson CS, 2012, PATHOLOGIC BASIS VET, V5th, P953; FRIES CL, 1995, CAN VET J, V36, P494; FUJIKAWA K, 1991, Kurume Medical Journal, V38, P159; KEMP HBS, 1981, CLIN ORTHOP RELAT R, P105; Kobayashi K, 1994, J TOXICOL PATHOL, V7, P329; MICKELSON MR, 1981, CLIN ORTHOP RELAT R, P287; Shen Feng, 2011, Chin J Traumatol, V14, P227; SINGLETON WB, 1979, J COMP PATHOL, V89, P57, DOI 10.1016/0021-9975(79)90009-4; Thompson K., 2007, JUBB KENNEDY PALMERS, VI, P1; WARREN DV, 1972, CANADIAN VET J, V13, P135	15	0	0	JAPANESE SOC TOXICOLOGIC PATHOLOGY	TOKYO	DEPT ACAD SOC, MEDICAL TRIBUNE INC, ITALIAN CULTURAL INST BLDG 8F 2-1-30, KUDAN MINAMI, CHIYODA, TOKYO, 102-0074, JAPAN	0914-9198	1881-915X		J TOXICOL PATHOL	J. Toxicol. Pathol.	SPR	2015	28	2					121	124		10.1293/tox.28.2014-0060		4	Pathology; Toxicology	Pathology; Toxicology	CH9GL	WOS:000354343900008		
J	Crowther, D; Trofimovich, P; Isaacs, T; Saito, K				Crowther, Dustin; Trofimovich, Pavel; Isaacs, Talia; Saito, Kazuya			Does a Speaking Task Affect Second Language Comprehensibility?	MODERN LANGUAGE JOURNAL			English	Article						comprehensibility; task; phonology; fluency; lexicon; grammar; pronunciation learning and teaching	FOREIGN ACCENT; INTELLIGIBILITY; PRONUNCIATION; LEARNERS; JUDGMENTS; FLUENCY; ENGLISH; COMPLEXITY; PERFORMANCE; ACCURACY	The current study investigated task effects on listener perception of second language (L2) comprehensibility (ease of understanding). Sixty university-level adult speakers of English from 4 first language (L1) backgrounds (Chinese, Romance, Hindi, Farsi), with 15 speakers per group, were recorded performing 2 tasks (IELTS long-turn speaking task and TOEFL iBT integrated listening/reading and speaking task). The speakers' audio recordings were evaluated using continuous sliding scales by 10 native English listeners for comprehensibility as well as for 10 linguistic variables drawn from the domains of pronunciation, fluency, lexis, grammar, and discourse. In the IELTS task, comprehensibility was associated solely with pronunciation and fluency categories (specifically, segmentals, word stress, rhythm, and speech rate), with the Farsi group being the only exception. However, in the cognitively more demanding TOEFL iBT integrated task, in addition to pronunciation and fluency variables, comprehensibility was also linked to several categories at the level of grammar, lexicon, and discourse for all groups. In both tasks, the relative strength of obtained associations also varied as a function of the speakers' L1. Results overall suggest that both task and speakers' L1 play important roles in determining ease of understanding for the listener, with implications for pronunciation teaching in mixed L1 classrooms and for operationalizing the construct of comprehensibility in assessments.	[Crowther, Dustin] Michigan State Univ, Dept Linguist & German Slav Asian & African Langu, E Lansing, MI 48823 USA; [Trofimovich, Pavel] Concordia Univ, Dept Educ, Montreal, PQ H3G 1M8, Canada; [Isaacs, Talia] Univ Bristol, Grad Sch Educ, Bristol BS8 1JA, Avon, England; [Saito, Kazuya] Waseda Univ, Sch Commerce, Shinjuku Ku, Tokyo 1698050, Japan	Crowther, D (reprint author), Michigan State Univ, Dept Linguist & German Slav Asian & African Langu, 500 West Lake Lansing Rd A17, E Lansing, MI 48823 USA.	crowth14@msu.edu; pavel.trofimovich@concordia.ca; Talia.Isaacs@bristol.ac.uk; kazuya.saito@waseda.jp			Social Sciences and Humanities Research Council of Canada (SSHRC); Fonds de Recherche sur la Societe et la Culture (FRQSC); Marie Curie Career Integration Grant (European Commission);  [26770202]	This study was funded by grants from the Social Sciences and Humanities Research Council of Canada (SSHRC) and Fonds de Recherche sur la Societe et la Culture (FRQSC) awarded to the second author, a Marie Curie Career Integration Grant (European Commission) awarded to the third author, and by the Grant-in-Aid for Scientific Research in Japan (No. 26770202) awarded to the fourth author. We are grateful to our participants, to Ze Shan Yao for his technical help, and to anonymous MLJ reviewers for their helpful input and feedback on the content of this article.	Munro MJ, 1999, LANG LEARN, V49, P285, DOI 10.1111/0023-8333.49.s1.8; Escudero P, 2004, STUD SECOND LANG ACQ, V26, P551, DOI 10.1017/S0272226310400021; Skehan P, 2009, APPL LINGUIST, V30, P510, DOI 10.1093/applin/amp047; Bongaerts T, 1999, SEC LANG ACQ RES, P133; Robinson P, 2001, APPL LINGUIST, V22, P27, DOI 10.1093/applin/22.1.27; Levis JM, 2005, TESOL QUART, V39, P369; Derwing TM, 2009, LANG TEACH, V42, P476, DOI 10.1017/S026144480800551X; Derwing TM, 2004, LANG LEARN, V54, P655, DOI 10.1111/j.1467-9922.2004.00282.x; Mackay IRA, 2006, APPL PSYCHOLINGUIST, V27, P157, DOI 10.1017/S0142716406060231; Kang O, 2010, MOD LANG J, V94, P554, DOI 10.1111/j.1540-4781.2010.01091.x; Munro MJ, 2011, LANG TEACHING, V44, P316, DOI 10.1017/S0261444811000103; Winke P, 2013, LANG TEST, V30, P231, DOI 10.1177/0265532212456968; Major RC, 2002, TESOL QUART, V36, P173, DOI 10.2307/3588329; Field J, 2005, TESOL QUART, V39, P399; Hahn LD, 2004, TESOL QUART, V38, P201; Yuan FY, 2003, APPL LINGUIST, V24, P1, DOI 10.1093/applin/24.1.1; ANDERSONHSIEH J, 1992, LANG LEARN, V42, P529, DOI 10.1111/j.1467-1770.1992.tb01043.x; FLEGE JE, 1995, SPEECH COMMUN, V16, P1, DOI 10.1016/0167-6393(94)00044-B; Brown A., 2005, TOEFL MONOGRAPH, V29; Chalhoub-Deville M., 2000, SYSTEM, V28, P523, DOI 10.1016/S0346-251X(00)00036-1; Crossley SA, 2015, APPL LINGUIST, V36, P570, DOI 10.1093/applin/amt056; Crowther D., 2015, TESOL Q, DOI [10.1002/tesq.203, DOI 10.1002/TESQ.203]; Derwing T., 1997, STUDIES 2 LANGUAGE A, V20, P1; Derwing T. M., 2003, CANADIAN MODERN LANG, V59, P476; Derwing TM, 2008, APPL LINGUIST, V29, P359, DOI 10.1093/applin/amm041; DICKERSON LJ, 1975, TESOL QUART, V9, P401, DOI 10.2307/3585624; Duanmu S., 2007, PHONOLOGY STANDARD C; Eckman FR, 2004, STUD SECOND LANG ACQ, V26, P513, DOI 10.1071/S027226310404001X; Educational Testing Service, 2006, OFF GUID NEW TOEFL I; Ejzenberg R., 2000, PERSPECTIVES FLUENCY, P287; Ellis R., 2001, RES PEDAGOGIC TASKS, P49; FAYER JM, 1987, LANG LEARN, V37, P313, DOI 10.1111/j.1467-1770.1987.tb00573.x; Field A., 2009, DISCOVERING STAT USI; Flege JE, 2003, PHONETICS PHONOLOGY, P319, DOI DOI 10.1515/9783110895094.319; Foote J. A., 2011, TESL CANADA J, V29, P1; Harding L., 2013, ENCY APPL LINGUISTIC, DOI [10.1002/9781405198431.wbeal0966, DOI 10.1002/9781405198431.WBEAL0966]; Hilton H. E., 2008, LANGUAGE LEARNING J, V36, P153, DOI DOI 10.1080/09571730802389983; Hutcheson GD, 1999, MULTIVARIATE SOCIAL; IELTS, 2009, OFF IELTS PRACT MAT; Isaacs T., 2011, INT STUDENTS CANADIA; Issacs T., 2012, STUDIES 2 LANGUAGE A, V34, P475; Jakeman V., 2008, NEW INSIGHT INTO IEL; Jenkins J., 2013, ENGLISH LINGUA FRANC; Jun S.-A., 2005, PROSODIC TYPOLOGY PH, P430, DOI DOI 10.1093/ACPROF:OSO/9780199249633.003.0016; Kormos J., 2006, SPEECH PRODUCTION 2; Labov W., 1966, SOCIAL STRATIFICATIO; LarsonHall J, 2009, SECOND LANG ACQUIS R, P1; Long M., 1996, HDB LANGUAGE ACQUISI, V2, P413, DOI DOI 10.1016/B978-012589042-7/50015-3; Mackey A., 2007, CONVERSATIONAL INTER, P407; Major Roy, 2001, FOREIGN ACCENT ONTOG; Martin James R., 2003, WORKING DISCOURSE ME; McDonough K., 2000, STUDIES 2 LANGUAGE A, V22, P471, DOI DOI 10.1017/S0272263100004022; Moyer A, 1999, STUDIES 2 LANGUAGE A, V21, P81, DOI DOI 10.1017/50272263199001035; Munro M., 2003, TESL CANADA J, V20, P38; Munro Murray J., 2001, STUDIES 2 LANGUAGE A, V23, P451; Ochs Elinor, 1979, DEV PRAGMATICS, P43; Qian DD, 2009, LANG ASSESS Q, V6, P113, DOI 10.1080/15434300902800059; Rau DV, 2009, LANG LEARN, V59, P581; Robinson P., 2005, IRAL-INT REV APPL LI, V43, P1, DOI DOI 10.1515/IRA1.2005.43.1.1; Robinson P., 2007, INVESTIGATING TASKS, P7; Saito K., 2015, APPL PSYCHOLINGUISTI, V35; Saito K., 2015, APPL LINGUISTICS, V36; Segalowitz N., 2010, COGNITIVE BASES 2 LA; Shackle C., 2001, LEARNER ENGLISH TEAC, P310; Skehan P., 1998, COGNITIVE APPROACH L; Skehan P., 1997, LANG TEACH RES, V1, P185, DOI DOI 10.1177/136216889700100302; Swan Michael, 2001, LEARNER ENGLISH TEAC; TARONE E, 1983, APPL LINGUIST, V4, P142, DOI 10.1093/applin/4.2.142; Tokumoto M, 2011, WORLD ENGLISH, V30, P392, DOI 10.1111/j.1467-971X.2011.01710.x; Trofimovich P, 2012, BILING-LANG COGN, V15, P905, DOI 10.1017/S1366728912000168; Upshur J. A., 1999, LANG TEST, V16, P82, DOI DOI 10.1177/026553229901600105; Wilson L., 2001, LEARNER ENGLISH TEAC, V2nd, P310	72	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0026-7902	1540-4781		MOD LANG J	Mod. Lang. J.	SPR	2015	99	1					80	95		10.1111/modl.12185		16	Education & Educational Research; Linguistics	Education & Educational Research; Linguistics	CH4GG	WOS:000353991300005		
J	Munezane, Y				Munezane, Yoko			Enhancing Willingness to Communicate: Relative Effects of Visualization and Goal Setting	MODERN LANGUAGE JOURNAL			English	Article						willingness to communicate; ideal L2 self; visualization; goal setting; classroom-based research	POSSIBLE SELVES; MOTIVATION; MODEL; PERSPECTIVE; ATTITUDES; EMOTIONS; L2	This article examines the relative effects of two treatmentsgoal setting and visualizationon enhancing Willingness to Communicate (WTC) among a group of 373 Japanese university EFL learners. Although longitudinal studies in both EFL and ESL settings have been conducted to examine the developmental aspect of WTC, no solid results of enhancing WTC through instruction have been found in EFL settings. Based on Dornyei's (2005) concept of the Ideal L2 Self, lessons were designed for the two treatment groups so learners could visualize themselves as future specialists in their field, discussing global issues and presenting their creative ideas for solving these global problems. For the second treatment group, a goal setting activity was introduced in which students articulated their speaking goals in each class. The nontreatment group, the visualization group, and the visualization plus goal setting group had approximately the same amount of communicative activities. The ANCOVA results suggest that the visualization treatment alone was not effective in enhancing learners' L2 WTC over the nontreatment group. However, when visualization was combined with goal setting, the increase in learners' L2 WTC was significantly larger compared to the visualization group, and by implication, significantly larger compared to the nontreatment group. Additionally, the impact of visualization and goal setting on learners' WTC was qualitatively explored.	Aoyama Gakuin Univ, Sch Int Polit Econ & Commun, Shibuya Ku, Tokyo 1508366, Japan	Munezane, Y (reprint author), Aoyama Gakuin Univ, Sch Int Polit Econ & Commun, Shibuya Ku, 4-4-25 Shibuya, Tokyo 1508366, Japan.	ymunezane@aoyamagakuin.jp					Ajzen I., 1988, ATTITUDES PERSONALIT; Yashima T, 2004, LANG LEARN, V54, P119, DOI 10.1111/j.1467-9922.2004.00250.x; Wolters CA, 2003, EDUC PSYCHOL, V38, P189, DOI 10.1207/S15326985EP3804_1; Seijts GH, 2004, ACAD MANAGE J, V47, P227; Oyserman D, 2002, J ADOLESCENCE, V25, P313, DOI 10.1006/jado.2002.0474; Zhong QY, 2013, SYSTEM, V41, P740, DOI 10.1016/j.system.2013.08.001; Barnard-Brak L, 2010, INT REV RES OPEN DIS, V11, P61; Baumgartner H, 2008, EUR J SOC PSYCHOL, V38, P685, DOI 10.1002/ejsp.467; HIGGINS ET, 1985, SOC COGNITION, V3, P51, DOI 10.1521/soco.1985.3.1.51; Zimmerman BJ, 1998, EDUC PSYCHOL, V33, P73, DOI 10.1207/s15326985ep3302&3_3; Kramsch C, 2014, MOD LANG J, V98, P296, DOI 10.1111/j.1540-4781.2014.12057.x; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037//0003-066X.41.9.954; Sohl SJ, 2009, PERS INDIV DIFFER, V47, P139, DOI 10.1016/j.paid.2009.02.013; Simons J, 2004, EDUC PSYCHOL REV, V16, P121, DOI 10.1023/B:EDPR.0000026609.94841.2f; Macintyre PD, 1998, MOD LANG J, V82, P545, DOI 10.2307/330224; Dornyei Z, 2009, SECOND LANG ACQUIS, P9; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Yashima T, 2008, SYSTEM, V36, P566, DOI 10.1016/j.system.2008.03.006; Oyserman D, 2004, J RES PERS, V38, P130, DOI 10.1016/S0092-6566(03)00057-6; MacIntyre PD, 2012, SYSTEM, V40, P533, DOI 10.1016/j.system.2012.10.014; MacIntyre PD, 2003, CAN MOD LANG REV, V59, P589; Oyserman D, 2006, J PERS SOC PSYCHOL, V91, P188, DOI 10.1037/0022-3541.91.1.188; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP063OA; Burgoon J. K., 1976, SPEECH MONOGR, V43, P60; Corno L., 1993, EDUC RES, V22, P14, DOI [10.3102/0013189X022002014, DOI 10.3102/0013189X022002014]; Corno L, 2001, SELF-REGULATED LEARNING AND ACADEMIC ACHIEVEMENT, SECOND ED., P191; Council of Europe, 2011, COMM EUR FRAM REF LA; Deci E. L., 1985, INTRINSIC MOTIVATION; Dornyei Z., 2005, PSYCHOL LANGUAGE LEA; Ellis K., 1998, MAGIC LAMP GOAL SETT; Frey B., 2002, SUCCESSFUL MANAGEMEN; Gawain S., 2002, CREATIVE VISUALIZATI; James W., 1890, PRINCIPLES PSYCHOL; Langdridge D., 2004, INTRO RES METHODS DA; Lewin K., 1951, FIELD THEORY SOCIAL; Liao X., 2004, ELT J, V58, P270, DOI 10.1093/elt/58.3.270; Linacre J. M., 2009, WINSTEPS MULTIPLE CH; Locke E. A., 1991, THEORY GOAL SETTING; LOCKE EA, 1981, PSYCHOL BULL, V90, P125, DOI 10.1037//0033-2909.90.1.125; Locke EA, 1996, APPL PREV PSYCHOL, V5, P117, DOI 10.1016/S0962-1849(96)80005-9; MacIntyre P., 2012, STUDIES 2 LANGUAGE L, V2, P193; MacIntyre P. D., 2007, MOD LANG J, V91, P565; MacIntyre P. D., 2010, APPL LINGUIST, V32, P149; Markus H, 2006, POSSIBLE SELVES THEO, pxi; Martin J, 2004, EDUC PSYCHOL, V39, P135, DOI 10.1207/s15326985ep3902_4; McCroskey J. C., 1985, ANN CONV SPEECH COMM; Miller RB, 2004, EDUC PSYCHOL REV, V16, P9, DOI 10.1023/B:EDPR.0000012343.96370.39; Ministry of Education Culture Sports Science Technology (MEXT), 2011, 5 PROP SPEC MEAS DEV; Munezane Y., 2010, DOCT WORKSH EUROSLA; Munezane Y., 2014, AAAL ANN C PORTL OR; Okayama Y., 2006, JALT 2005 SHARING OU, P372; Pintrich P. R., 2000, HDB SELF REGULATION, P452; Rasch G., 1960, PROBABILISTIC MODELS; Rogers C. R., 1951, CLIENT CTR THERAPY I; Segal HG, 2006, POSSIBLE SELVES: THEORY, RESEARCH AND APPLICATIONS, P79; Sick J. R., 2000, TEST YOUR WILLINGNES; Sick J. R., 2001, ANN CONV PACSLRF HON; Tabachnick B. G., 2007, USING MULTIVARIATE S; Tracy B., 2003, GOALS GET EVERYTHING; Watanabe M., 2013, JALT J, V35, P153; Whiteley S., 1997, USING VISUALIZATION	62	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0026-7902	1540-4781		MOD LANG J	Mod. Lang. J.	SPR	2015	99	1					175	191		10.1111/modl.12193		17	Education & Educational Research; Linguistics	Education & Educational Research; Linguistics	CH4GG	WOS:000353991300010		
J	Mizoguchi, N; Tsuji, H; Toyama, S; Kamada, T; Tsujii, H; Nakayama, Y; Mizota, A; Ohnishi, Y				Mizoguchi, Nobutaka; Tsuji, Hiroshi; Toyama, Shingo; Kamada, Tadashi; Tsujii, Hirohiko; Nakayama, Yuko; Mizota, Atsushi; Ohnishi, Yoshitaka		Working Grp Ophthalmologic Tumors	Carbon-ion radiotherapy for locally advanced primary or postoperative recurrent epithelial carcinoma of the lacrimal gland	RADIOTHERAPY AND ONCOLOGY			English	Article						Carbon ion radiotherapy; Charged particle therapy; Carcinoma of the lacrimal gland	ADENOID CYSTIC CARCINOMA; TUMORS; CANCER; CHEMOTHERAPY	Purpose: To evaluate the applicability of carbon ion beams for the treatment of carcinoma of the lacrimal gland with regard to normal tissue morbidity and local tumor control. Methods and materials: Between April 2002 and January 2011, 21 patients with locally advanced primary epithelial carcinoma of the lacrimal gland were enrolled in a Phase I/II clinical trial of carbon-ion radiotherapy (CIRT) at the National Institute of Radiological Sciences. Acute radiation toxicity was the primary endpoint of this dose-escalation study and the late toxicity, local control, and overall survival were additionally evaluated as secondary endpoints. Of the 21 subjects enrolled, all patients were followed for more than 6 months and analyzed. Results: The radiation dose was increased from the initial dose of 48.0 Gy equivalents (GyE)/12 fractions at 10% increments up to 52.8 GyE. Of the 21 patients, five received a total dose of 48.0 GyE, and 16 received a total dose of 52.8 GyE. No patient developed grade 3 or higher skin toxicity. As late ocular/visual toxicity, three patients had grade 3 retinopathy and seven patients lost their vision. Among the 10 patients treated until May 2005, five patients had local recurrence, three of whom had marginal recurrence. Therefore, the margin for the CTV (clinical target volume) was set to a range according to the orbital exenteration since June 2005. After the application of the extended margin, no local recurrence,has been observed. The three-year overall survival and local control rates were 82.2% and 79.0%, respectively. Conclusion: CIRT can be applied for primary epithelial carcinoma of the lacrimal gland, with a borderline acceptable morbidity and sufficient antitumor effect when an extended margin is adopted. (c)) 2015 Elsevier Ireland Ltd. All rights reserved.	[Mizoguchi, Nobutaka; Tsuji, Hiroshi; Toyama, Shingo; Kamada, Tadashi; Tsujii, Hirohiko] Natl Inst Radiol Sci, Res Ctr Hosp Charged Particle Therapy, Chiba 260, Japan; [Mizoguchi, Nobutaka; Nakayama, Yuko] Kanagawa Canc Ctr, Dept Radiat Oncol, Tokyo, Japan; [Mizota, Atsushi] Teikyo Univ, Sch Med, Dept Ophthalmol, Tokyo 173, Japan; [Ohnishi, Yoshitaka] Wakayama Med Univ, Dept Ophthalmol, Wakayama, Japan	Mizoguchi, N (reprint author), Natl Inst Radiol Sci, Res Ctr Hosp Charged Particle Therapy, Chiba 260, Japan.						Ahmad SM, 2009, OPHTHALMOLOGY, V116, P1210, DOI 10.1016/j.ophtha.2008.12.049; Tsuji H, 2007, INT J RADIAT ONCOL, V67, P857, DOI 10.1016/j.ijrobp.2006.09.022; [Anonymous], 1999, COMM TOX CRIT V2 0; Weis E, 2009, ARCH OPHTHALMOL-CHIC, V127, P1016, DOI 10.1001/archophthalmol.2009.209; Mizoe J, 2012, RADIOTHER ONCOL, V103, P32, DOI 10.1016/j.radonc.2011.12.013; Tsuji H, 2005, INT J RADIAT ONCOL, V63, P1153, DOI 10.1016/j.ijrobp.2005.04.022; Kamada T, 2002, J CLIN ONCOL, V20, P4466, DOI 10.1200/JCO.2002.10.050; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; [Anonymous], RTOG EORTC LAT RAD M; WRIGHT JE, 1992, BRIT J OPHTHALMOL, V76, P401, DOI 10.1136/bjo.76.7.401; BRADA M, 1987, RADIOTHER ONCOL, V9, P175; Endo M, 1996, JPN SOC THER RADIOL, V8, P231; Fleming ID, 1997, AJCC CANC STAGING MA, V5th, P273; Font RL, 1998, ARCH OPHTHALMOL-CHIC, V116, P613; Ohshima K, 2005, JPN J OPHTHALMOL, V49, P343, DOI 10.1007/s10384-005-0224-x; Meldrum ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P315; Skinner HD, 2011, CANCER-AM CANCER SOC, V117, P2801, DOI 10.1002/cncr.25813; Tse DT, 2006, AM J OPHTHALMOL, V141, P44, DOI 10.1016/j.ajo.2005.08.068; Tsujii H, 2004, RADIOTHER ONCOL, V73, pS41, DOI 10.1016/S0167-8140(04)80012-4	19	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-8140			RADIOTHER ONCOL	Radiother. Oncol.	MAR	2015	114	3					373	377		10.1016/j.radonc.2015.01.009		5	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CH0UL	WOS:000353737800016		
J	Tian, BW; Wang, L; Kashiwaya, K; Koike, K				Tian, Bingwei; Wang, Ling; Kashiwaya, Koki; Koike, Katsuaki			Combination of Well-Logging Temperature and Thermal Remote Sensing for Characterization of Geothermal Resources in Hokkaido, Northern Japan	REMOTE SENSING			English	Article							HEAT-FLOW DATA; LANDSAT-7 ETM+; INFRARED DATA; RETRIEVAL; GRADIENT; VOLCANO; ENERGY; CHINA	Geothermal resources have become an increasingly important source of renewable energy for electrical power generation worldwide. Combined Three Dimension (3D) Subsurface Temperature (SST) and Land Surface Temperature (LST) measurements are essential for accurate assessment of geothermal resources. In this study, subsurface and surface temperature distributions were combined using a dataset comprised of well logs and Thermal Infrared Remote sensing (TIR) images from Hokkaido island, northern Japan. Using 28,476 temperature data points from 433 boreholes sites and a method of Kriging with External Drift or trend (KED), SST distribution model from depths of 100 to 1500 m was produced. Regional LST was estimated from 13 scenes of Landsat 8 images. Resultant SST ranged from around 50 degrees C to 300 degrees C at a depth of 1500 m. Most of western and part of the eastern Hokkaido are characterized by high temperature gradients, while low temperatures were found in the central region. Higher temperatures in shallower crust imply the western region and part of the eastern region have high geothermal potential. Moreover, several LST zones considered to have high geothermal potential were identified upon clarification of the underground heat distribution according to 3D SST. LST in these zones showed the anomalies, 3 to 9 degrees C higher than the surrounding areas. These results demonstrate that our combination of TIR and 3D temperature modeling using well logging and geostatistics is an efficient and promising approach to geothermal resource exploration.	[Tian, Bingwei; Kashiwaya, Koki; Koike, Katsuaki] Kyoto Univ, Grad Sch Engn, Dept Urban Management, Kyoto 6158540, Japan; [Tian, Bingwei] Sichuan Univ, Hong Kong Polytech Univ, Inst Disaster Management & Reconstruct, Chengdu 610207, Peoples R China; [Wang, Ling] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Peoples R China	Koike, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Urban Management, Kyoto 6158540, Japan.	bwtian@gmail.com; lingrwang@gmail.com; kashiwaya.koki.8a@kyoto-u.ac.jp; koike.katsuaki.5x@kyoto-u.ac.jp	Tian, Bingwei/D-1822-2010	Tian, Bingwei/0000-0001-9031-3307			Agemar T, 2012, GEOTHERMICS, V44, P65, DOI 10.1016/j.geothermics.2012.07.002; AIST, VOLC JAP; Andres R.J., 1995, MONIT ACTIVE VOLCAN, V1, P301; Yu XL, 2014, REMOTE SENS-BASEL, V6, P9829, DOI 10.3390/rs6109829; Li ZL, 2013, REMOTE SENS ENVIRON, V131, P14, DOI 10.1016/j.rse.2012.12.008; Qin QM, 2011, INT J APPL EARTH OBS, V13, P552, DOI 10.1016/j.jag.2011.02.005; Jimenez-Munoz JC, 2014, IEEE GEOSCI REMOTE S, V11, P1840, DOI 10.1109/LGRS.2014.2312032; Bertani R, 2012, GEOTHERMICS, V41, P1, DOI 10.1016/j.geothermics.2011.10.001; van der Meer F, 2014, INT J APPL EARTH OBS, V33, P255, DOI 10.1016/j.jag.2014.05.007; Srivastava PK, 2009, ADV SPACE RES, V43, P1563, DOI 10.1016/j.asr.2009.01.023; Tanaka A, 2004, EARTH PLANETS SPACE, V56, P1195; Urai M, 2002, EARTH PLANETS SPACE, V54, P211; Barbier E, 2002, RENEW SUST ENERG REV, V6, P3, DOI 10.1016/S1364-0321(02)00002-3; Sobrino JA, 2004, REMOTE SENS ENVIRON, V90, P434, DOI 10.1016/j.rse.2004.02.003; Fridleifsson IB, 2001, RENEW SUST ENERG REV, V5, P299, DOI 10.1016/S1364-0321(01)00002-8; ARTIS DA, 1982, REMOTE SENS ENVIRON, V12, P313, DOI 10.1016/0034-4257(82)90043-8; Asaue H, 2006, J APPL GEOPHYS, V58, P296, DOI 10.1016/j.jappgeo.2005.05.006; BANNO S, 1992, ANNU REV EARTH PL SC, V20, P159, DOI 10.1146/annurev.ea.20.050192.001111; Bivand R., MAPTOOLS TOOLS READI; Bivand R., RGEOS INTERFACE GEOM; Bivand R, RGDAL BINDINGS GEOSP; Bourennane H, 2000, GEODERMA, V97, P255, DOI 10.1016/S0016-7061(00)00042-2; Ehara S., 1972, J FS HOKKAIDO U G, V3, P443; Flynn LP, 2001, REMOTE SENS ENVIRON, V78, P180, DOI 10.1016/S0034-4257(01)00258-9; Fridleifsson I., POSSIBLE ROLE CONTRI; Goslee S., LANDSAT RADIOMETRIC; Greenberg J. A., GDALUTILS WRAPPERS G; Guo W., 2002, ACTA METEOROL SIN, V6, P706; Harris AJL, 1999, INT J REMOTE SENS, V20, P3051, DOI 10.1080/014311699211615; Hellman MJ, 2004, J VOLCANOL GEOTH RES, V135, P195, DOI 10.1016/j.jvolgeores.2003.12.012; Hijmans RJ, RASTER GEOGRAPHIC DA; Hodder D. T., 1970, GEOTHERMICS, V2, P368, DOI 10.1016/0375-6505(70)90035-0; JAEA, TEMP PROF JAP; JAXA, HIGH RES LAND US LAN; Kahle D., GGMAP PACKAGE SPATIA; Kametani T., 1964, GEOPHYS EXPLOR, V17, P72; Kimura G., 1996, ISL ARC, V5, P262, DOI DOI 10.1111/J.1440-1738.1996.TB00031.X; Li Z.L., 2012, INT J REMOTE SENS, V34, P37; MARESCHAL JC, 1989, TECTONOPHYSICS, V164, P129, DOI 10.1016/0040-1951(89)90007-3; Minato M., GEOTECTONIC SYNTHESI; NASA, WHAT AR BAND DES LAN; Pebesma E., GSTAT SPATIAL SPATIO; Pebesma E., SP CLASSES METHODS S; Perpinan Lamigueiro O., RASTERVIS VISUALIZAT; R Core Team, 2014, R LANG ENV STAT COMP; Siebert L., 2010, VOLCANOES WORLD; Tanaka A, 2004, EARTH PLANETS SPACE, V56, P1191; Teng Y, 2007, GEOTHERMICS, V36, P518, DOI 10.1016/j.geothermics.2007.07.006; Tian B., 2014, P 2014 IEEE INT GEOS, P879; Tian B., TIR PACKAGE THERMAL; Vlassova L, 2014, REMOTE SENS-BASEL, V6, P4345, DOI 10.3390/rs6054345; Wang L, 2013, J EARTH SCI-CHINA, V24, P282, DOI 10.1007/s12583-013-0329-y; Wickham H, GGPLOT2 IMPLEMENTATI; Zvoleff A., WRSPATHROW FUNCTIONS	54	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-4292			REMOTE SENS-BASEL	Remote Sens.	MAR	2015	7	3					2647	2667		10.3390/rs70302647		21	Remote Sensing	Remote Sensing	CH0BZ	WOS:000353685200016		
J	Hosseini, R; Newlands, NK; Dean, CB; Takemura, A				Hosseini, Reza; Newlands, Nathaniel K.; Dean, Charmaine B.; Takemura, Akimichi			Statistical Modeling of Soil Moisture, Integrating Satellite Remote-Sensing (SAR) and Ground-Based Data	REMOTE SENSING			English	Article							SYNTHETIC-APERTURE RADAR; SURFACE-ROUGHNESS; EQUATION MODEL; FIELD-SCALE; RETRIEVAL; IMAGES; BAND; CALIBRATION; PREDICTION	We present a flexible, integrated statistical-based modeling approach to improve the robustness of soil moisture data predictions. We apply this approach in exploring the consequence of different choices of leading predictors and covariates. Competing models, predictors, covariates and changing spatial correlation are often ignored in empirical analyses and validation studies. An optimal choice of model and predictors may, however, provide a more consistent and reliable explanation of the high environmental variability and stochasticity of soil moisture observational data. We integrate active polarimetric satellite remote-sensing data (RADARSAT-2, C-band) with ground-based in-situ data across an agricultural monitoring site in Canada. We apply a grouped step-wise algorithm to iteratively select best-performing predictors of soil moisture. Integrated modeling approaches may better account for observed uncertainty and be tuned to different applications that vary in scale and scope, while also providing greater insights into spatial scaling (upscaling and downscaling) of soil moisture variability from the field- to regional scale. We discuss several methodological extensions and data requirements to enable further statistical modeling and validation for improved agricultural decision-support.	[Hosseini, Reza] IBM Res Collaboratory, Singapore 486048, Singapore; [Newlands, Nathaniel K.] Agr & Agri Food Canada, Lethbridge Res Ctr, Sci & Technol, Lethbridge, AB T1J 4B1, Canada; [Dean, Charmaine B.] Univ Western Ontario, Dept Stat & Actuarial Sci, Western Sci Ctr 262, London, ON N6A 5B7, Canada; [Takemura, Akimichi] Univ Tokyo, Grad Sch Informat Sci & Technol, Bunkyo Ku, Tokyo 1138656, Japan	Newlands, NK (reprint author), Agr & Agri Food Canada, Lethbridge Res Ctr, Sci & Technol, 5403 1st Ave South,POB 3000, Lethbridge, AB T1J 4B1, Canada.	rezah@sg.ibm.com; nathaniel.newlands@agr.gc.ca; cbdean@uwo.ca; takemura@stat.t.u-tokyo.ac.jp			Growing Forward Program of Agriculture and Agri-Food Canada (AAFC); National Science and Engineering Council of Canada (NSERC)	The authors would like to thank Heather McNairn and Amine Merzouki from Agriculture and Agri-Food Canada (AAFC-Ottawa, ON, Canada) for providing the processed RADARSAT-2 SAR and ground-based data from the AAFC Casselman agricultural monitoring site for use in this modeling study. We also thank them for their feedback in helping to initially frame and facilitate our modeling work. Funding was provided by the Growing Forward Program of Agriculture and Agri-Food Canada (AAFC) and the National Science and Engineering Council of Canada (NSERC)'s Visiting Fellows in Government Laboratories Program. We thank A. Potgieter (University of Queensland, Toowoomba) and three anonymous reviewers for their feedback and help in improving our manuscript.	Adams JR, 2013, CAN J REMOTE SENS, V39, P1, DOI 10.5589/m13-003; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Paloscia S, 2008, IEEE T GEOSCI REMOTE, V46, P3274, DOI 10.1109/TGRS.2008.920370; Oh Y, 2002, IEEE T GEOSCI REMOTE, V40, P1348, DOI 10.1109/TGRS.2002.800232; Baghdadi N, 2002, INT J REMOTE SENS, V23, P4325, DOI 10.1080/01431160110107671; Phillips AJ, 2014, COMPUT ELECTRON AGR, V107, P73, DOI 10.1016/j.compag.2014.02.011; Lakhankar T, 2009, REMOTE SENS-BASEL, V1, P3, DOI 10.3390/rs1010003; Finley AO, 2008, J AGR BIOL ENVIR ST, V13, P60, DOI 10.1198/108571108X273160; Pratola C, 2014, REMOTE SENS-BASEL, V6, P8190, DOI 10.3390/rs6098190; Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Quesney A, 2000, REMOTE SENS ENVIRON, V72, P290, DOI 10.1016/S0034-4257(99)00102-9; Gao G, 2010, SENSORS-BASEL, V10, P775, DOI 10.3390/s100100775; DUBOIS PC, 1995, IEEE T GEOSCI REMOTE, V33, P915, DOI 10.1109/36.406677; Zribi M, 2011, HYDROL EARTH SYST SC, V15, P345, DOI 10.5194/hess-15-345-2011; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; Shi JC, 1997, IEEE T GEOSCI REMOTE, V35, P1254; Baghdadi N, 2011, IEEE GEOSCI REMOTE S, V8, P14, DOI 10.1109/LGRS.2010.2050054; Li B, 2013, HYDROL EARTH SYST SC, V17, P1177, DOI 10.5194/hess-17-1177-2013; Schuurmann G, 2008, J CHEM INF MODEL, V48, P2140, DOI 10.1021/ci800253u; Merzouki A, 2011, IEEE J-STARS, V4, P128, DOI 10.1109/JSTARS.2011.2116769; Consonni V, 2009, J CHEM INF MODEL, V49, P1669, DOI 10.1021/ci900115y; Vereecken H, 2014, J HYDROL, V516, P76, DOI 10.1016/j.jhydrol.2013.11.061; He BB, 2014, REMOTE SENS-BASEL, V6, P10966, DOI 10.3390/rs61110966; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; Stein A, 1998, INT J REMOTE SENS, V19, P1793, DOI 10.1080/014311698215252; Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2; Banerjee S., 2003, HIERARCHICAL MODELIN; Bryant R, 2007, IEEE GEOSCI REMOTE S, V4, P137, DOI 10.1109/LGRS.2006.887146; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Geng H., 1996, CANADIAN J REMOTE SE, V22, P117; Glenn NF, 2003, COMPUT GEOSCI-UK, V29, P577, DOI 10.1016/S0098-3004(03)00050-5; Hastie T., 2009, ELEMENTS STAT LEARNI; Hosseini A., 2012, Journal of Nuts, V3, P45; Hosseini R, 2011, ENVIRON ECOL STAT, V18, P795, DOI 10.1007/s10651-010-0169-1; Hosseini R, 2012, J AGR BIOL ENVIR ST, V17, P283, DOI 10.1007/s13253-012-0090-1; Meade NG, 1999, ADV SPACE RES, V24, P935, DOI 10.1016/S0273-1177(99)00367-1; Ouchi K, 2013, REMOTE SENS-BASEL, V5, P716, DOI 10.3390/rs5020716; Pultz T. J., 1990, Canadian Journal of Remote Sensing, V16; Rahman MM, 2008, REMOTE SENS ENVIRON, V112, P391, DOI 10.1016/j.rse.2006.10.026; Ribeiro P. J., 2014, GEOR ANAL GEOSTATIST; Romano N, 2014, J HYDROL, V516, P6, DOI 10.1016/j.jhydrol.2014.01.026; Sano EE, 1998, REMOTE SENS ENVIRON, V64, P77, DOI 10.1016/S0034-4257(97)00170-3; Srivastava HS, 2003, IEEE T GEOSCI REMOTE, V41, P1638, DOI 10.1109/TGRS.2003.813356; Stein ML, 1999, INTERPOLATION SPATIA; Van der Heijden G. W. A. M., 2007, INT J REMOTE SENS, V28, P5485; Verhoest NEC, 2008, SENSORS-BASEL, V8, P4213, DOI 10.3390/s8074213	47	0	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-4292			REMOTE SENS-BASEL	Remote Sens.	MAR	2015	7	3					2752	2780		10.3390/rs70302752		29	Remote Sensing	Remote Sensing	CH0BZ	WOS:000353685200021		
J	Seto, M; Uriu, K				Seto, Mayumi; Uriu, Koichiro			Sample Size Allocation for Food Item Radiation Monitoring and Safety Inspection	RISK ANALYSIS			English	Article						Food safety and inspection; radioactive contamination; stochastic risk assessment	FUKUSHIMA NUCLEAR ACCIDENT; POWER-PLANT ACCIDENT; REGULATIONS; RADIOCESIUM; RESIDENTS; CHERNOBYL; CS-137; I-131	The objective of this study is to identify a procedure for determining sample size allocation for food radiation inspections of more than one food item to minimize the potential risk to consumers of internal radiation exposure. We consider a simplified case of food radiation monitoring and safety inspection in which a risk manager is required to monitor two food items, milk and spinach, in a contaminated area. Three protocols for food radiation monitoring with different sample size allocations were assessed by simulating random sampling and inspections of milk and spinach in a conceptual monitoring site. Distributions of I-131 and radiocesium concentrations were determined in reference to I-131 and radiocesium concentrations detected in Fukushima prefecture, Japan, for March and April 2011. The results of the simulations suggested that a protocol that allocates sample size to milk and spinach based on the estimation of I-131 and radiocesium concentrations using the apparent decay rate constants sequentially calculated from past monitoring data can most effectively minimize the potential risks of internal radiation exposure.	[Seto, Mayumi] Nara Womens Univ, Dept Informat & Comp Sci, Fac Sci, Nara 6308506, Japan; [Uriu, Koichiro] RIKEN, Theoret Biol Lab, Wako, Saitama 3510198, Japan	Seto, M (reprint author), Nara Womens Univ, Dept Informat & Comp Sci, Fac Sci, Kita Uoya Nishimachi, Nara 6308506, Japan.	seto@ics.nara-wu.ac.jp	Uriu, Koichiro/L-3596-2015		Japan Society for the Promotion of Science; RIKENiTHES project	KU was supported by the fellowship for young scientists from the Japan Society for the Promotion of Science. This research was partially supported by the RIKENiTHES project. We thank Isao Kawaguchi, National Institute of Radiological Sciences, for providing us with the requisite information and suggestions to carry on this study. We are grateful to two anonymous reviewers for their constructive comments.	Merz S, 2013, ENVIRON SCI TECHNOL, V47, P1248, DOI 10.1021/es3037498; [Anonymous], 2011, DAILY YOMIURI ONLINE; Steinhauser G, 2013, ENVIRON SCI POLLUT R, V20, P2527, DOI 10.1007/s11356-012-1140-5; Travnikova IG, 2001, RADIAT PROT DOSIM, V93, P331; Hamada N, 2012, J RADIAT RES, V53, P641, DOI 10.1093/jrr/rrs032; Xu S, 2013, ENVIRON SCI TECHNOL, V47, P10851, DOI 10.1021/es401527q; Steinhauser G, 2014, SCI TOTAL ENVIRON, V470, P800, DOI 10.1016/j.scitotenv.2013.10.029; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; Hamada N, 2012, J ENVIRON RADIOACTIV, V111, P83, DOI 10.1016/j.jenvrad.2011.08.008; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Ferrier PM, 2012, RISK ANAL, V33, P368; FSC, 2011, EM REP RAD NUCL FOOD; Harada KH, 2013, ENVIRON SCI TECHNOL, V47, P2520, DOI 10.1021/es304128t; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; IAEA, 2006, ENV CONS CHERN ACC T; IAEA, 1996, SAF SER, V115; ICRP, 1993, ANN ICRP PUBL, V63, P22; Lee SH, 2013, J RADIOANAL NUCL CH, V296, P727, DOI 10.1007/s10967-012-2030-5; MHLW, 2012, REV CONC INSP PLANN; MHLW, 2011, HANDL PROV REG VAL R; MHLW, 2011, HANDL FOOD CONT RAD; MHLW, 2011, MON INF ENV RAD LEV; Povinec R, 2013, FUKUSHIMA ACCIDENT R; Powell MR, 2013, RISK ANAL, V33, P385, DOI 10.1111/risa.12027; Steinhauser G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057760; Steinhauser G, 2012, ENVIRON SCI TECHNOL, V46, P12890, DOI 10.1021/es303280g; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; United Nations, 2013, SOURC EFF ION RAD RE; UNSCEAR, 2000, EXP EFF CHERN ACC AN; WHO, 1988, DERV INT LEV RAD FOO; WHO, 2012, PREL DOS EST NUCL AC	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0272-4332	1539-6924		RISK ANAL	Risk Anal.	MAR	2015	35	3					409	422		10.1111/risa.12276		14	Public, Environmental & Occupational Health; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Public, Environmental & Occupational Health; Mathematics; Mathematical Methods In Social Sciences	CH3ZZ	WOS:000353971300009		
J	Glausier, JR; Kimoto, S; Fish, KN; Lewis, DA				Glausier, Jill R.; Kimoto, Sohei; Fish, Kenneth N.; Lewis, David A.			LOWER REGULATOR OF G PROTEIN SIGNALING 4 MRNA AND PROTEIN LEVELS IN THE PREFRONTAL CORTEX IN SCHIZOPHRENIA	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Glausier, Jill R.; Kimoto, Sohei; Fish, Kenneth N.; Lewis, David A.] Univ Pittsburgh, Psychiat, Pittsburgh, PA USA; [Kimoto, Sohei] Nara Med Univ, Psychiat, Kashihara, Nara 634, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2115297	S288	S288				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200756		
J	Hirano, Y; Oribe, N; Onitsuka, T; Kanba, S; Mesholam-Gately, R; Seidman, LJ; Niznikiewicz, MA; McCarley, RW; Spencer, KM				Hirano, Yoji; Oribe, Naoya; Onitsuka, Toshiaki; Kanba, Shigenobu; Mesholam-Gately, Raquelle; Seidman, Larry J.; Niznikiewicz, Margaret A.; McCarley, Robert W.; Spencer, Kevin M.			PROGRESSIVE AUDITORY GAMMA OSCILLATION DEFICIT IN CLINICAL HIGH-RISK SUBJECTS AND FIRST-EPISODE SCHIZOPHRENIA	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Hirano, Yoji; Oribe, Naoya; Spencer, Kevin M.] VA Boston Healthcare Syst, Neural Dynam Lab, Psychiat, Boston, MA USA; [Hirano, Yoji; Oribe, Naoya; Mesholam-Gately, Raquelle; Seidman, Larry J.; Spencer, Kevin M.] Harvard Univ, Sch Med, Boston, MA USA; [Hirano, Yoji; Oribe, Naoya; Onitsuka, Toshiaki; Kanba, Shigenobu] Kyushu Univ, Grad Sch Med Sci, Neuropsychiat, Fukuoka 812, Japan; [Mesholam-Gately, Raquelle; Seidman, Larry J.] Beth Israel Deaconess Med Ctr, Psychiat, Boston, MA 02215 USA; [Seidman, Larry J.] Massachusetts Gen Hosp, Psychiat, Boston, MA 02114 USA; [Niznikiewicz, Margaret A.; McCarley, Robert W.] VA Boston Healthcare Syst, Lab Neurosci, Psychiat, Brockton, MA USA; [Niznikiewicz, Margaret A.; McCarley, Robert W.] Harvard Univ, Sch Med, Brockton, MA USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2087079	S19	S20				2	Psychiatry	Psychiatry	CG8HO	WOS:000353548200051		
J	Hofer, A; Mizuno, Y; Frajo-Apor, B; Kemmler, G; Rauch, A; Uchida, H				Hofer, Alex; Mizuno, Y.; Frajo-Apor, B.; Kemmler, G.; Rauch, A.; Uchida, Hiroyuki			RESILIENCE AND INTERNALIZED STIGMA	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Hofer, Alex; Frajo-Apor, B.; Kemmler, G.; Rauch, A.] Med Univ Innsbruck, Dept Psychiat & Psychotherapy, A-6020 Innsbruck, Austria; [Mizuno, Y.; Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2081287	S78	S78				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200208		
J	Ikai, S; Suzuki, T; Saruta, J; Tsukinoki, K; Tani, H; Nagai, N; Kitahata, R; Ohtani, A; Endo, A; Fujii, Y; Mimura, M; Uchida, H				Ikai, Saeko; Suzuki, T.; Saruta, J.; Tsukinoki, K.; Tani, H.; Nagai, N.; Kitahata, Ryosuke; Ohtani, Ai; Endo, Aki; Fujii, Y.; Mimura, Masaru; Uchida, Hiroyuki			EFFECTS OF WEEKLY ONE-HOUR HATHA YOGA THERAPY ON RESILIENCE AND STRESS LEVELS IN SCHIZOPHRENIA: A RANDOMIZED CONTROLLED EIGHT-WEEK TRIAL	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Ikai, Saeko; Suzuki, T.; Tani, H.; Nagai, N.; Kitahata, Ryosuke; Ohtani, Ai; Endo, Aki; Mimura, Masaru; Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Suzuki, T.] Inokashira Hosp, Dept Psychiat, Tokyo, Japan; [Saruta, J.; Tsukinoki, K.] Kanagawa Dent Univ, Grad Sch Dent, Dept Oral Sci, Yokohama, Kanagawa, Japan; [Saruta, J.; Tsukinoki, K.] Kanagawa Dent Univ, Grad Sch Dent, Res Inst Salivary Gland & Hlth Med, Yokohama, Kanagawa, Japan; [Fujii, Y.] Yamanashi Prefectural Kita Hosp, Dept Neuropsychiat, Kofu, Yamanashi, Japan; [Tani, H.] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Neuropsychiat, Ichikawa, Japan; [Nagai, N.] Tachikawa Hosp, Dept Neuropsychiat, Tokyo, Japan; [Uchida, Hiroyuki] Ctr Addict & Mental Hlth, Geriatr Psychiat Div, Toronto, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2085175	S315	S316				2	Psychiatry	Psychiatry	CG8HO	WOS:000353548200832		
J	Isobe, M; Miyata, J; Mori, Y; Murai, T; Takahashi, H				Isobe, Masanori; Miyata, Jun; Mori, Yasuo; Murai, Toshiya; Takahashi, Hidehiko			ALTERED INTER-NETWORK CONNECTIVITY BETWEEN DEFAULT MODE NETWORK AND SALIENCE NETWORK IN PEOPLE WITH SCHIZOPHRENIA	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Isobe, Masanori; Miyata, Jun; Mori, Yasuo; Murai, Toshiya; Takahashi, Hidehiko] Kyoto Univ, Psychiat, Kyoto, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2119234	S227	S227				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200602		
J	Iwata, Y; Uchida, H; Suzuki, T; Keefe, R; Plitman, EA; Mimura, M; Graff-Guerrero, A; Nakajima, S				Iwata, Yusuke; Uchida, Hiroyuki; Suzuki, Takefumi; Keefe, Richard; Plitman, Eric Alexander; Mimura, Masaru; Graff-Guerrero, Ariel; Nakajima, Shinichiro			EFFECTS OF GLUTAMATE MODULATORS ON COGNITIVE IMPAIRMENTS IN SCHIZOPHRENIA: A META-ANALYSIS OF DOUBLE-BLIND CONTROLLED TRIALS	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Iwata, Yusuke; Graff-Guerrero, Ariel; Nakajima, Shinichiro] Ctr Addict & Met Hlth, Toronto, ON, Canada; [Iwata, Yusuke; Uchida, Hiroyuki; Suzuki, Takefumi; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Shinanomachi, Japan; [Uchida, Hiroyuki; Suzuki, Takefumi; Nakajima, Shinichiro] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada; [Keefe, Richard] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Plitman, Eric Alexander] Univ Toronto, Inst Med Sci, Toronto, ON, Canada								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2114646	S316	S316				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200833		
J	Levine, SZ; Furukawa, T; Tanaka, S; Goldberg, Y; Samara, M; Davis, J; Cipriani, A; Leucht, S				Levine, Stephen Z.; Furukawa, T.; Tanaka, S.; Goldberg, Y.; Samara, M.; Davis, J.; Cipriani, A.; Leucht, S.			INITIAL SEVERITY AND EFFICACY OF ANTIPSYCHOTICS FOR SCHIZOPHRENIA: INDIVIDUAL LEVEL ANALYSES OF SIX PLACEBO-CONTROLLED STUDIES	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Levine, Stephen Z.; Goldberg, Y.] Univ Haifa, Community Mental Hlth, IL-31999 Haifa, Israel; [Furukawa, T.; Tanaka, S.] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Samara, M.; Leucht, S.] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-80290 Munich, Germany; [Cipriani, A.] Univ Oxford, Dept Psychiat, Oxford, England; [Davis, J.] Univ Illinois, Inst Psychiat, Chicago, IL USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2072239	S319	S319				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200842		
J	Matsuda, Y; Morimoto, T; Hatsuse, N; Sato, S; Furukawa, S; Iwata, K; Ikebuchi, E				Matsuda, Yasuhiro; Morimoto, Tsuhasa; Hatsuse, Norifumi; Sato, Sayaka; Furukawa, Shunichi; Iwata, Kazuhiko; Ikebuchi, Emi			EFFECTS OF COGNITIVE REHABILITATION USING ORIGINAL COMPUTER SOFTWARE IN SCHIZOPHRENIA: A RANDOMIZED CONTROLLED TRIAL	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Matsuda, Yasuhiro; Morimoto, Tsuhasa] Nara Med Univ, Sch Med, Dept Psychiat, Kashihara, Nara 634, Japan; [Hatsuse, Norifumi; Ikebuchi, Emi] Teikyo Univ, Dept Psychiat, Sch Med, Tokyo, Japan; [Sato, Sayaka] Natl Ctr Neurol & Psychiat, Dept Psychiat Rehabil, Natl Inst Mental Hlth, Kodaira, Tokyo, Japan; [Furukawa, Shunichi] Tokyo Metropolitan Police Hosp, Dept Psychiat, Nakano, Japan; [Iwata, Kazuhiko] Osaka Psychiat Med Ctr, Ctr Clin Res & Dev Initiat, Hirakata, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2087154	S90	S91				2	Psychiatry	Psychiatry	CG8HO	WOS:000353548200241		
J	Matsui, M; Otsuka, S; Hoshino, T; Miura, K; Higuchi, Y; Suzuki, M				Matsui, Mie; Otsuka, S.; Hoshino, T.; Miura, K.; Higuchi, Y.; Suzuki, M.			COGNITIVE REMEDIATION THERAPY FOCUSING ON STRATEGY COACHING FOR PATIENTS WITH SCHIZOPHRENIA	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Matsui, Mie; Otsuka, S.; Hoshino, T.; Miura, K.] Toyama Univ, Psychol, Toyama 930, Japan; [Higuchi, Y.; Suzuki, M.] Toyama Univ, Neuropsychiat, Toyama 930, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1			S55	S55				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200148		
J	Miyata, J; Sawamoto, N; Mori, Y; Isobe, M; Urayama, S; Aso, T; Fukuyama, H; Murai, T; Takahashi, H				Miyata, Jun; Sawamoto, Nobukatsu; Mori, Yasuo; Isobe, Masanori; Urayama, Shinichi; Aso, Toshihiko; Fukuyama, Hidenao; Murai, Toshiya; Takahashi, Hidehiko			ALTERED CONNECTIVITY WITHIN AND BETWEEN TWO DIFFERENT SALIENCE RELATED NETWORKS IN PEOPLE WITH SCHIZOPHRENIA	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Miyata, Jun; Mori, Yasuo; Isobe, Masanori; Murai, Toshiya; Takahashi, Hidehiko] Kyoto Univ, Dept Psychiat, Kyoto, Japan; [Sawamoto, Nobukatsu] Kyoto Univ, Dept Neurol, Kyoto, Japan; [Urayama, Shinichi; Aso, Toshihiko; Fukuyama, Hidenao] Kyoto Univ, Human Brain Res Ctr, Kyoto, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1			S234	S234				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200621		
J	Mizuno, Y; Hofer, A; Suzuki, T; Mimura, M; Fleischhacker, W; Uchida, H				Mizuno, Yuya; Hofer, Alex; Suzuki, Takefumi; Mimura, Masaru; Fleischhacker, Wolfgang; Uchida, Hiroyuki			A SYSTEMATIC REVIEW OF EVIDENCE ON RESILIENCE RESEARCH IN SCHIZOPHRENIA AND FUTURE DIRECTIONS	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Mizuno, Yuya; Suzuki, Takefumi; Mimura, Masaru; Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Hofer, Alex; Fleischhacker, Wolfgang] Med Univ Innsbruck, Dept Psychiat & Psychotherapy, A-6020 Innsbruck, Austria; [Suzuki, Takefumi] Inokashira Hosp, Dept Psychiat, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1			S56	S57				2	Psychiatry	Psychiatry	CG8HO	WOS:000353548200152		
J	Nakagome, K; Ikezawa, S; Mogami, T				Nakagome, Kazuyuki; Ikezawa, S.; Mogami, T.			THE CHALLENGES OF TRAINING CLINICIANS AND READYING CLINICS TO PROVIDE CR IN JAPAN	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Nakagome, Kazuyuki; Ikezawa, S.] Natl Ctr Neurol & Pychiatry, Psychiat, Kodaira, Tokyo, Japan; [Mogami, T.] Tottori Univ, Grad Sch Med Sci, Clin Psychol, Yonago, Tottori, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2079607	S129	S129				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200340		
J	Nakajima, S				Nakajima, Shinichiro			THE OPTIMAL DOPAMINE D2/3 RECEPTOR OCCUPANCY BY ANTIPSYCHOTICS IN PATIENTS WITH LATE-LIFE SCHIZOPHRENIA: A [11C]-RACLOPRIDE PET STUDY	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Nakajima, Shinichiro] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Nakajima, Shinichiro] Keio Univ, Dept Neuropsychiat, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1			S235	S235				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200623		
J	Nakajima, S; Caravaggio, F; Mamo, D; Mulsant, B; Chung, JK; Plitman, EA; Iwata, Y; Gerretsen, P; Uchida, H; Suzuki, T; Mar, W; Graff-Guerrero, A				Nakajima, Shinichiro; Caravaggio, Fernando; Mamo, David; Mulsant, Benoit; Chung, Jun Ku; Plitman, Eric Alexander; Iwata, Yusuke; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Mar, Wanna; Graff-Guerrero, Ariel			DOPAMINE D2 AND D3 RECEPTOR AVAILABILITY IN ANTIPSYCHOTIC-FREE PATIENTS WITH LATE-LIFE SCHIZOPHRENIA: A CROSS-SECTIONAL [11C]-(+)-PHNO AND [11C]-RACLOPRIDE PET STUDY	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Nakajima, Shinichiro; Caravaggio, Fernando; Mulsant, Benoit; Chung, Jun Ku; Plitman, Eric Alexander; Iwata, Yusuke; Gerretsen, Philip; Uchida, Hiroyuki; Mar, Wanna; Graff-Guerrero, Ariel] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Nakajima, Shinichiro; Iwata, Yusuke; Uchida, Hiroyuki; Suzuki, Takefumi] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Mamo, David] Univ Malta, Dept Psychiat, Fac Med, Msida, Malta; [Mamo, David] Univ Malta, Dept Psychiat, Fac Hlth Sci, Msida, Malta								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2193224	S266	S267				2	Psychiatry	Psychiatry	CG8HO	WOS:000353548200703		
J	Oshibuchi, H; Kawano, M; Inada, K; Ishigooka, J				Oshibuchi, Hidehiro; Kawano, Masahiko; Inada, Ken; Ishigooka, Jun			CLOZAPINE MODULATES DOPAMINE RELEASE DOPAMINERGIC STATE DEPENDENTLY IMPLICATING ITS SPECIFIC ACTION IN CONTRAST TO HALOPERIDOL	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Oshibuchi, Hidehiro; Kawano, Masahiko; Inada, Ken; Ishigooka, Jun] Tokyo Womens Med Univ, Psychiat, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2117557	S7	S8				2	Psychiatry	Psychiatry	CG8HO	WOS:000353548200021		
J	Ozeki, Y; Sekine, M; Fujii, K; Okayasu, H; Takano, Y; Shinozaki, T; Akiyama, K; Homma, H; Shimoda, K				Ozeki, Yuji; Sekine, M.; Fujii, K.; Okayasu, H.; Takano, Y.; Shinozaki, T.; Akiyama, K.; Homma, H.; Shimoda, K.			PHOSPHOSERINE PHOSPHATASE ACTIVITY IS ELEVATED AND NEGATIVELY CORRELATED WITH SERUM D-SERINE CONCENTRATION IN SCHIZOPHRENIA PATIENTS	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Ozeki, Yuji; Fujii, K.; Okayasu, H.; Takano, Y.; Shinozaki, T.] Dokkyo Med Univ, Sch Med, Dept Psychiat, Mibu, Tochigi, Japan; [Ozeki, Yuji] Natl Ctr Neurol & Psychiat, Dept Mental Disorder Res, Kodaira, Tokyo, Japan; [Sekine, M.; Homma, H.] Kitasato Univ, Lab Biomol Sci, Tokyo, Japan; [Akiyama, K.; Shimoda, K.] Dokkyo Med Univ, Sch Med, Dept Biol Psychiat & Neurosci, Mibu, Tochigi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2079800	S295	S295				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200776		
J	Plitman, E; de la Fuente-Sandoval, C; Leon-Ortiz, P; Reyes-Madrigal, F; Gomez-Cruz, G; Nakajima, S; Gerretsen, P; Chakravarty, MM; Chavez, S; Chung, JK; Caravaggio, F; Iwata, Y; Uy, D; Remington, G; Graff-Guerrero, A				Plitman, Eric; de la Fuente-Sandoval, Camilo; Leon-Ortiz, Pablo; Reyes-Madrigal, Francisco; Gomez-Cruz, Gladys; Nakajima, Shinichiro; Gerretsen, Philip; Chakravarty, M. Mallar; Chavez, Sofia; Chung, Jun Ku; Caravaggio, Fernando; Iwata, Yusuke; Uy, Danielle; Remington, Gary; Graff-Guerrero, Ariel			INCREASED MYO-INOSITOL AND CHOLINE LEVELS WITHIN THE ASSOCIATIVE STRIATUM OF ANTIPSYCHOTIC-NAIVE PATIENTS WITH FIRST-EPISODE PSYCHOSIS	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Plitman, Eric; Nakajima, Shinichiro; Gerretsen, Philip; Chavez, Sofia; Chung, Jun Ku; Caravaggio, Fernando; Iwata, Yusuke; Uy, Danielle; Graff-Guerrero, Ariel] Ctr Addict & Mental Hlth, Res Imaging Ctr, Multimodal Imaging Grp, Toronto, ON, Canada; [Plitman, Eric; Chung, Jun Ku; Caravaggio, Fernando] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [de la Fuente-Sandoval, Camilo; Reyes-Madrigal, Francisco; Gomez-Cruz, Gladys] Inst Nacl Neurol & Neurocirug, Expt Psychiat Lab, Mexico City, DF, Mexico; [de la Fuente-Sandoval, Camilo; Leon-Ortiz, Pablo] Inst Nacl Neurol & Neurocirug, Neuropsychiat Dept, Mexico City, DF, Mexico; [Nakajima, Shinichiro; Iwata, Yusuke] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Gerretsen, Philip; Chavez, Sofia; Remington, Gary; Graff-Guerrero, Ariel] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Chakravarty, M. Mallar] McGill Univ, Cerebral Imaging Ctr, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Remington, Gary] Ctr Addict & Mental Hlth, Schizophrenia Program, Toronto, ON, Canada								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2091319	S269	S270				2	Psychiatry	Psychiatry	CG8HO	WOS:000353548200710		
J	Pocivavsek, A; Wu, HQ; Okuyama, M; Kajii, Y; Bruno, JP; Schwarcz, R				Pocivavsek, Ana; Wu, Hui-Qiu; Okuyama, Masahiro; Kajii, Yasushi; Bruno, John P.; Schwarcz, Robert			THE SYSTEMICALLY ACTIVE KYNURENINE AMINOTRANSFERASE II INHIBITOR BF816 ATTENUATES CONTEXTUAL MEMORY DEFICIT INDUCED BY PRENATAL KYNURENINE ELEVATION IN RATS	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Pocivavsek, Ana; Wu, Hui-Qiu; Schwarcz, Robert] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Psychiat, Baltimore, MD 21201 USA; [Okuyama, Masahiro; Kajii, Yasushi] Dept 2, Med Chem Res Labs 1, Div Res, Yokohama, Kanagawa, Japan; [Okuyama, Masahiro; Kajii, Yasushi] Dept 2, Pharmacol Res Labs 1, Div Res, Yokohama, Kanagawa, Japan; [Bruno, John P.] Ohio State Univ, Neurosci, Columbus, OH 43210 USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2077115	S8	S9				2	Psychiatry	Psychiatry	CG8HO	WOS:000353548200023		
J	Remington, G; Lee, J; Takeuchi, H; Fervaha, G; Foussias, G; Agid, O; Farooq, S				Remington, Gary; Lee, Jimmy; Takeuchi, Hiroyoshi; Fervaha, Gagan; Foussias, George; Agid, Ofer; Farooq, Saeed			SUBTYPING SCHIZOPHRENIA BY TREATMENT RESPONSE: REFINING CRITERIA	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Remington, Gary; Lee, Jimmy; Takeuchi, Hiroyoshi; Fervaha, Gagan; Foussias, George; Agid, Ofer] Univ Toronto, Ctr Addict & Mental Hlth, Psychiat, Toronto, ON, Canada; [Lee, Jimmy] Duke NUS Grad Med Sch, Psychiat, Inst Mental Hlth, Singapore, Singapore; [Takeuchi, Hiroyoshi] Keio Univ, Neuropsychiat, Tokyo, Japan; [Farooq, Saeed] Lady Reading Hosp, Psychiat, Postgrad Med Inst, Peshawar, Pakistan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2093967	S330	S330				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200872		
J	Sato, S; Ikebuchi, E; Yamaguchi, S; Shimodaira, M; Taneda, A; Ichikawa, K; Ishii, K; Usui, T; Satake, N; Sakata, M; Nishio, M; Ito, J				Sato, Sayaka; Ikebuchi, Emi; Yamaguchi, Sosei; Shimodaira, Michiyo; Taneda, Ayano; Ichikawa, Ken; Ishii, Kazuko; Usui, Takuya; Satake, Naoko; Sakata, Masuhiro; Nishio, Masaaki; Ito, Junichiro			EFFECTS OF COGNITIVE REMEDIATION AND SUPPORTED EMPLOYMENT FOR PEOPLE WITH SEVERE MENTAL ILLNESS IN JAPAN_A RANDOMISED CONTROLLED TRIAL	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Sato, Sayaka; Yamaguchi, Sosei; Shimodaira, Michiyo; Taneda, Ayano; Ito, Junichiro] NCNP, Natl Inst Mental Hlth, Dept Psychiat Rehabil, Kodaira, Tokyo, Japan; [Ikebuchi, Emi] Teikyo Univ, Sch Med, Dept Psychiat, Tokyo, Japan; [Nishio, Masaaki] Tohoku Fukushi Univ, Dept Social Welf, Sendai, Miyagi, Japan; [Usui, Takuya] Nagaoka Hlth Care Ctr, Nagaokakyo, Japan; [Ishii, Kazuko] Hida Clin, Nagareyama, Japan; [Ichikawa, Ken] Kitasato Univ, East Hosp, Sagamihara, Kanagawa 228, Japan; [Satake, Naoko; Sakata, Masuhiro] NCNP, Natl Ctr Hosp, Dept Psychiat, Kodaira, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2085120	S189	S189				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200500		
J	Southcott, S; Yanagi, M; Lister, J; Tamminga, C				Southcott, Sarah; Yanagi, Masaya; Lister, Jacob; Tamminga, Carol			REVERSE TRANSLATION ANIMAL MODEL OF HIPPOCAMPAL DYSFUNCTION IN SCHIZOPHRENIA	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Southcott, Sarah; Tamminga, Carol] Univ Texas SW Med Ctr Dallas, Mol Psychiat, Dallas, TX 75390 USA; [Yanagi, Masaya] Kindai, Higashiosaka, Osaka, Japan; [Lister, Jacob] Yale Univ, New Haven, CT USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2114625	S10	S11				2	Psychiatry	Psychiatry	CG8HO	WOS:000353548200029		
J	Sumiyoshi, C; Takaki, M; Okahisa, Y; Sato, T; Sora, I; Nuechterlein, KH; Subotnik, KN; Harvey, PD; Sumiyoshi, T				Sumiyoshi, Chika; Takaki, Manabu; Okahisa, Yuko; Sato, Taku; Sora, Ichiro; Nuechterlein, Keith H.; Subotnik, Kenneth N.; Harvey, Philip D.; Sumiyoshi, Tomiki			FUNCTIONAL RECOVERY IN PATIENTS WITH SCHIZOPHRENIA: PREDICTING FACTORS FOR WORK OUTCOME	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Sumiyoshi, Chika] Fukushima Univ, Human Dev & Culture, Fukushima, Japan; [Takaki, Manabu; Okahisa, Yuko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Okayama, Japan; [Sato, Taku] Iwaki Meisei Univ, Coll Humanities, Dept Psychol, Iwaki, Fukushima 970, Japan; [Sora, Ichiro] Kobe Univ, Grad Sch Med, Kobe, Hyogo 657, Japan; [Nuechterlein, Keith H.; Subotnik, Kenneth N.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Harvey, Philip D.] Univ Miami, Miller Sch Med, Dept Psychiat, Sch Med, Miami, FL 33136 USA; [Sumiyoshi, Tomiki] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Dept Clin Res Promot, Kodaira, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2086529	S192	S192				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200508		
J	Uchida, H; Suzuki, T; Yaogi, G				Uchida, Hiroyuki; Suzuki, T.; Yaogi, G.			ANTIPSYCHOTIC TREATMENT AND RESILIENCE: A REVIEW AND CLINICAL IMPLICATIONS	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Uchida, Hiroyuki; Suzuki, T.; Yaogi, G.] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2081222	S37	S37				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200100		
J	Wartelsteiner, F; Hofer, A; Frajo-Apor, B; Kemmler, G; Rauch, AS; Mizuno, Y; Uchida, H				Wartelsteiner, Fabienne; Hofer, Alex; Frajo-Apor, Beatrice; Kemmler, Georg; Rauch, Anna-Sophia; Mizuno, Yuya; Uchida, Hiroyuki			THE IMPACT OF RESILIENCE ON QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Wartelsteiner, Fabienne; Hofer, Alex; Frajo-Apor, Beatrice; Kemmler, Georg; Rauch, Anna-Sophia] Med Univ Innsbruck, Dept Psychiat & Psychotherapy, A-6020 Innsbruck, Austria; [Mizuno, Yuya; Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2105277	S195	S195				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200515		
J	Yoshida, K; Imasaka, Y; Kubo, K; Suzuki, T; Mimura, M; Uchida, H				Yoshida, Kazunari; Imasaka, Yasushi; Kubo, Ken-ichiro; Suzuki, Takefumi; Mimura, Masaru; Uchida, Hiroyuki			RESILIENCE IN PATIENTS WITH SCHIZOPHRENIA: A COMPARATIVE STUDY BETWEEN A DISTANT ISLAND AND AN URBAN AREA	SCHIZOPHRENIA BULLETIN			English	Meeting Abstract	15th International Congress on Schizophrenia Research (ICOSR)	MAR 28-APR 01, 2015	Colorado Springs, CO						[Yoshida, Kazunari; Kubo, Ken-ichiro; Suzuki, Takefumi; Mimura, Masaru; Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Imasaka, Yasushi; Kubo, Ken-ichiro] Ohizumi Hosp, Dept Neuropsychiat, Tokyo, Japan; [Imasaka, Yasushi] Ohshima Med Ctr, Dept Neuropsychiat, Tokyo, Japan; [Suzuki, Takefumi] Inokashira Hosp, Dept Psychiat, Tokyo, Japan; [Uchida, Hiroyuki] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	MAR	2015	41			1		2081321	S158	S158				1	Psychiatry	Psychiatry	CG8HO	WOS:000353548200417		
J	Zhao, KD; Jiang, SY; Nakamura, E; Moriguti, T; Wet, HZ				Zhao KuiDong; Jiang ShaoYong; Nakamura, Eizo; Moriguti, Takuya; Wet HaiZhen			A preliminary study on boron isotope fractionation of major rock-forming minerals in granite	ACTA PETROLOGICA SINICA			Chinese	Article						Granite; Rock-forming minerals; Boron isotope; Fractionation factor; South China	MANNITOL COMPLEX; ION MICROPROBE; GEOCHEMISTRY; TOURMALINE; FLUID; SYSTEM; CHINA; TEMPERATURE; MANTLE; CONSTRAINTS	We present boron concentrations and boron isotopic compositions of whole-rocks and major rock-forming minerals (biotite, plagioclase, quartz) from two granites in South China. Biotite has highest boron concentrations, and plagioclase has medium boron concentrations. Quartz has very low boron concentrations. Boron in granite is predominantly present in the biotite and plagioclase structure replaced Si and/or Al. Trace boron in quartz may concentrate in the fluid inclusions. Biotite has lowest boron isotopic compositions and quartz has highest boron isotopic compositions. This study firstly proves that large differences of boron isotopic compositions exist between rock-forming minerals in granites. Boron isotopic fractionation between biotite and plagioclase is -9.3 parts per thousand for the Dadongshan granite and -6.6 parts per thousand for the Qianlishan granite, respectively. Boron isotopic fractionation between biotite and quartz is -9.9 parts per thousand for the Dadongshan granite and -10.2 parts per thousand for the Qiardishan granite, respectively. Combining oxygen isotopic data, we suggest the large boron isotopic differences between minerals may be induced by post-magma hydrothermal alteration. The T-dependent fractionation factor of boron isotopes between silicates containing tetrahedrally coordinated boron and neutral-acid fluids is approximated by the equation: 1000ln alpha(silicate-fluid) = -11.19 x (10(3)/T[K]) + 5.09. The main fractionation effect is due to the change from trigonal coordination of boron in fluids to tetrahedrally coordinated boron in silicates.	[Zhao KuiDong; Jiang ShaoYong] China Univ Geosci, Fac Earth Resources, State Key Lab Geol Proc & Mineral Resources, Collaborat Innovat Ctr Explorat Strateg Mineral R, Wuhan 430074, Peoples R China; [Jiang ShaoYong; Wet HaiZhen] Nanjing Univ, Sch Earth Sci & Engn, State Key Lab Mineral Deposits Res, Nanjing 210093, Jiangsu, Peoples R China; [Nakamura, Eizo; Moriguti, Takuya] Okayama Univ Misasa, Inst Study Earths Interior, Pheasant Mem Lab Geochem & Cosmochem, Tottori 6820193, Japan	Zhao, KD (reprint author), China Univ Geosci, Fac Earth Resources, State Key Lab Geol Proc & Mineral Resources, Collaborat Innovat Ctr Explorat Strateg Mineral R, Wuhan 430074, Peoples R China.	zhaokd@cug.edu.cn					Brenan JM, 1998, GEOCHIM COSMOCHIM AC, V62, P3337, DOI 10.1016/S0016-7037(98)00224-5; HOLTZ F, 1993, CONTRIB MINERAL PETR, V113, P492, DOI 10.1007/BF00698318; Williams LB, 2001, GEOCHIM COSMOCHIM AC, V65, P1769, DOI 10.1016/S0016-7037(01)00557-9; Meyer C, 2008, CONTRIB MINERAL PETR, V156, P259, DOI 10.1007/s00410-008-0285-1; VENGOSH A, 1995, CHEM GEOL, V120, P135, DOI 10.1016/0009-2541(94)00118-R; Hervig RL, 2002, AM MINERAL, V87, P769; Werding G, 1996, REV MINERAL, V33, P117; Marschall HR, 2011, ELEMENTS, V7, P313, DOI 10.2113/gselements.7.5.313; Jiang SY, 2001, PHYS CHEM EARTH PT A, V26, P851, DOI 10.1016/S1464-1895(01)00132-6; Zhao KD, 2011, ORE GEOL REV, V43, P243, DOI 10.1016/j.oregeorev.2011.07.002; Li XH, 2004, GEOL MAG, V141, P225, DOI 10.1017/S0016756803008823; Wunder B, 2005, LITHOS, V84, P206, DOI 10.1016/j.lithos.2005.02.003; PICHAVANT M, 1987, AM MINERAL, V72, P1056; Halenius U, 2010, GEOCHIM COSMOCHIM AC, V74, P5672, DOI 10.1016/j.gca.2010.06.033; Kaliwoda M, 2011, LITHOS, V125, P51, DOI 10.1016/j.lithos.2011.01.006; BOTTINGA Y, 1973, EARTH PLANET SC LETT, V20, P250, DOI 10.1016/0012-821X(73)90165-9; Peacock SM, 1999, CHEM GEOL, V160, P281, DOI 10.1016/S0009-2541(99)00103-5; PALMER MR, 1992, CHEM GEOL, V101, P123, DOI 10.1016/0009-2541(92)90209-N; Leeman WP, 1996, REV MINERAL, V33, P645; Palmer MR, 1996, REV MINERAL, V33, P709; Smith MP, 1996, GEOCHIM COSMOCHIM AC, V60, P1415, DOI 10.1016/0016-7037(96)00007-5; Trumbull RB, 1999, CHEM GEOL, V153, P125, DOI 10.1016/S0009-2541(98)00155-7; Tonarini S, 1998, EUR J MINERAL, V10, P941; ZHENG YF, 1993, EARTH PLANET SC LETT, V120, P247, DOI 10.1016/0012-821X(93)90243-3; Tonarini S, 2003, GEOCHIM COSMOCHIM AC, V67, P1863, DOI 10.1016/S0016-7037(02)00987-0; Jiang SY, 2008, LITHOS, V106, P1, DOI 10.1016/j.lithos.2008.04.004; SPIVACK AJ, 1987, GEOCHIM COSMOCHIM AC, V51, P1939, DOI 10.1016/0016-7037(87)90183-9; CHAUSSIDON M, 1992, EARTH PLANET SC LETT, V108, P229, DOI 10.1016/0012-821X(92)90025-Q; Jiang SY, 1998, EUR J MINERAL, V10, P1253; CHAUSSIDON M, 1993, GEOCHIM COSMOCHIM AC, V57, P5053, DOI 10.1016/0016-7037(93)90607-X; [黄会清 HUANG Huiqing], 2008, [高校地质学报, Geological Journal of China Universities], V14, P317; ISHIKAWA T, 1990, ANAL CHEM, V62, P2612, DOI 10.1021/ac00222a017; Jiang SY, 2000, GEOL J CHINA U, V6, p1 ; KAKIHANA H, 1977, B CHEM SOC JPN, V50, P158, DOI 10.1246/bcsj.50.158; Liu Y, 2005, GEOCHIM COSMOCHIM AC, V69, P3995, DOI 10.1016/j.gca.2005.04.009; Makishima A, 1997, ANAL CHEM, V69, P3754, DOI 10.1021/ac970383s; NAKAMURA E, 1992, CHEM GEOL, V94, P193, DOI 10.1016/0168-9622(92)90012-Y; Nakano T, 1998, INT J MASS SPECTROM, V176, P13, DOI 10.1016/S1387-3806(98)14014-9; PALMER MR, 1987, GEOCHIM COSMOCHIM AC, V51, P2319, DOI 10.1016/0016-7037(87)90285-7; Romer RL, 2014, GEOCHIM COSMOCHIM AC, V131, P98, DOI 10.1016/j.gca.2014.01.018; Rosner M, 2004, GEOSTAND GEOANAL RES, V28, P431, DOI 10.1111/j.1751-908X.2004.tb00761.x; Rustad JR, 2010, GEOCHIMICA COSMOCHIM, V73, P2843; Sanchez-Valle C, 2005, GEOCHIM COSMOCHIM AC, V69, P4301, DOI 10.1016/j.gca.2005.03.054; [孙涛 SUN Tao], 2006, [地质通报, Geological Bulletin of China], V25, P332; VENGOSH A, 1991, GEOCHIM COSMOCHIM AC, V55, P2591, DOI 10.1016/0016-7037(91)90375-F; Woodford DT, 2001, AM MINERAL, V86, P513; Xia QK, 2004, PROGR NATURAL SCI, V14, P417; Zeebe RE, 2005, GEOCHIM COSMOCHIM AC, V69, P2753, DOI 10.1016/j.gca.2004.12.011; [张敏 Zhang Min], 2003, [地球化学, Geochimica], V32, P529; Zheng YF, 1999, EPISODES, V22, P99	50	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1000-0569			ACTA PETROL SIN	Acta Petrol. Sin.	MAR	2015	31	3					740	746				7	Geology	Geology	CG2GK	WOS:000353092700008		
J	Ciepal, I; Klos, B; Kozela, A; Stephan, E; Kistryn, S; Biegun, A; Bodek, K; Deltuva, A; Eslami-Kalantari, M; Jha, V; Kalantar-Nayestanaki, N; Khatri, G; Kirillov, D; Kirillov, D; Kliczewski, S; Kravcikova, M; Kulessa, P; Machner, H; Magiera, A; Martinska, G; Messchendorp, J; Parol, W; Ramazani-Moghaddam-Arani, A; Roy, BJ; Sakai, H; Sekiguchi, K; Sitnik, I; Siudak, R; Skwira-Chalot, I; Sworst, R; Urban, J; Zejma, J				Ciepal, I.; Klos, B.; Kozela, A.; Stephan, E.; Kistryn, St.; Biegun, A.; Bodek, K.; Deltuva, A.; Eslami-Kalantari, M.; Jha, V.; Kalantar-Nayestanaki, N.; Khatri, G.; Kirillov, Da.; Kirillov, Di.; Kliczewski, St.; Kravcikova, M.; Kulessa, P.; Machner, H.; Magiera, A.; Martinska, G.; Messchendorp, J.; Parol, W.; Ramazani-Moghaddam-Arani, A.; Roy, B. J.; Sakai, H.; Sekiguchi, K.; Sitnik, I.; Siudak, R.; Skwira-Chalot, I.; Sworst, R.; Urban, J.; Zejma, J.			COULOMB FORCE EFFECTS IN DEUTERON-PROTON BREAKUP REACTION	ACTA PHYSICA POLONICA B			English	Article								A large set of cross-section data for the H-1 (d,pp)n breakup reaction was measured at 130 MeV deuteron beam energy with the Germanium Wall setup covering the range of very forward polar angles. In the investigated part of the phase-space, the dynamics is dominated by the Coulomb force influence. The data are compared with results of theoretical calculations based on the realistic Argonne V18 potential supplemented with the long-range electromagnetic component. The predictions also include the Urbana IX three nucleon force model. The cross-section data reveal seizable Coulomb force effects.	[Ciepal, I.; Kozela, A.; Kliczewski, St.; Kulessa, P.; Siudak, R.] H Niewodniczanski Inst Nucl Phys PAN, PL-31342 Krakow, Poland; [Klos, B.; Stephan, E.] Univ Silesia, PL-40007 Katowice, Poland; [Ciepal, I.; Kistryn, St.; Bodek, K.; Khatri, G.; Magiera, A.; Parol, W.; Sworst, R.; Zejma, J.] Jagiellonian Univ, PL-30348 Krakow, Poland; [Kirillov, Da.; Machner, H.] Forschungszentrum Julich, Inst Kernphys, D-52425 Julich, Germany; [Biegun, A.; Kalantar-Nayestanaki, N.; Messchendorp, J.; Ramazani-Moghaddam-Arani, A.] Univ Groningen, Kernfysisch Versneller Inst, NL-9747 AA Groningen, Netherlands; [Skwira-Chalot, I.] Univ Warsaw, Inst Expt Phys, PL-00681 Warsaw, Poland; Kyushu Inst Technol, Dept Phys, Kitakyushu, Fukuoka 8048550, Japan; [Kirillov, Di.; Sitnik, I.] Joint Inst Nucl Res, Dubna 141980, Russia; [Kravcikova, M.; Martinska, G.] Tech Univ, Kosice 04101, Slovakia; [Urban, J.] Safarik Univ, Kosice 04154, Slovakia; [Sakai, H.] Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan; [Sekiguchi, K.] Tohoku Univ, Sendai, Miyagi 9808578, Japan; [Jha, V.; Roy, B. J.] BARC, Bombay 400085, Maharashtra, India; [Deltuva, A.] Univ Lisbon, Ctr Fis Nucl, P-1649003 Lisbon, Portugal; [Eslami-Kalantari, M.] Yazd Univ, Fac Phys, Yazd, Iran	Ciepal, I (reprint author), H Niewodniczanski Inst Nucl Phys PAN, PL-31342 Krakow, Poland.		Deltuva, Arnoldas/M-3749-2013; Khatri, Ghanshyam/F-8841-2015	Deltuva, Arnoldas/0000-0002-0732-7749; Khatri, Ghanshyam/0000-0001-8901-3817	 [2012/05/E/ST2/02313];  [2012/05/B/ST2/02556]	This work was partially supplemented by the Polish 2013-2016 science founds as research Projects 2012/05/E/ST2/02313 and 2012/05/B/ST2/02556.	Ciepal I, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.017001; Deltuva A, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.057001; Kistryn S, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.044006; Kistryn St., 2006, PHYS LETT B, V641, P23; Stephan E, 2013, EUR PHYS J A, V49, DOI 10.1140/epja/i2013-13036-5; Stephan E, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.014003	6	0	0	WYDAWNICTWO UNIWERSYTETU JAGIELLONSKIEGO	KRAKOW	UL GRODZKA 26, KRAKOW, 31044, POLAND	0587-4254	1509-5770		ACTA PHYS POL B	Acta Phys. Pol. B	MAR	2015	46	3					459	462		10.5506/APhysPolB.46.459		4	Physics, Multidisciplinary	Physics	CG8NR	WOS:000353565500015		
J	Wang, LJ; Chen, FQ; Sun, Y; Mizusaki, T; Oi, M				Wang, Long-Jun; Chen, Fang-Qi; Sun, Yang; Mizusaki, Takahiro; Oi, Makito			APPLICATION OF THE PFAFFIAN ALGORITHM IN THE NUCLEAR STRUCTURE STUDY AT HIGH SPINS	ACTA PHYSICA POLONICA B			English	Article								To expand the multi-quasiparticle (qp) configuration space of the projected shell model, the Pfaffian algorithm is applied to facilitate calculations of the matrix elements. With inclusion of 6-qp states in the projected basis, the yrast band of Hf-166 at very high spins is studied, where the observed three anomalies in moment of inertia are well reproduced and explained by the contributions of the 2-qp, 4-qp, and 6-qp states, respectively.	[Wang, Long-Jun; Chen, Fang-Qi; Sun, Yang] Shanghai Jiao Tong Univ, Dept Phys & Astron, Shanghai 200240, Peoples R China; [Mizusaki, Takahiro; Oi, Makito] Senshu Univ, Inst Nat Sci, Chiyoda Ku, Tokyo 1018425, Japan	Wang, LJ (reprint author), Shanghai Jiao Tong Univ, Dept Phys & Astron, Shanghai 200240, Peoples R China.		Sun, Yang/P-2417-2015		National Natural Science Foundation of China [11135005]; 973 Program of China [2013CB834401]	Research at SJTU was supported by the National Natural Science Foundation of China (No. 11135005) and by the 973 Program of China (No. 2013CB834401).	Hara K, 1995, INT J MOD PHYS E, V4, P637, DOI 10.1142/S0218301395000250; Jensen DR, 2000, EUR PHYS J A, V8, P165; MOLLER P, 1995, ATOM DATA NUCL DATA, V59, P185, DOI 10.1006/adnd.1995.1002; Yadav RB, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.064306; HARA K, 1979, NUCL PHYS A, V332, P61, DOI 10.1016/0375-9474(79)90094-0; Mizusaki T, 2013, PHYS LETT B, V725, P175, DOI 10.1016/j.physletb.2013.07.005; STEPHENS FS, 1972, NUCL PHYS A, VA183, P257, DOI 10.1016/0375-9474(72)90658-6; Wang LJ, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.011303	8	0	0	WYDAWNICTWO UNIWERSYTETU JAGIELLONSKIEGO	KRAKOW	UL GRODZKA 26, KRAKOW, 31044, POLAND	0587-4254	1509-5770		ACTA PHYS POL B	Acta Phys. Pol. B	MAR	2015	46	3					497	500		10.5506/APhysPolB.46.497		4	Physics, Multidisciplinary	Physics	CG8NR	WOS:000353565500021		
J	Fujita, Y; Rubio, B; Adachi, T; Blank, B; Fujita, H; Gelletly, W; Molina, F; Orrigo, SEA				Fujita, Y.; Rubio, B.; Adachi, T.; Blank, B.; Fujita, H.; Gelletly, W.; Molina, F.; Orrigo, S. E. A.			GAMOW-TELLER EXCITATIONS STUDIED BY WEAK AND STRONG INTERACTIONS	ACTA PHYSICA POLONICA B			English	Article							BETA-DECAY; NUCLEI	Studying weak nuclear responses, especially the Gamow-Teller (GT) transitions starting from stable as well as unstable nuclei, provide crucial and critical information on nuclear structure. Therefore, the study of GT transitions is a key issue in nuclear physics and also nuclear-astrophysics. Under the assumption of isospin symmetry, it is expected that the structure of mirror nuclei and the GT transitions starting from their ground states are identical. We have studied the corresponding GT transitions starting from T-z = +/- 1 and +/- 2 p f -shell nuclei, respectively, by means of hadronic (He-3,t) charge-exchange reactions and mirror beta decays. The results on GT strength distributions measured in beta decays and (He-3,t) reactions performed at an intermediate incident energy of 140 MeV/nucleon and 0 degrees are compared. The combined results help provide an understanding of nuclear structure of nuclei far-from-stability.	[Fujita, Y.; Adachi, T.; Fujita, H.] Osaka Univ, Nucl Phys Res Ctr, Ibaraki, Osaka 5670047, Japan; [Fujita, Y.] Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan; [Rubio, B.; Molina, F.; Orrigo, S. E. A.] Univ Valencia, IFIC, CSIC, Valencia 46071, Spain; [Blank, B.] Univ Bordeaux 1, Ctr Etudes Nucl Bordeaux Gradignan, CNRS, IN2P3,UMR 5797, F-33175 Gradignan, France; [Gelletly, W.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England	Fujita, Y (reprint author), Osaka Univ, Nucl Phys Res Ctr, Ibaraki, Osaka 5670047, Japan.				MEXT, Japan [18540270, 22540310]; JSPS; CSICCPAN Consolider-Ingenio Program [CSD2007-00042]; Spanish MICINN [EPA2008-06419-C02-01, EPA2011-24553]; UK STFC [ST/F012012/1]; Region of Aquitaine	The high-resolution (<SUP>3</SUP>He, t) experiments were performed at RCNP, Osaka, and the beta-decay studies of T<INF>z</INF> = -1 nuclei at GSI as a part of RISING campaign. The <SUP>56</SUP>Zn beta-decay experiment was performed at GANIL, Caen. The authors are grateful to the participants in these experiments. This work was supported by MEXT, Japan under Grants No. 18540270 and No. 22540310; the Japan-Spain collaboration program by JSPS and CSIC; the Spanish MICINN under Grant No. EPA2008-06419-C02-01 and No. EPA2011-24553; CPAN Consolider-Ingenio 2010 Program CSD2007-00042; UK STFC Grant No. ST/F012012/1; and Region of Aquitaine.	Adachi T, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.024311; Adachi T, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.024308; Dossat C, 2007, NUCL PHYS A, V792, P18, DOI 10.1016/j.nuclphysa.2007.05.004; Fujita Y, 2011, PROG PART NUCL PHYS, V66, P549, DOI 10.1016/j.ppnp.2011.01.056; Langanke K, 2003, REV MOD PHYS, V75, P819, DOI 10.1103/RevModPhys.75.819; Fujita Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.112502; Fujita Y, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.014308; Molina F, 2015, PHYS REV C, V91, DOI 10.1103/PhysRevC.91.014301; TADDEUCCI TN, 1987, NUCL PHYS A, V469, P125, DOI 10.1016/0375-9474(87)90089-3; OSTERFELD F, 1992, REV MOD PHYS, V64, P491, DOI 10.1103/RevModPhys.64.491; Fujita H, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.034310; Fujita H, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.054329; Fujita Y, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.212501; Fujita Y, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.064312; Fujita Y, 1999, PHYS REV C, V59, P90, DOI 10.1103/PhysRevC.59.90; Hardy JC, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.055502; Hardy J. C., 2006, NUCL PHYS NEWS, V16, P11, DOI 10.1080/10506890601061502; Honma M, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.034335; Orrigo SEA, 2015, ACTA PHYS POL B, V46, P709, DOI 10.5506/APhysPolB.46.709; Orrigo SEA, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.222501; Rubio B, 2009, LECT NOTES PHYS, V764, P99, DOI 10.1007/978-3-540-85839-3_4	21	0	0	WYDAWNICTWO UNIWERSYTETU JAGIELLONSKIEGO	KRAKOW	UL GRODZKA 26, KRAKOW, 31044, POLAND	0587-4254	1509-5770		ACTA PHYS POL B	Acta Phys. Pol. B	MAR	2015	46	3					657	668		10.5506/APhysPolB.46.657		12	Physics, Multidisciplinary	Physics	CG8NR	WOS:000353565500047		
J	Orrigo, SEA; Rubio, B; Fujita, Y; Blank, B; Gelletly, W; Agramunt, J; Algora, A; Ascher, P; Bilgier, B; Caceres, L; Cakirli, RB; Fujita, H; Ganioglu, E; Gerbaux, M; Giovinazzo, J; Grevy, S; Kamalou, O; Kozer, HC; Kucuk, L; Kurtukian-Nieto, T; Molina, F; Popescu, L; Rogers, AM; Susoy, G; Stodel, C; Suzuki, T; Tamii, A; Thomas, JC				Orrigo, S. E. A.; Rubio, B.; Fujita, Y.; Blank, B.; Gelletly, W.; Agramunt, J.; Algora, A.; Ascher, P.; Bilgier, B.; Caceres, L.; Cakirli, R. B.; Fujita, H.; Ganioglu, E.; Gerbaux, M.; Giovinazzo, J.; Grevy, S.; Kamalou, O.; Kozer, H. C.; Kucuk, L.; Kurtukian-Nieto, T.; Molina, F.; Popescu, L.; Rogers, A. M.; Susoy, G.; Stodel, C.; Suzuki, T.; Tamii, A.; Thomas, J. C.			beta-DELAYED gamma-PROTON DECAY IN Zn-56: ANALYSIS OF THE CHARGED-PARTICLE SPECTRUM	ACTA PHYSICA POLONICA B			English	Article								A study of the beta decay of the proton-rich T-z = 2 nucleus Zn-56 has been reported in a recent publication. A rare and exotic decay mode, beta-delayed gamma-proton decay, has been observed there for the first time in the fp shell. Here, we expand on some of the details of the data analysis, focussing on the charged particle spectrum.	[Orrigo, S. E. A.; Rubio, B.; Agramunt, J.; Algora, A.; Molina, F.] Univ Valencia, Inst Fis Corpuscular, CSIC, Valencia 46071, Spain; [Fujita, Y.] Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan; [Blank, B.; Ascher, P.; Gerbaux, M.; Giovinazzo, J.; Grevy, S.; Kurtukian-Nieto, T.] Univ Bordeaux 1, CNRS IN2P3, Ctr Etud Nucl Bordeaux Gradignan, F-33175 Gradignan, France; [Gelletly, W.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England; [Algora, A.] Hungarian Acad Sci, Inst Nucl Res, H-4026 Debrecen, Hungary; [Cakirli, R. B.; Ganioglu, E.; Kozer, H. C.; Kucuk, L.; Susoy, G.] Istanbul Univ, Dept Phys, TR-34134 Istanbul, Turkey; [Caceres, L.; Kamalou, O.; Stodel, C.; Thomas, J. C.] Grand Accelerateur Natl Ions Lourds, F-1407 Caen, France; [Fujita, H.; Suzuki, T.; Tamii, A.] Osaka Univ, Nucl Phys Res Ctr, Ibaraki, Osaka 5670047, Japan; [Molina, F.] Comis Chilena Energia Nucl, Santiago, Chile; [Popescu, L.] CEN SCK, B-2400 Mol, Belgium; [Rogers, A. M.] Argonne Natl Lab, Div Phys, Argonne, IL 60439 USA	Orrigo, SEA (reprint author), Univ Valencia, Inst Fis Corpuscular, CSIC, Valencia 46071, Spain.		Popescu, Lucia/F-9964-2011		Spanish MICINN [FPA2008-06419-C02-01, FPA2011-24553]; CPAN Consolider-Ingenio Programme [CSD2007-00042]; MEXT, Japan [18540270, 22540310]; JSPS; CSIC; Istanbul University [5808]; UK Science and Technology Facilities Council (STFC) [ST/F012012/1]; Region of Aquitaine; Alexander von Humboldt foundation; Max-Planck-Partner Group	This work was supported by the Spanish MICINN grants FPA2008-06419-C02-01, FPA2011-24553; CPAN Consolider-Ingenio 2010 Programme CSD2007-00042; MEXT, Japan 18540270 and 22540310; Japan-Spain collaboration program of JSPS and CSIC; Istanbul University Scientific Research Projects, No. 5808; UK Science and Technology Facilities Council (STFC) Grant No. ST/F012012/1; Region of Aquitaine. R.B.C. acknowledges support from the Alexander von Humboldt foundation and the Max-Planck-Partner Group. We acknowledge the EXOGAM collaboration for the use of their clover detectors.	Orrigo SEA, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.222501	1	1	1	WYDAWNICTWO UNIWERSYTETU JAGIELLONSKIEGO	KRAKOW	UL GRODZKA 26, KRAKOW, 31044, POLAND	0587-4254	1509-5770		ACTA PHYS POL B	Acta Phys. Pol. B	MAR	2015	46	3					709	712		10.5506/APhysPolB.46.709		4	Physics, Multidisciplinary	Physics	CG8NR	WOS:000353565500055		
J	Browne, F; Bruce, AM; Sumikama, T; Nishizuka, I; Nishimura, S; Doornenbal, P; Lorusso, G; Patel, Z; Rice, S; Sinclair, L; Soderstrom, PA; Watanabe, H; Wu, J; Xu, ZY; Baba, H; Chiga, N; Carroll, R; Daido, R; Didierjean, F; Fang, Y; Gey, G; Ideguchi, E; Inabe, N; Isobe, T; Kameda, D; Kojouharov, I; Kurz, N; Kubo, T; Lalkovski, S; Li, Z; Lozeva, R; Naoki, N; Nishibata, H; Odahara, A; Podolyak, Z; Regan, PH; Roberts, OJ; Sakurai, H; Schaffner, H; Simpson, GS; Suzuki, H; Takeda, H; Tanaka, M; Taprogge, J; Werner, V; Wieland, O; Yagi, A				Browne, F.; Bruce, A. M.; Sumikama, T.; Nishizuka, I.; Nishimura, S.; Doornenbal, P.; Lorusso, G.; Patel, Z.; Rice, S.; Sinclair, L.; Soederstroem, P. -A.; Watanabe, H.; Wu, J.; Xu, Z. Y.; Baba, H.; Chiga, N.; Carroll, R.; Daido, R.; Didierjean, F.; Fang, Y.; Gey, G.; Ideguchi, E.; Inabe, N.; Isobe, T.; Kameda, D.; Kojouharov, I.; Kurz, N.; Kubo, T.; Lalkovski, S.; Li, Z.; Lozeva, R.; Naoki, N.; Nishibata, H.; Odahara, A.; Podolyak, Zs; Regan, P. H.; Roberts, O. J.; Sakurai, H.; Schaffner, H.; Simpson, G. S.; Suzuki, H.; Takeda, H.; Tanaka, M.; Taprogge, J.; Werner, V.; Wieland, O.; Yagi, A.			GAMMA-RAY SPECTROSCOPY IN THE VICINITY OF Zr-108	ACTA PHYSICA POLONICA B			English	Article							DEFORMATION	The half-lives of 2(1)(+) states were measured for Zr-102,Zr-104 and Mo-106,Mo-108 to test a new implementation of a LaBr3(Ce) array at the RIBF, RIKEN, Japan. The nuclei of interest were produced through the fission of a 345 MeV/nucleon U-238 beam and selected by the BigRIPS separator. Fission fragments were implanted into the WAS3ABi active stopper, surrounding which, 18 LaBr3 (Ce) detectors provided fast gamma-ray detection. Timing between the LaBr3 (Ce) array and plastic scintillators allowed for the measurement of half-lives of low-lying states. The preliminary results, which agree with literature values, are presented along with experimental details.	[Browne, F.; Bruce, A. M.; Roberts, O. J.] Univ Brighton, Sch Comp Engn & Math, Brighton BN2 4GJ, E Sussex, England; [Browne, F.; Nishimura, S.; Doornenbal, P.; Lorusso, G.; Patel, Z.; Rice, S.; Sinclair, L.; Soederstroem, P. -A.; Wu, J.; Baba, H.; Gey, G.; Inabe, N.; Isobe, T.; Kameda, D.; Kubo, T.; Naoki, N.; Sakurai, H.; Suzuki, H.; Takeda, H.; Taprogge, J.] RIKEN Nishina Ctr, Wako, Saitama 3510198, Japan; [Sumikama, T.; Nishizuka, I.; Chiga, N.] Tohoku Univ, Dept Phys, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Patel, Z.; Rice, S.; Carroll, R.; Podolyak, Zs; Regan, P. H.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England; [Sinclair, L.] Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England; [Watanabe, H.; Wu, J.] Beihang Univ, Dept Phys, Beijing 100191, Peoples R China; [Li, Z.] Peking Univ, Dept Phys, Beijing 100871, Peoples R China; [Xu, Z. Y.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Daido, R.; Fang, Y.; Ideguchi, E.; Nishibata, H.; Odahara, A.; Tanaka, M.; Yagi, A.] Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan; [Gey, G.; Simpson, G. S.] UJF, LPSC, INPG, CNRS,IN2P3, F-38026 Grenoble, France; [Gey, G.] ILL Grenoble, F-38042 Grenoble, France; [Kojouharov, I.; Kurz, N.; Schaffner, H.] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Didierjean, F.] CNRS, IPHC, IN2P3, Strasbourg, France; [Didierjean, F.; Lozeva, R.] Univ Strasbourg, Strasbourg, France; [Lalkovski, S.] Univ Sofia, Dept Phys, Sofia 1164, Bulgaria; [Regan, P. H.] Natl Phys Lab, Teddington TW11 0LW, Middx, England; [Taprogge, J.] Univ Autonoma Madrid, Dept Fis Teor, E-28049 Madrid, Spain; [Taprogge, J.] CSIC, Inst Estruct Mat, E-28006 Madrid, Spain; [Werner, V.] Yale Univ, AW Wright Nucl Struct Lab, New Haven, CT 06520 USA; [Werner, V.] Tech Univ Darmstadt, Inst Kernphys, D-64289 Darmstadt, Germany; [Wieland, O.] Ist Nazl Fis Nucl, Sez Milano, I-20133 Milan, Italy	Browne, F (reprint author), Univ Brighton, Sch Comp Engn & Math, Brighton BN2 4GJ, E Sussex, England.		SAKURAI, HIROYOSHI/G-5085-2014		UK STFC; UK NMO; D.O.E. [DE-FG02-91ER-40609]	We acknowledge the accelerator team for delivering the <SUP>238</SUP>U beam. This work was supported in part by the UK STFC, the UK NMO and D.O.E. grant No. DE-FG02-91ER-40609.	Hua H, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.014317; Fukuda N, 2013, NUCL INSTRUM METH B, V317, P323, DOI 10.1016/j.nimb.2013.08.048; Soderstrom PA, 2013, NUCL INSTRUM METH B, V317, P649, DOI 10.1016/j.nimb.2013.03.018; Penttila H, 1996, PHYS REV C, V54, P2760, DOI 10.1103/PhysRevC.54.2760; Hwang JK, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.044316; FEDERMAN P, 1979, PHYS REV C, V20, P820, DOI 10.1103/PhysRevC.20.820; Smith AG, 2004, PHYS LETT B, V591, P55, DOI 10.1016/j.physletb.2004.03.091; CHEIFETZ E, 1970, PHYS REV LETT, V25, P38, DOI 10.1103/PhysRevLett.25.38; Jared R.C., 1974, LBL2366, P38; Kubo T., 2012, PROG THEOR EXP PHYS, V2012; Nishimura S., 2012, PROG THEOR EXP PHYS, V2012; Patel Z., 2014, 47 RIKEN, V47; Raman S, 2001, ATOM DATA NUCL DATA, V78, P1, DOI 10.1006/adnd.2001.0858; Verma S, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.024308	14	1	1	WYDAWNICTWO UNIWERSYTETU JAGIELLONSKIEGO	KRAKOW	UL GRODZKA 26, KRAKOW, 31044, POLAND	0587-4254	1509-5770		ACTA PHYS POL B	Acta Phys. Pol. B	MAR	2015	46	3					721	724		10.5506/APhysPolB.46.721		4	Physics, Multidisciplinary	Physics	CG8NR	WOS:000353565500058		
J	Chioyama, H; Luo, HC; Ohba, T; Kanoh, H				Chioyama, Hideyuki; Luo, Hongchao; Ohba, Tomonori; Kanoh, Hirofumi			Temperature-Dependent Double-Step CO2 Occlusion of K2CO3 under Moist Conditions	ADSORPTION SCIENCE & TECHNOLOGY			English	Article							CARBON-DIOXIDE SORPTION; FLUIDIZED-BED REACTOR; FLUE-GAS; CAPTURING CO2; K2CO3/AL2O3; SORBENTS; BEHAVIOR; RECOVERY	In this study, CO2 occlusion of K2CO3 was examined at different temperatures under moist conditions. The CO2 occlusion rate increased with increasing temperatures, whereas the saturated occlusion amount decreased. The highest occlusion amount (i.e. 6.48 mmol.g(-1)) was obtained at 313 K. Results of X-ray powder diffraction analysis showed that the formation of bicarbonate as a result of the K2CO3 decomposition with CO2 and H2O involved two reactions with K4H2(CO3)(3)center dot 1.5H(2)O as an intermediate. It was determined that the lower saturated occlusion amount at higher temperatures originated from the exothermic property of the second reaction. Because the equilibrium constant for the bicarbonate formation is smaller at higher temperatures, the reaction does not proceed as quickly or efficiently according to Le Chatelier's principle. Therefore, the CO2 occlusion of K2CO3 is suitable for the saturated occlusion amount at lower temperatures.	[Chioyama, Hideyuki; Luo, Hongchao; Ohba, Tomonori; Kanoh, Hirofumi] Chiba Univ, Grad Sch Sci, Inage Ku, Chiba, Japan	Kanoh, H (reprint author), Chiba Univ, Grad Sch Sci, Inage Ku, 1-33 Yayoi Cho, Chiba, Japan.	kanoh@faculty.chiba-u.jp			Japan Society for the Promotion of Science [25620140]; A-STEP (Adaptable and Seamless Technology Transfer Program) from the Japan Science and Technology Agency;  [23350072]	This work was partially supported by a grant-in-aid for Fundamental Scientific Research (B) (Grant No. 23350072) and a grant-in-aid for Challenging Exploratory Research (Grant No. 25620140) from the Japan Society for the Promotion of Science, and A-STEP (Adaptable and Seamless Technology Transfer Program) from the Japan Science and Technology Agency. The authors would like to thank Enago (www.enago.jp) for the English language review.	Zhao CW, 2010, ENERG FUEL, V24, P1009, DOI 10.1021/ef901018f; Plaza MG, 2010, CHEM ENG J, V163, P41, DOI 10.1016/j.cej.2010.07.030; Sharonov VE, 2004, REACT KINET CATAL L, V82, P363, DOI 10.1023/B:REAC.0000034849.15412.d2; Presser V, 2011, ENERG ENVIRON SCI, V4, P3059, DOI 10.1039/c1ee01176f; Zhao CW, 2012, IND ENG CHEM RES, V51, P14361, DOI 10.1021/ie302497r; Zhao CW, 2012, ENERG FUEL, V26, P3062, DOI 10.1021/ef300225a; Lee SC, 2006, KOREAN J CHEM ENG, V23, P374, DOI 10.1007/BF02706737; Cavenati S, 2004, J CHEM ENG DATA, V49, P1095, DOI 10.1021/je0498917; HIRANO S, 1995, B CHEM SOC JPN, V68, P1030, DOI 10.1246/bcsj.68.1030; Nakahigashi Y, 2012, ADSORPT SCI TECHNOL, V30, P621, DOI 10.1260/0263-6174.30.7.621; Shigemoto N, 2006, ENERG FUEL, V20, P721, DOI 10.1021/ef.058027x; Zhao CW, 2012, ENERG FUEL, V26, P1401, DOI 10.1021/ef200725z; Zhao CW, 2009, ENERG FUEL, V23, P1766, DOI 10.1021/ef800889m; Zhao CW, 2010, IND ENG CHEM RES, V49, P12212, DOI 10.1021/ie1018035	14	1	1	MULTI-SCIENCE PUBL CO LTD	BRENTWOOD	5 WATES WAY, BRENTWOOD CM15 9TB, ESSEX, ENGLAND	0263-6174	2048-4038		ADSORPT SCI TECHNOL	Adsorpt. Sci. Technol.	MAR	2015	33	3					243	250				8	Chemistry, Applied; Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CH1HU	WOS:000353773100001		
J	Lee, T; Tan, WC; Matsumoto, A; Yeoh, FY				Lee, Ting; Tan, Wan-Cheng; Matsumoto, Akihiko; Yeoh, Fei-Yee			Methane Adsorption Microcalorimetry of Activated Carbon Fibre Synthesized from Empty Fruit Bunch Fibre	ADSORPTION SCIENCE & TECHNOLOGY			English	Article							METHYLENE-BLUE ADSORPTION; SUGAR-CANE BAGASSE; NATURAL-GAS; SULFURIC-ACID; STORAGE; EQUILIBRIUM; PRETREATMENT; ANTHRACITE; COMPONENTS; CELLULOSE	In this article, the methane adsorption behaviour of activated carbon fibre (ACF), a nanoporous material, was examined for adsorbed natural gas (ANG) applications. The ACF was produced from palm fibre-based materials through carbonization, followed by CO2 activation. The carbonization of empty fruit bunch (EFB) fibres was conducted at temperatures of 85-250 degrees C in an oxidative atmosphere. The produced ACF showed well-developed pore structure with high micropore volume and excellent pore-size distribution. The ACF, predominantly with microporous pores, fulfils the requirements as an excellent adsorbent for methane adsorption. The optimal carbonization conditions for improving methane adsorption capacity were achieved using concentrated H2SO4 at 250 degrees C, followed by activation at 900 degrees C. Only physisorption occurred during the adsorption of methane on ACF. The EFB fibre-derived ACF has high potential for use in NG adsorption and storage applications via ANG technology.	[Lee, Ting; Tan, Wan-Cheng; Yeoh, Fei-Yee] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong Tebal 14300, Penang, Malaysia; [Lee, Ting] Taylors Univ, Sch Engn, Subang Jaya 47500, Selangor, Malaysia; [Matsumoto, Akihiko] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Yeoh, FY (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Transkrian Engn Campus, Nibong Tebal 14300, Penang, Malaysia.	yeoh.usm@gmail.com			MYPHD Scholarship; Universiti Sains Malaysia; AUN/SEED-Net; Ministry of Education Malaysia; Ministry of Science, Technology and Innovation Malaysia	The financial support from the MYPHD Scholarship, the Universiti Sains Malaysia, the AUN/SEED-Net, the Ministry of Education Malaysia and the Ministry of Science, Technology and Innovation Malaysia is highly appreciated.	AMAL N.M.T., 2008, JURNAL TEKNOLOGI, V49, P189; Yang HS, 2007, COMPOS STRUCT, V77, P45, DOI 10.1016/j.compstruct.2005.06.005; Tan IAW, 2007, CHEM ENG J, V127, P111, DOI [10.1016/j.cej.2006.09.010, 10.1016/j.cej.200609.010]; Foo KY, 2011, CHEM ENG J, V166, P792, DOI 10.1016/j.cej.2010.11.019; Jones RA, 2007, INT J ENERG RES, V31, P1517, DOI 10.1002/er.1317; Linares-Solano A, 2008, ADSORPTION BY CARBONS, P431, DOI 10.1016/B978-008044464-2.50021-3; Mohammed MAA, 2012, BIORESOURCE TECHNOL, V110, P628, DOI 10.1016/j.biortech.2012.01.056; Ning P, 2012, SEP PURIF TECHNOL, V98, P321, DOI 10.1016/j.seppur.2012.07.001; Reed AR, 2004, INT J ENERG RES, V28, P131, DOI 10.1002/er.956; Esteves IAAC, 2008, SEP PURIF TECHNOL, V62, P281, DOI 10.1016/j.seppur.2008.01.027; TENG HS, 1995, IND ENG CHEM RES, V34, P3102, DOI 10.1021/ie00048a023; Shen DK, 2009, FUEL, V88, P1024, DOI 10.1016/j.fuel.2008.10.034; Skreiberg A, 2011, FUEL, V90, P2182, DOI 10.1016/j.fuel.2011.02.012; MATRANGA KR, 1992, CHEM ENG SCI, V47, P1569, DOI 10.1016/0009-2509(92)85005-V; Guo J, 2002, MATER LETT, V55, P334, DOI 10.1016/S0167-577X(02)00388-9; Olivares-Marin M, 2006, APPL SURF SCI, V252, P5980, DOI 10.1016/j.apsusc.2005.11.018; Bilba K, 1996, J ANAL APPL PYROL, V38, P61, DOI 10.1016/S0165-2370(96)00952-7; Brady TA, 1996, GAS SEP PURIF, V10, P97, DOI 10.1016/0950-4214(96)00007-2; Lozano-Castello D, 2002, FUEL, V81, P1777, DOI 10.1016/S0016-2361(02)00124-2; Khezami L, 2005, POWDER TECHNOL, V157, P48, DOI 10.1016/j.powtec.2005.05.009; Arami-Niya A, 2012, CHEM ENG RES DES, V90, P776, DOI 10.1016/j.cherd.2011.10.001; Lozano-Castello D, 2002, CARBON, V40, P989, DOI 10.1016/S0008-6223(01)00235-4; Olivares-Marin M, 2012, J ANAL APPL PYROL, V94, P131, DOI 10.1016/j.jaap.2011.11.019; Munir S, 2009, BIORESOURCE TECHNOL, V100, P1413, DOI 10.1016/j.biortech.2008.07.065; Ahmad AL, 2007, DYES PIGMENTS, V75, P263, DOI 10.1016/j.dyepig.2006.05.034; Moran JI, 2008, CELLULOSE, V15, P149, DOI 10.1007/s10570-007-9145-9; Arami-Niya A, 2011, CHEM ENG RES DES, V89, P657, DOI 10.1016/j.cherd.2010.10.003; Cuerda-Correa EM, 2006, APPL SURF SCI, V252, P6042, DOI 10.1016/j.apsusc.2005.11.013; Daulan C, 1998, FUEL, V77, P495, DOI 10.1016/S0016-2361(97)00202-0; Dilek C., 2008, AFR J BIOTECHNOL, V7, P3703; Guo J, 2005, J COLLOID INTERF SCI, V281, P285, DOI 10.1016/j.jcis.2004.08.101; Hari S.N, 2000, HDB NANOSTRUCTURED M, V1st; KATAGIRI A, 1981, B CHEM SOC JPN, V54, P1, DOI 10.1246/bcsj.54.1; Lee T, 2014, REV ADV MATER SCI, V36, P118; Lyubchik SB, 1997, CARBON, V35, P162, DOI 10.1016/S0008-6223(97)81121-9; Milton O., 2002, MAT SCI THIN FILMS; Nassar MM, 1996, J APPL POLYM SCI, V61, P885, DOI 10.1002/(SICI)1097-4628(19960808)61:6<885::AID-APP1>3.0.CO;2-D; Olivier J.P., 1994, STUDIES SURFACE SCI; Petitjean D., 1994, MOL CRYST LIQ CRYS A, V244, P213; Reynolds C., 2005, SAE 2005 WORLD C EXH; Shao XH, 2007, CARBON, V45, P188, DOI 10.1016/j.carbon.2006.07.006; Shirai Y., 2003, Mitigation and Adaptation Strategies for Global Change, V8, P237, DOI 10.1023/B:MITI.0000005641.97009.14; Stuart B., 2004, INFRARED SPECTROSCOP; Taufiq-Yap Y.H., 2013, INT J ENERG RES, V38, P1008; Valix M, 2008, MICROPOR MESOPOR MAT, V116, P513, DOI 10.1016/j.micromeso.2008.05.020; Vargas DP, 2013, ADSORPTION, V19, P1075, DOI 10.1007/s10450-013-9532-5; Walton KS, 2005, ADSORPTION, V11, P107, DOI 10.1007/s10450-005-4901-3; Zhang TY, 2010, BIORESOURCE TECHNOL, V101, P1983, DOI 10.1016/j.biortech.2009.10.046	48	0	0	MULTI-SCIENCE PUBL CO LTD	BRENTWOOD	5 WATES WAY, BRENTWOOD CM15 9TB, ESSEX, ENGLAND	0263-6174	2048-4038		ADSORPT SCI TECHNOL	Adsorpt. Sci. Technol.	MAR	2015	33	3					263	277				15	Chemistry, Applied; Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CH1HU	WOS:000353773100003		
J	Shimajiri, Y; Kitamura, Y; Nakamura, F; Momose, M; Saito, M; Tsukagoshi, T; Hiramatsu, M; Shimoikura, T; Dobashi, K; Hara, C; Kawabe, R				Shimajiri, Yoshito; Kitamura, Y.; Nakamura, F.; Momose, M.; Saito, M.; Tsukagoshi, T.; Hiramatsu, M.; Shimoikura, T.; Dobashi, K.; Hara, C.; Kawabe, R.			CATALOG OF DENSE CORES IN THE ORION A GIANT MOLECULAR CLOUD	ASTROPHYSICAL JOURNAL SUPPLEMENT SERIES			English	Article						catalogs; ISM: individual objects (Orion-A GMC)	SUBMILLIMETER-WAVE OBSERVATIONS; STAR-FORMING REGIONS; PHOTON-DOMINATED REGIONS; MASSIVE QUIESCENT CORES; YOUNG STELLAR OBJECTS; OPHIUCHI MAIN CLOUD; INTERSTELLAR CLOUDS; CHEMICAL-PROPERTIES; INITIAL CONDITIONS; DYNAMICAL STATE	We present Orion A giant molecular cloud core catalogs, which are based on a 1.1 mm map with an angular resolution of 36 '' (similar to 0.07 pc) and (CO)-O-18 (J = 1-0) data with an angular resolution of 26.4 '' (similar to 0.05 pc). We have cataloged 619 dust cores in the 1.1 mm map using the Clumpfind method. The ranges of the radius, mass, and density of these cores are estimated to be 0.01-0.20 pc, 0.6-1.2 x 10(2) M-circle dot, and 0.3 x 10(4)-9.2 x 10(6) cm(-3), respectively. We have identified 235 cores from the (CO)-O-18 data. The ranges of the radius, velocity width, LTE mass, and density are 0.13-0.34 pc, 0.31-1.31 km s(-1), 1.0-61.8 M-circle dot, and (0.8-17.5) x 10(3) cm(-3), respectively. From the comparison of the spatial distributions between the dust and (CO)-O-18 cores, four types of spatial relations were revealed: (1) the peak positions of the dust and (CO)-O-18 cores agree with each other (32.4% of the (CO)-O-18 cores), (2) two or more (CO)-O-18 cores are distributed around the peak position of one dust core (10.8% of the (CO)-O-18 cores), (3) 56.8% of the (CO)-O-18 cores are not associated with any dust cores, and (4) 69.3% of the dust cores are not associated with any (CO)-O-18 cores. The data sets and analysis are public.	[Shimajiri, Yoshito] Univ Paris Diderot, CEA Saclay, CNRS, IRFU Serv Astrophys,CEA,DSM,Lab AIM, F-91191 Gif Sur Yvette, France; [Shimajiri, Yoshito; Nakamura, F.; Saito, M.; Hiramatsu, M.; Kawabe, R.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Shimajiri, Yoshito; Saito, M.] Nobeyama Radio Observ, Minamisa Ku, Minamimaki, Nagano 3841305, Japan; [Kitamura, Y.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Momose, M.; Tsukagoshi, T.] Ibaraki Univ, Coll Sci, Bunkyo Ku, Mito, Ibaraki 3108512, Japan; [Shimoikura, T.; Dobashi, K.] Tokyo Gakugei Univ, Dept Astron & Earth Sci, Koganei, Tokyo 1848501, Japan; [Hara, C.] Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan	Shimajiri, Y (reprint author), Univ Paris Diderot, CEA Saclay, CNRS, IRFU Serv Astrophys,CEA,DSM,Lab AIM, F-91191 Gif Sur Yvette, France.	Yoshito.Shimajiri@cea.fr		SHIMOIKURA, Tomomi/0000-0002-1054-3004	JSPS for Young Scientists; JSPS KAKENHI [90610551, 26287030, 26610045, 26350186, 24244017]; French National Research Agency [ANR11BS560010STARFICH]; MEXT KAKENHI [23103004]	We acknowledge the anonymous referee for providing helpful suggestions to improve this paper. Y.S. was financially supported by a Research Fellowship from the JSPS for Young Scientists. This work was supported by JSPS KAKENHI Grant Number 90610551. Part of this work was supported by the French National Research Agency (grant no. ANR11BS560010STARFICH). K.S., T.S., and F.N., were supported by JSPS KAKENHI grant numbers, 26287030, 26610045, 26350186, and 24244017. M.M., and T.T., were supported by MEXT KAKENHI No. 23103004.	Ohashi N, 1997, ASTROPHYS J, V488, P317, DOI 10.1086/304685; Johnstone D, 1999, ASTROPHYS J, V510, pL49, DOI 10.1086/311792; Rodriguez-Franco A, 2001, ASTROPHYS J, V559, P985; FRERKING MA, 1982, ASTROPHYS J, V262, P590, DOI 10.1086/160451; Menten KM, 2007, ASTRON ASTROPHYS, V474, P515, DOI 10.1051/0004-6361:20078247; Pineda JE, 2009, ASTROPHYS J LETT, V699, pL134, DOI 10.1088/0004-637X/699/2/L134; WILLIAMS JP, 1994, ASTROPHYS J, V428, P693, DOI 10.1086/174279; Shimajiri Y, 2008, ASTROPHYS J, V683, P255, DOI 10.1086/588629; Rathborne JM, 2009, ASTROPHYS J, V699, P742, DOI 10.1088/0004-637X/699/1/742; GLASSGOLD AE, 1985, ASTROPHYS J, V290, P615, DOI 10.1086/163019; Tafalla M, 2002, ASTROPHYS J, V569, P815, DOI 10.1086/339321; Johnstone D, 2010, ASTROPHYS J, V711, P655, DOI 10.1088/0004-637X/711/2/655; Takahashi S, 2008, ASTROPHYS J, V688, P344, DOI 10.1086/592212; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; Motte F, 1998, ASTRON ASTROPHYS, V336, P150; BALLY J, 1987, ASTROPHYS J, V312, pL45, DOI 10.1086/184817; Furuya RS, 2009, ASTROPHYS J, V703, P1198, DOI 10.1088/0004-637X/703/2/1198; Davis CJ, 2009, ASTRON ASTROPHYS, V496, P153, DOI 10.1051/0004-6361:200811096; Kirk H, 2006, ASTROPHYS J, V646, P1009, DOI 10.1086/503193; Bergin EA, 2002, ASTROPHYS J, V570, pL101, DOI 10.1086/340950; Tatematsu K, 2008, PUBL ASTRON SOC JPN, V60, P407; COHEN M, 1979, ASTROPHYS J SUPPL S, V41, P743, DOI 10.1086/190641; MYERS PC, 1995, ASTROPHYS J, V449, pL65, DOI 10.1086/309631; Ripple F, 2013, MON NOT R ASTRON SOC, V431, P1296, DOI 10.1093/mnras/stt247; Chini R, 1997, ASTROPHYS J, V474, pL135, DOI 10.1086/310436; Kauffmann J, 2008, ASTRON ASTROPHYS, V487, P993, DOI 10.1051/0004-6361:200809481; Ikeda N, 2007, ASTROPHYS J, V665, P1194, DOI 10.1086/519484; Williams MJ, 2010, MON NOT R ASTRON SOC, V409, P1330, DOI 10.1111/j.1365-2966.2010.17406.x; Nagahama T, 1998, ASTRON J, V116, P336, DOI 10.1086/300392; Sandstrom KM, 2007, ASTROPHYS J, V667, P1161, DOI 10.1086/520922; Crutcher RM, 1999, ASTROPHYS J, V514, pL121, DOI 10.1086/311952; Shimajiri Y, 2011, PUBL ASTRON SOC JPN, V63, P105; Bally J, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/113; Belloche A, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015733; Bethell TJ, 2007, ASTROPHYS J, V667, P275, DOI 10.1086/520696; Buckle JV, 2012, MON NOT R ASTRON SOC, V422, P521, DOI 10.1111/j.1365-2966.2012.20628.x; CESARONI R, 1994, ASTRON ASTROPHYS, V281, P209; Dobashi K., 2005, PASJ, V57, P1; Dobashi K, 1996, ASTROPHYS J, V466, P282, DOI 10.1086/177509; Dzib SA, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/63; Friesen RK, 2010, ASTROPHYS J, V708, P1002, DOI 10.1088/0004-637X/708/2/1002; HILDEBRAND RH, 1983, Q J ROY ASTRON SOC, V24, P267; Hirota T, 2008, PUBL ASTRON SOC JPN, V60, P961; Ikeda N, 2009, ASTROPHYS J LETT, V705, pL95, DOI 10.1088/0004-637X/705/1/L95; Ikeda N, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/101; Johnstone D, 2006, ASTROPHYS J, V639, P259, DOI 10.1086/499258; Kramer C, 2008, ASTRON ASTROPHYS, V477, P547, DOI 10.1051/0004-6361:20077815; Lee K, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/100; Li D, 2013, ASTROPHYS J LETT, V768, DOI 10.1088/2041-8205/768/1/L5; Liszt HS, 2007, ASTRON ASTROPHYS, V476, P291, DOI 10.1051/0004-6361:20078502; Liu TT, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-4; Mardones D, 1997, ASTROPHYS J, V489, P719, DOI 10.1086/304812; Maruta H, 2010, ASTROPHYS J, V714, P680, DOI 10.1088/0004-637X/714/1/680; MCKEE CF, 1992, ASTROPHYS J, V399, P551, DOI 10.1086/171946; Megeath ST, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/6/192; Nakamura F, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/36; Nakamura F, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/25; Nutter D, 2007, MON NOT R ASTRON SOC, V374, P1413, DOI 10.1111/j.1365-2966.2006.11246.x; Onishi T, 2002, ASTROPHYS J, V575, P950, DOI 10.1086/341347; Polychroni D, 2013, ASTROPHYS J LETT, V777, DOI 10.1088/2041-8205/777/2/L33; Ren ZY, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/172; Rollig M, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220130; Saito M, 2001, ASTROPHYS J, V547, P840, DOI 10.1086/318383; Sanchez-Monge A, 2013, MON NOT R ASTRON SOC, V432, P3288, DOI 10.1093/mnras/stt679; Shimajiri Y, 2009, PUBL ASTRON SOC JPN, V61, P1055; Shimajiri Y, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322912; Shimajiri Y, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L20; Spaans M, 1996, ASTRON ASTROPHYS, V307, P271; Stanke T, 2007, ASTRON J, V133, P1307, DOI 10.1086/510619; Tachihara K, 2002, ASTRON ASTROPHYS, V385, P909, DOI 10.1051/0004-6361:20020180; Takahashi S, 2012, ASTROPHYS J LETT, V745, DOI 10.1088/2041-8205/745/1/L10; Takahashi S, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/57; Takahashi S, 2006, ASTROPHYS J, V651, P933, DOI 10.1086/507482; Takahashi S, 2009, ASTROPHYS J, V704, P1459, DOI 10.1088/0004-637X/704/2/1459; Takakuwa S, 2003, ASTROPHYS J, V584, P818, DOI 10.1086/345845; Tanaka T, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/34; TATEMATSU K, 1993, ASTROPHYS J, V404, P643, DOI 10.1086/172318; Tatematsu K, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/pst016; Tatematsu K, 1998, ASTROPHYS J SUPPL S, V118, P517, DOI 10.1086/313143; TOMISAKA K, 1988, ASTROPHYS J, V335, P239, DOI 10.1086/166923; Wall JV, 2012, CAMB OBSERVING HANDB, P1, DOI 10.1017/CBO9781139031998; Yonekura Y, 1997, ASTROPHYS J SUPPL S, V110, P21, DOI 10.1086/312994	82	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0067-0049	1538-4365		ASTROPHYS J SUPPL S	Astrophys. J. Suppl. Ser.	MAR	2015	217	1							7	10.1088/0067-0049/217/1/7		28	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7EY	WOS:000353466600007		
J	Tateuchi, K; Konishi, M; Motohara, K; Takahashi, H; Kato, NM; Kitagawa, Y; Todo, S; Toshikawa, K; Sako, S; Uchimoto, YK; Ohsawa, R; Asano, K; Ita, Y; Kamizuka, T; Komugi, S; Koshida, S; Manabe, S; Nakamura, T; Nakashima, A; Okada, K; Takagi, T; Tanabe, T; Uchiyama, M; Aoki, T; Doi, M; Handa, T; Kawara, K; Kohno, K; Minezaki, T; Miyata, T; Morokuma, T; Soyano, T; Tamura, Y; Tanaka, M; Tarusawa, K; Yoshii, Y				Tateuchi, Ken; Konishi, Masahiro; Motohara, Kentaro; Takahashi, Hidenori; Kato, Natsuko Mitani; Kitagawa, Yutaro; Todo, Soya; Toshikawa, Koji; Sako, Shigeyuki; Uchimoto, Yuka K.; Ohsawa, Ryou; Asano, Kentaro; Ita, Yoshifusa; Kamizuka, Takafumi; Komugi, Shinya; Koshida, Shintaro; Manabe, Sho; Nakamura, Tomohiko; Nakashima, Asami; Okada, Kazushi; Takagi, Toshinobu; Tanabe, Toshihiko; Uchiyama, Mizuho; Aoki, Tsutomu; Doi, Mamoru; Handa, Toshihiro; Kawara, Kimiaki; Kohno, Kotaro; Minezaki, Takeo; Miyata, Takashi; Morokuma, Tomoki; Soyano, Takeo; Tamura, Yoichi; Tanaka, Masuo; Tarusawa, Ken'ichi; Yoshii, Yuzuru			GROUND-BASED Pa alpha NARROW-BAND IMAGING OF LOCAL LUMINOUS INFRARED GALAXIES. I. STAR FORMATION RATES AND SURFACE DENSITIES	ASTROPHYSICAL JOURNAL SUPPLEMENT SERIES			English	Article						galaxies: interactions; galaxies: starburst; HII regions; infrared: galaxies; stars: formation	RESOLUTION MIDINFRARED OBSERVATIONS; INTEGRAL FIELD SPECTROSCOPY; ACTIVE GALACTIC NUCLEUS; H II REGIONS; INTERACTING GALAXY; STARBURST GALAXIES; SEYFERT-2 GALAXIES; FORMATION HISTORY; NEARBY GALAXIES; MERGER REMNANT	Luminous infrared galaxies (LIRGs) are enshrouded by a large amount of dust produced by their active star formation, and it is difficult to measure their activity in optical wavelengths. We have carried out Paa narrow-band imaging observations of 38 nearby star forming galaxies including 33 LIRGs listed in the IRAS Revised Bright Galaxy Sample catalog with the Atacama Near InfraRed camera on the University of Tokyo Atacama Observatory (TAO) 1.0 m telescope (miniTAO). Star formation rates (SFRs) estimated from the Paa fluxes, corrected for dust extinction using the Balmer decrement method (typically AV similar to 4.3 mag), show a good correlation with those from the bolometric infrared luminosity of the IRAS data within a scatter of 0.27 dex. This suggests that the correction of dust extinction for the Paa flux is sufficient in our sample. We measure the physical sizes and surface densities of infrared luminosities (Sigma L-(IR)) and the SFR (Sigma(SFR)) of star forming regions for individual galaxies, and we find that most of the galaxies follow a sequence of local ultra-luminous or luminous infrared galaxies (U/LIRGs) on the L(IR)-Sigma(L(IR)) and SFR-Sigma(SFR) plane. We confirm that a transition of the sequence from normal galaxies to U/LIRGs is seen at L(IR) = 8 x 10(10) L-circle dot. Also, we find that there is a large scatter in physical size, different from normal galaxies or ULIRGs. Considering the fact that most U/LIRGs are merging or interacting galaxies, this scatter may be caused by strong external factors or differences in their merging stages.	[Tateuchi, Ken; Konishi, Masahiro; Motohara, Kentaro; Takahashi, Hidenori; Kato, Natsuko Mitani; Kitagawa, Yutaro; Todo, Soya; Toshikawa, Koji; Sako, Shigeyuki; Uchimoto, Yuka K.; Ohsawa, Ryou; Asano, Kentaro; Kamizuka, Takafumi; Nakamura, Tomohiko; Okada, Kazushi; Tanabe, Toshihiko; Uchiyama, Mizuho; Doi, Mamoru; Kawara, Kimiaki; Kohno, Kotaro; Minezaki, Takeo; Miyata, Takashi; Morokuma, Tomoki; Tamura, Yoichi; Tanaka, Masuo; Yoshii, Yuzuru] Univ Tokyo, Grad Sch Sci, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Uchimoto, Yuka K.; Ita, Yoshifusa] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Komugi, Shinya] Kogakuin Univ, Div Liberal Arts, Hachioji, Tokyo 1920015, Japan; [Koshida, Shintaro] Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan; [Nakamura, Tomohiko; Nakashima, Asami] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Nakashima, Asami] Natl Astron Observ, Mitaka, Tokyo 1818588, Japan; [Takagi, Toshinobu] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Aoki, Tsutomu; Soyano, Takeo; Tarusawa, Ken'ichi] Univ Tokyo, Inst Astron, Kiso Observ, Nagano 3970101, Japan; [Doi, Mamoru; Kohno, Kotaro] Univ Tokyo, Res Ctr Early Univ RESCEU, Bunkyo Ku, Tokyo 1130033, Japan; [Handa, Toshihiro] Kagoshima Univ, Fac Sci, Kagoshima 8908580, Japan	Tateuchi, K (reprint author), Univ Tokyo, Grad Sch Sci, Inst Astron, 2-21-1 Osawa, Mitaka, Tokyo 1810015, Japan.	tateuchi@ioa.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan from the Japan Society for the Promotion of Science (JSPS) [17104002, 20040003, 20041003, 21018003, 21018005, 21684006, 22253002, 22540258, 23540261]; NAOJ Research Grant for Universities and Optical and Near-Infrared Astronomy Inter-University Cooperation Program - MEXT of Japan; Institutional Program for Young Researcher Overseas Visits	We deeply thank the referee (Dr. Guilin Liu) for useful comments and suggestions that helped improve the quality of the paper, and we also thank M. Malkan (UCLA) and S. Howard Transmittance (CfA) for enlightening discussions on this topic. This work is supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-Aid for Scientific Research (17104002, 20040003, 20041003, 21018003, 21018005, 21684006, 22253002, 22540258, and 23540261) from the Japan Society for the Promotion of Science (JSPS). Operation of ANIR on the miniTAO 1m telescope is also supported by NAOJ Research Grant for Universities and Optical and Near-Infrared Astronomy Inter-University Cooperation Program, supported by the MEXT of Japan. Part of this work has been supported by the Institutional Program for Young Researcher Overseas Visits operated by JSPS. The Image Reduction and Analysis Facility (IRAF) used in this paper is distributed by the National Optical Astronomy Observatories, which are operated by the Association of Universities for Research in Astronomy, Inc., under cooperative agreement with the National Science Foundation. We acknowledge the use of the HyperLeda database (http://leda.univ-lyon 1.fr).	Aguero EL, 2000, ASTRON J, V119, P94, DOI 10.1086/301172; Alonso-Herrero A, 2009, ASTRON ASTROPHYS, V506, P1541, DOI 10.1051/0004-6361/200911813; Alonso-Herrero A, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/2; Alonso-Herrero A, 2001, ASTROPHYS J, V546, P952; Alonso-Herrero A, 1999, MON NOT R ASTRON SOC, V302, P561, DOI 10.1046/j.1365-8711.1999.02171.x; Ann H. -B., 1996, JKAS, V29, P255; Saitoh TR, 2009, PUBL ASTRON SOC JPN, V61, P481; Schweizer F, 2007, ASTRON J, V133, P2132, DOI 10.1086/513317; Kim D, 2010, ASTROPHYS J, V724, P386, DOI 10.1088/0004-637X/724/1/386; Rothberg B, 2004, ASTRON J, V128, P2098, DOI 10.1086/425049; CONDON JJ, 1993, ASTRON J, V105, P1730, DOI 10.1086/116549; Iono D, 2005, ASTROPHYS J SUPPL S, V158, P1, DOI 10.1086/429093; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Corbett EA, 2003, ASTROPHYS J, V583, P670, DOI 10.1086/345414; Ho LC, 1997, ASTROPHYS J SUPPL S, V112, P315, DOI 10.1086/313041; CONDON JJ, 1991, ASTROPHYS J, V378, P65, DOI 10.1086/170407; Dopita MA, 2002, ASTROPHYS J SUPPL S, V143, P47, DOI 10.1086/342624; GENZEL R, 1995, ASTROPHYS J, V444, P129, DOI 10.1086/175588; Scoville NZ, 2001, ASTRON J, V122, P3017, DOI 10.1086/323445; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Yuan TT, 2010, ASTROPHYS J, V709, P884, DOI 10.1088/0004-637X/709/2/884; WILSON AS, 1991, ASTROPHYS J, V381, P79, DOI 10.1086/170630; Grimes JP, 2006, ASTROPHYS J, V648, P310, DOI 10.1086/505680; HUMMER DG, 1987, MON NOT R ASTRON SOC, V224, P801; Soifer BT, 2003, ASTRON J, V126, P143, DOI 10.1086/375647; Alonso-Herrero A, 2002, ASTRON J, V124, P166, DOI 10.1086/340963; Morganti R, 2007, ASTRON ASTROPHYS, V476, P735, DOI 10.1051/0004-6361:20077888; RUSH B, 1993, ASTROPHYS J SUPPL S, V89, P1, DOI 10.1086/191837; Alonso-Herrero A, 2006, ASTROPHYS J, V650, P835, DOI 10.1086/506958; Sanders DB, 2003, ASTRON J, V126, P1607, DOI 10.1086/376841; Paturel G, 2003, ASTRON ASTROPHYS, V412, P45, DOI 10.1051/0004-6361:20031411; Kim DC, 1998, ASTROPHYS J, V508, P627, DOI 10.1086/306409; Davies RI, 2004, ASTROPHYS J, V602, P148, DOI 10.1086/380995; Kennicutt RC, 2007, ASTROPHYS J, V671, P333, DOI 10.1086/522300; ANTONUCCI RRJ, 1985, ASTROPHYS J, V297, P621, DOI 10.1086/163559; Rieke GH, 2009, ASTROPHYS J, V692, P556, DOI 10.1088/0004-637X/692/1/556; Jenkins LP, 2005, MON NOT R ASTRON SOC, V357, P109, DOI 10.1111/j.1365-2966.2005.08616.x; Caputi KI, 2007, ASTROPHYS J, V660, P97, DOI 10.1086/512667; NAIM A, 1995, MON NOT R ASTRON SOC, V274, P1107; COLINA L, 1991, ASTROPHYS J, V370, P102, DOI 10.1086/169795; RICHTER OG, 1994, ASTRON J, V107, P99, DOI 10.1086/116837; Sanders DB, 1996, ANNU REV ASTRON ASTR, V34, P749, DOI 10.1146/annurev.astro.34.1.749; Hopkins AM, 2006, ASTROPHYS J, V651, P142, DOI 10.1086/506610; Soifer BT, 2000, ASTRON J, V119, P509, DOI 10.1086/301233; Colina L, 2001, ASTROPHYS J, V553, pL19, DOI 10.1086/320507; Calzetti D, 2007, ASTROPHYS J, V666, P870, DOI 10.1086/520082; Scoville NZ, 2000, ASTRON J, V119, P991, DOI 10.1086/301248; Barnes JE, 1996, ASTROPHYS J, V471, P115, DOI 10.1086/177957; Hirashita H, 2003, ASTRON ASTROPHYS, V410, P83, DOI 10.1051/0004-6361:20031144; Morganti R, 1998, ASTRON J, V115, P915, DOI 10.1086/300236; Daddi E, 2010, ASTROPHYS J LETT, V714, pL118, DOI 10.1088/2041-8205/714/1/L118; Stritzinger M, 2002, ASTRON J, V124, P2100, DOI 10.1086/342544; Levenson NA, 2005, ASTROPHYS J, V618, P167, DOI 10.1086/425913; Calzetti D, 2013, SECULAR EVOLUTION GA, P419; CHABOYER B, 1991, PUBL ASTRON SOC PAC, V103, P35, DOI 10.1086/132793; de Vaucouleurs G., 1991, S T, V82, P621; Diaz-Santos T., 2010, APJ, V723, P993; Falcke H, 1998, ASTROPHYS J, V494, pL155, DOI 10.1086/311176; Fernandez X, 2010, ASTRON J, V140, P1965, DOI 10.1088/0004-6256/140/6/1965; Goto T, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913182; Hill GJ, 1996, ASTROPHYS J, V462, P163, DOI 10.1086/177139; HOUGH JH, 1987, MON NOT R ASTRON SOC, V224, P1013; INGLIS MD, 1993, MON NOT R ASTRON SOC, V263, P895; Iono D, 2013, PUBL ASTRON SOC JPN, V65; Kennicutt RC, 2009, ASTROPHYS J, V703, P1672, DOI 10.1088/0004-637X/703/2/1672; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kewley LJ, 2002, ASTRON J, V124, P3135, DOI 10.1086/344487; Komugi S, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/138; Konishi M., 2015, PASJ IN PRESS; Koss M, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/2/L26; Lada CJ, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/190; Lai O., 1999, ESO C WORKSH P AD OP, V56, P555; Lauberts A., 1982, FINDING CHARTS ESO U; Liu GL, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/2/L41; Liu GL, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/27; Lord S. D., 1992, 103957 NASA; Lumsden SL, 2001, MON NOT R ASTRON SOC, V327, P459, DOI 10.1046/j.1365-8711.2001.04741.x; Lutz D., 1991, IAU S, P312; Malmquist K. G., 1925, OBSERVATORY, V48, P142; MAUDER W, 1994, ASTRON ASTROPHYS, V285, P44; MILES JW, 1994, ASTROPHYS J, V425, pL37, DOI 10.1086/187305; Minezaki T, 2010, PROC SPIE, V7733, DOI 10.1117/12.856694; MIRABEL IF, 1983, ASTROPHYS J, V270, pL35, DOI 10.1086/184065; Motohara K, 2011, REV MEX AST ASTR, V41, P83; Motohara K., 2010, P SOC PHOTO-OPT INS, V7735, P77353; Motohara K., 2008, P SOC PHOTO-OPT INS, V7014, P70142; Murphy TW, 1999, ASTROPHYS J, V525, pL85, DOI 10.1086/312350; Olsson E, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200811538; Peterson BW, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/11; PETROSIAN V, 1976, ASTROPHYS J, V209, pL1, DOI 10.1086/182253; Lopez JP, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220991; Roche N, 2007, REV MEX ASTRON ASTR, V43, P179; Rodriguez-Zaurin J, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201014879; Rujopakarn W, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/73; Rujopakarn W, 2010, ASTROPHYS J, V718, P1171, DOI 10.1088/0004-637X/718/2/1171; Rujopakarn W, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/93; Saito T., 2013, ASP C SER, P287; Sheen YK, 2009, ASTRON J, V138, P1911, DOI 10.1088/0004-6256/138/6/1911; Soifer BT, 2001, ASTRON J, V122, P1213, DOI 10.1086/322119; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Tanabe T, 2013, PUBL ASTRON SOC JPN, V65; Tateuchi K., 2012, PUBL KOREAN ASTRON S, V27, P297; Tateuchi K., 2013, ASP C SER, P301; Tateuchi K., 2012, P SOC PHOTO-OPT INS, V8446, P84467; Thomas HC, 2004, MON NOT R ASTRON SOC, V351, P362, DOI 10.1111/j.1365-2966.2004.07795.x; Totani T, 2011, PUBL ASTRON SOC JPN, V63, P1181; Tran HD, 2001, ASTROPHYS J, V554, pL19, DOI 10.1086/320926; Vaisanen P, 2012, MON NOT R ASTRON SOC, V420, P2209, DOI 10.1111/j.1365-2966.2011.20186.x; VANDENBROEK AC, 1991, ASTRON ASTROPHYS SUP, V91, P61; Veron-Cetty MP, 2006, ASTRON ASTROPHYS, V455, P773, DOI 10.1051/0004-6361:20065177; Vorontsov-Vel'Yaminov B. A., 1974, MORPHOLOGICAL CATALO, V5; WEST RM, 1976, ASTRON ASTROPHYS, V46, P327; Yoshii Y, 2010, PROC SPIE, V7733, DOI 10.1117/12.856680	113	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0067-0049	1538-4365		ASTROPHYS J SUPPL S	Astrophys. J. Suppl. Ser.	MAR	2015	217	1							UNSP 1	10.1088/0067-0049/217/1/1		26	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7EY	WOS:000353466600001		
J	Ito, S; Araya, J; Kurita, Y; Kobayashi, K; Takasaka, N; Yoshida, M; Hara, H; Minagawa, S; Wakui, H; Fujii, S; Kojima, J; Shimizu, K; Numata, T; Kawaishi, M; Odaka, M; Morikawa, T; Harada, T; Nishimura, SL; Kaneko, Y; Nakayama, K; Kuwano, K				Ito, Saburo; Araya, Jun; Kurita, Yusuke; Kobayashi, Kenji; Takasaka, Naoki; Yoshida, Masahiro; Hara, Hiromichi; Minagawa, Shunsuke; Wakui, Hiroshi; Fujii, Satoko; Kojima, Jun; Shimizu, Kenichiro; Numata, Takanori; Kawaishi, Makoto; Odaka, Makoto; Morikawa, Toshiaki; Harada, Toru; Nishimura, Stephen L.; Kaneko, Yumi; Nakayama, Katsutoshi; Kuwano, Kazuyoshi			PARK2-mediated mitophagy is involved in regulation of HBEC senescence in COPD pathogenesis	AUTOPHAGY			English	Article						COPD; mitophagy; PARK2; ROS; senescence; Baf A1; bafilomycin A(1); COPD; chronic obstructive pulmonary disease; CS; cigarette smoke; CSE; cigarette smoke extract; EM; electron microscopy; FEV1; forced expiratory volume in one second; FVC; forced vital capacity; HBEC; human bronchial epithelial cell; MAP1LC3; LC3; microtubule-associated protein 1 light chain 3; NAC; N-acetylcysteine; PCD; programmed cell death; PINK1; PTEN-induced putative kinase 1; ROS; reactive oxygen species; SA--Gal; senescence-associated -galactosidase; TLR; toll-like receptor; WB; western blotting	EPITHELIAL-CELL SENESCENCE; IDIOPATHIC PULMONARY-FIBROSIS; MITOCHONDRIAL DYSFUNCTION; INSUFFICIENT AUTOPHAGY; LUNG; DISEASE; INFLAMMATION; PARKIN; DYNAMICS; PROMOTES	Cigarette smoke (CS)-induced mitochondrial damage with increased reactive oxygen species (ROS) production has been implicated in COPD pathogenesis by accelerating senescence. Mitophagy may play a pivotal role for removal of CS-induced damaged mitochondria, and the PINK1 (PTEN-induced putative kinase 1)-PARK2 pathway has been proposed as a crucial mechanism for mitophagic degradation. Therefore, we sought to investigate to determine if PINK1-PARK2-mediated mitophagy is involved in the regulation of CS extract (CSE)-induced cell senescence and in COPD pathogenesis. Mitochondrial damage, ROS production, and cell senescence were evaluated in primary human bronchial epithelial cells (HBEC). Mitophagy was assessed in BEAS-2B cells stably expressing EGFP-LC3B, using confocal microscopy to measure colocalization between TOMM20-stained mitochondria and EGFP-LC3B dots as a representation of autophagosome formation. To elucidate the involvement of PINK1 and PARK2 in mitophagy, knockdown and overexpression experiments were performed. PINK1 and PARK2 protein levels in lungs from patients were evaluated by means of lung homogenate and immunohistochemistry. We demonstrated that CSE-induced mitochondrial damage was accompanied by increased ROS production and HBEC senescence. CSE-induced mitophagy was inhibited by PINK1 and PARK2 knockdown, resulting in enhanced mitochondrial ROS production and cellular senescence in HBEC. Evaluation of protein levels demonstrated decreased PARK2 in COPD lungs compared with non-COPD lungs. These results suggest that PINK1-PARK2 pathway-mediated mitophagy plays a key regulatory role in CSE-induced mitochondrial ROS production and cellular senescence in HBEC. Reduced PARK2 expression levels in COPD lung suggest that insufficient mitophagy is a part of the pathogenic sequence of COPD.	[Ito, Saburo; Araya, Jun; Kurita, Yusuke; Kobayashi, Kenji; Takasaka, Naoki; Yoshida, Masahiro; Hara, Hiromichi; Minagawa, Shunsuke; Wakui, Hiroshi; Fujii, Satoko; Kojima, Jun; Shimizu, Kenichiro; Numata, Takanori; Kawaishi, Makoto; Kaneko, Yumi; Nakayama, Katsutoshi; Kuwano, Kazuyoshi] Jikei Univ, Sch Med, Dept Internal Med, Div Resp Dis, Tokyo, Japan; [Odaka, Makoto; Morikawa, Toshiaki] Jikei Univ, Sch Med, Dept Surg, Div Chest Dis, Tokyo, Japan; [Harada, Toru] Jikei Univ, Sch Med, Dept Pathol, Tokyo, Japan; [Nishimura, Stephen L.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	Araya, J (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Resp Dis, Tokyo, Japan.	araya@jikei.ac.jp			Jikei University; Ministry of Education of Japan; Ministry of Health Labor and Welfare of Japan	This work was supported by grants from the Jikei University Graduate Research Grant to S.I., K. Kobayashi, and N.T., a Grant-In-Aid for Scientific Research from the Ministry of Education of Japan to J.A., H.H., J.K., K.S., K.N., and K. Kuwano, and Health and Labor Sciences Research Grants from the Ministry of Health Labor and Welfare of Japan to J.A. and K. Kuwano.	Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004.0309OC; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Zhou F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-78; Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012; dos Santos G, 2012, AM J PHYSIOL-LUNG C, V303, pL627, DOI 10.1152/ajplung.00225.2012; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V292, pL1211, DOI 10.1152/ajplung.00291.2006; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Hara H, 2013, AM J PHYSIOL-LUNG C, V305, pL737, DOI 10.1152/ajplung.00146.2013; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Hara H, 2012, AM J RESP CELL MOL, V46, P306, DOI 10.1165/rcmb.2011-0214OC; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JC132526; Feng D, 2013, EXP CELL RES, V319, P1697, DOI 10.1016/j.yexcr.2013.03.034; van der Toorn M, 2009, AM J PHYSIOL-LUNG C, V297, pL109, DOI 10.1152/ajplung.90461.2008; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Chilosi M, 2013, TRANSL RES, V162, P156, DOI 10.1016/j.trsl.2013.06.004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Marzetti E, 2013, AM J PHYSIOL-HEART C, V305, pH459, DOI 10.1152/ajpheart.00936.2012; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Mortaz E, 2010, EUR RESPIR J, V36, P1143, DOI 10.1183/09031936.00062209; Takasaka N, 2014, J IMMUNOL, V192, P958, DOI 10.4049/jimmunol.1302341; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Fujii S, 2012, ONCOIMMUNOLOGY, V1, P630, DOI 10.4161/onci.20297; Aoshiba Kazutetsu, 2009, Proc Am Thorac Soc, V6, P596, DOI 10.1513/pats.200904-017RM; Birrell MA, 2011, PHARMACOL THERAPEUT, V130, P364, DOI 10.1016/j.pharmthera.2011.03.007; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI [10.1146/annurev-pathol-121808-102144, 10.1140/annurev-pathol-121808-102144]; De Nardo D, 2013, AM J PATHOL, V184, P42; Hoffmann RF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-97; López-Otín Carlos, 2013, Cell, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Miura K, 2010, GASTROENTEROLOGY, V139; Oliveras-Salva M, 2011, J PARKINSON DIS, V1, P229, DOI 10.3233/JPD-2011-11041; Passos JF, 2012, AGING-US, V4, P74	45	2	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1554-8627	1554-8635		AUTOPHAGY	Autophagy	MAR	2015	11	3					547	559		10.1080/15548627.2015.1017190		13	Cell Biology	Cell Biology	CG8UB	WOS:000353587600011		
J	Tamai, H; Maruo, K; Ueno, H; Terao, K; Kotera, H; Suzuki, T				Tamai, H.; Maruo, K.; Ueno, H.; Terao, K.; Kotera, H.; Suzuki, T.			Development of low-fluorescence thick photoresist for high-aspect-ratio microstructure in bio-application	BIOMICROFLUIDICS			English	Article							SU-8 PHOTORESIST; MICROCHANNEL; LITHOGRAPHY; MEMS	In this study, we propose and evaluate a novel low-auto-fluorescence photoresist (SJI photoresist) for bio-application, e.g., in gene analysis and cell assay. The spin-coated SJI photoresist has a wide thickness range of ten to several hundred micrometers, and photoresist microstructures with an aspect ratio of over 7 and micropatterns of less than 2 mu m are successfully fabricated. The emission spectrum intensity of the SJI photoresist is found to be over 80% less than that of the widely used SU-8 photoresist. To evaluate the validity of using the proposed photoresist in bio-application for fluorescence observation, we demonstrate a chromosome extension device composed of the SJI photoresist. The normalized contrast ratio of the SJI photoresist exhibits a 50% improvement over that of the SU-8 photoresist; thus, the SJI photoresist is a versatile tool for bio-application. (C) 2015 AIP Publishing LLC.	[Tamai, H.; Ueno, H.; Terao, K.; Suzuki, T.] Kagawa Univ, Dept Intelligent Mech Syst Engn, Takamatsu, Kagawa 7610396, Japan; [Maruo, K.] Daicel Corp, Cent Res Ctr, Aboshi Ku, Himeji, Hyogo 6711283, Japan; [Kotera, H.] Kyoto Univ, Dept Microengn, Nishikyo Ku, Kyoto 6158540, Japan	Suzuki, T (reprint author), Kagawa Univ, Dept Intelligent Mech Syst Engn, 2217-20 Hayashi Cho, Takamatsu, Kagawa 7610396, Japan.	suzuki@eng.kagawa-u.ac.jp			Kagawa University Nanotechnology supporting office as part of the MEXT, JAPAN "Nanotechnology Project" [26289067]	This work was partly supported by a Grant-in-Aid for Scientific Research (B) (Grant No. 26289067) and by the Kagawa University Nanotechnology supporting office as part of the MEXT, JAPAN "Nanotechnology Project."	Anhoj TA, 2006, J MICROMECH MICROENG, V16, P1819, DOI 10.1088/0960-1317/16/9/009; Liu G, 2005, MICROSYST TECHNOL, V11, P343, DOI 10.1007/S00542-004-0452-X; Xu YC, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3687399; Pai JH, 2007, ANAL CHEM, V79, P8774, DOI 10.1021/ac071528q; Esch MB, 2012, BIOMED MICRODEVICES, V14, P895, DOI 10.1007/s10544-012-9669-0; Yang R, 2005, SENSOR ACTUAT B-CHEM, V110, P279, DOI 10.1016/j.snb.2005.02.006; Morikaku T, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/10/105016; Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006; Warkiani ME, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3637630; Lorenz H, 1997, J MICROMECH MICROENG, V7, P121, DOI 10.1088/0960-1317/7/3/010; Auzelyte V, 2006, MICROELECTRON ENG, V83, P2015, DOI 10.1016/j.mee.2006.04.001; Carlo D. D., 2006, LAB CHIP, V6, P1445, DOI DOI 10.1039/B605937F; Inoue M, 2012, MICRO NANO LETT, V7, P725, DOI 10.1049/mnl.2012.0216; Levinson H. J., 2005, PRINCIPLES LITHOGRAP, V2nd, P63; Meier RC, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3613668; Nakahara T., 2012, 2012 IEEE 25th International Conference on Micro Electro Mechanical Systems (MEMS), DOI 10.1109/MEMSYS.2012.6170374; Sato H, 2006, SENSOR ACTUAT A-PHYS, V128, P183, DOI 10.1016/j.sna.2005.12.043; Sato H, 2004, SENSOR ACTUAT A-PHYS, V111, P87, DOI 10.1016/j.sna.2003.10.009; Suzuki T., 2007, P MICR TOT AN SYST P, P1765; Suzuki T., 2012, MICROTAS 12 P 16 INT, P272; Terao K, 2012, ANALYST, V137, P2192, DOI 10.1039/c2an16010b; Walczak R, 2011, OPT APPL, V41, P873; Yamashita H., 2013, P IEEE OPT MEMS NAN, P69; Yang B, 2007, J VAC SCI TECHNOL B, V25, P2352, DOI 10.1116/1.2806975; Zhang ZY, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3659016	25	1	1	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1932-1058			BIOMICROFLUIDICS	Biomicrofluidics	MAR	2015	9	2							022405	10.1063/1.4917511		9	Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology; Physics, Fluids & Plasmas	Biochemistry & Molecular Biology; Biophysics; Science & Technology - Other Topics; Physics	CH2BN	WOS:000353829200006		
J	Zhang, L; Fu, YF; Jing, WW; Xu, Q; Zhao, W; Feng, M; Tachibana, H; Sui, GD; Cheng, XJ				Zhang, Li; Fu, Yongfeng; Jing, Wenwen; Xu, Qing; Zhao, Wang; Feng, Meng; Tachibana, Hiroshi; Sui, Guodong; Cheng, Xunjia			Rapid microfluidic immunoassay for surveillance and diagnosis of Cryptosporidium infection in human immunodeficiency virus-infected patients	BIOMICROFLUIDICS			English	Article							IMMUNOGLOBULIN-G ANTIBODIES; ENZYME-IMMUNOASSAY; SOUTH-INDIA; RESPONSES; CHILDREN; DIARRHEA; ANTIGEN; AIDS; PARASITES; DISEASES	Cryptosporidiosis has been reported to be associated with HIV/acquired immune deficiency syndrome, which greatly reduces the quality of life and shortens the life expectancy of HIV-infected patients. In order to properly treat the infected patients, accurate and automatic diagnostic tools need to be developed. In this study, a novel microfluidic immunochip system was presented for the surveillance and the rapid detection of Cryptosporidium infection in 190 HIV-infected patients from Guangxi, China, using the P23 antigen of Cryptosporidium. The procedure of detection can be completed within 10 min with 2 mu l sample consumption. The system also was evaluated using the standard ELISA method. Among 190 HIV-infected individuals, the rate of P23 positivity was 13.7%. Seropositivity in HIV-infected individuals was higher in female patients. The seropositivity to P23 was higher in HIV-infected individuals with high viral load, although the difference was statistically insignificant. Significantly higher Cryptosporidium seropositivity was observed in HIV-infected individuals with a CD4(+) T-cell count of <200 cells/mu l than in those with >= 200 cells/mu l. Our results also demonstrate that a lower CD4(+) T-cell count may reflect an increased accumulated risk for cryptosporidiosis. The detection system was further validated using the standard ELISA method and good correlation between the two methods was found (r = 0.80). Under the same sensitivity, this new microfluidic chip device had a specificity of 98.2%. This developed system may provide a powerful platform for the fast screening of Cryptospordium infection in HIV-infected patients. (C) 2015 AIP Publishing LLC.	[Zhang, Li; Fu, Yongfeng; Jing, Wenwen; Xu, Qing; Feng, Meng; Cheng, Xunjia] Fudan Univ, Dept Med Microbiol & Parasitol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhao, Wang; Sui, Guodong] Fudan Univ, Dept Environm Sci & Engn, Shanghai Key Lab Atmospher Particle Pollut Preven, Shanghai 200433, Peoples R China; [Tachibana, Hiroshi; Cheng, Xunjia] Tokai Univ, Sch Med, Dept Infect Dis, Isehara, Kanagawa 25911, Japan; [Sui, Guodong; Cheng, Xunjia] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Sui, GD (reprint author), Fudan Univ, Dept Environm Sci & Engn, Shanghai Key Lab Atmospher Particle Pollut Preven, Shanghai 200433, Peoples R China.	gsui@fudan.edu.cn; xjcheng@shmu.edu.cn			Major Project of the Eleventh Five-Year Plan [2009ZX10004-104]; National Science Foundation of China [81171594, 21377026]; Key Programs for Science and Technology Development of Shanghai [11441901700]	This work was supported by grants from the Major Project of the Eleventh Five-Year Plan (No. 2009ZX10004-104) and the National Science Foundation of China (Nos. 81171594 and 21377026) and the Key Programs for Science and Technology Development of Shanghai (No. 11441901700).	Petry F, 2010, EXP PARASITOL, V126, P304, DOI 10.1016/j.exppara.2010.05.022; Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916; WEBER R, 1991, J CLIN MICROBIOL, V29, P1323; Thompson RCA, 2005, ADV PARASIT, V59, P77, DOI 10.1016/S0065-308X(05)59002-X; Muthusamy D, 2006, J CLIN MICROBIOL, V44, P632, DOI 10.1128/JCM.44.2.632-634.2006; Katis IN, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4878696; Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408; Bissonnette L, 2010, CLIN MICROBIOL INFEC, V16, P1044, DOI 10.1111/j.1469-0691.2010.03282.x; Borad AJ, 2012, AM J TROP MED HYG, V86, P214, DOI 10.4269/ajtmh.2012.11-0273; Sarkar R, 2012, CLIN VACCINE IMMUNOL, V19, P849, DOI 10.1128/CVI.00051-12; Priest JW, 2005, J CLIN MICROBIOL, V43, P5298, DOI 10.1128/JCM.43.10.5298-5300.2005; Cama VA, 2007, J INFECT DIS, V196, P684, DOI 10.1086/519842; Frost FJ, 2004, ANN EPIDEMIOL, V14, P473, DOI 10.1016/j.annepidem.2003.06.002; Donovan RM, 1996, J INFECT DIS, V174, P401; Ong CS, 2005, AM J TROP MED HYG, V73, P288; Priest JW, 2001, CLIN DIAGN LAB IMMUN, V8, P415, DOI 10.1128/CDLI.8.2.415-423.2001; Manabe YC, 1998, CLIN INFECT DIS, V27, P536, DOI 10.1086/514701; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Gascoyne P, 2004, ACTA TROP, V89, P357, DOI 10.1016/j.actatropica.2003.11.009; Brockmann SO, 2008, INFECTION, V36, P450, DOI 10.1007/s15010-008-7317-7; Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; DUPONT HL, 1995, LANCET, V346, P352; Gong MM, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4817792; Gupta S, 2008, INDIAN J MED MICROBI, V26, P172; Kurniawan A, 2009, T ROY SOC TROP MED H, V103, P892, DOI 10.1016/j.trstmh.2009.02.017; Le Xiao-hua, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P339; McDonald V, 2011, EXPERT REV ANTI-INFE, V9, P1077, DOI [10.1586/eri.11.123, 10.1586/ERI.11.123]; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Mohammed MI, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4837755; Sandhu SK, 2006, J INFECT DIS, V194, P1428, DOI 10.1086/508194; Schmidt W, 2001, GASTROENTEROLOGY, V120, P984, DOI 10.1053/gast.2001.22557; Spencer K. L., 1997, INT J INFECT DIS, V1, P217, DOI 10.1016/S1201-9712(97)90041-2; Zhang JL, 2011, LAB CHIP, V11, P3516, DOI 10.1039/c1lc20516a; Zhang Y, 2013, ACM T KNOWL DISCOV D, V7, DOI 10.1145/2499907.2499910; Zhao W, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4793222	35	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1932-1058			BIOMICROFLUIDICS	Biomicrofluidics	MAR	2015	9	2							024114	10.1063/1.4916229		9	Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology; Physics, Fluids & Plasmas	Biochemistry & Molecular Biology; Biophysics; Science & Technology - Other Topics; Physics	CH2BN	WOS:000353829200022		
J	Ozaki, Y				Ozaki, Yukihiro			A Tribute to Professor Kwan Kim by Whikun Yi	BULLETIN OF THE KOREAN CHEMICAL SOCIETY			English	Biographical-Item									Kwansei Gakuin Univ, Nishinomiya, Hyogo, Japan	Ozaki, Y (reprint author), Kwansei Gakuin Univ, Nishinomiya, Hyogo, Japan.						KIM K, PUBLICATION LIST	1	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0253-2964	1229-5949		B KOREAN CHEM SOC	Bull. Korean Chem. Soc.	MAR	2015	36	3										2	Chemistry, Multidisciplinary	Chemistry	CG8QM	WOS:000353574800001		
J	Takeoka, K; Okumura, A; Maesakob, Y; Akasaka, T; Ohno, H				Takeoka, Kayo; Okumura, Atsuko; Maesakob, Yoshitomo; Akasaka, Takashi; Ohno, Hitoshi			Crizotinib resistance in acute myeloid leukemia with inv(2)(p23q13)/RAN binding protein 2 (RANBP2) anaplastic lymphoma kinase (ALK) fusion and monosomy 7	CANCER GENETICS			English	Article						Crizotinib resistance; AML with inv(2)(p23q13)/RANBP2-ALK and monosomy 7; del(1)(p13p22); p.G1269A mutation	CELL LUNG-CANCER; TYROSINE KINASE; NEUROBLASTOMA; INHIBITORS; MUTATIONS	This is the first report on the development of a p.G1269A mutation within the kinase domain (KO) of ALK after crizotinib treatment in RANBP2-ALK acute myeloid leukemia (AML). An elderly woman with AML with an inv(2)(p23q13)/RANBP2-ALK and monosomy 7 was treated with crizotinib. After a short-term hematological response and the restoration of normal hematopoiesis, she experienced a relapse of AML. Fluorescence in situ hybridization using the ALK break-apart probe confirmed the inv(2)(p23q13), while G-banded karyotyping revealed the deletion of a segment of the short arm of chromosome 1 [del(1)(p13p22)] after crizotinib therapy. The ALK gene carried a heterozygous mutation at the nucleotide position g.716751G>C within exon 25, causing the p.G1269A amino acid substitution within the ALK-KD. Reverse transcriptase PCR revealed that the mutated ALK allele was selectively transcribed and the mutation occurred in the ALK allele rearranged with RANBP2. As both the del(1)(p13p22) at the cytogenetic level and p.G1269A at the nucleotide level newly appeared after crizotinib treatment, it is likely that they were secondarily acquired alterations involved in crizotinib resistance. Although secondary genetic abnormalities in ALK are most frequently described in non small cell lung cancers harboring an ALK alteration, this report suggests that an ALK-KD mutation can occur independently of the tumor cell type or fusion partner after crizotinib treatment.	[Takeoka, Kayo; Okumura, Atsuko; Ohno, Hitoshi] Tenri Hosp, Tenri Inst Med Res, Nara, Japan; [Maesakob, Yoshitomo; Akasaka, Takashi; Ohno, Hitoshi] Tenri Hosp, Dept Hematol, Nara, Japan	Ohno, H (reprint author), Tenri Hosp, Tenri Inst Med Res, Nara, Japan.	hohno@tenriyorozu.jp			Tenri Foundation	This work was supported by the Tenri Foundation.	Gainor JF, 2013, J CLIN ONCOL, V31, P3987, DOI 10.1200/JCO.2012.45.2029; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Marino-Enriquez A, 2013, CANCER GENET-NY, V206, P357, DOI 10.1016/j.cancergen.2013.07.001; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Zhang S, 2011, CHEM BIOL DRUG DES, V78, P999, DOI 10.1111/j.1747-0285.2011.01239.x; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Malik SM, 2014, CLIN CANCER RES, V20, P2029, DOI 10.1158/1078-0432.CCR-13-3077; Shaw AT, 2013, J CLIN ONCOL, V31, P1105, DOI 10.1200/JCO.2012.44.5353; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lim JH, 2014, CANCER GENET-NY, V207, P40, DOI 10.1016/j.cancergen.2013.12.003; Maesako Y, 2014, LEUKEMIA, V28, P1935, DOI 10.1038/leu.2014.166; Maesako Y, 2014, INT J HEMATOL, V99, P202, DOI 10.1007/s12185-013-1482-x; Rottgers S, 2010, LEUKEMIA, V24, P1197, DOI 10.1038/leu.2010.18; Shaffer LG, 2013, ISCN 2013 INT SYSTEM; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI 10.1056/NEJMoa1311107	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2210-7762	2210-7770		CANCER GENET-NY	Cancer Genet.	MAR	2015	208	3					85	90		10.1016/j.cancergen.2015.01.003		6	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	CH2FE	WOS:000353840300005		
J	Ohuchi, H; Negishi, J; Noritake, K; Hayama, Y; Sakaguchi, H; Miyazaki, A; Kagisaki, K; Yamada, O				Ohuchi, Hideo; Negishi, Jun; Noritake, Kanae; Hayama, Yosuke; Sakaguchi, Heima; Miyazaki, Aya; Kagisaki, Koji; Yamada, Osamu			Prognostic Value of Exercise Variables in 335 Patients after the Fontan Operation: A 23-year Single-center Experience of Cardiopulmonary Exercise Testing	CONGENITAL HEART DISEASE			English	Article						Fontan; Exercise Testing; Peak Oxygen Uptake; Mortality; Heart Failure	CONGENITAL-HEART-DISEASE; VENTILATORY RESPONSE; ADULT PATIENTS; CAPACITY; MORTALITY; FAILURE; PERFORMANCE; MORBIDITY; TOLERANCE; IMPACT	BackgroundThe prognostic value of cardiopulmonary exercise testing (CPX) for mortality risk remains controversial in Fontan patients. PurposeOur goal of the present study was to clarify the prognostic value of major CPX variables and the factors determining exercise capacity in a large cohort of Fontan patients. MethodsSince 1990, heart rate (HR), oxygen uptake (VO2), and ventilatory equivalent for carbon dioxide production (VE/VCO2) at peak exercise were determined in 335 Fontan patients (185 years old), and the CPX variables were compared with the clinical profile and events. ResultsWhen compared with 209 controls, peak HR (148 +/- 24bpm), VO2 (27 +/- 7mL/kg/minute, [61 +/- 15%]), and VE/VCO2 (40 +/- 8 [117 +/- 24%]) were markedly impaired in the Fontan patients (P<.0001). During a follow-up of 3.1 +/- 2.7 years, 62 Fontan pathophysiological-associated events requiring unscheduled hospitalization (USH) occurred, and 24 patients died. All the CPX variables predicted the USH and mortality (P<.001-.0001). On multivariate analysis, in addition to use of diuretics (P=.0007) and low cardiac index (P=.0426), peak VO2 independently predicted the USH (hazard ratio: 0.95 per %, 95% confidence interval: 0.91-0.99, P=.014), while for mortality, multivariate analysis revealed that, in addition to heterotaxy syndrome (P=.0128) and year at first Fontan operation (P=.0532), peak VO2 independently predicted mortality (hazard ratio: 0.88 per %, 95% confidence interval: 0.76-0.98, P=.0217). ConclusionFontan patients exhibit markedly impaired CPX variables, and all the major variables, especially peak VO2, predicted the risk of both morbidity and mortality.	[Ohuchi, Hideo; Negishi, Jun; Noritake, Kanae; Hayama, Yosuke; Sakaguchi, Heima; Miyazaki, Aya; Yamada, Osamu] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka 5658565, Japan; [Kagisaki, Koji] Natl Cerebral & Cardiovasc Ctr, Dept Thorac Surg, Suita, Osaka 5658565, Japan	Ohuchi, H (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	hohuchi@hsp.ncvc.go.jp					Ponikowski P, 2001, CIRCULATION, V103, P967; Engelfriet P, 2005, EUR HEART J, V26, P2325, DOI 10.1093/eurheartj/ehi396; Cordina RL, 2013, INT J CARDIOL, V168, P780, DOI 10.1016/j.ijcard.2012.10.012; Shafer KM, 2012, J AM COLL CARDIOL, V60, P2115, DOI 10.1016/j.jacc.2012.08.970; Giardini A, 2009, J AM COLL CARDIOL, V53, P1548, DOI 10.1016/j.jacc.2009.02.005; Durongpisitkul K, 1997, J AM COLL CARDIOL, V29, P785; Roche F, 2001, CLIN PHYSIOL, V21, P335, DOI 10.1046/j.1365-2281.2001.00328.x; Ohuchi H, 1996, PEDIATR CARDIOL, V17, P7, DOI 10.1007/BF02505805; MANCINI DM, 1991, CIRCULATION, V83, P778; Inuzuka R, 2012, CIRCULATION, V125, P250, DOI 10.1161/CIRCULATIONAHA.111.058719; Ohuchi H, 2007, AM HEART J, V154, P165, DOI 10.1016/j.ahj.2007.03.031; Solomon SD, 2004, CIRCULATION, V110, P2180, DOI 10.1161/01.CIR.0000144474.65922.AA; Giardini A, 2009, INT J CARDIOL, V133, P74, DOI 10.1016/j.ijcard.2007.11.092; Greutmann M, 2011, HEART, V97, P1164, DOI 10.1136/hrt.2010.213579; Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800; Paridon SM, 2008, J AM COLL CARDIOL, V52, P99, DOI 10.1016/j.jacc.2008.02.081; Giardini A, 2008, ANN THORAC SURG, V85, P818, DOI 10.1016/j.athoracsur.2007.11.009; Fernandes SM, 2011, CONGENIT HEART DIS, V6, P294, DOI 10.1111/j.1747-0803.2011.00500.x; Diller GP, 2010, EUR HEART J, V31, P3073, DOI 10.1093/eurheartj/ehq356; Ohuchi H, 2011, ANN THORAC SURG, V92, P1457, DOI 10.1016/j.athoracsur.2011.05.055; Mahle WT, 1999, J AM COLL CARDIOL, V34, P1637, DOI 10.1016/S0735-1097(99)00392-7; Giardini A, 2008, EUR HEART J, V29, P1681, DOI 10.1093/eurheartj/ehn215; Mezzani A, 2003, AM HEART J, V145, P1102, DOI 10.1016/S0002-8703(03)00100-5; Giardini A, 2007, AM J CARDIOL, V99, P1462, DOI 10.1016/j.amjcard.2006.12.076; Magee AG, 1998, J AM COLL CARDIOL, V32, P502, DOI 10.1016/S0735-1097(98)00246-0; Radojevic J, 2013, INT J CARDIOL, V163, P305, DOI 10.1016/j.ijcard.2011.06.047; Bruns LA, 2001, J PEDIATR-US, V138, P505, DOI 10.1067/mpd.2001.113045; Bossers SS, J THORAC CA IN PRESS; Cunningham DJC, 1986, HDB PHYSL 3, VII, P475; Eriksson B O, 1980, Acta Paediatr Scand Suppl, V283, P20; GEWILLIG MH, 1990, J AM COLL CARDIOL, V15, P1424; Inai K, 2004, AM J CARDIOL, V93, P792, DOI 10.1016/j.amjcard.2003.11.062; Kono M., 1993, KAKU IGAKU, V13, P2; Liu YP, 2013, EXP THER MED, V5, P1559, DOI 10.3892/etm.2013.1064; Meadows J, 2008, J AM COLL CARDIOL, V52, P108, DOI 10.1016/j.jacc.2007.12.063; Ohuchi H, 2004, PEDIATR CARDIOL, V25, P513, DOI 10.1007/s00246-003-0652-7; Ohuchi H, 2004, CIRCULATION, V110, P2601, DOI 10.1161/01.CIR.0000145545.83564.51; Ohuchi H, 2014, INT J CARDIOL, V173, P277, DOI 10.1016/j.ijcard.2014.03.001; Ohuchi H, 2001, J AM COLL CARDIOL, V37, P1967, DOI 10.1016/S0735-1097(01)01266-9; Ohuchi H, 2007, INT J CARDIOL, V121, P36, DOI 10.1016/j.ijcard.2006.10.019; Ohuchi H, 2009, AM HEART J, V158, P30, DOI 10.1016/j.ahj.2009.04.021; Ohuchi H., 2013, JPN J PEDIAT MED, V45, P995; Weber KT, 1986, CARDIOPULMONARY EXER, V30, P180	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-079X	1747-0803		CONGENIT HEART DIS	Congenit. Heart Dis.	MAR-APR	2015	10	2					105	116		10.1111/chd.12222		12	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH0EN	WOS:000353692200012		
J	Takagi, K; Yone, Y; Takahashi, H; Sakai, R; Hojyo, H; Kamiura, T; Nomura, M; Liang, NS; Fukazawa, T; Miya, H; Yoshida, T; Sasa, K; Fujinuma, Y; Murayama, T; Oguma, H				Takagi, Kentaro; Yone, Yasumichi; Takahashi, Hiroyuki; Sakai, Rei; Hojyo, Hajime; Kamiura, Tatsuya; Nomura, Mutsumi; Liang, Naishen; Fukazawa, Tatsuya; Miya, Hisashi; Yoshida, Toshiya; Sasa, Kaichiro; Fujinuma, Yasumi; Murayama, Takeshi; Oguma, Hiroyuki			Forest biomass and volume estimation using airborne LiDAR in a cool-temperate forest of northern Hokkaido, Japan	ECOLOGICAL INFORMATICS			English	Article						LiDAR; Cool-temperate forest; Biomass; Timber volume	CARBON-DIOXIDE EXCHANGE; ABOVEGROUND BIOMASS; RAIN-FOREST; STANDS; RADAR; LASER	Trees are recognized as a carbon reservoir, and precise and convenient methods for forest biomass estimation are required for adequate carbon management Airborne light detection and ranging (LiDAR) is considered to be one of the solutions for large-scale forest biomass evaluation. To clarify the relationship between mean canopy height determined by airborne LiDAR and forest timber volume and biomass of cool-temperate forests in northern Hokkaido, Japan, we conducted LiDAR observations covering the total area of the Teshio Experimental Forest (225 km(2)) of Hokkaido University and compared the results with ground surveys and previous studies. Timber volume and aboveground tree carbon content of the studied forest stands ranged from 101.43 to 480.40 m(3) ha(-1) and from 30.78 to 180.54 MgC ha-1, respectively. The LiDAR mean canopy height explained the variation among stands well (volume: r(2) = 0.80, RMSE = 55.04 m(3) ha(-1); aboveground tree carbon content: = 0.78, RMSE = 19.10 MgC ha(-1)) when one simple linear regression equation was used for all types (hardwood, coniferous, and mixed) of forest stands. The determination of a regression equation for each forest type did not improve the prediction power for hardwood (volume: r(2) = 0.84, RMSE = 62.66 m(3) ha(-1); aboveground tree carbon content: r(2) = 0.76, RMSE = 27.05 MgC ha(-1)) or coniferous forests (volume: r(2) = 0.75, RMSE = 51.07 m(3) ha(-1); aboveground tree carbon content: r(2) = 0.58, RMSE = 19.00 MgC ha(-1)). Thus, the combined regression equation that includes three forest types appears to be adequate for practical application to large-scale forest biomass estimation. (C) 2015 Elsevier B.V. All rights reserved.	[Takagi, Kentaro; Takahashi, Hiroyuki; Sakai, Rei; Hojyo, Hajime; Kamiura, Tatsuya; Nomura, Mutsumi; Yoshida, Toshiya; Sasa, Kaichiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Sapporo, Hokkaido 0600809, Japan; [Yone, Yasumichi] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan; [Liang, Naishen; Oguma, Hiroyuki] Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Fukazawa, Tatsuya] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan; [Miya, Hisashi] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Fujinuma, Yasumi] Tottori Univ Environm Studies, Dept Environm Management, Tottori 6891111, Japan; [Murayama, Takeshi] Hokkaido Elect Power Co Inc, Dept Res & Dev, Ebetsu, Hokkaido 0670033, Japan	Takagi, K (reprint author), Hokkaido Univ, Teshio Expt Forest, Field Sci Ctr Northern Biosphere, Toikanbetsu, Horonobe 0982943, Japan.	kentt@fsc.hokudai.ac.jp	Takagi, Kentaro/C-2222-2012		JSPS KAKENHI [23255009, 25241002, 26292076, 21114008]	This research was part of the "CC-LaG experiment" project, which was carried out through the collaboration of Hokkaido University, the National Institute for Environmental Studies, and Hokkaido Electric Power Co., Inc. This work was partly supported by JSPS KAKENHI Grant Numbers 23255009, 25241002, 26292076 and 21114008. This study would not have been possible without the assistance of graduate students of Agriculture, Engineering, and Environment Science of Hokkaido University, and the cooperation of staff members of the Experimental Forests of Hokkaido University, the National Institute for Environmental Studies, and Hokkaido Electric Power Co., Inc.	Hirata R, 2007, AGR FOREST METEOROL, V147, P110, DOI 10.1016/j.agrformet.2007.07.005; Boudreau J, 2008, REMOTE SENS ENVIRON, V112, P3876, DOI 10.1016/j.rse.2008.06.003; Kronseder K, 2012, INT J APPL EARTH OBS, V18, P37, DOI 10.1016/j.jag.2012.01.010; Lefsky MA, 2002, GLOBAL ECOL BIOGEOGR, V11, P393, DOI 10.1046/j.1466-822x.2002.00303.x; Zhao KG, 2009, REMOTE SENS ENVIRON, V113, P182, DOI 10.1016/j.rse.2008.09.009; Means JE, 1999, REMOTE SENS ENVIRON, V67, P298, DOI 10.1016/S0034-4257(98)00091-1; Asner GP, 2009, ECOSYSTEMS, V12, P261, DOI 10.1007/s10021-008-9221-5; Naesset E, 1997, REMOTE SENS ENVIRON, V61, P246; Takagi K, 2009, GLOBAL CHANGE BIOL, V15, P1275, DOI 10.1111/j.1365-2486.2008.01795.x; Nelson RF, 2007, REMOTE SENS ENVIRON, V110, P98, DOI 10.1016/j.rse.2007.02.006; Banskota A, 2011, ANN FOREST SCI, V68, P347, DOI 10.1007/s13595-011-0023-0; Asner GP, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034009; Axelsson P., 2000, INT ARCH PHOTOGRAMM, VXXXIII, P75; Dubayah RO, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000933; Hayashi M., 2013, J JPN SOC PHOTOGRAMM, V52, P306; Kodani E., 2013, J JPN SOC PHOTOGRAMM, V52, P44; KOHYAMA T, 1992, ANN BOT-LONDON, V70, P451; Nakai Y, 2003, TELLUS B, V55, P305, DOI 10.1034/j.1600-0889.2003.01413.x; Nakajima K., 1948, TABLE STEM VOLUMES H; Shibata H, 2005, ECOL RES, V20, P325, DOI 10.1007/s11284-005-0048-7; Takagi K., 2010, Eurasian Journal of Forest Research, V13-1, P1; Takahashi H., 2006, T M HOKKAIDO BR JPN, V54, P93; Toyooka H., 1983, DISTRIBUTION MAP SAS; Tsuzuki H., 2006, Journal of the Japanese Forest Society, V88, P103, DOI 10.4005/jjfs.88.103; Vane Y., 2002, J REM SENS SOC JPN, V22, P531; Yone Y., 2008, Research Bulletin of the Hokkaido University Forests, V65, P61; Yone Y, 2005, PHYTON-ANN REI BOT A, V45, P517	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1574-9541	1878-0512		ECOL INFORM	Ecol. Inform.	MAR	2015	26		3				54	60		10.1016/j.ecoinf.2015.01.005		7	Ecology	Environmental Sciences & Ecology	CH0XC	WOS:000353744700006		
J	Gabor, A; Nora, M; Tamas, V; Tibor, K; Edina, P; Csaba, K; Oliver, S				Gabor, Andocs; Nora, Meggyeshazi; Tamas, Vancsik; Tibor, Krenacs; Edina, Papp; Csaba, Kovago; Oliver, Szasz			HYPERTHERMIA INDUCED IMMUNOGENIC CELL-DEATH	EUROPEAN JOURNAL OF CANCER			English	Meeting Abstract	2nd Immunotherapy of Cancer Conference	MAR 25-27, 2015	Munich, GERMANY						[Gabor, Andocs] Toyama Univ, Dept Radiol Sci, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Nora, Meggyeshazi; Tamas, Vancsik; Tibor, Krenacs] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Edina, Papp] Pazmany Peter Catholic Univ, Fac Informat Technol & Bion, Budapest, Hungary; [Csaba, Kovago] Szent Istvan Univ, Pharmacol & Toxicol Dept Fac Vet Sci, Budapest, Hungary; [Oliver, Szasz] Szent Istvan Univ, Dept Biotech, Godollo, Hungary							Andocs G, 2009, ELECTROMAGN BIOL MED, V28, P148, DOI 10.1080/15368370902724633; Szasz A, 2011, ONCOTHERMIA: PRINCIPLES AND PRACTICES, P1, DOI 10.1007/978-90-481-9498-8	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-8049	1879-0852		EUR J CANCER	Eur. J. Cancer	MAR	2015	51			1		ITOC2-018	S7	S7		10.1016/j.ejca.2015.01.031		1	Oncology	Oncology	CH2UJ	WOS:000353879900019		
J	Brandsdottir, B; Hooft, EEE; Mjelde, R; Murai, Y				Brandsdottir, Bryndis; Hooft, Emilie E. E.; Mjelde, Rolf; Murai, Yoshio			Origin and evolution of the Kolbeinsey Ridge and Iceland Plateau, N-Atlantic	GEOCHEMISTRY GEOPHYSICS GEOSYSTEMS			English	Article						N-Atlantic; crustal structure; rifting mechanics; mantle dynamics; plume-ridge interaction	JAN-MAYEN MICROCONTINENT; NORWEGIAN-GREENLAND SEA; CONTINENTAL BREAKUP MAGMATISM; CRUSTAL STRUCTURE; NORTH-ATLANTIC; SPREADING CENTER; MAGNETIC-ANOMALIES; TECTONIC EVOLUTION; OCEANIC-CRUST; LABRADOR-SEA	Variations in crustal structure along the 700 km long KRISE7 refraction/reflection and gravity profile, straddling 66.5 degrees N across the Iceland Shelf, Iceland Plateau and western Norway Basin confirm that extinct spreading centers coexisted with the now extinct aegir Ridge prior to the initiation of the Kolbeinsey Ridge at 26 Ma. The western 300 km of the profile, across the Iceland shelf, formed by rifting at the Kolbeinsey Ridge, whereas the eastern 400 km, across the Iceland Plateau and the western Norway Basin, formed by earlier rifting, possibly containing slivers of older oceanic or continental crust rifted off the central E-Greenland margin along with the Jan Mayen Ridge. Crustal thickness increases gradually across the Iceland shelf, from 12 to 13 km near the Kolbeinsey Ridge to 24-28 km near the eastern shelf edge, decreasing abruptly across the shelf edge, to 12-13 km. The Iceland Plateau has crustal thickness ranging from 12 to 15 km decreasing to 5-8 km across the western Norway Basin and 4-5 km at the aegir Ridge. We suggest that high-velocity lower crustal domes and corresponding gravity highs across the Iceland plateau mark the location of extinct rift axes that coexisted with the aegir Ridge. Similar lower crustal domes are associated with the currently active rift segments within Iceland and the Kolbeinsey Ridge.	[Brandsdottir, Bryndis] Univ Iceland, Inst Sci, Inst Earth Sci, IS-107 Reykjavik, Iceland; [Hooft, Emilie E. E.] Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; [Mjelde, Rolf] Univ Bergen, Dept Earth Sci, Bergen, Norway; [Murai, Yoshio] Hokkaido Univ, Inst Seismol & Volcanol, Sapporo, Hokkaido, Japan	Brandsdottir, B (reprint author), Univ Iceland, Inst Sci, Inst Earth Sci, Dunhaga 3, IS-107 Reykjavik, Iceland.	bryndis@hi.is			National Science Foundations of USA [NSF-OCE-9911243]; University of Hokkaido; University of Bergen; University of Iceland	The success of this experiment was due partly to the fair weather, but mainly to the professionalism and smooth interaction of the crews of R/V Hakon Mosby and the Icelandic Coast Guard Cutter AEgir, the University of Bergen air gun crew, and the University of Hokkaido OBS crew. We thank Hideki Shimamura, Tomoki Watanabe, Tadashi Yamashina, Testsuo Takanami, Andrew Barclay, Oystein Aanensen, and Asbjorn Breivik for their valuable contribution to the planning and executing of this survey. KRISE was funded by the National Science Foundations of USA (NSF-OCE-9911243) and Iceland, and the Universities of Hokkaido, Bergen and Iceland. The data for this paper are available upon request, contact bryndis@hi.is. We appreciate the use of the Upicker program provided by William Wilcock at the University of Washington and the TOMO2d joint refraction and reflection travel-time tomography software by Jun Korenaga, Yale University. The GMT software [Wessel and Smith, 1991] was used to generate most figures. We thank Asbjorn Breivik for providing magnetic and gravity maps, Leo Kristjansson for supplying rare reprints of scientific papers from the 1970s and the University of Texas Institute for Geophysics, Marine Geoscience Data System (Joyce Alsop, http://www.ig.utexas.edu/sdc/) for providing reflection data from the 1978 R/V Robert D. Conrad Cruise R2114, led by Peter Buhl and John B. Diebold (NSF 7805733). Comments by John R. Hopper and an anonymous reviewer helped improve the manuscript.	Allen RM, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000584; Korenaga J, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009248; Korenaga J, 2004, EARTH PLANET SC LETT, V218, P463, DOI 10.1016/S0012-821X(03)00674-5; Mjelde R, 2008, J GEOL SOC LONDON, V165, P31, DOI 10.1144/0016-76492007-018; MOSER TJ, 1991, GEOPHYSICS, V56, P59, DOI 10.1190/1.1442958; Foulger GR, 2006, GEOPHYS J INT, V165, P672, DOI 10.1111/j.1365-246X.2006.02941.x; Brandsdottir B, 2008, JOKULL, V58, P17; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; Gernigon L, 2012, MAR PETROL GEOL, V35, P1, DOI 10.1016/j.marpetgeo.2012.02.015; Greenhalgh EE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029440; WEIGEL W, 1995, MAR GEOPHYS RES, V17, P167, DOI 10.1007/BF01203425; Staples RK, 1997, J GEOPHYS RES-SOL EA, V102, P7849, DOI 10.1029/96JB03911; White RS, 2008, NATURE, V452, P460, DOI 10.1038/nature06687; Slater L, 2001, J PETROL, V42, P321, DOI 10.1093/petrology/42.2.321; Nielsen TK, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000662; Hopper JR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001996; TOOMEY DR, 1990, NATURE, V347, P639, DOI 10.1038/347639a0; Ito G, 2003, REV GEOPHYS, V41, DOI 10.1029/2002RG000117; Du ZJ, 2002, GEOPHYS J INT, V149, P349, DOI 10.1046/j.1365-246X.2002.01642.x; TALWANI M, 1977, GEOL SOC AM BULL, V88, P969, DOI 10.1130/0016-7606(1977)88<969:EOTNS>2.0.CO;2; MOSER TJ, 1992, B SEISMOL SOC AM, V82, P259; Holbrook WS, 2001, EARTH PLANET SC LETT, V190, P251, DOI 10.1016/S0012-821X(01)00392-2; CARLSON RL, 1984, NATURE, V311, P555, DOI 10.1038/311555a0; Gaina C, 2009, J GEOL SOC LONDON, V166, P601, DOI 10.1144/0016-76492008-112; PARKER RL, 1974, J GEOPHYS RES, V79, P1587, DOI 10.1029/JB079i011p01587; Bott M., 1971, MAR GEOPHYS RES, V1, P328; BOTT MHP, 1985, J GEOPHYS RES-SOLID, V90, P9953, DOI 10.1029/JB090iB12p09953; Brandsdottir B, 1997, J GEOPHYS RES-SOL EA, V102, P7867, DOI 10.1029/96JB03799; Breivik AJ, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004004; Breivik AJ, 2012, GEOPHYS J INT, V188, P798, DOI 10.1111/j.1365-246X.2011.05307.x; Darbyshire FA, 1998, GEOPHYS J INT, V135, P1131, DOI 10.1046/j.1365-246X.1998.00701.x; Du ZJ, 2001, GEOPHYS J INT, V145, P246; Eldholm O., 1990, GEOL N AMER, V1, P171; ELDHOLM O, 1974, GEOL SOC AM BULL, V85, P1661, DOI 10.1130/0016-7606(1974)85<1661:SDITNS>2.0.CO;2; ELDHOLM O, 1994, J GEOPHYS RES-SOL EA, V99, P2955, DOI 10.1029/93JB02879; Fedorova T, 2005, TECTONOPHYSICS, V396, P119, DOI 10.1016/j.tecto.2004.11.004; Flovenz G., 1991, TECTONOPHYSICS, V189, P1; Furmall A. V., 2010, THESIS U OREGON EUGE, P107; GAIRAUD H, 1978, OCEANOL ACTA, V1, P335; Gradstein F.M., 2012, GEOLOGIC TIME SCALE, V2; Grevemeyer I, 1997, MAR GEOPHYS RES, V19, P1, DOI 10.1023/A:1004288815129; GrOnlie G., 1979, NOR POLARINST SKR, V170, P25; Grunnaleite I, 1995, TECTONOPHYSICS, V252, P221, DOI 10.1016/0040-1951(95)00095-X; Herzberg C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001390; Hirth G, 1998, GEOPH MONOG SERIES, V106, P291; Holbrook W. S., 1992, CONTINENTAL LOWER CR, P451; Hooft EEE, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001123; Jansen E., 1996, P OCEAN DRILL PROGRA, V162, P253, DOI 10.2973/odp.proc.ir.162.108.1996; Johnson G. L., 1972, JOKULL, V21, P45; JOHNSON GL, 1967, DEEP-SEA RES, V14, P755, DOI 10.1016/S0011-7471(67)80012-3; Jones SM, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000361; Jung WY, 1997, J GEOPHYS RES-SOL EA, V102, P5065, DOI 10.1029/96JB03915; Kanazawa T., 1994, JAP EARTH PLAN SCI J, P341; KELEMEN PB, 1995, J GEOPHYS RES-SOL EA, V100, P10077, DOI 10.1029/95JB00924; Kharin G. N., 1976, INITIAL REPORTS DEEP, V38, P755, DOI 10.2973/dsdp.proc.38.116.1976; Kharin G. N., 1976, INITIAL REPORTS DEEP, V38, P685, DOI 10.2973/dsdp.proc.38.110.1976; Kodaira S, 1998, TERRA NOVA, V10, P27; Kodaira S, 1998, GEOPHYS J INT, V132, P383, DOI 10.1046/j.1365-246x.1998.00444.x; Korenaga J, 2001, J GEOPHYS RES-SOL EA, V106, P8853, DOI 10.1029/2000JB900416; Korenaga J, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001030; Korenaga J, 2000, J GEOPHYS RES-SOL EA, V105, P21591, DOI 10.1029/2000JB900188; KRISTJANSSON L, 1977, NATURE, V268, P325, DOI 10.1038/268325a0; Kuvaas B., 1997, 1 BREAK, V15, P239; Larsen H. C., 1988, EARLY TERTIARY VOLCA, V39, P95, DOI DOI 10.1144/GSL.SP.1988.039.01.10; Larsen H.C., 1998, P OC DRILL PROGR SCI, P503, DOI 10.2973/odp.proc.sr.152.240.1998; Leftwich TE, 2005, J GEODYN, V40, P23, DOI 10.1016/j.jog.2005.05.001; Lowrie W., 1979, M EWING SERIES, V2, P135; Menke W, 1996, GEOPHYS J INT, V126, P166, DOI 10.1111/j.1365-246X.1996.tb05275.x; Mertz D. F., 1991, EARTH PLANET SC LETT, V25, P411; Meyer O., 1972, DEUTSCH HYDROGR Z, V25, P193, DOI 10.1007/BF02299456; Mjelde R, 2002, MAR GEOPHYS RES, V23, P125; Mjelde R, 2007, MAR GEOPHYS RES, V28, P27, DOI 10.1007/s11001-006-9012-3; Mjelde R, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003026; Muller RD, 2001, GEOLOGY, V29, P203; Mutter J. C., 1988, GEOL SOC SPEC PUBL, V39, P35; MUTTER JC, 1988, J GEOPHYS RES-SOLID, V93, P1031, DOI 10.1029/JB093iB02p01031; Norddahl H, 2008, JOKULL, V58, P343; Nunns A., 1982, STUDIES CONTINENTAL, V34, P193; Ogg JG, 2012, GEOLOGIC TIME SCALE, V2, P85; OSLER JC, 1995, J GEOPHYS RES-SOL EA, V100, P2261, DOI 10.1029/94JB02890; PAIGE CC, 1982, ACM T MATH SOFTWARE, V8, P43, DOI 10.1145/355984.355989; Palmason G., 1971, CRUSTAL STRUCTURE IC; Peron-Pinvidic G, 2012, GEOPHYS J INT, V191, P385, DOI 10.1111/j.1365-246X.2012.05639.x; PITMAN WC, 1972, GEOL SOC AM BULL, V83, P619, DOI 10.1130/0016-7606(1972)83[619:SSITNA]2.0.CO;2; SAEMUNDSSON K., 1986, GEOLOGY N AM, P69; Sandwell DT, 1997, J GEOPHYS RES-SOL EA, V102, P10039, DOI 10.1029/96JB03223; Schilling J. -G., 1976, INITIAL REPORTS DEEP, V38, P741, DOI 10.2973/dsdp.proc.38.114.1976; Shorttle O, 2014, EARTH PLANET SC LETT, V395, P24, DOI 10.1016/j.epsl.2014.03.040; Sleep NH, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001672; Smallwood JR, 1999, J GEOPHYS RES-SOL EA, V104, P22885, DOI 10.1029/1999JB900176; SRIVASTAVA SP, 1986, GEOLOGY N AM, VM, P379; Talwani M., 1976, INITIAL REPORTS DEEP, V38, P1213, DOI 10.2973/dsdp.proc.38.134.1976; VOGT PR, 1980, J GEOPHYS-Z GEOPHYS, V47, P67; VOGT PR, 1974, J GEOPHYS RES, V79, P363, DOI 10.1029/JB079i002p00363; VOGT PR, 1970, J GEOPHYS RES, V75, P903, DOI 10.1029/JB075i005p00903; Wallrabe-Adams H. J., 1999, P ODP SCI RES, V162, P217, DOI [10.2973/odp.proc.sr.162.021.1999, DOI 10.2973/ODP.PROC.SR.162.021.1999]; Weir NRW, 2001, J GEOPHYS RES-SOL EA, V106, P6347, DOI 10.1029/2000JB900358; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI DOI 10.1029/90E000319; WHITE RS, 1992, J GEOL SOC LONDON, V149, P841, DOI 10.1144/gsjgs.149.5.0841; White RS, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005856	100	0	0	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	1525-2027			GEOCHEM GEOPHY GEOSY	Geochem. Geophys. Geosyst.	MAR	2015	16	3					612	634		10.1002/2014GC005540		23	Geochemistry & Geophysics	Geochemistry & Geophysics	CG9RN	WOS:000353656200003		
J	Barklage, M; Wiens, DA; Conder, JA; Pozgay, S; Shiobara, H; Sugioka, H				Barklage, Mitchell; Wiens, Douglas A.; Conder, James A.; Pozgay, Sara; Shiobara, Hajime; Sugioka, Hiroko			P and S velocity tomography of the Mariana subduction system from a combined land-sea seismic deployment	GEOCHEMISTRY GEOPHYSICS GEOSYSTEMS			English	Article						tomography; subduction zones	ARC SPREADING CENTERS; UPPER-MANTLE BENEATH; V-P/V-S; WAVE VELOCITY; GRAIN-SIZE; EARTHQUAKE-LOCATION; PACIFIC PLATE; LEAST-SQUARES; TRAVEL-TIMES; H2O CONTENTS	Seismic imaging provides an opportunity to constrain mantle wedge processes associated with subduction, volatile transport, arc volcanism, and back-arc spreading. We investigate the seismic velocity structure of the upper mantle across the Central Mariana subduction system using data from the 2003-2004 Mariana Subduction Factory Imaging Experiment, an 11 month deployment consisting of 20 broadband seismic stations installed on islands and 58 semibroadband ocean bottom seismographs. We determine the three-dimensional V-P and V-P/V-S structure using over 25,000 local and over 2000 teleseismic arrival times. The mantle wedge is characterized by slow velocity and high V-P/V-S beneath the fore arc, an inclined zone of slow velocity underlying the volcanic front, and a strong region of slow velocity beneath the back-arc spreading center. The slow velocities are strongest at depths of 20-30 km in the fore arc, 60-70 km beneath the volcanic arc, and 20-30 km beneath the spreading center. The fore-arc slow velocity anomalies occur beneath Big Blue seamount and are interpreted as resulting from mantle serpentinization. The depths of the maximum velocity anomalies beneath the arc and back arc are nearly identical to previous estimates of the final equilibrium depths of mantle melts from thermobarometry, strongly indicating that the low-velocity zones delineate regions of melt production in the mantle. The arc and back-arc melt production regions are well separated at shallow depths, but may be connected at depths greater than 80 km.	[Barklage, Mitchell; Wiens, Douglas A.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Conder, James A.] So Illinois Univ, Dept Geol, Carbondale, IL 62901 USA; [Pozgay, Sara] Greenesk, Cushnie, Alford, England; [Shiobara, Hajime] Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan; [Sugioka, Hiroko] JAMSTEC, Yokosuka, Kanagawa, Japan	Wiens, DA (reprint author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	doug@wustl.edu	Sugioka, Hiroko/O-7371-2015		National Science Foundation [OCE-0001938, EAR-0549056]	We thank numerous people for assistance with deploying and recovering the seismographs, particularly P. Shore, S. Webb, A. Sauter, B. Shiro, P. Jonke, J. Camacho, J. Kaipat, H. Iwamoto, and R. Chong, as well as the captains and the crews of the R/V Kaiyo, the R/V Wecoma, and the Super Emerald. Land seismic instrumentation was provided by the PASSCAL program of the Incorporated Research Institutions in Seismology (IRIS); the Lamont Ocean Bottom Seismograph Facility and the University of Tokyo provided ocean bottom seismographs. The data used for this study are available through the IRIS Data Management Center: http://www.iris.edu/ds/nodes/dmc/data/Dataset: MARIANAS 2003-2004. Network Code: XO. The paper was finished while D. Wiens was supported as a visiting professor by the Earthquake Research Institute, University of Tokyo. This research was supported by the MARGINS program under National Science Foundation grants OCE-0001938 and EAR-0549056.	KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; McCarthy C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048776; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10975, DOI 10.1029/2000JB900041; FRYER P, 1985, GEOLOGY, V13, P774, DOI 10.1130/0091-7613(1985)13<774:OAEOMF>2.0.CO;2; Aizawa Y, 2008, J PETROL, V49, P841, DOI 10.1093/petrology/egn007; Syracuse EM, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001963; Kamiya S, 2000, GEOPHYS RES LETT, V27, P819, DOI 10.1029/1999GL011080; Fryer P, 1999, GEOLOGY, V27, P103, DOI 10.1130/0091-7613(1999)027<0103:MBMVIF>2.3.CO;2; Faul UH, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002407; ZHAO DP, 1994, J GEOPHYS RES-SOL EA, V99, P22313, DOI 10.1029/94JB01149; Pavlis GL, 2004, COMPUT GEOSCI-UK, V30, P1079, DOI 10.1016/j.cageo.2004.06.010; Dalton CA, 2009, EARTH PLANET SC LETT, V284, P65, DOI 10.1016/j.epsl.2009.04.009; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; Takahashi N, 2007, GEOLOGY, V35, P203, DOI 10.1130/G23212A.1; STOLPER E, 1994, EARTH PLANET SC LETT, V121, P293, DOI 10.1016/0012-821X(94)90074-4; Isse T, 2009, EARTH PLANET SC LETT, V278, P107, DOI 10.1016/j.epsl.2008.11.032; Rawlinson N, 2004, GEOPHYS J INT, V157, P332, DOI 10.1111/j.1365-246X.2004.02188.x; Wiens DA, 2008, ANNU REV EARTH PL SC, V36, P421, DOI 10.1146/annurev.earth.33.092203.122633; Bostock MG, 2002, NATURE, V417, P536, DOI 10.1038/417536a; Parman SW, 2011, J PETROL, V52, P257, DOI 10.1093/petrology/egq079; Carlson RL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016600; Abers GA, 2014, GEOCHEM GEOPHY GEOSY, V15, P3521, DOI 10.1002/2014GC005444; Nakajima J, 2001, J GEOPHYS RES-SOL EA, V106, P21843, DOI 10.1029/2000JB000008; Wang Z, 2005, PHYS EARTH PLANET IN, V152, P144, DOI 10.1016/j.pepi.2005.06.010; Reyners M, 2006, GEOPHYS J INT, V165, P565, DOI 10.1111/j.1365-246X.2006.02897.x; [Anonymous], 2002, J GEOPHYS RES-SOL EA, DOI DOI 10.1029/2001JB000522; Zhao DP, 2001, PHYS EARTH PLANET IN, V127, P197, DOI 10.1016/S0031-9201(01)00228-X; Calvert AJ, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004939; Wade JA, 2005, J VOLCANOL GEOTH RES, V146, P139, DOI 10.1016/j.jvolgeores.2004.11.035; Pearce JA, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000895; Pearce JA, 2006, GEOPH MONOG SERIES, V166, P63; Christensen NI, 2004, INT GEOL REV, V46, P795, DOI 10.2747/0020-6814.46.9.795; Schellart WP, 2007, NATURE, V446, P308, DOI 10.1038/nature05615; VANDERHILST R, 1991, NATURE, V353, P37, DOI 10.1038/353037a0; Takahashi N, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005120; Faul UH, 2005, EARTH PLANET SC LETT, V234, P119, DOI 10.1016/j.epsl.2005.02.008; Shito A, 2006, GEOPHYS MONOGR SER, V168, P225, DOI 10.1029/168GM17; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001127; Kelley KA, 2010, J PETROL, V51, P1711, DOI 10.1093/petrology/egq036; Gorbatov A, 2003, EARTH PLANET SC LETT, V210, P527, DOI 10.1016/S0012-821X(03)-00165-1; Shaw AM, 2008, EARTH PLANET SC LETT, V275, P138, DOI 10.1016/j.epsl.2008.08.015; Hammond WC, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001789; Lee CTA, 2009, EARTH PLANET SC LETT, V279, P20, DOI 10.1016/j.epsl.2008.12.020; Wiens DA, 2006, EARTH PLANET SC LETT, V248, P30, DOI 10.1016/j.epsl.2006.04.011; Artemieva IM, 2004, GEOPHYS J INT, V157, P607, DOI 10.1111/j.1365-246X.2004.02195.x; Blackman DK, 1995, B SEISMOL SOC AM, V85, P1648; Christensen NI, 1996, J GEOPHYS RES-SOL EA, V101, P3139, DOI 10.1029/95JB03446; Conder JA, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001113; Conder JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015390; DeShon HR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021179; Emry EL, 2014, J GEOPHYS RES-SOL EA, V119, P3076, DOI 10.1002/2013JB010718; Graeber FM, 1999, J GEOPHYS RES-SOL EA, V104, P20237, DOI 10.1029/1999JB900037; Jackson I, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001225; Jaxybulatov K., 2013, SOLID EARTH, V4, P1, DOI [10.5194/se-4-1-2013, DOI 10.5194/SE-4-1-2013]; Karato S., 2003, GEOPHYS MONOGR SER, V138, P135, DOI DOI 10.1029/138GM08; Kato T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016757; Kelley KA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003732; Lebedev S, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2000JB000073; Matsuno T, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004326; Matsuno T, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003101; McCarthy C, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008384; Menke W., 1984, GEOPHYS DATA ANAL DI; Miller MS, 2004, EARTH PLANET SC LETT, V224, P363, DOI 10.1016/j.epsl.2004.05.018; Nakajima J, 2009, GONDWANA RES, V16, P470, DOI 10.1016/j.gr.2008.12.010; Nakajima J., 2014, EARTH PLANETS SPACE, V66, P1; PAIGE CC, 1982, ACM T MATH SOFTWARE, V8, P43, DOI 10.1145/355984.355989; Pozgay SH, 2007, GEOPHYS J INT, V170, P371, DOI 10.1111/j.1365-246X.2007.03433.x; Pozgay SH, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002313; Pyle ML, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006976; Reynard B, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030176; Roth EG, 2000, GEOPHYS RES LETT, V27, P601, DOI 10.1029/1999GL005418; Shiobara H, 2010, GEOPHYS J INT, V183, P1455, DOI 10.1111/j.1365-246X.2010.04799.x; Shiobara H., 2008, J SEISMOL SOC JPN, V61, P137; Stern R., 2003, GEOPHYS MONOGR SER, V138, P175, DOI [DOI 10.1029/138GM10, DOI 10.1029/1138GM1010]; Sundberg M, 2010, PHILOS MAG, V90, P2817, DOI 10.1080/14786431003746656; Tatsumi Y, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005121; Forsyth DW, 1998, SCIENCE, V280, P1215; Tibi R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034163; UM J, 1987, B SEISMOL SOC AM, V77, P972; VansDecar J. C., 1990, B SEISMOL SOC AM, V80, P150; vansKeken P. E., 2003, EARTH PLANET SC LETT, V215, P323; Wada I, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047705; Webb SC, 2001, B SEISMOL SOC AM, V91, P304, DOI 10.1785/0120000110; Wiens D. A., 2003, GEOPHYS MONOGR SER, V138, P59, DOI DOI 10.1029/138GM05; Wiens DA, 2006, GEOPH MONOG SERIES, V166, P43; WRIGHT SJ, 1986, GEOPHYS J INT, V87, P1041, DOI 10.1111/j.1365-246X.1986.tb01982.x	86	0	0	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	1525-2027			GEOCHEM GEOPHY GEOSY	Geochem. Geophys. Geosyst.	MAR	2015	16	3					681	704		10.1002/2014GC005627		24	Geochemistry & Geophysics	Geochemistry & Geophysics	CG9RN	WOS:000353656200006		
J	Thompson, DA; Hammond, JOS; Kendall, JM; Stuart, GW; Helffrich, GR; Keir, D; Ayele, A; Goitom, B				Thompson, D. A.; Hammond, J. O. S.; Kendall, J. -M.; Stuart, G. W.; Helffrich, G. R.; Keir, D.; Ayele, A.; Goitom, B.			Hydrous upwelling across the mantle transition zone beneath the Afar Triple Junction	GEOCHEMISTRY GEOPHYSICS GEOSYSTEMS			English	Article						mantle transition zone; water; mantle upwelling; East Africa	EARTHS UPPER-MANTLE; DEEP UPPER-MANTLE; SEISMIC EVIDENCE; EAST-AFRICA; STORAGE CAPACITY; HOT-SPOT; PLUME; WATER; DISCONTINUITY; ORIGIN	The mechanisms that drive the upwelling of chemical heterogeneity from the lower to upper mantle (e.g., thermal versus compositional buoyancy) are key to our understanding of whole mantle convective processes. We address these issues through a receiver function study on new seismic data from recent deployments located on the Afar Triple Junction, a location associated with deep mantle upwelling. The detailed images of upper mantle and mantle transition zone structure illuminate features that give insights into the nature of upwelling from the deep Earth. A seismic low-velocity layer directly above the mantle transition zone, interpreted as a stable melt layer, along with a prominent 520 km discontinuity suggest the presence of a hydrous upwelling. A relatively uniform transition zone thickness across the region suggests a weak thermal anomaly (<100 K) may be present and that upwelling must be at least partly driven by compositional buoyancy. The results suggest that the lower mantle is a source of volatile rich, chemically distinct upwellings that influence the structure of the upper mantle, and potentially the chemistry of surface lavas.	[Thompson, D. A.] Univ Aberdeen, Sch Geosci, Aberdeen, Scotland; [Thompson, D. A.; Stuart, G. W.] Univ Leeds, Inst Geophys & Tecton, Sch Earth & Environm, Leeds, W Yorkshire, England; [Thompson, D. A.; Kendall, J. -M.; Helffrich, G. R.; Goitom, B.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Hammond, J. O. S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London, England; [Helffrich, G. R.] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 152, Japan; [Keir, D.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [Ayele, A.] Univ Addis Ababa, Inst Geophys Space Sci & Astron, Addis Ababa, Ethiopia; [Goitom, B.] Eritrea Inst Technol, Dept Earth Sci, Asmera, Eritrea	Thompson, DA (reprint author), Univ Aberdeen, Sch Geosci, Aberdeen, Scotland.	david.thompson@abdn.ac.uk	Geophysical Equipment Facility, NERC/G-5260-2010		Addis Ababa University; Eritrea Institute of Technology; Afar National Regional State Government, Ethiopia; Southern Red Sea Region Administration, Eritrea; Natural Environment Research Council [R8/H10/64]; National Science Foundation [EAR-0552316]; NERC [NE/E007414/1, NE/D008611/1, NE/J012297/1, NE/I020342/1]; NSF [EAR-0635789]; BHP-Billiton	We would like to thank Addis Ababa University, Eritrea Institute of Technology, the Afar National Regional State Government, Ethiopia, and the Southern Red Sea Region Administration, Eritrea for support throughout the various experiments. The facilities of SEIS-UK are supported by the Natural Environment Research Council under agreement R8/H10/64. Seismic instruments were also supplied by IRIS-PASSCAL. The facilities of the IRIS Consortium are supported by the National Science Foundation under Cooperative agreement EAR-0552316 and by the Department of Energy National Nuclear Security Administration. Funding was provided by NERC grants NE/E007414/1, NE/D008611/1, and NE/J012297/1, NSF grant EAR-0635789, and BHP-Billiton. J.O.S.H. was supported by NERC Fellowship NE/I020342/1. All data are available through the Incorporated Research Institutions for Seismology (IRIS) Data Management Centre (DMC). We thank two anonymous reviewers for constructive comments that improved the clarity of the paper.	KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Wolfe CJ, 2009, SCIENCE, V326, P1388, DOI 10.1126/science.1180165; Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; Hammond JOS, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003738; Bastow ID, 2011, GEOL SOC AM SPEC PAP, V478, P51, DOI 10.1130/2011.2478(04); Weidner DJ, 1998, J GEOPHYS RES-SOL EA, V103, P7431, DOI 10.1029/97JB03511; Simmons NA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028009; Owens TJ, 2000, GEOPHYS RES LETT, V27, P827, DOI 10.1029/1999GL005429; Stixrude L, 2012, ANNU REV EARTH PL SC, V40, P569, DOI 10.1146/annurev.earth.36.031207.124244; Niu YL, 2012, EPISODES, V35, P310; Baker J, 1998, GEOLOGY, V26, P431, DOI 10.1130/0091-7613(1998)026<0431:MOTSMB>2.3.CO;2; Hammond JOS, 2014, GEOCHEM GEOPHY GEOSY, V15, P1878, DOI 10.1002/2013GC005185; Wolfe CJ, 1997, NATURE, V385, P245, DOI 10.1038/385245a0; Hansen SE, 2012, EARTH PLANET SC LETT, V319, P23, DOI 10.1016/j.epsl.2011.12.023; Nyblade AA, 2000, GEOLOGY, V28, P599; Cornwell DG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047575; Nyblade AA, 2000, GEOPHYS J INT, V142, P615, DOI 10.1046/j.1365-246x.2000.00179.x; Pearson DG, 2014, NATURE, V507, P221, DOI 10.1038/nature13080; Chang SJ, 2011, EARTH PLANET SC LETT, V302, P448, DOI 10.1016/j.epsl.2010.12.050; Meshesha D, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005549; Ligorria JP, 1999, B SEISMOL SOC AM, V89, P1395; Hammond JOS, 2013, GEOLOGY, V41, P635, DOI 10.1130/G33925.1; Tackley PJ, 2011, PHYS EARTH PLANET IN, V188, P150, DOI 10.1016/j.pepi.2011.04.013; Hansen SE, 2013, GEOPHYS J INT, V194, P118, DOI 10.1093/gji/ggt116; Angus DA, 2009, PHYS EARTH PLANET IN, V177, P206, DOI 10.1016/j.pepi.2009.09.002; Benoit MH, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001398; Ghosh S, 2013, EARTH PLANET SC LETT, V371, P103, DOI 10.1016/j.epsl.2013.04.011; DUNCAN RA, 1991, REV GEOPHYS, V29, P31, DOI 10.1029/90RG02372; Huerta AD, 2009, GEOPHYS J INT, V177, P1249, DOI [10.1111/j.1365-246X.2009.04092.X, 10.1111/j.1365-246X.2009.04092.x]; Deuss A, 2007, GEOL SOC AM SPEC PAP, V430, P121, DOI 10.1130/2007.2430(07); Pik R, 2006, CHEM GEOL, V226, P100, DOI 10.1016/j.chemgeo.2005.09.016; Hirschmann MM, 2006, ANNU REV EARTH PL SC, V34, P629, DOI 10.1146/annurev.earth.34.031405.125211; Helffrich G, 2000, REV GEOPHYS, V38, P141, DOI 10.1029/1999RG000060; REVENAUGH J, 1994, NATURE, V369, P474, DOI 10.1038/369474a0; Rychert CA, 2012, NAT GEOSCI, V5, P406, DOI [10.1038/ngeo1455, 10.1038/NGEO1455]; Benoit MH, 2006, GEOLOGY, V34, P329, DOI 10.1130/G22281.1; VANDECAR JC, 1995, NATURE, V378, P25, DOI 10.1038/378025a0; Shen Y, 1998, NATURE, V395, P62, DOI 10.1038/25714; Tauzin B, 2010, NAT GEOSCI, V3, P718, DOI 10.1038/NGEO969; Vinnik L, 2007, EARTH PLANET SC LETT, V262, P398, DOI 10.1016/j.epsl.2007.07.051; Thompson DA, 2011, EARTH PLANET SC LETT, V312, P28, DOI 10.1016/j.epsl.2011.09.037; Ebinger CJ, 1998, NATURE, V395, P788, DOI 10.1038/27417; Ferot A, 2012, EARTH PLANET SC LETT, V349, P218, DOI 10.1016/j.epsl.2012.06.022; Ferguson DJ, 2013, NATURE, V499, P70, DOI 10.1038/nature12292; Flanagan MP, 1998, J GEOPHYS RES-SOL EA, V103, P2673, DOI 10.1029/97JB03212; Montelli R, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001248; Gao SS, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007141; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Smyth JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026194; Inoue T, 2010, PHYS EARTH PLANET IN, V183, P245, DOI 10.1016/j.pepi.2010.08.003; Bastow ID, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002107; Beier C, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001933; Crotwell H.P., 1999, SEISMOL RES LETT, V70, P154, DOI DOI 10.1785/GSSRL.70.2.154; Frost DJ, 2007, EARTH PLANET SC LETT, V256, P182, DOI 10.1016/j.epsl.2007.01.023; Gu YJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000489; Huckfeldt M, 2013, EARTH PLANET SC LETT, V373, P194, DOI 10.1016/j.epsl.2013.05.003; Ito G., 2007, TREATISE GEOPHYS, V7, P371; Julia J, 2013, EARTH PLANET SC LETT, V368, P151, DOI 10.1016/j.epsl.2013.02.021; Kendall JM, 2005, NATURE, V433, P146, DOI 10.1038/nature03161; Lawrence JF, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003973; MCFADDEN PL, 1986, GEOPHYSICS, V51, P1879, DOI 10.1190/1.1442045; Nichols ARL, 2002, EARTH PLANET SC LETT, V202, P77, DOI 10.1016/S0012-821X(02)00758-6; Niu YL, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002048; Nyblade A. A., 2002, EOS T AGU, V83, P405, DOI DOI 10.1029/2002E0000296; OLSON P, 1991, J GEOPHYS RES-SOLID, V96, P4347, DOI 10.1029/90JB02530; Rooney TO, 2012, GEOLOGY, V40, P27, DOI 10.1130/G32382.1; Styles E, 2011, GEOPHYS J INT, V184, P1371, DOI 10.1111/j.1365-246X.2010.04914.x; Tauzin B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005364; Tenner TJ, 2012, CONTRIB MINERAL PETR, V163, P297, DOI 10.1007/s00410-011-0675-7; Wilson D, 2003, LEADING EDGE, V22, P232, DOI DOI 10.1190/1.1564528	70	2	2	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	1525-2027			GEOCHEM GEOPHY GEOSY	Geochem. Geophys. Geosyst.	MAR	2015	16	3					834	846		10.1002/2014GC005648		13	Geochemistry & Geophysics	Geochemistry & Geophysics	CG9RN	WOS:000353656200015		
J	Kars, M; Kodama, K				Kars, Myriam; Kodama, Kazuto			Authigenesis of magnetic minerals in gas hydrate-bearing sediments in the Nankai Trough, offshore Japan	GEOCHEMISTRY GEOPHYSICS GEOSYSTEMS			English	Article						iron sulfides; greigite; pyrrhotite; gas hydrate; Nankai Trough; IODP Expedition 316; C0008C	LOW-TEMPERATURE; GRAIN-SIZE; MARINE-SEDIMENTS; PYRRHOTITE; GREIGITE; REMAGNETIZATION; TRANSITION; DIAGENESIS; BEHAVIOR; GROWTH	Gas hydrate occurrence is one of the possible mechanisms invoked for iron sulfide formation. A high-resolution rock magnetic study was conducted in IODP Expedition 316 Hole C0008C located in the Megasplay Fault Zone of the Nankai Trough, offshore Japan. In this particular zone, no bottom simulating reflectors (BSR), indicating the base of the gas hydrate stability field, have been identified. Two hundred and eighteen Pleistocene samples were collected from 70 to 110 m CSF in order to document the changes in the concentration, grain size, and rock magnetic parameters of magnetic minerals, through the gas hydrate-bearing horizons. Two different populations of magnetic grains are recognized in the pseudosingle domain range. Three types of magnetic mineral assemblages are identified: iron oxides (magnetite), ferrimagnetic iron sulfides (greigite and pyrrhotite), and their mixture. Greigite and pyrrhotite are authigenic and constitute six layers, called IS1-IS6. IS1, IS3, IS4, and IS6 are associated with pore water anomalies, suggesting the occurrence of gas hydrates and anoxic conditions. IS2 and IS5 are probable gas hydrates horizons, although there is no independent data to confirm it. The remaining intervals are mainly composed of detrital iron oxides and paramagnetic iron sulfides. Two scenarios based on different diagenetic stages are proposed to explain the variations in the magnetic properties and mineralogy over the studied interval. The results suggest that rock magnetism appears useful to better constrain the gas hydrate distribution in Hole C0008C, and counterbalances the low resolution of pore water analyses and the absence of a BSR.	[Kars, Myriam; Kodama, Kazuto] Kochi Univ, Ctr Adv Marine Core Res, Nankoku, Kochi, Japan	Kars, M (reprint author), Kochi Univ, Ctr Adv Marine Core Res, Nankoku, Kochi, Japan.	jm-mkars@kochi-u.ac.jp					DAY R, 1977, PHYS EARTH PLANET IN, V13, P260, DOI 10.1016/0031-9201(77)90108-X; Hesse R, 2003, EARTH-SCI REV, V61, P149, DOI 10.1016/S0012-8252(02)00117-4; Muxworthy AR, 2000, GEOPHYS J INT, V140, P101, DOI 10.1046/j.1365-246x.2000.00999.x; Rowan CJ, 2009, EARTH PLANET SC LETT, V277, P223, DOI 10.1016/j.epsl.2008.10.016; Dunlop DJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000487; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; ROCHETTE P, 1990, EARTH PLANET SC LETT, V98, P319, DOI 10.1016/0012-821X(90)90034-U; Usman MO, 2014, INT J EARTH SCI, V103, P1141, DOI 10.1007/s00531-014-1011-z; DEKKERS MJ, 1989, GEOPHYS RES LETT, V16, P855, DOI 10.1029/GL016i008p00855; Peters C, 2003, PHYS CHEM EARTH, V28, P659, DOI 10.1016/S1474-7065(03)00120-7; Brothers LA, 1996, CHEM GEOL, V130, P1, DOI 10.1016/0009-2541(96)00007-1; DEKKERS MJ, 1989, PHYS EARTH PLANET IN, V57, P266, DOI 10.1016/0031-9201(89)90116-7; Strasser M, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003431; Muxworthy AR, 2002, EARTH PLANET SC LETT, V203, P369, DOI 10.1016/S0012-821X(02)00880-4; Roberts AP, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004715; Rochette P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024196; Wolfers P, 2011, SOLID STATE PHENOMEN, V170, P174, DOI 10.4028/www.scientific.net/SSP.170.174; KARLIN R, 1990, J GEOPHYS RES-SOLID, V95, P4405, DOI 10.1029/JB095iB04p04405; Ashi J, 2002, MAR GEOL, V187, P177, DOI 10.1016/S0025-3227(02)00265-7; Roberts AP, 2005, EARTH PLANET SC LETT, V231, P263, DOI 10.1016/j.epsl.2004.11.024; MOSKOWITZ BM, 1993, EARTH PLANET SC LETT, V120, P283, DOI 10.1016/0012-821X(93)90245-5; Roberts AP, 2000, J GEOPHYS RES-SOL EA, V105, P28461, DOI 10.1029/2000JB900326; Sagnotti L, 2005, GEOPHYS J INT, V160, P89, DOI 10.1111/j.1365-246X.2005.02485.X; Brown KM, 2001, EARTH PLANET SC LETT, V194, P97, DOI 10.1016/S0012-821X(01)00546-5; Kimura G, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003335; Ozdemir O, 2002, EARTH PLANET SC LETT, V194, P343, DOI 10.1016/S0012-821X(01)00562-3; Kao SJ, 2004, CHEM GEOL, V203, P153, DOI 10.1016/j.chemgeo.2003.09.007; Aubourg C, 2010, EARTH PLANET SC LETT, V294, P47, DOI 10.1016/j.epsl.2010.02.045; Aubourg C, 2012, GEOL SOC SPEC PUBL, V371, P181, DOI 10.1144/SP371.4; Banerjee S, 1997, J GEOPHYS RES-SOL EA, V102, P24825, DOI 10.1029/97JB01893; BERNER RA, 1984, GEOCHIM COSMOCHIM AC, V48, P605, DOI 10.1016/0016-7037(84)90089-9; Harrison RJ, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001987; Guo J., 2012, P INTEGRATED OCEAN D, V314, DOI [10.2204/iodp.proc.314315316.202.2012, DOI 10.2204/IODP.PROC.314315316.202]; Housen BA, 1996, EARTH PLANET SC LETT, V139, P509, DOI 10.1016/0012-821X(95)00245-8; Housen BA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000068; Kars M, 2011, GEOPHYS J INT, V186, P1029, DOI 10.1111/j.1365-246X.2011.05121.x; Kinoshita M., 2012, HYDRATE CONTENT ESTI; Kinoshita M., 2009, P INTEGRATED OCEAN D, V314, DOI [10.2204/iodp.proc.314315316.136.2009, DOI 10.2204/IODP.PROC.314315316.136.]; Kinoshita M, 2015, EARTH PLANETS SPACE, V67, DOI 10.1186/s40623-014-0171-1; Kinoshita M, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003609; Kopf A., 2011, P INT OCEAN DRILLING, V314, DOI [10.2204/iodp.proc.314315316.207.2011, DOI 10.2204/IODP.PROC.314315316.207]; Larrasoana J. C., 2006, OCEAN DRILLING PROGR, V204, P1; Larrasoana JC, 2007, EARTH PLANET SC LETT, V261, P350, DOI 10.1016/j.epsl.2007.06.032; LESLIE BW, 1990, J GEOPHYS RES-SOLID, V95, P4437, DOI 10.1029/JB095iB04p04437; Moore G. F., 2009, P IODP, P1, DOI [10.2204/iodp.proc.314315316.102.2009, DOI 10.2204/IODP.PROC.314315316.102.2009]; Musgrave RJ, 2006, GEOLOGY, V34, P117, DOI 10.1130/G22008.1; Paull C. K., 2000, OCEAN DRILLING PROGR, V164; Riedel M., 2010, P INTEGRATED OCEAN D, V311, DOI [10.2204/iodp.proc.311.213.2010, DOI 10.2204/IODP.PROC.311.213]; Roberts AP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009412; Roberts AP, 2011, REV GEOPHYS, V49, DOI 10.1029/2010RG000336; Rowan CJ, 2005, GEOLOGY, V33, P553, DOI 10.1130/G21382.1; Toki T, 2012, GEOCHEM J, V46, P89; Trehu A. M., 2003, OCEAN DRILLING PROGR, V204, DOI [10.2973/odp.proc.ir.204.2003, DOI 10.2973/ODP.PROC.IR.204.2003]; Wehland F, 2005, PHYS EARTH PLANET IN, V153, P181, DOI 10.1016/j.pepi.2005.05.006; Westbrook G. K., 1994, OCEAN DRILLING PROGR, V146, DOI [10.2973/odp.proc.ir.146-1.1994, DOI 10.2973/ODP.PROC.IR.146-1.1994]; Zhao X., 2011, P INTEGRATED OCEAN D, V314, DOI [10.2204/iodp.proc.314315316.215.2011, DOI 10.2204/IODP.PROC.314315316.215]	56	0	0	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	1525-2027			GEOCHEM GEOPHY GEOSY	Geochem. Geophys. Geosyst.	MAR	2015	16	3					947	961		10.1002/2014GC005614		15	Geochemistry & Geophysics	Geochemistry & Geophysics	CG9RN	WOS:000353656200022		
J	Kawase, S; Hosoya, K				Kawase, Seigo; Hosoya, Kazumi			Pseudorasbora pugnax, a new species of minnow from Japan, and redescription of P. pumila (Teleostei: Cyprinidae)	ICHTHYOLOGICAL EXPLORATION OF FRESHWATERS			English	Article								Pseudorasbora pugnax, new species, is described from the Ise Bay area in central Honshu, Japan. It is distinguished from its Japanese congener P. pumilla by the absence of a dark lateral stripe (vs. presence), 33-34 (vs. 34-35) vertebrae, a comparatively more developed infraorbital canal of the cephalic lateralis system with a rostral branch present (vs. absent), a nasal canal present (vs. absent) and mandibular canal complete (vs. incomplete). It is distinguished from the sympatric P. parva, by the longer head (27.5-31.9 % SL vs. 23.5-27.3), incomplete (vs. complete) lateral line, and incomplete (vs. complete) infraorbital, supraorbital and supratemporal canals of the cephalic lateralis. Pseudorasbora pumila is redescribed and a lectotype designated.	[Kawase, Seigo; Hosoya, Kazumi] Kinki Univ, Grad Sch Agr, Nara 6318505, Japan; [Kawase, Seigo] Lake Biwa Museum, Kusatsu, Shiga 5250001, Japan	Kawase, S (reprint author), Kinki Univ, Grad Sch Agr, 3327-204 Nakamachi, Nara 6318505, Japan.	kawauso0212@hotmail.co.jp			JSPS [24-4703]	We greatly appreciate Takahiko Mukai (Gifu University), Koji Tsukahara, Yoshiaki Miwa (Gifu Mino Ecological Research Group), Shinya Mitani (Toba Aquarium) and Jun-ichi Kitamura (Mie Prefectural Museum) for collecting the specimens of P. pugnax, Kiyotaka Takahashi (Conservation Society of Shinaimotsugo) and Kouichi Kawamura (Mie University) for their help and advice, and Naoto Hanzawa (Yamagata University) for providing helpful genetic information. We sincerely thank Tetsuji Nakabo (FAKU), M. J. P. Van Oijen, R. de Ruiter (RMNH), Keiichi Matsuura, Gento Shinohara (NSMT) and Masanari Matsuda (LBM) for observations or loan of material under their care, Ryu Uchiyama (nature photographer) and Toshihiko Morimune (KUN) for photographs of live specimens. Part of this study was financially supported by a Grant-in-Aid for JSPS Fellows (no. 24-4703 for S. Kawase).	Banarescu P., 1973, Tierreich, V93, P1; Bleeker P, 1860, ICHTHYOLOGIAE ARCHIP, VII; Britton J. R., 2010, FISH FISH, V11, P315; Fujita T, 2005, ICHTHYOL RES, V52, P336, DOI 10.1007/s10228-005-0290-6; Hosoya K, 1983, FRESHWATER FISHES, V9, P43; Hosoya K, 2002, FISHES JAPAN PICTORI, P253; Hosoya K, 2013, FISHES JAPAN PICTORI, Vthird, p[308, 1813]; Hubbs C. L., 2004, FISHES GREAT LAKES R; Kano Yuichi, 2010, Japanese Journal of Ichthyology, V57, P43; Kawamura Kouichi, 1997, Japanese Journal of Ichthyology, V44, P57; Kawanabe H., 2001, FRESHWATER FISHES JA; Konishi M, 2003, J FISH BIOL, V63, P213, DOI 10.1046/j.1095-8649.2003.00146.x; Matsuda M., 1988, ANN REPORTS BIWAKO B, V6, P31; Miyadi D., 1930, ZOOLOGICAL SOC JAPAN, V12, P445; Mukai Takahiko, 2011, P54; Nakamura M., 1969, CYPRINID FISHES JAPA; Nakamura M., 1963, KEYS FRESHWATER FISH; Nalbant T. T., 1973, TIERREICH, V93, pi; Niwa H., 1967, FISH OF KISO RIVER; Ohnaka T, 1999, NIPPON SUISAN GAKK, V65, P1005; Okada Y., 1960, J FAC FISH PREF U MI, V4, P267; Okada Y., 1957, ZOOLOGY, V13, P99; Tamaoki F., 1999, ANN REPORT TOBA AQUA, V10, P33; Temminck C. J., 1842, FAUNA JAPONICA SIVE; Uchiyama R., 1987, FRESHWATER FISH, V13, P74; Watanabe K, 2012, ENVIRON BIOL FISH, V94, P533, DOI 10.1007/s10641-010-9601-5; Watanabe K, 1998, ICHTHYOL RES, V45, P259, DOI 10.1007/BF02673924; Watanabe K, 2000, ICHTHYOL RES, V47, P43, DOI 10.1007/BF02674312; Watanabe K, 2009, ICHTHYOL RES, V55, P309; Wu H. W., 1939, Sinensia Nanking, V10, P92; Xiao Zhi, 2007, Acta Zootaxonomica Sinica, V32, P977	31	1	1	VERLAG DR FRIEDRICH PFEIL	MUNICH	WOLFRATSHAUSER STRASSE 27, MUNICH, D-81379, GERMANY	0936-9902			ICHTHYOL EXPLOR FRES	Ichthyol. Explor. Freshw.	MAR	2015	25	4					289	298				10	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CH2QP	WOS:000353870000001		
J	Yoshida, T; Hondou, M; Tabata, T; Kan, R; Kiyota, N; Kojima, H; Hosoe, K; Okano, H				Yoshida, Toshio; Hondou, Mikio; Tabata, Takekazu; Kan, Ryuji; Kiyota, Naohiro; Kojima, Hiroyuki; Hosoe, Koji; Okano, Hiroshi			SPARC64 XIFX: FUJITSU'S NEXT-GENERATION PROCESSOR FOR HIGH-PERFORMANCE COMPUTING	IEEE MICRO			English	Article								Sparc64 Xifx, Fujitsu's latest high-performance computing processor, includes a 34-core processor and achieves 1.1 teraflops of peak performance. This chip is designed for massive parallel supercomputer systems that realize high performance for a range of real applications. As groundwork for exascale supercomputing, it made major technological changes from the previous sparc64 processor in the instruction set architecture, microarchitecture, memory modules, and embedded interconnect.	[Yoshida, Toshio] Fujitsu, Next Generat Tech Comp Unit, LSI Dev Div, Minato, Tokyo, Japan; [Hondou, Mikio] Fujitsu, Next Generat Tech Comp Unit, Minato, Tokyo, Japan; [Tabata, Takekazu] Fujitsu, Enterprise Server Business Unit, Proc Dev Div, Minato, Tokyo, Japan; [Kan, Ryuji; Kiyota, Naohiro; Kojima, Hiroyuki] Fujitsu, Enterprise Server Business Unit, Minato, Tokyo, Japan; [Hosoe, Koji] Fujitsu, Next Generat Tech Comp Unit, Syst Dev Div, Minato, Tokyo, Japan; [Okano, Hiroshi] Fujitsu Labs, Server Technol Lab, Minato, Tokyo, Japan	Yoshida, T (reprint author), Fujitsu, Next Generat Tech Comp Unit, LSI Dev Div, Minato, Tokyo, Japan.	yoshida.toshio@jp.fujitsu.com; hondou@jp.fujitsu.com; tabata.takekazu@jp.fujitsu.com; kan.ryuji@jp.fujitsu.com; kiyota.naohiro@jp.fujitsu.com; kojima.hiroy-03@jp.fujitsu.com; hosoe@jp.fujitsu.com; okano.hiroshi@jp.fujitsu.com					Ajima Y., 2014, P 29 INT C SUP ISC 1, P498; [Anonymous], 2011, ADV TECHN SUP PRIME; Fujitsu, 2008, SPARC64 8FX EXT ARCH; Maruyama T., 2008, HOT CHIPS 20, V20; Maruyama T, 2010, IEEE MICRO, V30, P30, DOI 10.1109/MM.2010.40; Yoshida T., 2014, HOT CHIPS 26, V26; Yoshida T., 2013, HOT CHIPS 25, V25; Yoshida T, 2013, IEEE MICRO, V33, P16, DOI 10.1109/MM.2013.126	8	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0272-1732	1937-4143		IEEE MICRO	IEEE Micro	MAR-APR	2015	35	2					6	14				9	Computer Science, Hardware & Architecture; Computer Science, Software Engineering	Computer Science	CG8NQ	WOS:000353565400003		
J	Cao, GY; Chen, LN; Aihara, K				Cao, Guo-yun; Chen, Luo-nan; Aihara, Kazuyuki			Power System Voltage Stability Assessment Based on Branch Active Powers	IEEE TRANSACTIONS ON POWER SYSTEMS			English	Article						Bifurcations; DC power flows; maximum; power flow equation; power transfer capability; voltage collapse	SADDLE-NODE; FLOW; LOAD; CONTINUATION; BIFURCATION; MARGIN	We prove that the active power through a branch (referred to as branch active power) in a power system is a continuous function of the bifurcation parameter in the closed interval from an initial parameter value to the bifurcation-point value of a saddle-node bifurcation (SNB) or limit-induced bifurcation (LIB) of the power flow equation (PFE). Then we show that generally there is a sequence of branch active powers meeting maxima when the parameters are equal to intermediate values in the closed interval. These results can be used to qualitatively evaluate and classify the state of power system operation conditions in terms of voltage stability. Also, they well explain the limitation of the direct current (DC) power flow methods on stressed power systems. Numerical simulations of the IEEE 118-bus and 57-bus systems are used to illustrate the studies and their applications.	[Cao, Guo-yun; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Chen, Luo-nan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Cao, GY (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	guoyun.cao@gmail.com; lnchen@sibs.ac.cn; aihara@sat.t.u-tokyo.ac.jp			Aihara Project; FIRST program from JSPS; CSTP; NSFC [91029301, 61134013, 11326035]	This work was supported in part by the Aihara Project, the FIRST program from JSPS initiated by CSTP and NSFC projects under No. 91029301 and No. 61134013 and No. 11326035. Paper no. TPWRS-00322-2014.	Ajjarapu V, 2007, POWER ELECTRON POWER, P1, DOI 10.1007/978-0-387-32935-2; Chiang HD, 1997, IEEE T POWER SYST, V12, P173; Carreras BA, 2004, IEEE T CIRCUITS-I, V51, P1733, DOI 10.1109/TCSI.2004.834513; Kundur P, 2004, IEEE T POWER SYST, V19, P1387, DOI 10.1109/TPWRS.2004.825981; DOBSON I, 1993, IEEE T POWER SYST, V8, P905, DOI 10.1109/59.260912; Avalos RJ, 2009, IEEE T CIRCUITS-I, V56, P210, DOI 10.1109/TCSI.2008.925941; Greene S, 2002, IEEE T POWER SYST, V17, P34, DOI 10.1109/59.982190; Stott B, 2009, IEEE T POWER SYST, V24, P1290, DOI 10.1109/TPWRS.2009.2021235; CHIANG HD, 1995, IEEE T POWER SYST, V10, P623, DOI 10.1109/59.387897; Apostol T. M., 1974, MATH ANAL; Baldick R, 2003, IEEE T POWER SYST, V18, P1316, DOI 10.1109/TPWRS.2003.818723; Cao G., 2013, 201303 METR U TOK; Cao Guo-yun, 2008, Journal of Shanghai Jiaotong University (English Edition), V13, DOI 10.1007/s12204-008-0562-1; Cao GY, 2010, ELECTR POW COMPO SYS, V38, P1061, DOI 10.1080/15325001003649435; Courant R., 1989, INTRO CALCULUS ANAL; Cutsem T.V., 1998, VOLTAGE STABILITY EL; Gomez-Exposito A., 2009, ELECT ENERGY SYSTEMS; Grijalva S, 2005, IEEE T CIRCUITS-I, V52, P1406, DOI 10.1109/TCSI.2005.851698; Grijalva S., 2011, IEEE T POWER SYST, V27, P12; Kundur P., 1994, POWER SYSTEM STABILI; Kuznetsov Y. A., 1995, ELEMENTS APPL BIFURC; Taylor C. W., 1994, POWER SYSTEM VOLTAGE; Yorino N, 2005, IEEE T POWER SYST, V20, P130, DOI 10.1109/TPWRS.2004.831696	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-8950	1558-0679		IEEE T POWER SYST	IEEE Trans. Power Syst.	MAR	2015	30	2					989	996		10.1109/TPWRS.2014.2329731		8	Engineering, Electrical & Electronic	Engineering	CG9MQ	WOS:000353640300038		
J	Toomsan, Y; Chomphoo, S; Pakkarato, S; Watanabe, M; Kondo, H; Hipkaeo, W				Toomsan, Yanyong; Chomphoo, Surang; Pakkarato, Sawetree; Watanabe, Masahiko; Kondo, Hisatake; Hipkaeo, Wiphawi			Localization of Vesicular Inhibitory Amino Acid Transporter (VIAAT) in the Submandibular Salivary Gland Throughout the Postnatal Development of Mice	INTERNATIONAL JOURNAL OF MORPHOLOGY			English	Article						VIATT-immunoreactivity; GABA; Salivary glands; Arteriolar smooth muscle	GAMMA-AMINOBUTYRIC-ACID; ELEMENT-BINDING PROTEIN; GABA RECEPTORS; RAT ISLETS; GLYCINE; SYSTEM; CELLS; IDENTIFICATION; EXPRESSION; NEURONS	According to recent studies, it is highly possible that the occurrence of vesicular inhibitory amino acid transporter (VIAAT) is a good marker of GABA-signaling not only in the brain, but also in extra-brain tissue cells containing GABA and GAD. In view of this, the present study was attempted to localize VIAAT-immunoreactivity in the submandibular gland of mice. In the present study, the submandibular glands of male mice at various postnatal developmental stages were examined for detailed localization of VIAAT-immunoreactivity in immunohistochemistry at light microscopic level. The immunoreactivity for VIAAT was localized in epithelial cells of proximal and distal excretory ducts with the striated portion more intensely immunopositive at young postnatal stages. No significant immunoreactivity was seen in the acinar cells throughout the postnatal development. In addition, the immunoreactivity for VIAAT was detected in the salivary parasympathetic ganglionic neurons, but not in any nerve fibers surrounding the glandular cells. Furthermore, VIAAT-immunoreactivity was found in smooth muscle cells forming the outermost layer of intralobular arterioles. From the present findings, it is possible that GABA plays roles as paracrine and autocrine regulators in the saliva secretion as well as the gland development.	[Toomsan, Yanyong; Chomphoo, Surang; Pakkarato, Sawetree; Kondo, Hisatake; Hipkaeo, Wiphawi] Khon Kaen Univ, Fac Med, Dept Anat, Khon Kaen 40002, Thailand; [Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan; [Kondo, Hisatake] Keiai Kai Med Corp, Histol Lab, Maesawa, Japan	Hipkaeo, W (reprint author), Khon Kaen Univ, Fac Med, Dept Anat, Khon Kaen 40002, Thailand.	wiphawi@kku.ac.th	WATANABE, Masahiko/A-4055-2012		Invitation Research Grant, Faculty of Medicine, Khon Kaen University [I57323]	This work was supported by Invitation Research Grant, Faculty of Medicine, Khon Kaen University (No. I57323) to WH. We sincerely thank Mr. D. Hipkaeo for his technical support.	Amano O, 1998, HISTOCHEM J, V30, P591, DOI 10.1023/A:1003258514766; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; ZAJICEK G, 1985, ANAT REC, V213, P150, DOI 10.1002/ar.1092130206; Gammelsaeter R, 2004, J CELL SCI, V117, P3749, DOI 10.1242/jcs.01209; Watanabe M, 2002, INT REV CYTOL, V213, P1; Bormann J, 2000, TRENDS PHARMACOL SCI, V21, P16, DOI 10.1016/S0165-6147(99)01413-3; Chebib M, 1999, CLIN EXP PHARMACOL P, V26, P937, DOI 10.1046/j.1440-1681.1999.03151.x; DENNY PC, 1990, ANAT REC, V226, P489, DOI 10.1002/ar.1092260411; McIntire SL, 1997, NATURE, V389, P870; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; Patel VN, 2014, SEMIN CELL DEV BIOL, V25, P52, DOI 10.1016/j.semcdb.2013.12.001; Chessler SD, 2002, DIABETES, V51, P1763, DOI 10.2337/diabetes.51.6.1763; Fukuchi M, 2014, J NEUROCHEM, V131, P134, DOI 10.1111/jnc.12801; Gabella G., 1976, STRUCTURE AUTONOMIC; GRESIK EW, 1980, J HISTOCHEM CYTOCHEM, V28, P860; Hinds K, 2013, INVEST OPHTH VIS SCI, V54, P6798, DOI 10.1167/iovs.13-12362; Hsu CC, 1999, J BIOL CHEM, V274, P24366, DOI 10.1074/jbc.274.34.24366; Kawaguchi M., 1996, INT ACAD BIOMED DRUG, V11, P291; Kilb W, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00139; Kosuge Y, 2009, EUR J PHARMACOL, V610, P18, DOI 10.1016/j.ejphar.2009.02.043; MAYER ML, 1983, BRAIN RES, V260, P233, DOI 10.1016/0006-8993(83)90677-7; Nakamura Y, 2009, CELL TISSUE RES, V336, P203, DOI 10.1007/s00441-009-0767-0; Okubo M, 2013, J PHARMACOL SCI, V122, P42, DOI 10.1254/jphs.12241FP; Ouchi K, 2011, EUR J PHARMACOL, V657, P20, DOI 10.1016/j.ejphar.2011.01.029; ROBERTS E, 1982, ISRAEL J MED SCI, V18, P75; SAWAKI K, 1995, JPN J PHARMACOL, V67, P359, DOI 10.1254/jjp.67.359; SHIDA T, 1995, MOL BRAIN RES, V33, P261, DOI 10.1016/0169-328X(95)00138-I; Suckow AT, 2006, J MOL ENDOCRINOL, V36, P187, DOI 10.1677/jme.1.01866	30	0	0	SOC CHILENA ANATOMIA	TEMUCO	CASILLA 54-D, TEMUCO, 00000, CHILE	0717-9502	0717-9367		INT J MORPHOL	Int. J. Morphol.	MAR	2015	33	1					113	118				6	Anatomy & Morphology	Anatomy & Morphology	CG9HS	WOS:000353626300019		
J	Teramoto, M; Nishijima, M				Teramoto, Maki; Nishijima, Miyuki			Flavicella marina gen. nov., sp nov., a carotenoid-producing bacterium from surface seawater	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article							TIDAL FLAT SEDIMENT; PETROLEUM ALIPHATIC-HYDROCARBONS; LIQUID-CHROMATOGRAPHY; DEGRADING BACTERIUM; EMENDED DESCRIPTION; FLAVOBACTERIACEAE; MICROORGANISMS; FAMILY; ENVIRONMENT; STRAINS	A Gram-stain-negative, non-motile, mesophilic, aerobic, rod-shaped or spherical bacterium, strain 2A-7(T), was isolated from surface seawater at Muroto city, Kochi prefecture, Japan. The strain produced a pigment(s), the absorption spectrum of which closely resembled that of beta-carotene. Phylogenetic analyses based on 16S rRNA gene sequences showed that the strain fell within the family Flavobacteriaceae and clustered distantly with the type strains of species of the genus Lutibacter (up to 93.9% similarity). The DNA G+C content was 34.1 mol%. The major fatty acids were summed feature 3 (iso-C-15:0 2-OH and/or C-16:1 omega 7c), iso-C-17:0 3-OH and iso-C-15:0 3-0H. The major polar lipids were phosphatidylethanolamine and three unidentified lipids. Menaquinone 6 was detected as the sole isoprenoid quinone. On the basis of phenotypic, genotypic and chemotaxonomic data, strain 2A-7(T) represents a novel genus and species, for which the name Flavicella marina gen. nov., sp. nov. is proposed. The type strain of Flavicella marina is 2A-7(T) (=NBRC 110145(T)=KCTC 42197(T)).	[Teramoto, Maki] Kochi Univ, Oceanog Sect, Nanko Ku, Oko, Kochi 7838505, Japan; [Nishijima, Miyuki] TechnoSuruga Lab Co Ltd, Shimizu Ku, Shizuoka 4240065, Japan	Teramoto, M (reprint author), Kochi Univ, Oceanog Sect, Nanko Ku, Oko, Kochi 7838505, Japan.	maki.teramoto@kochi-u.ac.jp					C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; MARMUR J, 1961, J MOL BIOL, V3, P208; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Sohn JH, 2004, INT J SYST EVOL MICR, V54, P1483, DOI 10.1099/ijs.0.02945-0; Park S, 2010, INT J SYST EVOL MICR, V60, P610, DOI 10.1099/ijs.0.012401-0; Choi A, 2013, INT J SYST EVOL MICR, V63, P946, DOI 10.1099/ijs.0.043471-0; Lee SY, 2012, INT J SYST EVOL MICR, V62, P420, DOI 10.1099/ijs.0.030320-0; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/ijs.0.02136-0; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; van den Berg H, 2000, J SCI FOOD AGR, V80, P880, DOI 10.1002/(SICI)1097-0010(20000515)80:7<880::AID-JSFA646>3.3.CO;2-T; Teramoto M, 2011, INT J SYST EVOL MICR, V61, P375, DOI 10.1099/ijs.0.018671-0; Choi DH, 2006, INT J SYST EVOL MICR, V56, P771, DOI 10.1099/ijs.0.64146-0; LEIFSON E, 1963, J BACTERIOL, V85, P1183; Bowman JP, 2000, INT J SYST EVOL MICR, V50, P1861; DYKSTERHOUSE SE, 1995, INT J SYST BACTERIOL, V45, P116; TAKAICHI S, 1992, METHOD ENZYMOL, V213, P374; Nishijima M, 1997, J MICROBIOL METH, V28, P113, DOI 10.1016/S0167-7012(96)00972-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; FAUTZ E, 1980, FEMS MICROBIOL LETT, V8, P87, DOI 10.1111/j.1574-6968.1980.tb05056.x; Hansman RL, 2009, P NATL ACAD SCI USA, V106, P6513, DOI 10.1073/pnas.0810871106; Park SC, 2013, INT J SYST EVOL MICR, V63, P2678, DOI 10.1099/ijs.0.047670-0; Barrow G. I., 1993, COWAN STEELS MANUAL; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; KATAYAMAFUJIMURA Y, 1984, AGR BIOL CHEM TOKYO, V48, P3169; Kim KY, 2011, FEMS MICROBIOL LETT, V314, P89, DOI 10.1111/j.1574-6968.2010.02147.x; Teramoto M, 2003, FEBS LETT, V545, P120, DOI 10.1016/S0014-5793(03)00513-1; Teralmoto M, 2009, MICROBIOL-SGM, V155, P3362, DOI 10.1099/mic.0.030411-0; YOKOYAMA A, 1995, FISHERIES SCI, V61, P684	31	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	MAR	2015	65		3				799	804		10.1099/ijs.0.000018		6	Microbiology	Microbiology	CG9WF	WOS:000353670100010		
J	Kanno, M; Katayama, T; Morita, N; Tamaki, H; Hanada, S; Kamagata, Y				Kanno, Manabu; Katayama, Taiki; Morita, Naoki; Tamaki, Hideyuki; Hanada, Satoshi; Kamagata, Yoichi			Catenisphaera adipataccumulans gen. nov., sp nov., a member of the family Erysipelotrichaceae isolated from an anaerobic digester	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article							HUMAN FECES; BACTERIUM; SEDIMENTS; STRAIN; TREES	An obligately anaerobic bacterium, designated strain GK12(T), was isolated from an anaerobic digester in Fukagawa, Hokkaido Prefecture, Japan. The cells of strain GK12(T) were non-motile, non-spore-forming cocci that commonly occurred in chains. 16S rRNA gene sequence analysis revealed that strain GK12(T) was affiliated with the family Erysipelotrichaceae in the phylum Firmicutes and showed 91.8% sequence similarity to the most closely related species, Faecalicoccus acidiformans. The strain grew at 30-50 degrees C (optimally at 40 degrees C) and at pH 5.5-8.5 (optimally at pH 7.5). The main end product of glucose fermentation was lactate. Yeast extract was required for growth. The strain contained C-14:0, C-14:0 1,1-dimethoxyalkane (DMA), C-16:0 DMA and C-18:0 DMA as the major cellular fatty acids (>10% of the total). The polar lipid profile was composed of phosphatidylglycerol, phosphatidylinositol and an unidentified phospholipid. The whole-cell sugars were galactose, rhamnose and ribose. The cell-wall murein contained alanine, glutamic acid, lysine, serine and threonine, but not diaminopimelic acid. The G+C content of the genonnic DNA was 47.7 mol%. Based on phenotypic, phylogenetic and chemotaxonomic properties, a novel genus and species, Catenisphaera adipataccumulans gen. nov., sp. nov., is proposed to accommodate strain GK12(T) (=NBRC 108915(T)=DSM 25799(T)).	[Kanno, Manabu; Tamaki, Hideyuki; Hanada, Satoshi; Kamagata, Yoichi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Katayama, Taiki; Morita, Naoki] AIST, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Katayama, Taiki] AIST, Inst Georesources & Environm, Sapporo, Hokkaido, Japan	Kamagata, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki, Japan.	y.kamagata@aist.go.jp			New Energy and Industrial Technology Development Organization (NEDO) programme in Japan	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) programme in Japan. We thank Mizuho Muramatsu, Aya Akiba, Xian-Ying Meng and Tomohiro Hirose for the determination of the DNA G+C content, the enzyme activity, the transmission electron microscopy, and the amino acid contents of murein, respectively.	Downes J, 2000, INT J SYST EVOL MICR, V50, P979; Kageyama A, 2000, MICROBIOL IMMUNOL, V44, P23; Eggerth AH, 1935, J BACTERIOL, V30, P277; Salvetti E, 2011, INT J SYST EVOL MICR, V61, P2520, DOI 10.1099/ijs.0.029231-0; Willems A, 1997, INT J SYST BACTERIOL, V47, P1201; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; DITTMER JC, 1964, J LIPID RES, V5, P126; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; JACIN H, 1965, J CHROMATOGR, V18, P170, DOI 10.1016/S0021-9673(01)80341-1; Kanno M, 2013, APPL ENVIRON MICROB, V79, P6998, DOI 10.1128/AEM.02900-13; Kageyama A, 2000, MICROBIOL IMMUNOL, V44, P223; Greetham HL, 2004, ANAEROBE, V10, P301, DOI 10.1016/j.anaeoobe.2004.06.001; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812; CATO EP, 1974, INT J SYST BACTERIOL, V24, P256; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Verbarg S, 2004, INT J SYST EVOL MICR, V54, P221, DOI 10.1099/ijs.0.02898-0; Bosshard PP, 2002, INT J SYST EVOL MICR, V52, P1263, DOI 10.1099/ijs.0.02056-0; BARNES EM, 1977, J GEN MICROBIOL, V102, P45; DSMZ, 1983, CAT OF STRAINS, V3rd; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; KAMAGATA Y, 1991, INT J SYST BACTERIOL, V41, P191; Katayama T, 2014, APPL ENVIRON MICROB, V80, P1126, DOI 10.1128/AEM.03056-13; Migula W., 1990, SYSTEM DER BAKTERIEN, V2; Nichols B. W., 1964, FETT SEIFEN ANSTR, V66, P1003, DOI 10.1002/lipi.19640661207; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SCHLEIFE.KH, 1972, BACTERIOL REV, V36, P407; Schubert K, 2001, SYST APPL MICROBIOL, V24, P26, DOI 10.1078/0723-2020-00010; Stackebrandt E, 2009, BERGEYS MANUAL SYSTE, V3, P1299; TAKAHASHI T, 1987, INT J SYST BACTERIOL, V37, P166; Takeuchi M, 2014, INT J SYST EVOL MICR, V64, P462, DOI 10.1099/ijs.0.053397-0; Tamaki H, 2003, INT J SYST EVOL MICR, V53, P519, DOI 10.1099/ijs.0.02369-0	32	1	1	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	MAR	2015	65		3				805	810		10.1099/ijs.0.000021		6	Microbiology	Microbiology	CG9WF	WOS:000353670100011		
J	Phongsopitanun, W; Tanasupawat, S; Suwanborirux, K; Ohkuma, M; Kudo, T				Phongsopitanun, Wongsakorn; Tanasupawat, Somboon; Suwanborirux, Khanit; Ohkuma, Moriya; Kudo, Takuji			Actinomadura rayongensis sp nov., isolated from peat swamp forest soil	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; MAXIMUM-LIKELIHOOD; GEN. NOV.; ACID; IDENTIFICATION; SYSTEMATICS; PARSIMONY; SEQUENCES; MADURAE; STRAIN	A novel actinomycete strain RY35-68(T), isolated from a peat swamp forest soil sample in Rayong Province, Thailand, was characterized using a polyphasic approach. The strain belonged to the genus Actinomadura based on morphological and chemotaxonomic characteristics. Cell-wall analysis revealed the presence of meso-diaminopimelic acid and N-acetylmuramic acid in the peptidoglycan layer. The diagnostic sugar in whole-cell hydrolysates was identified as madurose. The predominant menaquinones were MK-9(H-6), MK-9(H-8) and MK-9(H-4). The major cellular fatty acids were C-16:0 and iso-C-16:0. The major polar lipids were diphosphatidylglycerol, phosphatidylinositol and phosphatidylinositol mannoside. The genomic DNA G+C content was 73.7 mol%. On the basis of 16S rRNA gene sequence similarity analysis, strain RY35-68(T) was closely related to the species Actinomadura atramentaria JCM 6250(T) (97.5%). The value of DNA DNA relatedness between strain RY35-68(T) and A. atramentaria JCM 6250T was 37.6-42.6 %. On the basis of its phenotypic characteristics and these results mentioned, this strain could be distinguished from the closely related type strain and represents a novel species of the genus Actinomadura, for which the name Actinomadura rayongensis sp. nov. (type strain RY35-68(T)=JCM 19830(T)=TISTR 2211(T)=PCU 332(T)) is proposed.	[Phongsopitanun, Wongsakorn; Tanasupawat, Somboon] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Biochem & Microbiol, Bangkok 10330, Thailand; [Suwanborirux, Khanit] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharmacognosy & Pharmaceut Bot, Bangkok 10330, Thailand; [Ohkuma, Moriya; Kudo, Takuji] RIKEN BioResource Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki 3050074, Japan	Tanasupawat, S (reprint author), Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Biochem & Microbiol, Bangkok 10330, Thailand.	Somboon.T@chula.ac.th	Ohkuma, Moriya/A-8100-2011		Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University	This research has been supported by the Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University, 2012. We thank Dr Maki Kitahara, Japan Collection of Microorganisms, RIKEN BioResource Center, Tsukuba, Japan for DNA DNA hybridization method and Professor Aharon Oren, the Hebrew University of Jerusalem, Jerusalem, Israel for the etymology.	ALTERAS I, 1988, MYCOPATHOLOGIA, V103, P55, DOI 10.1007/BF00437222; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Kampfer P, 1996, CAN J MICROBIOL, V42, P989; Yamada Y, 2000, INT J SYST EVOL MICR, V50, P823; Zhang ZS, 2001, INT J SYST EVOL MICR, V51, P373; UCHIDA K, 1984, J GEN APPL MICROBIOL, V30, P131, DOI 10.2323/jgam.30.131; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224; LECHEVALIER MP, 1977, BIOCHEM SYST ECOL, V5, P249, DOI 10.1016/0305-1978(77)90021-7; GORDON RE, 1974, INT J SYST BACTERIOL, V24, P54; STANECK JL, 1974, APPL MICROBIOL, V28, P226; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221; TOMIYASU I, 1982, J BACTERIOL, V151, P828; HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Arai T, 1975, CULTURE MEDIA ACTINO; Cascio A, 2011, J MED MICROBIOL, V60, P673, DOI 10.1099/jmm.0.027862-0; Euzeby J. P., 2014, LIST BACTERIAL NAMES; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; FELSENSTEIN J, 1983, ANNU REV ECOL SYST, V14, P313, DOI 10.1146/annurev.es.14.110183.001525; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; HIGGINS ML, 1967, J BACTERIOL, V94, P495; KAMALAM A, 1987, MYCOPATHOLOGIA, V97, P151, DOI 10.1007/BF00437238; Kim O. S., 2012, INT J SYST EVOL MICR, V62, P716, DOI DOI 10.1099/IJS.0.038075-0; Lane D. J., 1991, NUCL ACID TECHNIQUES, V4, P115, DOI DOI 10.1002/JOBM.3620310616; Lechevalier H. A., 1968, ACTINOMYCETALES, P393; LECHEVALIER M P, 1970, International Journal of Systematic Bacteriology, V20, P435; MIKAMI H, 1983, BUNSEKI KAGAKU, V32, pE207; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; MIYADOH S, 1987, INT J SYST BACTERIOL, V37, P342; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sasser M., 1990, USFCC NEWSL, V20, P16; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; TAMAOKA J, 1984, FEMS MICROBIOL LETT, V25, P125, DOI 10.1111/j.1574-6968.1984.tb01388.x; Tamura T, 2009, INT J SYST EVOL MICR, V59, P1867, DOI 10.1099/ijs.0.006858-0; Taylor H. D., 1958, COLOR HARMONY MANUAL; Trujillo ME, 2012, BERGYS MANUAL SYST B, V5, P1940; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463	38	1	1	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	MAR	2015	65		3				890	895		10.1099/ijs.0.000033		6	Microbiology	Microbiology	CG9WF	WOS:000353670100023		
J	Horino, H; Ito, M; Tonouchi, A				Horino, Haruka; Ito, Miyuki; Tonouchi, Akio			Clostridium oryzae sp nov., from soil of a Japanese rice field	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article							ANOXIC PADDY SOIL; 16S RIBOSOMAL-RNA; MAXIMUM-LIKELIHOOD; GENUS CLOSTRIDIUM; STRAW; BACTERIUM; SEQUENCES; PH; FERMENTATION; DIVERSITY	An obligately anaerobic bacterial strain designated KC3(T) was isolated from a rice straw-degrading culture, for which soil of a Japanese rice field was used as the inoculum. Cells of strain KC3(T) were determined to be non-cellulolytic, Gram-stain-positive, non-motile, ellipsoidal, spore-forming rods, 0.8-1x4-25 mu m. Endospores were formed at a terminal position in elongated cells (12-25 mu m, mean 15 mu m). The temperature range for growth was 20-50 degrees C, with an optimum at 37 degrees C. The pH range for growth was 5.0-7.5, with an optimum at pH 6.0 (slightly acidophilic). Strain KC3(T) fermented cellobiose to lactate, butfrate, acetate, formate, hydrogen and carbon dioxide. The major cellular fatty acids (>10%) were C-14:0, C-16:0 and C-19:0 cyclo 11,12 dimethylacetal. The DNA G+C content of strain KC3(T) was 37.5 mol%. 16S rRNA gene sequence analysis revealed that strain KC3T shared low sequence similarity (<93%) with type strains of the genus Clostridium sensu stricto (Clostridium rRNA cluster I). Analyses of the DNA gyrase A and ATP synthase beta subunit sequences supported the affiliation of strain KC3(T) to the genus Clostridium sensu stricto. The evidence presented here indicates that strain KC3(T) represents a novel species of the genus Clostridium, for which the name Clostridium oryzae sp. nov. is proposed. The type strain of Clostridium oryzae is KC3(T) (=DSM 28571(T)= NBRC 110163(T)).	[Horino, Haruka; Ito, Miyuki; Tonouchi, Akio] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan	Tonouchi, A (reprint author), Hirosaki Univ, Fac Agr & Life Sci, 3 Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	symbio@cc.hirosaki-u.ac.jp					Zhao J, 2014, MICROB ECOL, V67, P443, DOI 10.1007/s00248-013-0322-0; Glissmann K, 2000, FEMS MICROBIOL ECOL, V31, P117, DOI 10.1016/S0168-6496(99)00091-4; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846; Keis S, 2001, INT J SYST EVOL MICR, V51, P2095; Zhu Y, 2004, J BIOTECHNOL, V110, P143, DOI 10.1016/j.jbiotec.2004.02.006; GU X, 1995, MOL BIOL EVOL, V12, P546; Gupta RS, 2009, INT J SYST EVOL MICR, V59, P285, DOI 10.1099/ijs.0.001792-0; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; SLEAT R, 1984, APPL ENVIRON MICROB, V48, P88; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; SCHUTZ H, 1989, J GEOPHYS RES-ATMOS, V94, P16405, DOI 10.1029/JD094iD13p16405; Guo P, 2010, J MICROBIOL BIOTECHN, V20, P254, DOI 10.4014/jmb.0906.06035; TSUTSUKI K, 1987, SOIL SCI PLANT NUTR, V33, P13; Wiegel J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P654, DOI 10.1007/0-387-30744-3_20; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Weber S, 2001, APPL ENVIRON MICROB, V67, P1318, DOI 10.1128/AEM.67.3.1318-1327.2001; Broda DM, 1999, INT J SYST BACTERIOL, V49, P1539; Bru K, 2012, INT J HYDROGEN ENERG, V37, P14062, DOI 10.1016/j.ijhydene.2012.06.111; DUDA VI, 1987, ARCH MICROBIOL, V148, P121, DOI 10.1007/BF00425359; GOODWIN S, 1987, J BACTERIOL, V169, P2150; Hengstmann U, 1999, APPL ENVIRON MICROB, V65, P5050; Holdeman L.V., 1977, ANAEROBE LAB MANUAL; Hungate R. E., 1969, METHODS MICROBIOLO B, V3B, P117, DOI 10.1016/S0580-9517(08)70503-8; Inglett KS, 2011, INT J SYST EVOL MICR, V61, P2626, DOI 10.1099/ijs.0.024554-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; MILLER LT, 1982, J CLIN MICROBIOL, V16, P584; MONTVILLE TJ, 1985, APPL ENVIRON MICROB, V49, P733; Rainey F. A., 2009, BERGEYS MANUAL SYSTE, V3, P738; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; She D, 2012, CELL CHEM TECHNOL, V46, P207; Sugano A, 2005, SOIL SCI PLANT NUTR, V51, P51, DOI 10.1111/j.1747-0765.2005.tb00006.x; WATANABE A, 1993, SOIL SCI PLANT NUTR, V39, P707; ZUCKERKANDL EMILE, 1965, P97	34	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	MAR	2015	65		3				943	951		10.1099/ijs.0.000042		9	Microbiology	Microbiology	CG9WF	WOS:000353670100031		
J	Igarashi, K; Kashiwagi, K				Igarashi, Kazuei; Kashiwagi, Keiko			Modulation of Protein Synthesis by Polyamines	IUBMB LIFE			English	Review						protein synthesis; initiation; mRNA structure; bulged-out region of RNA; eIF5A; hypusine	S-ADENOSYLMETHIONINE DECARBOXYLASE; SELECTIVE STRUCTURAL-CHANGE; DOUBLE-STRANDED-RNA; OPEN READING FRAME; 18S RIBOSOMAL-RNA; BULGED-OUT REGION; ESCHERICHIA-COLI; ORNITHINE-DECARBOXYLASE; MESSENGER-RNA; POLYPEPTIDE-SYNTHESIS	Polyamines are ubiquitous small basic molecules that play important roles in cell growth and viability. Since polyamines mainly exist as a polyamine-RNA complex, we looked for proteins whose synthesis is preferentially stimulated by polyamines at the level of translation, and thus far identified 17 proteins in Escherichia coli and 6 proteins in eukaryotes. The mechanisms of polyamine stimulation of synthesis of these proteins were investigated. In addition, the role of eIF5A, containing hypusine formed from spermidine, on protein synthesis is described. These results clearly indicate that polyamines and eIF5A contribute to cell growth and viability through modulation of protein synthesis. (c) 2015 IUBMB Life, 67(3):160-169, 2015	[Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Clin Biochem, Chuo Ku, Chiba 2608675, Japan; [Igarashi, Kazuei] Amine Pharma Res Inst, Chuo Ku, Chiba, Japan; [Kashiwagi, Keiko] Chiba Inst Sci, Dept Clin Biochem, Fac Pharm, Choshi, Chiba, Japan	Igarashi, K (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	iga16077@faculty.chiba-u.jp			Ministry of Education, Science, Sports and Culture, Japan	The authors thank Dr. A. J. Michael for his help in preparing this manuscript. Research on polyamines in the author's laboratory is supported by a grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture, Japan.	MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; IGARASHI K, 1981, EUR J BIOCHEM, V114, P127; HELLER JS, 1976, P NATL ACAD SCI USA, V73, P1858, DOI 10.1073/pnas.73.6.1858; Nishimura K, 2005, BIOCHEM J, V385, P779; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; Nishimura K, 2009, INT J BIOCHEM CELL B, V41, P2251, DOI 10.1016/j.biocel.2009.04.021; Law GL, 2001, J BIOL CHEM, V276, P38036; Hanfrey C, 2005, J BIOL CHEM, V280, P39229, DOI 10.1074/jbc.M509340200; Yueh A, 1996, GENE DEV, V10, P1557, DOI 10.1101/gad.10.12.1557; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Uemura T, 2009, INT J BIOCHEM CELL B, V41, P2538, DOI 10.1016/j.biocel.2009.08.010; Park MH, 1997, BIOL SIGNAL, V6, P115; Hyvonen MT, 2006, RNA, V12, P1569, DOI 10.1261/rna.39806; QUIGLEY GJ, 1978, P NATL ACAD SCI USA, V75, P64, DOI 10.1073/pnas.75.1.64; Sakamoto A, 2012, INT J BIOCHEM CELL B, V44, P1877, DOI 10.1016/j.biocel.2012.07.010; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P9488, DOI 10.1073/pnas.0603597103; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Butcher NJ, 2007, J BIOL CHEM, V282, P28530, DOI 10.1074/jbc.M701265200; BAKKER EP, 1981, J BACTERIOL, V147, P820; Chung J, 2013, BIOCHEM J, V451, P257, DOI 10.1042/BJ20121553; Cohen S. S., 1998, GUIDE POLYAMINES; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791; Dias CAO, 2013, AMINO ACIDS, V44, P631, DOI 10.1007/s00726-012-1387-7; ECHANDI G, 1975, BIOCHEM BIOPH RES CO, V67, P1185, DOI 10.1016/0006-291X(75)90798-6; Higashi K, 2008, BIOCHEM BIOPH RES CO, V370, P572, DOI 10.1016/j.bbrc.2008.03.137; Higashi K, 2008, J BIOL CHEM, V283, P32989, DOI 10.1074/jbc.M806027200; IGARASHI K, 1975, BIOCHEM BIOPH RES CO, V67, P407, DOI 10.1016/0006-291X(75)90330-7; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; IGARASHI K, 1974, EUR J BIOCHEM, V48, P495, DOI 10.1111/j.1432-1033.1974.tb03790.x; Igarashi Kazuei, 2010, Int J Biochem Cell Biol, V42, P39, DOI 10.1016/j.biocel.2009.07.009; IGARASHI K, 1973, BIOCHIM BIOPHYS ACTA, V299, P325, DOI 10.1016/0005-2787(73)90356-0; IGARASHI K, 1982, EUR J BIOCHEM, V128, P597; IGARASHI K, 1980, BIOCHEM BIOPH RES CO, V96, P678, DOI 10.1016/0006-291X(80)91408-4; ITO K, 1990, J BIOL CHEM, V265, P13036; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; LINDEROTH N, 1983, BIOCHEM BIOPH RES CO, V117, P616, DOI 10.1016/0006-291X(83)91245-7; MAMONT PS, 1978, BIOCHEM BIOPH RES CO, V81, P58, DOI 10.1016/0006-291X(78)91630-3; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; OGASAWARA T, 1989, J BIOCHEM-TOKYO, V105, P164; Rossi D, 2014, AMINO ACIDS, V46, P645, DOI 10.1007/s00726-013-1618-6; Sambrook J, 2001, MOL CLONING LAB MANU, P50; TABOR H, 1982, P NATL ACAD SCI-BIOL, V79, P7087, DOI 10.1073/pnas.79.23.7087; Terui Y, 2015, AMINO ACIDS, V47, P345, DOI 10.1007/s00726-014-1867-z; Terui Y, 2010, J BIOL CHEM, V285, P28698, DOI 10.1074/jbc.M110.111195; WATANABE Y, 1983, BIOCHIM BIOPHYS ACTA, V740, P362, DOI 10.1016/0167-4781(83)90083-0; WATANABE Y, 1981, BIOCHIM BIOPHYS ACTA, V656, P134, DOI 10.1016/0005-2787(81)90078-2; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1521-6543	1521-6551		IUBMB LIFE	IUBMB Life	MAR	2015	67	3					160	169		10.1002/iub.1363		10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CH4DS	WOS:000353982900002		
J	Guzman, C; Ortega, R; Yamamori, M; Pena, RJ; Alvarez, JB				Guzman, Carlos; Ortega, Raul; Yamamori, Makoto; Pena, Roberto J.; Alvarez, Juan B.			Molecular characterization of two novel null waxy alleles in Mexican bread wheat landraces	JOURNAL OF CEREAL SCIENCE			English	Article						Wheat quality; Waxy proteins; Null alleles; Mexican landraces	TRITICUM-AESTIVUM; STARCH PROPERTIES; HEXAPLOID WHEATS; WX-A1 ALLELES; COMMON WHEAT; HIGH-AMYLOSE; DURUM-WHEAT; PROTEINS; GENES; IDENTIFICATION	Starch is composed of two glucose polymers: amylose, formed by long linear chains, and amylopectin, which is larger and highly branched. The ratio between the two polymers (usually 22-35% amylose, 68-75% amylopectin) affects the starch properties, thereby determining different aspects of wheat quality. Waxy protein, which is the sole enzyme responsible for amylose synthesis, showed polymorphism in a collection of one hundred and three Mexican landraces, including null alleles at Wx-A1 and Wx-B1 loci, respectively. Molecular characterization of these alleles showed that the null Wx-A1 allele presented in only one accession was novel (Wx-A1o) and involved a deletion spanning the three and a half last exons of the gene. Some of the accessions lacking the Wx-B1 protein contained the common allele Wx-B1b (12.6%) (deletion of approximately 67 kb), while four others (3.8%) possessed the novel Wx-B1l, characterized by the deletion of one cytosine in the second exon of the gene and leading to a change in the ORF. This novel allele is particularly interesting because the absence of the Wx-B1 protein in this case was not associated with the lack of the other genes included in the approximately 67 kb region lost with the common null allele Wx-B1b. (C) 2015 Elsevier Ltd. All rights reserved.	[Guzman, Carlos; Ortega, Raul; Alvarez, Juan B.] Univ Cordoba, Escuela Tecn Super Ingn Agron & Montes, Dept Genet, E-14071 Cordoba, Spain; [Guzman, Carlos; Pena, Roberto J.] Int Maize & Wheat Improvement Ctr CIMMYT, Global Wheat Program, Wheat Chem & Qual Lab, Texcoco 56237, Mexico; [Yamamori, Makoto] Natl Agr & Food Res Org NARD, NARO Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan	Guzman, C (reprint author), Univ Cordoba, Escuela Tecn Super Ingn Agron & Montes, Dept Genet, E-14071 Cordoba, Spain.	ge2gugac@uco.es; b92ormar@uco.es; yamamori@affrc.go.jp; j.pena@cgiar.org; jb.alvarez@uco.es	Alvarez, Juan B./I-3922-2012	Alvarez, Juan B./0000-0002-7036-1317	Spanish Ministry of Economy and Competitiveness [AGL2010-19643-C02-01]; European Regional Development Fund (FEDER) from the European Union; Fundacion Alfonso Martin Escudero	This research was supported by grant AGL2010-19643-C02-01 from the Spanish Ministry of Economy and Competitiveness, co-financed with European Regional Development Fund (FEDER) from the European Union. First author thanks Fundacion Alfonso Martin Escudero for a post-doctoral fellowship.	Guzman C, 2012, GENET RESOUR CROP EV, V59, P971, DOI 10.1007/s10722-012-9849-z; NAKAMURA T, 1995, MOL GEN GENET, V248, P253, DOI 10.1007/BF02191591; Saito M, 2009, MOL BREEDING, V23, P209, DOI 10.1007/s11032-008-9226-y; Trethowan RM, 2008, CROP SCI, V48, P1255, DOI 10.2135/cropsci2007.08.0477; Yamamori M, 2011, J CEREAL SCI, V54, P229, DOI 10.1016/j.jcs.2011.06.005; Zeng M, 1997, CEREAL CHEM, V74, P63, DOI 10.1094/CCHEM.1997.74.1.63; Urbano M, 2002, PLANT BREEDING, V121, P465, DOI 10.1046/j.1439-0523.2002.00758.x; Vrinten P, 1999, MOL GEN GENET, V261, P463; Nakamura T, 2006, GENES GENET SYST, V81, P361, DOI 10.1266/ggs.81.361; Regina A, 2006, P NATL ACAD SCI USA, V103, P3546, DOI 10.1073/pnas.0510737103; Yamamori M, 2009, EUPHYTICA, V165, P607, DOI 10.1007/s10681-008-9793-3; Yamamori M, 2000, THEOR APPL GENET, V101, P21, DOI 10.1007/s001220051444; Morell MK, 2001, EUPHYTICA, V119, P55, DOI 10.1023/A:1017550624902; Vanzetti LS, 2010, PLANT BREEDING, V129, P718, DOI 10.1111/j.1439-0523.2009.01741.x; NAKAMURA T, 1993, BIOCHEM GENET, V31, P75, DOI 10.1007/BF02399821; Saito M, 2005, THEOR APPL GENET, V110, P276, DOI 10.1007/s00122-004-1830-6; Ayala M, 2013, EUPHYTICA, V190, P53, DOI 10.1007/s10681-012-0773-2; Boggini G, 2001, EUPHYTICA, V119, P111, DOI 10.1023/A:1004031304997; Caballero L, 2010, GENET RESOUR CROP EV, V57, P657, DOI 10.1007/s10722-009-9501-8; Guzman C, 2012, ANN BOT-LONDON, V110, P1161, DOI 10.1093/aob/mcs201; Guzman C, 2011, MOL BREEDING, V28, P403, DOI 10.1007/s11032-010-9493-2; Guzman C, 2014, J CEREAL SCI, V60, P617, DOI 10.1016/j.jcs.2014.07.006; Marcoz-Ragot C, 2000, PLANT BREEDING, V119, P305, DOI 10.1046/j.1439-0523.2000.00510.x; McIntosh R.A., 2013, CATALOGUE GENE SYMBO; Monari AM, 2005, THEOR APPL GENET, V110, P1481, DOI 10.1007/s00122-005-1983-y; ODA M, 1980, CEREAL CHEM, V57, P253; Ortega R, 2014, GENET RESOUR CROP EV, V61, P369, DOI 10.1007/s10722-013-0040-y; Rodriguez-Quijano M, 1998, PLANT BREEDING, V117, P341, DOI 10.1111/j.1439-0523.1998.tb01951.x; Shariflou MR, 1999, PLANT BREEDING, V118, P275, DOI 10.1046/j.1439-0523.1999.118003275.x; YAMAMORI M, 1994, THEOR APPL GENET, V89, P179, DOI 10.1007/BF00225138	30	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0733-5210	1095-9963		J CEREAL SCI	J. Cereal Sci.	MAR	2015	62						8	14		10.1016/j.jcs.2014.11.003		7	Food Science & Technology	Food Science & Technology	CG8YE	WOS:000353600800002		
J	Kaneshige, T; Arata, N; Harada, S; Ohashi, T; Sato, S; Umehara, N; Saito, T; Saito, H; Murashima, A; Sago, H				Kaneshige, Terumi; Arata, Naoko; Harada, Shohei; Ohashi, Toshinori; Sato, Shiori; Umehara, Nagayoshi; Saito, Takakazu; Saito, Hidekazu; Murashima, Atsuko; Sago, Haruhiko			Changes in Serum Iodine Concentration, Urinary Iodine Excretion and Thyroid Function After Hysterosalpingography Using an Oil-Soluble Iodinated Contrast Medium (Lipiodol)	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							EARLY-PREGNANCY; DYSFUNCTION; WOMEN; AUTOIMMUNITY; POSTPARTUM; MANAGEMENT	Objective: Reports of hypothyroidism after hysterosalpingography (HSG) using lipiodol are emerging. The present study was designed to investigate the changes in serum iodine concentration (SIC), urinary iodine concentration/creatinine excretion (UI/Cr), and thyroid function before and after HSG using lipiodol. Methods: The prospective observation study included 22 infertile euthyroid women with no previous history of thyroid disease. All underwent HSG between April 2007 and August 2008 at our institution. Weexamined SIC, UI/Cr, and thyroid function before HSG, and at 4, 8, 12, and 24 weeks, and 9-12 months after HSG. Results: The median value of SIC and UI/Cr peaked at 4 weeks after HSG and remained at significantly high levels at 8, 12, and 24 weeks post-HSG compared with pre-HSG. In sync with the increase of iodine, themeanlevel of TSH significantly increased at 4, 8, 12, and 24 weeks post-HSG compared with pre-HSG. After 24 weeks, differences in SIC, UI/Cr, and TSH levels before and after HSG became nonsignificant. The mean value of free triiodothyronine and free thyroxine showed no significant difference at any of the time points compared with pre-HSG. Three cases (13.6%) showed transient high TSH (>5 mu IU/L) with normal thyroid hormones at 4 or 8 weeks after HSG. Conclusion: Thyroid monitoring shouldbeconducted in the first 4-8weeksafterHSGusing lipiodol and attention to thyroid dysfunction should be paid for up to 6 months after the procedure due to the possibility of excess iodine.	[Kaneshige, Terumi; Arata, Naoko; Sato, Shiori; Umehara, Nagayoshi; Saito, Takakazu; Saito, Hidekazu; Murashima, Atsuko; Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo 1578535, Japan; [Harada, Shohei] Natl Ctr Child Hlth & Dev, Div Neonatal Screening, Tokyo 1578535, Japan; [Harada, Shohei; Ohashi, Toshinori] Hitachi Chem Corp, Tokyo 1006606, Japan	Arata, N (reprint author), Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	arata-n@ncchd.go.jp			Japanese Foundation of Growth Science in Tokyo, Japan; Ministry of Health, Labor, and Welfare of Japan [H19-Kodomo-Ippan-002]	This work was supported by grants from the Japanese Foundation of Growth Science in Tokyo, Japan. This study was also supported in part by Health and Labor Sciences Research grants from the Ministry of Health, Labor, and Welfare of Japan (H19-Kodomo-Ippan-002).	Lazarus JH, 2012, NEW ENGL J MED, V366, P493, DOI 10.1056/NEJMoa1106104; De Vivo A, 2010, THYROID, V20, P633, DOI 10.1089/thy.2009.0323; WOLFF J, 1948, J BIOL CHEM, V174, P555; Ohashi T, 2000, CLIN CHEM, V46, P529; Abalovich M, 2007, GYNECOL ENDOCRINOL, V23, P279, DOI 10.1080/09513590701259542; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; van den Boogaard E, 2011, HUM REPROD UPDATE, V17, P605, DOI 10.1093/humupd/dmr024; Omoto A, 2013, J CLIN ENDOCR METAB, V98, P3910, DOI 10.1210/jc.2013-1066; Mekaru K, 2008, GYNECOL ENDOCRINOL, V24, P498, DOI 10.1080/09513590802246364; Negro R, 2010, J CLIN ENDOCR METAB, V95, pE44, DOI 10.1210/jc.2010-0340; MIYAMOTO Y, 1995, INVEST RADIOL, V30, P538, DOI 10.1097/00004424-199509000-00005; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; KONNO N, 1993, CLIN ENDOCRINOL, V38, P273, DOI 10.1111/j.1365-2265.1993.tb01006.x; Negro R, 2010, J CLIN ENDOCR METAB, V95, P1699, DOI 10.1210/jc.2009-2009; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Aso K, 2014, PEDIATR INT, V118, P319; Johnson Neil P, 2005, Treat Endocrinol, V4, P233, DOI 10.2165/00024677-200504040-00004; Leung AM, 2014, NAT REV ENDOCRINOL, V10, P136, DOI 10.1038/nrendo.2013.251; SLATER S, 1959, FERTIL STERIL, V10, P144	20	1	2	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	MAR	2015	100	3					E469	E472		10.1210/jc.2014-2731		4	Endocrinology & Metabolism	Endocrinology & Metabolism	CG5TR	WOS:000353358900013		
J	Morii, Y; Terashima, H; Koshi, M; Shimizu, T				Morii, Youhi; Terashima, Hiroshi; Koshi, Mitsuo; Shimizu, Taro			Numerical study of the effect of obstacles on the spontaneous ignition of high-pressure hydrogen	JOURNAL OF LOSS PREVENTION IN THE PROCESS INDUSTRIES			English	Article						Spontaneous ignition; Hydrogen safety; Detailed chemical kinetic model; Computational fluid dynamics	SELF-IGNITION; RELEASE; GAS; SCHEMES; SHOCK; TUBE	A numerical simulation of the spontaneous ignition of high-pressure hydrogen in a duct with two obstacles on the walls is conducted to explore the spontaneous ignition mechanisms. Two-dimensional rectangular ducts are adopted, and the Navier Stokes equations with a detailed chemical kinetic mechanism are solved by using direct numerical simulations. In this study, we focus on the effects of the initial pressure of hydrogen and the position of the obstacles on the ignition mechanisms. Our results demonstrate that the presence of obstacles significantly changes the spontaneous ignition mechanisms producing three distinct ignition mechanisms. In addition, the position of the obstacles drastically changes the interaction of shock waves with the contact surface, and spontaneous ignition may take place at a relatively low pressure in some obstacle positions, which is attributed to the propagation direction and interaction timing of two reflected shock waves. (C) 2015 Elsevier Ltd. All rights reserved.	[Morii, Youhi; Shimizu, Taro] Japan Aerosp Explorat Agcy, JAXAs Engn Digital Innovat Ctr, Sagamihara, Kanagawa 2525210, Japan; [Terashima, Hiroshi] Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1130032, Japan; [Koshi, Mitsuo] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	Morii, Y (reprint author), Japan Aerosp Explorat Agcy, JAXAs Engn Digital Innovat Ctr, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.	morii.yuuhi@jaxa.jp					Strang G., 1968, SIAM Journal on Numerical Analysis, V5, DOI 10.1137/0705041; Mogi T, 2008, J LOSS PREVENT PROC, V21, P199, DOI 10.1016/j.jlp.2007.06.008; Gamezo VN, 2008, COMBUST FLAME, V155, P302, DOI 10.1016/j.combustflame.2008.06.004; Wen JX, 2009, COMBUST FLAME, V156, P2173, DOI 10.1016/j.combustflame.2009.06.012; Bragin MV, 2011, INT J HYDROGEN ENERG, V36, P2589, DOI 10.1016/j.ijhydene.2010.04.128; Kim SD, 2009, J COMPUT PHYS, V228, P7634, DOI 10.1016/j.jcp.2009.07.006; Gottlieb S, 1998, MATH COMPUT, V67, P73, DOI 10.1090/S0025-5718-98-00913-2; Terashima H, 2014, INT J HYDROGEN ENERG, V39, P6013, DOI 10.1016/j.ijhydene.2014.01.129; MATHUR S, 1967, MOL PHYS, V12, P569, DOI 10.1080/00268976700100731; Bird R.B., 2007, TRANSPORT PHENOMENA; Dryer FL, 2007, COMBUST SCI TECHNOL, V179, P663, DOI 10.1080/00102200600713583; Fedkiw RP, 1997, J COMPUT PHYS, V132, P175, DOI 10.1006/jcph.1996.5622; Golub VV, 2008, J LOSS PREVENT PROC, V21, P185, DOI 10.1016/j.jlp.2007.06.012; Hirschfelder O.J., 1954, MOL THEORY GASES LIQ; Kim Y., 2012, P COMBUST INST, V34, P2057; Lee BJ, 2009, INT J HYDROGEN ENERG, V34, P8763, DOI 10.1016/j.ijhydene.2009.08.034; Leer B.V., 1982, LECT NOTE PHYS, V170, P507; Mott Y., 2014, 50 AIAA ASME SAE ASE, P2014; Shimizu K, 2011, J PROPUL POWER, V27, P383, DOI 10.2514/1.48553; Tani H., 2014, P COMBUST INST, V35, P2199; Teodorczyk A., 1995, J POWER TECHNOL, V79; Thomas G, 2002, SHOCK WAVES, V12, P111, DOI [10.1007/s00193-002-0148-z, 10.1007/s001930020148z]; Toro E. F., 1994, Shock Waves, V4, DOI 10.1007/BF01414629; Wamatz J., 1982, NUMERICAL METHODS LA; Wolanski P., 1972, P COMBUST INST, V14, P1217; Xu BP, 2009, J LOSS PREVENT PROC, V22, P279, DOI 10.1016/j.jlp.2008.07.007; Xu BP, 2012, INT J HYDROGEN ENERG, V37, P17571, DOI 10.1016/j.ijhydene.2012.04.150; Xu BP, 2014, INT J HYDROGEN ENERG, V39, P20503, DOI 10.1016/j.ijhydene.2014.04.141; Yamada E, 2011, INT J HYDROGEN ENERG, V36, P2560, DOI 10.1016/j.ijhydene.2010.05.011	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0950-4230	1873-3352		J LOSS PREVENT PROC	J. Loss Prev. Process Ind.	MAR	2015	34						92	99		10.1016/j.jlp.2015.01.020		8	Engineering, Chemical	Engineering	CH0WV	WOS:000353744000011		
J	Choi, K; Choi, K; Nishimura, K				Choi, Kwangseok; Choi, Kwansu; Nishimura, Koujirou			Experimental study on the influence of the nitrogen concentration in the air on the minimum ignition energies of combustible powders due to electrostatic discharges	JOURNAL OF LOSS PREVENTION IN THE PROCESS INDUSTRIES			English	Article						Electrostatic discharges; Minimum ignition energy; Inerting; Nitrogen; Dust explosions	COATING POLYMER POWDERS	As a useful method of preventing dust explosions, nitrogen (N-2), an incombustible gas, has been applied to an explosive atmosphere. This paper is a report that quantitatively determines whether the minimum ignition energy of powder depends on the nitrogen (or oxygen) concentration in the air. Hartman vertical-tube apparatus and six sample powders were used in this study. The results show that the minimum ignition energies of all of the powders used in this study increased with increased amounts of N-2 in the air. However, the effects were different in all of the sample powders. We finally suggest that the N-2 concentration of 84% (or above) prevents dust explosions due to electrostatic discharges in the industrial process with the sample powders used in this experiment. (C) 2015 Elsevier Ltd. All rights reserved.	[Choi, Kwangseok] Japan Natl Inst Occupat Safety & Hlth, Kiyose, Tokyo 2040024, Japan; [Choi, Kwansu] Konkuk Univ, Seoul 143701, South Korea; [Nishimura, Koujirou] Technol Inst Ind Safety, Sayama, Saitama 3501328, Japan	Choi, K (reprint author), Japan Natl Inst Occupat Safety & Hlth, 1-4-6 Umezono, Kiyose, Tokyo 2040024, Japan.	choiks@s.jniosh.go.jp					Ackroyd G., 2011, J PHYS C SER, V301, P1; Choi KS, 2005, JPN J APPL PHYS 2, V44, pL599, DOI 10.1143/JJAP.44.L599; [Anonymous], 1994, 124123 IEC; British Standards Institution (BSI), 2002, 13821 BS EN; Choi KS, 2006, JPN J APPL PHYS 1, V45, P5207, DOI 10.1143/JJAP.45.5207; Glor M., 1988, ELECTROSTATIC HAZARD, P69; Japanese Industrial Standards, 2002, JISZ8817; Schwenzfeuer K., 2001, 10 EFCE S LOSS PREV, P909; Yamaguma M, 2011, SCI TECHNOL ENERG MA, V72, P78	9	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0950-4230	1873-3352		J LOSS PREVENT PROC	J. Loss Prev. Process Ind.	MAR	2015	34						163	166		10.1016/j.jlp.2015.01.031		4	Engineering, Chemical	Engineering	CH0WV	WOS:000353744000017		
J	Akasaka, R; Zhou, Y; Lemmon, EW				Akasaka, Ryo; Zhou, Yong; Lemmon, Eric W.			A Fundamental Equation of State for 1,1,1,3,3-Pentafluoropropane (R-245fa)	JOURNAL OF PHYSICAL AND CHEMICAL REFERENCE DATA			English	Article						equation of state; R-245fa; thermodynamic properties	ORGANIC RANKINE-CYCLE; VAPOR-PRESSURES; ALTERNATIVE REFRIGERANTS; FLUORINATED PROPANE; BUTANE DERIVATIVES; LIQUID DENSITIES; HEAT-TRANSFER; R245FA; HFC-245FA; ORC	A new fundamental equation of state explicit in the Helmholtz energy is presented for 1,1,1,3,3-pentafluoropropane (R-245fa), based on recent experimental data for vapor pressures, densities, and sound speeds. The functional form uses Gaussian bell-shaped terms, according to recent trends in the development of accurate equations of state. The independent variables of the equation of state are temperature and density. The equation is valid for temperatures between the triple point (170.0 K) and 440 K, and for pressures up to 200 MPa. Estimated uncertainties in this range are 0.1% for vapor pressures, 0.1% for saturated liquid densities, 0.1% for liquid densities below 70 MPa, 0.2% for densities at higher pressures, 0.3% for vapor densities, 0.3% for liquid sound speeds, and 0.1% for vapor sound speeds. The uncertainties in the critical region are higher for all properties except vapor pressures. The equation shows reasonable extrapolation behavior at extremely low and high temperatures, and at high pressures. (C) 2015 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved.	[Akasaka, Ryo] Kyushu Sangyo Univ, Dept Mech Engn, Fac Engn, Higashi Ku, Fukuoka 8138503, Japan; [Zhou, Yong] Honeywell Integrated Technol China Co Ltd, Shanghai 201203, Peoples R China; [Lemmon, Eric W.] NIST, Appl Chem & Mat Div, Boulder, CO 80305 USA	Akasaka, R (reprint author), Kyushu Sangyo Univ, Dept Mech Engn, Fac Engn, Higashi Ku, 2-3-1 Matsukadai, Fukuoka 8138503, Japan.				Japan Science and Technology Agency (JST)	The authors would like to thank the Japan Science and Technology Agency (JST) for a grant that made it possible to complete this study. The authors are also grateful for the suggestions of Eiji Hihara, Shigeru Koyama, Yukihiro Higashi, Akio Miyara, Eiichi Sakaue, Katsuyuki Tanaka, Yohei Kayukawa, Yuya Kano, and Chieko Kondou.	Schmidt JW, 1996, FLUID PHASE EQUILIBR, V122, P187, DOI 10.1016/0378-3812(96)03044-0; BEYERLEIN AL, 1993, ASHRAE TRAN, V99, P368; Lemmon EW, 2009, J CHEM ENG DATA, V54, P3141, DOI 10.1021/je900217v; Wang ZW, 2004, J CHEM ENG DATA, V49, P1581, DOI 10.1021/je0342769; Defibaugh DR, 1997, J CHEM ENG DATA, V42, P160, DOI 10.1021/je960266e; Feng XJ, 2010, FLUID PHASE EQUILIBR, V290, P127, DOI 10.1016/j.fluid.2009.08.023; HWANG SH, 1992, J THERM ANAL, V38, P2515, DOI 10.1007/BF01974629; Ong CL, 2009, EXP THERM FLUID SCI, V33, P651, DOI 10.1016/j.expthermflusci.2009.01.002; Lemmon EW, 2006, J CHEM ENG DATA, V51, P785, DOI 10.1021/je050186n; Kang SH, 2012, ENERGY, V41, P514, DOI 10.1016/j.energy.2012.02.035; Boretti A, 2012, APPL THERM ENG, V36, P73, DOI 10.1016/j.applthermaleng.2011.11.060; Lujan JM, 2012, APPL THERM ENG, V40, P248, DOI 10.1016/j.applthermaleng.2012.02.020; Lemmon EW, 2005, J PHYS CHEM REF DATA, V34, P69, DOI 10.1063/1.1797813; Wei DH, 2007, ENERG CONVERS MANAGE, V48, P1113, DOI 10.1016/j.enconman.2006.10.020; Agostini B, 2008, INT J HEAT MASS TRAN, V51, P5415, DOI 10.1016/j.ijheatmasstransfer.2008.03.007; Bobbo S., 2003, P INT C REFR WASH DC; Bobbo S, 2001, FLUID PHASE EQUILIBR, V185, P255, DOI 10.1016/S0378-3812(01)00475-7; Di Nicola G, 2012, J THERM ANAL CALORIM, V108, P627, DOI 10.1007/s10973-011-1944-4; Di Nicola G, 2001, J CHEM ENG DATA, V46, P1619, DOI 10.1021/je0100387; Grebenkov A. J., 2004, ASHRAE RES PROJECT 1; Higashi Y., 2014, P 7 AS C REFR AIR CO; Kano Y., 2013, 4 IIR C THERM PROP T; Maruko K., 2013, P 2013 JSRAE ANN C T; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Pan J, 2006, J CHEM ENG DATA, V51, P186, DOI 10.1021/je0503251; Sotani T, 1999, FLUID PHASE EQUILIBR, V161, P325, DOI 10.1016/S0378-3812(99)00195-8; Span R, 1997, INT J THERMOPHYS, V18, P1415, DOI 10.1007/BF02575343; Yin JG, 2011, FLUID PHASE EQUILIBR, V307, P1, DOI 10.1016/j.fluid.2011.04.022; Zhang W, 2013, J CHEM ENG DATA, V58, P2307, DOI 10.1021/je400407z	29	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0047-2689	1529-7845		J PHYS CHEM REF DATA	J. Phys. Chem. Ref. Data	MAR	2015	44	1							013104	10.1063/1.4913493		11	Chemistry, Multidisciplinary; Chemistry, Physical; Physics, Multidisciplinary	Chemistry; Physics	CH2YB	WOS:000353890400004		
J	Itikawa, Y				Itikawa, Yukikazu			Cross Sections for Electron Collisions with Carbon Monoxide	JOURNAL OF PHYSICAL AND CHEMICAL REFERENCE DATA			English	Article						carbon monoxide; cross section; elastic scattering; electron collision; excitation; ionization; momentum transfer; recommended data; total scattering	EXTREME-ULTRAVIOLET EMISSION; DIATOMIC-MOLECULES; IMPACT EXCITATION; DISSOCIATIVE IONIZATION; ROTATIONAL-EXCITATION; ELASTIC-SCATTERING; B(3)SIGMA(+) STATE; HIGH-RESOLUTION; NEAR-THRESHOLD; ENERGY REGION	Cross section data are collected and reviewed for electron collisions with carbon monoxide. Collision processes included are total scattering, elastic scattering, momentum transfer, excitations of rotational, vibrational and electronic states, ionization, and dissociation. For each process, recommended values of the cross sections are presented, when possible. The literature has been surveyed through to the end of 2013. (C) 2015 AIP Publishing LLC.	[Itikawa, Yukikazu] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan	Itikawa, Y (reprint author), 3-16-3 Miwamidoriyama, Machida, Tokyo 1950055, Japan.	yukitikawa@nifty.com					Allan M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.042706; Zecca A, 1996, RIV NUOVO CIMENTO, V19, P1, DOI 10.1007/BF02742990; Itikawa Y, 2005, PHYS REP, V414, P1, DOI 10.1016/j.physrep.2005.04.002; Kawahara H, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.012713; LIU WH, 1994, ASTROPHYS J, V435, P909, DOI 10.1086/174872; KWAN CK, 1983, PHYS REV A, V27, P1328, DOI 10.1103/PhysRevA.27.1328; Shirai T, 2001, ATOM DATA NUCL DATA, V79, P143, DOI 10.1006/adnd.2001.0866; KARWASZ G, 1993, CHEM PHYS LETT, V211, P529, DOI 10.1016/0009-2614(93)80138-F; GOTE M, 1995, J PHYS B-AT MOL OPT, V28, P3957, DOI 10.1088/0953-4075/28/17/029; DUBOIS RD, 1976, J PHYS B-AT MOL OPT, V9, P2657, DOI 10.1088/0022-3700/9/15/016; Brunger MJ, 2002, PHYS REP, V357, P215, DOI 10.1016/S0370-1573(01)00032-1; McConkey JW, 2008, PHYS REP, V466, P1, DOI 10.1016/j.physrep.2008.05.001; RAPP D, 1965, J CHEM PHYS, V43, P1464, DOI 10.1063/1.1696957; RAPP D, 1965, J CHEM PHYS, V43, P1480, DOI 10.1063/1.1696958; Anzai K, 2012, EUR PHYS J D, V66, DOI 10.1140/epjd/e2011-20630-1; Beegle LW, 1999, ASTRON ASTROPHYS, V347, P375; BUCKMAN SJ, 1986, PHYS REV A, V34, P1561, DOI 10.1103/PhysRevA.34.1561; Campbell L, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036641; Campbell L, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016848; CHANDRA N, 1977, PHYS REV A, V16, P80, DOI 10.1103/PhysRevA.16.80; CHANTRANUPONG L, 1992, CHEM PHYS, V164, P183, DOI 10.1016/0301-0104(92)87142-V; Chung YS, 2002, J KOREAN PHYS SOC, V41, P682; CHUTJIAN A, 1980, J PHYS B-AT MOL OPT, V13, P1901, DOI 10.1088/0022-3700/13/9/019; Ciocca M, 1997, PHYS REV A, V55, P3547, DOI 10.1103/PhysRevA.55.3547; COSBY PC, 1993, J CHEM PHYS, V98, P7804, DOI 10.1063/1.464588; CRAWFORD OH, 1971, J PHYS PT B ATOM M P, V4, P494, DOI 10.1088/0022-3700/4/4/011; Elford M. T., 2003, PHOTON ELECT INTERAC, V17; Furlong JM, 1996, J PHYS B-AT MOL OPT, V29, P331, DOI 10.1088/0953-4075/29/2/020; GARCIA G, 1990, PHYS REV A, V42, P4400, DOI 10.1103/PhysRevA.42.4400; Gavin J, 2002, INT J MASS SPECTROM, V219, P351, DOI 10.1016/S1387-3806(02)00741-8; Gibson JC, 1996, J PHYS B-AT MOL OPT, V29, P3197, DOI 10.1088/0953-4075/29/14/026; HADDAD GN, 1983, AUST J PHYS, V36, P473; HAKE RD, 1967, PHYS REV, V158, P70, DOI 10.1103/PhysRev.158.70; Itikawa Y., 2007, MOL PROCESSES PLASMA; JAIN A, 1984, J PHYS B-AT MOL OPT, V17, pL29, DOI 10.1088/0022-3700/17/1/006; JAIN A, 1992, PHYS REV A, V45, P1644, DOI 10.1103/PhysRevA.45.1644; KANIK I, 1993, J GEOPHYS RES-PLANET, V98, P7447, DOI 10.1029/92JE02811; KANIK I, 1995, PHYS REV A, V51, P2067, DOI 10.1103/PhysRevA.51.2067; KANIK I, 1992, J PHYS B-AT MOL OPT, V25, P2189, DOI 10.1088/0953-4075/25/9/022; Karwasz G. P., 2003, PHOTON ELECT INTERAC, V17; Kato H, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2434169; Khristenko S. V., 1998, MOL THEIR SPECTROSCO; Kim YK, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2434163; Laporta V, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/045005; LECLAIR LR, 1994, CHEM PHYS, V189, P769, DOI 10.1016/0301-0104(94)00290-8; Mangan MA, 2000, J PHYS B-AT MOL OPT, V33, P3225, DOI 10.1088/0953-4075/33/17/305; MIDDLETON AG, 1993, J PHYS B-AT MOL OPT, V26, P1743, DOI 10.1088/0953-4075/26/11/009; Poparic G, 2001, J PHYS B-AT MOL OPT, V34, P381, DOI 10.1088/0953-4075/34/3/315; Ristic MM, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.042714; STAMATOV.A, 1970, J CHEM PHYS, V53, P2663, DOI 10.1063/1.1674387; Szmytkowski C, 1996, PHYS SCRIPTA, V54, P271, DOI 10.1088/0031-8949/54/3/006; TANAKA H, 1978, J CHEM PHYS, V69, P5329, DOI 10.1063/1.436560; Tian CC, 1998, J PHYS B-AT MOL OPT, V31, P895, DOI 10.1088/0953-4075/31/4/031; Tian CC, 1999, PHYS REV A, V59, P1955, DOI 10.1103/PhysRevA.59.1955; XING SL, 1995, PHYS REV A, V51, P414, DOI 10.1103/PhysRevA.51.414; Zetner PW, 1998, J PHYS B-AT MOL OPT, V31, P2395, DOI 10.1088/0953-4075/31/10/025; Zobel J., 1995, J PHYS B ATOM MOL PH, V28, P839; Zobel J, 1996, J PHYS B-AT MOL OPT, V29, P813, DOI 10.1088/0953-4075/29/4/021; Zubek M, 1997, J PHYS B-AT MOL OPT, V30, pL791, DOI 10.1088/0953-4075/30/22/002	59	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0047-2689	1529-7845		J PHYS CHEM REF DATA	J. Phys. Chem. Ref. Data	MAR	2015	44	1							013105	10.1063/1.4913926		17	Chemistry, Multidisciplinary; Chemistry, Physical; Physics, Multidisciplinary	Chemistry; Physics	CH2YB	WOS:000353890400005		
J	Tsunoda, K; Kitano, N; Kai, Y; Tsuji, T; Soma, Y; Jindo, T; Yoon, J; Okura, T				Tsunoda, Kenji; Kitano, Naruki; Kai, Yuko; Tsuji, Taishi; Soma, Yuki; Jindo, Takashi; Yoon, Jieun; Okura, Tomohiro			Transportation mode usage and physical, mental and social functions in older Japanese adults	JOURNAL OF TRANSPORT & HEALTH			English	Article						Going out; Physical activity; Mobility; Depression; Bicycle	LIFE-SPACE; ACTIVITY SCALE; ELDERLY PASE; ASSOCIATION; MOBILITY; DECLINE; PEOPLE; HEALTH; FALLS; TIME	Objective: The purpose of this study was to cross-sectionally examine associations between frequencies of bicycle and motor vehicle travel, physical and mental statuses and social networks. Methods: This study was conducted from 2009 to 2012 with 629 community-dwelling older adults (73.3 +/- 5.2 years old, female 53.7%) in Kasama City, Rural Japan. Travel status, physical activity scale for the elderly, Lubben social network scale and geriatric depression scale were collected via a self-administrated questionnaire. We also calculated a standardized physical function score through physical performance tests. Results: After adjusting for age, gender, education, living arrangement, body mass index and clinical history, we found a positive association between frequency of bicycle and motor vehicle travel and physical activity, social networks and mental status (Trend P < 0.05). Physical function was also significantly associated with motor vehicle travel (Trend P < 0.05). Additional analysis revealed that older adults who mainly stayed within a walking area were more likely to experience less physical activity and social networking and have diminished mental status and physical function (Trend P < 0.05). Conclusion: Extending the travel area through use of transportation modes might provide health benefits. Assessing transportation mode usage could improve screening and assistance strategies for people who are physically or mentally frail or lonely. (C) 2014 Elsevier Ltd. All rights reserved.	[Tsunoda, Kenji; Kai, Yuko] Meiji Yasuda Life Fdn Hlth & Welf, Phys Fitness Res Inst, Hachioji, Tokyo 1920001, Japan; [Kitano, Naruki; Soma, Yuki; Jindo, Takashi; Yoon, Jieun] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058574, Japan; [Kitano, Naruki; Tsuji, Taishi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028472, Japan; [Tsuji, Taishi] Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla 40014, Finland; [Okura, Tomohiro] Univ Tsukuba, Inst Hlth & Sport Sci, Tsukuba, Ibaraki 3058574, Japan	Tsunoda, K (reprint author), Meiji Yasuda Life Fdn Hlth & Welf, Phys Fitness Res Inst, 150 Tobuki, Hachioji, Tokyo 1920001, Japan.	tsunoda@my-zaidan.or.jp; s1230464@u.tsukuba.ac.jp; y-kai@my-zaidan.or.jp; tsuji.t.taishi@jyu.fi; s1330490@u.tsukuba.ac.jp; s1430522@u.tsukuba.ac.jp; s1330497@u.tsukuba.ac.jp; okura@taiiku.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22700690]	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aid for Young Scientists (B), No. 22700690, 2010-2011.	Hagiwara A, 2008, GERIATR GERONTOL INT, V8, P143, DOI 10.1111/j.1447-0594.2008.00463.x; Shumway-Cook A, 2000, PHYS THER, V80, P896; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627; Buchman AS, 2009, ARCH INTERN MED, V169, P1139, DOI 10.1001/archinternmed.2009.135; Fujita K, 2006, J EPIDEMIOL, V16, P261, DOI 10.2188/jea.16.261; Shimada H, 2010, ARCH GERONTOL GERIAT, V50, P140, DOI 10.1016/j.archger.2009.02.015; Tsunoda K, 2012, PREV MED, V55, P113, DOI 10.1016/j.ypmed.2012.05.013; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; Crowe M, 2008, J GERONTOL A-BIOL, V63, P1241; Boyle PA, 2010, J AM GERIATR SOC, V58, P1925, DOI 10.1111/j.1532-5415.2010.03058.x; Cabinet Office Government of Japan, 2010, ANN REP AG SOC; Fujita K, 2004, JAPANESE J PUBLIC HL, V51, P168; Gilmour H, 2012, HEALTH REP, V23, P23; Ishikawa H., 1996, THEOLOGIA DIAKONIA, V30, P115; Lubben J. E., 1988, FAM COMMUNITY HEALTH, V11, P42; Ministry of Health Labour and Welfare (MHLW), 2012, PREV MAN LONG TERM C; Satariano WA, 2012, AM J PUBLIC HEALTH, V102, P1508, DOI 10.2105/AJPH.2011.300631; Shinkai S., 2005, JPN J PUBLIC HLTH, V52, P443; Tanaka C, 2006, JPN J PUBL HLTH, V53, P671; Tsunoda K, 2013, GERIATR GERONTOL INT, V13, P919, DOI 10.1111/ggi.12032; Yatomi N., 1994, RONEN SHAKAI KAGAKU, V16, P29; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165	23	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2214-1405			J TRANSP HEALTH	J. Transp. Health	MAR	2015	2	1			SI		44	49		10.1016/j.jth.2014.10.003		6	Public, Environmental & Occupational Health; Transportation	Public, Environmental & Occupational Health; Transportation	CH2IN	WOS:000353849000007		
J	Egawa, Y; Mizuhata, Y; Sasamori, T; Tokitoh, N				Egawa, Yasunobu; Mizuhata, Yoshiyuki; Sasamori, Takahiro; Tokitoh, Norihiro			Unexpected photochemical reactions of 2-aryl-2-ethynyltrisilane derivative	MAIN GROUP METAL CHEMISTRY			English	Article						photolysis; silylene; trisilane	SI DOUBLE-BONDS; DISILENES; ORGANOPOLYSILANES; SYSTEM	The synthesis of cyclic disilene 10 was attempted by photolysis of 2-alkynyltrisilane 9. As a result, silylsilylene 14 was generated, along with the elimination of the alkynylsilane moiety, in the photolysis of 2-alkynyltrisilane 9, similar to the photolysis of alkynyldisilane. In addition, the product 14 trapped by triethylsilane underwent further photolysis to produce hydrosilylene 16.	[Egawa, Yasunobu; Mizuhata, Yoshiyuki; Sasamori, Takahiro; Tokitoh, Norihiro] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Tokitoh, N (reprint author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.	tokitoh@boc.kuicr.kyoto-u.ac.jp	Sasamori, Takahiro/C-4963-2009; Mizuhata, Yoshiyuki/P-8489-2015	Sasamori, Takahiro/0000-0001-5410-8488; Mizuhata, Yoshiyuki/0000-0001-5301-0024	Ministry of Education, Culture, Sports, Science and Technology of Japan [24109013, 23108707, 22350017, 25288021, 26410044, 21750042, B09]	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (Nos. 24109013, 23108707), Scientific Research (B) (Nos. 22350017, 25288021), Scientific Research (C) (No. 26410044), Young Scientist (B) (No. 21750042), Global COE Program (B09, 'Integrated Materials Science'), and Excellent Graduate Schools from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abe T, 2010, J AM CHEM SOC, V132, P5008, DOI 10.1021/ja101654b; Agou T, 2012, J AM CHEM SOC, V134, P4120, DOI 10.1021/ja300694p; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343; Fukazawa A, 2007, J AM CHEM SOC, V129, P14164, DOI 10.1021/ja0764207; Iwamoto T, 2009, J AM CHEM SOC, V131, P3156, DOI 10.1021/ja8093313; ISHIKAWA M, 1980, J ORGANOMET CHEM, V194, P147, DOI 10.1016/S0022-328X(00)86663-2; [Anonymous], 1981, ADV ORGANOMETALLIC C, DOI 10.1016/S0065-3055(08)60363-9; Kinjo R, 2007, J AM CHEM SOC, V129, P7766, DOI 10.1021/ja072759h; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Sato T, 2010, CHEM COMMUN, V46, P4402, DOI 10.1039/c0cc00406e; Kira M, 2006, ADV ORGANOMET CHEM, V54, P73, DOI 10.1016/S0065-3055(05)54003-6; Bejan I, 2007, ANGEW CHEM INT EDIT, V46, P5783, DOI 10.1002/anie.200701744; APELOIG Y, 1994, J AM CHEM SOC, V116, P9719, DOI 10.1021/ja00100a042; ARCHIBALD RS, 1992, ORGANOMETALLICS, V11, P3276, DOI 10.1021/om00046a026; CAVELIERFRONTIN F, 1991, TETRAHEDRON, V47, P9807, DOI 10.1016/S0040-4020(01)80720-1; HONG SK, 1994, B KOR CHEM SOC, V15, P68; Lee V. Y., 2010, ORGANOMETALLIC COMPO; Mizuhata Y, 2015, HETEROCYCLES, V90, P1111, DOI 10.3987/COM-14-S(K)81; Okazaki R., 1996, ADV ORGANOMET CHEM, V39, P231, DOI DOI 10.1016/S0065-3055(08)60469-4; Sakurai H, 2002, CHEM LETT, P22, DOI 10.1246/cl.2002.22; Sasamori T, 2007, CHEM LETT, V36, P588, DOI 10.1246/cl.2007.588; Sasamori T, 2008, ORGANOMETALLICS, V27, P3325, DOI 10.1021/om8003543; Tanaka R, 2006, ANGEW CHEM INT EDIT, V45, P6371, DOI 10.1002/anie.200602214	23	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0792-1241	2191-0219		MAIN GROUP MET CHEM	Main Group Met. Chem.	MAR	2015	38	1-2					51	55		10.1515/mgmc-2014-0042		5	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CH1XA	WOS:000353814800008		
J	Enomoto, M				Enomoto, Mitsuhiro			The future of bone marrow stromal cell transplantation for the treatment of spinal cord injury	NEURAL REGENERATION RESEARCH			English	Article							CLINICAL-TRIAL		[Enomoto, Mitsuhiro] Tokyo Med & Dent Univ, Grad Sch, Dept Orthopaed & Spinal Surg, Tokyo 1138519, Japan; [Enomoto, Mitsuhiro] Tokyo Med & Dent Univ, Hyperbar Med Ctr, Bunkyo Ku, Tokyo 1138519, Japan	Enomoto, M (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Orthopaed & Spinal Surg, 1-5-45 Yushima Bunkyo, Tokyo 1138519, Japan.	enomorth@tmd.ac.jp			Ministry of Health, Labour and Welfare; Japan Society for the Promotion of Science; General Insurance Association of Japan	This work is supported in part by the Ministry of Health, Labour and Welfare Sciences Research Grant, a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science and a Grant-in-Aid from the General Insurance Association of Japan.	Spiess MR, 2009, J NEUROTRAUM, V26, P2027, DOI 10.1089/neu.2008-0760; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Fukushima Kazuyuki, 2008, J Med Dent Sci, V55, P71; Widenfalk J, 2001, J NEUROSCI, V21, P3457; Jiang PC, 2013, EXP THER MED, V6, P140, DOI 10.3892/etm.2013.1083; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807; Ide C, 2010, BRAIN RES, V1332, P32, DOI 10.1016/j.brainres.2010.03.043; Suzuki Y, 2014, RESTOR NEUROL NEUROS, V32, P473, DOI 10.3233/RNN-130363; Ukegawa M, 2014, CELL TRANSPLANT; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570	12	0	0	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	MAR	2015	10	3					383	384		10.4103/1673-5374.153684		2	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	CH0VH	WOS:000353740000016		
J	Posoongnoen, S; Ubonbal, R; Thammasirirak, S; Daduang, J; Minami, H; Yamamoto, K; Daduang, S				Posoongnoen, Saijai; Ubonbal, Raksmont; Thammasirirak, Sompong; Daduang, Jureerut; Minami, Hiromichi; Yamamoto, Kenji; Daduang, Sakda			alpha-Amylase from Mon Thong durian (Durio zibethinus Murr. cv. Mon Thong)-nucleotide sequence analysis, cloning and expression	PLANT BIOTECHNOLOGY			English	Article						alpha-Amylase; Mon Thong durian; structural characterization; expression; amylase activity	CONSERVED DOMAIN DATABASE; SWISS-MODEL; ARABIDOPSIS-THALIANA; MOLECULAR-STRUCTURE; SUBSTRATE-BINDING; STARCH BINDING; CLEAVAGE SITES; SUGAR TONGS; PURIFICATION; METABOLISM	Amylase is hypothesized to involve in the initiation of intracellular starch granule digestion in the plastids of ripening durians. A putative alpha-amylase from Mon Thong durian (Durio zibethinus Murr. cv. Mon Thong; DzAmy3) was successfully isolated and its gene contain a 2,679 base pair open reading frame, which encodes 892 amino acids with a calculated molecular mass of 93.7 kDa and an isoelectric point of 5.77. The DzAmy3 contains starch binding domain with a putative plastid transit peptide and alpha-amylase like domain. Phylogenetic tree analysis proved it into the family three of plant alpha-amylases. The predicted structural model proposed a catalytic triad (Asp611, Glu636 and Asp719) for general acid/base hydrolysis. Recombinant DzAmy3 (rDzAmy3) was successfully expressed in Escherichia coli. rDzAmy3 hydrolyzed starch and ethylidene-pNP-G7 which confirms the authenticity of DzAmy3 gene and functional alpha-amylase. The rDzAmy3 had an optimum activity at pH 8.0 and 30 degrees C. It was stable in the pH range of 7-8 at 37 degrees C, temperature range of 5-20 degrees C and in the presence of 1% (v/v) Tween 20 and Triton X-100. Substrate specificity analysis revealed that rDzAmy3 was active toward beta-limit dextrin, starch, amylopectin, amylose and glycogen.	[Posoongnoen, Saijai; Ubonbal, Raksmont; Thammasirirak, Sompong; Daduang, Sakda] Khon Kaen Univ, Fac Sci, Dept Biochem, Prot & Prote Res Ctr Commercial & Ind Purposes Pr, Khon Kaen 40002, Thailand; [Daduang, Jureerut] Khon Kaen Univ, Fac Assoc Med Sci, Dept Clin Chem, Khon Kaen 40002, Thailand; [Minami, Hiromichi; Yamamoto, Kenji] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan	Posoongnoen, S (reprint author), Khon Kaen Univ, Fac Sci, Dept Biochem, Prot & Prote Res Ctr Commercial & Ind Purposes Pr, Khon Kaen 40002, Thailand.	sakdad@kku.ac.th			Human Resource Development in Science Project (Science Achievement Scholarship of Thailand, SAST); Khon Kaen University Research Fund; Nakhon Ratchasima Rajabhat University; Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, Japan	This research was supported by Human Resource Development in Science Project (Science Achievement Scholarship of Thailand, SAST). We would also like to thank the Khon Kaen University Research Fund, fiscal year 2009, and Nakhon Ratchasima Rajabhat University for their supports. We also acknowledge Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, Japan for supporting.	Añabesa M. S., 2006, Philippine Journal of Crop Science, V31, P29; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Yu TS, 2005, J BIOL CHEM, V280, P9773, DOI [10.1074/jbc.M413638200, 10.1074/jbc.M413865200]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Kumari A, 2010, PHYTOCHEMISTRY, V71, P1657, DOI 10.1016/j.phytochem.2010.06.012; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; KADZIOLA A, 1994, J MOL BIOL, V239, P104, DOI 10.1006/jmbi.1994.1354; Aiyer PV, 2005, AFR J BIOTECHNOL, V4, P1525; SOGAARD M, 1993, J BIOL CHEM, V268, P22480; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; Ho LH, 2015, FOOD CHEM, V168, P80, DOI 10.1016/j.foodchem.2014.07.020; Stanley D, 2005, BIOLOGIA, V60, P65; Glaring MA, 2011, FEBS J, V278, P1175, DOI 10.1111/j.1742-4658.2011.08043.x; Tripathi P, 2007, PHYTOCHEMISTRY, V68, P1623, DOI 10.1016/j.phytochem.2007.04.006; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Emanuelsson O, 1999, PROTEIN SCI, V8, P978; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Hamilton LM, 2000, ENZYME MICROB TECH, V26, P561, DOI 10.1016/S0141-0229(00)00141-1; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Lu MS, 2010, PROTEIN J, V29, P591, DOI 10.1007/s10930-010-9290-0; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Robert X, 2003, STRUCTURE, V11, P973, DOI 10.1016/S0969-2126(03)00151-5; Seung D, 2013, J BIOL CHEM, V288, P33620, DOI 10.1074/jbc.M113.514794; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Anwised P, 2013, PROTEIN J, V32, P172, DOI 10.1007/s10930-013-9474-5; Bai-Ngew S, 2014, INT J FOOD SCI TECH, V49, P230, DOI 10.1111/ijfs.12303; Ben Elarbi M, 2009, CR BIOL, V332, P426, DOI 10.1016/j.crvi.2009.01.002; Bozonnet S, 2007, FEBS J, V274, P5055, DOI 10.1111/j.1742-4658.2007.06024.x; Brena BM, 1996, J CHROMATOGR B, V684, P217, DOI 10.1016/0378-4347(96)00103-X; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kadziola A, 1998, J MOL BIOL, V278, P205, DOI 10.1006/jmbi.1998.1683; Kanwal B, 2004, INT J AGRIC BIOL, V6, P233; Ketsa S, 1998, J HORTIC SCI BIOTECH, V73, P575; Kuddus M, 2012, AFR J MICROBIOL RES, V6, P206, DOI 10.5897/AJMRX11.036; Lee CC, 2001, J PROTEIN CHEM, V20, P233, DOI 10.1023/A:1010904109747; Mikkelsen R, 2006, BIOCHEMISTRY-US, V45, P4674, DOI 10.1021/bi051712a; Mori H, 2002, EUR J BIOCHEM, V269, P5377, DOI 10.1046/j.1432-1033.2002.03185.x; Noman ASM, 2006, FOOD CHEM, V99, P444, DOI 10.1016/j.foodchem.2005.07.056; Peroni FHG, 2008, J AGR FOOD CHEM, V56, P7416, DOI 10.1021/jf800469w; Robert X, 2005, J BIOL CHEM, V280, P32968, DOI 10.1074/jbc.M505515200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Seymour G. B., 1993, BIOCH FRUIT RIPENING; Souza P, 2010, BRAZ J MICROBIOL, V41, P850, DOI DOI 10.1590/S1517-83822010000400004; Stanley D, 2002, BIOLOGIA, V57, P137; Subhadrabandhu S, 2001, DURIAN KING TROPICAL	48	0	0	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					1	10		10.5511/plantbiotechnology.14.1122a		10	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700001		
J	Reyes, TH; Maekawa, S; Sato, T; Yamaguchi, J				Reyes, Thais Huarancca; Maekawa, Shugo; Sato, Takeo; Yamaguchi, Junji			The Arabidopsis ubiquitin ligase ATL31 is transcriptionally controlled by WRKY33 transcription factor in response to pathogen attack	PLANT BIOTECHNOLOGY			English	Article						Defense response; PAMPs; WRKY transcription factor; ubiquitin ligase	PLANT DEFENSE RESPONSES; GENE-EXPRESSION; 14-3-3 PROTEINS; REGULATOR; PHOSPHORYLATION; ACTIVATION; RESISTANCE; ELEMENTS; BALANCE; TARGET	ATL31, an Arabidopsis RING-type ubiquitin ligase, plays a critical role in plant carbon/nitrogen (C/N)-nutrient responses during post-germinative growth and in defense responses to pathogen attack. ATL31 expression under these stress conditions suggested the presence of transcriptional regulators mediated by these stress signals. We recently reported that the expression pattern of WRKY33, a transcription factor involved in plant defense responses, is highly correlated with that of ATL31. In this study, we investigated the detailed relationship between the ATL31 gene and WRKY33. Using transient reporter analysis, we found that WRKY33 could significantly activate ATL31 transcription in plant cells. Transcript analysis of stable transgenic Arabidopsis plants overexpressing WRKY33 confirmed that the expression of ATL31 in response to the PAMPs flg22 and chitin was enhanced compared with wild-type plants, while expression was repressed in wrky33 mutants. Further detailed transient reporter analysis revealed that transactivation by WRKY33 is required and mediated through a specific W-box cis-acting element in the promoter region of the ATL31 gene. In contrast, WRKY33 did not regulate ATL31 expression during the C/N response. Taken together, these results demonstrate that WRKY33 acts as a transcription factor of ATL31 and positively regulates its expression during activation of plant defense responses.	[Reyes, Thais Huarancca] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan	Reyes, TH (reprint author), Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan.	jjyama@sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan;  [2511250104];  [2629218884];  [2666004604]	This work was supported by Grants-in-Aid for Scientific Research Nos. 2511250104, 2629218884 and 2666004604 to JY. THR was supported by a Scholarship from the Ministry of Education, Culture, Sports, Science and Technology of Japan (2014-2015).	Aguilar-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023934; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Sato T, 2009, PLANT J, V60, P852, DOI 10.1111/j.1365-313X.2009.04006.x; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Yamasaki K, 2013, TRENDS PLANT SCI, V18, P267, DOI 10.1016/j.tplants.2012.09.001; Aoyama S, 2014, PLANT CELL PHYSIOL, V55, P293, DOI 10.1093/pcp/pcu002; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; AXELOS M, 1992, PLANT PHYSIOL BIOCH, V30, P123; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; JEFFERSON RA, 1987, EMBO J, V6, P3901; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; Yasuda S, 2014, J BIOL CHEM, V289, P15179, DOI 10.1074/jbc.M113.533133; Buscaill P, 2014, CURR OPIN PLANT BIOL, V20, P35, DOI 10.1016/j.pbi.2014.04.004; Baccelli I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100959; Bakshi M, 2014, PLANT SIGNAL BEHAV, V9, DOI [10.4161/psb.27700, DOI 10.4161/PSB.27700]; Guzmán Plinio, 2012, Plant Signal Behav, V7, P1014, DOI 10.4161/psb.20851; Koiwai H, 2007, PLANT J, V51, P92, DOI 10.1111/j.1365-313X.2007.03120.x; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Lippok B, 2007, MOL PLANT MICROBE IN, V20, P420, DOI 10.1094/MPMI-20-4-0420; Maekawa S, 2012, PLANT MOL BIOL, V79, P217, DOI 10.1007/s11103-012-9907-0; Maekawa S, 2014, PLANT PHYSIOL, V164, P879, DOI 10.1104/pp.113.230995; Sato T, 2011, PLANT J, V68, P137, DOI 10.1111/j.1365-313X.2011.04673.x	35	0	0	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					11	+		10.5511/plantbiotechnology.14.1201b		12	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700002		
J	Nakaba, S; Takata, N; Yoshida, M; Funada, R				Nakaba, Satoshi; Takata, Naoki; Yoshida, Makoto; Funada, Ryo			Continuous expression of genes for xylem cysteine peptidases in long-lived ray parenchyma cells in Populus	PLANT BIOTECHNOLOGY			English	Article						Cell death; cysteine protease; heartwood formation; Populus; ray parenchyma	SECONDARY WALL SYNTHESIS; TRANSCRIPTION FACTORS; VESSEL FORMATION; TRANSITION ZONE; DEATH; ARABIDOPSIS; DIFFERENTIATION; SND1; FIBERS; TRICHOCARPA	XYLEM CYSTEINE PEPTIDASE 1 (XCP1) and XCP2 are key autolytic enzymes in programmed cell death of short-lived tracheary elements in plants. However, the patterns of expression of XCP genes remain to be clarified in long-lived ray parenchyma cells, which survive for several years after the completion of secondary wall formation. We isolated full-length cDNAs that encoded three XCPs (PsgXCP1, PsgXCP2A and PsgXCP2B) of Populus. The deduced amino acid sequences of the XCPs revealed three conserved catalytic residues, namely, cysteine (Cys), histidine (His) and asparagine (Asn), indicating that PsgXCP1, PsgXCP2A and PsgXCP2B might function as papain-like cysteine proteases. Ray parenchyma cells in hybrid poplar remained alive for several years, with continuous expression of XCP genes even after obvious secondary wall thickenings. Levels of expression of XCP genes were lower in the innermost annual ring of sapwood than in one and/or two outer annual rings from beyond the innermost sapwood. This result implies that autolysis of ray parenchyma cells might not be fully explained by dramatically enhanced expression of XCP genes just before their programmed death. In addition, the expression of PtaSND1-A1, PtaVND6-A1 and PtaMYB003 genes was detected in all annual ring in sapwood. Our observations suggest that the expression of genes associated with xylem differentiation such as secondary wall formation and cell death continues for several years in long-lived ray parenchyma cells before their death.	[Nakaba, Satoshi; Yoshida, Makoto; Funada, Ryo] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 1838509, Japan; [Takata, Naoki] Forestry & Forest Prod Res Inst, Forest Biores Ctr, Hitachi, Ibaraki 3191301, Japan; [Funada, Ryo] Kyung Hee Univ, Coll Life Sci, Yongin 446701, South Korea	Nakaba, S (reprint author), Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 1838509, Japan.	nakaba@cc.tuat.ac.jp	Funada, Ryo/C-2020-2013; Nakaba, Satoshi/C-3482-2013		Japan Society for the Promotion of Science [23380105, 24380090, 24880016, 25850121, 25850124]; Nisshin Sugar Manufacturing Co., Ltd.	This work was supported, in part, by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (nos. 23380105, 24380090, 24880016, 25850121 and 25850124) and by Scholarship and Education Funds from Nisshin Sugar Manufacturing Co., Ltd. The authors thank Dr. Keita Arakawa (Department of Forest Science, Hokkaido University) for providing plant materials. The authors also thank Dr. Yuzou Sano, Mr. Yoshihisa Sasaki, Mr. Shingo Suzuki (Department of Forest Science, Hokkaido University) and the staff of the Sapporo Experimental Nursery of Hokkaido University for support related to the collection of samples.	Yamaguchi M, 2011, PLANT J, V66, P579, DOI [10.1111/j.1365-313X.2011.04514.x, 10.1111/j.1365-313x.2011.04514.x]; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Escamez S, 2014, J EXP BOT, V65, P1313, DOI 10.1093/jxb/eru057; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; Yang JM, 2004, TREE PHYSIOL, V24, P461; Spicer Rachel, 2005, P457, DOI 10.1016/B978-012088457-5/50024-1; Fukuda H, 1997, PLANT CELL, V9, P1147, DOI 10.1105/tpc.9.7.1147; Taylor AM, 2002, WOOD FIBER SCI, V34, P587; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Li QZ, 2012, P NATL ACAD SCI USA, V109, P14699, DOI 10.1073/pnas.1212977109; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Bollhoner B, 2012, J EXP BOT, V63, P1081, DOI 10.1093/jxb/err438; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bamber RK, 1985, ABSTR, V46, P567; BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY; Courtois-Moreau CL, 2009, PLANT J, V58, P260, DOI 10.1111/j.1365-313X.2008.03777.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Hillis W. E., 1987, HEARTWOOD TREE EXUDA; Huang ZL, 2009, PLANT CELL REP, V28, P1717, DOI 10.1007/s00299-009-0771-6; IAWA (Committee on Nomenclature International Association of Wood Anatomists), 1964, MULT GLOSS TERMS US; Magel E., 2000, MOL CELL BIOL WOOD F, P363; Nakaba S, 2006, PLANT CELL REP, V25, P1143, DOI 10.1007/s00299-006-0194-6; Nakaba S, 2008, TREES-STRUCT FUNCT, V22, P623, DOI 10.1007/s00468-008-0220-0; Nakaba S, 2012, TREES-STRUCT FUNCT, V26, P743, DOI 10.1007/s00468-011-0640-0; Petzold HE, 2012, PHYSIOL PLANTARUM, V145, P121, DOI 10.1111/j.1399-3054.2011.01538.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Takata N, 2009, NEW PHYTOL, V181, P808, DOI 10.1111/j.1469-8137.2008.02714.x; Yoshida K, 2012, J WOOD SCI, V58, P89, DOI 10.1007/s10086-011-1234-6; Zhong RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069219	35	0	0	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					21	+		10.5511/plantbiotechnology.14.1208a		11	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700003		
J	Yamazaki, H; Suzui, N; Yin, YG; Kawachi, N; Ishii, S; Shimada, H; Fujimaki, S				Yamazaki, Haruaki; Suzui, Nobuo; Yin, Yong-Gen; Kawachi, Naoki; Ishii, Satomi; Shimada, Hiroaki; Fujimaki, Shu			Live-imaging evaluation of the efficacy of elevated CO2 concentration in a closed cultivation system for the improvement of bioproduction in tomato fruits	PLANT BIOTECHNOLOGY			English	Article						CO2 elevation; live-imaging; PETIS; tomato; translocation	PLANT; ACCUMULATION; TRANSPORT; SALINITY; TRACER	To maximize fruit yield of tomatoes cultivated in a controlled, closed system such as a greenhouse or a plant factory at a limited cost, it is important to raise the translocation rate of fixed carbon to fruits by tuning the cultivation conditions. Elevation of atmospheric CO2 concentration is a good candidate; however, it is technically difficult to evaluate the effect on fruit growth by comparing different individuals in different CO2 conditions because of large inter-individual variations. In this study, we employed a positron-emitting tracer imaging system (PETIS), which is a live-imaging technology for plant studies, and a short-lived radioisotope C-11 to quantitatively analyze immediate responses of carbon fixation and translocation in tomatoes in elevated CO2 conditions. We also developed a closed cultivation system to feed a test plant with CO2 at concentrations of 400, 1,500 and 3,000 ppm and a pulse of (CO2)-C-11. As a result, we obtained serial images of C-11 fixation by leaves and subsequent translocation into fruits. Carbon fixation was enhanced steadily by increasing the CO2 concentration, but the amount translocated into fruits saturated at 1,500 ppm on average. The translocation rate had larger inter-individual variation and showed less consistent responses to external CO2 conditions compared with carbon fixation. Our experimental system was demonstrated to be a valuable tool for the optimization of closed cultivation systems because it can trace the responses of carbon translocation in each individual, which are otherwise usually masked by inter-individual variation.	[Yamazaki, Haruaki; Shimada, Hiroaki] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 1258585, Japan; [Yamazaki, Haruaki; Suzui, Nobuo; Yin, Yong-Gen; Kawachi, Naoki; Ishii, Satomi; Fujimaki, Shu] Japan Atom Energy Agcy, Radiotracer Imaging Grp, Med & Biotechnol Applicat Unit, Quantum Beam Sci Ctr, Takasaki, Gumma 3701292, Japan	Yamazaki, H (reprint author), Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 1258585, Japan.	fujimaki.shu@jaea.go.jp	Suzui, Nobuo/C-5855-2013	Suzui, Nobuo/0000-0003-1081-7578	JSPS [23380155]	This study was partly supported by JSPS Grant-in-Aid for Scientific Research (B) No. 23380155. The tomato plants used in this research were provided by the National BioResource Project (NBRP), MEXT, JAPAN. We thank Mr H. Suto (Tokyo Nuclear Service Co., Ltd.) and Mr K. Imai (Beam Operation Co., Ltd.) for assistance in irradiation for <SUP>11</SUP>CO<INF>2</INF> production. We also thank Mr M. Oshida (Chiba Prefectural Agriculture and Forestry Research Center) for providing valuable advice on the CO<INF>2</INF> conditions.	Matsuhashi S, 2005, SOIL SCI PLANT NUTR, V51, P417, DOI 10.1111/j.1747-0765.2005.tb00047.x; Minchin PEH, 1996, J EXP BOT, V47, P1293, DOI 10.1093/jxb/47.Special_Issue.1293; Duan Z, 2014, PLANT CELL PHYSIOL, V55, P358, DOI 10.1093/pcp/pcu004; Suwa R, 2008, PLANT SCI, V175, P210, DOI 10.1016/j.plantsci.2008.03.022; Minchin PEH, 2005, NEW PHYTOL, V166, P771, DOI 10.1111/j.1469-8137.2005.01323.x; Makino A, 1999, PLANT CELL PHYSIOL, V40, P999; Fujimaki S, 2010, PLANT PHYSIOL, V152, P1796, DOI 10.1104/pp.109.151035; Yin YG, 2010, J EXP BOT, V61, P563, DOI 10.1093/jxb/erp333; Uchida H, 2004, NUCL INSTRUM METH A, V516, P564, DOI 10.1016/j.nima.2003.08.165; Fujimaki S, 2010, NITROGEN ASSIMILATIO, P119; Kato Kazuhisa, 2011, Plant Signal Behav, V6, P1172, DOI 10.4161/psb.6.8.16373; Kawachi N, 2011, NUCL INSTRUM METH A, V648, pS317, DOI 10.1016/j.nima.2010.10.152; Scott J.W., 1989, FLORIDA AGR EXPT STA, P1; TRIPP KE, 1991, PLANT PHYSIOL, V96, P713, DOI 10.1104/pp.96.3.713	14	0	0	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					31	+		10.5511/plantbiotechnology.14.1210a		8	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700004		
J	Lakshmanan, M; Yoshizumi, T; Sudesh, K; Kodama, Y; Numata, K				Lakshmanan, Manoj; Yoshizumi, Takeshi; Sudesh, Kumar; Kodama, Yutaka; Numata, Keiji			Double-stranded DNA introduction into intact plants using peptide-DNA complexes	PLANT BIOTECHNOLOGY			English	Article						Double-stranded DNA; gene carrier peptide; gene delivery	GENE DELIVERY; PLASMID DNA; CARRIERS; CELLS; TRANSFORMATION; TRANSFECTION; ADSORPTION; BACTERIA; DSRNA	Introducing exogenous genes into plant cells is an essential technique in many fields in plant science and biotechnology. Despite their huge advantages, disadvantages of current transfection methods include the requirement of expensive equipment, risk of gene damage, low transformation efficiency, transgene size limitations, and limitations of applicable plant types. Recently developed peptide-based gene carriers can deliver plasmid and double-stranded RNA. However, the delivery of double-stranded DNA (dsDNA), specifically PCR products, has not been studied. As dsDNA is handled in several plant science labs, peptide-based gene carriers are expected to be applicable to dsDNA in addition to plasmid DNA and double-stranded RNA. Here, we demonstrate dsDNA introduction into intact Nicotiana benthamiana leaves by using an ionic complex of a fusion peptide comprising (KH)(9) and Bp100 with dsDNA encoding Renilla luciferase as a reporter gene. The buffer condition for the complex preparation and infiltration significantly affected the transfection efficiency; this is because the structure of the complex in various protonated conditions contributed to the transfection efficiency. Structures of the complex and peptide are key factors for improving the peptide-based gene delivery system for plants.	[Lakshmanan, Manoj; Numata, Keiji] RIKEN, Ctr Sustainable Resource Sci, Biomass Engn Program, Cooperat Div,Enzyme Res Team, Wako, Saitama 3510198, Japan; [Lakshmanan, Manoj; Sudesh, Kumar] Univ Sains Malaysia, Sch Biol Sci, Ecobiomat Res Lab, Minden 11800, Penang, Malaysia; [Yoshizumi, Takeshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan; [Kodama, Yutaka] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi 3218505, Japan	Lakshmanan, M (reprint author), RIKEN, Ctr Sustainable Resource Sci, Biomass Engn Program, Cooperat Div,Enzyme Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	keiji.numata@riken.jp	Numata, Keiji/H-9751-2012; 	Sudesh, Kumar/0000-0003-4756-9192	New Energy and Industrial Technology Development Organization, Japan	N. received funding from the New Energy and Industrial Technology Development Organization, Japan. The authors have no conflict of interest to declare.	Numata K, 2012, MACROMOL BIOSCI, V12, P75, DOI 10.1002/mabi.201100274; Broothaerts W, 2005, NATURE, V433, P629, DOI 10.1038/nature03309; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161; Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Numata K, 2010, J CONTROL RELEASE, V146, P136, DOI 10.1016/j.jconrel.2010.05.006; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Osada K, 2010, J AM CHEM SOC, V132, P12343, DOI 10.1021/ja102739b; Numata K, 2006, MACROMOL BIOSCI, V6, P41, DOI 10.1002/mabi.200500160; Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028; Guo FQ, 2005, PLANT CELL, V17, P3436, DOI 10.1105/tpc.105.037770; Chen CP, 2007, FEBS LETT, V581, P1891, DOI 10.1016/j.febslet.2007.03.076; Chen QR, 2000, GENE THER, V7, P1698, DOI 10.1038/sj.gt.3301294; Chilton MD, 2005, NAT BIOTECHNOL, V23, P309, DOI 10.1038/nbt0305-309; Chugh A, 2008, FEBS J, V275, P2403, DOI 10.1111/j.1742-4658.2008.06384.x; Galbraith DW, 2007, NAT NANOTECHNOL, V2, P272, DOI 10.1038/nnano.2007.118; Lakshmanan M, 2013, BIOMACROMOLECULES, V14, P10, DOI 10.1021/bm301275g; MIRANDA A, 1992, J BACTERIOL, V174, P2288; Numata K, 2010, BIOMACROMOLECULES, V11, P3189, DOI 10.1021/bm101055m; Numata K, 2011, BIOCONJUGATE CHEM, V22, P1605, DOI 10.1021/bc200170u; Numata K, 2005, BIOMACROMOLECULES, V6, P2008, DOI 10.1021/bm0501151; Numata K, 2007, BIOMACROMOLECULES, V8, P2276, DOI 10.1021/bm070231z; Numata K, 2014, PLANT BIOTECHNOL J, V12, P1027, DOI 10.1111/pbi.12208; Unnamalai N, 2004, FEBS LETT, V566, P307, DOI 10.1016/j.febslet.2004.04.018	24	1	1	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					39	45		10.5511/plantbiotechnology.14.1210b		7	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700005		
J	Honma, Y; Yamakawa, T				Honma, Youhei; Yamakawa, Takashi			High-level expression of sucrose inducible sweet potato sporamin gene promoter: beta-glucuronidase fusion gene in transgenic Nicotiana plumbaginifolia	PLANT BIOTECHNOLOGY			English	Article						GUS; sporamin promoter; sucrose inducible promoter; Nicotiana plumbaginifolia	TOXIN B-SUBUNIT; ROOT STORAGE PROTEIN; HUMAN SERUM-ALBUMIN; AGROBACTERIUM-TUMEFACIENS; REGULATORY ELEMENTS; TOBACCO PLANTS; TRANSFORMATION; ACCUMULATION; TOLERANCE; MARKER	We produced transgenic Nicotiana plumbaginifolia plants which contained Spo(min) (sporamin minimal promoter)-GUS fused chimeric gene constructs with 5 types of signal sequences, such as cytosol, apoplast, ER, vacuole and plastid, and analyzed the GUS expression patterns after sucrose treatment. Spo(min) induced extremely high GUS activities after 6% and 10% sucrose treatment, especially in leaves. The high GUS activities were observed in leaves of the Spo(min)-ER-GUS construct treated with 6% or 10% sucrose. These were over 200 times higher than those in leaves with the 35S promoter-ER-GUS construct. The 10% sucrose treatment significantly altered GUS activities in all Spo(min) and 35S promoter constructs compared with those in the 6% sucrose treatment; some increased and some decreased. GUS activities in 2 months old plants were almost the same as 8 months old plants, indicating that GUS expression driven by Spo(min) was stably maintained. Also, even when sucrose treatment was stopped, GUS gene expression by Spo(min) continued for 10 days.	[Honma, Youhei; Yamakawa, Takashi] Univ Tokyo, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan	Honma, Y (reprint author), Univ Tokyo, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan.	ayama@mail.ecc.u-tokyo.ac.jp					FRALEY RT, 1983, P NATL ACAD SCI-BIOL, V80, P4803, DOI 10.1073/pnas.80.15.4803; Streatfield SJ, 2003, VACCINE, V21, P812, DOI 10.1016/S0264-410X(02)00605-9; Lee SK, 2007, PLANT MOL BIOL, V65, P531, DOI 10.1007/s11103-007-9153-z; MAESHIMA M, 1985, PHYTOCHEMISTRY, V24, P1899, DOI 10.1016/S0031-9422(00)83088-5; Benchabane M, 2008, PLANT BIOTECHNOL J, V6, P633, DOI 10.1111/j.1467-7652.2008.00344.x; Yang JJ, 2005, TRANSGENIC RES, V14, P313, DOI 10.1007/s11248-005-0272-5; Ku S, 2011, J KOREAN SOC APPL BI, V54, P275, DOI 10.3839/jksabc.2011.043; KIM DH, 1995, BIOL PHARM BULL, V18, P1184; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; LLOYD AM, 1986, SCIENCE, V234, P464, DOI 10.1126/science.234.4775.464; Shimizu M, 2005, PLANT J, V42, P877, DOI 10.1111/j.1365-313X.2005.02419.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Dennis ES, 2000, J EXP BOT, V51, P89, DOI 10.1093/jexbot/51.342.89; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Deryabin AN, 2003, RUSS J PLANT PHYSL+, V50, P449, DOI 10.1023/A:1024756320245; Fernandez-San Millan A, 2003, PLANT BIOTECHNOL J, V1, P71, DOI 10.1046/j.1467-7652.2003.00008.x; Fischer R, 2004, MOL FARMING PLANT MA; Guan ZJ, 2013, APPL MICROBIOL BIOT, V97, P2817, DOI 10.1007/s00253-012-4566-2; Hamorsky KT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002046; HATTORI T, 1991, PLANT CELL PHYSIOL, V32, P79; HATTORI T, 1990, PLANT MOL BIOL, V14, P595, DOI 10.1007/BF00027505; Hiwasa-Tanase K, 2011, PLANT CELL REP, V30, P113, DOI 10.1007/s00299-010-0949-y; Hong YF, 2008, PLANT MOL BIOL, V67, P347, DOI 10.1007/s11103-008-9324-6; ITURRIAGA G, 1989, PLANT CELL, V1, P381, DOI 10.1105/tpc.1.3.381; Jyothishwaran G, 2007, CURR SCI INDIA, V93, P770; Kajiura H, 2013, MOL BIOTECHNOL, V54, P784, DOI 10.1007/s12033-012-9626-4; Kang TJ, 2006, MOL BIOTECHNOL, V32, P93, DOI 10.1385/MB:32:2:093; Kim YW, 2010, PLANT BIOTECHNOL-NAR, V27, P333, DOI 10.5511/plantbiotechnology.27.333; Koehorst-van Putten HJ, 2012, PLANTA, V236, P1955; Kwak MS, 2008, PLANT CELL REP, V27, P1359, DOI 10.1007/s00299-008-0563-4; LINSMAIE.EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Mariscal A, 1998, ARCH ENVIRON CON TOX, V35, P588, DOI 10.1007/s002449900420; Martin T., 1992, GUS protocols: using the GUS gene as a reporter of gene expression., P23; Morikami A, 2005, MOL GENET GENOMICS, V272, P690, DOI 10.1007/s00438-004-1100-y; Moriwaki M, 1999, PLANT CELL REP, V19, P96, DOI 10.1007/s002990050717; Nausch H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048938; OHTA S, 1991, MOL GEN GENET, V225, P369; Shulga NY, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1158, DOI 10.1023/B:BIRY.0000046891.46282.c8; SIJMONS PC, 1990, BIO-TECHNOL, V8, P217, DOI 10.1038/nbt0390-217; Tsugawa H, 2004, PLANT CELL REP, V22, P759, DOI 10.1007/s00299-004-0758-2; Wang XG, 2001, BIOTECHNOL BIOENG, V72, P490, DOI 10.1002/1097-0290(20010220)72:4<490::AID-BIT1011>3.0.CO;2-0; Zhang P, 2003, PLANTA, V218, P192, DOI 10.1007/s00425-003-1098-0	42	0	0	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					47	53		10.5511/plantbiotechnology.14.1217a		7	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700006		
J	Sakamoto, S; Yoshida, K; Sugihara, S; Mitsuda, N				Sakamoto, Shingo; Yoshida, Kouki; Sugihara, Satoko; Mitsuda, Nobutaka			Development of a new high-throughput method to determine the composition of ten monosaccharides including 4-O-methyl glucuronic acid from plant cell walls using ultra-performance liquid chromatography	PLANT BIOTECHNOLOGY			English	Article						4-O-Methyl glucuronic acid; monosaccharide composition; plant cell wall; UPLC	QUANTITATIVE-DETERMINATION; POLYSACCHARIDE COMPOSITION; MECHANICAL-PROPERTIES; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; DOWN-REGULATION; ETHYL-ESTER; ARABIDOPSIS; RICE; BIOSYNTHESIS	Plant cell walls are an important dietary source for livestock, and could be an enormous resource for production of next-generation bioethanol and more valuable materials. Because polysaccharides are major components of plant cell walls, analysis of their composition is important. In this report, we established a high-throughput method to determine the composition of ten monosaccharides from plant cell walls simultaneously using ultra-performance liquid chromatography with p-aminobenzoic ethyl ester-labeling technology. Complete separation of a mixture of internal standards, 2-deoxyglucose and 3-O-methyl glucose, and ten monosaccharides, consisting of seven neutral and three acidic sugars including 4-O-methyl-D-glucuronic acid, which are frequently found in plant cell wall polysaccharides, can be obtained within 7 min using this system. Relative standard deviations of retention time and peak area value are lower than 1%. Linearity for broader dynamic ranges (0.02-2000 mg l(-1)), faster analysis and higher sensitivity than other traditional methods, including one that employs widely used high-performance anion exchange chromatography, are achieved. We evaluated this new method by analyzing the composition of cell walls from three model plants (Arabidopsis thaliana, rice and hybrid aspen) and confirmed that the obtained results for most monosaccharides are consistent with those in previous studies. These data suggest that our newly developed system could greatly contribute to the study of plant cell walls, especially research requiring high-throughput analysis.	[Sakamoto, Shingo; Mitsuda, Nobutaka] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Yoshida, Kouki] Taisei Corp, Ctr Technol, Totsuka Ku, Yokohama, Kanagawa 2450051, Japan; [Sugihara, Satoko] Nihon Waters KK, Ctr Technol, Shinagawa Ku, Tokyo 1400001, Japan	Sakamoto, S (reprint author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki 3058566, Japan.	nobutaka.mitsuda@aist.go.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) by Japan Science and Technology Agency (JST)	This work was supported by the Advanced Low Carbon Technology Research and Development Program (ALCA) by Japan Science and Technology Agency (JST) (to N. M.).	Albersheim P, 2010, PLANT CELL WALLS, P43; ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Yasuno S, 1997, BIOSCI BIOTECH BIOCH, V61, P1944; Swartz ME, 2005, J LIQ CHROMATOGR R T, V28, P1253, DOI 10.1081/JLC-200053046; Eudes A, 2012, PLANT BIOTECHNOL J, V10, P609, DOI 10.1111/j.1467-7652.2012.00692.x; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Persson S, 2007, PLANT CELL, V19, P237, DOI 10.1105/tpc.106.047720; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; DERUITER GA, 1992, ANAL BIOCHEM, V207, P176, DOI 10.1016/0003-2697(92)90520-H; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; Sannigrahi P, 2010, BIOFUEL BIOPROD BIOR, V4, P209, DOI 10.1002/bbb.206; Willfor S, 2005, WOOD SCI TECHNOL, V39, P601, DOI 10.1007/s00226-005-0039-4; Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501; KWON H, 1993, ANAL BIOCHEM, V215, P243, DOI 10.1006/abio.1993.1582; Urbanowicz BR, 2012, P NATL ACAD SCI USA, V109, P14253, DOI 10.1073/pnas.1208097109; BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; [Anonymous], 1990, METHOD BIOCHEM ANAL; Zhou YH, 2009, PLANT J, V57, P446, DOI 10.1111/j.1365-313X.2008.03703.x; Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Li M, 2009, PLANT J, V60, P1055, DOI 10.1111/j.1365-313X.2009.04022.x; Lee C, 2012, PLANT CELL PHYSIOL, V53, P1934, DOI 10.1093/pcp/pcs138; Kuroyama H, 2001, CARBOHYD RES, V333, P27, DOI 10.1016/S0008-6215(01)00114-8; Vignon MR, 1998, CARBOHYD RES, V307, P107, DOI 10.1016/S0008-6215(98)00002-0; Vega-Sanchez ME, 2012, PLANT PHYSIOL, V159, P56, DOI 10.1104/pp.112.195495; JONES TM, 1972, PLANT PHYSIOL, V49, P926, DOI 10.1104/pp.49.6.926; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Guadalupe Z, 2012, FOOD CHEM, V131, P367, DOI 10.1016/j.foodchem.2011.08.049; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; HOEBLER C, 1989, J AGR FOOD CHEM, V37, P360, DOI 10.1021/jf00086a020; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129; Lee CH, 2009, PLANT CELL PHYSIOL, V50, P1075, DOI 10.1093/pcp/pcp060; Bauer S, 2006, P NATL ACAD SCI USA, V103, P11417, DOI 10.1073/pnas.0604632103; Biswal AK, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-11; Carpita N. C., 1993, PLANT J, V1, P1, DOI [10.1111/j.1365-313X.1993.tb00007.x, DOI 10.1111/J.1365-313X.1993.TB00007.X]; Chong SL, 2013, CARBOHYD POLYM, V91, P626, DOI 10.1016/j.carbpol.2012.08.078; Doco T, 2001, CARBOHYD POLYM, V46, P249, DOI 10.1016/S0144-8617(00)00328-3; Guillarme D, 2008, EUR J PHARM BIOPHAR, V68, P430; Ishii T, 2010, CARBOHYD POLYM, V81, P964, DOI 10.1016/j.carbpol.2010.03.055; Iwase A, 2009, J BIOTECHNOL, V142, P279, DOI 10.1016/j.jbiotec.2009.05.011; Jensen JK, 2014, PLANT J, V80, P207, DOI 10.1111/tpj.12641; Kumagai Yuya, 2012, Frontiers of Chemical Science and Engineering, V6, P224; Lam TBT, 2000, J WOOD SCI, V46, P376, DOI 10.1007/BF00776399; Lee CH, 2011, PLANT CELL PHYSIOL, V52, P1289, DOI 10.1093/pcp/pcr075; MATSUURA F, 1988, GLYCOCONJUGATE J, V5, P13, DOI 10.1007/BF01048328; MCNEIL M, 1982, METHOD ENZYMOL, V83, P3; Nagel A, 2014, J AGR FOOD CHEM, V62, P2037, DOI 10.1021/jf404626d; NAKAMURA K, 1984, AGR BIOL CHEM TOKYO, V48, P753; Petersson P, 2008, J SEP SCI, V31, P2346, DOI 10.1002/jssc.200800064; Sakamoto S, 2014, PLANT CELL IN PRESS; Simolin H, 2009, IND CROP PROD, V29, P571; Sluiter A, 2008, NRELTP51042618; Smith BG, 1999, BIOCHEM SYST ECOL, V27, P33, DOI 10.1016/S0305-1978(98)00068-4; TAKEMOTO H, 1985, ANAL BIOCHEM, V145, P245, DOI 10.1016/0003-2697(85)90357-4; Yasuno S, 1999, BIOSCI BIOTECH BIOCH, V63, P1353, DOI 10.1271/bbb.63.1353; Zhang SJ, 2012, MOL PLANT, V5, P162, DOI 10.1093/mp/ssr076	59	0	0	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					55	+		10.5511/plantbiotechnology.15.0113a		25	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700007		
J	Anegawa, A; Ohnishi, M; Takagi, D; Miyake, C; Shichijo, C; Ishizaki, K; Fukaki, H; Mimura, T				Anegawa, Aya; Ohnishi, Miwa; Takagi, Daisuke; Miyake, Chikahiro; Shichijo, Chizuko; Ishizaki, Kimitsune; Fukaki, Hidehiro; Mimura, Tetsuro			Altered levels of primary metabolites in response to exogenous indole-3-acetic acid in wild type and auxin signaling mutants of Arabidopsis thaliana: A capillary electrophoresis-mass spectrometry analysis	PLANT BIOTECHNOLOGY			English	Article						Arabidopsis; auxin; auxin signaling mutants; CE-MS; metabolome; metabolomics	LATERAL ROOT-FORMATION; PLANT DEVELOPMENT; GENE-EXPRESSION; GROWTH; NITROGEN; ACCUMULATION; METABOLOMICS; STRESS; ARF19; ACID	A comprehensive analysis of the levels of primary metabolites in wild type (WT) and several auxin-signaling mutants namely, tir1, slr and arf7 arf19 of Arabidopsis thaliana has been performed using CE-MS, a technique particularly sensitive for the measurement of polar compounds. We first measured the levels of primary metabolites in shoots and roots, most of the analyzed metabolites were found to be quantitatively and qualitatively comparable in WT and three kinds of mutants (tir1, slr and arf7 arf19). Some amino acids such as GABA, Arg, Orn, Val, Thr, Leu and Ile exhibited a unique pattern of distribution between shoots and roots in both WT and the mutants. On the other hand, the mutant slr showed a quite different pattern of metabolites measured in the present study. Subsequently, the responses of primary metabolites to a short-term (60 min) application of exogenous IAA (10(-7), 10(-8) M) in WT and the mutants were characterized. Due to IAA treatments, some amino acids such as GABA in WT roots and Gly and Ala in WT shoots were altered, but not in the mutants. Gln was altered in slr shoots by 10(-7) M IAA treatment. Levels of G6P from the glycolic pathway were altered in WT roots and those of 2PG, 3PG were altered in tir1 shoots in response to IAA treatments. The levels of succinate in TCA cycle were altered by IAA treatments in WT shoots but not in the mutants. IAA treatment inhibited the respiration in WT roots. The suppression of respiration might account for the IAA-dependent alteration of some metabolites. Difference of auxin responses between WT and auxin-signaling mutants suggests that some metabolic processes are under IAA control.	[Anegawa, Aya; Ohnishi, Miwa; Shichijo, Chizuko; Ishizaki, Kimitsune; Fukaki, Hidehiro; Mimura, Tetsuro] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 6578501, Japan; [Takagi, Daisuke; Miyake, Chikahiro] Kobe Univ, Grad Sch Agr, Dept Biol & Environm Sci, Kobe, Hyogo 6578501, Japan	Anegawa, A (reprint author), Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 6578501, Japan.	mimura@kobe-u.ac.jp			Japan Science and Technology Corporation (JST) [CREST]; Japanese Ministry of Education, Sports, Culture, Science, and Technology on "Perceptive plants" [22120006]	This work was supported by Japan Science and Technology Corporation (JST) [Grant-in-Aid for Exploratory Research by CREST] and a Grant-in-Aid for Scientific Research of Priority Areas from the Japanese Ministry of Education, Sports, Culture, Science, and Technology on "Perceptive plants (22120006)".	Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Sulpice R, 2010, PLANT CELL, V22, P2872, DOI 10.1105/tpc.110.076653; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Tohge T, 2011, PLANT PHYSIOL, V157, P1469, DOI 10.1104/pp.111.185710; Etienne A, 2013, J EXP BOT, V64, P1451, DOI 10.1093/jxb/ert035; Lewis DR, 2011, PLANT PHYSIOL, V156, P144, DOI 10.1104/pp.111.172502; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Lendvai N, 2014, ENDOCRINOLOGY, V155, P27, DOI 10.1210/en.2013-1549; Nikiforova VJ, 2005, PLANT PHYSIOL, V138, P304, DOI 10.1104/pp.104.053793; Rawat SR, 1999, PLANT J, V19, P143, DOI 10.1046/j.1365-313X.1999.00505.x; Tiburcio AF, 1997, PHYSIOL PLANTARUM, V100, P664, DOI 10.1034/j.1399-3054.1997.1000330.x; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Armstrong JI, 2004, P NATL ACAD SCI USA, V101, P14978, DOI 10.1073/pnas.0404312101; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Watanabe CK, 2010, PLANT CELL PHYSIOL, V51, P810, DOI 10.1093/pcp/pcq033; Obata T, 2012, CELL MOL LIFE SCI, V69, P3225, DOI 10.1007/s00018-012-1091-5; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Sato S, 2004, PLANT J, V40, P151, DOI 10.1111/j.1365-313X.2004.02187.x; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Laskowski M, 2006, PLANT CELL PHYSIOL, V47, P788, DOI 10.1093/pcp/pcj043; Hayashi K, 2012, PLANT CELL PHYSIOL, V53, P965, DOI 10.1093/pcp/pcs035; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Tschoep H, 2009, PLANT CELL ENVIRON, V32, P300, DOI 10.1111/j.1365-3040.2008.01921.x; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; Bonner J, 1936, J GEN PHYSIOL, V20, P1, DOI 10.1085/jgp.20.1.1; Commoner B, 1941, J GEN PHYSIOL, V24, P279, DOI 10.1085/jgp.24.3.279; Davies JP, 2010, PLANT HORMONES, V3rd; Fukaki H, 2005, PLANT BIOTECHNOL, V22, P393, DOI 10.5511/plantbiotechnology.22.393; HACKETT DP, 1952, P NATL ACAD SCI USA, V38, P770, DOI 10.1073/pnas.38.9.770; KISHINAMI I, 1988, PLANT CELL PHYSIOL, V29, P581; Kusano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016989; MARRE E, 1957, PHYSIOL PLANTARUM, V10, P289, DOI 10.1111/j.1399-3054.1957.tb06951.x; Matsuda F, 2012, PLANT J, V70, P624, DOI 10.1111/j.1365-313X.2012.04903.x; MITCHELL JE, 1949, AM J BOT, V36, P368, DOI 10.2307/2437934; PARK KY, 1994, PHYSIOL PLANTARUM, V90, P382; Singla B, 2007, PLANT MOL BIOL, V65, P677, DOI 10.1007/s11103-007-9234-z; Sudre D, 2013, J EXP BOT, V64, P2665, DOI 10.1093/jxb/ert112; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	51	0	0	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					65	79		10.5511/plantbiotechnology.15.0116a		15	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700008		
J	Fujii, Y; Kodama, Y				Fujii, Yuta; Kodama, Yutaka			In planta comparative analysis of improved green fluorescent proteins with reference to fluorescence intensity and bimolecular fluorescence complementation ability	PLANT BIOTECHNOLOGY			English	Article						Arabidopsis; BiFC; BiFC competition; GFP; protein-protein interaction	LIVING CELLS; SUPERFOLDER GFP; VISUALIZATION; ASSAY; PERSPECTIVES; DIMERIZATION; ARABIDOPSIS; COMPLEXES; BIFC	Green fluorescent protein (GFP) was discovered from the jellyfish Aequorea victoria, and several improvements have been carried out to change its physicochemical properties. The resulting improved GFP variants have been used as reporter proteins for bioimaging techniques in various research fields including plant science. Almost all GFP variants were developed using Escherichia coli to improve fluorescence properties in mammalian cells, but the impact in other organisms such as plant cells remains to be determined. In this study, we performed comparative analysis of four improved GFP variants, GFP-S65T, eGFP, frGFP and sfGFP, with reference to the fluorescence intensity in Arabidopsis protoplasts, and found that sfGFP is the brightest. Using non-fluorescent fragments from the GFP variants, we also conducted bimolecular fluorescence complementation (BiFC) assays to find appropriate fragment pairs of GFP-based BiFC for visualization of protein-protein interactions in living plant cells. Our observations revealed that the brightest is the sfGFP-based BiFC. Further, as an evaluation method for the sfGFP-based BiFC, a BiFC competition assay was successfully completed for the first time in planta. The present study provides useful information for selection and improvement of the GFP molecule and its application to BiFC technology in plants.	[Fujii, Yuta; Kodama, Yutaka] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi 3218505, Japan	Fujii, Y (reprint author), Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi 3218505, Japan.	kodama@cc.utsunomiya-u.ac.jp			Japan Society for the Promotion of Science Research (JSPS) KAKENHI [26840088]; Plant Transgenic Design Initiative of University of Tsukuba; Cross-ministerial Strategic Innovation Promotion Program (SIP); Utsunomiya University	The authors thank Dr. Christopher Suarez (University of Notre Dame) for critical reading of the manuscript. The authors also thank the anonymous reviewers and the Associate Editor, Dr. Yukio Nagano (Saga University), for their comments and suggestions to improve this paper. This work was supported by the Japan Society for the Promotion of Science Research (JSPS) KAKENHI (No. 26840088) (Y.K.), the Plant Transgenic Design Initiative of University of Tsukuba (Y.K.), Cross-ministerial Strategic Innovation Promotion Program (SIP) (Y.K.), and research projects [CORE Adopted, CDI-F, UU-COE and UU-COE-Next] of Utsunomiya University (Y.K).	Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/000113943, 10.2144/0000113943]; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Fisher CL, 1997, BIOTECHNIQUES, V23, P570; Kodama Y, 2009, PLANT MOL BIOL, V70, P211, DOI 10.1007/s11103-009-9467-0; Kodama Y, 2010, P NATL ACAD SCI USA, V107, P19591, DOI 10.1073/pnas.1007836107; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; Jackson SE, 2006, EXPERT REV PROTEOMIC, V3, P545, DOI 10.1586/14789450.3.5.545; Andrews BT, 2007, J MOL BIOL, V373, P476, DOI 10.1016/j.jmb.2007.07.071; Vidi PA, 2008, MOL PHARMACOL, V74, P544, DOI 10.1124/mol.108.047472; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Arpino JAJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047132; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Gjetting SK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00234; Grinberg AV, 2004, MOL CELL BIOL, V24, P4294, DOI 10.1128/MCB.24.10.4294-4308.2004; Hudry B, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-5; Kodama Y, 2011, PLANT BIOTECHNOL-NAR, V28, P95, DOI 10.5511/plantbiotechnology.10.1105a; Kodama Yutaka, 2013, Methods Cell Biol, V113, P107, DOI 10.1016/B978-0-12-407239-8.00006-9; Kodama Y, 2008, BIOCHIMIE, V90, P547, DOI 10.1016/j.biochi.2007.10.001; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573	31	0	0	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					81	+		10.5511/plantbiotechnology.15.0120a		8	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700009		
J	Kurihara, Y; Okubo-Kurihara, E; Matsui, M				Kurihara, Yukio; Okubo-Kurihara, Emiko; Matsui, Minami			Polycistronic expression of RNA silencing suppressor protects its own mRNA from RNA silencing	PLANT BIOTECHNOLOGY			English	Article						IRES; RNA silencing; p19	INTERNAL INITIATION; PLANTS; TRANSLATION; ARABIDOPSIS; VIRUS; RIBOSOMES; REPORTER; BINDING; REGION; SYSTEM	The internal ribosome entry site (IRES) enables polycistronic expression of multiple genes from a single mRNA controlled by one promoter. In general, only the most 5' coding sequence is abundantly translated from polycistronic mRNAs in eukaryotic cells; IRES-mediated translation allows additional coding sequences at other positions to be translated at detectable levels. However, IRES-mediated translation often results in much lower protein expression than translation of single-gene mRNAs. We first aimed to improve IRES-mediated gene expression with a transient expression system based on Nicotiana benthamiana. We demonstrated that the presence of two cassettes comprised of an IRES-mediated Venus coding sequence results in higher Venus expression than one cassette. The double IRES cassette system is expected to be useful for expressing a gene of interest polycistronically in plants. Using the double IRES cassette system, we found that polycistronic expression of a reporter gene and two copies of an IRES-mediated RNA silencing suppressor gene protected the transcribed mRNA from RNA silencing-mediated degradation. This is the first report of a mRNA self-protection system from RNA silencing by IRES-mediated expression of a viral suppressor in plants.	[Kurihara, Yukio; Okubo-Kurihara, Emiko; Matsui, Minami] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Synthet Genom Res Team, Yokohama, Kanagawa 2300045, Japan	Kurihara, Y (reprint author), RIKEN Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Synthet Genom Res Team, Yokohama, Kanagawa 2300045, Japan.	minami@riken.jp			Japan Society for the Promotion of Science [25871119]	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science to Y. K. (No. 25871119).	Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Thompson SR, 2012, TRENDS MICROBIOL, V20, P558, DOI 10.1016/j.tim.2012.08.002; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Ha SH, 2010, PLANT BIOTECHNOL J, V8, P928, DOI 10.1111/j.1467-7652.2010.00543.x; Fujioka Y, 2007, PLANT CELL PHYSIOL, V48, P1243, DOI 10.1093/pep/pcm099; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Nemoto K, 2009, FEBS LETT, V583, P487, DOI 10.1016/j.febslet.2008.12.049; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; JANG SK, 1988, J VIROL, V62, P2636; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Bouabe H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1119; Kojima S, 1999, DNA Res, V6, P407, DOI 10.1093/dnares/6.6.407; Kurihara Y, 2007, J GEN VIROL, V88, P2347, DOI 10.1099/vir.0.82994-0; Skulachev MV, 1999, VIROLOGY, V263, P139, DOI 10.1006/viro.1999.9928; Velten J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030141; Weinhold A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-99; Yamamoto YY, 2003, PLANT J, V35, P273, DOI 10.1046/j.1365-313X.2003.01797.x	21	0	0	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					89	95		10.5511/plantbiotechnology.15.0120b		7	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700010		
J	Takayanagi, S; Takagi, Y; Hasegawa, H				Takayanagi, Shu; Takagi, Yuma; Hasegawa, Hiroshi			The shoot of Ranunculus nipponicus var. submersus, a submerged vascular plant, can actively take up nitrate from cool water	PLANT BIOTECHNOLOGY			English	Article						High-affinity nitrate transporter; nitrate uptake; NRT2; Ranunculus nipponicus var. submersus; submerged vascular plant	RICE SEEDLINGS; EXPRESSION; TRANSPORT; ARABIDOPSIS; TEMPERATURE; MACROPHYTES; INHIBITORS; AMMONIUM; NITROGEN; PERIOD	Nitrate uptake characteristics in the shoots of Ranunculus nipponicus var. submersus (Japanese name: Baikamo), a submerged eudicot adapted to groundwater temperature (approximately 15 degrees C), were investigated for the phytoremediation of nitrate-polluted groundwater. For the experiments, we developed a culture system that allows R. nipponicus growth under laboratory conditions. N-15-nitrate feeding experiments showed that apparent nitrate uptake by the shoots of R. nipponicus was approximately three times of that by the shoots of Egeria densa, a model submerged monocot, at 15 degrees C. A DNA fragment of the R. nipponicus high-affinity nitrate transporter (NRT2) was isolated and the deduced amino acid sequence of the partial RnNRT2 protein was similar to that of NRT2 in monocots rather than in eudicots. Real-time reverse transcription-PCR analysis revealed that after the shoots were fed 0.2 mM nitrate, RnNRT2 transcripts in the shoots of R. nipponicus were induced within 1 h, reached a maximum by 6 h and then decreased. At 15 degrees C, RnNRT2 transcripts in the shoots of R. nipponicus, in contrast to EdNRT2 transcripts in shoots of E. densa, were rapidly and strongly induced by nitrate. We concluded that the shoots of R. nipponicus have a system of high-affinity nitrate uptake actively functioning under cool conditions (15 degrees C) and may be useful for the clean-up of nitrate-contaminated groundwater.	[Takayanagi, Shu; Hasegawa, Hiroshi] Univ Shiga Prefecture, Grad Sch Environm Sci, Hikone, Shiga 5228533, Japan; [Takagi, Yuma] Qualicaps Co Ltd, Dept Res & Dev, Yamato Koriyama, Nara 6391032, Japan; [Hasegawa, Hiroshi] Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga 5228533, Japan	Takayanagi, S (reprint author), Univ Shiga Prefecture, Grad Sch Environm Sci, Hikone, Shiga 5228533, Japan.	otowa-hiroshi@leto.eonet.ne.jp					SASAKAWA H, 1978, PLANT PHYSIOL, V62, P665, DOI 10.1104/pp.62.4.665; VANDONK E, 1993, HYDROBIOLOGIA, V251, P19; Madsen TV, 2002, FRESHWATER BIOL, V47, P283, DOI 10.1046/j.1365-2427.2002.00802.x; Okamoto M, 2003, PLANT CELL PHYSIOL, V44, P304, DOI 10.1093/pcp/pcg036; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Cedergreen N, 2003, AQUAT BOT, V76, P203, DOI 10.1016/S0304-3770(03)00050-0; Araki R, 2006, BREEDING SCI, V56, P295, DOI 10.1270/jsbbs.56.295; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Miller AJ, 2007, J EXP BOT, V58, P2297, DOI 10.1093/jxb/erm066; Koga K, 2008, AQUAT BOT, V89, P1, DOI 10.1016/j.aquabot.2007.12.012; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Doyle J. J., 1991, NATO ASI SERIES H, V57, P283, DOI DOI 10.1007/978-3-642-83962-7_; Forde BG, 2000, BBA-BIOMEMBRANES, V1465, P219, DOI 10.1016/S0005-2736(00)00140-1; HASEGAWA H, 1990, JPN J CROP SCI, V59, P498; Kandori M, 2008, THESIS U SHIGA PREFE; Kimura Yasuo, 1998, Japanese Journal of Ecology (Tokyo), V48, P257; Koga K, 2007, J PLANT RES, V120, P167, DOI 10.1007/s10265-006-0060-1; Kunii H, 1997, B WATER PLANT SOC JP, V61, P1; Ministry of the Environment Japan, 2014, MON RES GROUNDW QUAL; Miyashita Y, 2004, B HOT SPRINGS RES I, V36, P25; Motonaga M, 2011, J CROP RES, V56, P29; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Takayanagi S, 2012, J PLANT RES, V125, P669, DOI 10.1007/s10265-012-0480-z; Takayanagi S, 2011, J PLANT RES, V124, P305, DOI 10.1007/s10265-010-0375-9; Trueman LJ, 1996, GENE, V175, P223, DOI 10.1016/0378-1119(96)00154-0; Tsujimoto R, 2007, PLANT CELL PHYSIOL, V48, P484, DOI 10.1093/pcp/pcm019; Vaast P, 1998, J PLANT NUTR, V21, P1551, DOI 10.1080/01904169809365502	30	0	0	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					97	102		10.5511/plantbiotechnology.14.1201a		6	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700011		
J	Sasaki, S; Yamamoto, KT				Sasaki, Shu; Yamamoto, Kotaro T.			Arabidopsis LAZY1 is a peripheral membrane protein of which the carboxy-terminal fragment potentially interacts with microtubules	PLANT BIOTECHNOLOGY			English	Article						Shoot gravitropism; microtubule; plasma membrane	ARG1 ALTERED-RESPONSE; AUXIN TRANSPORT; SHOOT GRAVITROPISM; GENE FAMILY; GRAVITY; SYSTEM; GROWTH; PLANTS; INFLORESCENCE; CYTOSKELETON	LAZY1 is a protein involved in gravity signaling of shoot gravitropism of rice, maize and Arabidopsis. Although the lazy1 mutants have been well-characterized, the function of the LAZY1 protein is still largely unknown. In this study, we used fluorescence microscopy to examine the subcellular localization of Arabidopsis LAZY1 (AtLAZY1) and its truncated proteins fused to GFP in tobacco leaves. We found that AtLAZY1 localizes to the plasma membrane through the C-terminal region, suggesting that the putative trans-membrane domain in the N-terminal half is not required for localization. Next, we took a biochemical approach to investigate the membrane association of AtLAZY1. Transiently expressed AtLAZY1 in transgenic Arabidopsis was fractionated in an insoluble fraction that contained membranous compartments. AtLAZY1 was solubilized by a non-ionic detergent or at a high pH condition, suggesting that AtLAZY1 is a peripheral membrane protein. We also found that when expressed in tobacco the C-terminal part of AtLAZY1 co-localized with microtubules. A microtubule binding assay showed that the C-terminal half of AtLAZY1, which localized to the plasma membrane, interacted with microtubules in vitro. These results suggest that AtLAZY1 may function with microtubules at the periphery of the plasma membrane in the gravity signaling process.	[Sasaki, Shu; Yamamoto, Kotaro T.] Hokkaido Univ, Grad Sch Life Sci, Biosyst Sci Course, Sapporo, Hokkaido 0600810, Japan; [Yamamoto, Kotaro T.] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Sasaki, S (reprint author), Hokkaido Univ, Grad Sch Life Sci, Biosyst Sci Course, Sapporo, Hokkaido 0600810, Japan.	kty@sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [19060008]	We are grateful to Dr. Tsuyoshi Nakagawa (Shimane University) for GATEWAY binary vector pGWBs. This work was supported in part by a Grant-in-Aid from Ministry of Education, Culture, Sports, Science and Technology, Japan to K.T.Y. (19060008).	Abe K, 1994, Biol Sci Space, V8, P221, DOI 10.2187/bss.8.221; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Yoshihara T, 2013, PLANT J, V74, P267, DOI 10.1111/tpj.12118; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Kumar NS, 2008, AM J BOT, V95, P177; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; Dong ZB, 2013, PLANT PHYSIOL, V163, P1306, DOI 10.1104/pp.113.227314; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Lucas JR, 2011, PLANT CELL, V23, P1889, DOI 10.1105/tpc.111.084970; Dardick C, 2013, PLANT J, V75, P618, DOI 10.1111/tpj.12234; Bisgrove SR, 2008, PLANT SCI, V175, P747, DOI 10.1016/j.plantsci.2008.08.009; Oda Y, 2012, SCIENCE, V337, P1333, DOI 10.1126/science.1222597; Morita MT, 2010, ANNU REV PLANT BIOL, V61, P705, DOI 10.1146/annurev.arplant.043008.092042; Sedbrook JC, 1999, P NATL ACAD SCI USA, V96, P1140, DOI 10.1073/pnas.96.3.1140; Volkmann D, 1999, MICROSC RES TECHNIQ, V47, P135, DOI 10.1002/(SICI)1097-0029(19991015)47:2<135::AID-JEMT6>3.0.CO;2-1; Baldwin KL, 2013, AM J BOT, V100, P126, DOI 10.3732/ajb.1200318; Baldwin A, 2005, PLANT PHYSIOL, V138, P715, DOI 10.1104/pp.105.063289; Boonsirichai K, 2003, PLANT CELL, V15, P2612, DOI 10.1105/tpc.015560; Harrison Benjamin, 2008, Plant Signal Behav, V3, P650; Shoji T, 2004, PLANT PHYSIOL, V136, P3933, DOI 10.1104/pp.104.051748	22	0	0	JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY	NARA	NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101, JAPAN	1342-4580			PLANT BIOTECHNOL-NAR	Plant Biotechnol.	MAR	2015	32	1					103	+		10.5511/plantbiotechnology.15.0106a		10	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CG8KG	WOS:000353555700012		
J	Yoshida, N; Yamaguchi, T; Saitou, K; Tanabe, S; Sugawara, K				Yoshida, Naoshin; Yamaguchi, Tomofumi; Saitou, Kei; Tanabe, Shigeo; Sugawara, Kenichi			Increasing corticospinal excitability in the antagonist muscle during muscle relaxation with a tracking task	SOMATOSENSORY AND MOTOR RESEARCH			English	Article						Antagonist muscle; muscle relaxation; tracking task	DORSAL INTEROSSEOUS MUSCLE; MOTOR EVOKED-POTENTIALS; HUMAN MOTONEURONS; HUMANS; CONTRACTION; STIMULATION; RECRUITMENT; ATTENTION; PRECISION; GRIP	The present study aimed to investigate corticospinal excitability changes during muscle relaxation with a tracking task. The motor-evoked potential, which was elicited from the flexor carpi radialis (agonist) and extensor carpi radialis (antagonist) muscles, was analyzed in terms of both the relaxation velocity and phase. Our results suggest that increasing corticospinal excitability in the antagonist muscle plays an important role in controlling the relaxation of the agonist muscle during gradual relaxation with a tracking task.	[Yoshida, Naoshin] Yokosuka Kyosai Hosp, Dept Rehabil, Yokosuka, Kanagawa, Japan; [Yamaguchi, Tomofumi] Keio Univ, Sch Med, Dept Rehabil Med, Shinjuku Ku, Tokyo, Japan; [Saitou, Kei] Niigata Univ Hlth & Welf, Niigata, Niigata, Japan; [Tanabe, Shigeo] Fujita Hlth Univ, Sch Hlth Sci, Fac Rehabil, Toyoake, Aichi, Japan; [Sugawara, Kenichi] Kanagawa Univ Human Serv, Sch Rehabil, Fac Hlth & Social Work, Yokosuka, Kanagawa 2388552, Japan	Sugawara, K (reprint author), Kanagawa Univ Human Serv, Sch Rehabil, Fac Hlth & Social Serv, 1-10-1 Heisei Cho, Yokosuka, Kanagawa 2388552, Japan.	sugawara-k@kuhs.ac.jp					ABBRUZZESE G, 1994, J PHYSIOL-LONDON, V481, P499; MUIR RB, 1983, BRAIN RES, V261, P312, DOI 10.1016/0006-8993(83)90635-2; Masakado Y, 1995, ELECTROMYOGR MOTOR C, V97, P290, DOI 10.1016/0924-980X(95)00188-Q; Conte A, 2007, EXP BRAIN RES, V182, P109, DOI 10.1007/s00221-007-0975-3; ROMAIGUERE P, 1993, EXP BRAIN RES, V95, P517; Begum T, 2005, NEUROSCI RES, V53, P428, DOI 10.1016/j.neures.2005.09.002; GANDEVIA SC, 1987, BRAIN, V110, P1117, DOI 10.1093/brain/110.5.1117; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528; SCHIEPPATI M, 1984, EXP BRAIN RES, V56, P448; SCHIEPPATI M, 1986, HUM NEUROBIOL, V5, P59; Kimura T, 2003, EXP BRAIN RES, V152, P123, DOI 10.1007/s00221-003-1518-1; Conte A, 2008, EXP BRAIN RES, V186, P393, DOI 10.1007/s00221-007-1244-1; Buccolieri A, 2004, J PHYSIOL-LONDON, V558, P685, DOI 10.1113/jphysiol.2004.064774; CHENEY PD, 1985, J NEUROPHYSIOL, V53, P805; Gorassini M, 2002, J NEUROPHYSIOL, V87, P1850, DOI 10.1152/jn.00024.2001; Hasegawa Y, 2001, EXP BRAIN RES, V140, P387, DOI 10.1007/s002210100842; Kasai T, 1999, MUSCLE NERVE, V22, P1419, DOI 10.1002/(SICI)1097-4598(199910)22:10<1419::AID-MUS12>3.0.CO;2-K; Rossini PM, 1996, MUSCLE NERVE, V19, P1302; SCHIEPPATI M, 1985, EXP BRAIN RES, V59, P249; Terada K, 1999, CLIN NEUROPHYSIOL, V110, P397, DOI 10.1016/S1388-2457(98)00017-0; Toma K, 2000, EXP BRAIN RES, V134, P417, DOI 10.1007/s002210000483	22	1	1	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0899-0220			SOMATOSENS MOT RES	Somatosens. Mot. Res.	MAR	2015	32	1					39	43		10.3109/08990220.2014.958215		5	Neurosciences	Neurosciences & Neurology	CH0SV	WOS:000353733600006		
J	Syczewska, EM; Struzik, ZR				Syczewska, E. M.; Struzik, Z. R.			Granger Causality and Transfer Entropy for Financial Returns	ACTA PHYSICA POLONICA A			English	Article; Proceedings Paper	7th Polish Symposium of Physics in Economy and Social Sciences (FENS)	MAY 14-17, 2014	Maria Curie Sklodowska Univ, Lublin, POLAND	Polish Minist Sci & Higher Educ, Polish Phys Soc	Maria Curie Sklodowska Univ		TIME-SERIES; INFORMATION-TRANSFER; DEPENDENCE; INFERENCE; TOOLBOX	Granger causality in its linear form has been shown by Barnett, Barrett and Seth [Phys. Rev. Lett. 103, 238701 (2009)] to be equivalent to transfer entropy in case of Gaussian distribution. Generalizations by Hlavackova-Schindler [Appl. Math. Sci. 5, 3637 (2011)] are applied to distributions typical for biomedical applications. The financial returns, which are of great importance in financial econometrics, typically do not have Gaussian distribution. Generalizations leading to the concept of nonlinear Granger causality (e. g. causality in variance, causality in risk), known and applied in econometric literature, seem to be less known outside this field. In the paper an overview of some of the definitions and applications is given. In particular, we indicate some recent econometric results concerning application of the tests in linear multivariate framework. We emphasize importance of other variants of Granger causality, and need of development of methods reflecting features of financial variables.	[Syczewska, E. M.] Warsaw Sch Econ, Inst Econometr, Dept Econ Anal, PL-02513 Warsaw, Poland; [Struzik, Z. R.] RIKEN Brain Sci Inst, Wako, Saitama 3510198, Japan; [Struzik, Z. R.] Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo 1130033, Japan; [Struzik, Z. R.] Univ Gdansk, Inst Theoret Phys & Astrophys, PL-80952 Gdansk, Poland	Syczewska, EM (reprint author), Warsaw Sch Econ, Inst Econometr, Dept Econ Anal, Madalinskiego 6-8, PL-02513 Warsaw, Poland.	ewams@sgh.waw.pl					Alexander C., 2008, MARKET RISK ANAL; SIMS CA, 1972, AM ECON REV, V62, P540; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Bauer D, 2012, J ECONOMETRICS, V169, P293, DOI 10.1016/j.jeconom.2012.01.023; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Granger CWJ, 2003, J ECONOMETRICS, V112, P69, DOI 10.1016/S0304-4076(02)00148-3; Granger CW, 2004, J TIME SER ANAL, V25, P649, DOI 10.1111/j.1467-9892.2004.01866.x; TODA HY, 1995, J ECONOMETRICS, V66, P225, DOI 10.1016/0304-4076(94)01616-8; CHAMBERLAIN G, 1982, ECONOMETRICA, V50, P569, DOI 10.2307/1912601; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Barnett L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.138105; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Bossomaier T., 2013, COMPLEX ADAPTIVE SYS, V1, P9; Box G. E., 1976, TIME SERIES ANAL FOR; Bruzda J., 2004, AUNC, V34, P183; Bruzda J., 2007, PROCESY NIELINIOWE Z; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Feller W., 1957, INTRO PROBABILITY TH, VII; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Granger C, 1994, J TIME SER ANAL, V15, P371, DOI 10.1111/j.1467-9892.1994.tb00200.x; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Granger C. W. J., 1993, MODELLING NONLINEAR; Granger C.W.J., 1969, ECONOMETRICA, V37, P424, DOI DOI 10.2307/1912791; HIEMSTRA C, 1994, J FINANC, V49, P1639, DOI 10.2307/2329266; Hlavackova-Schindler K., 2009, INFORM THEORY STAT L, P183, DOI 10.1007/978-0-387-84816-7_8; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Hlavakova-Schindler K., 2011, APPL MATH SCI, V5, P3637; Jizba P, 2012, PHYSICA A, V391, P2971, DOI 10.1016/j.physa.2011.12.064; Johansen S., 1995, LIKELIHOOD BASED INF; MALLIARIS AG, 1992, J FINANC QUANT ANAL, V27, P353, DOI 10.2307/2331324; Orzeszko W., 2012, PRZEGLAD STATYSTYCZN, V59, P369; Osinska M., 1993, SOME ASPECTS DYNAMIC, P135; Osinska M., 2008, EKONOMETRYCZNA ANALI; Rachev S.T., 2011, FJ FABOZZI SERIES FI; Subbotin M.T., 1923, MAT SBORNIK, V31, P296; Syczewska E.M., 2014, METODY ILOSCIOWE BAD, VXV, P169; Theodossiou P., 2000, SSRN, V11, P1; Tsay R.S., 2007, ANAL FINANCIAL TIME, V3rd	41	0	0	POLISH ACAD SCIENCES INST PHYSICS	WARSAW	AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND	0587-4246	1898-794X		ACTA PHYS POL A	Acta Phys. Pol. A	MAR	2015	127	3A					A129	A135				7	Physics, Multidisciplinary	Physics	CG8QE	WOS:000353573700024		
J	Masuyama, H				Masuyama, Hiroyuki			ERROR BOUNDS FOR AUGMENTED TRUNCATIONS OF DISCRETE-TIME BLOCK-MONOTONE MARKOV CHAINS UNDER GEOMETRIC DRIFT CONDITIONS	ADVANCES IN APPLIED PROBABILITY			English	Article						Augmented truncation; block monotonicity; blockwise dominance; pathwise ordering; geometric drift condition; level-dependent QBD; M/G/1-type Markov chain; GI/M/1-type Markov chain; GI/G/1-type Markov chain	APPROXIMATIONS; MATRICES; QUEUES	In this paper we study the augmented truncation of discrete-time block-monotone Markov chains under geometric drift conditions. We first present a bound for the total variation distance between the stationary distributions of an original Markov chain and its augmented truncation. We also obtain such error bounds for more general cases, where an original Markov chain itself is not necessarily block monotone but is blockwise dominated by a block-monotone Markov chain. Finally, we discuss the application of our results to GI/G/1-type Markov chains.	[Masuyama, Hiroyuki] Kyoto Univ, Kyoto 6068501, Japan	Masuyama, H (reprint author), Kyoto Univ, Dept Syst Sci, Grad Sch Informat, Kyoto 6068501, Japan.	masuyama@sys.i.kyoto-u.ac.jp			Japan Society for the Promotion of Science [24710165]	The author thanks an anonymous referee for his/her constructive comments and suggestions that helped to improve the presentation of this paper. The author's research was supported in part by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science under grant number 24710165.	ANDREW AL, 1993, SIAM J MATRIX ANAL A, V14, P903, DOI 10.1137/0614061; Liu YY, 2010, OPER RES LETT, V38, P218, DOI 10.1016/j.orl.2009.12.001; Tweedie RL, 1998, J APPL PROBAB, V35, P517; GIBSON D, 1987, STOCH PROC APPL, V24, P287, DOI 10.1016/0304-4149(87)90019-6; Baumann H, 2010, PROCEDIA COMPUT SCI, V1, P1555, DOI 10.1016/j.procs.2010.04.175; BREMAUD P., 1999, MARKOV CHAINS GIBBS; Bright L, 1995, COMM STAT STOCHASTIC, V11, P497; Chung K.L., 1967, MARKOV CHAINS STATIO; DALEY DJ, 1968, Z WAHRSCHEINLICHKEIT, V10, P305, DOI 10.1007/BF00531852; He QM, 2014, FUNDAMENTALS MATRIX; Horn R. A., 1990, MATRIX ANAL; Keilson J., 1977, STOCH P APPL, V5, P231, DOI 10.1016/0304-4149(77)90033-3; Kimura T, 2013, STOCH MODELS, V29, P190, DOI 10.1080/15326349.2013.783286; Li H., 2000, COMMUN STAT STOCH MO, V16, P313; Lucantoni D.M., 1991, COMMUN STAT STOCHAST, V7, P1; Lund R. B., 1996, ANN APPL PROBAB, V6, P218; Masuyama H, 2005, STOCH MODELS, V21, P885, DOI 10.1080/15326340500294603; MEYN S., 2009, MARKOV CHAINS STOCHA; Muller A., 2002, COMP METHODS STOCHAS; Phung-Duc T., 2010, P 5 INT C QUEUEING T, P46, DOI 10.1145/1837856.1837864; TAKINE T, 1994, PERFORM EVALUATION, V20, P131, DOI 10.1016/0166-5316(94)90010-8; Takine T., 2000, COMMUNICATIONS STAT, V16, P335; TIJMS H.C., 2003, 1 COURSE STOCHASTIC; Zhao YQQ, 1998, ADV APPL PROBAB, V30, P365	24	0	0	APPLIED PROBABILITY TRUST	SHEFFIELD	THE UNIVERSITY, SCHOOL MATHEMATICS STATISTICS, SHEFFIELD S3 7RH, ENGLAND	0001-8678	1475-6064		ADV APPL PROBAB	Adv. Appl. Probab.	MAR	2015	47	1					83	105				23	Statistics & Probability	Mathematics	CG4JZ	WOS:000353252700005		
J	Sakagawa, H				Sakagawa, Hironobu			PERSISTENCE PROBABILITY FOR A CLASS OF GAUSSIAN PROCESSES RELATED TO RANDOM INTERFACE MODELS	ADVANCES IN APPLIED PROBABILITY			English	Article						Persistence probability; random interface; Gaussian process; interacting diffusion process	FRACTIONAL BROWNIAN-MOTION; CRYSTAL; MAXIMUM; EXIT	We consider a class of Gaussian processes which are obtained as height processes of some (d + 1)-dimensional dynamic random interface model on Z(d). We give an estimate of persistence probability, namely, large T asymptotics of the probability that the process does not exceed a fixed level up to time T. The interaction of the model affects the persistence probability and its asymptotics changes depending on the dimension d.	[Sakagawa, Hironobu] Keio Univ, Yokohama, Kanagawa 2238522, Japan	Sakagawa, H (reprint author), Keio Univ, Dept Math, Fac Sci & Technol, Kouhoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	sakagawa@math.keio.ac.jp			JSPS [23740086]	This work was partially supported by the JSPS Grant-in-Aid for Young Scientists (B), No. 23740086.	Aurzada F, 2011, ELECTRON COMMUN PROB, V16, P392; Majumdar SN, 1999, CURR SCI INDIA, V77, P370; Molchan GM, 1999, COMMUN MATH PHYS, V205, P97, DOI 10.1007/s002200050669; Takeuchi KA, 2012, J STAT PHYS, V147, P853, DOI 10.1007/s10955-012-0503-0; Krug J, 1997, PHYS REV E, V56, P2702, DOI 10.1103/PhysRevE.56.2702; SLEPIAN D, 1962, BELL SYST TECH J, V41, P463; Bramson M, 2012, COMMUN PUR APPL MATH, V65, P1, DOI 10.1002/cpa.20390; Bolthausen E, 2001, ANN PROBAB, V29, P1670; Aurzada E, 2013, ANN I H POINCARE-PR, V49, P236; Aurzada F, 2011, ALEA-LAT AM J PROBAB, V8, P235; Aurzada F., 2012, PREPRINT; Dembo A, 2007, ANN I H POINCARE-PR, V43, P461, DOI 10.1016/j.anihpb.2006.07.001; Dembo A, 2013, ANN I H POINCARE-PR, V49, P873, DOI 10.1214/11-AIHP452; Dembo A, 2015, ANN PROBAB, V43, P85, DOI 10.1214/13-AOP852; Deuschel JD, 2005, INTERACTING STOCHASTIC SYSTEMS, P377, DOI 10.1007/3-540-27110-4_17; DEUSCHEL JD, 1989, ANN PROBAB, V17, P74, DOI 10.1214/aop/1176991495; Ferrari PA, 2004, STOCH PROC APPL, V114, P175, DOI 10.1016/j.spa.2004.05.003; Funaki T., 2005, LECT NOTES MATH, V1869, P103; Garet O., 2000, MARKOV PROCESS RELAT, V6, P205; Hammersley J. M., 1967, P 5 BERK S MATH STAT, P89; Lawler G. F., 2010, RANDOM WALK MODERN I; Li WV, 2004, ANN PROBAB, V32, P216; NEWELL GF, 1962, ANN MATH STAT, V33, P1306, DOI 10.1214/aoms/1177704363; Taylor J., 2007, RANDOM FIELDS GEOMET; UCHIYAMA K, 1980, Z WAHRSCHEINLICHKEIT, V54, P75, DOI 10.1007/BF00535355	25	0	0	APPLIED PROBABILITY TRUST	SHEFFIELD	THE UNIVERSITY, SCHOOL MATHEMATICS STATISTICS, SHEFFIELD S3 7RH, ENGLAND	0001-8678	1475-6064		ADV APPL PROBAB	Adv. Appl. Probab.	MAR	2015	47	1					146	163				18	Statistics & Probability	Mathematics	CG4JZ	WOS:000353252700008		
J	Fukushima, W; Honda, A; Murayama, R; Matsuda, Y; Tsuji, K; Hayashi, T; Sawahara, T; Ozawa, S; Okamot, Y; Takano, H				Fukushima, W.; Honda, A.; Murayama, R.; Matsuda, Y.; Tsuji, K.; Hayashi, T.; Sawahara, T.; Ozawa, S.; Okamot, Y.; Takano, H.			Effects of cedar pollen extract on the immune system in vitro	ALLERGOLOGIA ET IMMUNOPATHOLOGIA			English	Letter							HOUSE-DUST MITE; AIRWAY INFLAMMATION; ALLERGY; MICE		[Fukushima, W.; Honda, A.; Murayama, R.; Matsuda, Y.; Tsuji, K.; Hayashi, T.; Sawahara, T.; Takano, H.] Kyoto Univ, Grad Sch Engn, Dept Environm Engn, Div Environm Hlth,Nishikyo Ku,C Cluster, Kyoto 6158540, Japan; [Ozawa, S.] Daikin Ind Ltd, Tsukuba, Ibaraki 3050841, Japan; [Okamot, Y.] Daikin Ind Ltd, Kusatsu, Shiga 5258526, Japan	Takano, H (reprint author), Kyoto Univ, Grad Sch Engn, Dept Environm Engn, Div Environm Hlth,Nishikyo Ku,C Cluster, Kyoto 6158540, Japan.	htakano@health.env.kyoto-u.ac.jp					Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Pacciani V, 2012, ANN ALLERG ASTHMA IM, V109, P442, DOI 10.1016/j.anai.2012.09.001; Okuda M, 2003, ANN ALLERG ASTHMA IM, V91, P288; Okuyama Y, 2007, ATMOS ENVIRON, V41, P253, DOI 10.1016/j.atmosenv.2006.08.009; Conejero L, 2007, CLIN EXP ALLERGY, V37, P331, DOI 10.1111/j.1365-2222.2007.02660.x; Masuda Sawako, 2008, Arerugi, V57, P960; Platts-Mills TAE, 2012, CHEM IMMUNOL ALLERGY, V96, P1, DOI 10.1159/000331802; van Rijt LS, 2012, ALLERGY, V67, P1383, DOI 10.1111/all.12017; Wang Q, 2012, AEROBIOLOGIA, V28, P71, DOI 10.1007/s10453-011-9212-4; Yamamoto Y, 2007, J INTERF CYTOK RES, V27, P1019, DOI 10.1089/jir.2007.0061	10	0	0	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0301-0546	1578-1267		ALLERGOL IMMUNOPATH	Allergol. Immunopath.	MAR-APR	2015	43	2					222	224		10.1016/j.aller.2013.12.006		3	Allergy; Immunology	Allergy; Immunology	CF7OO	WOS:000352746400019		
J	Kojima, A; Matsushita, Y; Ogura, Y; Ishikawa, S; Noda, T; Murase, T; Harayama, H				Kojima, A.; Matsushita, Y.; Ogura, Y.; Ishikawa, S.; Noda, T.; Murase, T.; Harayama, H.			Roles of extracellular Ca2+ in the occurrence of full-type hyperactivation in boar ejaculated spermatozoa pre-incubated to induce the cAMP-triggered events	Andrology			English	Article						calcium; calpain; cAMP; hyperactivation; motility; pig; spermatozoa	PROTEIN-TYROSINE PHOSPHORYLATION; SPERM CAPACITATION; SIGNALING PATHWAYS; CALPAIN SYSTEM; BOVINE SPERM; ION CHANNELS; KINASE; CALCIUM; MOUSE; ACTIVATION	There are species differences in the regulatory system for sperm capacitation and subsequent hyperactivation between livestock and laboratory animals. In livestock spermatozoa, it is poorly understood when and how extracellular Ca2+ is necessary for hyperactivation, although it has been demonstrated that the [Ca2+](i) increase is indispensable to occurrence of hyperactivation. In this study, we examined necessity of extracellular Ca2+ for the initiation and maintenance of hyperactivation and then sought possible target molecule of Ca2+ that was involved in hyperactivation of boar spermatozoa. Boar ejaculated spermatozoa were pre-incubated with a cell-permeable cyclic adenosine monophosphate (cAMP) analog cBiMPS' and without CaCl2 to induce the cAMP-triggered events including capacitation-associated changes. Subsequently, they were incubated with CaCl2 to induce hyperactivation and then used for motility assessment. Many of the spermatozoa after the incubation exhibited full-type hyperactivation which was characterized by high-amplitude and extremely asymmetrical beating of whole middle piece and principal piece. The initiation of full-type hyperactivation required the millimolar concentration of CaCl2 in the medium. However, CaCl2 of the medium was less necessary for maintenance than initiation of full-type hyperactivation, as hyperactivated spermatozoa were barely affected by the incubation with the Ca2+-chelating reagent. On the other hand, the pre-treatment with the inhibitor for Ca2+-dependent protease calpain 1 and 2' clearly suppressed the occurrence of CaCl2-induced hyperactivation without influences on the percentages of motile spermatozoa. Western blotting and indirect immunofluorescence showed distribution of calpain 2 in the middle and principal pieces in which full-type hyperactivated spermatozoa exhibited extremely asymmetrical beating. On the basis of these results, we conclude that the millimolar concentration of extracellular Ca2+ is necessary for the initiation, but not for the maintenance of full-type hyperactivation in boar spermatozoa that beforehand undergo the cAMP-triggered events including capacitation-associated changes. Moreover, we suggest possible involvement of calpain 2 in the intracellular Ca2+ signal transduction leading to full-type hyperactivation.	[Kojima, A.; Matsushita, Y.; Ogura, Y.; Noda, T.; Harayama, H.] Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Div Anim Sci, Kobe, Hyogo 6578501, Japan; [Ishikawa, S.] Gen Technol Ctr Hyogo Prefecture Agr Forest & Fis, Awaji, Japan; [Murase, T.] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan	Harayama, H (reprint author), Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Div Anim Sci,Nada Ku, 1 Rokko Dai, Kobe, Hyogo 6578501, Japan.	harayama@kobe-u.ac.jp			Japan Society for the Promotion of Science [25450394, 26450427]	This work was supported in part by the Grants-in-Aid from Japan Society for the Promotion of Science to H.H. (25450394) and T.S. (26450427).	Marquez B, 2004, BIOL REPROD, V70, P1626, DOI 10.1095/biolreprod.103.026476; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Harayama H, 2012, MOL REPROD DEV, V79, P727, DOI 10.1002/mrd.22106; SCHAAP P, 1993, J BIOL CHEM, V268, P6323; Harayama H, 2013, J REPROD DEVELOP, V59, P421, DOI 10.1262/jrd.2013-056; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Schmidt H, 2004, REPRODUCTION, V128, P171, DOI 10.1530/rep.1.00153; Chang HX, 2011, BIOL REPROD, V85, P296, DOI 10.1095/biolreprod.110.089789; Hunter RHF, 2004, MOL REPROD DEV, V67, P243, DOI 10.1002/mrd.10390; Ignotz GG, 2005, BIOL REPROD, V73, P519, DOI 10.1095/biolreprod.105.040733; SORIMACHI H, 1994, FEBS LETT, V343, P1, DOI 10.1016/0014-5793(94)80595-4; Harayama H, 2004, MOL REPROD DEV, V69, P436, DOI 10.1002/mrd.20176; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Aitken RJ, 2013, MOL HUM REPROD, V19, P785, DOI 10.1093/molehr/gat067; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Harayama H, 2006, MOL REPROD DEV, V73, P1169, DOI 10.1002/mrd.20460; Harayama H, 2005, J ANDROL, V26, P732, DOI 10.2164/jandrol.05053; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Harayama H, 2008, MOL REPROD DEV, V75, P1396, DOI 10.1002/mrd.20882; Chang HX, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096578; CROALL DE, 1991, PHYSIOL REV, V71, P813; Harayama H, 2004, MOL REPROD DEV, V69, P194, DOI 10.1002/mrd.20099; Harayama H, 2003, J ANDROL, V24, P831; Kaneto M, 2002, ANIM REPROD SCI, V73, P197, DOI 10.1016/S0378-4320(02)00128-8; Motulsky H, 1995, INTUITIVE BIOSTATIST; Noda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057296; Noda T, 2012, THERIOGENOLOGY, V77, P1360, DOI 10.1016/j.theriogenology.2011.10.043; Yanagimachi R, 1970, Biol Reprod, V3, P147; YANAGIMA.R, 1969, J REPROD FERTIL, V18, P275; Yanagimachi R, 1994, PHYSL REPROD, V2, P189	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2047-2919	2047-2927		ANDROLOGY-US	Andrology	MAR	2015	3	2					321	331		10.1111/andr.12005		11	Andrology	Endocrinology & Metabolism	CG6HF	WOS:000353398800024		
J	Morimoto, Y; Yang, T				Morimoto, Yoshinori; Yang, Tong			Smoothing effect of the homogeneous Boltzmann equation with measure valued initial datum	ANNALES DE L INSTITUT HENRI POINCARE-ANALYSE NON LINEAIRE			English	Article						Boltzmann equation; Smoothing effect; Measure initial datum; Coercivity estimate	LITTLEWOOD-PALEY THEORY; MAXWELLIAN MOLECULES; ANGULAR CUTOFF; REGULARITY ISSUES; WEAK SOLUTIONS; ENERGY	We justify the smoothing effect for measure valued solutions to the space homogeneous Boltzmann equation of Maxwellian type cross sections. This is the first rigorous proof of the smoothing effect for any measure valued initial data except the single Dirac mass, which gives the optimal description on the regularity of solutions for positive time, caused by the singularity in the cross section. The main new ingredient in the proof is the introduction of a time degenerate coercivity estimate by using the microlocal analysis. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Morimoto, Yoshinori] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; [Yang, Tong] City Univ Hong Kong, Dept Math, Hong Kong, Hong Kong, Peoples R China	Morimoto, Y (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan.	morimoto@math.h.kyoto-u.ac.jp; matyang@cityu.edu.hk			Japan Society of the Promotion of Science [22540187]; General Research Fund of Hong Kong, CityU [103109]	Supported in part by Grant-in-Aid for Scientific Research No. 22540187, Japan Society of the Promotion of Science.; Supported in part by the General Research Fund of Hong Kong, CityU No. 103109.	Alexandre R, 2005, MATH MOD METH APPL S, V15, P907, DOI 10.1142/S0218202505000613; Alexandre R, 2009, DISCRETE CONT DYN S, V24, P1, DOI 10.3934/dcds.2009.24.1; Alexandre R, 2012, KYOTO J MATH, V52, P433, DOI 10.1215/21562261-1625154; Cannone M, 2010, COMMUN PUR APPL MATH, V63, P747; Chen YM, 2011, ARCH RATION MECH AN, V201, P501, DOI 10.1007/s00205-010-0393-8; Alexandre R, 2000, ARCH RATION MECH AN, V152, P327, DOI 10.1007/s002050000083; Villani C, 1998, ARCH RATION MECH AN, V143, P273, DOI 10.1007/s002050050106; Morimoto Y, 2010, J PSEUDO-DIFFER OPER, V1, P139, DOI 10.1007/s11868-010-0008-z; Morimoto Y, 2009, DISCRETE CONT DYN S, V24, P187, DOI 10.3934/dcds.2009.24.187; Pulvirenti A, 1996, ANN MAT PUR APPL, V171, P181, DOI 10.1007/BF01759387; Huo ZH, 2008, KINET RELAT MOD, V1, P453; Toscani G, 1999, J STAT PHYS, V94, P619, DOI 10.1023/A:1004589506756; Morimoto Y, 2012, KINET RELAT MOD, V5, P551, DOI 10.3934/krm.2012.5.551; Arkeryd L., 1972, ARCH RATIONAL MECH A, V34, P1; Carleman T, 1933, ACTA MATH-DJURSHOLM, V60, P91, DOI 10.1007/BF02398270; Desvillettes L, 2004, COMMUN PART DIFF EQ, V29, P133, DOI 10.1081/PDE-120028847; Jacob N., 2001, FOURIER ANAL SEMIGRO, V1; Lu XG, 2002, NONLINEAR ANAL-REAL, V3, P243, DOI 10.1016/S1468-1218(01)00026-8; Lu XG, 2012, J DIFFER EQUATIONS, V252, P3305, DOI 10.1016/j.jde.2011.10.021; TANAKA H, 1978, Z WAHRSCHEINLICHKEIT, V46, P67, DOI 10.1007/BF00535689; Villani C., 2002, HDB FLUID MATH FLUID; Villani C., 2008, COMMUNICATION	22	0	0	GAUTHIER-VILLARS/EDITIONS ELSEVIER	PARIS	23 RUE LINOIS, 75015 PARIS, FRANCE	0294-1449			ANN I H POINCARE-AN	Ann. Inst. Henri Poincare-Anal. Non Lineaire	MAR-APR	2015	32	2					429	442		10.1016/j.anihpc.2013.12.004		14	Mathematics, Applied	Mathematics	CG2GQ	WOS:000353093300008		
J	Takahashi, DA; Nitta, M				Takahashi, Daisuke A.; Nitta, Muneto			Counting rule of Nambu-Goldstone modes for internal and spacetime symmetries: Bogoliubov theory approach	ANNALS OF PHYSICS			English	Article						Nambu-Goldstone modes; Bogoliubov theory; Gross-Pitaevskii equation; Spinor Bose-Einstein condensates; Spontaneous symmetry breaking; Indefinite inner product space	BOSE-EINSTEIN CONDENSATION; ZERO MODES; DIAGONALIZATION; SYSTEMS; GASES; BOSONS; VORTEX; STATES	When continuous symmetry is spontaneously broken, there appear Nambu-Goldstone modes (NGMs) with linear or quadratic dispersion relation, which is called type-I or type-II, respectively. We propose a framework to count these modes including the coefficients of the dispersion relations by applying the standard Gross-Pitaevskii-Bogoliubov theory. Our method is mainly based on (i) zero-mode solutions of the Bogoliubov equation originated from spontaneous symmetry breaking and (ii) their generalized orthogonal relations, which naturally arise from well-known Bogoliubov transformations and are referred to as "sigma-orthogonality" in this paper. Unlike previous works, our framework is applicable without any modification to the cases where there are additional zero modes, which do not have a symmetry origin, such as quasi-NGMs, and/or where spacetime symmetry is spontaneously broken in the presence of a topological soliton or a vortex. As a by-product of the formulation, we also give a compact summary for mathematics of bosonic Bogoliubov equations and Bogoliubov transformations, which becomes a foundation for any problem of Bogoliubov quasiparticles. The general results are illustrated by various examples in spinor Bose-Einstein condensates (BECs). In particular, the result on the spin-3 BECs includes new findings such as a type-I-type-II transition and an increase of the type-II dispersion coefficient caused by the presence of a linearly-independent pair of zero modes. (C) 2014 Elsevier Inc. All rights reserved.	[Takahashi, Daisuke A.] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Takahashi, Daisuke A.; Nitta, Muneto] Keio Univ, Res & Educ Ctr Nat Sci, Yokohama, Kanagawa 2238521, Japan; [Nitta, Muneto] Keio Univ, Dept Phys, Yokohama, Kanagawa 2238521, Japan	Takahashi, DA (reprint author), RIKEN, Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	daisuke.takahashi.ss@riken.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25400268, 25103720]	We would like to thank Shun Uchino, Michikazu Kobayashi, and Masaya Kunimi for useful discussions. The work of MN is supported in part by Grant-in-Aid for Scientific Research (No. 25400268) and by the "Topological Quantum Phenomena" Grant-in-Aid for Scientific Research on Innovative Areas (No. 25103720) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Kawaguchi Y, 2012, PHYS REP, V520, P253, DOI 10.1016/j.physrep.2012.07.005; THOULESS DJ, 1961, NUCL PHYS, V22, P78, DOI 10.1016/0029-5582(61)90364-9; Watabe S, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.033627; Danshita I, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/3/044; Schmaljohann H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040402; Watabe S, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.053624; Ohmi T, 1998, J PHYS SOC JPN, V67, P1822, DOI 10.1143/JPSJ.67.1822; Diener RB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.190405; WEINBERG S, 1972, PHYS REV LETT, V29, P1698, DOI 10.1103/PhysRevLett.29.1698; Andrews MR, 1997, PHYS REV LETT, V79, P553, DOI 10.1103/PhysRevLett.79.553; Song JL, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.160408; Kawaguchi Y, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.053616; Kagan Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.130402; Turner AM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190404; Nicolis A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.011602; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; Stamper-Kurn DM, 2013, REV MOD PHYS, V85, P1191, DOI 10.1103/RevModPhys.85.1191; NIELSEN HB, 1976, NUCL PHYS B, V105, P445, DOI 10.1016/0550-3213(76)90025-0; Marti GE, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.155302; Myatt CJ, 1997, PHYS REV LETT, V78, P586, DOI 10.1103/PhysRevLett.78.586; Brauner T, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.085004; Stenger J, 1998, NATURE, V396, P345, DOI 10.1038/24567; Ho TL, 1998, PHYS REV LETT, V81, P742, DOI 10.1103/PhysRevLett.81.742; Watanabe H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.021601; Kuwamoto T, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.063604; Griesmaier A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160401; GEORGI H, 1975, PHYS REV D, V12, P508, DOI 10.1103/PhysRevD.12.508; COLEMAN S, 1969, PHYS REV, V177, P2239, DOI 10.1103/PhysRev.177.2239; Kovrizhin DL, 2001, PHYS LETT A, V287, P392, DOI 10.1016/S0375-9601(01)00503-5; Williamson J, 1936, AM J MATH, V58, P141, DOI 10.2307/2371062; Kato Y, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.013602; Watabe S, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.013616; Ho TL, 1996, PHYS REV LETT, V77, P3276, DOI 10.1103/PhysRevLett.77.3276; COLPA JHP, 1978, PHYSICA A, V93, P327, DOI 10.1016/0378-4371(78)90160-7; Nambu Y, 2004, J STAT PHYS, V115, P7, DOI 10.1023/B:JOSS.0000019827.74407.2d; GROSS EP, 1961, NUOVO CIMENTO, V20, P454, DOI 10.1007/BF02731494; Takeuchi H, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043612; Griffin A, 1996, PHYS REV B, V53, P9341, DOI 10.1103/PhysRevB.53.9341; Hayata T, 2014, PHYS LETT B, V735, P195, DOI 10.1016/j.physletb.2014.06.039; Arnold V I, 1989, MATH METHODS CLASSIC; Beekman A.J., 2014, ARXIV14081691; Bogolurov N.F., 1947, Journal of Physics, V11; Chang MS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.140403; Ciobanu CV, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.033607; COLPA JHP, 1986, PHYSICA A, V134, P377, DOI 10.1016/0378-4371(86)90056-7; COLPA JHP, 1986, PHYSICA A, V134, P417, DOI 10.1016/0378-4371(86)90057-9; Donnelly R. J., 1991, QUANTIZED VORTICES H; Fetter A. L., 2003, QUANTUM THEORY MANY; FETTER AL, 1972, ANN PHYS-NEW YORK, V70, P67, DOI 10.1016/0003-4916(72)90330-2; Galin D.M., 1982, AMS TRANSL, V118, P1; Hayata T., 2014, ARXIV14066271; Kobayashi M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.120403; Kobayashi M, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.025010; Kobayashi M, 2014, COLLOID SURFACE A, V440, P1, DOI 10.1016/j.colsurfa.2013.10.043; Kunimi M, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.063632; Mine M, 2007, ANN PHYS-NEW YORK, V322, P2327, DOI 10.1016/j.aop.2007.01.008; Nicolis A, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2013)055; Phuc NT, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.230401; Phuc NT, 2013, ANN PHYS-NEW YORK, V328, P158, DOI 10.1016/j.aop.2012.10.004; PITAEVSKII LP, 1961, SOV PHYS JETP-USSR, V13, P451; Smith H., 2002, BOSE EINSTEIN CONDEN; Takahashi DA, 2012, PHYSICA D, V241, P1589, DOI 10.1016/j.physd.2012.06.006; Takahashi D.A., 2014, UNPUB; Uchino S, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.063632; Uchino S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.230406; Watabe S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.063611; Watanabe H, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.101701; Watanabe H, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.191804; Watanabe H, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031057; Watanabe H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.181601; Watanabe H, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.125013; Yip SK, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.023625; Yukawa E, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.063614	73	7	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-4916	1096-035X		ANN PHYS-NEW YORK	Ann. Phys.	MAR	2015	354						101	156		10.1016/j.aop.2014.12.009		56	Physics, Multidisciplinary	Physics	CG2BI	WOS:000353079500007		
J	Ikeda, TN; Sakumichi, N; Polkovnikov, A; Ueda, M				Ikeda, Tatsuhiko N.; Sakumichi, Naoyuki; Polkovnikov, Anatoli; Ueda, Masahito			The second law of thermodynamics under unitary evolution and external operations	ANNALS OF PHYSICS			English	Article						Statistical mechanics; Thermodynamics; Quantum pure states; Isolated quantum systems	QUANTUM-SYSTEMS; ERGODIC THEOREM; THERMALIZATION; MECHANICS; DYNAMICS; PROOF	The von Neumann entropy cannot represent the thermodynamic entropy of equilibrium pure states in isolated quantum systems. The diagonal entropy, which is the Shannon entropy in the energy eigenbasis at each instant of time, is a natural generalization of the von Neumann entropy and applicable to equilibrium pure states. We show that the diagonal entropy is consistent with the second law of thermodynamics upon arbitrary external unitary operations. In terms of the diagonal entropy, thermodynamic irreversibility follows from the facts that quantum trajectories under unitary evolution are restricted by the Hamiltonian dynamics and that the external operation is performed without reference to the microscopic state of the system. (C) 2015 Elsevier Inc. All rights reserved.	[Ikeda, Tatsuhiko N.; Ueda, Masahito] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Tatsuhiko N.; Polkovnikov, Anatoli] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Sakumichi, Naoyuki] RIKEN, Nishina Ctr, Theoret Res Div, Wako, Saitama 3510198, Japan	Ikeda, TN (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.	ikeda@cat.phys.s.u-tokyo.ac.jp	Ueda, Masahito/G-3046-2012		KAKENHI [26287088, 22103005]; Photon Frontier Network Program, from MEXT of Japan; JSPS [24840];  [250588]	Fruitful discussions with Masahiro Hotta, Takashi Mori, Takahiro Sagawa, and Takanori Sugiyama are gratefully acknowledged. This work was supported by KAKENHI 26287088, a Grant-in-Aid for Scientific Research on Innovation Areas "Topological Quantum Phenomena" (KAKENHI 22103005), and the Photon Frontier Network Program, from MEXT of Japan. T.N.I. acknowledges the JSPS for financial support (Grant No. 248408). N.S. was supported by a Grant-in-Aid for JSPS Fellows (Grant No. 250588).	EDWARDS SF, 1975, J PHYS F MET PHYS, V5, P965, DOI 10.1088/0305-4608/5/5/017; Yukalov VI, 2011, LASER PHYS LETT, V8, P485, DOI 10.1002/lapl.201110002; LENARD A, 1978, J STAT PHYS, V19, P575, DOI 10.1007/BF01011769; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Lieb EH, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2013.0408; BOCCHIERI P, 1957, PHYS REV, V107, P337, DOI 10.1103/PhysRev.107.337; Reimann P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.160404; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; Linden N, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061103; Trotzky S, 2012, NAT PHYS, V8, P325, DOI [10.1038/nphys2232, 10.1038/NPHYS2232]; Goldstein S, 2010, P ROY SOC A-MATH PHY, V466, P3203, DOI 10.1098/rspa.2009.0635; Polkovnikov A, 2011, ANN PHYS-NEW YORK, V326, P486, DOI 10.1016/j.aop.2010.08.004; Popescu S, 2006, NAT PHYS, V2, P754, DOI 10.1038/nphys444; Reimann P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.190403; Tasaki H, 1998, PHYS REV LETT, V80, P1373, DOI 10.1103/PhysRevLett.80.1373; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Greiner M, 2002, NATURE, V419, P51, DOI 10.1038/nature00968; Polkovnikov A, 2011, REV MOD PHYS, V83, P863, DOI 10.1103/RevModPhys.83.863; Goldstein S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.050403; Short AJ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053009; D'Alessio L, 2013, ANN PHYS-NEW YORK, V333, P19, DOI 10.1016/j.aop.2013.02.011; Bagan E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.110504; Goldstein S, 2010, EUR PHYS J H, V35, P173, DOI 10.1140/epjh/e2010-00007-7; Goldstein S., ARXIV13036393; Lifshitz E.M., 1996, STAT PHYS, V5; Nielsen M, 2000, QUANTUM COMPUTATION; Sugita A., 2006, RIMS KOKYUROKU, V1507, P147; Tasaki H., ARXIV0009206; Tasaki H., ARXIV0011321; von Neumann J, 2010, EUR PHYS J H, V35, P201, DOI 10.1140/epjh/e2010-00008-5	30	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-4916	1096-035X		ANN PHYS-NEW YORK	Ann. Phys.	MAR	2015	354						338	352		10.1016/j.aop.2015.01.003		15	Physics, Multidisciplinary	Physics	CG2BI	WOS:000353079500021		
J	Budiyono, A; Gunara, BE; Okamura, M; Nakamura, K				Budiyono, Agung; Gunara, Bobby Eka; Okamura, Makoto; Nakamura, Katsuhiro			Maxwell speed distribution and analogue Hawking-Unruh temperature in an ontological model of a Harmonic oscillator ground state	ANNALS OF PHYSICS			English	Article						Ontological model; Quantum fluctuation; Harmonic oscillator ground state; Maxwell-Boltzmann distribution; Hawking-Unruh-like temperature	BLACK-HOLE EVAPORATION; QUANTUM DYNAMICS; QUANTIZATION	Within an ontological (hidden variable) model of quantum fluctuation, one can discuss the actual properties of a system regardless (independent) of measurement. Here we apply an ontological model proposed earlier to investigate a Harmonic oscillator in the quantum mechanical ground state. We first show that the actual speed of the oscillator fluctuates randomly following the Maxwell-Boltzmann distribution. On the other hand, the actual energy obeys a broad Gamma distribution with an average 3 (h) over bar omega/2, where omega is the classical angular frequency, so that one may conclude that the outcome of a single energy measurement reveals the average of the actual energy. The distribution of actual speed (energy) thus formally resembles the distribution of speed (energy) of an ideal gas in thermal equilibrium of temperature T-g = (h) over bar omega/2. We shall then argue that T-g can be written in a form analogous to the Hawking temperature for a Schwarzschild black hole in which the average distance of the oscillator from the origin plays the analogous role of the radius of the black hole event horizon. It can also written in a form analogous to the Unruh temperature experienced by a body moving with a uniform acceleration. In the analogy, the oscillator suffers an effective acceleration which balances the attractive force of the trapping Harmonic potential, thus keeps its average position away from the origin. (C) 2015 Elsevier Inc. All rights reserved.	[Gunara, Bobby Eka] Inst Teknol Bandung, Fac Math & Nat Sci, Bandung 40132, Indonesia; [Okamura, Makoto] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Nakamura, Katsuhiro] Natl Univ Uzbekistan, Fac Phys, Tashkent 100174, Uzbekistan; [Nakamura, Katsuhiro] Osaka City Univ, Dept Appl Phys, Sumiyoshi Ku, Osaka 5588585, Japan	Budiyono, A (reprint author), Omahe Ngainin Markini, Pati 59185, Jawa Tengah, Indonesia.	agungbymlati@gmail.com	Kyushu, RIAM/F-4018-2015		Program Riset dan Inovasi KK ITB	B.E.G. would like to thank ITB and DIKTI for Riset KK 2014, Riset Desentralisasi ITB-DIKTI 2014 and Program Riset dan Inovasi KK ITB 2015. A. B. is partially supported by Program Riset dan Inovasi KK ITB 2015. The final part of the paper is written while A. B. visited RIAM, Kyushu University.	UNRUH WG, 1981, PHYS REV LETT, V46, P1351, DOI 10.1103/PhysRevLett.46.1351; UNRUH WG, 1976, PHYS REV D, V14, P870, DOI 10.1103/PhysRevD.14.870; NELSON E, 1966, PHYS REV, V150, P1079, DOI 10.1103/PhysRev.150.1079; Ellis GFR, 2012, INTERFACE FOCUS, V2, P126, DOI 10.1098/rsfs.2011.0062; HAWKING SW, 1974, NATURE, V248, P30, DOI 10.1038/248030a0; 't Hooft G., 2002, ARXIVQUANTPH0212095V; Auletta G., 2012, INTERFACE, V5, P1159; Barcelo C, 2005, LIVING REV RELATIV, V8; Bartlett SD, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.012103; Bohm D., 1993, UNDIVIDED UNIVERSE O; Budiyono A, 2013, PHYSICA A, V392, P307, DOI 10.1016/j.physa.2012.09.002; Budiyono A, 2014, ANN PHYS-NEW YORK, V347, P170, DOI 10.1016/j.aop.2014.04.010; Budiyono A, 2014, INT J THEOR PHYS, V53, P3808, DOI 10.1007/s10773-014-2134-5; Budiyono A, 2013, PHYSICA A, V392, P43, DOI 10.1016/j.physa.2012.08.012; Budiyono A, 2012, PHYSICA A, V391, P4583, DOI 10.1016/j.physa.2012.05.046; Budiyono A, 2014, PHYSICA A, V399, P40, DOI 10.1016/j.physa.2013.12.040; de la Pena L, 2011, PHYS LETT A, V375, P1720, DOI 10.1016/j.physleta.2011.02.024; GARBACZEWSKI P, 1992, PHYS REV A, V46, P4634, DOI 10.1103/PhysRevA.46.4634; Heisenberg W., 1927, Zeitschrift fur Physik, V43, DOI 10.1007/BF01397280; Kennard E.H., 1927, Zeitschrift fur Physik, V44, DOI 10.1007/BF01391200; Kiefer Claus, 2007, QUANTUM GRAVITY; Markopoulou F, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.124029; Pearle P., 1997, QUANTUM CLASSICAL CO; Visser M, 1998, CLASSICAL QUANT GRAV, V15, P1767, DOI 10.1088/0264-9381/15/6/024	24	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-4916	1096-035X		ANN PHYS-NEW YORK	Ann. Phys.	MAR	2015	354						556	564		10.1016/j.aop.2015.01.016		9	Physics, Multidisciplinary	Physics	CG2BI	WOS:000353079500039		
J	Otsuka, A; Goto, M				Otsuka, Akihiro; Goto, Mika			Agglomeration economies in Japanese industries: the Solow residual approach	ANNALS OF REGIONAL SCIENCE			English	Article							PRODUCTIVE EFFICIENCY; TECHNICAL EFFICIENCY; CITY SIZE; EXTERNALITIES; SCALE	This paper proposes a new approach to measuring agglomeration economies in Japan. Under the proposed approach, we used the Solow residual to measure agglomeration economies and confirmed that agglomeration economies exist in both manufacturing and non-manufacturing industries. Furthermore, this paper shows that social overhead capital has a positive effect on agglomeration economies. Currently, agglomeration economies are robust only in metropolitan areas; however, they are present throughout Japan because of the disproportionate allocation of social overhead capital within the nation.	[Otsuka, Akihiro] Cent Res Inst Elect Power Ind, Socioecon Res Ctr, Chiyoda Ku, Tokyo 1008126, Japan; [Goto, Mika] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528552, Japan	Otsuka, A (reprint author), Cent Res Inst Elect Power Ind, Socioecon Res Ctr, Chiyoda Ku, 1-6-1 Otemachi, Tokyo 1008126, Japan.	akihiro@criepi.denken.or.jp; mikagoto@valdes.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [24530287]	This work was supported by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI) 24530287.	Ciccone A, 1996, AM ECON REV, V86, P54; HENDERSON JV, 1986, J URBAN ECON, V19, P47, DOI 10.1016/0094-1190(86)90030-6; Graham DJ, 2008, ANN REGIONAL SCI, V42, P267, DOI 10.1007/s00168-007-0156-0; Graham DJ, 2009, PAP REG SCI, V88, P63, DOI 10.1111/j.1435-5957.2008.00166.x; Henderson JV, 2003, J URBAN ECON, V53, P1, DOI 10.1016/S0094-1190(02)00505-3; Ciccone A, 2002, EUR ECON REV, V46, P213, DOI 10.1016/S0014-2921(00)00099-4; Otsuka A, 2010, PAP REG SCI, V89, P819, DOI 10.1111/j.1435-5957.2010.00286.x; Tveteras R, 2006, J REGIONAL SCI, V46, P605, DOI 10.1111/j.1467-9787.2006.00470.x; BEESON PE, 1989, J REGIONAL SCI, V29, P15, DOI 10.1111/j.1467-9787.1989.tb01219.x; Driffield N, 2001, REG STUD, V35, P391, DOI 10.1080/713693833; Fujita M., 2002, EC AGGLOMERATION; Glaeser EL, 2001, J ECON GEOGR, V1, P27, DOI DOI 10.1093/JEG/1.1.27; Kanemoto Y, 1996, J JPN INT ECON, V10, P379, DOI 10.1006/jjie.1996.0022; McCann P, 2001, URBAN REG EC; Mitra A, 2000, REV URBAN REGIONAL D, V12, P97, DOI 10.1111/1467-940X.00023; Mitra A, 1999, J URBAN ECON, V45, P490, DOI 10.1006/juec.1998.2100; MOOMAW RL, 1981, Q J ECON, V96, P675, DOI 10.2307/1880747; MOOMAW RL, 1983, REG SCI URBAN ECON, V13, P525, DOI 10.1016/0166-0462(83)90033-9; NAKAMURA R, 1985, J URBAN ECON, V17, P108, DOI 10.1016/0094-1190(85)90040-3; Otsuka A, 2015, REG STUD, V49, P518, DOI 10.1080/00343404.2013.795285; Otsuka A, 2014, REG STUD REG SCI, V1, P207; Rosenthal S, 2005, WORKING PAPER; Rosenthal SS, 2004, HDB REGIONAL URBAN E, V4	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0570-1864	1432-0592		ANN REGIONAL SCI	Ann. Reg. Sci.	MAR	2015	54	2					401	416		10.1007/s00168-015-0659-z		16	Economics; Environmental Studies; Geography	Business & Economics; Environmental Sciences & Ecology; Geography	CG5TD	WOS:000353356800004		
J	Komaki, F				Komaki, Fumiyasu			Asymptotic Properties of Bayesian Predictive Densities When the Distributions of Data and Target Variables are Different	BAYESIAN ANALYSIS			English	Article						differential geometry; Fisher-Rao metric; Jeffreys prior; Kullback-Leibler divergence; predictive metric	SHRINKAGE PRIORS; OBSERVABLES; REGRESSION	Bayesian predictive densities when the observed data x and the target variable y to be predicted have different distributions are investigated by using the framework of information geometry. The performance of predictive densities is evaluated by the Kullback-Leibler divergence. The parametric models are formulated as Riemannian manifolds. In the conventional setting in which x and y have the same distribution, the Fisher-Rao metric and the Jeffreys prior play essential roles. In the present setting in which x and y have different distributions, a new metric, which we call the predictive metric, constructed by using the Fisher information matrices of x and y, and the volume element based on the predictive metric play the corresponding roles. It is shown that Bayesian predictive densities based on priors constructed by using non-constant positive superharmonic functions with respect to the predictive metric asymptotically dominate those based on the volume element prior of the predictive metric.	[Komaki, Fumiyasu] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Bunkyo Ku, Tokyo 1138656, Japan; [Komaki, Fumiyasu] RIKEN Brain Sci Inst, Wako, Saitama 3510198, Japan	Komaki, F (reprint author), Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	komaki@mist.i.u-tokyo.ac.jp			 [23650144];  [26280005]	The author appreciates constructive comments of the associate editor. This research was partially supported by Grant-in-Aid for Scientific Research (23650144, 26280005).	Aitchison J, 1975, STAT PREDICTION ANAL; Amari S., 1985, DIFFERENTIAL GEOMETR; Kobayashi K, 2008, J MULTIVARIATE ANAL, V99, P1888, DOI 10.1016/j.jmva.2008.01.014; Komaki F, 2001, BIOMETRIKA, V88, P859, DOI 10.1093/biomet/88.3.859; George EI, 2008, ECONOMET THEOR, V24, P528, DOI 10.1017/S0266466608080213; George EI, 2006, ANN STAT, V34, P78, DOI 10.1214/009053606000000155; Bernardo J. M., 1992, BAYESIAN STATISTICS, V4, P35; Davies E. B., 1989, HEAT KERNELS SPECTRA; EFRON B, 1975, ANN STAT, V3, P1189, DOI 10.1214/aos/1176343282; Fushiki T, 2004, SCAND J STAT, V31, P403, DOI 10.1111/j.1467-9469.2004.02_127.x; Geisser Seymour, 1993, PREDICTIVE INFERENCE; Hartigan JA, 1998, ANN STAT, V26, P2083; Helgason S, 1984, GROUPS GEOMETRIC ANA; Komaki F, 2006, ANN STAT, V34, P808, DOI 10.1214/009053606000000010; Komaki F, 2007, ANN I STAT MATH, V59, P135, DOI 10.1007/s10463-006-0102-4; Komaki F, 1996, BIOMETRIKA, V83, P299, DOI 10.1093/biomet/83.2.299; Komaki F, 2004, ANN STAT, V32, P1744, DOI 10.1214/009053604000000445; Sweeting TJ, 2006, ANN STAT, V34, P441, DOI 10.1214/009053605000000804; ZIDEK JV, 1969, ANN I STAT MATH, V21, P291, DOI 10.1007/BF02532257	19	1	1	INT SOC BAYESIAN ANALYSIS	PITTSBURGH	CARNEGIE MELLON UNIV, DEPT STTISTICS, PITTSBURGH, PA 15213 USA	1931-6690	1936-0975		BAYESIAN ANAL	Bayesian Anal.	MAR	2015	10	1					31	51		10.1214/14-BA886		21	Mathematics, Interdisciplinary Applications; Statistics & Probability	Mathematics	CG1TY	WOS:000353058600002		
J	Keppler-Tasaki, S				Keppler-Tasaki, Stefan			Construction of the Past. Medieval Paintings since the Renaissance	BEITRAGE ZUR GESCHICHTE DER DEUTSCHEN SPRACHE UND LITERATUR			German	Book Review									[Keppler-Tasaki, Stefan] Univ Tokyo, German Dept, Bunkyo Ku, Tokyo 1130033, Japan	Keppler-Tasaki, S (reprint author), Univ Tokyo, German Dept, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	keppler@l.u-tokyo.ac.jp					KERTH S, 2012, VERGANGENHEIT KONSTR	1	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0005-8076	1865-9373		BEITR GESCH DEUT SPR	Beitr. Gesch. Deut. Sprache Lit.	MAR	2015	137	1					179	182		10.1515/bgsl-2015-0018		4	Language & Linguistics; Literature, German, Dutch, Scandinavian	Linguistics; Literature	CF9BC	WOS:000352855500016		
J	Mizutani, E; Oikawa, M; Kassai, H; Inoue, K; Shiura, H; Hirasawa, R; Kamimura, S; Matoba, S; Ogonuki, N; Nagatomo, H; Abe, K; Wakayama, T; Aiba, A; Ogura, A				Mizutani, Eiji; Oikawa, Mami; Kassai, Hidetoshi; Inoue, Kimiko; Shiura, Hirosuke; Hirasawa, Ryutaro; Kamimura, Satoshi; Matoba, Shogo; Ogonuki, Narumi; Nagatomo, Hiroaki; Abe, Kuniya; Wakayama, Teruhiko; Aiba, Atsu; Ogura, Atsuo			Generation of Cloned Mice from Adult Neurons by Direct Nuclear Transfer	BIOLOGY OF REPRODUCTION			English	Article						assisted reproductive technology; CA1 pyramidal cells; cloning; developmental biology; early development; hippocampus; mouse; neural cells; nuclear transfer; reprogramming	EMBRYONIC STEM-CELLS; X-CHROMOSOME INACTIVATION; GENE-EXPRESSION ANALYSIS; RNAI-MEDIATED KNOCKDOWN; FULL-TERM DEVELOPMENT; MOUSE EMBRYOS; PREIMPLANTATION EMBRYOS; DNA METHYLATION; CEREBRAL-CORTEX; TRICHOSTATIN-A	Whereas cloning mammals by direct somatic cell nuclear transfer has been successful using a wide range of donor cell types, neurons from adult brain remain "unclonable'' for unknown reasons. Here, using a combination of two epigenetic approaches, we examined whether neurons from adult mice could be cloned. First, we used a specific antibody to discover cell types with reduced amounts of a repressive histone mark-dimethylated histone H3 lysine 9 (H3K9me2)-and identified CA1 pyramidal cells in the hippocampus and Purkinje cells in the cerebellum as candidates. Second, reconstructed embryos were treated with trichostatin A (TSA), a potent histone deacetylase inhibitor. Using CA1 cells, cloned offspring were obtained at high rates, reaching 10.2% and 4.6% (of embryos transferred) for male and female donors, respectively. Cerebellar Purkinje cell nuclei were too large to maintain their genetic integrity during nuclear transfer, leading to developmental arrest of embryos. However, gene expression analysis using cloned blastocysts corroborated a high rate of genomic reprogrammability of CA1 pyramidal and Purkinje cells. Neurons from the hippocampal dentate gyrus and cerebral cortex, which had higher amounts of H3K9me2, could also be used for producing cloned offspring, but the efficiencies were low. A more thorough analysis revealed that TSA treatment was essential for cloning adult neuronal cells. This study demonstrates, to our knowledge for the first time, that adult neurons can be cloned by nuclear transfer. Furthermore, our data imply that reduced amounts of H3K9me2 and increased histone acetylation appear to act synergistically to improve the development of cloned embryos	[Mizutani, Eiji; Oikawa, Mami; Inoue, Kimiko; Shiura, Hirosuke; Hirasawa, Ryutaro; Kamimura, Satoshi; Matoba, Shogo; Ogonuki, Narumi; Abe, Kuniya; Ogura, Atsuo] RIKEN, Bioresource Ctr, Tsukuba, Ibaraki, Japan; [Mizutani, Eiji; Nagatomo, Hiroaki; Wakayama, Teruhiko] Univ Yamanashi, Fac Life & Environm Sci, Yamanashi, Japan; [Kassai, Hidetoshi; Aiba, Atsu; Ogura, Atsuo] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Anim Resources, Tokyo, Japan; [Inoue, Kimiko; Kamimura, Satoshi; Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan	Ogura, A (reprint author), RIKEN, Bioresource Ctr, Tsukuba, Ibaraki, Japan.	ogura@rtc.riken.go.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24780277, 2368004, 25112009, 23220011]; Sumitomo Foundation [120620]; RIKEN Epigenetics Program (Strategic Programs for RD)	Supported by Grant-in-Aids from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (no. 24780277 to E.M., no. 2368004 to K.I., and nos. 25112009 and 23220011 to A.O.), in part by a Grant for Basic Science Research Projects from the Sumitomo Foundation (no. 120620 to E.M.), and by the RIKEN Epigenetics Program (Strategic Programs for R&D). The microarray data have been submitted to NCBI Gene Expression Omnibus (GEO) under the accession number GSE65497.	Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Li JS, 2007, P NATL ACAD SCI USA, V104, P2738, DOI 10.1073/pnas.0611358104; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Bui HT, 2010, BIOL REPROD, V83, P454, DOI 10.1095/biolreprod.109.083337; Nguyen DK, 2006, BRAIN RES, V1126, P46, DOI 10.1016/j.brainres.2006.08.053; Wakayama S, 2008, P NATL ACAD SCI USA, V105, P17318, DOI 10.1073/pnas.0806166105; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Wakayama T, 2007, J REPROD DEVELOP, V53, P13, DOI 10.1262/jrd.18120; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Wakayama S, 2013, CELL STEM CELL, V12, P293, DOI 10.1016/j.stem.2013.01.005; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Inoue K, 2007, STEM CELLS, V25, P1279, DOI 10.1634/stemcells.2006-0747; NAGY A, 1990, DEVELOPMENT, V110, P815; Filion GJ, 2010, NAT GENET, V42, P4, DOI 10.1038/ng0110-4; Ohgane J, 2001, GENESIS, V30, P45, DOI 10.1002/gene.1031; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Okamoto I, 2000, DEVELOPMENT, V127, P4137; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hirasawa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076422; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Oikawa M, 2014, EPIGENETICS-US, V9, P204, DOI 10.4161/epi.26939; Nesterova TB, 2001, DEV BIOL, V235, P343, DOI 10.1006/dbio.2001.0295; Cibelli J, 2007, SCIENCE, V316, P990, DOI 10.1126/science.1143512; Eggan Kevin, 2004, Nature (London), V428, P44, DOI 10.1038/nature02375; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; Huynh KD, 2005, NAT REV GENET, V6, P410, DOI 10.1038/nrg1604; Kamimura S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110098; Kato Y, 2007, CLONING STEM CELLS, V9, P495, DOI 10.1089/clo.2007.0014; Kishigami S, 2006, FEBS LETT, V580, P1801, DOI 10.1016/j.febslet.2006.02.036; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Makino H, 2005, CLONING STEM CELLS, V7, P45, DOI 10.1089/clo.2005.7.45; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Mizutani E, 2012, DEV BIOL, V364, P56, DOI 10.1016/j.ydbio.2012.01.001; Mizutani E, 2006, REPRODUCTION, V132, P849, DOI 10.1530/rep.1.01010; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; Ohgane J, 2004, GENES CELLS, V9, P253, DOI 10.1111/j.1365-2443.2004.00720.x; Oikawa M, 2013, J REPROD DEVELOP, V59, P231, DOI 10.1262/jrd.2012-195; Osada T, 2005, J NEUROSCI, V25, P8368, DOI 10.1523/JNEUROSCI.1591-05.2005; Terashita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078380; Thuan Nguyen Van, 2010, J Reprod Dev, V56, P20; Yamagata K, 2009, HUM REPROD, V24, P2490, DOI 10.1093/humrep/dep236; Yamagata K, 2010, METHODS, V52, P259, DOI 10.1016/j.ymeth.2010.04.008; Yamazaki T, 2007, DEV BIOL, V304, P409, DOI 10.1016/j.ydbio.2006.12.046; Yamazaki Y, 2001, P NATL ACAD SCI USA, V98, P14022, DOI 10.1073/pnas.231489398	67	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	MAR 1	2015	92	3							81	10.1095/biolreprod.114.123455		11	Reproductive Biology	Reproductive Biology	CG3XS	WOS:000353213500011		
J	Sugawara, S; Ito, T; Sato, S; Sato, Y; Sasaki, A; Fukuda, T; Yamanaka, K; Sakatani, M; Takahashi, M; Kobayashi, M				Sugawara, Saiko; Ito, Toshihiko; Sato, Shiori; Sato, Yuki; Sasaki, Akira; Fukuda, Tomokazu; Yamanaka, Ken-ichi; Sakatani, Miki; Takahashi, Masashi; Kobayashi, Masayuki			Generation of aminoterminally truncated, stable types of bioactive bovine and porcine fibroblast growth factor 4 in Escherichia coli	BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY			English	Article						bovine; Escherichia coli; FGF4; porcine; recombinant; stable; truncate	COMMON NUCLEOTIDE-SEQUENCE; TROPHOBLAST STEM-CELLS; HOMEOPROTEIN EGAM1C; RECEPTOR-BINDING; STRUCTURAL GENE; IN-VITRO; 3 BREEDS; EXPRESSION; MOUSE; DIFFERENTIATION	Fibroblast growth factor 4 (FGF4) is a crucial growth factor for the development of mammalian embryos. We previously produced hexahistidine-tagged, bovine and porcine FGF4 (Pro(32) to Leu(206)) proteins without a secretory signal peptide at the aminoterminus in Escherichia coli. Here, we found that these were unstable; site-specific cleavage between Ser(54) and Leu(55) in both FGF4 derivatives was identified. In order to generate stable FGF4 derivatives and to investigate their biological activities, aminoterminally truncated and hexahistidine-tagged bovine and porcine FGF4 (Leu(55) to Leu(206)) proteins, termed HisbFGF4L and HispFGF4L, respectively, were produced in E. coli. These FGF4 derivatives were sufficiently stable and exerted mitogenic activities in fibroblasts. Treatment with the FGF4 derivatives promoted the phosphorylation of ERK1/2, which are crucial kinases in the FGF signaling pathway. In the presence of PD173074, an FGF receptor inhibitor, the phosphorylation of ERK1/2 was inhibited and resulted in abolition of the growth-promoting activity of FGF4 derivatives. Taken together, we demonstrate that HisbFGF4L and HispFGF4L are capable of promoting the proliferation of bovine- and porcine-derived cells, respectively, via an authentic FGF signaling pathway. These FGF4 derivatives may be applicable for dissecting the roles of FGF4 during embryogenesis in cattle and pigs. (C) 2014 International Union of Biochemistry and Molecular Biology, Inc.	[Sugawara, Saiko; Ito, Toshihiko; Sato, Shiori; Sato, Yuki; Sasaki, Akira; Kobayashi, Masayuki] Akita Prefectural Univ, Grad Sch Bioresource Sci, Akita 0100195, Japan; [Sasaki, Akira] Akita Res Inst Food & Brewing, Akita, Japan; [Fukuda, Tomokazu] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Yamanaka, Ken-ichi] Saga Univ, Fac Agr, Saga 840, Japan; [Sakatani, Miki] NARO Kyushu Okinawa Agr Res Ctr, Koshi, Japan; [Takahashi, Masashi] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan	Kobayashi, M (reprint author), Akita Prefectural Univ, Grad Sch Bioresource Sci, Lab Adv Anim Cell Technol, Akita 0100195, Japan.	makoba@akita-pu.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [24580413]; Akita Prefectural University President's Research Project [44, 79]	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI No. 24580413) and the Akita Prefectural University President's Research Project (H24Kendai-chi No. 44 and H25Kendai-chi No. 79) to Masayuki Kobayashi. The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.	Amarnath D, 2007, J REPROD DEVELOP, V53, P1247, DOI 10.1262/jrd.19096; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NISWANDER L, 1992, DEVELOPMENT, V114, P755; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Sugawara S, 2014, J BIOSCI BIOENG, V117, P525, DOI 10.1016/j.jbiosc.2013.10.009; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Fukuda T, 2012, BIOSCI BIOTECH BIOCH, V76, P1372, DOI 10.1271/bbb.120155; Soma M, 2011, BIOTECHNOL BIOTEC EQ, V25, P2679, DOI 10.5504/BBEQ.2011.0094; Fujii T, 2010, CELL REPROGRAM, V12, P617, DOI 10.1089/cell.2010.0017; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; Saito K, 2011, REPRODUCTION, V141, P259, DOI 10.1530/REP-10-0355; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Saito K, 2010, BIOL REPROD, V82, P687, DOI 10.1095/biolreprod.108.075697; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; DELLIBOVI P, 1988, MOL CELL BIOL, V8, P2933; Kreuger J, 2005, BIOCHEM J, V389, P145, DOI 10.1042/BJ20042129; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; BAIRD A, 1988, P NATL ACAD SCI USA, V85, P2324, DOI 10.1073/pnas.85.7.2324; RAPPOLEE DA, 1994, DEVELOPMENT, V120, P2259; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Iha M, 2012, REPRODUCTION, V143, P477, DOI 10.1530/REP-11-0379; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Yang QE, 2011, BIOL REPROD, V85, P946, DOI 10.1095/biolreprod.111.093203; BELLOSTA P, 1993, J CELL BIOL, V121, P705, DOI 10.1083/jcb.121.3.705; Bellosta P, 2001, MOL CELL BIOL, V21, P5946, DOI 10.1128/MCB.21.17.5946-5957.2001; FULLERPACE F, 1991, J CELL BIOL, V115, P547, DOI 10.1083/jcb.115.2.547; Hosoi Y, 2011, J REPROD DEVELOP, V57, P650, DOI 10.1262/jrd.11-043H; Sato S, 2012, ANIM SCI J, V83, P260, DOI 10.1111/j.1740-0929.2011.01000.x; Sugawara S, 2014, APPL BIOCHEM BIOTECH, V172, P206, DOI 10.1007/s12010-013-0544-0; Sugawara S., 2014, TOHOKU J ANIM SCI TE, V63, P38; Sugawara S, 2013, ANIM SCI J, V84, P275, DOI 10.1111/asj.12036; Sugawara S, 2013, BIOSCI BIOTECH BIOCH, V77, P173, DOI 10.1271/bbb.120698; Venkataraman G, 1999, P NATL ACAD SCI USA, V96, P3658, DOI 10.1073/pnas.96.7.3658	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-4513	1470-8744		BIOTECHNOL APPL BIOC	Biotechnol. Appl. Biochem.	MAR-APR	2015	62	2					164	172		10.1002/bab.1251		9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CG3FU	WOS:000353164500003		
J	Tanami, Y; Jinzaki, M; Kishi, S; Matheson, M; Vavere, AL; Rochitte, CE; Dewey, M; Chen, MY; Clouse, ME; Cox, C; Kuribayashi, S; Lima, JAC; Arbab-Zadeh, A				Tanami, Yutaka; Jinzaki, Masahiro; Kishi, Satoru; Matheson, Matthew; Vavere, Andrea L.; Rochitte, Carlos E.; Dewey, Marc; Chen, Marcus Y.; Clouse, Melvin E.; Cox, Christopher; Kuribayashi, Sachio; Lima, Joao A. C.; Arbab-Zadeh, Armin			Lack of Association Between Epicardial Fat Volume and Extent of Coronary Artery Calcification, Severity of Coronary Artery Disease, or Presence of Myocardial Perfusion Abnormalities in a Diverse, Symptomatic Patient Population Results From the CORE320 Multicenter Study	Circulation-Cardiovascular Imaging			English	Article						coronary artery disease; coronary stenosis; myocardial ischemia	MULTISLICE COMPUTED-TOMOGRAPHY; CARDIOVASCULAR RISK-FACTORS; VISCERAL ABDOMINAL FAT; ADIPOSE-TISSUE VOLUME; BODY-MASS INDEX; PERICARDIAL FAT; DIAGNOSTIC PERFORMANCE; METABOLIC SYNDROME; CT ANGIOGRAPHY; ATHEROSCLEROSIS	Background-Epicardial fat may play a role in the pathogenesis of coronary artery disease (CAD). We explored the relationship of epicardial fat volume (EFV) with the presence and severity of CAD or myocardial perfusion abnormalities in a diverse, symptomatic patient population. Methods and Results-Patients (n=380) with known or suspected CAD who underwent 320-detector row computed tomographic angiography, nuclear stress perfusion imaging, and clinically driven invasive coronary angiography for the CORE320 international study were included. EFV was defined as adipose tissue within the pericardial borders as assessed by computed tomography using semiautomatic software. We used linear and logistic regression models to assess the relationship of EFV with coronary calcium score, stenosis severity by quantitative coronary angiography, and myocardial perfusion abnormalities by single photon emission computed tomography (SPECT). Median EFV among patients (median age, 62.6 years) was 102 cm(3) (interquartile range: 53). A coronary calcium score of >= 1 was present in 83% of patients. Fifty-nine percent of patients had >= 1 coronary artery stenosis of >= 50% by quantitative coronary angiography, and 49% had abnormal myocardial perfusion results by SPECT. There were no significant associations between EFV and coronary artery calcium scanning, presence severity of >= 50% stenosis by quantitative coronary angiography, or abnormal myocardial perfusion by SPECT. Conclusions-In a diverse population of symptomatic patients referred for invasive coronary angiography, we did not find associations of EFV with the presence and severity of CAD or with myocardial perfusion abnormalities. The clinical significance of quantifying EFV remains uncertain but may relate to the pathophysiology of acute coronary events rather than the presence of atherosclerotic disease.	[Tanami, Yutaka; Jinzaki, Masahiro; Kuribayashi, Sachio] Keio Univ, Dept Radiol, Tokyo, Japan; [Kishi, Satoru; Vavere, Andrea L.; Lima, Joao A. C.; Arbab-Zadeh, Armin] Johns Hopkins Univ, Dept Med Cardiol, Baltimore, MD 21287 USA; [Matheson, Matthew; Cox, Christopher] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; [Rochitte, Carlos E.] InCor Heart Inst, Dept Med Cardiol, Sao Paulo, Brazil; [Dewey, Marc] Charite, Dept Radiol, Berlin, Germany; [Chen, Marcus Y.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Clouse, Melvin E.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA	Arbab-Zadeh, A (reprint author), Johns Hopkins Univ, Div Cardiol, 600 N Wolfe St,Blalock 524, Baltimore, MD 21287 USA.	azadeh1@jhmi.edu			Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, United States; National Institutes of Health [K23HL098368]; Toshiba Medical Systems	This work was funded, in part, by the Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, United States. Dr Arbab-Zadeh was funded by grant K23HL098368 from the National Institutes of Health. The parent study for this research, the CORE320 multicenter study, was sponsored by Toshiba Medical Systems.	Ahmadi N, 2010, ACAD RADIOL, V17, P1518, DOI 10.1016/j.acra.2010.08.017; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Tamarappoo B, 2010, JACC-CARDIOVASC IMAG, V3, P1104, DOI 10.1016/j.jcmg.2010.07.014; Hendel RC, 2009, J AM COLL CARDIOL, V53, P2201, DOI 10.1016/j.jacc.2009.02.013; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Sarin S, 2008, AM J CARDIOL, V102, P767, DOI 10.1016/j.amjcard.2008.04.058; de Vos AM, 2008, EUR HEART J, V29, P777, DOI 10.1093/eurheartj/ehm564; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; Djaberi R, 2008, AM J CARDIOL, V102, P1602, DOI 10.1016/j.amjcard.2008.08.010; Ding JZ, 2008, AM J CLIN NUTR, V88, P645; Carroll JF, 2008, OBESITY, V16, P600, DOI 10.1038/oby.2007.92; George RT, 2011, AM J ROENTGENOL, V197, P829, DOI 10.2214/AJR.10.5689; Arbab-Zadeh A, 2012, CIRCULATION, V125, P1147, DOI 10.1161/CIRCULATIONAHA.111.047431; Rochitte CE, 2014, EUR HEART J, V35, P1120, DOI 10.1093/eurheartj/eht488; Bucci M, 2011, ARTERIOSCL THROM VAS, V31, P211, DOI 10.1161/ATVBAHA.110.213827; Nakanishi R, 2011, ATHEROSCLEROSIS, V218, P363, DOI 10.1016/j.atherosclerosis.2011.07.093; Sacks HS, 2011, CLIN EXP PHARMACOL P, V38, P879, DOI 10.1111/j.1440-1681.2011.05601.x; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Vavere AL, 2011, J CARDIOVASC COMPUT, V5, P370, DOI 10.1016/j.jcct.2011.11.001; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Labounty TM, 2013, EUR HEART J-CARD IMG, V14, P456, DOI 10.1093/ehjci/jes179; Feinstein M, 2012, CIRCULATION, V126, P50, DOI 10.1161/CIRCULATIONAHA.111.057232; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Iwasaki K, 2011, CLIN CARDIOL, V34, P166, DOI 10.1002/clc.20840; Ueno K, 2009, CIRC J, V73, P1927; Inoue F, 2004, CIRC J, V68, P840, DOI 10.1253/circj.68.840; Marwan M, 2013, J CARDIOVASC COMPUT, V7, P3, DOI 10.1016/j.jcct.2013.01.002; Dey D, 2010, ATHEROSCLEROSIS, V209, P136, DOI 10.1016/j.atherosclerosis.2009.08.032; Ding JZ, 2008, OBESITY, V16, P1914, DOI 10.1038/oby.2008.278; Janik M, 2010, J NUCL CARDIOL, V17, P841, DOI 10.1007/s12350-010-9235-1; Miller JM, 2009, EUR RADIOL, V19, P816, DOI 10.1007/s00330-008-1203-7; Cerci RJ, 2012, CIRC-CARDIOVASC IMAG, V5, P587, DOI 10.1161/CIRCIMAGING.111.970608; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Brinkley TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028410; Burke GL, 2008, ARCH INTERN MED, V168, P928, DOI 10.1001/archinte.168.9.928; Chaldakov GN, 2012, CELL BIOL INT, V36, P327, DOI 10.1042/CBI20110422; De Schutter A, 2014, PROG CARDIOVASC DIS, V56, P401, DOI 10.1016/j.pcad.2013.08.003; Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582; Hachamovitch R, 2009, J NUCL CARDIOL, V16, P935, DOI 10.1007/s12350-009-9140-7; Kim HM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-83; Versteylen MO, 2012, EUR HEART J-CARD IMG, V13, P517, DOI 10.1093/ehjci/jes024; Willens HJ, 2008, ETHNIC DIS, V18, P311; Williams JK, 1996, TRENDS CARDIOVAS MED, V6, P53, DOI 10.1016/1050-1738(96)00008-4	44	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-9651	1942-0080		CIRC-CARDIOVASC IMAG	Circ.-Cardiovasc. Imaging	MAR	2015	8	3							e002676	10.1161/CIRCIMAGING.114.002676		9	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CG5CW	WOS:000353309700006		
J	Monjil, MS; Nozawa, T; Shibata, Y; Takemoto, D; Ojika, M; Kawakita, K				Monjil, Mohammad Shahjahan; Nozawa, Takeshi; Shibata, Yusuke; Takemoto, Daigo; Ojika, Makoto; Kawakita, Kazuhito			Methanol extract of mycelia from Phytophthora infestans-induced resistance in potato	COMPTES RENDUS BIOLOGIES			English	Article						Methanol extract of mycelia; Defence activities; Phytophthora infestans; Potato; Elicitor	SYSTEMIC ACQUIRED-RESISTANCE; CELL-SUSPENSION CULTURES; NITRIC-OXIDE; DISEASE RESISTANCE; SALICYLIC-ACID; PHYTOALEXIN ACCUMULATION; HYPERSENSITIVE RESPONSE; SIGNAL-TRANSDUCTION; DEFENSE RESPONSES; NADPH OXIDASE	Plants recognize certain microbial compounds as elicitors in their active defence mechanisms. It has been shown that a series of defence reactions are induced in potato plant cells after treatment with water-soluble hyphal wall components prepared from Phytophthora infestans. In this study, a methanol extract from mycelia of P. infestans (MEM), which contains lipophilic compounds, was used as another elicitor for the induction of the defence reactions in potato. MEM elicitor induced reactive oxygen species (ROS), especially O-2(-) and H2O2 production, and nitric oxide (NO) generation in potato leaves and suspension-cultured cells. Hypersensitive cell death was detected in potato leaves within 6-8 h after MEM elicitor treatment. The accumulation of phytoalexins was detected by MEM elicitor treatment in potato tubers. In potato suspension-cultured cells, several defence-related genes were induced by MEM elicitors, namely Strboh, Sthsr203J, StPVS3, StPR1, and StNR5, which regulate various defence-related functions. Enhanced resistance against P. infestans was found in MEM-treated potato plants. These results suggested that MEM elicitor is recognized by host and enhances defence activities to produce substances inhibitory to pathogens. (C) 2015 Academie des sciences. Published by Elsevier Masson SAS. All rights reserved.	[Monjil, Mohammad Shahjahan] Bangladesh Agr Univ, Dept Plant Pathol, Mymensingh 2202, Bangladesh; [Nozawa, Takeshi; Shibata, Yusuke; Takemoto, Daigo; Kawakita, Kazuhito] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ojika, Makoto] Nagoya Univ, Grad Sch Bioagr Sci, Plant Pathol Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Kawakita, K (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	smonjil@yahoo.com; kkawakit@agr.nagoya-u.ac.jp					Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Noritake T, 1996, PLANT CELL PHYSIOL, V37, P113; Zurbriggen MD, 2009, PLANT J, V60, P962, DOI 10.1111/j.1365-313X.2009.04010.x; BOSTOCK RM, 1981, SCIENCE, V212, P67, DOI 10.1126/science.212.4490.67; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Yamamizo C, 2006, PLANT PHYSIOL, V140, P681, DOI 10.1104/pp.105.074906; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Liljeroth E, 2010, EUR J PLANT PATHOL, V127, P171, DOI 10.1007/s10658-010-9582-4; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Grayer RJ, 2001, PHYTOCHEMISTRY, V56, P253, DOI 10.1016/S0031-9422(00)00450-7; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Vanetten H, 2001, PHYSIOL MOL PLANT P, V59, P83, DOI 10.1006/pmpp.2001.0350; Eschen-Lippold L, 2010, MOL PLANT MICROBE IN, V23, P585, DOI 10.1094/MPMI-23-5-0585; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Thoma I, 2003, PLANT J, V34, P363, DOI 10.1046/j.1365-313X.2003.01730.x; WARD ER, 1991, PLANT CELL, V3, P1085; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; KAMOUN S, 1993, MOL PLANT MICROBE IN, V6, P15, DOI 10.1094/MPMI-6-015; Yoshioka H, 2001, MOL PLANT MICROBE IN, V14, P725, DOI 10.1094/MPMI.2001.14.6.725; Apostol I., 1989, PLANT PHYSIOL, V90, P106; Boccara M, 2005, PLANT J, V43, P226, DOI 10.1111/j.1365-313X.2005.02443.x; Czernic P, 1996, PLANT MOL BIOL, V31, P255, DOI 10.1007/BF00021788; Doke N., 1983, PHYSL PLANT PATHOL, V23, P259; Doke N., 1991, ACTIVE OXYGEN OXIDAT, P84; Engstrom K, 1999, POTATO RES, V42, P43, DOI 10.1007/BF02358390; GLAZENER JA, 1981, PHYSIOL PLANT PATHOL, V19, P243; Halim VA, 2004, PHYSIOL MOL PLANT P, V64, P311, DOI 10.1016//j.pmpp.2004.10.003; Kato H, 2008, J GEN PLANT PATHOL, V74, P15, DOI 10.1007/s10327-007-0054-4; Leshem Y.Y., 2000, NITRIC OXIDE PLANTS, P154; Monjil M.S., 2013, INT J BIOSCI BIOTECH, V1, P78; Monjil MS, 2014, J GEN PLANT PATHOL, V80, P38, DOI 10.1007/s10327-013-0493-z; Monjil Mohammad Shahjahan, 2013, Nitric Oxide, V29, P34, DOI 10.1016/j.niox.2012.12.004; OSMAN S, 1985, PLANT SCI, V41, P205, DOI 10.1016/0168-9452(85)90090-1; Polkowska-Kowalczyk L, 2001, Z NATURFORSCH C, V56, P235; Pontier D, 1998, MOL PLANT MICROBE IN, V11, P544, DOI 10.1094/MPMI.1998.11.6.544; Sanchez Leandro M., 1992, Annals of the Phytopathological Society of Japan, V58, P664; SANCHEZ LM, 1993, PLANT SCI, V88, P141, DOI 10.1016/0168-9452(93)90085-E; STOSSEL P, 1981, MYCOPATHOLOGIA, V73, P153, DOI 10.1007/BF00575086; TAYLOR JL, 1990, MOL PLANT MICROBE IN, V3, P72; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Uruma S, 2009, J GEN PLANT PATHOL, V75, P257, DOI 10.1007/s10327-009-0176-y; VANETTEN HD, 1989, ANNU REV PHYTOPATHOL, V27, P143, DOI 10.1146/annurev.py.27.090189.001043; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Xu MJ, 2005, PLANT PHYSIOL, V139, P991, DOI 10.1104/pp.105.066407; Yamamoto Ayako, 2003, Journal of General Plant Pathology, V69, P218, DOI 10.1007/s10327-003-0039-x; Yeom SI, 2011, MOL PLANT MICROBE IN, V24, P671, DOI 10.1094/MPMI-08-10-0183; Yoshioka H, 1999, PLANT CELL PHYSIOL, V40, P993	52	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	1631-0691	1768-3238		CR BIOL	C. R. Biol.	MAR	2015	338	3					185	196		10.1016/j.crvi.2015.01.004		12	Biology	Life Sciences & Biomedicine - Other Topics	CG3LG	WOS:000353181100006		
J	Sasaki, N; Chen, HT; Sakamoto, D; Igarashi, T				Sasaki, Naoki; Chen, Hsiang-Ting; Sakamoto, Daisuke; Igarashi, Takeo			Facetons: face primitives for building 3D architectural models in virtual environments	COMPUTER ANIMATION AND VIRTUAL WORLDS			English	Article						geometric modeling; polygonal mesh; virtual reality		We present facetons, geometric modeling primitives designed for building architectural models especially effective for a virtual environment where six degrees of freedom input devices are available. A faceton is an oriented point floating in the air and defines a plane of infinite extent passing through the point. The polygonal mesh model is constructed by taking the intersection of the planes associated with the facetons. With the simple interaction of faceton, users can easily create 3D architecture models. The faceton primitive and its interaction reduce the overhead associated with standard polygonal mesh modeling, where users have to manually specify vertexes and edges which could be far away. The faceton representation is inspired by the research on boundary representations (B-rep) and constructive solid geometry, but it is driven by a novel adaptive bounding algorithm and is specifically designed for 3D modeling activities in an immersive virtual environment. We describe the modeling method and our current implementation. The implementation is still experimental but shows potential as a viable alternative to traditional modeling methods. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Sasaki, Naoki; Chen, Hsiang-Ting; Sakamoto, Daisuke; Igarashi, Takeo] Univ Tokyo, JST ERATO Igarashi Design Interface Project, Tokyo, Japan	Sasaki, N (reprint author), Univ Tokyo, JST ERATO Igarashi Design Interface Project, Tokyo, Japan.	naoki.sasaki@ui.is.s.u-tokyo.ac.jp					Andersons L, 2003, P 9 EUR WORKSH VIRT, P57, DOI 10.1145/769953.769960; [Anonymous], 2000, IEEE 3DUI 2013 Contestants, Patent No. 6628279; Lipson H, 1996, COMPUT AIDED DESIGN, V28, P651, DOI 10.1016/0010-4485(95)00081-X; Bourdot P, 2010, COMPUT AIDED DESIGN, V42, P445, DOI 10.1016/j.cad.2008.10.014; Branits B, 2007, WORLD BUILDER; Butterworth J, 1992, P 1992 S INT 3D GRAP, P135, DOI 10.1145/147156.147182; Fernandos T, 1999, P ACM S VIRT REAL SO, P147, DOI 10.1145/323663.323686; Galyean T. A., 1991, P 18 ANN C COMP GRAP, P267, DOI 10.1145/122718.122747; Hagens H, 1991, GEOMETRIC MODELING M; Laus M, 2012, P TEI 12 KINGST ONT, P275; Mas W, 2004, COMPUT AIDED DESIGN, V36, P903; Matsumiyas M, 2000, P ACM S VIRT REAL SO, P67; Raposo A, 2009, IEEE COMPUT GRAPH, V29, P91, DOI 10.1109/MCG.2009.118; Salamins P, 2006, P ACM S VIRT REAL SO, P27, DOI 10.1145/1180495.1180502; Schells B, 2000, IEEE 3DUI 2013 CONT, Patent No. 6628279; Schkolne S, 2001, P SIGCHI C HUM FACT, P261, DOI DOI 10.1145/365024.365114; Schmidts R, 2009, ACM T GRAPHIC, V28; Strouds I, 2006, BOUNDARY REPRESENTAT; Tsangs EKH, 1998, VRST 98 TAIP TAIW, P179; Zelezniks RC, 1996, P SIGGRAPH 96, P163, DOI DOI 10.1145/1185657.1185770	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1546-4261	1546-427X		COMPUT ANIMAT VIRT W	Comput. Animat. Virtual Worlds	MAR-APR	2015	26	2					185	194		10.1002/cav.1603		10	Computer Science, Software Engineering	Computer Science	CG3GB	WOS:000353165400009		
J	Finkelstein, EA; Sahasranaman, A; John, G; Haaland, BA; Bilger, M; Sloan, RA; Nang, EEK; Evenson, KR				Finkelstein, Eric A.; Sahasranaman, Aarti; John, Geraldine; Haaland, Benjamin A.; Bilger, Marcel; Sloan, Robert A.; Nang, Ei Ei Khaing; Evenson, Kelly R.			Design and baseline characteristics of participants in the TRial of Economic Incentives to Promote Physical Activity (TRIPPA): A randomized controlled trial of a six month pedometer program with financial incentives	CONTEMPORARY CLINICAL TRIALS			English	Article						Physical activity; Wearable technology; Pedometer; Incentives; Randomized controlled trial; Step goals	CARDIORESPIRATORY FITNESS; COST-EFFECTIVENESS; UNITED-STATES; DISEASE RISK; VALIDATION; SEDENTARY; HEALTH; ADULTS; WOMEN; ACCELEROMETER	Non-communicable diseases (NCDs) are emerging as the predominant global health challenge of this century. Physical inactivity is one of the primary risk factors for NCDs. Therefore, increasing physical activity levels is a public health imperative. The arrival of affordable wearable technologies, such as wireless pedometers, provides one strategy for encouraging walking. However, the effectiveness of these technologies in promoting sustained behavior change has not been established. Insights from economics suggest that incentives may be a useful strategy for increasing maintenance and effectiveness of behavior change interventions, including physical activity interventions that rely on wearable technologies. The aim of this trial is to test the effectiveness of a common wireless pedometer with or without one of two types of incentives (cash or donations to charity) for reaching weekly physical activity goals. We present here the design and baseline characteristics of participants of this four arm randomized controlled trial. 800 full-time employees (desk-bound office workers) belonging to 15 different worksites (on average, 53 (sd:37) employees at each worksite) were successfully randomized to one of four study arms. If shown to be effective, wearable technologies in concert with financial incentives may provide a scalable and affordable health promotion strategy for governments and employers seeking to increase the physical activity levels of their constituents. (C) 2015 Elsevier Inc. All rights reserved.	[Finkelstein, Eric A.; Sahasranaman, Aarti; John, Geraldine; Bilger, Marcel] Duke NUS Grad Med Sch, Program Hlth Serv Syst Res, Singapore 169857, Singapore; [Haaland, Benjamin A.] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA; [Haaland, Benjamin A.] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore 169856, Singapore; [Sloan, Robert A.] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; [Nang, Ei Ei Khaing] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Evenson, Kelly R.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA	Finkelstein, EA (reprint author), Duke NUS Grad Med Sch, Program Hlth Serv Syst Res, 8 Coll Rd,Level 4, Singapore 169857, Singapore.	eric.finkelstein@duke-nus.edu.sg	Nang, Ei Ei Khaing/C-2219-2011	Nang, Ei Ei Khaing/0000-0002-5361-0481	Singapore Ministry of Health's Health Services Research Competitive Research Grant [HSRG/022/2012]	This study is supported by the Singapore Ministry of Health's Health Services Research Competitive Research Grant (HSRG/022/2012).	Ajzen I., 1980, UNDERSTANDING ATTITU; Wood W, 2005, J PERS SOC PSYCHOL, V88, P918, DOI 10.1037/0022-3514.88.6.918; Finkelstein EA, 2002, J WOMEN HEALTH GEN-B, V11, P519, DOI 10.1089/152460902760277877; Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037//0033-2909.124.1.54; Thompson FE, 2004, PUBLIC HEALTH NUTR, V7, P1097, DOI 10.1079/PHN2004642; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Kang M, 2009, RES Q EXERCISE SPORT, V80, P648; Gulliford MC, 1999, AM J EPIDEMIOL, V149, P876; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Finkelstein EA, 2008, PREV MED, V47, P182, DOI 10.1016/j.ypmed.2008.05.002; Su YS, 2011, J STAT SOFTW, V45, P1; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; [Anonymous], 2010, EPIDEMIOLOGY CONTROL; Neal DT, 2006, CURR DIR PSYCHOL SCI, V15, P198, DOI 10.1111/j.1467-8721.2006.00435.x; Finkelstein EA, 2010, J OCCUP ENVIRON MED, V52, P971, DOI 10.1097/JOM.0b013e3181f274d2; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Singh MAF, 2002, J GERONTOL A-BIOL, V57, pM262; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Ariely D, 2008, PREDICTABLY IRRATION; Armstrong T, 2006, J PUBLIC HLTH, V14, P66, DOI DOI 10.1007/S10389-006-0024-X; Barba C, 2004, LANCET, V363, P157; Bech P, 1998, QUALITY LIFE PSYCHIA, P156; Cohen J, 2013, STAT POWER ANAL BEHA; Efron B., 1994, INTRO BOOTSTRAP, V57; EuroQol Group, 1990, Health Policy, V16, P199; Finkelstein EA, 2006, J WOMENS HEALTH, V15, P379, DOI 10.1089/jwh.2006.15.379; Gelman A, 2014, MI MISSING DATA IMPU; Guo F, 2013, P 1 ACM INT WORKSH P; Health Promotion Board, 2011, NAT PHYS ACT GUID PR; Lally P, 2007, INT J OBESITY, V32, P700, DOI DOI 10.1038/SJ.IJO.0803771; Land Transport Authority, 2014, PUBL TRANSP RID; Land Transport Authority, 2012, PERC HOUS OWN CAR; Ledger D., 2014, INSIDE WEARABLES; LI KH, 1991, J AM STAT ASSOC, V86, P1065, DOI 10.2307/2290525; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Rubin D. B., 2004, MULTIPLE IMPUTATION, V81; Sloan RA, 2013, SINGAP MED J, V54, P576; Strath SJ, 2008, PREV CHRONIC DIS, V5; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Tully Mark A, 2014, BMC Res Notes, V7, P952, DOI 10.1186/1756-0500-7-952; Van Domelen D, 2014, FUNCTIONS PROCESSING; W. H. Organization, 2010, GLOB STAT REP NONC D	51	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	MAR	2015	41						238	247		10.1016/j.cct.2015.01.020		10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CG0YQ	WOS:000353000500029		
J	Dymshits, AM; Sharygin, IS; Podborodnikov, IV; Litasov, KD; Shatskiy, AF; Otani, E; Pushcharovskii, DY				Dymshits, A. M.; Sharygin, I. S.; Podborodnikov, I. V.; Litasov, K. D.; Shatskiy, A. F.; Otani, E.; Pushcharovskii, D. Yu.			Thermal equation of state of NaMg0.5Si2.5O6 and new data on the compressibility of clinopyroxenes	DOKLADY EARTH SCIENCES			English	Article							X-RAY-DIFFRACTION; MAJORITE; SPODUMENE; CRYSTAL; JADEITE; PHASE	The results of studies of the P-V-T equations of state (EOS) of Na-pyroxene using the multi-anvil technique and synchrotron radiation at pressures up to 15.3 GPa and temperatures up to 1673 K are presented. By fitting the Birch-Murnaghan EOS, the following parameters were determined: V (0) = 407.2 (5) (3), the space group P2/n, K (T0) = 103 (2) GPa, K (T0) = 6.2 (7), a,K (T) /a,T = -0.018 (7), alpha = 3.38(13) + 0.65(62)T. Thus, despite the small volume of the cell, Na-pyroxene has a sufficiently high bulk modulus. This can be caused by the appearance of antipathetic bonds in Na-polyhedron, Si-tetrahedra rotation, and the ordering of Mg and Si cations in the M1 position. Thus, it is substantiated that the phase transformations in the minerals accompanied by the presence of Si in octahedral coordination are characterized by a significant change in the physical characteristics, such as density (rho) and bulk modulus (K (T) ). Such transformations occurring in the minerals and deep Earth can lead to significant jumps in the seismic wave velocities. Therefore, the presence of phases with silicon in sixfold coordination, such as Na-Ca majoritic garnet is of fundamental importance for understanding the Earth's upper mantle.	[Dymshits, A. M.; Sharygin, I. S.; Podborodnikov, I. V.; Litasov, K. D.; Shatskiy, A. F.] Russian Acad Sci, Siberian Branch, Sobolev Inst Geol & Mineral, Novosibirsk, Russia; [Dymshits, A. M.; Sharygin, I. S.; Podborodnikov, I. V.; Litasov, K. D.; Shatskiy, A. F.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Otani, E.] Tohoku Univ, Sendai, Miyagi 980, Japan; [Pushcharovskii, D. Yu.] Moscow MV Lomonosov State Univ, Moscow, Russia	Dymshits, AM (reprint author), Russian Acad Sci, Siberian Branch, Sobolev Inst Geol & Mineral, Novosibirsk, Russia.	A.Dymshits@gmail.com	Shatskiy, Anton/F-8731-2010; Sharygin, Igor/A-7754-2014; Dymshits, Anna/A-3862-2014; Litasov, Konstantin/A-5366-2014	Shatskiy, Anton/0000-0003-4554-9550; 	Ministry of Education and Science of the Russian Federation [14.B25.31.0032]; Russian Federation [MK-265.2014.5]; Russian Foundation for Basic Research [14-05-00957, 12-05-00250]	This work was supported by the Ministry of Education and Science of the Russian Federation (project no. 14.B25.31.0032), a grant of the President of the Russian Federation (MK-265.2014.5), and the Russian Foundation for Basic Research (project nos. 14-05-00957 and 12-05-00250).	ANGEL RJ, 1988, NATURE, V335, P156, DOI 10.1038/335156a0; Angel RJ, 2014, Z KRISTALLOGR, V229, P405, DOI 10.1515/zkri-2013-1711; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Shirey SB, 2013, REV MINERAL GEOCHEM, V75, P355, DOI 10.2138/rmg.2013.75.12; Dorogokupets PI, 2007, HIGH PRESSURE RES, V27, P431, DOI 10.1080/08957950701659700; Arlt T, 2000, PHYS CHEM MINER, V27, P719, DOI 10.1007/s002690000116; Pushcharovsky DY, 2012, EARTH-SCI REV, V113, P94, DOI 10.1016/j.earscirev.2012.03.004; Dymshits AM, 2014, PHYS EARTH PLANET IN, V227, P68, DOI 10.1016/j.pepi.2013.11.005; Gatta GD, 2005, PHYS CHEM MINER, V32, P132, DOI 10.1007/s00269-005-0450-2; HAZEN RM, 1994, PHYS CHEM MINER, V21, P344; Mccarthy AC, 2008, AM MINERAL, V93, P198, DOI 10.2138/am.2008.2521; PACALO REG, 1992, GEOPHYS RES LETT, V19, P1895, DOI 10.1029/92GL01944; Reichmann HJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015106; Sinogeikin S. V., 2002, GEOPHYS RES LETT, V29, P41; Yang HX, 2009, AM MINERAL, V94, P942, DOI 10.2138/am.2009.3084	15	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1028-334X	1531-8354		DOKL EARTH SCI	Dokl. Earth Sci.	MAR	2015	461	1					273	276		10.1134/S1028334X15030113		4	Geosciences, Multidisciplinary	Geology	CG4EJ	WOS:000353235800015		
J	Iwasaki, K; Harada, N; Sasaki, K; Yamane, S; Iida, K; Suzuki, K; Hamasaki, A; Nasteska, D; Shibue, K; Joo, E; Harada, T; Hashimoto, T; Asakawa, Y; Hirasawa, A; Inagaki, N				Iwasaki, Kanako; Harada, Norio; Sasaki, Kazuki; Yamane, Shunsuke; Iida, Keiko; Suzuki, Kazuyo; Hamasaki, Akihiro; Nasteska, Daniela; Shibue, Kimitaka; Joo, Erina; Harada, Takanari; Hashimoto, Toshihiro; Asakawa, Yoshinori; Hirasawa, Akira; Inagaki, Nobuya			Free Fatty Acid Receptor GPR120 Is Highly Expressed in Enteroendocrine K Cells of the Upper Small Intestine and Has a Critical Role in GIP Secretion After Fat Ingestion	ENDOCRINOLOGY			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; INCRETIN HORMONES; OBESITY; GLP-1; MICE; DIET; RELEASE	Gastric inhibitory polypeptide (GIP) is an incretin secreted from enteroendocrine K cells in response to meal ingestion. Recently free fatty acid receptor G protein-coupled receptor (GPR) 120 was identified as a lipid sensor involved in glucagon-like peptide-1 secretion. However, Gpr 120 gene expression and its role in K cells remain unclear, partly due to difficulties in separation of K cells from other intestinal epithelial cells. In this study, we purified K cells using GIP-green fluorescent protein (GFP) knock-in mice, in which K cells can be visualized by GFP fluorescence. GFP-positive cells (K cells) were observed in the small intestine but not in the stomach and colon. K cell number and GIP content in K cells were significantly higher in the upper small intestine than those in the lower small intestine. We also examined the expression levels of several free fatty acid receptors in K cells. Among free fatty acid receptors, GPR120 was highly expressed in the K cells of the upper small intestine compared with the lower small intestine. To clarify the role of GPR120 on K cells in vivo, we used GPR120-deficient mice (GPR120(-/-)). GPR120(-/-) exhibited significantly lower GIP secretion (75% reduction, P < .01) after lard oil ingestion compared with that in wild-type mice. Consistently, pharmacological inhibition of GPR120 with grifolic acid methyl ether in wild-type mice significantly attenuated lard oil-induced GIP secretion. In conclusion, GPR120 is expressed abundantly in K cells of the upper small intestine and plays a critical role in lipid-induced GIP secretion.	[Iwasaki, Kanako; Harada, Norio; Sasaki, Kazuki; Yamane, Shunsuke; Suzuki, Kazuyo; Hamasaki, Akihiro; Nasteska, Daniela; Shibue, Kimitaka; Joo, Erina; Harada, Takanari; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto 6068507, Japan; [Iida, Keiko; Hirasawa, Akira] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto 6068507, Japan; [Hashimoto, Toshihiro; Asakawa, Yoshinori] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan	Inagaki, N (reprint author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	inagaki@metab.kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan; Suzuken Memorial Foundation; Japan Association for Diabetes Education and Care; Novo Nordisk Pharma	This work was supported by scientific research grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and from the Ministry of Health, Labor, and Welfare, Japan. This study was also supported by Suzuken Memorial Foundation, grants for young researchers from the Japan Association for Diabetes Education and Care, and grants from Novo Nordisk Pharma.	Egerod KL, 2012, ENDOCRINOLOGY, V153, P5782, DOI 10.1210/en.2012-1595; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; NAUCK MA, 1986, J CLIN ENDOCR METAB, V63, P492; Ogawa E, 2011, BIOCHEM BIOPH RES CO, V404, P115, DOI 10.1016/j.bbrc.2010.11.077; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Nasteska D, 2014, DIABETES, V63, P2332, DOI 10.2337/db13-1563; Mortensen K, 2003, REGUL PEPTIDES, V114, P189, DOI 10.1016/S0167-0115(03)00125-3; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Schirra J, 1996, J CLIN INVEST, V97, P92, DOI 10.1172/JCI118411; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; HAUNER H, 1988, ANN NUTR METAB, V32, P282, DOI 10.1159/000177467; PEDERSON RA, 1975, DIABETES, V24, P1050, DOI 10.2337/diabetes.24.12.1050; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; Engelstoft MS, 2013, CURR OPIN PHARMACOL, V13, P912, DOI 10.1016/j.coph.2013.09.018; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; BAILEY CJ, 1986, ACTA ENDOCRINOL-COP, V112, P224; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Seino Y, 2010, J DIABETES INVEST, V1, P8, DOI 10.1111/j.2040-1124.2010.00022.x; Brown J C, 1975, Recent Prog Horm Res, V31, P487; CREUTZFELDT W, 1978, DIABETOLOGIA, V14, P15, DOI 10.1007/BF00429703; Damholt AB, 1999, CELL TISSUE RES, V298, P287, DOI 10.1007/s004419900093; FALKO JM, 1975, J CLIN ENDOCR METAB, V41, P260; FLATT PR, 1983, DIABETES, V32, P433, DOI 10.2337/diabetes.32.5.433; Fujita Y, 2008, AM J PHYSIOL-ENDOC M, V295, P648; Gault VA, 2005, DIABETES, V54, P2436, DOI 10.2337/diabetes.54.8.2436; Gilor C, 2013, DOMEST ANIM ENDOCRIN, V45, P49, DOI 10.1016/j.domaniend.2013.04.004; Harada N, 2011, J DIABETES INVEST, V2, P193, DOI 10.1111/j.2040-1124.2010.00078.x; Harada N, 2008, AM J PHYSIOL-ENDOC M, V294, P61; Hashimoto T, 2005, HETEROCYCLES, V65, P2431; Kieffer TJ, 2003, TRENDS PHARMACOL SCI, V24, P110, DOI 10.1016/S0165-6147(03)00031-2; Naitoh R, 2008, BIOCHEM BIOPH RES CO, V376, P21, DOI 10.1016/j.bbrc.2008.08.052; Pederson RA, 1994, GUT PEPTIDES BIOCH P; Suzuki K, 2013, J BIOL CHEM, V288, P1929, DOI 10.1074/jbc.M112.423137; Tolhurst G, 2008, DIABETES, V61, P364; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009; Yamane S, 2012, J DIABETES INVEST, V3, P81; Yeung CM, 1999, MOL CELL ENDOCRINOL, V154, P161, DOI 10.1016/S0303-7207(99)00106-9; Yoder SM, 2010, AM J PHYSIOL-GASTR L, V299, P476	49	2	3	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	MAR	2015	156	3					837	846		10.1210/en.2014-1653		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CG4QS	WOS:000353272000008		
J	Matsuda, K; Fujishima, Y; Maeda, N; Mori, T; Hirata, A; Sekimoto, R; Tsushima, Y; Masuda, S; Yamaoka, M; Inoue, K; Nishizawa, H; Kita, S; Ranscht, B; Funahashi, T; Shimomura, I				Matsuda, Keisuke; Fujishima, Yuya; Maeda, Norikazu; Mori, Takuya; Hirata, Ayumu; Sekimoto, Ryohei; Tsushima, Yu; Masuda, Shigeki; Yamaoka, Masaya; Inoue, Kana; Nishizawa, Hitoshi; Kita, Shunbun; Ranscht, Barbara; Funahashi, Tohru; Shimomura, Iichiro			Positive Feedback Regulation Between Adiponectin and T-Cadherin Impacts Adiponectin Levels in Tissue and Plasma of Male Mice	ENDOCRINOLOGY			English	Article							GENOME-WIDE ASSOCIATION; ADIPOSE-SPECIFIC PROTEIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; PHOSPHOLIPASE-D; ENDOTHELIAL-CELLS; HUMAN-SERUM; CDH13; GENE; RECEPTOR	Adiponectin (Adipo), a multimeric adipocyte-secreted protein abundant in the circulation, is implicated in cardiovascular protective functions. Recent work documented that Adipo locally associates with responsive tissues through interactions with T-cadherin (Tcad), an atypical, glycosylphosphatidylinositol (GPI)-anchored cadherin cell surface glycoprotein. Mice deficient for Tcad lack tissue-associated Adipo, accumulate Adipo in the circulation, and mimic the Adipo knockout (KO) cardiovascular phenotype. In reverse, Tcad protein is visibly reduced from cardiac tissue in Adipo-KO mice, suggesting interdependent regulation of the 2 proteins. Here, we evaluate the effect of Adipo on Tcad protein expression. Adipo and Tcad proteins were colocalized in aorta, heart, and skeletal muscle. Adipo positively regulated levels of Tcad protein in vivo and in endothelial cell (EC) cultures. In Tcad-KO mice, binding of endogenous and exogenously administered Adipo to cardiovascular tissues was dramatically reduced. Consistently, knockdown of Tcad in cultured murine vascular ECs significantly diminished Adipo binding. In search for a possible mechanism, we found that enzymatic cleavage of Tcad with phosphatidylinositol-specific phospholipase C increases plasma Adipo while decreasing tissue-bound levels. Similarly, pretreatment of cultured ECs with serum containing Adipo attenuated phosphatidylinositol-specific phospholipase C-mediated Tcad cleavage. In vivo administration of adenovirus producing Adipo suppressed plasma levels of GPI phospholipase D, the endogenous cleavage enzyme for GPI-anchored proteins. In conclusion, our data show that both circulating and tissue-bound Adipo levels are dependent on Tcad and, in reverse, regulate tissue Tcad levels through a positive feedback loop that operates by suppressing phospholipase-mediated Tcad release from the cell surface.	[Matsuda, Keisuke; Fujishima, Yuya; Maeda, Norikazu; Mori, Takuya; Hirata, Ayumu; Tsushima, Yu; Masuda, Shigeki; Yamaoka, Masaya; Inoue, Kana; Nishizawa, Hitoshi; Kita, Shunbun; Funahashi, Tohru; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan; [Hirata, Ayumu; Kita, Shunbun; Funahashi, Tohru] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Suita, Osaka 5650871, Japan; [Ranscht, Barbara] NIH, Sanford Burnham Med Res Inst, Designated Canc Ctr, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA	Maeda, N (reprint author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	norikazu_maeda@endmet.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [22590979, 24390238, 22126008]; National Institutes of Health [MH103861]; Takeda Science Foundation	This work was supported in part by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) 22590979 (to N.M.), a Grant-in-Aid for Scientific Research (B) 24390238 (to I.S.), and a Grant-in-Aid for Scientific Research on Innovative Areas 22126008 (to T.F.); the National Institutes of Health Grant MH103861 (to B.R.); and the Takeda Science Foundation (to N.M.).	Almabouada F, 2013, J BIOL CHEM, V288, P3112, DOI 10.1074/jbc.M112.404624; LOW MG, 1988, P NATL ACAD SCI USA, V85, P980, DOI 10.1073/pnas.85.4.980; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; SCHERER PE, 1995, J BIOL CHEM, V270, P26746; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Gao H, 2013, DIABETES, V62, P4277, DOI 10.2337/db13-0129; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Hu E, 1996, J BIOL CHEM, V271, P10697; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/S0016-5085(03)01509-9; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; VESTAL DJ, 1992, J CELL BIOL, V119, P451, DOI 10.1083/jcb.119.2.451; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Yokota T, 2000, BLOOD, V96, P1723; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; DAVITZ MA, 1987, SCIENCE, V238, P81, DOI 10.1126/science.2443973; DEALMEIDA MLC, 1988, BIOCHEM BIOPH RES CO, V150, P476; Fava C, 2011, AM J CARDIOL, V108, P1432, DOI 10.1016/j.amjcard.2011.06.068; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Joshi MB, 2007, FASEB J, V21, P3083, DOI 10.1096/fj.06-7723com; Kasahara DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065829; Komura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071271; Kurtz TA, 2004, METABOLISM, V53, P138, DOI 10.1016/j.metabol.2003.09.004; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076199; Mori T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04895; Tsushima Y, 2013, J BIOL CHEM, V288, P27138, DOI 10.1074/jbc.M113.485094; Tyrberg B, 2011, ISLETS, V3, P327, DOI 10.4161/isl.3.6.17705; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423	49	1	1	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	MAR	2015	156	3					934	946		10.1210/en.2014-1618		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CG4QS	WOS:000353272000016		
J	Ni, YH; Nagashimada, M; Zhan, LL; Nagata, N; Kobori, M; Sugiura, M; Ogawa, K; Kaneko, S; Ota, T				Ni, Yinhua; Nagashimada, Mayumi; Zhan, Lili; Nagata, Naoto; Kobori, Masuko; Sugiura, Minoru; Ogawa, Kazunori; Kaneko, Shuichi; Ota, Tsuguhito			Prevention and Reversal of Lipotoxicity-Induced Hepatic Insulin Resistance and Steatohepatitis in Mice by an Antioxidant Carotenoid, beta-Cryptoxanthin	ENDOCRINOLOGY			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; VITAMIN-E; SERUM CONCENTRATIONS; LIVER-DISEASE; MACROPHAGES; OBESITY; TOCOPHEROL; ATHEROSCLEROSIS	Excessive hepatic lipid accumulation promotes macrophages/Kupffer cells activation, resulting in exacerbation of insulin resistance and progression of nonalcoholic steatohepatitis (NASH). However, few promising treatment modalities target lipotoxicity-mediated hepatic activation/polarization of macrophages for NASH. Recent epidemiological surveys showed that serum beta-cryptoxanthin, an antioxidant carotenoid, was inversely associated with the risks of insulin resistance and liver dysfunction. In the present study, we first showed that beta-cryptoxanthin administration ameliorated hepatic steatosis in high-fat diet-induced obese mice. Next, we investigated the preventative and therapeutic effects of beta-cryptoxanthin using a lipotoxic model of NASH: mice fed a high-cholesterol and high-fat (CL) diet. After 12 weeks of CL diet feeding, beta-cryptoxanthin administration attenuated insulin resistance and excessive hepatic lipid accumulation and peroxidation, with increases in M1-type macrophages/Kupffer cells and activated stellate cells, and fibrosis in CL diet-induced NASH. Comprehensive gene expression analysis showed that beta-cryptoxanthin down-regulated macrophage activation signal-related genes significantly without affecting most lipid metabolism-related genes in the liver. Importantly, flow cytometry analysis revealed that, on a CL diet, beta-cryptoxanthin caused a predominance of M2 over M1 macrophage populations, in addition to reducing total hepatic macrophage and T-cell contents. In parallel, beta-cryptoxanthin decreased lipopolysaccharide-induced M1 marker mRNA expression in peritoneal macrophages, whereas it augmented IL-4-induced M2 marker mRNA expression, in a dose-dependent manner. Moreover, beta-cryptoxanthin reversed steatosis, inflammation, and fibrosis progression in preexisting NASH in mice. In conclusion, beta-cryptoxanthin prevents and reverses insulin resistance and steatohepatitis, at least in part, through an M2-dominant shift in macrophages/Kupffer cells in a lipotoxic model of NASH.	[Ni, Yinhua; Nagashimada, Mayumi; Zhan, Lili; Nagata, Naoto; Ota, Tsuguhito] Kanazawa Univ, Brain Liver Interface Med Res Ctr, Dept Cell Metab & Nutr, Kanazawa, Ishikawa 9208641, Japan; [Ni, Yinhua; Kaneko, Shuichi; Ota, Tsuguhito] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan; [Kobori, Masuko] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Sugiura, Minoru] Natl Agr & Food Res Org, Natl Inst Fruit Tree Sci, Citrus Res Div, Shizuoka, Shizuoka 4240292, Japan; [Ogawa, Kazunori] Natl Agr & Food Res Org, Natl Inst Fruit Tree Sci, Grape & Persimmon Res Div, Higashihiroshima, Hiroshima 7392494, Japan	Ota, T (reprint author), Kanazawa Univ, Brain Liver Interface Med Res Ctr, Dept Cell Metab & Nutr, Kanazawa, Ishikawa 9208641, Japan.	tota@staff.kanazawa-u.ac.jp	Ni, Yinhua /H-3079-2015; Nagata, Naoto/D-9261-2012	Ni, Yinhua /0000-0001-7738-5971; Nagata, Naoto/0000-0002-2389-2334	Research and Development Projects for Application in Promoting New Policy of Agriculture Forestry and Fisheries Grant [22027]; Ministry of Agriculture, Forestry and Fishers, Japan; Research Project on Development of Agricultural Products and Foods with Health-Promoting Benefits (NARO); Ministry of Education, Culture, Sports, Science and Technology of Japan [25282017]; Kao Research Council or the Study of Healthcare Science; Japan Research Foundation for Clinical Pharmacology	This work was supported by the Research and Development Projects for Application in Promoting New Policy of Agriculture Forestry and Fisheries Grant 22027, from the Ministry of Agriculture, Forestry and Fishers, Japan (to T.O., M.K., M.S., and K.O.); Research Project on Development of Agricultural Products and Foods with Health-Promoting Benefits (NARO); the Grant-in-Aid for Scientific Research (B) 25282017 from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Kao Research Council or the Study of Healthcare Science; and Japan Research Foundation for Clinical Pharmacology (T.O.).	Ruhl CE, 2003, GASTROENTEROLOGY, V124, P1821, DOI 10.1016/S0016-5085(03)00395-0; Gunanti IR, 2014, J NUTR, V144, P489, DOI 10.3945/jn.113.183137; Chung MY, 2010, J NUTR BIOCHEM, V21, P1200, DOI 10.1016/j.jnutbio.2009.10.006; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Neuhouser ML, 2001, J NUTR, V131, P2184; Sugiura M, 2005, J EPIDEMIOL, V15, P180, DOI 10.2188/jea.15.180; Sugiura M, 2006, J EPIDEMIOL, V16, P71, DOI 10.2188/jea.16.71; Yadav D, 2002, AM J GASTROENTEROL, V97, P2634, DOI 10.1016/S0002-9270(02)04399-X; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Matsumoto A, 2007, BIOCHEM PHARMACOL, V74, P256, DOI 10.1016/j.bcp.2007.04.014; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Sutti S, 2014, HEPATOLOGY, V59, P886, DOI 10.1002/hep.26749; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Katsuura S, 2009, MOL NUTR FOOD RES, V53, P1396, DOI 10.1002/mnfr.200800566; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; LEO MA, 1993, HEPATOLOGY, V17, P977; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Haegele AD, 2000, CANCER EPIDEM BIOMAR, V9, P421; Kobori M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098294; Ogawa K., 2013, Nippon Shokuhin Kagaku Kogaku Kaishi = Journal of the Japanese Society for Food Science and Technology, V60, P498, DOI 10.3136/nskkk.60.498; Rock CL, 1996, J AM DIET ASSOC, V96, P693, DOI 10.1016/S0002-8223(96)00190-3; Sugiura M, 2014, BIOSCI BIOTECH BIOCH, V78, P307, DOI 10.1080/09168451.2014.878220; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607	30	2	2	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	MAR	2015	156	3					987	999		10.1210/en.2014-1776		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CG4QS	WOS:000353272000020		
J	Mukudai, S; Matsuda, KI; Nishio, T; Sugiyama, Y; Bando, H; Hirota, R; Sakaguchi, H; Hisa, Y; Kawata, M				Mukudai, Shigeyuki; Matsuda, Ken Ichi; Nishio, Takeshi; Sugiyama, Yoichiro; Bando, Hideki; Hirota, Ryuichi; Sakaguchi, Hirofumi; Hisa, Yasuo; Kawata, Mitsuhiro			Differential Responses to Steroid Hormones in Fibroblasts From the Vocal Fold, Trachea, and Esophagus	ENDOCRINOLOGY			English	Article							HUMAN-SKIN FIBROBLASTS; ESTROGEN-RECEPTOR-ALPHA; DERMAL PAPILLA CELLS; ELASTIN SYNTHESIS; GENE-EXPRESSION; CULTURED-CELLS; SEX-HORMONES; COLLAGEN; ANDROGEN; GROWTH	There is accumulating evidence that fibroblasts are target cells for steroids such as sex hormones and corticoids. The characteristics of fibroblasts vary among tissues and organs. Our aim in this study is to examine differences in responses to steroid hormones among fibroblasts from different cervicothoracic regions. We compared the actions of steroid hormones on cultured fibroblasts from the vocal folds, which are considered to be the primary target of steroid hormones, and the trachea and esophagus in adult male rats. Expression of steroid hormone receptors (androgen receptor, estrogen receptor alpha, and glucocorticoid receptor) was identified by immunofluorescence histochemistry. Androgen receptor was much more frequently expressed in fibroblasts from the vocal fold than in those from the trachea and esophagus. Cell proliferation analysis showed that administration of testosterone, estradiol, or corticosterone suppressed growth of all 3 types of fibroblasts. However, mRNA expression for extracellular matrix-associated genes, including procollagen I and III and elastin, and hyaluronic acid synthase I was elevated only by addition of testosterone to fibroblasts from the vocal fold. These results indicate that each steroid hormone exerts region-specific effects on cervicothoracic fibroblasts with different properties through binding to specific receptors.	[Mukudai, Shigeyuki; Matsuda, Ken Ichi; Kawata, Mitsuhiro] Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kyoto 6028566, Japan; [Mukudai, Shigeyuki; Nishio, Takeshi; Sugiyama, Yoichiro; Bando, Hideki; Hirota, Ryuichi; Sakaguchi, Hirofumi; Hisa, Yasuo] Kyoto Prefectural Univ Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6028566, Japan	Kawata, M (reprint author), Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, Kawaramachi Hirokoji, Kyoto 6028566, Japan.	mkawata@koto.kpu-m.ac.jp			Ministry of Education, Science, Sports, Culture and Technology, Japan [KAKENHI 24300128, KAKENHI 25293350, KAKENHI 23500396]	This work was supported by the Ministry of Education, Science, Sports, Culture and Technology, Japan (Grants-in-Aid for Scientific Research KAKENHI 24300128 to M.K., KAKENHI 25293350 to Y.H., and KAKENHI 23500396 to K.I.M.).	Amer HE, 2011, J LARYNGOL OTOL, V125, P829, DOI 10.1017/S0022215111000831; SMITH TJ, 1984, J CLIN INVEST, V74, P2157, DOI 10.1172/JCI111642; Ohno Hideki, 2012, Okajimas Folia Anatomica Japonica, V89, P35; PRATT WB, 1978, J INVEST DERMATOL, V71, P24, DOI 10.1111/1523-1747.ep12543774; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Morimoto M, 1996, NEUROSCI RES, V26, P235, DOI 10.1016/S0168-0102(96)01105-4; Peterson JR, 2013, DEV PSYCHOBIOL, V55, P818, DOI 10.1002/dev.21072; Coletta RD, 2002, ORAL MICROBIOL IMMUN, V17, P186, DOI 10.1034/j.1399-302X.2002.170309.x; Brudzynski SM, 2009, ILAR J, V50, P43; RUSSELL SB, 1995, J INVEST DERMATOL, V104, P241, DOI 10.1111/1523-1747.ep12612788; Soldano S, 2010, ANN NY ACAD SCI, V1193, P25, DOI 10.1111/j.1749-6632.2009.05296.x; Kawata M, 2001, ARCH HISTOL CYTOL, V64, P353, DOI 10.1679/aohc.64.353; Kitagawa T, 2009, J CLIN ENDOCR METAB, V94, P1288, DOI 10.1210/jc.2008-1053; Masuda H, 1998, CELL STRESS CHAPERON, V3, P256, DOI 10.1379/1466-1268(1998)003<0256:EALOCB>2.3.CO;2; Thornton MJ, 2002, EXP DERMATOL, V11, P487, DOI 10.1034/j.1600-0625.2002.110601.x; Pelletier G, 2004, HISTOL HISTOPATHOL, V19, P629; Mortensen M, 2010, CURR OPIN OTOLARYNGO, V18, P487, DOI 10.1097/MOO.0b013e32833fe112; Matsuda KI, 2008, NEUROSCI LETT, V441, P94, DOI 10.1016/j.neulet.2008.05.108; Campagnolo AM, 2010, ANN OTO RHINOL LARYN, V119, P133; Goto Y, 1999, AM J RESP CELL MOL, V20, P312; BROWN TR, 1981, MOL CELL BIOCHEM, V36, P3, DOI 10.1007/BF02354827; CASTOR CW, 1962, J LAB CLIN MED, V60, P788; Fischer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024490; GADSON PF, 1984, J BIOL CHEM, V259, P1236; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; GROSSFELD H, 1959, ENDOCRINOLOGY, V65, P777; Haczynski J, 2002, INT J MOL MED, V10, P149; Harries M, 1998, J LARYNGOL OTOL, V112, P451; HARVEY W, 1974, ANN RHEUM DIS, V33, P437, DOI 10.1136/ard.33.5.437; Holterhus PM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-376; HOSOKAWA M, 1981, CONNECT TISSUE RES, V9, P115; Jenkins Cathleen, 2007, BMC Cardiovasc Disord, V7, P13, DOI 10.1186/1471-2261-7-13; KAHARI VM, 1994, BIOCHEM BIOPH RES CO, V201, P1189, DOI 10.1006/bbrc.1994.1831; Kawata M, 2001, NEUROSCI RES, V40, P197, DOI 10.1016/S0168-0102(01)00253-X; Kawata M, 2008, J NEUROENDOCRINOL, V20, P673, DOI 10.1111/j.1365-2826.2008.01727.x; KIESEWETTER F, 1993, J INVEST DERMATOL, V101, pS98, DOI 10.1111/1523-1747.ep12363015; King A, 2001, J VOICE, V15, P553, DOI 10.1016/S0892-1997(01)00055-8; KOFOED JA, 1972, ACTA ENDOCRINOL-COP, V69, P87; Krecicki T, 2006, MED SCI MONITOR, V12, pCR351; Liu YM, 2006, HUM REPROD, V21, P303, DOI 10.1093/humrep/dei296; Matsuda K, 2008, J CELL BIOCHEM, V103, P136, DOI 10.1002/jcb.21393; MECHAM RP, 1984, J BIOL CHEM, V259, P2414; Parkar MH, 1996, ARCH ORAL BIOL, V41, P979, DOI 10.1016/S0003-9969(96)00053-2; Philips N, 2003, J AM AGING ASSOC, V26, P59, DOI 10.1007/s11357-003-0006-7; Raj A, 2010, J VOICE, V24, P363, DOI 10.1016/j.jvoice.2008.10.005; Surmeli M, 2011, EUR ARCH OTO-RHINO-L, V268, P261, DOI 10.1007/s00405-010-1337-5; TAKEDA T, 1975, ACTA PATHOL JAPON, V25, P135; Tateya T, 2005, ANN OTO RHINOL LARYN, V114, P183; Zhou H, 2011, LARYNGOSCOPE, V121, P1915, DOI 10.1002/lary.21920; Zhou HY, 2011, MOL VIS, V17, P3415	50	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	MAR	2015	156	3					1000	1009		10.1210/en.2014-1605		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CG4QS	WOS:000353272000021		
J	Barron, AM; Brown, MA; Morgan, TE; Pike, CJ				Barron, Anna M.; Brown, Meghan A.; Morgan, Todd E.; Pike, Christian J.			Impact of Continuous Versus Discontinuous Progesterone on Estradiol Regulation of Neuron Viability and Sprouting After Entorhinal Cortex Lesion in Female Rats	ENDOCRINOLOGY			English	Article							HORMONE REPLACEMENT THERAPY; HIPPOCAMPAL SLICE CULTURES; EARLY ESTROGEN PREVENTION; ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; CEREBRAL-ISCHEMIA; LAYER-II; MEDROXYPROGESTERONE ACETATE; OVARIECTOMIZED RATS; REDUCED METABOLITES	Because the estrogen-based hormone therapy (HT) in postmenopausal women typically contains a progestogen component, understanding the interactions between estrogens and progestogens is critical for optimizing the potential neural benefits of HT. An important issue in this regard is the use of continuous vs discontinuous hormone treatments. Although sex steroid hormone levels naturally exhibit cyclic fluctuation, many HT formulations include continuous delivery of hormones. Recent findings from our laboratory and others have shown that coadministration of progesterone (P-4) can either attenuate or augment beneficial actions of 17 beta-estradiol (E-2) in experimental models depending in part upon the delivery schedule of P-4. In this study, we demonstrate that the P-4 delivery schedule in combined E-2 and P-4 treatments alters degenerative and regenerative outcomes of unilateral entorhinal cortex lesion. We assessed how lesion-induced degeneration of layer II neurons in entorhinal cortex layer and deafferentation in dentate gyrus are affected by ovariectomy and treatments with E-2 alone or in combination with either continuous or discontinuous P4. Our results demonstrate the combined efficacy of E-2 and P-4 is dependent on the administration regimen. Importantly, the discontinuous-combined E-2 + P-4 regimen had the greatest neuroprotective efficacy for both end points. These data extend a growing literature that indicates qualitative differences in the neuroprotective effects of E-2 as a function of cotreatment with continuous versus discontinuous P-4, the understanding of which has important implications for HT in postmenopausal women.	[Barron, Anna M.; Brown, Meghan A.; Morgan, Todd E.; Pike, Christian J.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Barron, Anna M.] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan	Pike, CJ (reprint author), Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA.	cjpike@usc.edu			National Institutes of Health [P01AG026572]; American Australian Neurological Fellowship; Japanese Society for the Promotion of Science	This work was supported by National Institutes of Health Grant P01AG026572 (R. Brinton/Project 3 CJP). A.M.B. is supported by the American Australian Neurological Fellowship and the Japanese Society for the Promotion of Science.	Altholtz LY, 2006, J AM ASSOC LAB ANIM, V45, P17; Bimonte-Nelson HA, 2004, NEUROREPORT, V15, P2659, DOI 10.1097/00001756-200412030-00021; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; Carroll JC, 2010, ENDOCRINOLOGY, V151, P2713, DOI 10.1210/en.2009-1487; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Ramsden M, 2003, BRAIN RES, V971, P239, DOI 10.1016/S0006-8993(03)02365-5; GEDDES JW, 1985, SCIENCE, V230, P1179, DOI 10.1126/science.4071042; Garay L, 2009, BRAIN RES, V1283, P177, DOI 10.1016/j.brainres.2009.04.057; Azcoitia I, 1999, J NEUROCYTOL, V28, P699, DOI 10.1023/A:1007025219044; Stone DJ, 1997, EXP NEUROL, V143, P313, DOI 10.1006/exnr.1996.6360; Toung TJ, 2004, J CEREBR BLOOD F MET, V24, P1160, DOI 10.1097/01.WCB.0000135594.13576.D2; Rosario ER, 2006, BRAIN RES, V1099, P206, DOI 10.1016/j.brainres.2006.03.127; Bali N, 2012, ENDOCRINOLOGY, V153, P759, DOI 10.1210/en.2011-1699; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibbs RB, 2000, NEUROSCIENCE, V101, P931, DOI 10.1016/S0306-4522(00)00433-4; Garcia-Segura LM, 1998, NEUROREPORT, V9, P593, DOI 10.1097/00001756-199803090-00006; Jayaraman A, 2012, ENDOCRINOLOGY, V153, P5467, DOI 10.1210/en.2012-1464; Stone DJ, 1998, J NEUROSCI, V18, P3180; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Harman SM, 2005, CLIMACTERIC, V8, P3, DOI 10.1080/13697130500042417; Liu LF, 2010, ENDOCRINOLOGY, V151, P5782, DOI 10.1210/en.2010-0005; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; Kadish I, 2002, J NEUROSCI, V22, P4095; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Bickler PE, 2005, ANESTHESIOLOGY, V103, P532, DOI 10.1097/00000542-200509000-00016; Carroll JC, 2008, NEUROSCI LETT, V445, P229, DOI 10.1016/j.neulet.2008.09.010; Aguirre C, 2010, J NEUROCHEM, V115, P1277, DOI 10.1111/j.1471-4159.2010.07038.x; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.braineres.2004.04.032; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Wong AM, 2009, ENDOCRINOLOGY, V150, P324, DOI 10.1210/en.2008-0988; Zardooz H, 2010, PHYSIOL RES, V59, P973; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; SINGH M, 1995, ENDOCRINOLOGY, V136, P2320, DOI 10.1210/en.136.5.2320; Gray JJ, 2005, ANESTHESIOLOGY, V102, P606, DOI 10.1097/00000542-200503000-00020; Haim S, 2003, J ENDOCRINOL INVEST, V26, P1013; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Aguirre CC, 2009, EUR J NEUROSCI, V29, P447, DOI 10.1111/j.1460-9568.2008.06591.x; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Barron Anna M, 2012, Front Biosci (Elite Ed), V4, P976; CABALKA LM, 1992, NEUROBIOL AGING, V13, P283, DOI 10.1016/0197-4580(92)90041-U; CUMMINGS BJ, 1992, BRAIN RES, V591, P271, DOI 10.1016/0006-8993(92)91707-L; Edwards HE, 1999, BRAIN RES, V838, P136, DOI 10.1016/S0006-8993(99)01619-4; FEDER HH, 1984, ANNU REV PSYCHOL, V35, P165, DOI 10.1146/annurev.psych.35.1.165; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Henderson VW, 2009, SEMIN REPROD MED, V27, P283, DOI 10.1055/s-0029-1216281; Jayaraman A, 2009, J NEUROENDOCRINOL, V21, P77, DOI 10.1111/j.1365-2826.2008.01801.x; Lawrence M, 1999, FAM PRACT, V16, P335, DOI 10.1093/fampra/16.4.335; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Magnaghi V, 2006, J PERIPHER NERV SYST, V11, P111, DOI 10.1111/j.1085-9489.2006.00075.x; MAHESH VB, 1987, J STEROID BIOCHEM, V27, P665, DOI 10.1016/0022-4731(87)90135-X; Mannino CA, 2005, J PAIN, V6, P809, DOI 10.1016/j.jpain.2005.07.007; MARRONE BL, 1977, HORM BEHAV, V8, P391, DOI 10.1016/0018-506X(77)90013-7; Miller VM, 2009, J CARDIOVASC TRANSL, V2, P228, DOI 10.1007/s12265-009-9104-y; MORSE JK, 1992, EXP NEUROL, V118, P47, DOI 10.1016/0014-4886(92)90021-H; Perederiy JV, 2013, J NEUROSCI, V33, P4754, DOI 10.1523/JNEUROSCI.4785-12.2013; PETERSON DA, 1994, J NEUROSCI, V14, P6872; Ramirez JJ, 1996, P NATL ACAD SCI USA, V93, P15512, DOI 10.1073/pnas.93.26.15512; Ramirez JJ, 1999, J NEUROSCI, V19, part. no.; Rhodes ME, 2004, EPILEPSIA, V45, P1531, DOI 10.1111/j.0013-9580.2004.16504.x; RODIER WI, 1971, J COMP PHYSIOL PSYCH, V74, P365, DOI 10.1037/h0030568; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Sheehan D, 1980, THEORY PRACTICE HIST; Singh M, 2008, FRONT BIOSCI-LANDMRK, V13, P1083, DOI 10.2741/2746; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; STEWARD O, 1977, BRAIN RES, V125, P11, DOI 10.1016/0006-8993(77)90356-0; Strom JO, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-39; Tierney MC, 2009, PSYCHONEUROENDOCRINO, V34, P1065, DOI 10.1016/j.psyneuen.2009.02.009; Watson C, 2007, RAT BRAIN STEREOTAXI; Wise-Faberowski L, 2005, ANESTH ANALG, V101, P651, DOI 10.1213/01.ane.0000167382.79889.7c; Woolley CS, 1998, HORM BEHAV, V34, P140, DOI 10.1006/hbeh.1998.1466; Yang HY, 2007, BEHAV BRAIN RES, V184, P174, DOI 10.1016/j.bbr.2007.07.005; Zhang F, 2014, EXP THER MED, V8, P471, DOI 10.3892/etm.2014.1769; Zhao LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031267	77	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	MAR	2015	156	3					1091	1099		10.1210/en.2014-1216		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CG4QS	WOS:000353272000029		
J	Hara, K; Adachi, N; Akanuma, N; Ito, M; Okazaki, M; Matsubara, R; Adachi, T; Ishii, R; Kanemoto, K; Matsuura, M; Hara, E; Kato, M; Onuma, T				Hara, Koichiro; Adachi, Naoto; Akanuma, Nozomi; Ito, Masumi; Okazaki, Mitsutoshi; Matsubara, Ryoji; Adachi, Takuya; Ishii, Ryouhei; Kanemoto, Kousuke; Matsuura, Masato; Hara, Eriko; Kato, Masaaki; Onuma, Teiichi			Dissociative experiences in epilepsy: Effects of epilepsy-related factors on pathological dissociation	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Psychogenic nonepileptic seizure; Dissociation; DES; Seizure frequency	PSYCHOGENIC NONEPILEPTIC SEIZURES; GENERAL-POPULATION; ABUSE HISTORY; SYMPTOMS; DISORDER; SCALE; PSEUDOSEIZURES; RELIABILITY; BEHAVIOR; DIARIES	Psychogenic nonepileptic seizures (PNESs) in patients with epilepsy can be categorized as dissociative disorders. The prevalence of PNESs in patients with epilepsy appears to be much higher than that of dissociative experiences in nonclinical subjects. In order to clarify as to whether epilepsy-related factors were associated with pathological dissociation, we conducted a controlled study with 225 patients with epilepsy and 334 nonclinically matched individuals. All participants completed the Japanese version of the Dissociative Experiences Scale (DES). There was no significant difference in the DES score (DES-S) between the group with epilepsy and the control group. The group with epilepsy showed a significantly higher DES taxon (DES-T; a subset of DES-S and an index of pathological dissociation) than the control group. Thirty-one out of the 225 patients with epilepsy (13.8%) had PNESs. Because of its strong association with the DES-S and DES-T, PNESs can be regarded as a symptom of dissociation. With multiple regression analysis, the patients with a shorter duration of epilepsy, higher seizure frequency, or shorter period in education tend to suffer from pathological dissociation. These findings demonstrate that patients with epilepsy are more prone to experiencing pathological dissociation when having certain clinical factors. (C) 2014 Elsevier Inc. All rights reserved.	[Hara, Koichiro] Asai Hosp, Togane, Japan; [Hara, Koichiro] Asahi Gen Hosp, Asahi, Japan; [Adachi, Naoto; Akanuma, Nozomi; Ito, Masumi; Okazaki, Mitsutoshi; Kato, Masaaki; Onuma, Teiichi] Natl Ctr Hosp Neurol & Psychiat, Kodaira, Tokyo, Japan; [Adachi, Naoto; Adachi, Takuya] Adachi Mental Clin, Sapporo, Hokkaido 0040867, Japan; [Akanuma, Nozomi] South London & Maudsley NHS Fdn Trust, London, England; [Ito, Masumi] Jozen Clin, Sapporo, Hokkaido, Japan; [Matsubara, Ryoji] Sapporo Hanazono Hosp, Sapporo, Hokkaido, Japan; [Ishii, Ryouhei] Osaka Univ, Epilepsy Ctr, Osaka, Japan; [Kanemoto, Kousuke] Aichi Med Univ Hosp, Nagakute, Aichi, Japan; [Matsuura, Masato; Hara, Eriko] Tokyo Med & Dent Univ, Tokyo, Japan; [Kato, Masaaki; Onuma, Teiichi] Musashino Kokubunji Clin, Kokubunji, Tokyo, Japan	Adachi, N (reprint author), Adachi Mental Clin, Kitano 7-5-12, Sapporo, Hokkaido 0040867, Japan.	adacchan@tky2.3web.ne.jp					Adachi N, 1998, EPILEPSIA, V39, P628, DOI 10.1111/j.1528-1157.1998.tb01431.x; Adachi N, 2008, J NERV MENT DIS, V196, P417, DOI 10.1097/NMD.0b013e31816ff36d; Adachi N, 2005, EPILEPSIA, V46, P1502, DOI 10.1111/j.1528-1167.2005.05005.x; Adachi T, 2005, JPN J PSYCHIAT TREAT, V20, P625; Akyuz G, 2004, EPILEPTIC DISORD, V6, P187; Rosik CH, 2012, J TRAUMA DISSOCIATIO, V13, P69, DOI 10.1080/15299732.2011.606739; Mazza M, 2009, EPILEPSY RES, V84, P91, DOI 10.1016/j.eplepsyres.2008.12.008; Guralnik O, 2007, J NERV MENT DIS, V195, P983, DOI 10.1097/NMD.0b013e1815c19cd; Fisher RS, 2012, EPILEPSY BEHAV, V24, P304, DOI 10.1016/j.yebeh.2012.04.128; Reuber M, 2003, EPILEPSY RES, V57, P159, DOI 10.1016/j.eplepsyres.2003.11.004; Harden CL, 1997, SEIZURE, V6, P151, DOI 10.1016/S1059-1311(97)80070-2; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Putnam FW, 1996, J NERV MENT DIS, V184, P673, DOI 10.1097/00005053-199611000-00004; Waller NG, 1997, J ABNORM PSYCHOL, V106, P499, DOI 10.1037/0021-843X.106.4.499; Mitchell JW, 2012, EPILEPSY BEHAV, V25, P307, DOI 10.1016/j.yebeh.2012.08.022; Goldstein LH, 2006, J NEUROL NEUROSUR PS, V77, P616, DOI 10.1136/jnnp.2005.066878; Waller NG, 1996, PSYCHOL METHODS, V1, P300, DOI 10.1037/1082-989X.1.3.300; Alper K, 1997, EPILEPSIA, V38, P991, DOI 10.1111/j.1528-1157.1997.tb01481.x; DUNN GE, 1993, AM J PSYCHIAT, V150, P1043; Devinsky O, 2001, J NEUROPSYCH CLIN N, V13, P367, DOI 10.1176/appi.neuropsych.13.3.367; ROSS CA, 1990, AM J PSYCHIAT, V147, P1547; Beghi E, 2008, EPILEPSY COMPREHENSI, P65; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Bernstein-Carlson E, 1993, DISSOCIATION, V6, P16; Binder LM, 1998, ARCH CLIN NEUROPSYCH, V13, P513, DOI 10.1016/S0887-6177(97)00042-5; Commission on Classification and Terminology of the International League Against Epilepsy, 1989, EPILEPSIA, V30, P389; Dikel TN, 2003, EPILEPSY BEHAV, V4, P644, DOI 10.1016/j.yebeh.2003.08.006; Ehling T, 2008, Prog Brain Res, V167, P307; Gates JR, 1991, EPILEPSY BEHAV, P251; Hisano T, 1992, J JPN EPI SOC, V10, P209; BANCAUD J, 1981, EPILEPSIA, V22, P489; Ito M, 2009, EPILEPSY BEHAV, V16, P491, DOI 10.1016/j.yebeh.2009.08.017; Kuyk J, 2003, EPILEPSY BEHAV, V4, P13, DOI 10.1016/S1525-5050(02)00683-2; Lancman ME, 2001, PSYCHIATRIC ISSUES IN EPILEPSY: A PRACTICAL GUIDE TO DIAGNOSIS AND TREATMENT, P341; Maaranen P, 2005, AUST NZ J PSYCHIAT, V39, P387, DOI 10.1111/j.1440-1614.2005.01586.x; Nardo D, 2013, ACTA PSYCHIAT SCAND, V128, P222, DOI 10.1111/acps.12026; Neil JC, 1996, APPL RES MENT RETARD, V7, P285; NEUGEBAUER R, 1989, NEUROEPIDEMIOLOGY, V8, P228, DOI 10.1159/000110187; Ozcetin A, 2009, NORD J PSYCHIAT, V63, P462, DOI 10.3109/08039480903029728; Prueter C, 2002, EPILEPSIA, V43, P188, DOI 10.1046/j.1528-1157.2002.45900.x; RAMSAY RE, 1993, NON-EPILEPTIC SEIZURES, P47; Spitzer Carsten, 2006, J Trauma Dissociation, V7, P51, DOI 10.1300/J229v07n01_05; Umesue M, 1996, DISSOCIATION, V9, P182; World Health Organization, 1992, ICD 10 CLASS MENT BE	44	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	MAR	2015	44						185	191		10.1016/j.yebeh.2014.12.018		7	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CG4AI	WOS:000353221600033		
J	Matsumoto, R; Mikuni, N; Tanaka, K; Usami, K; Fukao, K; Kunieda, T; Takahashi, Y; Miyamoto, S; Fukuyama, H; Takahashi, R; Ikeda, A				Matsumoto, Riki; Mikuni, Nobuhiro; Tanaka, Keiko; Usami, Kiyohide; Fukao, Kenjiro; Kunieda, Takeharu; Takahashi, Yukitoshi; Miyamoto, Susumu; Fukuyama, Hidenao; Takahashi, Ryosuke; Ikeda, Akio			Possible induction of multiple seizure foci due to parietal tumour and anti-NMDAR antibody	EPILEPTIC DISORDERS			English	Article						anti-NMDAR antibody; secondary epileptogenesis; oligoastrocytoma; autoimmune epilepsy	RECEPTOR ENCEPHALITIS; AUTOANTIBODIES	Formes frustes of encephalopathy associated with anti-NMDAR antibody have been recently described in cases of chronic epilepsy. We report a young woman with a parietal lesion and anti-NMDAR antibody who acquired bilateral, secondary epileptogenesis in the temporal lobes within a period as short as six years. Removal of the primary epileptogenic lesion of oligoastrocytoma in the right parietal lobe resulted in seizure freedom, disappearance of secondary foci, and substantial decrease of the antibody titre. Chronic exposure to anti-NMDAR antibody, albeit at a low titre, may have resulted in a smoldering chronic course and relatively early acquisition of reversible secondary foci without development of a high degree of epileptogenicity and structural changes.	[Matsumoto, Riki; Ikeda, Akio] Kyoto Univ Grad Sch Med, Dept Epilepsy Movement Disorders & Physiol, Kyoto, Japan; [Mikuni, Nobuhiro; Kunieda, Takeharu; Miyamoto, Susumu] Kyoto Univ Grad Sch Med, Dept Neurosurg, Kyoto, Japan; [Fukao, Kenjiro] Kyoto Univ Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Tanaka, Keiko] Kanazawa Med Univ, Dept Neurol, Uchinada, Ishikawa, Japan; [Usami, Kiyohide; Takahashi, Ryosuke] Kyoto Univ Grad Sch Med, Dept Neurol, Kyoto, Japan; [Takahashi, Yukitoshi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan; [Fukuyama, Hidenao] Kyoto Univ Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Mikuni, Nobuhiro] Sapporo Med Univ, Dept Neurosurg, Sapporo, Hokkaido, Japan	Matsumoto, R (reprint author), Kyoto Univ Grad Sch Med, Dept Epilepsy Movement Disorders & Physiol, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	matsumot@kuhp.kyoto-u.ac.jp		Matsumoto, Riki/0000-0003-3985-9210; Ikeda, Akio/0000-0002-0790-2598	Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26282218, 26293209]; Japan Epilepsy Research Foundation; GlaxoSmithKline KK; Nihon Kohden Corporation; Otsuka Pharmaceutical Co.; UCB Japan Co., Ltd.	We thank Prof. Angela Vincent for measuring anti-VGKC complex antibody and onconeuronal antibodies, and Dr. M. Yamada, Saigata National Hospital, for valuable comments on the histological evaluation of the tumour. This work was partly supported by Grants-in-Aid for Scientific Research (B) 26282218, 26293209 from the Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Research Grant from the Japan Epilepsy Research Foundation.; The Department of Epilepsy, Movement Disorders and Physiology, at Kyoto University Graduate School of Medicine, is an endowment department, supported by grants from GlaxoSmithKline KK, Nihon Kohden Corporation, Otsuka Pharmaceutical Co., and UCB Japan Co., Ltd.	Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Niehusmann P, 2009, ARCH NEUROL-CHICAGO, V66, P458, DOI 10.1001/archneurol.2009.5; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Zhang Q, 2012, NEUROBIOL DIS, V45, P610, DOI 10.1016/j.nbd.2011.09.019; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Iizuka T, 2008, NEUROLOGY, V70, P504, DOI 10.1212/01.wnl.0000278388.90370.c3; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Kimura A, 2007, EUR NEUROL, V58, P152, DOI 10.1159/000104716; MORRELL F, 1985, ARCH NEUROL-CHICAGO, V42, P318; Takahashi Y, 2003, NEUROLOGY, V61, P891	10	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	1294-9361	1950-6945		EPILEPTIC DISORD	Epileptic Disord.	MAR	2015	17	1					89	94		10.1684/epd.2015.0725		6	Clinical Neurology	Neurosciences & Neurology	CG1JU	WOS:000353029700012		
J	Shatskiy, A; Gavryushkin, PN; Litasov, KD; Koroleva, ON; Kupriyanov, IN; Borzdov, YM; Sharygin, IS; Funakoshi, K; Palyanov, YN; Ohtani, E				Shatskiy, Anton; Gavryushkin, Pavel N.; Litasov, Konstantin D.; Koroleva, Olga N.; Kupriyanov, Igor N.; Borzdov, Yuri M.; Sharygin, Igor S.; Funakoshi, Kenichi; Palyanov, Yuri N.; Ohtani, Eiji			Na-Ca carbonates synthesized under upper-mantle conditions: Raman spectroscopic and X-ray diffraction studies	EUROPEAN JOURNAL OF MINERALOGY			English	Article						Na-Ca carbonates; shortite; nyerereite; high-pressure experiment; Raman spectroscopy; X-ray diffraction	UDACHNAYA-EAST PIPE; UP KAWAI-CELL; OLDOINYO-LENGAI; 6 GPA; CRYSTAL STRUCTURE; PHASE-RELATIONS; SHORTITE; KIMBERLITE; NYEREREITE; INCLUSIONS	The new Na4Ca(CO3)(3), Na2Ca3(CO3)(4) and Na2Ca4(CO3)(5) compounds were synthesized in the system Na2CO3-CaCO3 in multianvil experiments at 6 GPa and characterized by Raman spectroscopy. In addition, the Na2Ca3(CO3)(4) compound was studied using in situ energy dispersive and single-crystal X-ray diffraction. Single bands in the CO32- symmetric stretching region (v(1)) and out-of-plane bending region (v(2)) in the Na4Ca(CO3)(3) Raman spectrum suggest a single crystallographically distinct carbonate group in the structure. In contrast, the spectra of Na2Ca3(CO3)(4) and Na2Ca4(CO3)(5) show two and three bands, respectively, in both the symmetric stretching region (v(1)) and out-of-plane bending region (v(2)), suggesting more than one crystallographically distinct carbonate group in the unit cell. Raman activity in the forbidden v(2) mode and multiple bands are observed in the in-plane bending region (v(4)) for the three compounds, proving the reduction of site symmetry of the CO32- ions with the loss of the threefold rotation axis (D-3h -> D-2h or C-s). Such a decrease in symmetry suggests distortion of the group itself, but may be attained by rearrangements of the coordinated metal cations as in the aragonite-group carbonates. At 6.5 GPa and 1000 degrees C, the structure of Na2Ca3(CO3)(4) was found to be orthorhombic or monoclinic with a beta angle close to 90 degrees and the lattice parameters: a = 7.3357(6) angstrom, b = 8.0377(9) angstrom, and c = 31.5322 (32) angstrom, with V = 929.59(14) angstrom(3). No structural changes were observed during pressure decrease down to 1 GPa, while a discontinuous increase in unit-cell parameters and volume was observed upon decompression from 1 GPa at room temperature. This indicates a pressure-induced phase transition to a structurally related ambient-pressure phase. The abnormally long c-parameter and proximity of the beta-angle to 90 degrees of Na2Ca3(CO3)(4) at ambient conditions suggest that, in the monoclinic system, the metric symmetry is higher than the Laue symmetry, which is a common sign for merohedral twinning.	[Shatskiy, Anton; Gavryushkin, Pavel N.; Litasov, Konstantin D.; Kupriyanov, Igor N.; Borzdov, Yuri M.; Sharygin, Igor S.; Palyanov, Yuri N.; Ohtani, Eiji] Russian Acad Sci, Siberian Branch, VS Sobolev Inst Geol & Mineral, Novosibirsk 630090, Russia; [Shatskiy, Anton; Gavryushkin, Pavel N.; Litasov, Konstantin D.; Sharygin, Igor S.; Palyanov, Yuri N.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Koroleva, Olga N.] Russian Acad Sci, Ural Branch, Inst Mineral, Miass 456317, Russia; [Funakoshi, Kenichi] Japan Synchrotron Radiat Res Inst, SPring 8, Kouto, Hyogo 6785198, Japan; [Ohtani, Eiji] Tohoku Univ, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan	Shatskiy, A (reprint author), Russian Acad Sci, Siberian Branch, VS Sobolev Inst Geol & Mineral, Koptyuga Pr 3, Novosibirsk 630090, Russia.	anton.antonshatskiy.shatskiy@gmail.com	Shatskiy, Anton/F-8731-2010; Sharygin, Igor/A-7754-2014; Palyanov, Yuri/C-6864-2011; Kupriyanov, Igor/O-2399-2013; Litasov, Konstantin/A-5366-2014; Koroleva, Olga/A-8854-2013	Shatskiy, Anton/0000-0003-4554-9550; 	Russian Scientific Fund [14-17-00609]; Ministry of education and science of Russian Federation [14.B25.31.0032]	This work was supported by the Russian Scientific Fund (proposal No. 14-17-00609) and performed under the project of the Ministry of education and science of Russian Federation (No. 14.B25.31.0032). The synchrotron radiation experiments were performed at the BL04B1 in SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI).	COOPER AF, 1975, AM J SCI, V275, P534; Shatskiy A, 2013, AM MINERAL, V98, P2164, DOI 10.2138/am.2013.4436; Grassi D, 2011, J PETROL, V52, P765, DOI 10.1093/petrology/egr002; FRECH R, 1980, SPECTROCHIM ACTA A, V36, P915, DOI 10.1016/0584-8539(80)80044-4; BROOKER MH, 1971, J CHEM PHYS, V54, P4788, DOI 10.1063/1.1674754; Giuliani A, 2012, GEOLOGY, V40, P967, DOI 10.1130/G33221.1; DAWSON JB, 1962, NATURE, V195, P1075, DOI 10.1038/1951075a0; Litasov KD, 2008, PHYS EARTH PLANET IN, V168, P191, DOI 10.1016/j.pepi.2008.06.018; Kujumzelis TG, 1938, Z PHYS, V109, P586, DOI 10.1007/BF01341586; Shatskiy A, 2013, AM MINERAL, V98, P2172, DOI 10.2138/am.2013.4418; Zaitsev AN, 2006, LITHOS, V91, P191, DOI 10.1016/j.lithos.2006.03.018; Mernagh TP, 2011, SPECTROCHIM ACTA A, V80, P82, DOI 10.1016/j.saa.2011.01.034; Golovin AV, 2003, DOKL EARTH SCI, V388, P93; Kamenetsky VS, 2013, CHEM GEOL, V353, P96, DOI 10.1016/j.chemgeo.2012.09.022; Dorogokupets PI, 2007, HIGH PRESSURE RES, V27, P431, DOI 10.1080/08957950701659700; Zaitsev AN, 2002, CAN MINERAL, V40, P103, DOI 10.2113/gscanmin.40.1.103; Zaitsev AN, 2009, GEOL ORE DEPOSIT+, V51, P608, DOI 10.1134/S1075701509070095; Herbst-Irmer R, 1998, ACTA CRYSTALLOGR B, V54, P443, DOI 10.1107/S0108768197018454; Frost RL, 2007, POLYHEDRON, V26, P4503, DOI 10.1016/j.poly.2007.06.003; Zaitsev AN, 2010, GEOL ORE DEPOSIT+, V52, P630, DOI 10.1134/S1075701510070159; Shatskiy A, 2013, AM MINERAL, V98, P1593, DOI 10.2138/am.2013.4407; KOGARKO LN, 1991, CONTRIB MINERAL PETR, V109, P124, DOI 10.1007/BF00687205; SCHEETZ BE, 1977, AM MINERAL, V62, P36; Kamenetsky VS, 2009, LITHOS, V112, P334, DOI 10.1016/j.lithos.2009.03.032; Kamenetsky VS, 2012, LITHOS, V152, P173, DOI 10.1016/j.lithos.2012.04.032; Kavanagh JL, 2009, EARTH PLANET SC LETT, V286, P404, DOI 10.1016/j.epsl.2009.07.011; Kamenetsky VS, 2008, J PETROL, V49, P823; Kamenetsky MB, 2004, GEOLOGY, V32, P845, DOI 10.1130/G20821.1; ADLER HH, 1963, AM MINERAL, V48, P839; Kaminsky F, 2009, MINERAL MAG, V73, P797, DOI 10.1180/minmag.2009.073.5.797; Kamenetsky VS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029389; Palyanov YN, 2010, CRYST GROWTH DES, V10, P3169, DOI 10.1021/cg100322p; Bottcher ME, 1996, J RAMAN SPECTROSC, V27, P859, DOI 10.1002/(SICI)1097-4555(199611)27:11<859::AID-JRS40>3.0.CO;2-T; Sharygin IS, 2013, EUR J MINERAL, V25, P825, DOI 10.1127/0935-1221/2013/0025-2315; ASPDEN JA, 1981, MINERAL MAG, V44, P201, DOI 10.1180/minmag.1981.044.334.14; COOPER AF, 1974, J GEOL, V82, P667; DICKENS B, 1971, J RES NBS A PHYS CH, VA 75, P129, DOI 10.6028/jres.075A.013; DICKENS B, 1971, J RES NBS A PHYS CH, VA 75, P27, DOI 10.6028/jres.075A.004; Fahey JJ, 1939, AM MINERAL, V24, P514; Farmer V. C., 1974, MINERALOGICAL SOC MO, V4, P227; FRANKIS EJ, 1973, NATURE-PHYS SCI, V246, P124; Frost RL, 2008, SPECTROCHIM ACTA A, V71, P143, DOI 10.1016/j.saa.2007.11.021; Golovin A. V., 2012, 10 INT KIMB C BANG I, p10IKC; Jagniecki EA, 2013, GEOCHIM COSMOCHIM AC, V115, P31, DOI 10.1016/j.gca.2013.04.005; KRAFT S, 1991, J GEOPHYS RES-SOL EA, V96, P17997, DOI 10.1029/91JB01749; Mattsson HB, 2009, B VOLCANOL, V71, P1179, DOI 10.1007/s00445-009-0288-4; MCKIE D, 1977, Z KRISTALLOGR, V145, P73, DOI 10.1524/zkri.1977.145.1-2.73; MEEKES H, 1986, PHYS REV B, V34, P4240, DOI 10.1103/PhysRevB.34.4240; Mitchell RH, 2011, J PETROL, V52, P1265, DOI 10.1093/petrology/egq069; Sato T, 1996, J PHYS SOC JPN, V65, P482, DOI 10.1143/JPSJ.65.482; Sharma S. K., 1980, CARNEGIE I WASH YB, V79, P322; Shatskiy A, 2011, AM MINERAL, V96, P541, DOI 10.2138/am.2011.3643; Shatskiy A, 2011, PHYS EARTH PLANET IN, V189, P92, DOI 10.1016/j.pepi.2011.08.001; SOKOLOV SV, 1979, DOKL AKAD NAUK SSSR+, V247, P1253; Watldnson D. H., 1973, J GEOL, V81, P229; Yegorov N. K., 1988, DOKL AKAD NAUK SSSR, V30, P188	56	1	1	E SCHWEIZERBARTSCHE VERLAGSBUCHHANDLUNG	STUTTGART	NAEGELE U OBERMILLER, SCIENCE PUBLISHERS, JOHANNESSTRASSE 3A, D 70176 STUTTGART, GERMANY	0935-1221	1617-4011		EUR J MINERAL	Eur. J. Mineral.	MAR-APR	2015	27	2					175	184		10.1127/ejm/2015/0027-2426		10	Mineralogy	Mineralogy	CG5ED	WOS:000353313000003		
J	Soda, K				Soda, Kuniyasu			Biological Effects of Polyamines on the Prevention of Aging-associated Diseases and on Lifespan Extension	FOOD SCIENCE AND TECHNOLOGY RESEARCH			English	Review						polyamine; spermine; abnormal methylation; lifespan extension; aging-associated diseases	FED METHYL-DEFICIENT; AGE-RELATED-CHANGES; ACID-DEFINED DIETS; DNA METHYLATION; ORNITHINE-DECARBOXYLASE; RAT-LIVER; S-ADENOSYLMETHIONINE; NATURAL POLYAMINE; CARDIOVASCULAR-DISEASE; DEVELOPMENTAL-CHANGES	Healthy foods such as beans, mushrooms, vegetables, and seafood and healthy dietary patterns such as the Mediterranean diet and Japanese food have higher concentrations of polyamines (spermine and spermidine). The continuous intake of high-polyamine foods has been shown to increase whole blood polyamine levels in mice and humans. In addition, high-polyamine chow inhibited aging-associated pathological changes in Jc1:ICR male mice and extended their lifespan. Aging is accompanied by decreased DNA methyltransferase activities, increased proinflammatory status, and enhanced abnormal gene methylation status, which is considered to be part of the pathogenesis of aging-associated diseases. In vitro and in vivo experiments have shown that polyamine supplementation reversed such changes induced by aging and polyamine-deficiency. In addition, polyamines have many biological activities that may contribute to the inhibition of lifestyle-related diseases such as diabetes, hyperlipemia, and arteriosclerosis. The possible role of dietary polyamines in human health is discussed.	Jichi Med Univ, Saitama Med Ctr, Cardiovasc Res Inst, Saitama, Saitama 3308503, Japan	Soda, K (reprint author), Jichi Med Univ, Saitama Med Ctr, Cardiovasc Res Inst, 1-847 Amanuma, Saitama, Saitama 3308503, Japan.	soda@jichi.ac.jp					Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; TADOLINI B, 1984, BIOCHEM BIOPH RES CO, V122, P550, DOI 10.1016/S0006-291X(84)80068-6; Borghini A, 2013, ATHEROSCLEROSIS, V230, P202, DOI 10.1016/j.atherosclerosis.2013.07.038; Wallace K, 2010, CANCER PREV RES, V3, P1552, DOI 10.1158/1940-6207.CAPR-10-0047; Jafarnejad A, 2008, LIFE SCI, V82, P301, DOI 10.1016/j.lfs.2007.11.015; Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759; Frostesjo L, 1997, J BIOL CHEM, V272, P4359; Shih DM, 1998, NATURE, V394, P284; Soda K, 2009, J NUTR SCI VITAMINOL, V55, P361, DOI 10.3177/jnsv.55.361; Soda K, 2005, J IMMUNOL, V175, P237; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Persson L, 2009, ESSAYS BIOCHEM, V46, P11, DOI [10.1042/bse0460002, 10.1042/BSE0460002]; Strong R, 2013, J GERONTOL A-BIOL, V68, P6, DOI 10.1093/gerona/gls070; Fujisawa S, 2005, ANTICANCER RES, V25, P965; Douki T, 2000, RADIAT RES, V153, P29, DOI 10.1667/0033-7587(2000)153[0029:PARIDO]2.0.CO;2; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; Cipolla B, 2003, BIOCHEM SOC T, V31, P384, DOI 10.1042/BST0310384; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11428, DOI 10.1073/pnas.89.23.11428; Sava IG, 2006, FREE RADICAL BIO MED, V41, P1272, DOI 10.1016/j.freeradbiomed.2006.07.008; Belle NAV, 2004, BRAIN RES, V1008, P245, DOI 10.1016/j.brainres.2004.02.036; Chiu SM, 1998, RADIAT RES, V149, P543, DOI 10.2307/3579900; Maegawa S, 2014, GENOME RES, V24, P580, DOI 10.1101/gr.157529.113; Nishimura K, 2006, J BIOCHEM, V139, P81, DOI 10.1093/jb/mvj003; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; BHAVE MR, 1988, CARCINOGENESIS, V9, P343, DOI 10.1093/carcin/9.3.343; WILSON VL, 1987, J BIOL CHEM, V262, P9948; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Farbiszewski R, 1996, NEUROCHEM RES, V21, P1497, DOI 10.1007/BF02533097; Warters RL, 1999, RADIAT RES, V151, P354, DOI 10.2307/3579948; CHRISTMAN JK, 1993, CARCINOGENESIS, V14, P551, DOI 10.1093/carcin/14.4.551; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Couzin-Frankel J, 2011, SCIENCE, V334, P1194, DOI 10.1126/science.334.6060.1194; Tsuji T, 2001, ONCOGENE, V20, P24, DOI 10.1038/sj.onc.1204051; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Potter SM, 1998, NUTR REV, V56, P231; Minois N, 2011, AGING-US, V3, P716; Hine D, 2012, IUBMB LIFE, V64, P157, DOI 10.1002/iub.588; Lopatina N, 2002, J CELL BIOCHEM, V84, P324, DOI 10.1002/jcb.10015; Zhang ZY, 2002, MECH AGEING DEV, V123, P1257; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; GILLIS S, 1981, J CLIN INVEST, V67, P937, DOI 10.1172/JCI110143; BARDOCZ S, 1990, BIOCHIM BIOPHYS ACTA, V1034, P46, DOI 10.1016/0304-4165(90)90151-L; BARDOCZ S, 1995, BRIT J NUTR, V73, P819, DOI 10.1079/BJN19950087; BEDFORD MR, 1988, ANN NUTR METAB, V32, P265, DOI 10.1159/000177462; Binh PNT, 2010, HEALTH, V2, P1390, DOI 10.4236/health.2010.212206; Binh PNT, 2011, NUTR DIET S, V3, P1; BRUNE B, 1991, EXP CELL RES, V195, P323, DOI 10.1016/0014-4827(91)90380-D; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; CHIRICOLO M, 1995, GERONTOLOGY, V41, P227; Cipolla BG, 2007, AMINO ACIDS, V33, P203, DOI 10.1007/s00726-007-0524-1; DAS R, 1982, EXP GERONTOL, V17, P95, DOI 10.1016/0531-5565(82)90042-0; de la Peña N C, 2000, Arch Med Res, V31, P546, DOI 10.1016/S0188-4409(00)00238-1; DIZIK M, 1991, CARCINOGENESIS, V12, P1307, DOI 10.1093/carcin/12.7.1307; ELWORTHY P, 1989, BIOCHIM BIOPHYS ACTA, V993, P212, DOI 10.1016/0304-4165(89)90166-9; FERIOLI ME, 1976, EXP GERONTOL, V11, P153, DOI 10.1016/0531-5565(76)90026-7; Gaboriau F, 2005, REDOX REP, V10, P9, DOI 10.1179/135100005X21561; GARCEA R, 1989, CARCINOGENESIS, V10, P1183, DOI 10.1093/carcin/10.7.1183; Gierman HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112430; GOLBUS J, 1990, EUR J IMMUNOL, V20, P1869, DOI 10.1002/eji.1830200836; GOSS SPA, 1995, CHEM RES TOXICOL, V8, P800, DOI 10.1021/tx00047a021; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Ha HC, 1998, BIOCHEM BIOPH RES CO, V244, P298, DOI 10.1006/bbrc.1998.8258; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; HELD KD, 1991, INT J RADIAT BIOL, V59, P699, DOI 10.1080/09553009114550611; HOLM I, 1988, BIOCHIM BIOPHYS ACTA, V972, P239, DOI 10.1016/0167-4889(88)90198-X; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; JANNE J, 1969, BIOCHIM BIOPHYS ACTA, V174, P769, DOI 10.1016/0005-2787(69)90310-4; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; Kano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056056; Kee K, 2004, J BIOL CHEM, V279, P40076, DOI 10.1074/jbc.M406002200; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Koponen T, 2012, AMINO ACIDS, V42, P427, DOI 10.1007/s00726-011-1013-0; LAITINEN SI, 1982, NEUROCHEM RES, V7, P1477, DOI 10.1007/BF00965090; Li YP, 2010, EXP GERONTOL, V45, P312, DOI 10.1016/j.exger.2009.12.008; LOVAAS E, 1991, FREE RADICAL BIO MED, V11, P455, DOI 10.1016/0891-5849(91)90061-7; MAMONT PS, 1981, BIOCHEM J, V196, P411; Marzabadi MR, 1996, FREE RADICAL BIO MED, V21, P375, DOI 10.1016/0891-5849(96)00038-X; Mendez JD, 2005, BIOMED PHARMACOTHER, V59, P283, DOI 10.1016/j.biopha.2005.05.006; Newton GL, 1997, RADIAT RES, V148, P272, DOI 10.2307/3579612; Newton GL, 1996, RADIAT RES, V145, P776, DOI 10.2307/3579370; Niiranen K, 2006, J CELL MOL MED, V10, P933, DOI 10.2755/jcmm010.004.02; Nishibori N, 2007, FOOD CHEM, V100, P491, DOI 10.1016/j.foodchem.2005.09.070; Nishimura K, 2001, EXP PARASITOL, V97, P95, DOI 10.1006/expr.2000.4588; OKUMURA M, 1993, EUR J IMMUNOL, V23, P1057, DOI 10.1002/eji.1830230512; ONO T, 1993, AGE AGEING, V22, pS34; Pakala R, 2003, THROMB RES, V110, P47, DOI 10.1016/S0049-3848(03)00287-1; PALLIS M, 1993, SCAND J IMMUNOL, V38, P559, DOI 10.1111/j.1365-3083.1993.tb03241.x; PAPAZAFIRI P, 1987, BIOCHEM J, V242, P479; Pegg AE, 2011, BIOCHEM J, V433, P139, DOI 10.1042/BJ20101228; Pirinen E, 2010, AMINO ACIDS, V38, P549, DOI 10.1007/s00726-009-0416-7; PISCIOTT.AV, 1967, NATURE, V215, P193, DOI 10.1038/215193a0; POGRIBNY IP, 1995, CANCER RES, V55, P1894; POWERS DC, 1992, CELL IMMUNOL, V141, P444, DOI 10.1016/0008-8749(92)90162-I; RAJALAKSHMI S, 1978, BIOCHEMISTRY-US, V17, P4515, DOI 10.1021/bi00614a024; Richardson BC, 2002, J NUTR, V132, p2401S; Romanenko EB, 1998, BIOCHEMISTRY-MOSCOW+, V63, P159; ROMANOV G A, 1980, Molekulyarnaya Biologiya (Moscow), V14, P357; RUSSELL DH, 1970, ENDOCRINOLOGY, V86, P1414; Schleiffer R, 2000, CANCER DETECT PREV, V24, P542; SHANTZ LM, 1992, BIOCHEM J, V288, P511; Sjoholm A, 1996, AM J PHYSIOL-CELL PH, V270, pC1105; Soda Kuniyasu, 2012, Glob J Health Sci, V4, P170, DOI 10.5539/gjhs.v4n6p170; Soda K, 2010, MED HYPOTHESES, V75, P299, DOI 10.1016/j.mehy.2010.03.008; Soda K., 2011, SOYABEAN AND HLTH, P489; Soda K., 2009, NEW FOOD IND, V51, P55; Soda K., 2010, NEW FOOD IND, V52, P66; Soda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064357; Soda K., 2011, J JAPANESE SOC PAREN, V26, P9; Soda K., 2012, NEW FOOD IND, V54, P27; SPOTHEIMMAURIZOT M, 1995, INT J RADIAT BIOL, V68, P571, DOI 10.1080/09553009514551561; Suzuki Y, 2003, LIFE SCI, V73, P1289, DOI 10.1016/S0024-3205(03)00426-0; Sy D, 1999, INT J RADIAT BIOL, V75, P953; TADOLINI B, 1988, BIOCHEM J, V249, P33; Teixeira D, 2002, J NUTR, V132, P3715; Ushijima T, 2005, CANCER SCI, V96, P206, DOI 10.1111/j.1349-7006.2005.00035.x; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138; VANYUSHI.BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; WELSH N, 1990, BIOCHEM J, V271, P393; WHITE R, 1983, J BIOL CHEM, V258, P8943; WILCOX JN, 1995, J NUTR, V125, pS631; Yamamoto D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012554; YOSHINAGA K, 1993, EXP GERONTOL, V28, P565, DOI 10.1016/0531-5565(93)90045-F; ZAPISEK WF, 1992, CARCINOGENESIS, V13, P1869, DOI 10.1093/carcin/13.10.1869	126	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1344-6606			FOOD SCI TECHNOL RES	Food Sci. Technol. Res.	MAR	2015	21	2					145	157		10.3136/fstr.21.145		13	Food Science & Technology	Food Science & Technology	CG6SC	WOS:000353431700001		
J	Santiago, DM; Matsushita, K; Noda, T; Tsuboi, K; Yamada, D; Murayama, D; Koaze, H; Yamauchi, H				Santiago, Dennis Marvin; Matsushita, Koki; Noda, Tatsuya; Tsuboi, Kazumasa; Yamada, Daiju; Murayama, Daiki; Koaze, Hiroshi; Yamauchi, Hiroaki			Effect of Purple Sweet Potato Powder Substitution and Enzymatic Treatments on Bread Making Quality	FOOD SCIENCE AND TECHNOLOGY RESEARCH			English	Article						purple sweet potato; bread making quality; alpha-amylase; hemicellulase; specialty bread	FUNGAL ALPHA-AMYLASE; WHEAT-FLOUR; BREADMAKING QUALITY; DOUGH RHEOLOGY; IMPROVEMENT; XYLANASE; ENZYMES; VARIETIES; BLENDS	Specialty breads substituted with non-wheat flour like purple sweet potato have been attracting attention because of their added nutrients, flavor, and color. Although the addition of non-wheat flour to specialty breads often results in lower loaf volume, this can be improved by enzyme treatments. In this context, this study investigated the effects of purple sweet potato powder (PSPP) substitution and enzyme treatments using alpha-amylase and hemicellulase on gassing power (GP), gas retention of dough (GRID), color and specific loaf volume (SLY) of bread. Results showed that the addition of PSPP produces bread crumbs with light purple color but low GRD and SLY of bread. On the other hand, alpha-amylase and hemicellulase improved the GRID, SLY and GP of PSPP-substituted bread by degrading the damaged starch and hemicellulose. Thus, these improved properties indicate acceptable quality of the bread.	[Santiago, Dennis Marvin] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Santiago, Dennis Marvin] Univ Philippines Los Banos, Coll Agr, Food Sci Cluster, Laguna 4031, Philippines; [Matsushita, Koki; Noda, Tatsuya; Tsuboi, Kazumasa; Yamada, Daiju; Murayama, Daiki; Koaze, Hiroshi; Yamauchi, Hiroaki] Obihiro Univ Agr & Vet Med, Dept Food Sci, Obihiro, Hokkaido 0808555, Japan	Yamauchi, H (reprint author), Obihiro Univ Agr & Vet Med, Dept Food Sci, West 2-11, Obihiro, Hokkaido 0808555, Japan.	yamauchi@obihiro.ac.jp					AACC, 1991, 0801 AACC; Teow CC, 2007, FOOD CHEM, V103, P829, DOI 10.1016/j.foodchem.2006.09.033; Gupta R, 2003, PROCESS BIOCHEM, V38, P1599, DOI 10.1016/S0032-9592(03)00053-0; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Kim HW, 2012, FOOD CHEM, V130, P966, DOI 10.1016/j.foodchem.2011.08.031; Bovell-Benjamin AC, 2007, ADV FOOD NUTR RES, V52, P1, DOI 10.1016/S1043-4526(06)52001-7; Rumbaoa RGO, 2009, FOOD CHEM, V113, P1133, DOI 10.1016/j.foodchem.2008.08.088; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Goesaert H, 2009, J CEREAL SCI, V50, P345, DOI 10.1016/j.jcs.2009.04.010; Mohammed I, 2012, IND CROP PROD, V36, P196, DOI 10.1016/j.indcrop.2011.09.006; Yamauchi H, 2004, FOOD SCI TECHNOL RES, V10, P247, DOI 10.3136/fstr.10.247; Hathorn CS, 2008, LWT-FOOD SCI TECHNOL, V41, P803, DOI 10.1016/j.lwt.2007.06.020; Rosell CM, 2011, FLOUR AND BREADS AND THEIR FORTIFICATION IN HEALTH AND DISEASE PREVENTION, P3, DOI 10.1016/B978-0-12-380886-8.10001-7; Stojceska V, 2008, FOOD CHEM, V110, P865, DOI 10.1016/j.foodchem.2008.02.074; Patel MJ, 2012, J CEREAL SCI, V56, P644, DOI 10.1016/j.jcs.2012.08.002; Antonio G.C., 2011, FRUIT VEGETABLE CERE, V5, P1; AOAC, 2000, OFFICIAL METHODS ANA; Brown H., 1998, MODERN BAKING, V12, P50; Brown H., 1996, MODERN BAKING, V12, P58; Caballero PA, 2007, J FOOD ENG, V81, P42, DOI 10.1016/j.jfoodeng.2006.10.007; Dewettinck K, 2008, J CEREAL SCI, V48, P243, DOI 10.1016/j.jcs.2008.01.003; Gibson T. S., 1991, J CEREAL SCI, V15, P15; Jiang ZQ, 2005, FOOD RES INT, V38, P37, DOI 10.1016/j.foodres.2004.07.007; Kano Mitsuyoshi, 2005, Biosci Biotechnol Biochem, V69, P979, DOI 10.1271/bbb.69.979; Kim JH, 2006, FOOD RES INT, V39, P117, DOI 10.1016/j.foodres.2005.06.008; Lu GQ, 2011, FLOUR AND BREADS AND THEIR FORTIFICATION IN HEALTH AND DISEASE PREVENTION, P407, DOI 10.1016/B978-0-12-380886-8.10037-6; MEUSER F, 1994, CEREAL FOOD WORLD, V39, P222; Montilla E.C., 2011, FRUIT VEG CEREAL SCI, V5, P19; Ray R.C., 2011, INT J FOOD SCI TECH, V46, P1; Schoenlechner R, 2013, LWT-FOOD SCI TECHNOL, V51, P361, DOI 10.1016/j.lwt.2012.10.020; Shah AR, 2006, BIORESOURCE TECHNOL, V97, P2047, DOI 10.1016/j.biortech.2005.10.006; Yamauchi H, 2004, FOOD SCI TECHNOL RES, V10, P314, DOI 10.3136/fstr.10.314; Yamauchi H, 2000, J JPN SOC FOOD SCI, V47, P46; Yamauchi H., 2001, Food Science and Technology Research, V7, P120, DOI 10.3136/fstr.7.120	34	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1344-6606			FOOD SCI TECHNOL RES	Food Sci. Technol. Res.	MAR	2015	21	2					159	165		10.3136/fstr.21.159		7	Food Science & Technology	Food Science & Technology	CG6SC	WOS:000353431700002		
J	Morita, A; Araki, T; Ikegami, S; Okaue, M; Sumi, M; Ueda, R; Sagara, Y				Morita, Airi; Araki, Tetsuya; Ikegami, Shoma; Okaue, Misako; Sumi, Masahiro; Ueda, Reiko; Sagara, Yasuyuki			Coupled Stepwise PLS-VIP and ANN Modeling for Identifying and Ranking Aroma Components Contributing to the Palatability of Cheddar Cheese	FOOD SCIENCE AND TECHNOLOGY RESEARCH			English	Article						partial least-squares regression-variable importance in projection (PLS-VIP); artificial neural network (ANN); gas chromatography / olfactometry (GC/O); fermented food; food kansei model	FOOD KANSEI MODEL; GAS CHROMATOGRAPHY/OLFACTOMETRY; ORAL CARCINOGENESIS; FLAVOR COMPOUNDS; FULL-FAT; PROFILES; IDENTIFICATION; DESIGN	A consumer-oriented methodological approach for the quality evaluation of Cheddar cheese as a typical fermented food was developed. Datasets were obtained from gas chromatography/olfactometry (GC/O) analysis and sensory evaluation of 10 Cheddar cheese samples. The GC/O analysis identified 43 aroma components under the categories of 14 aroma descriptors. Consumer evaluation of palatability was performed by 59 housewives. Factor analysis of the GC/O data identified aroma descriptors that have positive or negative correlations with palatability scores. Twelve aroma components were prioritized using stepwise partial least-squares regression with variable importance in projection (PLS-VIP). An artificial neural network (ANN) model was constructed to demonstrate the nonlinear relationships among the raw GC/O data of the samples and the palatability scores. Coupling stepwise PLS-VIP and ANN resulted in successful identification and ranking of aroma components contributing to the palatability of Cheddar cheese, and in modeling their nonlinear relationships.	[Morita, Airi; Araki, Tetsuya] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ward, Tokyo 1138657, Japan; [Ikegami, Shoma] Morinaga Milk Ind Co Ltd, Food Sci & Technol Inst, Zama, Kanagawa 2528583, Japan; [Okaue, Misako; Sumi, Masahiro] Morinaga Milk Ind Co Ltd, Prod Evaluat Ctr, Zama, Kanagawa 2528583, Japan; [Ueda, Reiko; Sagara, Yasuyuki] Food Kansei Commun Corp, Bunkyo Ward, Tokyo 1130022, Japan	Morita, A (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ward, 1-1-1 Yayoi, Tokyo 1138657, Japan.	5984268624@mail.ecc.u-tokyo.ac.jp					Akiyama M, 2012, FOOD BIOPROCESS TECH, V5, P1924, DOI 10.1007/s11947-011-0527-5; Michishita T, 2010, J FOOD SCI, V75, pS477, DOI 10.1111/j.1750-3841.2010.01828.x; Milo C, 1997, J AGR FOOD CHEM, V45, P3590, DOI 10.1021/jf970152m; BORGGAARD C, 1992, ANAL CHEM, V64, P545, DOI 10.1021/ac00029a018; Roy K, 2009, EUR J MED CHEM, V44, P2913, DOI 10.1016/j.ejmech.2008.12.004; Whetstine MEC, 2005, J AGR FOOD CHEM, V53, P3126, DOI 10.1021/jf048278o; Saurina J, 2010, TRAC-TREND ANAL CHEM, V29, P234, DOI 10.1016/j.trac.2009.11.008; Zehentbauer G, 2002, FLAVOUR FRAG J, V17, P300, DOI 10.1002/ffj.1102; FOX PF, 1995, ADV EXP MED BIOL, V367, P59; Whetstine MEC, 2006, J DAIRY SCI, V89, P505; Thomsen M, 2012, INT DAIRY J, V26, P41, DOI 10.1016/j.idairyj.2012.04.009; Engel W, 1999, EUR FOOD RES TECHNOL, V209, P237, DOI 10.1007/s002170050486; ACREE TE, 1984, FOOD CHEM, V14, P273, DOI 10.1016/0308-8146(84)90082-7; Kim MK, 2011, J SENS STUD, V26, P278, DOI 10.1111/j.1745-459X.2011.00343.x; BHANDARE P, 1993, APPL SPECTROSC, V47, P1214, DOI 10.1366/0003702934067928; Chi-Hyuck J., 2009, P INT C COMP IND ENG, P1302; Ciosek P., 2005, TALANTA, V67, P560; Ikeda G, 2004, FOOD SCI TECHNOL RES, V10, P396, DOI 10.3136/fstr.10.396; Ikeda G, 2006, FOOD SCI TECHNOL RES, V12, P261, DOI 10.3136/fstr.12.261; Kosikowski FV., 1958, 38 FAO, P15; MAFF (Ministry of Agriculture Forestry and Fisheries of Japan), 2013, SUPPL DEM TABL CHEES; McGorrin RJ, 2001, ROY SOC CH, P67, DOI 10.1039/9781847550859-00067; NAGAMACHI M, 1995, INT J IND ERGONOM, V15, P3, DOI 10.1016/0169-8141(94)00052-5; Onishi M, 2011, BIOSCI BIOTECH BIOCH, V75, P261, DOI 10.1271/bbb.100572; Parliament T. H., 2000, S SERIES, V756, P44; Sagara Y., 1994, NIPPON SHOKUHIN KAGA, V56, P317; Shibata M, 2008, FOOD SCI TECHNOL RES, V14, P367, DOI 10.3136/fstr.14.367; Singh T.K., 2003, COMPR REV FOOD SCI F, V2, P166, DOI 10.1111/j.1541-4337.2003.tb00021.x; Suriyaphan O, 2001, J AGR FOOD CHEM, V49, P1382, DOI 10.1021/jf001121l; Ueda R, 2008, FOOD SCI TECHNOL RES, V14, P445, DOI 10.3136/fstr.14.445; USDA, 2013, DAIR WORLD MARK TRAD; Wang CY, 1999, PHOTOCHEM PHOTOBIOL, V69, P471, DOI 10.1111/j.1751-1097.1999.tb03314.x; Wang CY, 2003, LASER SURG MED, V32, P318, DOI 10.1002/lsm.10153; Wold S., 1984, NATO ASI SER C-MATH, V138, P17	34	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1344-6606			FOOD SCI TECHNOL RES	Food Sci. Technol. Res.	MAR	2015	21	2					175	186		10.3136/fstr.21.175		12	Food Science & Technology	Food Science & Technology	CG6SC	WOS:000353431700004		
J	Dammak, I; Neves, M; Souilem, S; Isoda, H; Sayadi, S; Nakajima, M				Dammak, Ilyes; Neves, Marcos; Souilem, Safa; Isoda, Hiroko; Sayadi, Sami; Nakajima, Mitsutoshi			Material Balance of Olive Components in Virgin Olive Oil Extraction Processing	FOOD SCIENCE AND TECHNOLOGY RESEARCH			English	Article						olive oil; operation; material balance; saccharides; polyphenols; enzymatic activities	PHENOLIC-COMPOUNDS; TEMPERATURE; QUALITY; PASTE; TIME	Processing of olive fruits using a three-phase extraction system for the production of virgin olive oil was analyzed to clarify the material balance of olive fruit components, i.e., oil, water, carbohydrates, proteins, minerals and polyphenols. The estimated total olive material balance based on mass flow indicated a final oil extraction yield of around 83.3%, with an initial olive fruit mass flow of 500 kg/h. The remaining oil was discharged as a by-product, mainly in olive cake (8.9%) and olive mill water (7.8%). The material balance of carbohydrates showed that the majority were discharged in olive cake (73.3 kg/h) and olive mill water (27.7 kg/h). The material balance of polyphenols, the most important functional compounds in olives, was determined because of their importance to olive oil chemical stability. Results showed an increase in polyphenols content during malaxation operation (17.6%), which was correlated with several enzymatic reactions directly reflected in the composition of virgin olive oil.	[Dammak, Ilyes; Neves, Marcos; Souilem, Safa; Isoda, Hiroko; Nakajima, Mitsutoshi] Univ Tsukuba, Alliance Res North Africa ARENA, Ibaraki 3058572, Japan; [Dammak, Ilyes; Souilem, Safa; Sayadi, Sami] Ctr Biotechnol Sfax, Lab Environm Bioproc, Sfax, Tunisia	Nakajima, M (reprint author), Univ Tsukuba, Alliance Res North Africa ARENA, Ibaraki 3058572, Japan.	nakajima.m.fu@u.tsukuba.ac.jp			Science and Technology Research Partnership for Sustainable Development-SATREPS project, from JICA / JST, Japan	We thank Mr. Kamel Kachaou, owner of the olive oil factory; Ms. Samira Abidi for her technical assistance in the HPLC analysis; Dr. Maher Boukhris, Dr. Gaith Rigane, and Mr. Slim Loukil from CBS, Tunisia; and Dr. Zheng Wang, Dr. Miyuki Hara and Dr. Kana Miyata from the University of Tsukuba, Japan, for their help during this work. This research was funded by the Science and Technology Research Partnership for Sustainable Development-SATREPS project, from JICA / JST, Japan.	Amirante P., 2009, ITALIAN J AGRON S, V4, P147; LETUTOUR B, 1992, PHYTOCHEMISTRY, V31, P1173, DOI 10.1016/0031-9422(92)80255-D; Rodis PS, 2002, J AGR FOOD CHEM, V50, P596, DOI 10.1021/jf010864j; Artajo LS, 2007, EUR FOOD RES TECHNOL, V225, P617, DOI 10.1007/s00217-006-0456-0; Servili M, 2004, J CHROMATOGR A, V1054, P113, DOI 10.1016/j.chroma.2004.08.070; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ryan D, 2002, J AGR FOOD CHEM, V50, P6716, DOI 10.1021/jf025736p; Di Giovacchino L, 2002, GRASAS ACEITES, V53, P179; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Ranalli A, 2003, EUR J LIPID SCI TECH, V105, P57, DOI 10.1002/ejlt.200390018; AOAC, 1990, APPR METH ASS OFF AN; AOAC, 2000, APPR METH ASS OFF AN, V17th; AOAC, 1995, APPR METH ASS OFF AN, V16th; BeMiller JN, 2009, FOOD SCI TECHNOL-INT, pXVII, DOI 10.1016/B978-0-12-746275-2.00023-9; Bonn G, 1998, ANAL CHEM CARBOHYDRA, P26; Boskou D., 2006, OLIVE OIL CHEM TECHN, V2, P73; Bouaziz M., 2006, J ARID LAND STUDIES, V15, P435; BRITSCH L, 1985, PHYTOCHEMISTRY, V24, P1975, DOI 10.1016/S0031-9422(00)83103-9; Brummer Y., 2005, UNDERSTANDING CARBOH, P68; Caponio F, 2001, EUR FOOD RES TECHNOL, V212, P156, DOI 10.1007/s002170000225; Di Giovacchino L, 1996, INFLUENCE EXTRACTION, P12; Inarejos-Garcia AM, 2009, EUR FOOD RES TECHNOL, V228, P671, DOI 10.1007/s00217-008-0977-9; IOOC, 2002, REC TRANDS TABL OL M, P18; Koutsaftakis A, 1999, J AM OIL CHEM SOC, V76, P1477, DOI 10.1007/s11746-999-0188-y; MACKNESS MI, 1983, BIOCHEM PHARMACOL, V32, P2291, DOI 10.1016/0006-2952(83)90175-2; Niaounakis M, 2006, WASTE MANAG SER, V5, P23; NORKRANS B, 1950, PHYSIOL PLANTARUM, V3, P75, DOI 10.1111/j.1399-3054.1950.tb07494.x; Petrakis C., 2006, OLIVE OIL CHEM TECHN, P191; Ryan D, 1998, ANALYST, V123, p31R, DOI 10.1039/a708920a; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Siniscalco V., 1988, RIV ITALIANA SOSTANZ, P65; Siniscalco V., 1989, RIV ITAL SOSTANZE CR, V46, P85; Takac Serpil, 2009, Recent Patents on Chemical Engineering, V2, DOI 10.2174/1874478810902030230; TSIMIDOU M, 1992, FOOD CHEM, V45, P141, DOI 10.1016/0308-8146(92)90025-W; Vlyssides AG, 2004, J CLEAN PROD, V12, P603, DOI 10.1016/S0959-6526(03)00078-7	35	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1344-6606			FOOD SCI TECHNOL RES	Food Sci. Technol. Res.	MAR	2015	21	2					193	205		10.3136/fstr.21.193		13	Food Science & Technology	Food Science & Technology	CG6SC	WOS:000353431700006		
J	Kawahara, T; Nakayama, D; Tanaka, K; Yasui, H				Kawahara, Takeshi; Nakayama, Daichi; Tanaka, Katsumi; Yasui, Hisako			Effect of Oral Administration of the IgE-suppressive Wild Yeast Strain Saccharomyces paradoxus P01 on the Development of Atopic Dermatitis-like Symptoms in NC/Nga Mice	FOOD SCIENCE AND TECHNOLOGY RESEARCH			English	Article						Saccharomyces; probiotics; atopic dermatitis; anti-allergic; IgE; IL-12	ALLERGIC AIRWAY INFLAMMATION; EOSINOPHILS; CEREVISIAE; DECTIN-1; CELLS; HYPERPRODUCTION; SENSITIZATION; RECOGNITION; PROBIOTICS; RESPONSES	The oral intake of probiotic microorganisms has been investigated as a potential approach to prevent IgE-associated allergic diseases, including atopic dermatitis (AD). However, the effects of potentially edible wild yeast strains of the genus Saccharomyces on allergic symptoms remain poorly understood. In this study, we investigated the effects in the NC/Nga AD mouse model of Saccharomyces paradoxus P01 (P01), a wild strain selected based on its suppressive effect on IgE production in vitro. Compared to animals on a P01-free diet, mice fed a P01-supplemented diet had a markedly reduced incidence of skin lesions and picryl chloride-induced ear thickening and inflammation. Serum IgE levels and IgE production by spleen cells in mice fed the P01-supplemented diet were significantly lower than those of control mice. These results suggest that oral intake of specific IgE-suppressive wild strains of Saccharomyces yeast may be effective in suppressing IgE production and alleviating IgE-associated allergic symptoms.	[Kawahara, Takeshi; Nakayama, Daichi] Shinshu Univ, Grad Sch Agr, Nagano 3994598, Japan; [Kawahara, Takeshi] Shinshu Univ, Dept Interdisciplinary Genome Sci & Cell Metab, IBS, ICCER, Nagano 3994598, Japan; [Tanaka, Katsumi; Yasui, Hisako] Kiso Town Resources Inst, Nagano 3978588, Japan	Kawahara, T (reprint author), Shinshu Univ, Grad Sch Agr, 8304 Minamiminowa, Nagano 3994598, Japan.	tkawafb@shinshu-u.ac.jp					DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Patel M, 2005, J IMMUNOL, V174, P7558; de Vries JE, 1998, J ALLERGY CLIN IMMUN, V102, P165, DOI 10.1016/S0091-6749(98)70080-6; Williams HC, 2000, CLIN EXP DERMATOL, V25, P522, DOI 10.1046/j.1365-2230.2000.00698.x; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Rodrigues ACP, 2000, J APPL MICROBIOL, V89, P404, DOI 10.1046/j.1365-2672.2000.01128.x; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Salminen S, 1999, TRENDS FOOD SCI TECH, V10, P107, DOI 10.1016/S0924-2244(99)00027-8; Moslehi-Jenabian S, 2010, NUTRIENTS, V2, P449, DOI 10.3390/nu2040449; Simpson EL, 2010, CURR MED RES OPIN, V26, P633, DOI 10.1185/03007990903512156; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Orlic S, 2007, INT J FOOD SCI TECH, V42, P95, DOI 10.1111/j.1365-2621.2006.01217.x; Liu FT, 2011, CLIN REV ALLERG IMMU, V41, P298, DOI 10.1007/s12016-011-8252-4; SANDERSON CJ, 1992, BLOOD, V79, P3101; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Fuchs B, 2010, INT ARCH ALLERGY IMM, V152, P131, DOI 10.1159/000265534; Kawahara T, 2013, FOOD SCI TECHNOL RES, V19, P1019; Kim Nam Yeun, 2012, Korean J Pediatr, V55, P193, DOI 10.3345/kjp.2012.55.6.193; KITAGAKI H, 1995, J INVEST DERMATOL, V105, P749, DOI 10.1111/1523-1747.ep12325538; Knothe S, 2011, IMMUNOBIOLOGY, V216, P110, DOI 10.1016/j.imbio.2010.05.003; Kuitunen M, 2012, CLIN EXP ALLERGY, V42, P991, DOI 10.1111/j.1365-2222.2012.04023.x; Lin JY, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-1; de Llanos R, 2006, ANTON LEEUW INT J G, V90, P221, DOI 10.1007/s10482-006-9077-7; Majdak A, 2002, FOOD TECHNOL BIOTECH, V40, P103; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Matsumoto M, 1999, J IMMUNOL, V162, P1056; Ohata E, 2011, FOOD SCI TECHNOL RES, V17, P537; Okada M., 2000, PHARMACOMETRICS, V59, P135; Pawankar R., 2013, WAO WHITE BOOK ALLER, P11; Qamar A, 2001, INFECT IMMUN, V69, P2762, DOI 10.1128/IAI.69.4.2762-2765.2001; Segawa S, 2008, INT J FOOD MICROBIOL, V121, P1, DOI 10.1016/j.ijfoodmicro.2007.10.004; Simon D, 2004, ALLERGY, V59, P561, DOI 10.1111/j.1398-9995.2004.00476.x; Werfel Thomas, 2008, V94, P101, DOI 10.1159/000154935; Zheng H, 2011, INT IMMUNOPHARMACOL, V11, P511, DOI 10.1016/j.intimp.2010.12.022	38	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1344-6606			FOOD SCI TECHNOL RES	Food Sci. Technol. Res.	MAR	2015	21	2					223	230		10.3136/fstr.21.223		8	Food Science & Technology	Food Science & Technology	CG6SC	WOS:000353431700009		
J	Mikami, N; Tsujimura, J; Sato, A; Narasada, A; Shigeta, M; Kato, M; Hata, S; Hitomi, E				Mikami, Nana; Tsujimura, Junko; Sato, Ayumi; Narasada, Akiko; Shigeta, Mayumi; Kato, Motoshi; Hata, Shuichi; Hitomi, Eri			Green Rooibos Extract from Aspalathus linearis, and its Component, Aspalathin, Suppress Elevation of Blood Glucose Levels in Mice and Inhibit alpha-amylase and alpha-glucosidase Activities in vitro	FOOD SCIENCE AND TECHNOLOGY RESEARCH			English	Article						green rooibos; Aspalathus linearis; aspalathin; postprandial blood glucose level; alpha-amylase; alpha-glucosidase; dihydrochalcone	QUANTITATIVE CHARACTERIZATION; ANTIOXIDANT ACTIVITY; TEA; POLYPHENOLS; RATS; HYPERGLYCEMIA; FLAVONOIDS; JEJUNUM; CELLS	To evaluate the suppressive effects of green rooibos (Aspalathus linearis) unfermented tea on postprandial hyperglycemia, we orally administered four carbohydrates with or without green rooibos extract (GRE) and its major flavonoid aspalathin (Asp). GRE significantly suppressed the elevation of blood glucose levels after glucose, maltose, and starch intake. Asp also lowered the levels for all four carbohydrates. To clarify the mechanism underlying these results, we performed an intraperitoneal glucose tolerance test (IPGTT) and measured the ability of GRE and Asp to inhibit the activities of carbohydrate-hydrolyzing enzymes in vitro. In IPGTT, GRE and Asp did not show suppressive effects on blood glucose, while they dose-dependently inhibited the activities of a-glucosidase and a-amylase in vitro. These results showed that GRE and Asp suppress the elevation of blood glucose levels. It was indicated that these effects may result from the suppression of glucose absorption and the inhibition of carbohydrate-hydrolyzing enzyme activities by GRE and Asp.	[Mikami, Nana; Tsujimura, Junko; Sato, Ayumi; Narasada, Akiko; Shigeta, Mayumi; Kato, Motoshi; Hitomi, Eri] Yamaguchi Prefectural Univ, Fac Nursing & Nutr, Yamaguchi, Yamaguchi 7538502, Japan; [Hata, Shuichi] Tama Biochem Co, Shinjuku Ku, Tokyo 1600023, Japan; [Mikami, Nana] Sapporo Med Univ, Dept Biomed Engn, Sch Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Mikami, N (reprint author), Yamaguchi Prefectural Univ, Fac Nursing & Nutr, 3-2-1 Sakurabatake, Yamaguchi, Yamaguchi 7538502, Japan.	mikami7@sapmed.ac.jp					Krafczyk N, 2009, J AGR FOOD CHEM, V57, P6838, DOI 10.1021/jf901614y; Kim SH, 2011, INT J MOL SCI, V12, P3757, DOI 10.3390/ijms12063757; Joubert E, 2012, J AGR FOOD CHEM, V60, P9171, DOI 10.1021/jf302583r; Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099; Deguchi Y, 1998, NIPPON NOGEIK KAISHI, V72, P923; Cermak R, 2004, BRIT J NUTR, V91, P849, DOI 10.1079/BJN20041128; Kawano A, 2009, PHYTOMEDICINE, V16, P437, DOI 10.1016/j.phymed.2008.11.009; Muraoka O, 2011, J NAT MED-TOKYO, V65, P142, DOI 10.1007/s11418-010-0474-x; Alzaid F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078932; Franz MJ, 2010, J AM DIET ASSOC, V110, P1852, DOI 10.1016/j.jada.2010.09.014; Shimizu M, 2000, BIOFACTORS, V13, P61; Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832; Baba H, 2009, PEDIATR INT, V51, P700, DOI 10.1111/j.1442-200X.2009.02835.x; Bramati L, 2002, J AGR FOOD CHEM, V50, P5513, DOI 10.1021/jf025697h; Bramati L, 2003, J AGR FOOD CHEM, V51, P7472, DOI 10.1021/jf0347721; Ceriello A, 2003, DIABETOLOGIA, V46, pM9, DOI 10.1007/s00125-002-0931-5; Fukasawa R, 2009, J OLEO SCI, V58, P275, DOI 10.5650/jos.58.275; GERRITS PM, 1993, AM J CLIN NUTR, V58, P796; Heinrich T, 2012, J AGR FOOD CHEM, V60, P5221, DOI 10.1021/jf300170j; Helliwell PA, 2002, J PHYSIOL-LONDON, V544, P579, DOI 10.1113/jphysiol.2002.028209; Kodama T, 2005, EUR J CLIN NUTR, V59, P384, DOI 10.1038/sj.ejcn.1602085; Krafczyk N, 2008, J AGR FOOD CHEM, V56, P3368, DOI 10.1021/jf703701n; Li YY, 2009, SER OPER SUPP CH MAN, V3, P199; MORTON JF, 1983, ECON BOT, V37, P164, DOI 10.1007/BF02858780; Muller CJF, 2012, PHYTOMEDICINE, V20, P32, DOI 10.1016/j.phymed.2012.09.010; Saito Y, 2007, J JPN SOC FOOD SCI, V54, P563; Snijman PW, 2007, MUTAT RES-GEN TOX EN, V631, P111, DOI 10.1016/j.mrgentox.2007.03.009; Son MJ, 2013, EUR J NUTR, V52, P1607, DOI 10.1007/s00394-012-0466-6; Wakabayashi S., 1999, J JPN ASS DIETARY FI, V3, P13; WAKABAYASHI S, 1995, J ENDOCRINOL, V144, P533, DOI 10.1677/joe.0.1440533	30	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1344-6606			FOOD SCI TECHNOL RES	Food Sci. Technol. Res.	MAR	2015	21	2					231	240		10.3136/fstr.21.231		10	Food Science & Technology	Food Science & Technology	CG6SC	WOS:000353431700010		
J	Yoshida, S; Hosoya, T; Inui, S; Masuda, H; Kumazawa, S				Yoshida, Shuhei; Hosoya, Takahiro; Inui, Saori; Masuda, Hideki; Kumazawa, Shigenori			Component Analysis of Wasabi Leaves and an Evaluation of their Anti-inflammatory Activity	FOOD SCIENCE AND TECHNOLOGY RESEARCH			English	Article						Wasabia japonica Matsumura; leaves; components analysis; anti-inflammatory; J774.1 cells	6-METHYLSULFINYLHEXYL ISOTHIOCYANATE; MASS-SPECTROMETRY; JAPONICA; GLUCOSIDES; IDENTIFICATION; HORSERADISH; GLYCOSIDES; EXPRESSION	The methanol extracts of wasabi leaves (Wasabia japonica Matsumura) from Shizuoka, Japan have been found to inhibit the production of nitric oxide (NO) in an in vitro assay using murine macrophage J774.1 cells stimulated with lipopolysaccharide. Fourteen known compounds, including five phenylpropanoid glycosides (1 - 4 and 9), three phenylpropanoids (5 - 7), a phenolic glycoside (8), two flavonoid glycosides (10 and 11), two terpenoids (12 and 13) and a carotenoid (14), were isolated from wasabi leaves collected from Shizuoka and their structures elucidated using spectroscopic methods. This study therefore represents the first reported isolation of compounds 8, 9, 12, 13 and 14 from wasabi leaves. 5-Hydroxy ferulic acid methyl ester (5) and all-trans-lutein (14) were found to inhibit NO production in J774.1 cells with IC50 values of 22 and 25 mu M, respectively. The results therefore suggested that these compounds are the active components of wasabi leaves.	[Yoshida, Shuhei; Hosoya, Takahiro; Inui, Saori; Kumazawa, Shigenori] Univ Shizuoka, Dept Food & Nutr Sci, Suruga Ku, Shizuoka 4228526, Japan; [Masuda, Hideki] Tamaruya Honten Co Ltd, Aoi Ku, Shizuoka 4200852, Japan	Hosoya, T (reprint author), Univ Shizuoka, Dept Food & Nutr Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	t-hosoya@u-shizuoka-ken.ac.jp					Hosoya T, 2008, PHYTOCHEMISTRY, V69, P827, DOI 10.1016/j.phytochem.2007.08.021; Ono H, 1998, BIOSCI BIOTECH BIOCH, V62, P363, DOI 10.1271/bbb.62.363; Hosoya T, 2005, TETRAHEDRON, V61, P7037, DOI 10.1016/j.tet.2005.04.061; Rafi MM, 2007, MOL NUTR FOOD RES, V51, P333, DOI 10.1002/mnfr.200600170; KLICK S, 1988, PHYTOCHEMISTRY, V27, P2177; Goupy P, 2013, IND CROP PROD, V44, P496, DOI 10.1016/j.indcrop.2012.10.004; Kinae N, 2000, BIOFACTORS, V13, P265; Watanabe M, 2003, PHYTOCHEMISTRY, V62, P733, DOI 10.1016/S0031-9422(02)00613-1; DUBOIS MA, 1985, PHYTOCHEMISTRY, V24, P1077, DOI 10.1016/S0031-9422(00)83186-6; Eliseu R., 2012, MAR DRUGS, V10, P1784; Englert G., 1995, CAROTENOIDS B, V1B, P164; Fritz B., 2012, MOL NUTR FOOD RES, V56, P205; Goi H., 1985, J ANTIBACT ANTIFUNG, V13, P199; HORHAMMER L, 1958, Arch Pharm Ber Dtsch Pharm Ges, V291/63, P126, DOI 10.1002/ardp.19582910305; INOUYE S, 1983, J ANTIBACT ANTIFUNG, V11, P609; KOJIMA M, 1973, YAKUGAKU ZASSHI, V93, P453; Miyake Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1911, DOI 10.1271/bbb.70115; Mohamed KM, 1999, PHYTOCHEMISTRY, V50, P859, DOI 10.1016/S0031-9422(98)00603-7; Morimitsu Y, 2000, MECH AGEING DEV, V116, P125, DOI 10.1016/S0047-6374(00)00114-7; MOSS GP, 1976, PURE APPL CHEM, V47, P97, DOI 10.1351/pac197647020097; Ogawa T, 2010, FOOD CHEM, V118, P239, DOI 10.1016/j.foodchem.2009.04.113; Park JH, 2011, ARCH PHARM RES, V34, P533, DOI 10.1007/s12272-011-0403-x; Takaichi S., 2009, LOW TEMP SCI, V67, P347; Tsopmo A, 2010, J AGR FOOD CHEM, V58, P8715, DOI 10.1021/jf101412y	24	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1344-6606			FOOD SCI TECHNOL RES	Food Sci. Technol. Res.	MAR	2015	21	2					247	253		10.3136/fstr.21.247		7	Food Science & Technology	Food Science & Technology	CG6SC	WOS:000353431700012		
J	Miyaguchi, Y; Tomatsuri, T; Toyoda, A; Inoue, E; Ogawa, Y				Miyaguchi, Yuji; Tomatsuri, Takuya; Toyoda, Atsushi; Inoue, Eiichi; Ogawa, Yasuki			Effect of Yacon Tuber (Smallanthus sonchifolius)-derived Fructooligosaccharides on the Intestinal Flora and Immune System of OVA-sensitized BALB/c Mice	FOOD SCIENCE AND TECHNOLOGY RESEARCH			English	Article						cytokines; fructooligosaccharides; ovalbumin; prebiotics; yacon	BROWN-NORWAY RATS; SMALLANTHUS-SONCHIFOLIUS; AIRWAY INFLAMMATION; ALLERGEN; OLIGOSACCHARIDES; INTERLEUKIN-4; EXPRESSION; CYTOKINES; DISEASE; ASTHMA	Yacon (Smallanthus sonchifolius) tuber contains fructooligosaccharides (FOS). FOS are known as prebiotics that beneficially affect the host, i.e., improve the intestinal flora balance and enhance the immunomodulatory potential. In this study, we investigated the effect of a yacon extract rich in FOS (YOS) on the intestinal flora and immune system of BALB/c mice sensitized and challenged with ovalbumin in comparison with an extract with acid-degraded FOS (YAH). During the 4-week test period, the amount of YOS intake was lower than that of YAH; however, a significant increase in body weight was not shown among any of the test groups. Sneezing events were observed in OVA-treated mice. It was found that administration of yacon FOS improved the intestinal flora. Further, it was suggested that administration of yacon-derived FOS could epidemiologically improve the Th1/Th2 cytokine balance through its prebiotic effect on the number of beneficial bacteria in the animal	[Miyaguchi, Yuji; Tomatsuri, Takuya; Toyoda, Atsushi; Inoue, Eiichi; Ogawa, Yasuki] Ibaraki Univ, Coll Agr, Ibaraki 3000393, Japan; [Miyaguchi, Yuji; Toyoda, Atsushi; Inoue, Eiichi] Ibaraki Univ Cooperat Agr & Med Sci IUCAM, Ami, Ibaraki 3000393, Japan; [Miyaguchi, Yuji; Toyoda, Atsushi; Inoue, Eiichi; Ogawa, Yasuki] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan	Miyaguchi, Y (reprint author), Ibaraki Univ, Coll Agr, 3-2-1 Chuo Ami Machi, Ibaraki 3000393, Japan.	miyaguti@mx.ibaraki.ac.jp					REEVES PG, 1993, J NUTR, V123, P1939; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257; Campos D, 2012, FOOD CHEM, V135, P1592, DOI 10.1016/j.foodchem.2012.05.088; Haczku A, 1996, IMMUNOLOGY, V88, P247, DOI 10.1111/j.1365-2567.1996.tb00011.x; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Simonovska B, 2003, J CHROMATOGR A, V1016, P89, DOI 10.1016/S0021-9673(03)01183-X; Goto K, 1995, BIOSCI BIOTECH BIOCH, V59, P2346; Lopez HW, 2000, J NUTR BIOCHEM, V11, P500, DOI 10.1016/S0955-2863(00)00109-1; Kelly-Quagliana KA, 2003, NUTR RES, V23, P257, DOI 10.1016/S0271-5317(02)00516-X; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; Bouhnik Y, 1999, J NUTR, V129, P113; L'Homme C, 2003, J AGR FOOD CHEM, V51, P224, DOI 10.1021/jf0204699; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Yan XJ, 1999, J AGR FOOD CHEM, V47, P4711, DOI 10.1021/jf981305o; Asami T., 1989, SOIL SCI PLANT NUTR, V60, P122; BEJ AK, 1991, APPL ENVIRON MICROB, V57, P2429; COYLE AJ, 1995, AM J RESP CELL MOL, V13, P54; Dubois M.K., 1956, ANAL CHEM, V26, P351; ELWOOD W, 1991, J ALLERGY CLIN IMMUN, V88, P951, DOI 10.1016/0091-6749(91)90253-K; EYRE P, 1972, VET REC, V91, P134; Fujitani Shinobu, 2007, Allergol Int, V56, P131, DOI 10.2332/allergolint.O-06-450; Graefe S, 2004, FIELD CROP RES, V86, P157, DOI 10.1016/j.fcr.2003.08.003; Grethel T., 2012, NUTR RES, V32, P884; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kim A.R., 2010, J KOREAN SOC FOOD SC, V39, P210; Leigh R, 2004, AM J RESP CRIT CARE, V169, P860, DOI 10.1164/rccm.200305-706OC; MITSUOKA T, 1987, NAHRUNG, V31, P427; Miyaguchi Y, 2012, J JPN SOC FOOD SCI, V59, P175; NAKAJIMA H, 1992, AM REV RESPIR DIS, V146, P374; Poo-Zobel B., 2002, BR J NUTR, V87, P273; Renfu Y., 2010, BIOCHEM BIOPH RES CO, V399, P531; Takubo M, 2006, BIOL PHARM BULL, V29, P689, DOI 10.1248/bpb.29.689; Till S, 1997, J ALLERGY CLIN IMMUN, V99, P563, DOI 10.1016/S0091-6749(97)70085-X; Vos AP, 2006, INT IMMUNOPHARMACOL, V6, P1277, DOI 10.1016/j.intimp.2006.03.010; Watzl B., 2005, BR J NUTR, V93, P49, DOI 10.1079/BJN20041357; Yasuda A, 2010, INT J IMMUNOPATH PH, V23, P727; Yatsuzuka R, 2007, BIOL PHARM BULL, V30, P1557, DOI 10.1248/bpb.30.1557	38	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1344-6606			FOOD SCI TECHNOL RES	Food Sci. Technol. Res.	MAR	2015	21	2					255	262		10.3136/fstr.21.255		8	Food Science & Technology	Food Science & Technology	CG6SC	WOS:000353431700013		
J	Ochi, H; Mizutani, M; Hayashi, S				Ochi, Hiroshi; Mizutani, Masami; Hayashi, Sachio			Physiologically Active Substances of Okara Koji	FOOD SCIENCE AND TECHNOLOGY RESEARCH			English	Article						okara; koji; physiological activity; acid protease; ACE inhibitory activity		The physiologically active substances of okara koji, a fermented soybean residue from tofu (bean curd) manufacturing, were examined. First, kojis were made with rice or barley using 14 different koji molds. Next, the acid degree, protease activity, antioxidative activity (DPPH radical scavenging activity), and angiotensin-converting enzyme (ACE) inhibitory activity of the kojis were measured. Four koji molds were selected for high levels of physiologically active substances. Finally, it was confirmed that kojis produced using the selected koji molds showed increased levels of physiologically active substances such as acid proteases and ACE inhibitory substances.	[Ochi, Hiroshi] Miyazaki Prefectural Inst Publ Hlth & Environm, Miyazaki, Miyazaki 8892155, Japan; [Ochi, Hiroshi; Hayashi, Sachio] Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, Miyazaki, Miyazaki 8892192, Japan; [Mizutani, Masami] Miyazaki Prefectural Food Res & Dev Ctr, Miyazaki, Miyazaki 8800303, Japan	Hayashi, S (reprint author), Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, 1-1 Gakuen Kibanadai Nishi, Miyazaki, Miyazaki 8892192, Japan.	shayashi@cc.miyazaki-u.ac.jp					HORIUCHI M, 1982, J CHROMATOGR, V233, P123, DOI 10.1016/S0378-4347(00)81738-7; Iwashita A., 1994, J BREWING SOC JAPAN, V89, P869; Kagawa Y., 2009, 5 CORRECTIONS SUPPLE; Kawamura Y., 2000, J BREWING SOC JAPAN, V95, P386; Koide S., 1996, RECENT TREND EFFECTI, P74; Matsuda S., 2000, NIPPON SHOKUHIN HOZO, V26, P199; Matsuo M, 1997, BIOSCI BIOTECH BIOCH, V61, P1968; Michihata T., 2004, ISHIKAWA PREFECTURE, V53, P49; Miyake Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2515, DOI 10.1271/bbb.70310; Nishiya T, 2003, BREWING SOC JAPAN, p[181, 221]; Ochi H., 2014, NIPPON SHOKUHIN HOZO, V40, P161; Suda I, 2000, FOOD FUNCTION RES ME, P218; Yoshii H, 1995, NATL MISO ENG SOC, P51	13	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1344-6606			FOOD SCI TECHNOL RES	Food Sci. Technol. Res.	MAR	2015	21	2					271	274		10.3136/fstr.21.271		4	Food Science & Technology	Food Science & Technology	CG6SC	WOS:000353431700015		
J	Saito, T; Abe, D; Nogata, Y				Saito, Takeshi; Abe, Daigo; Nogata, Yoichi			Coffee Diterpenes Potentiate the Cytolytic Activity of KHYG-1 NK Leukemia Cells	FOOD SCIENCE AND TECHNOLOGY RESEARCH			English	Article						cafestol; granzyme B; kahweol; natural killer cell	CHOLESTEROL-RAISING FACTOR; KAHWEOL; CAFESTOL; TRANSCRIPTION; BREWS	Natural killer (NK) cells play a critical role in early host defense against tumor and virus-infected cells. Here, we report that two coffee diterpenes, cafestol and kahweol, potentiate the cytotoxic activity of KHYG-1, an NK leukemia cell line, against the NK-sensitive cell line K562. Western blot analysis and quantitative real-time PCR indicated that cafestol and kahweol markedly enhanced the expression of granzyme B. While both diterpenes had no or little effect on the expression of other cytotoxic effector molecules, kahweol elevated the phosphorylated forms of ATF-2, c-Jun and CREB transcription factors, which might participate in granzyme B gene expression. These results suggested that cafestol and kahweol upregulate granzyme B expression by activating transcription factors, leading to enhanced cytolytic activity of NK cells.	[Saito, Takeshi; Abe, Daigo; Nogata, Yoichi] NARO Western Reg Agr Res Ctr, Zentsuji, Kagawa 7658508, Japan	Nogata, Y (reprint author), NARO Western Reg Agr Res Ctr, 1-3-1 Senyu Cho, Zentsuji, Kagawa 7658508, Japan.	ynogata@affrc.go.jp					HANSON RD, 1993, BLOOD, V82, P2749; Urgert R, 1996, J ROY SOC MED, V89, P618; Yagita M, 2000, LEUKEMIA, V14, P922, DOI 10.1038/sj.leu.2401769; Gross G, 1997, FOOD CHEM TOXICOL, V35, P547, DOI 10.1016/S0278-6915(96)00123-8; Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7; URGERT R, 1995, J AGR FOOD CHEM, V43, P2167, DOI 10.1021/jf00056a039; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Babichuk CK, 1997, J BIOL CHEM, V272, P18564, DOI 10.1074/jbc.272.30.18564; Boekschoten MV, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-7; Fumimoto R, 2012, J PHARMACOL SCI, V118, P479, DOI 10.1254/jphs.11212FP; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Urgert R, 1997, AM J CLIN NUTR, V65, P519; WEUSTENVANDERWOUW MPME, 1994, J LIPID RES, V35, P721	13	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1344-6606			FOOD SCI TECHNOL RES	Food Sci. Technol. Res.	MAR	2015	21	2					281	284		10.3136/fstr.21.281		4	Food Science & Technology	Food Science & Technology	CG6SC	WOS:000353431700017		
J	Shimizu, T; Yaegashi, H; Ito, T; Kanematsu, S				Shimizu, Takeo; Yaegashi, Hajime; Ito, Tsutae; Kanematsu, Satoko			Systemic RNA interference is not triggered by locally-induced RNA interference in a plant pathogenic fungus, Rosellinia necatrix	FUNGAL GENETICS AND BIOLOGY			English	Article						Autonomously replicating vector; RNA interference; Rosellinia necatrix; Systemic RNAi	MUCOR-CIRCINELLOIDES; GENE; POLYMERASE; TRANSIENT; PATHWAYS; ELEGANS	The white root rot fungus, Rosellinia necatrix, damages a wide range of fruit trees. R. necatrix is known to host a variety of mycoviruses, and several of these have potential as biological control agents. RNA interference (RNAi) is a fungal defense mechanism against viral infection, and it is therefore important to understand the RNAi amplification and transmission systems in R. necatrix for effective use of mycoviruses in disease control. In this study, we describe an intriguing RNAi signal transmission phenomenon in R. necatrix. In R. necatrix transformants with autonomously replicating vectors carrying a hairpin structure to induce RNAi, the gene silencing effect was distributed locally and unevenly, based on the vector distribution. This indicates that R. necatrix has no mechanism to propagate silencing signals systemically, unlike Caenorhabditis elegans and Arabidopsis thaliana. Furthermore, the expression of RNA-dependent RNA polymerase homologs was not upregulated during RNAi induction, suggesting that silencing signals are not amplified at sufficient levels to induce systemic RNAi in R. necatrix. Our results also suggest that, in addition to hairpin-induced RNAi, there is either a 5' transitive RNAi or quelling-like gene silencing system in R. necatrix. This is the first study demonstrating that systemic RNAi is not induced by local RNAi in fungi. (C) 2015 Elsevier Inc. All rights reserved.	[Shimizu, Takeo; Yaegashi, Hajime; Ito, Tsutae; Kanematsu, Satoko] Natl Agr & Food Res Org NARO, Apple Res Stn, Inst Fruit Tree Sci, Morioka, Iwate 0200123, Japan	Kanematsu, S (reprint author), Natl Agr & Food Res Org NARO, Apple Res Stn, Inst Fruit Tree Sci, 92-24 Nabeyashiki, Morioka, Iwate 0200123, Japan.	satokok@affrc.go.jp	Shimizu, Takeo/O-2787-2015		JSPS KAKENHI [25292031]	This work was supported by JSPS KAKENHI Grant Number 25292031.	Whisson SC, 2005, MOL PLANT PATHOL, V6, P153, DOI [10.1111/j.1364-3703.2005.00272.x, 10.1111/J.1364-3703.2005.00272.X]; Kanematsu S, 2004, PHYTOPATHOLOGY, V94, P561, DOI 10.1094/PHYTO.2004.94.6.561; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Calo S, 2012, MOL MICROBIOL, V83, P379, DOI 10.1111/j.1365-2958.2011.07939.x; Chiba S, 2009, J VIROL, V83, P12801, DOI 10.1128/JVI.01830-09; Fernandez EQ, 2012, FUNGAL GENET BIOL, V49, P294, DOI 10.1016/j.fgb.2012.01.011; Shih JD, 2011, RNA, V17, P1057, DOI 10.1261/rna.2596511; Nicolas FE, 2003, EMBO J, V22, P3983, DOI 10.1093/emboj/cdg384; Nicolas FE, 2007, FUNGAL GENET BIOL, V44, P504, DOI 10.1016/j.fgb.2006.09.003; Hammond TM, 2005, GENETICS, V169, P607, DOI 10.1534/genetics.035964; Pliego C, 2012, MOL PLANT PATHOL, V13, P226, DOI 10.1111/j.1364-3703.2011.00753.x; Nicolas FE, 2010, NUCLEIC ACIDS RES, V38, P5535, DOI 10.1093/nar/gkq301; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Nakayashiki H, 2008, CURR OPIN MICROBIOL, V11, P494, DOI 10.1016/j.mib.2008.10.001; dos Santos ACC, 2009, FUNGAL GENET BIOL, V46, P825, DOI 10.1016/j.fgb.2009.06.012; Bleichrodt R, 2013, STUD MYCOL, P31, DOI 10.3114/sim0007; Cervantes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069283; Dang YK, 2011, EUKARYOT CELL, V10, P1148, DOI 10.1128/EC.05109-11; Fischer SEJ, 2010, INT J BIOCHEM CELL B, V42, P1306, DOI 10.1016/j.biocel.2010.03.006; Haro J.P., 2009, EUKARYOT CELL, V8, P1486; Hoopen G.M., 2006, CROP PROT, V25, P89; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Uddin MN, 2013, WIRES RNA, V4, P279, DOI 10.1002/wrna.1160; Saraiva M., 2014, FUNGAL BIOL; Segers GC, 2007, P NATL ACAD SCI USA, V104, P12902, DOI 10.1073/pnas.0702500104; Shimizu T, 2014, FUNGAL BIOL-UK, V118, P413, DOI 10.1016/j.funbio.2014.02.006; Shimizu T, 2012, CURR GENET, V58, P129, DOI 10.1007/s00294-012-0370-x; Tijsterman M, 2004, CURR BIOL, V14, P111, DOI 10.1016/j.cub.2003.12.029; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Yaegashi H, 2013, VIROLOGY, V444, P409, DOI 10.1016/j.virol.2013.07.010; Zhang DX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108653	31	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1087-1845	1096-0937		FUNGAL GENET BIOL	Fungal Genet. Biol.	MAR	2015	76						27	35		10.1016/j.fgb.2015.02.001		9	Genetics & Heredity; Mycology	Genetics & Heredity; Mycology	CG7ZU	WOS:000353527200004		
J	Toh-e, A; Ohkusu, M; Shimizu, K; Kawamoto, S				Toh-e, Akio; Ohkusu, Misako; Shimizu, Kiminori; Kawamoto, Susumu			Positional cloning in Cryptococcus neoformans and its application for identification and cloning of the gene encoding methylenetetrahydrofolate reductase	FUNGAL GENETICS AND BIOLOGY			English	Article						Chromosome loss; Cryptococcus neoformans; Methionine biosynthesis; Methylenetetrahydrofolate reductase (MTHFR); Mitotic mapping; Positional cloning	SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; LINKAGE MAP; VIRULENCE; YEAST; DNA; COMPLEMENTATION; FILOBASIDIELLA; TRANSFORMATION; RECOMBINATION	Cryptococcus neoformans, a basidiomycetous human pathogenic yeast, has been widely used in research fields in medical mycology as well as basic biology. Gene cloning or identification of the gene responsible for a mutation of interest is a key step for functional analysis of a particular gene. The availability therefore, of the multiple methods for cloning is desirable. In this study, we proposed a method for a mapping-based gene identification/cloning (positional cloning) method in C neoformans. To this end, we constructed a series of tester strains, one of whose chromosomes was labeled with the URA5 gene. A heterozygous diploid constructed by crossing one of the tester strains to a mutant strain of interest loses a chromosome(s) spontaneously, which is the basis for assigning a recessive mutant gene to a particular chromosome in the mitotic mapping method. Once the gene of interest is mapped to one of the 14 chromosomes, classical genetic crosses can then be performed to determine its more precise location. The positional information thus obtained can then be used to significantly narrow down candidate genes by referring to the Cryptococcus genome database. Each candidate gene is then examined whether it would complement the mutation. We successfully applied this method to identify CNA07390 encoding methylenetetrahydrofolate reductase as the gene responsible for a methionine-requiring mutant in our mutant collection. (C) 2015 Elsevier Inc. All rights reserved.	[Toh-e, Akio; Ohkusu, Misako; Shimizu, Kiminori; Kawamoto, Susumu] Chiba Univ, Med Mycol Res Ctr, Chuo Ku, Chiba 2608673, Japan	Toh-e, A (reprint author), Chiba Univ, Med Mycol Res Ctr, Chuo Ku, Inohana 1-8-1, Chiba 2608673, Japan.	toh-e@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23659219]	Part of this study was supported by a Grant in Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology, Japan to AT (23659219).	Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515; Chang YC, 1998, INFECT IMMUN, V66, P2230; EDMAN JC, 1992, MOL CELL BIOL, V12, P2777; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Shimizu K, 2014, FUNGAL GENET BIOL, V69, P13, DOI 10.1016/j.fgb.2014.05.007; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602; Chang YC, 1996, INFECT IMMUN, V64, P1977; Cao MQ, 2009, PROTOPLASMA, V235, P107, DOI 10.1007/s00709-009-0036-9; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; CHANG YC, 1994, MOL CELL BIOL, V14, P4912; KWONCHUNG KJ, 1975, MYCOLOGIA, V67, P1197, DOI 10.2307/3758842; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Espeso EA, 2005, GENETICS, V171, P835, DOI 10.1534/genetics.105.044578; FALCO SC, 1982, CELL, V29, P573, DOI 10.1016/0092-8674(82)90173-8; Forche A, 2000, FUNGAL GENET BIOL, V31, P189, DOI 10.1006/fgbi.2000.1240; Fu J, 2006, FUNGAL GENET BIOL, V43, P200, DOI 10.1016/j.fgb.2005.09.007; Li HM, 2010, MYCOSCIENCE, V51, P272, DOI 10.1007/s10267-010-0038-7; Marra RE, 2004, GENETICS, V167, P619, DOI 10.1534/genetics.103.023408; MATTHEWS RG, 1984, J BIOL CHEM, V259, P1647; PONTECORVO G, 1953, J GEN MICROBIOL, V8, P198; Raymond RK, 1999, ARCH BIOCHEM BIOPHYS, V372, P300, DOI 10.1006/abbi.1999.1498; Shan XY, 1999, J BIOL CHEM, V274, P32613, DOI 10.1074/jbc.274.46.32613; TOHE A, 1973, J BACTERIOL, V113, P727; VANDERWALT JP, 1976, A VAN LEEUW J MICROB, V42, P157; Wakem P., 1990, GENETICS, V125, P333; WHITE CW, 1985, J BACTERIOL, V161, P1231; Yan Z, 2007, CURR GENET, V51, P187, DOI 10.1007/s00294-006-0115-9	31	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1087-1845	1096-0937		FUNGAL GENET BIOL	Fungal Genet. Biol.	MAR	2015	76						70	77		10.1016/j.fgb.2015.02.007		8	Genetics & Heredity; Mycology	Genetics & Heredity; Mycology	CG7ZU	WOS:000353527200008		
J	Matsuura, Y; Fujino, H; Hashimoto, R; Yasuda, Y; Yamamori, H; Ohi, K; Takeda, M; Imura, O				Matsuura, Yukako; Fujino, Haruo; Hashimoto, Ryota; Yasuda, Yuka; Yamamori, Hidenaga; Ohi, Kazutaka; Takeda, Masatoshi; Imura, Osamu			Standing postural instability in patients with schizophrenia: Relationships with psychiatric symptoms, anxiety, and the use of neuroleptic medications	GAIT & POSTURE			English	Article						Schizophrenia; Postural instability; Proprioception; Anxiety; Extrapyramidal symptoms	VISUAL INFORMATION; JAPANESE PATIENTS; CEREBELLAR; SWAY; SIGNS	The purpose of this study was to assess postural instability in patients with schizophrenia using a pressure-sensitive platform and to examine the effects of anxiety, psychiatric symptoms, and the use of neuroleptic medications on postural sway. Participants were 23 patients with schizophrenia and 23 healthy controls. We found that the patients showed greater overall postural instability than the controls. Furthermore, they demonstrated greater instability when the test was performed with the eyes closed than with the eyes open. However, removal of visual input had less impact on the indices of postural instability in the patients than in the controls, suggesting that schizophrenia is associated with difficulties in integrating visual information and proprioceptive signals. Furthermore, in contrast to the controls, anxiety exacerbated postural instability in the patients. There were significant associations between postural stability and psychiatric symptoms in the patients without extrapyramidal symptoms, whereas medication dose did not significantly correlate with postural stability. (C) 2015 Elsevier B.V. All rights reserved.	[Matsuura, Yukako; Fujino, Haruo; Imura, Osamu] Osaka Univ, Grad Sch Human Sci, Suita, Osaka 5650871, Japan; [Hashimoto, Ryota] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka 5650871, Japan; [Hashimoto, Ryota; Yasuda, Yuka; Yamamori, Hidenaga; Ohi, Kazutaka; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Suita, Osaka 5650871, Japan; [Yamamori, Hidenaga] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Suita, Osaka 5650871, Japan	Imura, O (reprint author), Osaka Univ, Grad Sch Human Sci, 1-2 Yamadaoka, Suita, Osaka 5650871, Japan.	osamui@hus.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [K06]; Japanese Ministry of Health, Labour and Welfare [H22-seishin-ippan-001]; JSPS [22390225, 26860924]	We would like to thank all the individuals who participated in this study. This study was supported, in part, by Global COE Program "Center of Human-Friendly Robotics Based on Cognitive Neuroscience" of the Ministry of Education, Culture, Sports, Science and Technology, Japan (K06). This work was also supported, in part, by research grants from the Japanese Ministry of Health, Labour and Welfare (H22-seishin-ippan-001) and JSPS KAKENHI (Grant numbers: 22390225 and 26860924). No additional external funding was received for this study. The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Ahlgren-Rimpilainen A, 2010, J NERV MENT DIS, V198, P601, DOI 10.1097/NMD.0b013e3181ea16bc; American Psychiatric Association, 2002, DIAGN STAT MAN MENT; Ichimiya T, 2001, BIOL PSYCHIAT, V49, P20, DOI 10.1016/S0006-3223(00)01081-7; Ageberg E, 2001, SCAND J MED SCI SPOR, V11, P47, DOI 10.1034/j.1600-0838.2001.011001047.x; Wada M, 2001, NEUROSCI LETT, V302, P157, DOI 10.1016/S0304-3940(01)01662-7; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Beedie SA, 2011, J PSYCHIATR NEUROSCI, V36, P150, DOI 10.1503/jpn.090169; Stensdotter AK, 2013, GAIT POSTURE, V38, P918, DOI 10.1016/j.gaitpost.2013.04.017; Bolmont B, 2002, NEUROSCI LETT, V329, P96, DOI 10.1016/S0304-3940(02)00578-5; Fujino H, 2012, JPN PSYCHOL RES, V54, P388, DOI 10.1111/j.1468-5884.2012.00517.x; Fujino H, 2014, PSYCHIAT CLIN NEUROS, V68, P534, DOI 10.1111/pcn.12165; Koreki A, 2011, J CLIN PSYCHOPHARM, V31, P16, DOI 10.1097/JCP.0b013e318205e192; BUCHANAN RW, 1989, PSYCHIAT RES, V27, P335, DOI 10.1016/0165-1781(89)90148-0; Marvel CL, 2004, SCHIZOPHR RES, V68, P363, DOI 10.1016/j.schres.2003.09.003; Fukumoto M, 2014, PSYCHIAT CLIN NEUROS, V68, P234, DOI 10.1111/pcn.12119; Bernard JA, 2014, HUM BRAIN MAPP, V35, P4064, DOI 10.1002/hbm.22458; CALIGIURI MP, 1994, BIOL PSYCHIAT, V35, P104, DOI 10.1016/0006-3223(94)91199-1; Goto F, 2011, NEUROSCI LETT, V487, P204, DOI 10.1016/j.neulet.2010.10.023; Inada T, 2002, SCHIZOPHR RES, V57, P227, DOI 10.1016/S0920-9964(01)00314-0; Japan Society for Equilibrium Research, 1983, EQUILIBRIUM RES, V42, P367; Kent JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041808; Kinney DK, 1999, SCHIZOPHR RES, V35, P99, DOI 10.1016/S0920-9964(98)00121-2; Nakagawa H, 1993, Acta Otolaryngol Suppl, V504, P112; Nakai Y, 1992, Seishin Shinkeigaku Zasshi, V94, P611; Ohno H, 2004, NEUROSCI LETT, V364, P37, DOI 10.1016/j.neulet.2004.04.014; Okawa T, 1995, EQUILIBRIUM RES, V54, P296; Spielberger CD, 1970, MANUAL STATE TRAIT A; Takamatsu K., 1992, THEORY TREATMENT CLI, P214; Tsuru M, 1982, DEV REHABILITATION P, P169	29	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	MAR	2015	41	3					847	851		10.1016/j.gaitpost.2015.03.006		5	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	CG3WB	WOS:000353209200019		
J	Rouhani, H; Abe, MO; Nakazawa, K; Popovic, MR; Masani, K				Rouhani, Hossein; Abe, Masaki O.; Nakazawa, Kimitaka; Popovic, Milos R.; Masani, Kei			Heel strike detection using split force-plate treadmill	GAIT & POSTURE			English	Article						Gait phase; Stride interval; Foot switch	GROUND REACTION FORCES; WALKING SPEED; VARIABILITY	A common source of error when detecting heel-strike moments utilizing split force-plate treadmills is unwillingly stepping on contra-lateral force-plate. In this study, we quantified this error when heel-strike was detected based on such erroneous data and compared three methods to investigate how well the heel-strikes and stride-intervals were detected with erroneous data. Eleven subjects walked on a split force-plate treadmill for more than 20 min. We used 20 N and 50% body-weight thresholds to detect the heel-strike moments (HS20N and HS50%, respectively). Besides, we used linear approximation to estimate the unaffected force profile from affected force-plate data, and subsequently to detect the heel-strike moments (HSest). We used heel-strike moments detected by a foot-switch as a reference to compare accuracy of HS20N, HS50% and HSest. HS20N and HSest detected heel-strike moments accurately for unaffected force-plate data (median(max) errors for all subjects: 9(23) and 9(37) ms) but HS50% showed significantly larger errors (52(74) ms). Unlike HS50% and HSest, HS20N was considerably affected by the affected force-plate data (23(68) ms). The error in stride-interval measurement was relatively small using any methods for unaffected force-plate data (3(7), 6(8), and 6(12) ms), while stride-interval errors were large for some subjects when using HS20N for affected data (6(175) ms). We concluded that unwillingly stepping on contra-lateral force-plate occurred a few percent and up to 37.7% of all strides (median: 12.9%). Our proposed method (HSest) robustly showed small errors for heel-strike detection and stride-interval calculation consistently among subjects, while HS50% and HS20N showed large errors depending on subjects. (C) 2015 Elsevier B.V. All rights reserved.	[Rouhani, Hossein; Popovic, Milos R.; Masani, Kei] Univ Hlth Network, Lyndhurst Ctr, Rehabil Engn Lab, Toronto Rehabil Inst, Toronto, ON M4G 3V9, Canada; [Rouhani, Hossein; Popovic, Milos R.; Masani, Kei] Univ Toronto, Inst Biomat & Biomed Engn, Rehabil Engn Lab, Toronto, ON M5S 3G9, Canada; [Abe, Masaki O.] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Nakazawa, Kimitaka] Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Rouhani, H (reprint author), Toronto Rehabil Inst, Lyndhurst Ctr, Rehabil Engn Lab, 520 Sutherland Dr, Toronto, ON M4G 3V9, Canada.	hossein.rouhani@utoronto.ca			Toronto Rehabilitation Institute - University Health Network; Ministry of Health and Long-Term Care in Ontario; Swiss National Science Foundation [PBELP3137539, P300P2-147865/1]; Spinal Cord Injury Ontario Foundation	The authors acknowledge the support of the Toronto Rehabilitation Institute - University Health Network which receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario. HR was supported by Swiss National Science Foundation Grant (PBELP3137539 and P300P2-147865/1), the Spinal Cord Injury Ontario Foundation and the Toronto Rehabilitation Institute - University Health Network.	Abe MO, 2010, HUM MOVEMENT SCI, V29, P556, DOI 10.1016/j.humov.2010.03.002; Dingwell JB, 2010, GAIT POSTURE, V32, P348, DOI 10.1016/j.gaitpost.2010.06.004; Masani K, 2002, J APPL PHYSIOL, V92, P1885, DOI 10.1152/japplphysiol.00969.2000; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Belli A, 2001, J BIOMECH, V34, P105, DOI 10.1016/S0021-9290(00)00125-1; Bollens B, 2012, NEUROSCIENCE, V210, P234, DOI 10.1016/j.neuroscience.2012.02.039; Tesio L, 2010, J BIOMECH, V43, P938, DOI 10.1016/j.jbiomech.2009.10.049	8	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	MAR	2015	41	3					863	866		10.1016/j.gaitpost.2015.02.021		4	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	CG3WB	WOS:000353209200023		
J	Fernandez, JA; Bubner, EJ; Takeuchi, Y; Yoshizaki, G; Wang, T; Cummins, SF; Elizur, A				Fernandez, J. A.; Bubner, E. J.; Takeuchi, Y.; Yoshizaki, G.; Wang, T.; Cummins, S. F.; Elizur, A.			Primordial germ cell migration in the yellowtail kingfish (Seriola lalandi) and identification of stromal cell-derived factor 1	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Yellowtail kingfish; Primordial germ cell; Stromal cell-derived factor; Perciform	CHEMOKINE RECEPTOR CXCR4; GASTROPOD HALIOTIS; PGC MIGRATION; MICE LACKING; ZEBRAFISH; GUIDANCE; SDF-1; COLONIZATION; EXPRESSION; SURVIVAL	Primordial germ cells (PGCs) are progenitors of the germ cell lineage, giving rise to either spermatogonia or oogonia after the completion of gonadal differentiation. Currently, there is little information on the mechanism of PGCs migration leading to the formation of the primordial gonad in perciform fish. Yellowtail kingfish (Seriola lalandi) (YTK) (order Perciforms) inhabit tropical and temperate waters in the southern hemisphere. Fundamental details into the molecular basis of larval development in this species can be easily studied in Australia, as they are commercially cultured and readily available. In this study, histological analysis of YTK larvae revealed critical time points for the migration of PGCs to the genital ridge, resulting in the subsequent development of the primordial gonad. In YTK larvae at 3, 5, 7 and 10 days post hatch (DPH), PGCs were not yet enclosed by somatic cells, indicating the primordial gonad had not yet started to form. While at 15, 18 and 20 DPH PGCs had already settled at the genital ridge and started to become enclosed by somatic cells indicating the primordial gonad had started to develop. A higher number of PGCs were observed in the larvae at 15 and 18 DPH indicating PGCs proliferation, which corresponds with them becoming enclosed by the somatic cells. Directional migration of PGCs toward the genital ridge is a critical event in the subsequent development of a gonad. In zebrafish, mouse and chicken, stromal-cell derived factor (SDF1) signalling is one of the key molecules for PGC migration. We subsequently isolated from YTK the SDF1 (Slal-SDF1) gene, which encodes for a 98-residue precursor protein with a signal peptide at the N-terminus. There is spatial conservation between fish species of four cysteine residues at positions C-9, C-11, C-34 and C-49, expected to form disulphide bonds and stabilize the SDF structure. In YTK, Slal-SDF1 gene expression analyses shows that this gene is expressed in larvae from 1 to 22 DPH and demonstrates distinct spatial localisation in the larvae at 7 DPH. These results provide a platform for further studies into the molecular machinery of PGC migration in yellowtail kingfish, as well as other perciform fish species. (C) 2015 Elsevier Inc. All rights reserved.	[Fernandez, J. A.; Wang, T.; Cummins, S. F.; Elizur, A.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld, Australia; [Bubner, E. J.] Flinders Univ S Australia, Lincoln Marine Sci Ctr, Sch Biol Sci, Port Lincoln, SA, Australia; [Bubner, E. J.] Australia Seafood Corporative Res Ctr, Bedford Pk, SA, Australia; [Takeuchi, Y.; Yoshizaki, G.] Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Tokyo, Japan	Elizur, A (reprint author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld, Australia.	AElizur@usc.edu.au			Australian Seafood Cooperative Research Centre Grant; Flinders University PhD fellowship; University of the Sunshine Coast Grant; Australian Academy of Sciences; ARC Future Fellowship [FT110100990]	This project was supported by the Australian Seafood Cooperative Research Centre Grant to A.E., and Flinders University PhD fellowship to E.B., a University of the Sunshine Coast Grant to A.E. and S.C. and PhD fellowship to J.A.F., an Australian Academy of Sciences travel Grant to Japan to A.E. and an ARC Future Fellowship to S.C. (FT110100990). We are grateful to Cleanseas Tuna for generously providing us the facilities and the larvae used in this study. We acknowledge the provision of generous time allocations on supercomputers from the Australian Partnership of Advanced Computing (Australian National University).	Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269; Takeuchi Y, 2009, BIOL REPROD, V81, P1055, DOI 10.1095/biolreprod.109.077701; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Okutsu T, 2007, SCIENCE, V317, P1517, DOI 10.1126/science.1145626; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Yoon C, 1997, DEVELOPMENT, V124, P3157; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Laing KJ, 2004, DEV COMP IMMUNOL, V28, P443, DOI 10.1016/j.dci.2003.09.006; Raz E, 2004, CURR OPIN CELL BIOL, V16, P169, DOI 10.1016/.ceb.2004.01.004; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; HAMAGUCHI S, 1982, CELL TISSUE RES, V227, P139; Herpin A, 2008, DEV BIOL, V320, P319, DOI 10.1016/j.ydbio.2008.03.030; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Crump M.P., 1997, TSOLUTION STRUCTURE; Cummins SF, 2009, INT J DEV BIOL, V53, P1081, DOI 10.1387/ijdb.082791sc; Hinman VF, 2002, DEV GENES EVOL, V212, P141, DOI 10.1007/s00427-002-0223-6; Morita T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097873; Morita Tetsuro, 2012, Biology of Reproduction, V86, P1; NIEUWKOOP PD, 1976, J EMBRYOL EXP MORPH, V35, P159; Nomiyama H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-222; Rost B, 2004, NUCLEIC ACIDS RES, V32, P321; Ryu EK, 2007, PROTEINS, V67, P1193, DOI 10.1002/prot.21350; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sasado T, 2008, DEV BIOL, V320, P328, DOI 10.1016/j.ydbio.2008.05.544; Smith A, 2014, DEV SPERMATOGONISL G; Yazawa R, 2010, BIOL REPROD, V82, P896, DOI 10.1095/biolreprod.109.081281	37	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	MAR 1	2015	213						16	23		10.1016/j.ygcen.2015.02.007		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CG5WZ	WOS:000353367900003		
J	Pandit, NP; Bhandari, RK; Kobayashi, Y; Nakamura, M				Pandit, Narayan Prasad; Bhandari, Ramji Kumar; Kobayashi, Yasuhisa; Nakamura, Masaru			High temperature-induced sterility in the female Nile tilapia, Oreochromis niloticus	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Nile tilapia; High temperature; Sterility; Germ cells	DEPENDENT SEX DETERMINATION; GERM-CELL DEGENERATION; HIGH WATER TEMPERATURE; ODONTESTHES-BONARIENSIS; FOLLICULAR DEVELOPMENT; AROMATASE INHIBITOR; PATAGONINA-HATCHERI; GONADAL DEVELOPMENT; SOMATIC GROWTH; RAINBOW-TROUT	High temperature treatments induce germ cell loss in gonads of vertebrate animals, including fish. It could be a reliable source for induction of sterility if the treatments led to a permanent loss of germ cells. Here we report that heat treatment at 37 degrees C for 45-60 days caused a complete loss of germ cells in female Nile tilapia, Oreochromis niloticus, and that sterility was achieved in fish at all stages of their life cycle. Unlike previous observations, germ cells did not repopulate even after returning them to the water at control conditions suggesting permanent depletion of germ cells. Gonadal somatic cells immunopositive for 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) were clustered at one end of the germ cell depleted gonads close to the blood vessel. Serum level of testosterone, 11-ketotestosterone, and 17 beta-estradiol was significantly decreased in sterile fish compared to control. Body weight of sterile fish was higher than control fish at the end of experiment. Our observations of increased growth and permanent sterilization in the high temperature-treated fish suggest that this method could be an appropriate and eco-friendly tool for inducing sterility in fish with a higher thermal tolerance. (C) 2015 Elsevier Inc. All rights reserved.	[Pandit, Narayan Prasad; Bhandari, Ramji Kumar; Kobayashi, Yasuhisa; Nakamura, Masaru] Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Motobu, Okinawa 9050227, Japan; [Nakamura, Masaru] Okinawa Churashima Fdn, Motobu, Okinawa 9050206, Japan; [Pandit, Narayan Prasad] Tribhuvan Univ, IAAS, Rupendehi, Nepal; [Bhandari, Ramji Kumar] Univ Missouri, Sch Biol Sci, Columbia, MO 65211 USA	Bhandari, RK (reprint author), Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Sesoko 3422, Motobu, Okinawa 9050227, Japan.	bhandarir@missouri.edu; m-nakamura@oki-chura.jp			Japan Society for the Promotion of Science (JSPS) [23658166]	This study was supported by Grants-in-Aid (23658166) from Japan Society for the Promotion of Science (JSPS) to MN. This study would not be possible without a contribution of Sesoko Station, Tropical Biosphere Research Center of the University of the Ryukyus. Authors thank Ms. Caitlin Jandegain, University of Missouri for invaluable comments on the manuscript. MN and NP designed experiment, NP performed experiment, YK, RB, and NP analyzed data and wrote the manuscript.	Alvarenga E.R., 2009, BIOL REPROD, V80, P537; RIJNSDORP AD, 1990, NETH J SEA RES, V25, P279, DOI 10.1016/0077-7579(90)90027-E; WOLFENSON D, 1995, BIOL REPROD, V52, P1106, DOI 10.1095/biolreprod52.5.1106; Baroiller JF, 2001, COMP BIOCHEM PHYS C, V130, P399, DOI 10.1016/S1532-0456(01)00267-8; Ito LS, 2008, PHYSIOL BIOCHEM ZOOL, V81, P762, DOI 10.1086/590219; Soria FN, 2008, PHYSIOL BIOCHEM ZOOL, V81, P898, DOI 10.1086/588178; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; BAROILLER JF, 1995, J EXP ZOOL, V273, P216, DOI 10.1002/jez.1402730306; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; ASAHINA K, 1995, FISHERIES SCI, V61, P491; Uchida D, 2004, COMP BIOCHEM PHYS A, V137, P11, DOI 10.1016/S1095-6433(03)00178-8; Bhatta S, 2012, P NATL ACAD SCI USA, V109, P11408, DOI 10.1073/pnas.1118704109; Kitano T, 1999, J MOL ENDOCRINOL, V23, P167, DOI 10.1677/jme.0.0230167; Baras E, 2001, AQUACULTURE, V192, P187, DOI 10.1016/S0044-8486(00)00452-X; YAMAZAKI F, 1983, AQUACULTURE, V33, P329, DOI 10.1016/0044-8486(83)90413-1; Goto-Kazeto R, 2006, AQUACULTURE, V254, P617, DOI 10.1016/j.aquaculture.2005.10.009; Kobayashi T, 2002, MECH DEVELOP, V111, P167, DOI 10.1016/S0925-4773(01)00613-X; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Rozenboim I, 2007, POULTRY SCI, V86, P1760; BILLIG H, 1993, ENDOCRINOLOGY, V133, P2204, DOI 10.1210/en.133.5.2204; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Bhandari RK, 2006, GEN COMP ENDOCR, V145, P20, DOI 10.1016/j.ygcen.2005.06.014; SKINNER MK, 1991, ENDOCR REV, V12, P45; DYGERT PH, 1990, T AM FISH SOC, V119, P791, DOI 10.1577/1548-8659(1990)119<0791:SCIECA>2.3.CO;2; Hayashi Y, 2010, MOL REPROD DEV, V77, P679, DOI 10.1002/mrd.21203; THORGAARD GH, 1983, GENETICS, V103, P771; SPOTILA JR, 1987, HERPETOLOGICA, V43, P74; FERGUSON MWJ, 1983, J ZOOL, V200, P143; Kobayashi T, 1996, ZOOL SCI, V13, P909, DOI 10.2108/zsj.13.909; Azaza MS, 2008, J THERM BIOL, V33, P98, DOI 10.1016/j.jtherbio.2007.05.007; Basavaraja N., 1997, INDIAN J FISHERIES, V44, P165; Bezault E, 2007, AQUACULTURE, V272, pS3, DOI 10.1016/j.aquaculture.2007.07.227; Byamungu N, 2001, AQUACULTURE, V198, P109, DOI 10.1016/S0044-8486(00)00605-0; Byerly MT, 2005, N AM J AQUACULT, V67, P331, DOI 10.1577/A05-008.1; Carr JW, 1997, ICES J MAR SCI, V54, P1064, DOI 10.1016/S1054-3139(97)80010-0; COWLES RB, 1945, AM NAT, V79, P417, DOI 10.1086/281277; D'Cotta H, 2001, MOL REPROD DEV, V59, P265, DOI 10.1002/mrd.1031; FAO, 2012, STAT WORLD FISH AQ 2; Felip A, 2001, J EXP ZOOL, V290, P384, DOI 10.1002/jez.1079; Felip A, 1999, AQUACULTURE, V173, P389, DOI 10.1016/S0044-8486(98)00464-5; GUDJONSSON S, 1991, AQUACULTURE, V98, P133, DOI 10.1016/0044-8486(91)90378-K; Harlow PS, 1999, HERPETOLOGICA, V55, P205; Ito LS, 2003, J EXP ZOOL PART A, V297A, P169, DOI 10.1002/jez.a.10249; Lee KH, 2009, SEX DEV, V3, P225, DOI 10.1159/000228723; Lim C., 2008, TILAPIA BIOL CULTURE; Majhi SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006132; Majhi SK, 2009, THERIOGENOLOGY, V71, P1162, DOI 10.1016/j.theriogenology.2008.12.008; MOL K, 1994, FISH PHYSIOL BIOCHEM, V13, P209, DOI 10.1007/BF00004359; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Ruksana S, 2010, COMP BIOCHEM PHYS C, V152, P69, DOI 10.1016/j.cbpc.2010.02.014; Skinner M.K., 2010, HDB CELL SIGNALING, P2663, DOI 10.1016/B978-0-12-374145-5.00314-4; Socher SA, 1997, J UROLOGY, V157, P1986, DOI 10.1016/S0022-5347(01)64915-2; Strassmann C.A., 2002, FISH PHYSIOL BIOCHEM, V26, P13; Strussmann CA, 1997, J EXP ZOOL, V278, P167, DOI 10.1002/(SICI)1097-010X(19970615)278:3<167::AID-JEZ6>3.3.CO;2-0; Strussmann CA, 1998, COMP BIOCHEM PHYS A, V119, P637, DOI 10.1016/S1095-6433(97)00477-7; Tessema M, 2006, AQUACULTURE, V258, P270, DOI 10.1016/j.aquaculture.2006.04.041; THORGAARD GH, 1979, GENETICS, V93, P961; Tiwary BK, 2004, REV FISH BIOL FISHER, V14, P391, DOI 10.1007/s11160-004-8361-8; Tiwary BK, 2001, FISH PHYSIOL BIOCHEM, V24, P9, DOI 10.1023/A:1011159615057; Vanderhyden BC, 1998, BIOL REPROD, V59, P1296, DOI 10.1095/biolreprod59.6.1296; Western PS, 2000, GENE, V241, P223, DOI 10.1016/S0378-1119(99)00466-7	62	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	MAR 1	2015	213						110	117		10.1016/j.ygcen.2015.01.028		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CG5WZ	WOS:000353367900013		
J	Fukuda, T; Fukuda-Ohashi, N; Doi, K; Matsubara, T; Yahagi, N				Fukuda, Tatsuma; Fukuda-Ohashi, Naoko; Doi, Kent; Matsubara, Takehiro; Yahagi, Naoki			Effective Pre-hospital Care for Out-of-hospital Cardiac Arrest Caused by Respiratory Disease	Heart Lung and Circulation			English	Article						Out-of-hospital cardiac arrest; Respiratory disease; Prehospital care; Cardiopulmonary resuscitation; Rescue breathing; Advanced airway management	AMERICAN-HEART-ASSOCIATION; EMERGENCY CARDIOVASCULAR CARE; ONLY CARDIOPULMONARY-RESUSCITATION; ADVANCED AIRWAY MANAGEMENT; POPULATION-BASED COHORT; CHEST-COMPRESSION; NONCARDIAC ORIGIN; ENDOTRACHEAL INTUBATION; STROKE-FOUNDATION; MEDICAL-SERVICES	Background The relationship between pre-hospital care and the prognosis of out-of-hospital cardiac arrest (OHCA) caused by respiratory disease is unclear. This study aimed to assess the impact of pre-hospital care on the prognosis of OHCA caused by respiratory disease. Methods In a nationwide, population-based, observational study, we enrolled 121,081 adults aged >= 18 years who experienced OHCA from January 1, 2010, to December 31, 2010. The primary endpoint was favourable neurological outcomes. Results Of the 120,256 eligible adult OHCA patients, 7,071 (5.9%) experienced OHCA caused by respiratory disease. Of these 7,071 patients, 3,911 (55.3%) received no cardiopulmonary resuscitation (CPR), 2,403 (34.0%) received chest-compression-only CPR, and 757 (10.7%) received conventional CPR by a bystander. There was no significant difference between the three types of bystander CPR with regard to the neurological outcome (no CPR: OR 0.68, 95% CI 0.39-1.24, p = 0.1951; chest-compression-only CPR: OR 0.68, 95% CI 0.37-1.29, p = 0.2295; and conventional CPR: as a reference). Pre-hospital administration of epinephrine (OR 0.37, 95% CI 0.13-0.85, p = 0.0170) and the implementation of advanced airway management (OR 0.32, 95% CI 0.19-0.52, p < 0.0001) were associated with poor neurological outcomes. Conclusions Even in OHCA caused by respiratory disease, not only pre-hospital epinephrine administration but also pre-hospital advanced airway management and rescue breathing in bystander CPR may not be critical.	[Fukuda, Tatsuma; Fukuda-Ohashi, Naoko; Doi, Kent; Matsubara, Takehiro; Yahagi, Naoki] Univ Tokyo, Grad Sch Med, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138655, Japan	Fukuda, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tatsumafukuda-jpn@umin.ac.jp					Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; CUMMINS RO, 1991, CIRCULATION, V84, P960; Engdahl J, 2003, RESUSCITATION, V57, P33, DOI 10.1016/S0300-9572(02)00433-1; Kuisma M, 1997, EUR HEART J, V18, P1122; Ferguson LP, 2012, CIRCULATION, V126, P335, DOI 10.1161/CIRCULATIONAHA.111.085100; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Hess EP, 2007, RESUSCITATION, V72, P200, DOI 10.1016/j.resuscitation.2006.06.040; Hanif MA, 2010, ACAD EMERG MED, V17, P926, DOI 10.1111/j.1553-2712.2010.00829.x; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Studnek JR, 2010, ACAD EMERG MED, V17, P918, DOI 10.1111/j.1553-2712.2010.00827.x; Iwami T, 2012, CIRCULATION, V126, P2844, DOI 10.1161/CIRCULATIONAHA.112.109504; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; Ong MEH, 2007, ANN EMERG MED, V50, P635, DOI 10.1016/j.annemergmed.2007.03.028; Kitamura T, 2010, CIRCULATION, V122, P293, DOI 10.1161/CIRCULATIONAHA.109.926816; Engdahl J, 2002, RESUSCITATION, V52, P235, DOI 10.1016/S0300-9572(01)00464-6; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Travers AH, 2010, CIRCULATION, V122, pS676, DOI 10.1161/CIRCULATIONAHA.110.970913; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Egly J, 2011, PREHOSP EMERG CARE, V15, P44, DOI 10.3109/10903127.2010.514090; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Fire and Disaster Management Agency, 2013, 1 AID RESC OP JAP; Fukuda T, 2013, RESUSCITATION, V84, P964, DOI 10.1016/j.resuscitation.2013.02.019; Fukuda T, 2014, J CRIT CARE, V29, P840, DOI 10.1016/j.jcrc.2014.03.034; Fukuda T, 2014, INT J CARDIOL, V176, P910, DOI 10.1016/j.ijcard.2014.08.057; Herlitz J, 2003, HEART, V89, P25, DOI 10.1136/heart.89.1.25; Japan Resuscitation Council, 2012, JRC GUID 2010; Nakahara S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6829; Nolan JP, 2010, RESUSCITATION, V81, pE1, DOI 10.1016/j.resuscitation.2010.08.002; Ogawa T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7106; Pitts S, 2004, LANCET, V364, P313, DOI 10.1016/S0140-6736(04)16740-8; Shin Sang Do, 2012, Resuscitation, V83, P313, DOI 10.1016/j.resuscitation.2011.10.028; Nagao K, 2007, LANCET, V369, P920; Statistical Research and Training Institute, 2013, JAP STAT YB 2013	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1443-9506	1444-2892		HEART LUNG CIRC	Heart Lung Circ.	MAR	2015	24	3					241	249		10.1016/j.hlc.2014.09.004		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4FF	WOS:000353238500006		
J	Helfrich, J; Kraus, D; Ortner, A; Frydrych, S; Schaumann, G; Hartley, NJ; Gregori, G; Kettle, B; Riley, D; Carroll, DC; Notley, MM; Spindloe, C; Roth, M				Helfrich, J.; Kraus, D.; Ortner, A.; Frydrych, S.; Schaumann, G.; Hartley, N. J.; Gregori, G.; Kettle, B.; Riley, D.; Carroll, D. C.; Notley, M. M.; Spindloe, C.; Roth, M.			Investigation of the solid-liquid phase transition of carbon at 150 GPa with spectrally resolved X-ray scattering	High Energy Density Physics			English	Article						Warm dense matter; Liquid carbon; X-ray Thomson scattering; Laser-driven shock wave	THOMSON SCATTERING; FREE-ENERGY; PLASMAS; GRAPHITE; DIAGRAM; URANUS; ELECTRONS; INTERIOR; NEPTUNE	We have resolved the solid-liquid phase transition of carbon at pressures around 150 GPa. High-pressure samples of different temperatures were created by laser-driven shock compression of graphite and varying the initial density from 1.30 g/cm(3) to 2.25 g/cm(3). In this way, temperatures from 5700 K to 14,500 K could be achieved for relatively constant pressure according to hydrodynamic simulations. From measuring the elastic X-ray scattering intensity of vanadium K-alpha radiation at 4.95 keV at a scattering angle of 126 degrees, which is very sensitive to the solid-liquid transition, we can determine whether the sample had transitioned to the fluid phase. We find that samples of initial density 1.3 g/cm(3) and 1.85 g/cm(3) are liquid in the compressed states, whereas samples close to the ideal graphite crystal density of 2.25 g/cm(3) remain solid, probably in a diamond-like state. (C) 2015 Elsevier B.V. All rights reserved.	[Helfrich, J.; Kraus, D.; Ortner, A.; Frydrych, S.; Schaumann, G.; Roth, M.] Tech Univ Darmstadt, Inst Kernphys, D-64289 Darmstadt, Germany; [Kraus, D.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Hartley, N. J.] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Gregori, G.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England; [Kettle, B.; Riley, D.] Queens Univ Belfast, Ctr Plasma Phys, Belfast BT7 1NN, Antrim, North Ireland; [Carroll, D. C.; Notley, M. M.; Spindloe, C.] STFC, Rutherford Appleton Lab, Cent Laser Facil, Didcot OX11 0OX, Oxon, England	Helfrich, J (reprint author), Tech Univ Darmstadt, Inst Kernphys, Schlossgartenstr 9, D-64289 Darmstadt, Germany.	j.helfrich@gsi.de	Kraus, Dominik/H-3251-2011	Kraus, Dominik/0000-0002-6350-4180	BMBF Project [05P12RDFA1]; EPSRC [EP/K009591/1]	We thank the staff scientists, laser technicians and the target lab engineers of the Central Laser Facility at Rutherford Appleton Laboratory for their assistance and motivation. This work was supported by the BMBF Project 05P12RDFA1 and by EPSRC grant EP/K009591/1.	Ma T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.065001; Kraus D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.255501; Gregori G, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026412; MacKinnon AJ, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4876611; ROSS M, 1981, NATURE, V292, P435, DOI 10.1038/292435a0; Chihara J, 2000, J PHYS-CONDENS MAT, V12, P231, DOI 10.1088/0953-8984/12/3/303; Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638; Bundy FP, 1996, CARBON, V34, P141, DOI 10.1016/0008-6223(96)00170-4; Rygg JR, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4766464; Wang XF, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.185701; Correa AA, 2006, P NATL ACAD SCI USA, V103, P1204, DOI 10.1073/pnas.0510489103; Glenzer SH, 2009, REV MOD PHYS, V81, P1625, DOI 10.1103/RevModPhys.81.1625; Chung DDL, 2000, J MATER ENG PERFORM, V9, P161, DOI 10.1361/105994900770346105; Dufour P, 2007, NATURE, V450, P522, DOI 10.1038/nature06318; MacFarlane JJ, 2006, J QUANT SPECTROSC RA, V99, P381, DOI 10.1016/j.jqsrt.2005.05.031; Stanley S, 2004, NATURE, V428, P151, DOI 10.1038/nature02376; CHIHARA J, 1987, J PHYS F MET PHYS, V17, P295, DOI 10.1088/0305-4608/17/2/002; HUBBARD WB, 1991, SCIENCE, V253, P648, DOI 10.1126/science.253.5020.648; Correa AA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.024101; Eggert J.H., 2009, NAT PHYS, V6, P4043; Eisenberger P., 1970, PHYS REV A, V2; Fried LE, 2000, PHYS REV B, V61, P8734, DOI 10.1103/PhysRevB.61.8734; Gauthier M, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4896175; Ghiringhelli LM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.145701; Ghiringhelli LM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.055702; Gregori G, 2004, PHYS PLASMAS, V11, P2754, DOI 10.1063/1.1689664; Grumbach MP, 1996, PHYS REV B, V54, P15730, DOI 10.1103/PhysRevB.54.15730; GUST WH, 1980, PHYS REV B, V22, P4744, DOI 10.1103/PhysRevB.22.4744; James R., 1962, OPTICAL PRINCIPALS D; Kraus D, 2012, HIGH ENERG DENS PHYS, V8, P46, DOI 10.1016/j.hedp.2011.11.011; Kritcher AL, 2007, HIGH ENERG DENS PHYS, V3, P156, DOI 10.1016/j.hedp.2007.02.012; Madhusudhan N, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/2/L40; Lyon S. P., 1992, LAUR923407 LANL; Marsh S. P., 1980, LASL SHOCK HUGONIOT; Molodets AM, 1999, COMBUST EXPLO SHOCK+, V35, P185, DOI 10.1007/BF02674436; Pauling L., 1931, Z KRYSTALLOGR MINERA, V81, P1; PAVLOVSK.MN, 1966, JETP LETT-USSR, V4, P116; SCHUMACHER M, 1975, J PHYS B-AT MOL OPT, V8, P1428, DOI 10.1088/0022-3700/8/9/010; Sheffield J., 2010, PLASMA SCATTERING EL, V2nd; van Thiel M., 1977, UCRL50108 LAW LIV LA; VANTHIEL M, 1993, REE PHYS REV B, V48, P3591; Wunsch K., 2011, THESIS U WARWICK	42	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1574-1818	1878-0563		HIGH ENERG DENS PHYS	High Energy Density Phys.	MAR	2015	14						38	43		10.1016/j.hedp.2015.02.003		6	Physics, Fluids & Plasmas	Physics	CG5KY	WOS:000353331800007		
J	Vandamme, N; Chen, HL; Gaucher, A; Behaghel, B; Lemaitre, A; Cattoni, A; Dupuis, C; Bardou, N; Guillemoles, JF; Collin, S				Vandamme, Nicolas; Chen, Hung-Ling; Gaucher, Alexandre; Behaghel, Benoit; Lemaitre, Aristide; Cattoni, Andrea; Dupuis, Christophe; Bardou, Nathalie; Guillemoles, Jean-Francois; Collin, Stephane			Ultrathin GaAs Solar Cells With a Silver Back Mirror	IEEE Journal of Photovoltaics			English	Article						GaAs; light-trapping; thin film	EPITAXIAL LIFT-OFF	We report on the fabrication and characterization of ultrathin GaAs solar cells with a silver back mirror and absorber thicknesses of only t = 120 nm and t = 220 nm. The silver back mirror is combined with localized ohmic contacts. Without antireflection coating, Fabry-Perot resonances lead to strong enhancement over single-pass absorption (up to 4), and external quantum efficiency reaches 0.8 at resonance wavelengths. An analytical model is used to determine the resonance wavelengths and the absorption maxima. Ashort-circuit improvement of 27% results from the enhanced absorption induced by the Fabry-Perot resonances. By implementing an additional antireflection coating, short-circuit currents reach 16.3 mA/cm(2) for t = 120 nm and 20.7 mA/cm(2) for t = 220 nm, corresponding to efficiencies of 8.7 % and 12.9 %, respectively.	[Vandamme, Nicolas; Chen, Hung-Ling; Gaucher, Alexandre; Behaghel, Benoit; Lemaitre, Aristide; Cattoni, Andrea; Dupuis, Christophe; Bardou, Nathalie; Collin, Stephane] CNRS, Lab Photon Nanostruct, F-91460 Marcoussis, France; [Guillemoles, Jean-Francois] IRDEP CNRS EDF Chim ParisTech, Inst Rech & Dev Energie Photovolta, F-78400 Chatou, France; [Guillemoles, Jean-Francois] Univ Tokyo, CNRS RCAST, LIA NextPV, Tokyo 1538904, Japan	Vandamme, N (reprint author), CNRS, Lab Photon Nanostruct, F-91460 Marcoussis, France.	jf-guillemoles@chimie-paristech.fr; stephane.collin@lpn.cnrs.fr	Lemaitre, Aristide/B-9899-2009	Lemaitre, Aristide/0000-0003-1892-9726	French ANR; French RENATECH network	This work was supported in part by the French ANR projects 3D-BROM, NATHISOL, and ULTRACIS-M and by the French RENATECH network.	Li XH, 2014, J APPL PHYS, V115, DOI 10.1063/1.4862931; Nakayama K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988288; Paire M, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3604789; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Miller OD, 2012, IEEE J PHOTOVOLT, V2, P303, DOI 10.1109/JPHOTOV.2012.2198434; Cattoni A, 2011, NANO LETT, V11, P3557, DOI 10.1021/nl201004c; Steiner MA, 2013, J APPL PHYS, V113, DOI 10.1063/1.4798267; Bauhuis GJ, 2009, SOL ENERG MAT SOL C, V93, P1488, DOI 10.1016/j.solmat.2009.03.027; Ferry VE, 2011, NANO LETT, V11, P4239, DOI 10.1021/nl202226r; Yang WQ, 2014, J APPL PHYS, V115, DOI 10.1063/1.4878156; Yoon J, 2010, NATURE, V465, P329, DOI 10.1038/nature09054; Born M., 1999, PRINCIPLES OPTICS; Cheng CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2583; Kao Z. Jehl Li, 2012, PROGR PHOTOVOLTAICS, V20, P582; Kayes B. M., 2011, P 37 IEEE PHOT SPEC, P4, DOI DOI 10.1109/PVSC.2011.6185831; Massiot I, 2014, ACS PHOTONICS, V1, P878, DOI 10.1021/ph500168b; Palik E. D., 1985, HDB OPTICAL CONSTANT; Saleh B. E. A., 2007, FUNDAMENTALS PHOTONI	18	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3381			IEEE J PHOTOVOLT	IEEE J. Photovolt.	MAR	2015	5	2					565	570		10.1109/JPHOTOV.2014.2371236		6	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CG7YW	WOS:000353524800014		
J	Farrell, DJ; Sodabanlu, H; Wang, YP; Sugiyama, M; Okada, Y				Farrell, Daniel J.; Sodabanlu, Hassanet; Wang, Yunpeng; Sugiyama, Masakazu; Okada, Yoshitaka			Can a Hot-Carrier Solar Cell also be an Efficient Up-converter?	IEEE Journal of Photovoltaics			English	Article						Hot-carriers; quantum wells; up-conversion		The hot-carrier solar cell is a very ambitious device concept, which has a thermodynamic efficiency limit of around 84% when operated at the maximum power point. However, if the same device is instead operated at open circuit, then it becomes an efficient radiator of blackbody radiation at the temperature of the hot carriers. Such a configuration is similar to a thermal photovoltaic converter, but one in which the thermal gradient is maintained by a hot electron-hole gas rather than by a physically hot lattice. In this scheme (see Fig. 1), a low-bandgap hot-carrier material is placed behind a conventional solar cell and absorbs sub-bandgap photons, generating a hot-carrier distribution which re-radiates this energy, some of which can be collected by the solar cell located above. The additional photons have been thermally up-converted by a "hot-carrier radiator." We will discuss the thermodynamic efficiency limit of a hot-carrier radiator placed behind a conventional single-junction solar cell, and present some experimental results toward developing a proof-of-concept device using strain-balanced quantum wells.	[Farrell, Daniel J.; Sodabanlu, Hassanet; Wang, Yunpeng; Okada, Yoshitaka] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538504, Japan; [Sugiyama, Masakazu] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan	Farrell, DJ (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538504, Japan.	farrell@mbe.rcast.u-tokyo.ac.jp; sodabanlu@hotaka.t.u-tokyo.ac.jp; wangyunpeng@hotaka.t.u-tokyo.ac.jp; sugiyama@sogo.t.u-tokyo.ac.jp; okada@mbe.rcast.u-tokyo.ac.jp	Sugiyama, Masakazu/P-9616-2015	Sugiyama, Masakazu/0000-0002-4303-4038	JSPS	D. J. Farrell would like to a thank the JSPS for providing a research fellowship, which allowed this work to be completed, the RCAST team for their help and guidance, and J.-F. Guillemoles for helpful discussions regarding Stokes and anti- Stokes photoluminescence.	Le Bris A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3489405; Tomic S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125348; Pandey A, 2008, SCIENCE, V322, P929, DOI 10.1126/science.1159832; Vurgaftman I, 2001, J APPL PHYS, V89, P5815, DOI 10.1063/1.1368156; Farrell DJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3636401; Takeda Y, 2009, J APPL PHYS, V105, DOI 10.1063/1.3086447; Hirst LC, 2014, IEEE J PHOTOVOLT, V4, P244, DOI 10.1109/JPHOTOV.2013.2289321; FRENSLEY WR, 1992, SUPERLATTICE MICROST, V11, P347, DOI 10.1016/0749-6036(92)90396-M; Fuhrer M., 2013, P AIP C 9 INT C CONC, V1556, P34; Konig D, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.10NO02, 10.1143/JJAP.51.10ND02]; Wurfel P, 1997, SOL ENERG MAT SOL C, V46, P43, DOI 10.1016/S0927-0248(96)00092-X	11	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3381			IEEE J PHOTOVOLT	IEEE J. Photovolt.	MAR	2015	5	2					571	576		10.1109/JPHOTOV.2014.2373817		6	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CG7YW	WOS:000353524800015		
J	Inoue, T; Watanabe, K; Toprasertpong, K; Fujii, H; Sugiyama, M; Nakano, Y				Inoue, Tomoyuki; Watanabe, Kentaroh; Toprasertpong, Kasidit; Fujii, Hiromasa; Sugiyama, Masakazu; Nakano, Yoshiaki			Enhanced Light Trapping in Multiple Quantum Wells by Thin-Film Structure and Backside Grooves With Dielectric Interface	IEEE JOURNAL OF PHOTOVOLTAICS			English	Article						Gallium arsenide; photovoltaic (PV) cells; quantum well devices; thin-film devices; III-V semiconductor materials	GAAS SOLAR-CELLS; EFFICIENCIES; SILICON	Insertion of multiple quantum wells (MQWs) into the i-region of GaAs p-i-n solar cells can shift the effective bandgap to the optimal value for single-junction solar cells under high sunlight concentration. The quantum efficiency corresponding to the absorption by MQWs must be sufficiently high for achieving high-efficiency single-junction MQW solar cells. Here, we report light-trapping thin-film MQW solar cells for increasing photoabsorption in MQWs. In order to suppress the free-carrier absorption loss and enhance the light trapping, only the active layers including MQWs were processed to a cell by flip-chip bonding and dissolution of a conductive GaAs substrate. The periodic grooves formed on the back side of the cell scattered photons in the subbandgap range and trapped light inside the cell. For absorption loss reduction in a back contact metal, a dielectric interlayer was introduced between the metal and GaAs. The light-trapping structure resulted in a fivefold increase in effective optical path length compared with the physical thickness of MQWs. External quantum efficiency at wavelengths longer than the GaAs edge exceeded 50% with only 20-period MQWs. As a result, we achieved thin-film light-trapping MQW solar cells with 20% conversion efficiency.	[Inoue, Tomoyuki; Toprasertpong, Kasidit; Fujii, Hiromasa; Sugiyama, Masakazu; Nakano, Yoshiaki] Univ Tokyo, Sch Engn, Dept Elect Engn & Informat Syst, Tokyo 1138654, Japan; [Watanabe, Kentaroh] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan	Inoue, T (reprint author), Univ Tokyo, Sch Engn, Dept Elect Engn & Informat Syst, Tokyo 1138654, Japan.	inoue@hotaka.t.u-tokyo.ac.jp; kentaroh@hotaka.t.u-tokyo.ac.jp; toprasertpong@hotaka.t.u-tokyo.ac.jp; fujii@hotaka.t.u-tokyo.ac.jp; sugiyama@ee.t.u-tokyo.ac.jp; nakano@ee.t.u-tokyo.ac.jp	Sugiyama, Masakazu/P-9616-2015	Sugiyama, Masakazu/0000-0002-4303-4038	New Energy and Industrial Technology Development Organization, Japan	This work was supported in part by Research and Development of Innovative Solar Cell program, New Energy and Industrial Technology Development Organization, Japan.	ADACHI S, 1983, J ELECTROCHEM SOC, V130, P2427, DOI 10.1149/1.2119608; Ekins-Daukes NJ, 1999, APPL PHYS LETT, V75, P4195, DOI 10.1063/1.125580; Fujii H, 2014, PROG PHOTOVOLTAICS, V22, P784, DOI 10.1002/pip.2454; YABLONOVITCH E, 1982, IEEE T ELECTRON DEV, V29, P300, DOI 10.1109/T-ED.1982.20700; King RR, 2012, PROG PHOTOVOLTAICS, V20, P801, DOI 10.1002/pip.1255; Green MA, 2002, PROG PHOTOVOLTAICS, V10, P235, DOI 10.1002/pip.404; Barnham K, 1996, J APPL PHYS, V80, P1201, DOI 10.1063/1.362857; Singh PK, 2001, SOL ENERG MAT SOL C, V70, P103, DOI 10.1016/S0927-0248(00)00414-1; Mendes MJ, 2014, NANOSCALE, V6, P4796, DOI 10.1039/c3nr06768h; Bauhuis GJ, 2009, SOL ENERG MAT SOL C, V93, P1488, DOI 10.1016/j.solmat.2009.03.027; Bermel P, 2007, OPT EXPRESS, V15, P16986, DOI 10.1364/OE.15.016986; ARAUJO GL, 1990, IEEE T ELECTRON DEV, V37, P1402, DOI 10.1109/16.108204; Benitez P, 2010, OPT EXPRESS, V18, pA25, DOI [10.1364/OE.18.000A25, 10.1364/OE.18.0000A25]; Cabrera C. I., 2013, NATURE RESOURCES, V4, P235; Catchpole K. R., 2012, J APPL PHYS, V112; Catchpole K. R., 2008, APPL PHYS LETT, V93; Dimroth F., 2012, PROG PHOTOVOLTAICS, V22, P227; Forsberg F., 2013, J MICROMECH MICROENG, V23; Inoue T., 2013, P 28 EUR PV SOL EN C, P595; Jones RK, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10ND01; JONES SH, 1990, J ELECTROCHEM SOC, V137, P1653, DOI 10.1149/1.2086747; Kayes B. M., 2011, P 37 IEEE PHOT SPEC, P4, DOI DOI 10.1109/PVSC.2011.6185831; Liu S., 2014, 40 IEEE PHOT SPEC C; Schockley W., 1961, J APPL PHYS, V32, P510; Sugiyama M., 2012, J PHYS D, V46; Tan H., 2013, APPL PHYS LETT, V102; Vandamme N., 2014, 40 IEEE PHOT SPEC C; Watanabe K, 2014, IEEE J PHOTOVOLT, V4, P1086, DOI 10.1109/JPHOTOV.2014.2312486; Watanabe K., 2012, P 38 IEEE PHOT SPEC; Zeng L., 2006, APPL PHYS LETT, V89	30	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3381			IEEE J PHOTOVOLT	IEEE J. Photovolt.	MAR	2015	5	2					697	703		10.1109/JPHOTOV.2015.2392941		7	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CG7YW	WOS:000353524800033		
J	Umemura, S				Umemura, Shin-ichiro			Focused ultrasound transducer for thermal treatment	INTERNATIONAL JOURNAL OF HYPERTHERMIA			English	Review						Air-backed transducer; focused array transducer; matching layer; ultrasound	VORTEX PHASED-ARRAY; PROSTATE-CANCER; SURGERY; HYPERTHERMIA; DESIGN; TISSUE; SYSTEM	Air-backed transducers have been employed for thermal ultrasonic treatment including both ablation and hyperthermia because the power efficiency rather than the bandwidth is a main concern, unlike a typical imaging transducer working in a pulse mode. The characteristic of an air-backed piezoelectric transducer with a matching layer is analysed, and the role and choice of the matching layer is discussed. An element size of a focused array transducer, appropriate for such thermal treatment, is then estimated, and the characteristic of a piezoceramic transducer element of such a size was numerically analysed using a finite element code. The characteristic of a piezocomposite transducer element is also numerically analysed and its suitability to such a therapeutic array transducer is discussed.	[Umemura, Shin-ichiro] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 9808579, Japan	Umemura, S (reprint author), Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, Aoba 6-6-05, Sendai, Miyagi 9808579, Japan.	sumemura@ecei.tohoku.ac.jp					Funaki K, 2007, J MINIM INVAS GYN, V14, P616, DOI 10.1016/j.jmig.2007.04.009; FOSTER RS, 1993, EUR UROL, V23, P330; Clement GT, 2000, PHYS MED BIOL, V45, P3707, DOI 10.1088/0031-9155/45/12/314; Daum DR, 1999, IEEE T ULTRASON FERR, V46, P1254, DOI 10.1109/58.796130; SMITH WA, 1991, IEEE T ULTRASON FERR, V38, P40, DOI 10.1109/58.67833; PARKER KJ, 1983, ULTRASOUND MED BIOL, V9, P363, DOI 10.1016/0301-5629(83)90089-3; CLINE HE, 1995, RADIOLOGY, V194, P731; CAIN CA, 1986, IEEE T MICROW THEORY, V34, P542, DOI 10.1109/TMTT.1986.1133390; de Jong N, 1985, Ultrasonics, V23, P176, DOI 10.1016/0041-624X(85)90027-7; Ergun AS, 2011, ULTRASONICS, V51, P786, DOI 10.1016/j.ultras.2011.03.006; GELET A, 1993, EUR UROL, V23, P44; HILL CR, 1994, ULTRASOUND MED BIOL, V20, P271, DOI 10.1016/0301-5629(94)90067-1; HYNYNEN K, 1981, ULTRASOUND MED BIOL, V7, P397, DOI 10.1016/0301-5629(81)90051-X; Lweesy K, 2009, MED BIOL ENG COMPUT, V47, P635, DOI 10.1007/s11517-009-0478-4; OCHELTREE KB, 1984, IEEE T SON ULTRASON, V31, P526; PERSSON HW, 1985, ULTRASONICS, V23, P83, DOI 10.1016/0041-624X(85)90037-X; Ristic V. M., 1983, PRINCIPLES ACOUSTIC; Rivens IH, 1996, IEEE T ULTRASON FERR, V43, P1023, DOI 10.1109/58.542047; Uchida T, 2002, UROLOGY, V59, P394, DOI 10.1016/S0090-4295(01)01624-7; UMEMURA SI, 1990, INT J HYPERTHER, V6, P641, DOI 10.3109/02656739009140960	20	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0265-6736	1464-5157		INT J HYPERTHER	Int. J. Hyperthermia	MAR	2015	31	2					216	221		10.3109/02656736.2015.1008059		6	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CG3GP	WOS:000353167300012		
J	Yamauchi, I; Nagaoka, S				Yamauchi, Isamu; Nagaoka, Sadao			An economic analysis of deferred examination system: Evidence from a policy reform in Japan	INTERNATIONAL JOURNAL OF INDUSTRIAL ORGANIZATION			English	Article						Patent; Examination; Option value; R&D	PATENT-OFFICE	We investigate how a deferred patent examination system promotes ex-ante screening of patent applications, which reduces both the number of granted patents and the use of economic resources for examinations, without reducing the return from R&D. Based on a real option theory, we develop a model of examination request behaviors. Exploiting the responses of Japanese firms to recent policy reform, we find that the shortening of the allowable period for an examination request significantly increases both eventual and early requests, controlling for the blocking use of a pending patent application. This effect is stronger in technology areas with higher uncertainty. These results support the importance of uncertainty for an applicant and of ex-ante screening. (C) 2015 Elsevier B.V. All rights reserved.	[Yamauchi, Isamu] Res Inst Econ Trade & Ind, Tokyo, Japan; [Nagaoka, Sadao] Hitotsubashi Univ, Inst Innovat Res, Tokyo, Japan	Yamauchi, I (reprint author), 1-3-1 Kasumigaseki,Chiyoda Ku, Tokyo 1008901, Japan.	yamauchi-isamu@rieti.go.jp; nagaoka@iir.hit-u.ac.jp					Goto A, 2007, RES POLICY, V36, P1431, DOI 10.1016/j.respol.2007.06.005; PAKES A, 1986, ECONOMETRICA, V54, P755, DOI 10.2307/1912835; O'Donoghue T, 1998, J ECON MANAGE STRAT, V7, P1, DOI 10.1111/j.1430-9134.1998.00001.x; Matutes C, 1996, RAND J ECON, V27, P60, DOI 10.2307/2555792; Harhoff D, 2009, MANAGE SCI, V55, P1969, DOI 10.1287/mnsc.1090.1069; Cornelli F, 1999, RAND J ECON, V30, P197, DOI 10.2307/2556077; Deng Y, 2007, INT J IND ORGAN, V25, P121, DOI 10.1016/j.ijindorg.2006.03.001; GILBERT R, 1990, RAND J ECON, V21, P106, DOI 10.2307/2555497; Henkel J., 2010, SSRN WORKING PAPER S, V1738912; Koenen J., 2011, CESIFO WORKING PAPER, V3657; Nagaoka S., 2009, RIETI DISCUSSION PAP, V09-E-010; Nagaoka S., 2013, 4 AS PAC INN C NAT T; Palangkaraya A, 2008, ECON LETT, V101, P243, DOI 10.1016/j.econlet.2008.08.014; Regibeau P, 2010, J IND ECON, V58, P222; Sampat B.N., 2011, J LAW ECON, V53, P399; Scotchmer S, 1999, RAND J ECON, V30, P181, DOI 10.2307/2556076; Yamauchi I., 2013, 1312 IIR	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7187	1873-7986		INT J IND ORGAN	Int. J. Ind. Organ.	MAR	2015	39						19	28		10.1016/j.ijindorg.2015.01.003		10	Economics	Business & Economics	CG2FR	WOS:000353090800003		
J	Miyagiwa, K; Ohno, Y				Miyagiwa, Kaz; Ohno, Yuka			International harmonization of the patent-issuing rules	INTERNATIONAL JOURNAL OF INDUSTRIAL ORGANIZATION			English	Article						R&D competition; Patent laws and legislation; Intellectual property rights; Patent priority rules; Sequential innovation; Management of technological innovation and R&D	INNOVATION	Using a dynamic model of patent races for two sequential innovations, Scotchmer & Green (1990) compared the effect on R&D incentives of the two patent-issuing rules, first-to-invent and first-to-file, and found first-to-file more conducive to R&D. We show that their result depends on their assumption of fixed innovation probabilities. When innovation probabilities are endogenous for the intermediate invention, their result can be reversed. Our analysis has the obvious implications on the evaluation of the Leahy-Smith America Invents Act (2011), whereby the U.S. switched from first-to-invent to first-to-file. (C) 2015 Elsevier B.V. All rights reserved.	[Miyagiwa, Kaz] Florida Int Univ, Dept Econ, Miami, FL 33199 USA; [Miyagiwa, Kaz] Osaka Univ, ISER, Suita, Osaka 565, Japan; [Ohno, Yuka] Hokkaido Univ, Dept Econ, Sapporo, Hokkaido 0600809, Japan	Ohno, Y (reprint author), Hokkaido Univ, Dept Econ, Kite 9 Nishi 7, Sapporo, Hokkaido 0600809, Japan.	yuka_ohno@econ.hokudai.ac.jp					SCOTCHMER S, 1990, RAND J ECON, V21, P131, DOI 10.2307/2555499; Abrams DS, 2013, STANFORD LAW REV, V65, P517; CHANG HF, 1995, RAND J ECON, V26, P34, DOI 10.2307/2556034; Cohen L., 2005, 0522 AER BROOK JOINT; Hart H.D., 2007, INTERFERENCE WHAT MU; Kao T, 2009, MANCH SCH, V77, P512, DOI 10.1111/j.1467-9957.2009.02108.x; LEE T, 1980, Q J ECON, V94, P429, DOI 10.2307/1884551; Lo S.-T., 2009, DOES IT MATTER UNPUB; Miyagiwa K., 2015, J EC MANAG IN PRESS; Saftlas H., 2011, STANDARD POORS  0602	10	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7187	1873-7986		INT J IND ORGAN	Int. J. Ind. Organ.	MAR	2015	39						81	89		10.1016/j.ijindorg.2015.02.004		9	Economics	Business & Economics	CG2FR	WOS:000353090800008		
J	Asuke, T				Asuke, Taro			Transverse projective structures of foliations and infinitesimal derivatives of the Godbillon-Vey class	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						foliations; Godbillon-Vey class; Bott class; derivatives; projective structures	CONNECTIONS	We study transverse projective structures of foliations and construct an invariant, which is a homomorphism from a foliated cohomology to the ordinary one. It is shown that the infinitesimal derivatives of the Godbillon-Vey class and the Bott class are determined by the invariant. As a corollary, a rigidity theorem for the Godbillon-Vey class and the Bott class is shown.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Asuke, T (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	asuke@ms.u-tokyo.ac.jp			 [24224002]	The author is partly supported by Grant-in-Aid for Scientific research (No. 24224002). A part of this work is done while the author enjoys his visit to the "Institute de Mathematiques de Toulouse". He would like to express his gratitude for their warm hospitality, especially to J. Rebelo.	AGAOKA Y, 1983, J MATH KYOTO U, V22, P701; Asuke T., 2003, ASIAN J MATH, V7, P239; Asuke T., 2014, PREPRINT; Asuke T., 2010, MSJ MEMOIRS, V24; Asuke T., J MATH SCI; Asuke T, 2009, TOHOKU MATH J, V61, P393; Baum P., 1972, J DIFFER GEOM, V7, P279; BLUMENTHAL RA, 1987, ILLINOIS J MATH, V31, P327; Bott R., 1972, LECT NOTES MATH, V279; Crampin M, 2007, J GEOM PHYS, V57, P691, DOI 10.1016/j.geomphys.2006.03.007; Duchamp T. E., 1979, J DIFFER GEOM, V14, P317; Heitsch J., 1975, COMMENT MATH HELV, V15, P197; Heitsch J., 1978, J DIFFER GEOM, V13, P311; HEITSCH JL, 1978, ANN MATH, V108, P421, DOI 10.2307/1971183; Hlavaty V., 1928, MATH Z, V26, P142; KATO M, 1991, J ALGEBRA, V138, P424, DOI 10.1016/0021-8693(91)90180-G; KOBAYASHI S, 1964, J MATH MECH, V13, P215; Kobayashi S., 1963, FDN DIFFERENTIAL GEO, VI; Kobayashi S., 1972, TRANSFORMATION GROUP; Maszczyk T, 1999, MATH Z, V230, P329, DOI 10.1007/PL00004695; MORITA S, 1979, J MATH SOC JPN, V31, P693; NISHIKAWA S, 1976, J MATH SOC JPN, V28, P223; ROBERTS CW, 1995, DIFFER GEOM APPL, V5, P237, DOI 10.1016/0926-2245(95)92848-Y; TAKEUCHI M, 1980, J MATH SOC JPN, V32, P119; Thomas TY, 1925, P NATL ACAD SCI USA, V11, P199, DOI 10.1073/pnas.11.4.199; Tondeur P., 1988, FOLIATIONS RIEMANNIA; Whitehead J. H. C., 1931, ANN MATH, V32, P327, DOI 10.2307/1968195	27	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	MAR	2015	26	4							1540001	10.1142/S0129167X15400017		29	Mathematics	Mathematics	CG4YO	WOS:000353295700002		
J	Hasegawa, M; Honda, A; Naokawa, K; Saji, K; Umehara, M; Yamada, K				Hasegawa, Masaru; Honda, Atsufumi; Naokawa, Kosuke; Saji, Kentaro; Umehara, Masaaki; Yamada, Kotaro			Intrinsic properties of surfaces with singularities	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Singularity; wave front; cross cap; intrinsic; the Gauss-Bonnet theorem	FRONTS; SPACE	In this paper, we give two classes of positive semi-definite metrics on 2-manifolds. The one is called a class of Kossowski metrics and the other is called a class of Whitney metrics: The pull-back metrics of wave fronts which admit only cuspidal edges and swallowtails in R-3 are Kossowski metrics, and the pull-back metrics of surfaces consisting only of cross cap singularities are Whitney metrics. Since the singular sets of Kossowski metrics are the union of regular curves on the domains of definitions, and Whitney metrics admit only isolated singularities, these two classes of metrics are disjoint. In this paper, we give several characterizations of intrinsic invariants of cuspidal edges and cross caps in these classes of metrics. Moreover, we prove Gauss-Bonnet type formulas for Kossowski metrics and for Whitney metrics on compact 2-manifolds.	[Hasegawa, Masaru] Univ Sao Paulo, Inst Ciencias Matemat & Comp, BR-13566590 Sao Carlos, SP, Brazil; [Honda, Atsufumi] Miyakonojo Natl Coll Technol, Miyazaki 8858567, Japan; [Naokawa, Kosuke; Saji, Kentaro] Kobe Univ, Dept Math, Fac Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Umehara, Masaaki] Tokyo Inst Technol, Dept Math & Comp Sci, Meguro Ku, Tokyo 1528552, Japan; [Yamada, Kotaro] Tokyo Inst Technol, Dept Math, Meguro Ku, Tokyo 1528551, Japan	Hasegawa, M (reprint author), Univ Sao Paulo, Inst Ciencias Matemat & Comp, Ave Trabalhador Sao Carlense,400 Ctr, BR-13566590 Sao Carlos, SP, Brazil.	mhasegawa@icrnc.usp.br; atsufumi@cc.miyakonojo-nct.ac.jp; naokawa@port.kobe-u.ac.jp; saji@math.kobe-u.ac.jp; umehara@is.titech.ac.jp; kotaro@math.titech.ac.jp			FAPESP [2013/02543-1]; Japan Society for the Promotion of Science [26400087, 262457005, 26400006]	The authors are grateful to Wayne Rossman and the referee for valuable comments. The first author was supported by the FAPESP post-doctoral grant number 2013/02543-1. The third author was partly supported by the Grant-in-Aid for JSPS Fellows. The fourth, fifth and sixth authors were partially supported by Grant-in-Aid for Scientific Research (C) No. 26400087, Scientific Research (A) No. 262457005, and Scientific Research (C) No. 26400006, respectively, from the Japan Society for the Promotion of Science.	Saji K, 2009, ANN MATH, V169, P491; Kokubu M, 2005, PAC J MATH, V221, P303; Fukui T., 2012, J SINGUL, V4, P35; Fukui T, 2005, TOHOKU MATH J, V57, P469, DOI 10.2748/tmj/1140727069; Hasegawa M, 2014, SEL MATH-NEW SER, V20, P769, DOI 10.1007/s00029-013-0134-6; Kobayashi S., 1964, FDN DIFFERENTIAL GEO, VI; Kossowski M, 2002, ANN GLOB ANAL GEOM, V21, P19, DOI 10.1023/A:1014239727720; Kossowski M., 2004, J GEOM, V81, P101, DOI 10.1007/s00022-004-2511-y; KUIPER NH, 1975, MATH SCAND, V36, P83; LANGEVIN R, 1995, CAN J MATH, V47, P544, DOI 10.4153/CJM-1995-030-5; Martins L. F., 2013, ARXIV13082136; MARTINS L. F., ARXIV14124099; Naokawa K., TOHOKU MATH IN PRESS; Saji K, 2012, J GEOM ANAL, V22, P383, DOI 10.1007/s12220-010-9193-5; Saji K, 2008, KYUSHU J MATH, V62, P259, DOI 10.2206/kyushujm.62.259; Spivak M., 1999, COMPREHENSIVE INTRO, V3rd; WEST J., 1995, THESIS LIVERPOOL U; Whitney H., 1943, DUKE MATH J, V10, P161, DOI 10.1215/S0012-7094-43-01016-6	18	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	MAR	2015	26	4							1540008	10.1142/S0129167X1540008X		34	Mathematics	Mathematics	CG4YO	WOS:000353295700009		
J	Itoh, J; Rouyer, J; Vilcu, C				Itoh, Jin-ichi; Rouyer, Joel; Vilcu, Costin			Moderate smoothness of most Alexandrov surfaces	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Alexandrov surface; Baire categories; Gaussian curvature	TYPICAL CONVEX SURFACES; CURVATURE; SPACES; BODIES; POINTS	We show that, in the sense of Baire categories, a typical Alexandrov surface with curvature bounded below by kappa has no conical points. We use this result to prove that, on such a surface (unless it is flat), at a typical point, the lower and the upper Gaussian curvatures are equal to kappa and infinity, respectively.	[Itoh, Jin-ichi] Kumamoto Univ, Fac Educ, Kumamoto 8608555, Japan; [Rouyer, Joel; Vilcu, Costin] Acad Romana, Inst Math Simion Stoilow, Bucharest 70700, Romania	Itoh, J (reprint author), Kumamoto Univ, Fac Educ, Kumamoto 8608555, Japan.	j-itoh@gpo.kumamoto-u.ac.jp; Joel.Rouyer@ymail.com; Costin.Vilcu@imar.ro			Romanian National Authority for Scientific Research, CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-0533]	The authors are indebted to Tudor Zamfirescu for suggesting the topic of this paper and for very useful discussions, especially concerning the curvatures of convex surfaces. The second and third authors were supported by the grant PN-II-ID-PCE-2011-3-0533 of the Romanian National Authority for Scientific Research, CNCS-UEFISCDI.	Adiprasito K., J NONLINEAR IN PRESS; Adiprasito K, 2012, GEOMETRIAE DEDICATA, V159, P267, DOI 10.1007/s10711-011-9658-0; Adiprasito K, 2012, J CONVEX ANAL, V19, P385; Aleksandrov A. D., 1967, INTRINSIC GEOMETRY S; ALEKSANDROV AD, 1986, RUSS MATH SURV+, V41, P1, DOI 10.1070/RM1986v041n03ABEH003311; Vilcu C, 2008, MATH ANN, V340, P543, DOI 10.1007/s00208-007-0159-2; ZAMFIRESCU T, 1980, MATH ANN, V252, P217, DOI 10.1007/BF01420084; Burago D., 2001, COURSE METRIC GEOMET; Gruber P. M., 1993, HDB CONVEX GEOMETRY, VVol. A, P1327; GRUBER PM, 1977, MATH ANN, V229, P259, DOI 10.1007/BF01391471; KLEE V, 1959, MATH ANN, V139, P51, DOI 10.1007/BF01459822; Machigashira Y, 1998, J MATH SOC JPN, V50, P859, DOI 10.2969/jmsj/05040859; BURAGO Y, 1992, RUSS MATH SURV+, V47, P1, DOI 10.1070/RM1992v047n02ABEH000877; Petersen P., 2006, GRADUATE TEXTS MATH, V171; Rouyer J., 2014, P MATH STAT, V96, P249; Rouyer J., ARXIV13114873MATHMG; Rouyer J, 2011, TOPOL APPL, V158, P2140, DOI 10.1016/j.topol.2011.07.003; SCHNEIDER R, 1979, MATH ANN, V240, P177, DOI 10.1007/BF01364632; Schneider R, 2015, P AM MATH SOC, V143, P387; Shiohama K., 1992, LECT NOTES SERIES; ZAMFIRESCU T, 1987, MONATSH MATH, V103, P241, DOI 10.1007/BF01364343; Zamfirescu T., 1991, ATTI SEMIN MAT FIS, V39, P139; ZAMFIRESCU T, 1987, MONATSH MATH, V103, P57, DOI 10.1007/BF01302711; ZAMFIRESCU T, 1988, PAC J MATH, V131, P191; ZAMFIRESCU T, 1980, MATH Z, V174, P135, DOI 10.1007/BF01293533; ZAMFIRESCU T, 1982, INVENT MATH, V69, P253, DOI 10.1007/BF01399505	26	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	MAR	2015	26	4							1540004	10.1142/S0129167X15400042		14	Mathematics	Mathematics	CG4YO	WOS:000353295700005		
J	Maeda, Y; Rosenberg, S; Torres-Ardila, F				Maeda, Yoshiaki; Rosenberg, Steven; Torres-Ardila, Fabian			The geometry of loop spaces I: H-s-Riemannian metrics	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Loop spaces; Levi-Civita connections; pseudodifferential operators		A Riemannian metric on a manifold M induces a family of Riemannian metrics on the loop space LM depending on a Sobolev space parameter s. We compute the connection forms of these metrics and the higher symbols of their curvature forms, which take values in pseudodifferential operators (Psi DOs). These calculations are used in the followup paper [10] to construct Chern-Simons classes on TLM which detect nontrivial elements in the diffeomorphism group of certain Sasakian 5-manifolds associated to Kahler surfaces.	[Maeda, Yoshiaki] Tohoku Univ, Tohoku Forum Creat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Rosenberg, Steven] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Torres-Ardila, Fabian] Univ Massachusetts, Ctr Sci & Math Context, Boston, MA 02125 USA	Maeda, Y (reprint author), Tohoku Univ, Tohoku Forum Creat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	maeda@math.keio.ac.jp; sr@math.bu.edu; fabian.torres-ardila@umb.edu			JSPS [25610015, 23340018]	Our many discussions with Sylvie Paycha are gratefully acknowledged. We also thank Dan Freed for pointing out an error in an earlier version of the paper. The first author is supported in part by JSPS KAKENHI Nos. 25610015 and 23340018.	EELLS J, 1966, B AM MATH SOC, V72, P751, DOI 10.1090/S0002-9904-1966-11558-6; ATIYAH MF, 1967, ANN MATH, V86, P374, DOI 10.2307/1970694; Freed D., 1984, INSTANTONS 4 MANIFOL; FREED DS, 1988, J DIFFER GEOM, V28, P223; Gilkey P., 1984, INVARIANCE THEORY HE; Hormander L., 2007, ANAL LINEAR PARTIAL, V1994; Lang S., 1995, DIFFERENTIAL RIEMANN; Larrain-Hubach A., 2011, SPECTRAL THEORY GEOM, V532; Larrain-Hubach A, 2009, LETT MATH PHYS, V89, P265, DOI 10.1007/s11005-009-0352-1; Maeda Y., ARXIV14072491; Omori H., 1997, INFINITE DIMENSIONAL; Paycha S., 2013, GEOMETRIC TOPOLOGICA; Seeley R. T., 1967, SINGULAR INTEGRALS, V10, P288; Shubin M., 2001, PSEUDODIFFERENTIAL O; Spivak M.D., 1979, COMPREHENSIVE INTRO; Warner F W, 1971, FDN DIFFERENTIABLE M	16	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	MAR	2015	26	4							1540002	10.1142/S0129167X15400029		26	Mathematics	Mathematics	CG4YO	WOS:000353295700003		
J	Nakagawa, Y				Nakagawa, Yasuhiro			On the examples of Nill and Paffenholz	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Toric Fano manifolds; symmetric toric Fano manifolds; Einstein-Kahler metrics; Chow stability; Koiso-Sakane's examples	COMPACT COMPLEX-MANIFOLDS; KAHLER-EINSTEIN METRICS; TORIC MANIFOLDS	In 1999, Batyrev and Selivanova introduced the notion of "symmetric toric Fano manifolds" and proved that every symmetric toric Fano manifold admits an Einstein-Kahler metric ([1]). For n <= 4, every Einstein-Kahler toric Fano n-fold is symmetric. Hence, it was conjectured that every Einstein-Kahler toric Fano manifold is symmetric. However, in [6], Nill and Paffenholz constructed the counter-examples of this conjecture. In this paper, we shall construct higher-dimensional generalizations of their examples and also discuss the Chow unstability of these generalizations.	Saga Univ, Dept Math, Grad Sch Sci & Engn, Saga 8408502, Japan	Nakagawa, Y (reprint author), Saga Univ, Dept Math, Grad Sch Sci & Engn, 1 Honjo Machi, Saga 8408502, Japan.	yasunaka@ms.saga-u.ac.jp			JSPS [23540080]	Partly supported by JSPS Grant-in-Aid for Scientific Research (C) No. 23540080.	FUTAKI A, 1983, INVENT MATH, V73, P437, DOI 10.1007/BF01388438; Ono H, 2012, ANN I FOURIER, V62, P1265; Wang XJ, 2004, ADV MATH, V188, P87, DOI 10.1016/j.aim.2003.09.009; MABUCHI T, 1987, OSAKA J MATH, V24, P705; Batyrev VV, 1999, J REINE ANGEW MATH, V512, P225; KOISO N, 1986, LECT NOTES MATH, V1201, P165; KOISO N, 1988, OSAKA J MATH, V25, P933; Nill B., 2011, BEITR ALGEBRA GEOM, V52, P297; Oda T., 1988, ERGEBNISSE MATH IHRE, V15; Ono H, 2011, J MATH SOC JPN, V63, P1377, DOI 10.2969/jmsj/06341377; SAKANE Y, 1986, OSAKA J MATH, V23, P585	11	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	MAR	2015	26	4							1540007	10.1142/S0129167X15400078		15	Mathematics	Mathematics	CG4YO	WOS:000353295700008		
J	Noguchi, J				Noguchi, Junjiro			A remark to a division algorithm in the proof of Oka's first coherence theorem	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Oka coherence; several complex variables		The problem is the locally finite generation of a relation sheaf R(tau(1),..., tau(q)) in O-Cn. After tau(j) reduced toWeierstrass' polynomials in z(n), it is the key for applying an induction on n to show that elements of R(tau(1),..., tau(q)) are expressed as a finite linear sum of z(n)-polynomial- like elements of degree at most p = max(j) deg(zn) tau(j) over O-Cn. In that proof one is used to use a division by tau(j) of the maximum degree, deg(zn) tau(j) = p (Oka (1948); Cartan (1950); Hormander (1966); Narasimhan (1966); Nishino (1996), etc.) Here we shall confirm that the division above works by making use of tau(k) of the minimum degree, minj deg(zn) tau(j), and show that there is a degree structure in the locally finite generator system. This proof is naturally compatible with the simple case when some tau(j) is a unit, and gives some improvement in the degree estimate of generators.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Noguchi, J (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan.	noguchi@ms.u-tokyo.ac.jp			 [23340029]	The present note is an outcome of a series of lectures by the author from March to May 2014 at the University of Roma II, "Tor Vergata" by the kind invitation of Professor F. Bracci, to whom he expresses sincere gratitude. This research was supported in part by Grant-in-Aid for Scientific Research (B) 23340029.	Cartan H., 1950, B SOC MATH FRANCE, V78, P29; Hironaka H., 1981, INTRO ANAL SPACES; Hormander L., 1989, INTRO COMPLEX ANAL S, V3rd; Narasimhan R., 1966, LECT NOTES MATH, V25; Nishino T., 1996, FUNCTION THEORY SEVE; Noguchi J., 2013, ANAL FUNCTION THEORY; Oka K., 1949, KODAI MATH SEM REP, V1, P15, DOI 10.2996/kmj/1138833536; Oka K., 1950, B SOC MATH FRANCE, V78, P1; Oka K., 1961, FONCTIONS ANAL PLUSI	9	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	MAR	2015	26	4							1540005	10.1142/S0129167X15400054		8	Mathematics	Mathematics	CG4YO	WOS:000353295700006		
J	Ohsawa, T				Ohsawa, Takeo			Stability of pseudoconvexity of disc bundles over compact Riemann surfaces and application to a family of Galois coverings	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Disc bundle; compact Riemann surface; pseudoconvex	HARMONIC-MAPPINGS; LEVI PROBLEM; MANIFOLDS; SPACES; VARIETIES; FIBER	It is proved that Galois coverings of smooth families of compact Riemann surfaces over Stein manifolds are holomorphically convex if the covering transformation groups are isomorphic to discrete subgroups of the automorphism group of the unit disc. The proof is based on an extension of the fact that disc bundles over compact Kahler manifolds are weakly 1-complete.	Nagoya Univ, Grad Sch Math, Nagoya, Aichi 4648602, Japan	Ohsawa, T (reprint author), Nagoya Univ, Grad Sch Math, Nagoya, Aichi 4648602, Japan.	ohsawa@math.nagoya-u.ac.jp					Adachi M, 2014, PUBL RES I MATH SCI, V50, P153, DOI 10.4171/PRIMS/127; KOLLAR J, 1993, INVENT MATH, V113, P177, DOI 10.1007/BF01244307; Katzarkov L, 1998, ANN SCI ECOLE NORM S, V31, P525, DOI 10.1016/S0012-9593(98)80105-5; EELLS J, 1964, AM J MATH, V86, P109, DOI 10.2307/2373037; Ohsawa T, 1998, NAGOYA MATH J, V149, P1; DIEDERICH K, 1982, MATH ANN, V261, P255, DOI 10.1007/BF01456222; Coltoiu M, 2000, MICH MATH J, V47, P369; Eyssidieux P, 2012, ANN MATH, V176, P1545, DOI 10.4007/annals.2012.176.3.4; Behnke H., 1949, MATH ANN, V120, P430, DOI 10.1007/BF01447838; Bers L., 1960, B AM MATH SOC, V66, P94, DOI 10.1090/S0002-9904-1960-10413-2; BERS L, 1973, ACTA MATH-DJURSHOLM, V130, P89, DOI 10.1007/BF02392263; Coltoiu M, 2000, NAGOYA MATH J, V157, P1; DIEDERICH K, 1985, PUBL RES I MATH SCI, V21, P819, DOI 10.2977/prims/1195178932; GRAUERT H, 1958, ANN MATH, V68, P460, DOI 10.2307/1970257; NAPIER T, 1990, MATH ANN, V286, P433, DOI 10.1007/BF01453583; NAPIER T, 1992, MATH ANN, V294, P523, DOI 10.1007/BF01934340; Ohsawa T, 1997, NAGOYA MATH J, V147, P107; Ohsawa T, 1996, NAGOYA MATH J, V142, P1; Remmert R., 1998, MAT HIST MATH 20 SIE, V3, P203; Shafarevich I. R., 2013, BASIC ALGEBRAIC GEOM, V2; UEDA T, 1983, J MATH KYOTO U, V22, P583; Vajaitu V, 1996, CR ACAD SCI I-MATH, V322, P823; Yamaguchi H., 1976, J MATH KYOTO U, V16, P71	23	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	MAR	2015	26	4							1540003	10.1142/S0129167X15400030		7	Mathematics	Mathematics	CG4YO	WOS:000353295700004		
J	Tadano, H				Tadano, Homare			Gap theorems for compact gradient Sasaki-Ricci solitons	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Sasaki manifold; Sasaki-Einstein manifold; gradient Sasaki-Ricci soliton; gap theorem	EINSTEIN MANIFOLDS; KAHLER-METRICS; FLOW; UNIQUENESS; EXAMPLES	In this paper, by using estimates for the transverse Ricci curvature in terms of the Sasaki-Futaki invariant, we shall give some gap theorems for compact gradient Sasaki-Ricci solitons by showing some necessary and sufficient conditions for the solitons to be Sasaki-Einstein. Our results may be regarded as a Sasaki geometry version of recent works by Li and Fernandez-Lopez and Garcia-Rio.	Osaka Univ, Dept Math, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Tadano, H (reprint author), Osaka Univ, Dept Math, Grad Sch Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	h-tadano@cr.math.sci.osaka-u.ac.jp			Moriyasu Graduate Student Scholarship Foundation	This work was supported by Moriyasu Graduate Student Scholarship Foundation.	Futaki A, 2009, J DIFFER GEOM, V83, P585; Martelli D, 2008, COMMUN MATH PHYS, V280, P611, DOI 10.1007/s00220-008-0479-4; FUTAKI A, 1983, INVENT MATH, V73, P437, DOI 10.1007/BF01388438; Boyer CP, 2005, ANN MATH, V162, P557; Futaki A, 2013, ASIAN J MATH, V17, P17; Smoczyk K, 2010, INT J MATH, V21, P951, DOI 10.1142/S0129167X10006331; Nitta Y, 2012, TOHOKU MATH J, V64, P453; CAO HD, 1985, INVENT MATH, V81, P359, DOI 10.1007/BF01389058; He WY, 2013, J GEOM ANAL, V23, P1876, DOI 10.1007/s12220-012-9311-7; Boyer CP, 2008, COMMUN MATH PHYS, V279, P705, DOI 10.1007/s00220-008-0429-1; Collins TC, 2013, T AM MATH SOC, V365, P1277; Boyer C. P., 2005, REND CIRC MAT PALE S, P57; Boyer C. P., 2008, OXFORD MATH MONOGRAP; Chavel I., 1984, EIGENVALUES RIEMANNI, V115; Cho K, 2008, COMMUN MATH PHYS, V277, P439, DOI 10.1007/s00220-007-0374-4; Chow B., 2006, GRADUATE STUDIES MAT, V77; Fernandez-Lopez M, 2012, INT J MATH, V23, DOI 10.1142/S0129167X12500723; Gauntlett JP, 2004, ADV THEOR MATH PHYS, V8, P711; Gauntlett J.P., 2006, ADV THEOR MATH PHYS, V8, P987; Hasegawa I., 1981, J HOKKAIDO U ED, V32, P1; Li HZ, 2008, ARCH MATH, V91, P187, DOI 10.1007/s00013-008-2628-6; Lichnerowicz A., 1958, GEOMETRIE GROUPES TR; Mabuchi T, 2013, TOHOKU MATH J, V65, P243; Martelli D, 2006, COMMUN MATH PHYS, V268, P39, DOI 10.1007/s00220-006-0087-0; NISHIKAWA S, 1988, TOHOKU MATH J, V40, P599, DOI 10.2748/tmj/1178227924; Nitta Y, 2014, ANN SCUOLA NORM-SCI, V13, P207; Sasaki S., 1962, J MATH SOC JAPAN, V14, P249; Sparks J., 2011, SURVEYS DIFF GEOM, V16, P265; Tian G, 2007, J AM MATH SOC, V20, P675, DOI 10.1090/S0894-0347-06-00552-2; Tondeur P., 1997, MONOGRAPHS MATH, V90	30	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	MAR	2015	26	4							1540009	10.1142/S0129167X15400091		17	Mathematics	Mathematics	CG4YO	WOS:000353295700010		
J	Yoshikawa, KI				Yoshikawa, Ken-Ichi			Degenerations of Calabi-Yau threefolds and BCOV invariants	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Analytic torsion; Calabi-Yau threefolds; BCOV invariant	HOLOMORPHIC DETERMINANT BUNDLES; ANALYTIC-TORSION; QUILLEN METRICS; MANIFOLDS; MODULI; SPACE	In [M. Bershadsky, S. Cecotti, H. Ooguri and C. Vafa, Holomorphic anomalies in topological field theories, Nucl. Phys. B 405 (1993) 279 304; M. Bershadsky, S. Cecotti, H. Ooguri and C. Vafa, Kodaira-Spencer theory of gravity and exact results for quantum string amplitudes, Commun. Math. Phys. 165 (1994) 311-427], by expressing the physical quantity F-1 in two distinct ways, Bershadsky-Cecotti-Ooguri-Vafa discovered a remarkable equivalence between Ray-Singer analytic torsion and elliptic instanton numbers for Calabi-Yau threefolds. After their discovery, in [H. Fang, Z. Lu and K.-I. Yoshikawa, Analytic torsion for Calabi-Yau threefolds, J. Differential Geom. 80 (2008) 175-250], a holomorphic torsion invariant for Calabi-Yau threefolds corresponding to F-1, called BCOV invariant, was constructed. In this article, we study the asymptotic behavior of BCOV invariants for algebraic one-parameter degenerations of Calabi-Yau threefolds. We prove the rationality of the coefficient of logarithmic divergence and give its geometric expression by using a semi-stable reduction of the given family.	Kyoto Univ, Dept Math, Fac Sci, Kyoto 6068502, Japan	Yoshikawa, KI (reprint author), Kyoto Univ, Dept Math, Fac Sci, Kyoto 6068502, Japan.	yosikawa@math.kyoto-u.ac.jp			JSPS [23340017, 22244003, 22224001, 25220701]	The author thanks Professor Y. Namikawa for helpful discussions about Kodaira-Spencer maps. The author is partially supported by JSPS Grants-in-Aid (B) 23340017, (A) 22244003, (S) 22224001, (S) 25220701.	STEENBRINK J, 1976, INVENT MATH, V31, P229, DOI 10.1007/BF01403146; BERSHADSKY M, 1994, COMMUN MATH PHYS, V165, P311, DOI 10.1007/BF02099774; QUILLEN D, 1985, FUNCT ANAL APPL+, V19, P31, DOI 10.1007/BF01086022; SCHMID W, 1973, INVENT MATH, V22, P211, DOI 10.1007/BF01389674; BISMUT JM, 1991, PUBL MATH-PARIS, P1; RAY DB, 1973, ANN MATH, V98, P154, DOI 10.2307/1970909; BERSHADSKY M, 1993, NUCL PHYS B, V405, P279, DOI 10.1016/0550-3213(93)90548-4; BISMUT JM, 1988, COMMUN MATH PHYS, V115, P301, DOI 10.1007/BF01466774; Bismut JM, 1997, J ALGEBRAIC GEOM, V6, P19; BISMUT JM, 1988, COMMUN MATH PHYS, V115, P49, DOI 10.1007/BF01238853; Fang H, 2005, J REINE ANGEW MATH, V588, P49; Fang H, 2008, J DIFFER GEOM, V80, P175; Griffiths P., 1984, ANN MATH STUD, V106, P29; Kempf G., 1973, LECT NOTES MATH, V339; Lu ZQ, 2004, J INST MATH JUSSIEU, V3, P185, DOI 10.1017/S1474748004000076; Lu ZQ, 2001, J GEOM ANAL, V11, P103; Lu ZQ, 2013, MATH ANN, V357, P469, DOI 10.1007/s00208-013-0907-4; Yoshikawa K.-I., 2014, ARXIV14100212; Yoshikawa K.-I., 2010, ARXIV10072835; Yoshikawa KI, 2007, MATH ANN, V337, P61, DOI 10.1007/s00208-006-0027-5; Zucker S., TOPICS TRANSCENDENTA, P121	21	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	MAR	2015	26	4							1540010	10.1142/S0129167X15400108		33	Mathematics	Mathematics	CG4YO	WOS:000353295700011		
J	Honda, A; Tsuji, K; Matsuda, Y; Hayashi, T; Fukushima, W; Sawahara, T; Kudo, H; Murayama, R; Takano, H				Honda, Akiko; Tsuji, Kenshi; Matsuda, Yugo; Hayashi, Tomohiro; Fukushima, Wataru; Sawahara, Takahiro; Kudo, Hitomi; Murayama, Rumiko; Takano, Hirohisa			Effects of Air Pollution-Related Heavy Metals on the Viability and Inflammatory Responses of Human Airway Epithelial Cells	INTERNATIONAL JOURNAL OF TOXICOLOGY			English	Article						airway epithelial cells; heavy metals; oxidation states of metals; viability; proinflammatory responses	DIESEL EXHAUST PARTICLES; FINE PARTICULATE MATTER; MUCIN GENE-EXPRESSION; RESIDUAL FUEL-OIL; IN-VITRO; NUCLEAR TRANSLOCATION; OXIDATIVE STRESS; CHROMIUM; COMBUSTION; MANGANESE	Various metals produced from human activity are ubiquitously detected in ambient air. The metals may lead to induction and/or exacerbation of respiratory diseases, but the significant metals and factors contributing to such diseases have not been identified. To compare the effects of each metal and different oxidation states of metals on human airway, we examined the viability and production of interleukin (IL)-6 and IL-8 using BEAS-2B cell line, derived from human airway epithelial cells. Airway epithelial cells were exposed to Mn2+, V4+, V5+, Cr3+, Cr6+, Zn2+, Ni2+, and Pb2+ at a concentration of 0.5, 5, 50, or 500 mol/L for 24 hours. Mn and V decreased the cell viability in a concentration-dependent manner, and V5+ tended to have a greater effect than V4+. The Cr decreased the cell viability, and (Cr+6) at concentrations of 50 and 500 mol/L was more toxic than (Cr+3). Zn at a concentration of 500 mol/L greatly decreased the cell viability, whereas Ni at the same concentration increased it. Pb produced fewer changes. Mn and Ni at a concentration of 500 mol/L induced the significant production of IL-6 and IL-8. However, most of the metals including (V+4, V+5), (Cr+3, Cr+6), Zn, and Pb inhibited the production of both IL-6 and IL-8. The present results indicate that various heavy metals have different effects on toxicity and the proinflammatory responses of airway epithelial cells, and those influences also depend on the oxidation states of the metals.	[Honda, Akiko; Tsuji, Kenshi; Matsuda, Yugo; Hayashi, Tomohiro; Fukushima, Wataru; Sawahara, Takahiro; Kudo, Hitomi; Murayama, Rumiko; Takano, Hirohisa] Kyoto Univ, Dept Environm Engn, Div Environm Hlth, Grad Sch Engn,Nishikyo Ku, Kyoto 6158540, Japan	Honda, A (reprint author), Kyoto Univ, Dept Environm Engn, Div Environm Hlth, Grad Sch Engn,C Cluster,Nishikyo Ku, Kyoto 6158540, Japan.	akko@health.env.kyoto-u.ac.jp			Japan Automobile Research Institute; Uehara Memorial Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was partly supported by Japan Automobile Research Institute and Uehara Memorial Foundation.	Veranth JM, 2006, ENVIRON HEALTH PERSP, V114, P341, DOI 10.1289/ehp.8360; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Pierce LM, 1996, TOXICOL APPL PHARM, V138, P1, DOI 10.1006/taap.1996.9999; Spokes LJ, 1995, AQUAT GEOCHEM, V1, P355; Carter JD, 1997, TOXICOL APPL PHARM, V146, P180, DOI 10.1006/taap.1997.8254; TAYLOR MJC, 1994, ANALYST, V119, P1263, DOI 10.1039/an9941901263; Cherian MG, 2000, CELL MOL BIOL, V46, P347; Salnikow K, 2004, TOXICOL APPL PHARM, V196, P258, DOI 10.1016/j.taap.2004.01.003; Samet JM, 1998, AM J PHYSIOL-LUNG C, V275, pL551; Bautista MV, 2009, J IMMUNOL, V183, P2159, DOI 10.4049/jimmunol.0803022; Patel MM, 2009, AM J RESP CRIT CARE, V180, P1107, DOI 10.1164/rccm.200901-0122OC; BeruBe K, 2010, ATLA-ALTERN LAB ANIM, V38, P49; LEVINE SJ, 1993, AM J PHYSIOL, V265, pL360; Jaspers I, 1999, J BIOL CHEM, V274, P31025, DOI 10.1074/jbc.274.43.31025; Kimbrough DE, 1999, CRIT REV ENV SCI TEC, V29, P1, DOI 10.1080/10643389991259164; Cachon BF, 2014, ENVIRON POLLUT, V185, P340, DOI 10.1016/j.envpol.2013.10.026; Honda A, 2014, J APPL TOXICOL, V34, P250, DOI 10.1002/jat.2871; Wichmann HE, 2007, INHAL TOXICOL, V19, P241, DOI 10.1080/08958370701498075; Lei YC, 2004, ENVIRON RES, V95, P71, DOI 10.1016/S0013-9351(03)00136-1; Kim YM, 2006, AM J PHYSIOL-LUNG C, V290, pL1028, DOI 10.1152/ajplung.00479.2005; Forti E, 2011, TOXICOL IN VITRO, V25, P454, DOI 10.1016/j.tiv.2010.11.013; Riley MR, 2003, TOXICOLOGY, V190, P171, DOI 10.1016/S0300-483X(03)00162-8; Fuentes-Mattei E, 2010, TOXICOL APPL PHARM, V243, P381, DOI 10.1016/j.taap.2009.12.009; Knaapen AM, 2002, MOL CELL BIOCHEM, V234, P317, DOI 10.1023/A:1015970023889; Huffman GP, 2000, J AIR WASTE MANAGE, V50, P1106; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P173; Adamson IYR, 1999, TOXICOL APPL PHARM, V157, P43, DOI 10.1006/taap.1999.8658; Alfaro-Moreno E, 2009, ENVIRON RES, V109, P528, DOI 10.1016/j.envres.2009.02.010; Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520; Wild Pascal, 2009, V472, P139, DOI 10.1007/978-1-60327-492-0_6; Pascal LE, 2004, TOXICOL LETT, V147, P143, DOI 10.1016/j.toxlet.2003.11.004; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Schmid M, 2007, ENVIRON INT, V33, P385, DOI 10.1016/j.envint.2006.12.003; Berube KA, 1999, ATMOS ENVIRON, V33, P1599, DOI 10.1016/S1352-2310(98)00384-7; Dorman DC, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-121; Egiebor E, 2013, INT J ENV RES PUB HE, V10, P5209, DOI 10.3390/ijerph10105209; Hirshon JM, 2008, ENVIRON HEALTH PERSP, V116, P826, DOI 10.1289/ehp.10759; Honda A, 2014, TOXICOL MECH METHOD, V24, P191, DOI 10.3109/15376516.2013.876136; KINNULA VL, 1994, AM J RESP CELL MOL, V11, P568; Lagorio Susanna, 2006, Environ Health, V5, P11, DOI 10.1186/1476-069X-5-11; Lighty JS, 2000, J AIR WASTE MANAGE, V50, P1565; Linak WP, 2000, P COMBUST INST, V28, P2651; Nemec AA, 2009, AM J RESP CELL MOL, V41, P69, DOI 10.1165/rcmb.2008-0409OC; O'Hara KA, 2007, BIOCHEM J, V402, P261, DOI 10.1042/BJ20061427; Okuda T, 2008, CHEMOSPHERE, V72, P917, DOI 10.1016/j.chemosphere.2008.03.033; SEIGNEUR C, 1995, ENVIRON SCI TECHNOL, V29, P222, DOI 10.1021/es00001a029; Thacker EL, 2006, VET RES, V37, P469, DOI 10.1051/vetres:2006011; Var F, 2000, ATMOS ENVIRON, V34, P2755, DOI 10.1016/S1352-2310(99)00353-2; Veranth JM, 2008, TOXICOL IN VITRO, V22, P498, DOI 10.1016/j.tiv.2007.10.011; Zhang L, 2013, HUM EXP TOXICOL, V32, P1155, DOI 10.1177/0960327112470272	50	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1091-5818	1092-874X		INT J TOXICOL	Int. J. Toxicol.	MAR-APR	2015	34	2					195	203		10.1177/1091581815575757		9	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CG7CA	WOS:000353458600007		
J	Nishiyama, Y; Kamiya, K; Matsumoto, T; Morimatsu, F				Nishiyama, Yasutaka; Kamiya, Kumiko; Matsumoto, Takashi; Morimatsu, Fumiki			The Validation of the NH Immunochromato O157 Test Kit	JOURNAL OF AOAC INTERNATIONAL			English	Article								NH Immunochromato O157 is an immunochromatographic test for detection of Escherichia coil O157:H7 and O157:NM in food. It enables simple and rapid testing for the target organism after 18-24 h enrichment. In inclusivity and exclusivity testing, all 50 O157:H7 strains and 15 O157:NM strains tested positive, while all 33 exclusivity strains yielded negative results. Taken together, all 98 strains tested in inclusivity/exclusivity testing were identified correctly. NH Immunochromato O157 method was compared to U.S. Department of Agriculture Food Safety and Inspection Service Microbiology Laboratory Guidebook, Chapter 5.08, reference method for detection of E. coli O157:H7 in 25 g of raw ground beef. The performance of both methods was revealed to be statistically equivalent. Autoclaved and non-autoclaved sample enrichments yielded the same results, showing sterilization is not mandatory for testing with NH Immunochromato O157. The results of the robustness study were not statistically different in all conditions, suggesting that NH Immunochromato produce reliable results under various conditions. However, the users are recommended to follow the instruction when applying sample to the test strip, because a smaller sample volume may produce invalid result.	[Nishiyama, Yasutaka; Kamiya, Kumiko; Matsumoto, Takashi; Morimatsu, Fumiki] NH Foods Ltd, R&D Ctr, Tsukuba, Ibaraki 3002646, Japan	Nishiyama, Y (reprint author), NH Foods Ltd, R&D Ctr, 3-3 Midorigahara, Tsukuba, Ibaraki 3002646, Japan.	ya.nishiyama@nipponham.co.jp					AOAC INTERNATIONAL Methods Committee Guidelines for Validation of Microbiological Methods for Food and Environmental Surfaces, 2012, AOAC INT METH COMM G, V19th; Hoemer R., 2011, J AOAC INT, V94, P1835; Least Cost Formulations Ltd, MPN CALC; U. S. Department of Agriculture Food Safety and Inspection Service, 2014, MICR LAB GUID	4	0	0	AOAC INT	GAITHERSBURG	481 N FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 USA	1060-3271	1944-7922		J AOAC INT	J. AOAC Int.	MAR-APR	2015	98	2					379	389		10.5740/jaoacint.14-255		11	Chemistry, Analytical; Food Science & Technology	Chemistry; Food Science & Technology	CG5EE	WOS:000353313100021		
J	Watanabe, E				Watanabe, Eiichi			Small therapeutic window of warfarin in Japanese population	Journal of Cardiology			English	Editorial Material						Warfarin; Stroke; Bleeding; Death	NONVALVULAR ATRIAL-FIBRILLATION; INTERNATIONAL NORMALIZED RATIO; J-RHYTHM REGISTRY; SECONDARY PREVENTION; STROKE PREVENTION; OPTIMAL INTENSITY; ANTICOAGULATION; ASSOCIATION; RISK		Fujita Hlth Univ, Sch Med, Dept Cardiol, Toyoake, Aichi 4701192, Japan	Watanabe, E (reprint author), Fujita Hlth Univ, Sch Med, Dept Cardiol, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	enwatan@fujita-hu.ac.jp					Atarashi H, 2011, CIRC J, V75, P1328, DOI 10.1253/circj.CJ-10-1119; Ay H, 2008, ANN NEUROL, V64, P499, DOI 10.1002/ana.21456; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Yamaguchi T, 2000, STROKE, V31, P817; Hannon N, 2011, STROKE, V42, P2503, DOI 10.1161/STROKEAHA.110.602235; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Oden A, 2002, BRIT MED J, V325, P1073, DOI 10.1136/bmj.325.7372.1073; ISO H, 1989, AM J EPIDEMIOL, V130, P925; Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Atarashi H, 2011, J CARDIOL, V57, P95, DOI 10.1016/j.jjcc.2010.09.002; Yasaka M, 2001, INTERNAL MED, V40, P1183, DOI 10.2169/internalmedicine.40.1183; Inoue H., 2013, CIRC J; Yamashita T, 2015, J CARDIOL, V65, P175, DOI 10.1016/j.jjcc.2014.07.013	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					171	172		10.1016/j.jjcc.2014.09.003		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700001		
J	Yamaguchi, T; Takahashi, N				Yamaguchi, Takanori; Takahashi, Naohiko			We should pay more attention to renal function before initiation of warfarin therapy	Journal of Cardiology			English	Editorial Material						Renal impairment; Warfarin; Genotype	ATRIAL-FIBRILLATION; MAJOR HEMORRHAGE; KIDNEY-FUNCTION; BLEEDING RISK; MANAGEMENT		[Yamaguchi, Takanori; Takahashi, Naohiko] Oita Univ, Fac Med, Dept Cardiol & Clin Examinat, Yufu, Oita 8795593, Japan	Yamaguchi, T (reprint author), Oita Univ, Fac Med, Dept Cardiol & Clin Examinat, Idaigaoka 1-1, Yufu, Oita 8795593, Japan.	takanoriyamaguch@oita-u.ac.jp					Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONHA.106.653048; Limdi NA, 2010, AM J KIDNEY DIS, V56, P823, DOI 10.1053/j.ajkd.2010.05.023; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Marinigh R, 2011, J AM COLL CARDIOL, V57, P1339, DOI 10.1016/j.jacc.2010.12.013; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Limdi NA, 2009, J AM SOC NEPHROL, V20, P912, DOI 10.1681/ASN.2008070802; DiMarco JP, 2005, AM HEART J, V149, P650, DOI 10.1016/j.ahj.2004.11.015; Reinecke H, 2009, J AM SOC NEPHROL, V20, P705, DOI 10.1681/ASN.2007111207; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Pichette V, 2003, CURR DRUG METAB, V4, P91, DOI 10.2174/1389200033489532; Palareti G, 2009, THROMB HAEMOSTASIS, V102, P268, DOI 10.1160/TH08-11-0730; Ichihara N, 2015, J CARDIOL, V65, P178, DOI 10.1016/j.jjcc.2014.08.008; McMahan DA, 1998, J GEN INTERN MED, V13, P311, DOI 10.1046/j.1525-1497.1998.00096.x; Rubboli A, 2011, WORLD J CARDIOL, V11, P351	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					173	174		10.1016/j.jjcc.2014.10.001		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700002		
J	Yamashita, T; Inoue, H; Okumura, K; Atarashi, H; Origasa, H				Yamashita, Takeshi; Inoue, Hiroshi; Okumura, Ken; Atarashi, Hirotsugu; Origasa, Hideki		J-RHYTHM Registry Investigators	Warfarin anticoagulation intensity in Japanese nonvalvular atrial fibrillation patients: A J-RHYTHM Registry analysis	Journal of Cardiology			English	Article						Atrial fibrillation; Warfarin; INR; Stroke; Intracranial hemorrhage	INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HEMORRHAGE; PREVENTION; STROKE; RISK; AF	Background: To maximize protection against stroke with minimal bleeding, warfarin therapy in nonvalvular atrial fibrillation (NVAF) requires tight control within a narrow therapeutic range, which might depend on racial variations. Methods: The J-RHYTHM Registry followed 6404 NVAF patients treated with warfarin for 2 years. Using international normalized ratios (INRs) at or closest to the embolic and intracranial hemorrhagic (ICH) events, we determined odds ratios for ischemic stroke/systemic embolism (SE) and ICH according to any given INR with a reference INR range including 2.0. Results: lschemic stroke and SE occurred in 97 of the patients and ICH occurred in 49. The estimated INR-risk relationships showed characteristics of Japanese NVAF patients. Compared to INR-risk relationships reported for Westerners, those observed in Japanese patients were virtually identical for ischemic stroke/SE and shifted leftward by approximately 0.5 INR for ICH. Conclusion: This is the largest Japanese study providing fundamental data necessary to establish optimal anticoagulation intensities. Japanese NVAF patients may require narrower therapeutic ranges than Westerners. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Yamashita, Takeshi] Cardiovasc Inst, Tokyo 1060031, Japan; [Inoue, Hiroshi] Toyama Univ, Sch Med, Dept Internal Med 2, Toyama 930, Japan; [Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol, Hirosaki, Aomori, Japan; [Atarashi, Hirotsugu] Tama Nagayama Hosp, Nippon Med Sch, Dept Cardiol, Tama, Japan; [Origasa, Hideki] Toyama Univ, Sch Med, Div Biostat & Clin Epidemiol, Toyama 930, Japan	Yamashita, T (reprint author), Cardiovasc Inst, Minato Ku, Nishi Azabu 3-2-19, Tokyo 1060031, Japan.	yamt-tky@umin.ac.jp			Japan Heart Foundation	This study was planned by the Japanese Society of Electro-cardiology and supported by a grant from the Japan Heart Foundation. We thank the Medi-Skette Corporation for data management and statistical advice.	Atarashi H, 2011, CIRC J, V75, P1328, DOI 10.1253/circj.CJ-10-1119; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; HYLEK EM, 1994, ANN INTERN MED, V120, P897; Akao M, 2013, J CARDIOL, V61, P260, DOI 10.1016/j.jjcc.2012.12.002; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; Naganuma M, 2012, THROMB RES, V130, P21, DOI 10.1016/j.thromres.2011.11.005; Atarashi H, 2011, J CARDIOL, V57, P95, DOI 10.1016/j.jjcc.2010.09.002; Yasaka M, 2001, INTERNAL MED, V40, P1183, DOI 10.2169/internalmedicine.40.1183; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802	11	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					175	177		10.1016/j.jjcc.2014.07.013		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700003		
J	Ichihara, N; Ishigami, T; Umemura, S				Ichihara, Naoaki; Ishigami, Tomoaki; Umemura, Satoshi			Effect of impaired renal function on the maintenance dose of warfarin in Japanese patients	Journal of Cardiology			English	Article						Renal impairment; Non-renal elimination; Dose-effect relationship; Warfarin	NONRHEUMATIC ATRIAL-FIBRILLATION; ORAL ANTICOAGULANT-THERAPY; BLEEDING COMPLICATIONS; HEMODIALYSIS-PATIENTS; POTENTIAL INTERACTION; CYTOCHROME P4502C9; VKORC1 GENOTYPES; DRUG-METABOLISM; CYP2C9 GENOTYPE; KIDNEY-FUNCTION	Background: Chronic kidney disease (CKD) alters dose-effect relationship not only of drugs eliminated by the kidney but also of some drugs metabolized by the liver and not renally excreted. It is not known whether impaired renal function alters dose-effect relationship of warfarin in Asian patients. It is also unknown whether the maintenance dose of warfarin can be predicted more accurately by incorporating renal function in Asians. Methods: This was a cross-sectional study of patients receiving constant doses of warfarin who had PT-INR within 1.5-3.0 for 3 months or longer. Results: In a total of 137 participants, the estimated creatinine clearance (eCrCI) was 62.5 +/- 25.5 [ml/ min] and the warfarin dose was 3.21 +/- 1.46 [mg/day] (both mean +/- standard deviation). There was a significant correlation between warfarin dose and eCrCI (p < 0.0001, r(2) = 0.23). In a stepwise linear regression with the maintenance dose of warfarin as the dependent variable, eCrCI as well as age, body weight, intra-individual average prothrombin time/international normalized ratio (PT-INR), and genotype of VKORC1 -1639 G>A polymorphism were chosen as independent variables. The coefficient of determination (r(2)) of this formula was 0.47. A regression equation with all the same explanatory variables except for eaCrCI had an r(2) of 0.41. Conclusions: The maintenance warfarin dose was positively correlated with kidney function as represented by eCrCI in Japanese patients. Incorporating eCrCI improved accuracy of predicting warfarin maintenance dose in this population. (C) 2014 Published by Elsevier Ltd on behalf of Japanese College of Cardiology.	[Ichihara, Naoaki] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA; [Ishigami, Tomoaki; Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan	Ichihara, N (reprint author), 20 Webster St Apt 401, Brookline, MA 02446 USA.	nai807@mail.harvard.edu			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [26461257]; Yokohama Foundation for Advancement of Medical Science	T.I. is supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) no. 26461257, and Yokohama Foundation for Advancement of Medical Science.	van Dijk KN, 2004, THROMB HAEMOSTASIS, V91, P95, DOI 10.1160/TH03-05-0325; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Kimura R, 2007, THROMB RES, V120, P181, DOI 10.1016/j.thromres.2006.09.007; Limdi NA, 2010, AM J KIDNEY DIS, V56, P823, DOI 10.1053/j.ajkd.2010.05.023; Palareti G, 2005, BRIT J HAEMATOL, V129, P72, DOI 10.1111/j.1365-2141.2005.05417.x; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; KOUDSTAAL PJ, 1995, NEW ENGL J MED, V333, P5; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; RETTIE AE, 1992, CHEM RES TOXICOL, V5, P54, DOI 10.1021/tx00025a009; White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239; Du Bois D, 1916, ARCH INTERN MED, V17, P863; Winkelmayer WC, 2011, CLIN J AM SOC NEPHRO, V6, P2662, DOI 10.2215/CJN.04550511; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Ohno M, 2009, EUR J CLIN PHARMACOL, V65, P1097, DOI 10.1007/s00228-009-0685-9; Visser LE, 2002, THROMB HAEMOSTASIS, V88, P705; Yoshizawa M, 2009, THROMB RES, V124, P161, DOI 10.1016/j.thromres.2008.11.011; Takahashi H, 2003, CLIN PHARMACOL THER, V73, P253, DOI 10.1067/mcp.2003.26; Dreisbach AW, 2008, EXPERT OPIN DRUG MET, V4, P1065, DOI [10.1517/17425255.4.8.1065 , 10.1517/17425250802273527]; Go AS, 2009, CIRCULATION, V119, P1363, DOI 10.1161/CIRCULATIONAHA.108.816082; [Anonymous], 2012, 2012 NAT HLTH NUTR S; Shen JI, 2012, CURR OPIN NEPHROL HY, V21, P600, DOI 10.1097/MNH.0b013e32835856fd; Limdi NA, 2009, J AM SOC NEPHROL, V20, P912, DOI 10.1681/ASN.2008070802; Sun H, 2006, PHARMACOL THERAPEUT, V109, P1, DOI 10.1016/j.pharmthera.2005.05.010; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Nolin TD, 2008, CLIN PHARMACOL THER, V83, P898, DOI 10.1038/clpt.2008.59; [Anonymous], WARF TABL 0 5 MG 1 M; Washington C, 2007, J CLIN PHARMACOL, V47, P1320, DOI 10.1177/0091270007305504; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Teichert M, 2011, BRIT J HAEMATOL, V153, P379, DOI 10.1111/j.1365-2141.2011.08633.x; Canadian Agency for Drugs and Technologies in Health, 2013, ANT AG PREV STROK SY; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Dreisbach AW, 2003, CLIN PHARMACOL THER, V73, P475, DOI 10.1016/S0009-9236(03)00015-8; FORFAR JC, 1982, AM HEART J, V103, P445, DOI 10.1016/0002-8703(82)90292-7; Friberg L., 2014, EUR HEART J, P983; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Inoue H, 2013, GUIDELINES PHARMACOT; Inoue T, 2009, DRUG METAB PHARMACOK, V24, P153; January CT, 2014, J AM COLL CARDIOL; KDIGO Workgroup, 2013, KIDNEY INT, V3; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Klein TE, 2009, NEW ENGL J MED, V360, P753; Knijff-Dutmer EAJ, 2003, QJM-INT J MED, V96, P513, DOI 10.1093/qjmed/hcg090; LEWIS RJ, 1970, J CLIN INVEST, V49, P907, DOI 10.1172/JCI106310; Lo DS, 2006, THROMB RES, V118, P385, DOI 10.1016/j.thromres.2005.03.031; Miyagata Y, 2011, INT HEART J, V52, P44, DOI 10.1536/ihj.52.44; Momper JD, 2010, ADV CHRONIC KIDNEY D, V17, P384, DOI 10.1053/j.ackd.2010.05.009; Mushiroda T, 2006, J HUM GENET, V51, P249, DOI 10.1007/s10038-005-0354-5; Obayashi K, 2006, CLIN PHARMACOL THER, V80, P169, DOI 10.1016/j.clpt.2006.04.010; Orfila GM, 2009, PHARM WORLD SCI, V31, P224, DOI 10.1007/s11096-008-9265-9; PETERSEN P, 1989, LANCET, V1, P175; Schaefer MG, 2003, AM J HEALTH-SYST PH, V60, P1319; Ufer M, 2004, J CHROMATOGR B, V809, P217, DOI 10.1016/j.jchromb.2004.06.023; Wakasugi M, 2013, CLIN EXP NEPHROL, V18, P662; Wittkowsky AK, 2004, PHARMACOTHERAPY, V24, P1311, DOI 10.1592/phco.24.14.1311.43144; Yang F, 2010, EUROPACE, V12, P1666, DOI 10.1093/europace/euq387	58	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					178	184		10.1016/j.jjcc.2014.08.008		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700004		
J	Nakano, Y; Condo, T; Osanai, H; Murase, Y; Nakashima, Y; Asano, H; Ajioka, M; Sakai, K; Inden, Y; Murohara, T				Nakano, Yoshihisa; Condo, Takahisa; Osanai, Hiroyuki; Murase, Yosuke; Nakashima, Yoshihito; Asano, Hiroshi; Ajioka, Masayoshi; Sakai, Kazuyoshi; Inden, Yasuya; Murohara, Toyoaki			Clinical usefulness of measuring prothrombin time and soluble fibrin levels in Japanese patients with atrial fibrillation receiving rivaroxaban	Journal of Cardiology			English	Article						Anticoagulant; Atrial fibrillation; Coagulation function; Rivaroxaban; Stroke prevention	INTERNATIONAL NORMALIZED RATIO; FACTOR XA INHIBITOR; COAGULATION ASSAYS; WARFARIN; STROKE; PREVENTION; REGISTRY; THERAPY; AF	Background: Rivaroxaban is currently used to prevent stroke in patients with atrial fibrillation. Measuring coagulation function may help clinicians to understand the effects of this drug and the associated risk of bleeding. Methods and results: Rivaroxaban was given to 136 patients with non-valvular atrial fibrillation. Mean age was 74.5 +/- 9.0 years (men: 63.2%) and mean CHADS(2) score (+/- SD) was 1.8 +/- 1.2. Prothrombin times (PTs) and plasma soluble fibrin (SF) levels were examined in 84 out of 136 patients at baseline and at least 2 weeks thereafter. In 48 patients we were able to collect blood at exact times, namely just before and 3 h after rivaroxaban administration, corresponding to the trough and peak concentrations. Mean peak PT in 48 patients was 17.1 +/- 3.6 s and median peak SF level was 1.46 mu g/mL. Multiple regression analysis showed that female sex, high brain natriuretic peptide, and high dose were independent factors prolonging the peak PT. Patients with peak PTs >= 20 s experienced significantly more bleeding events. Among 29 of 46 patients newly treated with rivaroxaban without any previous anticoagulant, we examined coagulation function at the exact trough and peak times. In 29 patients, peak PT was significantly more prolonged than the baseline or trough PT (p < 0.001 for both), whereas trough PT was comparable to the baseline PT. In contrast, both trough and peak SF levels in these newly treated patients were significantly reduced than at baseline (p = 0.003 and p < 0.001, respectively). Conclusions: In Japanese patients with non-valvular atrial fibrillation receiving rivaroxaban, a prolonged peak PT (>= 20 s) could indicate increased risk of bleeding, and both trough and peak SF levels were reduced relative to baseline. PT and SF are both valuable measures of coagulation status in patients receiving rivaroxaban, regardless of prior anticoagulant history. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Nakano, Yoshihisa; Inden, Yasuya; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668560, Japan; [Condo, Takahisa] Nagoya Univ, Grad Sch Med, Dept Adv Med Cardiopulm Dis, Nagoya, Aichi 4668560, Japan; [Osanai, Hiroyuki; Murase, Yosuke; Nakashima, Yoshihito; Asano, Hiroshi; Ajioka, Masayoshi; Sakai, Kazuyoshi] Tosei Gen Hosp, Dept Cardiovasc Med, Aichi, Japan	Condo, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Adv Med Cardiopulm Dis, Shouwa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668560, Japan.	takahisa@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		Bayer Yakuhin Ltd.; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer	Hiroyuki Osanai, Masayoshi Ajioka, Yasuya lnden, and Toyoaki Murohara have received lecture fees from Bayer Yakuhin Ltd., Boehringer Ingelheim, Bristol-Myers Squibb, and Pfizer.	Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Samama MM, 2010, THROMB HAEMOSTASIS, V103, P815, DOI 10.1160/TH09-03-0176; Fox KAA, 2011, EUR HEART J, V32, P2387, DOI 10.1093/eurheartj/ehr342; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Lindhoff-Last E, 2010, THER DRUG MONIT, V32, P673, DOI 10.1097/FTD.0b013e3181f2f264; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Hillarp A, 2011, J THROMB HAEMOST, V9, P133, DOI 10.1111/j.1538-7836.2010.04098.x; KOUDSTAAL PJ, 1995, NEW ENGL J MED, V333, P5; Ohsawa M, 2005, J EPIDEMIOL, V15, P194, DOI 10.2188/jea.15.194; Akao M, 2013, J CARDIOL, V61, P260, DOI 10.1016/j.jjcc.2012.12.002; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; WOLF PA, 1991, STROKE, V22, P983; Yasaka M, 2001, INTERNAL MED, V40, P1183, DOI 10.2169/internalmedicine.40.1183; Dempfle CE, 1999, THROMB HAEMOSTASIS, V82, P673; Ogawa S, 2010, CIRC J, V74, P2479, DOI 10.1253/circj.CJ-88-0001; Molenaar PJ, 2012, CLIN CHEM LAB MED, V50, P1799, DOI 10.1515/cclm-2012-0055; Sudo A, 2009, INT J HEMATOL, V89, P572, DOI 10.1007/s12185-009-0323-4; Suzuki S, 2014, CIRC J, V78, P763, DOI 10.1253/circj.CJ-13-1380; Tanigawa T, 2013, DRUG METAB PHARMACOK, V28, P59, DOI 10.2133/dmpk.DMPK-12-RG-034; Tsuji A, 2008, INT J HEMATOL, V88, P448, DOI 10.1007/s12185-008-0173-5	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					185	190		10.1016/j.jjcc.2014.07.021		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700005		
J	Tajiri, K; Sato, A; Harunari, T; Shimojo, N; Yamaguchi, I; Aonuma, K				Tajiri, Kazuko; Sato, Akira; Harunari, Tomohiko; Shimojo, Nobutake; Yamaguchi, Iwao; Aonuma, Kazutaka			Impact of rivaroxaban compared with warfarin on the coagulation status in Japanese patients with non-valvular atrial fibrillation: A preliminary analysis of the prothrombin fragment 1+2 levels	Journal of Cardiology			English	Article						Rivaroxaban; Atrial fibrillation; Anticoagulants; Warfarin; Coagulation	ORAL ANTICOAGULANT-THERAPY; D-DIMER LEVELS; J-ROCKET AF; ACTIVATION; EVENTS; PLASMA; REGISTRY; PEPTIDE; BLOOD	Background: Rivaroxaban is an oral anticoagulant that effectively prevents thromboembolic complications using fixed doses without requiring laboratory monitoring. In this study, we aimed to examine the coagulation status in patients with non-valvular atrial fibrillation (NVAF) treated with rivaroxaban compared with warfarin. Methods and results: The study group consisted of 85 consecutive Japanese patients with NVAF who received rivaroxaban (n = 33) or warfarin (n = 52) from June 2013 to February 2014. We compared the coagulation status between the rivaroxaban and warfarin treatments. The prothrombin time (PT) values did not significantly differ between the two groups. However, the prothrombin fragment 1 + 2 (F1 + 2) level, a marker of thrombin generation, was significantly higher in the rivaroxaban group than the warfarin group (202 +/- 88 pmol/l vs. 114 +/- 79 pmol/l, p < 0.001). Next, we collected blood samples from 18 patients taking rivaroxaban at 3 h and 15 h after the drug intake and evaluated the time-dependent changes in the coagulation status. The PT values at 3 h after the drug intake were significantly more prolonged than those at 15 h (p < 0.001). However, there were no significant differences in the F1 + 2 levels between the two time points (194 +/- 73 pmol/l [at 3 h] vs. 165 +/- 61 pmol/l [at 15 h], p = 0.112). Conclusions: Our preliminary results suggest that the thrombin generation level is stable regardless of the time elapsed after rivaroxaban intake, and warfarin treatment may inhibit thrombin generation more aggressively than rivaroxaban. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Tajiri, Kazuko; Sato, Akira; Harunari, Tomohiko; Shimojo, Nobutake; Aonuma, Kazutaka] Univ Tsukuba, Fac Med, Div Cardiovasc, Tsukuba, Ibaraki 3058575, Japan; [Tajiri, Kazuko; Harunari, Tomohiko; Shimojo, Nobutake; Yamaguchi, Iwao] Sumiyoshi Clin Hosp, Mito, Ibaraki, Japan; [Yamaguchi, Iwao] Ibaraki Hlth Serv Assoc Inst, Mito, Ibaraki, Japan	Tajiri, K (reprint author), Univ Tsukuba, Fac Med, Div Cardiovasc, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	ktajiri@md.tsukuba.ac.jp					Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Karkouti K, 2010, ANESTH ANALG, V110, P1533, DOI 10.1213/ANE.0b013e3181db7991; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Yeh CH, 2012, CIRC RES, V111, P1069, DOI 10.1161/CIRCRESAHA.112.276741; ARONSON DL, 1977, J CLIN INVEST, V60, P1410, DOI 10.1172/JCI108902; Francart SJ, 2014, THROMB HAEMOSTASIS, V111, P1133, DOI 10.1160/TH13-10-0871; Nozawa T, 2006, INT J CARDIOL, V109, P59, DOI 10.1016/j.ijcard.2005.05.049; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI 10.1093/eurheartj/ehq278; [Anonymous], 2010, CIRC J, V74, P2479; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; Garcia D, 2010, BLOOD, V115, P15, DOI 10.1182/blood-2009-09-241851; Vene N, 2003, THROMB HAEMOSTASIS, V90, P1163, DOI 10.1160/TH03-06-0363; Naruse Y, 2013, CIRC-CARDIOVASC INTE, V6, P444, DOI 10.1161/CIRCINTERVENTIONS.113.000179; Nakatani Y, 2012, CIRC J, V76, P317, DOI 10.1253/circj.CJ-11-0885; Yasaka M, 2012, CIRC J, V76, P2086, DOI 10.1253/circj.CJ-12-0923; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; LIP GYH, 1995, BRIT HEART J, V73, P527; Mahe I, 2002, THROMB RES, V107, P1, DOI 10.1016/S0049-3848(02)00184-6; PELZER H, 1991, THROMB HAEMOSTASIS, V65, P153; Sadanaga Tsuneaki, 2010, J Am Coll Cardiol, V55, P2225, DOI 10.1016/j.jacc.2009.12.049; Suzuki S, 2014, CIRC J, V78, P763, DOI 10.1253/circj.CJ-13-1380; Tagawa ST, 2008, BJU INT, V102, P1086, DOI 10.1111/j.1464-410X.2008.07780.x	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					191	196		10.1016/j.jjcc.2014.08.006		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700006		
J	Kawai, H; Watanabe, E; Yamamoto, M; Harigaya, H; Sano, K; Takatsu, H; Muramatsu, T; Naruse, H; Sobue, Y; Motoyama, S; Sarai, M; Takahashi, H; Arakawa, T; Kan, S; Sugiura, A; Murohara, T; Ozaki, Y				Kawai, Hideki; Watanabe, Eiichi; Yamamoto, Mayumi; Harigaya, Hiroto; Sano, Kan; Takatsu, Hidemaro; Muramatsu, Takashi; Naruse, Hiroyuki; Sobue, Yoshihiro; Motoyama, Sadako; Sarai, Masayoshi; Takahashi, Hiroshi; Arakawa, Tomoharu; Kan, Shino; Sugiura, Atsushi; Murohara, Toyoaki; Ozaki, Yukio			Major bleeding complications related to combined antithrombotic therapy in atrial fibrillation patients 12 months after coronary artery stenting	Journal of Cardiology			English	Article						Antithrombotic therapy; Atrial fibrillation; Coronary artery stent	ANTIPLATELET THERAPY; ORAL ANTICOAGULANT; STROKE; RISK; INTERVENTION; GUIDELINES; THROMBOSIS; IMPLANTATION; PROGNOSIS; DISEASE	Background and purpose: Many patients with atrial fibrillation (AF) and coronary artery stent deployment are given both antiplatelet drug and warfarin. Little information is available as to the relationship between the antithrombotic therapies in the late phase after stenting and the clinical outcomes of these patients. We examined the clinical outcomes of AF patients 12 months after coronary artery stenting. Methods: We retrospectively examined 146 patients and classified them into three groups according to the antithrombotic therapies [dual antiplatelet therapy (DAPT), single antiplatelet therapy (SAPT) plus warfarin, and DAPT plus warfarin] 12 months after stenting. We defined the primary endpoint as Thrombolysis in Myocardial Infarction major bleeding and the secondary endpoint as a composite of adverse events (CAE: all-cause death, nonfatal myocardial infarction, intracranial bleeding, and cerebral infarction). Results: During a median follow-up of 37 months, major bleeding and CAE were observed in 14(9.6%) and 46 (31.5%) patients, respectively. DAPT plus warfarin was an independent risk factor for major bleeding in a multivariate Cox hazard regression model after adjustment for age, gender, and the type of AF (hazard ratio: 4.20; 95% confidence interval: 1.13-17.27; p = 0.033). No significant clinical variables were found for CAE. Conclusions: Prolonged use of DAPT with warfarin significantly increases the risk of major bleeding in AF patients after coronary artery stenting. Individualized antithrombotic treatment is required in these patients to prevent major bleeding. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Kawai, Hideki; Watanabe, Eiichi; Yamamoto, Mayumi; Muramatsu, Takashi; Naruse, Hiroyuki; Sobue, Yoshihiro; Motoyama, Sadako; Sarai, Masayoshi; Ozaki, Yukio] Fujita Hlth Univ, Dept Cardiol, Toyoake, Aichi, Japan; [Harigaya, Hiroto; Kan, Shino] Nagoya Mem Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Sano, Kan; Sugiura, Atsushi] Hekinan Municipal Hosp, Dept Cardiol, Hekinan, Japan; [Takatsu, Hidemaro; Arakawa, Tomoharu] Daido Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Takahashi, Hiroshi] Fujita Hlth Univ, Dept Med Stat, Toyoake, Aichi, Japan; [Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan	Kawai, H (reprint author), 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	hkawai@fujita-hu.ac.jp	Murohara, Toyoaki/M-4958-2014				Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Hart RG, 2007, ANN INTERN MED, V146, P857; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Toyoda K, 2008, STROKE, V39, P1740, DOI 10.1161/STROKEAHA.107.504993; Fauchier L, 2012, AM J CARDIOL, V110, P7, DOI 10.1016/j.amjcard.2012.02.042; TANAKA H, 1981, STROKE, V12, P460; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI 10.1093/eurheartj/ehq278; Hohnloser SH, 2007, J AM COLL CARDIOL, V50, P2156, DOI 10.1016/j.jacc.2007.07.076; Benjamin EJ, 1998, CIRCULATION, V98, P946; Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311; Lamberts M, 2014, CIRCULATION, V129, P1577, DOI 10.1161/CIRCULATIONAHA.113.004834; Levey AS, 1999, ANN INTERN MED, V130, P461; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Vardi M, 2014, CLIN CARDIOL, V37, P103, DOI 10.1002/clc.22226; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Ruiz-Nodar JM, 2008, J AM COLL CARDIOL, V51, P818, DOI 10.1016/j.jacc.2007.11.035; Kiyohara Y, 2003, STROKE, V34, P2343, DOI 10.1161/01.STR.0000091845.14833.43; CHESEBRO JH, 1987, CIRCULATION, V76, P142; Goto Koji, 2014, Am J Cardiol, V114, P70, DOI 10.1016/j.amjcard.2014.03.060; Guyatt GH, 2012, CHEST, V141, p53S, DOI 10.1378/chest.11-2288; Manzano-Fernandez S, 2008, CHEST, V134, P559, DOI 10.1378/chest.08-0350; O'Connor RE, 2010, CIRCULATION, V122, pS787, DOI 10.1161/CIRCULATIONAHA.110.971028; Rapezzi C, 2008, EUR HEART J, V29, P277, DOI 10.1093/eurheartj/ehm498; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					197	202		10.1016/j.jjcc.2014.08.013		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700007		
J	Okada, M; Nakashima, Y; Nomura, T; Miura, T; Nao, T; Yoshimura, M; Sano, Y; Matsunaga, N				Okada, Munemasa; Nakashima, Yoshiteru; Nomura, Takafumi; Miura, Toshiro; Nao, Tomoko; Yoshimura, Masayuki; Sano, Yuichi; Matsunaga, Naofumi			Coronary vasodilation by the use of sublingual nitroglycerin using 64-slice dual-source coronary computed tomography angiography	Journal of Cardiology			English	Article						Coronary computed tomography angiography; Nitroglycerin; Coronary vasodilation	LONG-ACTING NITRATES; INTRACORONARY ULTRASOUND; DIAGNOSTIC-ACCURACY; ARTERY-DISEASE; CT ANGIOGRAPHY; HEART-RATE; RESPONSES	Background: Sublingual nitroglycerin capsules or spray is routinely used to treat anginal attacks and to maximally dilate the epicardial coronary arteries during coronary angiography. These dilated coronary vessels have an advantage, but increased heart rates were disadvantageous for coronary computed tomography angiography (CTA). Purpose: The influence of applying nitroglycerin was analyzed regarding the coronary diameter, coronary luminal attenuation, evaluable number of coronary segments, heart rate (HR), HR variability, the optimal reconstruction phase, and image scoring of CTA in the same patients using a 64-slice dualsource CT. Methods and subjects: Fifty-two patients with atypical chest pain underwent coronary CTA before and after the administration of sublingual nitroglycerin without heart rate control. The coronary diameter and luminal attenuation were measured on short-axial images in each coronary segment. The coronary vasodilation ratios (VRs) were calculated from the coronary diameters at the same location before and after the use of nitroglycerin. The local institutional review board approved this study and written informed consent was obtained from all the patients. Results: No significant differences were noted in the HR variability or optimal reconstruction phase, despite an increase in HR after the use of nitroglycerin. Nitroglycerin significantly enlarged the coronary artery diameter, and VRs of each coronary segment ranged from 7.54% to 22.26%. As compared with baseline coronary diameter, VRs of minor segments (16.91%) were significantly larger than those of major segments (11.35%), and the magnitude of VR correlated with the baseline coronary diameter (r = -0.48, p < 0.001). Coronary luminal attenuation significantly increased due to additional administration of contrast material after the use of nitroglycerin (p < 0.01), but no significant difference was noted in the image quality after the use of nitroglycerin. Conclusion: Sublingual nitroglycerin significantly enlarged the coronary diameters, especially in peripheral small coronary arteries, and increased the evaluable number of coronary segments on coronary CTA. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Okada, Munemasa; Nomura, Takafumi; Matsunaga, Naofumi] Yamaguchi Univ, Grad Sch Med, Dept Radiol, Yamaguchi, Japan; [Nakashima, Yoshiteru] Yamaguchi Grand Hosp, Dept Radiol, Yamaguchi, Japan; [Miura, Toshiro] Tokuyama Cent Hosp, Dept Cardiol, Yamaguchi, Japan; [Nao, Tomoko; Yoshimura, Masayuki] Yamaguchi Univ, Grad Sch Med, Dept Cardiol, Yamaguchi, Japan; [Sano, Yuichi] Yamaguchi Univ, Dept Radiol, Yamaguchi, Japan	Okada, M (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Radiol, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	radokada@yamaguchi-u.ac.jp					Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004; ABRAMS J, 1980, NEW ENGL J MED, V302, P1234, DOI 10.1056/NEJM198005293022205; ABRAMS J, 1985, AM HEART J, V110, P216; Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218; Pfister M, 1998, HEART, V80, P365; Schoepf UJ, 2004, RADIOLOGY, V232, P18, DOI 10.1148/radiol.2321030636; Hollenberg SM, 1999, CATHETER CARDIO INTE, V46, P282, DOI 10.1002/(SICI)1522-726X(199903)46:3<282::AID-CCD5>3.0.CO;2-9; Vavuranakis M, 1999, J AM COLL CARDIOL, V34, P1075, DOI 10.1016/S0735-1097(99)00331-9; Decramer I, 2008, AM J ROENTGENOL, V190, P219, DOI 10.2214/AJR.07.2648; Chun EJ, 2008, J COMPUT ASSIST TOMO, V32, P86, DOI 10.1097/rct.0b013e318059befa; Thadani U, 2006, EXPERT OPIN DRUG SAF, V5, P667, DOI 10.1517/14740338.5.5.667; Achenbach S, 2006, J AM COLL CARDIOL, V48, P1919, DOI 10.1016/j.jacc.2006.08.012; ELIASZIW M, 1994, PHYS THER, V74, P777; Schachinger V, 2000, CIRCULATION, V101, P1899; Austen W G, 1975, Circulation, V51, P5; BROWN BG, 1981, CIRCULATION, V64, P1089; COHEN MV, 1973, CIRC RES, V33, P445; FELDMAN RL, 1982, CIRCULATION, V66, P321; Gerber TC, 2006, SEMIN ULTRASOUND CT, V27, P42, DOI 10.1053/j.sult.2005.11.005; Harnon M., 2006, J AM COLL CARDIOL, V48, P1896; Leschka S, 2008, AM J ROENTGENOL, V190, P1583, DOI 10.2214/AJR.07.2000; McCollough C, 2008, 96 AAPM; PINTO FJ, 1992, CIRCULATION, V85, P69; Tearashima M., 2005, J AM COLL CARDIOL, V45, P104; Weustink AC, 2008, RADIOLOGY, V248, P792, DOI 10.1148/radiol.2483072098; Weustink AC, 2007, J AM COLL CARDIOL, V50, P786, DOI 10.1016/j.jacc.2007.04.068	26	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					230	236		10.1016/j.jjcc.2014.05.012		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700012		
J	Ishikawa, J; Ishikawa, S; Kario, K				Ishikawa, Joji; Ishikawa, Shizukiyo; Kario, Kazuomi		JMS Cohort Study Investigator Grp	Relationships between the QTc interval and cardiovascular, stroke, or sudden cardiac mortality in the general Japanese population	Journal of Cardiology			English	Article						QTc interval; Cardiovascular death; Sudden cardiac death; Stroke; Myocardial infarction	CORONARY-HEART-DISEASE; PROGNOSTIC-SIGNIFICANCE; HEALTHY-PERSONS; RISK-FACTOR; ALL-CAUSE; PROLONGATION; DEATH; HYPERTENSION; PREVALENCE; DURATION	Background: We attempted to evaluate whether the relationship between the QTc interval and mortality (including sudden cardiac death) is linear or J-shaped in the general Japanese population, who tend to be at greater risk of strokes than cardiac events. Methods: we classified 10,804 subjects according to their Bazett QTc interval quartiles (determined by electrocardiography) at the baseline and followed them up for a mean period of 141.9 +/- 28.3 months (127,712 person-years). Results: In total, 878 subjects died during the study period. including 104 from cardiovascular events, 100 from stroke, and 46 from sudden cardiac death. In a Cox proportional hazards regression model adjusted for conventional cardiovascular risk factors, the risk of cardiovascular mortality increased progressively with the QTc interval quartile [Q2, hazard ratio (HR) = 0.94 (0.43-2.03); Q3, HR = 1.11 (0.53-2.34); Q4, HR = 2.21 (1.12-4.36); HR are vs. Q1]. A parallel analysis found that the risk of stroke mortality was marginally increased in the highest Bazett QTc interval quartile [HR = 1.93 (0.97-3.85)]. On the other hand, the risk of sudden cardiac death exhibited a J-shaped relationship with the Bazett QTc interval quartile [Q1, HR = 8.58(1.07-69.05); Q3, HR = 7.17(0.88-58.73); Q4, HR 13.18(1.72-101.03); HR are vs. Q2]. Conclusion: In the general Japanese population, cardiovascular and stroke mortality increase progressively with the Bazett QTc interval quartile, while the risk of sudden cardiac death exhibits a j-shaped relationship with the latter variable. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Ishikawa, Joji; Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi 3290498, Japan; [Ishikawa, Shizukiyo] Jichi Med Univ, Ctr Community Med, Div Community & Family Med, Shimotsuke, Tochigi 3290498, Japan	Ishikawa, J (reprint author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	george@jichi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Foundation for the Development of the Community, Tochigi, Japan	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan and grants from the Foundation for the Development of the Community, Tochigi, Japan.	Al-Khatib SM, 2003, JAMA-J AM MED ASSOC, V289, P2120, DOI 10.1001/jama.289.16.2120; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; Salles G, 2005, HYPERTENSION, V46, P1207, DOI 10.1161/01.HYP.0000185517.53179.43; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; Funada A, 2008, CLIN CARDIOL, V31, P270, DOI 10.1002/clc.20208; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516; Gallagher MM, 2006, AM J CARDIOL, V98, P933, DOI 10.1016/j.amjcard.2006.04.035; Anttonen O, 2007, CIRCULATION, V116, P714, DOI 10.1161/CIRCULATIONAHA.106.676551; Zhang YY, 2011, ARCH INTERN MED, V171, P1727, DOI 10.1001/archinternmed.2011.433; DEKKER JM, 1994, CIRCULATION, V90, P779; Gaita F, 2003, CIRCULATION, V108, P965, DOI 10.1161/01.CIR.0000085071.28695.C4; Soliman EZ, 2012, J AM COLL CARDIOL, V59, P1460, DOI 10.1016/j.jacc.2012.01.025; ALGRA A, 1991, CIRCULATION, V83, P1888; LEPESCHKIN E, 1952, CIRCULATION, V6, P378; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Gussak I, 2000, CARDIOLOGY, V94, P99, DOI 10.1159/000047299; GOLDBERG RJ, 1991, AM J CARDIOL, V67, P55, DOI 10.1016/0002-9149(91)90099-7; Ishikawa Shizukiyo, 2002, J Epidemiol, V12, P408; Ishikawa S, 2008, J EPIDEMIOL, V18, P144, DOI 10.2188/jea.JE2007438; Karjalainen J, 1997, HEART, V77, P543; Maebuchi D, 2010, HYPERTENS RES, V33, P916, DOI 10.1038/hr.2010.88; Maebuchi D, 2008, HYPERTENS RES, V31, P1339, DOI 10.1291/hypres.31.1339; Moriya M, 2007, PACE, V30, P1522; Okin PM, 2000, CIRCULATION, V101, P61; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Schillaci G, 2006, ARCH INTERN MED, V166, P909, DOI 10.1001/archinte.166.8.909	27	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					237	242		10.1016/j.jjcc.2015.05.008		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700013		
J	Matsushita, K; Muramatsu, T; Kondo, T; Maeda, K; Shintani, S; Murohara, T				Matsushita, Kunihiro; Muramatsu, Takashi; Kondo, Takahisa; Maeda, Kengo; Shintani, Satoshi; Murohara, Toyoaki		NAGOYA HEART Study Grp	Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance (vol 56, pg 111, 2010)	Journal of Cardiology			English	Correction									[Matsushita, Kunihiro; Muramatsu, Takashi; Kondo, Takahisa; Maeda, Kengo; Shintani, Satoshi; Murohara, Toyoaki; NAGOYA HEART Study Grp] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan	Murohara, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	murohara@med.nagoya-u.ac.jp					Matsushita K, 2010, J CARDIOL, V56, P111, DOI 10.1016/j.jjcc.2010.03.004	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					259	259		10.1016/j.jjcc.2015.01.001		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700018		
J	Iwakura, K				Iwakura, Katsuomi			Stress hyperglycemia and microvascular obstruction after acute myocardial infarction	Journal of Cardiology			English	Editorial Material						Hyperglycemia; Microvascular dysfunction; Cardiac magnetic resonance imaging	NO-REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; GLUCOSE; MORTALITY; RISK; ERA		Sakurabashi Watanabe Hosp, Div Cardiol, Kita Ku, Osaka 5300001, Japan	Iwakura, K (reprint author), Sakurabashi Watanabe Hosp, Div Cardiol, Kita Ku, 2-4-32 Umeda, Osaka 5300001, Japan.	iwakura@mac.com					Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Ndrepepa G, 2010, J AM COLL CARDIOL, V55, P2383, DOI 10.1016/j.jacc.2009.12.054; Iwakura K, 2003, J AM COLL CARDIOL, V41, P1, DOI 10.1016/S0735-1097(02)02626-8; Ito H, 2006, NAT CLIN PRACT CARD, V3, P499, DOI 10.1038/ncpcardio0632; Wahab NN, 2002, J AM COLL CARDIOL, V40, P1748, DOI 10.1016/S0735-1097(02)02483-X; OSWALD GA, 1984, LANCET, V1, P1264; Ceriello A, 2005, EUR HEART J, V26, P328, DOI 10.1093/eurheartj/ehi049; Marfella R, 2003, DIABETES CARE, V26, P3129, DOI 10.2337/diacare.26.11.3129; Timmer JR, 2011, CIRCULATION, V124, P704, DOI 10.1161/CIRCULATIONAHA.110.985911; Ishihara M, 2005, AM HEART J, V150, P814, DOI 10.1016/j.ahj.2004.12.020; Norhammar A, 2002, LANCET, V359, P2140, DOI 10.1016/S0140-6736(02)09089-X; Ota S, 2015, J CARDIOL, V65, P272, DOI 10.1016/j.jjcc.2014.10.013; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					270	271		10.1016/j.jjcc.2014.11.012		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700020		
J	Ota, S; Tanimoto, T; Orii, M; Hirata, K; Shiono, Y; Shimamura, K; Matsuo, Y; Yamano, T; Ino, Y; Kitabata, H; Yamaguchi, T; Kubo, T; Tanaka, A; Imanishi, T; Akasaka, T				Ota, Shingo; Tanimoto, Takashi; Orii, Makoto; Hirata, Kumiko; Shiono, Yasutsugu; Shimamura, Kunihiro; Matsuo, Yoshiki; Yamano, Takashi; Ino, Yasushi; Kitabata, Hironori; Yamaguchi, Tomoyuki; Kubo, Takashi; Tanaka, Atsushi; Imanishi, Toshio; Akasaka, Takashi			Association between hyperglycemia at admission and microvascular obstruction in patients with ST-segment elevation myocardial infarction	Journal of Cardiology			English	Article						Hyperglycemia at admission; Cardiovascular magnetic resonance imaging; Microvascular obstruction	PERCUTANEOUS CORONARY INTERVENTION; NO-REFLOW PHENOMENON; STRESS HYPERGLYCEMIA; CONTRAST ENHANCEMENT; REPERFUSION; IMPACT; TRIAL; ANGIOPLASTY; PREDICTOR; MORTALITY	Background: Blood glucose level at admission in ST-segment elevation myocardial infarction (STEMI) is a predictor of heart failure and mortality. A previous study showed the association between hyperglycemia and microvascular dysfunction using myocardial contrast echocardiography. Late gadolinium enhancement (LGE) cardiovascular magnetic resonance imaging (CMR) can demonstrate microvascular obstruction (MVO) as the area with hypointense core within LGE. This study was performed to investigate the association between hyperglycemia at admission and MVO using CMR in patients with STEMI. Methods: Ninety-three patients with first STEMI who were treated by percutaneous coronary intervention (PCI) were included. CMR was performed within 7 days after PCI. Venous blood was collected routinely immediately after admission for plasma glucose determination before intravenous injection of some medications. Samples were analyzed in the hospital's central laboratory. We performed LGE-CMR to assess the presence of MVO. Results: MVO was found in 34(37%) of all 93 patients; their glucose level at admission was significantly higher than that of patients who did not exhibit MVO [204 (153-267) mg/dl vs. 157 (127-200) mg/dl. p = 0.002]. There were no differences in glycosylated hemoglobin and incidence of diabetes mellitus between the two groups. A multivariable logistic regression analysis showed that glucose level at admission was an independent predictor of MVO (odds ratio, 1.014; 95% confidence interval, 1.004 to 1.023; p = 0.006). The glucose level at admission 190 mg/di was the best threshold value for identifying MVO. The occurrence of MVO was significantly higher in the patients with glucose level at admission 190 mg/dl compared with the patients with glucose level <190 mg/dl (18(53%) vs. 16(27%). p = 0.0231. Conclusions: Hyperglycemia at admission in STEMI patients who were treated by PCI was associated with the presence of MVO assessed by LGE-CMR. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Ota, Shingo; Tanimoto, Takashi; Orii, Makoto; Hirata, Kumiko; Shiono, Yasutsugu; Shimamura, Kunihiro; Matsuo, Yoshiki; Yamano, Takashi; Ino, Yasushi; Kitabata, Hironori; Yamaguchi, Tomoyuki; Kubo, Takashi; Tanaka, Atsushi; Imanishi, Toshio; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418510, Japan	Ota, S (reprint author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418510, Japan.	wakayama_hirosaki@yahoo.co.jp					Bondarenko O, 2005, J CARDIOV MAGN RESON, V7, P481, DOI 10.1081/JCMR-200053623; ITO H, 1992, CIRCULATION, V85, P1699; Kaltoft A, 2006, CIRCULATION, V114, P40, DOI 10.1161/CIRCULATIONAHA.105.595660; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Booth G, 2001, AM J PHYSIOL-ENDOC M, V280, pE848; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; OSWALD GA, 1987, DIABETIC MED, V4, P68; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Burzotta F, 2005, J AM COLL CARDIOL, V46, P371, DOI 10.1016/j.jacc.2005.04.057; LOTAN CS, 1992, CIRCULATION, V86, P1018; Marfella R, 2000, CIRCULATION, V101, P2247; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; Iwakura K, 2003, J AM COLL CARDIOL, V41, P1, DOI 10.1016/S0735-1097(02)02626-8; Bolk J, 2001, INT J CARDIOL, V79, P207, DOI 10.1016/S0167-5273(01)00422-3; Ozaki Y, 2011, CIRC-CARDIOVASC IMAG, V4, P620, DOI 10.1161/CIRCIMAGING.111.965616; Rochitte CE, 1998, CIRCULATION, V98, P1006; Ito H, 1996, CIRCULATION, V93, P223; JUDD RM, 1995, CIRCULATION, V92, P1902; Shiono Y, 2013, JACC-CARDIOVASC INTE, V6, P847, DOI 10.1016/j.jcin.2013.01.142; Kim RJ, 1999, CIRCULATION, V100, P1992; de Waha S, 2010, EUR HEART J, V31, P2660, DOI 10.1093/eurheartj/ehq247; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; BRAUNWALD E, 1994, CIRCULATION, V89, P1545; Simonetti OP, 2001, RADIOLOGY, V218, P215; SEWDARSEN M, 1987, DIABETES RES CLIN EX, V6, P47; Nijveldt R, 2008, J AM COLL CARDIOL, V52, P181, DOI 10.1016/j.jacc.2008.04.006; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; Ishihara M, 2005, AM HEART J, V150, P814, DOI 10.1016/j.ahj.2004.12.020; Hokama JY, 2000, J DIABETES COMPLICAT, V14, P96, DOI 10.1016/S1056-8727(00)00068-4; Engler RL, 1986, AM J PHYSIOL, V251, P314; Ishii H, 2005, CIRCULATION, V112, P1284, DOI 10.1161/CIRCULATIONAHA.104.530329; Khan JN, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-38; OSWALD GA, 1986, BRIT MED J, V293, P917; Rubenstein JC, 2008, AM HEART J, V156, P498, DOI 10.1016/j.ahj.2008.04.012; TANSEY M J B, 1986, Canadian Journal of Cardiology, V2, P326	35	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					272	277		10.1016/j.jjcc.2014.10.013		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700021		
J	Hon, Y; Yoda, S; Nakanishi, K; Tano, A; Suzuki, Y; Matsumoto, N; Hirayama, A				Hon, Yusuke; Yoda, Shunichi; Nakanishi, Kanae; Tano, Ayako; Suzuki, Yasuyuki; Matsumoto, Naoya; Hirayama, Atsushi			Myocardial ischemic reduction evidenced by gated myocardial perfusion imaging after treatment results in good prognosis in patients with coronary artery disease	Journal of Cardiology			English	Article						Radionuclide imaging; Myocardial ischemic reduction; Revascularization; Prognosis; Coronary artery disease	EMISSION COMPUTED-TOMOGRAPHY; FRACTIONAL FLOW RESERVE; OPTIMAL MEDICAL THERAPY; CHRONIC KIDNEY-DISEASE; JAPANESE PATIENTS; J-ACCESS; AUTOMATED QUANTIFICATION; SEPARATE ACQUISITION; RISK STRATIFICATION; NUCLEAR CARDIOLOGY	Background: There are no nuclear cardiology reports indicating the prediction of prognosis based on ischemic reduction after revascularization in Japanese patients with coronary artery disease (CAD). We aimed to evaluate quantitatively ischemia using myocardial perfusion single photon emission computed tomography (SPECT) before and after treatment such as revascularization and to determine a relationship between the ischemic reduction and the incidence of major cardiac events (MCEs) after the treatment in patients with CAD. Methods: We retrospectively investigated 513 patients who underwent rest 20111 and stress Tc-99m-tetrofosmin myocardial perfusion SPECT between October 2004 and March 2011 and who had a significant stenosis with 75% or greater narrowing of the coronary arterial diameter detected by coronary angiography performed after confirmation of >= 5% ischemia with SPECT. The patients underwent the treatment including revascularization and medication and thereafter were re-evaluated with SPECT during a chronic phase and followed up to confirm prognosis for >= 1 year. The follow-up period was 33.4 +/- 16.4 months. The endpoint was the incidence of the MCEs consisting of cardiac death, non-fatal myocardial infarction, and unstable angina pectoris. Results: During the follow-up, 45 patients experienced MCEs comprising cardiac death (n = 13), nonfatal myocardial infarction (n = 3), and unstable angina pectoris (n = 29). The multivariate Cox proportional hazards regression model analysis for the risk of the MCEs showed the changes in the summed difference score % (p = 0.0102) and the stress left ventricular ejection fraction after the treatment (p = 0.0146) as significant independent variables. The incidence of the MCEs significantly decreased in the patients with >= 5% ischemic reduction than in the patients without >= 5% ischemic reduction and in the patients without residual ischemia than in the patients with the residual ischemia. Conclusion: Myocardial ischemic reduction detected by nuclear cardiology leads to a decrease in MCE rates after treatment in Japanese patients with CAD. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Hon, Yusuke; Yoda, Shunichi; Nakanishi, Kanae; Tano, Ayako; Suzuki, Yasuyuki; Matsumoto, Naoya; Hirayama, Atsushi] Nihon Univ, Sch Med, Dept Cardiol, Tokyo 1738610, Japan	Yoda, S (reprint author), Nihon Univ, Sch Med, Dept Cardiol, Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.	masteryoda@mf.point.ne.jp					De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Nakajima K, 2009, EUR J NUCL MED MOL I, V36, P2049, DOI 10.1007/s00259-009-1207-9; Nishimura T, 2008, EUR J NUCL MED MOL I, V35, P319, DOI 10.1007/s00259-007-0608-x; Hachamovitch R, 1998, CIRCULATION, V97, P535; Yoda S, 2012, J CARDIOL, V60, P377, DOI 10.1016/j.jjcc.2012.06.011; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; BERMAN DS, 1993, J AM COLL CARDIOL, V22, P1455; Nakamura S, 2010, THER APHER DIAL, V14, P379, DOI 10.1111/j.1744-9987.2010.00823.x; Yoda S, 2005, CIRC J, V69, P301, DOI 10.1253/circj.69.301; Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Yoda S, 2013, J CARDIOL, V62, P224, DOI 10.1016/j.jjcc.2013.04.001; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Hida S, 2012, CIRC J, V76, P430, DOI 10.1253/circj.CJ-11-0946; Matsumoto N, 2007, CIRC J, V71, P1580, DOI 10.1253/circj.71.1580; Nanasato M, 2014, J CARDIOL, V63, P159, DOI 10.1016/j.jjcc.2013.07.006; Yoda S, 2014, J CARDIOL, V63, P350, DOI 10.1016/j.jjcc.2013.10.004	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					278	284		10.1016/j.jjcc.2014.06.015		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700022		
J	Sadamatsu, K; Koide, S; Nakano, K; Yoshida, K				Sadamatsu, Kenji; Koide, Sachiko; Nakano, Kayoko; Yoshida, Keiki			Heart rate control with single administration of a long-acting beta-blocker at bedtime before coronary computed tomography angiography	Journal of Cardiology			English	Article						Coronary disease; Heart rate; Beta adrenergic receptors; Tomography	IMAGE QUALITY; DIAGNOSTIC-ACCURACY; CT ANGIOGRAPHY; EFFICACY; IVABRADINE; SAFETY; IMPACT	Background: Beta-blockers are used to control the heart rate prior to coronary computed tomography (CT) angiography. However, in-hospital administration is time-consuming, and it is hard to decrease the heart rate to <60 beats per minute (bpm) when the initial heart rate is increased. In this study, we examined whether the single administration of long-acting beta-blocker at bedtime before angiography is effective for achieving the target heart rate. Methods and results: A total of 314 consecutive patients with a resting heart rate >60 bpm who underwent coronary CT angiography were retrospectively collected. Either bisoprolol or atenolol was orally administered the night before to 166 patients (beta group), and no additional medication was administered to the other 148 patients (control group). When the heart rate was >60 bpm on arrival, a beta-blocker or verapamil was orally administered at the discretion of the physician. Although the baseline heart rate was not significantly different between the groups, the beta-blocker treatment the night before significantly reduced the heart rate compared to control group upon arrival at the hospital and at the time of angiography. The rate of achievement of a heart rate <60 bpm on arrival at the hospital was significantly higher in the beta group, and even after the additional treatment. Conclusions: Bedtime administration of a long-acting beta-blocker the night before coronary CT angiography is an effective option to achieve the target heart rate at the time of examination. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Sadamatsu, Kenji; Yoshida, Keiki] Saga Ken Med Ctr Koseikan, Dept Cardiol, Saga 8408571, Japan; [Koide, Sachiko; Nakano, Kayoko] Saga Ken Med Ctr Koseikan, Dept Nursing, Saga 8408571, Japan	Sadamatsu, K (reprint author), Saga Ken Med Ctr Koseikan, Dept Cardiol, 400 Nakabaru, Saga 8408571, Japan.	k-sadamatsu@umin.ac.jp					Adile KK, 2012, BRIT J RADIOL, V85, pE424, DOI 10.1259/bjr/22102914; Brodoefel H, 2008, EUR J RADIOL, V66, P134, DOI 10.1016/j.ejrad.2007.05.013; Shapiro MD, 2008, EUR J RADIOL, V66, P37, DOI 10.1016/j.ejrad.2007.05.006; Dewey M, 2010, AM J ROENTGENOL, V194, P93, DOI 10.2214/AJR.09.2833; Maffei E, 2009, EUR RADIOL, V19, P2931, DOI 10.1007/s00330-009-1509-0; Guaricci AI, 2012, INT J CARDIOL, V156, P28, DOI 10.1016/j.ijcard.2010.10.035; de Graaf FR, 2010, AM J CARDIOL, V105, P767, DOI 10.1016/j.amjcard.2009.10.058; Mahabadi AA, 2010, RADIOLOGY, V257, P614, DOI 10.1148/radiol.10100140; Achenbach S, 2012, J CARDIOVASC COMPUT, V6, P91, DOI 10.1016/j.jcct.2011.11.006; Jimenez-Juan L, 2013, INT J CARDIOVAS IMAG, V29, P199, DOI 10.1007/s10554-012-0049-x; Luecke C, 2012, EUR J RADIOL, V81, P2221, DOI 10.1016/j.ejrad.2011.09.019; Pichler P, 2012, AM J CARDIOL, V109, P169, DOI 10.1016/j.amjcard.2011.08.025; Roberts WT, 2009, BRIT J RADIOL, V82, P267, DOI 10.1259/bjr/24574758	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					293	297		10.1016/j.jjcc.2014.07.007		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700024		
J	Taniguchi, Y; Otake, H; Shinke, T; Nakagawa, M; Hariki, H; Inoue, T; Osue, T; Hiranuma, N; Nishio, R; Kinutani, H; Iwasaki, M; Konishi, A; Kuroda, M; Hirata, K				Taniguchi, Yu; Otake, Hiromasa; Shinke, Toshiro; Nakagawa, Masayuki; Hariki, Hirotoshi; Inoue, Takumi; Osue, Tsuyoshi; Hiranuma, Noritoshi; Nishio, Ryo; Kinutani, Hiroto; Iwasaki, Masamichi; Konishi, Akihide; Kuroda, Masaru; Hirata, Ken-ichi			Two-year vessel healing after everolimus-eluting stent implantation: Serial assessment by optical coherence tomography	Journal of Cardiology			English	Article						Optical coherence tomography; Everolimus-eluting stents; Long-term vessel healing	FOLLOW-UP; INTRAVASCULAR ULTRASOUND; NEOINTIMAL COVERAGE; BARE-METAL; NEOATHEROSCLEROSIS; THROMBOSIS	Background: Previous reports have suggested the importance of delayed arterial healing and the development of neoatherosclerosis as major contributors to stent thrombosis and delayed restenosis. The difference of in vivo assessment of long-term vessel healing between first-generation drug-eluting stents and current generation everolimus-eluting stents (EESs) is limited. The aim of this study was to evaluate long-term arterial healing in EES in comparison with the first generation sirolimus-eluting stents (SES). Methods: We evaluated 31 EES (23 patients) and 8 SES (7 patients) by serial optical coherence tomography at 12 months (mid-phase) and 24 months (late-phase) after stenting and evaluated the change in neointimal thickness (NIT), the percentages of uncovered struts, pen-strut low intensity area (PLIA; region around stent struts homogenously lower-intensity appearance than surrounding tissue), and thrombus. Results: Although the average NIT showed no significant changes from the mid- to the late-phase follow-up in both EES and SES groups, the change in NIT and minimum lumen area was significantly larger in SES than EES (5.2 +/- 29.4 vs. 37.2 +/- 48.9; p = 0.02, 0.06 +/- 0.36 vs. 0.45 +/- 0.74; p = 0.04. respectively). The incidence of uncovered struts and struts with PLIA of EES was lower than those of SES, at both phases. Stents with in-stent thrombus of EES tended to be lower than that of SES at both phase follow-ups. Conclusion: Although both SES and EES showed progressive luminal narrowing from the mid- to the late-phase follow-up, the extent of delayed lumen narrowing and delayed neointimal proliferation was significantly less in the second generation EES than the first generation SES. EESs seem to offer sustained stability in efficacy, without sacrificing safety, up to 2 years after implantation. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Taniguchi, Yu; Otake, Hiromasa; Shinke, Toshiro; Nakagawa, Masayuki; Hariki, Hirotoshi; Inoue, Takumi; Osue, Tsuyoshi; Hiranuma, Noritoshi; Nishio, Ryo; Kinutani, Hiroto; Iwasaki, Masamichi; Konishi, Akihide; Kuroda, Masaru; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc & Resp Med, Kobe, Hyogo 6500017, Japan	Otake, H (reprint author), Kobe Univ, Grad Sch Med, Dept Cardiol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hotake@med.kobe-u.ac.jp					Kang SJ, 2011, CIRCULATION, V123, P2954, DOI 10.1161/CIRCULATIONAHA.110.988436; Matsumoto D, 2007, EUR HEART J, V28, P961, DOI 10.1093/eurheartj/ehl413; Kim JS, 2012, JACC-CARDIOVASC IMAG, V5, P1147, DOI 10.1016/j.jcmg.2012.01.024; Wentzel JJ, 2001, CIRCULATION, V103, P1740; Claessen BE, 2009, CIRC-CARDIOVASC INTE, V2, P339, DOI 10.1161/CIRCINTERVENTIONS.108.831800.108.831800; Takano M, 2009, J AM COLL CARDIOL, V55, P26, DOI 10.1016/j.jacc.2009.08.032; Otake H, 2009, JACC-CARDIOVASC INTE, V2, P459, DOI 10.1016/j.jcin.2009.03.003; Nakagawa Y, 2010, AM J CARDIOL, V106, P329, DOI 10.1016/j.amjcard.2010.03.031; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; Awata M, 2007, CIRCULATION, V116, P910, DOI 10.1161/CIRCULATIONAHA.105.609057; Inoue T, 2011, HEART, V97, P1379, DOI 10.1136/hrt.2010.204339; Katoh H, 2009, CIRC J, V73, P1033; Kim SJ, 2013, INT J CARDIOVAS IMAG, V29, P967, DOI 10.1007/s10554-012-0179-1; Kim TH, 2011, INT J CARDIOVAS IMAG, V27, P875, DOI 10.1007/s10554-010-9729-6; Kuriyama N, 2011, JACC-CARDIOVASC INTE, V4, P123, DOI 10.1016/j.jcin.2010.09.013; Mintz GS, 2012, JACC-CARDIOVASC INTE, V5, P21, DOI 10.1016/j.jcin.2011.10.010; Mizoguchi T, 2014, INT J CARDIOL, V171, P224, DOI 10.1016/j.ijcard.2013.12.021; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Nishio R, 2012, CIRC J, V76, P2348, DOI 10.1253/circj.CJ-12-0476; Otake H, 2012, INT J CARDIOL, V157, P38, DOI 10.1016/j.ijcard.2010.11.006; Takano M, 2007, HEART, V93, P1533, DOI 10.1136/hrt.2007.131714; Takano M, 2010, CIRC-CARDIOVASC INTE, V3, P476, DOI 10.1161/CIRCINTERVENTIONS.110.957118	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					298	304		10.1016/j.jjcc.2014.07.003		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700025		
J	Masaki, N; Hakuno, D; Toya, T; Shiraishi, Y; Kujiraoka, T; Namba, T; Yada, H; Kimura, K; Miyazaki, K; Adachi, T				Masaki, Nobuyuki; Hakuno, Daihiko; Toya, Takumi; Shiraishi, Yasunaga; Kujiraoka, Takehiko; Namba, Takayuki; Yada, Hirotaka; Kimura, Kazuo; Miyazaki, Koji; Adachi, Takeshi			Association between brachial-ankle pulse wave velocity and the ratio of (L)-arginine to asymmetric dimethylarginine in patients undergoing coronary angiography	Journal of Cardiology			English	Article						Asymmetric dimethylarginine; Nitric oxide; Brachial-ankle pulse wave velocity	VASCULAR INDEX CAVI; ARTERIAL STIFFNESS; NITRIC-OXIDE; L-ARGININE; LIQUID-CHROMATOGRAPHY; ENDOTHELIAL FUNCTION; DISEASE; MORTALITY; PLASMA; PRESSURE	Background: Endothelial dysfunction causes vasomotor dysregulation and vascular stiffening in addition to structural changes. By influencing NO synthesis, deficiency of (L)-arginine relative to asymmetric dimethylarginine (ADMA), which is an (L)-arginine derivative that acts as a competitive NO synthase inhibitor, may lead to the promotion of arterial stiffness. This study investigated the relationship between the (L)-arginine/ADMA ratio and brachial-ankle pulse wave velocity (baPWV), an indicator of arterial stiffness. Methods and results: This cross-sectional study enrolled 74 patients (62 men, 12 women; mean age, 67 10 years) undergoing elective coronary angiography. A total of 54 (73%) patients had coronary artery disease. Serum (L)-arginine and ADMA were measured by high-performance liquid chromatography with fluorescence detection. The ratio of (L)-arginine to ADMA and the serum (L)-arginine level was associated with baPWV in univariate regression analysis ((L)-arginine/ADMA ratio: beta = -0.323, p = 0.005; (L)-arginine: beta = -0.247, p = 0.034). In addition, baPWV was related to blood hemoglobin concentration, hematocrit, brain natriuretic peptide level, symmetric dimethylarginine, renal function, blood pressure, and heart rate. In multivariate analysis, the (L)-arginine/ADMA ratio was a significant predictor of baPWV (beta = -0.310, p < 0.001). In subgroup analyses, the (L)-arginine/ADMA ratio was associated with baPWV in elderly patients (n = 46. beta = -0.359, p = 0.004), and in younger patients (n = 28, beta = -0.412, p = 0.006). Conclusion: A low L-arginine/ADMA ratio may be associated with high baPWV in patients undergoing coronary angiography. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Masaki, Nobuyuki; Hakuno, Daihiko; Toya, Takumi; Shiraishi, Yasunaga; Kujiraoka, Takehiko; Namba, Takayuki; Yada, Hirotaka; Kimura, Kazuo; Miyazaki, Koji; Adachi, Takeshi] Natl Def Med College, Dept Cardiovasc Med, Tokorozawa, Saitama 3528165, Japan	Masaki, N (reprint author), Natl Def Med College, Dept Cardiovasc Med, 3-2 Namiki, Tokorozawa, Saitama 3528165, Japan.	masakinobuyuki@hotmail.com			Ministry of Defense, Japan	This work was supported in part by a grant (to TA) from the Ministry of Defense, Japan.	Angel K, 2012, ATHEROSCLEROSIS, V225, P160, DOI 10.1016/j.atherosclerosis.2012.08.033; McEniery CM, 2006, HYPERTENSION, V48, P602, DOI 10.1161/01.HYP.0000239206.64270.5f; Izuhara M, 2008, CIRC J, V72, P1762, DOI 10.1253/circj.CJ-08-0152; Selcuk MT, 2007, CORONARY ARTERY DIS, V18, P545; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Koyoshi R, 2012, CIRC J, V76, P1469, DOI 10.1253/circj.CJ-11-1283; Brunner EJ, 2011, HYPERTENSION, V57, P1003, DOI 10.1161/HYPERTENSIONAHA.110.168864; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Morris SM, 2012, CURR OPIN CLIN NUTR, V15, P64, DOI 10.1097/MCO.0b013e32834d1a08; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29; Caplin B, 2012, ARTERIOSCL THROM VAS, V32, P1343, DOI 10.1161/ATVBAHA.112.247726; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Usui M, 1998, LIFE SCI, V62, P2425, DOI 10.1016/S0024-3205(98)00225-2; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; van der Zwan LP, 2011, CLIN SCI, V121, P71, DOI 10.1042/CS20100595; Anderssohn M, 2012, J CARD FAIL, V18, P904, DOI 10.1016/j.cardfail.2012.10.011; Cesarone MR, 1999, INT ANGIOL, V18, P127; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Cho SW, 2013, J CARDIOL, V62, P131, DOI 10.1016/j.jjcc.2013.03.014; Weber T, 2007, AM J HYPERTENS, V20, P256, DOI 10.1016/j.amjhpyper.2006.09.009; Luiking YC, 2012, AM J PHYSIOL-ENDOC M, V303, pE1177, DOI 10.1152/ajpendo.00284.2012; Wilkinson IB, 2004, HYPERTENSION, V44, P112, DOI 10.1161/01.HYP.0000138068.03893.40; Vlachopoulos C, 2012, HYPERTENSION, V60, P556, DOI 10.1161/HYPERTENSIONAHA.112.194779; Morris SM, 2005, VASC MED, V10, pS83, DOI 10.1191/1358863x05vm601oa; Boger RH, 2007, J NUTR, V137, p1650S; Brenner T, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/210454; Cighetti G, 2002, CLIN CHEM, V48, P2266; Dioguardi FS, 2011, J NUTRIGENET NUTRIGE, V4, P90, DOI 10.1159/000327777; Erez A, 2011, AM J MED GENET C, V157C, P45, DOI 10.1002/ajmg.c.30289; Haines Ricci J, 2011, Int J Biochem Mol Biol, V2, P8; Heffernan KS, 2010, J CARDIOVASC PHARM T, V15, P17, DOI 10.1177/1074248409354599; Heresztyn T, 2004, J CHROMATOGR B, V805, P325, DOI 10.1016/j.jchromb.2004.03.020; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Kocaman SA, 2008, CORONARY ARTERY DIS, V19, P469, DOI 10.1097/MCA.0b013e328311d32b; Lind L, 2009, ATHEROSCLEROSIS, V203, P544, DOI 10.1016/j.atherosclerosis.2008.07.016; Ochiai M, 2012, INT J CARDIOL, V155, P257, DOI 10.1016/j.ijcard.2010.10.004; Seljeflot I, 2011, J CARD FAIL, V17, P135, DOI 10.1016/j.cardfail.2010.09.003; Visser M, 2012, BRIT J NUTR, V107, P1458, DOI 10.1017/S0007114511004648; Yasmin, 2005, ARTERIOSCLER THROMB, V25, P372; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					311	317		10.1016/j.jjcc.2014.06.005		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700027		
J	Murakami, H; Sasaki, H; Sasaki, S; Hata, S; Sugimoto, Y; Yakabe, D; Hirokami, M				Murakami, Hironori; Sasaki, Haruki; Sasaki, Shunsuke; Hata, Shinya; Sugimoto, Yoichiro; Yakabe, Daisuke; Hirokami, Mitsugu			Prognosis of medically treated patients at least 80 years old with severe sclerotic aortic stenosis	Journal of Cardiology			English	Article						Aortic stenosis; Elderly; Prognosis; Aortic valve replacement	CONGESTIVE-HEART-FAILURE; CONVERTING ENZYME-INHIBITORS; LEFT-VENTRICULAR MASS; VALVE-REPLACEMENT; RISK-FACTORS; CARDIOVASCULAR HEALTH; OF-CARDIOLOGY; TRANSCATHETER; FRAMINGHAM; OUTCOMES	Background: The prevalence of severe sclerotic aortic stenosis (ScAS) in those at least >= 80 years old has been increasing in Japan: however, the prognosis of these Japanese patients without surgical treatment has not been reported. Methods and results: Ninety consecutive patients with medically treated severe ScAS were prospectively studied. To assess further event-free survival rate (EFSR) from either cardiac (heart failure or cardiac death) events or noncardiac deaths, they were divided into three groups based on aortic valve area (AVA) at the initial diagnosis (group A: AVA <= 0.6 cm(2), group B: 0.6 cm(2) < AVA <= 0.8 cm(2), and group C: 0.8 cm(2) < AVA <= 1.0 cm(2)). In comparison, 73 consecutive patients >= 80 years old with moderate ScAS (group M: 1.0 cm(2) <= AVA <= 1.5 cm(2)) were also enrolled. The EFSR in group A was significantly lower than that in the other groups (p < 0.05) while no difference was seen among the other groups although the EFSR from cardiac events in group B was lower than the moderate group (p < 0.05). Multivariate analysis showed that the cardiac risk factors were AVA <= 0.6 cm(2) and left ventricular ejection fraction (EF) <= 55%. Conclusions: Since patients with AVA <= 0.6 cm(2) have a significantly worse prognosis, more symptoms, and higher prevalence of cardiac events, early aortic valve replacement should be considered in this group. Furthermore, patients having AVA ranging from 0.6 to 0.8 cm(2) have a worse prognosis in cardiac events compared to group M. In addition, EF <= 55% is another significant factor for cardiac events. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Murakami, Hironori; Sasaki, Haruki; Sasaki, Shunsuke; Hata, Shinya; Sugimoto, Yoichiro; Yakabe, Daisuke; Hirokami, Mitsugu] Teine Keijinkai Hosp, Ctr Cardiovasc, Div Cardiol, Sapporo, Hokkaido 0068111, Japan	Murakami, H (reprint author), Teine Keijinkai Hosp, Ctr Cardiovasc, Div Cardiol, Teine Ku, 1-12 Maeda, Sapporo, Hokkaido 0068111, Japan.	dfwnoris@yahoo.co.jp					Tamburino C, 2012, AM J CARDIOL, V109, P1487, DOI 10.1016/j.amjcard.2012.01.364; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.05.007; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Gottdiener JS, 2002, ANN INTERN MED, V137, P631; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee DS, 2009, CIRCULATION, V119, P3070, DOI 10.1161/CIRCULATIONAHA.108.815944; de Simone G, 2008, EUR HEART J, V29, P741, DOI 10.1093/eurheartj/ehm605; Rosenhek R, 2004, CIRCULATION, V110, P1291, DOI 10.1161/01.CIR.0000140723.15274.53; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Dunlay SM, 2009, AM J MED, V122, P1023, DOI 10.1016/j.amjmed.2009.04.022; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Lieb W, 2009, CIRCULATION, V119, P3085, DOI 10.1161/CIRCULATIONAHA.108.824243; Barasch E, 2014, CIRC J, V78, P232, DOI 10.1253/circj.CJ-13-0821; Iung B, 2005, EUR HEART J, V24, P2714; Kannel W B, 2000, Heart Fail Rev, V5, P167; Kitai T, 2011, HEART, V97, P2029, DOI 10.1136/heartjnl-2011-300137; Likosky DS, 2009, CIRCULATION, V120, pS127, DOI 10.1161/CIRCULATIONAHA.108.842641; Murakami H, 2008, SHINZO, V40, P458; Newby DE, 2006, HEART, V92, P729, DOI 10.1136/hrt.2005.066852; Okita H, 2012, JPN CIRC SOC, P1; Shibayama K, 2013, CIRC J, V76, P1761; Varadarajan P, 2006, EUR J CARDIO-THORAC, V30, P722, DOI 10.1016/j.ejcts.2006.07.028	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					330	336		10.1016/j.jjcc.2014.06.006		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700030		
J	Taguchi, T; Adachi, H; Hoshizaki, H; Oshima, S; Kurabayashi, M				Taguchi, Tetsuya; Adachi, Hitoshi; Hoshizaki, Hiroshi; Oshima, Shigeru; Kurabayashi, Masahiko			Effect of physical training on ventilatory patterns during exercise in patients with heart disease	Journal of Cardiology			English	Article						Cardiac rehabilitation; Respiratory pattern; Rapid and shallow breathing; Heart disease	CHRONIC CARDIAC-FAILURE; PULMONARY-FUNCTION; CONTROLLED-TRIAL; FOLLOW-UP; CAPACITY; RESPONSES	Background: Exercise training is known to improve the shortness of breath experienced by patients with heart disease when the ventilatory pattern becomes abnormal during exercise. However, the precise relationship between breathing patterns and the effect of exercise training has not been elucidated to date. We evaluated the relationship between the effect of exercise training on exercise tolerance and the amelioration of the ventilatory response during exercise in such patients. Methods and results: Patients with heart disease (n = 170) underwent cardiopulmonary exercise testing twice (pre- and postexercise training for 3-6 months). They were divided into the exercise training group (Group E, n = 123) and control group (Group C, n = 47). Regression line relating tidal volume to respiratory rate (TV-RR slope) during a ramp protocol below the inflection point was regarded as an indicator of rapid ventilation. Tidal volume after the inflection point was regarded as an indicator of shallow ventilation (TV at plateau). The TV-RR slope and TV at plateau improved after exercise training from 94.8 +/- 45.9 to 129.9 +/- 69.5 (p < 0.001) and from 1473.6 +/- 321.9 mL to 1673.2 +/- 355.1 mL (p < 0.001), respectively, in Group E. In contrast, no improvement was evident in Group C. In total, %anaerobic threshold (%AT) [AT improving ratio = (post-AT - pre-AT)/pre-AT x 100] was positively correlated with both %TV-RR slope [TV-RR slope improving ratio = (post-TV-RR slope - pre-TV-RR slope)/pre-TV-RR slope x 100] (r = 0.60) and %TV at plateau [TV at plateau improving ratio = (post-TV at plateau - pre-TV at plateau)/pre-TV at plateau x 100] (r = 0.51). Conclusion: Exercise training improved the rapidness and depth of breathing during exercise. Therefore, improvement of abnormal ventilatory patterns is correlated with exercise tolerance. (C) 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.	[Taguchi, Tetsuya; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Gunma, Japan; [Adachi, Hitoshi; Hoshizaki, Hiroshi; Oshima, Shigeru] Gunme Prefectural Cardiovasc Ctr, Gunma, Japan	Taguchi, T (reprint author), 3-39-15 Showamachi, Maebashi, Gumma 3718511, Japan.	m10702029@gunma-u.ac.jp					Akaishi S, 2008, J CARDIOL, V52, P195, DOI 10.1016/j.jjcc.2008.07.004; Roveda F, 2003, J AM COLL CARDIOL, V42, P854, DOI 10.1016/S0735-1097(03)00831-3; Piepoli MF, 2006, CIRCULATION, V114, P126, DOI 10.1161/CIRCULATIONAHA.105.605980; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020; MANCINI DM, 1995, CIRCULATION, V91, P320; Piepoli M, 1996, CIRCULATION, V93, P940; MANCINI DM, 1991, J AM COLL CARDIOL, V18, P492; Clark AL, 1996, J AM COLL CARDIOL, V28, P1092, DOI 10.1016/S0735-1097(96)00323-3; Puri S, 1999, CIRCULATION, V99, P1190; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558; Ponikowski PP, 2001, CIRCULATION, V104, P2324, DOI 10.1161/hc4401.098491; WEBER KT, 1982, CIRCULATION, V65, P1213; Belardinelli R, 1998, J AM COLL CARDIOL, V31, P1027, DOI 10.1016/S0735-1097(98)00040-0; Chua TP, 1996, J AM COLL CARDIOL, V27, P650, DOI 10.1016/0735-1097(95)00523-4; COATS AJS, 1992, CIRCULATION, V85, P2119; FAGGIANO P, 1993, CARDIOLOGY, V83, P30, DOI 10.1159/000175944; GALLAGHER CG, 1986, AM REV RESPIR DIS, V133, P581; Guazzi M, 1999, AM HEART J, V138, P460, DOI 10.1016/S0002-8703(99)70148-1; HAUGE A, 1975, J APPL PHYSIOL, V38, P608; MYERS J, 1992, AM HEART J, V124, P710, DOI 10.1016/0002-8703(92)90282-Z; NERY LE, 1983, CHEST, V83, P446, DOI 10.1378/chest.83.3.446; PAINTAL AS, 1969, J PHYSIOL-LONDON, V203, P511; RAVENSCRAFT SA, 1993, CHEST, V103, P54, DOI 10.1378/chest.103.1.54; WEBER KT, 1985, AM J CARDIOL, V55, pA22, DOI 10.1016/0002-9149(85)90792-1; YOKOYAMA H, 1994, CHEST, V106, P1007, DOI 10.1378/chest.106.4.1007	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0914-5087	1876-4738		J CARDIOL	J. Cardiol.	MAR-APR	2015	65	3-4					343	348		10.1016/j.jjcc.2014.06.004		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG4IV	WOS:000353249700032		
J	Nishizawa, T; Suzuki, H; Kanai, T; Yahagi, N				Nishizawa, Toshihiro; Suzuki, Hidekazu; Kanai, Takanori; Yahagi, Naohisa			Proton pump inhibitor alone vs proton pump inhibitor plus mucosal protective agents for endoscopic submucosal dissection-induced ulcer: a systematic review and meta-analysis	JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION			English	Review						mucosal protective agents; endoscopic submucosal dissection; ulcer; rebamipide	HELICOBACTER-PYLORI; ECABET SODIUM; COMBINATION THERAPY; MONGOLIAN GERBILS; GASTRIC-ULCER; REBAMIPIDE; POLAPREZINC; DRUG; ERADICATION; EFFICACY	Mucosal protective agents may improve healing of patients with endoscopic submucosal dissection-induced ulcers. The present study systematically evaluated published clinical trials to determine whether combined therapeutic use of mucosal protective agents and proton pump inhibitors can improve the outcome of patients with endoscopic submucosal dissection-induced ulcers compared to treatment with proton pump inhibitors alone. PubMed, the Cochrane Library, and the Igaku-Chuo-Zasshi database were searched to identify eligible randomized trials for systematic review. We identified 11 randomized trials for inclusion in our study (1,160 patients). Pooled endoscopic submucosal dissection-induced ulcer healing rates were 45.8% and 34.4% for patients with or without mucosal protective agents, respectively. The odds ratio was 2.28 (95% confidence interval, 1.57-3.31) with no significant study heterogeneity. In conclusion, the systematic review and meta-analysis showed that the combined therapeutic use of proton pump inhibitors and mucosal protective agents improved healing rates of endoscopic submucosal dissection-induced ulcers compared to treatment with proton pump inhibitor monotherapy.	[Nishizawa, Toshihiro; Yahagi, Naohisa] Keio Univ, Sch Med, Ctr Canc, Div Res & Dev Minimally Invas Treatment,Shinjuku, Tokyo 1608582, Japan; [Nishizawa, Toshihiro; Suzuki, Hidekazu; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1608582, Japan	Suzuki, H (reprint author), Keio Univ, Sch Med, Ctr Canc, Div Res & Dev Minimally Invas Treatment,Shinjuku, 35 Shinanomachi, Tokyo 1608582, Japan.	hsuzuki@a6.keio.jp	Suzuki, Hidekazu/J-4396-2013		Princess Takamatsu Cancer Research grants; Smoking Research Foundation; Keio Gijuku Academic Development Fund	This work was supported by Princess Takamatsu Cancer Research grants (to H.S.), a grant from the Smoking Research Foundation (to H.S.), and the Keio Gijuku Academic Development Fund (to H.S.).	Nishizawa T, 2009, DIGESTION, V79, P259, DOI 10.1159/000213241; Fujiwara S, 2011, J GASTROENTEROL, V46, P595, DOI 10.1007/s00535-011-0372-3; Akagi M, 2013, CURR PHARM DESIGN, V19, P106; Shin WG, 2012, GASTROINTEST ENDOSC, V75, P739, DOI 10.1016/j.gie.2011.11.004; Inaba T, 2010, HEPATO-GASTROENTEROL, V57, P678; Asakuma Y, 2009, HEPATO-GASTROENTEROL, V56, P1270; Terano A, 2007, J GASTROENTEROL, V42, P690, DOI 10.1007/s00535-007-2076-2; SUZUKI M, 1994, GUT, V35, P1375, DOI 10.1136/gut.35.10.1375; Yang ZP, 2011, DIGESTION, V84, P315, DOI 10.1159/000331138; Kobayashi M, 2012, DIGEST DIS SCI, V57, P119, DOI 10.1007/s10620-011-1850-4; Ito Y, 1998, EUR J PHARMACOL, V345, P193, DOI 10.1016/S0014-2999(97)01622-1; Kato T, 2010, J GASTROENTEROL, V45, P285, DOI 10.1007/s00535-009-0157-0; Naito Y, 2010, EXPERT REV GASTROENT, V4, P261, DOI [10.1586/egh.10.25, 10.1586/EGH.10.25]; Araki H, 2012, J CLIN BIOCHEM NUTR, V51, P185, DOI 10.3164/jcbn.12-14; Haruma K, 2003, ALIMENT PHARM THERAP, V18, P153, DOI 10.1046/j.1365-2036.18.s1.17.x; Hyun Y, 2010, DIGEST ENDOSC, V22, pA45; Imagawa A, 2012, GASTROENTEROL ENDOSC, V51, P2191; Miyahara R, 2013, GASTROINTEST ENDOS S, V55, P2764; Munakata W, 2003, LUMINESCENCE, V18, P330, DOI 10.1002/bio.745; Nishizawa T, 2014, DIGEST ENDOSC, V26, P701, DOI 10.1111/den.12342; Ogasawara N, 2011, J CLIN BIOCHEM NUTR, V48, P154, DOI 10.3164/jcbn.10-69; Sakita T, 1970, JPN J GASTROENTEROL, V67, P984; Sawaguchi M, 2011, GASTROINTEST ENDOSC, V73, pAB424; Suzuki H, 2001, ALIMENT PHARM THERAP, V15, P715, DOI 10.1046/j.1365-2036.2001.00960.x; Suzuki H, 1998, DIGEST DIS SCI, V43, p181S; Takayama M, 2013, WORLD J GASTROENTERO, V19, P5706, DOI 10.3748/wjg.v19.i34.5706; Ueda K, 2009, J PHARMACOL SCI, V110, P285, DOI 10.1254/jphs.09056FP; Wang J, 2014, INTERNAL MED, V53, P1243, DOI 10.2169/internalmedicine.53.2160; Yahagi N, 2013, TECH GASTROINTESTINA, V15, P96, DOI [10.1016/j.tgie.2013.02.004, DOI 10.1016/J.TGIE.2013.02.004]; Yoshida N, 2013, J JPN SOC GASTROENTE, V110, pA888	30	0	0	JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION	KYOTO	KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN	0912-0009	1880-5086		J CLIN BIOCHEM NUTR	J. Clin. Biochem. Nutr.	MAR 1	2015	56	2					85	90		10.3164/jcbn.14-101		6	Nutrition & Dietetics	Nutrition & Dietetics	CG6TE	WOS:000353434500001		
J	Itoh, K; Ye, P; Matsumiya, T; Tanji, K; Ozaki, T				Itoh, Ken; Ye, Peng; Matsumiya, Tomoh; Tanji, Kunikazu; Ozaki, Taku			Emerging functional cross-talk between the Keap1-Nrf2 system and mitochondria	JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION			English	Review						mitochondria; Nrf2; heme oxygenase-1; p62; NRF-1	TRANSCRIPTION FACTOR NRF2; CONTROLS CELLULAR APOPTOSIS; FRATAXIN DEFICIENCY LEADS; OXIDATIVE STRESS; HEME OXYGENASE-1; CARBON-MONOXIDE; SELECTIVE AUTOPHAGY; FRIEDREICHS-ATAXIA; HYPOBARIC HYPOXIA; PROTEIN	Nuclear factor erythroid-derived 2-related factor 2 (Nrf2) was originally identified as a positive regulator of drug detoxifying enzyme gene expression during exposure to environmental electrophiles. Currently, Nrf2 is known to regulate the expression of hundreds of cytoprotective genes to counteract endogenously or exogenously generated oxidative stress. Furthermore, when activated in human tumors by somatic mutations, Nrf2 confers growth advantages and chemoresistance by regulating genes involved in various processes such as the pentose phosphate pathway and nucleotide synthesis in addition to antioxidant proteins. Interestingly, increasing evidence shows that Nrf2 is associated with mitochondrial biogenesis during environmental stresses in certain tissues such as the heart. Furthermore, SKN-1, a functional homolog of Nrf2 in C. elegans, is activated by mitochondrial reactive oxygen species and extends life span by promoting mitochondrial homeostasis (i.e., mitohormesis). Similarly, Nrf2 activation was recently observed in the heart of surfeit locus protein 1 (Surf1) -/- mice in which cellular respiration was decreased due to cytochrome c oxidase defects. In this review, we critically examine the relationship between Nrf2 and mitochondria and argue that the Nrf2 stress pathway intimately communicates with mitochondria to maintain cellular homeostasis during oxidative stress.	[Itoh, Ken; Ye, Peng] Hirosaki Univ, Grad Sch Med, Ctr Adv Med Res, Dept Stress Response Sci, Hirosaki, Aomori 0368562, Japan; [Matsumiya, Tomoh] Hirosaki Univ, Grad Sch Med, Dept Vasc Biol, Inst Brain Sci, Hirosaki, Aomori 0368562, Japan; [Tanji, Kunikazu] Hirosaki Univ, Grad Sch Med, Dept Neuropathol, Inst Brain Sci, Hirosaki, Aomori 0368562, Japan; [Ozaki, Taku] Hirosaki Univ, Grad Sch Med, Res Ctr Child Mental Dev, Hirosaki, Aomori 0368562, Japan	Itoh, K (reprint author), Hirosaki Univ, Grad Sch Med, Ctr Adv Med Res, Dept Stress Response Sci, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	itohk@cc.hirosaki-u.ac.jp			Hirosaki University Institutional Research Grant; MEXT, Japan [26111010]	We thank Drs. Junsei Mimura, Atsushi Maruyama and Hiromi Yamazaki for their helpful advice and discussion. This work was supported by a Hirosaki University Institutional Research Grant and Grant-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" (No. 26111010) of MEXT, Japan.	Abrahamsen G, 2013, DIS MODEL MECH, V6, P489, DOI 10.1242/dmm.010884; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Anedda A, 2013, FREE RADICAL BIO MED, V61, P395, DOI 10.1016/j.freeradbiomed.2013.04.007; MacGarvey NC, 2012, AM J RESP CRIT CARE, V185, P851, DOI 10.1164/rccm.201106-1152OC; Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Hancock R, 2012, FREE RADICAL BIO MED, V52, P444, DOI 10.1016/j.freeradbiomed.2011.10.486; Chien WL, 2011, J NEUROCHEM, V117, P643, DOI 10.1111/j.1471-4159.2011.07229.x; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; Hota SK, 2008, J NEUROSCI RES, V86, P1142, DOI 10.1002/jnr.21554; Gan L, 2010, EUR J NEUROSCI, V31, P967, DOI 10.1111/j.1460-9568.2010.07138.x; Zhu H, 2012, CARDIOVASC TOXICOL, V12, P39, DOI 10.1007/s12012-011-9136-9; Hota KB, 2012, HIPPOCAMPUS, V22, P723, DOI 10.1002/hipo.20934; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; BRAND MD, 1991, BIOCHEM J, V275, P81; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Athale J, 2012, FREE RADICAL BIO MED, V53, P1584, DOI 10.1016/j.freeradbiomed.2012.08.009; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kim SK, 2014, ANTIOXID REDOX SIGN, V20, P2589, DOI 10.1089/ars.2012.5138; Koh H, 2012, MOL CELLS, V34, P7, DOI 10.1007/s10059-012-0100-8; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Shan YX, 2013, ANTIOXID REDOX SIGN, V19, P1481, DOI 10.1089/ars.2012.4537; Pulliam DA, 2013, ANTIOXID REDOX SIGN, V19, P1373, DOI 10.1089/ars.2012.4950; Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Ludtmann MHR, 2014, BIOCHEM J, V457, P415, DOI 10.1042/BJ20130863; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Kosaka K, 2010, J BIOCHEM, V147, P73, DOI 10.1093/jb/mvp149; D'Oria V, 2013, INT J MOL SCI, V14, P7853, DOI 10.3390/ijms14047853; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Xu Y, 2013, CANCER RES, V73, P4406, DOI 10.1158/0008-5472.CAN-12-4297; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Barhwal K, 2009, NEUROSCIENCE, V161, P501, DOI 10.1016/j.neuroscience.2009.02.086; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Dominy JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015008; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Pulliam DA, 2014, BIOCHEM J, V462, P359, DOI 10.1042/BJ20140291; Niture SK, 2011, CELL DEATH DIFFER, V18, P439, DOI 10.1038/cdd.2010.114; Chan K, 1966, P NATL ACAD SCI USA, V93, P13943; Dassa EP, 2008, BIOCHEM BIOPH RES CO, V368, P620, DOI 10.1016/j.bbrc.2008.01.125; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ishii T, 1996, BIOCHEM BIOPH RES CO, V226, P456, DOI 10.1006/bbrc.1996.1377; Matigian Abrahamsen G, 2010, DIS MODEL MECH, V3, P785; Niture SK, 2011, J BIOL CHEM, V286, P44542, DOI 10.1074/jbc.M111.275073; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Piantadosi CA, 2002, ANTIOXID REDOX SIGN, V4, P259, DOI 10.1089/152308602753666316; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Ricart KC, 2009, BIOCHEM J, V419, P427, DOI 10.1042/BJ20081350; Sahdeo S, 2014, HUM MOL GENET, V23, P6848, DOI 10.1093/hmg/ddu408; Seibenhener ML, 2013, BEHAV BRAIN RES, V248, P94, DOI 10.1016/j.bbr.2013.04.006; Seibenhener ML, 2013, BBA-MOL CELL RES, V1833, P452, DOI 10.1016/j.bbamcr.2012.11.004; Tanti GK, 2014, FREE RADICAL BIO MED, V75, P1, DOI 10.1016/j.freeradbiomed.2014.07.009	68	7	7	JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION	KYOTO	KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN	0912-0009	1880-5086		J CLIN BIOCHEM NUTR	J. Clin. Biochem. Nutr.	MAR 1	2015	56	2					91	97		10.3164/jcbn.14-134		7	Nutrition & Dietetics	Nutrition & Dietetics	CG6TE	WOS:000353434500002		
J	Shimada, S; Todoki, K; Omori, Y; Toyama, T; Matsuo, M; Wada-Takahashi, S; Takahashi, S; Lee, MC				Shimada, Shigeru; Todoki, Kazuo; Omori, Yoichi; Toyama, Toshizo; Matsuo, Masato; Wada-Takahashi, Satoko; Takahashi, Shun-suke; Lee, Masaichi-Chang-il			Contribution of nitrergic nerve in canine gingival reactive hyperemia	JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION			English	Article						reactive hyperemia; nitrergic nerve; nitric oxide; gingiva	NITRIC-OXIDE; MYOCARDIAL-ISCHEMIA; HYPOXIA; ACTIVATION; RESPONSES; BLOCKADE; CHANNELS; INCREASE; NO	Reactive hyperemia reflects a compensatory vasodilation response of the local vasculature in ischemic tissue. The purpose of this study is to clarify the mechanism of regulation of this response in gingival circulation by using pharmacological analysis of reactive hyperemia and histochemical analysis of gingival tissue. Application of pressure to the gingiva was used to create temporary ischemia, and gingival blood flow was measured after pressure release. Reactive hyperemia increased in proportion to the duration of pressure. Systemic hemodynamics remained unaffected by the stimulus; therefore, the gingival reactive hyperemia reflected a local adjustment in circulation. Gingival reactive hyperemia was significantly suppressed by nitric oxide (NO) synthase inhibitors, especially the neural NO synthase-selective antagonist 7-nitroindazole, but not by anticholinergic drugs, beta-blockers, or antihistaminergic drugs. Moreover, immunohistochemical staining for neural NO synthase and histochemical staining for NADPH diaphorase activity were both positive in the gingival perivascular region. These histochemical and pharmacological analyses show that reactive hyperemia following pressure release is mediated by NO-induced vasodilation. Furthermore, histochemical analysis strongly suggests that NO originates from nitrergic nerves. Therefore, NO may play an important role in the neural regulation of local circulation in gingival tissue ischemia.	[Shimada, Shigeru; Omori, Yoichi; Wada-Takahashi, Satoko; Takahashi, Shun-suke] Kanagawa Dent Univ, Grad Sch Dent, Dept Oral Sci, Yokosuka, Kanagawa 2388580, Japan; [Todoki, Kazuo] Kanagawa Dent Univ, Grad Sch Dent, Jr Coll, Dept Nursing, Yokosuka, Kanagawa 2388580, Japan; [Toyama, Toshizo] Kanagawa Dent Univ, Grad Sch Dent, Div Microbiol, Dept Infect Control, Yokosuka, Kanagawa 2388580, Japan; [Matsuo, Masato] Kanagawa Dent Univ, Grad Sch Dent, Inst Frontier Oral Sci, Dept Tissue Engn, Yokosuka, Kanagawa 2388580, Japan; [Lee, Masaichi-Chang-il] Kanagawa Dent Univ, Grad Sch Dent, Yokosuka Shonan Disaster Hlth Emergency Res Ctr, Yokosuka, Kanagawa 2388580, Japan; [Lee, Masaichi-Chang-il] Kanagawa Dent Univ, Grad Sch Dent, ESR Labs, Yokosuka, Kanagawa 2388580, Japan	Lee, MC (reprint author), Kanagawa Dent Univ, Grad Sch Dent, Yokosuka Shonan Disaster Hlth Emergency Res Ctr, 82 Inaoka Cho, Yokosuka, Kanagawa 2388580, Japan.	lee@kdu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [10557167, 18592149, 19592371, 23593049, 23660047]	This research was supported in part by grants from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) (No. 10557167, 18592149, 19592371, 23593049, 23660047).	Sugiyama S, 2012, J CLIN BIOCHEM NUTR, V51, P108, DOI 10.3164/jcbn.11-103; Semenza GL, 2000, J CLIN INVEST, V106, P809, DOI 10.1172/JCI11223; Moncada S., 2006, V176, P213; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Law AS, 1999, J DENT RES, V78, P1585; Huang AL, 2007, ARTERIOSCL THROM VAS, V27, P2113, DOI 10.1161/ATVBAHA.107.147322; Harrison DG, 2006, J INTERN MED, V259, P351, DOI 10.1111/j.1365-2796.2006.01621.x; Paul SAM, 2004, J CELL PHYSIOL, V200, P20, DOI 10.1002/jcp.10479; AVERSANO T, 1991, CIRC RES, V69, P618; Bijlstra PJ, 1996, DIABETOLOGIA, V39, P1562, DOI 10.1007/s001250050615; EWALD U, 1985, ACTA PAEDIATR SCAND, V74, P77, DOI 10.1111/j.1651-2227.1985.tb10924.x; Feil R, 2005, TRENDS MOL MED, V11, P71, DOI 10.1016/j.molmed.2004.12.001; FURCHGOTT RF, 1993, J CARDIOVASC PHARM, V22, pS1; Henrich M, 2002, MOL CELL NEUROSCI, V20, P307, DOI 10.1006/mcne.2002.1111; Henrich M, 2004, NEUROSCIENCE, V128, P337, DOI 10.1016/j.neuroscience.2004.06.057; Hirota K, 2011, J CLIN BIOCHEM NUTR, V49, P16, DOI 10.3164/jcbn.10-101; Horowitz JD, 2010, CURR OPIN CARDIOL, V25, P329, DOI 10.1097/HCO.0b013e328339f191; KASKI JC, 1993, EUR HEART J, V14, P32; Mohamed KM, 2004, EXP MOL PATHOL, V76, P143, DOI 10.1016/j.yexmp.2003.10.005; Murad F, 2008, CAN J OPHTHALMOL, V43, P291, DOI 10.3129/i08-044; Omori Y, 2002, REDOX REP, V7, P300, DOI 10.1179/135100002125000839; Pagliaro P, 2001, Ital Heart J, V2, P660; Presta A, 1997, NITRIC OXIDE-BIOL CH, V1, P74, DOI 10.1006/niox.1996.0110; SCHAPER W, 1983, EUR HEART J, V4, P73; SHIMAMOTO K, 1992, AGENT ACTION SUPPL, V38, P90; Tews DS, 2001, MICROSC RES TECHNIQ, V55, P181, DOI 10.1002/jemt.1169; Wang Y, 1995, Adv Pharmacol, V34, P71; WOLIN MS, 1991, KLIN WOCHENSCHR, V69, P1046, DOI 10.1007/BF01645156; Zubrow AB, 2004, NEUROSCIENCE, V125, P937, DOI 10.1016/j.neuroscience.2004.02.027	30	0	0	JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION	KYOTO	KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN	0912-0009	1880-5086		J CLIN BIOCHEM NUTR	J. Clin. Biochem. Nutr.	MAR 1	2015	56	2					98	104		10.3164/jcbn.14-71		7	Nutrition & Dietetics	Nutrition & Dietetics	CG6TE	WOS:000353434500003		
J	Takahashi, Y; Ichimori, K; Okano, M; Goto, H				Takahashi, Yushi; Ichimori, Kohji; Okano, Masahito; Goto, Hirofumi			Novel antioxidant capacity assay for lipophilic compounds using electron paramagnetic resonance spectroscopy	JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION			English	Article						tert-butoxyl; BAC; spin trapping; ORAC	FREE-RADICALS; IN-VITRO; OXYGEN; FLUORESCENCE; PEROXYL; PLASMA; AAPH; ORAC; SUPEROXIDE; CAPABILITY	A novel antioxidant capacity assay for lipophilic compounds was developed using electron paramagnetic resonance (EPR) spectroscopy. The assay is based on antioxidant's scavenging ability against the tert-butoxyl radical generated photolytically from ditert-butyl peroxide in ethyl acetate, and named the tert-butoxyl-based antioxidant capacity (BAC) assay. The radical was trapped by spin trap, 5,5-dimethyl-1-pyrroline-N-oxide, and EPR signal intensity of the spin adduct was used as a quantitative marker of radical levels. Signal intensity decreased in a dose-dependent manner in the presence of an antioxidant that competitively reacts with the radical, which was utilized to evaluate BAC values. The BAC method enabled the accurate estimation of antioxidant capacity for lipophilic materials that may counteract lipid peroxidation in biological membranes. The BAC values for quercetin and caffeic acid are 0.639 +/- 0.020 and 0.118 +/- 0.012 trolox equivalents, respectively, which are much smaller than values obtained by other aqueous methods such as H-ORAC and ORAC-EPR. Thus, antioxidants present in a non-aqueous environment should be evaluated using a non-aqueous system. In combination with in situ ascorbate reduction, the BAC method was capable of accurately determining the antioxidant capacity of water-insoluble materials that may be reduced in living cells.	[Takahashi, Yushi; Goto, Hirofumi] Japan Food Res Labs, Sect Biochem Anal, Naka Ku, Nagoya, Aichi 4600011, Japan; [Ichimori, Kohji] Gigatec Co Ltd, Sagamihara, Kanagawa 2520307, Japan; [Okano, Masahito] JEOL RESONANCE Inc, Tokyo 1968558, Japan	Ichimori, K (reprint author), Gigatec Co Ltd, Sagamihara, Kanagawa 2520307, Japan.	k-ichimori@jcom.home.ne.jp					Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; Mitani S, 2008, J AGR FOOD CHEM, V56, P4406, DOI 10.1021/jf703770m; Li TR, 2011, DYES PIGMENTS, V88, P103, DOI 10.1016/j.dyepig.2010.05.008; BERGSTEN P, 1990, J BIOL CHEM, V265, P2584; JANZEN EG, 1984, METHOD ENZYMOL, V105, P188; Yamaguchi T, 1998, BIOSCI BIOTECH BIOCH, V62, P1201, DOI 10.1271/bbb.62.1201; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bhagavan HN, 2006, FREE RADICAL RES, V40, P445, DOI 10.1080/10715760600617843; YEN GC, 1994, J AGR FOOD CHEM, V42, P629, DOI 10.1021/jf00039a005; WAYNER DDM, 1985, FEBS LETT, V187, P33, DOI 10.1016/0014-5793(85)81208-4; Niki E, 2010, FREE RADICAL BIO MED, V49, P503, DOI 10.1016/j.freeradbiomed.2010.04.016; JANZEN EG, 1982, CAN J CHEM, V60, P2725, DOI 10.1139/v82-392; Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w; Kohri S, 2009, ANAL BIOCHEM, V386, P167, DOI 10.1016/j.ab.2008.12.022; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; MUKAI K, 1991, J ORG CHEM, V56, P4188, DOI 10.1021/jo00013a021; MILLER NJ, 1993, CLIN SCI, V84, P407; GHISELLI A, 1995, FREE RADICAL BIO MED, V18, P29, DOI 10.1016/0891-5849(94)00102-P; BUETTNER GR, 1990, METHOD ENZYMOL, V186, P127; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Gazi HA, 2011, J CHEM SCI, V123, P265; GLAZER AN, 1988, FASEB J, V2, P2487; Gutteridge J.M.C., 2007, FREE RADICALS BIOL M; Howard JA, 1984, LANDOLT BORNSTEIN, p[12, 298]; Krainev AG, 1996, J CHEM SOC PERK T 2, P747, DOI 10.1039/p29960000747; Nakajima A, 2013, APPL MAGN RESON, V44, P997, DOI 10.1007/s00723-013-0463-9; Nakajima A, 2012, ANAL BIOANAL CHEM, V403, P1961, DOI 10.1007/s00216-012-6021-8; Papas A.M., 1999, ANTIOXIDANT STATUS D; Parkins MJ, 1974, J CHEM SOC PARKIN T, V2, P297; Posokhov YO, 2010, ANAL BIOCHEM, V407, P284, DOI 10.1016/j.ab.2010.07.035; RESZKA K, 1993, FREE RADICAL RES COM, V19, pS33; Rojas W. R. U., 1998, J CHEM SOC PERK T, V2, P2009; Sueishi Y, 2012, J CLIN BIOCHEM NUTR, V50, P127, DOI 10.3164/jcbn.11-21; Sueishi Y, 2010, Z PHYS CHEM, V224, P921, DOI 10.1524/zpch.2010.5536; Togashi DM, 2009, J PHYS CHEM A, V113, P2757, DOI 10.1021/jp808121y; Whitehead TG, 1992, ANAL CHIM ACTA, V226, P265	36	0	0	JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION	KYOTO	KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN	0912-0009	1880-5086		J CLIN BIOCHEM NUTR	J. Clin. Biochem. Nutr.	MAR 1	2015	56	2					105	110		10.3164/jcbn.14-36		6	Nutrition & Dietetics	Nutrition & Dietetics	CG6TE	WOS:000353434500004		
J	Funahashi, S; Okazaki, Y; Ito, D; Asakawa, A; Nagai, H; Tajima, M; Toyokuni, S				Funahashi, Satomi; Okazaki, Yasumasa; Ito, Daiki; Asakawa, Atsushi; Nagai, Hirotaka; Tajima, Masafumi; Toyokuni, Shinya			Asbestos and multi-walled carbon nanotubes generate distinct oxidative responses in inflammatory cells	JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION			English	Article						asbestos; multi-walled carbon nanotubes; neutrophil; macrophage; NADPH oxidase	MESOTHELIAL CARCINOGENESIS; MALIGNANT MESOTHELIOMA; DNA-DAMAGE; MACROPHAGES; FIBERS; IRON; NANOMATERIALS; CYTOTOXICITY; CROCIDOLITE; ACTIVATION	Asbestos exposure is considered a social burden by causing mesothelioma. Despite the use of synthetic materials, multi-walled carbon nanotubes (MWCNTs) are similar in dimension to asbestos and produce mesothelioma in animals. The role of inflammatory cells in mesothelial carcinogenesis remains unclear. Here, we evaluated the differences in inflammatory cell responses following exposure to these fibrous materials using a luminometer and L-012 (8-amino-5-chloro-7-phenylpyrido[3,4-d]pyridazine-1,4-(2H,3H) dione) to detect reactive oxygen species (ROS). Rat peripheral blood or RAW264.7 cells were used to assess the effects on neutrophils and macrophages, respectively. Crocidolite and amosite induced significant ROS generation by neutrophils with a peak at 10 min, whereas that of chrysotile was similar to 25% of the crocidolite/amosite response. MWCNTs with different diameters (similar to 15, 50, 115 and 145 nm) and different carcinogenicity did not induce significant ROS in peripheral blood. However, the MWCNTs induced a comparable amount of ROS in RAW264.7 cells to that following asbestos treatment. The peaks for MWCNTs (0.5-1.5 h) were observed earlier than those for asbestos (1-5 h). Apocynin and superoxide dismutase significantly inhibited ROS generation for each fiber, suggesting an involvement of NADPH oxidase and superoxide. Thus, asbestos and MWCNTs induce different oxidative responses in inflammatory cells, indicating the importance of mesothelial cell evaluation for carcinogenesis.	[Funahashi, Satomi; Okazaki, Yasumasa; Ito, Daiki; Nagai, Hirotaka; Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Showa Ku, Nagoya, Aichi 4668550, Japan; [Asakawa, Atsushi; Tajima, Masafumi] ATTO Corp, Taito Ku, Tokyo 1110041, Japan	Toyokuni, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	toyokuni@med.nagoya-u.ac.jp	Toyokuni, Shinya/C-1358-2010	Toyokuni, Shinya/0000-0002-5757-1109	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24390094, 221S0001-04, 24108001]	We would like to thank Nobuyuki Misawa for excellent technical assistance. This work was supported in part by a grant-in-aid for research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (24390094; 221S0001-04; 24108001).	Aierken D, 2014, NAGOYA J MED SCI, V76, P149; Nagai H, 2011, P NATL ACAD SCI USA, V108, pE1330, DOI 10.1073/pnas.1110013108; Iwata T, 2003, IND HEALTH, V41, P32, DOI 10.2486/indhealth.41.32; Jiang L, 2012, J PATHOL, V228, P366, DOI 10.1002/path.4075; Sakamoto Y, 2009, J TOXICOL SCI, V34, P65; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Chen B, 2011, BIOMED ENVIRON SCI, V24, P593, DOI 10.3967/0895-3988.2011.06.002; Takagi A, 2008, J TOXICOL SCI, V33, P105, DOI 10.2131/jts.33.105; Nagai H, 2011, CANCER SCI, V102, P2118, DOI 10.1111/j.1349-7006.2011.02087.x; Imada I, 1999, ANAL BIOCHEM, V271, P53, DOI 10.1006/abio.1999.4107; Toyokuni S, 2013, ADV DRUG DELIVER REV, V65, P2098, DOI 10.1016/j.addr.2013.05.011; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Sun BB, 2013, SMALL, V9, P1595, DOI 10.1002/smll.201201962; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; DOLL NJ, 1982, INT ARCH ALLER A IMM, V68, P17; DONALDSON K, 1984, BRIT J EXP PATHOL, V65, P81; IARC, 2012, IARC MON EV CARC RIS, P219; ISHIZAKI T, 1994, ENVIRON RES, V66, P208, DOI 10.1006/enrs.1994.1056; Jiang L, 2008, CANCER SCI, V99, P2142, DOI 10.1111/j.1349-7006.2008.00934.x; KINNULA VL, 1995, FREE RADICAL BIO MED, V18, P391, DOI 10.1016/0891-5849(94)00149-E; KORKINA LG, 1992, MUTAT RES, V265, P245, DOI 10.1016/0027-5107(92)90053-5; Kubo Y, 2012, J CLIN BIOCHEM NUTR, V51, P221, DOI 10.3164/jcbn.12-39; KUMAR V., 2013, ROBBINS BASIC PATHOL; Meng ZX, 2011, J NANOSCI NANOTECHNO, V11, P3126, DOI 10.1166/jnn.2011.3761; Murphy FA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-8; Nagai H, 2013, PATHOL INT, V63, P457, DOI 10.1111/pin.12093; Nagai H, 2012, CANCER SCI, V103, P1378, DOI 10.1111/j.1349-7006.2012.02326.x; Nagai H, 2010, ARCH BIOCHEM BIOPHYS, V502, P1, DOI 10.1016/j.abb.2010.06.015; NYBERG P, 1991, ENVIRON RES, V55, P157, DOI 10.1016/S0013-9351(05)80172-0; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Roggli VL, 2004, PATHOLOGY ASBESTOS A; Toyokuni S, 2009, NAGOYA J MED SCI, V71, P1; TOYOKUNI S, 1992, J INORG BIOCHEM, V47, P241, DOI 10.1016/0162-0134(92)84069-Y; TOYOKUNI S, 1993, CARCINOGENESIS, V14, P223, DOI 10.1093/carcin/14.2.223	36	1	1	JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION	KYOTO	KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN	0912-0009	1880-5086		J CLIN BIOCHEM NUTR	J. Clin. Biochem. Nutr.	MAR 1	2015	56	2					111	117		10.3164/jcbn.14-92		7	Nutrition & Dietetics	Nutrition & Dietetics	CG6TE	WOS:000353434500005		
J	Shimizu, S; Ishigamori, R; Fujii, G; Takahashi, M; Onuma, W; Terasaki, M; Yano, T; Mutoh, M				Shimizu, Satomi; Ishigamori, Rikako; Fujii, Gen; Takahashi, Mami; Onuma, Wakana; Terasaki, Masaru; Yano, Tomohiro; Mutoh, Michihiro			Involvement of NADPH oxidases in suppression of cyclooxygenase-2 promoter-dependent transcriptional activities by sesamol	JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION			English	Article						cyclooxygenase-2; NADPH oxidase; sesame; sesamol; colon cancer	COLON-CANCER CELLS; HYDROGEN-PEROXIDE; CARCINOGENESIS; ADIPOCYTES; INSULIN; OIL	Cyclooxygenase-2 (COX-2) has been shown to play an important role in colon carcinogenesis. Moreover, one of the components of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, NADPH oxidase 1 (NOX1), dominantly expressed in the colon, is implicated in the pathogenesis of colon cancer. We have reported that sesamol, one of the lignans in sesame seeds, suppressed COX-2 gene transcriptional activity in human colon cancer cells, and also suppressed intestinal polyp formation in Apc-mutant mice. In the present study, we investigated the involvement of NADPH oxidase in the inhibition of COX-2 transcriptional activity by sesamol. We found that several NADPH oxidase inhibitors, such as apocynin, showed suppressive effects on COX-2 transcriptional activity. Moreover, sesamol significantly suppressed NOX1 mRNA levels in a dose-dependent manner. In addition, we demonstrated that knockdown of NOX1 successfully suppressed COX-2 transcriptional activity. These results suggest that inhibition of NADPH oxidase, especially NOX1, may be involved in the mechanism of the suppression of COX-2 transcriptional activity by sesamol.	[Shimizu, Satomi; Ishigamori, Rikako; Fujii, Gen; Onuma, Wakana; Mutoh, Michihiro] Natl Canc Ctr, Res Inst, Div Canc Prevent Res, Chuo Ku, Tokyo 1040045, Japan; [Takahashi, Mami] Natl Canc Ctr, Res Inst, Cent Anim Div, Chuo Ku, Tokyo 1040045, Japan; [Shimizu, Satomi; Yano, Tomohiro] Toyo Univ, Grad Sch Life Sci, Itakura, Gunma 3740193, Japan; [Onuma, Wakana] Tokyo Univ Sci, Sch Pharmaceut Sci, Noda, Chiba 2788510, Japan; [Terasaki, Masaru] Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, Dept Hlth & Environm Sci, Ishikari, Hokkaido 0610293, Japan	Mutoh, M (reprint author), Natl Canc Ctr, Res Inst, Div Canc Prevent Res, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	mimutoh@ncc.go.jp			Ministry of Health, Labour, and Welfare of Japan; Japan Cancer Society; National Cancer Center Research Core Facility	This work was supported by Grants-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour, and Welfare of Japan, and also from Grants-in-Aid for Project Future, Relay for Life (Japan Cancer Society), and also supported by the National Cancer Center Research Core Facility.	Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Laurent E, 2008, INT J CANCER, V123, P100, DOI 10.1002/ijc.23423; Sancho P, 2011, FREE RADICAL BIO MED, V51, P1789, DOI 10.1016/j.freeradbiomed.2011.08.011; RIGAS B, 1993, J LAB CLIN MED, V122, P518; Lin WN, 2011, BRIT J PHARMACOL, V163, P1691, DOI 10.1111/j.1476-5381.2011.01312.x; HIROSE N, 1992, ANTICANCER RES, V12, P1259; Kajla S, 2012, FASEB J, V26, P2049, DOI 10.1096/fj.11-196360; Shao JY, 2004, J BIOL CHEM, V279, P14287, DOI 10.1074/jbc.M313276200; Suh YA, 1999, NATURE, V401, P79; Mutoh M, 2000, CARCINOGENESIS, V21, P959, DOI 10.1093/carcin/21.5.959; Mutoh M, 2006, CURR PHARM DESIGN, V12, P2375, DOI 10.2174/138161206777698972; Arbiser JL, 2001, AM J PATHOL, V159, P483, DOI 10.1016/S0002-9440(10)61720-8; Hagiwara A, 1996, TERATOGEN CARCIN MUT, V16, P317; Jacklin A, 2003, ANN NY ACAD SCI, V1010, P374, DOI 10.1196/annals.1299.068; Kamizato M, 2009, J GASTROENTEROL, V44, P1172, DOI 10.1007/s00535-009-0119-6; LAWRENCE JC, 1978, J BIOL CHEM, V253, P2104; Lin CC, 2012, AM J PHYSIOL-LUNG C, V303, pL401, DOI 10.1152/ajplung.00090.2012; McCarty MF, 2012, MED HYPOTHESES, V78, P45, DOI 10.1016/j.mehy.2011.09.039; MUKHERJEE SP, 1978, BIOCHEM PHARMACOL, V27, P2589, DOI 10.1016/0006-2952(78)90332-5; SALERNO JW, 1991, ANTICANCER RES, V11, P209; Shimizu S, 2014, J CLIN BIOCHEM NUTR, V54, P95, DOI 10.3164/jcbn.13-91	21	0	0	JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION	KYOTO	KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN	0912-0009	1880-5086		J CLIN BIOCHEM NUTR	J. Clin. Biochem. Nutr.	MAR 1	2015	56	2					118	122		10.3164/jcbn.14-89		5	Nutrition & Dietetics	Nutrition & Dietetics	CG6TE	WOS:000353434500006		
J	Sakane, C; Ohta, H; Shidoji, Y				Sakane, Chiharu; Ohta, Hiromichi; Shidoji, Yoshihiro			Measurement of lysine-specific demethylase-1 activity in the nuclear extracts by flow-injection based time-of-flight mass spectrometry	JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION			English	Article						lysine-specific demethylase 1; time-of-flight mass spectrometry; consecutive reactions; epigenetics	HISTONE DEMETHYLASE; HIGH-THROUGHPUT; LSD1; INHIBITION; CELLS; ASSAY; ACID	Lysine-specific demethylase 1 (LSD1/KDM1A), a histone-modifying enzyme, is upregulated in many cancers, especially in neuroblastoma, breast cancer and hepatoma. We have established a simple method to measure LSD1 activity using a synthetic N-terminal 21-mer peptide of histone H3, which is dimethylated at Lys-4 (H3K4me2). After the enzyme reaction, a substrate of H3K4me2 and two demethylated products, H3K4me1 and H3K4me0, were quantitatively determined by flow injection time-of-flight mass spectrometry (FI-TOF/MS). By using recombinant human LSD1, a nonlinear fitting simulation of the data obtained by FI-TOF/MS produced typical consecutive-reaction kinetics. Apparent K-m and k(cat) values of hLSD1 for the first and second demethylation reactions were found to be in the range of reported values. Tranylcypromine was shown to inhibit LSD1 activity with an IC50 of 6.9 mu M for the first demethylation reaction and 5.8 mu M for the second demethylation reaction. The FI-TOF/MS assay revealed that the endogenous LSD1 activity was higher in the nuclear extracts of SH-SY5Y cells than in He La or PC-3 cells, and this is in accordance with the immunoblotting data using an anti-LSD1 antibody. A simple, straightforward FI-TOF/MS assay is described to efficiently measure LSD1 activity in the nuclear extracts of cultured cells.	[Sakane, Chiharu; Shidoji, Yoshihiro] Nagasaki Univ, Grad Sch Human Hlth Sci, Mol & Cellular Biol, Nagoya, Nagasaki 8512195, Japan; [Ohta, Hiromichi] Nagasaki Univ, Sasebo, Nagasaki 8588580, Japan	Shidoji, Y (reprint author), Nagasaki Univ, Grad Sch Human Hlth Sci, Mol & Cellular Biol, 1-1-1 Manabino, Nagoya, Nagasaki 8512195, Japan.	shidoji@sun.ac.jp			Project Research Fund of University of Nagasaki, Japan	This work was financially supported by the research fund, Project Research Fund of the University of Nagasaki, Japan.	Abdulla A., 2013, J BIOCH PHARM RES, V1, P56; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Vasilatos SN, 2013, CARCINOGENESIS, V34, P1196, DOI 10.1093/carcin/bgt033; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Benelkebir H, 2011, BIOORGAN MED CHEM, V19, P3709, DOI 10.1016/j.bmc.2011.02.017; Cui SAY, 2011, MOL CELL BIOL, V31, P3298, DOI 10.1128/MCB.05310-11; Chen XH, 2006, J AM CHEM SOC, V128, P12520, DOI 10.1021/ja063676o; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Willmann D, 2012, INT J CANCER, V131, P2704, DOI 10.1002/ijc.27555; Campbell RM, 2014, J CLIN INVEST, V124, P64, DOI 10.1172/JCI71605; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Plant M, 2011, ANAL BIOCHEM, V419, P217, DOI 10.1016/j.ab.2011.07.002; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Blair LP, 2011, EPIGENETICS-US, V6, P491, DOI 10.4161/epi.6.4.14531; Fomeris F, 2009, FEBS J, V276, P4304; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Kaur P, 2014, NUTR REV, V71, P441; Mimasu S, 2008, BIOCHEM BIOPH RES CO, V366, P15, DOI 10.1016/j.bbrc.2007.11.066; Sakane C, 2014, BIOCHEM BIOPH RES CO, V444, P24, DOI 10.1016/j.bbrc.2013.12.144; Schmidt DMZ, 2007, BIOCHEMISTRY-US, V46, P4408, DOI 10.1021/bi0618621; Tsukada Y, 2010, COLD SPRING HARB PRO, V2010; Wang CH, 2012, ASSAY DRUG DEV TECHN, V10, P179, DOI 10.1089/adt.2011.0395	25	0	0	JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION	KYOTO	KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN	0912-0009	1880-5086		J CLIN BIOCHEM NUTR	J. Clin. Biochem. Nutr.	MAR 1	2015	56	2					123	131		10.3164/jcbn.14-99		9	Nutrition & Dietetics	Nutrition & Dietetics	CG6TE	WOS:000353434500007		
J	Kiyose, C; Saito, K; Yachi, R; Muto, C; Igarashi, O				Kiyose, Chikako; Saito, Kazuki; Yachi, Rieko; Muto, Chie; Igarashi, Osamu			Changes in the concentrations of vitamin E analogs and their metabolites in rat liver and kidney after oral administration	JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION			English	Article						Vitamin E metabolism; CEHC; CYP3A; rat liver; rat kidney	NATRIURETIC HORMONE PRECURSOR; GAMMA-TOCOPHEROL METABOLITE; ALPHA-TOCOPHEROL; SODIUM-EXCRETION; LLU-ALPHA; TOCOTRIENOL; DETERMINANT; URINARY; CYP4F1	Vitamin E analog, such as alpha- and gamma-tocopherol, can undergo omega-oxidation without cleavage of the chroman ring, and this pathway is responsible for generation of the major urinary vitamin E metabolite, carboxyethyl hydroxychroman. However, it is still unclear how carboxyethyl hydroxychroman is changed in various tissues after vitamin E intake. We therefore investigated changes in the concentrations of alpha- and gamma-tocopherol and their metabolites in rat liver and kidney. The concentration of alpha-tocopherol in rat liver increased until 6 h after oral administration, and then decreased. The change in the concentration of alpha-carboxyethyl hydroxychroman in rat liver in the alpha-Toc group slowly increased until 12 h after oral administration. Cytochrome P450 3A1 mRNA expression significantly increased from 12 h after the start of alpha-tocopherol administration. The change in the concentration of gamma-carboxyethyl hydroxychroman in rat liver in the gamma-Toc group markedly increased until 12 h after oral administration. On the other hand, gamma-carboxyethyl hydroxychroman in rat kidney showed greater accumulation than alpha-carboxyethyl hydroxychroman from 3 h to 24 h after oral administration. From these results, we considered that gamma-carboxyethyl hydroxychroman formed in the liver continues to be released into the bloodstream and is transported to the kidney rapidly.	[Kiyose, Chikako; Muto, Chie; Igarashi, Osamu] Kanagawa Inst Technol, Grad Sch, Dept Appl Chem, Atsugi, Kanagawa 2430292, Japan; [Kiyose, Chikako; Saito, Kazuki; Yachi, Rieko] Kanagawa Inst Technol, Dept Nutr & Life Sci, Atsugi, Kanagawa 2430292, Japan	Kiyose, C (reprint author), Kanagawa Inst Technol, Grad Sch, Dept Appl Chem, 1030 Shimoogino, Atsugi, Kanagawa 2430292, Japan.	kiyose@bio.kanagawa-it.ac.jp			 [20500726]	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI) (C) (No.20500726).	Abe C, 2007, LIPIDS, V42, P637, DOI 10.1007/s11745-007-3064-2; Kiyose C, 2001, LIPIDS, V36, P467, DOI 10.1007/s11745-001-0744-2; Lebold KM, 2012, AM J CLIN NUTR, V96, P801, DOI 10.3945/ajcn.112.038620; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; Saito H, 2003, J LIPID RES, V44, P1530, DOI 10.1194/jlr.M300061-JLR200; Wechter WJ, 1996, P NATL ACAD SCI USA, V93, P6002, DOI 10.1073/pnas.93.12.6002; Brigelius-Flohe R, 1999, FASEB J, V13, P1145; TRABER MG, 1994, FREE RADICAL BIO MED, V16, P229, DOI 10.1016/0891-5849(94)90148-1; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Muto C, 2013, J CLIN BIOCHEM NUTR, V52, P32, DOI 10.3164/jcbn.12-97; Birringer M, 2001, FREE RADICAL BIO MED, V31, P226, DOI 10.1016/S0891-5849(01)00574-3; CHEN LP, 1993, ARCH BIOCHEM BIOPHYS, V300, P18, DOI 10.1006/abbi.1993.1003; Imaoka Susumu, 2005, Drug Metab Pharmacokinet, V20, P478, DOI 10.2133/dmpk.20.478; Kantoci D, 1997, J PHARMACOL EXP THER, V282, P648; Kikuta Y, 1999, ARCH BIOCHEM BIOPHYS, V369, P193, DOI 10.1006/abbi.1999.1271; Traber MG, 2005, FREE RADICAL BIO MED, V38, P773, DOI 10.1016/j.freeradbiomed.2004.11.027; Uchida T, 2011, J NUTR SCI VITAMINOL, V57, P326, DOI 10.3177/jnsv.57.326; UEDA T, 1990, J MICRONUTR ANAL, V7, P79; Uto H, 2004, J NUTR SCI VITAMINOL, V50, P277; Uto-Kondo H, 2007, J CLIN BIOCHEM NUTR, V41, P211, DOI 10.3164/jcbn.2007030; Uto-Kondo H, 2007, J NUTR SCI VITAMINOL, V53, P301, DOI 10.3177/jnsv.53.301; Yachi R, 2013, J CLIN BIOCHEM NUTR, V52, P146, DOI 10.3164/jcbn.12-101	22	0	0	JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION	KYOTO	KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN	0912-0009	1880-5086		J CLIN BIOCHEM NUTR	J. Clin. Biochem. Nutr.	MAR 1	2015	56	2					143	148		10.3164/jcbn.14-107		6	Nutrition & Dietetics	Nutrition & Dietetics	CG6TE	WOS:000353434500009		
J	Taira, R; Yamaguchi, S; Shimizu, K; Nakamura, K; Ayabe, T; Taira, T				Taira, Risa; Yamaguchi, Sayori; Shimizu, Kyoko; Nakamura, Kiminori; Ayabe, Tokiyoshi; Taira, Toshio			Bacterial cell wall components regulate adipokine secretion from visceral adipocytes	JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION			English	Article						gut microbiota; visceral adipocyte; adipokine secretion; lipopolysaccharide; peptidoglycan	HIGH-FAT-DIET; INSULIN-RESISTANCE; ADIPONECTIN; OBESITY; MICE; BIFIDOBACTERIA; PROTEIN; CANCER; RATS; ENDOTOXEMIA	Recent studies suggest a relationship between intestinal microbiota and metabolic syndromes; however, the underlying mechanism remains unclear. To clarify this issue, we assessed the effects of bacterial cell wall components on adiponectin, leptin and resistin secretion from rat visceral adipocytes in vitro. We also measured the relative population of Firmicutes and Bacteroidetes in fecal microbiota and the amount of fecal mucin as an intestinal barrier function, when mice were fed a high-fat diet. In the present study, we demonstrated that bacterial cell wall components affect the secretion of adipokines, depending on the presence of antigens from gram-positive or gram-negative bacteria. Lipopolysaccharide markedly inhibited adiponectin, leptin, and resistin secretion, whereas peptidoglycan increased adiponectin secretion and decreased resistin secretion in vitro. In vivo experiments showed that the high-fat diet increased the population of Firmicutes and decreased that of Bacteroidetes. In contrast, the high-fat diet downregulated the stool output and fecal mucin content. These results demonstrate that bacterial cell wall components affect the onset of metabolic syndromes by mediating the secretion of adipokines from visceral adipose tissue. Furthermore, we believe that metabolic endotoxemia is not due to the increasing dominance of gram-negative bacteria, Bacteroidetes, but due to the depression of intestinal barrier function.	[Taira, Risa] Hokkaido Univ, Sch Sci, Dept Biol Sci, Div Biol,Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Yamaguchi, Sayori; Shimizu, Kyoko; Taira, Toshio] Cosmo Bio Co Ltd, Primary Cell Div, Sapporo, Hokkaido 0630061, Japan; [Nakamura, Kiminori; Ayabe, Tokiyoshi] Hokkaido Univ, Grad Sch Life Sci, Fac Adv Life Sci, Dept Cell Biol Sci,Kita Ku, Sapporo, Hokkaido 0010021, Japan	Taira, T (reprint author), Cosmo Bio Co Ltd, Primary Cell Div, YS Bldg,1-12 12 Nishimachi Kita, Sapporo, Hokkaido 0630061, Japan.	toshio-taira@cosmobio.co.jp			Northern Advancement Center for Science and Technology (NOASTEC) of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by a grant-in-aid for Frontier Technology Research from the Northern Advancement Center for Science and Technology (NOASTEC) of Japan and a grant-in-aid for Knowledge Cluster Phase II, Sapporo Bio-S from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Goktas S, 2005, UROLOGY, V65, P1168, DOI 10.1016/j.urology.2004.12.053; GIBSON GR, 1995, J NUTR, V125, P1401; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Wang ZT, 2006, J TRAUMA, V61, P650, DOI 10.1097/01.ta.0000196574.70614.27; MITSUOKA T, 1984, NAHRUNG, V28, P619; Nishida M, 2007, MED MOL MORPHOL, V40, P55, DOI 10.1007/s00795-007-0366-7; Ishikawa M, 2005, CLIN CANCER RES, V11, P466; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Matsuzawa Y, 2003, HORM RES, V60, P56, DOI 10.1159/000074502; Okazaki Y, 2011, J NUTR, V141, P1975, DOI 10.3945/jn.111.144246; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; CROWTHER RS, 1987, ANAL BIOCHEM, V163, P170, DOI 10.1016/0003-2697(87)90108-4; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Nakata M, 2007, BIOCHEM BIOPH RES CO, V353, P1046, DOI 10.1016/j.bbrc.2006.12.134; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; BoveeOudenhoven IMJ, 1997, GUT, V40, P497; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ecburg PB, 2005, SCIENCE, V308, P1635; Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079; Griffiths EA, 2004, DIGEST DIS SCI, V49, P579, DOI 10.1023/B:DDAS.0000026302.92898.ae; Gu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081724; Lee SJ, 2013, NUTR RES PRACT, V7, P446, DOI 10.4162/nrp.2013.7.6.446; Lim JY, 2008, FEBS LETT, V582, P3473, DOI 10.1016/j.febslet.2008.09.012; Shimizu K, 2006, CELL BIOL INT, V30, P381, DOI 10.1016/j.cellbi.2005.12.013; Wu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077585	28	3	3	JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION	KYOTO	KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN	0912-0009	1880-5086		J CLIN BIOCHEM NUTR	J. Clin. Biochem. Nutr.	MAR 1	2015	56	2					149	154		10.3164/jcbn.14-74		6	Nutrition & Dietetics	Nutrition & Dietetics	CG6TE	WOS:000353434500010		
J	Fujiwara, K; Inoue, T; Yorifuji, N; Iguchi, M; Sakanaka, T; Narabayashi, K; Kakimoto, K; Nouda, S; Okada, T; Ishida, K; Abe, Y; Masuda, D; Takeuchi, T; Fukunishi, S; Umegaki, E; Akiba, Y; Kaunitz, JD; Higuchi, K				Fujiwara, Kaori; Inoue, Takuya; Yorifuji, Naoki; Iguchi, Munetaka; Sakanaka, Taisuke; Narabayashi, Ken; Kakimoto, Kazuki; Nouda, Sadaharu; Okada, Toshihiko; Ishida, Kumi; Abe, Yosuke; Masuda, Daisuke; Takeuchi, Toshihisa; Fukunishi, Shinya; Umegaki, Eiji; Akiba, Yasutada; Kaunitz, Jonathan D.; Higuchi, Kazuhide			Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration	JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION			English	Article						GLP-1; GLP-2; DPP4; DPP8; sitagliptin	INFLAMMATORY-BOWEL-DISEASE; LOW-DOSE ASPIRIN; CROHNS-DISEASE; BICARBONATE SECRETION; EXPERIMENTAL COLITIS; IV; MICE; TEDUGLUTIDE; EXPRESSION; IMPACT	The gut incretin glucagon-like peptide-1 (GLP-1) and the intestinotropic hormone GLP-2 are released from enteroendocrine L cells in response to ingested nutrients. Treatment with an exogenous GLP-2 analogue increases intestinal villous mass and prevents intestinal injury. Since GLP-2 is rapidly degraded by dipeptidyl peptidase 4 (DPP4), DPP4 inhibition may be an effective treatment for intestinal ulcers. We measured mRNA expression and DPP enzymatic activity in intestinal segments. Mucosa! DPP activity and GLP concentrations were measured after administration of the DPP4 inhibitor sitagliptin (STG). Small intestinal ulcers were induced by indomethacin (IM) injection. STG was given before IM treatment, or orally administered after IM treatment with or without an elemental diet (ED). DPP4 mRNA expression and enzymatic activity were high in the jejunum and ileum. STG dose-dependently suppressed ileal mucosal enzyme activity. Treatment with STG prior to IM reduced small intestinal ulcer scores. Combined treatment with STG and ED accelerated intestinal ulcer healing, accompanied by increased mucosa! GLP-2 concentrations. The reduction of ulcers by ED and STG was reversed by co-administration of the GLP-2 receptor antagonist. DPP4 inhibition combined with luminal nutrients, which up-regulate mucosal concentrations of GLP-2, may be an effective therapy for the treatment of small intestinal ulcers.	[Fujiwara, Kaori; Inoue, Takuya; Yorifuji, Naoki; Iguchi, Munetaka; Sakanaka, Taisuke; Narabayashi, Ken; Kakimoto, Kazuki; Nouda, Sadaharu; Okada, Toshihiko; Ishida, Kumi; Abe, Yosuke; Masuda, Daisuke; Takeuchi, Toshihisa; Fukunishi, Shinya; Umegaki, Eiji; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 5698686, Japan; [Akiba, Yasutada; Kaunitz, Jonathan D.] Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA USA; [Akiba, Yasutada; Kaunitz, Jonathan D.] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA; [Kaunitz, Jonathan D.] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA	Inoue, T (reprint author), Osaka Med Coll, Dept Internal Med 2, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	ureuretakuwan@yahoo.co.jp					Wang JH, 2011, J PHARMACOL EXP THER, V339, P464, DOI 10.1124/jpet.111.184788; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Drozdowski L, 2009, WORLD J GASTROENTERO, V15, P385, DOI 10.3748/wjg.15.385; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Yu DMT, 2009, J HISTOCHEM CYTOCHEM, V57, P1025, DOI 10.1369/jhc.2009.953760; Dube PE, 2007, AM J PHYSIOL-ENDOC M, V293, pE460, DOI 10.1152/ajpendo.00149.2007; Jeppesen PB, 2001, GASTROENTEROLOGY, V120, P806, DOI 10.1053/gast.2001.22555; Tolhurst G, 2009, J PHYSIOL-LONDON, V587, P27, DOI 10.1113/jphysiol.2008.164012; Inoue T, 2014, DIGEST DIS SCI, V59, P1286, DOI 10.1007/s10620-013-3001-6; Jeppesen PB, 2005, GUT, V54, P1224, DOI 10.1136/gut.2004.061440; Hildebrandt M, 2001, SCAND J GASTROENTERO, V36, P1067, DOI 10.1080/003655201750422675; Berger JS, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2007.10.002; OMORAIN C, 1984, BRIT MED J, V288, P1859; Reimer MK, 2002, EUR J ENDOCRINOL, V146, P717, DOI 10.1530/eje.0.1460717; Higuchi K, 2009, J GASTROENTEROL, V44, P879, DOI 10.1007/s00535-009-0102-2; Hartmann B, 2000, ENDOCRINOLOGY, V141, P4013, DOI 10.1210/en.141.11.4013; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Boushey RP, 1999, AM J PHYSIOL-ENDOC M, V277, pE937; Buchman AL, 2010, INFLAMM BOWEL DIS, V16, P962, DOI 10.1002/ibd.21117; DARMOUL D, 1994, BIOCHEM BIOPH RES CO, V203, P1224, DOI 10.1006/bbrc.1994.2313; Fisher M, 2006, CURR MED RES OPIN, V22, P1239, DOI 10.1185/030079906X112624; Frezza EE, 2007, DIGEST DIS SCI, V52, P643, DOI 10.1007/s10620-006-9096-2; Geier MS, 2005, J CELL PHYSIOL, V204, P687, DOI 10.1002/jcp.20333; Handa O, 2014, J CLIN BIOCHEM NUTR, V54, P2, DOI 10.3164/jcbn.13-84; Inoue T, 2012, AM J PHYSIOL-GASTR L, V303, pG810, DOI 10.1152/ajpgi.00195.2012; Ito Y, 2013, J CLIN BIOCHEM NUTR, V53, P55, DOI 10.3164/jcbn.12-116; Liu XW, 2008, AM J PHYSIOL-REG I, V295, pR1794, DOI 10.1152/ajpregu.90616.2008; Mizukami K, 2012, J CLIN BIOCHEM NUTR, V51, P216, DOI 10.3164/jcbn.12-27; SAHARA N, 1983, ACTA HISTOCHEM CYTOC, V16, P494; Takasaki K, 2004, EUR J PHARMACOL, V505, P237, DOI 10.1016/j/ejphar.204.10.018; Takasaki K, 2004, J PHARMACOL SCI, V95, P291, DOI 10.1254/jphs.SC0040043; Xiao Q, 2000, AM J PHYSIOL-REG I, V278, pR1057; Yamamoto T, 2005, INFLAMM BOWEL DIS, V11, P580, DOI 10.1097/01.MIB.0000161307.58327.96; Yazbeck R, 2010, INFLAMM BOWEL DIS, V16, P1340, DOI 10.1002/ibd.21241	34	1	1	JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION	KYOTO	KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN	0912-0009	1880-5086		J CLIN BIOCHEM NUTR	J. Clin. Biochem. Nutr.	MAR 1	2015	56	2					155	162		10.3164/jcbn.14-111		8	Nutrition & Dietetics	Nutrition & Dietetics	CG6TE	WOS:000353434500011		
J	Higashi, Y; Konno, K				Higashi, Yasuhiko; Konno, Kazunori			Simple determination of o-phenylphenol in skin lotion by high-performance liquid chromatography coupled with fluorescence detection after pre-column derivatization with 4-(N-chloroformylmethyl-N-methylamino)-7-nitro-2,1,3-benzoxadiazole	JOURNAL OF COSMETIC SCIENCE			English	Article							COLUMN-SWITCHING HPLC; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; UV ANALYSIS; 4-FLUORO-7-NITRO-2,1,3-BENZOXADIAZOLE; RESIDUES; SODIUM; FRUITS; AGENTS; VEGETABLES	o-Phenylphenol (OPP) in skin lotion was quantitated by high-performance liquid chromatography coupled with fluorescence detection after pre-column derivatization with 4-(N-chloroformylmethyl-N-methylamino)-7-nitro-2,1,3-benzoxadiazole (NBD-COCI) in borate buffer (pH 8.5) at room temperature for 2 min. The col. umn [150 mm x 3.0 mm internal diameter (id.)), which contained 5 Am particles of C-18 packing material, was eluted at room temperature (flow rate: 0.5 ml/min) with mobile phase prepared by addition of acetonitrile (550 ml) to 450 ml of Milli-Q water containing trifluoroacetic acid (0.1 v/v%). 2-Hydroxyfluorene was used as an internal standard. The retention times of NBD-CO-OPP and NBD-CO-IS derivatives were 16.2 and 22.2 min, respectively. The calibration plot was linear in the range of 0.01-0.2 mu g/ml with an r(2) value of 0.9960, and the lower limit of detection was 0.003 mu g/ml (at a signal-to-noise ratio of 3:1; absolute amount of 12 pg/20 mu l injection). The coefficient of variation was less than 8.8%. Contents of OPP in three skin lotions were determined with the present system, and the recovery from spiked samples was satisfactory.	[Higashi, Yasuhiko; Konno, Kazunori] Hokuriku Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Kanazawa, Ishikawa 9201181, Japan	Higashi, Y (reprint author), Hokuriku Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Kanagawa Machi, Kanazawa, Ishikawa 9201181, Japan.	y-higashi@hokuriku-u.ac.jp					Ye X, 2008, TALANTA, V76, P865, DOI 10.1016/j.talanta.2008.04.034; Huang JQ, 2013, INT J COSMETIC SCI, V35, P346, DOI 10.1111/ics.12040; Higashi Y, 2007, J LIQ CHROMATOGR R T, V30, P2747, DOI 10.1080/10826070701560850; Darbre PD, 2008, J APPL TOXICOL, V28, P561, DOI 10.1002/jat.1358; Davoren M, 2006, TOXICOL IN VITRO, V20, P1190, DOI 10.1016/j.tiv.2006.03.005; Charnock C, 2007, J CLIN PHARM THER, V32, P567, DOI 10.1111/j.1365-2710.2007.00854.x; Bomhard EM, 2002, CRIT REV TOXICOL, V32, P551, DOI 10.1080/20024091064318; Higashi Y, 2009, J LIQ CHROMATOGR R T, V32, P2372, DOI 10.1080/10826070903188013; Toyo'oka T, 2003, BIOMED CHROMATOGR, V17, P133, DOI 10.1002/bmc.223; Imai K, 2003, YAKUGAKU ZASSHI, V123, P901, DOI 10.1248/yakushi.123.901; Blasco C, 2002, J CHROMATOGR A, V947, P227, DOI 10.1016/S0021-9673(02)00009-2; Higashi Y, 2006, BIOMED CHROMATOGR, V20, P423, DOI 10.1002/bmc.577; Fukushima T, 2004, BIOMED CHROMATOGR, V18, P813, DOI 10.1002/bmc.394; Higashi Y, 2009, J LIQ CHROMATOGR R T, V32, P1141, DOI 10.1080/10826070902841844; Higashi Y, 2011, J LIQ CHROMATOGR R T, V34, P18, DOI 10.1080/10826076.2011.534689; Higashi Y., 2014, J ANAL CHEM IN PRESS; Kolbe N, 2006, J AGR FOOD CHEM, V54, P5736, DOI 10.1021/jf060753q; TAKAHASHI M, 1989, CARCINOGENESIS, V10, P1163, DOI 10.1093/carcin/10.7.1163; Thompson RD, 2001, J AOAC INT, V84, P815; World Health Organization, 2006, GUID DRINK WAT QUAL, V1, P427; Yamazaki Y, 1999, J AOAC INT, V82, P1474; Yang L, 2004, ANAL SCI, V20, P199, DOI 10.2116/analsci.20.199; Yu L, 1997, J AOAC INT, V80, P651	23	0	0	SOC COSMETIC CHEMISTS	NEW YORK	120 WALL STREET, SUITE 2400, NEW YORK, NY 10005-4088 USA	1525-7886			J COSMET SCI	J. Cosmet. Sci.	MAR-APR	2015	66	2					129	137				9	Chemistry, Applied; Dermatology	Chemistry; Dermatology	CG3KO	WOS:000353179300005		
J	Amagai, M				Amagai, Masayuki			Message from the former president of JSID: Towards a bright future for JSID	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Editorial Material									Keio Univ, Sch Med, Dept Dermatol, Tokyo 108, Japan	Amagai, M (reprint author), Keio Univ, Sch Med, Dept Dermatol, Tokyo 108, Japan.	amagai@med.keio.ac.jp						0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAR	2015	77	3					137	138		10.1016/j.jdermsci.2015.02.003		2	Dermatology	Dermatology	CG1ZD	WOS:000353073800001		
J	Natsuga, K				Natsuga, Ken			Plectin-related skin diseases	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Review						Epidermal basement membrane; Hemidesmosome; Muscular dystrophy; Pyloric atresia	EPIDERMOLYSIS-BULLOSA SIMPLEX; PREMATURE TERMINATION CODON; MUCOUS-MEMBRANE INVOLVEMENT; ONSET MUSCULAR-DYSTROPHY; PYLORIC ATRESIA; PARANEOPLASTIC PEMPHIGUS; PRENATAL-DIAGNOSIS; STRATIFIED EPITHELIA; HUMAN AUTOANTIBODIES; MYASTHENIC SYNDROME	Plectin has been characterized as a linker protein that is expressed in many cell types and is distinctive in various isoforms in the N-terminus and around the rod domain due to complicated alternative splicing of PLEC, the gene encoding plectin. Plectin deficiency causes autosomal recessive epidermolysis bullosa simplex (EBS) with involvement of the skin and other organs, such as muscle and gastrointestinal tract, depending on the expression pattern of the defective protein. In addition, a point mutation in the rod domain of plectin leads to autosomal dominant EBS, called as EBS-Ogna. Plectin can be targeted by circulating autoantibodies in subepidermal autoimmune blistering diseases. This review summarizes plectin-related skin diseases, from congenital to autoimmune disorders. (C) 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan	Natsuga, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	natsuga@med.hokudai.ac.jp					Charlesworth A, 2003, J INVEST DERMATOL, V121, P1344, DOI 10.1111/j.1523-1747.2003.12639.x; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Rezniczek GA, 2003, HUM MOL GENET, V12, P3181, DOI 10.1093/hmg/ddg345; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151; Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Natsuga K, 2012, J IMMUNOL, V188, P5792, DOI [10.4049/jimmunol.1003402, 10.4049/jimmunol.1103402]; Ruzzi L, 1997, J CLIN INVEST, V99, P2826, DOI 10.1172/JCI119474; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; ISHIKO A, 1993, J CLIN INVEST, V91, P1608, DOI 10.1172/JCI116368; Gundesli H, 2010, AM J HUM GENET, V87, P834, DOI 10.1016/j.ajhg.2010.10.017; Goldie SJ, 2012, CANCER RES, V72, P3424, DOI 10.1158/0008-5472.CAN-12-0423; Ackerl R, 2007, J CELL SCI, V120, P2435, DOI 10.1242/jcs.004481; Charlesworth A, 2013, BRIT J DERMATOL, V168, P808, DOI 10.1111/bjd.12202; Winter L, 2014, J CLIN INVEST, V124, P1144, DOI 10.1172/JCI71919; Aho S, 1999, J INVEST DERMATOL, V113, P422, DOI 10.1046/j.1523-1747.1999.00695.x; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; Nikolskaia OV, 2003, BRIT J DERMATOL, V149, P1143, DOI 10.1111/j.1365-2133.2003.05659.x; Mellerio JE, 1997, BRIT J DERMATOL, V137, P898, DOI 10.1111/j.1365-2133.1997.tb01549.x; Zhang T, 2004, GENOME RES, V14, P79, DOI 10.1101/gr.1225204; Banwell BL, 1999, J NEUROPATH EXP NEUR, V58, P832, DOI 10.1097/00005072-199908000-00006; Andra K, 2003, J INVEST DERMATOL, V120, P189, DOI 10.1046/j.1523-1747.2003.12027.x; Gache Y, 1996, J CLIN INVEST, V97, P2289, DOI 10.1172/JCI118671; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Bauer JW, 2001, AM J PATHOL, V158, P617, DOI 10.1016/S0002-9440(10)64003-5; Chan LS, 1998, J INVEST DERMATOL, V110, P103, DOI 10.1046/j.1523-1747.1998.00107.x; Schroder R, 2002, J NEUROPATH EXP NEUR, V61, P520; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; GOLAN TD, 1993, J INVEST DERMATOL, V100, P316, DOI 10.1111/1523-1747.ep12469994; Winter L, 2013, ACTA NEUROPATHOL, V125, P77, DOI 10.1007/s00401-012-1026-0; Koss-Harnes D, 2002, J INVEST DERMATOL, V118, P87, DOI 10.1046/j.0022-202x.2001.01591.x; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; Natsuga K, 2011, J INVEST DERMATOL, V131, P1869, DOI 10.1038/jid.2011.143; Castanon MJ, 2013, HISTOCHEM CELL BIOL, V140, P33, DOI 10.1007/s00418-013-1102-0; Bolling MC, 2010, J INVEST DERMATOL, V130, P1178, DOI 10.1038/jid.2009.390; Bolling MC, 2014, J INVEST DERMATOL, V134, P273, DOI 10.1038/jid.2013.277; Buijsrogge JJA, 2005, CLIN EXP DERMATOL, V30, P531, DOI 10.1111/j.1365-2230.2005.01854.x; Buijsrogge JJA, 2009, BRIT J DERMATOL, V161, P762, DOI 10.1111/j.1365-2133.2009.09206.x; Chavanas S, 1996, J CLIN INVEST, V98, P2196, DOI 10.1172/JCI119028; Chen Q, 2013, CLIN EXP DERMATOL, V38, P792, DOI 10.1111/ced.12116; Dang M, 1998, LAB INVEST, V78, P195; Elliott CE, 1997, GENOMICS, V42, P115, DOI 10.1006/geno.1997.4724; Fassihi H, 2010, DERMATOL CLIN, V28, P231, DOI 10.1016/j.det.2010.02.001; Feldrihan V, 2014, HUM IMMUNOL, V75, P354, DOI 10.1016/j.humimm.2014.01.005; Forrest K, 2010, NEUROMUSCULAR DISORD, V20, P709, DOI 10.1016/j.nmd.2010.06.003; Fujiwara S, 2001, J BIOL CHEM, V276, P13340, DOI 10.1074/jbc.M011386200; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; Hirako Y, 2014, EXP CELL RES, V324, P172, DOI 10.1016/j.yexcr.2014.04.002; Kiritsi D, 2013, J INVEST DERMATOL, V133, P270, DOI 10.1038/jid.2012.248; Kiss M, 2005, J AUTOIMMUN, V24, P1, DOI 10.1016/j.jaut.2004.09.007; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Koss-Harnes D, 2004, ACTA DERM-VENEREOL, V84, P124, DOI 10.1080/00015550310007094; Kunz ME, 2000, J INVEST DERMATOL, V114, P376, DOI 10.1046/j.1523-1747.2000.00856.x; Laffitte E, 2001, BRIT J DERMATOL, V144, P136, DOI 10.1046/j.1365-2133.2001.03963.x; Maman E, 1998, AM J MED GENET, V78, P127, DOI 10.1002/(SICI)1096-8628(19980630)78:2<127::AID-AJMG6>3.0.CO;2-L; Maselli RA, 2011, CLIN GENET, V80, P444, DOI 10.1111/j.1399-0004.2010.01602.x; McLean WHI, 1996, GENE DEV, V10, P1724, DOI 10.1101/gad.10.14.1724; McMillan JR, 2007, MUSCLE NERVE, V35, P24, DOI 10.1002/mus.20655; Miyamoto S, BR J DERMAT IN PRESS; Nakamura H, 2011, INT J DERMATOL, V50, P439, DOI 10.1111/j.1365-4632.2010.04771.x; Nakamura H, 2005, J MOL DIAGN, V7, P28, DOI 10.1016/S1525-1578(10)60005-0; Natsuga K, 2010, HUM MUTAT, V31, pE1687, DOI 10.1002/humu.21330; Natsuga K, 2010, HUM MUTAT, V31, P308, DOI 10.1002/humu.21189; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Ohnishi Y, 2000, BRIT J DERMATOL, V142, P813, DOI 10.1046/j.1365-2133.2000.03434.x; Pfendner E, 2005, J INVEST DERMATOL, V124, P111, DOI 10.1111/j.0022-202X.2004.23564.x; Pfendner E, 2005, EXP DERMATOL, V14, P241, DOI 10.1111/j.0906-6705.2005.00324.x; Proby C, 1999, J INVEST DERMATOL, V112, P153, DOI 10.1046/j.1523-1747.1999.00498.x; Pulkkinen L, 1996, HUM MOL GENET, V5, P1539, DOI 10.1093/hmg/5.10.1539; Rezniczek GA, 2010, DERMATOL CLIN, V28, P33, DOI 10.1016/j.det.2009.10.004; Rouan F, 2000, J INVEST DERMATOL, V114, P381, DOI 10.1046/j.1523-1747.2000.00880.x; Sawamura D, 2007, J INVEST DERMATOL, V127, P1537, DOI 10.1038/sj.jid.5700707; Schara U, 2004, EUR J PEDIATR, V163, P218, DOI 10.1007/s00431-004-1410-4; Selcen D, 2011, NEUROLOGY, V76, P327, DOI 10.1212/WNL.0b013e31820882bd; Shimizu H, 2006, PRENATAL DIAG, V26, P1260, DOI 10.1002/pd.1603; Solano-Lopez G, BR J DERMAT IN PRESS; Takeichi T, BR J DERMAT IN PRESS; Takizawa Y, 1999, J INVEST DERMATOL, V112, P109, DOI 10.1046/j.1523-1747.1999.00461.x; Tolar J, 2013, LANCET, V382, P1214, DOI 10.1016/S0140-6736(13)61897-8; Valencia RG, 2013, MOL BIOL CELL, V24, P768, DOI 10.1091/mbc.E12-06-0488; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Walko G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002396; Wally V, 2008, J INVEST DERMATOL, V128, P568, DOI 10.1038/sj.jid.5701152; Yin J, INT J DERMA IN PRESS; Yiu EM, 2011, MUSCLE NERVE, V44, P135, DOI 10.1002/mus.22076	85	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAR	2015	77	3					139	145		10.1016/j.jdermsci.2014.11.005		7	Dermatology	Dermatology	CG1ZD	WOS:000353073800002		
J	Tokura, Y; Fujiyama, T; Ikeya, S; Tatsuno, K; Aoshima, M; Kasuya, A; Ito, T				Tokura, Yoshiki; Fujiyama, Toshiharu; Ikeya, Shigeki; Tatsuno, Kazuki; Aoshima, Masahiro; Kasuya, Akira; Ito, Taisuke			Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Review						Leukoderma; Rhododendrol; Tyrosinase	TYROSINASE; VITILIGO; CELLS	Recently, an unexpected outbreak of patients with leukoderma occurred in Japan with the use of brightening/lightening cosmetics containing rhododendrol (RD). Patients developed leukoderma mostly on the skin sites repeatedly applied with RD, but some patients also had vitiligo-like lesions on the non-applied sites. RD is a tyrosinase-competitive inhibiting substance, thereby serving as an inhibitor of melanin synthesis. Upon inhibition of tyrosinase, RD is converted to new products such as tyrosinase-catalyzed hydroxyl-metabolite, which damage melanocytes. The melanocyte cell lysates seem to induce T-cell response. The frequencies of CD8(+) T cells in both lesional skin and peripheral blood are significantly higher in the RD leukoderma as well as non-segmental vitiligo patients than in normal controls. In HLA-A*02:01 positive cases, circulating Melan-A-specific cytotoxic T cells can be detected at a high frequency. It is thus suggested that RD-induced leukoderma is induced by not only cytolysis of melanocytes but also subsequent immune reactions toward melanocytes. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Tokura, Yoshiki; Fujiyama, Toshiharu; Ikeya, Shigeki; Tatsuno, Kazuki; Aoshima, Masahiro; Kasuya, Akira; Ito, Taisuke] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Tokura, Y (reprint author), Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, Handayama 1-20-1, Hamamatsu, Shizuoka 4313192, Japan.	tokura@hama-med.ac.jp			Research Fund for Rhododendrol-induced Leukoderma	Research Fund for Rhododendrol-induced Leukoderma.	Akazawa H, 2006, BIOL PHARM BULL, V29, P1970, DOI 10.1248/bpb.29.1970; Toosi S, 2012, J INVEST DERMATOL, V132, P2601, DOI 10.1038/jid.2012.181; ROMAGUERA C, 1981, CONTACT DERMATITIS, V7, P159, DOI 10.1111/j.1600-0536.1981.tb04598.x; Iwadate T, 2014, BIOORG MED CHEM LETT, V24, P122, DOI 10.1016/j.bmcl.2013.11.063; Sasaki M, 2014, PIGM CELL MELANOMA R, V27, P754, DOI 10.1111/pcmr.12269; Fujiyama T, 2014, J DERMATOL SCI, V75, P43, DOI 10.1016/j.jdermsci.2014.04.005; Ito S, 2014, PIGM CELL MELANOMA R, V27, P1149, DOI [10.1111/pcmr.12300, 10.1111/pcmr.12303]; Ito S, 2014, PIGM CELL MELANOMA R, V27, P744, DOI 10.1111/pcmr.12275; Aoyama YIA, 2014, JPN J DERMATOL, V124, P2095; Fujiyama T, 2015, J DERMATOL SCI, V77, P190, DOI 10.1016/j.jdermsci.2015.01.017; Kasamatsu S, 2014, J DERMATOL SCI, V76, P16, DOI 10.1016/j.jdermsci.2014.07.001; Lang KS, 2001, J INVEST DERMATOL, V116, P891, DOI 10.1046/j.1523-1747.2001.01363.x; Nishioka M, 2015, J DERMATOL SCI, V77, P188, DOI 10.1016/j.jdermsci.2015.02.014; STEVENSON CJ, 1981, BRIT J DERMATOL, V105, P51, DOI 10.1111/j.1365-2133.1981.tb01310.x; Tanemura A, 2015, J DERMATOL SCI, V77, P185, DOI 10.1016/j.jdermsci.2015.01.002; Yang LL, 2015, J DERMATOL SCI, V77, P182, DOI 10.1016/j.jdermsci.2015.01.006; Zhang BX, 2013, EUR J DERMATOL, V23, P331, DOI 10.1684/ejd.2013.2011	17	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAR	2015	77	3					146	149		10.1016/j.jdermsci.2015.02.001		4	Dermatology	Dermatology	CG1ZD	WOS:000353073800003		
J	Yang, LL; Yang, F; Wataya-Kaneda, M; Tanemura, A; Tsuruta, D; Katayama, I				Yang, Lingli; Yang, Fei; Wataya-Kaneda, Mari; Tanemura, Atsuhi; Tsuruta, Daisuke; Katayama, Ichiro			4-(4-Hydroroxyphenyl)-2-butanol (rhododendrol) activates the autophagy-lysosome pathway in melanocytes: Insights into the mechanisms of rhododendrol-induced leukoderma	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter						Autophagy; Rhododendrol; Leukoderma	DEPIGMENTATION; VITILIGO		[Yang, Lingli; Yang, Fei; Wataya-Kaneda, Mari; Tanemura, Atsuhi; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Course Integrated Med, Dept Dermatol, Suita, Osaka 5650871, Japan; [Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan	Wataya-Kaneda, M (reprint author), Osaka Univ, Grad Sch Med, Course Integrated Med, Dept Dermatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mkaneda@derma.med.osaka-u.ac.jp					Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Westerhof W, 2007, PIGM CELL RES, V20, P345, DOI 10.1111/j.1600-0749.2007.00399.x; JIMBOW K, 1974, J INVEST DERMATOL, V62, P436, DOI 10.1111/1523-1747.ep12701679; INOUE T, 1978, YAKUGAKU ZASSHI, V98, P41; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Boissy RE, 2004, PIGM CELL RES, V17, P208, DOI 10.1111/j.1600-0749.2004.00130.x; Ito S, 2014, PIGMENT CELL MELANOM; Kasamatsu S, 2014, J DERMATOL SCI; MCGUIRE J, 1971, J INVEST DERMATOL, V57, P256, DOI 10.1111/1523-1747.ep12261579; Sasaki M, 2014, PIGMENT CELL MELANOM	10	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAR	2015	77	3					182	185		10.1016/j.jdermsci.2015.01.006		4	Dermatology	Dermatology	CG1ZD	WOS:000353073800008		
J	Tanemura, A; Yang, LL; Yang, F; Nagata, Y; Wataya-Kaneda, M; Fukai, K; Tsuruta, D; Ohe, R; Yamakawa, M; Suzuki, T; Katayama, I				Tanemura, Atsushi; Yang, Lingli; Yang, Fei; Nagata, Yuiko; Wataya-Kaneda, Mari; Fukai, Kazuyoshi; Tsuruta, Daisuke; Ohe, Rintaro; Yamakawa, Mitsunori; Suzuki, Tamio; Katayama, Ichiro			An immune pathological and ultrastructural skin analysis for rhododenol-induced leukoderma patients	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter						Rhododenol-induced leukoderma; Histopathological and ultrastructural analyses of the skin; Immune-competent cells	VITILIGO	As reported in the mass media on July 2013, numerous consumers who had used the cosmetic ingredient containing rhododendrol (4-(4-hydroxyphenyl)-2-butanol, Trade name; rhododenol), which is a melanin inhibitor isolated from Acer nikoense Maxim, released from Kanebo Cosmetics Inc. (Tokyo, Japan) noticed leukoderma patches on their face, neck and hands. We have experienced 32 cases that developed leukoderma after using such cosmetics so far and skin biopsy samples in some cases were obtained from both leukoderma and pigmented lesions. A histopathological analysis for skin lesions obtained from such patients notably showed basal hypo-pigmentation, melanin incontinence, and remaining melanocytes in most patients which is not relevant in vitiligo vulgaris. Subsequently, we comprehensively carried out immunohistochemical analyses of immune-competent cells infiltration to assess the effect of the cellular immune response to inducible hypopigmentation. Furthermore, detailed morphological observations performed by electron-microscopy notably showed the presence of melanocytes with only a small number of melanosomes, dermal fibroblasts containing melanosome globules and melanophages whereas no damage associated with melanosome transfer and the basal layer apparatus. These findings provide a cue to diagnose as rhododenol-induced leukoderma differentiate from vitiligo vulgaris and for rhododendrol to induce local immunity in addition to melanocyte damage. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Tanemura, Atsushi; Yang, Lingli; Yang, Fei; Nagata, Yuiko; Wataya-Kaneda, Mari; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol Integrated Med, Suita, Osaka 5650871, Japan; [Fukai, Kazuyoshi; Tsuruta, Daisuke] Osaka City Univ, Dept Dermatol, Grad Sch Med, Osaka, Japan; [Ohe, Rintaro; Yamakawa, Mitsunori] Yamagata Univ, Fac Med, Dept Pathol Diagnost, Yamagata 990, Japan; [Suzuki, Tamio] Yamagata Univ, Fac Med, Dept Dermatol, Yamagata 990, Japan	Tanemura, A (reprint author), Osaka Univ, Grad Sch Med, Dept Dermatol Integrated Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tanemura@derma.med.osaka-u.ac.jp					Unver N, 2006, BRIT J DERMATOL, V155, P119, DOI 10.1111/j.1365-2133.2006.07210.x; NORRIS DA, 1994, PIGM CELL RES, V7, P193, DOI 10.1111/j.1600-0749.1994.tb00049.x; Ando H, 2012, J INVEST DERMATOL, V132, P1222, DOI 10.1038/jid.2011.413; Fushiya S, 1998, PLANTA MED, V64, P598, DOI 10.1055/s-2006-957529; Ito S, 2014, PIGMENT CELL MELANOM; Itoi S, 2014, J DERMATOL SCI, V73, P83, DOI 10.1016/j.jdermsci.2013.09.004; Lang KS, 2001, J INVEST DERMATOL, V116, P891, DOI 10.1046/j.1523-1747.2001.01363.x; Sasaki M, 2014, PIGMENT CELL MELANOM; Wang CQF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018907	9	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAR	2015	77	3					185	188		10.1016/j.jdermsci.2015.01.002		4	Dermatology	Dermatology	CG1ZD	WOS:000353073800009		
J	Nishioka, M; Tanemura, A; Yang, LL; Tanaka, A; Arase, N; Katayama, I				Nishioka, Megumi; Tanemura, Atsushi; Yang, Lingli; Tanaka, Aya; Arase, Noriko; Katayama, Ichiro			Possible involvement of CCR4(+)CD8(+) T cells and elevated plasma CCL22 and CCL17 in patients with Rhododenol-induced leukoderma	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter						Rhododendrol-induced leukoderma; CCR4; CCL22; Immune response	CHEMOKINE RECEPTOR CCR4; RECRUITMENT; VITILIGO; THYMUS; LIGAND; SKIN; TARC		[Nishioka, Megumi; Tanemura, Atsushi; Yang, Lingli; Tanaka, Aya; Arase, Noriko; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka 5650871, Japan	Tanemura, A (reprint author), Osaka Univ, Grad Sch Med, Dept Dermatol Integrated Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tanemura@derma.med.osaka-u.ac.jp					Wenzel J, 2005, J INVEST DERMATOL, V124, P1241, DOI 10.1111/j.0022-202X.2005.23755.x; Vestergaard C, 2000, J INVEST DERMATOL, V115, P640, DOI 10.1046/j.1523-1747.2000.00115.x; Mariani M, 2004, EUR J IMMUNOL, V34, P231, DOI 10.1002/eji.200324429; Sasaki M, 2014, PIGM CELL MELANOMA R, V27, P754, DOI 10.1111/pcmr.12269; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Kondo T, 2009, INT IMMUNOL, V21, P523, DOI 10.1093/intimm/dxp019; Mantovani S, 2003, J INVEST DERMATOL, V121, P308, DOI 10.1046/j.1523-1747.2003.12368.x; Tanemura A, 2015, J DERMATOL SCI; Zhang BX, 2013, EUR J DERMATOL, V23, P331, DOI 10.1684/ejd.2013.2011	10	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAR	2015	77	3					188	190		10.1016/j.jdermsci.2015.02.014		3	Dermatology	Dermatology	CG1ZD	WOS:000353073800010		
J	Fujiyama, T; Ikeya, S; Ito, T; Tatsuno, K; Aoshima, M; Kasuya, A; Sakabe, J; Suzuki, T; Tokura, Y				Fujiyama, Toshiharu; Ikeya, Shigeki; Ito, Taisuke; Tatsuno, Kazuki; Aoshima, Masahiro; Kasuya, Akira; Sakabe, Jun-ichi; Suzuki, Takahiro; Tokura, Yoshiki			Melanocyte-specific cytotoxic T lymphocytes in patients with rhododendrol-induced leukoderma	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter							OCCUPATIONAL VITILIGO; DISEASE		[Fujiyama, Toshiharu; Ikeya, Shigeki; Ito, Taisuke; Tatsuno, Kazuki; Aoshima, Masahiro; Kasuya, Akira; Sakabe, Jun-ichi; Suzuki, Takahiro; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Fujiyama, T (reprint author), Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, Handayama 1-20-1, Hamamatsu, Shizuoka 4313192, Japan.	fujiyama@hama-med.ac.jp					Toosi S, 2012, J INVEST DERMATOL, V132, P2601, DOI 10.1038/jid.2012.181; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; Sasaki M, 2014, PIGM CELL MELANOMA R, V27, P754, DOI 10.1111/pcmr.12269; Fujiyama T, 2014, J DERMATOL SCI, V75, P43, DOI 10.1016/j.jdermsci.2014.04.005; Aoyama YIA, 2014, JPN J DERMATOL, V124, P2095; JAMES O, 1977, LANCET, V2, P1217; Lang KS, 2001, J INVEST DERMATOL, V116, P891, DOI 10.1046/j.1523-1747.2001.01363.x; Oliver EASL, 1939, JAMA-J AM MED ASSOC, V113, P927; STEVENSON CJ, 1981, BRIT J DERMATOL, V105, P51, DOI 10.1111/j.1365-2133.1981.tb01310.x; WALLACE A B, 1951, Lancet, V1, P501	10	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAR	2015	77	3					190	192		10.1016/j.jdermsci.2015.01.017		3	Dermatology	Dermatology	CG1ZD	WOS:000353073800011		
J	Paravina, RD; Ghinea, R; Herrera, LJ; Bona, AD; Igiel, C; Linninger, M; Sakai, M; Takahashi, H; Tashkandi, E; Perez, MD				Paravina, Rade D.; Ghinea, Razvan; Herrera, Luis J.; Bona, Alvaro D.; Igiel, Christopher; Linninger, Mercedes; Sakai, Maiko; Takahashi, Hidekazu; Tashkandi, Esam; del Mar Perez, Maria			Color Difference Thresholds in Dentistry	Journal of Esthetic and Restorative Dentistry			English	Article							RESTORATIVE MATERIALS; DENTURE TEETH; ACCEPTABILITY; STABILITY; PERCEPTIBILITY; IDENTIFICATION; PORCELAIN; SHADES	PurposeThe aim of this prospective multicenter study was to determine 50:50% perceptibility threshold (PT) and 50:50% acceptability threshold (AT) of dental ceramic under simulated clinical settings. Materials and MethodsThe spectral radiance of 63 monochromatic ceramic specimens was determined using a non-contact spectroradiometer. A total of 60 specimen pairs, divided into 3 sets of 20 specimen pairs (medium to light shades, medium to dark shades, and dark shades), were selected for psychophysical experiment. The coordinating center and seven research sites obtained the Institutional Review Board (IRB) approvals prior the beginning of the experiment. Each research site had 25 observers, divided into five groups of five observers: dentistsD, dental studentsS, dental auxiliariesA, dental techniciansT, and lay personsL. There were 35 observers per group (five observers per group at each site x7 sites), for a total of 175 observers. Visual color comparisons were performed using a viewing booth. Takagi-Sugeno-Kang (TSK) fuzzy approximation was used for fitting the data points. The 50:50% PT and 50:50% AT were determined in CIELAB and CIEDE2000. The t-test was used to evaluate the statistical significance in thresholds differences. ResultsThe CIELAB 50:50% PT was E-ab=1.2, whereas 50:50% AT was E-ab=2.7. Corresponding CIEDE2000 (E-00) values were 0.8 and 1.8, respectively. 50:50% PT by the observer group revealed differences among groups D, A, T, and L as compared with 50:50% PT for all observers. The 50:50% AT for all observers was statistically different than 50:50% AT in groups T and L. ConclusionA 50:50% perceptibility and ATs were significantly different. The same is true for differences between two color difference formulas E-00/E-ab. Observer groups and sites showed high level of statistical difference in all thresholds. Clinical SignificanceVisual color difference thresholds can serve as a quality control tool to guide the selection of esthetic dental materials, evaluate clinical performance, and interpret visual and instrumental findings in clinical dentistry, dental research, and subsequent standardization. The importance of quality control in dentistry is reinforced by increased esthetic demands of patients and dental professionals.	[Paravina, Rade D.] Univ Texas Houston, Sch Dent, Dept Restorat Dent & Prosthodont, Houston, TX 77054 USA; [Paravina, Rade D.] HCBB, Houston, TX USA; [Ghinea, Razvan; del Mar Perez, Maria] Univ Granada, Fac Sci, Dept Opt, Granada, Spain; [Herrera, Luis J.] Univ Granada Higher Tech, Sch Informat Technol & Telecommun Engn, Dept Comp Architecture & Comp Technol, Granada, Spain; [Bona, Alvaro D.] Univ Passo Fundo, Sch Dent, Passo Fundo, Brazil; [Igiel, Christopher] Johannes Gutenberg Univ Mainz, Univ Med Ctr, D-55122 Mainz, Germany; [Linninger, Mercedes] Semmelweis Univ, Fac Dent, Dept Prosthodont, H-1085 Budapest, Hungary; [Sakai, Maiko] Harvard Univ, Sch Dent Med, Dept Restorat Dent & Biomat Sci, Boston, MA 02115 USA; [Takahashi, Hidekazu] Tokyo Med & Dent Univ, Fac Dent, Oral Biomat Engn, Tokyo, Japan; [Tashkandi, Esam] King Saud Univ, Coll Dent, Dept Prosthodont, Riyadh, Saudi Arabia	Paravina, RD (reprint author), Univ Texas Houston, Sch Dent Houston, Dept Restorat Dent & Prosthodont, 7500 Cambridge St, Houston, TX 77054 USA.	Rade.Paravina@uth.tmc.edu	Herrera, Luis /L-2392-2014; Ghinea, Razvan/E-4235-2015; 	Herrera, Luis /0000-0003-3220-9389; Ghinea, Razvan/0000-0001-8865-2430; Della Bona, Alvaro/0000-0002-8312-7503; Perez Gomez, Maria Del Mar/0000-0003-1528-3659	Dentistry and American Dental Association [ISO/TC 106]	The authors wish to express their appreciation and thanks to: Rolf Kuehni, for advice on the experiment design; Judit Borbely, Takuji Ikemi, Ana Ionescu, Shigemi Ishikawa Nagai, Oscar Pecho, Herbert Scheller, and Satoko Sekine, for their help in data collection; all the observers that kindly participated in this study, Vita Zahnfabrik, for fabrication of specimens based on our specification; and J. Robert Kelly and Sharon Stanford, for their support through ISO/TC 106 Dentistry and American Dental Association.	Paravina RD, 2009, J PROSTHODONT, V18, P618, DOI 10.1111/j.1532-849X.2009.00465.x; Wee AG, 2007, J PROSTHET DENT, V98, P101, DOI 10.1016/S0022-3913(07)60043-2; Ragain JC, 2000, COLOR RES APPL, V25, P278, DOI 10.1002/1520-6378(200008)25:4<278::AID-COL8>3.0.CO;2-F; Douglas RD, 2007, J PROSTHET DENT, V97, P200, DOI 10.1016/j.prosdent.2007.02.012; RUYTER IE, 1987, DENT MATER, V3, P246, DOI 10.1016/S0109-5641(87)80081-7; Douglas RD, 1998, J PROSTHET DENT, V79, P254, DOI 10.1016/S0022-3913(98)70233-1; Da Silva JD, 2008, J PROSTHET DENT, V99, P361, DOI 10.1016/S0022-3913(08)60083-9; Leow MEL, 2006, PROSTHET ORTHOT INT, V30, P5, DOI 10.1080/03093640500465096; Pointer MR, 1998, COLOR RES APPL, V23, P52, DOI 10.1002/(SICI)1520-6378(199802)23:1<52::AID-COL8>3.0.CO;2-2; Lindsey DT, 2007, J DENT, V35, P593, DOI 10.1016/j.jdent.2007.03.006; Ghinea R, 2010, J DENT, V38, pE57, DOI 10.1016/j.jdent.2010.07.008; Alghazali N, 2012, J DENT, V40, pE10, DOI 10.1016/j.jdent.2012.04.023; Luo MR, 2001, COLOR RES APPL, V26, P340, DOI 10.1002/col.1049; Perez MD, 2011, J DENT, V39, pE37, DOI 10.1016/j.jdent.2011.09.007; KUEHNI RG, 1979, COLOR RES APPL, V4, P83; Barrett AA, 2002, J PROSTHET DENT, V88, P591, DOI 10.1067/mpr.2002.129892; Berns RS, 2000, BILLMEYER SALTZMANS; CIE, 1986, CIE PUBL, V15.2; COOK WD, 1985, BIOMATERIALS, V6, P257, DOI 10.1016/0142-9612(85)90022-5; Dietschi D, 2012, AUST DENT J, V57, P446, DOI 10.1111/adj.12001; Herrera LJ, 2010, APPL OPTICS, V49, P422, DOI 10.1364/AO.49.000422; Herrera LJ, 2011, FUZZY SET SYST, V171, P1, DOI 10.1016/j.fss.2010.10.009; Hu X, 2010, J DENT RES, V89, P1522, DOI 10.1177/0022034510378012; International Organization for Standardization, 2011, 28642 ISOTR; Ishikawa-Nagai S, 2009, J DENT, V37, pE57, DOI 10.1016/j.jdent.2009.04.004; JOHNSTON WM, 1989, J DENT RES, V68, P819, DOI 10.1177/00220345890680051301; Kuehni RG, 2011, COLOR RES APPL, V26, P384; Melgosa M., 2001, OPTICA PURA APLICADA, V34, P1; Moon A, 2014, J ESTHET RESTOR DENT, V26, P247, DOI 10.1111/jerd.12109; Paravina Rade D, 2009, J Esthet Restor Dent, V21, P133, DOI 10.1111/j.1708-8240.2009.00246.x; Paravina RD, 2009, J ESTHET RESTOR DENT, V21, P202, DOI 10.1111/j.1708-8240.2009.00255.x; Perez MM, 2000, APPL OPTICS, V39, P4021, DOI 10.1364/AO.39.004021; Ragain J C Jr, 2001, J Esthet Restor Dent, V13, P41, DOI 10.1111/j.1708-8240.2001.tb00250.x; Sailer I, 2014, INT J PERIODONT REST, V34, P757, DOI 10.11607/prd.2174; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116; Uchimura JYT, 2014, J ESTHET RESTOR DENT, V26, P279, DOI 10.1111/jerd.12106; Wyszecki G., 1982, COLOR SCI CONCEPTS M	37	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1496-4155	1708-8240		J ESTHET RESTOR DENT	J. Esthet. Restor. Dent.	MAR-APR	2015	27			1	SI		S1	S9		10.1111/jerd.12149		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CG7TS	WOS:000353508700001		
J	Ansoldi, S; Tanaka, T				Ansoldi, S.; Tanaka, T.			Tunnelling with wormhole creation	JOURNAL OF EXPERIMENTAL AND THEORETICAL PHYSICS			English	Article							1ST-ORDER PHASE-TRANSITION; FALSE-VACUUM DECAY; EARLY UNIVERSE; GENERAL-RELATIVITY; BLACK-HOLES; SPACE; DYNAMICS; BUBBLES; FATE	The description of quantum tunnelling in the presence of gravity shows subtleties in some cases. We discuss wormhole production in the context of the spherically symmetric thin-shell approximation. By presenting a fully consistent treatment based on canonical quantization, we solve a controversy present in the literature.	[Ansoldi, S.] Natl Inst Nucl Phys INFN, I-34149 Trieste, Italy; [Ansoldi, S.] Univ Udine, I-33100 Udine, Italy; [Tanaka, T.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Tanaka, T.] Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068502, Japan	Ansoldi, S (reprint author), Natl Inst Nucl Phys INFN, I-34149 Trieste, Italy.	tanaka@yukawa.kyoto-u.ac.jp		Ansoldi, Stefano/0000-0002-5613-7693	Department of Physics of Kyoto University;  [24103006];  [24103001];  [26287044]	This work was supported in part by the Grant-in-Aid for Scientific Research (nos. 24103006, 24103001, and 26287044). One of us, S. A., would like to heartfully thank the Department of Physics of Kyoto University for extended hospitality and support.	YAMAMOTO K, 1995, ASTROPHYS J, V455, P412, DOI 10.1086/176588; GOTT JR, 1982, NATURE, V295, P304, DOI 10.1038/295304a0; BLAU SK, 1987, PHYS REV D, V35, P1747, DOI 10.1103/PhysRevD.35.1747; BEREZIN VA, 1987, PHYS REV D, V36, P2919, DOI 10.1103/PhysRevD.36.2919; BUCHER M, 1995, PHYS REV D, V52, P5538, DOI 10.1103/PhysRevD.52.5538; SATO K, 1982, PHYS LETT B, V108, P103, DOI 10.1016/0370-2693(82)91152-2; ISRAEL W, 1967, NUOVO CIMENT B, V48, P463, DOI 10.1007/BF02712210; KODAMA H, 1982, PROG THEOR PHYS, V68, P1979, DOI 10.1143/PTP.68.1979; FARHI E, 1990, NUCL PHYS B, V339, P417, DOI 10.1016/0550-3213(90)90357-J; COLEMAN S, 1980, PHYS REV D, V21, P3305, DOI 10.1103/PhysRevD.21.3305; [Anonymous], ARXIVGRQC9408003; ISRAEL W, 1966, NUOVO CIMENT B, V44, P1, DOI 10.1007/BF02710419; CALLAN CG, 1977, PHYS REV D, V16, P1762, DOI 10.1103/PhysRevD.16.1762; COLEMAN S, 1977, PHYS REV D, V16, P1248, DOI 10.1103/PhysRevD.16.1248; KRAUS P, 1995, NUCL PHYS B, V433, P403, DOI 10.1016/0550-3213(94)00411-7; Ansoldi S, 2008, PROG THEOR PHYS, V120, P985, DOI 10.1143/PTP.120.985; Ansoldi S., 2007, P C QUANT EM GRAV TH; BEREZIN VA, 1991, PHYS REV D, V43, pR3112; Blanco-Pillado J. J., 2010, J COSMOL ASTROPART P, V1005; Bucher M., 1995, NUCL PHYS B, V43, P173; Carroll S. M., 2009, JHEP, V0911; Garriga J, 1998, PHYS REV D, V57, P2230, DOI 10.1103/PhysRevD.57.2230; Garriga J, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2006/01/017; KODAMA H, 1981, PROG THEOR PHYS, V66, P2052, DOI 10.1143/PTP.66.2052; LAVRELASHVILI GV, 1985, PHYS LETT B, V161, P280, DOI 10.1016/0370-2693(85)90761-0; LEE K, 1987, PHYS REV D, V36, P1088, DOI 10.1103/PhysRevD.36.1088; MAEDA KI, 1982, PHYS LETT B, V108, P98, DOI 10.1016/0370-2693(82)91151-0; SATO K, 1981, PROG THEOR PHYS, V66, P2287, DOI 10.1143/PTP.66.2287; SATO K, 1981, PROG THEOR PHYS, V65, P1443, DOI 10.1143/PTP.65.1443; TANAKA T, 1992, PROG THEOR PHYS, V88, P503, DOI 10.1143/PTP.88.503; TANAKA T, 1994, PHYS REV D, V50, P6444, DOI 10.1103/PhysRevD.50.6444	31	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1063-7761	1090-6509		J EXP THEOR PHYS+	J. Exp. Theor. Phys.	MAR	2015	120	3			SI		460	469		10.1134/S1063776115030139		10	Physics, Multidisciplinary	Physics	CF7CE	WOS:000352712900014		
J	Watanabe, A; Seno, S; Kogure, E; Seki, K; Sakamoto, T; Okada, Y; Shimazu, H				Watanabe, Atsushi; Seno, Shin-ichiro; Kogure, Eiki; Seki, Kensuke; Sakamoto, Takeshi; Okada, Youji; Shimazu, Hideaki			Kinetic Study of the Radical Scavenging of Capsaicin in Homogeneous Solutions and Aqueous Triton X-100 Micellar Suspensions	JOURNAL OF FOOD SCIENCE			English	Article						antioxidative site; capsaicin; DPPH; galvinoxyl; pH dependence; phenolate anion; phenolic OH group; pKa; rate constant	LOSS ELECTRON-TRANSFER; HYDROGEN-ATOM ABSTRACTION; LIPID-PEROXIDATION; ANTIOXIDANT ACTIVITY; OXIDATIVE STRESS; VITAMIN-E; MECHANISM; PHENOLS; SYSTEM; ACID	A kinetic study of capsaicin (CAP) toward radicals has been performed using stopped-flow spectrophotometry in detail. The second-order rate constants (k(2)) for the reaction of CAP toward 2,2-diphenyl-1-picrylhydrazyl (DPPH) and galvinoxyl have been measured in methanol, ethanol, 2-propanol/water (5: 1, v/v), and aqueous micellar suspensions containing 5% Triton X-100 (pH 4.0 to 10.0), respectively. The decay rates of DPPH and galvinoxyl for the reaction with CAP increased linearly in a concentration-dependent manner in homogeneous solutions and aqueous micellar suspensions. However, the k(2) for CAP obtained in an aqueous micellar suspension showed notable pH dependence; that is, the reactivity of CAP increased with an increasing pH value from 4 to 10. In addition, a good correlation between the k(2) value and the molar fraction of CAP (phenolate anion (CAP-O-)/undeprotonated form (CAP-OH)) was observed. These properties are associated with the pKa of CAP. Furthermore, it was found that the CAP-O-reacts with galvinoxyl about 6 times as fast as the CAP-OH. These results indicate that sequential proton loss electron transfer from the phenolic hydrogen of CAP may be responsible for the scavenging of radicals in an aqueous micellar suspensions.	[Watanabe, Atsushi; Seno, Shin-ichiro; Kogure, Eiki; Shimazu, Hideaki] Kyorin Univ, Fac Hlth Sci, Dept Physiol Biol Engn & Med Informat Engn, Hachioji, Tokyo 1928508, Japan; [Seki, Kensuke] Kyorin Univ, Fac Hlth Sci, Dept Radiat Safety Management, Hachioji, Tokyo 1928508, Japan; [Sakamoto, Takeshi] Kyorin Univ, Fac Hlth Sci, Dept Med Radiol Technol, Hachioji, Tokyo 1928508, Japan; [Okada, Youji] Kyorin Univ, Fac Hlth Sci, Dept Analyt Chem, Hachioji, Tokyo 1928508, Japan	Okada, Y (reprint author), Kyorin Univ, Fac Hlth Sci, Dept Analyt Chem, 476 Miyashita Cho, Hachioji, Tokyo 1928508, Japan.	yokada@ks.kyorin-u.ac.jp					Alberti A, 2008, J PHYS CHEM A, V112, P5700, DOI 10.1021/jp801890g; Musialik M, 2005, ORG LETT, V7, P4951, DOI 10.1021/ol051962j; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Smeets AJ, 2009, EUR J NUTR, V48, P229, DOI 10.1007/s00394-009-0006-1; Galano A, 2012, J PHYS CHEM B, V116, P1200, DOI 10.1021/jp211172f; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Okada Y, 2001, REDOX REP, V6, P117, DOI 10.1179/135100001101536120; Xie J, 2014, J AGR FOOD CHEM, V62, P4251, DOI 10.1021/jf500180u; Noguchi N, 1998, BIOCHEM PHARMACOL, V55, P785, DOI 10.1016/S0006-2952(97)00533-9; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Mukai K, 1997, J PHYS CHEM A, V101, P3746, DOI 10.1021/jp9706745; Ohara K, 2006, B CHEM SOC JPN, V79, P1501, DOI 10.1246/bcsj.79.1501; Foti MC, 2008, J ORG CHEM, V73, P9270, DOI 10.1021/jo8016555; Litwinienko G, 2007, ACCOUNTS CHEM RES, V40, P222, DOI 10.1021/ar0682029; Apak R, 2013, PURE APPL CHEM, V85, P957, DOI 10.1351/PAC-REP-12-07-15; Chaudhuri S, 2014, J PHYS CHEM A, V118, P3934, DOI 10.1021/jp502904r; STEENKEN S, 1982, J PHYS CHEM-US, V86, P3661, DOI 10.1021/j100215a033; Litwinienko G, 2004, J ORG CHEM, V69, P5888, DOI 10.1021/jo049254j; Litwinienko G, 2005, J ORG CHEM, V70, P8982, DOI 10.1021/jo051474p; Kogure K, 2002, BBA-GEN SUBJECTS, V1573, P84, DOI 10.1016/S0304-4165(02)00335-5; Chanda S, 2008, DRUG METAB DISPOS, V36, P670, DOI 10.1124/dmd.107.019240; Frankel E. N., 1995, Lipid Technology, V7, P77; Galano A, 2012, J PHYS CHEM B, V116, P7129, DOI 10.1021/jp302810w; Gandhi NM, 2004, J RADIAT RES, V45, P461, DOI 10.1269/jrr.45.461; Ganyuk LN, 1979, THEOR EXP CHEM, V14, P421, DOI 10.1007/BF00516922; Grilj J, 2012, PHYS CHEM CHEM PHYS, V14, P6352, DOI 10.1039/c2cp23577c; Itoh S, 2008, J PHYS CHEM A, V112, P448, DOI 10.1021/jp075894p; Kaiser J, 2014, SCIENCE, V343, P477, DOI 10.1126/science.343.6170.477; Lambert JW, 2006, J PHYS CHEM B, V110, P2351, DOI 10.1021/jp0561266; McLatchie LM, 2001, BRIT J PHARMACOL, V132, P899, DOI 10.1038/sj.bjp.0703900; NIKI E, 1987, British Journal of Cancer, V55, P153; Okada Y, 2002, REDOX REP, V7, P153, DOI 10.1179/135100002125000398; Okada Y, 2010, J AM OIL CHEM SOC, V87, P1397, DOI 10.1007/s11746-010-1628-4; Stevenson C, 2014, FASEB J, V28, P644; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	MAR	2015	80	3					C577	C583		10.1111/1750-3841.12798		7	Food Science & Technology	Food Science & Technology	CG1VW	WOS:000353064400013		
J	Tong, B; Xing, YP; Muramatsu, Y; Ohta, T; Kose, H; Zhou, HM; Yamada, T				Tong, Bin; Xing, Yan Ping; Muramatsu, Youji; Ohta, Takeshi; Kose, Hiroyuki; Zhou, Huan Min; Yamada, Takahisa			Association of expression levels in skeletal muscle and a SNP in the MYBPC1 gene with growth-related trait in Japanese Black beef cattle	JOURNAL OF GENETICS			English	Article						association; expression; growth-related trait; MYBPC1 gene; single nucleotide polymorphism	BINDING-PROTEIN-C; CARCASS TRAITS; MYOSIN		[Tong, Bin; Yamada, Takahisa] Niigata Univ, Dept Agrobiol, Fac Agr, Nishi Ku, Niigata 9502181, Japan; [Xing, Yan Ping; Zhou, Huan Min] Inner Mongolia Agr Univ, Coll Life Sci, Inner Mongolia Key Lab Biomfg, Hohhot 010018, Peoples R China; [Muramatsu, Youji] Kansai Univ Welf Sci, Fac Hlth Sci Welf, Dept Nutr Sci Well being, Osaka 5820026, Japan; [Ohta, Takeshi] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Takatsuki, Osaka 5691125, Japan; [Kose, Hiroyuki] Int Christian Univ, Div Nat Sci, Dept Life Sci, Mitaka, Tokyo 1818585, Japan	Yamada, T (reprint author), Niigata Univ, Dept Agrobiol, Fac Agr, Nishi Ku, Niigata 9502181, Japan.	tyamada@agr.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [14360166]; Japanese Livestock Technology Association	This work was supported by the Grant-in-Aid for Scientific Research (B) (no. 14360166) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the research funds of Japanese Livestock Technology Association.	Chen Z, 2011, BIOCHEM J, V436, P437, DOI 10.1042/BJ20102007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sasaki Y, 2006, J ANIM SCI, V84, P317; Kamanga-Sollo E, 2011, J ANIM SCI, V89, P3473, DOI 10.2527/jas.2011-4123; Japan Meat Grading Association (JMGA), 1988, NEW BEEF CARC GRAD S; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; PEPE FA, 1975, J MOL BIOL, V99, P609, DOI 10.1016/S0022-2836(75)80175-6; Sato N, 2003, MOL BIOL CELL, V14, P3180, DOI 10.1091/mbc.E02-10-0685; Takasuga A, 2007, MAMM GENOME, V18, P125, DOI 10.1007/s00335-006-0096-5; Tong B, 2014, ANIM GENET, V45, P611, DOI 10.1111/age.12172	10	0	0	INDIAN ACAD SCIENCES	BANGALORE	C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA	0022-1333	0973-7731		J GENET	J. Genet.	MAR	2015	94	1					135	137		10.1007/s12041-015-0471-7		3	Genetics & Heredity	Genetics & Heredity	CG4BH	WOS:000353225200018		
J	Hitomi, T; Matsuura, N; Shigematsu, Y; Okano, Y; Shinozaki, E; Kawai, M; Kobayashi, H; Harada, KH; Koizumi, A				Hitomi, Toshiaki; Matsuura, Norio; Shigematsu, Yosuke; Okano, Yoshiyuki; Shinozaki, Eri; Kawai, Masahiko; Kobayashi, Hatasu; Harada, Kouji H.; Koizumi, Akio			Importance of molecular diagnosis in the accurate diagnosis of systemic carnitine deficiency	JOURNAL OF GENETICS			English	Article						newborn screening; SLC22A5 gene; systemic carnitine deficiency	OCTN2; TRANSPORTER; MUTATIONS; FIBROBLASTS; GENE		[Hitomi, Toshiaki; Matsuura, Norio; Kobayashi, Hatasu; Harada, Kouji H.; Koizumi, Akio] Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Kyoto 6068501, Japan; [Shigematsu, Yosuke] Univ Fukui, Dept Hlth Sci, Fac Med Sci, Fukui 9101193, Japan; [Okano, Yoshiyuki] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo 6638501, Japan; [Shinozaki, Eri] Ishikawa Prefectural Cent Hosp, Kanazawa, Ishikawa 9208530, Japan; [Kawai, Masahiko] Kyoto Univ Hosp, Dept Pediat NICU, Sakyo Ku, Kyoto 6068507, Japan	Koizumi, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Kyoto 6068501, Japan.	koizumi.akio.5v@kyoto-u.ac.jp			Japan Society for the Promotion of Science [20590598, 17109007]	This work was supported by Grant-in-Aid for Scientific Research (C) (no. 20590598) and (S) (no. 17109007) from the Japan Society for the Promotion of Science.	Tang NLS, 1999, HUM MOL GENET, V8, P655, DOI 10.1093/hmg/8.4.655; Lee NC, 2010, MOL GENET METAB, V100, P46, DOI 10.1016/j.ymgme.2009.12.015; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; El-Hattab AW, 2010, GENET MED, V12, P19, DOI [10.1097/GIM.0b013e3181c5e6f7, 10.1097/GIM.0b013c3181c5e6f7]; ERIKSSON BO, 1988, EUR J PEDIATR, V147, P662, DOI 10.1007/BF00442488; CHAPOY PR, 1980, NEW ENGL J MED, V303, P1389, DOI 10.1056/NEJM198012113032403; Koizumi A, 1999, HUM MOL GENET, V8, P2247, DOI 10.1093/hmg/8.12.2247; Lamhonwah AM, 2004, J INHERIT METAB DIS, V27, P473, DOI 10.1023/B:BOLI.0000037339.25821.87; Lamhonwah AM, 2002, AM J MED GENET, V111, P271, DOI 10.1002/ajmg.10585; Magoulas PL, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-68; TREEM WR, 1988, NEW ENGL J MED, V319, P1331, DOI 10.1056/NEJM198811173192006	11	1	1	INDIAN ACAD SCIENCES	BANGALORE	C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA	0022-1333	0973-7731		J GENET	J. Genet.	MAR	2015	94	1					147	150		10.1007/s12041-015-0486-0		4	Genetics & Heredity	Genetics & Heredity	CG4BH	WOS:000353225200021		
J	Li, CF; Li, JB; Ding, WW; Franke, D; Yao, YJ; Shi, HS; Pang, X; Cao, Y; Lin, J; Kulhanek, DK; Williams, T; Bao, R; Briais, A; Brown, EA; Chen, YF; Clift, PD; Colwell, FS; Dadd, KA; Hernandez-Almeida, I; Huang, XL; Hyun, S; Jiang, T; Koppers, AAP; Li, QY; Liu, CL; Liu, QS; Liu, ZF; Nagai, RH; Peleo-Alampay, A; Su, X; Sun, Z; Tejada, MLG; Trinh, HS; Yeh, YC; Zhang, CL; Zhang, F; Zhang, GL; Zhao, XX				Li, Chun-Feng; Li, Jiabiao; Ding, Weiwei; Franke, Dieter; Yao, Yongjian; Shi, Hesheng; Pang, Xiong; Cao, Ying; Lin, Jian; Kulhanek, Denise K.; Williams, Trevor; Bao, Rui; Briais, Anne; Brown, Elizabeth A.; Chen, Yifeng; Clift, Peter D.; Colwell, Frederick S.; Dadd, Kelsie A.; Hernandez-Almeida, Ivan; Huang, Xiao-Long; Hyun, Sangmin; Jiang, Tao; Koppers, Anthony A. P.; Li, Qianyu; Liu, Chuanlian; Liu, Qingsong; Liu, Zhifei; Nagai, Renata H.; Peleo-Alampay, Alyssa; Su, Xin; Sun, Zhen; Tejada, Maria Luisa G.; Hai Son Trinh; Yeh, Yi-Ching; Zhang, Chuanlun; Zhang, Fan; Zhang, Guo-Liang; Zhao, Xixi			Seismic stratigraphy of the central South China Sea basin and implications for neotectonics	JOURNAL OF GEOPHYSICAL RESEARCH-SOLID EARTH			English	Article						South China Sea; seismic stratigraphy; seismic facies; neotectonism; IODP Expedition 349; core-well-seismic integration	NORTHERN CONTINENTAL-MARGIN; TECTONIC IMPLICATIONS; TRACE-ELEMENT; EVOLUTION; TAIWAN; EXTENSION; SUBDUCTION; VOLCANISM; ARC; CONSTRAINTS	Coring/logging data and physical property measurements from International Ocean Discovery Program Expedition 349 are integrated with, and correlated to, reflection seismic data to map seismic sequence boundaries and facies of the central basin and neighboring regions of the South China Sea. First-order sequence boundaries are interpreted, which are Oligocene/Miocene, middle Miocene/late Miocene, Miocene/Pliocene, and Pliocene/Pleistocene boundaries. A characteristic early Pleistocene strong reflector is also identified, which marks the top of extensive carbonate-rich deposition in the southern East and Southwest Subbasins. The fossil spreading ridge and the boundary between the East and Southwest Subbasins acted as major sedimentary barriers, across which seismic facies changes sharply and cannot be easily correlated. The sharp seismic facies change along the Miocene-Pliocene boundary indicates that a dramatic regional tectonostratigraphic event occurred at about 5Ma, coeval with the onsets of uplift of Taiwan and accelerated subsidence and transgression in the northern margin. The depocenter or the area of the highest sedimentation rate switched from the northern East Subbasin during the Miocene to the Southwest Subbasin and the area close to the fossil ridge in the southern East Subbasin in the Pleistocene. The most active faulting and vertical uplifting now occur in the southern East Subbasin, caused most likely by the active and fastest subduction/obduction in the southern segment of the Manila Trench and the collision between the northeast Palawan and the Luzon arc. Timing of magmatic intrusions and seamounts constrained by seismic stratigraphy in the central basin varies and does not show temporal pulsing in their activities.	[Li, Chun-Feng; Cao, Ying; Li, Qianyu; Liu, Chuanlian; Liu, Zhifei; Zhang, Chuanlun; Zhao, Xixi] Tongji Univ, State Key Lab Marine Geol, Shanghai 200092, Peoples R China; [Li, Jiabiao; Ding, Weiwei] State Ocean Adm, Key Lab Submarine Geosci, Inst Oceanog 2, Hangzhou, Zhejiang, Peoples R China; [Franke, Dieter] Fed Inst Geosci & Nat Resources, Hannover, Germany; [Yao, Yongjian] Guangzhou Marine Geol Survey, Guangzhou, Guangdong, Peoples R China; [Shi, Hesheng; Pang, Xiong] China Natl Offshore Oil Co Ltd, Shenzhen Branch, Shenzhen, Peoples R China; [Lin, Jian; Zhang, Fan] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Kulhanek, Denise K.] Texas A&M Univ, Int Ocean Discovery Program, College Stn, TX USA; [Williams, Trevor] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Bao, Rui] Swiss Fed Inst Technol, Geologcal Inst, Zurich, Switzerland; [Briais, Anne] Univ Toulouse, CNRS, Geosci Environm Toulouse, Toulouse, France; [Brown, Elizabeth A.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Chen, Yifeng] Chinese Acad Sci, Guangzhou Inst Geochem, Key Lab Marginal Sea Geol, Guangzhou, Guangdong, Peoples R China; [Clift, Peter D.] Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA; [Clift, Peter D.] A&M Coll, Baton Rouge, LA USA; [Colwell, Frederick S.; Koppers, Anthony A. P.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Dadd, Kelsie A.] Macquarie Univ, Dept Earth & Planetary Sci, N Ryde, NSW, Australia; [Hernandez-Almeida, Ivan] Univ Bern, Inst Geog Oeschger Ctr Climate Change, Bern, Switzerland; [Huang, Xiao-Long] Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Isotope Geochem, Guangzhou, Guangdong, Peoples R China; [Hyun, Sangmin] Korea Inst Ocean Sci & Technol, Marine Environm & Conservat Res Div, Ansan, South Korea; [Jiang, Tao] China Univ Geosci, Fac Earth Resources, Dept Marine Sci & Engn, Wuhan 430074, Peoples R China; [Liu, Qingsong] Chinese Acad Sci, State Key Lab Lithospher Evolut, Inst Geol & Geophys, Beijing, Peoples R China; [Nagai, Renata H.] Univ Sao Paulo, Dept Phys Chem & Geol Oceanog, Sao Paulo, Brazil; [Peleo-Alampay, Alyssa] Univ Philippines, Natl Inst Geol Sci, Quezon City 1101, Philippines; [Su, Xin] China Univ Geosci, Sch Marine Geosci, Beijing, Peoples R China; [Sun, Zhen] Chinese Acad Sci, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Tejada, Maria Luisa G.] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Hai Son Trinh] Minist Nat Resources & Environm, Dept Sci & Technol, Hanoi, Vietnam; [Yeh, Yi-Ching] Taiwan Ocean Res Inst, Kaohsiung, Taiwan; [Zhang, Guo-Liang] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Geol & Environm, Qingdao, Peoples R China	Li, CF (reprint author), Tongji Univ, State Key Lab Marine Geol, Shanghai 200092, Peoples R China.	cfl@tongji.edu.cn	Huang, Xiao-Long/E-4032-2010; HERNANDEZ ALMEIDA, IVAN/G-3134-2015	Huang, Xiao-Long/0000-0002-3138-986X; HERNANDEZ ALMEIDA, IVAN/0000-0002-9329-8357	National Science Foundation of China [91428309, 91028007]; Program for New Century Excellent Talents in University; Research Fund for the Doctoral Program of Higher Education of China [20100072110036]; GMT; Seismic Unix	This research is funded by National Science Foundation of China (grants 91428309 and 91028007), Program for New Century Excellent Talents in University, and Research Fund for the Doctoral Program of Higher Education of China (grant 20100072110036). This research also used samples and/or data provided by the International Ocean Discovery Program (IODP). We thank the officers, technician, engineers, and crew members of D/V JOIDES Resolution for their critical contributions. Data processing and mapping is supported by GMT [Wessel and Smith, 1995] and Seismic Unix [Cohen and Stockwell, 2002]. We also thank Ryan Lester, an anonymous reviewer, and the Associate Editor for their very detailed review and helpful comments. Data related to IODP Expedition 349 will be available for downloading from the IODP website (www.iodp.org) after the moratorium period, which will end on 30 March 2015. Reflection seismic data are from State Key Laboratory of Marine Geology, Tongji University; Second Institute of Oceanography, State Oceanic Administration, China; Federal Institute for Geosciences and Natural Resources, Hannover, Germany; Guangzhou Marine Geological Survey, China; and China National Offshore Oil Company Ltd.	Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; TENG LS, 1990, TECTONOPHYSICS, V183, P57, DOI 10.1016/0040-1951(90)90188-E; Franke D, 2011, MAR PETROL GEOL, V28, P1187, DOI 10.1016/j.marpetgeo.2011.01.004; Li ZX, 2007, GEOLOGY, V35, P179, DOI 10.1130/G23193A.1; Yan QS, 2008, SCI CHINA SER D, V51, P550, DOI 10.1007/s11430-008-0026-3; Huang CY, 2001, J ASIAN EARTH SCI, V19, P619, DOI 10.1016/S1367-9120(00)00065-1; Yang TF, 1996, TECTONOPHYSICS, V258, P85, DOI 10.1016/0040-1951(95)00180-8; Barckhausen U, 2014, MAR PETROL GEOL, V58, P599, DOI 10.1016/j.marpetgeo.2014.02.022; BRIAIS A, 1993, J GEOPHYS RES-SOL EA, V98, P6299, DOI 10.1029/92JB02280; Li CF, 2014, GEOCHEM GEOPHY GEOSY, V15, P4958, DOI 10.1002/2014GC005567; CHUNG SL, 1994, CHEM GEOL, V112, P1, DOI 10.1016/0009-2541(94)90101-5; Ding WW, 2013, TECTONOPHYSICS, V582, P162, DOI 10.1016/j.tecto.2012.09.026; RANGIN C, 1995, TECTONOPHYSICS, V243, P209, DOI 10.1016/0040-1951(94)00207-P; Ludmann T, 2001, MAR GEOL, V172, P331, DOI 10.1016/S0025-3227(00)00129-8; Zhou XM, 2000, TECTONOPHYSICS, V326, P269, DOI 10.1016/S0040-1951(00)00120-7; Zhu MZ, 2009, TECTONOPHYSICS, V476, P397, DOI 10.1016/j.tecto.2009.06.015; Xu YG, 2012, CHINESE SCI BULL, V57, P3150, DOI 10.1007/s11434-011-4921-1; Zhou XM, 2006, EPISODES, V29, P26; Li CF, 2008, MAR GEOPHYS RES, V29, P223, DOI 10.1007/s11001-008-9059-4; Ludmann T, 1999, TECTONOPHYSICS, V311, P113, DOI 10.1016/S0040-1951(99)00155-9; Yan P, 2001, TECTONOPHYSICS, V338, P1; Yan P, 2006, J ASIAN EARTH SCI, V27, P647, DOI 10.1016/j.jseaes.2005.06.005; [Anonymous], 2014, S CHINA SEA TECTONIC, P349; Hsu SK, 2004, MAR GEOPHYS RES, V25, P29, DOI 10.1007/s11001-005-0731-7; Li CF, 2012, CHINESE SCI BULL, V57, P3165, DOI 10.1007/s11434-012-5063-9; Clift P, 2001, MAR PETROL GEOL, V18, P929, DOI 10.1016/S0264-8172(01)00037-X; Bautista BC, 2001, TECTONOPHYSICS, V339, P279, DOI 10.1016/S0040-1951(01)00120-2; Biq C C, 1972, PET GEOL TAIWAN, V20, P1; Cao Y., 2014, 2014 FALL M AGU SAN; CHAI BHT, 1972, AM J SCI, V272, P389; Chung SL, 1997, LITHOS, V40, P203, DOI 10.1016/S0024-4937(97)00028-5; Clift PD, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004048; Cohen J. K., 2002, CWP SU SEIMIC UN X R; Gradstein F.M., 2012, GEOLOGIC TIME SCALE, V2; Han X. Q., 2011, ANN M SHANGH, P26; Hutchison CS, 2010, J ASIAN EARTH SCI, V39, P371, DOI 10.1016/j.jseaes.2010.04.013; Jin Q., 1989, GEOLOGY HYDROCARBON; Koppers A. A. P., 2014, 2014 FALL M AGU SAN; Kudrass H. R., 1986, MAR PETROL GEOL, V3, P19, DOI 10.1016/0264-8172(86)90053-X; Li C. -F., 2013, IODP SCI PROSP, V349, DOI [10.2204/iodp.sp.349.2013, DOI 10.2204/IODP.SP.349.2013]; Li CF, 2010, GEOPHYS J INT, V182, P1229, DOI 10.1111/j.1365-246X.2010.04702.x; Li CF, 2007, MAR GEOPHYS RES, V28, P59, DOI 10.1007/s11001-007-9014-9; Li L, 2014, BASIN RES, V26, P106, DOI 10.1111/bre.12045; Liu WN, 2014, MAR PETROL GEOL, V58, P721, DOI 10.1016/j.marpetgeo.2014.06.005; RU K, 1986, AAPG BULL, V70, P1136; Sheriff R. E., 1980, SEISMIC STRATIGRAPHY, P1; Shi HS, 2012, INT GEOL REV, V54, P1801, DOI 10.1080/00206814.2012.677136; Su D., 1989, BASIN RES, V2, P205, DOI DOI 10.1111/J.1365-2117.1989.TB00036.X; Taylor B, 1980, TECTONIC GEOLOGIC EV, P89; Taylor B., 1983, GEOPHYS MONOGR SER, V23, P23, DOI DOI 10.1029/GM027P0023; Wang P., 2000, P OC DRILL PROGR IN, V184, P1, DOI DOI 10.2973/ODP.PROC.IR.184.109.2000; Wang P., 2000, P OC DRILL PROGR IN, V184; Wang P., 2014, GEOLOGY CHINA SEAS; Wang X. J., 1985, GEOCHEMICA, V4, P332; Wessel P., 1995, EOS T AM GEOPHYS UN, V76, P329, DOI DOI 10.1029/95EO00198; Yao B, 1995, GEOLOGICAL RES S CHI, V7, P1; Yao B., 1994, GEOLOGICAL MEMOIR S, P1; Yao YJ, 2012, J ASIAN EARTH SCI, V60, P114, DOI 10.1016/j.jseaes.2012.08.003	58	0	0	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9313	2169-9356		J GEOPHYS RES-SOL EA	J. Geophys. Res.-Solid Earth	MAR	2015	120	3					1377	1399		10.1002/2014JB011686		23	Geochemistry & Geophysics	Geochemistry & Geophysics	CG3EF	WOS:000353160200001		
J	Oohashi, K; Hirose, T; Takahashi, M; Tanikawa, W				Oohashi, Kiyokazu; Hirose, Takehiro; Takahashi, Miki; Tanikawa, Wataru			Dynamic weakening of smectite-bearing faults at intermediate velocities: Implications for subduction zone earthquakes	JOURNAL OF GEOPHYSICAL RESEARCH-SOLID EARTH			English	Article						marine sediments; friction experiment; velocity weakening; decollement; megasplay fault; tsunamigenic earthquakes	SEISMIC SLIP PROPAGATION; PLATE BOUNDARY; THERMAL PRESSURIZATION; FRICTION EXPERIMENTS; SEISMOGENIC ZONE; QUARTZ GOUGE; RICH GOUGE; SEDIMENTS; PERMEABILITY; TEMPERATURE	The hydrous clay mineral smectite, which is pervasive in sediments on subducting oceanic plates, is thought to weaken and stabilize subduction thrust faults. However, these frictional properties of smectite alone cannot explain the large coseismic slip in the vicinity of a trench. Here we performed friction experiments to demonstrate the rate dependence of friction at slip rates from 30 mu m/s to 1.3m/s for water-saturated smectite-quartz mixtures with various smectite contents, so as to shed light on the frictional response of smectite-bearing faults at intermediate to high slip rates. At slip rates of 30 to 150 mu m/s, the friction coefficients decreased gradually from 0.5-0.6 to 0.1 with an increase in smectite content from 20 to 50 wt %. In contrast, at slip rates higher than 1.3mm/s, friction exhibited marked slip weakening, resulting in low friction coefficients of 0.1-0.05, even for low smectite contents (roughly <30 wt %). Drastic slip weakening occurred at smectite contents of 10-30 wt % at slip rates of similar to 10mm/s, which is 1 to 2 orders of magnitude lower than the slip rate at which slip weakening was observed in previous experiments on various rock types. The intermediate velocity weakening could be attributed to a rise in pore pressure caused by both shear-enhanced compaction and microscopic thermal pressurization of pore fluids. This process could weaken the fault even below seismic slip rates, leading to an acceleration of fault motion and potentially facilitating large coseismic slip and a stress drop in the vicinity of a trench.	[Oohashi, Kiyokazu] Yamaguchi Univ, Grad Sch Sci & Engn, Dept Earth Sci, Yamaguchi, Japan; [Hirose, Takehiro; Tanikawa, Wataru] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Kochi, Japan; [Takahashi, Miki] Natl Inst Adv Ind Sci & Technol, Act Fault & Earthquake Res Ctr, Tsukuba, Ibaraki, Japan	Oohashi, K (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, Dept Earth Sci, Yamaguchi, Japan.	oohashik@yamaguchi-u.ac.jp			JSPS [25-04960, 25287135]; MEXT KANAME [21107004]	We thank Kyuichi Kanagawa, Masaya Suzuki, Osamu Tadai, and Hiroko Kitajima for constructive discussions and technical help. We sincerely thank Andre Niemeijer, Dan Faulkner, Diane Moore, Robert Holdsworth, and an anonymous reviewer for careful and constructive reviews and comments on an earlier version of this paper. This work was supported by a JSPS Grant-in-Aid for JSPS fellows (25-04960) to K.O., a JSPS Grant-in-Aid for Scientific Research (25287135) to T.H., and MEXT KANAME grant 21107004. All experimental raw data used in this study are archived at the Kochi Institute for Core Sample Research, at the Japan Agency for Marine-Earth Science and Technology (contact hiroset@jamstec.go.jp) and at the National Institute of Advanced Industrial Science and Technology (contact miki.takahashi@aist.go.jp).	Andrews DJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2002JB001942; Oohashi K, 2011, J STRUCT GEOL, V33, P1122, DOI 10.1016/j.jsg.2011.01.007; Hirose T, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003207; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; Niemeijer A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB000838; LOGAN JM, 1987, TECTONOPHYSICS, V144, P87, DOI 10.1016/0040-1951(87)90010-2; Sakaguchi A, 2011, GEOLOGY, V39, P395, DOI 10.1130/G31642.1; Kozdon JE, 2013, B SEISMOL SOC AM, V103, P1275, DOI 10.1785/0120120136; Saffer DM, 2003, EARTH PLANET SC LETT, V215, P219, DOI 10.1016/S0012-821X(03)00424-2; Han R, 2011, GEOLOGY, V39, P599, DOI 10.1130/G31842.1; Goldsby DL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015240; Bos B, 2001, J STRUCT GEOL, V23, P1187, DOI 10.1016/S0191-8141(00)00184-X; Brantut N, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005551; Han R, 2007, SCIENCE, V316, P878, DOI 10.1126/science.1139763; DOMENICO PA, 1965, WATER RESOUR RES, V1, P563, DOI 10.1029/WR001i004p00563; Tembe S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006383; Brown KM, 2003, EARTH PLANET SC LETT, V214, P589, DOI 10.1016/S0012-821X(03)00388-1; Masuda T, 2000, GEOPHYS RES LETT, V27, P2773, DOI 10.1029/1999GL008460; Hyndman RD, 1997, ISL ARC, V6, P244, DOI 10.1111/j.1440-1738.1997.tb00175.x; GRIFFIN JJ, 1968, DEEP-SEA RES, V15, P433, DOI 10.1016/0011-7471(68)90051-X; COLTENBRADLEY VA, 1987, AAPG BULL, V71, P1414; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Oohashi K, 2013, J GEOPHYS RES-SOL EA, V118, P2067, DOI 10.1002/jgrb.50175; Hirose T, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030049; Gamage K, 2011, MAR GEOL, V279, P19, DOI 10.1016/j.margeo.2010.10.010; Aoki S., 2001, CLAY SCI, V11, P431; Archard J. F., 1958, WEAR, V2, P438, DOI DOI 10.1016/0043-1648(59)90159-0; COLE TG, 1983, CLAY MINER, V18, P239, DOI 10.1180/claymin.1983.018.3.02; Collettini C, 2009, NATURE, V462, P907, DOI 10.1038/nature08585; Cummins PR, 2000, GEOPHYS RES LETT, V27, P2725, DOI 10.1029/1999GL011139; Faulkner DR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048552; French ME, 2014, J GEOPHYS RES-SOL EA, V119, P1777, DOI 10.1002/2013JB010757; Ingebritsen S.E., 1998, GROUNDWATER GEOLOGIC; Kameda J., 2014, GEOLOGY, V43, P155; Kenney TC, 1967, P GEOT C SHEAR STREN, V1, P123; Kitajima H, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007038; O'Hara K, 2005, J STRUCT GEOL, V27, P1892, DOI 10.1016/j.jsg.2005.04.013; Oinuma K., 1966, P 14 NAT C CLAYS CLA, P209; Park JO, 2014, GEOPHYS RES LETT, V41, P7057, DOI 10.1002/2014GL061096; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; Shimamoto T., 1994, STRUCT GEOL, V39, P65; SUMMERS R, 1977, INT J ROCK MECH MIN, V14, P155, DOI 10.1016/0148-9062(77)90007-9; Takahashi M, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004678; Tanikawa W, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008956; Tanikawa W, 2012, J STRUCT GEOL, V38, P90, DOI 10.1016/j.jsg.2011.08.013; Tanikawa W, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007013; Tanikawa W, 2013, EARTH PLANET SC LETT, V382, P150, DOI 10.1016/j.epsl.2013.08.052; Togo T, 2012, J STRUCT GEOL, V38, P139, DOI 10.1016/j.jsg.2011.12.014; Ujiie K, 2011, GEOL SOC SPEC PUBL, V359, P267, DOI 10.1144/SP359.15; Underwood M. B., 2013, P INT OC DRILL PROGR, V322, DOI [10.2204/iodp.proc.322.202.2013, DOI 10.2204/IODP.PROC.322.202.2013]; Yamaguchi A, 2011, GEOLOGY, V39, P995, DOI 10.1130/G32038.1	51	0	0	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9313	2169-9356		J GEOPHYS RES-SOL EA	J. Geophys. Res.-Solid Earth	MAR	2015	120	3					1572	1586		10.1002/2015JB011881		15	Geochemistry & Geophysics	Geochemistry & Geophysics	CG3EF	WOS:000353160200012		
J	Wei, W; Zhao, DP; Xu, JD; Wei, FX; Liu, GM				Wei, Wei; Zhao, Dapeng; Xu, Jiandong; Wei, Feixiang; Liu, Guoming			P and S wave tomography and anisotropy in Northwest Pacific and East Asia: Constraints on stagnant slab and intraplate volcanism	JOURNAL OF GEOPHYSICAL RESEARCH-SOLID EARTH			English	Article						seismic tomography; seismic anisotropy; subduction zones; mantle wedge; slab dehydration; intraplate volcanism	MANTLE TRANSITION ZONE; NOMINALLY ANHYDROUS MINERALS; BENEATH NORTHEAST CHINA; TRENCH-PARALLEL ANISOTROPY; PHILIPPINE SEA PLATE; SEISMIC ANISOTROPY; SHEAR-WAVE; SUBDUCTION ZONES; AZIMUTHAL ANISOTROPY; FABRIC TRANSITIONS	We determined three-dimensional P and S wave velocities and P wave azimuthal anisotropic tomography of the Northwest Pacific subduction zones by inverting 1,225,086 P wave and 335,117 S wave arrival times from 13,413 earthquakes. Our results show some differences between P and S wave images for the stagnant Pacific slab in the mantle transition zone (MTZ) beneath Northeast China. The stagnant slab looks thicker in the P wave image than that in the S wave image, which may reflects the effects of both hydration and lower temperature in the MTZ, though differences in the resolution of P and S wave tomography may also have some effects. The Changbai intraplate volcanism is caused by hot and wet upwelling in the big mantle wedge above the stagnant Pacific slab. Our P wave anisotropy tomography shows that the fast velocity direction (FVD) in the subducting Philippine Sea plate beneath the Ryukyu arc is NE-SW (trench parallel), which is consistent with the spreading direction of the West Philippine Basin during its initial opening stage, suggesting that it may reflect the fossil anisotropy. A striking variation of the FVD with depth is revealed in the subducting Pacific slab beneath the Northeast Japan arc, which may be caused by slab dehydration that changed elastic properties of the slab with depth. The FVD in the mantle wedge beneath the Northeast Japan and Ryukyu arcs is trench normal, which reflects subduction-induced convection. Beneath the Kuril and Izu-Bonin arcs where oblique subduction occurs, the FVD in the mantle wedge is nearly normal to the moving direction of the downgoing Pacific plate, suggesting that the oblique subduction together with the complex slab morphology have disturbed the mantle flow.	[Wei, Wei; Xu, Jiandong; Wei, Feixiang] China Earthquake Adm, Inst Geol, Key Lab Act Tecton & Volcano, Beijing, Peoples R China; [Zhao, Dapeng] Tohoku Univ, Dept Geophys, Sendai, Miyagi 980, Japan; [Liu, Guoming] Changbaishan Volcano Observ, Antu, Peoples R China	Wei, W (reprint author), China Earthquake Adm, Inst Geol, Key Lab Act Tecton & Volcano, Beijing, Peoples R China.	weiwei25011@gmail.com			Special Fund of State Public Institute for Basic Research [IGCEA 1402]; Japan Society for the Promotion of Science [Kiban-S 11050123]	This work was supported by a Special Fund of State Public Institute for Basic Research (grant IGCEA 1402) and a grant from the Japan Society for the Promotion of Science (Kiban-S 11050123). We thank the data center of the China Seismic Networks for providing the arrival time data used in this study. The authors are grateful to E.R. Engdahl for providing his reprocessed ISC data sets (http://www.isc.ac.uk/ehbbulletin/) and to J.O.S. Hammond and X.B. He for thoughtful discussions. We appreciate R.L. Nowack (the Editor), M. Faccenda, the Associate Editor, and an anonymous reviewer for their thoughtful comments and suggestions which have improved this paper.	Ai YS, 2003, EARTH PLANET SC LETT, V212, P63, DOI 10.1016/S0012-821X(03)00266-8; Anglin D. K., 2005, Geophysical Research Letters, V32, DOI 10.1029/2005GL022714; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; INOUE T, 1995, GEOPHYS RES LETT, V22, P117, DOI 10.1029/94GL02965; Sinogeikin SV, 2003, PHYS EARTH PLANET IN, V136, P41, DOI 10.1016/S0031-9201(03)00022-0; Nakajima J, 2004, EARTH PLANET SC LETT, V225, P365, DOI 10.1016/j.epsl.2004.06.011; SHEARER PM, 1992, NATURE, V355, P791, DOI 10.1038/355791a0; Litasov KD, 2006, GEOPHYS MONOGR SER, V168, P95, DOI 10.1029/168GM08; Liu X, 2013, GEOPHYS J INT, V194, P1069, DOI 10.1093/gji/ggt150; Widiyantoro S, 1999, EARTH PLANET SC LETT, V173, P91, DOI 10.1016/S0012-821X(99)00216-2; Huang XG, 2005, NATURE, V434, P746, DOI 10.1038/nature03426; Huang ZC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046804; Heit B, 2010, GEOPHYS J INT, V183, P252, DOI 10.1111/j.1365-246X.2010.04714.x; Karato S, 2011, EARTH PLANET SC LETT, V301, P413, DOI 10.1016/j.epsl.2010.11.038; THOMSEN L, 1986, GEOPHYSICS, V51, P1954, DOI 10.1190/1.1442051; Li C, 2006, PHYS EARTH PLANET IN, V154, P180, DOI 10.1016/j.pepi.2005.09.008; Bolfan-Casanova N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017182; Jung H, 2011, EARTH PLANET SC LETT, V307, P535, DOI 10.1016/j.epsl.2011.05.041; Obayashi M, 2013, GEOPHYS RES LETT, V40, P5652, DOI 10.1002/2013GL057401; Bokelmann GHR, 2002, GEOPHYS J INT, V148, P278, DOI 10.1046/j.1365-246X.2002.01614.x; Higo Y, 2001, GEOPHYS RES LETT, V28, P3505, DOI 10.1029/2001GL013194; Tang YC, 2014, NAT GEOSCI, V7, P470, DOI 10.1038/NGEO2166; Hearn TM, 1996, J GEOPHYS RES-SOL EA, V101, P8403, DOI 10.1029/96JB00114; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; Kuritani T, 2011, NAT GEOSCI, V4, P713, DOI [10.1038/ngeo1250, 10.1038/NGEO1250]; Maggi A, 2006, EARTH PLANET SC LETT, V250, P53, DOI 10.1016/j.epsl.2006.07.010; Faccenda M, 2014, TECTONOPHYSICS, V614, P1, DOI 10.1016/j.tecto.2013.12.020; Cao A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006876; Hirschmann MM, 2005, EARTH PLANET SC LETT, V236, P167, DOI 10.1016/j.epsl.2005.04.022; Zhao DP, 2009, PHYS EARTH PLANET IN, V173, P197, DOI 10.1016/j.pepi.2008.11.009; Kincaid C, 2003, NATURE, V425, P58, DOI 10.1038/nature01923; Karato S, 2008, ANNU REV EARTH PL SC, V36, P59, DOI 10.1146/annurev.earth.36.031207.124120; Zhao D, 2001, EARTH PLANET SC LETT, V192, P251, DOI 10.1016/S0012-821X(01)00465-4; Huang ZC, 2011, GEOPHYS J INT, V184, P1428, DOI 10.1111/j.1365-246X.2011.04934.x; HESS HH, 1964, NATURE, V203, P629, DOI 10.1038/203629a0; Katayama I, 2009, NATURE, V461, P1114, DOI 10.1038/nature08513; Bastow ID, 2012, GEOPHYS J INT, V190, P1271, DOI 10.1111/j.1365-246X.2012.05559.x; Wei W, 2012, J ASIAN EARTH SCI, V60, P88, DOI 10.1016/j.jseaes.2012.08.001; Di Leo JF, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004417; Faccenda M, 2008, NATURE, V455, P1097, DOI 10.1038/nature07376; Li XQ, 2003, EARTH PLANET SC LETT, V216, P679, DOI 10.1016/S0012-821X(03)00555-7; Lynner C, 2014, GEOCHEM GEOPHY GEOSY, V15, P2262, DOI 10.1002/2014GC005239; Healy D, 2009, EARTH PLANET SC LETT, V283, P75, DOI 10.1016/j.epsl.2009.03.037; SENO T, 1993, J GEOPHYS RES-SOL EA, V98, P17941, DOI 10.1029/93JB00782; Ye LL, 2011, GEOPHYS J INT, V186, P706, DOI 10.1111/j.1365-246X.2011.05063.x; SMYTH JR, 1987, AM MINERAL, V72, P1051; Zhao DP, 2013, GONDWANA RES, V23, P595, DOI 10.1016/j.gr.2012.08.004; Li J, 2013, EARTH PLANET SC LETT, V367, P71, DOI 10.1016/j.epsl.2013.02.026; Helffrich G, 2000, REV GEOPHYS, V38, P141, DOI 10.1029/1999RG000060; Wei HQ, 2007, LITHOS, V96, P315, DOI 10.1016/j.lithos.2006.10.004; Ohtani E, 2004, PHYS EARTH PLANET IN, V143, P255, DOI 10.1016/j.pepi.2003.09.015; Engdahl ER, 1998, B SEISMOL SOC AM, V88, P722; Lei JS, 2005, TECTONOPHYSICS, V397, P281, DOI 10.1016/j.tecto.2004.12.009; Widiyantoro S, 2011, GEOL SOC SPEC PUBL, V355, P139, DOI 10.1144/SP355.7; NAKANISHI M, 1992, GEOPHYS J INT, V109, P701, DOI 10.1111/j.1365-246X.1992.tb00126.x; Yuan KQ, 2013, EARTH PLANET SC LETT, V374, P132, DOI 10.1016/j.epsl.2013.05.031; Zhao DP, 2007, GONDWANA RES, V11, P120, DOI 10.1016/j.gr.2006.06.006; Zhao DP, 2013, GEOPHYS J INT, V195, P706, DOI 10.1093/gji/ggt289; Long MD, 2006, PHYS EARTH PLANET IN, V155, P300, DOI 10.1016/j.pepi.2006.01.003; Fukao Y, 2009, ANNU REV EARTH PL SC, V37, P19, DOI 10.1146/annurev.earth.36.031207.124224; Takeuchi N, 2014, J GEOPHYS RES-SOL EA, V119, P7667, DOI 10.1002/2014JB011161; RAITT RW, 1969, J GEOPHYS RES, V74, P3095, DOI 10.1029/JB074i012p03095; Stern RJ, 2002, REV GEOPHYS, V40, DOI 10.1029/2001RG000108; Zhao DP, 2004, PHYS EARTH PLANET IN, V146, P3, DOI 10.1016/j.pepi.2003.07.032; VANDERHILST R, 1991, NATURE, V353, P37, DOI 10.1038/353037a0; Karato S, 2006, REV MINERAL GEOCHEM, V62, P343, DOI 10.2138/rmg.2006.62.15; Wei W, 2013, PHYS EARTH PLANET IN, V222, P47, DOI 10.1016/j.pepi.2013.07.002; Jacobsen SD, 2006, REV MINERAL GEOCHEM, V62, P321, DOI 10.2138/rmg.2006.62.14; Flanagan MP, 1998, J GEOPHYS RES-SOL EA, V103, P2673, DOI 10.1029/97JB03212; Gorbatov A, 2003, EARTH PLANET SC LETT, V210, P527, DOI 10.1016/S0012-821X(03)-00165-1; HILDE TWC, 1984, TECTONOPHYSICS, V102, P85, DOI 10.1016/0040-1951(84)90009-X; Zhao DP, 2012, GEOPHYS J INT, V190, P816, DOI 10.1111/j.1365-246X.2012.05550.x; Long MD, 2008, SCIENCE, V319, P315, DOI 10.1126/science.1150809; Jung H, 2001, SCIENCE, V293, P1460, DOI 10.1126/science.1062235; Faccenda M, 2014, PHYS EARTH PLANET IN, V227, P1, DOI 10.1016/j.pepi.2013.11.015; McCormack K, 2013, GEOPHYS RES LETT, V40, P1697, DOI 10.1002/grl.50369; Smyth JR, 2006, GEOPHYS MONOGR SER, V168, P1, DOI 10.1029/168GM02; Hall CE, 2000, J GEOPHYS RES-SOL EA, V105, P28009, DOI 10.1029/2000JB900297; Richard GC, 2010, PHYS EARTH PLANET IN, V183, P280, DOI 10.1016/j.pepi.2010.02.009; BACKUS GE, 1965, J GEOPHYS RES, V70, P3429, DOI 10.1029/JZ070i014p03429; Bijwaard H, 1998, J GEOPHYS RES-SOL EA, V103, P30055, DOI 10.1029/98JB02467; CHRISTENSEN NI, 1984, GEOPHYS J ROY ASTR S, V76, P89, DOI 10.1111/j.1365-246X.1984.tb05025.x; Eberhart-Phillips D, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005947; Eberhart-Phillips D, 2004, GEOPHYS J INT, V156, P237, DOI 10.1046/j.1365-246X.2003.02044.x; Foley BJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046021; Frost DJ, 2007, EARTH PLANET SC LETT, V256, P182, DOI 10.1016/j.epsl.2007.01.023; FUKAO Y, 1992, J GEOPHYS RES-SOL EA, V97, P4809, DOI 10.1029/91JB02749; Gu YJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000489; Gu YJ, 2012, EARTH PLANET SC LETT, V331, P269, DOI 10.1016/j.epsl.2012.03.023; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Huang JL, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004066; Huang ZC, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003343; Ishise M, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003599; Jacobsen SD, 2006, GEOPHYS MONOGR SER, V168, P131; Kavner A, 2003, EARTH PLANET SC LETT, V214, P645, DOI [10.1016/S0012-821X(03)00402-3, 10.1016/S012-821X(03)00402-3]; Kennett BLN, 2004, PHYS EARTH PLANET IN, V146, P87, DOI 10.1016/j.pepi.2003.07.033; Kneller EA, 2008, EARTH PLANET SC LETT, V268, P268, DOI 10.1016/j.epsl.2008.01.004; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Komabayashi T, 2005, PHYS EARTH PLANET IN, V153, P191, DOI 10.1016/j.pepi.2005.07.001; PAIGE CC, 1982, ACM T MATH SOFTWARE, V8, P43, DOI 10.1145/355984.355989; Schmandt B, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003668; SHEARER PM, 1991, J GEOPHYS RES-SOL EA, V96, P18147, DOI 10.1029/91JB01592; Smyth JR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014418; Suetsugu D, 2010, PHYS EARTH PLANET IN, V183, P270, DOI 10.1016/j.pepi.2010.09.004; SUETSUGU D, 2006, EARTHS DEEP WATER CY, V168, P237; Tian Y, 2012, GEOPHYS J INT, V190, P629, DOI 10.1111/j.1365-246X.2012.05512.x; Tono Y, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2009JB006290; Trampert J, 2002, SCIENCE, V296, P1297, DOI 10.1126/science.1070264; Wang J, 2009, TECTONOPHYSICS, V469, P137, DOI 10.1016/j.tecto.2009.02.005; Wang J, 2008, PHYS EARTH PLANET IN, V170, P115, DOI 10.1016/j.pepi.2008.07.042; Wang J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004081; Wang J, 2013, GEOPHYS J INT, V193, P1166, DOI 10.1093/gji/ggt086; Wirth EA, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004180; WOOD BJ, 1995, SCIENCE, V268, P74, DOI 10.1126/science.268.5207.74; Wookey J, 2002, NATURE, V415, P777; Yeh YL, 2013, TECTONOPHYSICS, V592, P94, DOI 10.1016/j.tecto.2013.02.005; ZHAO DP, 1992, J GEOPHYS RES-SOL EA, V97, P19909, DOI 10.1029/92JB00603	117	4	4	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9313	2169-9356		J GEOPHYS RES-SOL EA	J. Geophys. Res.-Solid Earth	MAR	2015	120	3					1642	1666		10.1002/2014JB011254		25	Geochemistry & Geophysics	Geochemistry & Geophysics	CG3EF	WOS:000353160200016		
J	Naoi, M; Nakatani, M; Kgarume, T; Khambule, S; Masakale, T; Ribeiro, L; Philipp, J; Horiuchi, S; Otsuki, K; Miyakawa, K; Watanabe, A; Moriya, H; Murakami, O; Yabe, Y; Kawakata, H; Yoshimitsu, N; Ward, A; Durrheim, R; Ogasawara, H				Naoi, Makoto; Nakatani, Masao; Kgarume, Thabang; Khambule, Sifiso; Masakale, Thabang; Ribeiro, Luiz; Philipp, Joachim; Horiuchi, Shigeki; Otsuki, Kenshiro; Miyakawa, Koji; Watanabe, Atsushi; Moriya, Hirokazu; Murakami, Osamu; Yabe, Yasuo; Kawakata, Hironori; Yoshimitsu, Nana; Ward, Anthony; Durrheim, Raymond; Ogasawara, Hiroshi			Quasi-static slip patch growth to 20 m on a geological fault inferred from acoustic emissions in a South African gold mine	JOURNAL OF GEOPHYSICAL RESEARCH-SOLID EARTH			English	Article						acoustic emission; induced earthquake; aseismic slip; b value; microseismicity	REPEATING EARTHQUAKES; SOURCE PARAMETERS; STICK-SLIP; B-VALUE; MAGNITUDE; NUCLEATION; RUPTURE; JAPAN; COMPLETENESS; PROPAGATION	Three months of acoustic emission (AE) monitoring in a South African gold mine down to M-w -5 revealed a newly emergent planar cluster of 7557 events -3.9M(w)-1.8 (typical rupture radius of 6-70cm) that expanded with time to reach a size of 20m on a preexisting geological fault near an active mining front 1km beneath the ground. It had a sharply defined, planar configuration, with hypocenters aggregated within a thickness of only several decimeters. We infer that the zone defines an aseismic slip patch on the fault, wherein the individual AEs represent failures of very small asperities being loaded by the aseismic slip. Additional support for the interpretation was obtained by analyzing composite focal mechanisms and repeating events. The patch expansion over 2months was likely quasistatic because all individual AEs ruptured much smaller areas than the cluster size at the corresponding time. The b values dropped gradually from 2.6 to 1.4, consistent with a significant increase in shear stress expected of the mining style. Another cluster with similar characteristics emerged later on a neighboring part of the same fault and grew to a 10m extent in the last weeks of the study period. The quasi-static expansion of inferred localized slow-slip patches to sizes of 10-20m suggests that the critical crack length on natural faults can be at least as large, much exceeding the decimeter range derived from laboratory stick-slip experiments on saw-cut rocks.	[Naoi, Makoto; Nakatani, Masao; Miyakawa, Koji; Watanabe, Atsushi; Yoshimitsu, Nana] Kyoto Univ, Earthquake Res Inst, Bunkyo Ku, Kyoto 6068501, Japan; [Kgarume, Thabang; Durrheim, Raymond] CSIR, Pretoria, South Africa; [Khambule, Sifiso; Masakale, Thabang] Open House Management Solut, Potchefstroom, South Africa; [Ribeiro, Luiz; Ward, Anthony] SeismoGen Cc, Carletonville, South Africa; [Philipp, Joachim] GMuG Gesell Mat Prufung & Geophys MbH, Bad Nauheim, Germany; [Horiuchi, Shigeki] Home Seismometer Corp, Shirakawa, Japan; [Otsuki, Kenshiro] Tohoku Univ, Grad Sch Sci, Dept Earth Sci, Aoba Ku, Sendai, Miyagi 980, Japan; [Moriya, Hirokazu] Tohoku Univ, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 980, Japan; [Murakami, Osamu] Ritsumeikan Univ, Res Org Sci & Engn, Kusatsu, Japan; [Yabe, Yasuo] Tohoku Univ, Grad Sch Sci, Res Ctr Predict Earthquakes & Volcan Erupt, Aoba Ku, Sendai, Miyagi 980, Japan; [Kawakata, Hironori; Ogasawara, Hiroshi] Ritsumeikan Univ, Coll Sci & Engn, Kusatsu, Japan; [Durrheim, Raymond] Univ Witwatersrand, Johannesburg, South Africa	Naoi, M (reprint author), Kyoto Univ, Grad Sch Engn, Dept Civil & Earth Resources Engn, Kyoto Daigaku Katsura Cluster C,Nishikyo Ku, Kyoto 6068501, Japan.	naoi.makoto.4z@kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21224012, 21246134, 26249137, 26887022]; JST/JICA; SATREPS; MEXT's Observation and Research Program for Prediction of Earthquakes and Volcanic Eruptions; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	We thank Sibanye Gold Ltd., operator of the Cooke 4 mine, for approving our publication and the personnel at the mine and at the Institute of Mine Seismology for facilitating our project. We dedicate this paper to late Gilbert Morema, who was the real engine of the AE observation. We also thank, Thomas H. W. Goebel, anonymous reviewers, and the Associate Editor for constructive reviews. This project was funded by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (21224012, 21246134, 26249137, and 26887022). It was also funded by JST/JICA, SATREPS, and the MEXT's Observation and Research Program for Prediction of Earthquakes and Volcanic Eruptions. R.J.D. acknowledges support from the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation. The waveform data and the event catalog used in the manuscript cannot be accessible because they were obtained in a mine owned by a commercial company.	Aki K., 1965, B EARTHQ RES I TOKYO, V43, P237; Yabe Y, 2003, PURE APPL GEOPHYS, V160, P1163; Nadeau RM, 1998, B SEISMOL SOC AM, V88, P790; Ohnaka M, 1999, J GEOPHYS RES-SOL EA, V104, P817, DOI 10.1029/1998JB900007; Goebel THW, 2013, GEOPHYS RES LETT, V40, P2049, DOI 10.1002/grl.50507; Igarashi T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001920; McLaskey GC, 2014, J GEOPHYS RES-SOL EA, V119, P6323, DOI 10.1002/2014JB011220; DODGE DA, 1995, J GEOPHYS RES-SOL EA, V100, P9865, DOI 10.1029/95JB00871; OKUBO PG, 1984, J GEOPHYS RES, V89, P5817, DOI 10.1029/JB089iB07p05817; Schorlemmer D, 2005, NATURE, V437, P539, DOI 10.1038/nature04094; Woessner J, 2005, B SEISMOL SOC AM, V95, P684, DOI 10.1785/0120040007; DIETERICH JH, 1978, J GEOPHYS RES, V83, P3940, DOI 10.1029/JB083iB08p03940; Manthei G, 2005, B SEISMOL SOC AM, V95, P1674, DOI 10.1785/0120040076; Hainzl S, 2004, GEOPHYS J INT, V159, P1090, DOI 10.1111/j.1365-246X.2004.02463.x; Shapiro SA, 1997, GEOPHYS J INT, V131, pF15, DOI 10.1111/j.1365-246X.1997.tb01215.x; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; HANKS TC, 1979, J GEOPHYS RES, V84, P2348, DOI 10.1029/JB084iB05p02348; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Wiemer S, 2000, B SEISMOL SOC AM, V90, P859, DOI 10.1785/0119990114; Matsuzawa T, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014632; Bachmann CE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051480; Kwiatek G, 2011, B SEISMOL SOC AM, V101, P2592, DOI 10.1785/0120110094; Parotidis M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018110; DIETERICH JH, 1992, TECTONOPHYSICS, V211, P115, DOI 10.1016/0040-1951(92)90055-B; DAS S, 1981, J GEOPHYS RES, V86, P6039, DOI 10.1029/JB086iB07p06039; DIETERICH JH, 1981, GEOPHYS RES LETT, V8, P653, DOI 10.1029/GL008i007p00653; ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133; Horiuchi S., 2011, IUGG GEN ASS MELB AU, P3430; Kawakata H., 2011, 2011 FALL M; Naoi M, 2014, PURE APPL GEOPHYS, V171, P2665, DOI 10.1007/s00024-013-0721-7; Naoi M., 2015, TECTONOPHYS IN PRESS; Ogasawara H., 2014, P 48 US ROCK MECH GE, P14; Ohnaka M., 1986, GEOPHYS MONOGR AM GE, V37, P13; OHNAKA M, 1993, J PHYS EARTH, V41, P45; Parotidis M., 2005, Journal of Geophysical Research-Part B-Solid Earth, V110, DOI 10.1029/2004JB003267; Sakaguchi K., 1992, J MINING MAT PROCESS, V108, P455; Scholz C. H., 1968, Bulletin of the Seismological Society of America, V58; Scholz C.H., 2002, MECH EARTHQUAKES FAU; Shearer PM, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000685; SHI Y, 1982, B SEISMOL SOC AM, V72, P1677; Sugawara K., 1999, INT J ROCK MECH MIN, V36, P307; Utsu T, 1965, GEOPHYS B HOKKAIDO U, V13, P99; Van Aswegen G., 1993, P 3 INT S ROCKB SEIS; Yukutake Y, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008036	44	2	2	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9313	2169-9356		J GEOPHYS RES-SOL EA	J. Geophys. Res.-Solid Earth	MAR	2015	120	3					1692	1707		10.1002/2014JB011165		16	Geochemistry & Geophysics	Geochemistry & Geophysics	CG3EF	WOS:000353160200019		
J	Yue, H; Lay, T; Li, LY; Yamazaki, Y; Cheung, KF; Rivera, L; Hill, EM; Sieh, K; Kongko, W; Muhari, A				Yue, Han; Lay, Thorne; Li, Linyan; Yamazaki, Yoshiki; Cheung, Kwok Fai; Rivera, Luis; Hill, Emma M.; Sieh, Kerry; Kongko, Widjo; Muhari, Abdul			Validation of linearity assumptions for using tsunami waveforms in joint inversion of kinematic rupture models: Application to the 2010 Mentawai M-w 7.8 tsunami earthquake	JOURNAL OF GEOPHYSICAL RESEARCH-SOLID EARTH			English	Article						2010 Mentawai earthquake; joint inversion; tsunami inversion; tsunami earthquake; shallow megathrust; tsunami linearity	TOHOKU-OKI EARTHQUAKE; FREE-SURFACE FLOW; COSEISMIC SLIP; RADAR INTERFEROMETRY; GEODETIC DATA; LANDERS EARTHQUAKE; FAULT; MOTION; CHILE; DEFORMATION	Tsunami observations have particular importance for resolving shallow offshore slip in finite-fault rupture model inversions for large subduction zone earthquakes. However, validations of amplitude linearity and choice of subfault discretization of tsunami Green's functions are essential when inverting tsunami waveforms. We explore such validations using four tsunami recordings of the 25 October 2010 Mentawai M-w 7.8 tsunami earthquake, jointly inverted with teleseismic body waves and 1Hz GPS (high-rate GPS) observations. The tsunami observations include near-field and far-field deep water recordings, as well as coastal and island tide gauge recordings. A nonlinear, dispersive modeling code, NEOWAVE, is used to construct tsunami Green's functions from seafloor excitation for the linear inversions, along with performing full-scale calculations of the tsunami for the inverted models. We explore linearity and finiteness effects with respect to slip magnitude, variable rake determination, and subfault dimensions. The linearity assumption is generally robust for the deep water recordings, and wave dispersion from seafloor excitation is important for accurate description of near-field Green's functions. Breakdown of linearity produces substantial misfits for short-wavelength signals in tide gauge recordings with large wave heights. Including the tsunami observations in joint inversions provides improved resolution of near-trench slip compared with inversions of only seismic and geodetic data. Two rupture models, with fine-grid (15km) and coarse-grid (30km) spacing, are inverted for the Mentawai event. Stronger regularization is required for the fine model representation. Both models indicate a shallow concentration of large slip near the trench with peak slip of similar to 15m. Fully nonlinear forward modeling of tsunami waveforms confirms the validity of these two models for matching the tsunami recordings along with the other data.	[Yue, Han; Lay, Thorne] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Yue, Han] CALTECH, Div Geol & Planetary Sci, Seismol Lab, Pasadena, CA 91125 USA; [Li, Linyan; Yamazaki, Yoshiki; Cheung, Kwok Fai] Univ Hawaii Manoa, Dept Ocean & Resources Engn, Honolulu, HI 96822 USA; [Rivera, Luis] Univ Strasbourg, CNRS, Inst Phys Globe Strasbourg, Strasbourg, France; [Hill, Emma M.; Sieh, Kerry] Nanyang Technol Univ, Earth Observ Singapore, Singapore 639798, Singapore; [Kongko, Widjo] Indonesian Agcy Assessment & Applicat Technol, Coastal Dynam Res Ctr, Yogyakarta, Indonesia; [Muhari, Abdul] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan	Lay, T (reprint author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	tlay@ucsc.edu	Hill, Emma/B-7037-2011	Hill, Emma/0000-0003-0231-5818	NSF [EAR1245717]	We appreciate helpful reviews by two anonymous reviewers. This work made use of GMT, SAC, and MATLAB software. The IRIS data management center was used to access the seismic data from Global Seismic Network and Federation of Digital Seismic Network stations. The GITEWS GPS buoy data in Mentawai were provided by the Badan Meteorology and Geofisika (BMKG), Indonesia. DART buoy data were obtained from the NOAA National Data Buoy Center. The authors thank Jane Sexton of Geoscience Australia for the digital elevation model of Cocos Island and the tide gauge coordinates. The SuGAr network is jointly operated by the Earth Observatory of Singapore and the Indonesia Institute of Sciences (LIPI). This work was supported in part by NSF grant EAR1245717 (T.L.).	Hill EM, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009159; HARTZELL SH, 1983, B SEISMOL SOC AM, V73, P1553; SATAKE K, 1987, J PHYS EARTH, V35, P241; Burgmann R, 2000, ANNU REV EARTH PL SC, V28, P169, DOI 10.1146/annurev.earth.28.1.169; Yue H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048700; Singh SC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048935; Bletery Q, 2014, J GEOPHYS RES-SOL EA, V119, P7636, DOI 10.1002/2014JB011261; GOLDSTEIN RM, 1993, SCIENCE, V262, P1525, DOI 10.1126/science.262.5139.1525; Romano F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00385; Tsai VC, 2013, GEOPHYS RES LETT, V40, P492, DOI 10.1002/grl.50147; Shen ZK, 2009, NAT GEOSCI, V2, P718, DOI 10.1038/NGEO636; Yue H, 2013, B SEISMOL SOC AM, V103, P1242, DOI 10.1785/0120120119; Wang RJ, 1999, B SEISMOL SOC AM, V89, P733; Satake K, 2013, B SEISMOL SOC AM, V103, P1473, DOI 10.1785/0120120122; Watada S, 2014, J GEOPHYS RES-SOL EA, V119, P4287, DOI 10.1002/2013JB010841; Yamazaki Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049130; Yue H, 2014, J GEOPHYS RES-SOL EA, V119, P5574, DOI 10.1002/2014JB011082; MASSONNET D, 1993, NATURE, V364, P138, DOI 10.1038/364138a0; FREYMUELLER J, 1994, B SEISMOL SOC AM, V84, P646; Lay T, 2010, B SEISMOL SOC AM, V100, P969, DOI 10.1785/0120090274; Allgeyer S, 2014, GEOPHYS RES LETT, V41, P2368, DOI 10.1002/2014GL059348; Pollitz FF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048632; Melgar D, 2013, J GEOPHYS RES-SOL EA, V118, P5939, DOI 10.1002/2013JB010506; Lay T, 2013, EARTH PLANET SC LETT, V375, P57, DOI 10.1016/j.epsl.2013.05.005; Lay T, 2014, GEOPHYS RES LETT, V41, P3818, DOI 10.1002/2014GL060238; SATAKE K, 1993, J GEOPHYS RES-SOL EA, V98, P4553, DOI 10.1029/92JB01553; An C, 2014, GEOPHYS RES LETT, V41, P3988, DOI 10.1002/2014GL060567; Wang RJ, 2003, COMPUT GEOSCI-UK, V29, P195, DOI 10.1016/S0098-3004(02)00111-5; Yue H, 2013, J GEOPHYS RES-SOL EA, V118, P5453, DOI 10.1002/jgrb.50379; Bai YF, 2013, J FLUID MECH, V726, P226, DOI 10.1017/jfm.2013.213; Johnson JM, 1996, J GEOPHYS RES-SOL EA, V101, P523, DOI 10.1029/95JB02806; Kanamori H, 2014, ANNU REV EARTH PL SC, V42, P7, DOI 10.1146/annurev-earth-060313-055034; Ji C, 2002, B SEISMOL SOC AM, V92, P1192, DOI 10.1785/0120000916; Satake K, 2013, PURE APPL GEOPHYS, V170, P1567, DOI 10.1007/s00024-012-0536-y; Saito T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049089; [Anonymous], 2004, GEOPHYS RES LETT; Yue H, 2014, J GEOPHYS RES-SOL EA, V119, P7786, DOI 10.1002/2014JB011340; Lorito S, 2011, NAT GEOSCI, V4, P173, DOI [10.1038/ngeo1073, 10.1038/NGEO1073]; Tong XP, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006625; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Tanioka Y, 1996, GEOPHYS RES LETT, V23, P861, DOI 10.1029/96GL00736; Avouac JP, 2014, EARTH PLANET SC LETT, V391, P128, DOI 10.1016/j.epsl.2014.01.036; Bai YF, 2013, INT J NUMER METH FL, V71, P403, DOI 10.1002/fld.3664; Bai YF, 2014, GEOPHYS RES LETT, V41, P8512, DOI 10.1002/2014GL061686; Bilek SL, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047864; Kaijura K., 1963, B EARTHQ RES I TOKYO, V41, P535; KIKUCHI M, 1993, J GEOPHYS RES-SOL EA, V98, P15797, DOI 10.1029/93JB01568; KIKUCHI M, 1991, B SEISMOL SOC AM, V81, P2335; Yamazaki Y, 2011, INT J NUMER METH FL, V67, P2081, DOI 10.1002/fld.2485; Lay T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046552; Lay T, 2013, TECTONOPHYSICS, V608, P1109, DOI 10.1016/j.tecto.2013.07.001; Lay T, 2011, EARTH PLANETS SPACE, V63, P797, DOI 10.5047/eps.2011.05.030; Lay T., 2014, EARTH PLANET SC LETT, V409, P133; Newman AV, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046498; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Romano F, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006665; Romano F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05631; SATAKE K, 1989, J GEOPHYS RES-SOLID, V94, P5627, DOI 10.1029/JB094iB05p05627; Simons M, 2007, TREATISE GEOPHYS, V3, P391, DOI [10.1016/B978-044452748-6.00059-6, DOI 10.1016/B978-044452748-6.00059-6]; Yamazaki Y., 2012, NEOWAVE P RES 2011 N, P239; Yamazaki Y, 2009, INT J NUMER METH FL, V61, P473, DOI 10.1002/fld.1952; Yokota Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050098; Zumberge JF, 1997, J GEOPHYS RES-SOL EA, V102, P5005, DOI 10.1029/96JB03860	63	1	1	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9313	2169-9356		J GEOPHYS RES-SOL EA	J. Geophys. Res.-Solid Earth	MAR	2015	120	3					1728	1747		10.1002/2014JB011721		20	Geochemistry & Geophysics	Geochemistry & Geophysics	CG3EF	WOS:000353160200021		
J	Jiang, GY; Xu, XW; Chen, GH; Liu, YJ; Fukahata, Y; Wang, H; Yu, GH; Tan, XB; Xu, CJ				Jiang, Guoyan; Xu, Xiwei; Chen, Guihua; Liu, Yajing; Fukahata, Yukitoshi; Wang, Hua; Yu, Guihua; Tan, Xibin; Xu, Caijun			Geodetic imaging of potential seismogenic asperities on the Xianshuihe-Anninghe-Zemuhe fault system, southwest China, with a new 3-D viscoelastic interseismic coupling model	JOURNAL OF GEOPHYSICAL RESEARCH-SOLID EARTH			English	Article						interseismic deformation; 3-D viscoelastic coupling model; geodetic inversions; slip deficit rate distribution; asperity model	RECEIVER FUNCTION-ANALYSIS; CRUSTAL STRUCTURE BENEATH; EASTERN TIBETAN PLATEAU; WAVE VELOCITY STRUCTURE; SAN-ANDREAS FAULT; WESTERN SICHUAN; SUBDUCTION ZONE; ACTIVE TECTONICS; HALF-SPACE; SLOW SLIP	We use GPS and interferometric synthetic aperture radar (InSAR) measurements to image the spatial variation of interseismic coupling on the Xianshuihe-Anninghe-Zemuhe (XAZ) fault system. A new 3-D viscoelastic interseismic deformation model is developed to infer the rotation and strain rates of blocks, postseismic viscoelastic relaxation, and interseismic slip deficit on the fault surface discretized with triangular dislocation patches. The inversions of synthetic data show that the optimal weight ratio and smoothing factor are both 1. The successive joint inversions of geodetic data with different viscosities reveal six potential fully coupled asperities on the XAZ fault system. Among them, the potential asperity between Shimian and Mianning, which does not exist in the case of 10(19)Pas, is confirmed by the published microearthquake depth profile. Besides, there is another potential partially coupled asperity between Daofu and Kangding with a length scale up to 140km. All these asperity sizes are larger than the minimum resolvable wavelength. The minimum and maximum slip deficit rates near the Moxi town are 7.0 and 12.7mm/yr, respectively. Different viscosities have little influence on the roughness of the slip deficit rate distribution and the fitting residuals, which probably suggests that our observations cannot provide a good constraint on the viscosity of the middle lower crust. The calculation of seismic moment accumulation on each segment indicates that the Songlinkou-Selaha (S4), Shimian-Mianning (S7), and Mianning-Xichang (S8) segments are very close to the rupture of characteristic earthquakes. However, the confidence level is confined by sparse near-fault observations.	[Jiang, Guoyan; Xu, Xiwei; Chen, Guihua; Yu, Guihua; Tan, Xibin] China Earthquake Adm, Inst Geol, Key Lab Act Tecton & Volcano, Beijing, Peoples R China; [Liu, Yajing] McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ, Canada; [Fukahata, Yukitoshi] Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan; [Wang, Hua] Guangdong Univ Technol, Dept Surveying Engn, Guangzhou, Guangdong, Peoples R China; [Xu, Caijun] Wuhan Univ, Sch Geodesy & Geomat, Wuhan 430072, Peoples R China	Xu, XW (reprint author), China Earthquake Adm, Inst Geol, Key Lab Act Tecton & Volcano, Beijing, Peoples R China.	xiweixu@vip.sina.com			Basic Scientific Funding of Institute of Geology, China Earthquake Administration [JB-14-03]; National Natural Science Foundation of China [41404012, 41372221]; China Postdoctoral Science Foundation [2014 M560102]	We thank Paul Tregoning, Associate Editor Yan Jiang, and an anonymous reviewer for their suggestions that have helped to improve the presentation of this manuscript. This study is supported by the Basic Scientific Funding of Institute of Geology, China Earthquake Administration (JB-14-03), the National Natural Science Foundation of China (41404012 and 41372221), and the China Postdoctoral Science Foundation (2014 M560102).	Maerten F, 2005, B SEISMOL SOC AM, V95, P1654, DOI 10.1785/0120030181; Savage JC, 2001, J GEOPHYS RES-SOL EA, V106, P21995, DOI 10.1029/2000JB000127; Papadimitriou E, 2004, PURE APPL GEOPHYS, V161, P1683, DOI 10.1007/s00024-003-2471-4; Li HY, 2009, EARTH PLANET SC LETT, V282, P201, DOI 10.1016/j.epsl.2009.03.021; Zhu AL, 2005, CHINESE J GEOPHYS-CH, V48, P629; Li HY, 2012, GEOPHYS J INT, V188, P131, DOI 10.1111/j.1365-246X.2011.05205.x; Sun XX, 2014, GEOPHYS RES LETT, V41, P1479, DOI 10.1002/2014GL059269; Zhang ZJ, 2011, J ASIAN EARTH SCI, V40, P977, DOI 10.1016/j.jseaes.2010.03.010; SAVAGE JC, 1970, B SEISMOL SOC AM, V60, P1877; Wang YX, 2013, TECTONOPHYSICS, V584, P191, DOI 10.1016/j.tecto.2012.09.003; Wang WL, 2014, J GEOPHYS RES-SOL EA, V119, P1061, DOI 10.1002/2013JB010317; Copley A, 2007, GEOPHYS J INT, V169, P683, DOI 10.1111/j.1365-246X.2007.03343.x; Zhou LQ, 2012, GEOPHYS J INT, V189, P1565, DOI 10.1111/j.1365-246X.2012.05423.x; ALLEN CR, 1991, GEOL SOC AM BULL, V103, P1178, DOI 10.1130/0016-7606(1991)103<1178:FSOAHA>2.3.CO;2; Hyodo M, 2003, EARTH PLANETS SPACE, V55, P667; Jiang GY, 2013, GEOPHYS J INT, V194, P1011, DOI 10.1093/gji/ggt141; Fukahata Y, 2006, GEOPHYS J INT, V166, P418, DOI 10.1111/j.1365-246X.2006.02921.x; SCHWARTZ DP, 1984, J GEOPHYS RES, V89, P5681, DOI 10.1029/JB089iB07p05681; Liu QY, 2009, CHINESE J GEOPHYS-CH, V52, P309; Wang H, 2013, GEOPHYS J INT, V193, P11, DOI 10.1093/gji/ggs095; Jiang GY, 2014, TECTONOPHYSICS, V615, P85, DOI 10.1016/j.tecto.2013.12.022; Bai DH, 2010, NAT GEOSCI, V3, P358, DOI 10.1038/NGEO830; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Deng QD, 2003, SCI CHINA SER D, V46, P356; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; Johnson KM, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003096; Burgmann R, 2006, GEOLOGY, V34, P221, DOI 10.1130/G22064.1; McCaffrey R, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003307; TAPPONNIER P, 1977, J GEOPHYS RES, V82, P2905, DOI 10.1029/JB082i020p02905; COMNINOU M, 1975, J ELASTICITY, V5, P203, DOI 10.1007/BF00126985; Xu ZJ, 2010, TECTONOPHYSICS, V491, P185, DOI 10.1016/j.tecto.2009.11.022; Xu XM, 2013, J ASIAN EARTH SCI, V73, P121, DOI 10.1016/j.jseaes.2013.04.018; Copley A, 2008, GEOPHYS J INT, V174, P1081, DOI 10.1111/j.1365-246X.2008.03853.x; Liang SM, 2013, J GEOPHYS RES-SOL EA, V118, P5722, DOI 10.1002/2013JB010503; Schmidt DA, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003397; Wang KL, 2012, NATURE, V484, P327, DOI 10.1038/nature11032; McCaffrey R, 2008, NAT GEOSCI, V1, P316, DOI 10.1038/ngeo178; Yang YJ, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008810; Xu XW, 2008, SCI CHINA SER D, V51, P1209, DOI 10.1007/s11430-008-0097-1; Brocher TA, 2005, B SEISMOL SOC AM, V95, P2081, DOI 10.1785/0120050077; Zhang PZ, 2013, TECTONOPHYSICS, V584, P7, DOI 10.1016/j.tecto.2012.02.021; Clark MK, 2000, GEOLOGY, V28, P703, DOI 10.1130/0091-7613(2000)28<703:TOBTEM>2.0.CO;2; Clark MK, 2005, GEOPHYS J INT, V162, P575, DOI 10.1111/j.1365-246X.2005.02580.x; Heidbach O, 2007, EARTH PLANET SC LETT, V257, P299, DOI 10.1016/j.epsl.2007.02.042; Hu JF, 2011, EARTH PLANET SC LETT, V306, P77, DOI 10.1016/j.epsl.2011.03.034; SAVAGE JC, 1973, J GEOPHYS RES, V78, P832, DOI 10.1029/JB078i005p00832; Bejar-Pizarro M, 2013, NAT GEOSCI, V6, P462, DOI [10.1038/ngeo1802, 10.1038/NGEO1802]; Ohta Y, 2006, EARTH PLANET SC LETT, V247, P108, DOI 10.1016/j.epsl.2006.05.013; Bell MA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049762; Burgmann R, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003648; [陈桂华 CHEN Guihua], 2008, [地震地质, Seismology and Geology], V30, P58; Deng Q., 1979, PHYS EARTH PLANET IN, V18, P257; Desbrun M., 1999, SIGGRAPH, V99, P317; Elliott JR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033659; Evans EL, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008398; Fu YYV, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007160; Fukahata Y, 2005, GEOPHYS J INT, V161, P507, DOI 10.1111/j.1365-246X.2005.02594.x; He HL, 2003, ANN GEOPHYS-ITALY, V46, P1035; Johnson KM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007703; Jonsson S, 2002, B SEISMOL SOC AM, V92, P1377, DOI 10.1785/0120000922; Kanda RVS, 2013, GEOPHYS J INT, V192, P38, DOI 10.1093/gji/ggs028; Kato N, 2007, GEOPHYS J INT, V169, P286, DOI 10.1111/j.1365-246X.2006.03313.x; Liu YJ, 2014, J GEOPHYS RES-SOL EA, V119, P6512, DOI 10.1002/2014JB011144; Ludwig WJ, 1970, SEAS               1, P53; MATSUURA M, 1986, J GEOPHYS RES-SOLID, V91, P2661, DOI 10.1029/JB091iB12p12661; MATSUURA M, 1989, GEOPHYS J INT, V96, P23, DOI 10.1111/j.1365-246X.1989.tb05247.x; Meade BJ, 2009, B SEISMOL SOC AM, V99, P3124, DOI 10.1785/0120090088; Noda H., 2013, NATURE, V492, P518; NUR A, 1974, SCIENCE, V183, P204, DOI 10.1126/science.183.4121.204; Peyret M, 2013, GEOPHYS J INT, V192, P929, DOI 10.1093/gji/ggs085; Pollitz FF, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005174; Qian H., 1990, EARTHQUAKE RES CHINA, V6, P43; Ran HL, 2006, CHINESE J GEOPHYS-CH, V49, P153; Ran YK, 2008, SCI CHINA SER D, V51, P1224, DOI 10.1007/s11430-008-0104-6; Ren Jin-wei, 1989, Seismology and Geology, V11; Savage JC, 1998, J GEOPHYS RES-SOL EA, V103, P7281, DOI 10.1029/98JB00148; SAVAGE JC, 1978, J GEOPHYS RES, V83, P3369, DOI 10.1029/JB083iB07p03369; Shen ZK, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003421; Stark P. B., 1995, J COMPUTATIONAL STAT, V10, P129; [田勤俭 TIAN Qinjian], 2008, [地震地质, Seismology and Geology], V30, P400; Wang CY, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004607; Wang H, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036560; Wang KL, 2001, EARTH PLANETS SPACE, V53, P295; Wang SJ, 2010, J TRADIT CHIN MED, V30, P30, DOI 10.3969/j.issn.1005-5053.2010.5.006; Wang Y., 2003, J GEOPHYS RES, V108, P2442, DOI [10.1029/2002JB001973, DOI 10.1029/2002JB001973]; Welstead S. T., 1999, FRACTAL WAVELET IMAG, P51; Wen XZ, 2008, SCI CHINA SER D, V51, P1375, DOI 10.1007/s11430-008-0114-4; Wen XZ, 2008, PHYS EARTH PLANET IN, V168, P16, DOI 10.1016/j.pepi.2008.04.013; Wen X.Z., 2000, SEISMOLOGY GEOLOGY, V22, P239; Xu X W, 2003, SCI CHINA D S, V33, P151; Yang Zhuoxin, 2011, Acta Seismologica Sinica, V33, DOI 10.3969/j.issn.0253-3782.2011.04.003; Yao HJ, 2008, GEOPHYS J INT, V173, P205, DOI 10.1111/j.1365-246X.2007.03696.x; [易桂喜 Yi Guixi], 2004, [地震学报, Acta Seismologica Sinica], V26, P294; Yi GX, 2008, CHINESE J GEOPHYS-CH, V51, P1719; [易桂喜 Yi Guixi], 2005, [地震, Earthquake], V25, P58; ZHOU H, 1983, B SEISMOL SOC AM, V73, P537; Zhou R., 2001, EARTHQUAKE RES CHINA, V17, P253; Zhou R., 2001, ACTA SEISMOL SIN, V23, P263	98	2	2	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9313	2169-9356		J GEOPHYS RES-SOL EA	J. Geophys. Res.-Solid Earth	MAR	2015	120	3					1855	1873		10.1002/2014JB011492		19	Geochemistry & Geophysics	Geochemistry & Geophysics	CG3EF	WOS:000353160200028		
J	Nagai, T; Shinohara, I; Zenitani, S				Nagai, T.; Shinohara, I.; Zenitani, S.			Ion acceleration processes in magnetic reconnection: Geotail observations in the magnetotail	JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS			English	Article						magnetic reconnection; magnetotail; substorm; space plasma; particle acceleration; plasma sheet	HALL CURRENT SYSTEM; HYBRID SIMULATIONS; DECOUPLING REGION; DYNAMICS; FIELD	Ion outflow formation processes in magnetic reconnection are investigated on the basis of 3-D ion velocity distribution function observations for magnetic reconnection in the magnetotail with the spacecraft Geotail. Ion acceleration processes up to 40keV can be divided into two types, and these two types consist of two-step processes. The first type is found close to the X line in the central part of the ion-electron decoupling region of magnetic reconnection where an intense crosstail current layer exists and electrons make high-speed outflow jets. In this region, inflowing ions and ions making the meandering motion coexist. Ions are accelerated up to similar to 10keV in the north-south direction during the inflowing process, and then they are accelerated farther by the reconnection electric field in the duskward direction. The second type is found far from the X line in the outer parts of the ion-electron decoupling region of magnetic reconnection. In this region, the Hall current loops are formed and the inflowing Hall electrons exist near the separatrix layers. Ions are accelerated and make the dawnward motion inside the Hall current loop in the inflowing process, and then they are farther accelerated to form tailward and earthward outflows. In this region, significant amount of ions is supplied as inflows, and outflows containing ions in the wide energy range (5-40keV) are formed. Hence, both the north-south (vertical) electric field, which is probably the Hall electric field, and the duskward reconnection electric field operate ion acceleration processes for magnetic reconnection in the magnetotail.	[Nagai, T.] Tokyo Inst Technol, Dept Earth & Planetary Sci, Tokyo 152, Japan; [Shinohara, I.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Zenitani, S.] Natl Inst Nat Sci, Natl Astron Observ Japan, Mitaka, Tokyo, Japan	Nagai, T (reprint author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Tokyo 152, Japan.	nagai@geo.titech.ac.jp	Zenitani, Seiji/D-7988-2013		JSPS [25400476, 6247082A]	All Geotail data are from the Institute of Space and Astronautical Science/Japan Aerospace Exploration Agency (ISAS/JAXA). The magnetic field and ion moment data are available from the Data Archives and Transmission System (DARTS) of ISAS (http://www.darts.isas.jaxa.jp/). Ion velocity distribution function data in ASCII format can also be obtained from DARTS. The work of T.N. was supported by the JSPS Grant-in-Aid for Scientific Research 25400476 and 6247082A.	Hoshino M, 1998, J GEOPHYS RES-SPACE, V103, P4509, DOI 10.1029/97JA01785; Aunai N, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016688; Zenitani S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051938; Nagai T, 2013, J GEOPHYS RES-SPACE, V118, P7703, DOI 10.1002/2013JA019135; Paschmann G, 2013, SPACE SCI REV, V178, P385, DOI 10.1007/s11214-012-9957-2; Nagai T, 1998, J GEOPHYS RES-SPACE, V103, P4419, DOI 10.1029/97JA02190; Drake JF, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013701; Egedal J, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013520; Paschmann G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035297; Wang RS, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014553; Fuselier SA, 2011, SPACE SCI REV, V160, P95, DOI 10.1007/s11214-011-9820-x; Lin Y, 1996, J GEOPHYS RES, V101, P19859, DOI 10.1029/96JA01457; Nagai T, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009900; Aunai N, 2011, ANN GEOPHYS-GERMANY, V29, P1571, DOI 10.5194/angeo-29-1571-2011; Nagai T, 2013, J GEOPHYS RES-SPACE, V118, P1667, DOI 10.1002/jgra.50247; Nagai T, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016283; Egedal J, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014650; Nagai T, 2001, J GEOPHYS RES-SPACE, V106, P25929, DOI 10.1029/2001JA900038; Wygant JR, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010708; MUKAI T, 1994, J GEOMAGN GEOELECTR, V46, P669; KRAUSSVARBAN D, 1995, GEOPHYS RES LETT, V22, P3271, DOI 10.1029/95GL03414; Arzner K, 2001, J GEOPHYS RES-SPACE, V106, P3827, DOI 10.1029/2000JA000179; Chen LJ, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013385; Cowley S. W. H., 1985, SOLAR SYSTEM MAGNETI, P121; Egedal J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.025006; KOKUBUN S, 1994, J GEOMAGN GEOELECTR, V46, P7; Lottermoser RF, 1998, J GEOPHYS RES-SPACE, V103, P4547, DOI 10.1029/97JA01872; Mukai T, 1996, J GEOMAGN GEOELECTR, V48, P541; Nagai T, 1998, J GEOPHYS RES-SPACE, V103, P4441, DOI 10.1029/97JA02449; Nagai T, 2002, PHYS PLASMAS, V9, P3705, DOI 10.1063/1.1499117; Nakamura MS, 1998, J GEOPHYS RES-SPACE, V103, P4531, DOI 10.1029/97JA01843; Sonnerup B. U. O., 1979, SOLAR SYSTEM PLASMA, P45; SPEISER TW, 1965, J GEOPHYS RES, V70, P4219, DOI 10.1029/JZ070i017p04219; Treumann R.A., 2013, FRONT PHYS, V1, P31, DOI DOI 10.3389/FPHY.2013.00031; Wang RS, 2013, GEOPHYS RES LETT, V40, P2511, DOI 10.1002/grl.50537; Zenitani S, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4821963	36	2	2	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9380	2169-9402		J GEOPHYS RES-SPACE	J. Geophys. Res-Space Phys.	MAR	2015	120	3					1766	1783		10.1002/2014JA020737		18	Astronomy & Astrophysics	Astronomy & Astrophysics	CG4EY	WOS:000353237600021		
J	Higashimori, K; Hoshino, M				Higashimori, Katsuaki; Hoshino, Masahiro			Ion beta dependence on the development of Alfvenic fluctuations in reconnection jets	JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS			English	Article						magnetic reconnection; turbulence; ion plasma beta; Alfven wave; plasma sheet boundary layer; ion temperature anisotropy	SHEET BOUNDARY-LAYER; MAGNETIC RECONNECTION; PLASMA SHEET; MAGNETOHYDRODYNAMIC TURBULENCE; MAGNETOTAIL RECONNECTION; PARTICLE MOTION; DISTANT TAIL; SOLAR-WIND; FIELD; GEOTAIL	The generation of magneto-hydro-dynamic (MHD) to ion-scale fluctuations in collisionless magnetic reconnection is discussed using a two-dimensional electromagnetic hybrid code. It is shown that reconnection jets become turbulent specifically in low beta conditions, (i0)<0.1-0.2 (where (i0) is the ion plasma beta in initial inflow regions). The fluctuations observed in reconnection jets consist of outgoing Alfvenic fluctuations. As probable candidates for the origin of Alfvenic fluctuations, this study focused on the dynamics in the plasma sheet boundary layer (PSBL) and a current sheet. We suggest that PSBL ion dynamics play an important part in excitation and suppression of waves. PSBL beam ions drive Alfven waves in MHD to ion scale, k(i)<0.5 ((i) is ion inertial length), independent of (i0). On the other hand, because the beam temperature is highly correlated with that of inflowing ions, the waves decay by cyclotron damping as the value of the inflow ion beta increases. Local linear analysis suggests that this damping signature changes in (i0)approximate to 0.1-0.2 and suppresses the wave activity of Alfven modes in high beta reconnection jets.	[Higashimori, Katsuaki; Hoshino, Masahiro] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo, Japan	Higashimori, K (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Tokyo, Japan.	higashi@eps.s.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [12J10000]	We enjoyed discussions with N. Yokoi, M. Fujimoto, T. Amano, and K. Hirabayashi, and thank reviewers for valuable comments on this paper. This research is partially supported by Japan Society for the Promotion of Science (JSPS; grant 12J10000). Data for this study are generated by the hybrid simulation code as described in section 2, and the data are available on request (higashi@eps.s.u-tokyo.ac.jp).	Hoshino M, 1998, J GEOPHYS RES-SPACE, V103, P4509, DOI 10.1029/97JA01785; Loureiro NF, 2009, MON NOT R ASTRON SOC, V399, pL146, DOI 10.1111/j.1745-3933.2009.00742.x; Eastwood JP, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.035001; SAITO Y, 1995, J GEOPHYS RES, V100, P23567, DOI 10.1029/95JA01675; Lazarian A, 1999, ASTROPHYS J, V517, P700, DOI 10.1086/307233; HOSHINO M, 1994, GEOPHYS RES LETT, V21, P2935, DOI 10.1029/94GL02094; Kowal G, 2009, ASTROPHYS J, V700, P63, DOI 10.1088/0004-637X/700/1/63; Higashimori K, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA016817; Drake JF, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013701; Yokoi N, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4851976; Karimabadi H, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4828395; FRIED BD, 1959, PHYS FLUIDS, V2, P337, DOI 10.1063/1.1705933; Hoshino M, 2000, J GEOPHYS RES-SPACE, V105, P337, DOI 10.1029/1999JA900426; Higashimori K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.255001; Karimabadi H, 1999, J GEOPHYS RES-SPACE, V104, P12313, DOI 10.1029/1999JA900089; WEIBEL ES, 1959, PHYS REV LETT, V2, P83, DOI 10.1103/PhysRevLett.2.83; Matthaeus WH, 2011, SPACE SCI REV, V160, P145, DOI 10.1007/s11214-011-9793-9; Swisdak M, 2008, ASTROPHYS J, V680, P999, DOI 10.1086/588088; Liu YH, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3685755; Lin Y, 1996, J GEOPHYS RES, V101, P19859, DOI 10.1029/96JA01457; VASYLIUNAS VM, 1975, REV GEOPHYS, V13, P303, DOI 10.1029/RG013i001p00303; TAKAHASHI K, 1988, J GEOPHYS RES, V93, P8558, DOI 10.1029/JA093iA08p08558; Hesse M, 1998, J GEOPHYS RES-SPACE, V103, P26479, DOI 10.1029/98JA01570; GOLDSTEIN ML, 1995, ANNU REV ASTRON ASTR, V33, P283, DOI 10.1146/annurev.astro.33.1.283; EASTWOOD JW, 1972, PLANET SPACE SCI, V20, P1555, DOI 10.1016/0032-0633(72)90182-1; Che H, 2011, NATURE, V474, P184, DOI 10.1038/nature10091; DECOSTER RJ, 1979, J GEOPHYS RES-SPACE, V84, P5099, DOI 10.1029/JA084iA09p05099; GARY SP, 1984, PHYS FLUIDS, V27, P1852, DOI 10.1063/1.864797; Arzner K, 2001, J GEOPHYS RES-SPACE, V106, P3827, DOI 10.1029/2000JA000179; BUCHNER J, 1989, J GEOPHYS RES, V94, P11821, DOI 10.1029/JA094iA09p11821; Daughton W, 2011, AIP Conference Proceedings, V1320, DOI 10.1063/1.3544319; Fujimoto K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.265004; GARY SP, 1990, J GEOPHYS RES, V95, P8085, DOI 10.1029/JA095iA06p08085; Grigorenko EE, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011986; HILL TW, 1975, J GEOPHYS RES-SPACE, V80, P4689, DOI 10.1029/JA080i034p04689; Hirabayashi K, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4831754; Karimabadi H, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010750; KAWANO H, 1994, GEOPHYS RES LETT, V21, P2887, DOI 10.1029/94GL02106; Lottermoser RF, 1998, J GEOPHYS RES-SPACE, V103, P4547, DOI 10.1029/97JA01872; MATTHAEUS WH, 1982, J GEOPHYS RES-SPACE, V87, P6011, DOI 10.1029/JA087iA08p06011; NISHIDA A, 1994, GEOPHYS RES LETT, V21, P2947, DOI 10.1029/94GL01421; SPEISER TW, 1965, J GEOPHYS RES, V70, P4219, DOI 10.1029/JZ070i017p04219; Takada T, 2005, ADV SPACE RES, V36, P1883, DOI 10.1016/j.asr.2003.09.075; Yokoi N, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3641968; Zenitani S, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2836623	45	1	1	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9380	2169-9402		J GEOPHYS RES-SPACE	J. Geophys. Res-Space Phys.	MAR	2015	120	3					1803	1813		10.1002/2014JA020544		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CG4EY	WOS:000353237600023		
J	Imai, M; Lecacheux, A; Moncuquet, M; Bagenal, F; Higgins, CA; Imai, K; Thieman, JR				Imai, Masafumi; Lecacheux, Alain; Moncuquet, Michel; Bagenal, Fran; Higgins, Charles A.; Imai, Kazumasa; Thieman, James R.			Modeling Jovian hectometric attenuation lanes during the Cassini flyby of Jupiter	JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS			English	Article						Jupiter; Cassini; RPWS; ray tracing; hectometric radio emissions; attenuation lanes; polarization analysis	IO PLASMA TORUS; DECAMETRIC MODULATION LANES; RADIO-EMISSION SPECTRUM; LATITUDINAL STRUCTURE; KILOMETRIC RADIATION; CURRENT SHEET; MAGNETOSPHERE; VOYAGER; GALILEO; FIELD	The Jupiter encounter by the Cassini spacecraft in late 2000 and early 2001 unveiled persistent properties of Jupiter's hectometric (HOM) radiation originating along auroral magnetic field lines in the polar regions. One of the unique properties of the HOM dynamic spectrum, known as attenuation lanes, appears as rotationally modulated, well-defined regions of lowered intensity, flanked by regions of enhancement. These lanes seem to be the result of refraction of radio waves in a high-density medium-either caused by Case (i) enhanced density in the magnetic L-shell connected to Io's orbit or Case (ii) in the Io plasma torus itself or both. In this paper, we investigate the HOM ray paths of 0.5-3.0 MHz emissions with various cone half-angles in the continuous radio longitudes generating at the magnetic L-value equal to 30. We use bi-kappa particle distributions to derive diffusive equilibrium distributions of density in the Io plasma torus. The enhanced density irregularities along the Io flux shell ribbon region can be described with a Gaussian density distribution of a maximum density n(0) and breadth (half-width of the distribution across the flux shell) sigma. As a result, we found that the interpretation of Case (i) can be accounted for by the attenuation lanes which appear for all cone half-angles, and the reasonable flux shell density n(0) is, on top of specific latitude-dependent density from the diffusive equilibrium model, estimated as 100 cm(-3) with the half-width sigma = 5.0 Io radii.	[Imai, Masafumi] Kyoto Univ, Dept Geophys, Kyoto, Japan; [Imai, Masafumi; Lecacheux, Alain; Moncuquet, Michel] Observ Paris, CNRS, Lab Etud Spatiales & Instrumentat Astrophys, F-92195 Meudon, France; [Bagenal, Fran] Univ Colorado Boulder, Lab Atmospher & Space Phys, Boulder, CO USA; [Higgins, Charles A.] Middle Tennessee State Univ, Dept Phys & Astron, Murfreesboro, TN 37130 USA; [Imai, Kazumasa] Kochi Natl Coll Technol, Dept Elect Engn & Informat Sci, Kochi, Japan; [Thieman, James R.] Univ Maryland Baltimore Cty, Baltimore, MD 21228 USA	Imai, M (reprint author), Kyoto Univ, Dept Geophys, Kyoto, Japan.	imai@kugi.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	The authors appreciate the referees for fruitful comments with the careful reading of the manuscript. They are also indebted to all members of the Cassini RPWS team, especially to the principal investigators D. A. Gurnett and W. S. Kurth. This work at Kyoto University was supported by a grant-in-aid for Research Fellows of the Japan Society for the Promotion of Science (JSPS). M.I. thanks LESIA of the Observatoire de Paris-Meudon for the generous hospitality during his 1 year visit. Data used for this article are available through request to the authors.	Acuna M. H., 1983, PHYSICS JOVIAN MAGNE, P1, DOI DOI 10.1017/CBO9780511564574.003; ALEXANDER JK, 1981, J GEOPHYS RES-SPACE, V86, P8529, DOI 10.1029/JA086iA10p08529; Edwards TM, 2001, PLANET SPACE SCI, V49, P1115, DOI 10.1016/S0032-0633(00)00164-1; Gurnett DA, 2004, SPACE SCI REV, V114, P395, DOI 10.1007/s11214-004-1434-0; BIGG EK, 1964, NATURE, V203, P1008, DOI 10.1038/2031008a0; DESCH MD, 1974, ASTROPHYS J, V194, pL57, DOI 10.1086/181667; Khurana KK, 1997, J GEOPHYS RES-SPACE, V102, P11295, DOI 10.1029/97JA00563; KIMURA I, 1966, RADIO SCI, V1, P269; Ergun RE, 1998, GEOPHYS RES LETT, V25, P2061, DOI 10.1029/98GL00570; REINER MJ, 1993, J GEOPHYS RES-PLANET, V98, P18767, DOI 10.1029/93JE01779; Hess SLG, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016262; WU CS, 1979, ASTROPHYS J, V230, P621, DOI 10.1086/157120; Alexeev II, 2005, ANN GEOPHYS-GERMANY, V23, P809; LECACHEUX A, 1978, ASTRON ASTROPHYS, V70, P701; Bagenal F, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016294; Khurana KK, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010757; Gurnett DA, 2002, NATURE, V415, P985, DOI 10.1038/415985a; Vogt MF, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016148; CONNERNEY JEP, 1981, J GEOPHYS RES-SPACE, V86, P8370, DOI 10.1029/JA086iA10p08370; BAGENAL F, 1994, J GEOPHYS RES, V99, P11043, DOI 10.1029/93JA02908; Bagenal F., 2014, SPACE SCI REV, DOI [10.1007/s11214-014-0036-8, DOI 10.1007/S11214-014-0036-8]; BARROW CH, 1995, ASTRON ASTROPHYS, V301, P903; Birdsall C. K., 2005, PLASMA PHYS; BIRMINGHAM TJ, 1981, J GEOPHYS RES-SPACE, V86, P8497, DOI 10.1029/JA086iA10p08497; Boudjada MY, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016354; Boudjada MY, 2001, PLANET SPACE SCI, V49, P1151, DOI 10.1016/S0032-0633(01)00022-8; BROWN LW, 1974, ASTROPHYS J, V194, pL159, DOI 10.1086/181693; Budden K. G., 1985, PROPAGATION RADIO WA; Carr T. D., 1983, PHYSICS JOVIAN MAGNE, P226, DOI 10.1017/CBO9780511564574.009; Chapman S., 1940, GEOMAGN AERON, V2, P639; Clarke J.T., 2004, JUPITER PLANET SATEL, P639; Connerney JEP, 1998, J GEOPHYS RES-SPACE, V103, P11929, DOI 10.1029/97JA03726; CUMMINGS WD, 1980, J GEOPHYS RES-SPACE, V85, P2108, DOI 10.1029/JA085iA05p02108; DIVINE N, 1983, J GEOPHYS RES-SPACE, V88, P6889, DOI 10.1029/JA088iA09p06889; DULK GA, 1967, ICARUS, V7, P173, DOI 10.1016/0019-1035(67)90062-0; ENGLE IM, 1992, J GEOPHYS RES, V97, P17169, DOI 10.1029/92JA02036; ENGLE IM, 1991, J GEOPHYS RES, V96, P7793, DOI 10.1029/90JA02391; Fischer G, 2001, PLANETARY RADIO EMIS, P347; Fung SF, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010658; Green J. L., 1988, PLANETARY RADIO EMIS, P343; Green J. L., 1992, PHYSICS JOVIAN MAGNE, P91; GREEN JL, 1984, RADIO SCI, V19, P556, DOI 10.1029/RS019i002p00556; Gurnett DA, 1998, GEOPHYS RES LETT, V25, P1841, DOI 10.1029/98GL01400; Haselgrove J., 1955, C PHYSICS IONOSPHERE, P355; HASHIMOTO K, 1983, J GEOPHYS RES-SPACE, V88, P2010, DOI 10.1029/JA088iA03p02010; Hess S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033656; Hess SLG, 2010, PLANET SPACE SCI, V58, P1188, DOI 10.1016/j.pss.2010.04.011; Higgins CA, 1998, J GEOPHYS RES-SPACE, V103, P26679, DOI 10.1029/98JA02393; HIGGINS CA, 1995, J GEOPHYS RES, V100, P19487, DOI 10.1029/95JA01128; Higgins CA, 2001, RADIO SCI, V36, P1713, DOI 10.1029/2000RS002457; Higgins CA, 1999, GEOPHYS RES LETT, V26, P389, DOI 10.1029/1998GL900302; Hill TW, 1974, GEOPHYS RES LETT, V1, DOI 10.1029/GL001i001p00003; IMAI K, 1992, GEOPHYS RES LETT, V19, P953, DOI 10.1029/92GL00942; Imai K, 1997, J GEOPHYS RES-SPACE, V102, P7127, DOI 10.1029/96JA03960; Imai M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034987; Imai M., 2011, PLANETARY RADIO EMIS, P167, DOI [10.1553/PRE7s167, DOI 10.1553/PRE7S167]; Imai M, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016456; Kimura I., 1997, DISCOVERY MAGNETOSPH, V7, P119, DOI [10.1029/HG007p0119, DOI 10.1029/HG007P0119]; Kimura T, 2008, PLANET SPACE SCI, V56, P1155, DOI 10.1016/j.pss.2008.03.001; Kurth WS, 1997, GEOPHYS RES LETT, V24, P1171, DOI 10.1029/97GL00988; LADREITER HP, 1991, ANN GEOPHYS, V9, P784; LADREITER HP, 1990, J GEOPHYS RES, V95, P6423, DOI 10.1029/JA095iA05p06423; LADREITER HP, 1990, ANN GEOPHYS, V8, P477; LADREITER HP, 1991, J GEOPHYS RES, V96, P21207, DOI 10.1029/91JA02265; LADREITER HP, 1994, PLANET SPACE SCI, V42, P919, DOI 10.1016/0032-0633(94)90052-3; Lamy L, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043415; LECACHEUX A, 1981, J GEOPHYS RES-SPACE, V86, P8523, DOI 10.1029/JA086iA10p08523; Lecacheux A., 2011, PLANETARY RADIO EMIS, P13, DOI [10.1553/PRE7s13, DOI 10.1553/PRE7S13]; LECACHEUX A, 1980, J GEOPHYS RES-SPACE, V85, P6877, DOI 10.1029/JA085iA12p06877; Macher W., 2008, THESIS GRAZ U TECHNO; Menietti J. D., 1996, GEOPHYS RES, V101, P27, DOI [10.1029/96JA02403, DOI 10.1029/96JA02403]; MENIETTI JD, 1984, J GEOPHYS RES-SPACE, V89, P9089, DOI 10.1029/JA089iA10p09089; MENIETTI JD, 1984, J GEOPHYS RES-SPACE, V89, P1489, DOI 10.1029/JA089iA03p01489; Menietti JD, 1999, RADIO SCI, V34, P1005, DOI 10.1029/1999RS900036; Menietti JD, 2003, PLANET SPACE SCI, V51, P533, DOI 10.1016/S0032-0633(03)00078-3; Menietti JD, 2001, RADIO SCI, V36, P1723, DOI 10.1029/2000RS002458; Moncuquet M, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA900124; ORTEGAMOLINA A, 1991, J GEOPHYS RES, V96, P11441, DOI 10.1029/90JA00103; Pierrard V, 2009, PLANET SPACE SCI, V57, P1260, DOI 10.1016/j.pss.2009.04.011; Ralston A., 1960, MATH METHODS DIGITAL, P95; Rief G., 2013, THESIS KARL FRANZENS; RIIHIMAA JJ, 1968, ASTRON J, V73, P265, DOI 10.1086/110627; SCHNEIDER NM, 1995, ASTROPHYS J, V450, P450, DOI 10.1086/176155; Smith E. J., 1976, JUPITER, P788; Smyth WH, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016094; Stix T.H., 1992, WAVES PLASMAS; Thomas N., 2004, JUPITER PLANET SATEL, P561; Treumann RA, 2006, ASTRON ASTROPHYS REV, V13, P229, DOI 10.1007/s00159-006-0001-y; Vogl DF, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010261; Yabroff I., 1961, Journal of Research of the National Bureau of Standards, V65D; Zarka P, 1998, J GEOPHYS RES-PLANET, V103, P20159, DOI 10.1029/98JE01323	91	0	0	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9380	2169-9402		J GEOPHYS RES-SPACE	J. Geophys. Res-Space Phys.	MAR	2015	120	3					1888	1907		10.1002/2014JA020815		20	Astronomy & Astrophysics	Astronomy & Astrophysics	CG4EY	WOS:000353237600029		
J	Gkioulidou, M; Ohtani, S; Mitchell, DG; Ukhorskiy, AY; Reeves, GD; Turner, DL; Gjerloev, JW; Nose, M; Koga, K; Rodriguez, JV; Lanzerotti, LJ				Gkioulidou, Matina; Ohtani, S.; Mitchell, D. G.; Ukhorskiy, A. Y.; Reeves, G. D.; Turner, D. L.; Gjerloev, J. W.; Nose, M.; Koga, K.; Rodriguez, J. V.; Lanzerotti, L. J.			Spatial structure and temporal evolution of energetic particle injections in the inner magnetosphere during the 14 July 2013 substorm event	JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS			English	Article						energetic particle injections; substorms; dipolarization fronts; inner magnetosphere; bubbles	ALLEN PROBES OBSERVATIONS; GEOSYNCHRONOUS ORBIT; ION INJECTIONS; PLASMA SHEET; ACCELERATION; STORM; DIPOLARIZATION; MAGNETOTAIL; CLUSTER; MOTION	Recent results by the Van Allen Probes mission showed that the occurrence of energetic ion injections inside geosynchronous orbit could be very frequent throughout the main phase of a geomagnetic storm. Understanding, therefore, the formation and evolution of energetic particle injections is critical in order to quantify their effect in the inner magnetosphere. We present a case study of a substorm event that occurred during a weak storm (Dst similar to-40nT) on 14 July 2013. Van Allen Probe B, inside geosynchronous orbit, observed two energetic proton injections within 10min, with different dipolarization signatures and duration. The first one is a dispersionless, short-timescale injection pulse accompanied by a sharp dipolarization signature, while the second one is a dispersed, longer-timescale injection pulse accompanied by a gradual dipolarization signature. We combined ground magnetometer data from various stations and in situ particle and magnetic field data from multiple satellites in the inner magnetosphere and near-Earth plasma sheet to determine the spatial extent of these injections, their temporal evolution, and their effects in the inner magnetosphere. Our results indicate that there are different spatial and temporal scales at which injections can occur in the inner magnetosphere and depict the necessity of multipoint observations of both particle and magnetic field data in order to determine these scales.	[Gkioulidou, Matina; Ohtani, S.; Mitchell, D. G.; Ukhorskiy, A. Y.; Gjerloev, J. W.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Reeves, G. D.] Los Alamos Natl Lab, Los Alamos, NM USA; [Turner, D. L.] Aerosp Corp, Space Sci Dept, El Segundo, CA 90245 USA; [Nose, M.] Kyoto Univ, Grad Sch Sci, Data Anal Ctr Geomagnetism & Space Magnetism, Kyoto, Japan; [Koga, K.] Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki, Japan; [Rodriguez, J. V.] Univ Colorado Boulder, Cooperat Inst Res Environm Sci, Boulder, CO USA; [Rodriguez, J. V.] NOAA, Natl Geophys Data Ctr, Boulder, CO 80303 USA; [Lanzerotti, L. J.] New Jersey Inst Technol, Ctr Solar Terr Res, Newark, NJ 07102 USA	Gkioulidou, M (reprint author), Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA.	gkioum1@jhuapl.edu	Nose, Masahito/B-1900-2015; Gkioulidou, Matina/G-9009-2015; Reeves, Geoffrey/E-8101-2011	Nose, Masahito/0000-0002-2789-3588; Reeves, Geoffrey/0000-0002-7985-8098	JHU/APL under NASA [937836, NAS5-01072]; NSF [AGS-1303646]; International Space Science Institute's (ISSI) International Teams program; NASA [NAS5-01072, NNX12AJ52G, NAS5-02099]; National Geophysical Data Center (NGDC) Task II under the CIRES; NOAA; University of Colorado; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25287127]	The authors thank team discussions with the larger RBSPICE and Van Allen Probes teams. The RBSPICE instrument was supported by JHU/APL subcontract 937836 to the New Jersey Institute of Technology under NASA prime contract NAS5-01072. MG was also supported by NSF grant AGS-1303646 and the International Space Science Institute's (ISSI) International Teams program. SO was supported by NASA grant NNX12AJ52G. D.L.T. was supported by NASA's THEMIS (contract NAS5-02099) and Van Allen Probes (contract NAS5-01072) missions. J.V.R. was supported by National Geophysical Data Center (NGDC) Task II under the CIRES Cooperative Agreement between NOAA and the University of Colorado. MN was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-Aid Scientific Research (B) (grant 25287127). Solar wind data and AL and SYM-H indices were retrieved from OMNIweb service. The Wp index was retrieved from http://s-cubed.info/. One second resolution magnetometer data were collected at various magnetic observatories within the INTERMAGNET project. One minute resolution magnetometer data were collected at various magnetic observatories within the SuperMAG project. We thank the national institutes that support the magnetic observatories and INTERMAGNET (www.intermagnet.org) and SuperMAG (http://supermag.jhuapl.edu/) projects for promoting high standards of magnetic observatory practice. Magnetic field data from the geosynchronous ETS-8 satellite were provided by the Japan Aerospace Exploration Agency upon request. THEMIS-D data were retrieved with the Space Physics Environment Data Analysis System (SPEDAS) software (http://themis.igpp.ucla.edu/software.shtml). GOES 15 magnetometer data were retrieved from CDAweb service. GOES MAGPD data are available upon request from NGDC Van Allen Probes RBSPICE data were retrieved from http://rbspice.ftecs.com/, and HOPE and MagEIS data were retrieved from http://www.rbsp-ect.lanl.gov/rbsp_ect.php. LANL-01A data were provided by the Los Alamos National Laboratory upon request.	Thomsen MF, 2001, J GEOPHYS RES-SPACE, V106, P8405, DOI 10.1029/2000JA000080; Reeves GD, 2013, SCIENCE, V341, P991, DOI 10.1126/science.1237743; PONTIUS DH, 1990, GEOPHYS RES LETT, V17, P49, DOI 10.1029/GL017i001p00049; Tsyganenko NA, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010798; Gabrielse C, 2014, J GEOPHYS RES-SPACE, V119, P2512, DOI 10.1002/2013JA019638; BAUMJOHANN W, 1990, J GEOPHYS RES, V95, P3801, DOI 10.1029/JA095iA04p03801; Yang J, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017415; Yang J, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016346; Birn J, 1997, J GEOPHYS RES-SPACE, V102, P2325, DOI 10.1029/96JA03032; Blake JB, 2013, SPACE SCI REV, V179, P383, DOI 10.1007/s11214-013-9991-8; Nakamura R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015763; Lyons LR, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017265; GONZALEZ WD, 1994, J GEOPHYS RES, V99, P5771, DOI 10.1029/93JA02867; Yu YQ, 2014, GEOPHYS RES LETT, V41, P1126, DOI 10.1002/2014GL059322; Runov A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038980; Angelopoulos V, 1996, J GEOPHYS RES, V101, P4967, DOI 10.1029/95JA02722; Nose M, 2012, SPACE WEATHER, V10, DOI 10.1029/2012SW000785; Sitnov MI, 2014, J GEOPHYS RES-SPACE, V119, DOI 10.1002/2014JA020205; Nose M, 2014, J GEOPHYS RES-SPACE, V119, P4639, DOI 10.1002/2014JA019806; Malaspina DM, 2014, GEOPHYS RES LETT, V41, P5693, DOI 10.1002/2014GL061109; REEVES GD, 1990, GEOPHYS RES LETT, V17, P2015, DOI 10.1029/GL017i011p02015; Gkioulidou M, 2014, J GEOPHYS RES-SPACE, V119, DOI 10.1002/2014JA020096; Kletzing CA, 2013, SPACE SCI REV, V179, P127, DOI 10.1007/s11214-013-9993-6; ANGELOPOULOS V, 1992, J GEOPHYS RES, V97, P4027, DOI 10.1029/91JA02701; Chaston CC, 2014, GEOPHYS RES LETT, V41, P209, DOI 10.1002/2013GL058507; Ohtani S, 1998, J GEOPHYS RES-SPACE, V103, P6815, DOI 10.1029/98JA00013; Thorne RM, 2013, NATURE, V504, P411, DOI 10.1038/nature12889; MAUK BH, 1983, J GEOPHYS RES-SPACE, V88, P3055, DOI 10.1029/JA088iA04p03055; Mauk B. H., 2012, SPACE SCI REV, V179, P3, DOI [10.1007/s11214-012-9908-y, DOI 10.1007/S11214-012-9908-Y]; McIlwain C., 1974, MAGNETOSPHERIC PHYS; McPherron R. L, 1973, J GEOPHYS RES, V78, P3133, DOI 10.1029/JA078i016p03131; Mitchell DG, 2013, SPACE SCI REV, V179, P263, DOI 10.1007/s11214-013-9965-x; Mozer FS, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.235002; Parks G.K., 2004, PHYS SPACE PLASMAS I; Reeves G. D., 1996, EUR SPACE AGENCY SPE, P579; Runov A, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016316; Sergeev V, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016500; Sergeev VA, 2014, GEOPHYS RES LETT, V41, P1106, DOI 10.1002/2014GL059309; Wolf RA, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA012010	39	3	3	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9380	2169-9402		J GEOPHYS RES-SPACE	J. Geophys. Res-Space Phys.	MAR	2015	120	3					1924	1938		10.1002/2014JA020872		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CG4EY	WOS:000353237600031		
J	Yue, C; Wang, CP; Lyons, L; Wang, Y; Hsu, TS; Henderson, M; Angelopoulos, V; Lui, ATY; Nagai, T				Yue, Chao; Wang, Chih-Ping; Lyons, Larry; Wang, Yongli; Hsu, Tung-Shin; Henderson, Michael; Angelopoulos, Vassilis; Lui, A. T. Y.; Nagai, Tsugunobu			A 2-D empirical plasma sheet pressure model for substorm growth phase using the Support Vector Regression Machine	JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS			English	Article						plasma sheet pressure model; substorm growth phase; support vector regression machine	SOLAR-WIND; MAGNETIC-FIELD; BALLOONING INSTABILITY; MIDDISTANT MAGNETOTAIL; GEOTAIL OBSERVATIONS; MAGNETOSPHERE; INSTRUMENT; SPACECRAFT; BOUNDARY; ONSETS	The plasma sheet pressure and its spatial structure during the substorm growth phase are crucial to understanding the development and initiation of substorms. In this paper, we first statistically analyzed the growth phase pressures using Geotail and Time History of Events and Macroscale Interactions during Substorms data and identified that solar wind dynamic pressure (P-SW), energy loading, and sunspot number as the three primary factors controlling the growth phase pressure change. We then constructed a 2-D equatorial empirical pressure model and an error model within r20R(E) using the Support Vector Regression Machine with the three factors as input. The model predicts the plasma sheet pressure accurately with median errors of 5%, and predicted pressure gradients agree reasonably well with observed gradients obtained from two-probe measurements. The model shows that pressure increases linearly as P-SW increases, and the P-SW effect is stronger under lower energy loading. However, the pressure responses to energy loading and sunspot number are nonlinear. The pressure increases first with increasing loading or sunspot number, then remains relatively constant after reaching a peak value at similar to 8000kVmin loading or sunspot number of similar to 80. The loading effect is stronger when P-SW is lower and the pressure variations are stronger near midnight than away from midnight. The sunspot number effect is clearer at smaller r. The pressure model can also be applied to understand the pressure changes observed during a substorm event by providing evaluations of the effects of energy loading and P-SW, as well as the temporal and spatial effects along the spacecraft trajectory.	[Yue, Chao; Wang, Chih-Ping; Lyons, Larry] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90089 USA; [Wang, Yongli] Univ Maryland Baltimore Cty, Goddard Planetary Heliophys Inst, Baltimore, MD USA; [Hsu, Tung-Shin; Angelopoulos, Vassilis] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90024 USA; [Henderson, Michael] Los Alamos Natl Lab, Space Sci & Applicat, Los Alamos, NM USA; [Lui, A. T. Y.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Nagai, Tsugunobu] Tokyo Inst Technol, Dept Earth & Planetary Sci, Tokyo 152, Japan	Yue, C (reprint author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90089 USA.	yuechao@atmos.ucla.edu			NASA [NNX11AJ12G, NNX08A135G]; NSF [ATM-1003595]; IGPPS Program at Los Alamos National Laboratory	The work by C. Yue, C.-P. Wang, and L.R. Lyons at UCLA has been supported by NASA grants NNX11AJ12G and NNX08A135G, NSF grant ATM-1003595, and IGPPS Program at Los Alamos National Laboratory. We also acknowledge Jianzhu Ma (Toyota Technological Institute at Chicago, Chicago, USA) for the very helpful discussion of SVRM. And the LibSVM can be found online at http://www.csie.ntu.edu.tw/similar to cjlin/libsvm/. All Geotail data are from the Institute of Space and Astronautical Science/Japan Aerospace Exploration Agency (ISAS/JAXA) through the Data Archives and Transmission System (DARTS) of ISAS (http://www.darts.isas.jaxa.jp/). All THEMIS data are from THEMIS official website (http://themis.ssl.berkeley.edu/data_files.shtml). And the solar wind, IMF parameters, and the geomagnetic indices were obtained from the NASA OMNI database. The observed monthly sunspot numbers are from the "radio and space weather service" website (http://www.ips.gov.au/Solar/1/6).	Angelopoulos V., 1996, SPEC PUBL EUR SPACE, V389, P17; Wang CP, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015028; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Wing S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030453; SPENCE HE, 1993, J GEOPHYS RES, V98, P15487, DOI 10.1029/93JA01531; Auster HU, 2008, SPACE SCI REV, V141, P235, DOI 10.1007/s11214-008-9365-9; Yue C, 2013, J GEOPHYS RES-SPACE, V118, P6166, DOI 10.1002/2013JA018943; ANGELOPOULOS V, 1993, GEOPHYS RES LETT, V20, P1711, DOI 10.1029/93GL00847; SPENCE HE, 1989, J GEOPHYS RES, V94, P5264, DOI 10.1029/JA094iA05p05264; WILLIAMS DJ, 1994, J GEOMAGN GEOELECTR, V46, P39; Wang CP, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011545; Gonzalez WD, 1999, SPACE SCI REV, V88, P529, DOI 10.1023/A:1005160129098; McFadden JP, 2008, SPACE SCI REV, V141, P277, DOI 10.1007/s11214-008-9440-2; Machida S, 2009, ANN GEOPHYS-GERMANY, V27, P1035; BAUMJOHANN W, 1990, GEOPHYS RES LETT, V17, P45, DOI 10.1029/GL017i001p00045; Ohtani S, 2014, J GEOPHYS RES-SPACE, V119, P322, DOI 10.1002/2013JA019410; WEIMER DR, 1995, J GEOPHYS RES, V100, P19595, DOI 10.1029/95JA01755; Wang CP, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013849; Miyashita Y, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013225; Wang Y, 2013, J GEOPHYS RES-SPACE, V118, P2173, DOI 10.1002/jgra.50226; Xing X, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016539; Shue JH, 1997, J GEOPHYS RES-SPACE, V102, P9497, DOI 10.1029/97JA00196; MUKAI T, 1994, J GEOMAGN GEOELECTR, V46, P669; Nishimura Y, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016768; BAKER DN, 1990, J GEOPHYS RES, V95, P6591, DOI 10.1029/JA095iA05p06591; Ban PP, 2011, RADIO SCI, V46, DOI 10.1029/2010RS004633; Borovsky JE, 1997, J GEOPHYS RES-SPACE, V102, P22089, DOI 10.1029/96JA02469; Borovsky JE, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011447; Borovsky JE, 1998, J GEOPHYS RES-SPACE, V103, P17617, DOI 10.1029/97JA02986; Chang C.C., 2001, LIBSVM LIB SUPPORT V; Drucker H, 1997, ADV NEUR IN, V9, P155; FAIRFIELD DH, 1981, J GEOPHYS RES-SPACE, V86, P1396, DOI 10.1029/JA086iA03p01396; Gavrishchaka VV, 2001, J GEOPHYS RES-SPACE, V106, P29911, DOI 10.1029/2001JA900118; Gkioulidou M, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013955; Hsu TS, 2012, ADV SPACE RES, V50, P1317, DOI 10.1016/j.asr.2012.06.034; Huang SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-9; KOKUBUN S, 1994, J GEOMAGN GEOELECTR, V46, P7; Liu DD, 2011, MON NOT R ASTRON SOC, V413, P2877, DOI 10.1111/j.1365-2966.2011.18359.x; Liu WW, 1997, J GEOPHYS RES-SPACE, V102, P4927, DOI 10.1029/96JA03561; MCPHERSO.RL, 1970, J GEOPHYS RES, V75, P5592, DOI 10.1029/JA075i028p05592; MIURA A, 1989, J GEOPHYS RES, V94, P15231, DOI 10.1029/JA094iA11p15231; Miyashita Y, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009939; Miyashita Y, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015608; Miyashita Y, 2001, J GEOPHYS RES-SPACE, V106, P6259, DOI 10.1029/2000JA000233; Miyashita Y, 2000, J GEOPHYS RES-SPACE, V105, P15913, DOI 10.1029/1999JA000392; PETRINEC SM, 1993, GEOPHYS RES LETT, V20, P2695, DOI 10.1029/93GL02847; Pu ZY, 1997, J GEOPHYS RES-SPACE, V102, P14397, DOI 10.1029/97JA00772; SANNY J, 1994, J GEOPHYS RES, V99, P5805, DOI 10.1029/93JA03235; Sergeev V, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA015689; SERGEEV VA, 1990, J GEOPHYS RES, V95, P3819, DOI 10.1029/JA095iA04p03819; Tsyganenko NA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009707; Vapnik V.N., 1963, Avtomatika i Telemekhanika, V24; Wang CP, 2013, J GEOPHYS RES-SPACE, V118, P6154, DOI 10.1002/jgra.50585; Xing X, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014315; Yue C, 2014, J GEOPHYS RES-SPACE, V119, P8202, DOI 10.1002/2014JA020172	55	2	2	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9380	2169-9402		J GEOPHYS RES-SPACE	J. Geophys. Res-Space Phys.	MAR	2015	120	3					1957	1973		10.1002/2014JA020787		17	Astronomy & Astrophysics	Astronomy & Astrophysics	CG4EY	WOS:000353237600033		
J	LaBelle, J; Yan, X; Broughton, M; Pasternak, S; Dombrowski, M; Anderson, RR; Frey, HU; Weatherwax, AT; Ebihara, Y				LaBelle, J.; Yan, X.; Broughton, M.; Pasternak, S.; Dombrowski, M.; Anderson, R. R.; Frey, H. U.; Weatherwax, A. T.; Ebihara, Y.			Further evidence for a connection between auroral kilometric radiation and ground-level signals measured in Antarctica	JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS			English	Article						AKR	AKR EMISSION CONE; HIGH-FREQUENCY; SATELLITE; POLAR; HISS	Inspired by recent observations of three cases of coincident ground-level auroral kilometric radiation (AKR)-like signals and outgoing AKR measured with the Geotail satellite, investigation of 2008 data from four Antarctic observatories yields >30 additional examples. The occurrence rate peaks near 22 MLT similar to that of AKR. Polarization measurements of one event show it to be right-hand polarized. Correlation analysis of ground-level and satellite data suggests an imperfect correlation with 2-3 sigma significance, although occasionally much better. (Perfect correlation is not expected, for at least two reasons: distant satellites detect AKR from many sources over a significant part of the oval, and many effects can hinder transmission of AKR from those sources to either distant satellites or ground stations.) Statistical analysis of the existing quantity of data is therefore suggestive but does not prove a connection between the ground-level AKR-like signals and outgoing AKR. However, two other methods provide evidence favoring such a connection. The first full-resolution measurements of ground-level AKR-like signals show that their fine structure strongly resembles that of AKR as known from high-resolution spacecraft receivers. Two case studies show that the location of active aurora, presumed connected with the AKR sources, controls whether or not the ground station detects the AKR, or which of several ground stations detects it most strongly. These investigations strengthen the hypothesis that through some mechanism, sources of outgoing AKR detected by distant satellites occasionally generate signals detectable as whistler mode waves at low altitude or right-hand polarized signals at ground level.	[LaBelle, J.; Yan, X.; Broughton, M.; Pasternak, S.; Dombrowski, M.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [Anderson, R. R.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Frey, H. U.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Weatherwax, A. T.] Siena Coll, Dept Phys & Astron, Loudonville, NY USA; [Ebihara, Y.] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan	LaBelle, J (reprint author), Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA.	james.labelle@dartmouth.edu	Ebihara, Yusuke/D-1638-2013; 	Ebihara, Yusuke/0000-0002-2293-1557; Frey, Harald/0000-0001-8955-3282	NSF Office of Polar Programs [ANT-1043230, ANT-1141817, ANT-0638587, ANT-0840158]; National Institute of Polar Research, Japan; NSF [ANT-0638587];  [ANT-1142161]	The authors thank the Geotail plasma wave instrument team, especially Hirotsugu Kojima, for providing Geotail data. D. Menietti and J. Pickett provided helpful advice about Cluster data and Figures 4a and 4b. Engineers David McGaw and Mike Trimpi made significant contributions to the ground-based instruments used in this study. Work at Dartmouth College was supported by NSF Office of Polar Programs awards ANT-1043230 and ANT-1141817. Work at University of California was supported by ANT-1142161. Work at Siena College was supported by NSF Office of Polar Programs awards ANT-0638587 and ANT-0840158. Work at Kyoto University was supported by National Institute of Polar Research, Japan, with deployment and logistical support at South Pole provided by NSF under award ANT-0638587. The ground-based data used in this study are available at http://www.dartmouth.edu/similar to spacephy/labelle_group, or by emailing james.labelle@dartmouth.edu. The satellite data used in this study are available at http://www.rish.kyoto-u.ac.jp/space/gtlpwi, or by emailing kojima.hirotsugu.6m@kyoto-u.ac.jp.	ALEXANDER JK, 1976, J GEOPHYS RES-SPACE, V81, P5948, DOI 10.1029/JA081i034p05948; BAHNSEN A, 1987, GEOPHYS RES LETT, V14, P471, DOI 10.1029/GL014i004p00471; MORIOKA A, 1981, J GEOMAGN GEOELECTR, V33, P37; SIREN JC, 1975, J GEOPHYS RES, V80, P93, DOI 10.1029/JA080i001p00093; BAUMBACK MM, 1987, GEOPHYS RES LETT, V14, P119, DOI 10.1029/GL014i002p00119; DUNCKEL N, 1970, J GEOPHYS RES, V75, P1854, DOI 10.1029/JA075i010p01854; GURNETT DA, 1974, J GEOPHYS RES, V79, P4227, DOI 10.1029/JA079i028p04227; Ebihara Y, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012087; CALVERT W, 1981, GEOPHYS RES LETT, V8, P1159, DOI 10.1029/GL008i011p01159; DEFERAUDY H, 1987, GEOPHYS RES LETT, V14, P511, DOI 10.1029/GL014i005p00511; OYA H, 1985, J GEOMAGN GEOELECTR, V37, P37; Mende SB, 2000, SPACE SCI REV, V91, P243, DOI 10.1023/A:1005271728567; Ye S, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012473; MELROSE DB, 1976, ASTROPHYS J, V207, P651, DOI 10.1086/154532; WU CS, 1979, ASTROPHYS J, V230, P621, DOI 10.1086/157120; Gurnett DA, 1997, SPACE SCI REV, V79, P195, DOI 10.1023/A:1004966823678; Benedictov E. A., 1966, ADV SPACE RES, VVI, P110; MELLOTT MM, 1988, J GEOPHYS RES, V93, P7515, DOI 10.1029/JA093iA07p07515; GREEN JL, 1985, J GEOPHYS RES-SPACE, V90, P9641, DOI 10.1029/JA090iA10p09641; GREEN JL, 1977, J GEOPHYS RES-SPACE, V82, P1825, DOI 10.1029/JA082i013p01825; Gurnett D. A., 1981, GEOPHYS MONOGR SER, V25, P341; Krasovskiy V. L., 1983, GEOMAGN AERON, V23, P702; LaBelle J, 1999, J GEOPHYS RES-SPACE, V104, P28101, DOI 10.1029/1999JA900397; LaBelle J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046411; Lewicki P., 2007, STAT METHODS APPL; Menietti JD, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA017168; Menietti JD, 1996, J GEOPHYS RES-SPACE, V101, P10673, DOI 10.1029/96JA00362; Menietti JD, 2000, J GEOPHYS RES-SPACE, V105, P18857, DOI 10.1029/1999JA000389; Menietti JD, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011339; Mutel RL, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011660; Mutel R. L., 2011, PLANETARY RADIO EMIS, VVII, P241; Mutel RL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033377; Press W. H., 1986, NUMERICAL RECIPES, P472; Shutte N, 1997, J GEOPHYS RES-SPACE, V102, P2105, DOI 10.1029/96JA01116; SIREN JC, 1972, NATURE-PHYS SCI, V238, P118; Treumann RA, 2006, ASTRON ASTROPHYS REV, V13, P229, DOI 10.1007/s00159-006-0001-y	36	0	0	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9380	2169-9402		J GEOPHYS RES-SPACE	J. Geophys. Res-Space Phys.	MAR	2015	120	3					2061	2075		10.1002/2014JA020977		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CG4EY	WOS:000353237600039		
J	Imajo, S; Yoshikawa, A; Uozumi, T; Ohtani, S; Nakamizo, A; Marshall, R; Shevtsov, BM; Akulichev, VA; Sukhbaatar, U; Liedloff, A; Yumoto, K				Imajo, S.; Yoshikawa, A.; Uozumi, T.; Ohtani, S.; Nakamizo, A.; Marshall, R.; Shevtsov, B. M.; Akulichev, V. A.; Sukhbaatar, U.; Liedloff, A.; Yumoto, K.			Pi2 pulsations observed around the dawn terminator	JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS			English	Article						Pi2 pulsations; dawn terminator; meridional ionospheric current; ULF waves; oscillatory FACs; equatorial enhancement	2 MAGNETIC PULSATIONS; POLAR ELECTRIC-FIELD; EQUATORIAL LATITUDES; PI-2 PULSATIONS; MAGNETOSPHERE; DEPENDENCE; STATIONS; DAYTIME; EVENT; WAVES	We examined Pi2 pulsations observed simultaneously at low-latitude stations (L = 1.15 - 2.33) around the dawn terminator. Those Pi2 pulsations observed in the sunlit region were polarized in the azimuthal (D, positive eastward) direction. We found that the D component oscillations in the dark and sunlit regions were in antiphase, whereas the H component oscillated in phase. A statistical analysis indicates that these D component phase reversals occurred about 0.5 h sunward of the dawn terminator at100 km in altitude, corresponding to the highly conducting E layer. The azimuthal polarization and D component phase reversals related to the dawn terminator cannot be explained by the existing models of low-latitude Pi2s (e.g., cavity resonance or substorm current wedge oscillations). Similar D component phase reversals were also found on the dusk side although the amplitude of the D component is smaller than that of the H component. We suggest that the meridional ionospheric current in the sunlit region adjacent to the dawn terminator drives the D component oscillations in antiphase with those D oscillations produced by the oscillatory field-aligned current (FAC) on the postmidnight side. The meridional current is expected to form a part of a current system that extends from the postmidnight FAC to the equatorial Cowling current. The D component oscillations in the Northern and Southern Hemispheres are also in antiphase, indicating that the current system is symmetric with respect to the equator.	[Imajo, S.; Yoshikawa, A.; Yumoto, K.] Kyushu Univ, Dept Earth & Planetary Sci, Fukuoka 812, Japan; [Yoshikawa, A.; Uozumi, T.; Yumoto, K.] Kyushu Univ, Int Ctr Space Weather Sci & Educ, Fukuoka 812, Japan; [Ohtani, S.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Nakamizo, A.] Natl Inst Informat & Commun Technol, Corp Planning Dept, Tokyo, Japan; [Marshall, R.] Bur Meteorol, IPS Radio Serv, Sydney, NSW, Australia; [Marshall, R.] Bur Meteorol, IPS Space Serv, Sydney, NSW, Australia; [Shevtsov, B. M.] Inst Cosmophys Res & Radio Wave Propagat, Paratunka, Russia; [Akulichev, V. A.] FEB RAS, Pacific Oceanol Inst, Vladivostok, Russia; [Sukhbaatar, U.] Mongolian Acad Sci, Res Ctr Astron & Geophys, Ulaanbaatar, Mongol Peo Rep; [Liedloff, A.] CSIRO Land & Water, Darwin, NT, Australia	Imajo, S (reprint author), Kyushu Univ, Dept Earth & Planetary Sci, Fukuoka 812, Japan.	imajo@kyudai.jp			JSPS; Ministry of Education, Culture, Sports, Science, and Technology [18253005, 22253007]	This work was supported in part by JSPS Core-to-Core Program, B. Asia-Africa Science Platforms. MAGDAS/CPMN magnetic data were provided by the principal investigator of MAGDAS/CPMN project (http://magdas.serc.kyushu-u.ac.jp/). MAGDAS magnetic data from ASB and AMA are supported with the help of Koji Nosakon and Kenichi Isami, respectively. We thank the national institutes that support INTERMAGNET for promoting high standards of magnetic observatory practice (www.intermagnet.org). The Kakioka magnetic field data were provided by the Kakioka Geomagnetic Observatory (http://www.kakioka-jma.go.jp). AL index was provided by the Kyoto WDC (http://wdc.kugi.kyoto-u.ac.jp). Financial support for this research was provided by the Ministry of Education, Culture, Sports, Science, and Technology in the form of Grant-in-Aid for Overseas Scientific Survey (18253005 and 22253007).	Allan W, 1996, GEOPHYS RES LETT, V23, P765, DOI 10.1029/96GL00661; Yumoto K, 2001, EARTH PLANETS SPACE, V53, P981; NISHIDA A, 1968, J GEOPHYS RES, V73, P1795, DOI 10.1029/JA073i005p01795; Yumoto K, 2007, B ASTRON SOC INDIA, V35, P511; ARAKI T, 1977, PLANET SPACE SCI, V25, P373, DOI 10.1016/0032-0633(77)90053-8; KIKUCHI T, 1979, J ATMOS TERR PHYS, V41, P927, DOI 10.1016/0021-9169(79)90094-1; SUTCLIFFE PR, 1991, J GEOPHYS RES, V96, P1543, DOI 10.1029/90JA02007; Shinohara M, 1997, GEOPHYS RES LETT, V24, P2279, DOI 10.1029/97GL02146; Panov EV, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041971; Keiling A, 2014, J GEOPHYS RES-SPACE, V119, P2717, DOI 10.1002/2013JA019085; Han DS, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010576; SASTRY TS, 1983, J ATMOS TERR PHYS, V45, P733; Sutcliffe PR, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014757; BAUMJOHANN W, 1984, PLANET SPACE SCI, V32, P1361, DOI 10.1016/0032-0633(84)90079-5; Keiling A, 2011, SPACE SCI REV, V161, P63, DOI 10.1007/s11214-011-9818-4; Kikuchi T, 1996, J GEOPHYS RES-SPACE, V101, P17161, DOI 10.1029/96JA01299; SUTCLIFFE PR, 1989, GEOPHYS RES LETT, V16, P887, DOI 10.1029/GL016i008p00887; Nose M, 2006, EARTH PLANETS SPACE, V58, P775; Nose M, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009747; Kepko L, 2001, J GEOPHYS RES-SPACE, V106, P1903, DOI 10.1029/2000JA000158; ARAKI T, 1994, GEOPH MONOG SERIES, V81, P183; Gopalswamy N, 2006, SOLAR INFLUENCE HELI, P309; Imajo S, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-20; Itonaga M, 1998, J GEOPHYS RES-SPACE, V103, P9285, DOI 10.1029/98JA00288; Itonaga M, 1996, J GEOMAGN GEOELECTR, V48, P1451; Kepko L, 1999, J GEOPHYS RES-SPACE, V104, P25021, DOI 10.1029/1999JA900361; KITAMURA TI, 1988, J GEOMAGN GEOELECTR, V40, P621; LESTER M, 1983, J GEOPHYS RES-SPACE, V88, P7958, DOI 10.1029/JA088iA10p07958; Li Y, 1998, J GEOPHYS RES-SPACE, V103, P2343, DOI 10.1029/97JA02921; Motoba T, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA900156; SAITO T, 1968, J GEOPHYS RES, V73, P267, DOI 10.1029/JA073i001p00267; SAKA O, 1980, J ATMOS TERR PHYS, V42, P517, DOI 10.1016/0021-9169(80)90012-4; Tanaka YM, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012585; Uozumi T, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014163; Uozumi T, 2000, GEOPHYS RES LETT, V27, P1619, DOI 10.1029/1999GL010767; Yanagihara K., 1966, MEM KAKIOKA MAGN OBS, V12, P57; Yoshikawa A., 2012, 2012 AGU FALL M SAN; YUMOTO K, 1994, J GEOMAGN GEOELECTR, V46, P925	38	0	0	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9380	2169-9402		J GEOPHYS RES-SPACE	J. Geophys. Res-Space Phys.	MAR	2015	120	3					2088	2098		10.1002/2013JA019691		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CG4EY	WOS:000353237600041		
J	Fukushima, D; Shiokawa, K; Otsuka, Y; Nishioka, M; Kubota, M; Tsugawa, T; Nagatsuma, T; Komonjinda, S; Yatini, CY				Fukushima, D.; Shiokawa, K.; Otsuka, Y.; Nishioka, M.; Kubota, M.; Tsugawa, T.; Nagatsuma, T.; Komonjinda, S.; Yatini, C. Y.			Geomagnetically conjugate observation of plasma bubbles and thermospheric neutral winds at low latitudes	JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS			English	Article						plasma bubble; geomagnetic conjugate observation; airglow; thermospheric wind; equatorial ionosphere	EQUATORIAL F-REGION; ELECTRIC-FIELD; IONOSPHERE; AIRGLOW; DEPLETIONS; IMAGERS; DRIFTS	This is the first paper that reports simultaneous observations of zonal drift of plasma bubbles and the thermospheric neutral winds at geomagnetically conjugate points in both hemispheres. The plasma bubbles were observed in the 630nm nighttime airglow images taken by using highly sensitive all-sky airglow imagers at Kototabang, Indonesia (geomagnetic latitude (MLAT): 10.0 degrees S), and Chiang Mai, Thailand (MLAT: 8.9 degrees N), which are nearly geomagnetically conjugate stations, for 7h from 13 to 20UT (from 20 to 03LT) on 5 April 2011. The bubbles continuously propagated eastward with velocities of 100-125m/s. The 630nm images at Chiang Mai and those mapped to the conjugate point of Kototabang fit very well, which indicates that the observed plasma bubbles were geomagnetically connected. The eastward thermospheric neutral winds measured by two Fabry-Perot interferometers were 70-130m/s at Kototabang and 50-90m/s at Chiang Mai. We compared the observed plasma bubble drift velocity with the velocity calculated from the observed neutral winds and the model conductivity, to investigate the F region dynamo contribution to the bubble drift velocity. The estimated drift velocities were 60-90% of the observed velocities of the plasma bubbles, suggesting that most of the plasma bubble velocity can be explained by the F region dynamo effect.	[Fukushima, D.; Shiokawa, K.; Otsuka, Y.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Nishioka, M.; Kubota, M.; Tsugawa, T.; Nagatsuma, T.] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan; [Komonjinda, S.] Chiang Mai Univ, Fac Sci, Dept Phys & Mat Sci, Chiang Mai 50000, Thailand; [Yatini, C. Y.] Indonesian Natl Inst Aeronaut & Space, Bandung, Indonesia	Fukushima, D (reprint author), Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan.	fukusima@stelab.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS;  [13573006];  [20244080];  [764]	We thank Y. Katoh, M. Satoh, Y. Yamamoto, and Y. Hamaguchi of STEL, Nagoya University, for their helpful support in the development and operation of the optical instruments of STEL. The airglow observation at Kototabang was carried out in collaboration with the Research Institute for Sustainable Humanosphere, Kyoto University, Japan, and the National Institute of Aeronautics and Space (LAPAN), Indonesia. The airglow observation at Chiang Mai and the ionosonde observations at Kototabang and Chiang Mai were operated by NICT, Japan, as part of the SEALION project. The airglow and FPI observations at Chiang Mai were carried out in cooperation with Chiang Mai University, NICT, and STEL. The data for all-sky images at Kototabang and FPIs at Kototabang and Chiang Mai are available at STEL, Nagoya University. The data for all-sky images at Chiang Mai and ionosondes at Kototabang and Chiang Mai are available at NICT. This work was supported by grants-in-aid for Scientific Research (13573006, 20244080, and Priority Area 764) and by Strategic Funds for the Promotion of Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was supported by the JSPS Core-to-Core Program, B. Asia-Africa Science Platforms.	Abalde JR, 2001, J GEOPHYS RES-SPACE, V106, P30331, DOI 10.1029/2001JA001115; Shiokawa K, 2009, EARTH PLANETS SPACE, V61, P479; SOBRAL JHA, 1991, J ATMOS TERR PHYS, V53, P729, DOI 10.1016/0021-9169(91)90124-P; Chapagain NP, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017620; Burke WJ, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010583; Bilitza D, 2008, ADV SPACE RES, V42, P599, DOI 10.1016/j.asr.2007.07.048; Chapagain NP, 2013, J GEOPHYS RES-SPACE, V118, P1802, DOI 10.1002/jgra.50238; MENDILLO M, 1982, J GEOPHYS RES-SPACE, V87, P7641, DOI 10.1029/JA087iA09p07641; Sahai Y, 2000, J ATMOS SOL-TERR PHY, V62, P1377, DOI 10.1016/S1364-6826(00)00179-6; Shiokawa K, 2012, EARTH PLANETS SPACE, V64, P1033, DOI 10.5047/eps.2012.05.004; RISHBETH H, 1971, PLANET SPACE SCI, V19, P357, DOI 10.1016/0032-0633(71)90098-5; Shiokawa K, 1999, EARTH PLANETS SPACE, V51, P887; Shiokawa K, 2004, ANN GEOPHYS-GERMANY, V22, P3137; Finlay CC, 2010, GEOPHYS J INT, V183, P1216, DOI 10.1111/j.1365-246X.2010.04804.x; COLEY WR, 1994, J GEOPHYS RES, V99, P341, DOI 10.1029/93JA02205; Abdu MA, 2001, J ATMOS SOL-TERR PHY, V63, P869, DOI 10.1016/S1364-6826(00)00201-7; FARLEY DT, 1986, J GEOPHYS RES, V91, P3723, DOI 10.1029/JA091iA12p13723; FEJER BG, 1985, J GEOPHYS RES-SPACE, V90, P2249, DOI 10.1029/JA090iA12p12249; GANGULY S, 1987, J GEOPHYS RES, V92, P1199, DOI 10.1029/JA092iA02p01199; JOHNSTON JE, 1993, J GEOPHYS RES, V98, P21593, DOI 10.1029/93JA02318; Kelley MC, 2009, INT GEOPHYS SER, V96, P1; Kubota M., 2009, J NATL I INF COMMUN, V56, P299; Maruyama T, 2007, ANN GEOPHYS-GERMANY, V25, P1569; Miyoshi Y, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017373; Otsuka Y, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015347; Picone JM, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2002JA009430; Sobral JHA, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013896; SOBRAL JHA, 1993, J GEOPHYS RES, V98, P7791, DOI 10.1029/92JA01839	28	0	0	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9380	2169-9402		J GEOPHYS RES-SPACE	J. Geophys. Res-Space Phys.	MAR	2015	120	3					2222	2231		10.1002/2014JA020398		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CG4EY	WOS:000353237600051		
J	Sasaki, S; Nagano, Y; Kaneko, S; Imamura, S; Koabayshi, T; Fukubayashi, T				Sasaki, Shogo; Nagano, Yasuharu; Kaneko, Satoshi; Imamura, Shoichiro; Koabayshi, Takuma; Fukubayashi, Toru			The Relationships Between the Center of Mass Position and the Trunk, Hip, and Knee Kinematics in the Sagittal Plane: A Pilot Study on Field-Based Video Analysis for Female Soccer Players	JOURNAL OF HUMAN KINETICS			English	Article						two-dimensional assessment; risk factor; anterior cruciate ligament; injury prevention	CRUCIATE LIGAMENT INJURY; JOINT KINEMATICS; MECHANISMS; MOTION; RECONSTRUCTION; BASKETBALL; SEQUENCES; PREVENTION; PATTERNS; FOOTBALL	Athletes with non-contact anterior cruciate ligament tears have common features in the sagittal plane; namely, the body's center of mass (COM) is located posterior to the base of support, the trunk and knee joints are extended, and the hip angle is flexed. However, the relationships among these variables have not been assessed in field-based movements. This study sought to determine relationships between distances from the COM to the base of support and the trunk, hip, and knee positions in women while playing soccer. Sixty events (29 single-leg landing and 31 single-leg stopping events) were analyzed using two-dimensional video analysis. The relationships among the measurement variables were determined using the Pearson's product-moment correlation coefficient, and stepwise multiple linear regression models were used to explore the relationships between the COM position and the kinematic variables. The distance from the COM to the base of support displayed a moderate negative relationship with the trunk angle (r = -0.623, p < .0001, r(2) = 0.388) and a strong positive relationship with the limb angle (r = 0.869, p < .0001, r(2) = 0.755). The limb, knee, and trunk angles were selected in the best regression model (adjusted r(2) = 0.953, p < .0001, f(2) = 20.277). These findings suggest that an increased trunk angle and a decreased limb angle at initial contact are associated with a safer COM position. Neuromuscular training may be useful for controlling the trunk and lower limb positions during dynamic activities.	[Sasaki, Shogo] Tokyo Ariake Univ Med & Hlth Sci, Fac Hlth Sci, Tokyo 1350063, Japan; [Nagano, Yasuharu] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Japan; [Kaneko, Satoshi] Waseda Univ, Grad Sch Sport Sci, Saitama, Japan; [Imamura, Shoichiro] Tokyo Ariake Univ Med & Hlth Sci, Grad Sch, Tokyo, Japan; [Koabayshi, Takuma] Sapporo Med Univ, Dept Orthoped Surg, Sapporo, Hokkaido, Japan; [Fukubayashi, Toru] Waseda Univ, Fac Sport Sci, Saitama, Japan	Sasaki, S (reprint author), Tokyo Ariake Univ Med & Hlth Sci, Fac Hlth Sci, Koto Ku, 2-9-1 Ariake, Tokyo 1350063, Japan.	sasaki@tau.ac.jp			JSPS KAKENHI Grant [24700671]	We gratefully acknowledge the Kanto Ladies Soccer League for cooperating in this research. This study was supported by JSPS KAKENHI Grant Number 24700671.	ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Hewett TE, 2009, BRIT J SPORT MED, V43, P417, DOI 10.1136/bjsm.2009.059162; Powell JW, 2000, AM J SPORT MED, V28, P385; Boden BP, 2009, AM J SPORT MED, V37, P252, DOI 10.1177/0363546508328107; Sheehan FT, 2012, AM J SPORT MED, V40, P1068, DOI 10.1177/0363546512437850; Zazulak BT, 2007, AM J SPORT MED, V35, P368, DOI 10.1177/0363546506297909; Boden BP, 2010, J AM ACAD ORTHOP SUR, V18, P520; Koga H, 2011, CLIN J SPORT MED, V21, P271, DOI 10.1097/JSM.0b013e31821899ec; Blackburn JT, 2008, CLIN BIOMECH, V23, P313, DOI 10.1016/j.clinbiomech.2007.10.003; Shimokochi Y, 2009, J ATHL TRAINING, V44, P33, DOI 10.4085/1062-6050-44.1.33; Nagano Y, 2011, J SPORT SCI, V29, P1525, DOI 10.1080/02640414.2011.599038; Fauno P, 2006, INT J SPORTS MED, V27, P75, DOI 10.1055/s-2005-837485; Harmon KG, 1998, CLIN J SPORT MED, V8, P260, DOI 10.1097/00042752-199810000-00002; Myer GD, 2008, CLIN SPORT MED, V27, P425, DOI 10.1016/j.csm.2008.02.006; Krosshaug T, 2005, J BIOMECH, V38, P919, DOI 10.1016/j.jbiomech.2004.04.033; Hashemi J, 2011, J BIOMECH, V44, P577, DOI 10.1016/j.jbiomech.2010.11.013; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Krosshaug T, 2007, SCAND J MED SCI SPOR, V17, P508, DOI 10.1111/j.1600-0838.2006.00558.x; Junge A, 2007, BRIT J SPORT MED, V41, pI3, DOI 10.1136/bjsm.2007.036020; Boden BP, 2009, J BONE JOINT SURG AM, V91A, P2381, DOI 10.2106/JBJS.H.01721; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Myer GD, 2008, BRIT J SPORT MED, V42, P614, DOI 10.1136/bjsm.2007.046086; Krosshaug T, 2007, GAIT POSTURE, V26, P378, DOI 10.1016/j.gaitpost.2006.10.010; Bere T, 2013, AM J SPORT MED, V41, P1067, DOI 10.1177/0363546513479341; Bjordal JM, 1997, AM J SPORT MED, V25, P341, DOI 10.1177/036354659702500312; Federation Internationale de Football Association, 2007, BIG COUNT STAT PACK; Federation Internationale de Football Association, 2007, HLTH FITN FEM FOOTB; Junge Astrid, 2004, Sports Med, V34, P929, DOI 10.2165/00007256-200434130-00004; Koyanagi M, 2006, KNEE SURG SPORT TR A, V14, P88, DOI 10.1007/s00167-004-0609-2; Zaffagnini S, 2014, KNEE, V21, P731, DOI 10.1016/j.knee.2014.02.005	31	0	0	DE GRUYTER OPEN LTD	WARSAW	BOGUMILA ZUGA 32A ST, 01-811 WARSAW, POLAND	1640-5544	1899-7562		J HUM KINET	J. Hum. Kinet.	MAR	2015	45	1					71	80		10.1515/hukin-2015-0008		10	Sport Sciences	Sport Sciences	CG3DW	WOS:000353159100008		
J	Furuta, T				Furuta, Takayuki			PRECISE LOWER BOUND OF f(A)-f(B) FOR A > B > 0 AND NON-CONSTANT OPERATOR MONOTONE FUNCTION f ON [0, infinity)	JOURNAL OF MATHEMATICAL INEQUALITIES			English	Article						Lowner-Heinz inequality; strictly positive order; operator monotone function		A and B be strictly positive operators on a Hilbert space H such that A - B >= m > 0. Then the following inequalities hold for any non-constant operator monotone function f on [0, infinity) : f(A) - f(B) >= f (parallel to B parallel to + m) - f (parallel to B parallel to) >= f(parallel to A parallel to|) - f(parallel to A parallel to - m) > 0. In particularly, let A > B. Then f(A) - f(B) >= f(parallel to B parallel to + 1/parallel to(A - B)(-1) parallel to) - f(parallel to B parallel to) >= f(parallel to A parallel to|) - f(parallel to A parallel to - 1/parallel to(A - B)(-1) parallel to > 0. We shall state the typical concrete example of these operator inequalities. Let A > B. Then the following inequalities hold as an extension of celebrated Lowner-Heinz inequality A(r) - B-r >= (parallel to B parallel to| + 1/(parallel to(A - B)(-1)parallel to)(r) - parallel to B parallel to(r) >= parallel to A parallel to|(r) - (parallel to A parallel to-1/parallel to(A - B)(-1)parallel to(r) > 0 for 0 < r <= 1 and also the following inequalities hold logA - logB >= log (parallel to B parallel to + 1/parallel to(A - B)(-1) parallel to) - log parallel to B parallel to >= log parallel to A parallel to - log(parallel to A parallel to - 1/parallel to(A - B)(-1)parallel to > 0.	Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368560, Japan	Furuta, T (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, 1 Bunkyo Cho, Hirosaki, Aomori 0368560, Japan.	furuta@rs.kagu.tus.ac.jp					Bhatia R, 1997, MATRIX ANAL; FURUTA T., 2013, J MATH INEQUAL, V341, P93; Moslehian MS, 2012, LINEAR ALGEBRA APPL, V437, P2359, DOI 10.1016/j.laa.2012.05.027; Zhan X., 2002, MATRIX INEQUALITIES; ZUO HONGLIAN, J MATH INEQ IN PRESS	5	0	0	ELEMENT	ZAGREB	R AUSTRIJE 11, 10000 ZAGREB, CROATIA	1846-579X			J MATH INEQUAL	J. Math. Inequal.	MAR	2015	9	1					47	52		10.7153/jmi-09-04		6	Mathematics, Applied; Mathematics	Mathematics	CG7YU	WOS:000353524600004		
J	Fukui, H; Iwahashi, H; Endoh, S; Nishio, K; Yoshida, Y; Hagihara, Y; Horie, M				Fukui, Hiroko; Iwahashi, Hitoshi; Endoh, Shigehisa; Nishio, Keiko; Yoshida, Yasukazu; Hagihara, Yoshihisa; Horie, Masanori			Ascorbic acid attenuates acute pulmonary oxidative stress and inflammation caused by zinc oxide nanoparticles	JOURNAL OF OCCUPATIONAL HEALTH			English	Article						Antioxidants; Inflammation; Metals; Nanoparticles; Oxidative stress	ZNO NANOPARTICLES; IN-VITRO; CYTOTOXICITY; EXPOSURE; NANOMATERIALS; INDUCTION; CELLS; GENOTOXICITY; APOPTOSIS; TOXICITY	Objectives: It is known that inhalation of zinc oxide nanoparticles (ZnO NPs) induces acute pulmonary dysfunction, including oxidative stress, inflammation, and injury, but there are no reports on how to prevent these adverse effects. We have previously reported that the pulmonary symptoms caused by ZnO NPs were associated with oxidative stress; in the present study, we therefore investigated the use of ascorbic acid (AA), which is known as vitamin C, to prevent these toxic effects. Methods: A ZnO NP dispersion was introduced into rat lungs by intratracheal injection, and thereafter a 1% aqueous AA solution was given as drinking water. Bronchoalveolar lavage fluid was collected at 1 day and 1 week after injection, and lactate dehydrogenase (LDH) activity, heme oxygenase-1 (HO-1), and interleukin-6 (IL-6) levels were measured. In addition, expression of the chemokine cytokine-induced neutrophil chemoattractants (CINCs), HO-1, and metallothionein-1 (MT-1) genes in the lungs were determined. Results: Acute oxidative stress induced by ZnO NPs was suppressed by supplying AA. Increases in LDH activity and IL-6 concentration were also suppressed by AA, as was the expression of the CINC-1, CINC-3, and HO-1 genes. Conclusions: Oral intake of AA prevents acute pulmonary oxidative stress and inflammation caused by ZnO NPs. Intake of AA after unanticipated exposure to ZnO NPs is possibly the first effective treatment for the acute pulmonary dysfunction they cause.	[Fukui, Hiroko; Iwahashi, Hitoshi] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Fukui, Hiroko; Nishio, Keiko; Yoshida, Yasukazu; Hagihara, Yoshihisa; Horie, Masanori] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst HRI, Tokyo, Japan; [Endoh, Shigehisa] AIST, Res Inst Environm Management Technol EMTECH, Tokyo, Japan	Fukui, H (reprint author), Gifu Univ, United Grad Sch Agr Sci, 1-1 Yanagido, Gifu 5011193, Japan.	hiroko-fukui@aist.go.jp					Akhtar MJ, 2010, TOXICOL IN VITRO, V24, P1139, DOI 10.1016/j.tiv.2010.03.002; Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385; Fukui H, 2012, CHEM-BIOL INTERACT, V198, P29, DOI 10.1016/j.cbi.2012.04.007; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Xia TA, 2011, ACS NANO, V5, P1223, DOI 10.1021/nn1028482; Ho M, 2011, INHAL TOXICOL, V23, P947, DOI 10.3109/08958378.2011.629235; Sharma V, 2012, MUTAT RES-GEN TOX EN, V745, P84, DOI 10.1016/j.mrgentox.2011.12.009; Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005; Roy R, 2011, J BIOMED NANOTECHNOL, V7, P110, DOI 10.1166/jbn.2011.1226; Kim YH, 2010, AM J RESP CRIT CARE, V182, P1398, DOI 10.1164/rccm.201002-0185OC; Gojova A, 2007, ENVIRON HEALTH PERSP, V115, P403, DOI 10.1289/ehp.8497; Heng BC, 2011, ARCH TOXICOL, V85, P1517, DOI 10.1007/s00204-011-0722-1; Wu WD, 2010, ENVIRON HEALTH PERSP, V118, P982, DOI 10.1289/ehp.0901635; Ahmad J, 2012, TOXICOL APPL PHARM, V259, P160, DOI 10.1016/j.taap.2011.12.020; Tsukaguchi H, 1999, NATURE, V399, P70; Horie M, 2009, CHEM RES TOXICOL, V22, P1415, DOI 10.1021/tx900171n; Landsiedel R, 2010, ADV MATER, V22, P2601, DOI 10.1002/adma.200902658; Song WH, 2010, TOXICOL LETT, V199, P389, DOI 10.1016/j.toxlet.2010.10.003; Chuang HC, 2014, NANOTOXICOLOGY, V8, P593, DOI 10.3109/17435390.2013.809809; Kim IS, 2010, J NANOSCI NANOTECHNO, V10, P3453, DOI 10.1166/jnn.2010.2340; De Barardis B, 2010, TOXICOL APPL PHARM, V246, P116; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Hone M, 2012, CHEM RES TOXICOL, V25, p:605, DOI [10.1021/tx200470e, DOI 10.1021/TX200470E]; Hone M, 2011, J OCCUP HEALTH, V53, P64; Huang CC, 2011, TOXICOL IN VITRO, V24, P45; Kermanizadeh A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-96; MAKINO T, 1982, CLIN CHIM ACTA, V120, P127; Osman FI, 2010, NANOMEDICINE, V6, P1193; Peake J, 2004, EXERC IMMUNOL REV, V10, P129; Tebbe B, 1997, J INVEST DERMATOL, V108, P302, DOI 10.1111/1523-1747.ep12286468; Tsou TC, 2011, J HAZARD MATER, V183, P182	31	2	2	JAPAN SOC OCCUPATIONAL HEALTH	TOKYO	1-29-8 SHINJUKU, SHINJUKU-KU, TOKYO, 160, JAPAN	1341-9145	1348-9585		J OCCUP HEALTH	J. Occup. Health	MAR	2015	57	2					118	125				8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG2JA	WOS:000353099500004		
J	Mori, K; Nagata, M; Hiraoka, M; Kudo, M; Nagata, T; Kajiki, S				Mori, Koji; Nagata, Masako; Hiraoka, Mika; Kudo, Megumi; Nagata, Tomohisa; Kajiki, Shigeyuki			Surveys on the competencies of specialist occupational physicians and effective methods for acquisition of competencies in Japan	JOURNAL OF OCCUPATIONAL HEALTH			English	Article						Case-based learning; Certification program; Competencies; On-the-job training; Specialist occupational physicians; Training methods	AMERICAN-COLLEGE; MEDICINE; DELPHI	Objectives: The aim of this study was to study the necessary competencies for specialist occupational physicians in Japan and the effective training methods for acquiring them. Methods: A competency list (61 items) was developed for the questionnaires in the study by making use of existing competency lists from the Japan Society for Occupational Health (JSOH) as well as lists from the US and Europe. Certified senior occupational physicians (CSOPs) in the certification program of the JSOH completed a questionnaire on the necessary competencies. Examiners of the examination for certified occupational physicians (COPS) completed another questionnaire on effective training methods. Results: All 61 competencies in the questionnaires were evaluated as "necessary". Some of the competencies in the list from the JSOH were evaluated lower than the items added from the American and European lists. When the respondents were categorized into a "practical group", the members of which mainly provided occupational health services, an "academic group", the members of which belonged to research or education institutes such as medical schools, and all others, the practical group evaluated some competencies significantly higher than the academic group, particularly those related to work accommodation. Among three options for training methods, the most effective methods were lectures and textbooks for 5 competency items, on-the-job training (OJT) for 30 items, and case-based learning (CBL) for 29 items. Conclusions: Some competencies should be added to the JSOH list. CBL should be introduced in training programs for specialist occupational physicians.	[Mori, Koji; Nagata, Masako; Hiraoka, Mika; Kudo, Megumi] Univ Occupat & Environm Hlth, Occupat Hlth Training Ctr, Kitakyushu, Fukuoka 8078555, Japan; [Mori, Koji; Nagata, Tomohisa; Kajiki, Shigeyuki] Univ Occupat & Environm Hlth, Dept Occupat Hlth Practice & Management, Kitakyushu, Fukuoka 8078555, Japan	Mori, K (reprint author), Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Occupat Hlth Practice & Management, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	kmori@med.uoeh-u.ac.jp			Occupational Health Promotion Foundation	We thank the CSOPs and COP examiners from the JSOH for their cooperation. This study was supported by the Occupational Health Promotion Foundation.	Kesler D, 2008, J OCCUP ENVIRON MED, V50, P712, DOI 10.1097/JOM.0b013e318173a90d; Baker BA, 2007, J OCCUP ENVIRON MED, V49, P388, DOI 10.1097/JOM.0b013e31803b947c; Harber P, 2005, J OCCUP ENVIRON MED, V47, P161, DOI 10.1097/01.jom.0000152924.60289.c9; [Anonymous], 2004, SANGYO EISEIGAKU ZAS, V46, P89; Brackman LA, 2007, INT J OCCUP ENV HEAL, V14, P51; Braeckman L, 2009, J OCCUP ENVIRON MED, V51, P1455, DOI 10.1097/JOM.0b013e3181bfa4ff; Cloeren M, 2014, J OCCUP ENVIRON MED, V56, pE21, DOI 10.1097/JOM.0000000000000173; Harvard School of Public Health, HSPH NEWS; KOH D, 1995, OCCUP MED-OXFORD, V45, P27, DOI 10.1093/occmed/45.1.27; MacDonald E, 2000, OCCUPATIONAL MED EUR; Macdonald EB, 2000, OCCUP ENVIRON MED, V57, P98, DOI 10.1136/oem.57.2.98; Ministry of Health Labor and Welfare, OV INT MEAS HLTH PRO; Ministry of Health Labor and Welfare, GUID MAINT PROM WORK; Mori K, 2011, PUBLIC HLTH ED CASE, V5th, P153; Reetoo KN, 2005, OCCUP ENVIRON MED, V62, P406, DOI 10.1136/oem.2004.017061; The University of Glasgow, 2004, COMP OCC PHYS CUST P; UEMS Occupational Medicine, 2014, ASS TOOL OCC MED POR; World Health Organization, 1995, REC 2 M WHO COLL CTR	18	0	0	JAPAN SOC OCCUPATIONAL HEALTH	TOKYO	1-29-8 SHINJUKU, SHINJUKU-KU, TOKYO, 160, JAPAN	1341-9145	1348-9585		J OCCUP HEALTH	J. Occup. Health	MAR	2015	57	2					126	141				16	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG2JA	WOS:000353099500005		
J	Hayashi, T; Odagiri, Y; Takamiya, T; Ohya, Y; Inoue, S				Hayashi, Toshio; Odagiri, Yuko; Takamiya, Tomoko; Ohya, Yumiko; Inoue, Shigeru			Organizational justice and insomnia: Relationships between justice components and insomnia symptoms among private company workers in Japan	JOURNAL OF OCCUPATIONAL HEALTH			English	Article						Insomnia; Organizational justice; Psychosocial factor	EFFORT-REWARD IMBALANCE; WHITEHALL-II; PROSPECTIVE COHORT; SLEEP; HEALTH; ASSOCIATION; DEPRESSION; INJUSTICE; EMPLOYEES; INEQUITY	Objectives: Organizational justice (OJ) is an important psychosocial factor and it consists of several components. Previous studies have shown that low perceived OJ is associated with various health problems. However, the relationships between each justice component and health outcomes have not been fully examined. The purpose of this study was to clarify the relationships between OJ and insomnia, including OJ components and insomnia symptoms. Methods: Cross-sectional self-reported questionnaire data from 1,893 employees (92.2% of subjects) were collected. OJ was measured using the Japanese version of the OJ questionnaire, which has four components (distributive, procedural, interpersonal and informational). Insomnia was assessed with the Athens Insomnia Scale. Logistic regression analysis, with insomnia as a dependent variable and OJ as an independent variable, was conducted. Results: Subjects with low overall OJ had a higher risk of insomnia (adjusted odds ratio (AOR), 2.37; 95% confidence interval (Cl), 1.59 to 3.53) and two insomnia symptoms (AOR of 2.47 and 95% CI of 1.68 to 3.65 for sleep induction problem; AOR of 1.73 and 95% Cl of 1.21 to 2.48 for sleep maintenance problem). The four justice components were all associated with insomnia and sleep induction problems. Sleep maintenance problems were associated with only the distributive justice component. Conclusions: All four justice components were associated with both insomnia and sleep induction problems. Sleep maintenance problems, however, showed different features. Specifically, the distributive justice component seemed to be a key factor in the relationship between OJ and insomnia. These findings might provide useful information for preventing the adverse effects of insomnia.	[Hayashi, Toshio; Odagiri, Yuko; Takamiya, Tomoko; Ohya, Yumiko; Inoue, Shigeru] Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Tokyo 1608402, Japan	Hayashi, T (reprint author), Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Shinjyuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	toshio7.hayashi@toshiba.co.jp					ADAMS JS, 1965, ADV EXP SOC PSYCHOL, V2, P267; Ambrose ML, 2005, HANDBOOK OF ORGANIZATIONAL JUSTICE, P59; Kaneita Y, 2006, J CLIN PSYCHIAT, V67, P196; Ndjaboue R, 2012, OCCUP ENVIRON MED, V69, P694, DOI 10.1136/oemed-2011-100595; Riemann D, 2009, SLEEP MED REV, V13, P205, DOI 10.1016/j.smrv.2008.06.001; Grynderup MB, 2013, OCCUP ENVIRON MED, V70, P380, DOI 10.1136/oemed-2012-101000; Greenberg J, 2006, J APPL PSYCHOL, V91, P58, DOI 10.1037/0021-9010.91.1.58; Kivimaki M, 2003, PSYCHOL MED, V33, P319, DOI 10.1017/S0033291702006591; Rugulies R, 2009, J PSYCHOSOM RES, V66, P75, DOI 10.1016/j.jpsychores.2008.05.005; Hillman DR, 2006, SLEEP, V29, P299; Kivimaki M, 2005, ARCH INTERN MED, V165, P2245, DOI 10.1001/archinte.165.19.2245; Ota A, 2009, SLEEP MED, V10, P1112, DOI 10.1016/j.sleep.2009.03.005; Ozminkowski RJ, 2007, SLEEP, V30, P263; Ota A, 2005, SLEEP MED, V6, P353, DOI 10.1016/j.sleep.2004.12.008; Okajima I, 2013, PSYCHIAT CLIN NEUROS, V67, P420, DOI 10.1111/pcn.12073; Hanson LLM, 2011, SLEEP, V34, P1403, DOI 10.5665/SLEEP.1288; Utsugi M, 2005, SLEEP, V28, P728; Elovainio M, 2002, AM J PUBLIC HEALTH, V92, P105, DOI 10.2105/AJPH.92.1.105; Kivimaki M, 2003, OCCUP ENVIRON MED, V60, P27, DOI 10.1136/oem.60.1.27; Kivimaki M, 2007, OCCUP ENVIRON MED, V64, P659, DOI 10.1136/oem.2006.031310; Elovainio M, 2009, PSYCHOSOM MED, V71, P334, DOI 10.1097/PSY.0b013e3181960665; Yoshioka E, 2008, AM J IND MED, V51, P148, DOI 10.1002/ajim.20543; Colquitt JA, 2001, J APPL PSYCHOL, V86, P386, DOI 10.1037//0021-9010.86.3.386; Ylipaavalniemi J, 2005, SOC SCI MED, V61, P111, DOI 10.1016/j.socscimed.2004.11.038; Rosekind MR, 2010, J OCCUP ENVIRON MED, V52, P91, DOI 10.1097/JOM.0b013e3181c78c30; Ferrie JE, 2006, OCCUP ENVIRON MED, V63, P443, DOI 10.1136/oem.2005.022269; Kessler RC, 2011, SLEEP, V34, P1161, DOI 10.5665/SLEEP.1230; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; Inoue A, 2013, INT J BEHAV MED, V20, P265, DOI 10.1007/s12529-012-9224-7; Nomura K, 2009, SLEEP MED, V10, P626, DOI 10.1016/j.sleep.2008.06.010; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Colquitt JA, 2005, HANDBOOK OF ORGANIZATIONAL JUSTICE, P3; Green MJ, 2012, SLEEP, V35, P815, DOI 10.5665/sleep.1882; Greenberg J., 1993, JUSTICE WORKPLACE AP, P79; Hayashi T, 2011, J OCCUP ENVIRON MED, V53, P174, DOI 10.1097/JOM.0b013e31820665cd; Leventhal G. S., 1980, SOCIAL EXCHANGE ADV, P27, DOI DOI 10.1007/978-1-4613-3087-5_2; Metlaine A, 2005, IND HEALTH, V43, P11, DOI 10.2486/indhealth.43.11; Pigeon WR, 2010, INDIAN J MED RES, V131, P321; Shibaoka M, 2010, IND HEALTH, V48, P66; Shimomitsu T., 1998, REPORT RES GRANT PRE, P107; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037//1076-8998.1.1.27; Thibaut J., 1975, PROCEDURAL JUSTICE P	42	0	0	JAPAN SOC OCCUPATIONAL HEALTH	TOKYO	1-29-8 SHINJUKU, SHINJUKU-KU, TOKYO, 160, JAPAN	1341-9145	1348-9585		J OCCUP HEALTH	J. Occup. Health	MAR	2015	57	2					142	150				9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG2JA	WOS:000353099500006		
J	Yamauchi, T; Yamano, Y; Yamanaka, K; Hata, A; Nakadate, T; Kuroda, Y; Endo, Y; Endo, G				Yamauchi, Takenori; Yamano, Yuko; Yamanaka, Kenzo; Hata, Akihisa; Nakadate, Toshio; Kuroda, Yoshiki; Endo, Yoko; Endo, Ginji			Possible production of arsenic hemoglobin adducts via exposure to arsine	JOURNAL OF OCCUPATIONAL HEALTH			English	Article						Acute poisoning; Adduct; Arsine; Biomarker; Hemoglobin	REINFORCED-PLASTICS WORKERS; ETHYLENE-OXIDE; OCCUPATIONAL EXPOSURE; STYRENE OXIDE; GLUTATHIONE TRANSFERASES; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; ACRYLONITRILE; BINDING; BLOOD	Objectives: Arsine is an arsenic compound generated as a by-product in metal refineries. Accidental poisoning occurs sporadically; however, the administrative level for workers has not been established. Thus, it is essential to identify a highly specific biomarker for risk management in the workplace. The aim of this study was to identify an arsenic adduct, a potential biomarker, in the plasma. Methods: Preserved mouse blood was exposed to arsine in vitro, and the plasma was separated. The residual clot of the control sample was hemolyzed using ultrapure water, and the supernatant was collected. Plasma from mice exposed to arsine in vivo was also separated from blood. Immunoprecipitation assays were conducted using all samples after ultrafiltration, and three fractions were collected. The total arsenic concentration in each fraction was quantified using inductively coupled plasma mass spectrometry (ICP-MS). The three in vitro samples and the eluate fraction from immunoprecipitation were analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Results: In the exposed samples, the arsenic concentration in the fraction containing immunocomplexes was higher when immunoprecipitation was conducted with an anti-globin antibody. Three peaks were specifically observed in arsine-exposed samples after MALDI-TOF-MS analysis. Two of them were around m/z 15,000, and the other was m/z 15,700. The latter peak was confirmed even after immunoprecipitation. Conclusions: Globin forms an adduct with arsenic after both in vitro and in vivo exposure to arsine. This adduct together with hemoglobinuria could be a candidate biomarker of acute arsine poisoning in plasma.	[Yamauchi, Takenori; Kuroda, Yoshiki] Miyazaki Univ, Fac Med, Dept Publ Hlth, Miyazaki, Japan; [Yamano, Yuko; Nakadate, Toshio] Showa Univ, Sch Med, Dept Hyg & Prevent Med, Tokyo 1428555, Japan; [Yamanaka, Kenzo] Nihon Univ, Sch Pharm, Lab Environm Toxicol & Carcinogenesis, Tokyo 102, Japan; [Hata, Akihisa] Chiba Inst Sci, Fac Risk & Crisis Management, Dept Environm Secur Syst, Div Clin Lab Sci, Chiba, Japan; [Endo, Yoko] Kansai Rosai Hosp, Res Ctr Occupat Poisoning, Amagasaki, Hyogo, Japan; [Endo, Ginji] Osaka City Univ, Grad Sch Med, Dept Prevent Med & Environm Hlth, Osaka, Japan	Yamauchi, T (reprint author), Showa Univ, Sch Med, Dept Hyg & Prevent Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	yamano@med.showa-u.ac.jp			Health Labour Sciences Research Grant for Research on Occupational Safety and Health from the Ministry of Health, Labour and Welfare of Japan [23250301]; JSPS KAKENHI [25860463]	This study was supported by a Health Labour Sciences Research Grant for Research on Occupational Safety and Health (23250301) from the Ministry of Health, Labour and Welfare of Japan and JSPS KAKENHI Grant Number 25860463.	Fennell TR, 2000, CANCER EPIDEM BIOMAR, V9, P705; Yoshimura Y, 2011, J OCCUP HEALTH, V53, P45, DOI 10.1539/joh.L10108; Pakulska Daria, 2006, International Journal of Occupational Medicine and Environmental Health, V19, P36, DOI 10.2478/v10001-006-0003-z; Kurooka H, 2013, BIOCHEM BIOPH RES CO, V433, P579, DOI 10.1016/j.bbrc.2013.03.027; Higashikawa Y, 2008, J ANAL TOXICOL, V32, P344; Lu ML, 2004, CHEM RES TOXICOL, V17, P1733, DOI 10.1021/tx049756s; CHENG CN, 1979, APPL ENVIRON MICROB, V38, P494; Watanabe J, 2007, J BIOL CHEM, V282, P23698, DOI 10.1074/jbc.M702163200; CHRISTAKOPOULOS A, 1993, SCAND J WORK ENV HEA, V19, P255; Fidder A, 2000, ARCH TOXICOL, V74, P207, DOI 10.1007/s002040000117; Fustinoni S, 1998, INT ARCH OCC ENV HEA, V71, P35, DOI 10.1007/s004200050247; Hagmar L, 2001, SCAND J WORK ENV HEA, V27, P219; Hatlelid KM, 1996, J TOXICOL ENV HEALTH, V47, P145, DOI 10.1080/009841096161852; HATLELID KM, 1995, FUND APPL TOXICOL, V25, P302, DOI 10.1006/faat.1995.1066; Irvine GW, 2013, BIOCHEM BIOPH RES CO, V433, P477, DOI 10.1016/j.bbrc.2013.03.026; JENKINS GC, 1965, BRIT MED J, V2, P78; Kato K, 2014, J TOXICOL SCI, V39, P301; KIPLING MD, 1964, BRIT J IND MED, V21, P74; LADOU J, 1983, SCAND J WORK ENV HEA, V9, P42; LANDRIGAN PJ, 1982, SCAND J WORK ENV HEA, V8, P169; Naranmandura H, 2008, CHEM RES TOXICOL, V21, P678, DOI 10.1021/tx700383g; Ogawa M, 2006, J OCCUP HEALTH, V48, P314, DOI 10.1539/joh.48.314; POPP RA, 1982, BIOCHEM GENET, V20, P199, DOI 10.1007/BF00484946; Rael LT, 2006, TOXICOL SCI, V90, P142, DOI 10.1093/toxsci/kfj054; Romeo L, 1997, AM J IND MED, V32, P211, DOI 10.1002/(SICI)1097-0274(199709)32:3<211::AID-AJIM5>3.0.CO;2-#; Schettgen T, 2002, TOXICOL LETT, V134, P65, DOI 10.1016/S0378-4274(02)00164-9; Schmidt AC, 2012, J MASS SPECTROM, V47, P949, DOI 10.1002/jms.3025; SEPAI O, 1993, ARCH TOXICOL, V67, P28, DOI 10.1007/BF02072031; SEVERI M, 1994, SCAND J WORK ENV HEA, V20, P451; Tavares R, 1996, CARCINOGENESIS, V17, P2655, DOI 10.1093/carcin/17.12.2655; Thier R, 2001, MUTAT RES-FUND MOL M, V482, P41, DOI 10.1016/S0027-5107(01)00208-1; Thier R, 1999, ARCH TOXICOL, V73, P197, DOI 10.1007/s002040050606; TING D, 1990, CARCINOGENESIS, V11, P755, DOI 10.1093/carcin/11.5.755; YeowellOConnell K, 1996, CANCER EPIDEM BIOMAR, V5, P205	34	0	0	JAPAN SOC OCCUPATIONAL HEALTH	TOKYO	1-29-8 SHINJUKU, SHINJUKU-KU, TOKYO, 160, JAPAN	1341-9145	1348-9585		J OCCUP HEALTH	J. Occup. Health	MAR	2015	57	2					161	168				8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG2JA	WOS:000353099500008		
J	Kimura, R; Mori, M; Tajima, M; Somemura, H; Sasaki, N; Yamamoto, M; Nakamura, S; Okanoya, J; Ito, Y; Otsubo, T; Tanaka, K				Kimura, Risa; Mori, Makiko; Tajima, Miyuki; Somemura, Hironori; Sasaki, Norio; Yamamoto, Megumi; Nakamura, Saki; Okanoya, June; Ito, Yukio; Otsubo, Tempei; Tanaka, Katsutoshi			Effect of a brief training program based on cognitive behavioral therapy in improving work performance: A randomized controlled trial	JOURNAL OF OCCUPATIONAL HEALTH			English	Article						Brief cognitive behavioral therapy; Cognitive behavioral therapy; Occupational mental health; Positive mental health; Web-based cognitive behavioral therapy; Work performance	POSITIVE PSYCHOLOGY; EXPLANATORY FLEXIBILITY; DEPRESSIVE SYMPTOMS; INTERVENTIONS; WORKPLACE; STRESS; HEALTH; PSYCHOTHERAPY; PRODUCTIVITY; METAANALYSIS	Objectives: Efforts to improve performance in the workplace with respect to positive mental health have increased, and cognitive behavioral therapy (CBT) has recently attracted attention as an intervention measure to this end. Here, we conducted a randomized controlled trial to evaluate the effectiveness of a brief training program on CBT for improving work performance of employees. Methods: The participants were employees of an electric company in Japan. The intervention consisted of 1 group session of CBT (120 min) and web-based CBT homework for 1 month. We evaluated employees in both the intervention and control groups at baseline and follow-up after three months. The main outcome was work performance, which was evaluated by a subjective score from 1 to 10. The secondary outcome was self-evaluation of cognitive flexibility. Analyses were conducted based on ITT. Results: In the intervention group, 84 participants attended the group session, with 79 subsequently completing at least 1 instance of online homework. ITT analysis showed that the subjective performance of the intervention group was significantly improved compared with that of the control group (1.47 vs. 0.69, mean difference 0.78 [95% confidence interval {CI}, 0.05 to 1.51], Cohen's d=0.31). The ability to recognize dysfunctional thinking patterns and change them to positive ones significantly improved in the intervention group compared to the control group (0.71 vs. 0.26, mean difference 0.45 [95% CI 0.06 to 0.83], d=0.33). However, after adjustment for baseline scores, no significant difference was observed. The ability to view a situation from multiple perspectives and expand one's repertoire of thought patterns in the intervention group also significantly improved (0.83 vs. 0.35, mean difference 0.48 [95% CI 0.35 to 0.95], d=0.29), but here again, significance was lost after adjusting for baseline scores. Discussion: Our results suggest that a brief training program that combines a group CBT session with webbased CBT homework improved subjective work performance. In addition, this program might help improve employees' cognitive flexibility.	[Kimura, Risa; Mori, Makiko; Somemura, Hironori; Sasaki, Norio; Yamamoto, Megumi; Nakamura, Saki; Okanoya, June; Ito, Yukio; Tanaka, Katsutoshi] Kitasato Univ, Dept Occupat Mental Hlth, Grad Sch Med Sci, Sagamihara, Kanagawa 2520373, Japan; [Tajima, Miyuki] Natl Ctr Cognit Behav Therapy & Res, Tokyo, Japan; [Otsubo, Tempei] JCHO Tokyo Shinjuku Med Ctr, Dept Psychiat, Tokyo, Japan	Kimura, R (reprint author), Kitasato Univ, Grad Sch Med Sci Occupat Mental Hlth, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	risarisa39@aol.com					Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Hirt ER, 2008, J PERS SOC PSYCHOL, V94, P214, DOI 10.1037/0022-3514.94.2.94.2.214; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Kaltenthaler E, 2008, PSYCHOL MED, V38, P1521, DOI 10.1017/S0033291707002607; Proudfoot JG, 2009, PERS INDIV DIFFER, V46, P147, DOI 10.1016/j.paid.2008.09.018; Dennis JP, 2010, COGNITIVE THER RES, V34, P241, DOI 10.1007/s10608-009-9276-4; DERUBEIS RJ, 1990, J CONSULT CLIN PSYCH, V58, P862, DOI 10.1037//0022-006X.58.6.862; Moore MT, 2007, BEHAV THER, V38, P325, DOI 10.1016/j.beth.2006.06.007; van der Klink JJL, 2001, AM J PUBLIC HEALTH, V91, P270, DOI 10.2105/AJPH.91.2.270; Johnco C, 2013, J ANXIETY DISORD, V27, P576, DOI 10.1016/j.janxdis.2012.10.004; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Fledderus M, 2010, AM J PUBLIC HEALTH, V100, P2372, DOI 10.2105/AJPH.2010.196196; de Vente W, 2008, J OCCUP HEALTH PSYCH, V13, P214, DOI 10.1037/1076-8998.13.3.214; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Fresco DM, 2007, J SOC CLIN PSYCHOL, V26, P595, DOI 10.1521/jscp.2007.26.5.595; McDaid D, 2005, INT REV PSYCHIATR, V17, P365, DOI 10.1080/09540260500238397; Hayes AM, 1998, J CONSULT CLIN PSYCH, V66, P939, DOI 10.1037/0022-006X.66.6.939; De Dreu CKW, 2008, J PERS SOC PSYCHOL, V94, P739, DOI 10.1037/0022-3514.94.5.739; Pomaki G, 2012, J OCCUP REHABIL, V22, P182, DOI 10.1007/s10926-011-9338-9; Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16; Bee PE, 2010, GEN HOSP PSYCHIAT, V32, P337, DOI 10.1016/j.genhosppsych.2010.01.006; Bhui KS, 2012, J ENV PUBLIC HLTH, V2012, DOI [DOI 10.1155/2012/515874, 10.1155/2012/515874]; Cape J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-38; Crowe M, 2012, J PSYCHIATR MENT HLT, V19, P681, DOI 10.1111/j.1365-2850.2011.01840.x; Donkin L, 2012, J MED INTERNET RES, V14, P262, DOI 10.2196/jmir.2100; Figueroa IJ, 2012, P HUM FACT ERG SOC A, V56, P1099; Furukawa TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035330; Graveling RA, 2008, REV WORKPLACE INTERV; Grime PR, 2004, OCCUP MED-OXFORD, V54, P353, DOI 10.1093/occmed/kqh077; Hasson H, 2010, HEALTH EDUC RES, V25, P596, DOI 10.1093/her/cyq005; Kojima R, 2010, IND HEALTH, V48, P495, DOI 10.2486/indhealth.MS1135; Lam RW, 2011, ANN CLIN PSYCHIATRY, V23, P11; Marine A, COCHRANE DATABASE SY; Powell John, 2013, J Med Internet Res, V15, pe2, DOI 10.2196/jmir.2240; Rubin DB, 1987, MULTIPLE IMPUTATION; Schueller SM, 2012, J MED INTERNET RES, V14, P4, DOI 10.2196/jmir.1850; Slade M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-26; World Health Organization, 2013, MENT HLTH ACT PLAN 2; Youmans RJ, 2011, P HUM FACT ERG SOC A, V55, P914; Young JE, 2001, CLIN HDB PSYCHOL DIS, V3rd, P264	40	0	0	JAPAN SOC OCCUPATIONAL HEALTH	TOKYO	1-29-8 SHINJUKU, SHINJUKU-KU, TOKYO, 160, JAPAN	1341-9145	1348-9585		J OCCUP HEALTH	J. Occup. Health	MAR	2015	57	2					169	178				10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG2JA	WOS:000353099500009		
J	Tanaka, A; Hirata, M; Matsumura, N; Kiyohara, Y				Tanaka, Akiyo; Hirata, Miyuki; Matsumura, Nagisa; Kiyohara, Yutaka			Tissue distribution of indium after repeated intratracheal instillations of indium-tin oxide into the lungs of hamsters	JOURNAL OF OCCUPATIONAL HEALTH			English	Article						Hamsters; Indium; Indium-tin oxide; Intratracheal instillation; Lung clearance; Tissue indium concentration	PULMONARY TOXICITY; FACILITY	Objectives: The aim of this study was to analyze the tissue distribution of indium after intratracheally instilling indium-tin oxide (ITO) into the lungs of hamsters. Methods: Male Syrian hamsters received an intratracheal dose of 3 mg/kg or 6 mg/kg of ITO particles containing 2.2 mg/kg or 4.5 mg/kg of indium, twice weekly for 8 weeks. In parallel, control hamsters received only an intratracheal dose of distilled water. A subset of hamsters was euthanized periodically throughout the study from 8 up to 78 weeks after the final instillation. The distribution of indium in the lungs, liver, kidneys and spleen, as well as pathological changes in the liver, kidneys, and spleen, was determined. Results: The contents of indium in the lungs in the two ITO groups gradually decreased over the 78-week observation period, with elimination half-lives of approximately 142 weeks for the 3 mg/kg ITO group and 124 weeks for the 6 mg/kg ITO. The indium concentrations in the liver, kidneys, and spleen gradually increased throughout the observation period. Although foci of the lesions were observed histopathologically in the extrapulmonary organs among the two ITO groups, the control group showed similar lesions. Conclusions: The results clearly demonstrate that the clearance of indium from the body is extremely slow after intratracheal instillation in hamsters.	[Tanaka, Akiyo; Hirata, Miyuki; Matsumura, Nagisa; Kiyohara, Yutaka] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 8128581, Japan	Tanaka, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Higashi Ku, EC Bldg 2F,6-10-1 Hakozaki, Fukuoka 8128581, Japan.	atanaka@envmed.med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24108009, 23390164, 23249033]; New Energy and Industrial Technology Development Organization (NEDO) Incorporated Administrative Agency under the Ministry of Economy, Trade and Industry (METI)	This study was funded in part by a Grant-in-Aid for Scientific Research on Innovative Areas (24108009) and Grants-in-Aid for Scientific Research (B) (23390164) and (A) (23249033) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the New Energy and Industrial Technology Development Organization (NEDO) Incorporated Administrative Agency under the Ministry of Economy, Trade and Industry (METI).	Cummings KJ, 2013, AM J IND MED, V56, P300, DOI 10.1002/ajim.22125; Tanaka A, 2010, THIN SOLID FILMS, V518, P2934, DOI 10.1016/j.tsf.2009.10.123; Omae K, 2011, INT ARCH OCC ENV HEA, V84, P471, DOI 10.1007/s00420-010-0575-6; Tanaka A, 2010, J OCCUP HEALTH, V52, P14; Cummings KJ, 2010, AM J RESP CRIT CARE, V181, P458, DOI 10.1164/rccm.200907-1022CR; Nagano K, 2011, J OCCUP HEALTH, V53, P175; Choi Sungyeul, 2013, Ann Occup Environ Med, V25, P24, DOI 10.1186/2052-4374-25-24; Hoet P, 2012, TOXICOL LETT, V213, P122, DOI 10.1016/j.toxlet.2011.07.004; Nogami H, 2008, J JPN RESP SOC, V46, P60; Tolcin AC, 2013, 2011 MINERALS YB, VOnline; Yamazaki K, 2000, J OCCUP HEALTH, V42, P169, DOI 10.1539/joh.42.169	11	0	0	JAPAN SOC OCCUPATIONAL HEALTH	TOKYO	1-29-8 SHINJUKU, SHINJUKU-KU, TOKYO, 160, JAPAN	1341-9145	1348-9585		J OCCUP HEALTH	J. Occup. Health	MAR	2015	57	2					189	192				4	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG2JA	WOS:000353099500011		
J	Kawai, T; Mitsuyoshi, K; Ikeda, M				Kawai, Toshio; Mitsuyoshi, Koji; Ikeda, Masayuki			Promising biological monitoring for occupational 1,2-Dichloropropane exposure by urinalysis for unmetabolized solvent	JOURNAL OF OCCUPATIONAL HEALTH			English	Article						1,2-Dichloropropane; Biomonitoring; Occupational exposure; Unmetabolized solvent; Urinalysis	CHOLANGIOCARCINOMA; WORKERS; URINE	Objectives: The aim of this study was to examine the applicability of urinalysis for unmetabolized solvent to biomonitor 1,2-dichloropropane (1,2-DCP) exposure. Methods: Thirty three male printers exposed to 1,2-DCP and 5 nonexposed male controls participated in the study. The 8-hr average levels of exposure to 1,2-DCP in air and 1,2-DCP in the end-of-shift urine samples were measured with capillary FID-GC. Results: The geometric mean (the maximum) concentrations was 7.1 ppm (23.1 ppm) for 1,2-DCP in air, and the level in urine (without correction for urine density) was 77 mu g/l (247 mu g/l). A regression analysis showed a correlation coefficient of 0.909 (p<0.01). No 1,2-DCP was detected in the urine samples from nonexposed subjects. Conclusions: The high correlation and low background (essentially zero) showed that urinalysis for unmetabolized 1,2-DCP is a promising tool for biomonitoring of occupational exposure to this carcinogenic solvent at lower levels (e.g. <1 ppm).	[Kawai, Toshio; Mitsuyoshi, Koji] Osaka Occupat Hlth Serv Ctr, Osaka, Japan; [Ikeda, Masayuki] Kyoto Ind Hlth Assoc, Kyoto 6048472, Japan	Ikeda, M (reprint author), Kyoto Ind Hlth Assoc, Nakagyo Ku, 67 Nishinokyo Kitatsuboicho, Kyoto 6048472, Japan.	m-71-ikeda@nifty.com					Kubo S, 2014, J HEPATO-BIL-PAN SCI, V21, P479, DOI 10.1002/jhbp.86; KAWAI T, 1992, INT ARCH OCC ENV HEA, V64, P223, DOI 10.1007/BF00378279; Kumagai S, 2013, OCCUP ENVIRON MED, V70, P508, DOI 10.1136/oemed-2012-101246; BARTELS MJ, 1990, XENOBIOTICA, V20, P1035; Benborahim-Tallaa L, 2014, LANCET ONCHOLOGY; HIRAYAMA T, 1979, AM IND HYG ASSOC J, V40, P1091, DOI 10.1080/15298667991430749; Ikeda M, 1999, TOXICOL LETT, V108, P99, DOI 10.1016/S0378-4274(99)00078-8; Japan Society for Analytical Chemistry (ed.), 1998, AN REL AN RES, P52; Japan Society for Occupational Health, 2013, J OCCUP HEALTH, V55, P422; Kawai T, 2011, IND HEALTH, V49, P24, DOI 10.2486/indhealth.MS1157; Kawai T, 1996, INT ARCH OCC ENV HEA, V68, P289, DOI 10.1007/BF00409413; Mitsuyoshi H, 1999, SANGYO EISEIGAKU ZAS, V41, P507; Mitsuyoshi K, 1998, 38 ANN M KINK OCC HL; Suda M, 2014, SANGYO IGAKU ZASSHI, V56, P357	14	1	1	JAPAN SOC OCCUPATIONAL HEALTH	TOKYO	1-29-8 SHINJUKU, SHINJUKU-KU, TOKYO, 160, JAPAN	1341-9145	1348-9585		J OCCUP HEALTH	J. Occup. Health	MAR	2015	57	2					197	199				3	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG2JA	WOS:000353099500013		
J	So, K; Haraguchi, K; Asakura, K; Isami, K; Sakimoto, S; Shirakawa, H; Mori, Y; Nakagawa, T; Kaneko, S				So, Kanako; Haraguchi, Kayo; Asakura, Kayoko; Isami, Koichi; Sakimoto, Shinya; Shirakawa, Hisashi; Mori, Yasuo; Nakagawa, Takayuki; Kaneko, Shuji			Involvement of TRPM2 in a wide range of inflammatory and neuropathic pain mouse models	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						TRPM2; Inflammatory pain; Neuropathic pain; Pain models; Knockout mice	INDUCED PERIPHERAL NEUROPATHY; POTENTIAL MELASTATIN 2; OXIDATIVE STRESS; INCISIONAL PAIN; CA2+ INFLUX; MICROGLIA CONTRIBUTES; MECHANICAL ALLODYNIA; THERAPEUTIC TARGETS; DIABETIC-NEUROPATHY; TACTILE ALLODYNIA	Recent evidence suggests a role of transient receptor potential melastatin 2 (TRPM2) in immune and inflammatory responses. We previously reported that TRPM2 deficiency attenuated inflammatory and neuropathic pain in some pain mouse models, including formalin-or carrageenan-induced inflammatory pain, and peripheral nerve injury-induced neuropathic pain models, while it had no effect on the basal mechanical and thermal nociceptive sensitivities. In this study, we further explored the involvement of TRPM2 in various pain models using TRPM2-knockout mice. There were no differences in the chemo-nociceptive behaviors evoked by intraplantar injection of capsaicin or hydrogen peroxide between wildtype and TRPM2-knockout mice, while acetic acid-induced writhing behavior was significantly attenuated in TRPM2-knockout mice. In the postoperative incisional pain model, no difference in mechanical allodynia was observed between the two genotypes. By contrast, mechanical allodynia in the monosodium iodoacetate-induced osteoarthritis pain model and the experimental autoimmune encephalomyelitis model were significantly attenuated in TRPM2-knockout mice. Furthermore, mechanical allodynia in paclitaxel-induced peripheral neuropathy and streptozotocin-induced painful diabetic neuropathy models were significantly attenuated in TRPM2-knockout mice. Taken together, these results suggest that TRPM2 plays roles in a wide range of pathological pain models based on peripheral and central neuroinflammation, rather than physiological nociceptive pain. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[So, Kanako; Haraguchi, Kayo; Asakura, Kayoko; Isami, Koichi; Sakimoto, Shinya; Shirakawa, Hisashi; Nakagawa, Takayuki; Kaneko, Shuji] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Sakyo Ku, Kyoto 6068501, Japan; [Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Nakagawa, Takayuki] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kyoto 6068507, Japan	Nakagawa, T (reprint author), Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	tknakaga@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sport, Science and Technology of Japan [24111527]; Japan Society for the Promotion of Science [23790641, 24390016, 26293019]; Salt Science Research Foundation [14C4]	The authors would like to thank Dr. Fumimasa Amaya (Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan) for teaching us the techniques used in studying the postoperative incisional pain model. This work was supported in part by Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sport, Science and Technology of Japan (a Grant-in-Aid for Scientific Research on Innovative Area 'Brain Environment' to T.N. [24111527]), and the Japan Society for the Promotion of Science (Grant-in-Aids for Young Scientist (B) to T.N. [23790641] and Scientific Research (B) to S.K. [24390016] and T.N. [26293019]), and by a grant from the Salt Science Research Foundation, No. 14C4.	DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Knowles H, 2013, IMMUNOL RES, V55, P241, DOI 10.1007/s12026-012-8373-8; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; Jaggi AS, 2012, TOXICOLOGY, V291, P1, DOI 10.1016/j.tox.2011.10.019; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Ruiz-Medina J, 2013, EUR J PAIN, V17, P75, DOI 10.1002/j.1532-2149.2012.00172.x; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Naziroglu M, 2011, J MEMBRANE BIOL, V241, P69, DOI 10.1007/s00232-011-9363-9; Ito S, 2012, J PHARMACOL EXP THER, V342, P53, DOI 10.1124/jpet.111.187401; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Miller RE, 2012, P NATL ACAD SCI USA, V109, P20602, DOI 10.1073/pnas.1209294110; Brennan Timothy J, 2005, Anesthesiol Clin North America, V23, P1, DOI 10.1016/j.atc.2004.11.009; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Olechowski CJ, 2009, PAIN, V141, P156, DOI 10.1016/j.pain.2008.11.002; Zhou JY, 2014, MOL NEUROBIOL, V49, P536, DOI 10.1007/s12035-013-8537-0; Pogatzki EM, 2003, ANESTHESIOLOGY, V99, P1023, DOI 10.1097/00000542-200310000-00041; Romero-Sandoval A, 2008, BRAIN RES, V1219, P116, DOI 10.1016/j.brainres.2008.05.004; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Takahashi N, 2011, CELL CALCIUM, V50, P279, DOI 10.1016/j.ceca.2011.04.006; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; Callahan BL, 2008, J PAIN, V9, P174, DOI 10.1016/j.jpain.2007.10.011; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Xu J, 2010, ANESTHESIOLOGY, V112, P153, DOI 10.1097/ALN.0b013e3181c2952e; Cao L, 2008, EUR J IMMUNOL, V38, P448, DOI [10.1002/eji.200737485, 10.1002/eji.2007374851]; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Loeser JD, 2008, PAIN, V137, P473, DOI 10.1016/j.pain.2008.04.025; Wen YR, 2009, ANESTHESIOLOGY, V110, P155, DOI 10.1097/ALN.0b013e318190bc16; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Fujita I, 2012, J PHARM PHARMACOL, V64, P747, DOI 10.1111/j.2042-7158.2012.01468.x; Harvey VL, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-18; Isami K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066410; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lewis ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105883; Melzer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047617; Miyake T, 2014, BIOCHEM BIOPH RES CO, V444, P212, DOI 10.1016/j.bbrc.2014.01.022; Sagar DR, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-88; SAKURADA T, 1992, NEUROPHARMACOLOGY, V31, P1279, DOI 10.1016/0028-3908(92)90057-V; Tsuda M, 2008, GLIA, V56, P378, DOI 10.1002/glia.20623; Zhang ZY, 2012, AM J PHYSIOL-ENDOC M, V302, pE807, DOI 10.1152/ajpendo.00239.2011; Zhong ZY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2608	54	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					237	243		10.1016/j.jphs.2014.10.003		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900001		
J	Tasaka, Y; Yasunaga, D; Kiyoi, T; Tanaka, M; Tanaka, A; Suemaru, K; Araki, H				Tasaka, Yuichi; Yasunaga, Daiki; Kiyoi, Takeshi; Tanaka, Mamoru; Tanaka, Akihiro; Suemaru, Katsuya; Araki, Hiroaki			Involvement of stimulation of alpha(7) nicotinic acetylcholine receptors in the suppressive effect of tropisetron on dextran sulfate sodium-induced colitis in mice	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Ulcerative colitis; Cholinergic; Anti-inflammatory; alpha(7) nACh receptor; Macrophage	INFLAMMATORY-BOWEL-DISEASE; ACTIVE ULCERATIVE-COLITIS; MURINE MODEL; VAGUS NERVE; ANTAGONIST; THERAPIES; TRIAL; RATS	Ulcerative colitis (UC) involves chronic inflammation of the large intestine. Several agents are used to treat UC, but adverse side effects are remaining problems. We examined the effect of tropisetron as a new type of drug for UC using a dextran sulfate sodium (DSS)-induced model of colitis in mice. We developed a DSS-induced model of colitis and calculated the Disease Activity Index and colon length. We measured myeloperoxidase activity and determined the protein level and mRNA level of cytokines in the colon. DSS-induced colitis was ameliorated by administration of tropisetron and PNU282987. Preadministration of methyllycaconitine diminished the suppressive effect of tropisetron upon DSSinduced colitis. These findings suggested that alpha 7 nicotinic acetylcholine receptors (alpha 7 nAChRs) were related to the suppressive effect of tropisetron on DSS-induced colitis. Additionally, stimulation of alpha 7 nAChRs decreased the colon level of interleukin-6 and interferon-gamma upon DSS administration. Furthermore, stimulation of alpha 7 nAChRs decreased macrophage infiltration, with expression of alpha 7 nAChR increased by DSS administration. These results suggest that the underlying mechanism of this suppressive effect on DSS-induced colitis is via stimulation of alpha 7 nAChRs and involves suppression of expression of pro-inflammatory cytokines. Tropisetron could be a new type of therapeutic agent for UC. c 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Tasaka, Yuichi; Yasunaga, Daiki; Tanaka, Mamoru; Tanaka, Akihiro; Araki, Hiroaki] Ehime Univ Hosp, Div Pharm, Toon, Ehime 7910295, Japan; [Kiyoi, Takeshi] Ehime Univ, Integrated Ctr Sci, Toon, Ehime 7910295, Japan; [Suemaru, Katsuya] Shujitsu Univ, Sch Pharm, Naka Ku, Okayama, Okayama 7038516, Japan	Tanaka, A (reprint author), Ehime Univ Hosp, Div Pharm, 454 Shitsukawa, Toon, Ehime 7910295, Japan.	akiki@m.ehime-u.ac.jp					Fiebich BL, 2004, SCAND J RHEUMATOL, V33, P28, DOI 10.1080/03009740410006998; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Zenlea T, 2014, WORLD J GASTROENTERO, V20, P3146, DOI 10.3748/wjg.v20.i12.3146; Sandborn WJ, 1997, ANN INTERN MED, V126, P364; Borovikova LV, 2000, NATURE, V405, P458; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Engel MA, 2010, J GASTROENTEROL, V45, P571, DOI 10.1007/s00535-010-0219-3; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Ghia JE, 2009, GASTROENTEROLOGY, V136, P2280, DOI 10.1053/j.gastro.2009.02.069; Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Macor JE, 2001, BIOORG MED CHEM LETT, V11, P319, DOI 10.1016/S0960-894X(00)00670-3; Hirata I, 2007, WORLD J GASTROENTERO, V13, P1666; Fakhfouri G, 2010, HUM EXP TOXICOL, V29, P321, DOI 10.1177/0960327110362702; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; HARRIES AD, 1982, BRIT MED J, V284, P706; Cui WY, 2010, J NEUROIMMUNE PHARM, V5, P479, DOI 10.1007/s11481-010-9210-2; Endo M, 2013, J PHARMACOL SCI, V123, P176, DOI 10.1254/jphs.13121FP; Ingram JR, 2005, INFLAMM BOWEL DIS, V11, P1092, DOI 10.1002/ibd.3780111209; Ingram JR, 2005, CLIN GASTROENTEROL H, V3, P1107, DOI 10.1053/S1542-3565(05)00849-9; Kawahara R, 2011, EUR J PHARMACOL, V650, P411, DOI 10.1016/j.ejphar.2010.10.031; LOGAN RFA, 1984, BRIT MED J, V288, P751; Motavallian Azadeh, 2013, Bioimpacts, V3, P169, DOI 10.5681/bi.2013.021; Mousavizadeh K, 2009, EUR J CLIN INVEST, V39, P375, DOI 10.1111/j.1365-2362.2009.02102.x; Ohkawara T, 2005, SCAND J GASTROENTERO, V40, P1049, DOI 10.1080/00365520510023161; Strober W, 1997, IMMUNOL TODAY, V18, P61, DOI 10.1016/S0167-5699(97)01000-1; Thompson AI, 2011, INFLAMM BOWEL DIS, V17, P831, DOI 10.1002/ibd.21375; Vega L. d. l., 2005, BIOCHEM PHARMACOL, V70, P369, DOI 10.1016/j.bcp.2005.04.031	29	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					275	283		10.1016/j.jphs.2014.12.016		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900005		
J	Aizawa, K; Takahari, Y; Higashijima, N; Serizawa, K; Yogo, K; Ishizuka, N; Endo, K; Fukuyama, N; Hirano, K; Ishida, H				Aizawa, Ken; Takahari, Youko; Higashijima, Naoko; Serizawa, Kenichi; Yogo, Kenji; Ishizuka, Nobuhiko; Endo, Koichi; Fukuyama, Naoto; Hirano, Katsuya; Ishida, Hideyuki			Nicorandil prevents sirolimus-induced production of reactive oxygen species, endothelial dysfunction, and thrombus formation	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Nicorandil; Sirolimus; Thrombosis; Reactive oxygen species; Endothelial cells	DRUG-ELUTING STENTS; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; INDUCED APOPTOSIS; NITRIC-OXIDE; MITOCHONDRIAL; INFLAMMATION; PACLITAXEL; ATHEROSCLEROSIS; EXPRESSION	Sirolimus (SRL) is widely used to prevent restenosis after percutaneous coronary intervention. However, its beneficial effect is hampered by complications of thrombosis. Several studies imply that reactive oxygen species (ROS) play a critical role in endothelial dysfunction and thrombus formation. The present study investigated the protective effect of nicorandil (NIC), an anti-angina agent, on SRL-associated thrombosis. In human coronary artery endothelial cells (HCAECs), SRL stimulated ROS production, which was prevented by co-treatment with NIC. The preventive effect of NIC on ROS was abolished by 5-hydroxydecanoate but not by 1H-[1,2,4] oxadiazolo[4,3-a] quinoxalin-1-one. NIC also inhibited SRL-induced up-regulation of NADPH oxidase subunit p22(phox) mRNA. Co-treatment with NIC and SRL significantly up-regulated superoxide dismutase 2. NIC treatment significantly improved SRL-induced decrease in viability of HCAECs. The functional relevance of the preventive effects of NIC on SRL-induced ROS production and impairment of endothelial viability was investigated in a mouse model of thrombosis. Pretreatment with NIC inhibited the SRL-induced acceleration of FeCl3-initiated thrombus formation and ROS production in the testicular arteries of mice. In conclusion, NIC prevented SRL-induced thrombus formation, presumably due to the reduction of ROS and to endothelial protection. The therapeutic efficacy of NIC could represent an additional option in the prevention of SRL-related thrombosis. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Aizawa, Ken; Serizawa, Kenichi; Yogo, Kenji; Ishizuka, Nobuhiko; Endo, Koichi] Chugai Pharmaceut Co Ltd, Prod Res Dept, Shizuoka 4128513, Japan; [Takahari, Youko] Tokai Univ, Sch Med, Teaching & Res Support Ctr, Isehara, Kanagawa 2591193, Japan; [Higashijima, Naoko; Fukuyama, Naoto; Ishida, Hideyuki] Tokai Univ, Sch Med, Dept Physiol, Isehara, Kanagawa 2591193, Japan; [Hirano, Katsuya] Kagawa Univ, Fac Med, Dept Cardiovasc Physiol, Miki, Kagawa 7610793, Japan	Hirano, K (reprint author), Kagawa Univ, Fac Med, Dept Cardiovasc Physiol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	khirano@med.kagawa-u.ac.jp	Hirano, Katsuya/B-2785-2008	Hirano, Katsuya/0000-0003-0164-1283			Suski JM, 2012, METHODS MOL BIOL, V810, P183, DOI 10.1007/978-1-61779-382-0_12; Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89; Serizawa K, 2012, J PHARMACOL SCI, V119, P349, DOI 10.1254/jphs.12067FP; Krychtiuk KA, 2013, HAMOSTASEOLOGIE, V33, P269, DOI 10.5482/HAMO-13-07-0039; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI 10.1089/ARS.2008.2220; Finn AV, 2005, CIRCULATION, V112, P270, DOI 10.1161/CIRCULATIONAHA.104.508937; Azumi H, 1999, CIRCULATION, V100, P1494; Nagata K, 2003, J MOL CELL CARDIOL, V35, P1505, DOI 10.1016/j.yjmcc.2003.09.018; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Petaja J, 2011, THROMB RES, V127, pS34, DOI 10.1016/S0049-3848(10)70153-5; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Lovren F, 2008, AM J PHYSIOL-HEART C, V295, pH1377, DOI 10.1152/ajpheart.00331.2008; Liou JY, 2011, PHARMACOLOGY, V87, P144, DOI 10.1159/000323555; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Facundo HTF, 2005, J BIOENERG BIOMEMBR, V37, P75, DOI 10.1007/s10863-005-4130-1; Ma Q, 2012, ANGIOLOGY, V63, P330, DOI 10.1177/0003319711418219; Jabs A, 2008, J AM COLL CARDIOL, V51, P2130, DOI 10.1016/j.jacc.2008.01.058; Kvietys PR, 2012, FREE RADICAL BIO MED, V52, P556, DOI 10.1016/j.freeradbiomed.2011.11.002; Horinaka S, 2010, CIRC J, V74, P503, DOI 10.1253/circj.CJ-09-0649; Chatterjee S, 2008, CURR DRUG METAB, V9, P554, DOI 10.2174/138920008784892119; Date T, 2005, J CARDIOVASC PHARM, V46, P721, DOI 10.1097/01.fjc.0000184466.37951.76; Eguchi Y, 2009, CIRC J, V73, P554; Dargie HJ, 2002, LANCET, V359, P1269; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Li LX, 2009, ARTERIOSCL THROM VAS, V29, P732, DOI 10.1161/ATVBAHA.108.183210; Ono H, 2004, AM HEART J, V148, DOI 10.1016/j.ahj.2004.05.014; Plass CA, 2012, JACC-CARDIOVASC INTE, V5, P741, DOI 10.1016/j.jcin.2012.03.021; TAIRA N, 1989, AM J CARDIOL, V63, pJ18, DOI 10.1016/0002-9149(89)90200-2; Tajima M, 2008, EUR J PHARMACOL, V579, P86, DOI 10.1016/j.ejphar.2007.10.074; Taubman MB, 2008, THROMB RES, V122, pS78, DOI 10.1016/S0049-3848(08)70025-2; Wessely R, 2007, THROMB HAEMOSTASIS, V97, P1003, DOI 10.1160/TH-6-10-0586	32	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					284	291		10.1016/j.jphs.2014.12.017		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900006		
J	Takarada, T; Nakamichi, N; Kakuda, T; Nakazato, R; Kokubo, H; Ikeno, S; Nakamura, S; Hinoi, E; Yoneda, Y				Takarada, Takeshi; Nakamichi, Noritaka; Kakuda, Takami; Nakazato, Ryota; Kokubo, Hiroshi; Ikeno, Shinsuke; Nakamura, Saki; Hinoi, Eiichi; Yoneda, Yukio			Daily oral intake of theanine prevents the decline of 5-bromo-2 '-deoxyuridine incorporation in hippocampal dentate gyrus with concomitant alleviation of behavioral abnormalities in adult mice with severe traumatic stress	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Theanine; Traumatic stress; BrdU incorporation; Dentate gyrus; Behaviors	CELL-PROLIFERATION; DOPAMINE RELEASE; RAT-BRAIN; NEUROGENESIS; GLUTAMINE; GLUTAMYLETHYLAMIDE; RECEPTORS; TRANSPORT; GERBILS	Posttraumatic stress disorder is a long-lasting psychiatric disease with the consequence of hippocampal atrophy in humans exposed to severe fatal stress. We demonstrated a positive correlation between the transient decline of 5-bromo-2 '-deoxyuridine (BrdU) incorporation in the hippocampal dentate gyrus (DG) and long-lasting behavioral abnormalities in mice with traumatic stress. Here, we investigated pharmacological properties of theanine on the declined BrdU incorporation and abnormal behaviors in mice with traumatic stress. Prior daily oral administration of theanine at 50-500 mg/kg for 5 days significantly prevented the decline of BrdU incorporation, while theanine significantly prevented the decline in the DG even when administered for 5 days after stress. Consecutive daily administration of theanine significantly inhibited the prolonged immobility in mice with stress in forced swimming test seen 14 days later. Although traumatic stress significantly increased spontaneous locomotor activity over 30 min even when determined 14 days later, the increased total locomotion was significantly ameliorated following the administration of theanine at 50 mg/kg for 14 days after stress. These results suggest that theanine alleviates behavioral abnormalities together with prevention of the transient decline of BrdU incorporation in the hippocampal DG in adult mice with severe traumatic stress. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Takarada, Takeshi; Nakamichi, Noritaka; Nakazato, Ryota; Kokubo, Hiroshi; Ikeno, Shinsuke; Nakamura, Saki; Hinoi, Eiichi; Yoneda, Yukio] Kanazawa Univ, Grad Sch Med Pharmaceut & Hlth Sci, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan; [Kakuda, Takami] Fukuoka Univ, Res Ctr Composite Mat, Fukuoka 8140180, Japan	Yoneda, Y (reprint author), Kanazawa Univ, Grad Sch Med Pharmaceut & Hlth Sci, Div Pharmaceut Sci, Mol Pharmacol Lab, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [22500330, 24650196]	This work was in part supported by Grants-in-Aids for Scientific Research to TT (No. 22500330) and YY (No. 24650196) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; Kimura K, 2007, BIOL PSYCHOL, V74, P39, DOI 10.1016/j.biopsycho.2006.06.006; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Kakuda T, 2000, NEUROSCI LETT, V289, P189, DOI 10.1016/S0304-3940(00)01286-6; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Yokogoshi H, 1998, NEUROCHEM RES, V23, P667, DOI 10.1023/A:1022490806093; Yamauchi K, 2002, NUTRITION, V18, P329, DOI 10.1016/S0899-9007(01)00788-2; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Li Y, 2012, J NEUROSCI, V32, P3529, DOI 10.1523/JNEUROSCI.3469-11.2012; Liu JL, 1998, J NEUROSCI, V18, P7768; Kakuda T, 2002, BIOSCI BIOTECH BIOCH, V66, P2683; Pechnick RN, 2008, P NATL ACAD SCI USA, V105, P1358, DOI 10.1073/pnas.0711030105; Bai F, 2003, NEUROPHARMACOLOGY, V44, P1013, DOI 10.1016/S0028-3908(03)00104-7; Goto T, 1996, FOODS FOOD INGREDIEN, V170, P46; Ito M, 2007, J NEUROCHEM, V101, P1392, DOI 10.1111/j.1471-4159.2006.04423.x; Kakuda T, 2008, J NEUROSCI RES, V86, P1846, DOI 10.1002/jnr.21637; Ogura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048270; SCHOUSBOE A, 1979, J NEUROCHEM, V32, P943, DOI 10.1111/j.1471-4159.1979.tb04579.x; Takeda A, 2011, CELL MOL NEUROBIOL, V31, P1079, DOI 10.1007/s10571-011-9707-0; Tamaki K, 2008, J NEUROCHEM, V105, P1642, DOI 10.1111/j.1471-4159.2008.05253.x; Unno K, 2011, FREE RADICAL RES, V45, P966, DOI 10.3109/10715762.2011.566869; YONEDA Y, 1983, J NEUROCHEM, V40, P350, DOI 10.1111/j.1471-4159.1983.tb11289.x	23	1	1	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					292	297		10.1016/j.jphs.2014.12.018		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900007		
J	Takahashi-Niki, K; Inafune, A; Michitani, N; Hatakeyama, Y; Suzuki, K; Sasaki, M; Kitamura, Y; Niki, T; Iguchi-Ariga, SMM; Ariga, H				Takahashi-Niki, Kazuko; Inafune, Ayako; Michitani, Naruyuki; Hatakeyama, Yoshitaka; Suzuki, Kotaro; Sasaki, Mai; Kitamura, Yoshihisa; Niki, Takeshi; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Parkinson's disease; DJ-1; Compound; MPTP; Neuroprotection	OXIDATIVE STRESS; ANDROGEN RECEPTOR; TYROSINE-HYDROXYLASE; ANTIOXIDATIVE STRESS; LINKED PARK7; WILD-TYPE; DJ-1; PROTEIN; NEURODEGENERATION; GENE	Parkinson's disease (PD) is caused by dopaminergic cell death in the substantia nigra, leading to a reduced level of dopamine in the striatum. Oxidative stress is one of the causes of PD. Since symptomatic PD therapies are used, identification of compounds or proteins that inhibit oxidative stress-induced neuronal cell death is necessary. DJ-1 is a causative gene product of familial PD and plays a role in anti-oxidative stress reaction. We have identified various DJ-1-binding compounds, including compound-23, that restored neuronal cell death and locomotion defects observed in neurotoxin-induced PD models. In this study, wild-type and DJ-1-knockout mice were injected intraperitoneally with 1 mg/kg of compound-23 and then with 30 mg/kg of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) at 1 h after injection. Five days after administration, the effects of compound-23 on MPTP-induced locomotion deficits, on dopaminergic cell death and on brain dopamine levels were analyzed by rotor rod tests, by staining cells with an anti-TH antibody and by an HPLC, respectively. The results showed that compound-23 inhibited MPTP-induced reduction of retention time on the rotor rod bar, neuronal cell death in the substantia nigra and striatum and dopamine content in wild-type mice but not in DJ-1-knockout mice, indicating a DJ-1-dependent effect of compound-23. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Takahashi-Niki, Kazuko; Ariga, Hiroyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Inafune, Ayako; Michitani, Naruyuki; Hatakeyama, Yoshitaka; Suzuki, Kotaro; Sasaki, Mai] New Drug Res Ctr Inc, Cent Res Lab, Toiso, Eniwa 0611405, Japan; [Kitamura, Yoshihisa] Kyoto Pharmaceut Univ, Dept Clin & Translat Physiol, Yamashina Ku, Kyoto 6078414, Japan; [Niki, Takeshi; Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Ariga, H (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp			GlaxoSmithKline in China; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) in Japan	This work was supported by grants from GlaxoSmithKline in China and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) in Japan.	Shinbo YM, 2005, INT J ONCOL, V26, P641; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.imb.2005.12.030; Ishikawa S, 2010, J BIOL CHEM, V285, P39718, DOI 10.1074/jbc.M110.137034; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Niki T, 2003, MOL CANCER RES, V1, P247; Yanagida T, 2009, J PHARMACOL SCI, V109, P463, DOI 10.1254/jphs.08323SC; Miyazaki S, 2008, J NEUROCHEM, V105, P2418, DOI 10.1111/j.1471-4159.2008.05327.x; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Kitamura Y, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-48; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Yamane K, 2009, INT J MOL SCI, V10, P4789, DOI 10.3390/ijms10114789	26	1	1	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					305	310		10.1016/j.jphs.2015.01.010		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900009		
J	Tsuchiya, N; Kodama, D; Goto, S; Togari, A				Tsuchiya, Norika; Kodama, Daisuke; Goto, Shigemi; Togari, Akifumi			Shear stress-induced Ca2+ elevation is mediated by autocrine-acting glutamate in osteoblastic MC3T3-E1 cells	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Mechanotransduction; Shear stress; Glutamate; Autocrine; Osteoblast	D-ASPARTATE RECEPTOR; MECHANICAL STRAIN; RAT OSTEOBLASTS; ATP SECRETION; BONE-CELLS; FLUID-FLOW; EXPRESSION; RELEASE; DIFFERENTIATION; MECHANOTRANSDUCTION	Mechanical loading is an important regulatory factor in bone homeostasis. Neurotransmitters, such as glutamate and ATP, are known to be released from osteoblasts, but their roles have been less studied. In this study, we investigated the role of transmitter release in mechanotransduction. To identify from where transmitters were released, focal fluid flow was applied to a single cell of MC3T3-E1, mouse calvaria-derived osteoblastic cell line, by using a glass micropipette. Intracellular Ca2+ elevation induced by the focal shear stress was eliminated by either GdCl3, a mechanosensing channel inhibitor, or removal of extracellular Ca2+. On the other hand, the focal shear stress-induced Ca2+ elevation was also significantly suppressed by inositol triphosphate receptor antagonist or vesicular release inhibitors. These results suggest that not only mechanosensitive channel-mediated Ca2+ influx but also some autocrine transmitters are involved in mechanotransduction. Additionally, glutamate receptor antagonists, but not ATP receptor antagonist, suppressed most of the focal shear stress-induced Ca2+ elevation. Therefore, it is suggested that glutamate is released from osteoblasts following the activation of mechanosensitive Ca2+ channels and acts in an autocrine manner. The glutamate release may have a significant role in the initial event of mechanotransduction in bone tissue. (C) 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. All rights reserved.	[Tsuchiya, Norika; Kodama, Daisuke; Togari, Akifumi] Aichi Gakuin Univ, Sch Dent, Dept Pharmacol, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Tsuchiya, Norika; Goto, Shigemi] Aichi Gakuin Univ, Sch Dent, Dept Orthodont, Chikusa Ku, Nagoya, Aichi 4648651, Japan	Togari, A (reprint author), Aichi Gakuin Univ, Sch Dent, Dept Pharmacol, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	togariaf@dpc.aichi-gakuin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24791988]	Our studies mentioned in this review were partly supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 24791988 to D.K.).	Kobayashi T, 2010, CURR OPIN CELL BIOL, V22, P669, DOI 10.1016/j.ceb.2010.08.023; Olsen SM, 2011, ANN BIOMED ENG, V39, P688, DOI 10.1007/s10439-010-0203-3; Morimoto R, 2006, EMBO J, V25, P4175, DOI 10.1038/sj.emboj.7601317; Skerry T. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P166; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989; Orriss IR, 2006, BONE, V39, P300, DOI 10.1016/j.bone.2006.02.063; Genetos DC, 2005, J BONE MINER RES, V20, P41, DOI 10.1359/jbmr.041009; Smalt R, 1997, AM J PHYSIOL-ENDOC M, V273, pE751; Burger EH, 1999, FASEB J, V13, pS101; Gardinier J, 2014, AM J PHYSIOL-CELL PH, V306, pC1058, DOI 10.1152/ajpcell.00254.2013; Yamamoto K, 2011, J CELL SCI, V124, P3477, DOI 10.1242/jcs.087221; Orriss IR, 2009, J CELL PHYSIOL, V220, P155, DOI 10.1002/jcp.21745; Hinoi E, 2002, BIOCHEM BIOPH RES CO, V297, P452, DOI 10.1016/S0006-291X(02)02223-4; Lin TH, 2008, EUR J PHARMACOL, V589, P37, DOI 10.1016/j.ejphar.2008.04.060; Orriss IR, 2010, CURR OPIN PHARMACOL, V10, P322, DOI 10.1016/j.coph.2010.01.003; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319; Szczesniak AM, 2005, BONE, V37, P63, DOI 10.1016/j.bone.2003.10.016; Hinoi E, 2003, FASEB J, V17, P1532, DOI 10.1096/fj.02-0820fje; Lloyd SA, 2012, J BONE MINER RES, V27, P2359, DOI 10.1002/jbmr.1687; Lu XL, 2012, J BONE MINER RES, V27, P563, DOI 10.1002/jbmr.1474; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Rodat-Despoix L, 2013, CELL CALCIUM, V53, P327, DOI 10.1016/j.ceca.2013.02.002; Mizoguchi F, 2008, J CELL PHYSIOL, V216, P47, DOI 10.1002/jcp.21374; Kim MH, 2008, J NEUROSCI, V28, P10852, DOI 10.1523/JNEUROSCI.0894-08.2008; Biswas P, 2009, J BONE MINER RES, V24, P1450, DOI [10.1359/jbmr.090306, 10.1359/JBMR.090306]; Brakspear KS, 2012, FRONT ENDOCRINOL LAU; Chenu C, 2002, MICROSC RES TECHNIQ, V58, P70, DOI 10.1002/jemt.10120; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635; Fujita H, 2012, J PHARMACOL SCI, V119, P112, DOI 10.1254/jphs.12068SC; Ho ML, 2005, OSTEOPOROSIS INT, V16, P1780, DOI 10.1007/s00198-005-1928-y; Hoebertz A, 2000, BONE, V27, P503, DOI 10.1016/S8756-3282(00)00351-3; Hughes S, 2006, J CELL PHYSIOL, V206, P738, DOI 10.1002/jcp.20536; Ihara H, 2005, BIOCHEM BIOPH RES CO, V326, P329, DOI 10.1016/j.bbrc.2004.11.037; Kamioka H, 2006, J BONE MINER RES, V21, P1012, DOI 10.1359/JBMR.060408; Li JL, 2008, BONE, V43, P469, DOI 10.1016/j.bone.2008.05.018; Lopez-Ayon G Monserratt, 2014, F1000Res, V3, P162, DOI 10.12688/f1000research.4448.1; Martinez-Galan JR, 2012, J NEUROSCI RES, V90, P1913, DOI 10.1002/jnr.23087; Miyauchi A, 2000, J BIOL CHEM, V275, P3335, DOI 10.1074/jbc.275.5.3335; Nishitani WS, 2011, PLOS ONE; Tojyo Y, 2014, J PHARMACOL SCI, V125, P340, DOI 10.1254/jphs.14R06CP; Walker LM, 2000, J CELL BIOCHEM, V79, P648, DOI 10.1002/1097-4644(20001215)79:4<648::AID-JCB130>3.0.CO;2-Q; Yang R, 2014, J PHARMACOL SCI, V124, P169, DOI 10.1254/jphs.13184FP	43	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					311	318		10.1016/j.jphs.2015.01.005		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900010		
J	Minami, K; Shinsato, Y; Yamamoto, M; Takahashi, H; Zhang, SX; Nishizawa, Y; Tabata, S; Ikeda, R; Kawahara, K; Tsujikawa, K; Chijiiwa, K; Yamada, K; Akiyama, S; Perez-Torras, S; Pastor-Anglada, M; Furukawa, T; Yasuo, T				Minami, Kentaro; Shinsato, Yoshinari; Yamamoto, Masatatsu; Takahashi, Homare; Zhang, Shaoxuan; Nishizawa, Yukihiko; Tabata, Sho; Ikeda, Ryuji; Kawahara, Kohich; Tsujikawa, Kazutake; Chijiiwa, Kazuo; Yamada, Katsushi; Akiyama, Shin-ichi; Perez-Torras, Sandra; Pastor-Anglada, Marcal; Furukawa, Tatsuhiko; Yasuo, Takeda			Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Gemcitabine; Pancreatic cancer; Anticancer agent resistance; Nucleoside transporter; Ribonucleotide reductase	LUNG-CANCER; NUCLEOSIDE TRANSPORTER; MULTIDRUG-RESISTANCE; DNA-SYNTHESIS; 2,2-DIFLUORODEOXYCYTIDINE; DRUG; OVEREXPRESSION; ADENOCARCINOMA; SENSITIVITY; EXPRESSION	Gemcitabine is widely used for pancreatic, lung, and bladder cancer. However, drug resistance against gemcitabine is a large obstacle to effective chemotherapy. Nucleoside transporters, nucleoside and nucleotide metabolic enzymes, and efflux transporters have been reported to be involved in gemcitabine resistance. Although most of the resistant factors are supposed to be related to each other, it is unclear how one factor can affect the other one. In this study, we established gemcitabine-resistant pancreatic cancer cell lines. Gemcitabine resistance in these cells is caused by two major processes: a decrease in gemcitabine uptake and overexpression of ribonucleotide reductase large subunit (RRM1). Knockdown of RRM1, but not the overexpression of concentrative nucleoside transporter 1 (CNT1), could completely overcome the gemcitabine resistance. RRM1 knockdown in gemcitabine-resistant cells could increase the intracellular accumulation of gemcitabine by increasing the nucleoside transporter expression. Furthermore, a synergistic effect was observed between hydroxyurea, a ribonucleotide reductase (RR) inhibitor, and gemcitabine on the gemcitabine-resistant cells. Here we indicate that RR is one of the most promising targets to overcome gemcitabine resistance in gemcitabine-resistant cells with dual resistant factors. (C) 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Minami, Kentaro; Nishizawa, Yukihiko; Tabata, Sho; Ikeda, Ryuji; Yamada, Katsushi; Yasuo, Takeda] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Clin Pharm & Pharmacol, Kagoshima 8908544, Japan; [Minami, Kentaro; Shinsato, Yoshinari; Yamamoto, Masatatsu; Takahashi, Homare; Tabata, Sho; Kawahara, Kohich; Akiyama, Shin-ichi; Furukawa, Tatsuhiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Kagoshima 8908544, Japan; [Shinsato, Yoshinari; Yamamoto, Masatatsu; Kawahara, Kohich; Furukawa, Tatsuhiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Res Adv Diag & Therapy Canc, Kagoshima 8908544, Japan; [Takahashi, Homare; Chijiiwa, Kazuo] Miyazaki Univ, Sch Med, Dept Surg Oncol & Regulat Organ Funct, Miyazaki 8891692, Japan; [Zhang, Shaoxuan] Jilin Univ, Inst Frontier Med Sci, Mol Genet Lab, Changchun 130021, Peoples R China; [Tabata, Sho] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; [Tsujikawa, Kazutake] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650817, Japan; [Yamada, Katsushi] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Clin Pharmacol, Sasebo, Nagasaki 8593298, Japan; [Akiyama, Shin-ichi] Kyushu Natl Canc Ctr, Clin Res Ctr, Minami Ku, Fukuoka 8111395, Japan; [Perez-Torras, Sandra; Pastor-Anglada, Marcal] Univ Barcelona, Dept Biochem & Mol Biol, Inst Biomed & Oncol Programme, Natl Biomed Res Inst Liver & Gastrointestinal Dis, E-08028 Barcelona, Spain	Furukawa, T (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	furukawa@m3.kufm.kagoshima-u.ac.jp			Platform for Drug Discovery, Informatics and Structural Life Science from Ministry of Education, Culture, Sports, Science and Technology of Japan by JSPS KAKENHI [26890020, 26670160]; Mitsui Life Social Welfare Foundation; Takeda Science Foundation; Suzuken Memorial Foundation; Astellas Foundation; Kodama Memorial Fund for Medical Research; Foundation for Promotion of Cancer Research in Japan; Osaka Cancer Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; MINECO, Spain [SAF2011-23660]	This work was supported in part by Grants-In-Aid for Science; the Platform for Drug Discovery, Informatics and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan by JSPS KAKENHI Grant Number 26890020, 26670160; the Mitsui Life Social Welfare Foundation; the Takeda Science Foundation; the Suzuken Memorial Foundation; a research grant from the Astellas Foundation for Research on Metabolic isorders; the Kodama Memorial Fund for Medical Research; the Foundation for Promotion of Cancer Research in Japan; the Osaka Cancer Research Foundation; and The Mochida Memorial Foundation for Medical and Pharmaceutical Research and SAF2011-23660 from MINECO, Spain.	Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Weizman N, 2014, ONCOGENE, V33, P3812, DOI 10.1038/onc.2013.357; Mata JF, 2001, MOL PHARMACOL, V59, P1542; HUANG P, 1991, CANCER RES, V51, P6110; Komatsu M, 2000, CANCER RES, V60, P1312; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Mackey JR, 1999, J NATL CANCER I, V91, P1876, DOI 10.1093/jnci/91.21.1876; Owatari S, 2007, CANCER RES, V67, P4860, DOI 10.1158/0008-5472.CAN-06-3096; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Garcia-Manteiga J, 2003, CLIN CANCER RES, V9, P5000; Goan YG, 1999, CANCER RES, V59, P4204; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Hopper-Borge E, 2009, CANCER RES, V69, P178, DOI 10.1158/0008-5472.CAN-08-1420; Shinsato Y, 2013, ONCOTARGET, V4, P2261; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Rauchwerger DR, 2000, CANCER RES, V60, P6075; Bhutia YD, 2011, CANCER RES, V71, P1825, DOI 10.1158/0008-5472.CAN-10-2736; BYRNE JA, 1992, CANCER GENET CYTOGEN, V59, P206, DOI 10.1016/0165-4608(92)90216-U; Carpelan-Holmstrom M, 2005, GUT, V54, P385, DOI 10.1136/gut.2004.047191; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Errasti-Murugarren E, 2007, J PHYSL, V582, P1249; Miwa M, 1998, CLIN CANCER RES, V4, P493; Nishio R, 2011, CANCER SCI, V102, P622, DOI 10.1111/j.1349-7006.2010.01837.x; Oguri T, 2006, MOL CANCER THER, V5, P1800, DOI 10.1158/1535-7163.MCT-06-0025; Rosell R, 2004, CLIN CANCER RES, V10, p4215S, DOI 10.1158/1078-0432.CCR-040006; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Sigmond J, 2007, BIOCHEM PHARMACOL, V73, P1548, DOI 10.1016/j.bcp.2007.01.025; VANHAPEREN VWTR, 1994, CANCER RES, V54, P4138; Wang QC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070191; Zhao BH, 2001, ONCOGENE, V20, P8154, DOI 10.1038/sj.onc.1205027; Zhou BS, 2013, CANCER RES, V73, P6484, DOI 10.1158/0008-5472.CAN-13-1094	33	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					319	325		10.1016/j.jphs.2015.01.006		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900011		
J	Baba, S; Enomoto, T; Horisawa, T; Hashimoto, T; Ono, M				Baba, Satoko; Enomoto, Takeshi; Horisawa, Tomoko; Hashimoto, Takashi; Ono, Michiko			Blonanserin extensively occupies rat dopamine D-3 receptors at antipsychotic dose range	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Dopamine; D-3 receptor; D-2 receptor; Antipsychotic; Occupancy	5-HT1A PARTIAL AGONISM; D3 RECEPTORS; IN-VITRO; SCHIZOPHRENIA; DRUGS; VIVO; D2; RISPERIDONE; ANTAGONISM; LURASIDONE	Antagonism of the dopamine D-3 receptor has been hypothesized to be beneficial for schizophrenia cognitive deficits, negative symptoms and extrapyramidal symptoms. However, recent animal and human studies have shown that most antipsychotics do not occupy D-3 receptors in vivo, despite their considerable binding affinity for this receptor in vitro. In the present study, we investigated the D-3 receptor binding of blonanserin, a dopamine D-2/D-3 and serotonin 5-HT2A receptors antagonist, in vitro and in vivo. Blonanserin showed the most potent binding affinity for human D-3 receptors among the tested atypical antipsychotics (risperidone, olanzapine and aripiprazole). Our GTP gamma S-binding assay demonstrated that blonanserin acts as a potent full antagonist for human D-3 receptors. All test-drugs exhibited antipsychotic-like efficacy in methamphetamine-induced hyperactivity in rats. Treatment with blonanserin at its effective dose blocked the binding of [3H]-(+)-PHNO, a D-2/D-3 receptor radiotracer, both in the D-2 receptor-rich region (striatum) and the D-3 receptor-rich region (cerebellum lobes 9 and 10). On the other hand, the occupancies of other test-drugs for D-3 receptors were relatively low. In conclusion, we have shown that blonanserin, but not other tested antipsychotics, extensively occupies D-3 receptors in vivo in rats. (C) 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. All rights reserved.	[Baba, Satoko; Enomoto, Takeshi; Horisawa, Tomoko; Hashimoto, Takashi; Ono, Michiko] Sumitomo Dainippon Pharma Co Ltd, Drug Res Div, Suita, Osaka 5640053, Japan	Enomoto, T (reprint author), Sumitomo Dainippon Pharma Co Ltd, Drug Res Div, 33-94 Enoki Cho, Suita, Osaka 5640053, Japan.	takeshi-enomoto@ds-pharma.co.jp					Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; Nakajima S, 2013, EUR NEUROPSYCHOPHARM, V23, P799, DOI 10.1016/j.euroneuro.2013.05.006; Gyertyan I, 2011, NEUROCHEM INT, V59, P925, DOI 10.1016/j.neuint.2011.07.002; Kapur S, 2001, AM J PSYCHIAT, V158, P360, DOI 10.1176/appi.ajp.158.3.360; Ohno Y, 2010, PHARMACOL BIOCHEM BE, V96, P175, DOI 10.1016/j.pbb.2010.04.027; MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238; Gross G, 2013, N-S ARCH PHARMACOL, V386, P155, DOI 10.1007/s00210-012-0806-3; Nagai T, 2003, NEUROREPORT, V14, P269, DOI 10.1097/01.wnr.0000053063.88427.9e; Kiss B, 2011, SYNAPSE, V65, P467, DOI 10.1002/syn.20867; Shimizu S, 2014, PROG NEURO-PSYCHOPH, V50, P157, DOI 10.1016/j.pnpbp.2013.12.013; Huang M, 2014, J NEUROCHEM, V128, P938, DOI 10.1111/jnc.12512; Mizrahi R, 2011, SCHIZOPHR RES, V131, P63, DOI 10.1016/j.schres.2011.05.005; LEVESQUE D, 1992, P NATL ACAD SCI USA, V89, P8155, DOI 10.1073/pnas.89.17.8155; Kishi T, 2013, J PSYCHIATR RES, V47, P149, DOI 10.1016/j.jpsychires.2012.10.011; Graff-Guerrero A, 2009, ARCH GEN PSYCHIAT, V66, P606, DOI 10.1001/archgenpsychiatry.2009.43; Ohoyama K, 2011, EUR J PHARMACOL, V653, P47, DOI 10.1016/j.ejphar.2010.11.023; McCormick PN, 2010, NEUROPSYCHOPHARMACOL, V35, P1826, DOI 10.1038/npp.2010.50; Girgis RR, 2011, NEUROPSYCHOPHARMACOL, V36, P887, DOI 10.1038/npp.2010.228; Ishibashi T, 2010, J PHARMACOL EXP THER, V334, P171, DOI 10.1124/jpet.110.167346; Meltzer HY, 2012, HANDB EXP PHARMACOL, V212, P87, DOI 10.1007/978-3-642-25761-2_4; McCormick PN, 2013, PHARMACOL RES, V70, P66, DOI 10.1016/j.phrs.2013.01.002; Horiguchi M, 2013, BEHAV BRAIN RES, V247, P158, DOI 10.1016/j.bbr.2013.03.027; Hida H, 2014, NEUROPSYCHOPHARMACOL; Hori H, 2014, J NEUROPSYCHIATR DIS, V10, P527; Murasaki M, 2008, JPN J CLIN PSYCHOPHA, V11, P845; Newman-Tancredi A, 1999, MOL PHARMACOL, V55, P564; Richtand NM, 2001, NEUROSCI BIOBEHAV R, V25, P427, DOI 10.1016/S0149-7634(01)00023-9; SENOGLES SE, 1990, J BIOL CHEM, V265, P4507; Slifstein M, 2013, AM COLL NEUROPSYCHOP; Tenjin T, 2012, HUM PSYCHOPHARM CLIN, V27, P90, DOI 10.1002/hup.1276; Une T, 2007, JPN J CLIN PSYCHOPHA, V10, P1263	31	2	2	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					326	331		10.1016/j.jphs.2015.01.007		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900012		
J	Nakajima, N; Watanabe, S; Kiyoi, T; Tanaka, A; Suemaru, K; Araki, H				Nakajima, Noriko; Watanabe, Shinichi; Kiyoi, Takeshi; Tanaka, Akihiro; Suemaru, Katsuya; Araki, Hiroaki			Evaluation of edaravone against radiation-induced oral mucositis in mice	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Antioxidant effect; Edaravone; Mouse; Oral mucositis; Radiation	RATS; RADIOTHERAPY; DERMATITIS; THERAPY	Oral mucositis induced by radiotherapy for cancers of the head and neck reduce the quality of life of patients. However, effective therapeutic agents are lacking. Symptomatic treatment involves local anesthesia and analgesia. We focused on the antioxidant effects of edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one; Radicut (R)). Oral mucositis was induced on the tongue tips of mice using a single dose of X-rays (20 Gy). To evaluate the protective effect of edaravone (30 and 300 mg/kg), administration was carried out 30 min before irradiation. Survival, oral mucositis score, myeloperoxidase activity, and levels of 2-Thiobarbituric acid reactive substances were measured, and all were improved compared with those of control mice. A significant difference was not found in terms of survival due to edaravone. Histopathologic findings also highlighted the beneficial features of edaravone. Edaravone reduced the production of reactive oxygen species. These findings suggest that the protective effect of edaravone against radiation-induced oral mucositis is through an antioxidant effect. (C) 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. All rights reserved.	[Nakajima, Noriko] Ehime Univ, Grad Sch Med, Dept Clin Pharm, Toon, Ehime 7910295, Japan; [Watanabe, Shinichi; Tanaka, Akihiro; Araki, Hiroaki] Ehime Univ Hosp, Div Pharm, Toon, Ehime 7910295, Japan; [Kiyoi, Takeshi] Ehime Univ, Integrated Ctr Sci, Toon, Ehime 7910295, Japan; [Suemaru, Katsuya] Shujitsu Univ, Sch Pharm, Okayama 7038516, Japan	Watanabe, S (reprint author), Ehime Univ Hosp, Div Pharm, 454 Shitsukawa, Toon, Ehime 7910295, Japan.	kinnin@m.ehime-u.ac.jp			Ono Pharmaceutical Company; Institution of Collaborative Relations in Ehime University	This research was supported in part by grants from Ono Pharmaceutical Company and the Institution of Collaborative Relations in Ehime University.	Sonis ST, 2009, ORAL ONCOL, V45, P1015, DOI 10.1016/j.oraloncology.2009.08.006; Elting LS, 2008, CANCER-AM CANCER SOC, V113, P2704, DOI 10.1002/cncr.23898; Motomura K, 2010, NEUROSCI LETT, V485, P65, DOI 10.1016/j.neulet.2010.08.065; Matsukura T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P817; Rubenstein EB, 2004, CANCER-AM CANCER SOC, V100, P2026, DOI 10.1002/cncr.20163; Ahmad A, 2012, MOL CELL BIOCHEM, V367, P215, DOI 10.1007/s11010-012-1335-6; Migliorati C, 2013, SUPPORT CARE CANCER, V21, P333, DOI 10.1007/s00520-012-1605-6; Anzai K, 2004, J RADIAT RES, V45, P319, DOI 10.1269/jrr.45.319; Braun DP, 2013, J ALTERN COMPLEM MED, V19, P198, DOI 10.1089/acm.2011.0657; Chen JG, 2007, J PHARMACOL SCI, V103, P317, DOI 10.1254/jphs.FP0061235; Dorr W, 2002, CELL PROLIFERAT, V35, P60, DOI 10.1046/j.1365-2184.35.s1.6.x; Ishii J, 2007, NEUROSCI LETT, V423, P225, DOI 10.1016/j.neulet.2007.07.029; Kaji H, 2009, J CLIN PHARM THER, V34, P197, DOI 10.1111/j.1365-2710.2008.00993.x; Kitagawa J, 2008, J RADIAT RES, V49, P49, DOI 10.1269/jrr.07038; Lamson D W, 1999, Altern Med Rev, V4, P304; Li CY, 2011, MED ORAL PATOL ORAL, V16, pE348, DOI 10.4317/medoral.16.e348; MOSES R, 1986, BRIT J CANCER, V53, P12; Sasano N, 2010, CANCER LETT, V293, P52, DOI 10.1016/j.canlet.2009.12.020; Sonis ST, 2000, ORAL ONCOL, V36, P373, DOI 10.1016/S1368-8375(00)00012-9; Wardley AM, 1998, ARCH ORAL BIOL, V43, P567, DOI 10.1016/S0003-9969(98)00031-4; Watanabe S, 2014, J RADIAT RES, V55, P1107, DOI 10.1093/jrr/rru067; Yamamura K, 1998, J BIOMED MATER RES, V43, P313, DOI 10.1002/(SICI)1097-4636(199823)43:3<313::AID-JBM12>3.0.CO;2-G	22	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					339	343		10.1016/j.jphs.2015.02.001		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900014		
J	Tokita, Y; Akiho, H; Nakamura, K; Ihara, E; Yamamoto, M				Tokita, Yohei; Akiho, Hirotada; Nakamura, Kazuhiko; Ihara, Eikichi; Yamamoto, Masahiro			Contraction of gut smooth muscle cells assessed by fluorescence imaging	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Neurotransmitter; Smooth muscle cell contraction; Kampo; Daikenchuto; Hydroxy-sanshool	GASTROINTESTINAL-TRACT; SENSORY NEURONS; DAIKENCHUTO; MEDICINE; INFLAMMATION; DYSFUNCTION; PERSISTENT; ACROLEIN; MODEL; KAMPO	Here we discuss the development of a novel cell imaging system for the evaluation of smooth muscle cell (SMC) contraction. SMCs were isolated from the circular and longitudinal muscular layers of mouse small intestine by enzymatic digestion. SMCs were stimulated by test agents, thereafter fixed in acrolein. Actin in fixed SMCs was stained with phalloidin and cell length was determined by measuring diameter at the large end of phalloidin-stained strings within the cells. The contractile response was taken as the decrease in the average length of a population of stimulated-SMCs. Various mediators and chemically identified compounds of daikenchuto (DKT), pharmaceutical-grade traditional Japanese prokinetics, were examined. Verification of the integrity of SMC morphology by phalloidin and DAPI staining and semi-automatic measurement of cell length using an imaging analyzer was a reliable method by which to quantify the contractile response. Serotonin, substance P, prostaglandin E-2 and histamine induced SMC contraction in concentration-dependent manner. Two components of DKT, hydroxy-alpha-sanshool and hydroxy-beta-sanshool, induced contraction of SMCs. We established a novel cell imaging technique to evaluate SMC contractility. This method may facilitate investigation into SMC activity and its role in gastrointestinal motility, and may assist in the discovery of new prokinetic agents. (C) 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. All rights reserved.	[Tokita, Yohei] Tsumura & Co, Kampo Sci Strategies Div, Comprehens Kampo Res Planning Dept, Minato Ku, Tokyo 1078521, Japan; [Tokita, Yohei; Yamamoto, Masahiro] Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Ami, Ibaraki 3001192, Japan; [Akiho, Hirotada] Kitakyushu Municipal Med Ctr, Dept Gastroenterol, Kokurakita Ku, Kitakyushu, Fukuoka 8020077, Japan; [Akiho, Hirotada; Nakamura, Kazuhiko; Ihara, Eikichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan	Tokita, Y (reprint author), Tsumura & Co, Kampo Sci Strategies Div, Comprehens Kampo Res Planning Dept, Minato Ku, 2-17-11 Akasaka, Tokyo 1078521, Japan.	tokita_youhei@mail.tsumura.co.jp			Tsumura Co.	H.A. and K.N. have received grant support from Tsumura & Co. Y.T. and M.Y. are employed by Tsumura & Co. E.I. have no conflicts of interest to declare.	De Winter BY, 2010, WORLD J GASTROENTERO, V16, P5523, DOI 10.3748/wjg.v16.i44.5523; Narahashi T, 2008, P JPN ACAD B-PHYS, V84, P147, DOI 10.2183/pjab/84.147; Bayguinov PO, 2010, J PHYSIOL-LONDON, V588, P399, DOI 10.1113/jphysiol.2009.181172; Moreels TG, 2001, EUR J PHARMACOL, V423, P211, DOI 10.1016/S0014-2999(01)01088-3; Hashimoto K, 2001, PLANTA MED, V67, P179, DOI 10.1055/s-2001-11513; Munekage M, 2011, DRUG METAB DISPOS, V39, P1784, DOI 10.1124/dmd.111.040097; Mikkelsen HB, 2010, J CELL MOL MED, V14, P818, DOI 10.1111/j.1582-4934.2010.01025.x; Sanders KM, 2008, NEUROGASTROENT MOTIL, V20, P39, DOI 10.1111/j.1365-2982.2008.01108.x; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Kono T, 2009, SURGERY, V146, P837, DOI 10.1016/j.surg.2009.06.012; Akiho H, 2005, GASTROENTEROLOGY, V129, P131, DOI 10.1053/j.gastro.2005.03.049; Bitar KN, 1982, AM J PHYSIOL, V242, P400; BOTELLA A, 1993, EUR J PHARMACOL, V237, P131, DOI 10.1016/0014-2999(93)90102-N; CARSTENS.EL, 1971, J CELL BIOL, V50, P529, DOI 10.1083/jcb.50.2.529; Cho SY, 2005, J PHYSIOL-LONDON, V565, P243, DOI 10.1113/jphysiol.2005.084574; Iwabu J, 2010, DRUG METAB DISPOS, V38, P2040, DOI 10.1124/dmd.110.033589; Koo JY, 2007, EUR J NEUROSCI, V26, P1139, DOI 10.1111/j.1460-9568.2007.05743.x; Manabe N, 2010, AM J PHYSIOL-GASTR L, V298, P970; Mizutani T, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01396.x; SAITO T, 1976, J HISTOCHEM CYTOCHEM, V24, P1258; Tokita Y, 2007, J PHARMACOL SCI, V104, P303, DOI 10.1254/jphs.FP0070831; Tokita Y, 2011, J PHARMACOL SCI, V115, P75, DOI 10.1254/jphs.10226FP; Wells RW, 2004, PFLUG ARCH EUR J PHY, V448, P515, DOI 10.1007/s00424-004-1286-1; Xu L, 2007, CLIN EXP PHARMACOL P, V34, P120, DOI 10.1111/j.1440-1681.2007.04465.x	24	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					344	351		10.1016/j.jphs.2015.02.002		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900015		
J	Hikichi, H; Hiyoshi, T; Marumo, T; Tomishima, Y; Kaku, A; Iida, I; Urabe, H; Tamita, T; Yasuhara, A; Karasawa, J; Chaki, S				Hikichi, Hirohiko; Hiyoshi, Tetsuaki; Marumo, Toshiyuki; Tomishima, Yasumitsu; Kaku, Ayaka; Iida, Izumi; Urabe, Hiroki; Tamita, Tomoko; Yasuhara, Akito; Karasawa, Jun-ichi; Chaki, Shigeyuki			Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						TASP0443294; mGlu2 receptor positive allosteric modulator; Hyperlocomotion; Social memory; EEG	PHARMACOLOGICAL CHARACTERIZATION; SOCIAL RECOGNITION; SCHIZOPHRENIA; AGONIST; RAT; MODELS; LY379268; POTENT; MEMORY; SLEEP	Glutamatergic dysfunction has been implicated in psychiatric disorders such as schizophrenia. The stimulation of metabotropic glutamate (mGlu) 2 receptor has been shown to be effective in a number of animal models of schizophrenia. In this study, we investigated the antipsychotic profiles of (2S)-5-methyl-2-{[4-(1,1,1-trifluoro-2-methylpropan-2-yl)phenoxy]methyl}-2,3-dihydroimidazo[2,1-b][1,3] oxazole-6-carboxamide (TASP0443294), a newly synthesized positive allosteric modulator of the mGlu2 receptor. TASP0443294 potentiated the response of human mGlu2 and rat mGlu2 receptors to glutamate with EC50 values of 277 and 149 nM, respectively, without affecting the glutamate response of human mGlu3 receptor. TASP0443294 was distributed in the brain and cerebrospinal fluid after peroral administration in rats. The peroral administration of TASP0443294 inhibited methamphetamine-induced hyperlocomotion in rats, which was attenuated by an mGlu2/3 receptor antagonist, and improved social memory impairment induced by 5R, 10S-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a, d] cyclohepten-5,10-imine hydrogen maleate (MK-801) in rats. Furthermore, TASP0443294 reduced the ketamine-induced basal gamma hyperactivity in the prefrontal cortex and suppressed rapid eye movement (REM) sleep in rats. These findings indicate that TASP0443294 is an mGlu2 receptor positive allosteric modulator with antipsychotic activity, and that the suppression of aberrant gamma oscillations and REM sleep could be considered as neurophysiological biomarkers for TASP0443294. (C) 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. All rights reserved.	[Hikichi, Hirohiko; Hiyoshi, Tetsuaki; Marumo, Toshiyuki; Tomishima, Yasumitsu; Kaku, Ayaka; Karasawa, Jun-ichi; Chaki, Shigeyuki] Taisho Pharmaceut Co Ltd, Pharmacol Labs, Kita Ku, Saitama, Saitama 3319530, Japan; [Iida, Izumi] Taisho Pharmaceut Co Ltd, Drug Safety & Pharmacokinet Labs, Kita Ku, Saitama, Saitama 3319530, Japan; [Urabe, Hiroki; Tamita, Tomoko; Yasuhara, Akito] Taisho Pharmaceut Co Ltd, Chem Labs, Kita Ku, Saitama, Saitama 3319530, Japan	Hikichi, H (reprint author), Taisho Pharmaceut Co Ltd, Pharmacol Labs, Kita Ku, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan.	h-hikichi@so.taisho.co.jp					Jones NC, 2012, INT J NEUROPSYCHOPH, V15, P657, DOI 10.1017/S1461145711000848; Hikichi H, 2013, J PHARMACOL SCI, V122, P10, DOI 10.1254/jphs.13036FP; Ahnaou A, 2009, EUR J PHARMACOL, V603, P62, DOI 10.1016/j.ejphar.2008.11.018; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Fell MJ, 2008, J PHARMACOL EXP THER, V326, P209, DOI 10.1124/jpet.108.136861; Fell MJ, 2011, J PHARMACOL EXP THER, V336, P165, DOI 10.1124/jpet.110.172957; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Shigemoto R, 1997, J NEUROSCI, V17, P7503; Krystal JH, 2003, PSYCHOPHARMACOLOGY, V169, P215, DOI 10.1007/s00213-003-1582-z; Rorick-Kehn LM, 2007, PSYCHOPHARMACOLOGY, V193, P121, DOI 10.1007/s00213-007-0758-3; Hiyoshi T, 2014, NEUROSCI LETT, V567, P30, DOI 10.1016/j.neulet.2014.03.025; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Galici R, 2006, J PHARMACOL EXP THER, V318, P173, DOI 10.1124/jpet.106.102046; Akanmu MA, 2005, BRAIN RES, V1048, P138, DOI 10.1016/j.brainres.2005.04.064; Galici R, 2005, J PHARMACOL EXP THER, V315, P1181, DOI 10.1124/jpet.105.091074; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Ferguson JN, 2001, J NEUROSCI, V21, P8278; OHISHI H, 1993, J COMP NEUROL, V335, P252, DOI 10.1002/cne.903350209; Zhang YQ, 2005, J PHARMACOL EXP THER, V315, P1212, DOI 10.1124/jpet.105.090308; Schaffhauser H, 2003, MOL PHARMACOL, V64, P798, DOI 10.1124/mol.64.4.798; Bannerman DM, 2002, EXP BRAIN RES, V142, P395, DOI 10.1007/s00221-001-0938-z; Lavreysen H, 2013, J PHARMACOL EXP THER, V346, P514, DOI 10.1124/jpet.113.204990; Marek GJ, 2010, EUR J PHARMACOL, V639, P81, DOI 10.1016/j.ejphar.2010.02.058; Chaki S, 2010, EUR J PHARMACOL, V639, P59, DOI 10.1016/j.ejphar.2009.12.041; Lopez-Rodriguez F, 2007, ARCH MED RES, V38, P52, DOI 10.1016/j.arcmed.2006.07.004; Bubenikova-Valesova V, 2008, NEUROSCI BIOBEHAV R, V32, P1014, DOI 10.1016/j.neubiorev.2008.03.012; DANTZER R, 1990, BEHAV BRAIN RES, V40, P53, DOI 10.1016/0166-4328(90)90042-D; Feinberg I, 2002, PHARMACOL BIOCHEM BE, V73, P467, DOI 10.1016/S0091-3057(02)00843-2; Funakoshi T, 2002, LIFE SCI, V71, P1371, DOI 10.1016/S0024-3205(02)01863-5; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Shimazaki T, 2010, PSYCHOPHARMACOLOGY, V209, P263, DOI 10.1007/s00213-010-1794-y; Suazo V, 2012, PROG NEURO-PSYCHOPH, V38, P270, DOI 10.1016/j.pnpbp.2012.04.010	33	1	1	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					352	361		10.1016/j.jphs.2015.02.004		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900016		
J	Yamazaki, M; Okabe, M; Yamamoto, N; Yarimizu, J; Harada, K				Yamazaki, Mayako; Okabe, Mayuko; Yamamoto, Noriyuki; Yarimizu, Junko; Harada, Katsuya			Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						5-HT5A receptor; Cognitive impairment; Y-maze; Water maze; Occupancy	COGNITIVE IMPAIRMENT; SEROTONIN RECEPTOR; ALZHEIMERS-DISEASE; PASSIVE-AVOIDANCE; RHESUS-MONKEYS; ANIMAL-MODELS; SCHIZOPHRENIA; BRAIN; ASSOCIATION; MAZE	Despite the human 5-HT5A receptor being cloned in 1994, the biological function of this receptor has not been extensively characterized due to a lack of specific ligands. We recently reported that the selective 5-HT5A receptor antagonist ASP5736 ameliorated cognitive impairment in several animal models of schizophrenia. Given that areas of the brain with high levels of 5-HT5A receptor expression, such as the hippocampus and cerebral cortex, have important functions in cognition and memory, we evaluated the chemically diverse, potent and brain-penetrating 5-HT5A receptor antagonists ASP5736, AS2030680, and AS2674723 in rodent models of cognitive dysfunction associated with dementia. Each of these compounds exhibited a high affinity for recombinant 5-HT5A receptors that was comparable to that of the non-selective ligand of this receptor, lysergic acid diethylamide (LSD). Although each compound had a low affinity for other receptors, 5-HT5A was the only receptor for which all three compounds had a high affinity. Each of the three compounds ameliorated scopolamine-induced working memory deficit in mice and improved reference memory impairment in aged rats at similar doses. Further, ASP5736 decreased the binding of LSD to 5-HT5A receptors in the olfactory bulb of rats in a dose-dependent manner and occupied 15%-50% of brain 5-HT5A receptors at behaviorally effective doses. These results indicate that the 5-HT5A receptor is involved in learning and memory and that treatment with 5-HT5A receptor antagonists might be broadly effective for cognitive impairment associated with not only schizophrenia but also dementia. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Yamazaki, Mayako; Okabe, Mayuko; Yamamoto, Noriyuki; Yarimizu, Junko; Harada, Katsuya] Astellas Pharma Inc, Drug Discovery Res, Neurosci Res Unit, Tsukuba, Ibaraki 3058585, Japan	Yamazaki, M (reprint author), Astellas Pharma Inc, Drug Discovery Res, Neurosci Res Unit, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	mayako.yamazaki@astellas.com					Birkett JT, 2000, NEUROREPORT, V11, P2017, DOI 10.1097/00001756-200006260-00042; Pasqualetti M, 1998, MOL BRAIN RES, V56, P1, DOI 10.1016/S0169-328X(98)00003-5; Schliebs R, 2006, J NEURAL TRANSM, V113, P1625, DOI 10.1007/s00702-006-0579-2; REES S, 1994, FEBS LETT, V355, P242, DOI 10.1016/0014-5793(94)01209-1; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; ARNSTEN AFT, 1994, PSYCHOPHARMACOLOGY, V116, P143, DOI 10.1007/BF02245056; Maurice T, 1997, EUR J PHARMACOL, V328, P9, DOI 10.1016/S0014-2999(97)83020-8; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Oliver KR, 2000, BRAIN RES, V867, P131, DOI 10.1016/S0006-8993(00)02273-3; ERLANDER MG, 1993, P NATL ACAD SCI USA, V90, P3452, DOI 10.1073/pnas.90.8.3452; GOLDMANRAKIC PS, 1981, NEUROSCIENCE, V6, P177, DOI 10.1016/0306-4522(81)90053-1; Harada K, 2012, EUR J PHARMACOL, V685, P59, DOI 10.1016/j.ejphar.2012.04.013; Drescher KU, 2006, 36 ANN M SOC NEUR OC; Grailhe R, 1999, NEURON, V22, P581, DOI 10.1016/S0896-6273(00)80712-6; ICHIHARA K, 1988, PHARMACOL BIOCHEM BE, V30, P107, DOI 10.1016/0091-3057(88)90431-5; INGRAM DK, 1981, NEUROBIOL AGING, V2, P41, DOI 10.1016/0197-4580(81)90058-0; Iwata N, 2001, MOL PSYCHIATR, V6, P217, DOI 10.1038/sj.mp.4000829; MANDEL RJ, 1989, BEHAV BRAIN RES, V31, P221, DOI 10.1016/0166-4328(89)90004-1; MATSUOKA N, 1992, J PHARMACOL EXP THER, V263, P436; MATTHES H, 1993, MOL PHARMACOL, V43, P313; Moore TL, 2005, BEHAV BRAIN RES, V160, P208, DOI 10.1016/j.bbr.2004.12.003; PACKARD MG, 1989, PHARMACOL BIOCHEM BE, V33, P511, DOI 10.1016/0091-3057(89)90378-X; PLASSAT JL, 1992, EMBO J, V11, P4779; Takizawa R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005495; Thomas DR, 2006, PHARMACOL THERAPEUT, V111, P707, DOI 10.1016/j.pharmthera.2005.12.006; YAMAZAKI M, 1995, J PHARMACOL EXP THER, V272, P256; Yamazaki M, 2014, EUR NEUROPSYCHOPHARM, V24, P1698, DOI 10.1016/j.euroneuro.2014.07.009; Yamazaki M, 1996, J PHARMACOL EXP THER, V279, P1157	28	2	2	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					362	369		10.1016/j.jphs.2015.02.006		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900017		
J	Kojima, A; Matsumoto, A; Nishida, H; Reien, Y; Iwata, K; Shirayama, T; Yabe-Nishimura, C; Nakaya, H				Kojima, Akiteru; Matsumoto, Akio; Nishida, Hirofumi; Reien, Yoshie; Iwata, Kazumi; Shirayama, Takeshi; Yabe-Nishimura, Chihiro; Nakaya, Haruaki			A protective role of Nox1/NADPH oxidase in a mouse model with hypoxia-induced bradycardia	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						NADPH oxidase; Sinoatrial node; Hypoxia	SINOATRIAL NODE; NADPH OXIDASE; HYPERPOLARIZING FACTOR; MICE; ACTIVATION; ATRIAL; NOX1; FIBRILLATION; CHANNELS; CELLS	Although it has been reported that endotoxin-induced expression of Nox1 in the heart contributes to apoptosis in cardiomyocytes, functional role of Nox1 at the physiological expression level has not been elucidated. The aim of this study was to clarify the role of Nox1 under a hypoxic condition using wild-type (WT, Nox1(+/Y)) and Nox1-deficient (Nox1(-/Y)) mice. ECG recordings from anesthetized mice revealed that Nox1(-/Y) mice were more sensitive to hypoxia, resulting in bradycardia, compared to WT mice. Atrial and ventricular electrocardiograms recorded from Langendorff-perfused hearts revealed that hypoxic perfusion more rapidly decreased heart rate in Nox1(-/Y) hearts compared with WT hearts. Sinus node recovery times measured under a hypoxic condition were prolonged more markedly in the Nox1(-/Y) hearts. Sinoatrial node dysfunction of Nox1(-/Y) hearts during hypoxia was ameriolated by the pretreatment with the Ca2+ channel blocker nifedipine or the K+ channel opener pinacidil. Spontaneous action potentials were recorded from enzymatically-isolated sinoatrial node (SAN) cells under a hypoxic condition. There was no significant difference in the elapsed times from the commencement of hypoxia to asystole between WT and Nox1(-/Y) SAN cells. These findings suggest that Nox1 may have a protective effect against hypoxia-induced SAN dysfunction. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Kojima, Akiteru; Matsumoto, Akio; Nishida, Hirofumi; Reien, Yoshie; Nakaya, Haruaki] Chiba Univ, Grad Sch Med, Dept Pharmacol, Chiba 2608670, Japan; [Kojima, Akiteru; Shirayama, Takeshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan; [Iwata, Kazumi; Yabe-Nishimura, Chihiro] Kyoto Prefectural Univ Med, Dept Pharmacol, Kyoto, Japan	Nakaya, H (reprint author), Chiba Univ, Grad Sch Med, Dept Pharmacol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	nakaya@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23390053]	We are grateful to I Sakashita for her secretarial assistance. This work was supported in part by a Grant-in-Aid from Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant 23390053).	Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Matsuno K, 2012, FREE RADICAL BIO MED, V53, P1718, DOI 10.1016/j.freeradbiomed.2012.08.590; Shafique E, 2013, AGING-US, V5, P515; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Cho HS, 2003, J PHYSIOL-LONDON, V550, P169, DOI 10.1113/jphysiol.2003.040501; Ohashi J, 2012, CIRC J, V76, P1768, DOI 10.1253/circj.CJ-12-0197; Goyal P, 2004, FREE RADICAL BIO MED, V36, P1279, DOI 10.1016/j.freeradbiomed.2004.02.071; Deussen A, 2006, BASIC RES CARDIOL, V101, P453, DOI 10.1007/s00395-006-0621-4; Gebremedhin D, 2010, J CEREBR BLOOD F MET, V30, P1777, DOI 10.1038/jcbfm.2010.70; Zhang DX, 2012, CIRC RES, V110, P471, DOI 10.1161/CIRCRESAHA.111.258871; Braunersreuther V, 2013, J MOL CELL CARDIOL, V64, P99, DOI 10.1016/j.yjmcc.2013.09.007; Feng J, 2013, ARTERIOSCLER THROMB, V30, P1703; Fujita H, 2006, BRIT J PHARMACOL, V149, P573, DOI 10.1038/sj.bjp.0706891; Fukuzaki K, 2008, J PHYSIOL-LONDON, V586, P2767, DOI 10.1113/jphysiol.2007.148932; Iwata K, 2014, ARTERIOSCL THROM VAS, V34, P110, DOI 10.1161/ATVBAHA.113.302107; Jiang SX, 2014, CARDIOVASC RES, V102, P79, DOI 10.1093/cvr/cvu027; Okada T, 2000, J CARDIOVASC PHARM, V35, P145, DOI 10.1097/00005344-200001000-00019; Rathore R, 2008, FREE RADICAL BIO MED, V45, P1223, DOI 10.1016/j.freeradbiomed.2008.06.012; Ribe D, 2008, FREE RADICAL BIO MED, V44, P1433, DOI 10.1016/j.freeradbiomed.2007.12.035; Sakamoto N, 1998, BRIT J PHARMACOL, V125, P283, DOI 10.1038/sj.bjp.0702060; Suzuki K, 2014, J PHARMACOL SCI, V125, P406, DOI 10.1254/jphs.14023FP; Verheijck EE, 1998, CIRCULATION, V97, P1623; Wakimoto H, 2001, CARDIOVASC RES, V50, P463, DOI 10.1016/S0008-6363(01)00264-4	24	1	1	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					370	376		10.1016/j.jphs.2015.02.007		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900018		
J	Omori, Y; Nakajima, M; Nishimura, K; Takahashi, E; Arai, T; Akahira, M; Suzuki, T; Kainoh, M				Omori, Yu; Nakajima, Mayumi; Nishimura, Kazumi; Takahashi, Eiki; Arai, Tadamasa; Akahira, Masato; Suzuki, Tomohiko; Kainoh, Mie			Analgesic effect of GT-0198, a structurally novel glycine transporter 2 inhibitor, in a mouse model of neuropathic pain	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Neuropathic pain; Glycine; Glycine transporter; Partial sciatic nerve ligation	SCIATIC-NERVE INJURY; RAT SPINAL-CORD; POSTHERPETIC PAIN; RECEPTOR; MICE; HYPERALGESIA; ALLODYNIA; GLYT2; SENSITIZATION; CNS	This study was conducted to identify the characteristic pharmacological features of GT-0198 that is phenoxymethylbenzamide derivatives. GT-0198 inhibited the function of glycine transporter 2 (GlyT2) in human GlyT2-expressing HEK293 cells and did not bind various major transporters or receptors of neurotransmitters in a competitive manner. Thus, GT-0198 is considered to be a comparatively selective GlyT2 inhibitor. Intravenous, oral, and intrathecal injections of GT-0198 decreased the pain-related response in a model of neuropathic pain with partial sciatic nerve ligation. This result suggests that GT-0198 has an analgesic effect. The analgesic effect of GT-0198 was abolished by the intrathecal injection of strychnine, a glycine receptor antagonist. Therefore, GT-0198 is considered to exhibit its analgesic effect via the activation of a glycine receptor by glycine following presynaptic GlyT2 inhibition in the spinal cord. In summary, GT-0198 is a structurally novel GlyT2 inhibitor bearing a phenoxymethylbenzamide moiety with in vivo efficacy in behavioral models of neuropathic pain. (C) 2015 Toray Industries, Inc. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Omori, Yu; Nakajima, Mayumi; Nishimura, Kazumi; Takahashi, Eiki; Arai, Tadamasa; Akahira, Masato; Suzuki, Tomohiko; Kainoh, Mie] Toray Industries Ltd, Pharmaceut Res Labs, Kamakura, Kanagawa 2488555, Japan	Omori, Y (reprint author), Toray Industries Ltd, Pharmaceut Res Labs, 10-1,Tebiro 6 Chome, Kamakura, Kanagawa 2488555, Japan.	Yu_Omori@nts.toray.co.jp					Yoshikawa S, 2012, EUR UROL, V62, P704, DOI 10.1016/j.eururo.2012.01.044; Tanabe M, 2008, ANESTHESIOLOGY, V108, P929, DOI 10.1097/ALN.0b013e31816c9044; BECKER CM, 1988, EMBO J, V7, P3717; Eulenburg V, 2005, TRENDS BIOCHEM SCI, V30, P325, DOI 10.1016/j.tibs.2005.04.004; Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Haranishi Y, 2010, ANESTH ANALG, V110, P615, DOI 10.1213/ANE.0b013e3181c7ebbb; Malmberg AB, 1998, PAIN, V76, P215, DOI 10.1016/S0304-3959(98)00045-1; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; DUBUISSON D, 1977, PAIN, V4, P161; ZAFRA F, 1995, J NEUROSCI, V15, P3952; SIVILOTTI L, 1994, J NEUROPHYSIOL, V72, P169; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; Bradaia A, 2004, J PHYSIOL-LONDON, V559, P169, DOI 10.1113/jphysiol.2004.068858; Hermanns H, 2008, NEUROSCI LETT, V445, P214, DOI 10.1016/j.neulet.2008.09.012; Huang W, 2000, NEUROL RES, V22, P160; JURSKY F, 1995, J NEUROCHEM, V64, P1026; MALMBERG AB, 1992, SCIENCE, V257, P1276, DOI 10.1126/science.1381521; Mingorance-Le Meur A, 2013, BRIT J PHARMACOL, V170, P1053, DOI 10.1111/bph.12343; MITCHELL K, 1993, J NEUROSCI, V13, P2371; Morita K, 2008, J PHARMACOL EXP THER, V326, P633, DOI 10.1124/jpet.108.136267; Nishikawa Y, 2010, J PHARMACOL SCI, V112, P352, DOI 10.1254/jphs.09351FP; Sasaki A, 2008, J PHARMACOL SCI, V108, P266, DOI 10.1254/jphs.08154FP; Sherman SE, 1997, J NEUROPHYSIOL, V78, P628; Simpson RK, 1997, NEUROCHEM RES, V22, P75; Takasaki I, 2000, JPN J PHARMACOL, V83, P319, DOI 10.1254/jjp.83.319; Takasaki I, 2002, ANESTHESIOLOGY, V96, P1168, DOI 10.1097/00000542-200205000-00021; Takasaki I, 2000, PAIN, V86, P95, DOI 10.1016/S0304-3959(00)00240-2; Whitehead KJ, 2004, NEUROSCIENCE, V126, P381, DOI 10.1016/j.neuroscience.2004.04.006; Wiles AL, 2006, J NEUROCHEM, V99, P781, DOI 10.1111/j.1471-4159.2006.04107.x; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	34	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					377	381		10.1016/j.jphs.2015.02.010		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900019		
J	Miyawaki, K; Araki, H; Yoshimura, H				Miyawaki, Kazumi; Araki, Hiroaki; Yoshimura, Hiroyuki			Disruption of running activity rhythm following restricted feeding in female mice: Preventive effects of antidepressants	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Wheel-running activity; Circadian rhythm; Chronometrical analysis; Antidepressant drugs; Female mice	ACTIVITY-STRESS ULCER; CENTRAL 5-HT1A RECEPTORS; DEPRESSIVE-LIKE STATE; FORCED SWIMMING TEST; CIRCADIAN-RHYTHMS; SELF-STARVATION; ACTIVITY WHEELS; RATS; SEROTONIN; PHARMACOLOGY	Biological rhythms are critical in the etiology of mood disorders; therefore, effective mood disorder treatments should address rhythm disturbances. Among the variables synchronized with the light-dark cycle, spontaneous activity in rodents is useful for investigating circadian rhythms. However, previous studies have focused only on the increase of wheel-running activity under restricted feeding conditions, while little information is available on circadian rhythm of running activity. In this study, chronometrical analysis was used to assess whether circadian rhythms during wheel-running are altered by restricted feeding and affected by antidepressant drugs. Wheel revolutions were automatically recorded and analyzed using cosinor-rhythmometry in 8-week old ICR albino mice. When feeding was restricted to 1 h per day (21:00-22:00), wheel-running rhythms were reliably disrupted. Female mice exhibited marked alterations in the pattern and extent of wheel-running beginning on day 1. Subchronic treatment with imipramine or paroxetine, as well as tandospirone and (-)-DOI, prevented wheel-running rhythm disruption. Thus, altering the circadian activity rhythms of female mice on a 1-h feeding schedule may be useful for investigating disturbances in biological rhythms. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Miyawaki, Kazumi; Araki, Hiroaki] Ehime Univ, Grad Sch Med, Dept Clin Pharm, Toon City, Ehime 7910295, Japan; [Yoshimura, Hiroyuki] Res Inst Alternat Med, Behav Pharmacol Lab, Toon City, Ehime 7910202, Japan	Miyawaki, K (reprint author), Ehime Univ, Grad Sch Med, Dept Clin Pharm, Toon City, Ehime 7910295, Japan.	miyawaki.kazumi.my@ehime-u.ac.jp					ANDERSON IM, 1994, J PSYCHOPHARMACOL, V8, P238, DOI 10.1177/026988119400800407; Duncan WC, 1996, PHARMACOL THERAPEUT, V71, P253, DOI 10.1016/S0163-7258(96)00092-7; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; LUCKI I, 1994, NEUROSCI BIOBEHAV R, V18, P85, DOI 10.1016/0149-7634(94)90039-6; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203; Kornstein SG, 2000, J AFFECT DISORDERS, V60, P1, DOI 10.1016/S0165-0327(99)00158-5; Parry BL, 2001, NEUROPSYCHOPHARMACOL, V25, pS102, DOI 10.1016/S0893-133X(01)00340-2; Bekku N, 2006, PSYCHOPHARMACOLOGY, V187, P170, DOI 10.1007/s00213-006-0395-2; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Nagayama H, 1998, PSYCHOPHARMACOLOGY, V135, P279, DOI 10.1007/s002130050510; Su J, 2013, J PHARMACOL SCI, V123, P246, DOI 10.1254/jphs.13145FP; WATANABE K, 1990, JPN J PHARMACOL, V52, P421, DOI 10.1254/jjp.52.421; Gelenberg AJ, 2000, J CLIN PSYCHIAT, V61, P712; Ohdo S, 2007, J PHARMACOL SCI, V103, P155, DOI 10.1254/jphs.FMJ06003X6; Bekku N, 2005, PSYCHOPHARMACOLOGY, V183, P300, DOI 10.1007/s00213-005-0179-0; Casper R C, 1998, Depress Anxiety, V8 Suppl 1, P96, DOI 10.1002/(SICI)1520-6394(1998)8:1+<96::AID-DA15>3.0.CO;2-4; Courtet, 2012, EUR NEUROPSYCHOPHA S, V22, pS476; Dingle H, 2014, MIGRATION: THE BIOLOGY OF LIFE ON THE MOVE, 2ND EDITION, P1, DOI 10.1093/acprof:oso/9780199640386.001.0001; FINGER FW, 1969, J COMP PHYSIOL PSYCH, V68, P461, DOI 10.1037/h0027490; Gomez F, 1998, PSYCHOPHARMACOLOGY, V140, P127, DOI 10.1007/s002130050749; Goodnick P J, 2000, Expert Opin Pharmacother, V1, P903, DOI 10.1517/14656566.1.5.903; GUTTMAN R, 1975, BEHAV BIOL, V13, P127, DOI 10.1016/S0091-6773(75)90898-6; HALL JF, 1954, J COMP PHYSIOL PSYCH, V47, P362, DOI 10.1037/h0060276; Hayashi H, 1992, HYPERTENS RES, V15, P127, DOI 10.1291/hypres.15.127; HELLHAMMER DH, 1983, PSYCHOSOM MED, V45, P115; Horikawa K, 2013, J PHARMACOL SCI, V123, P402, DOI 10.1254/jphs.13170SC; Lu JQ, 1996, PSYCHOPHARMACOLOGY, V123, P42, DOI 10.1007/BF02246279; Maurizio F, 2004, J CLIN PSYCHI, V65, P27; Monteleone P, 2001, PROG NEUROPSYHOPHARM, V35, P1569; Nagayama H, 1999, PSYCHOSOM MED, V61, P618; Nagayama H, 1996, PSYCHOPHARMACOLOGY, V127, P113, DOI 10.1007/BF02805983; Pare WP, 1975, PHYSIOL BEHAV, V16, P699; PARE WP, 1974, B PSYCHONOMIC SOC, V4, P546; PARE WP, 1973, B PSYCHONOMIC SOC, V2, P213; PARE WP, 1986, PHYSIOL BEHAV, V36, P699, DOI 10.1016/0031-9384(86)90357-4; PARE WP, 1978, PSYCHOL REP, V43, P591; ROUTTENB.A, 1967, J COMP PHYSIOL PSYCH, V64, P414, DOI 10.1037/h0025205; ROUTTENB.A, 1968, J COMP PHYSIOL PSYCH, V66, P234, DOI 10.1037/h0025977; Salvatore Paola, 2012, Dialogues Clin Neurosci, V14, P369; Sloan K, 2003, PSYCHIAT CLIN N AM, V26, P581; Tahara Y, 2014, J PHARMACOL SCI, V124, P320, DOI 10.1254/jphs.13R06CR; TICHER A, 1995, PHYSIOL BEHAV, V57, P37, DOI 10.1016/0031-9384(94)E0108-G; TSUDA A, 1982, PHYSIOL BEHAV, V28, P349, DOI 10.1016/0031-9384(82)90084-1; Weber M, 2009, PSYCHOPHARMACOLOGY, V203, P753, DOI 10.1007/s00213-008-1420-4; Yokota S, 2005, J PHARMACOL SCI, V98, P103, DOI 10.1254/jphs.SC0050058; YOSHIMURA H, 1991, EUR J PHARMACOL, V200, P147, DOI 10.1016/0014-2999(91)90677-I	47	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					382	390		10.1016/j.jphs.2015.02.015		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900020		
J	Aoki, Y; Nishizawa, D; Hasegawa, J; Kasai, S; Yoshida, K; Koukita, Y; Ichinohe, T; Nagashima, M; Katoh, R; Satoh, Y; Tagami, M; Hayashida, M; Fukuda, K; Ikeda, K				Aoki, Yoshinori; Nishizawa, Daisuke; Hasegawa, Junko; Kasai, Shinya; Yoshida, Kaori; Koukita, Yoshihiko; Ichinohe, Tatsuya; Nagashima, Makoto; Katoh, Ryoji; Satoh, Yasuo; Tagami, Megumi; Hayashida, Masakazu; Fukuda, Ken-ichi; Ikeda, Kazutaka			Association between the rs1465040 single-nucleotide polymorphism close to the transient receptor potential subfamily C member 3 (TRPC3) gene and postoperative analgesic requirements	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						TRPC3; Analgesics; Polymorphism	MAJOR ABDOMINAL-SURGERY; SENSITIVITY	An association between postoperative analgesic requirements in subjects who underwent orthognathic surgery and the rs1465040 single-nucleotide polymorphism close to the transient receptor potential subfamily C member 3 (TRPC3) gene was suggested by our previous genome-wide association study. To verify this association, we analyzed the association between the rs1465040 SNP and analgesic requirements, including opioid requirements, after open abdominal surgery. The association between the rs1465040 SNP and postoperative analgesic requirements was confirmed in the open abdominal surgery group (P = 0.036), suggesting that the TRPC3 SNP may contribute to predicting postoperative analgesic requirements. (C) 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. All rights reserved.	[Aoki, Yoshinori; Nishizawa, Daisuke; Hasegawa, Junko; Kasai, Shinya; Yoshida, Kaori; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Setagaya Ku, Tokyo 1568506, Japan; [Aoki, Yoshinori; Yoshida, Kaori; Koukita, Yoshihiko; Ichinohe, Tatsuya; Fukuda, Ken-ichi] Tokyo Dent Coll, Dept Dent Anesthesiol, Chiyoda Ku, Tokyo 1010061, Japan; [Nagashima, Makoto; Katoh, Ryoji] Toho Univ, Sakura Med Ctr, Dept Surg, Sakura Ku, Chiba 2858741, Japan; [Satoh, Yasuo; Tagami, Megumi] Toho Univ, Sakura Med Ctr, Dept Anesthesiol, Sakura Ku, Chiba 2858741, Japan; [Hayashida, Masakazu] Juntendo Univ, Dept Anesthesiol, Bunkyo Ku, Tokyo 1138431, Japan	Ikeda, K (reprint author), Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	ikeda-kz@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology MEXT of Japan (Tokyo, Japan) [22790518, 23390377, 24659549, 24790544, 25116532, 26293347, 26860360]; Ministry of Health, Labour and Welfare (MHLW) of Japan (Tokyo, Japan) [H21-3jigan-ippan-011, H22-Iyaku-015, H25-Iyaku-020, H26-Kakushintekigan-ippan-060, 14524680]; Smoking Research Foundation (Tokyo, Japan); Astellas Foundation for Research on Metabolic Disorders (Tokyo, Japan)	We are grateful to the volunteers for their participation in this study and the anesthesiologists and surgeons at Tokyo Dental College, Tokyo, Japan. This work was supported by grants from the (Ministry of Education, Culture, Sports, Science and Technology MEXT of Japan) (Tokyo, Japan; no. 22790518, 23390377, 24659549, 24790544, 25116532, 26293347, and 26860360), Ministry of Health, Labour and Welfare (MHLW) of Japan (Tokyo, Japan; no. H21-3jigan-ippan-011, H22-Iyaku-015, H25-Iyaku-020, H26-Kakushintekigan-ippan-060, and 14524680), Smoking Research Foundation (Tokyo, Japan), and Astellas Foundation for Research on Metabolic Disorders (Tokyo, Japan). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhani H, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-43; Nishizawa D, 2014, MOL PSYCHIATR, V19, P55, DOI 10.1038/mp.2012.164; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Becker EBE, 2011, CEREBELLUM, V10, P296, DOI 10.1007/s12311-011-0253-6; Kehlet H, 2001, BRIT J ANAESTH, V87, P62, DOI 10.1093/bja/87.1.62; Fukuda K, 2009, PAIN, V147, P194, DOI 10.1016/j.pain.2009.09.004; Quick K, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120068; Hayashida M, 2008, PHARMACOGENOMICS, V9, P1605, DOI 10.2217/14622416.9.11.1605; Moriyama A, 2013, J PHARMACOL SCI, V121, P48, DOI 10.1254/jphs.12159FP; Nagatsuka C, 2000, Anesth Prog, V47, P119; Nishizawa D, 2015, J PHARM SCI, V126, P253; Nishizawa D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007060; Staaf S, 2009, PAIN, V144, P187, DOI 10.1016/j.pain.2009.04.013; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Zhao ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032628	15	1	1	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					391	393		10.1016/j.jphs.2015.02.005		3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900021		
J	Koriyama, Y; Hisano, S; Ogai, K; Sugitani, K; Furukawa, A; Kato, S				Koriyama, Yoshiki; Hisano, Suguru; Ogai, Kazuhiro; Sugitani, Kayo; Furukawa, Ayako; Kato, Satoru			Involvement of neuronal nitric oxide synthase in N-methyl-N-nitrosourea-induced retinal degeneration in mice	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Neurotoxicity; Nitric oxide; Retina	PHOTORECEPTOR CELL-DEATH; RETINITIS-PIGMENTOSA; ANIMAL-MODELS; RAT RETINA; MECHANISMS; CYCLASE	N-methyl-N-nitrosourea (MNU) is widely used to study the mechanism of retinal degenerative diseases (RDs) because of its selectivity of photoreceptor cell death. Many reports suggest that excessive nitric oxide (NO) plays a crucial role in neuronal cell death. We hypothesized that nitric oxide synthase (NOS)/NO are involved in photoreceptor cell death by MNU. We found that the levels of NO increased after MNU treatment. Furthermore, we demonstrated that neuronal NOS specific inhibitor attenuated photoreceptor cell death by MNU in mice. We believe that our findings might be a new target for the treatment of RDs. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Koriyama, Yoshiki; Furukawa, Ayako] Suzuka Univ Med Sci, Grad Sch, Suzuka 5138670, Japan; [Koriyama, Yoshiki; Furukawa, Ayako] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka 5138670, Japan; [Hisano, Suguru; Kato, Satoru] Kanazawa Univ, Grad Sch Med, Dept Mol Neurobiol, Kanazawa, Ishikawa, Japan; [Ogai, Kazuhiro] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Wellness Promot Sci Ctr, Kanazawa, Ishikawa, Japan; [Sugitani, Kayo] Kanazawa Univ, Grad Sch Med, Div Hlth Sci, Kanazawa, Ishikawa, Japan	Koriyama, Y (reprint author), Suzuka Univ Med Sci, Grad Sch, 3500-3 Minamitamagaki, Suzuka 5138670, Japan.	koriyama@suzuka-u.ac.jp					Donovan M, 2001, J BIOL CHEM, V276, P23000, DOI 10.1074/jbc.M005359200; Rossmiller B, 2012, MOL VIS, V18, P2479; Tsubura A, 2010, HISTOL HISTOPATHOL, V25, P933; Tsuruma K, 2012, J PHARMACOL SCI, V118, P351, DOI 10.1254/jphs.11110FP; KOCH KW, 1994, EMBO J, V13, P3312; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Yoshizawa K, 2000, EXP EYE RES, V71, P629, DOI 10.1006/exer.2000.0921; Oka T, 2007, EXP NEUROL, V204, P39, DOI 10.1016/j.expneurol.2006.09.011; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; Cheon EW, 2003, NEUROREPORT, V14, P329, DOI 10.1097/01.wnr.0000058034.29600.6d; HERROLD KM, 1967, ARCH OPHTHALMOL-CHIC, V78, P650; Komeima K, 2008, FREE RADICAL BIO MED, V45, P905, DOI 10.1016/j.freeradbiomed.2008.06.020; Neufeld AH, 2000, J COMP NEUROL, V416, P269, DOI 10.1002/(SICI)1096-9861(20000110)416:2<269::AID-CNE11>3.0.CO;2-2; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772	15	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAR	2015	127	3					394	396		10.1016/j.jphs.2015.02.008		3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG2QG	WOS:000353118900022		
J	Li, YR; Uchida, A; Abe, A; Yamamoto, A; Hirano, T; Kunitake, H				Li, Yiran; Uchida, Asuka; Abe, Akiha; Yamamoto, Akihiro; Hirano, Tomonari; Kunitake, Hisato			Effects of Polyamines on Self-incompatibility-like Responses in Pollen Tubes of Citrus Cultivars, Banpeiyu and Hyuganatsu	JOURNAL OF THE AMERICAN SOCIETY FOR HORTICULTURAL SCIENCE			English	Article						HPLC; pollen culture; putrescine; spermidine; spermine; stylar crude protein	GERMINATING APPLE POLLEN; DECARBOXYLASE ACTIVITY; PAPAVER-RHOEAS; JAPANESE PEAR; S-RNASE; BIOSYNTHESIS; NICOTIANA; STRESS; GROWTH; GENE	Citrus is a genus with gametophytic self-incompatibility, which prevents fertilization by self-pollination. Polyamines (PAs), as a class of active small molecules, widely participate in various cellular activities. To investigate the effects of the changes in PA contents lputrescine, spermidine (SPD), and sperminel on pollen tube growth in self-incompatible (SI) plants, we cultured pollen of Citrus maxima 'Banpeiyu' and C. tamurana 'Hyuganatsu' in a Citrus mature pollen culture system and detected the PA content changes in pollen by high-performance liquid chromatography (HPLC) analysis during germination and after treatment with crude protein extracts of compatible or incompatible styles. We profiled the PA content changes during the germination course in pollen of 'Banpeiyu' and 'Hyuganatsu' by HPLC, and identified increases of free and perchloric-acid-insoluble SPD contents in pollen tubes in the incompatible treatment. Exogenous SPD treatment obviously increased the SPD contents in the pollen tube, inhibited pollen tube elongation, and resulted in some abnormal morphological alterations, such as tip inflation, tube content leakage and tip twist, which were observed in both `Banpeiyu' and 'Hyuganatsu' pollen tubes exposed to incompatible treatment. This finding implied that SPD might participate in the SI response in Citrus.	[Li, Yiran; Uchida, Asuka] Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, Miyazaki 8892192, Japan; [Abe, Akiha; Yamamoto, Akihiro; Hirano, Tomonari; Kunitake, Hisato] Miyazaki Univ, Fac Agr, Miyazaki 8892192, Japan	Kunitake, H (reprint author), Miyazaki Univ, Fac Agr, 1-1 Gakuenkibanadai Nishi, Miyazaki 8892192, Japan.	hkuni@cc.miyazaki-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [KAKENHI 25660029]	We are grateful to Dr. Masahiro Mii of Graduate School of Horticulture, Chiba University, for his advice and critical reading of this manuscript. This study was supported by a Grant-in-Aid for Scientific Research (KAKENHI 25660029) from the Japan Society for the Promotion of Science (JSPS).	BAGNI N, 1981, PLANT PHYSIOL, V68, P727, DOI 10.1104/pp.68.3.727; Wheeler MJ, 2009, NATURE, V459, P992, DOI 10.1038/nature08027; Couee I, 2004, PLANT CELL TISS ORG, V76, P1, DOI 10.1023/A:1025895731017; BOKERN M, 1995, PHYTOCHEMISTRY, V39, P1371, DOI 10.1016/0031-9422(95)00151-V; Antognoni F, 2008, PLANT BIOLOGY, V10, P334, DOI 10.1111/j.1438-8677.2007.00016.x; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; GALSTON AW, 1983, BIOSCIENCE, V33, P382, DOI 10.2307/1309107; Hanfrey C, 2001, PLANT J, V27, P551, DOI 10.1046/j.1365-313X.2001.01100.x; Wu JY, 2010, PLANT J, V63, P1042, DOI 10.1111/j.1365-313X.2010.04301.x; Bagni N, 2001, AMINO ACIDS, V20, P301, DOI 10.1007/s007260170046; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; LAM TBT, 1992, PHYTOCHEMISTRY, V31, P1179; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Chowdhury ZA, 1997, EXP CELL RES, V231, P38, DOI 10.1006/excr.1996.3448; Miao HX, 2011, PLANT SCI, V180, P358, DOI 10.1016/j.plantsci.2010.10.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Chai LJ, 2011, MOL BIOL REP, V38, P1, DOI 10.1007/s11033-010-0070-x; Chai LJ, 2011, MOL BIOL REP, V38, P4429, DOI 10.1007/s11033-010-0571-7; CHIBI F, 1994, PHYSIOL PLANTARUM, V92, P61; Cohen S. S., 1998, GUIDE POLYAMINES; Del Duca S, 2010, AMINO ACIDS, V38, P659, DOI 10.1007/s00726-009-0426-5; Falasca G, 2010, PLANT PHYSIOL BIOCH, V48, P565, DOI 10.1016/j.plaphy.2010.02.013; FOOTE HCC, 1994, P NATL ACAD SCI USA, V91, P2265, DOI 10.1073/pnas.91.6.2265; Gentile A, 2012, AMINO ACIDS, V42, P1025, DOI 10.1007/s00726-011-1017-9; HIRATSUKA S, 1991, J JPN SOC HORTIC SCI, V60, P257; Hiratsuka S, 2012, SEX PLANT REPROD, V25, P347, DOI 10.1007/s00497-012-0202-7; Kim JH, 2011, J JPN SOC HORTIC SCI, V80, P404, DOI 10.2503/jjshs1.80.404; LEE HS, 1994, NATURE, V367, P560, DOI 10.1038/367560a0; Mattoo AK, 2010, AMINO ACIDS, V38, P405, DOI 10.1007/s00726-009-0399-4; MURFETT J, 1994, NATURE, V367, P563, DOI 10.1038/367563a0; Niimi Y, 1997, J JPN SOC HORTIC SCI, V65, P835; SCARAMAGLI S, 1995, J PLANT PHYSIOL, V147, P113; Song JJ, 2001, PLANT SCI, V161, P507, DOI 10.1016/S0168-9452(01)00435-6; SPERANZA A, 1984, PHYSIOL VEG, V22, P323; Tao R, 2010, SCI HORTIC-AMSTERDAM, V124, P423, DOI 10.1016/j.scienta.2010.01.025; Uchida A., 2012, THESIS U MIYAZAKI MI; Uchida Asuka, 2012, Horticultural Research (Japan), V11, P173; Yamamoto A, 2012, J PLANT BIOL, V55, P191, DOI 10.1007/s12374-011-0072-9; Yamamoto M, 2006, J JPN SOC HORTIC SCI, V75, P372, DOI 10.2503/jjshs.75.372	39	1	1	AMER SOC HORTICULTURAL SCIENCE	ALEXANDRIA	113 S WEST ST, STE 200, ALEXANDRIA, VA 22314-2851 USA	0003-1062	2327-9788		J AM SOC HORTIC SCI	J. Am. Soc. Hortic. Sci.	MAR	2015	140	2					183	190				8	Horticulture	Agriculture	CG4JA	WOS:000353250200010		
J	Fukumoto, K				Fukumoto, Kentaro			What Happens Depends on When It Happens: Copula-Based Ordered Event History Analysis of Civil War Duration and Outcome	JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION			English	Article						Competing risk; Interdependence; Intrastate conflict; Rebel; Separate estimation	TIME; MODELS; END	Scholars are interested in not just what event happens but also when the event happens. If there is dependence among events or dependence between time and events, however, the currently common methods (e.g., competing risks approaches) produce biased estimates. To deal with these problems, this article proposes a new method of copula-based ordered event history analysis (COEHA). A merit of working with copulas is that, whatever marginal distributions time and event variables follow (including the Cox model), researchers can derive whatever joint distribution exists between the two. Application of the COEHA model to a dataset from civil wars supports two controversial hypotheses. First, as wars become longer, rebel victory becomes more likely but settlement does not (there is dependence between time and events at both tails). Second, stronger rebels make wars shorter but do not necessarily tend to win, as experts predict but fail to establish (rebels' strength shortens time but has no effect on which events occur). Supplementary materials for this article are available online.	[Fukumoto, Kentaro] Gakushuin Univ, Fac Law, Dept Polit Sci, Toshima Ku, Tokyo 1718588, Japan	Fukumoto, K (reprint author), Washington Univ, Dept Polit Sci, St Louis, MO 63130 USA.	Kentaro.Fukumoto@gakushuin.ac.jp			Japan Society for the Promotion of Science [20330023]; Abe Yoshishige Memorial Educational Fund	This work was supported by the Japan Society for the Promotion of Science (grant number 20330023) and Abe Yoshishige Memorial Educational Fund. The author appreciates David E. Cunningham, Kristian Skrede Gleditsch, and Idean Salehyan for making their data available and Janet Box-Steffensmeier, Frederick Boehmke, Robert Franzese, Jude Hays, Matt Loftis, John Londregan, and Yasuhiro Omori for their comments.	Aalen OO, 2008, STAT BIOL HEALTH, P1; Akcinaroglu S, 2012, J CONFLICT RESOLUT, V56, P879, DOI 10.1177/0022002712445741; Regan PM, 2002, J CONFLICT RESOLUT, V46, P55, DOI 10.1177/0022002702046001004; Slantchev BL, 2004, AM J POLIT SCI, V48, P813; Boehmke FJ, 2006, AM J POLIT SCI, V50, P192, DOI 10.1111/j.1540-5907.2006.00178.x; Cunningham DE, 2009, J CONFLICT RESOLUT, V53, P570, DOI 10.1177/0022002709336458; Carpenter D, 2012, AM J POLIT SCI, V56, P98, DOI 10.1111/j.1540-5907.2011.00544.x; Balch-Lindsay D, 2008, J PEACE RES, V45, P345, DOI 10.1177/0022343308088815; Fearon JD, 2004, J PEACE RES, V41, P275, DOI 10.1177/0022343304043770; DeRouen KR, 2004, J PEACE RES, V41, P303, DOI 10.1177/0022343304043771; Mason TD, 1999, POLIT RES QUART, V52, P239, DOI 10.2307/449218; Bennett Scott D., 1998, J CONFLICT RESOLUT, V42, P344, DOI 10.1177/0022002798042003007; Boehmke FJ, 2006, POLIT ANAL, V14, P421, DOI 10.1093/pan/mpj014; Box-Steffensmeier Janet M., 2004, EVENT HIST MODELING; Box-Steffensmeier JM, 2006, STAT MED, V25, P3518, DOI 10.1002/sim.2434; Brandt P, 2008, DEFENCE PEACE ECON, V19, P415, DOI 10.1080/10242690701823267; CARD D, 1995, J LABOR ECON, V13, P32, DOI 10.1086/298367; Chiba D., 2015, POLITICAL S IN PRESS; Falco-Gimeno A, 2012, BRIT J POLIT SCI, V42, P393, DOI 10.1017/S0007123411000366; Fukumoto K, 2009, AM J POLIT SCI, V53, P740; Gibler D. M., 2012, J CONFLICT RESOLUT, V57, P258; Gordon SC, 2002, AM J POLIT SCI, V46, P200, DOI 10.2307/3088423; Hougaard P., 2000, ANAL MULTIVARIATE SU; Huang XL, 2008, BIOMETRICS, V64, P1090, DOI 10.1111/j.1541-0420.2008.00986.x; Jenke E., 2012, WORKING PAPER; Kachi A., 2013, MIDW POL SCI ASS ANN; Mason TD, 1996, J CONFLICT RESOLUT, V40, P546, DOI 10.1177/0022002796040004002; Moore M, 2012, INT INTERACT, V38, P325, DOI 10.1080/03050629.2012.676511; Nelsen R.B., 2006, INTRO COPULAS; Quiroz Flores A., 2008, WORKING PAPER; R Development Core Team, 2010, R LANG ENV STAT COMP; Smith A., 2004, ELECTION TIMING; Therneau TM, 2000, MODELING SURVIVAL DA; Thyne Clayton L., 2009, INT RELATIONS AFFECT; TRIVEDI P. K., 2007, COPULA MODELING INTR	35	0	0	AMER STATISTICAL ASSOC	ALEXANDRIA	732 N WASHINGTON ST, ALEXANDRIA, VA 22314-1943 USA	0162-1459	1537-274X		J AM STAT ASSOC	J. Am. Stat. Assoc.	MAR	2015	110	509					83	92		10.1080/01621459.2014.979994		10	Statistics & Probability	Mathematics	CG7HS	WOS:000353474200008		
J	Inaba, M; Daimon, H				Inaba, Minoru; Daimon, Hideo			Development of Highly Active and Durable Platinum Core-shell Catalysts for Polymer Electrolyte Fuel Cells	JOURNAL OF THE JAPAN PETROLEUM INSTITUTE			English	Review						Polymer electrolyte fuel cell; Platinum; Gold; Palladium; Core-shell catalyst; Oxygen reduction reaction	OXYGEN REDUCTION; MONOLAYER ELECTROCATALYSTS; ALLOY SURFACES; NANOPARTICLES; STABILITY; METAL; FE; NI	Polymer electrolyte fuel cells (PEFCs) are clean and highly efficient energy sources without emission of global warming CO2 gas, and have been developed as electric power sources in fuel cell vehicles (FCVs). One of the most important issues in the development of PEFCs is currently a drastic reduction of Pt usage by an improvement in the activity for oxygen reduction reaction at the Pt cathode catalyst. To improve the activity of the Pt catalyst, we have so far developed core-shell catalysts using Pt monolayer shell covered on Au or Pd core materials. In this review article, a novel preparation method for Pt monolayer formation on non-Pt core nanoparticles that is suitable for mass production of the core-shell catalysts, and the results on the activity and durability of the resulting core-shell catalysts are overviewed. The potentials and difficulties of the core-shell catalysts for use in practical FCVs are discussed.	[Inaba, Minoru] Doshisha Univ, Dept Mol Chem & Biochem, Kyotanabe, Kyoto 6100321, Japan; [Daimon, Hideo] Doshisha Univ, Adv Res & Educ, Kyotanabe, Kyoto 6100321, Japan	Inaba, M (reprint author), Doshisha Univ, Dept Mol Chem & Biochem, 1-3 Tatara Miyakodani, Kyotanabe, Kyoto 6100321, Japan.	minaba@mail.doshisha.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan	This work has been supported by New Energy and Industrial Technology Development Organization (NEDO), Japan. We acknowledge Prof. Hiroshi Jinnai of Kyusyu University and Dr. Yuji Ohtsuka of Toray Research Center for TEM-EDX analysis of the core-shell catalysts.	Zhang JL, 2005, ANGEW CHEM INT EDIT, V44, P2132, DOI 10.1002/anie.200462335; Sasaki K, 2010, ELECTROCHIM ACTA, V55, P2645, DOI 10.1016/j.electacta.2009.11.106; Wanjala BN, 2011, J MATER CHEM, V21, P4012, DOI 10.1039/c0jm02682d; Borup R, 2007, CHEM REV, V107, P3904, DOI 10.1021/cr050182l; Stamenkovic V, 2002, J PHYS CHEM B, V106, P11970, DOI 10.1021/jp021182h; Shao MH, 2011, NANO LETT, V11, P3714, DOI 10.1021/nl2017459; Gan L, 2013, NANO LETT, V13, P1131, DOI 10.1021/nl304488q; Zhang J, 2004, J PHYS CHEM B, V108, P10955, DOI 10.1021/jp0379953; Xiao S, 2006, EUR PHYS J B, V54, P479, DOI 10.1140/epjb/e2007-00018-6; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Brankovic SR, 2001, SURF SCI, V474, pL173, DOI 10.1016/S0039-6028(00)01103-1; Toda T, 1999, J ELECTROCHEM SOC, V146, P3750, DOI 10.1149/1.1392544; Shao MH, 2011, J PHYS CHEM LETT, V2, P67, DOI 10.1021/jz1015789; GAUTHIER Y, 1992, SURF SCI, V276, P1, DOI 10.1016/0039-6028(92)90689-4; [Anonymous], 2011, FUEL CELL COMM C JAP, P7; Daimon H., 2013, 224 M EL SOC SAN FRA; Daimon H., 2014, SHOKUBAI CATALYSTS C, V56, P161; Daimon H., 2012, SHOKUBAI, V54, P190; de Boer F. R, 1999, COHESION METALS TRAN; Ikehata Y., 2013, 224 M EL SOC SAN FRA; Inaba M., 2013, ELECTROCHEMISTRY, V81, P641; Inaba M., 2012, ECS T, V50, P65; Maki E., 2012, 222 M EL SOC HON OCT; Nishikawa T., 2013, 224 M EL SOC SAN FRA; Wang X., 2011, 220 M EL SOC BOST OC	25	0	0	JAPAN PETROLEUM INST	TOKYO	YOYU-KANDA BLDG. 4F, 1-8-4 KANDASUDA-CHO, CHIYODA-KU, TOKYO, 108-0041, JAPAN	1346-8804			J JPN PETROL INST	J. Jpn. Pet. Inst	MAR	2015	58	2					55	63		10.1627/jpi.58.55		9	Energy & Fuels; Engineering, Petroleum	Energy & Fuels; Engineering	CG5WX	WOS:000353367700001		
J	Takeguchi, T				Takeguchi, Tatsuya			CO Tolerant Anode Catalyst for Residential Fuel Cell System	JOURNAL OF THE JAPAN PETROLEUM INSTITUTE			Japanese	Review						Polymer electrolyte fuel cell; Residential fuel cell; Platinum ruthenium catalyst; Bifunctional mechanism; Platinum ruthenium bonding; Carbon monoxide tolerance	RUTHENIUM AD-ATOMS; ELECTROCHEMICAL OXIDATION; SUPPORTED PLATINUM; CARBON-MONOXIDE; ELECTROCATALYSTS; METHANOL; SURFACE; SNO2; ELECTROOXIDATION; ENHANCEMENT	From the viewpoint of environmental protection, residential fuel cell systems are expected to be widely used. Pt-Ru/C catalyst is usually used as anode catalyst for fuel cell, CO strongly adsorbed on Pt is removed by oxidation to CO2. Since CO adsorbed on Pt reacts with OH adsorbed on Ru, Pt-Ru bonding on the surface of Pt-Ru particle is active site for CO oxidation via bifunctional mechanism or water-gas shift reaction. Enthalpy of homo bonding such as Pt-Pt or Ru-Ru is lower than that of Pt-Ru. Pt and Ru atoms are randomly distributed and number of Pt-Ru bonding is theoretically maximum for the Pt-Ru catalyst prepared by rapid quenching method. Hydrogen oxidation reaction effectively proceeds even in the presence of high concentration of CO.	Iwate Univ, Fac Engn, Morioka, Iwate 0208551, Japan	Takeguchi, T (reprint author), Iwate Univ, Fac Engn, 4-3-5 Ueda, Morioka, Iwate 0208551, Japan.	takeguch@iwate-u.ac.jp					Shim J, 2001, J POWER SOURCES, V102, P172, DOI 10.1016/S0378-7753(01)00817-5; Stamenkovic VR, 2003, J AM CHEM SOC, V125, P2736, DOI 10.1021/ja028771l; WATANABE M, 1975, J ELECTROANAL CHEM, V60, P275, DOI 10.1016/0368-1874(75)87031-6; Mukerjee S, 2004, J ELECTROCHEM SOC, V151, pA1094, DOI 10.1149/1.1759363; Scott FJ, 2010, J PHYS CHEM C, V114, P442, DOI 10.1021/jp908582r; Yamazaki S, 2006, ANGEW CHEM INT EDIT, V45, P3120, DOI 10.1002/anie.200504379; Igarashi H, 2001, PHYS CHEM CHEM PHYS, V3, P306, DOI 10.1039/b007768m; Takeguchi T, 2007, J ELECTROCHEM SOC, V154, pB1132, DOI 10.1149/1.2775161; Watanabe M, 2000, J PHYS CHEM B, V104, P1762, DOI 10.1021/jp993001q; Takeguchi T, 2012, J AM CHEM SOC, V134, P14508, DOI 10.1021/ja304939q; WATANABE M, 1975, J ELECTROANAL CHEM, V60, P267, DOI 10.1016/S0022-0728(75)80261-0; Matsui T, 2006, J POWER SOURCES, V155, P152, DOI 10.1016/j.jpowsour.2005.05.003; Bian CR, 2002, J PHYS CHEM B, V106, P8587, DOI 10.1021/jp0204861; GASTEIGER HA, 1995, J PHYS CHEM-US, V99, P8945, DOI 10.1021/j100022a002; Ioroi T, 2003, J ELECTROCHEM SOC, V150, pA1225, DOI 10.1149/1.1598211; Oh J, 2010, J PHYS CHEM LETT, V1, P463, DOI 10.1021/jz900158y; Okanishi T, 2006, APPL CATAL A-GEN, V298, P181, DOI 10.1016/j.apcata.2005.09.035; Ueda A, 2003, CATAL TODAY, V84, P223, DOI 10.1016/S0920-5861(03)00277-3; Wang GX, 2009, J ELECTROCHEM SOC, V156, pB862, DOI 10.1149/1.3133249; Yamanaka T, 2010, J POWER SOURCES, V195, P6398, DOI 10.1016/j.jpowsour.2010.04.007	20	0	0	JAPAN PETROLEUM INST	TOKYO	YOYU-KANDA BLDG. 4F, 1-8-4 KANDASUDA-CHO, CHIYODA-KU, TOKYO, 108-0041, JAPAN	1346-8804			J JPN PETROL INST	J. Jpn. Pet. Inst	MAR	2015	58	2					64	70		10.1627/jpi.58.64		7	Energy & Fuels; Engineering, Petroleum	Energy & Fuels; Engineering	CG5WX	WOS:000353367700002		
J	Ishihara, T				Ishihara, Tatsumi			Low Temperature Solid Oxide Fuel Cells Using LaGaO3-based Oxide Electrolyte on Metal Support	JOURNAL OF THE JAPAN PETROLEUM INSTITUTE			English	Review						Low temperature SOFC; Lanthanum gallate; Thin film; Nickel-iron porous metal; Oxide anode; Direct hydrocarbon SOFC	ION CONDUCTOR; DOPED LAGAO3; DIFFUSION; MAGNESIUM; STRONTIUM; ANODES; SR	Solid oxide fuel cells (SOFCs) can directly convert the chemical energy of various fuels to electric power with unmatched energy conversion efficiency. The oxide ion conductivity of LaGaO3 doped with Sr and Mg (LSGM) is introduced and application of LSGM to low temperature SOFCs is explained. Power density at lower temperature was dramatically increased by application of LSGM film manufactured with laser ablation techniques. By application of a suitable buffer layer, the cell using LSGM thin film electrolyte had reasonable power density (0.2W cm(-2)) at 773 K. Ce0.6Mn0.3Fe0.1O2(CMF) oxide had high activity for the anodic reaction and insertion of a CMF layer much improved the maximum power density (0.17W cm(-2) at 673 K). Oxide anode consisting of Ce06Mn0.3Fe0.1O2(CMF)-La0.6Sr0.4Fe0.9Mn0.1O3 (LSFM) (= 12.5 : 87.5 wt%) enabled the use of dry hydrocarbon for fuel with almost no coke deposition.	Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Dept Appl Chem, Fac Engn,Nishi Ku, Fukuoka 8190395, Japan	Ishihara, T (reprint author), Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Dept Appl Chem, Fac Engn,Nishi Ku, Motooka 744, Fukuoka 8190395, Japan.	ishihara@cstf.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24226016]	Part of this study was financially supported by a Grant-in-Aid for Scientific Research (S) (No. 24226016) from the Ministry of Education, Culture, Sports, Science and Technology.	Tao SW, 2004, CHEM REC, V4, P83, DOI 10.1002/tcr.20003; Huang PN, 1996, J ELECTROCHEM SOC, V143, P1644, DOI 10.1149/1.1836692; Huang KQ, 1998, J AM CERAM SOC, V81, P2565; Kim G, 2009, ELECTROCHEM SOLID ST, V12, pB48, DOI 10.1149/1.3065971; ISHIHARA T, 1995, SOLID STATE IONICS, V79, P147, DOI 10.1016/0167-2738(95)00054-A; Huang KQ, 2000, J ALLOY COMPD, V303, P454, DOI 10.1016/S0925-8388(00)00626-5; Tao SW, 2003, NAT MATER, V2, P320, DOI 10.1038/nmat871; [Anonymous], 2004, FUEL CELL HDB; FENG M, 1994, EUR J SOL STATE INOR, V31, P663; Islam MS, 1996, J SOLID STATE CHEM, V124, P230, DOI 10.1006/jssc.1996.0231; MINH NQ, 1993, J AM CERAM SOC, V76, P563, DOI 10.1111/j.1151-2916.1993.tb03645.x; Shin TH, 2011, J AM CHEM SOC, V133, P19399, DOI 10.1021/ja206278f; Chueh WC, 2012, NAT MATER, V11, P155, DOI [10.1038/nmat3184, 10.1038/NMAT3184]; Brett DJL, 2008, CHEM SOC REV, V37, P1568, DOI 10.1039/b612060c; Ishihara T, 1997, J AM CHEM SOC, V119, P2747, DOI 10.1021/ja964128l; Wachsman ED, 2011, SCIENCE, V334, P935, DOI 10.1126/science.1204090; Cozzolino R, 2011, INT J HYDROGEN ENERG, V36, P8030, DOI 10.1016/j.ijhydene.2011.01.052; Ishihara T., 2013, MATER HIGH TEMP, P97; Ishihara T, 2009, FUEL CELL HYDRO ENER, P1, DOI 10.1007/978-0-387-77708-5; Ju YW, 2010, ELECTROCHEM SOLID ST, V13, pB139, DOI 10.1149/1.3494029; Majewski P, 2001, J ALLOY COMPD, V329, P253, DOI 10.1016/S0925-8388(01)01583-3; ROSTRUPN.JR, 1974, J CATAL, V33, P184, DOI 10.1016/0021-9517(74)90263-2; Singhal S.C., 2003, HIGH TEMPERATURE SOL; U. S. Energy flow, 2012, EN US; Yan JW, 2005, ELECTROCHEM SOLID ST, V8, pA389, DOI 10.1149/1.1943568	25	0	0	JAPAN PETROLEUM INST	TOKYO	YOYU-KANDA BLDG. 4F, 1-8-4 KANDASUDA-CHO, CHIYODA-KU, TOKYO, 108-0041, JAPAN	1346-8804			J JPN PETROL INST	J. Jpn. Pet. Inst	MAR	2015	58	2					71	78		10.1627/jpi.58.71		8	Energy & Fuels; Engineering, Petroleum	Energy & Fuels; Engineering	CG5WX	WOS:000353367700003		
J	Eguchi, K				Eguchi, Koichi			Performance and Degradation of Ni-based Cermet Anode for Solid Oxide Fuel Cells	JOURNAL OF THE JAPAN PETROLEUM INSTITUTE			English	Review						Solid oxide fuel cell; Ni-YSZ cermet; Internal reforming; Carbon deposition; Microstructure; Degradation	CARBON DEPOSITION; SUBSEQUENT DETERIORATION; POWER-GENERATION; ELECTRODE; SOFCS	Solid oxide fuel cells (SOFCs) have high conversion efficiency and excellent fuel flexibility for various fuels. The possibility of internal reforming of methane and other hydrocarbons for power generation has been investigated. Fuel flexibility is important for high conversion efficiency and simplified generation systems. Carbon deposition may cause deterioration. Deposition of carbon was effectively avoided by steam and CO2 formed by power generation. Another approach to avoid carbon deposition is to design catalysts less active for carbon formation. The deposition rates were significantly affected by types of metal and oxide in the cermet material and were related to the ionic/electronic conductivities of oxides and dissolution of carbon in the metal species. Extensive dilution of hydrocarbon fuel with water may lead to extremely high water concentrations in the downstream region of the fuel cell under discharge condition. High water content damages the Ni surface and catalytic activity by strong adsorption of water. Reconstruction and analyses of three-dimensional microstructures by focused ion beam-scanning electron microscopy were effective to clarify the degradation of the fuel electrode.	Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Eguchi, K (reprint author), Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	eguchi@scl.kyoto-u.ac.jp					Eguchi K, 2002, SOLID STATE IONICS, V152, P411, DOI 10.1016/S0167-2738(02)00351-X; [Anonymous], P 1 12 INT S SOL OX; Gorte RJ, 2002, J POWER SOURCES, V106, P10, DOI 10.1016/S0378-7753(01)01021-7; Iwai H, 2010, J POWER SOURCES, V195, P955, DOI 10.1016/j.jpowsour.2009.09.005; Sumi H, 2011, J POWER SOURCES, V196, P4451, DOI 10.1016/j.jpowsour.2011.01.061; [Anonymous], 2014, EXT ABSTR S SOFC JAP; Eguchi K, 2009, CATAL TODAY, V146, P154, DOI 10.1016/j.cattod.2009.01.033; Iida T, 2007, J ELECTROCHEM SOC, V154, pB234, DOI 10.1149/1.2405837; Kikuchi R, 2004, J JPN PETROL INST, V47, P225, DOI 10.1627/jpi.47.225; Matsui T, 2010, J ELECTROCHEM SOC, V157, pB776, DOI 10.1149/1.3336830; Matsui T, 2008, J ELECTROCHEM SOC, V155, pB1136, DOI 10.1149/1.2975337; Matsui T, 2007, ECS TRANSACTIONS, V7, P1437, DOI 10.1149/1.2729248	12	0	0	JAPAN PETROLEUM INST	TOKYO	YOYU-KANDA BLDG. 4F, 1-8-4 KANDASUDA-CHO, CHIYODA-KU, TOKYO, 108-0041, JAPAN	1346-8804			J JPN PETROL INST	J. Jpn. Pet. Inst	MAR	2015	58	2					79	85		10.1627/jpi.58.79		7	Energy & Fuels; Engineering, Petroleum	Energy & Fuels; Engineering	CG5WX	WOS:000353367700004		
J	Higo, T; Hashimoto, T; Mukai, D; Nagatake, S; Ogo, S; Sugiura, Y; Sekine, Y				Higo, Takuma; Hashimoto, Takashi; Mukai, Daiki; Nagatake, Satoshi; Ogo, Shuhei; Sugiura, Yukihiro; Sekine, Yasushi			Effect of Hydrocarbon Structure on Steam Reforming over Ni/perovskite Catalyst	JOURNAL OF THE JAPAN PETROLEUM INSTITUTE			English	Article						Hydrocarbon steam reforming; Nickel catalyst; Hydrogen production; Adsorption state; SSITKA	NICKEL-CATALYSTS; NI/LA0.7SR0.3ALO3-DELTA CATALYST; HYDROGEN-PRODUCTION; CARBON DEPOSITION; NI CATALYSTS; TOLUENE; MECHANISM; METHANE; COKING; OXYGEN	Ni/perovskite-type oxide catalyst (Ni/La0.7Sr0.3AlO2.85: LSAO) shows high catalytic activity and low carbon formation during the steam reforming of aromatic hydrocarbons because of the high mobility of lattice oxygen in the support. The reaction mechanisms of the catalyst were investigated by characterizations and catalytic activity tests for steam reforming of various hydrocarbons including toluene, methylcyclohexane, and n-heptane. The catalytic performance was affected by the reactant structure, as revealed by Arrhenius plots and FT-IR analyses. Adsorption state and stability of reaction intermediates were very important factors in the catalytic activity for steam reforming.	[Higo, Takuma; Hashimoto, Takashi; Mukai, Daiki; Nagatake, Satoshi; Ogo, Shuhei; Sugiura, Yukihiro; Sekine, Yasushi] Waseda Univ, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan; [Sugiura, Yukihiro] JX Nippon Oil & Energy Corp, Cent Tech Res Lab, Naka Ku, Yokohama, Kanagawa 2310815, Japan	Sekine, Y (reprint author), Waseda Univ, Dept Appl Chem, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	ysekine@waseda.jp	Ogo, shuhei/E-8589-2011				Mukai D, 2013, APPL CATAL A-GEN, V453, P60, DOI 10.1016/j.apcata.2012.11.040; Trimm DL, 1997, CATAL TODAY, V37, P233, DOI 10.1016/S0920-5861(97)00014-X; Mukai D, 2013, APPL CATAL A-GEN, V466, P190, DOI 10.1016/j.apcata.2013.06.052; Takeguchi T, 2002, J POWER SOURCES, V112, P588, DOI 10.1016/S0378-7753(02)00471-8; Lamacz A, 2011, CATAL TODAY, V176, P347, DOI 10.1016/j.cattod.2010.11.067; Gould BD, 2007, J CATAL, V250, P209, DOI 10.1016/j.jcat.2007.06.020; Urasaki K, 2005, APPL CATAL A-GEN, V286, P23, DOI 10.1016/j.apcata.2005.02.020; Kalamaras CM, 2011, J CATAL, V279, P287, DOI 10.1016/j.jcat.2011.01.024; Li BT, 2007, J CATAL, V245, P144, DOI 10.1016/j.jcat.2006.10.004; Wang LS, 2004, APPL CATAL A-GEN, V257, P43, DOI 10.1016/S0926-860X(03)00590-8; BARTHOLOMEW CH, 1982, CATAL REV, V24, P67, DOI 10.1080/03602458208079650; Sekine Y, 2013, APPL CATAL A-GEN, V451, P160, DOI 10.1016/j.apcata.2012.11.005; Borowiecki T, 2004, APPL CATAL A-GEN, V270, P27, DOI 10.1016/j.apcata.2004.03.044; BOROWIECKI T, 1994, CATAL LETT, V25, P309, DOI 10.1007/BF00816310; Buffoni IN, 2009, CATAL COMMUN, V10, P1656, DOI 10.1016/j.catcom.2009.05.003; DUPREZ D, 1992, APPL CATAL A-GEN, V82, P111, DOI 10.1016/0926-860X(92)85001-R; Mukai D, 2014, APPL CATAL A-GEN, V471, P157, DOI 10.1016/j.apcata.2013.11.032; Polychronopoulou K, 2006, CATAL TODAY, V112, P89, DOI 10.1016/j.cattod.2005.11.037; ROSTRUPN.JR, 1973, J CATAL, V31, P173, DOI 10.1016/0021-9517(73)90326-6; ROSTRUPN.JR, 1974, J CATAL, V33, P184, DOI 10.1016/0021-9517(74)90263-2; Sugiura Y, 2013, INT J HYDROGEN ENERG, V38, P7822, DOI 10.1016/j.ijhydene.2013.04.095; Xie C, 2011, APPL CATAL A-GEN, V394, P32, DOI 10.1016/j.apcata.2010.12.019; Zhuang Q., 1991, APPL CATAL, V70, P1, DOI 10.1016/S0166-9834(00)84149-4	23	0	0	JAPAN PETROLEUM INST	TOKYO	YOYU-KANDA BLDG. 4F, 1-8-4 KANDASUDA-CHO, CHIYODA-KU, TOKYO, 108-0041, JAPAN	1346-8804			J JPN PETROL INST	J. Jpn. Pet. Inst	MAR	2015	58	2					86	96		10.1627/jpi.58.86		11	Energy & Fuels; Engineering, Petroleum	Energy & Fuels; Engineering	CG5WX	WOS:000353367700005		
J	Ishihara, A; Tanaka, S; Aiba, M; Hashimoto, T; Nasu, H				Ishihara, Atsushi; Tanaka, Shohei; Aiba, Mina; Hashimoto, Tadanori; Nasu, Hiroyuki			Preparation of Alumina-supported Cobalt-molybdenum Catalysts by Sol-gel Method and Hydrodesulfurization Activities	JOURNAL OF THE JAPAN PETROLEUM INSTITUTE			English	Article						Hydrodesulfurization; Dibenzothiophene; Alumina support; Cobalt-molybdenum catalyst; Sol-gel method	RADIOISOTOPE TRACER METHOD; RHODIUM CARBONYL-COMPLEX; SURFACE-AREA TIO2; SULFUR BEHAVIOR; SULFIDATION STATE; HYDROGENATION; DIBENZOTHIOPHENE; COMO; DBT; H2S	Al2O3-supported Co and Mo catalysts were prepared by the sol-gel method, in which Co and/or Mo species were added at the hydrolysis of Al tri-s-butoxide. XRD patterns, N-2 adsorption and desorption, amounts of NO adsorption and NO species by FT-IR were measured to characterize the catalysts. Catalysts with active components Co and Mo separately supported by the sol-gel method had higher activity for hydrodesulfurization of dibenzothiophene. Mo-Co/Al2O3-supported, in which Mo species was supported on Co/Al2O3-supported by the sol-gel method, showed the highest activities at lower temperature, indicating that the Co species was effectively dispersed on Al2O3-supported during the preparation of Co/Al2O3-supported. Catalysts in which Co and Mo species were simultaneously supported had lower activity, indicating that both Co and Mo species were dispersed and reduced interaction between Co and Mo. Co-Mo/sol-gelAl(2)O(3)-supported, with the Co species supported on Mo/sol-gelAl(2)O(3)-supported, showed the highest activity among sol-gelAl(2)O(3)-supported supported CoMo catalysts, indicating that the Mo species was effectively dispersed during the preparation of Mo/sol-gelAl(2)O(3)-supported. Biphenyl was selectively obtained. NO adsorption measurement showed that the amount of NO adsorbed was almost same for Mo-Co/Al2O3-supported sulfided once or twice. hi contrast, sol-gel CoMo/Al2O3-supported, with the Co and Mo added simultaneously by the sol-gel method, showed significant decrease in NO adsorption after second sulfiding, which would be related to the lower stability of sol-gelCoMo/Al2O3-supported prepared by the sol-gel method. Al2O3-supported-supported Co-Mo catalysts prepared using the sol-gel method had relatively high surface areas (282-544 m(2)/g) and relatively smaller pore sizes (3.7-6.3 nm).	[Ishihara, Atsushi; Tanaka, Shohei; Aiba, Mina; Hashimoto, Tadanori; Nasu, Hiroyuki] Mie Univ, Grad Sch Engn, Tsu, Mie 5148507, Japan	Ishihara, A (reprint author), Mie Univ, Grad Sch Engn, 1577 Kurima Machiya Cho, Tsu, Mie 5148507, Japan.	ishihara@chem.mie-u.ac.jp	Ishihara, Atsushi/N-9481-2015; HASHIMOTO, Tadanori/J-3909-2013	Ishihara, Atsushi/0000-0002-6390-8898; HASHIMOTO, Tadanori/0000-0003-2887-7536			Pawelec B, 2001, APPL CATAL A-GEN, V206, P295, DOI 10.1016/S0926-860X(00)00605-0; OKAMOTO Y, 1989, J CATAL, V120, P29, DOI 10.1016/0021-9517(89)90248-0; PECORARO TA, 1981, J CATAL, V67, P430, DOI 10.1016/0021-9517(81)90303-1; Ferdous D, 2004, APPL CATAL A-GEN, V260, P153, DOI 10.1016/j.apcata.2003.10.009; Yoshinaka S, 1998, CATAL TODAY, V45, P293, DOI 10.1016/S0920-5861(98)00232-6; Vissenberg MJ, 2001, J CATAL, V198, P151, DOI 10.1006/jcat.2000.3132; Ishihara A, 2005, APPL CATAL A-GEN, V289, P163, DOI 10.1016/j.apcata.2005.04.056; Kwak C, 2000, APPL CATAL A-GEN, V200, P233, DOI 10.1016/S0926-860X(00)00635-9; Ishihara A, 2008, J JPN PETROL INST, V51, P73, DOI 10.1627/jpi.51.73; Bautista FM, 1998, APPL CATAL A-GEN, V170, P159, DOI 10.1016/S0926-860X(98)00046-5; Dumeignil F, 2003, APPL CATAL A-GEN, V249, P255, DOI 10.1016/S0926-860X(03)00307-7; Fujikawa T, 2001, APPL CATAL A-GEN, V205, P71, DOI 10.1016/S0926-860X(00)00552-4; Ishihara A., 1996, SEKIYU GAKKAISHI, V39, P26; ISHIHARA A, 1994, J CATAL, V150, P212, DOI 10.1006/jcat.1994.1337; Ishihara A, 2005, APPL CATAL A-GEN, V292, P50, DOI 10.1016/j.apcata.2005.04.041; Ishihara A, 2005, J JPN PETROL INST, V48, P37, DOI 10.1627/jpi.48.37; Ishihara A, 2003, J CATAL, V217, P59, DOI 10.1016/S0021-9517(03)00031-9; Ishihara A, 2004, J CATAL, V224, P243, DOI 10.1016/j.jcat.2004.02.031; Kabe T., 1999, HYDRODESULFURIZATION; Lebihan L, 1994, J SOL-GEL SCI TECHN, V2, P837, DOI 10.1007/BF00486361; Lecrenay E, 1998, APPL CATAL B-ENVIRON, V18, P325, DOI 10.1016/S0926-3373(98)00054-X; Lee J, 2004, J MOL CATAL A-CHEM, V209, P155, DOI 10.1016/j.molcata.2003.08.020; Lee J, 2004, J MOL CATAL A-CHEM, V213, P207, DOI 10.1016/j.molcata.2003.10.046; Qian WH, 2001, PHYS CHEM CHEM PHYS, V3, P261, DOI 10.1039/b007991j; Sugioka M, 1998, CATAL TODAY, V45, P327, DOI 10.1016/S0920-5861(98)00241-7	25	0	0	JAPAN PETROLEUM INST	TOKYO	YOYU-KANDA BLDG. 4F, 1-8-4 KANDASUDA-CHO, CHIYODA-KU, TOKYO, 108-0041, JAPAN	1346-8804			J JPN PETROL INST	J. Jpn. Pet. Inst	MAR	2015	58	2					103	109				7	Energy & Fuels; Engineering, Petroleum	Energy & Fuels; Engineering	CG5WX	WOS:000353367700007		
J	Farobie, O; Matsumura, Y				Farobie, Obie; Matsumura, Yukihiko			Effectiveness of Spiral Reactor for Biodiesel Production Using Supercritical t-Butyl Methyl Ether (MTBE)	JOURNAL OF THE JAPAN PETROLEUM INSTITUTE			English	Article						Biomass; Biodiesel; MTBE; Spiral reactor; Supercritical fluid	WASTE COOKING OIL; DIMETHYL CARBONATE; THERMAL-STABILITY; RAPESEED OIL; SOYBEAN OIL; OPTIMIZATION; METHANOL; FUEL; CONVERSION; ACETATE	A new approach to non-catalytic biodiesel production under supercritical conditions of t-butyl methyl ether (MTBE) using a novel spiral reactor is proposed. Previously, canola oil was reacted with MTBE under supercritical conditions to generate fatty acid methyl esters (FAME) and glycerol t-butyl ether (GTBE). To conduct this reaction more effectively, a novel spiral reactor that could also serve as heat exchanger was employed in this study. Using a pressure of 10 MPa and an oil-to-MTBE molar ratio of 1: 40, experiments were performed at 250-400 degrees C over 6-30 mm. Complete conversion to FAME (FAME yield of 1.00 mol/mol) was rapidly achieved in 20 min at 385 degrees C. The results revealed that the spiral reactor is superior to a conventional reactor because of the improved FAME yield and thermal efficiency.	[Farobie, Obie; Matsumura, Yukihiko] Hiroshima Univ, Inst Engn, Div Energy & Environm Engn, Higashihiroshima, Hiroshima 7398527, Japan	Matsumura, Y (reprint author), Hiroshima Univ, Inst Engn, Div Energy & Environm Engn, 1-4-1 Kagamiyama, Higashihiroshima, Hiroshima 7398527, Japan.	mat@hiroshima-u.ac.jp	Matsumura, Yukihiko/D-5105-2011	Matsumura, Yukihiko/0000-0002-1341-0493	Japan Indonesia Presidential Scholarship (JIPS), the World Bank Institute	OF would like to thank Japan Indonesia Presidential Scholarship (JIPS), the World Bank Institute for supporting his study in Japan.	Imahara H, 2008, FUEL, V87, P1, DOI 10.1016/j.fuel.2007.04.003; Saka S, 2001, FUEL, V80, P225, DOI 10.1016/S0016-2361(00)00083-1; Wahidin S, 2014, ENERG CONVERS MANAGE, V84, P227, DOI 10.1016/j.enconman.2014.04.034; Kiatkittipong W, 2011, COMPUT CHEM ENG, V35, P2034, DOI 10.1016/j.compchemeng.2011.01.016; Rathore V, 2007, FUEL, V86, P2650, DOI 10.1016/j.fuel.2007.03.014; Xie WL, 2014, ENERG CONVERS MANAGE, V79, P34, DOI 10.1016/j.enconman.2013.11.041; Abd Rabu R, 2013, ENERG CONVERS MANAGE, V65, P764, DOI 10.1016/j.enconman.2012.02.031; Klepacova K, 2007, APPL CATAL A-GEN, V328, P1, DOI 10.1016/j.apcata.2007.03.031; Silva C, 2007, IND ENG CHEM RES, V46, P5304, DOI 10.1021/ie070310r; Frusteri F, 2009, APPL CATAL A-GEN, V367, P77, DOI 10.1016/j.apcata.2009.07.037; Goembira F, 2013, BIORESOURCE TECHNOL, V131, P47, DOI 10.1016/j.biortech.2012.12.130; He HY, 2007, FUEL, V86, P442, DOI 10.1016/j.fuel.2006.07.035; Demirbas A, 2011, ENERG CONVERS MANAGE, V52, P163, DOI 10.1016/j.enconman.2010.06.055; Demirbas A, 2003, ENERG CONVERS MANAGE, V44, P2093, DOI 10.1016/S0196-8904(02)00234-0; Farobie O, 2014, FUEL, V135, P172, DOI 10.1016/j.fuel.2014.06.049; Goembira F, 2012, FUEL, V97, P373, DOI 10.1016/j.fuel.2012.02.051; Ilham Z, 2012, FUEL, V97, P670, DOI 10.1016/j.fuel.2012.02.066; Ilham Z, 2009, BIORESOURCE TECHNOL, V100, P1793, DOI 10.1016/j.biortech.2008.09.050; Lin RH, 2013, FUEL, V106, P593, DOI 10.1016/j.fuel.2012.12.013; Niza NM, 2013, APPL ENERG, V101, P198, DOI [10.1016/j.apenergy.2012.03.033, 10.1016/j.apenergs.2012.03.033]; Patle DS, 2014, ENERG CONVERS MANAGE, V85, P361, DOI 10.1016/j.enconman.2014.05.034; Sasanami K., 2014, 1 AS C BIOM SCI ACBS, pP19; Tashtoush GM, 2004, ENERG CONVERS MANAGE, V45, P2697, DOI 10.1016/j.enconman.2003.12.009	23	2	2	JAPAN PETROLEUM INST	TOKYO	YOYU-KANDA BLDG. 4F, 1-8-4 KANDASUDA-CHO, CHIYODA-KU, TOKYO, 108-0041, JAPAN	1346-8804			J JPN PETROL INST	J. Jpn. Pet. Inst	MAR	2015	58	2					110	117		10.1627/jpi.58.110		8	Energy & Fuels; Engineering, Petroleum	Energy & Fuels; Engineering	CG5WX	WOS:000353367700008		
J	Ha, JH; Wang, J; Lee, WJ; Choi, YJ; Lee, HY; Kim, JG; Harima, H				Ha, Ju-Hyung; Wang, Juan; Lee, Won-Jae; Choi, Young-Jun; Lee, Hae-Yong; Kim, Jung-Gon; Harima, Hiroshi			Effects of the group V/III ratio and a gan inter-layer on the crystal quality of InN grown by using the hydride vapor-phase epitaxy method	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Substrates; X-ray diffraction; Hydride vapor-phase epitaxy; InN	RAMAN-SCATTERING; PULSED MOVPE; BAND GAP; TEMPERATURE; FILMS; SYSTEM; METAL	The hydride vapor-phase epitaxy (HVPE) method was used to deposit high-quality InN layers on GaN inter-layer/sapphire (0001) structures that had been fabricated by using either the HVPE method or the metal-organic chemical-phase deposition (MOCVD) method. The effects of the group V/III ratio and different GaN inter-layers on the crystal quality of the InN layers were systemically investigated. The InN layer grown at a low Group V/III ratio revealed a high crystal quality with a two-dimensional (2D) growth mode. Also, the 110.7-nm-thick InN layer grown by using HVPE on a GaN inter-layer/sapphire (0001) substrate structure that had been fabricated by using MOCVD had a high crystal quality, with the full width at half maximum (FWHM) of the InN X-ray diffraction (XRD) peak being about 844 arcsec, and a smooth surface with an atomic force microscopy (AFM) roughness of about 0.07 nm. On the other hand, the 145.7-nm-thick InN layer grown by using HVPE on a GaN inter-layer/sapphire (0001) substrate structure that had been fabricated by using the HVPE method had a lower crystal quality, a FWHM value for the InN (0002) peak of about 2772 arcsec, and a surface roughness of about 3.73 nm. In addition, the peak of the E2 (high) phonon mode for the 110.7-nm-thick InN layer grown by using HVPE on a GaN inter-layer/sapphire (0001) structure that had been fabricated by using MOCVD was detected at 491 cm -1 and had a FWHM of 9.9 cm(-1). As a result, InN layers grown by using HVPE on GaN inter-layer/sapphire (0001) substrate structures fabricated by using MOCVD have a high crystal quality and a reduced Raman value, which agrees well with the results of the XRD analysis.	[Ha, Ju-Hyung; Wang, Juan; Lee, Won-Jae] Dong Eui Univ, Dept Mat & Component Engn, Elect Ceram Ctr, Busan 614714, South Korea; [Choi, Young-Jun; Lee, Hae-Yong] LumiGNtech Co Ltd, Seoul 153801, South Korea; [Kim, Jung-Gon; Harima, Hiroshi] Kyoto Inst Technol, Dept Elect, Kyoto 6068585, Japan	Ha, JH (reprint author), Dong Eui Univ, Dept Mat & Component Engn, Elect Ceram Ctr, Busan 614714, South Korea.	leewj@deu.ac.kr					Bhuiyan AG, 2003, J APPL PHYS, V94, P2779, DOI 10.1063/1.1595135; Chen WC, 2013, THIN SOLID FILMS, V529, P169, DOI 10.1016/j.tsf.2012.06.031; Mohammad SN, 1996, PROG QUANT ELECTRON, V20, P361, DOI 10.1016/S0079-6727(96)00002-X; Heying B, 1996, APPL PHYS LETT, V68, P643, DOI 10.1063/1.116495; Jamil M, 2008, J CRYST GROWTH, V310, P4947, DOI 10.1016/j.jcrysgro.2008.07.122; Lee KJ, 2004, APPL PHYS LETT, V85, P1502, DOI 10.1063/1.1784046; Matsuoka T, 2002, APPL PHYS LETT, V81, P1246, DOI 10.1063/1.1499753; Wu J, 2002, APPL PHYS LETT, V80, P3967, DOI 10.1063/1.1482786; Davydov VY, 1999, APPL PHYS LETT, V75, P3297, DOI 10.1063/1.125330; Harima H, 2002, J PHYS-CONDENS MAT, V14, pR967, DOI 10.1088/0953-8984/14/38/201; Johnson MC, 2004, J CRYST GROWTH, V272, P400, DOI 10.1016/j.jcrysgro.2004.08.057; Kikuchi J, 2006, JPN J APPL PHYS 2, V45, pL1203, DOI 10.1143/JJAP.45.L1203; Kikuchi J, 2007, PHYS STATUS SOLIDI C, V4, P2419, DOI 10.1002/pssc.200674764; Kim JG, 2012, PHYS STATUS SOLIDI B, V249, P779, DOI 10.1002/pssb.201147452; Kumagai Y, 2010, PHYS STATUS SOLIDI C, V7, DOI 10.1002/pssc.200983519; Kumagai Y, 2007, J CRYST GROWTH, V300, P57, DOI 10.1016/j.jcrysgro.2006.10.202; Lua C. J., 2003, APPL PHYS LETT, V83, P2817; Luo WK, 2012, J CRYST GROWTH, V340, P18, DOI 10.1016/j.jcrysgro.2011.11.037; Ruterana P, 2010, PHYS STATUS SOLIDI C, V7, P1301, DOI 10.1002/pssc.200983123; Singh P, 2004, SUPERLATTICE MICROST, V36, P537, DOI [10.1016/j.spmi.2004.10.002, 10.1016/j.spmi.2004.010.002]; Takahashi N, 1997, JPN J APPL PHYS 2, V36, pL743, DOI 10.1143/JJAP.36.L743; Takahashi N, 1997, J CRYST GROWTH, V172, P298, DOI 10.1016/S0022-0248(96)00751-8; Wang H, 2009, SEMICOND SCI TECH, V24, DOI 10.1088/0268-1242/24/5/055001; Wang XQ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364884; Zhou J, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-5	25	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAR	2015	66	6					994	1000		10.3938/jkps.66.994		7	Physics, Multidisciplinary	Physics	CF9IK	WOS:000352878000023		
J	Wang, T; Liu, Y; Guo, Q; Zhang, B; Sheng, K; Li, C; Yin, Y				Wang, Tao; Liu, Yan; Guo, Qing; Zhang, Bin; Sheng, Kuang; Li, Can; Yin, You			Tunable bandgap of monolayer black phosphorus by using vertical electric field: A DFT study	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Black phosphorus; Bandgap; Electric field	MOBILITY	Using a ab initio plane-wave ultrasoft pseudopotential method based on the generalized gradient approximation (GGA), we investigate the bandgap tuning in monolayer black phosphorus by applying external electric fields perpendicular to the layers. The bandgap continuously decreases with increasing applied electric fields, eventually rendering them metallic. We use the giant Stark effect, which is essentially characterized by an interlayer spacing to explain the rate of change of the bandgap with the applied external field. The atomic distance and charges also contribute to the semiconductor-to-metal transition. Our investigations show the bandgap change for the fabrication of novel electronic and photonic devices.	[Wang, Tao; Liu, Yan; Guo, Qing; Zhang, Bin; Sheng, Kuang] Zhejiang Univ, Dept Radiol, Affiliated Hosp 2, Coll Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Li, Can] China Jiliang Univ, Sch Mat Sci & Engn, Ctr Coordinat Bond Engn, Hangzhou 310018, Peoples R China; [Yin, You] Gunma Univ, Div Elect & Informat, Kiryu, Gunma 3768515, Japan	Wang, T (reprint author), Zhejiang Univ, Dept Radiol, Affiliated Hosp 2, Coll Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China.	canli1983@gmail.com; yinyou@gunma-u.ac.jp	Li, Can/I-2866-2012	Li, Can/0000-0002-0370-2695	National Natural Science Foundation of China [61176101]; Ph.D. Programs Foundation of the Ministry of Education of China [20120101120156]; Key Laboratory of Nanodevices and Applications, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences [14JG01]	The research work is supported by the National Natural Science Foundation of China (Grant No 61176101), by the Ph.D. Programs Foundation of the Ministry of Education of China (20120101120156) and by the Key Laboratory of Nanodevices and Applications, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences (14JG01).	Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Liu H, 2014, ACS NANO, V8, P4033, DOI 10.1021/nn501226z; Das S, 2014, NANO LETT, V14, P5733, DOI 10.1021/nl5025535; Du YL, 2010, J APPL PHYS, V107, DOI 10.1063/1.3386509; Khoo KH, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.201401; KEYES RW, 1953, PHYS REV, V92, P580, DOI 10.1103/PhysRev.92.580; Li LK, 2014, NAT NANOTECHNOL, V9, P372, DOI [10.1038/nnano.2014.35, 10.1038/NNANO.2014.35]; Ishigami M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056804; Maruyama Y., 1982, PHYSICA B, V105B, P99; MORITA A, 1986, APPL PHYS A-MATER, V39, P227, DOI 10.1007/BF00617267; Prytz O, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/1/015502; Qiao JS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5475; Sequal M. D., 2002, J PHYS-CONDENS MAT, V14, P2717; TAKAO Y, 1981, PHYSICA B & C, V105, P93, DOI 10.1016/0378-4363(81)90222-9; Zheng FW, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085423	15	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAR	2015	66	6					1031	1034		10.3938/jkps.66.1031		4	Physics, Multidisciplinary	Physics	CF9IK	WOS:000352878000029		
J	Mizumori, Y; Mochiduki, Y; Nakahara, Y; Kawamura, T; Sasaki, S; Morimoto, A; Tsukamoto, H				Mizumori, Yasuyuki; Mochiduki, Yoshiro; Nakahara, Yasuharu; Kawamura, Tetsuji; Sasaki, Shin; Morimoto, Akie; Tsukamoto, Hiroaki			Effects of bronchoscopic lung volume reduction using transbronchial infusion of autologous blood and thrombin in patients with severe chronic obstructive pulmonary disease	JOURNAL OF THORACIC DISEASE			English	Article						Bronchoscopy; lung volume reduction; chronic obstructive pulmonary disease (COPD); emphysema; respiratory function tests	COLLATERAL VENTILATION; SEVERE EMPHYSEMA; AIRWAY BYPASS; SURGERY; THERAPY; TRIAL; HYPERINFLATION; FEASIBILITY; INJECTION; IMPROVES	Background: Existing medical treatments have limitations in the management of very severe chronic obstructive pulmonary disease (COPD). Methods: We performed bronchoscopic lung volume reduction (BLVR) using transbronchial infusion of autologous blood and thrombin (BLVR with blood) in three patients with very severe COPD whose dyspnea could not be relieved by maximum medical management. Two patients underwent BLVR with blood in the left and right lungs at intervals of a half-year or a year, and one patient underwent this procedure in only the right lung. We assessed the changes in pulmonary function, exercise capacity and quality of life before and after BLVR with blood in a total of five procedures. Results: The subjects were 58- to 74-year-old males. Their forced expiratory volume in one second (FEV1) percent predicted ranged from 14.8% to 23.4%. BLVR with blood achieved significant improvements as follows (values before -> after the procedure, mean +/- standard deviation): FEV1 0.45r the L -> 0.76r the L (P=0.004), inspiratory capacity 1.50cityo L -> 2.05 +/-.05c L (P=0.015), 3-minute walk test 46.8nuteo m -> 89.6 +/- 34.5 m (P=0.004). Lung function peaked several months after BLVR with blood and returned to nearly the baseline level in 6 months, but exercise capacity was better than that at baseline for at least 12 months. St. George's Respiratory Questionnaire (SGRQ), measured in two patients before and 12 months after the procedure, showed remarkable improvements (-15.6 and -11.9 units). Conclusions: BLVR with blood is an effective palliative treatment for very severe COPD.	[Mizumori, Yasuyuki; Mochiduki, Yoshiro; Nakahara, Yasuharu; Kawamura, Tetsuji; Sasaki, Shin; Morimoto, Akie; Tsukamoto, Hiroaki] Natl Hosp Org Himeji Med Ctr, Dept Resp Med, Himeji, Hyogo, Japan	Mizumori, Y (reprint author), 68 Honmachi, Himeji, Hyogo 6708520, Japan.	yamizumori@hmj-net.hosp.go.jp					Cardoso PFG, 2007, J THORAC CARDIOV SUR, V134, P974, DOI 10.1016/j.jtcvs.2007.05.040; Wood DE, 2007, J THORAC CARDIOV SUR, V133, P65, DOI 10.1016/j.jtcvs.2006.06.051; Shah PL, 2013, LANCET RESP MED, V1, P233, DOI 10.1016/S2213-2600(13)70047-X; Sterman DH, 2010, RESPIRATION, V79, P222, DOI 10.1159/000259318; Refaely Y, 2010, EUR RESPIR J, V36, P20, DOI 10.1183/09031936.00106009; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Wan IYP, 2006, CHEST, V129, P518, DOI 10.1378/chest.129.3.518; Slebos DJ, 2012, CHEST, V142, P574, DOI 10.1378/chest.11-07-30; Gompelmann D, 2010, RESPIRATION, V80, P419, DOI 10.1159/000319441; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Herth FJF, 2011, RESPIRATION, V82, P36, DOI 10.1159/000322649; Hopkinson NS, 2005, AM J RESP CRIT CARE, V171, P453, DOI 10.1164/rccm.200407-961OC; Criner GJ, 2009, AM J RESP CRIT CARE, V179, P791, DOI 10.1164/rccm.200810-1639OC; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321; Aljuri N, 2009, J APPL PHYSIOL, V106, P774, DOI 10.1152/japplphysiol.91075.2008; Snell GI, 2009, ANN THORAC SURG, V88, P1993, DOI 10.1016/j.athoracsur.2009.06.038; Choong CK, 2008, AM J RESP CRIT CARE, V178, P902, DOI 10.1164/rccm.200712-1832OC; Ninane V, 2012, EUR RESPIR J, V39, P1319, DOI 10.1183/09031936.00019711; Cetti EJ, 2006, THORAX, V61, P371, DOI 10.1136/thx.2006.060509; Flaherty KR, 2001, CHEST, V119, P1337, DOI 10.1378/chest.119.5.1337; Gompelmann D, 2013, RESPIRATION, V86, P324, DOI 10.1159/000354175; Herth Felix J F, 2010, Ther Adv Respir Dis, V4, P225, DOI 10.1177/1753465810368553; Ingenito EP, 2003, AM J RESP CRIT CARE, V167, P771, DOI 10.1164/rccm.200208-842OC; Kanoh S, 2009, ANN THORAC SURG, V87, P1266, DOI 10.1016/j.athoracsur.2008.08.037; Kanoh S, 2008, THORAX, V63, P564, DOI 10.1136/thx.2007.087957; Kobayashi Hideo, 2009, Nihon Kokyuki Gakkai Zasshi, V47, P765; Lausberg HF, 2003, ANN THORAC SURG, V75, P393, DOI 10.1016/S0003-4975(02)04553-8; MORRELL NW, 1994, AM J RESP CRIT CARE, V150, P635; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Strange Charlie, 2007, BMC Pulm Med, V7, P10, DOI 10.1186/1471-2466-7-10	30	0	0	PIONEER BIOSCIENCE PUBL CO	HONG KONG	9A GOLD SHINE TOWER, 346-348 QUEEN'S RD CENTRAL, SHEUNG WAN, HONG KONG, 00000, PEOPLES R CHINA	2072-1439	2077-6624		J THORAC DIS	J. Thorac. Dis.	MAR	2015	7	3					413	421		10.3978/j.issn.2072-1439.2015.01.10		9	Respiratory System	Respiratory System	CG1SL	WOS:000353054200047		
J	Shibano, T; Endo, S; Tetsuka, K; Saito, T; Kanai, N; Yashiro, T				Shibano, Tomoki; Endo, Shunsuke; Tetsuka, Kenji; Saito, Tsutomu; Kanai, Nobuyuki; Yashiro, Takashi			Aberrant aneurysm of adult-type pulmonary sequestration: report of a case	JOURNAL OF THORACIC DISEASE			English	Article						Pulmonary sequestration; adult; aberrant aneurysm; endovascular plug; video-assisted thoracic surgery (VATS)	ARTERY	Aberrant pulmonary artery exposed by high-blood pressure over a long period in adult-type pulmonary sequestration can be susceptible to arteriosclerotic change and aneurysmal formation. Dividing this aneurysmal artery has a risk of stump leakage and aneurysm. We herein report a 64-year-old man with an aberrant aneurysm of intralobar pulmonary sequestration. Thoracoscopic resection of the sequestrated lung was performed uneventfully by prior endovascular occlusion of the aberrant aneurysm.	[Shibano, Tomoki; Endo, Shunsuke; Tetsuka, Kenji; Saito, Tsutomu; Kanai, Nobuyuki; Yashiro, Takashi] Jichi Med Univ, Dept Gen Thorac Surg Cardiac Surg Pathol & Anat, Shimotsuke, Tochigi 3290498, Japan	Tetsuka, K (reprint author), Jichi Med Univ, Dept Gen Thorac Surg, Shimotsuke, Tochigi 3290498, Japan.	tcvshun@jichi.ac.jp					Ando K, 2012, ANN THORAC SURG, V93, P319, DOI 10.1016/j.athoracsur.2011.05.103; Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; Cil B, 2008, DIAGN INTERV RADIOL, V14, P35; Greben CR, 2012, J VASC INTERV RADIOL, V23, P477, DOI 10.1016/j.jvir.2011.12.504; Ragusa M, 2010, ANN THORAC SURG, V89, pE7, DOI 10.1016/j.athoracsur.2009.10.064; Saxena Pankaj, 2011, Asian Cardiovasc Thorac Ann, V19, P357, DOI 10.1177/0218492311419447; Shibano T, 2015, ASVIDE; Shyam S, 2012, EUR J CARDIO-THORAC, V42, P592, DOI 10.1093/ejcts/ezs295	8	0	0	PIONEER BIOSCIENCE PUBL CO	HONG KONG	9A GOLD SHINE TOWER, 346-348 QUEEN'S RD CENTRAL, SHEUNG WAN, HONG KONG, 00000, PEOPLES R CHINA	2072-1439	2077-6624		J THORAC DIS	J. Thorac. Dis.	MAR	2015	7	3					E33	E36		10.3978/j.issn.2072-1439.2015.02.15		4	Respiratory System	Respiratory System	CG1SL	WOS:000353054200008		
J	Sawada, Y; Aiba, S; Takyu, M; Repin, R; Nais, J; Kitayama, K				Sawada, Yoshimi; Aiba, Shin-ichiro; Takyu, Masaaki; Repin, Rimi; Nais, Jamili; Kitayama, Kanehiro			Community dynamics over 14 years along gradients of geological substrate and topography in tropical montane forests on Mount Kinabalu, Borneo	JOURNAL OF TROPICAL ECOLOGY			English	Article						die-back; drought; El Nino-Southern Oscillation; growth; mortality; soil fertility	RAIN-FORESTS; HABITAT ASSOCIATIONS; EVALUATING TURNOVER; SPECIES RICHNESS; CANOPY DIEBACK; TREES; RECRUITMENT; MORTALITY; PRODUCTIVITY; FLORISTICS	To understand the variation in community dynamics of tropical montane forests along gradients of soil fertility, death, recruitment and growth of trees (>= 5 cm diameter) were monitored over 14 y (1997-2011) in nine plots placed in a matrix of three geological substrate types (Quaternary sediments, Tertiary sedimentary rocks and ultrabasic rocks) and three topographical units (ridge, middle and lower slopes) on Mount Kinabalu, Borneo. The plot area was 0.05 ha for ridge, 0.1 ha for middle slope and 0.2 ha (on ultrabasic rocks) and 1 ha (on the other substrates) for lower slope. Recruitment rates did not show a consistent pattern across geological substrates or topographies. Mortality rates were relatively high in almost all plots during the 1997-1999 period, including the El Nino drought, and in three plots on ultrabasic rocks during 2001-2005. Binomial logistic regression analyses showed that mortality during 1997-1999 increased with soil fertility (soluble phosphorus). Background mortality, excluding these periods, did not differ across geological substrates or topographies. The average growth rate during 1997-2011 was higher on more fertile soils and positively correlated with mortality during 1997-1999. We suggest that a high mortality rate during the drought period was related to high species diversity on more fertile soils, whereas a lower growth rate was related to stunted structures on poorer soils.	[Sawada, Yoshimi; Aiba, Shin-ichiro] Kagoshima Univ, Grad Sch Sci & Engn, Korimoto, Kagoshima 8900065, Japan; [Takyu, Masaaki] Tokyo Univ Agr, Grad Sch Agr, Dept Forest Sci, Setagaya Ku, Tokyo 1568502, Japan; [Repin, Rimi; Nais, Jamili] Sabah Pk, Kota Kinabalu 88806, Sabah, Malaysia; [Kitayama, Kanehiro] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	Sawada, Y (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, Korimoto, Kagoshima 8900065, Japan.	ysawada@sci.kagoshima-u.ac.jp	Aiba, Shin-ichiro/A-3011-2010	Aiba, Shin-ichiro/0000-0001-9852-7748	Japan Society for the Promotion of Science KAKENHI [18255003, 22255002, 23255003]	We thank staff members of the Sabah Parks for their continuous support during the fieldwork throughout the study. For the English language review, we would like to thank Enago (www.enago.jp). This study was supported by Japan Society for the Promotion of Science KAKENHI grant numbers 18255003, 22255002 and 23255003.	Aiba S, 2005, ECOL RES, V20, P279, DOI 10.1007/s11284-005-0043-z; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Aiba S, 2004, PLANT ECOL, V174, P147, DOI 10.1023/B:VEGE.0000046059.92806.49; Takyu M, 2002, PLANT ECOL, V159, P35, DOI 10.1023/A:1015512400074; Mage SM, 2013, ECOSYSTEMS, V16, P284, DOI 10.1007/s10021-012-9612-5; SPERRY JS, 1994, ECOLOGY, V75, P1736, DOI 10.2307/1939633; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1046/j.0022-0477.2001.00615.x; Aiba S, 1999, PLANT ECOL, V140, P139, DOI 10.1023/A:1009710618040; Lawrence D, 2003, J TROP ECOL, V19, P239, DOI 10.1017/S0266467403003274; Davis SD, 1999, AM J BOT, V86, P1367, DOI 10.2307/2656919; CASTELLO JD, 1995, BIOSCIENCE, V45, P16, DOI 10.2307/1312531; Madelaine C, 2007, J TROP ECOL, V23, P277, DOI 10.1017/S0266467406003944; Brodribb TJ, 2000, PLANT CELL ENVIRON, V23, P1381, DOI 10.1046/j.1365-3040.2000.00647.x; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; MUELLERDOMBOIS D, 1983, PAC SCI, V37, P317; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Aiba SI, 2002, J TROP ECOL, V18, P215, DOI 10.1017/S0266467402002146; Yanagisawa N, 1999, ECOL RES, V14, P165, DOI 10.1046/j.1440-1703.1999.00295.x; Becker P, 1999, BIOTROPICA, V31, P93, DOI 10.1111/j.1744-7429.1999.tb00120.x; Bellingham PJ, 2000, BIOTROPICA, V32, P378, DOI 10.1111/j.1744-7429.2000.tb00484.x; BUCKLEY RC, 1980, BIOTROPICA, V12, P124, DOI 10.2307/2387728; Dezzeo N, 1997, PLANT ECOL, V132, P197, DOI 10.1023/A:1009719805461; HERWITZ SR, 1994, BIOTROPICA, V26, P350, DOI 10.2307/2389228; JACOBI JD, 1983, NEW ZEAL J ECOL, V6, P79; Jones HG, 1992, PLANTS MICROCLIMATE; Kitayama K, 2004, ECOSYSTEMS, V7, P259, DOI 10.1007/s10021-003-0229-6; KITAYAMA K., 1999, SABAH PARKS NATURE J, V2, P85; LAWESSON J. E., 1988, VEGETATIO, V77, P97; Leighton M, 1986, TROPICAL RAIN FOREST, P75; Lingenfelder M, 2009, PLANT ECOL, V201, P267, DOI 10.1007/s11258-008-9568-x; PHILLIPS O, 1995, SCIENCE, V268, P894, DOI 10.1126/science.268.5212.894-a; Phillips OL, 2004, PHILOS T ROY SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; PHILLIPS OL, 1994, P NATL ACAD SCI USA, V91, P2805, DOI 10.1073/pnas.91.7.2805; PROCTOR J, 1983, J ECOL, V71, P237, DOI 10.2307/2259975; Proctor J., 1975, Advances in Ecological Research, V9, P255, DOI 10.1016/S0065-2504(08)60291-3; SHEIL D, 1995, SCIENCE, V268, P894, DOI 10.1126/science.268.5212.894; SWAINE M. D., 1987, J TROP ECOL, V3, pii; Takyu M, 2003, OECOLOGIA, V134, P397, DOI 10.1007/s00442-002-1115-1; TANNER EVJ, 1977, J ECOL, V65, P883, DOI 10.2307/2259385; Toledo J.J., 2011, FOREST ECOL MANAG, V262, P331; WARD LK, 1982, J APPL ECOL, V19, P917, DOI 10.2307/2403293; YAMAKURA T., 1996, TROPICS, V6, P1	43	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-4674	1469-7831		J TROP ECOL	J. Trop. Ecol.	MAR	2015	31		2				117	128		10.1017/S0266467414000777		12	Ecology	Environmental Sciences & Ecology	CG3YN	WOS:000353216100002		
J	Oshima, C; Tokumoto, Y; Nakagawa, M				Oshima, Chiaki; Tokumoto, Yuji; Nakagawa, Michiko			Biotic and abiotic drivers of dipterocarp seedling survival following mast fruiting in Malaysian Borneo	JOURNAL OF TROPICAL ECOLOGY			English	Article						density dependence; Dipterocarpaceae; Janzen-Connell hypothesis; Lambir; masting; predator satiation hypothesis; seedling recruitment	TROPICAL RAIN-FOREST; SPECIES SHADE TOLERANCE; DENSITY-DEPENDENCE; TREE SEEDLINGS; POPULATION-DYNAMICS; TEMPERATE FOREST; GROWTH; REGENERATION; DIVERSITY; PREDATION	South-East Asian tropical rain forests experience sporadic, but profuse, seed production after general flowering, leading to the synchronous emergence of various seedlings and subsequent seedling dynamics, which play a crucial role in determining species distribution and coexistence. We examined the relative importance of both biotic (initial height, conspecific seedling density) and abiotic (canopy openness, per cent sand, soil water content) drivers using survival data for 1842 seedlings of 12 dipterocarp species for 1.5 y following mast fruiting in an old-growth Bornean tropical rain forest. More than 30% of all dipterocarp seedlings survived 1.5 y after mast fruiting. When all species were analysed together, we found that initial seedling height, canopy openness and conspecific seedling density affected dipterocarp seedling survival. Negative density dependence indicated that predators were not satiated, but dipterocarp seedlings rather suffered from host-specific natural enemies or intraspecific competition. Species-level analyses of seven dipterocarp species showed large variation in response to biotic and abiotic factors. These results suggest that interspecific differences in the relative importance of biotic and abiotic effects on seedling survival might contribute to species coexistence.	[Oshima, Chiaki] Nagoya Univ, Fac Agr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Tokumoto, Yuji; Nakagawa, Michiko] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nakagawa, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	miko@agr.nagoya-u.ac.jp			Research Institute for Humanity and Nature [D-04]; Japanese Ministry of Education, Science, and Culture [20687002, 23255002, 26660124]; JSPS [226034]	We thank the Forest Department Sarawak and Sarawak Forestry Corporation for permitting research activities in Lambir Hills National Park, and researchers and local people for helping with field survey. This study was financially supported by the Research Institute for Humanity and Nature Project (D-04), Grants-in-Aid from the Japanese Ministry of Education, Science, and Culture (20687002, 23255002 and 26660124), and JSPS Research Fellowship for Young Scientists to Y.T. (226034).	Aiba M, 2005, ANN BOT-LONDON, V96, P313, DOI 10.1093/aob/mci179; Aiba M, 2007, J VEG SCI, V18, P379, DOI 10.1658/1100-9233(2007)18[379:VIJSAR]2.0.CO;2; Kobe RK, 2011, ECOL LETT, V14, P503, DOI 10.1111/j.1461-0248.2011.01612.x; Cao KF, 2001, J TROP ECOL, V17, P163, DOI 10.1017/S0266467401001110; Sun IF, 2007, J ECOL, V95, P818, DOI 10.1111/j.1365-2745.2007.01235.x; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Sakai S, 2006, AM J BOT, V93, P1134, DOI 10.3732/ajb.93.8.1134; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Queenborough SA, 2009, P R SOC B, V276, P4197, DOI 10.1098/rspb.2009.0921; Anderson DR, 1998, J APPL STAT, V25, P263; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; Maycock CR, 2005, J VEG SCI, V16, P635, DOI 10.1658/1100-9233(2005)016[0635:RODDLI]2.0.CO;2; ITOH A, 1995, J TROP ECOL, V11, P517; Chen L, 2010, ECOL LETT, V13, P695, DOI 10.1111/j.1461-0248.2010.01468.x; Curran LM, 2000, ECOL MONOGR, V70, P129, DOI 10.1890/0012-9615(2000)070[0129:ETOTSS]2.0.CO;2; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Shibata M, 2002, ECOLOGY, V83, P1727, DOI 10.2307/3071991; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Paine CET, 2008, BIOTROPICA, V40, P432, DOI 10.1111/j.1744-7429.2007.00390.x; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Walker LR, 2003, BIOTROPICA, V35, P472; Lin LX, 2012, J ECOL, V100, P905, DOI 10.1111/j.1365-2745.2012.01964.x; Bai XJ, 2012, OECOLOGIA, V170, P755, DOI 10.1007/s00442-012-2348-2; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Cannon CH, 2007, ECOL LETT, V10, P956, DOI 10.1111/j.1461-0248.2007.01089.x; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; Norton DA, 1988, FUNCT ECOL, V2, P399, DOI 10.2307/2389413; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Sakai S, 1999, AM J BOT, V86, P1414, DOI 10.2307/2656924; Appanah S., 1985, Journal of Tropical Ecology, V1, P225; Bagchi R, 2011, PHILOS T R SOC B, V366, P3246, DOI 10.1098/rstb.2011.0034; Bebber DP, 2004, J TROP ECOL, V20, P11, DOI 10.1017/S0266467404006133; Blundell AG, 2004, J TROP ECOL, V20, P229, DOI 10.1017/S0266467403001123; Brown N, 1999, PHILOS T R SOC B, V354, P1847, DOI 10.1098/rstb.1999.0526; BROWN ND, 1992, PHILOS T ROY SOC B, V335, P369, DOI 10.1098/rstb.1992.0028; Burslem DFRP, 1996, BIOTROPICA, V28, P636, DOI 10.2307/2389050; CONNELL J H, 1971, P298; Davies S.J., 2005, POLLINATION ECOLOGY, P22; Delissio LJ, 2003, J TROP ECOL, V19, P489, DOI 10.1017/S0266467403003547; Delissio LJ, 2002, J TROP ECOL, V18, P645, DOI 10.1017/S0266467402002420; Everham EM, 1996, AM J BOT, V83, P1063; Gelman A, 2006, DATA ANAL USING REGR; Ichie T, 2001, J TROP ECOL, V17, P371, DOI 10.1017/S0266467401001250; Ishizuka S, 1998, TROPICS, V8, P31; ITOH A, 1995, ECOL RES, V10, P327, DOI 10.1007/BF02347859; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; Kume T, 2011, AGR FOREST METEOROL, V151, P1183, DOI 10.1016/j.agrformet.2011.04.005; Lamontagne JM, 2007, J ECOL, V95, P991, DOI 10.1111/j.1365-2745.2007.01266.x; Lee H. S., 2002, Journal of Tropical Forest Science, V14, P379; Nakagawa M, 2012, BIOTROPICA, V44, P715, DOI 10.1111/j.1744-7429.2012.00907.x; NG F. S. P., 1991, MANUAL FOREST FRUITS; Norden N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001079; Philipson CD, 2012, BIOTROPICA, V44, P627, DOI 10.1111/j.1744-7429.2011.00833.x; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1046/j.1095-8312.2002.00016.x; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; Takeuchi Y, 2007, FOREST ECOL MANAG, V247, P167, DOI 10.1016/j.foreco.2007.04.028; Takeuchi Y, 2005, FOREST ECOL MANAG, V208, P237, DOI 10.1016/j.foreco.2004.12.002; Tokumoto Y, 2009, PLANT SPEC BIOL, V24, P104, DOI 10.1111/j.1442-1984.2009.00243.x; TURNER IM, 1990, J TROP ECOL, V6, P469; Visser MD, 2011, J ECOL, V99, P1033, DOI 10.1111/j.1365-2745.2011.01825.x; Whitmore TC, 1984, TROPICAL RAIN FOREST; Yagihashi T, 2010, J TROP ECOL, V26, P551, DOI 10.1017/S026646741000026X	70	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-4674	1469-7831		J TROP ECOL	J. Trop. Ecol.	MAR	2015	31		2				129	137		10.1017/S026646741400073X		9	Ecology	Environmental Sciences & Ecology	CG3YN	WOS:000353216100003		
J	Nakamura, M; Itoh, N				Nakamura, Michio; Itoh, Noriko			Larger chimpanzee-dispersed seeds are elongated at Mahale, Tanzania: possible consequence of plant-disperser interaction?	JOURNAL OF TROPICAL ECOLOGY			English	Article						African forest; endozoochory; large seeds; Mahale Mountains National Park; Pan troglodytes; primates; seed dispersal; seed swallowing	RESERVE	Apes are important long-distance dispersers of large seeds in African tropical forests. Seed size and shape are likely to affect the ease of swallowing for an animal species. If an endozoochorous seed is larger than the digestive tract of an animal, the seed cannot be swallowed, and a round seed is more difficult to swallow than an elongated seed of the same length. In order to test if such a correlation exists between the seed size and its shape, we investigated the length and width of chimpanzee-dispersed seeds at the Mahale Mountains National Park, Tanzania. Among the 14 species of seeds, longer seeds had significantly narrower relative widths, and thus, they were more ovoid. Since the chimpanzee is the largest arboreal frugivore at Mahale, their food selection might have influenced the shape of larger seeds. The chimpanzee's selective consumption of such fruits with longer, elongated seeds may have facilitated the selective dispersal of such plant species in that area.	[Nakamura, Michio; Itoh, Noriko] Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Kyoto 6068203, Japan	Nakamura, M (reprint author), Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, 2-24 Tanaka Sekiden Cho, Kyoto 6068203, Japan.	nakamura@wrc.kyoto-u.ac.jp					McConkey KR, 2000, AM J PRIMATOL, V52, P13, DOI 10.1002/1098-2345(200009)52:1<13::AID-AJP2>3.0.CO;2-Y; Lambert JE, 1998, AM J PRIMATOL, V45, P9, DOI 10.1002/(SICI)1098-2345(1998)45:1<9::AID-AJP3>3.0.CO;2-#; Poulsen JR, 2001, J TROP ECOL, V17, P787; Lord JM, 2004, AUSTRAL ECOL, V29, P430, DOI 10.1111/j.1442-9993.2004.01382.x; WRANGHAM RW, 1994, J TROP ECOL, V10, P355; IDANI G, 1986, PRIMATES, V27, P441, DOI 10.1007/BF02381889; Lucas PW, 1998, AM J PRIMATOL, V45, P29, DOI 10.1002/(SICI)1098-2345(1998)45:1<29::AID-AJP4>3.0.CO;2-Y; Chapman Colin A., 1995, Evolutionary Anthropology, V4, P74, DOI 10.1002/evan.1360040303; Forget P. M., 2007, Seed dispersal: theory and its application in a changing world, P5, DOI 10.1079/9781845931650.001; Gross-Camp ND, 2009, AM J PRIMATOL, V71, P901, DOI 10.1002/ajp.20727; Lambert JE, 1999, AM J PHYS ANTHROPOL, V109, P365, DOI 10.1002/(SICI)1096-8644(199907)109:3<365::AID-AJPA6>3.3.CO;2-H; Nakamura Michio, 2012, P339; TAKASAKI H., 1983, AFR STUDY MONOGR, V3, P105; TUTIN CEG, 1991, J TROP ECOL, V7, P181	14	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-4674	1469-7831		J TROP ECOL	J. Trop. Ecol.	MAR	2015	31		2				183	186		10.1017/S0266467414000765		4	Ecology	Environmental Sciences & Ecology	CG3YN	WOS:000353216100008		
J	Inagaki, N; Onouchi, H; Maezawa, H; Kuroda, S; Kaku, K				Inagaki, Nobuya; Onouchi, Hitoshi; Maezawa, Hideaki; Kuroda, Shingo; Kaku, Kohei			Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study	LANCET DIABETES & ENDOCRINOLOGY			English	Article							BLOOD-GLUCOSE CONTROL; DOSING FREQUENCY; MEDICATION ADHERENCE; DPP-4 INHIBITOR; EFFICACY; MELLITUS; PLACEBO; COHORT	Background Trelagliptin is a novel once-weekly oral DPP-4 inhibitor. We assessed the efficacy and safety of trelagliptin versus the daily oral DPP-4 inhibitor alogliptin in Japanese patients with type 2 diabetes. Methods We did a randomised, double-blind, active-controlled, parallel-group, phase 3, non-inferiority study at 26 sites in Japan. We included individuals with type 2 diabetes inadequately controlled by diet and exercise. We randomly assigned patients (2:2:1) to receive trelagliptin (100 mg) once per week, alogliptin (25 mg) once per day, or placebo for 24 weeks. Randomisation was done electronically and independently from the study with permuted blocks of ten patients. Patients and clinicians were masked to group assignment. Patients in the trelagliptin group were given trelagliptin once a week and oral alogliptin placebo every day, whereas patients in the alogliptin group were given oral trelagliptin placebo once a week and oral alogliptin every day (double-dummy design). Patients in the placebo group were given an oral alogliptin placebo once a day and an oral trelagliptin placebo once a week. Our primary outcome was between-groups difference in change in HbA(1c) concentration from baseline to the end of treatment. The non-inferiority margin was 0.4%. Our analysis included all patients who were randomised and received at least one dose of study drug. The study is registered with ClinicalTrials.gov, number NCT01632007. Findings Between May 26, 2012, and Nov 20, 2012, we enrolled 357 patients. 243 patients were included in the analysis (101 for trelagliptin, 92 for alogliptin, and 50 for placebo). In the primary analysis, the least squares mean change in HbA(1c) concentration was -0.33% in the trelagliptin group (SE 0.059) and -0.45% in the alogliptin group (0.061) based on the ANCOVA model. The least squares mean diff erence (trelagliptin minus alogliptin) of change from baseline in HbA(1c) concentration was 0.11% (95% CI -0.054 to 0.281). Trelagliptin was non-inferior to alogliptin. Both active groups had significantly reduced mean HbA(1c) concentrations at end of treatment compared with placebo (p< 0.0001). The frequency of adverse events was similar between groups. No hypoglycaemia was reported with trelagliptin and the drug was well tolerated. Interpretation The once-weekly DPP-4 inhibitor trelagliptin showed similar efficacy and safety to alogliptin once daily in Japanese patients with type 2 diabetes. Trelagliptin could be a useful new antidiabetes drug that needs to be given once a week.	[Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto 6068507, Japan; [Onouchi, Hitoshi; Maezawa, Hideaki; Kuroda, Shingo] Takeda Pharmaceut Co, Pharmaceut Dev Div, Osaka, Japan; [Kaku, Kohei] Kawasaki Med Univ, Okayama, Japan	Inagaki, N (reprint author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto 6068507, Japan.	inagaki@metab.kuhp.kyoto-u.ac.jp			Takeda; Content Ed Net (Madrid, Spain)	This study was funded by an unrestricted research grant from Takeda. We thank the sponsor for assistance with data monitoring and collection, and for funding editorial support that was provided by Kathy Croom and David Figgitt, Content Ed Net (Madrid, Spain). We also thank all investigators; without their clinical dedication this study would not have been possible.	Patel A, 2008, NEW ENGL J MED, V358, P2560; Rathmann W, 2013, DIABETES OBES METAB, V15, P55, DOI 10.1111/j.1463-1326.2012.01674.x; Inagaki N, 2014, LANCET DIABETES ENDO, V2, P125, DOI 10.1016/S2213-8587(13)70149-9; Recker RR, 2005, MAYO CLIN PROC, V80, P856; Briesacher BA, 2008, PHARMACOTHERAPY, V28, P437, DOI 10.1592/phco.28.4.437; Biftu T, 2014, J MED CHEM, V57, P3205, DOI 10.1021/jm401992e; Paes AHP, 1997, DIABETES CARE, V20, P1512, DOI 10.2337/diacare.20.10.1512; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Yabe D, 2012, J DIABETES INVEST, V3, P70, DOI 10.1111/j.2040-1124.2011.00141.x; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Coleman CI, 2012, J MANAGE CARE PHARM, V18, P527; Seino Y, 2011, CURR MED RES OPIN, V27, P1781, DOI 10.1185/03007995.2011.599371; Polonsky WH, 2011, DIABETES OBES METAB, V13, P144, DOI 10.1111/j.1463-1326.2010.01327.x; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Kardas P, 2005, DIABETES OBES METAB, V7, P722, DOI 10.1111/j.1463-1326.2004.00462.x; Center for Drug Evaluation and Research, 2008, DRAFT GUID IND DIAB; Dezii CM, 2002, SOUTHERN MED J, V95, P68; García-Pérez Luis-Emilio, 2013, Diabetes Ther, V4, P175, DOI 10.1007/s13300-013-0034-y; Kruk ME, 2006, CLIN THER, V28, P1989, DOI 10.1016/j.clinthera.2006.12.011; Matsuno K, 2012, J JAPAN DIABETES S1, V55, pS117; Tiv M, 2007, PLOS ONE, V7; Turner RC, 1998, LANCET, V352, P837	24	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2213-8587			LANCET DIABETES ENDO	Lancet Diabetes Endocrinol.	MAR	2015	3	3					191	197		10.1016/S2213-8587(14)70251-7		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CG1KM	WOS:000353031500022		
J	Kiso, Y; Kamimoto, Y; Hosogi, K; Jung, YJ				Kiso, Yoshiaki; Kamimoto, Yuki; Hosogi, Katsuya; Jung, Yong-Jun			Inverse HPLC approach for the evaluation of repulsive interaction between ionic solutes and a membrane polymer	MEMBRANE WATER TREATMENT			English	Article						reverse osmosis; nanofiltration; polyamide; ionic solute; electrochemical interaction; HPLC	PHARMACEUTICALLY ACTIVE COMPOUNDS; ENDOCRINE DISRUPTING COMPOUNDS; NANOFILTRATION MEMBRANES; CELLULOSE-ACETATE; ORGANIC SOLUTES; ADSORPTION PROPERTIES; DIELECTRIC EXCLUSION; REJECTION PROPERTIES; AROMATIC PESTICIDES; NF/RO MEMBRANES	Rejection of ionic solutes by reverse osmosis (RO) and nanofiltration (NF) membranes is controlled mainly by electrochemical interaction as well as pore size, but it is very difficult to directly evaluate such electrochemical interaction. In this work, we used an inverse HPLC method to investigate the interaction between ionic solutes and poly (m- phenylenediaminetrimesoyl) (PPT), a polymer similar to the skin layer of polyamide RO and NF membranes. Silica gel particles coated with PPT were used as the stationary phase, and aqueous solutions of the ionic solutes were used as the mobile phase. Chromatographs obtained for the ionic solutes showed features typical of exclusion chromatographs: the ionic solutes were eluted faster than water (mobile phase), and the exclusion intensity of the ionic solute decreased with increasing solute concentration, asymptotically approaching a minimum value. The charge density of PPT was estimated to be ca. 0.007 mol/L. On the basis of minimum exclusion intensity, the exclusion distances between a salt and neutralized PPT was examined, and the following average values were obtained: 0.49 nm for 1:1 salts, 0.57 nm for 2:1 salts, 0.60 nm for 1:2 salts, and 0.66 nm for 2:2 salts. However, NaAsO2 and H3BO3, which are dissolved at neutral pH in their undissociated forms, were not excluded.	[Kiso, Yoshiaki; Hosogi, Katsuya] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418586, Japan; [Kamimoto, Yuki] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Jung, Yong-Jun] Catholic Univ Pusan, Dept Environm Engn, Busan 609757, South Korea	Jung, YJ (reprint author), Catholic Univ Pusan, Dept Environm Engn, Busan 609757, South Korea.	yjjung@cup.ac.kr			Research Project on Development of Innovative Membrane Separation Technology; New Energy and Industrial Technology Development Organization (NEDO) of Japan	This work was financially supported by the Research Project on Development of Innovative Membrane Separation Technology, sponsored by the New Energy and Industrial Technology Development Organization (NEDO) of Japan.	Bellona C, 2005, J MEMBRANE SCI, V249, P227, DOI 10.1016/j.memsci.2004.09.041; Wang XL, 1997, J MEMBRANE SCI, V135, P19, DOI 10.1016/S0376-7388(97)00125-7; Verliefde ARD, 2008, J MEMBRANE SCI, V322, P52, DOI 10.1016/j.memsci.2008.05.022; Comerton AM, 2007, J MEMBRANE SCI, V303, P267, DOI 10.1016/j.memsci.2007.07.025; Kimura K, 2003, J MEMBRANE SCI, V227, P113, DOI 10.1016/j.memsci.2003.09.005; Malaisamy R, 2011, SEP PURIF TECHNOL, V77, P367, DOI 10.1016/j.seppur.2011.01.005; Bowen WR, 2002, CHEM ENG SCI, V57, P1121, DOI 10.1016/S0009-2509(01)00413-4; Yaroshchuk AE, 2001, SEP PURIF TECHNOL, V22-3, P143, DOI 10.1016/S1383-5866(00)00159-3; Plakas KV, 2012, DESALINATION, V287, P255, DOI 10.1016/j.desal.2011.08.003; Jung YJ, 2005, DESALINATION, V180, P63, DOI 10.1016/j.desal.2004.11.087; Ghaffour N, 2013, DESALINATION, V309, P197, DOI 10.1016/j.desal.2012.10.015; HEPLER LG, 1975, CHEM REV, V75, P585, DOI 10.1021/cr60297a003; Semiao AJC, 2013, J MEMBRANE SCI, V431, P244, DOI 10.1016/j.memsci.2012.11.080; Tansel B, 2012, SEP PURIF TECHNOL, V86, P119, DOI 10.1016/j.seppur.2011.10.033; Kimura K, 2003, J MEMBRANE SCI, V221, P89, DOI 10.1016/S0376-7388(03)00248-5; Schaep J, 2001, J MEMBRANE SCI, V188, P129, DOI 10.1016/S0376-7388(01)00368-4; WANG XL, 1995, J CHEM ENG JPN, V28, P186, DOI 10.1252/jcej.28.186; Szymczyk A, 2005, J MEMBRANE SCI, V252, P77, DOI 10.1016/j.memsci.2004.12.002; Kiso Y, 2001, J MEMBRANE SCI, V192, P1, DOI 10.1016/S0376-7388(01)00411-2; Bowen WR, 2002, CHEM ENG SCI, V57, P1393, DOI 10.1016/S0009-2509(01)00412-2; Bruggen B.V., 2003, ENVIRON PROG, V22, P46; David A. B., 2006, J MEMBRANE SCI, V281, P480; Deon S, 2009, SEP PURIF TECHNOL, V69, P225, DOI 10.1016/j.seppur.2009.07.022; Dolar D, 2012, PROCESS SAF ENVIRON, V90, P147, DOI 10.1016/j.psep.2011.08.007; KISO Y, 1989, CHROMATOGRAPHIA, V28, P279, DOI 10.1007/BF02260775; Kiso Y, 2011, J MEMBRANE SCI, V369, P290, DOI 10.1016/j.memsci.2010.12.005; Kiso Y, 1999, J APPL POLYM SCI, V71, P1657, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1657::AID-APP13>3.0.CO;2-W; KISO Y, 1986, CHROMATOGRAPHIA, V22, P55, DOI 10.1007/BF02257298; Kiso Y, 2001, J MEMBRANE SCI, V182, P205, DOI 10.1016/S0376-7388(00)00567-6; KISO Y, 1986, CHROMATOGRAPHIA, V22, P341, DOI 10.1007/BF02268787; Kiso Y, 2010, J MEMBRANE SCI, V358, P101, DOI 10.1016/j.memsci.2010.04.034; Kiso Y, 2014, MEMBR WATER TREAT, V5, P171; Kiso Y, 1999, J APPL POLYM SCI, V74, P1037, DOI 10.1002/(SICI)1097-4628(19991031)74:5<1037::AID-APP1>3.0.CO;2-L; Lint W. B. S., 2004, J MEMBRANE SCI, V243, P365	34	0	0	TECHNO-PRESS	DAEJEON	PO BOX 33, YUSEONG, DAEJEON 305-600, SOUTH KOREA	2005-8624	2092-7037		MEMBR WATER TREAT	Membr. Water Treat.	MAR	2015	6	2					127	139		10.12989/mwt.2015.6.2.127		13	Engineering, Chemical; Water Resources	Engineering; Water Resources	CG4AL	WOS:000353222100004		
J	Hashimoto, Y; Matsuzaki, E; Higashi, K; Takahashi-Yanaga, F; Takano, A; Hirata, M; Nishimura, F				Hashimoto, Yoko; Matsuzaki, Etsuko; Higashi, Katsumasa; Takahashi-Yanaga, Fumi; Takano, Aiko; Hirata, Masato; Nishimura, Fusanori			Sphingosine-1-phosphate inhibits differentiation of C3H10T1/2 cells into adipocyte	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						cAMP; C/EBP beta; Adipogenic differentiation; Mesenchymal stem cell; C3H10T1/2; Sphingosine-1-phosphate	MESENCHYMAL STEM-CELLS; ALKALINE-PHOSPHATASE EXPRESSION; SPHINGOSINE 1-PHOSPHATE; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; 3T3-L1 CELLS; BETA-CATENIN; ACTIVATION; FTY720; GENE	Mesenchymal stem cells (MSCs) can differentiate into a number of cell types, including adipocytes and osteoblasts. MSC differentiation into adipocytes inhibits osteogenic differentiation and vice versa. Therefore, understanding the mechanisms of MSC differentiation at the signaling level can lead to the development of novel therapeutic strategies toward tissue regeneration. Sphingosine-1-phosphate (S1P) is a signaling molecule that regulates many cellular responses, including cellular differentiation. However, the effects of S1P on MSC differentiation are largely unknown. The purpose of study was to investigate whether S1P drives MSCs toward either adipogenic or osteogenic differentiation, and if so, to clarify the underlying signaling mechanisms for such differentiation. We found that S1P inhibited adipogenic differentiation of C3H10T1/2 multipotent stem cells, while promoting their osteogenic differentiation. During adipogenic differentiation, S1P suppressed the cAMP accumulation in a Gi-protein-dependent manner. The Gi-dependent S1P signaling suppressed C/EBP beta expression, which is essential for adipogenic differentiation. Furthermore, S1P did not affect cAMP-independent adipogenic differentiation. These findings suggest that S1P suppresses cAMP accumulation, leading to inhibition of C/EBP beta expression, thereby resulting in decreased adipogenic differentiation of C3H10T1/2 cells. Thus, our findings provide novel molecular mechanisms as regards how S1P inhibits adipogenic differentiation of C3H10T1/2 cells, indicating a potential beneficial role for regeneration and repair of tissues.	[Hashimoto, Yoko; Matsuzaki, Etsuko; Higashi, Katsumasa; Takano, Aiko; Nishimura, Fusanori] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Periodontal Sect, Fukuoka 812, Japan; [Matsuzaki, Etsuko] Fukuoka Dent Coll, Dept Operat Dent & Endodontol, Sawara Ku, Fukuoka 8140193, Japan; [Takahashi-Yanaga, Fumi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Pharmacol, Fukuoka 812, Japan; [Hirata, Masato] Kyushu Univ, Lab Mol & Cellular Biochem, Fac Dent Sci, Fukuoka 812, Japan	Matsuzaki, E (reprint author), Fukuoka Dent Coll, Dept Operat Dent & Endodontol, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.	matsuzaki@college.fdcnet.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26462886, 24229009, 25253201]	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid for Scientific Research: 26462886 to EM, 24229009 to MH, 25253201 to FN). We would like to thank the Research Support Center, Graduate School of Medical Sciences, Kyushu University for assistance.	Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Matsuzaki E, 2013, BONE, V55, P315, DOI 10.1016/j.bone.2013.04.008; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Means CK, 2008, J BIOL CHEM, V283, P11954, DOI 10.1074/jbc.M707422200; Wang J, 2014, AM J PHYSIOL-ENDOC M, V306, pE756, DOI 10.1152/ajpendo.00549.2013; Moon MH, 2012, EXP MOL MED, V44, P603, DOI 10.3858/emm.2012.44.10.069; Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Hashimoto T, 2009, J LIPID RES, V50, P602, DOI 10.1194/jlr.M800206-JLR200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Nincheri P, 2009, CELL MOL LIFE SCI, V66, P1741, DOI 10.1007/s00018-009-9181-8; Sato C, 2012, BIOCHEM BIOPH RES CO, V423, P200, DOI 10.1016/j.bbrc.2012.05.130; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Khayat G, 2012, DIFFERENTIATION, V83, P179, DOI 10.1016/j.diff.2011.12.004; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Hao W, 2010, INT ORTHOP, V34, P1341, DOI 10.1007/s00264-009-0946-3; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Matsuzaki E, 2006, J BONE MINER RES, V21, P1307, DOI 10.1359/JBMR.060512; Carpio LC, 1999, PROSTAG LEUKOTR ESS, V61, P267, DOI 10.1054/plef.1999.0100; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Aronin CEP, 2010, BIOMATERIALS, V31, P6417, DOI 10.1016/j.biomaterials.2010.04.061; Aronin CEP, 2010, TISSUE ENG PT A, V16, P1801, DOI 10.1089/ten.tea.2009.0539; Huang K, 2014, BIOCHIMIE, V102, P47, DOI 10.1016/j.biochi.2014.02.005; Jia BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034114; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Pandey V, 2009, BBA-GEN SUBJECTS, V1790, P57, DOI 10.1016/j.bbagen.2008.08.008; Pitson SM, 2009, NEUROSIGNALS, V17, P242, DOI 10.1159/000231891; Rahman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051746; Reusch JE, 2012, MOL CELL BIOL, V20, P1008; Roztocil E, 2009, SURGERY, V145, P34, DOI 10.1016/j.surg.2008.08.001; Sakaue H, 1998, J BIOL CHEM, V273, P28945, DOI 10.1074/jbc.273.44.28945; SMAS CM, 1995, BIOCHEM J, V309, P697; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; Zhao ZQ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-37	38	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	MAR	2015	401	1-2					39	47		10.1007/s11010-014-2290-1		9	Cell Biology	Cell Biology	CF8YU	WOS:000352848900005		
J	Watada, H; Fujitani, Y				Watada, Hirotaka; Fujitani, Yoshio			Minireview: Autophagy in Pancreatic beta-Cells and Its Implication in Diabetes	MOLECULAR ENDOCRINOLOGY			English	Review							ENDOPLASMIC-RETICULUM STRESS; ISLET-ASSOCIATED MACROPHAGES; PARKINSONS-DISEASE; CYTOPLASMIC INCLUSIONS; ATG7-DEFICIENT MICE; SELECTIVE AUTOPHAGY; MAMMALIAN AUTOPHAGY; OXIDATIVE STRESS; FAILURE; INSULIN	Autophagy is a conserved system for the degradation of cytoplasmic proteins and organelles. During insulin resistance, in which insulin secretion is enhanced and beta-cell mass is increased owing to changes in the expression and function of various proteins in pancreatic beta-cells, autophagic activity appears to also be enhanced to adapt to the dynamic changes occurring in beta-cells. Indeed, defective autophagy in beta-cells recapitulates several features that are observed in islets during the development of type 2 diabetes mellitus. In addition, the dyregulation of autophagic activity appears to occur in the beta-cells of type 2 diabetic model mice and type 2 diabetes mellitus patients. These lines of evidence suggest that autophagic failure may be implicated in the pathophysiology of type 2 diabetes mellitus. In this review, we summarized the recent findings regarding how autophagy in beta-cells is regulated and how dysfunction of the autophagic machinery may lead to the dysfunction of beta-cells.	[Watada, Hirotaka; Fujitani, Yoshio] Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo 1138421, Japan; [Watada, Hirotaka; Fujitani, Yoshio] Juntendo Univ, Grad Sch Med, Ctr Mol Diabetol, Tokyo 1138421, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Therapeut Innovat Diabet, Tokyo 1138421, Japan; [Fujitani, Yoshio] Juntendo Univ, Grad Sch Med, Japan Sci & Technol Agcy JST, CREST Program, Tokyo 1138421, Japan	Watada, H (reprint author), Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hwatada@juntendo.ac.jp			Ministry of Education, Sports and Culture of Japan [23390244, 26293220, 26111518, 22590996]; Daiichi-Sankyo Foundation of Life Science; UBE Foundation	This work was supported by The Ministry of Education, Sports and Culture of Japan Grants 23390244, 26293220, and 26111518 (to H.W.) and 22590996 (to Y.F.), Daiichi-Sankyo Foundation of Life Science (H.W. and Y.F.), and the UBE Foundation (H.W.).	Abe H, 2013, ENDOCRINOLOGY, V154, P4512, DOI 10.1210/en.2013-1578; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Bartolome A, 2014, DIABETES, V63, P2996, DOI 10.2337/db13-0970; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Richardson SJ, 2009, DIABETOLOGIA, V52, P1686, DOI 10.1007/s00125-009-1410-z; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Mizukami H, 2014, DIABETES CARE, V37, P1966, DOI 10.2337/dc13-2018; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; ORCI L, 1984, J CELL BIOL, V98, P222, DOI 10.1083/jcb.98.1.222; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Kim J, 2014, J CLIN INVEST, V124, P3311, DOI 10.1172/JCI69625; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Yaekura K, 2003, J BIOL CHEM, V278, P9715, DOI 10.1074/jbc.M211352200; Arias E, 2011, CURR OPIN CELL BIOL, V23, P184, DOI 10.1016/j.ceb.2010.10.009; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Shigihara N, 2014, J CLIN INVEST, V124, P3634, DOI 10.1172/JCI69866; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Steneberg P, 2013, DIABETES, V62, P2004, DOI 10.2337/db12-1045; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Fujitani Y, 2009, AUTOPHAGY, V5, P280, DOI 10.1016/j.cmet.2008.08.009; HALBAN PA, 1980, J BIOL CHEM, V255, P6003; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Klionsky DJ, 2007, AUTOPHAGY, V3, P413; Marsh BJ, 2007, MOL ENDOCRINOL, V21, P2255, DOI 10.1210/me.2007-0077; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Costes S, 2014, AUTOPHAGY, V10, P1004, DOI 10.4161/auto.28478; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Kitada T, 1998, NATURE, V392, P605; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Li SL, 2013, J BIOL CHEM, V288, P30094, DOI 10.1074/jbc.M113.494286; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Hosokawa N, 2009, AUTOPHAGY, V5, P973; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Bachar-Wikstrom E, 2013, DIABETES, V62, P1227, DOI 10.2337/db12-1474; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Bugliani M, 2013, MOL CELL ENDOCRINOL, V367, P1, DOI 10.1016/j.mce.2012.12.001; Farquhar M G, 1977, Adv Exp Med Biol, V80, P37; Fujitani Y, 2009, ISLETS, V1, P151, DOI 10.4161/isl.1.2.9057; Leibowitz G, 2011, J DIABETES INVEST, V2, P82, DOI 10.1111/j.2040-1124.2010.00094.x; Nakaso K, 2004, BRAIN RES, V1012, P42, DOI 10.1016/j.brainres.2004.03.029; Ogihara T, 2010, J DIABETES INVEST, V1, P123, DOI 10.1111/j.2040-1124.2010.00021.x; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Yamamoto E, 2014, BIOCHEM BIOPH RES CO, V453, P19, DOI 10.1016/j.bbrc.2014.09.040	88	2	3	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0888-8809			MOL ENDOCRINOL	Mol. Endocrinol.	MAR	2015	29	3					338	348		10.1210/me.2014-1367		11	Endocrinology & Metabolism	Endocrinology & Metabolism	CG4XH	WOS:000353291900002		
J	Tashiro, S; Lanctot, C				Tashiro, Satoshi; Lanctot, Christian			The International Nucleome Consortium	NUCLEUS			English	Article						international consortium; nucleome; 4D genome organization; research themes; scientific collaboration	GENOME; ARCHITECTURE; ORGANIZATION; CELLS	The eukaryotic genome adopts in the cell nucleus a 3-dimensional configuration that varies with cell types, developmental stages and environmental condition as well as between normal and pathological states. Understanding genome function will therefore require the elucidation of the structure-function relationship of the cell nucleus as a complex, dynamic biological system, referred to as the nucleome. This exciting and timely task calls for a multi-faceted, interdisciplinary and multi-national effort. We propose the establishment of an International Nucleome Consortium to coordinate this effort worldwide.	[Tashiro, Satoshi] Hiroshima Univ, Inst Radiat Biol & Med, Minami Ku, Hiroshima, Japan; [Tashiro, Satoshi] Hiroshima Univ, Res Ctr Math Chromatin Live Dynam RcMcD, Minami Ku, Hiroshima, Japan; [Lanctot, Christian] Charles Univ Prague, Fac Med 1, Inst Cellular Biol & Pathol, Prague, Czech Republic	Tashiro, S (reprint author), Hiroshima Univ, Inst Radiat Biol & Med, Minami Ku, Hiroshima, Japan.	ktashiro@hiroshima-u.ac.jp; christian.lanctot@lf1.cuni.cz			Czech Science Foundation [P305/12/1246]; Charles University in Prague [PrVOUK P27/LF1/1, UNCE 204022]; Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan	C.L. is supported by the Czech Science Foundation (grant P305/12/1246) and Charles University in Prague (PrVOUK P27/LF1/1 and UNCE 204022). S.T. is supported by Grants-in-Aid and the Platform for Dynamic Approaches to Living System, from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Rosa A, 2014, INT REV CEL MOL BIO, V307, P275, DOI 10.1016/B978-0-12-800046-5.00009-6; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nora EP, 2013, BIOESSAYS, V35, P818, DOI 10.1002/bies.201300040; Gibcus JH, 2013, MOL CELL, V49, P773, DOI [10.1016/j.molcel.2013.02.011, 10.1016/j.molce1.2013.02.011]; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Gonzalez I, 2014, MOL CELL, V54, P485, DOI 10.1016/j.molcel.2014.03.004; Cremer C., 2013, SPRINGER HDB LASERS, P1359; Markaki Y, 2010, Cold Spring Harb Symp Quant Biol, V75, P475, DOI 10.1101/sqb.2010.75.042; Pederson T, 2014, MOL BIOL CELL, V25, P3466, DOI 10.1091/mbc.E14-03-0790; Plessy C, 2012, BIOESSAYS, V35, P131; Rajapakse I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.48	19	2	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1949-1034	1949-1042		NUCLEUS-PHILA	Nucleus	MAR-APR	2015	6	2					89	92		10.1080/19491034.2015.1022703		4	Cell Biology	Cell Biology	CG3IH	WOS:000353173000001		
J	Kawada, N; Nakanishi, K; Ohama, T; Nishida, M; Yamauchi-Takihara, K; Moriyama, T				Kawada, Noritaka; Nakanishi, Kaori; Ohama, Tohru; Nishida, Makoto; Yamauchi-Takihara, Keiko; Moriyama, Toshiki			Gender differences in the relationship between blood pressure and body mass index during adolescence	OBESITY RESEARCH & CLINICAL PRACTICE			English	Article						Female; Overweight; Obesity; Underweight; Student	RENIN-ANGIOTENSIN SYSTEM; OBESITY HYPERTENSION; SEX-DIFFERENCES; CHILDHOOD; RISK; CONSEQUENCES; ADIPONECTIN; OVERWEIGHT; PREVENTION; ADULTHOOD	Objective: In adults, gender and obesity play significant roles in the regulation of blood pressure (BP). This study investigated the effects of gender and body mass index (BMI) on BP during adolescence. Design and setting: A cross-sectional and longitudinal study involving 6838 students under twenty years old (median, eighteen years old; male, 4624; female, 2214) at Osaka University visited the Healthcare Center for their matriculation health examination from April to May in the years 2008, 2009, and 2010, and re-visited the Healthcare Center for their student health examination from May to June in the years 2011, 2012, and 2013. Methods: Height, body weight, and BP were measured in students both on and 3 years after admission to Osaka University. Results: On admission, the slope of the regression line for BMI and systolic BP (SBP) in non-underweight students was significantly different between genders. SBP and diastolic BP (DBP) increased in both genders during the observation period. Among male students who had a normal BMI on admission, those who had an increase in BMI of over 4% during the observation period showed a greater increase in SBP than those who had a change in BMI of -4% to 4%. On the other hand, female students showed no change in BP with the increase in BMI. Conclusions: The magnitude of BP elevation with increased BMI was associated with gender during adolescence. This may be a cause of the higher prevalence of hypertension in adult males. (C) 2014 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.	[Kawada, Noritaka; Nakanishi, Kaori; Ohama, Tohru; Nishida, Makoto; Yamauchi-Takihara, Keiko; Moriyama, Toshiki] Osaka Univ, Hlth Care Ctr, Toyonaka, Osaka 5600043, Japan	Kawada, N (reprint author), Osaka Univ, Hlth Care Ctr, Machikaneyama Cho 1-17, Toyonaka, Osaka 5600043, Japan.	nk37@kid.med.osaka-u.ac.jp			Japan Ministry of Education, Culture, Sports, Science, and Technology [24500854, 22500663];  [H24-nanchitou(jin)-ippan-006]	This work was supported by Grant-in-Aid for Scientific Research of Japan Ministry of Education, Culture, Sports, Science, and Technology (No. 24500854 to K. Yamauchi-Takihara, and No. 22500663 to M. Nishida) and by Grant-in-Aid for Design of the comprehensive health care system for chronic kidney disease (CKD) based on the individual risk assessment by Specific Health Checkups (H24-nanchitou(jin)-ippan-006 to T. Moriyama).	Xue BJ, 2013, AM J PHYSIOL-REG I, V305, pR459, DOI 10.1152/ajpregu.00222.2013; Samson SL, 2014, ENDOCRIN METAB CLIN, V43, P1, DOI 10.1016/j.ecl.2013.09.009; Canale MP, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/865965; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Frigolet ME, 2013, J NUTR BIOCHEM, V24, P2003, DOI 10.1016/j.jnutbio.2013.07.002; Maric-Bilkan C, 2012, GENDER MED, V9, P287, DOI 10.1016/j.genm.2012.06.005; DYER AR, 1989, J HUM HYPERTENS, V3, P299; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Juonala M, 2013, CURR OPIN LIPIDOL, V24, P57, DOI 10.1097/MOL.0b013e32835a7ed4; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Gomez-Sanchez EP, 2003, AM J PHYSIOL-ENDOC M, V285, pE272, DOI 10.1152/ajpendo.00409.2002; Xiong XQ, 2014, ACTA PHYSIOL, V210, P468, DOI 10.1111/apha.12182; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Jones DW, 2004, HYPERTENSION, V43, P1, DOI 10.1161/01.HYP.0000110061.06674.ca; MAXWELL MH, 1982, LANCET, V2, P33; Aizawa-Abe M, 2000, J CLIN INVEST, V105, P1243, DOI 10.1172/JCI8341; Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Fungfuang Wirasak, 2013, Lab Anim Res, V29, P168, DOI 10.5625/lar.2013.29.3.168; Nakaya H, 2001, J AM SOC NEPHROL, V12, P659; Chappell MC, 2008, GENDER MED, V5, pS65, DOI 10.1016/j.genm.2008.03.007; Florian JP, 2009, CLIN SCI, V118, P61; Kim DH, 2013, HYPERTENSION, V62, P27, DOI 10.1161/HYPERTENSIONAHA.113.01453; Maranon R, 2013, CLIN SCI, V125, P311, DOI 10.1042/CS20130140; Marcus JA, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-013-0411-y; Ohashi K, 2011, AM J HYPERTENS, V24, P263, DOI 10.1038/ajh.2010.216; VanHorn L, 1997, JAMA-J AM MED ASSOC, V278, P1779, DOI 10.1001/jama.278.21.1779; Yamamoto R, 2012, AM J KIDNEY DIS, V59, P343, DOI 10.1053/j.ajkd.2011.08.032; Zhou MS, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-12	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1871-403X	1878-0318		OBES RES CLIN PRACT	Obes. Res. Clin. Pract.	MAR-APR	2015	9	2					141	151		10.1016/j.orcp.2014.07.001		11	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CG1XJ	WOS:000353068500005		
J	Wanezaki, S; Tachibana, N; Nagata, M; Saito, S; Nagao, K; Yanagita, T; Kohno, M				Wanezaki, Satoshi; Tachibana, Nobuhiko; Nagata, Mayuko; Saito, Shintaro; Nagao, Koji; Yanagita, Teruyoshi; Kohno, Mitsutaka			Soy beta-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease	OBESITY RESEARCH & CLINICAL PRACTICE			English	Article						NAFLD; beta CG; OLETF; Fatty acid synthase	CONJUGATED LINOLEIC-ACID; OLETF RATS; TRIGLYCERIDE LEVELS; PROTEIN; DIET; SUPPRESSES; ISOMER; MICE	Nonalcoholic fatty liver disease (NAFLD) has a variety of causes including calorie over-intake, an unbalanced diet, and/or genetic dysfunction of lipid metabolism. We hypothesized that NAFLD symptoms could be mitigated by specific nutritional factors. Here, we show that the potential for soy beta-conglycinin (beta CG) to improve obesity-induced metabolic abnormalities in the Otsuka Long Evans Tokushima fatty (OLETF) rat model of NAFLD. Long Evans Tokushima Otsuka (i.e., wild-type) and OLETF rats were provided a normal diet containing 20% casein for 4 weeks as a control. In a third (beta CG) group, OLETF rats were fed a diet in which half of the casein was replaced by beta CG. There was no difference in food intake between groups. Rats in the beta CG group had decreased liver weight and lipid content (triglycerides, cholesterol, and phospholipids) compared to controls. In addition, beta CG consumption decreased fatty acid synthase gene expression and enzymatic activity. These findings indicate that dietary intake of beta CG can improve obesity-induced metabolic dysfunction, possibly via suppression of de novo fatty acid synthesis. (C) 2014 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.	[Wanezaki, Satoshi; Kohno, Mitsutaka] Fuji Oil Co Ltd, R&D, Inst Basic Res, Tsukubamirai, Ibaraki 3002497, Japan; [Tachibana, Nobuhiko; Nagata, Mayuko] Fuji Oil Co Ltd, R&D, Inst Basic Res, Izumisano, Osaka 5988540, Japan; [Saito, Shintaro; Nagao, Koji] Saga Univ, Dept Appl Biochem & Food Sci, Saga 8408502, Japan; [Yanagita, Teruyoshi] Nishikyushu Univ, Fac Hlth & Social Welf Sci, Dept Hlth & Nutr Sci, Kanzaki, Saga 8428585, Japan	Wanezaki, S (reprint author), Fuji Oil Co Ltd, R&D, Inst Basic Res, 4-3 Kinunodai, Tsukubamirai, Ibaraki 3002497, Japan.	wanezaki.satoshi@so.fujioil.co.jp					Kopelman PG, 2000, NATURE, V404, P635; Ikeda I, 2006, BBA-GEN SUBJECTS, V1760, P800, DOI 10.1016/j.bbagen.2006.02.017; Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; Inoue N, 2011, BIOSCI BIOTECH BIOCH, V75, P2304, DOI 10.1271/bbb.110451; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Aoyama T, 2001, BIOSCI BIOTECH BIOCH, V65, P1071, DOI 10.1271/bbb.65.1071; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Kohno M, 2006, J ATHEROSCLER THROMB, V13, P247; Moriyama T, 2004, BIOSCI BIOTECH BIOCH, V68, P352, DOI 10.1271/bbb.68.352; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Yamazaki T, 2012, J NUTR BIOCHEM, V23, P123, DOI 10.1016/j.jnutbio.2010.11.006; Tachibana N, 2010, BIOSCI BIOTECH BIOCH, V74, P1250, DOI 10.1271/bbb.100088; Homma Yasuhiko, 2004, J Atheroscler Thromb, V11, P265; Inoue N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-85; Mortensen RF, 2001, IMMUNOL RES, V24, P163, DOI 10.1385/IR:24:2:163; Nagao K, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-8; Nagao K, 2010, J AGR FOOD CHEM, V58, P9028, DOI 10.1021/jf1020329; Nagao K, 2003, BIOCHEM BIOPH RES CO, V306, P134, DOI 10.1016/S0006-291X(03)00929-X; Nakamuta M, 2005, INT J MOL MED, V16, P631; Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228; Wang YM, 2006, BIOSCI BIOTECH BIOCH, V70, P355, DOI 10.1271/bbb.70.355	23	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1871-403X	1878-0318		OBES RES CLIN PRACT	Obes. Res. Clin. Pract.	MAR-APR	2015	9	2					168	174		10.1016/j.orcp.2014.03.005		7	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CG1XJ	WOS:000353068500008		
J	Xu, H; Watanabe, M; Qureshi, AR; Heimburger, O; Barany, P; Anderstam, B; Eriksson, M; Stenvinkel, P; Lindholm, B				Xu, Hong; Watanabe, Makoto; Qureshi, Abdul Rashid; Heimburger, Olof; Barany, Peter; Anderstam, Bjorn; Eriksson, Monica; Stenvinkel, Peter; Lindholm, Bengt			OXIDATIVE DNA DAMAGE AND MORTALITY IN HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS	PERITONEAL DIALYSIS INTERNATIONAL			English	Article						End-stage renal disease; dialysis modality; oxidative stress; comorbidity; all-cause mortality	CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; CARDIOVASCULAR-DISEASE; PROTEIN PRODUCTS; CONTROLLED-TRIAL; RISK-FACTOR; STRESS; FAILURE; ATHEROSCLEROSIS; MORBIDITY	Background and Aims: Increased oxidative stress in dialysis patients is thought to contribute to increased mortality; however, confirmatory data are scarce. We analyzed the serum concentration of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative stress, in relation to mortality in hemodialysis (HD) and peritoneal dialysis (PD) patients. Methods: Serum 8-OHdG, interleukin 6 (IL-6), other biochemical markers, Davies comorbidity score, and protein-energy wasting (PEW) were assessed in 303 prevalent patients treated with HD (n = 220; age: 63 +/- 14 years) or PD (n = 83; age: 64 +/- 14 years). Mortality was assessed after a median follow-up of 31 months. Results: The median (25th -75th percentile) concentration of 8-OHdG was higher in HD than in PD patients: 1.3 ng/mL (0.9 -1.8 ng/mL) versus 0.5 ng/mL (0.4 - 0.6 ng/mL), p < 0.001. The HD modality (standard beta = 0.57, p < 0.001) and dialysis vintage (standard beta = 0.12, p = 0.02) were independent predictors of serum 8-OHdG in a multivariable linear regression model including age, sex, body mass index, dialysis modality (HD or PD), preceding time on dialysis (dialysis vintage), PEW, comorbidity score, IL-6, and use of angiotensin converting-enzyme inhibitors or angiotensin II receptor blockers or statins. During follow-up, 107 patients died. In multivariable Cox regression models including all 303 patients and adjusted for age, sex, body mass index, dialysis modality, dialysis vintage, and comorbidity score, 8-OHdG was significantly associated with all-cause mortality (adjusted hazard ratio: 1.40; 95% confidence limits: 1.05, 1.87 for 1 standard deviation increase of 8-OHdG). In subgroup analyses according to dialysis modality, 8-OHdG was associated with mortality in HD patients but not in PD patients. Conclusions: Oxidative stress as assessed by 8-OHdG is an independent predictor of all-cause mortality in dialysis patients. This association was seen in HD patients, but no such association could be demonstrated for PD patients.	[Xu, Hong; Qureshi, Abdul Rashid; Heimburger, Olof; Barany, Peter; Anderstam, Bjorn; Eriksson, Monica; Stenvinkel, Peter; Lindholm, Bengt] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Clin Sci Intervent & Technol,Div Renal Med, S-14186 Stockholm, Sweden; [Xu, Hong; Qureshi, Abdul Rashid; Heimburger, Olof; Barany, Peter; Anderstam, Bjorn; Eriksson, Monica; Stenvinkel, Peter; Lindholm, Bengt] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Baxter Novum, S-14186 Stockholm, Sweden; [Xu, Hong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nephrol, Beijing 100730, Peoples R China; [Watanabe, Makoto] Showa Univ, Sch Med Tokyo, Dept Med, Div Nephrol, Tokyo, Japan	Lindholm, B (reprint author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Renal Med, K56, S-14186 Stockholm, Sweden.	bengt.lindholm@ki.se	Qureshi, Abdul Rashid Tony/G-1358-2010; 	Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Stenvinkel, Peter/0000-0002-8785-4820	Amgen; Swedish Medical Research Council; Osterman foundation; Martin Rind foundation; Westman foundation; Baxter Healthcare Corporation	We acknowledge generous grants from Amgen that sponsored the present study. Grant support was also received from the Swedish Medical Research Council and the Osterman, Martin Rind, and Westman foundations. Baxter Novum is the result of a grant from Baxter Healthcare Corporation to the Karolinska Institutet. We thank Britta Hylander, Karolinska University Hospital Solna, and Guna Germanis, Danderyd Hospital, for recruitment of PD patients; Asa Linde and Annika Nilsson, Anki Emmoth, and Ulrika Jensen at our investigational unit for collection and preparation of samples; and Ann-Christin Bragfors-Helin at our renal laboratory for biochemical analyses.	Al-Hweish A, 2010, HEMODIAL INT, V14, P308, DOI 10.1111/j.1542-4758.2010.00455.x; Davies SJ, 2002, NEPHROL DIAL TRANSPL, V17, P1085, DOI 10.1093/ndt/17.6.1085; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Jiang JP, 2012, ATHEROSCLEROSIS, V224, P187, DOI 10.1016/j.atherosclerosis.2012.06.022; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Brunet P, 2011, KIDNEY BLOOD PRESS R, V34, P284, DOI 10.1159/000327131; Huh JY, 2012, PERITON DIALYSIS INT, V32, P20, DOI 10.3747/pdi.2009.00228; Dounousi E, 2006, AM J KIDNEY DIS, V48, P752, DOI 10.1053/j.ajkd.2006.08.015; de Mattos AM, 2012, THER APHER DIAL, V16, P68, DOI 10.1111/j.1744-9987.2011.01009.x; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Kaya Y, 2012, NEPHROL DIAL TRANSPL, V27, P1164, DOI 10.1093/ndt/gfr443; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Zhou QG, 2012, NEPHROLOGY, V17, P642, DOI 10.1111/j.1440-1797.2012.01640.x; Kalantar-Zadeh K, 2006, AM J KIDNEY DIS, V48, P59, DOI 10.1053/j.ajkd.2006.03.047; Ikizler TA, 2002, CLIN NEPHROL, V58, P190; Tepel M, 2003, CIRCULATION, V107, P992, DOI 10.1161/01.CIR.0000050628.11305.30; Himmelfarb J, 2000, KIDNEY INT, V58, P2571, DOI 10.1046/j.1523-1755.2000.00443.x; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Del Vecchio L, 2011, SEMIN DIALYSIS, V24, P56, DOI 10.1111/j.1525-139X.2010.00819.x; Collins AJ, 2009, CLIN J AM SOC NEPHRO, V4, pS5, DOI 10.2215/CJN.05980809; Antonelou MH, 2011, J PROTEOMICS, V74, P2441, DOI 10.1016/j.jprot.2011.04.009; Bayes B, 2006, NEPHROL DIAL TRANSPL, V21, P984, DOI 10.1093/ndt/gfi294; Castoldi G, 2010, CLIN BIOCHEM, V43, P1387, DOI 10.1016/j.clinbiochem.2010.08.028; Eknoyan G, 1999, MINER ELECTROL METAB, V25, P100, DOI 10.1159/000057429; Furuya R, 2009, NEPHRON CLIN PRACT, V112, pC255, DOI 10.1159/000224792; Grahl DA, 2007, BLOOD PURIFICAT, V25, P210, DOI 10.1159/000100419; Guerin A, 2007, ADV CARDIOL, V44, P187; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; KASAI H, 1984, GANN, V75, P1037; Mastalerz-Migas A, 2006, J PHYSIOL PHARMACOL, V57, P199; Morinaga H, 2012, PERITON DIALYSIS INT, V32, P453, DOI 10.3747/pdi.2011.00032; Samouilidou EC, 2012, RENAL FAILURE, V34, P160, DOI 10.3109/0886022X.2011.641515; Snaedal S, 2009, AM J KIDNEY DIS, V53, P1024; Tamura Y, 2011, INT J MOL MED, V28, P683, DOI 10.3892/ijmm.2011.769; Tarng DG, 2000, AM J KIDNEY DIS, V36, P934, DOI 10.1053/ajkd.2000.19086; TWARDOWSKI ZJ, 1995, NEPHROL DIAL TRANSPL, V10, P2160	40	2	2	MULTIMED INC	TORONTO	66 MARTIN ST, TORONTO, ON L9T 2R2, CANADA	0896-8608			PERITON DIALYSIS INT	Perit. Dial. Int.	MAR-APR	2015	35	2					206	215		10.3747/pdi.2013.00259		10	Urology & Nephrology	Urology & Nephrology	CG5QN	WOS:000353348500013		
J	Sakurada, T; Kojima, S; Oishi, D; Koitabashi, K; Shibagaki, Y; Kimura, K				Sakurada, Tsutomu; Kojima, Shigeki; Oishi, Daisuke; Koitabashi, Kenichiro; Shibagaki, Yugo; Kimura, Kenjiro			Automated Peritoneal Dialysis for a Patient with Hearing Loss: A Case Report	PERITONEAL DIALYSIS INTERNATIONAL			English	Article						Automated peritoneal dialysis; APD; hearing loss; warning signal			[Sakurada, Tsutomu; Kojima, Shigeki; Oishi, Daisuke; Koitabashi, Kenichiro; Shibagaki, Yugo; Kimura, Kenjiro] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan	Sakurada, T (reprint author), St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan.	sakurada@marianna-u.ac.jp					Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Moncrief J W, 1993, ASAIO J, V39, P62, DOI 10.1097/00002480-199301000-00014; Horikawa C, 2013, J CLIN ENDOCR METAB, V98, P51, DOI 10.1210/jc.2012-2119; Hameed R, 2001, POSTGRAD MED J, V77, P523, DOI 10.1136/pmj.77.910.523; KIRIKAE ICHIRO, 1964, LARYNGOSCOPE, V74, P205; Kushner A, 2000, Adv Perit Dial, V16, P163; Seidowsky A, 2013, CLIN NEPHROL, V80, P456, DOI 10.5414/CN107063; Tokyo Shinyu Co. Ltd., NEW SILWATCH NEXT GE; Uchida Shinya, 2010, Masui, V59, P784; Watanabe M, 2004, J JPN SOC DIAL THER, V37, P151	10	0	0	MULTIMED INC	TORONTO	66 MARTIN ST, TORONTO, ON L9T 2R2, CANADA	0896-8608			PERITON DIALYSIS INT	Perit. Dial. Int.	MAR-APR	2015	35	2					229	+		10.3747/pdi.2013.00340		2	Urology & Nephrology	Urology & Nephrology	CG5QN	WOS:000353348500016		
J	Iwakami, S; Hashimoto, M; Matsushima, K; Watanabe, H; Hamamura, K; Uchino, A				Iwakami, Satoshi; Hashimoto, Masato; Matsushima, Ken-ichi; Watanabe, Hiroaki; Hamamura, Kenshiro; Uchino, Akira			Multiple-herbicide resistance in Echinochloa crus-galli var. formosensis, an allohexaploid weed species, in dry-seeded rice	PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY			English	Article						ACCase; ALS; Non-target-site-based resistance; Taiwan barnyard grass	ACETYL-COA CARBOXYLASE; PHYLLOPOGON STAPF KOSS.; ACETOLACTATE SYNTHASE; INHIBITING HERBICIDES; MOLECULAR CHARACTERIZATION; GLYPHOSATE RESISTANCE; CROP PRODUCTION; INHERITANCE; EXPRESSION; BIOTYPES	Biotypes of Echinochloa crus-galli var. formosensis with resistance to cyhalofop-butyl, an acetyl-CoA carboxylase (ACCase) inhibitor, have been found in dry-seeded rice fields in Okayama, Japan. We collected two lines with suspected resistance (Ecf27 and Ecf108) from dry-seeded rice fields and investigated their sensitivity to cyhalofop-butyl and other herbicides. Both lines exhibited approximately 7-fold higher resistance to cyhalofop-butyl than a susceptible line. Ecf108 was susceptible to penoxsulam, an acetolactate synthase (ALS) inhibitor. On the other hand, Ecf27 showed resistance to penoxsulam and two other ALS inhibitors: propyrisulfuron and pyriminobac-methyl. The alternative herbicides butachlor, thiobencarb, and bispyribac-sodium effectively controlled both lines. To examine the molecular mechanisms of resistance, we amplified and sequenced the target-site encoding genes in Ecf27, Ecf108, and susceptible lines. Partial sequences of six ACCase genes and full-length sequences of three ALS genes were examined. One of the ACCase gene sequences encodes a truncated aberrant protein due to a frameshift mutation in both lines. Comparisons of the genes among Ecf27, Ecf108, and the susceptible lines revealed that none of the ACCases and ALSs in Ecf27 and Ecf108 have amino acid substitutions that are known to confer herbicide resistance, although a single amino acid substitution was found in each of three ACCases in Ecf108. Our study reveals the existence of a multiple-herbicide resistant biotype of E. crus-galli var. formosensis at Okayama, Japan that shows resistance to cyhalofop-butyl and several ALS inhibitors. We also found a biotype that is resistant only to cyhalofop-butyl among the tested herbicides. The resistance mechanisms are likely to be non-target-site based, at least in the multiple-herbicide resistant biotype. (C) 2015 Elsevier Inc. All rights reserved.	[Iwakami, Satoshi] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Iwakami, Satoshi; Matsushima, Ken-ichi; Watanabe, Hiroaki; Uchino, Akira] NARO Agr Res Ctr, Crop Prod Syst Div, Tsukuba, Ibaraki 3058666, Japan; [Hashimoto, Masato; Hamamura, Kenshiro] Japan Assoc Adv Phytoregulators, Ushiku 3001211, Japan	Uchino, A (reprint author), NARO Agr Res Ctr, Crop Prod Syst Div, 3-1-1 Kannondai, Tsukuba, Ibaraki 3058666, Japan.	uchino@affrc.go.jp			Japan Association for Advancement of Phyto-Regulators	We are grateful to Dr. Daisuke Aoki and Dr. Yuichiro Nakayama for providing the seeds of Ec/99-J-197 and Ec/04-J-44. We also thank Junko Okabe, Sachiko Inanuma, Hiroko Kato, and Namiko Yamada for their technical help. We dedicate this paper to the late Dr. Yasuo Tomihisa, who helped us collect the plant materials. This work was partly supported by a grant from the Japan Association for Advancement of Phyto-Regulators.	Akasaka M., 2006, J WEED SCI TECH, V51, P110; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; Yasuor H, 2009, J AGR FOOD CHEM, V57, P3653, DOI 10.1021/jf8039999; YABUNO T, 1966, JPN J BOT, V19, P277; Panozzo S, 2013, PESTIC BIOCHEM PHYS, V105, P93, DOI 10.1016/j.pestbp.2012.12.003; Yu Q, 2013, HEREDITY, V110, P220, DOI 10.1038/hdy.2012.69; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Delye C, 2013, PEST MANAG SCI, V69, P176, DOI 10.1002/ps.3318; Delye C, 2005, WEED SCI, V53, P728, DOI 10.1614/WS-04-203R.1; Zmienko A, 2014, THEOR APPL GENET, V127, P1, DOI 10.1007/s00122-013-2177-7; Bakkali Y, 2007, J AGR FOOD CHEM, V55, P4052, DOI 10.1021/jf0624749; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Pozniak CJ, 2004, CROP SCI, V44, P1434; Cummins I, 2013, P NATL ACAD SCI USA, V110, P5812, DOI 10.1073/pnas.1221179110; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tranel PJ, 2002, WEED SCI, V50, P700, DOI 10.1614/0043-1745(2002)050[0700:RROWTA]2.0.CO;2; Iwakami S, 2014, PLANT PHYSIOL, V165, P618, DOI 10.1104/pp.113.232843; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Yu Q, 2014, PLANT PHYSIOL, V166, P1106, DOI 10.1104/pp.114.242750; Riar DS, 2013, J AGR FOOD CHEM, V61, P278, DOI 10.1021/jf304675j; Aoki D, 2008, WEED BIOL MANAG, V8, P233, DOI 10.1111/j.1445-6664.2008.00303.x; Belz RG, 2011, WEED RES, V51, P321, DOI 10.1111/j.1365-3180.2011.00862.x; Breccia G, 2013, PLANT SCI, V208, P28, DOI 10.1016/j.plantsci.2013.03.008; Delye C, 2015, PEST MANAG SCI, V71, P675, DOI 10.1002/ps.3818; Fischer AJ, 2000, WEED SCI, V48, P225, DOI 10.1614/0043-1745(2000)048[0225:HREOAE]2.0.CO;2; Ghio C, 2013, THEOR APPL GENET, V126, P2957, DOI 10.1007/s00122-013-2185-7; Heap I, 2014, INT SURVEY HERBICIDE; Hirayama S., 2012, J WEED SCI TECH S, V57, P127; Huan Z., 2011, SCIENCEPAPER ONLINE; Huan ZB, 2011, J PESTIC SCI, V36, P461, DOI 10.1584/jpestics.G11-29; Huan ZB, 2013, WEED SCI, V61, P537, DOI 10.1614/WS-D-13-00010.1; Im S-H, 2009, KOREAN J WEED SCI, V29, P178; Imaizumi T, 2008, WEED RES, V48, P448, DOI 10.1111/j.1365-3180.2008.00644.x; Iwakami S, 2012, PEST MANAG SCI, V68, P1098, DOI 10.1002/ps.3287; Jugulam M, 2014, PLANT PHYSIOL, V166, P1200, DOI 10.1104/pp.114.242826; Kaloumenos N.S., 2012, PEST MANAG SCI, V69, P865; Kaundun SS, 2014, PEST MANAG SCI, V70, P1405, DOI 10.1002/ps.3790; Matzenbacher F.O., 2014, J AGR SCI FIRSTVIEW, P1; Nasu H., 2011, J WEED SCI TECHNOL S, V56, P14; Ohno S., 1970, EVOLUTION GENE DUPLI; Ostlie M., 2014, THEOR APPL GENET, V128, P343; Ruiz-Santaella JP, 2006, J PLANT DIS PROTECT, P95; Saika H, 2014, PLANT PHYSIOL, V166, P1232, DOI 10.1104/pp.113.231266; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; SEEFELDT SS, 1995, WEED TECHNOL, V9, P218; Seefeldt SS, 1998, WEED SCI, V46, P170; Tal A, 2004, PEST MANAG SCI, V60, P1013, DOI 10.1002/ps.903; Tsuji R, 2003, WEED SCI, V51, P740, DOI 10.1614/P2002-143; Watanabe H, 2011, WEED BIOL MANAG, V11, P175, DOI 10.1111/j.1445-6664.2011.00419.x; Won O.J., 2014, WEED TURF SCI, V3, P110; Yamasue Yuji, 2001, Weed Biology and Management, V1, P28, DOI 10.1046/j.1445-6664.2001.00008.x; Yu Q, 2014, PEST MANAG SCI, V70, P1340, DOI 10.1002/ps.3710	53	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0048-3575	1095-9939		PESTIC BIOCHEM PHYS	Pest. Biochem. Physiol.	MAR	2015	119						1	8		10.1016/j.pestbp.2015.02.007		8	Biochemistry & Molecular Biology; Entomology; Physiology	Biochemistry & Molecular Biology; Entomology; Physiology	CG5WQ	WOS:000353367000001		
J	Olsson, SK; Matsunaga, H; Kataoka, Y; Johansson, M; Matsumura, J; Westin, M; Ostmark, E				Olsson, S. K.; Matsunaga, H.; Kataoka, Y.; Johansson, M.; Matsumura, J.; Westin, M.; Ostmark, E.			A SEM study on the use of epoxy functional vegetable oil and reactive UV-absorber as UV-protecting pretreatment for wood	POLYMER DEGRADATION AND STABILITY			English	Article						UV-absorber; Epoxy functional vegetable oil; Linseed oil; 2-Hydroxy-4(2,3-epoxypropoxy)-benzophenone (HEPBP)	LIGHT; PHOTODEGRADATION; ULTRAVIOLET	The present study investigates the ageing performance of a UV protective system for wood, comprising the reactive UV absorber 2-hydroxy-4(2,3-epoxypropoxy)-benzophenone (HEPBP) and epoxy functional vegetable oils (linseed and soybean oil). Scots pine samples of radial or cross-sectional surfaces were treated using a combination of the two components, or using only one of the oils. The treated samples were then aged in a Weather-Ometer for 2 x 60 h and analysed using VPSEM to follow the degradation of the wood substrate in the exact same spot before, during and after ageing. The results of the radial surfaces show slightly less degradation of samples treated with a combination of HEPBP and oil, and for the cross-sectional surfaces an even stronger protective effect is visible. For samples treated with only one of the two oils, no improvement was detectable. The radial surfaces were also analysed using FTIR where the results indicate presence of the protective treatment even after 120 h of exposure. Overall the combined pretreatment of HEPBP and epoxy functional linseed oil was concluded to have a photo-stabilising effect of the wood substrate. (C) 2015 Elsevier Ltd. All rights reserved.	[Olsson, S. K.; Ostmark, E.] SP Tech Res Inst Sweden, S-11486 Stockholm, Sweden; [Matsunaga, H.; Kataoka, Y.] Forestry & Forest Prod Res Inst, Dept Wood Improvement, Tsukuba, Ibaraki 3058687, Japan; [Johansson, M.] KTH Royal Inst Technol, Sch Chem Sci & Engn, Dept Fibre & Polymer Technol, S-10044 Stockholm, Sweden; [Matsumura, J.] Kyushu Univ, Fac Agr, Lab Wood Sci, Fukuoka 8128581, Japan; [Westin, M.] SP Tech Res Inst Sweden, S-50115 Boras, Sweden	Olsson, SK (reprint author), SP Tech Res Inst Sweden, Box 5609, S-11486 Stockholm, Sweden.	Sara.olsson@sp.se; matskg@kth.se; mats.westin@sp.se; emma.ostmark@sp.se	Johansson, Mats/G-3085-2010		Lantmannens Forskningsstiftelse [20120019]; Wallenberg Wood Science Centre (WWSC); Sveriges Fargfabrikanters Forening (Sveff)	The authors would like to acknowledge Lantmannens Forskningsstiftelse (application number 20120019), Wallenberg Wood Science Centre (WWSC) and Sveriges Fargfabrikanters Forening (Sveff) for financial support, and the Forestry and Forest Products Research Institute (FFPRI) together with Kyushu University for enabling this cooperation and work.	ANDERSON EL, 1991, APPL SPECTROSC, V45, P641, DOI 10.1366/0003702914336930; ANDERSON EL, 1991, APPL SPECTROSC, V45, P648, DOI 10.1366/0003702914336769; HON DNS, 1978, WOOD SCI, V11, P118; Lazzari M, 1999, POLYM DEGRAD STABIL, V65, P303, DOI 10.1016/S0141-3910(99)00020-8; Lesar B, 2011, POLYM DEGRAD STABIL, V96, P1271, DOI 10.1016/j.polymdegradstab.2011.04.006; Browne F. L., 1957, Forest Products Journal, V7, P308; Evans P, 2010, TLS-TIMES LIT SUPPL, P30; Evans PD, 2008, WOOD SCI TECHNOL, V42, P251, DOI 10.1007/s00226-007-0175-0; Hatae F, 2012, P 11 PAC RIM BIOB CO, P226; Hatae F, 2012, P INT RES GROUP WOOD; Hon DN-S, 1981, P 2 INT C ENV DEGR E, P519; Horn AH, 1994, APPL SPECTROSC, V48, P662; Jones FN, 2007, ORGANIC COATINGS SCI, V3rd, P295; Kataoka Y, 2007, HOLZFORSCHUNG, V61, P23; Kataoka Y, 2001, J WOOD SCI, V47, P325; Kiguchi M, 1998, POLYM DEGRAD STABIL, V61, P33, DOI 10.1016/S0141-3910(97)00124-9; Kotlik P, 2014, J CULT HERIT, V15, P44, DOI 10.1016/j.culher.2013.01.002; Manasek Z, 1976, J APPL CHEM-USSR, V49, P1129; Olsson KS, 2014, POLYM DEGRAD STABIL, V110, P405; Olsson KS, 2012, POLYM DEGRAD STABIL, V97, P1779; Park BS, 1996, MOKUZAI GAKKAISHI, V42, P1; Tomak ED, 2011, J MATER SCI, V46, P598, DOI 10.1007/s10853-010-4859-8; Vollmer S., 2010, THESIS BRIT COLUMBIA; Walinder M, 2009, WOOD MAT SCI ENG, V1-2, P46; Westin M., 2002, UTVARDERING NY METOD; Wicks Jr ZW, 2007, ORGANIC COATINGS SCI, V3rd, P97	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	MAR	2015	113				SI		40	45		10.1016/j.polymdegradstab.2015.01.005		6	Polymer Science	Polymer Science	CG2AU	WOS:000353078100005		
J	Akiba, Y				Akiba, Yasuyuki			Quest for the quark-gluon plasma-hard and electromagnetic probes	Progress of Theoretical and Experimental Physics			English	Article							COLLISIONS; COLLABORATION	The experimental results of RHIC in its first decade firmly established that a new form of quantum chromodynamics matter, a quark-gluon plasma (QGP), is formed in heavy-ion collisions at RHIC. The experimental study of heavy-ion collisions with hard and electromagnetic probes plays a central role in establishing the formation of QGP at RHIC and in the subsequent investigation of its properties. The study of QGP at RHIC based on hard and electromagnetic probes is reviewed.	RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan	Akiba, Y (reprint author), RIKEN, Nishina Ctr, Hirosawa 2-1, Wako, Saitama 3510198, Japan.	akiba@bnl.gov					Adare A., ARXIV14042246; Adare A., 2012, PHYS REV LETT, V109; Adare A, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.054907; Adare A, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.054912; Adare A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.172301; Adare A., 2012, PHYS REV LETT, V109; Adare A, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.072008; Adare A, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.011902; Adcox K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.192303; Adler S. S., 2009, PHYS REV LETT, V103; Adler SS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.012304; Adler SS, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.071102; Adler SS, 2005, PHYS REV C, V72, DOI [10.1103/PhysRevC.72.024901, 10.1103/PhysRevC.72.0249001]; Adler SS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.032001; van Hees H, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.034913; Adare A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.122301; Adare A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.252002; Adare A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.142301; Adler SS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.202301; Ackermann KH, 2001, PHYS REV LETT, V86, P402, DOI 10.1103/PhysRevLett.86.402; Huovinen P, 2006, ANNU REV NUCL PART S, V56, P163, DOI 10.1146/annurev.nucl.54.070103.181236; Adare A, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.034911; Bazavov A, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.054503; Adams J, 2005, NUCL PHYS A, V757, P102, DOI 10.1016/j.nuclphysa.2005.03.085; Adare A, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.034911; Moore GD, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.064904; Adare A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.232301; Fries RJ, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.044902; Kovtun PK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111601; Adcox K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.022301; Adler SS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.012002; Adare A, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.044905; Adler SS, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.034910; WANG XN, 1992, PHYS REV LETT, V68, P1480, DOI 10.1103/PhysRevLett.68.1480; Adler SS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.082301; Turbide S, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.014903; Adcox K, 2005, NUCL PHYS A, V757, P184, DOI 10.1016/j.nuclphysa.2005.03.086; Adler SS, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.034909; Baier R, 1997, NUCL PHYS B, V483, P291, DOI 10.1016/S0550-3213(96)00553-6; Adler SS, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.072303; Adare A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.132301; Adler SS, 2003, PHYS REV LETT, V91, DOI [10.1103/PhysRevLett.91.182301, 10.1103/PhysRevLett.91.072301]; Cacciari M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.122001; Eskola KJ, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/04/065; Matsui T., 1986, PHYS LETT B, V178	45	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							03A105	10.1093/ptep/ptu080		12	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000004		
J	Baym, G; Hatsuda, T				Baym, Gordon; Hatsuda, Tetsuo			Polarization of direct photons from gluon anisotropy in ultrarelativistic heavy ion collisions	Progress of Theoretical and Experimental Physics			English	Article							PARTICLE; PLASMA	We show how anisotropy in momentum of the gluon distribution in ultrarelativistic heavy ion collisions gives rise to polarization of direct photons produced via gluon-quark Compton scattering, as well as by quark-antiquark annihilation into a gluon-photon pair. We estimate the polarization asymmetry from the Compton process within a toy model where the polarized photons are produced from thermal gluons scattered by heavy-quark scattering centers moving with Bjorken boost-invariant flow, and find that it could be as large as 10%. We conclude that polarization measurements of directly produced photons can shed light on gluon pressure anisotropy in the early stages of collisions.	[Baym, Gordon] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Baym, Gordon; Hatsuda, Tetsuo] RIKEN, iTHES Res Grp, Wako, Saitama 3510198, Japan; [Baym, Gordon; Hatsuda, Tetsuo] RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan; [Hatsuda, Tetsuo] Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan	Baym, G (reprint author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	thatsuda@riken.jp	Hatsuda, Tetsuo/C-2901-2013		NSF [PHY09-69790, PHY13-05891]; JSPS [25287066]; RIKEN iTHES project	We both thank the RIKEN iTHES project for partial support during the course of this research. This research was also supported in part by NSF Grants PHY09-69790 and PHY13-05891, and JSPS Grants-in-Aid No. 25287066.	Adam R., ARXIV14095738 PLANCK; Ade P A. R., ARXIV150200596ASTROP; Romatschke P, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.036004; Aoki Y, 2006, NATURE, V443, P675, DOI 10.1038/nature05120; Adare A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.122302; Adare A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.132301; Schenke B, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.025023; BJORKEN JD, 1983, PHYS REV D, V27, P140, DOI 10.1103/PhysRevD.27.140; Goloviznin VV, 2013, JETP LETT+, V98, P61, DOI 10.1134/S0021364013150071; GOLOVIZNIN VV, 1988, SOV J NUCL PHYS+, V48, P1099; Ipp A, 2008, PHYS LETT B, V666, P315, DOI 10.1016/j.physletb.2008.07.076; Kapusta J.I., 2006, FINITE TEMPERATURE F; Martinez M, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.034917; ROY PK, 1995, PHYS REV D, V51, P4884, DOI 10.1103/PhysRevD.51.4884; Samtleben D, 2007, ANNU REV NUCL PART S, V57, P245, DOI 10.1146/annurev.nucl.54.070103.181232; Stankus P, 2005, ANNU REV NUCL PART S, V55, P517, DOI 10.1146/annurev.nucl.53.041002.110533; Strickland M., ARXIV14011188NUCLTH; Yee HU, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.026001	18	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							031D01	10.1093/ptep/ptv024		9	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000023		
J	Esumi, S				Esumi, ShinIchi			Soft physics results from the PHENIX experiment	Progress of Theoretical and Experimental Physics			English	Article								High-energy heavy-ion collisions at RHIC-BNL and LHC-CERN provide a unique opportunity to study the properties of the high-temperature and high-density nuclear matter called the quark-gluon plasma (QGP), which is supposed to exist in the early universe or inside neutron stars. The PHENIX experiment is one of the major experiments at RHIC to study the properties of QGP, especially focusing on various particle identification capabilities including photons, leptons, and hadrons. This article summarizes the soft physics results from the PHENIX experiment, such as (1) global properties like transverse energy and multiplicity measurements as well as centrality determination, (2) transverse momentum distribution and the nuclear modification factor, which represents the modification of the spectra in A + A collisions relative to the binary-collision-scaled superposition of p+p data, (3) space-time properties with Hanbury Brown and Twiss (HBT) interferometry correlation measurement and source imaging, (4) elliptic collective expansion and higher-order harmonic event anisotropy, and (5) di-hadron correlation, jet modification, and medium response known as jet-quenching from the partonic energy loss and redistribution of the lost energy. These results are reviewed and discussed.	Univ Tsukuba, Inst Phys, Tsukuba, Ibaraki 3058571, Japan	Esumi, S (reprint author), Univ Tsukuba, Inst Phys, Tenno Dai 1-1-1, Tsukuba, Ibaraki 3058571, Japan.	esumi.shinichi.gn@u.tsukuba.ac.jp			MEXT; JSPS KAKENHI [25105504]	We thank the staff of the Collider-Accelerator and Physics Departments at BNL and the PHENIX Collaboration for their vital contributions. We also acknowledge support from MEXT and JSPS KAKENHI Grant Number 25105504.	Adare A, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.011901; Adare A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.032301; Adare A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.172301; Adare A, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.024906; Adler SS, 2005, PHYS REV LETT, V94, DOI [10.1103/PhysRevLett.94.122302, 10.1103/PhysRevLett.94.082302]; Afanasiev S, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.024909; Afanasiev S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.142301; Adare A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.212301; Adler SS, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.034908; Afanasiev S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.052301; Adare A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.232302; Adare A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.062301; Adare A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.122302; Adare A, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.064914; Adler SS, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.034909; Afanasiev S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.232301; Adare A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.252301	17	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							03A104	10.1093/ptep/ptu069		15	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000002		
J	Hamada, Y; Kawai, H; Kawana, K				Hamada, Yuta; Kawai, Hikaru; Kawana, Kiyoharu			Weak scale from the maximum entropy principle	Progress of Theoretical and Experimental Physics			English	Article							COSMOLOGICAL CONSTANT; MULTIVERSE	The theory of the multiverse and wormholes suggests that the parameters of the Standard Model (SM) are fixed in such a way that the radiation of the S-3 universe at the final stage S-rad becomes maximum, which we call the maximum entropy principle. Although it is difficult to confirm this principle generally, for a few parameters of the SM, we can check whether S-rad actually becomes maximum at the observed values. In this paper, we regard S-rad at the final stage as a function of the weak scale (the Higgs expectation value) v(h), and show that it becomes maximum around v(h) = O(300 GeV) when the dimensionless couplings in the SM, i.e., the Higgs self-coupling, the gauge couplings, and the Yukawa couplings are fixed. Roughly speaking, we find that the weak scale is given by v(h) similar to T-BBN(2)/(M-pl y(e)(5)), where y(e) is the Yukawa coupling of electron, T-BBN is the temperature at which the Big Bang nucleosynthesis starts, and M-pl is the Planck mass.	[Hamada, Yuta; Kawai, Hikaru; Kawana, Kiyoharu] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan	Hamada, Y (reprint author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.	hamada@gauge.scphys.kyoto-u.ac.jp; hkawai@gauge.scphys.kyoto-u.ac.jp; kiyokawa@gauge.scphys.kyoto-u.ac.jp			SCOAP3	Open Access funding: SCOAP<SUP>3</SUP>.	Alekhin S, 2012, PHYS LETT B, V716, P214, DOI 10.1016/j.physletb.2012.08.024; COLEMAN S, 1988, NUCL PHYS B, V310, P643, DOI 10.1016/0550-3213(88)90097-1; Hamada Y, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.053009; Masina I, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.053001; Kawai H, 2013, INT J MOD PHYS A, V28, DOI 10.1142/S0217751X13400010; Hamada Y, 2014, INT J MOD PHYS A, V29, DOI 10.1142/S0217751X14500997; Kawai H, 2012, PROG THEOR PHYS, V127, P689; Berengut JC, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.085018; CLAUDSON M, 1982, NUCL PHYS B, V195, P297, DOI 10.1016/0550-3213(82)90401-1; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Bezrukov F., 2012, J HIGH ENERGY PHYS, V1210, P140; Buttazzo D., 2013, J HIGH ENERGY PHYS, V1312, P089, DOI DOI 10.1007/JHEP12(2013)089; Carena M., 2012, J HIGH ENERGY PHYS, V50, P152; D'Onofrio M., 2012, POS LATTICE, V2012, P055; Degrassi G., 2012, J HIGH ENERGY PHYS, V1208, DOI DOI 10.1007/JHEP08(2012)098; Hamada Y., ARXIV13057055HEPPH; Jegerlehner F., ARXIV13047813HEPPH; Jegerlehner F., ARXIV13056652HEPPH; Kawai H, 2011, INT J MOD PHYS A, V26, P3107, DOI 10.1142/S0217751X11053730; Kobakhidze A., ARXIV14044709HEPPH; Weinberg S., 2008, COSMOLOGY	21	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							033B06	10.1093/ptep/ptv011		17	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000012		
J	Hosokawa, K; Murata, A; Nakano, Y; Onishi, Y; Sekiya, H; Takeuchi, Y; Tasaka, S				Hosokawa, K.; Murata, A.; Nakano, Y.; Onishi, Y.; Sekiya, H.; Takeuchi, Y.; Tasaka, S.			Development of a high-sensitivity 80 L radon detector for purified gases	Progress of Theoretical and Experimental Physics			English	Article							SUPER-KAMIOKANDE DETECTOR	In underground particle physics experiments, the radioactive noble gas Rn-222 generated from the decay chain of the uranium series could be a serious background source. We have been developing high-sensitivity radon detectors to assay radon in the Kamioka underground laboratory. In order to achieve a further low background level, we developed a new radon detector with better hermeticity. The high-voltage dependence and humidity dependence of the detection efficiencies were obtained through our calibration systems. The background level of the new radon detector was also measured.	[Hosokawa, K.; Murata, A.; Onishi, Y.; Takeuchi, Y.] Kobe Univ, Dept Phys, Kobe, Hyogo 6578501, Japan; [Nakano, Y.; Sekiya, H.] Univ Tokyo, Kamioka Observ, Inst Cosm Ray Res, Gifu 5061205, Japan; [Sekiya, H.; Takeuchi, Y.] Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan; [Sekiya, H.; Takeuchi, Y.] WPI, Kavli IPMU, Worcester, MA USA; [Tasaka, S.] Gifu Univ, Informat & Multimedia Ctr, Gifu 5011193, Japan	Hosokawa, K (reprint author), Kobe Univ, Dept Phys, Kobe, Hyogo 6578501, Japan.	takeuchi@phys.sci.kobe-u.ac.jp			JSPS KAKENHI [24340050, 25.2848]; ICRR Joint-Usage	This work was supported by JSPS KAKENHI Grant-Number 24340050, 25.2848, and ICRR Joint-Usage.	FREESE K, 1988, PHYS REV D, V37, P3388, DOI 10.1103/PhysRevD.37.3388; Drukier K. A., 1986, PHYS REV D, V33, P3495; Fukuda S, 2003, NUCL INSTRUM METH A, V501, P418, DOI 10.1016/S0168-9002(03)00425-X; Hosokawa K, 2013, J PHYS CONF SER, V469, DOI 10.1088/1742-6596/469/1/012007; IIDA T, 1988, HEALTH PHYS, V54, P139, DOI 10.1097/00004032-198802000-00001; Kotrappa P., 1981, HEALTH PHYS, V46, P35; Mitsuda C, 2003, NUCL INSTRUM METH A, V497, P414, DOI 10.1016/S0168-9002(02)01923-X; Takeuchi Y, 1999, NUCL INSTRUM METH A, V421, P334, DOI 10.1016/S0168-9002(98)01204-2	8	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							033H01	10.1093/ptep/ptv018		7	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000018		
J	Ikeno, N; Yamagata-Sekihara, J; Nagahiro, H; Hirenzaki, S				Ikeno, Natsumi; Yamagata-Sekihara, Junko; Nagahiro, Hideko; Hirenzaki, Satoru			Formation spectra of pionic atoms in the Green's function method	Progress of Theoretical and Experimental Physics			English	Article							SIGMA-HYPERNUCLEI; NUCLEI; STATE	We study the formation spectra of deeply bound pionic atoms in the (d, He-3) reactions using the Green's function method, stimulated by recent developments in experimental techniques. The Green's function method is considered to be a better theoretical formalism than the effective number approach to evaluate the formation rate of unstable systems. We compare the calculated results by the Green's function method with those by the effective number approach in various cases. We find that the differences between the results obtained by both methods are reasonably small and we can reaffirm that the effective number approach is a good theoretical method for the analyses of the previous experimental data with typical binding-energy errors of Delta B. E. greater than or similar to 20 keV for the deeply bound pionic atoms. On the other hand, we think that theoretical results using the Green's function method will be necessary in the near future to deduce precise information on the pion properties in nuclei from analyses of the pionic atom data with better accuracy than before.	[Ikeno, Natsumi] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan; [Ikeno, Natsumi] Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068502, Japan; [Yamagata-Sekihara, Junko; Nagahiro, Hideko] Osaka Univ, Res Ctr Nucl Phys RCNP, Osaka 5670047, Japan; [Yamagata-Sekihara, Junko; Nagahiro, Hideko; Hirenzaki, Satoru] Nara Womens Univ, Dept Phys, Nara 6308506, Japan; [Hirenzaki, Satoru] High Energy Accelerator Res Org KEK, Inst Particle & Nucl Studies, J PARC Branch, KEK Theory Ctr, Tokai, Ibaraki 3191106, Japan	Ikeno, N (reprint author), Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan.	ikeno@nucl.phys.tohoku.ac.jp			Nara Women's University Intramural Grant for Young Women Researchers [24540274];  [25-40229]	We acknowledge the fruitful discussions on the experimental side with K. Itahashi, T. Nishi, and H. Fujioka. We thank D. Jido for the useful and stimulating discussions. This work was partly supported by a Nara Women's University Intramural Grant for Young Women Researchers, Grants-in-Aid for Scientific Research (No. 24540274), and a Grant-in-Aid for JSPS Fellows (No. 25-40229).	Geissel H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.122301; Hayano RS, 1999, EUR PHYS J A, V6, P99, DOI 10.1007/s100500050322; Hirenzaki S, 1997, PHYS REV C, V55, P2719, DOI 10.1103/PhysRevC.55.2719; Ikeno N, 2011, PROG THEOR PHYS, V126, P483, DOI 10.1143/PTP.126.483; Ikeno N., 2014, THESIS NARA WOMENS T; Ikeno N, 2011, EUR PHYS J A, V47, DOI 10.1140/epja/i2011-11161-9; Ikeno N., 2013, PROG THEOR EXP PHYS, V2013; Itzykson C, 1980, QUANTUM FIELD THEORY; Jido D, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.045202; Koike T, 2008, NUCL PHYS A, V804, P231, DOI 10.1016/j.nuclphysa.2008.01.015; Koike T, 2007, PHYS LETT B, V652, P262, DOI 10.1016/j.physletb.2007.07.038; Morimatsu O., 1994, Progress in Particle and Nuclear Physics, V33, DOI 10.1016/0146-6410(94)90051-5; MORIMATSU O, 1985, NUCL PHYS A, V435, P727, DOI 10.1016/0375-9474(85)90185-X; MORIMATSU O, 1988, NUCL PHYS A, V483, P493, DOI 10.1016/0375-9474(88)90081-4; Nagahiro H, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.035205; NIEVES J, 1993, NUCL PHYS A, V554, P509, DOI 10.1016/0375-9474(93)90245-S; Nishi T, 2013, NUCL INSTRUM METH B, V317, P290, DOI 10.1016/j.nimb.2013.05.055; Suzuki K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.072302; Yamagata J, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.014604; Yamazaki T, 2012, PHYS REP, V514, P1, DOI 10.1016/j.physrep.2012.01.003	20	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							033D01	10.1093/ptep/ptv013		13	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000014		
J	Kanda, N; Naka, S				Kanda, N.; Naka, S.			Bi-local field in gravitational shockwave background	Progress of Theoretical and Experimental Physics			English	Article								Particles with almost light velocity are able to be sources of shockwave gravity (SWG). Then, for ultra-high-energy particles, there exist two-body scatterings such that one particle is scattered from the gravitational background produced by another particle. Since the spacetime of SWG is closely related to a pp-wave solution of the AdS-type background, this type of interaction is also interesting in AdS dual gauge theories. From those viewpoints, the scattering of point particles or strings by SWG were studied. In this paper, we study the case of the bi-local models, which are simple relativistic bound systems having a close relation with specific modes of open strings. In particular, we analyze the bound-state effect on the scattering amplitudes, which describe the interaction between this model and SWG.	[Kanda, N.; Naka, S.] Nihon Univ, Dept Phys, Coll Sci & Technol, Tokyo 1018308, Japan	Kanda, N (reprint author), Nihon Univ, Dept Phys, Coll Sci & Technol, Tokyo 1018308, Japan.	naka@phys.cst.nihon-u.ac.jp; nkanda@phys.cst.nihon-u.ac.jp			SCOAP3	Open Access funding: SCOAP<SUP>3</SUP>.	AMATI D, 1988, PHYS LETT B, V210, P92, DOI 10.1016/0370-2693(88)90355-3; DeWitt B. S., 1964, RELATIVITY GROUP TOP, V1963, P735; Goto T., 1979, SUPPL PROG THEOR PHY, V67, P69; Gruzinov A., 2014, ARXIV14094555Y1GRQC; Hooft G. 't, 1987, PHYS LETT B, V198, P61; KLIMCIK C, 1988, PHYS LETT B, V208, P373, DOI 10.1016/0370-2693(88)90632-6; NAKA S, 1984, PROG THEOR PHYS, V71, P648, DOI 10.1143/PTP.71.648; Nastase H., ARXIV0410124HEPTH; Synge J. L., 1960, RELATIVITY GEN THEOR, P47; Yukawa H., 1949, PHYS REV, V76, pL300; Yukawa H., 1948, PROG THEOR PHYS, V3, pL205; Yukawa H., 1948, PROG THEOR PHYS, V3, pL452	12	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							033B10	10.1093/ptep/ptv025		12	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000024		
J	Kishimoto, I; Masuda, T; Takahashi, T; Takemoto, S				Kishimoto, Isao; Masuda, Toru; Takahashi, Tomohiko; Takemoto, Shoko			Open string fields as matrices	Progress of Theoretical and Experimental Physics			English	Article							MODEL	We show that the action expanded around Erler-Maccaferri's N D-brane solution describes the N + 1 D-brane system where one D-brane disappears due to tachyon condensation. String fields on multi-branes can be regarded as block matrices of a string field on a single D-brane in the same way as matrix theories.	[Kishimoto, Isao] Niigata Univ, Fac Educ, Niigata 9502181, Japan; [Masuda, Toru; Takahashi, Tomohiko; Takemoto, Shoko] Nara Womens Univ, Dept Phys, Nara 6308506, Japan	Kishimoto, I (reprint author), Niigata Univ, Fac Educ, Niigata 9502181, Japan.	tomo@asuka.phys.nara-wu.ac.jp			SCOAP3	Open Access funding: SCOAP<SUP>3</SUP>.	Ishibashi N, 1997, NUCL PHYS B, V498, P467, DOI 10.1016/S0550-3213(97)00290-3; WITTEN E, 1986, NUCL PHYS B, V268, P253, DOI 10.1016/0550-3213(86)90155-0; Banks T, 1997, PHYS REV D, V55, P5112, DOI 10.1103/PhysRevD.55.5112; Schnabl M, 2006, ADV THEOR MATH PHYS, V10, P433; Bonora L, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2644-y; Bonora L., ARXIV14120936HEPTH; Ellwood I., 2007, J HIGH ENERGY PHYS, V0702, P096; Erler T., 2014, J HIGH ENERGY PHYS, V1410, P029; Erler T., 2009, J HIGH ENERGY PHYS, V0910, P066; Inatomi S, 2011, PROG THEOR PHYS, V126, P1077; Ishibashi N., ARXIV14086319HEPTH; Kishimoto I, 2002, PROG THEOR PHYS, V108, P591, DOI 10.1143/PTP.108.591; Takahashi T., 2002, J HIGH ENERGY PHYS, V0203, P033; ZWIEBACH B, 1992, MOD PHYS LETT A, V7, P1079, DOI 10.1142/S0217732392000951	14	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							033B05	10.1093/ptep/ptv023		8	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000022		
J	Kishimoto, T; Matsuoka, K; Fukumoto, T; Umehara, S				Kishimoto, T.; Matsuoka, K.; Fukumoto, T.; Umehara, S.			Calcium isotope enrichment by means of multi-channel counter-current electrophoresis for the study of particle and nuclear physics	Progress of Theoretical and Experimental Physics			English	Article							DOUBLE-BETA DECAY; ELECTROMIGRATION	We have developed a new method for enrichment of large amounts of calcium isotopes for the future study of Ca-48 double beta decay. The method is called multi-channel counter-current electrophoresis (MCCCE). We present the concept of MCCCE, in which the power density in the migration path is the key to efficient enrichment of a large amount of materials. In MCCCE, ions migrate in multi-channels on a boron nitride (BN) plate, allowing a substantial increase in the power density to be achieved. We made a tiny prototype instrument and obtained an enrichment factor of 3 for the ratio of the abundance of Ca-48 to Ca-43 over that of natural abundance. This corresponds to an enrichment factor of 6 for Ca-48 to Ca-40. This remarkably large enrichment factor demonstrates that MCCCE is a realistic and promising method for the enrichment of large amounts of ions. It can be applied to many other elements and compounds.	[Kishimoto, T.] Osaka Univ, Dept Phys, Grad Sch Sci, Toyonaka, Osaka 5600041, Japan; [Kishimoto, T.; Matsuoka, K.; Umehara, S.] Osaka Univ, Res Ctr Nucl Phys, Osaka 5670047, Japan; [Fukumoto, T.] Osaka Univ, Dept Chem, Grad Sch Sci, Toyonaka, Osaka 5600041, Japan	Kishimoto, T (reprint author), Osaka Univ, Dept Phys, Grad Sch Sci, 1-1 Machikaneyamacho, Toyonaka, Osaka 5600041, Japan.	kisimoto@phys.sci.osaka-u.ac.jp			JSPS KAKENHI [24224007]; MEXT KAKENHI [26104003]	This work was supported by a JSPS KAKENHI Grant-in-Aid for Scientific Research (S) 24224007 and a MEXT KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas 26104003.	FUJII Y, 1985, Z NATURFORSCH A, V40, P843; KOBAYASHI N, 1982, J CHROMATOGR, V252, P121, DOI 10.1016/S0021-9673(01)88403-X; Barabash AS, 2014, PHYS-USP+, V57, P482, DOI [10.3367/UFNe.0184.201405f.0524, 10.3367/UFNr.0184.201405f.0524]; BREWER AK, 1947, J RES NAT BUR STAND, V38, P137, DOI 10.6028/jres.038.005; Kemp G, 1998, BIOTECHNOL APPL BIOC, V27, P9; Kishimoto T., 2003, P 4 INT WORKSH NEUTR, P338; Kishimoto T., 2009, INT J MOD PHYS E, V10, P2129; Umehara S, 2014, EPJ WEB CONF, V66, DOI 10.1051/epjconf/20146608008	8	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							033D03	10.1093/ptep/ptv020		10	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000020		
J	Kunitomo, H				Kunitomo, Hiroshi			Symmetries and Feynman rules for the Ramond sector in open superstring field theory	Progress of Theoretical and Experimental Physics			English	Article							STRING THEORY; SUPERSYMMETRY; INVARIANCE; AMPLITUDE	We examine the symmetries of the action supplemented by the constraint in the WZW-type open superstring field theory. It is found that this pseudo-action has additional symmetries provided we impose the constraint after the transformation. Respecting these additional symmetries, we propose a prescription for the new Feynman rules for the Ramond sector. It is shown that the new rules reproduce the well-known on-shell four-and five-point amplitudes with external fermions.	Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068502, Japan	Kunitomo, H (reprint author), Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068502, Japan.	kunitomo@yukawa.kyoto-u.ac.jp			SCOAP3	Open Access funding: SCOAP<SUP>3</SUP>.	Berkovits N, 2000, PHYS LETT B, V478, P343, DOI 10.1016/S0370-2693(00)00246-X; Bergshoeff E, 2001, CLASSICAL QUANT GRAV, V18, P3359, DOI 10.1088/0264-9381/18/17/303; GIDDINGS SB, 1986, PHYS LETT B, V176, P362, DOI 10.1016/0370-2693(86)90179-6; FRIEDAN D, 1986, NUCL PHYS B, V271, P93; WITTEN E, 1986, NUCL PHYS B, V268, P253, DOI 10.1016/0550-3213(86)90155-0; ZWIEBACH B, 1993, NUCL PHYS B, V390, P33, DOI 10.1016/0550-3213(93)90388-6; BERKOVITS N, 1995, NUCL PHYS B, V450, P90, DOI 10.1016/0550-3213(95)00259-U; Berkovits N., 2001, JHEP, V0111, P047; Berkovits N, 1996, NUCL PHYS B, V459, P439, DOI 10.1016/0550-3213(95)00620-6; Berkovits N., 2004, J HIGH ENERGY PHYS, V0411, P038; Fuji H., 2007, JHEP, V0701, P01; GIDDINGS SB, 1986, NUCL PHYS B, V278, P242, DOI 10.1016/0550-3213(86)90211-7; Kroyter M., 2012, JHEP, V1203, P0; KUGO T, 1989, PHYS LETT B, V226, P48, DOI 10.1016/0370-2693(89)90287-6; Kunitomo H., 2014, PROG THEOR EXP PHYS, V2014; Kunitomo H., 2014, PTEP, V2014; Michishita Y., 2005, J HIGH ENERGY PHYS, V0501, P012; Michishita Y., 2012, NATURAL SCI, V63, P17; Michishita Y., 2007, COMMUNICATION; Okawa Y., 2004, J HIGH ENERGY PHYS, V0407, P042; SAADI M, 1989, ANN PHYS-NEW YORK, V192, P213, DOI 10.1016/0003-4916(89)90126-7; Sen A., ARXIV14080571HEPTH; Torii S., 2012, JHEP, V1204, P050; ZWIEBACH B, 1991, COMMUN MATH PHYS, V142, P193, DOI 10.1007/BF02099176	24	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							033B11	10.1093/ptep/ptv027		22	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000026		
J	Makino, H; Suzuki, H				Makino, Hiroki; Suzuki, Hiroshi			Renormalizability of the gradient flow in the 2D O(N) non-linear sigma model	Progress of Theoretical and Experimental Physics			English	Article							ENERGY-MOMENTUM TENSOR; STOCHASTIC QUANTIZATION; BETA-FUNCTION; LATTICE; GAUGE; FERROMAGNETS; DIMENSIONS; SYSTEMS; FIELDS	It is known that the gauge field and its composite operators evolved by the Yang-Mills gradient flow are ultraviolet (UV) finite without any multiplicative wave function renormalization. In this paper, we prove that the gradient flow in the 2D O(N) non-linear sigma model possesses a similar property: The flowed N-vector field and its composite operators are UV finite without multiplicative wave function renormalization. Our proof in all orders of perturbation theory uses a (2 + 1)-dimensional field theoretical representation of the gradient flow, which possesses local gauge invariance without gauge field. As an application of the UV finiteness of the gradient flow, we construct the energy-momentum tensor in the lattice formulation of the O(N) non-linear sigma model that automatically restores the correct normalization and the conservation law in the continuum limit.	[Makino, Hiroki; Suzuki, Hiroshi] Kyushu Univ, Dept Phys, Higashi Ku, Fukuoka 8128581, Japan	Makino, H (reprint author), Kyushu Univ, Dept Phys, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	hsuzuki@phys.kyushu-u.ac.jp			 [23540330]	We would like to thank Koji Harada for helpful discussion on perturbation theory in the non-linear sigma model and Kengo Kikuchi for exposition on his work, Ref. [8]. We are grateful to Martin Luscher for explaining the hard part of the proof in Ref. [13] patiently to us. The work of H.S. is supported in part by a Grant-in-Aid for Scientific Research 23540330.	BREZIN E, 1976, PHYS REV LETT, V36, P691, DOI 10.1103/PhysRevLett.36.691; Asakawa M, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.011501; WOLFF U, 1989, PHYS REV LETT, V62, P361, DOI 10.1103/PhysRevLett.62.361; Aoki S., ARXIV14128249HEPTH; Aoki S, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-2890-7; Balog J., 2012, J HIGH ENERGY PHYS, V1211, P140; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; BERNREUTHER W, 1986, PHYS REV LETT, V57, P1383, DOI 10.1103/PhysRevLett.57.1383; Bogli M., 2012, J HIGH ENERGY PHYS, V1204, P117; Borsanyi S., 2012, J HIGH ENERGY PHYS, V1209, P010; BREZIN E, 1976, PHYS REV D, V14, P2615, DOI 10.1103/PhysRevD.14.2615; CARACCIOLO S, 1990, ANN PHYS-NEW YORK, V197, P119, DOI 10.1016/0003-4916(90)90203-Z; CARACCIOLO S, 1988, NUCL PHYS B, V309, P612, DOI 10.1016/0550-3213(88)90332-X; DAVID F, 1982, NUCL PHYS B, V209, P433, DOI 10.1016/0550-3213(82)90266-8; Fodor Z., 2012, J HIGH ENERGY PHYS, V1211, P007; Fritzsch P., 2013, JHEP, V1310, P008; FUJIKAWA K, 1984, Z PHYS C PART FIELDS, V25, P179, DOI 10.1007/BF01557477; Hasenfratz A., ARXIV14105886HEPLAT; HIKAMI S, 1978, J PHYS A-MATH GEN, V11, P1141, DOI 10.1088/0305-4470/11/6/015; HIKAMI S, 1983, NUCL PHYS B, V215, P555, DOI 10.1016/0550-3213(83)90260-2; Kikuchi K., ARXIV14082185HEPTH; Luscher M., ARXIV13085598HEPLAT; Luscher M., 2013, J HIGH ENERGY PHYS, V1304, P123; Luscher M., 2010, J HIGH ENERGY PHYS, V1008, P071; Luscher M., 2011, J HIGH ENERGY PHYS, V1102, P051; Luscher M., 2014, J HIGH ENERGY PHYS, V1406, P105; Makino H., ARXIV14128218HEPLAT; Makino H., ARXIV14034772V4HEPLA; MAKINO H, 2014, PROG THEOR EXP PHYS, V2014, pB6302; MIGDAL AA, 1975, ZH EKSP TEOR FIZ+, V69, P1457; Monahan C., 2014, POS LATTICE, V2014, P330; Noaki J., 2013, POS LATTICE, P263; Nogradi D., 2012, JHEP, V1205, P089; Patella A., 2013, J HIGH ENERGY PHYS, V1311, P212; Peskin M E, 1995, INTRO QUANTUM FIELD; POLYAKOV AM, 1975, PHYS LETT B, V59, P79, DOI 10.1016/0370-2693(75)90161-6; SUZUKI H, 2013, PROG THEOR EXP PHYS, V2013, pB8303; Taylor J.C., 1976, GAUGE THEORIES WEAK; WOLFF U, 1990, NUCL PHYS B, V334, P581, DOI 10.1016/0550-3213(90)90313-3; ZINNJUSTIN J, 1986, NUCL PHYS B, V275, P135, DOI 10.1016/0550-3213(86)90592-4; ZINNJUSTIN J, 1988, NUCL PHYS B, V295, P297, DOI 10.1016/0550-3213(88)90358-6; Zinn-Justin J., 1974, LECT INT SUMM I THEO	42	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							033B08	10.1093/ptep/ptv028		30	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000027		
J	Matsuura, S; Misumi, T; Ohta, K				Matsuura, So; Misumi, Tatsuhiro; Ohta, Kazutoshi			Exact results in discretized gauge theories	Progress of Theoretical and Experimental Physics			English	Article							FIELD-THEORIES; LATTICE FORMULATION; EXACT SUPERSYMMETRY; LOCALIZATION	We apply the localization technique to topologically twisted N = (2, 2) supersymmetric gauge theory on a discretized Riemann surface (the generalized Sugino model). We exactly evaluate the partition function and the vacuum expectation value (vev) of a specific Q-closed operator. We show that both the partition function and the vev of the operator depend only on the Euler characteristic and the area of the discretized Riemann surface and are independent of the details of the discretization. This localization technique may not only simplify the numerical analysis of supersymmetric lattice models but also connect the well defined equivariant localization to the empirical supersymmetric localization.	[Matsuura, So; Misumi, Tatsuhiro] Keio Univ, Dept Phys, Yokohama, Kanagawa 2238521, Japan; [Ohta, Kazutoshi] Meiji Gakuin Univ, Inst Phys, Yokohama, Kanagawa 2448539, Japan	Matsuura, S (reprint author), Keio Univ, Dept Phys, Hiyoshi Campus,4-1-1 Hiyoshi, Yokohama, Kanagawa 2238521, Japan.	s.matsu@phys-h.keio.ac.jp; misumi@phys-h.keio.ac.jp; kohta@law.meijigakuin.ac.jp			SCOAP3	Open Access funding: SCOAP<SUP>3</SUP>.	Sugino F, 2009, NUCL PHYS B, V808, P292, DOI 10.1016/j.nuclphysb.2008.09.035; Cohen AG, 2003, J HIGH ENERGY PHYS; Cohen AG, 2003, J HIGH ENERGY PHYS; KAZAKOV VA, 1993, NUCL PHYS B, V397, P214, DOI 10.1016/0550-3213(93)90342-M; ITZYKSON C, 1980, J MATH PHYS, V21, P411, DOI 10.1063/1.524438; Ohta K, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.105018; Beasley C, 2005, J DIFFER GEOM, V70, P183; Pestun V, 2012, COMMUN MATH PHYS, V313, P71, DOI 10.1007/s00220-012-1485-0; DUISTERMAAT JJ, 1982, INVENT MATH, V69, P259, DOI 10.1007/BF01399506; BLAU M, 1995, J MATH PHYS, V36, P2192, DOI 10.1063/1.531038; Blau M., ARXIV9310144HEPTH; Denef F, 2002, J HIGH ENERGY PHYS; Giedt J., 2004, JHEP, V0409; Hanada M, 2012, NUCL PHYS B, V857, P335, DOI 10.1016/j.nuclphysb.2011.12.014; Hanada M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.065014; HARISHCHANDRA, 1957, AM J MATH, V79, P87, DOI 10.2307/2372387; Kanamori I., ARXIV07112099; Kanamori I., ARXIV07112132; Kanamori I, 2009, NUCL PHYS B, V811, P420, DOI 10.1016/j.nuclphysb.2008.11.021; Kaplan DB, 2005, J HIGH ENERGY PHYS; Kaplan DB, 2003, J HIGH ENERGY PHYS; Kapustin A., 2010, JHEP, V1003, P089, DOI DOI 10.1007/JHEP03(2010)089; Karki T., ARXIV9402041HEPTH; Kikukawa Y, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.094508; Kirillov A. A., 1976, GRUNDLEHREN MATH WIS, V220; KOGAN II, 1993, NUCL PHYS B, V395, P547, DOI 10.1016/0550-3213(93)90047-S; Kostant B., 1970, C INT MATH, V2, P395; Matsuura S, 2014, PROG THEOR EXP PHYS, DOI 10.1093/ptep/ptu153; Matsuura S., 2014, J HIGH ENERGY PHYS, V1404, P088; MIGDAL AA, 1975, ZH EKSP TEOR FIZ+, V69, P810; Ohta K., 2014, J HIGH ENERGY PHYS, V1411, P123; Ohta K., 2013, PROG THEOR EXP PHYS, V2013; Ohta K, 2007, PROG THEOR PHYS, V117, P317, DOI 10.1143/PTP.117.317; Ohta K., 2007, POS LAT 2007, V2007, P279; SAKAI N, 1983, NUCL PHYS B, V229, P173, DOI 10.1016/0550-3213(83)90359-0; Souriau J. M., 1997, PROGR MATH; Sugino F, 2004, J HIGH ENERGY PHYS; Sugino F, 2006, PHYS LETT B, V635, P218, DOI 10.1016/j.physletb.2006.02.064; Sugino F, 2005, J HIGH ENERGY PHYS; Sugino F, 2004, J HIGH ENERGY PHYS; Suzuki H, 2007, J HIGH ENERGY PHYS; Szabo R. J., ARXIV9608068HEPTH; Szabo R. J., 2000, LECT NOTES PHYS M, V63, P1; WITTEN E, 1991, INT J MOD PHYS A, V6, P2775, DOI 10.1142/S0217751X91001350; Witten E., 1992, Journal of Geometry and Physics, V9, DOI 10.1016/0393-0440(92)90034-X; WITTEN E, 1988, COMMUN MATH PHYS, V117, P353, DOI 10.1007/BF01223371	46	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							033B07	10.1093/ptep/ptv021		19	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000021		
J	Misumi, T; Nitta, M; Sakai, N				Misumi, Tatsuhiro; Nitta, Muneto; Sakai, Norisuke			Classifying bions in Grassmann sigma models and non-Abelian gauge theories by D-branes	Progress of Theoretical and Experimental Physics			English	Article							CLASSICAL-SOLUTIONS; QUANTUM-MECHANICS; SYMMETRY BREAKING; CHIRAL FIELD; Q-KINKS; LARGE-N; SUPERSYMMETRY; VORTICES; DUALITY; KAHLER	We classify bions in the Grassmann Gr(NF),(NC) sigma model (including the CPNF-1 model) on R-1 x S-1 with twisted boundary conditions. We formulate these models as U(N-C) gauge theories with N-F flavors in the fundamental representations. These theories can be promoted to supersymmetric gauge theories and, further, can be embedded into D-brane configurations in type-II superstring theories. We focus on specific configurations composed of multiple fractional instantons, termed neutral bions and charged bions, which are identified as perturbative infrared renormalons by Unsal and his collaborators [G. V. Dunne and M. Unsal, J. High Energy Phys. 1211, 170 (2012); G. V. Dunne and M. Unsal, Phys. Rev. D 87, 025015 (2013)]. We show that D-brane configurations, as well as the moduli matrix, offer a very useful tool to classify all possible bion configurations in these models. In contrast to the CPNF-1 model, there exist Bogomol'nyi-Prasad-Sommerfield (BPS) fractional instantons with topological charges greater than unity (of order N-C) that cannot be reduced to a composite of an instanton and fractional instantons. As a consequence, we find that the Grassmann sigma model admits neutral bions made of BPS and anti-BPS fractional instantons, each of which has a topological charge greater (less) than one (minus one), that are not decomposable into an instanton-anti-instanton pair and the rest. The CPNF-1 model is found to have no charged bions. In contrast, we find that the Grassmann sigma model admits charged bions, for which we construct exact non-BPS solutions of the field equations.	[Misumi, Tatsuhiro] Keio Univ, Dept Phys, Yokohama, Kanagawa 2238521, Japan; Keio Univ, Res & Educ Ctr Nat Sci, Yokohama, Kanagawa 2238521, Japan	Misumi, T (reprint author), Keio Univ, Dept Phys, Hiyoshi 4-1-1, Yokohama, Kanagawa 2238521, Japan.	misumi@phys-h.keio.ac.jp; nitta@phys-h.keio.ac.jp; norisuke.sakai@gmail.com			SCOAP3	Open Access funding: SCOAP<SUP>3</SUP>.	ALVAREZGAUME L, 1983, COMMUN MATH PHYS, V91, P87, DOI 10.1007/BF01206053; Anber M M, 2011, J HIGH ENERGY PHYS, V1106, P136; Eto M, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.125008; Eto M, 2009, NUCL PHYS B, V815, P495, DOI 10.1016/j.nuclphysb.2009.01.019; Argyres PC, 1996, NUCL PHYS B, V471, P159, DOI 10.1016/0550-3213(96)00210-6; Eto M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.125011; Eto M, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.105009; Eto M, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.125006; Argyres P, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.121601; LINDSTROM U, 1983, NUCL PHYS B, V222, P285, DOI 10.1016/0550-3213(83)90638-7; Eto M, 2008, PHYS LETT B, V669, P98, DOI 10.1016/j.physletb.2008.09.007; Isozumi Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.161601; Eto M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.161601; Eto M, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.065021; Auzzi R, 2003, NUCL PHYS B, V673, P187, DOI 10.1016/j.nuclphysb.2003.09.029; ALVAREZGAUME L, 1981, COMMUN MATH PHYS, V80, P443, DOI 10.1007/BF01208280; Shifman M, 2007, REV MOD PHYS, V79, P1139, DOI 10.1103/RevModPhys.79.1139; BOGOMOLNYI EB, 1976, SOV J NUCL PHYS+, V24, P449; Cossu G, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.094509; Ogilvie MC, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/48/483001; Nakano E, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.045002; Shifman M, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.125012; Eto M, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.125025; Dunne GV, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.041701; Higashijima K, 2000, PROG THEOR PHYS, V103, P635, DOI 10.1143/PTP.103.635; HITCHIN NJ, 1987, COMMUN MATH PHYS, V108, P535, DOI 10.1007/BF01214418; Giveon A, 1999, REV MOD PHYS, V71, P983, DOI 10.1103/RevModPhys.71.983; HOSOTANI Y, 1983, PHYS LETT B, V126, P309, DOI 10.1016/0370-2693(83)90170-3; ABRAHAM ERC, 1992, PHYS LETT B, V291, P85, DOI 10.1016/0370-2693(92)90122-K; Isozumi Y, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.125014; Brendel W, 2009, PHYS LETT B, V676, P116, DOI 10.1016/j.physletb.2009.04.055; Balachandran AP, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.074009; Nishimura H, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.014018; Harland D, 2009, J MATH PHYS, V50, DOI 10.1063/1.3266172; Shifman M, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.065004; Antoniadis I, 1997, INT J MOD PHYS A, V12, P4907, DOI 10.1142/S0217751X97002620; Eto M, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.025011; WITTEN E, 1978, PHYS LETT B, V78, P97, DOI 10.1016/0370-2693(78)90357-X; Arai M, 2003, NUCL PHYS B, V652, P35, DOI 10.1016/S0550-3213(03)00009-9; BOGOMOLNY EB, 1980, PHYS LETT B, V91, P431, DOI 10.1016/0370-2693(80)91014-X; Eto M, 2008, NUCL PHYS B, V788, P120, DOI 10.1016/j.nuclphysb.2007.06.020; Shifman M, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.045004; Bolognesi S, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.065013; Tong D, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.065003; Shifman M, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.025013; Dunne GV, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.025015; Myers JC, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.125030; Arai M, 2005, PROG THEOR PHYS, V113, P657, DOI 10.1143/PTP.113.657; Ferretti L, 2008, NUCL PHYS B, V789, P84, DOI 10.1016/j.nuclphysb.2007.07.021; Eto M, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.105002; Gauntlett JP, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.025010; FATEEV VA, 1994, PHYS REV LETT, V73, P1750, DOI 10.1103/PhysRevLett.73.1750; Eto M, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.085004; Fujimori T, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.105004; Eto M, 2006, PHYS LETT B, V632, P384, DOI 10.1016/j.physletb.2005.10.017; TAUBES CH, 1980, COMMUN MATH PHYS, V72, P277, DOI 10.1007/BF01197552; ZINNJUSTIN J, 1981, NUCL PHYS B, V192, P125, DOI 10.1016/0550-3213(81)90197-8; DIN AM, 1980, NUCL PHYS B, V174, P397, DOI 10.1016/0550-3213(80)90291-6; PRASAD MK, 1975, PHYS REV LETT, V35, P760, DOI 10.1103/PhysRevLett.35.760; Zinn-Justin J, 2004, ANN PHYS-NEW YORK, V313, P197, DOI 10.1016/j.aop.2004.04.004; FATEEV VA, 1994, NUCL PHYS B, V424, P505, DOI 10.1016/0550-3213(94)90405-7; ZUMINO B, 1979, PHYS LETT B, V87, P203, DOI 10.1016/0370-2693(79)90964-X; Eto M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.161601; ABRAHAM ERC, 1992, PHYS LETT B, V295, P225, DOI 10.1016/0370-2693(92)91558-Q; Eto M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.091602; AOYAMA S, 1980, NUOVO CIMENTO A, V57, P176, DOI 10.1007/BF02776450; 't Hooft G., 1979, SUBNUCL SER, V15, P943; Arai M., 2003, Garden of quanta. Essays in honor of Hiroshi Ezawa, DOI 10.1142/9789812795106_0018; Argyres P. C., 2012, J HIGH ENERGY PHYS, V1208, P063; Basar G, 2013, J HIGH ENERGY PHYS, V1310; Bruckmann F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.051602; Bruckmann F., ARXIV14082229HEPTH; Cherman A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.021601; Cherman A., ARXIV14031277HEPTH; Cossu G., 2009, JHEP, V0907, P048; Dabrowski R, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.025020; DADDA A, 1979, NUCL PHYS B, V152, P125, DOI 10.1016/0550-3213(79)90083-X; DIN AM, 1981, NUCL PHYS B, V182, P151, DOI 10.1016/0550-3213(81)90463-6; Dunne GV, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.105009; Dunne G.V., 2012, JHEP, V1211, P170; Ecalle J., 1981, FONCTIONS RESURGENTE, VI-III; Eto M, 2005, AIP CONF PROC, V805, P354; Eto M, 2006, PHYS REV D, V73, DOI [10.1103/PhysRevD.73.125008, 10.1103/PhysRevD.73.085008]; Eto M, 2006, J PHYS A-MATH GEN, V39, pR315, DOI 10.1088/0305-4470/39/26/R01; Eto M, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.085005; Eto M., 2011, J HIGH ENERGY PHYS, V1112, P017; Eto M., 2009, J HIGH ENERGY PHYS, V0906, P004; Eto M., 2014, PROG THEOR EXP PHYS, V2014; Eto M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.252003; Eto M, 2006, NUCL PHYS B, V752, P140, DOI 10.1016/j.nuclphysb.2006.06.026; Hanany A., 2003, JHEP, V0307; Hanany A, 1997, NUCL PHYS B, V492, P152; Hanany A, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/04/066; HOSOTANI Y, 1989, ANN PHYS-NEW YORK, V190, P233, DOI 10.1016/0003-4916(89)90015-8; Inami T, 2006, NUCL PHYS B, V752, P391, DOI 10.1016/j.nuclphysb.2006.06.015; Isozumi Y, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.065018; Kashiwa K., 2013, J HIGH ENERGY PHYS, V1305, P042; Kobayashi M, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.085003; Lambert ND, 2000, NUCL PHYS B, V569, P606, DOI 10.1016/S0550-3213(99)00610-0; Meisinger PN, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.025012; Misumi T., 2014, J HIGH ENERGY PHYS, V1406, P181; Misumi T, 2014, J HIGH ENERGY PHYS, V1406, P164; Myers J. C., 2009, JHEP, V0907, P095; Nitta M, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.125004; Ohta K., 2013, PROG THEOR EXP PHYS, V2013; Polyakov A. M., 1989, GAUGE FIELDS STRINGS; Polyakov A. M., 1975, JETP LETT, V22, P245; Poppitz E, 2012, J HIGH ENERGY PHYS, V1210, P115; Poppitz E, 2009, JHEP, V0909; Shifman M, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.125007; Shifman M, 2009, CAM M MATH, P1, DOI 10.1017/CBO9780511575693; Tong D., ARXIV05092I6HEPTH; Tong D, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.025013; Unsal M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.065001; Unsal M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.032005; Zakrzewski W. J., 1989, LOW DIMENSIONAL SIGM	116	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							033B02	10.1093/ptep/ptv009		42	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000010		
J	Nagamiya, S				Nagamiya, Shoji			Scientific endeavors towards RHIC and the PHENIX experiment	Progress of Theoretical and Experimental Physics			English	Article							HEAVY-ION COLLISIONS; NUCLEON; MATTER; MULTIPLICITY	Experimental activities towards the Relativistic HeavyIon Collider (RHIC) were initiated at the beginning of the 1990s. In the middle of the 1990s the PHENIX proposal was approved as one of two major experiments at RHIC. I will describe how a typical scientist considered physics, the detector and society in those days.	[Nagamiya, Shoji] RIKEN, Wako, Saitama 3510198, Japan; [Nagamiya, Shoji] KEK, Tsukuba, Ibaraki 3050801, Japan	Nagamiya, S (reprint author), RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	shoji.nagamiya@riken.jp					JAFFE RL, 1990, NUCL PHYS B, V337, P509, DOI 10.1016/0550-3213(90)90506-9; BAGLIN C, 1989, PHYS LETT B, V220, P471, DOI 10.1016/0370-2693(89)90905-2; [Anonymous], 1993, PHENIX CONC DES REP; VANHOVE L, 1982, PHYS LETT B, V118, P138, DOI 10.1016/0370-2693(82)90617-7; Adcox K, 2005, NUCL PHYS A, V757, P184, DOI 10.1016/j.nuclphysa.2005.03.086; Adler SS, 2003, PHYS REV LETT, V91, DOI [10.1103/PhysRevLett.91.182301, 10.1103/PhysRevLett.91.072301]; E802 Collaboration, 1990, PHYS REV LETT, V64, P849; ABBOTT T, 1987, PHYS LETT B, V197, P285, DOI 10.1016/0370-2693(87)90385-6; LISSAUER D, 1991, PHYS LETT B, V253, P15, DOI 10.1016/0370-2693(91)91355-Y; Mastsui T., 1986, PHYS LETT B, V178, P416; BAMBERGER A, 1987, PHYS LETT B, V184, P271, DOI 10.1016/0370-2693(87)90581-8; NA35 Collaboration, 1988, Z PHYS C, V38, P19; NAGAMIYA S, 1988, NUCL PHYS A, V488, pC3; RUUSKANEN PV, 1992, NUCL PHYS A, V544, pC169; TAKAHASHI Y, 1987, NUCL PHYS A, V461, pC263	15	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							03A101	10.1093/ptep/ptu068		13	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000001		
J	Nakamura, S; Okazawa, F; Matsuo, Y				Nakamura, Satoshi; Okazawa, Futoshi; Matsuo, Yutaka			Recursive method for the Nekrasov partition function for classical Lie groups	Progress of Theoretical and Experimental Physics			English	Article							INSTANTONS; CONJECTURE	The Nekrasov partition function for supersymmetric gauge theories with general Lie groups is, so far, not known in a closed form, while there is a definition in terms of the integral. In this paper, as an intermediate step to derive the closed form, we give a recursion formula among partition functions, which can be derived from the integral. We apply the method to a toy model that reflects the basic structure of partition functions for BCD-type Lie groups and obtain a closed expression for the factor associated with the generalized Young diagram.	[Nakamura, Satoshi; Okazawa, Futoshi; Matsuo, Yutaka] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Nakamura, S (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	satoshi@hep-th.phys.s.u-tokyo.ac.jp			SCOAP3	Open Access funding: SCOAP<SUP>3</SUP>.	Alday LF, 2010, LETT MATH PHYS, V91, P167, DOI 10.1007/s11005-010-0369-5; Flume R, 2003, INT J MOD PHYS A, V18, P2541, DOI 10.1142/S0217751X03013685; Szenes A, 2004, INVENT MATH, V158, P453, DOI 10.1007/s00222-004-0375-2; Nakajima H, 2005, INVENT MATH, V162, P313, DOI 10.1007/s00222-005-0444-1; Nekrasov N, 2004, COMMUN MATH PHYS, V252, P359, DOI 10.1007/s00220-004-1189-1; Alba VA, 2011, LETT MATH PHYS, V98, P33, DOI 10.1007/s11005-011-0503-z; Morozov A, 2014, LETT MATH PHYS, V104, P585, DOI 10.1007/s11005-014-0681-6; ATIYAH MF, 1978, PHYS LETT A, V65, P185, DOI 10.1016/0375-9601(78)90141-X; [Anonymous], ARXIV0306238HEPTH; Schiffmann O, 2013, PUBL MATH-PARIS, P213, DOI 10.1007/s10240-013-0052-3; Bruzzo U., 2003, JHEP, V0305, P054; Fateev V. A., 2010, JHEP, V1002; Fucito F., 2004, JHEP, V0410, P037; Hollands L., 2011, J HIGH ENERGY PHYS, V1103, P053; Jeffrey L. C., ARXIV9307001ALGGEOM; Kanno S., 2013, J HIGH ENERGY PHYS, V1308, P028; Keller C. A., 2012, J HIGH ENERGY PHYS, V1203, P045; Marino M., 2004, JHEP, V0405, P021; Matsuo Y., 2014, J HIGH ENERGY PHYS, V1409, P028; Maulik D., ARXIV12111287; Nakajima H., 1999, U LECT SERIES, V18; SEIBERG N, 1994, NUCL PHYS B, V426, P19, DOI 10.1016/0550-3213(94)90124-4; Shadchin S., ARXIV0502180HEPTH	23	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3								10.1093/ptep/ptv014		19	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000015		
J	Nakazawa, K; Endo, Y; Fukunaga, S; Hoshino, K; Hwang, SH; Imai, K; Ito, H; Itonaga, K; Kanda, T; Kawasaki, M; Kim, JH; Kinbara, S; Kobayashi, H; Mishina, A; Ogawa, S; Shibuya, H; Sugimura, T; Soe, MK; Takahashi, H; Takahashi, T; Tint, KT; Umehara, K; Yoon, CS; Yoshida, J				Nakazawa, K.; Endo, Y.; Fukunaga, S.; Hoshino, K.; Hwang, S. H.; Imai, K.; Ito, H.; Itonaga, K.; Kanda, T.; Kawasaki, M.; Kim, J. H.; Kinbara, S.; Kobayashi, H.; Mishina, A.; Ogawa, S.; Shibuya, H.; Sugimura, T.; Soe, M. K.; Takahashi, H.; Takahashi, T.; Tint, K. T.; Umehara, K.; Yoon, C. S.; Yoshida, J.			The first evidence of a deeply bound state of Xi(-)-N-14 system	Progress of Theoretical and Experimental Physics			English	Article							LAMBDA-HYPERNUCLEI; CAPTURE; MODEL; REST	We have observed a deeply bound state of the Xi(-)-N-14 system that decayed into twin single-hypernuclei in nuclear emulsion exposed in the E373 experiment at KEK-PS. The process is uniquely identified as Xi(-) + N-14 -> Be-10(Lambda) + He-5(Lambda). We have measured the binding energy of the Xi(-)-N-14 system, B Xi-, to be 4.38 +/- 0.25MeV, which is significantly larger than that of the Xi(-)-N-14 3D atomic state (0.17 MeV), if both single-hypernuclei are emitted in the ground state from at-rest capture of a Xi-hyperon. If the Be-10(Lambda) nucleus is produced in an excited state, the B Xi- value mentioned above decreases by the excitation energy. Model calculations based on known values for Be-9 excited states have predicted two excited states in the bound region. Even in the case of Be-10(Lambda) production in the highest excited state, the B Xi- value is far from the 3D atomic level of the Xi(-)-N-14 system by more than 3.7 standard deviations. The event provides the first clear evidence of a deeply bound state of the Xi(-)-N-14 system by an attractive Xi N interaction.	[Nakazawa, K.; Endo, Y.; Hoshino, K.; Ito, H.; Itonaga, K.; Kanda, T.; Kawasaki, M.; Kinbara, S.; Kobayashi, H.; Mishina, A.; Sugimura, T.; Soe, M. K.; Tint, K. T.; Umehara, K.; Yoshida, J.] Gifu Univ, Dept Phys, Gifu 5011193, Japan; [Fukunaga, S.; Ogawa, S.; Shibuya, H.] Toho Univ, Dept Phys, Funabashi, Chiba 2748510, Japan; [Hwang, S. H.; Imai, K.] JAEA, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Kim, J. H.; Yoon, C. S.] Gyeongsang Natl Univ, Dept Phys, Jinju 660701, South Korea; [Takahashi, H.; Takahashi, T.] KEK, Inst Particle & Nucl Studies, Tsukuba, Ibaraki 3050801, Japan	Nakazawa, K (reprint author), Gifu Univ, Dept Phys, 1-1 Yanagido, Gifu 5011193, Japan.	nakazawa@gifu-u.ac.jp			Endo Seijiro Science Foundation; JSPS KAKENHI [14340069, 23224006]; MEXT KAKENHI [08239103, 24105002]; Korea Grant [NRF-2013R1A1A2061654]	The authors thank the KEK staff for support during the experiment, Professors D. H. Davis and D. Tovee for discussion on the analysis, and Professors E. Hiyama, Y. Yamamoto, T. Yamada, and T. Koike for theoretical comments. This work was supported by the Endo Seijiro Science Foundation in 2007, by JSPS KAKENHI Grant Numbers 14340069, and 23224006, MEXT KAKENHI Grant Numbers 08239103 (Priority Area), and 24105002 (Innovative Area 2404), and by a Korea Grant (NRF-2013R1A1A2061654).	Ahn JK, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.014003; Fukuda T, 1998, PHYS REV C, V58, P1306, DOI 10.1103/PhysRevC.58.1306; Hashimoto O, 2006, PROG PART NUCL PHYS, V57, P564, DOI 10.1016/j.ppnp.2005.07.001; Takahashi H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.212502; Ishii N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.022001; Aoki S, 2009, NUCL PHYS A, V828, P191, DOI 10.1016/j.nuclphysa.2009.07.005; Inoue T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.162002; Hiyama E, 2012, PROG THEOR PHYS, V128, P105; JAFFE RL, 1977, PHYS REV LETT, V38, P195, DOI 10.1103/PhysRevLett.38.195; Khaustov P, 2000, PHYS REV C, V61, DOI 10.1103/PhysRevC.61.054603; AOKI S, 1991, PROG THEOR PHYS, V85, P1287, DOI 10.1143/PTP.85.1287; DANYSZ M, 1963, NUCL PHYS, V49, P121, DOI 10.1016/0029-5582(63)90080-4; AOKI S, 1993, PROG THEOR PHYS, V89, P493; AOKI S, 1995, PHYS LETT B, V355, P45, DOI 10.1016/0370-2693(95)00688-H; Batty CJ, 1999, PHYS REV C, V59, P295, DOI 10.1103/PhysRevC.59.295; Bielich J. S., 2008, NUCL PHYS A, V804, P309; Dalitz R. H., 1989, R SOC P A, V426, P1; Davis DH, 2005, NUCL PHYS A, V754, p3C, DOI 10.1016/j.nuclphysa.2005.01.002; Firestone R. B., 1996, TABLE ISOTOPES, V1, P6; Gogami T., 2014, THESIS TOHOKU U; Ichikawa A., 2001, THESIS KYOTO U; Ichikawa A, 2001, PHYS LETT B, V500, P37, DOI 10.1016/S0370-2693(01)00049-1; Imai K., J PARC E07 EXPT SYST; Millener DJ, 2012, NUCL PHYS A, V881, P298, DOI 10.1016/j.nuclphysa.2012.01.019; Nagae T., 2015, J PARC E05 EXPT PROP; Nakazawa K, 2010, PROG THEOR PHYS SUPP, P335; Takahashi H., 2003, THESIS KYOTO U; Tanida K., J PARC E03 EXPT PROP; Yamaguchi M, 2001, PROG THEOR PHYS, V105, P627, DOI 10.1143/PTP.105.627; Yoshida J., 2014, THESIS KYOTO U, V1	30	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2050-3911			PROG THEOR EXP PHYS	Prog. Theor. Exp. Phys.	MAR	2015		3							033D02	10.1093/ptep/ptv008		11	Physics, Multidisciplinary	Physics	CG7YO	WOS:000353524000009		
J	Hurtado, C; Wielandt, AM; Zarate, AJ; Kronberg, U; Castro, M; Yamagiwa, K; Ito, T; Eishi, Y; Contreras, L; Lopez-Kostner, F				Hurtado, Claudia; Maria Wielandt, Ana; Zarate, Alejandro J.; Kronberg, Udo; Castro, Magdalena; Yamagiwa, Ken; Ito, Takashi; Eishi, Yoshinobu; Contreras, Luis; Lopez-Koestner, Francisco			Molecular analysis of sporadic colon cancer	REVISTA MEDICA DE CHILE			Spanish	Article						BRAF protein, human; Colonic neoplasms; KRAS protein, human; PIK3CA protein, human	METASTATIC COLORECTAL-CANCER; MICROSATELLITE-INSTABILITY; PIK3CA MUTATIONS; MISMATCH REPAIR; THERAPEUTIC-IMPLICATIONS; KRAS MUTATIONS; POOR SURVIVAL; GENE MUTATION; ASPIRIN USE; BRAF V600E	Background: In Chile, colorectal cancer (CRC) is often diagnosed in late stages. Thus, surgical treatment must be complemented with chemotherapy. KRAS mutations and microsatellite instability have been detected in these tumors. However, the response to treatment in patients without KRAS mutations varies and requires a better understanding. Aim: To determine the frequency and distribution of somatic point mutations in KRAS, BRAF and PIK3CA genes and microsatellite instability status (MSI) in patients with colon cancer (CC). Material and Methods: A prospective observational study of patients undergoing surgery for colon cancer. Tumor-derived DNA was analyzed by polymerase chain reaction (PCR) for the most frequent mutations of KRAS, BRAF and PIK3CA. PCR was also used to analyze MSL Results: Fifty-eight patients with sporadic CC were analyzed, 16 showed KRAS mutations (G12R, G12D, G12V, G13D) and out of the 42 patients that did not show any mutation, 10 had mutations in BRAF (V600E) and PIK3CA (E542K, E545D, E545K, Q546E, H1047R). BRAF mutations alone or in combination with PIK3CA mutations were observed in 27% of high MSI tumors and in 2% of tumors without instability (p < 0.049). A higher percentage of high MSI tumors were located in the right colon (p < 0.001), and showed BRAF mutation (p < 0.020). Conclusions: The highest percentage of high MSI and BRAF mutations was observed in the right colon. Therefore, this study suggests the presence of different molecular features between right and left colon tumors that should be considered when defining the therapeutic management.	[Hurtado, Claudia; Maria Wielandt, Ana; Zarate, Alejandro J.; Kronberg, Udo; Lopez-Koestner, Francisco] Clin Las Condes, Lab Oncol & Genet Mol, Unidad Coloproctol, Santiago 7591018, Chile; [Castro, Magdalena] Clin Las Condes, Direcc Acad, Santiago 7591018, Chile; [Yamagiwa, Ken; Ito, Takashi] Tokyo Med & Dent Univ, Subdirecc Invest Latin Amer Collaborat Res Ctr, Santiago, Chile; [Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Tokyo, Japan; [Contreras, Luis] Clin Las Condes, Serv Patol, Santiago 7591018, Chile	Hurtado, C (reprint author), Clin Las Condes, Lab Oncol & Genet Mol, Fontecilla 174, Santiago 7591018, Chile.	churtado@clc.cl					Amatu Alessio, 2013, Ann Transl Med, V1, P12, DOI 10.3978/j.issn.2305-5839.2013.01.03; Jancik S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/150960; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Balschun K, 2011, J MOL DIAGN, V13, P436, DOI 10.1016/j.jmoldx.2011.03.002; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Heinemann V, 2009, CANCER TREAT REV, V35, P262, DOI 10.1016/j.ctrv.2008.11.005; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Raptis S, 2007, J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; Peeters M, 2009, ONCOLOGIST, V14, P29, DOI 10.1634/theoncologist.2008-0167; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489; Minoo P, 2010, INT J ONCOL, V37, P707, DOI 10.3892/ijo_00000720; Boparai KS, 2011, AM J PATHOL, V178, P2700, DOI 10.1016/j.ajpath.2011.02.023; Sinicrope FA, 2012, CLIN CANCER RES, V18, P1506, DOI 10.1158/1078-0432.CCR-11-1469; Ciardiello F, 2011, TARGET ONCOL, V6, P133, DOI 10.1007/s11523-011-0181-x; Di Fiore F, 2010, BRIT J CANCER, V103, P1765, DOI 10.1038/sj.bjc.6606008; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Kato S, 2007, INT J CANCER, V121, P1771, DOI 10.1002/ijc.22890; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Boland CR, 1998, CANCER RES, V58, P5248; Vilar E, 2008, BRIT J CANCER, V99, P1607, DOI 10.1038/sj.bjc.6604691; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Nishihara R, 2013, JAMA-J AM MED ASSOC, V309, P2563, DOI 10.1001/jama.2013.6599; Bazan V, 2005, ANN ONCOL, V16, P50, DOI 10.1093/annonc/mdi908; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Heinemann V, 2013, CANCER TREAT REV, V39, P592, DOI 10.1016/j.ctrv.2012.12.011; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Modest DP, 2011, ANTI-CANCER DRUG, V22, P913, DOI 10.1097/CAD.0b013e3283493160; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042; Petrelli F, 2011, INT J COLORECTAL DIS, V26, P823, DOI 10.1007/s00384-011-1149-0; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Berg M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013978; Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68; Di Nicolantonio F, 2002, J CLIN ONCOL, V6, P5705; Egoavil CM, 2011, PATHOLOGY, V43, P228, DOI 10.1097/PAT.0b013e3283437613; Herreros-Villanueva M, 2011, MOL BIOL REP, V38, P1347, DOI 10.1007/s11033-010-0236-6; Kakar S, 2008, ARCH PATHOL LAB MED, V132, P958, DOI 10.1043/1543-2165(2008)132[958:CCCIMP]2.0.CO;2; Kwon MJ, 2011, PATHOL RES PRACT, V207, P762, DOI 10.1016/j.prp.2011.10.002; László Landherr, 2010, Magy Onkol, V54, P383, DOI 10.1556/MOnkol.54.2010.4.13; Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238; Roa I, 2013, REV MED CHILE, V141, P1166, DOI 10.4067/S0034-98872013000900009; Roa I, 2014, REV MED CHILE, V142, P55, DOI 10.4067/S0034-98872014000100009; Stefanoff CG, 2003, DIAGN MOL PATHOL, V12, P79, DOI 10.1097/00019606-200306000-00003; Velho S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-255; Zarate AJ, 2013, COLORECTAL DIS, V15, P47, DOI 10.1111/j.1463-1318.2012.03110.x	54	0	0	SOC MEDICA SANTIAGO	SANTIAGO 9	BERNARDA MORIN 488 PROVIDENCIA, CASILLA 168 CORREO 55, SANTIAGO 9, 00000, CHILE	0034-9887	0717-6163		REV MED CHILE	Rev. Medica Chile	MAR	2015	143	3					310	319				10	Medicine, General & Internal	General & Internal Medicine	CG3KG	WOS:000353178500005		
J	Tsuboi, K; Matsumoto, H; Fukawa, T; Tanioka, A; Sugino, K; Ikeda, Y; Yonezawa, S; Gennaka, S; Kimura, M				Tsuboi, Kazuma; Matsumoto, Hidetoshi; Fukawa, Tadashi; Tanioka, Akihiko; Sugino, Kazuyoshi; Ikeda, Yoshika; Yonezawa, Shuichi; Gennaka, Shuichi; Kimura, Mutsumi			Simulation Study on Optical Absorption Property of Fiber- and Fabric-Shaped Organic Thin-Film Solar Cells with Resin Sealing Layer	SEN-I GAKKAISHI			Japanese	Article							DEVICES	Recently, fibers and fabrics have been considered as promising platforms for low-cost flexible electronics and multifunctional fabrics, referred to as electronic fibers (e-fibers), electronic textiles (e-textiles), or smart textiles. Fiber- and fabric-shaped organic thin-film solar cells can be used over a wide range of applications as an energy harvester for smart textiles such as clothing, bags, curtains, tents, awnings, and shading elements. In the present study, to examine the optical absorption property of fiber- and fabric-shaped organic thin-film solar cells, we carried out geometrical optics simulations by using both the ray-tracing and transfer matrix methods for the resin-sealed photovoltaic fibers with core-sheath structure. It was found that the light absorption by single photovoltaic fiber with a appropriate thickness of sealing layer is approximately equivalent to that by the flat-panel solar cells. In addition, the light absorption by the photovoltaic fabrics composed of the sealed photovoltaic fibers was improved compared with the flat panel cells due to the interchange of light between fibers in the fabrics (increased by a maximum of 24 % for the plain-woven fabric). These results demonstrated that both the thickness controlling of transparent resin sealing layer and the weaving of photovoltaic fibers are a promising light management approach in fiber- and fabric-shaped organic thinfilm solar cells.	[Tsuboi, Kazuma; Matsumoto, Hidetoshi; Fukawa, Tadashi; Tanioka, Akihiko] Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan; [Sugino, Kazuyoshi; Ikeda, Yoshika; Yonezawa, Shuichi; Gennaka, Shuichi; Kimura, Mutsumi] Suminoe Text Co Ltd, Tech Ctr, Ando Cho, Nara 6391064, Japan; Shinshu Univ, Fac Text Sci & Technol, Dept Funct Polymer Sci, Ueda, Nagano 3868567, Japan	Matsumoto, H (reprint author), Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.		Matsumoto, Hidetoshi/C-6863-2011; Kimura, Mutsumi/D-4516-2014	Matsumoto, Hidetoshi/0000-0002-4949-1184; Kimura, Mutsumi/0000-0003-3050-8254			JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Cai X, 2012, PHYS CHEM CHEM PHYS, V14, P125, DOI 10.1039/c1cp22613d; Bedeloglu A, 2010, TEXT RES J, V80, P1065, DOI 10.1177/0040517509352520; Liu DY, 2012, ACS NANO, V6, P11027, DOI 10.1021/nn304638z; Ng A, 2010, J PHYS CHEM C, V114, P15094, DOI 10.1021/jp104398f; Lee MR, 2009, SCIENCE, V324, P232, DOI 10.1126/science.1168539; Zou DC, 2012, NANO ENERGY, V1, P273, DOI 10.1016/j.nanoen.2012.01.005; Bedeloglu A., 2011, SOLAR CELLS NEW ASPE; Ikeda Y., 2014, P 8 AACH DRESD INT T, pP14; Kaltenbrunner M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1772; Kimura M, 2009, SEN-I GAKKAISHI, V65, pP36; Masuda A., 2014, FIBER PREPRINTS JAPA, V69, p1C07; Miura H, 2010, SEN-I GAKKAISHI, V66, P280; Onishi T., 2013, FUNCTION MAT, V33, P11; Zhang Z., 2014, ADV FUNCT MATER	15	0	0	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	MAR	2015	71	3					121	126				6	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CG6RA	WOS:000353428700010		
J	Yamamoto, M; Nishikawa, G; Afifi, AM; Lee, JC; Yamane, H				Yamamoto, Masaki; Nishikawa, Goro; Afifi, Amalina M.; Lee, Jae-chang; Yamane, Hideki			Effect of the Take-Up Velocity on the Higher-Order Structure of the Melt-Electrospun PLLA/PDLA Blend Fibers	SEN-I GAKKAISHI			English	Article							ENANTIOMERIC POLY(LACTIC ACID)S; STEREOCOMPLEX FORMATION; CRYSTAL; SPUN	The higher-order structure and the formations of SC and HC of the PLLA/PDLA blend melt-electrospun fibers collected on a rotating target were investigated. The diameter of the fiber decreased and the orientation factor increased with increasing take-up velocity. The formation of SC was promoted with decreasing fiber diameter and with increasing take-up velocity. The fiber collected on the fixed target was amorphous and did not show the molecular orientation to any particular directions indicating that the stretching of the fiber by the electrostatic force did not give much molecular orientation to the fiber. On the other hand, the stretching of the fiber by applying the mechanical taking-up gave a significant degree of the molecular orientation to the fiber direction. The crystalline orientation of HC of the annealed fiber was higher than that of SC.	[Yamamoto, Masaki; Nishikawa, Goro; Yamane, Hideki] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biobased Mat Sci, Kyoto 6068585, Japan; [Afifi, Amalina M.] Univ Malaya, Dept Mech Engn, Kuala Lumpur 50603, Malaysia; [Lee, Jae-chang] Korea Res Inst Chem Technol, Ulsan 681802, South Korea	Yamane, H (reprint author), Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biobased Mat Sci, Kyoto 6068585, Japan.		Engineering, Faculty /I-7935-2015	Engineering, Faculty /0000-0002-4848-7052			TSUJI H, 1994, J APPL POLYM SCI, V51, P337, DOI 10.1002/app.1994.070510216; Ishii D, 2009, BIOMACROMOLECULES, V10, P237, DOI 10.1021/bm8009363; Zhang JM, 2007, MACROMOLECULES, V40, P1049, DOI 10.1021/ma061693s; Takasaki M, 2003, J MACROMOL SCI PHYS, VB42, P403, DOI 10.1081/MB-120021570; IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034; Tsuji H, 2006, BIOMACROMOLECULES, V7, P3316, DOI 10.1021/bm060786e; STEIN RS, 1958, J POLYM SCI, V31, P327, DOI 10.1002/pol.1958.1203112309; TSUJI H, 1993, MACROMOLECULES, V26, P6918, DOI 10.1021/ma00077a032; HOOGSTEEN W, 1990, MACROMOLECULES, V23, P634, DOI 10.1021/ma00204a041; Brizzolara D, 1996, MACROMOLECULES, V29, P191, DOI 10.1021/ma951144e; TSUJI H, 1991, MACROMOLECULES, V24, P5651, DOI 10.1021/ma00020a026; De Santis P., 1968, BIOPOLYMERS, V6, P199; Hermans P. H., 1946, CONTRIBUTION PHYS CE; Hermans P.H., 1939, KOLLOID Z, V88, P68, DOI 10.1007/BF01518890; Hyun J.-Y., 2013, INT TEXT C 2013 DAEG; Masaki D, 2008, SEN-I GAKKAISHI, V64, P212; Monticelli O, 2014, MACROMOLECULES, V47, P4718, DOI 10.1021/ma500528a; Nishikawa G, 2013, SEN-I GAKKAISHI, V69, P118; Okihara T., 1988, B I CHEM RES KYOTO U, V66, P271; Wilchinsky Z. W., 1963, ADV XRAY ANAL, V6, P231; Yamamoto M., AM J MACROMOL UNPUB	21	0	0	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	MAR	2015	71	3					127	133				7	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CG6RA	WOS:000353428700011		
J	Ogino, T; Tanaka, H; Takatsu, Y; Sumitani, T				Ogino, Takeshi; Tanaka, Hiroshi; Takatsu, Yasuyuki; Sumitani, Tatsuaki			Analysis on the Change in Heat Quantity and the Heat-Generating Mechanism in Moisture-Adsorbing/Desorbing Fiber Materials, Associated with Adsorption and Desorption of Water Vapor	SEN-I GAKKAISHI			Japanese	Article								In this report, we look at the change in heat quantity and the heat-generating mechanism in moisture-adsorbing/desorbing fiber materials, associated with adsorption and desorption of water vapor. As the moisture-adsorbing/desorbing fiber materials, use was made of a salt of a polyacrylic acid fiber (hereinafter as "AF-Na") whose starting material was an acrylic fiber and which had a highly crosslinked structure, and a polyacrylic acid fiber (hereinafter as "AF-H") in which almost all functional groups in a salt of an acrylic fiber were substituted with carboxylic acid. We conducted an experimental study on the change in quantity of adsorption/desorption heat associated with adsorption and desorption of water vapor in these materials, along with the change in the relative humidity. For these materials, we calculated the quantity of adsorption/desorption heat per functional group and the quantity of heat per gram of adsorbed/desorbed water vapor. Generally, the adsorption energy of water vapor is assumed to be equal to its condensation energy. In this context, however, we assumed that the adsorption heat of water vapor was equal to the sum of a water condensation heat and a hydrogen bond-derived energy. Further, we similarly measured the adsorption heat in cellulosic fibers and wool, estimated the adsorption heat and the heat quantity per gram of water vapor on a hydrophilic functional group constituting a natural fiber, and compared the results with those on the functional groups in AF-Na and AF-H. Consequently, the functional group which showed the greatest adsorption heat was found to be the carboxylic salt. Regarding the hydrogen bounding pattern, hardly any difference was found among the carboxylic acid function, hydroxyl group and the carboxylic salt function.	[Ogino, Takeshi] Mizuno Corp, Prod Res & Dev Div, Osaka 5598510, Japan; [Tanaka, Hiroshi; Takatsu, Yasuyuki] Fukuoka Inst Tech, Dept Mech Engn, Fukuoka 8110295, Japan; [Sumitani, Tatsuaki] Toyobo Co Ltd, Plast Div, Adv Polymer Dept, Osaka 5308230, Japan	Ogino, T (reprint author), Mizuno Corp, Prod Res & Dev Div, Osaka 5598510, Japan.						Alexander Peter, 1959, TEXTILE MACHINERY SO, P293; [Anonymous], 1982, HDB ADHESION, V2nd, P11; [Anonymous], 1995, SPSJ POL WAT, P220; Fujii T., 1974, PROGR HEAT TRANSFER, V3, P6; Matsumoto K., 1999, J TEXTILE MACHINERY, V52, P131; Matsumoto K., 1999, J TEXTILE MACHINERY, V52, P105; Ogino T, 2014, SEN-I GAKKAISHI, V70, P160; Talcizawa A., 1992, MEMBRANE, P270	8	0	0	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	MAR	2015	71	3					134	140				7	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CG6RA	WOS:000353428700012		
J	Ataku, H; Nishijima, K; Mori, A; Fujita, N; Sasaki, K				Ataku, Hanako; Nishijima, Keiko; Mori, Ayumi; Fujita, Nobuyuki; Sasaki, Kazumi			Differential Identification and Quantification of Cashmere, Sheep and Yak Fibers in Textiles Using Liquid Chromatography/Mass Spectrometry	SEN-I GAKKAISHI			English	Article							FLIGHT MASS-SPECTROMETRY; HAIR	We discovered cysteine-free and species-specific marker peptides in the whole tryptic digest. of animal fibers, which enable rapid identification of cashmere, sheep and yak fibers without pretreatment such as keratin extraction, reduction or reductive alkylation. A simple method for differential identification. and quantification of cashmere, sheep and yak in textile products using these marker peptides by liquid chromatography/mass spectrometry (LC/MS) has been developed. The amino acid sequence of each marker peptide was determined by the MS/MS measurement. Each marker peptide was subsequently synthesized and its identity to the peptide from textile samples was confirmed. Commercial textile products were subjected to the measurement with the synthetic peptides as reference markers, and the blending ratios were calculated within an accuracy of 5 % compared with the conventional microscopic method.	[Ataku, Hanako; Nishijima, Keiko; Mori, Ayumi; Fujita, Nobuyuki; Sasaki, Kazumi] Natl Inst Technol & Evaluat, Biol Resource Ctr, Shibuya Ku, Tokyo 1510066, Japan	Sasaki, K (reprint author), Natl Inst Technol & Evaluat, Biol Resource Ctr, Shibuya Ku, 2-49-10 Nishihara, Tokyo 1510066, Japan.	bio_proteome@nite.go.jp					Paolella S, 2013, J MASS SPECTROM, V48, P919, DOI 10.1002/jms.3222; Subramanian S, 2005, J BIOTECHNOL, V116, P153, DOI 10.1016/j.jbiotec.2004.10.015; Ataku H., 2008, P 56 ASMS C MASS SPE, P667; Hollemeyer K, 2002, ANAL CHEM, V74, P5960, DOI 10.1021/ac020347f; Izuchi Yukari, 2013, Mass Spectrom (Tokyo), V2, pA0023, DOI 10.5702/massspectrometry.A0023; Kerkhoff K, 2009, TEXT RES J, V79, P69, DOI 10.1177/0040517508090488; Kim Y, 2013, IND ENG CHEM RES, V52, P5563, DOI 10.1021/ie4003415; Kurabayashi T., 2009, 34 INT C INFR MILL T, DOI 10.1109/ICLMW.2009.5325564; Ohashi S, 2012, SEN-I GAKKAISHI, V68, P276; Sasaki K., 2013, SENI GAKKAI PREPRINT, V68, p2PA52; Wu GF, 2008, SPECTROSC SPECT ANAL, V28, P1260; Yamazaki S, 2006, MOL CELL PROTEOMICS, V5, P811, DOI 10.1074/mcp.M500312-MCP200	12	0	0	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	MAR	2015	71	3					141	150				10	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CG6RA	WOS:000353428700013		
J	Yamada, H; Shimamoto, D; Wakano, A				Yamada, Hiroyuki; Shimamoto, Daichi; Wakano, Ayako			Importance of Informal Training for the Spread of Agricultural Technologies: Farmers as in-Residence Extension Workers and Their Motivation for Sustainable Development	SUSTAINABLE DEVELOPMENT			English	Article						extension; training; incentive; motivation; rice farming; Cambodia	INCENTIVES; BEHAVIOR	We report the importance of informal training in introducing new post-harvest technologies in rice farming through informal contacts by exploring answers from both in-residence extension workers ('key farmers') and ordinary farmers in rural Cambodia. We use survey data collected in Cambodian villages between December 2012 and January 2013. While in-residence extension workers are well motivated and informal training plays a crucial role, lack of an appropriate financial incentive for the key farmers might hamper the sustainability of the project. We also emphasize that any intervention for rural development must avoid social exclusion and nepotism. Copyright (c) 2015 John Wiley & Sons, Ltd and ERP Environment	[Yamada, Hiroyuki] Osaka Univ, Osaka Sch Int Publ Policy, Toyonaka, Osaka 560, Japan; [Shimamoto, Daichi] Waseda Univ, Fac Polit Sci & Econ, Shinjuku Ku, Tokyo, Japan; [Wakano, Ayako] Osaka Univ, Grad Sch Econ, Toyonaka, Osaka 560, Japan	Yamada, H (reprint author), Osaka Univ, Osaka Sch Int Publ Policy, Toyonaka, Osaka 560, Japan.	hyamada@osipp.osaka-u.ac.jp					Alexander KS, 2010, SUSTAIN DEV, V18, P62, DOI 10.1002/sd.428; Ameur C, 1994, 247 WORLD BANK; Anderson J. R., 2007, HDB AGR EC, V3, P2343, DOI DOI 10.1016/S1574-0072(06)03044-1; Bowles S, 2012, J ECON LIT, V50, P368, DOI 10.1257/jel.50.2.368; Carpenter J, 2010, J PUBLIC ECON, V94, P911, DOI 10.1016/j.jpubeco.2010.07.007; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Hayami Y, 2009, J DEV STUD, V45, P96, DOI 10.1080/00220380802468595; BIRKHAEUSER D, 1991, ECON DEV CULT CHANGE, V39, P607, DOI 10.1086/451893; Axinn G, 1988, GUIDE ALTERNATIVE EX; Bank W, 1996, WORLD BANK PARTICIPA; Birner R, 2007, 729 INT FOOD POL RES; Evenson R.E., 2001, HDB AGR EC A, V1, P574; Feder G, 2004, J AGR ECON, V55, P217, DOI [10.1111/j.1477-9552.2004.tb00094.x, DOI 10.1111/J.1477-9552.2004.TB00094.X)]; Feder G, 2001, NAT RES MAN, V19, P313; Feder G, 2010, 959 INT FOOD POL RES; Garforth C., 1982, PROGR RURAL EXTENSIO, V1, P43; Gautam M, 2000, AGR EXTENSION KENYA; JARRETT FG, 1985, AGR ADMIN EXT, V18, P217, DOI 10.1016/0309-586X(85)90092-5; Kaimowitz D., 1991, Agricultural extension: worldwide institutional evolution and forces for change., P101; Linardi S, 2011, J PUBLIC ECON, V95, P445, DOI 10.1016/j.jpubeco.2010.06.020; Maredia M, 2001, FUTURE IMPACT ASSESS; Olsons M, 1965, LOGIC COLLECTIVE ACT; Rivera WM, 2001, AGR RURAL EXTENSION; Rivera WM, 2002, CONTRACTING AGR EXTE; Rola A.C., 2002, J INT AGR EXTENSION, V9, P65; Wakano A, 2014, DISCUSSION PAPERS EC	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0968-0802	1099-1719		SUSTAIN DEV	Sustain. Dev.	MAR	2015	23	2					124	134		10.1002/sd.1580		11	Planning & Development	Public Administration	CG1TW	WOS:000353058400006		
J	Kawamura, Y; Kuwabara, S; Kania, SA; Kato, H; Hamagishi, M; Fujiwara, N; Sato, T; Tomida, J; Tanaka, K; Bemis, DA				Kawamura, Yoshiaki; Kuwabara, Saki; Kania, Stephen A.; Kato, Hisayuki; Hamagishi, Manami; Fujiwara, Nagatoshi; Sato, Takuichi; Tomida, Junko; Tanaka, Kaori; Bemis, David A.			Porphyromonas pogonae sp nov., an anaerobic but low concentration oxygen adapted coccobacillus isolated from lizards (Pogona vitticeps) or human clinical specimens, and emended description of the genus Porphyromonas Shah and Collins 1988	SYSTEMATIC AND APPLIED MICROBIOLOGY			English	Article						Porphyromonas; Central bearded dragons; Pogona vitticeps; Human clinical specimen; 16S rRNA sequence; DNA-DNA hybridization	COMB-NOV; DEOXYRIBONUCLEIC-ACID; GINGIVAL SULCUS; MITIS GROUP; RECLASSIFICATION; IDENTIFICATION; STREPTOCOCCUS; CREVIORICANIS; INFECTIONS; SALIVOSA	During the process of identifying a Gram-negative coccobacillus isolated from a human clinical specimen, we found that the isolate's 16S rRNA gene had very close sequence identity with that of a variant Porphyromonas isolated from polymicrobial infections in the central bearded dragon, a species of lizard [2]. The 16S rRNA gene sequences of the human isolate and of six isolates from lizards were nearly identical (99.9-100%). Phylogenetic analysis placed all of these isolates in a single phylogenetic cluster well separated from other species in the genus Porphyromonas. The closest species was Porphyromoncts catoniae with 90.7-90.9% sequence identity, although there was less than 6% DNA similarity between the P. catoniae type strain and our representative isolates from lizards (PAGU 1787(T)) and human (PAGU 1776). These isolates could grow under anaerobic or microaerobic conditions (6% 02 atmosphere). The isolates were positive for catalase and very strong beta-hemolytic activity, but did not show black or brown pigmentation. Biochemically, the isolates could be differentiated from closely related species by pyroglutamic acid arylamidase and glycine arylamidase activity, and some others. The fermentation products mainly included succinic acid and propionic acid. The major fatty acids detected in cells of the isolates were iso-C15:0, anteiso-C15:0, and 3OH-iso-C17:0. The G + C content was 43.0 +/- 0.62 mol%. The species name Porphyromonas pogonae sp. nov. is proposed for these isolates with the type strain of PAGU 1787(T) (=MI 10-1288(T) = JCM 19732(T) = ATCC BAA-2643(T)). (C) 2014 Elsevier GmbH. All rights reserved.	[Kawamura, Yoshiaki; Kuwabara, Saki; Tomida, Junko] Aichi Gakuin Univ, Sch Pharm, Dept Microbiol, Nagoya, Aichi 4648650, Japan; [Kania, Stephen A.; Bemis, David A.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Kato, Hisayuki] Fujita Hlth Univ Med, Dept Otolaryngol, Toyoake, Aichi 4701192, Japan; [Hamagishi, Manami] Fujita Hlth Univ Med, Dept Clin Lab, Toyoake, Aichi 4701192, Japan; [Fujiwara, Nagatoshi] Tezukayama Gakuin Univ, Fac Contemporary Human Life Sci, Dept Food & Nutr, Nara, Nara 6318585, Japan; [Sato, Takuichi] Tohoku Univ, Grad Sch Dent, Div Oral Ecol & Biochem, Sendai, Miyagi 9808575, Japan; [Tanaka, Kaori] Gifu Univ, Life Sci Res Ctr, Div Anaerob Res, Gifu, Gifu 5011194, Japan	Kawamura, Y (reprint author), Aichi Gakuin Univ, Sch Pharm, Dept Microbiol, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	kawamura@dpc.agu.ac.jp					Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224; Kawamura Y, 1999, MICROBIOL-UK, V145, P2605; Summanen PH, 2009, INT J SYST EVOL MICR, V59, P1727, DOI 10.1099/ijs.0.001909-0; Kawamura Y, 2012, MICROBIOL IMMUNOL, V56, P21, DOI 10.1111/j.1348-0421.2011.00401.x; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Kawamura Y, 1998, INT J SYST BACTERIOL, V48, P921; LOVE DN, 1994, INT J SYST BACTERIOL, V44, P204; SHAH HN, 1988, INT J SYST BACTERIOL, V38, P128; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Lewis JP, 2009, MICROBIOL-SGM, V155, P3758, DOI 10.1099/mic.0.027953-0; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Kawamura Y, 2009, FEMS MICROBIOL LETT, V298, P118, DOI 10.1111/j.1574-6968.2009.01703.x; Bemis DA, 2011, J VET DIAGN INVEST, V23, P99, DOI 10.1177/104063871102300116; Li Y, 2003, SYST APPL MICROBIOL, V26, P523, DOI 10.1078/072320203770865828; WILLEMS A, 1995, INT J SYST BACTERIOL, V45, P578; Fournier D, 2001, INT J SYST EVOL MICR, V51, P1179; CARLSSON J, 1973, APPL MICROBIOL, V25, P287; COLLINS MD, 1981, MICROBIOL REV, V45, P316; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P674; HIRASAWA M, 1994, INT J SYST BACTERIOL, V44, P637; Holdeman L.V., 1997, ANAEROBE LAB MANUAL, V4th, P125; Kato T., 1997, DENT JPN, V33, P27; Krieg N.R., 2011, BERGEYS MANUAL SYSTE, V4, P61; LOVE DN, 1992, INT J SYST BACTERIOL, V42, P434; LOVE DN, 1995, INT J SYST BACTERIOL, V45, P90; McCracken Helen E., 1999, P252; MENARD C, 1995, INFECT IMMUN, V63, P2522; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sakamoto M, 2013, INT J SYST EVOL MICR, V63, P454, DOI 10.1099/ijs.0.042531-0; SHAH HN, 1995, INT J SYST BACTERIOL, V45, P586; STEWART JS, 1990, J ZOO WILDLIFE MED, V21, P180; Teanpaisan R, 1999, J MED MICROBIOL, V48, P741; Tomidaa J, 2011, SYST APPL MICROBIOL, V34, P503, DOI 10.1016/j.syapm.2011.08.003; Wagener K, 2014, INT J SYST EVOL MICR, V64, P642, DOI 10.1099/ijs.0.057307-0	36	2	2	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0723-2020			SYST APPL MICROBIOL	Syst. Appl. Microbiol.	MAR	2015	38	2					104	109		10.1016/j.syapm.2014.11.004		6	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CG5VT	WOS:000353364700005		
J	Nakatani, A				Nakatani, Ayami			Dressing Miss World with Balinese Brocades: The "Fashionalization" and "Heritagization of Handwoven Textiles in Indonesia	TEXTILE-THE JOURNAL OF CLOTH & CULTURE			English	Article						Indonesia; Bali; traditional textiles; fashion; cultural heritage; consumption	CULTURE	On the basis of extensive field research in a weaving village located in Eastern Bali, Indonesia, the present study aims to explore the changing meanings and practices involving handmade textiles in Indonesia, especially those of Bali, within the spectrum of the producing and consuming ends in relation to the framework of "fashionalization" (the process of appropriating traditional, non-Western dress styles or materials by fashion experts) and "heritagization" (the process in which the diverse elements constituting the cultural pluralism of Indonesia are consciously put together to create a category of common heritage). The cloth to be discussed is called songket: a supplementary weft ikat with metal-wrapped thread, woven on a traditional handloom and constituting the special ceremonial attire of local Balinese. While deeply embedded in local cultural norms and hierarchies, its production and consumption were subject to external forces such as economic change, the formation of national as well as regional identity, and the dynamics of contemporary fashion. In the course of the development of the tourist industry, this sumptuous cloth became particularly appealing for the urban well-to-do, precisely because of its historical link with aristocratic prestige and its expensive price. By clothing themselves and their families with songket at ceremonies, they could demonstrate their economic standing in "respectable" ways and express their identity as Balinese. The more recent expansion of the market for songket beyond Bali, due to the renewed interest of Indonesian designers in appropriating local textiles into their creations, may jeopardize historical and cultural ties between local weavers and urban consumers who shared cultural traditions in which they both understood the meaning and original purpose of the cloth being produced.	Okayama Univ, Anthropol, Okayama 7008530, Japan	Nakatani, A (reprint author), Okayama Univ, Anthropol, Okayama 7008530, Japan.	nakatani@cc.okayama-u.ac.jp					Agung A. A. Ayu Ketut, 1997, BUSANA ADAT BALI; SCHNEIDER J, 1987, ANNU REV ANTHROPOL, V16, P409; Aragon L. V., 1999, ETHNOS, V64, P151; Bali BPS Provinsi, 2012, BAL DAL ANGK; Chaldun A., 2003, ATLAS ILMU PENGETAHU; Chaldun A., 2001, ATLAS ILMU PENGETAHU; Dinas Kebudayaan Propinsi Daerah Tingkat I Bali, 1994, TAT BUS AD BAL; Djamadil A. A., 1976, MENGENAL KEBUDAYAAN, V2; Ehlers T. B., 1993, CRAFTS WORLD MARKET, P181; Eicher J., 1995, DRESS ETHNICITY CHAN; Hansen KT, 2004, ANNU REV ANTHROPOL, V33, P369, DOI 10.1146/annurev.anthro.33.070203.143805; Hardjono J., 1990, DEV MAJALAYA TEXTILE; Hauser-Schaublin Brigitta, 1991, BALINESE TEXTILES; Hill H. C., 1980, B INDONES ECON STUD, V16, P83, DOI 10.1080/00074918012331333789; Hill H. C., 1992, 87 I SE AS STUD; Kagami H., 1995, JAPANESE J ETHNOLOGY, V60, P32; Kartiwa S., 1989, SONGKET WEAVING INDO; Koentjaraningrat, 1985, PERSEPSI MASYARAKAT, P99; Kondo D., 1997, ABOUT FACE PERFORMIN; Leshkowich A. M., 2003, FASH THEORY, V7, P281, DOI 10.2752/136270403778051970; Moss L. A., 1994, FRAGILE TRADITIONS I, P91; Nakatani A., 2003, INEQUALITY CRISIS SO, P118; Nakatani A., 1999, STAYING LOCAL GLOBAL, P203; Nakatani A., 2003, GENDER MODERNITY PER, P87; Nakatani A., 1995, INDONESIA CIRCLE, V67, P249; Niessen Sandra, 2003, REORIENTING FASHION, P243; Owen N., 1981, TEXTILE DISPLACEMENT; Pelras C., 1962, OBJETS MONDES, V2, P215; Polhemus T., 1978, FASHION ANTIFASHION; Ramseyer U., 1983, INDONESIA CIRCLE, V30, P17; Ramseyer U., 1987, INDONESIA CIRCLE, V42, P3; Rannseyer U., 1991, BALINESE TEXTILES, P117; Rodgers S, 2011, TEXTILE EC POWER VAL, P21; Schefold R, 1998, BIJDR TAAL-LAND-V, V154, P259; Tarlo Emma, 1996, CLOTHING MATTERS DRE; Taylor JG, 1997, OUTWARD APPEARANCES, P85; VOLKMAN TA, 1994, AM ETHNOL, V21, P564, DOI 10.1525/ae.1994.21.3.02a00060; Waterbury R., 1989, CLOTH HUMAN EXPERIEN, P243; Yampolsky P, 1995, BIJDR TAAL-LAND-V, V151, P700	39	0	0	BLOOMSBURY PUBLISHING  PLC	LONDON	50 BEDFORD SQ, LONDON, WC1B 3DP, ENGLAND	1475-9756	1751-8350		TEXTILE	Textile	MAR	2015	13	1					30	49		10.2752/175183515x14235680035700		20	Humanities, Multidisciplinary	Arts & Humanities - Other Topics	CG6TN	WOS:000353435400002		
J	Furuse, M; Mukouyama, T; Tamaki, D				Furuse, Mizuki; Mukouyama, Takashi; Tamaki, Dai			TOTALLY NORMAL CELLULAR STRATIFIED SPACES AND APPLICATIONS TO THE CONFIGURATION SPACE OF GRAPHS	Topological Methods in Nonlinear Analysis			English	Article						Cellular stratified space; configuration space; acycylic category	BRAID-GROUPS	The notion of regular cell complexes plays a central role in topological combinatorics because of its close relationship with posets. A generalization, called totally normal cellular stratified spaces, was introduced in [3], [19] by relaxing two conditions; face posets are replaced by acyclic categories and cells with incomplete boundaries are allowed. The aim of this article is to demonstrate the usefulness of totally normal cellular stratified spaces by constructing a combinatorial model for the configuration space of graphs. As an application, we obtain a simpler proof of Ghrist's theorem on the homotopy dimension of the configuration space of graphs. We also make sample calculations of the fundamental group of ordered and unordered configuration spaces of two points for small graphs.	[Furuse, Mizuki; Mukouyama, Takashi; Tamaki, Dai] Shinshu Univ, Dept Math Sci, Matsumoto, Nagano 3908621, Japan	Furuse, M (reprint author), Shinshu Univ, Dept Math Sci, Matsumoto, Nagano 3908621, Japan.	rivulus@shinshu-u.ac.jp					Abrams A., 2000, THESIS U CALIFORNIA; FADELL E, 1962, DUKE MATH J, V29, P231, DOI 10.1215/S0012-7094-62-02924-1; Arnold V.I., 1969, MAT ZAMETKI, V5, P227; Basabe I., ARXIV10091851V5; Bessis D., ARXIVMATH0610778; Chen J., ARXIV11116699; COHEN FR, 1978, INVENT MATH, V46, P99, DOI 10.1007/BF01393249; Eilenberg S., 1952, FDN ALGEBRAIC TOPOLO; Fadell E, 1962, MATH SCAND, V10, P111; Farley D, 2012, FORUM MATH, V24, P827, DOI 10.1515/FORM.2011.086; Farley D, 2005, ALGEBR GEOM TOPOL, V5, P1075, DOI 10.2140/agt.2005.5.1075; Ghrist R., 2001, AMS IP STUD ADV MATH, V24, P29; HIMMELBE.CJ, 1965, AM MATH MON, V72, P1103, DOI 10.2307/2315960; Kim JH, 2012, T AM MATH SOC, V364, P309; Kozlov D, 2008, ALGORITHM COMP MATH, V21, P1; Kurlin V, 2012, HOMOL HOMOTOPY APPL, V14, P159, DOI 10.4310/HHA.2012.v14.n1.a8; May J. P., 1972, LECT NOTES MATH, V271; Sabalka L, 2009, GROUP GEOM DYNAM, V3, P469; Tamaki D., ARXIV11114774; Tamaki D., ARXIV11063772; Tamaki D., 2011, P 2011 INT S NONL TH, P200	21	0	0	JULIUSZ SCHAUDER CTR NONLINEAR STUDIES	TORUN	UL CHOPINA 12/18, TORUN, 87-100, POLAND	1230-3429			TOPOL METHOD NONL AN	Topol. Methods Nonlinear Anal.	MAR	2015	45	1					169	214				46	Mathematics	Mathematics	CG5VE	WOS:000353363200011		
J	Kuroda, K; Hibi, D; Ishii, Y; Yokoo, Y; Takasu, S; Kijima, A; Matsushita, K; Masumura, K; Kodama, Y; Yanai, T; Sakai, H; Nohmi, T; Ogawa, K; Umemura, T				Kuroda, Ken; Hibi, Daisuke; Ishii, Yuji; Yokoo, Yuh; Takasu, Shinji; Kijima, Aki; Matsushita, Kohei; Masumura, Ken-ichi; Kodama, Yukio; Yanai, Tokuma; Sakai, Hiroki; Nohmi, Takehiko; Ogawa, Kumiko; Umemura, Takashi			Role of p53 in the Progression from Ochratoxin A-Induced DNA Damage to Gene Mutations in the Kidneys of Mice	TOXICOLOGICAL SCIENCES			English	Article						ochratoxin A; p53; DNA damage; gene mutation	DOUBLE-STRAND BREAKS; GPT DELTA RATS; INDUCED GENOTOXICITY; CELL-PROLIFERATION; REPAIR PATHWAYS; MOUSE; APOPTOSIS; CARCINOGENICITY; EXPRESSION; MUTAGENICITY	Carcinogenic doses of ochratoxin A (OTA) cause increases of mutant frequencies (MFs) of the red/gam gene (Spi(-)) in the kidneys of p53-deficient gpt delta mice, but not in p53-proficient mice. Here, we investigated the role of p53 in the progression from OTA-induced DNA damage to gene mutations. To this end, p53-proficient and -deficient mice were administered 5 mg/kg OTA for 3 days or 4 weeks by gavage. After 3 days of administration, comet assays were performed and there were no differences in the degrees of OTA-induced DNA damage between p53-proficient and -deficient mice. However, the frequencies of gamma-H2AX-positive tubular epithelial cells in p53-deficient mice were significantly higher than those in p53-proficient mice, implying that p53 inhibited the progression from DNA damage to DNA double-strand breaks (DSBs). Evaluation of global gene expression and relevant mRNA/protein expression levels demonstrated that OTA increased the expression of Cdkn1a, which encodes the p21 protein, in p53-proficient mice, but not in p53-deficient mice. Moreover, in p53-deficient mice, mRNA levels of cell cycle progression and DSB repair (homologous recombination repair [HR])-related genes were significantly increased. Thus, G(1)/S arrest due to activation of the p53/p21 pathway may contribute to the prevention of DSBs in p53-proficient mice. In addition, single base deletions/insertions/substitutions were predominant, possibly due to HR. Overall, these results suggested that OTA induced DSBs at the carcinogenic target site in mice and that p53/p21-mediated cell cycle control prevented an increase in the formation of DSBs, leading to gene mutations.	[Kuroda, Ken; Hibi, Daisuke; Ishii, Yuji; Yokoo, Yuh; Takasu, Shinji; Kijima, Aki; Matsushita, Kohei; Ogawa, Kumiko; Umemura, Takashi] Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo 1588501, Japan; [Masumura, Ken-ichi] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan; [Kodama, Yukio] Natl Inst Hlth Sci, Div Toxicol, Setagaya Ku, Tokyo 1588501, Japan; [Yanai, Tokuma; Sakai, Hiroki] Gifu Univ, Fac Appl Biol Sci, Dept Vet Med, Gifu 5011193, Japan; [Nohmi, Takehiko] Natl Inst Hlth Sci, Biol Safety Res Ctr, Tokyo 1588501, Japan	Umemura, T (reprint author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	umemura@nihs.go.jp					Akman SA, 2012, TOXINS, V4, P267, DOI 10.3390/toxins4040267; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Kuroda K, 2014, MUTAGENESIS, V29, P27, DOI 10.1093/mutage/get054; Redon CE, 2011, AGING-US, V3, P168; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Inturi S, 2014, MUTAT RES-FUND MOL M, V763, P53, DOI 10.1016/j.mrfmmm.2014.04.002; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; BENDELE AM, 1985, J NATL CANCER I, V75, P733; Cavin C, 2007, TOXICOL SCI, V96, P30, DOI 10.1093/toxscikfl169; Ali R, 2014, DRUG CHEM TOXICOL, V37, P227, DOI 10.3109/01480545.2013.838775; Quiros S, 2010, CELL CYCLE, V9, P168, DOI 10.4161/cc.9.1.10363; Pfohl-Leszkowicz A, 2012, CHEM RES TOXICOL, V25, P252, DOI 10.1021/tx200430f; Nohmi T, 1996, ENVIRON MOL MUTAGEN, V28, P465, DOI 10.1002/(SICI)1098-2280(1996)28:4<465::AID-EM24>3.0.CO;2-C; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Lodygin D, 2002, J CLIN INVEST, V110, P1717, DOI 10.1172/JCI200216588; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; HARPER JW, 1995, MOL BIOL CELL, V6, P387; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Adler M, 2009, CARCINOGENESIS, V30, P711, DOI 10.1093/carcin/bgp049; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Smith ML, 2002, MUTAGENESIS, V17, P149, DOI 10.1093/mutage/17.2.149; TSUKADA T, 1993, ONCOGENE, V8, P3313; Llorente B, 2008, CELL CYCLE, V7, P859; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; European Food Safety Authority EFSA, 2006, EFSA J, V365, P1; Gatz SA, 2006, CELL DEATH DIFFER, V13, P1003, DOI 10.1038/sj.cdd.4401903; Hibi D, 2011, TOXICOL SCI, V122, P406, DOI 10.1093/toxsci/kfr139; Hibi D, 2013, J TOXICOL SCI, V38, P57; Hibi D, 2013, TOXICOLOGY, V304, P92, DOI 10.1016/j.tox.2012.12.005; IARC, 1993, IARC MON EV CARC RIS, V56, P489; Jackson SP, 2001, BIOCHEM SOC T, V29, P655, DOI 10.1042/0300-5127:0290655; Kondo N, 2010, J NUCL ACIDS, V2010, DOI DOI 10.4061/2010/543531; Lian HG, 2014, TOXICOL LETT, V226, P214, DOI 10.1016/j.toxlet.2014.02.002; Masumura K, 2011, ENVIRON MOL MUTAGEN, V52, DOI 10.1002/em.20610; National Toxicology Program (NTP), 1989, NAT TOX PROGR TECH R, V358, P1; Nohmi T, 2005, ENVIRON MOL MUTAGEN, V45, P150, DOI 10.1002/em.20110; Nohmi T, 2000, MUTAT RES-FUND MOL M, V455, P191, DOI 10.1016/S0027-5107(00)00077-4; Puget N, 1997, CANCER RES, V57, P828; Sasaki YF, 2000, CRIT REV TOXICOL, V30, P629, DOI 10.1080/10408440008951123; Seo YR, 2002, ONCOGENE, V21, P731, DOI 10.1038/sj.onc.1205129; Tendler Y, 1999, MOL BRAIN RES, V72, P40, DOI 10.1016/S0169-328X(99)00202-8; Velasco-Miguel S, 2003, DNA REPAIR, V2, P91, DOI 10.1016/S1568-7864(02)00189-1	43	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	MAR	2015	144	1					65	76		10.1093/toxsci/kfu267		12	Toxicology	Toxicology	CG8FP	WOS:000353543000010		
J	Tanaka, T; Wang, LY; Kimura, M; Abe, H; Mizukami, S; Yoshida, T; Shibutani, M				Tanaka, Takeshi; Wang, Liyun; Kimura, Masayuki; Abe, Hajime; Mizukami, Sayaka; Yoshida, Toshinori; Shibutani, Makoto			Developmental Hypothyroidism Abolishes Bilateral Differences in Sonic Hedgehog Gene Control in the Rat Hippocampal Dentate Gyrus	TOXICOLOGICAL SCIENCES			English	Article						hypothyroidism; hippocampus; midline 1 (Mid1); sonic hedgehog (Shh); neurogenesis; rat	OPITZ-SYNDROME GENE; THYROID-HORMONE; MANGANESE CHLORIDE; ANTITHYROID AGENTS; CELL MAINTENANCE; PHOSPHATASE 2A; ADULT BRAIN; NEUROGENESIS; EXPRESSION; EXPOSURE	Both developmental and adult-stage hypothyroidism disrupt rat hippocampal neurogenesis. We previously showed that exposing mouse offspring to manganese permanently disrupts hippocampal neurogenesis and abolishes the asymmetric distribution of cells expressing Mid1, a molecule regulated by sonic hedgehog (Shh) signaling. The present study examined the involvement of Shh signaling on the disruption of hippocampal neurogenesis in rats with hypothyroidism. Pregnant rats were treated with methimazole (MMI) at 0 or 200ppm in the drinking water from gestation day 10-21 days after delivery (developmental hypothyroidism). Adult male rats were treated with MMI in the same manner from postnatal day (PND) 46 to PND 77 (adult-stage hypothyroidism). Developmental hypothyroidism reduced the number of Mid1(+) cells within the subgranular zone of the dentate gyrus of offspring on PND 21, and consequently abolished the normal asymmetric predominance of Mid1(+) cells on the right side through the adult stage. In control animals, Shh was expressed in a subpopulation of hilar neurons, showing asymmetric distribution with left side predominance on PND 21; however, this asymmetry did not continue through the adult stage. Developmental hypothyroidism increased Shh(+) neurons bilaterally and abolished the asymmetric distribution pattern on PND 21. Adult hypothyroidism also disrupted the asymmetric distribution of Mid1(+) cells but did not affect the distribution of Shh(+) hilar neurons. The results suggest that the hippocampal neurogenesis disruption seen in hypothyroidism involves changes in asymmetric Shh(+) neuron distribution in developmental hypothyroidism and altered Mid1 expression in both developmental and adult-stage hypothyroidism.	[Tanaka, Takeshi; Wang, Liyun; Kimura, Masayuki; Abe, Hajime; Mizukami, Sayaka; Yoshida, Toshinori; Shibutani, Makoto] Tokyo Univ Agr & Technol, Lab Vet Pathol, Fuchu, Tokyo 1838509, Japan; [Tanaka, Takeshi; Kimura, Masayuki; Abe, Hajime; Mizukami, Sayaka] Gifu Univ, United Grad Sch Vet Sci, Pathogenet Vet Sci, Gifu, Gifu 5011193, Japan	Shibutani, M (reprint author), Tokyo Univ Agr & Technol, Lab Vet Pathol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	mshibuta@cc.tuat.ac.jp	Yoshida, Toshinori/B-7255-2015		Japan Society for the Promotion of Science (JSPS) [25292170]	Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS; Grant No. 25292170).	Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Zoeller RT, 2004, J NEUROENDOCRINOL, V16, P809, DOI 10.1111/j.1365-2826.2004.01243.x; Koromilas C, 2010, METAB BRAIN DIS, V25, P339, DOI 10.1007/s11011-010-9208-8; Lavado-Autric R, 2003, J CLIN INVEST, V111, P1073, DOI 10.1172/JCI200316262; Gilbert ME, 2011, TOXICOL SCI, V124, P432, DOI 10.1093/toxsci/kfr244; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Heidari R, 2013, DRUG CHEM TOXICOL, V36, P403, DOI 10.3109/01480545.2012.749272; Charytoniuk D, 2002, J PHYSIOLOGY-PARIS, V96, P9, DOI 10.1016/S0928-4257(01)00075-4; Fujimoto H, 2012, REPROD TOXICOL, V34, P93, DOI 10.1016/j.reprotox.2012.03.005; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Bernal J, 2002, J ENDOCRINOL INVEST, V25, P268; Wang LY, 2013, TOXICOL SCI, V136, P154, DOI 10.1093/toxsci/kft183; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Axelstad M, 2008, TOXICOL APPL PHARM, V232, P1, DOI 10.1016/j.taap.2008.05.020; Kohl MM, 2011, NAT NEUROSCI, V14, P1413, DOI 10.1038/nn.2915; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Sawano E, 2013, INT J DEV NEUROSCI, V31, P751, DOI 10.1016/j.ijdevneu.2013.09.007; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Shiraki A, 2012, ARCH TOXICOL, V86, P1559, DOI 10.1007/s00204-012-0846-y; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Mavromatakis YE, 2011, MECH DEVELOP, V128, P90, DOI 10.1016/j.mod.2010.11.002; Shibutani M, 2009, REPROD TOXICOL, V28, P297, DOI 10.1016/j.reprotox.2009.04.011; Wang LY, 2012, TOXICOL SCI, V127, P508, DOI 10.1093/toxsci/kfs110; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Cambray S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1817; Cortes C, 2012, THYROID, V22, P951, DOI 10.1089/thy.2010.0400; Fang M, 2011, NEUROSCIENCE, V182, P62, DOI 10.1016/j.neuroscience.2011.02.060; Gilbert ME, 2006, BRAIN RES, V1069, P10, DOI 10.1016/j.brainres.2005.10.049; Gong JA, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-50; Granata A, 2003, DEV BIOL, V258, P397, DOI 10.1016/S0012-1606(03)00131-3; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Lancioni A, 2010, J NEUROSCI, V30, P2880, DOI 10.1523/JNEUROSCI.4196-09.2010; Litingtung Ying, 2000, Nature Neuroscience, V3, P979; MARCHANT B, 1972, ENDOCRINOLOGY, V91, P747; Mellough Carla B., 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P67; Montero-Pedrazuela A, 2006, MOL PSYCHIATR, V11, P361, DOI 10.1038/sj.mp.4001802; Ramirez M, 2004, CURR PROTEIN PEPT SC, V5, P497, DOI 10.2174/1389203043379350; Saegusa Y, 2010, REPROD TOXICOL, V29, P407, DOI 10.1016/j.reprotox.2010.03.006; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067	43	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	MAR	2015	144	1					128	137		10.1093/toxsci/kfu266		10	Toxicology	Toxicology	CG8FP	WOS:000353543000015		
J	Hayashi, Y; Oishi, M; Kita, D; Watanabe, T; Tachibana, O; Hamada, J				Hayashi, Yasuhiko; Oishi, Masahiro; Kita, Daisuke; Watanabe, Takuya; Tachibana, Osamu; Hamada, Jun-ichio			Pure Lymphocytic Infundibuloneurohypophysitis Caused by the Rupture of Rathke's Cleft Cyst: Report of 2 Cases and Review of the Literature	TURKISH NEUROSURGERY			English	Article						Hypophysitis; Rathke's cleft cyst; Lymphocyte; Diabetes insipidus	GRANULOMATOUS HYPOPHYSITIS; SECONDARY; NEUROSARCOIDOSIS	The major symptoms that are caused by Rathke's cleft cysts (RCCs) are visual disturbances, headaches, and endocrine insufficiencies. Among these symptoms, the endocrine insufficiencies are thought to result from the spreading of inflammation that is induced by the cyst contents onto the pituitary gland or the compression of the gland and the pituitary stalk by RCCs. Here, we present 2 rare cases with lymphocytic infundibulohypophysitis with the sudden onset of headaches and subsequent diabetes insipidus (DI). Magnetic resonance imaging revealed remarkable swelling of the pituitary gland with a small mass that was located between the anterior and the posterior lobe of the pituitary gland. Transsphenoidal surgery was performed to remove the mass, and pathological examinations of the cyst wall demonstrated that the epithelial tissue of the RCC and the posterior lobe were affected by massive lymphocytic infiltration.The clinical courses and pathological results of these patients strongly suggested that the rupture of the RCC onto the posterior lobe caused the lymphocytic hypophysitis. Postoperatively, the DI could be controlled with a smaller amount of anti-diuretic hormone replacement compared to that required preoperatively.	[Hayashi, Yasuhiko; Oishi, Masahiro; Kita, Daisuke; Watanabe, Takuya; Tachibana, Osamu; Hamada, Jun-ichio] Kanazawa Med Univ, Dept Neurosurg, Kanazawa, Ishikawa, Japan	Hayashi, Y (reprint author), Kanazawa Med Univ, Dept Neurosurg, Kanazawa, Ishikawa, Japan.	yahayashi@med.kanazawa-u.ac.jp					El-Mahdy W, 1998, NEUROSURGERY, V42, P7, DOI 10.1097/00006123-199801000-00003; Goyal M, 2000, AM J NEURORADIOL, V21, P1466; Honegger J, 1997, NEUROSURGERY, V40, P713, DOI 10.1097/00006123-199704000-00010; Bellastella A, 2003, EUR J ENDOCRINOL, V149, P363, DOI 10.1530/eje.0.1490363; Gutenberg A, 2006, EUR J ENDOCRINOL, V155, P101, DOI 10.1530/eje.1.02183; Hashimoto K, 1997, ENDOCR J, V44, P1, DOI 10.1507/endocrj.44.1; Kim JE, 2004, J NEUROSURG, V100, P33, DOI 10.3171/jns.2004.100.1.0033; Daikokuya H, 2000, NEURORADIOLOGY, V42, P532; Bullmann C, 2000, EUR J ENDOCRINOL, V142, P365, DOI 10.1530/eje.0.1420365; Donadieu J, 2004, J PEDIATR-US, V144, P344, DOI 10.1016/j.jpeds.2003.12.030; Fehn M, 1999, Pituitary, V1, P303, DOI 10.1023/A:1009923029942; Hama S, 2002, J NEUROSURG, V96, P209; Hashimoto K, 2002, ENDOCR J, V49, P605, DOI 10.1507/endocrj.49.605; Heshmati HM, 1998, ENDOCR J, V45, P357, DOI 10.1507/endocrj.45.357; Janeczko C, 2009, J CLIN NEUROSCI, V16, P599, DOI 10.1016/j.jocn.2008.04.031; Kita D, 2007, NEUROL MED-CHIR, V47, P85, DOI 10.2176/nmc.47.85; Nishikawa T, 2007, NEUROL MED-CHIR, V47, P136, DOI 10.2176/nmc.47.136; Pachner MJ, 1994, ACTA NEUROCHIR, V126, P38; SAUTNER D, 1995, ACTA NEUROPATHOL, V90, P637; Schittenhelm J, 2008, NEUROSURG REV, V31, P157, DOI 10.1007/s10143-008-0120-1; Sonnet E, 2006, J ENDOCRINOL INVEST, V29, P353; Yuyama R, 2002, NEUROL SURG TOKYO, V30, P95	22	0	0	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAR	2015	25	2					332	336		10.5137/1019-5149.JTN.9776-13.0		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG0AH	WOS:000352928500025		
J	Jiang, F; Tsuji, T				Jiang, Fei; Tsuji, Takeshi			Impact of interfacial tension on residual CO2 clusters in porous sandstone	WATER RESOURCES RESEARCH			English	Article						interfacial tension; porous media; residual phase characterization; lattice Boltzmann method	LATTICE-BOLTZMANN SIMULATIONS; PORE-SCALE; 2-PHASE FLOW; RELATIVE PERMEABILITY; CAPILLARY-PRESSURE; OIL-WET; MEDIA; WATER; DISPLACEMENT; IMBIBITION	We develop a numerical simulation that uses the lattice Boltzmann method to directly calculate the characteristics of residual nonwetting-phase clusters to quantify capillary trapping mechanisms in real sandstone. For this purpose, a digital-rock-pore model reconstructed from micro-CT-scanned images of Berea sandstone is filtered and segmented into a binary file. The residual-cluster distribution is generated following simulation of the drainage and imbibition processes. The characteristics of the residual cluster in terms of size distribution, major length, interfacial area, and sphericity are investigated under conditions of different interfacial tension (IFT). Our results indicate that high interfacial tension increases the residual saturation and leads to a large size distribution of residual clusters. However, low interfacial tension results in a larger interfacial area, which is beneficial for dissolution and reaction processes during geological carbon storage. Analysis of the force balance acting on the residual clusters demonstrates that trapping stability is higher in high interfacial tension case, and the interfacial tension should be a controlling factor for the trapping stability in addition to the pore geometry and connectivity. The proposed numerical method can handle the complex displacement of multicomponent systems in porous media. By using this method, we can obtain residual-cluster distributions under different conditions for optimizing the storage capacity of carbon-storage projects.	[Jiang, Fei; Tsuji, Takeshi] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 812, Japan	Jiang, F (reprint author), Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 812, Japan.	jiang@i2cner.kyushu-u.ac.jp	Tsuji, Takeshi/I-5679-2014	Tsuji, Takeshi/0000-0003-0951-4596	I2CNER; World Premier International Research Center Initiative (WPI), Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; JSPS [26887028]	The authors are grateful for the useful advice and suggestions from Jianhui Yang. The authors would like to acknowledge the support of the I2CNER, which is sponsored by the World Premier International Research Center Initiative (WPI), Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This study was partially supported by a Grant-in-Aid for Research Activity Start-up from the JSPS (grant 26887028). Micro-CT data used to reconstruct the digital rock model is archived by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC), and is available from the authors.	Andrew M, 2014, WATER RESOUR RES, V50, P8760, DOI 10.1002/2014WR015970; Dong H, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036307; Ferrari A, 2013, ADV WATER RESOUR, V57, P19, DOI 10.1016/j.advwatres.2013.03.005; Boek ES, 2010, COMPUT MATH APPL, V59, P2305, DOI 10.1016/j.camwa.2009.08.063; VIZIKA O, 1994, J COLLOID INTERF SCI, V165, P386, DOI 10.1006/jcis.1994.1243; Prodanovic M, 2006, J COLLOID INTERF SCI, V304, P442, DOI 10.1016/j.jcis.2006.08.048; Tartakovsky AM, 2006, ADV WATER RESOUR, V29, P1464, DOI 10.1016/j.advwatres.2005.11.014; Iglauer S, 2012, J COLLOID INTERF SCI, V375, P187, DOI 10.1016/j.jcis.2012.02.025; Nguyen VH, 2006, J PETROL SCI ENG, V52, P54, DOI 10.1016/j.petrol.2006.03.020; Ramstad T, 2012, TRANSPORT POROUS MED, V94, P487, DOI 10.1007/s11242-011-9877-8; Armstrong RT, 2014, GEOPHYS RES LETT, V41, P55, DOI 10.1002/2013GL058075; Hirai S, 1997, ENERGY, V22, P363, DOI 10.1016/S0360-5442(96)00135-1; d'Humieres D, 2002, PHILOS T ROY SOC A, V360, P437, DOI 10.1098/rsta.2001.0955; Ahrenholz B, 2008, ADV WATER RESOUR, V31, P1151, DOI 10.1016/j.advwatres.2008.03.009; BLUNT MJ, 1995, PHYS REV E, V52, P6387, DOI 10.1103/PhysRevE.52.6387; Andrew M, 2013, GEOPHYS RES LETT, V40, P3915, DOI 10.1002/grl.50771; Pentland CH, 2010, SPE J, V15, P274; DIAS MM, 1986, J PHYS A-MATH GEN, V19, P3131, DOI 10.1088/0305-4470/19/15/034; Al-Raoush RI, 2009, ENVIRON SCI TECHNOL, V43, P4796, DOI 10.1021/es802566s; Pan CX, 2006, COMPUT FLUIDS, V35, P898, DOI 10.1016/j.compfluid.2005.03.008; Renard P, 2013, ADV WATER RESOUR, V51, P168, DOI 10.1016/j.advwatres.2011.12.001; Prodanovic M, 2007, ADV WATER RESOUR, V30, P214, DOI 10.1016/j.advwatres.2005.05.015; Iglauer S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056315; Gaus I, 2010, INT J GREENH GAS CON, V4, P73, DOI 10.1016/j.ijggc.2009.09.015; Pan C, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002120; Joekar-Niasar V, 2012, CRIT REV ENV SCI TEC, V42, P1895, DOI 10.1080/10643389.2011.574101; Wildenschild D, 2011, ENRGY PROCED, V4, P4945, DOI 10.1016/j.egypro.2011.02.464; Jettestuen E, 2013, WATER RESOUR RES, V49, P4645, DOI 10.1002/wrcr.20334; Landry CJ, 2011, GEOFLUIDS, V11, P209, DOI 10.1111/j.1468-8123.2011.00333.x; Raeini AQ, 2012, J COMPUT PHYS, V231, P5653, DOI 10.1016/j.jcp.2012.04.011; Bailey P., 2009, ICPP 09 INT C PAR PR; Buick JM, 2000, PHYS REV E, V61, P5307, DOI 10.1103/PhysRevE.61.5307; DHUMIERES D, 1994, PROGR ASTRONAUT AERO, V159, P450; FERREOL B, 1995, TRANSPORT POROUS MED, V20, P3, DOI 10.1007/BF00616923; Genty A, 2013, TRANSPORT POROUS MED, V96, P271, DOI 10.1007/s11242-012-0087-9; Gouet-Kaplan M, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007350; Guo ZL, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046308; Herring AL, 2014, INT J GREENH GAS CON, V25, P93, DOI 10.1016/j.ijggc.2014.04.003; Hilfer R, 1996, TRANSPORT POROUS MED, V22, P53, DOI 10.1007/BF00974311; Iglauer S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049680; Jiang F, 2014, TRANSPORT POROUS MED, V104, P205, DOI 10.1007/s11242-014-0329-0; Juanes R, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004806; Kantzas A., 2001, SOC PET ENG RESERVOI, DOI [10.2118/75116-PA, DOI 10.2118/75116-PA]; Kumar M, 2010, PETROPHYSICS, V51, P323; Liu HH, 2014, ADV WATER RESOUR, V73, P144, DOI 10.1016/j.advwatres.2014.07.010; Lorensen W. E., 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422; Metz B., 2005, IPCC SPECIAL REPORT; Morrow N. R., 1988, SOC PET ENG RESERVOI, DOI [10.2118/14423-PA, DOI 10.2118/14423-PA]; Pentland CH, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046683; Raeini AQ, 2014, ADV WATER RESOUR, V74, P116, DOI 10.1016/j.advwatres.2014.08.012; Meakin P, 2009, REV GEOPHYS, V47, DOI 10.1029/2008RG000263; Tolke J., 2006, Computers & Fluids, V35, DOI 10.1016/j.compfluid.2005.08.010; Tolke Jonas, 2010, Leading Edge, V29, DOI 10.1190/1.3284055; Yang JH, 2013, WATER RESOUR RES, V49, P8531, DOI 10.1002/2013WR013877; YANUKA M, 1984, J MICROSC-OXFORD, V135, P159; Zhou GZ, 2013, CHINESE SCI BULL, V58, P2970, DOI 10.1007/s11434-013-5889-9	56	1	1	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0043-1397	1944-7973		WATER RESOUR RES	Water Resour. Res.	MAR	2015	51	3					1710	1722		10.1002/2014WR016070		13	Environmental Sciences; Limnology; Water Resources	Environmental Sciences & Ecology; Marine & Freshwater Biology; Water Resources	CG3DU	WOS:000353158800019		
J	Mashiko, T; Otani, K; Kawano, R; Konno, T; Kaneko, N; Ito, Y; Watanabe, E				Mashiko, Toshihiro; Otani, Keisuke; Kawano, Ryutaro; Konno, Takehiko; Kaneko, Naoki; Ito, Yumiko; Watanabe, Eiju			Development of Three-Dimensional Hollow Elastic Model for Cerebral Aneurysm Clipping Simulation Enabling Rapid and Low Cost Prototyping	WORLD NEUROSURGERY			English	Article						3D model; 3D printing; Cerebral aneurysm; Clipping; Rapid prototyping; Surgical simulation; Surgical training	VIRTUAL-REALITY ENVIRONMENT; NEURAL MECHANISMS; SURGICAL SIMULATION; INFORMATION; EDUCATION; TOMOGRAPHY; RETRACTION; TACTILE; SURGERY; CELLS	OBJECTIVE: We developed a method for fabricating a three-dimensional hollow and elastic aneurysm model useful for surgical simulation and surgical training. In this article, we explain the hollow elastic model prototyping method and report on the effects of applying it to presurgical simulation and surgical training. METHODS: A three-dimensional printer using acrylonitrile-butadiene-styrene as a modeling material was used to produce a vessel model. The prototype was then coated with liquid silicone. After the silicone had hardened, the acrylonitrile-butadiene-styrene was melted with xylene and removed, leaving an outer layer as a hollow elastic model. RESULTS: Simulations using the hollow elastic model were performed in 12 patients. In all patients, the clipping proceeded as scheduled. The surgeon's postoperative assessment was favorable in all cases. This method enables easy fabrication at low cost. CONCLUSION: Simulation using the hollow elastic model is thought to be useful for understanding of three-dimensional aneurysm structure.	[Mashiko, Toshihiro; Otani, Keisuke; Konno, Takehiko; Kaneko, Naoki; Ito, Yumiko; Watanabe, Eiju] Jichi Med Univ, Dept Neurosurg, Shimotsuke, Tochigi, Japan; [Kawano, Ryutaro] Jichi Med Univ, Med Simulat Ctr, Shimotsuke, Tochigi, Japan	Mashiko, T (reprint author), Jichi Med Univ, Dept Neurosurg, Shimotsuke, Tochigi, Japan.	mashiko@jichi.ac.jp					Wurm G, 2004, J NEUROSURG, V100, P139, DOI 10.3171/jns.2004.100.1.0139; Reznick RK, 2006, NEW ENGL J MED, V355, P2664; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Kimura T, 2009, NEUROSURGERY, V65, P719, DOI 10.1227/01.NEU.0000354350.88899.07; Hadjikhani N, 1998, J NEUROSCI, V18, P1072; Wong GKC, 2007, NEUROSURGERY, V61, P564; Tsutsui KI, 2005, NEUROSCI RES, V51, P221, DOI 10.1016/j.neures.2004.11.006; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Kockro RA, 2007, NEUROSURGERY, V61, P379, DOI [10.1227/01.neu.0000303997.12645.26, 10.1227/01.NEU.0000280115.43893.1C]; Lemole GM, 2007, NEUROSURGERY, V61, P142, DOI 10.1227/01.NEU.0000255485.65450.49; Satava RM, 2001, SURG ENDOSC, V15, P232, DOI 10.1007/s004640000369; Miles FA, 1998, EUR J NEUROSCI, V10, P811, DOI 10.1046/j.1460-9568.1998.00112.x; Gnanalingham KK, 2006, CLIN NEUROL NEUROSUR, V108, P117, DOI 10.1016/j.clineuro.2005.11.001; Webb PA, 2000, J MED ENG TECHNOL, V24, P149, DOI 10.1080/03091900050163427; Wurm G, 2011, SURG INNOV, V18, P294, DOI 10.1177/1553350610395031; Futami K, 2004, NEUROL MED-CHIR, V44, P6, DOI 10.2176/nmc.44.6; D'Urso PS, 1999, SURG NEUROL, V52, P490, DOI 10.1016/S0090-3019(99)00143-3; Grefkes C, 2002, NEURON, V35, P173, DOI 10.1016/S0896-6273(02)00741-9; Anzai A, 1999, J NEUROPHYSIOL, V82, P891; Anzai A, 1999, J NEUROPHYSIOL, V82, P909; Banati RB, 2000, NEUROPSYCHOLOGIA, V38, P115, DOI 10.1016/S0028-3932(99)00074-3; Chueh JY, 2009, AM J NEURORADIOL, V30, P1159, DOI 10.3174/ajnr.A1543; Miga MI, 2001, NEUROSURGERY, V49, P75, DOI 10.1097/00006123-200107000-00012; Servos P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047788; Stadie AT, 2008, J NEUROSURG, V108, P382, DOI 10.3171/JNS/2008/108/2/0382; Vigneron LM, 2009, COMPUT AIDED SURG, V14, P1, DOI 10.3109/10929080903052677; Webster R, 2002, ST HEAL T, V85, P570	28	4	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2015	83	3					351	361		10.1016/j.wneu.2013.10.032		11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG1MN	WOS:000353036900030		
J	Nakajima, M; Miyajima, M; Ogino, I; Sugano, H; Akiba, C; Domon, N; Karagiozov, KL; Arai, H				Nakajima, Madoka; Miyajima, Masakazu; Ogino, Ikuko; Sugano, Hidenori; Akiba, Chihiro; Domon, Naoko; Karagiozov, Kostadin L.; Arai, Hajime			Use of External Lumbar Cerebrospinal Fluid Drainage and Lumboperitoneal Shunts with Strata NSC Valves in Idiopathic Normal Pressure Hydrocephalus: A Single-Center Experience	WORLD NEUROSURGERY			English	Article						Cerebrospinal fluid; Dementia; Idiopathic normal pressure hydrocephalus	GUIDELINES; MANAGEMENT; JAPAN; INPH	OBJECTIVE: In Japan, idiopathic normal pressure hydrocephalus (iNPH) currently is treated mainly with lumboperitoneal (LP) shunts. Our aim was to evaluate whether LP shunting via the use of Medtronic Strata NSC programmable valves was as effective as ventriculoperitoneal shunting in the treatment of patients with iNPH from the perspectives of safety and symptomatic improvement rate. METHODS: The clinical records of 51 iNPH patients (mean age, 75 years; males, 29), who underwent placement of Medtronic Strata NSC LP shunt systems were reviewed retrospectively as a cohort. LP shunting was evaluated with the modified Rankin Scale, the Japan Normal-Pressure Hydrocephalus Grading Scale, the Mini-Mental State Examination, the Frontal Assessment Battery, and the Trail-Making Test A as outcome measures. RESULTS: Modified Rankin Scale scores improved from 3.2 to 2.2 (P < 0.01), indicating a 64% response rate 12 months after treatment. Total Japan Normal-Pressure Hydrocephalus Grading Scale scores decreased from 6.5 to 4.0 (P < 0.01), indicating a response rate of 81%. Mini-Mental State Examination scores improved from 22.2 to 25.4 (P < 0.01), Frontal Assessment Battery scores improved from 11.7 to 13.4 (P < 0.05), and Trail-Making Test A scores improved from 122.3 to 112.7 (P=0.60). During the 12-month follow-up period, complications requiring surgery were observed in 6 cases (11.8%). CONCLUSION: LP shunts showed effectiveness rates that were similar to those of ventriculoperitoneal shunts. Despite the relatively high complication rate, LP shunts can be recommended for the treatment of patients with iNPH because of their minimal invasiveness and lack of lethal complications.	[Nakajima, Madoka; Miyajima, Masakazu; Ogino, Ikuko; Sugano, Hidenori; Akiba, Chihiro; Domon, Naoko; Karagiozov, Kostadin L.; Arai, Hajime] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 113, Japan	Nakajima, M (reprint author), Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 113, Japan.	madoka66@juntendo.ac.jp					Bloch O, 2012, J CLIN NEUROSCI, V19, P1107, DOI 10.1016/j.jocn.2011.11.019; ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Mori E, 2012, NEUROL MED-CHIR, V52, P775; REITAN RM, 1985, J CLIN PSYCHOL, V41, P245, DOI 10.1002/1097-4679(198503)41:2<245::AID-JCLP2270410219>3.0.CO;2-D; Ishikawa M, 2004, NEUROL MED-CHIR, V44, P222, DOI 10.2176/nmc.44.222; Klinge P, 2012, ACTA NEUROL SCAND, V126, P145, DOI 10.1111/j.1600-0404.2012.01676.x; Tanaka N, 2009, NEUROEPIDEMIOLOGY, V32, P171, DOI 10.1159/000186501; Hellstrom P, 2012, ACTA NEUROL SCAND, V126, P229, DOI 10.1111/j.1600-0404.2012.01677.x; Mori K, 2001, J NEUROSURG, V95, P970, DOI 10.3171/jns.2001.95.6.0970; Dubois B, 2000, NEUROLOGY, V55, P1621; Iseki C, 2009, J NEUROL SCI, V277, P54, DOI 10.1016/j.jns.2008.10.004; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hashimoto Masaaki, 2010, Cerebrospinal Fluid Res, V7, P18, DOI 10.1186/1743-8454-7-18; Ishii K, 2008, EUR RADIOL, V18, P2678, DOI 10.1007/s00330-008-1044-4; Kaijima Mitsunobu, 2011, No Shinkei Geka, V39, P497; Kitagaki H, 1998, AM J NEURORADIOL, V19, P1277; Toma AK, 2010, J NEUROSURG, V113, P1304, DOI 10.3171/2010.6.JNS1020; Yates Paul A, 2014, Front Neurol, V4, P205, DOI 10.3389/fneur.2013.00205	18	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2015	83	3					387	393		10.1016/j.wneu.2014.08.004		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG1MN	WOS:000353036900035		
J	Naim, MN; Jaafar, AR; Abu Bakar, NF; Baharuddin, AS; Basha, RK; Lenggoro, IW				Naim, M. Nazli; Jaafar, Atiqah Raihan; Abu Bakar, Noor Fitrah; Baharuddin, Azhari Samsu; Basha, Roseliza Kadir; Lenggoro, I. Wuled			Deposition of nanostructures derived from electrostatically stabilised TiO2 aqueous suspension onto a biocomposite	ADVANCED POWDER TECHNOLOGY			English	Article						Colloid; Spray dry; Coir dust; Surface roughness; Deposition velocity	TURBULENT DUCT FLOWS; ROUGH SURFACES; DISPERSIONS; PARTICLES; NANOPARTICLES; SMOOTH; CARBON; LIQUID; MODEL	A nanostructure derived from TiO2 particle deposition onto a biocomposite surface derived from coir dust (CD) was developed to control degradation using a spray dry technique. To stabilise and reduce the size of dispersed particles, the TiO2 powder was prepared in deionised water at pH 10 and sonicated at 20 kHz and 400 W. The coir dust was obtained from coconut kernel waste and underwent drying treatment before it was mixed with polypropylene (PP) as the substrate. The suspension consisted of particles with an average size and zeta value of 285 nm and -19.2 mV, respectively. The suspension was spray dried onto a hot-pressed substrate (biocomposite) with a surface roughness between 0.23 and 1.57 lm at ambient temperature. Scanning electron microscopy image analysis and Fourier transform infrared spectroscopy analysis indicated that the TiO2 particles were successfully deposited onto the substrate, shown by the existence of a carboxylic acid group (-COOH) in the CD matrix. Moreover, the weight of the deposited substrate increased exponentially with deposition time compared to pure PP substrate. However, the deposition rate of TiO2 nanoparticles was limited by the ratio of the substrate surface roughness to particle diameter, as predicted by a previous study. (C) 2014 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Naim, M. Nazli; Jaafar, Atiqah Raihan; Baharuddin, Azhari Samsu; Basha, Roseliza Kadir] Univ Putra Malaysia, Dept Proc & Food Engn, Fac Engn, Serdang 43400, Selangor, Malaysia; [Abu Bakar, Noor Fitrah] Univ Teknol MARA, Fac Chem Engn, Shah Alam 40450, Malaysia; [Lenggoro, I. Wuled] Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Lenggoro, I. Wuled] Tokyo Univ Agr & Technol, Dept Chem Engn, Koganei, Tokyo 1848588, Japan	Naim, MN (reprint author), Univ Putra Malaysia, Dept Proc & Food Engn, Fac Engn, Serdang 43400, Selangor, Malaysia.	nazli@eng.upm.edu.my	Lenggoro, Wuled/B-8629-2009	Lenggoro, Wuled/0000-0002-0048-8486	Research University Grant Scheme, (RUGS, Grant initiative 5) Universiti Putra Malaysia, Serdang, Selangor, Malaysia [9199812]	The authors are grateful to Dr. Rajagopalan Prabu for technical contributions and Dr. Masao Gen for discussion of the results. This study was supported by the Research University Grant Scheme, (RUGS, Grant initiative 5, 9199812) Universiti Putra Malaysia, Serdang, Selangor, Malaysia.	Hult EL, 2000, CELLULOSE, V7, P35, DOI 10.1023/A:1009236932134; Kmetty A, 2010, PROG POLYM SCI, V35, P1288, DOI 10.1016/j.progpolymsci.2010.07.002; Mandzy N, 2005, POWDER TECHNOL, V160, P121, DOI 10.1016/j.powtec.2005.08.020; Kikuchi Y, 1997, J PHOTOCH PHOTOBIO A, V106, P51, DOI 10.1016/S1010-6030(97)00038-5; Sunada K, 1998, ENVIRON SCI TECHNOL, V32, P726, DOI 10.1021/es970860o; Minabe T, 2000, J PHOTOCH PHOTOBIO A, V137, P53, DOI 10.1016/S1010-6030(00)00350-6; Tian L, 2007, J AEROSOL SCI, V38, P377, DOI 10.1016/j.jaerosci.2006.12.003; FANNING PE, 1993, CARBON, V31, P721, DOI 10.1016/0008-6223(93)90009-Y; Hartman RPA, 1999, J AEROSOL SCI, V30, P823, DOI 10.1016/S0021-8502(99)00033-6; WOOD NB, 1981, J AEROSOL SCI, V12, P275, DOI 10.1016/0021-8502(81)90127-0; GURAV A, 1993, AEROSOL SCI TECH, V19, P411, DOI 10.1080/02786829308959650; Shchukin DG, 2011, ADV MATER, V23, P1922, DOI 10.1002/adma.201004494; Browne L.W., 1973, ATMOS ENVIRON, V8, P801; FAN FG, 1993, J AEROSOL SCI, V24, P45, DOI 10.1016/0021-8502(93)90084-M; HEIJMAN SGJ, 1995, LANGMUIR, V11, P422, DOI 10.1021/la00002a010; Herrmann AS, 1998, POLYM DEGRAD STABIL, V59, P251, DOI 10.1016/S0141-3910(97)00169-9; Kim DJ, 2011, CHEM ENG J, V167, P308, DOI 10.1016/j.cej.2010.12.069; Lopez MCB, 2000, MICROPOR MESOPOR MAT, V34, P171; Maille V., 2006, APPL CATAL A-GEN, V315, P1; Naim MN, 2009, J CERAM SOC JPN, V117, P127, DOI 10.2109/jcersj2.117.127; Naim MN, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.06GH17; ORON A, 1986, J AEROSOL SCI, V17, P903, DOI 10.1016/0021-8502(86)90017-0; Sato K, 2008, J AM CERAM SOC, V91, P2481, DOI 10.1111/j.1551-2916.2008.02493.x; STRAUSS H, 1993, CHEM ENG SCI, V48, P323, DOI 10.1016/0009-2509(93)80020-Q; Weisz AD, 2001, SOLID STATE IONICS, V143, P125, DOI 10.1016/S0167-2738(01)00840-2; Zhang HF, 2000, J FLUID MECH, V406, P55, DOI 10.1017/S0022112099007284	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	MAR	2015	26	2					362	367		10.1016/j.apt.2014.11.006		6	Engineering, Chemical	Engineering	CF6VU	WOS:000352695400004		
J	Molkenova, A; Taniguchi, I				Molkenova, Anara; Taniguchi, Izumi			Preparation and characterization of SiO2/C nanocomposites by a combination of mechanochemical-assisted sol-gel and dry ball milling processes	ADVANCED POWDER TECHNOLOGY			English	Article						SiO2/C; Mechanochemical-assisted sol-gel process; Ball milling; Lithium-ion batteries; Anode; Nanocomposites	LITHIUM-ION BATTERIES; HIGH-PERFORMANCE ANODES; ELECTROCHEMICAL PROPERTIES; STORAGE PERFORMANCE; CARBON; NANOSPHERES	A novel preparation route was developed for synthesizing SiO2/C nanocomposites through a mechanochemical-assisted sol-gel process combined with a high-energy dry ball milling process. The effect of process parameters, such as milling time, rotation speed and carbon content, on the structure and morphology of SiO2/C nanocomposites was investigated by X-ray diffraction, Fourier transform infrared spectroscopy, field-emission scanning electron microscopy and transmission electron microscopy with energy-dispersive spectroscopy. It was demonstrated from the physical characterization that the proposed preparation route might be an effective synthesis route for SiO2/C nanocomposites consisting of highly dispersed carbon nanoparticles on fine amorphous SiO2 particles. The electrochemical performance was characterized using Li vertical bar 1 M LiPF6 in EC: DMC = 1: 1 vertical bar SiO2/C cells in the potential range from 0.01 to 3.0 V versus Li/Li+. The SiO2/C nanocomposite prepared under optimized process conditions exhibited a highly stable reversible capacity of 663 mA h g(1) (872 mA h g-SiO21) at a current density of 46 mA g (1) after 30 cycles with no capacity fading. (C) 2014 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder	[Molkenova, Anara; Taniguchi, Izumi] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem Engn, Meguro Ku, Tokyo 1528552, Japan	Taniguchi, I (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem Engn, Meguro Ku, 12-1,Ookayama 2, Tokyo 1528552, Japan.	taniguchi.i.aa@m.titech.ac.jp	Taniguchi, Izumi/C-1332-2015	Taniguchi, Izumi/0000-0002-2833-6994			Chang WS, 2012, ENERG ENVIRON SCI, V5, P6895, DOI 10.1039/c2ee00003b; Hu YS, 2008, ANGEW CHEM INT EDIT, V47, P1645, DOI 10.1002/anie.200704287; Gao B, 2001, ADV MATER, V13, P816, DOI 10.1002/1521-4095(200106)13:11<816::AID-ADMA816>3.0.CO;2-P; Sasidharan M, 2011, J MATER CHEM, V21, P13881, DOI 10.1039/c1jm10864f; Ning LJ, 2004, J POWER SOURCES, V133, P229, DOI 10.1016/j.jpowsour.2004.01.048; Yao Y, 2011, J POWER SOURCES, V196, P10240, DOI 10.1016/j.jpowsour.2011.08.009; Shao B, 2013, POWDER TECHNOL, V235, P1, DOI 10.1016/j.powtec.2012.09.040; Konarova M, 2009, POWDER TECHNOL, V191, P111, DOI 10.1016/j.powtec.2008.09.013; Feng XJ, 2013, PHYS CHEM CHEM PHYS, V15, P14420, DOI 10.1039/c3cp51799c; Tu JG, 2014, J PHYS CHEM C, V118, P7357, DOI 10.1021/jp5011023; Guo H, 2012, ELECTROCHIM ACTA, V74, P271, DOI 10.1016/j.electacta.2012.04.086; Guo BK, 2008, ELECTROCHEM COMMUN, V10, P1876, DOI 10.1016/j.elecom.2008.09.032; Wang J, 2011, J POWER SOURCES, V196, P4811, DOI 10.1016/j.jpowsour.2011.01.053; Sun Q, 2008, APPL SURF SCI, V254, P3774, DOI 10.1016/j.apsusc.2007.11.058; McCormick PG, 1998, JOM-J MIN MET MAT S, V50, P61, DOI 10.1007/s11837-998-0290-x; Avvakumov E., 2004, CHEM SUSTAINABLE DEV, V12, P287; Dai F, 2012, RSC ADV, V2, P12710, DOI 10.1039/c2ra22187j; Doan T.N.L., 2012, POWDER TECHNOL, V217, P574; Favors Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep04605; Feng XJ, 2013, J SOLID STATE ELECTR, V17, P2461, DOI 10.1007/s10008-013-2128-x; Gong HX, 2013, INT J ELECTROCHEM SC, V8, P9811; Lazarevic ZZ, 2009, SCI SINTER, V41, P19, DOI 10.2298/SOS0901019L; Li XF, 2012, MICROPOR MESOPOR MAT, V151, P488, DOI 10.1016/j.micromeso.2011.09.003; Yan N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01568	24	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	MAR	2015	26	2					377	384		10.1016/j.apt.2014.11.013		8	Engineering, Chemical	Engineering	CF6VU	WOS:000352695400006		
J	Matsumoto, M; Wada, Y; Onoe, K				Matsumoto, Masakazu; Wada, Yoshinari; Onoe, Kaoru			Change in glycine polymorphs induced by minute-bubble injection during antisolvent crystallisation	ADVANCED POWDER TECHNOLOGY			English	Article						Minute-bubbles; Gas-liquid interface; Antisolvent crystallisation; Polymorphism; Supersaturation	ANTI-SOLVENT CRYSTALLIZATION; CRYSTAL-STRUCTURE; BETA-GLYCINE; AMINO-ACIDS; PARTICLES; TRANSFORMATION; SOLUBILITY; NUCLEATION; CHLORIDE; GROWTH	In this study, to develop a crystallisation technique that enables the control of polymorphism under constant temperature, we studied the antisolvent crystallisation of glycine using the gas-liquid interfaces around N2 minute-bubbles as new crystallisation fields where nucleation progresses predominantly. At the minute gas-liquid interfaces, local supersaturation increases due to the accumulation of glycine and antisolvent caused by the negative surface potential of the minute-bubbles. Thus, the nucleation rate is faster and the production of metastable/unstable polymorph is accelerated. At a solution temperature of 303 K, the saturated glycine solution and methanol as an antisolvent were mixed by the two different addition orders as follows: Gly solution/MeOH system, methanol was added into a saturated glycine solution; MeOH/Gly solution system, a saturated glycine solution was added into methanol. While mixing methanol with the saturated glycine solution, N-2 minute-bubbles with an average diameter of 10 mu m were continuously supplied to the mixed solution using a self-supporting bubble generator and a glycine polymorph was produced. In both systems, the generation rate of supersaturation in the bulk solution (rC/CS) was varied in the range of 1.2-71.3 min (1) by controlling the addition rate of methanol or the saturated glycine solution. For comparison, antisolvent crystallisation free of minute-bubbles was performed. Consequently, N-2 minute-bubble injection enabled the selective crystallisation of the metastable alpha-form or unstable beta-form at lower r(C/CS) and decreased the r(C/CS) necessary for alpha-form or beta-form production by approximately 1/2 during antisolvent crystallisation. (C) 2014 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Matsumoto, Masakazu] Nihon Univ, Coll Ind Technol, Dept Basic Sci, Narashino, Chiba 2758576, Japan; [Wada, Yoshinari; Onoe, Kaoru] Chiba Inst Technol, Fac Engn, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan	Matsumoto, M (reprint author), Nihon Univ, Coll Ind Technol, Dept Basic Sci, 2-11-1 Shinei, Narashino, Chiba 2758576, Japan.	matsumoto.masakazu@nihon-u.ac.jp					IITAKA Y, 1961, ACTA CRYSTALLOGR, V14, P1, DOI 10.1107/S0365110X61000012; Zhou GX, 2006, CRYST GROWTH DES, V6, P892, DOI 10.1021/cg0504049; Allen K, 2002, CRYST GROWTH DES, V2, P523, DOI 10.1021/cg025568t; Tamura H, 2014, ADV POWDER TECHNOL, V25, P847, DOI 10.1016/j.apt.2013.12.010; Boldyreva EV, 2003, J THERM ANAL CALORIM, V73, P409, DOI 10.1023/A:1025405508035; Xu JJ, 2012, J CRYST GROWTH, V354, P13, DOI 10.1016/j.jcrysgro.2012.05.036; MARSH RE, 1958, ACTA CRYSTALLOGR, V11, P654, DOI 10.1107/S0365110X58001717; Takiyama H, 2012, ADV POWDER TECHNOL, V23, P273, DOI 10.1016/j.apt.2012.04.009; Sekar C, 2009, SPECTROCHIM ACTA A, V74, P1160, DOI 10.1016/j.saa.2009.09.026; Ha JM, 2004, J AM CHEM SOC, V126, P3382, DOI 10.1021/ja049724r; Ma CY, 2007, ADV POWDER TECHNOL, V18, P707, DOI 10.1163/156855207782514932; Ferreira LA, 2004, CHEM ENG SCI, V59, P3117, DOI 10.1016/j.ces.2004.05.001; IITAKA Y, 1960, ACTA CRYSTALLOGR, V13, P35, DOI 10.1107/S0365110X60000066; Tanaka M, 2011, ADV POWDER TECHNOL, V22, P125, DOI 10.1016/j.apt.2010.09.012; Madras G, 2004, CHEM ENG SCI, V59, P2753, DOI 10.1016/j.ces.2004.03.022; Ferrari ES, 2003, CRYST GROWTH DES, V3, P53, DOI 10.1021/cg025561b; Srinivasan K, 2008, J CRYST GROWTH, V311, P156, DOI 10.1016/j.jcrysgro.2008.10.084; Abbas A, 2007, CHEM ENG SCI, V62, P2445, DOI 10.1016/j.ces.2007.01.052; Blanco M, 2000, ANAL CHIM ACTA, V407, P247, DOI 10.1016/S0003-2670(99)00828-4; Bouchard A, 2007, J CHEM ENG DATA, V52, P1626, DOI 10.1021/je700014k; Cao WJ, 2002, J PHARMACEUT BIOMED, V30, P1111, DOI 10.1016/S0731-7085(02)00419-3; DEY BP, 1988, INDIAN J CHEM A, V27, P297; Drebushchak TN, 2002, J STRUCT CHEM+, V43, P835, DOI 10.1023/A:1022885510109; Duffy D, 2012, CHEM ENG SCI, V77, P112, DOI 10.1016/j.ces.2012.01.047; Fischer E, 1905, BER DTSCH CHEM GES, V38, P2914, DOI 10.1002/cber.19050380395; Guangwen He, 2011, Journal of Crystal Growth, V314, DOI 10.1016/j.jcrysgro.2010.11.105; Lee HE, 2011, INT J PHARMACEUT, V420, P274, DOI 10.1016/j.ijpharm.2011.08.044; Malluin J. W., 1993, CRYSTALLIZATION; Marjatta L. K., 2006, INT J PHARMACEUT, V320, P23; Matsumoto M, 2010, CHEM ENG RES DES, V88, P1624, DOI 10.1016/j.cherd.2010.02.007; Matsumoto M, 2013, J CRYST GROWTH, V373, P73, DOI 10.1016/j.jcrysgro.2012.11.022; Matsumoto M, 2009, J CHEM ENG JPN, V42, pS242; Rabesiaka M, 2010, J CRYST GROWTH, V312, P1860, DOI 10.1016/j.jcrysgro.2010.03.011; Torbeev VY, 2005, CRYST GROWTH DES, V5, P2190, DOI 10.1021/cg050200s; UusiPenttila M, 1996, J CRYST GROWTH, V166, P967, DOI 10.1016/0022-0248(95)00920-5	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	MAR	2015	26	2					415	421		10.1016/j.apt.2014.11.014		7	Engineering, Chemical	Engineering	CF6VU	WOS:000352695400011		
J	Mizutani, M; Yasuda, M; Matsusaka, S				Mizutani, Megumi; Yasuda, Masatoshi; Matsusaka, Shuji			Advanced characterization of particles triboelectrically charged by a two-stage system with vibrations and external electric fields	ADVANCED POWDER TECHNOLOGY			English	Article						Particle tribocharging; Repeated contact; Vibration; Electric field; Initial charge	PNEUMATIC CONVEYING SYSTEM; SOLIDS PIPE-FLOW; CONTACT ELECTRIFICATION; ELECTROSTATIC CHARGE; FLUIDIZED-BEDS; AEROSOL FLOW; BULK POWDERS; TRIBOELECTRIFICATION; REENTRAINMENT; DEPOSITION	In this study, we propose a new method to effectively characterize particle tribocharging caused by repeated contact with a wall in an external electric field. We perform experiments using a two-stage system consisting of two inclined vibrating plates and electrodes. The mass flow rate and charge of particles were controlled at the first vibrating plate, and the charge that was transferred from the plate to the particles was obtained from the difference between the charges on particles at the lower and upper ends of the second vibrating plate. In addition, electric currents generated by the charge transfer were simultaneously measured at the second vibrating plate. From these measurements, we verified that the charge balance in this system holds. Furthermore, we found that the charge transfer depends on various factors, such as the initial charge, chemical and electrical properties, travel length of particles, and the external electric field. We also found that the equilibrium charge of particles depends on the chemical property and external electric field. The equilibrium charge and the rate of tribocharging were evaluated analytically from the relationship between the initial and transferred charges without changing the travel distance of particles. This method enables the rapid and reliable analysis of the particle tribocharging process. (C) 2014 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Mizutani, Megumi; Yasuda, Masatoshi; Matsusaka, Shuji] Kyoto Univ, Dept Chem Engn, Kyoto 6158510, Japan	Matsusaka, S (reprint author), Kyoto Univ, Dept Chem Engn, Kyoto 6158510, Japan.	matsu@cheme.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26289288]	This research was supported in part by a Grant-in-Aid for Scientific Research (B) (No. 26289288) from the Japan Society for the Promotion of Science (JSPS).	Adhiwidjaja I, 2000, ADV POWDER TECHNOL, V11, P221, DOI 10.1163/156855200750172330; Akashi T., 2013, J SOC POWDER TECHNOL, V30, P845; Lim EWC, 2013, IND ENG CHEM RES, V52, P15863, DOI 10.1021/ie402511p; Higashiyama Y, 1997, J ELECTROSTAT, V42, P63, DOI 10.1016/S0304-3886(97)00131-9; Hamaker HC, 1937, PHYSICA, V4, P1058, DOI 10.1016/S0031-8914(37)80203-7; He C, 2014, POWDER TECHNOL, V253, P1, DOI 10.1016/j.powtec.2013.10.042; Matsusaka S, 2008, CHEM ENG SCI, V63, P1353, DOI 10.1016/j.ces.2007.07.010; Grzybowski BA, 2003, NAT MATER, V2, P241, DOI 10.1038/nmat860; Matsusaka S, 2003, ADV POWDER TECHNOL, V14, P143, DOI 10.1163/156855203763593958; Matsusaka S, 2010, CHEM ENG SCI, V65, P5781, DOI 10.1016/j.ces.2010.07.005; Sowinski A, 2012, CHEM ENG SCI, V71, P552, DOI 10.1016/j.ces.2011.11.031; Wu GQ, 2013, WASTE MANAGE, V33, P585, DOI 10.1016/j.wasman.2012.10.014; Ireland PM, 2010, POWDER TECHNOL, V198, P189, DOI 10.1016/j.powtec.2009.11.017; Matsusaka S, 1996, ADV POWDER TECHNOL, V7, P141, DOI 10.1016/S0921-8831(08)60509-9; Bunchatheeravate P, 2013, AICHE J, V59, P2308, DOI 10.1002/aic.14025; Dwari RK, 2015, ADV POWDER TECHNOL, V26, P31, DOI 10.1016/j.apt.2014.08.001; Jones T B, 1991, POWDER HANDLING ELEC; Kleber W, 1998, PARTICUL SCI TECHNOL, V16, P43, DOI 10.1080/02726359808906783; Leong FY, 2009, AICHE J, V55, P1390, DOI 10.1002/aic.11751; Matsusaka S, 2006, CHEM ENG SCI, V61, P2254, DOI 10.1016/j.ces.2005.05.006; Matsusaka Shuji, 2012, Journal of the Society of Powder Technology, Japan, V49; Matsusaka S., 2013, J SOC POWDER TECHNOL, V50, P632; Matsusaka S, 2007, ADV POWDER TECHNOL, V18, P229, DOI 10.1163/156855207780208673; Matsusaka Shuji, 2012, Journal of the Society of Powder Technology, Japan, V49; Matsusaka S., 2008, J SOC POWDER TECHNOL, V45, P380; Matsusaka S, 2003, ADV POWDER TECHNOL, V14, P127, DOI 10.1163/156855203762469939; Matsusaka S, 2015, ADV POWDER TECHNOL, V26, P149, DOI 10.1016/j.apt.2014.08.017; Matsusaka S., 2011, KONA POWDER PART J, V29, P27; Matsuyama T., 1998, KONA, V16, P223; Matsuyama T., 2007, PART PART SYST CHAR, V24, P1; Mizutani M., 2013, J SOC POWDER TECHNOL, V50, P832; OGUCHI T, 1993, WEAR, V168, P91, DOI 10.1016/0043-1648(93)90202-W; Schein L. B., 1992, ELECTROPHOTOGRAPHY D; Supuk E, 2009, PART PART SYST CHAR, V26, P7, DOI 10.1002/ppsc.200800015; Supuk E, 2011, KONA POWDER PART J, P208; Techaumnat B, 2009, J ELECTROSTAT, V67, P686, DOI 10.1016/j.elstat.2009.03.004; Theerachaisupakij W, 2002, ADV POWDER TECHNOL, V13, P287, DOI 10.1163/156855202320252453; Yao J, 2004, IND ENG CHEM RES, V43, P7181, DOI 10.1021/ie049661l; Yao J, 2014, PARTICUOLOGY, V15, P82, DOI 10.1016/j.partic.2013.01.010	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	MAR	2015	26	2					454	461		10.1016/j.apt.2014.11.021		8	Engineering, Chemical	Engineering	CF6VU	WOS:000352695400017		
J	Nakamura, H; Deguchi, N; Watano, S				Nakamura, Hideya; Deguchi, Naoki; Watano, Satoru			Development of tapered rotating fluidized bed granulator for increasing yield of granules	ADVANCED POWDER TECHNOLOGY			English	Article						Fluidization; Granulation; Rotating fluidized bed; Tapered vessel; Particle entrainment	COATER	A rotating fluidized bed granulator is an attractive technique for handling fine cohesive powders. However, significant particle entrainment and following serious loss of granules have been a major hurdle for its practical use. We here proposed a novel tapered rotating fluidized bed granulator in order to reduce the particle entrainment and increase the yield of granules. The tapered rotating fluidized bed consists of a cylindrical vessel with two frustum ends, in which superficial velocity of the fluidization air is less increased toward an air exit at the center of the vessel. Wet granulation of a fine cohesive powder classified into Geldart Group C was conducted by the developed tapered rotating fluidized bed, and its performance as a granulator for handling a fine cohesive powder was evaluated. The results showed that the particle entrainment was decreased by merely modifying the vessel geometry to the tapered geometry, resulting in a significantly increase in the yield of granules. The particle size distribution of the granules showed unimodal distribution, confirming that granules are able to be prepared from a fine cohesive powder without coarse granules. (C) 2014 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Nakamura, Hideya; Deguchi, Naoki; Watano, Satoru] Osaka Prefecture Univ, Dept Chem Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Nakamura, H (reprint author), Osaka Prefecture Univ, Dept Chem Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	hnakamura@chemeng.osakafu-u.ac.jp					GELDART D, 1973, POWDER TECHNOL, V7, P285, DOI 10.1016/0032-5910(73)80037-3; Qian GH, 2001, AICHE J, V47, P1022, DOI 10.1002/aic.690470509; CHEN YM, 1987, AICHE J, V33, P722, DOI 10.1002/aic.690330504; Nakamura H, 2009, CHEM ENG PROCESS, V48, P178, DOI 10.1016/j.cep.2008.03.003; Watano S, 2004, POWDER TECHNOL, V141, P172, DOI 10.1016/j.powtec.2003.03.001; Sau DC, 2007, CHEM ENG J, V132, P151, DOI 10.1016/j.cej.2007.01.036; Watano S, 2003, POWDER TECHNOL, V131, P250, DOI 10.1016/S0032-5910(03)00007-X; Eliaers P, 2014, POWDER TECHNOL, V258, P242, DOI 10.1016/j.powtec.2014.03.033; Schaafsma SH, 2006, CHEM ENG SCI, V61, P4467, DOI 10.1016/j.ces.2006.01.040; Depypere F, 2009, J FOOD ENG, V93, P324, DOI 10.1016/j.jfoodeng.2009.01.042; KAO J, 1987, AICHE J, V33, P858, DOI 10.1002/aic.690330520; Kuzmin AO, 2005, CHEM ENG J, V107, P55, DOI 10.1016/j.cej.2004.12.010; Nakamura H, 2007, POWDER TECHNOL, V171, P106, DOI 10.1016/j.powtec.2006.08.021; DIFELICE R, 1991, AICHE J, V37, P1668, DOI 10.1002/aic.690371109; Nakamura H, 2013, CHEM ENG SCI, V91, P70, DOI 10.1016/j.ces.2013.01.022; Nakamura H, 2014, CHEM ENG SCI, V116, P725, DOI 10.1016/j.ces.2014.05.052; SHI YF, 1984, IND ENG CHEM FUND, V23, P484, DOI 10.1021/i100016a018	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	MAR	2015	26	2					494	499		10.1016/j.apt.2014.12.003		6	Engineering, Chemical	Engineering	CF6VU	WOS:000352695400022		
J	Tanaka, H; Moriwaki, N; Ishikawa, T; Nakayama, T				Tanaka, Hidekazu; Moriwaki, Nozomi; Ishikawa, Tatsuo; Nakayama, Takenori			Simulating study of atmospheric corrosion of Zn-Ni alloy coating on steels in marine zone: Structure and properties of artificially synthesized Ni(II)-doped zinc hydroxychloride rust particles	ADVANCED POWDER TECHNOLOGY			English	Article						Zinc hydroxychloride; Zinc rust; Particle morphology; Atmospheric corrosion; Molecular adsorption	SULFATE ELECTROLYTES; COATED STEEL; ELECTRODEPOSITION; RESISTANCE; NAZN4CL(OH)6SO4.6H2O; AUTOMOBILES; PRODUCTS; BEHAVIOR; SHEETS; TESTS	To simulate the atmospheric corrosion of Zn-Ni alloy coating on the steel in marine zone, artificial Ni(II)doped zinc hydroxychloride (Zn-5(OH)(8)Cl-2 center dot H2O:ZHC) rust particles were prepared by hydrolysis of ZnO particles in a mixture of aqueous ZnCl2 and NiCl2 solutions at 85 degrees C and were characterized by various means. Then, the Ni(II)/(Zn(II) + Ni(II)) atomic ratio in starting solution (X-Ni) was 0-0.10. XRD results indicated that crystallization of the layered structure of ZHC was strongly inhibited with an increase of X-Ni and no new particles were generated. The Ni(II) was incorporated into ZHC crystal by substitution with Zn(II) and the Ni/(Zn + Ni) molar ratio in the particles was almost consistent with X-Ni. The ZHC particles formed at X-Ni = 0 were hexagonal plate with a size of ca. 3.2 mu m and a thickness of ca. 0.3 mu m. Increasing X-Ni reduced the size and thickness of ZHC particles. Besides, addition of Ni(II) suppressed the adsorption of CO2 and SO2 gasses on ZHC, because of layered structure of this material to be disintegrated. The foregoing results suggest that atmospheric corrosion of Zn-Ni alloy coating in marine zone forms dense and compact zinc rust layer composed of fine Ni(II)-doped ZHC particles with a low affinity to corrosive gasses on the steels, leading to the suppression of further corrosion of steel. Also, role of Ni on the atmospheric corrosion of Zn-Ni alloy coating in marine zone can be suggested by studying the structure and properties of artificial Ni(II)-doped ZHC rust particles. (C) 2015 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Tanaka, Hidekazu; Moriwaki, Nozomi] Shimane Univ, Grad Sch Sci & Engn, Dept Chem, Matsue, Shimane 6908504, Japan; [Ishikawa, Tatsuo] Osaka Univ Educ, Sch Chem, Kashiwara, Osaka 5828582, Japan; [Nakayama, Takenori] Kobe Steel Ltd, Mat Res Lab, Nishi Ku, Kobe, Hyogo 6152271, Japan	Tanaka, H (reprint author), Shimane Univ, Grad Sch Sci & Engn, Dept Chem, 1060 Nishikawatsu, Matsue, Shimane 6908504, Japan.	hidekazu@riko.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japanese Government [23760699, 26420739]	The authors are sincerely grateful to Mr. Tsunao Yoneyama of Department of Biosignaling and Radioisotope Experiment Center for Integrated Research in Science of Shimane University for his help with TEM observation. This study was partly supported by the Grant-in-Aid for Young Scientists Fund (B) (23760699) and for Scientific Research (C) (26420739) from the Ministry of Education, Culture, Sports, Science and Technology, Japanese Government.	Alfantazi AM, 1996, CORROSION, V52, P880; Ishikawa T, 2004, CORROS SCI, V46, P329, DOI 10.1016/S0010-938X(03)00155-0; Ramanauskas R, 1998, CORROS SCI, V40, P401, DOI 10.1016/S0010-938X(97)00144-3; ODNEVALL I, 1993, CORROS SCI, V34, P1213, DOI 10.1016/0010-938X(93)90082-R; LIPPENS BC, 1965, J CATAL, V4, P319, DOI 10.1016/0021-9517(65)90307-6; Tanaka H, 2007, J SOLID STATE CHEM, V180, P2061, DOI 10.1016/j.jssc.2007.05.001; Miranda FJF, 1997, J ELECTROCHEM SOC, V144, P3441, DOI 10.1149/1.1838030; ODNEVALL I, 1993, CORROS SCI, V34, P1231, DOI 10.1016/0010-938X(93)90083-S; JONES DA, 1985, CORROSION, V41, P357; Yoo JD, 2013, CORROS SCI, V70, P1, DOI 10.1016/j.corsci.2012.10.024; Conde A, 2011, CORROS SCI, V53, P1489, DOI 10.1016/j.corsci.2011.01.021; Quintana P, 1996, APPL SURF SCI, V99, P325, DOI 10.1016/0169-4332(96)00597-1; Miranda FJF, 1997, J ELECTROCHEM SOC, V144, P3449, DOI 10.1149/1.1838031; WILCOX GD, 1993, CORROS SCI, V35, P1251, DOI 10.1016/0010-938X(93)90345-H; Baes C. F., 1986, HYDROLYSIS CATIONS; Binran Kagaku, 1993, CHEM HDB; Crotty D., 1996, MET FINISH, V94, P54, DOI 10.1016/0026-0576(96)82103-9; Feitknecht W., 1959, CHEM IND, V36, P1102; HALL DE, 1983, PLAT SURF FINISH, V70, P59; Hu CC, 2006, ELECTROCHIM ACTA, V51, P4125, DOI 10.1016/j.electacta.2005.11.031; KAWAFUKU J, 1991, TETSU TO HAGANE, V77, P995; Kim HS, 2003, CORROS SCI, V45, P1505, DOI 10.1016/S0010-938X(02)00228-7; LAMBERT MR, 1985, IND ENG CHEM PROD RD, V24, P378, DOI 10.1021/i300019a008; Leygraf C, 2000, ATMOSPHERIC CORROSIO; MIYOSHI Y, 1983, T IRON STEEL I JPN, V23, P974; Mosavat SH, 2012, CORROS SCI, V59, P81, DOI 10.1016/j.corsci.2012.02.012; ODNEVALL I, 1994, CORROS SCI, V36, P1077, DOI 10.1016/0010-938X(94)90205-4; Odnevall I., 1994, CORROS SCI, V36, P1467; Qui Q., 2002, CORROS SCI, V33, P2789; Rahsepar M, 2009, CORROS SCI, V51, P2537, DOI 10.1016/j.corsci.2009.06.030; Sakoda A., 1989, HYOMEN GIJYUTSU, V40, P164; Savall C, 2006, MAT SCI ENG A-STRUCT, V430, P165, DOI 10.1016/j.msea.2006.05.025; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sillen LG, 1964, STABILITY CONSTANTS; Tanaka H, 2008, CORROS SCI, V50, P3154, DOI 10.1016/j.corsci.2008.08.022; Tanaka H, 2011, CORROS SCI, V53, P2502, DOI 10.1016/j.corsci.2011.04.006; Tanaka H, 2011, CORROS SCI, V53, P696, DOI 10.1016/j.corsci.2010.10.018	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	MAR	2015	26	2					612	617		10.1016/j.apt.2015.01.010		6	Engineering, Chemical	Engineering	CF6VU	WOS:000352695400036		
J	Yoshida, M; Sanagawa, T; Okano, S; Yamamoto, H; Oshitani, J; Gotoh, K; Paul, J; Koch, T; Peukert, W				Yoshida, Mikio; Sanagawa, Tomoya; Okano, Shun-ichiro; Yamamoto, Hiroaki; Oshitani, Jun; Gotoh, Kuniaki; Paul, Jonas; Koch, Thomas; Peukert, Wolfgang			Effects of an adhesive force of admixed particles on compressed packing fractions in a particle bed	ADVANCED POWDER TECHNOLOGY			English	Article						Packing fraction; Compressed particle bed; Admixture of nano-particles; Chemical surface modification	ALUMINUM POWDERS; GLIDANTS; MIXTURE	One of the techniques for a reduction in particle cohesiveness is the admixing of nano-particles. However, the mechanism of cohesiveness reduction has not yet been clarified. In this study we focused on a compressed packing fraction as one of the values reflecting the cohesiveness and flowability in a compressed particle flow. In order to estimate the mechanism of the reduction, the effects of an adhesive force of admixed particles on the packing fraction were investigated experimentally. In the experiments, silica particles with 397 and 8 nm diameters were used as the main and the admixed particles, respectively. The surfaces of the admixed particles were modified chemically in order to vary their adhesive force with maintaining morphological and mechanical characteristics. At more than 2.0% mixing mass ratios, the decreasing rate with increasing the mass ratio in net difference value of packing fraction for modified admixed particles was smaller than that for the raw particles. A calculation of the packing fraction of the admixed particles in the voids of main particles revealed that difference of the decreasing rates could be attributed to the difference of cohesivenesses between raw and modified admixed particles. The maximum packing fraction achieved by the modified admixed particles was lower than that achieved by the raw admixed particles. However, when a mixture of main and admixed particles was packed by tapping, the packing fraction with modified admixed particles was higher than that with raw admixed particles. This implied that the adequate adhesive force of admixed particles is different by the applied compression force value. (C) 2015 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Yoshida, Mikio; Sanagawa, Tomoya; Okano, Shun-ichiro; Yamamoto, Hiroaki; Oshitani, Jun; Gotoh, Kuniaki] Okayama Univ, Grad Sch Nat Sci & Technol, Div Chem & Biotechnol, Kita Ku, Okayama 7008530, Japan; [Paul, Jonas; Koch, Thomas; Peukert, Wolfgang] Univ Erlangen Nurnberg, Inst Particle Technol, D-91058 Erlangen, Germany	Yoshida, M (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Div Chem & Biotechnol, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	myoshida@cc.okayama-u.ac.jp			Japan Society for the Promotion of Science [18004]	This study was supported by the Core-to-Core Program promoted by the Japan Society for the Promotion of Science (Project No. 18004).	Schmidt J, 2014, POWDER TECHNOL, V261, P78, DOI 10.1016/j.powtec.2014.04.003; Chen YH, 2010, COLLOID SURFACE A, V361, P66, DOI 10.1016/j.colsurfa.2010.03.015; Meyer K, 2004, POWDER TECHNOL, V139, P40, DOI 10.1016/j.powtec.2003.09.007; Il'in AP, 2002, COMBUST EXPLO SHOCK+, V38, P665, DOI 10.1023/A:1021140227639; Jonat S, 2004, POWDER TECHNOL, V141, P31, DOI 10.1016/j.powtec.2004.01.020; Masuda H., 2006, POWDER TECHNOLOGY HD, P157; Ohta KM, 2003, PHARMACEUT RES, V20, P804, DOI 10.1023/A:1023497922211; Ohta K.M., 2003, J SURF SCI SOC JPN, V24, P608; Podczeck F, 1998, PARTICLE PARTICLE AD; Sindel U, 1998, J PHARM SCI, V87, P524, DOI 10.1021/js9604321; Yoshida M, 2013, ADV POWDER TECHNOL, V24, P560, DOI 10.1016/j.apt.2013.01.004; Zimmermann I, 2004, Z PHYS CHEM, V218, P51, DOI 10.1524/zpch.218.1.51.25388	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	MAR	2015	26	2					626	631		10.1016/j.apt.2015.01.014		6	Engineering, Chemical	Engineering	CF6VU	WOS:000352695400039		
J	Nakatuka, Y; Yoshida, H; Fukui, K; Matuzawa, M				Nakatuka, Yuta; Yoshida, Hideto; Fukui, Kunihiro; Matuzawa, Mitsuharu			The effect of particle size distribution on effective zeta-potential by use of the sedimentation method	ADVANCED POWDER TECHNOLOGY			English	Article						Zeta-potential; Liquid sedimentation; Ultrasonic dispersion; Sub-micron silica	BALANCE METHOD; CANDIDATES	A new method of effective zeta-potential measurement by use of the liquid sedimentation balance method is developed. The test samples used were spherical silica particles, and an ultrasonic probe was used to enhance particle dispersion. In order to obtain reliable data, rapid change in sedimentation mass due to a small air bubble detachment from the detection tray is corrected in the data analysis process. The new method can be used to estimate the effective zeta-potential of each particle size range. The absolute value of negative zeta-potential of small particles is greater than that of large particles. The absolute values of negative zeta-potential increased with the increase of the ultrasonic probe power. The absolute value of negative zeta-potential shows a maximum value at the initial stage after the dispersion process, however it decreases over an elapsed time period. After an elapsed time greater than approximately 200 h, the zeta-potential shows a constant value. The data obtained by the new method qualitatively agreed with the conventional method. (C) 2015 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Nakatuka, Yuta; Yoshida, Hideto; Fukui, Kunihiro] Hiroshima Univ, Dept Chem Engn, Hiroshima 7398527, Japan; [Matuzawa, Mitsuharu] Hitachi Chem Co Ltd, Shimodate works, Chikusei, Ibaragi 3068524, Japan	Yoshida, H (reprint author), Hiroshima Univ, Dept Chem Engn, 1-4-1 Kagamiyama, Hiroshima 7398527, Japan.	r736619@hiroshima-u.ac.jp					[Anonymous], 1990, Z8822 JAP STAND ASS; Fukui K, 2000, J CHEM ENG JPN, V33, P393, DOI 10.1252/jcej.33.393; Fukui K, 2002, KAGAKU KOGAKU RONBUN, V28, P161; Romanus K., 2010, ADV POWDER TECHNOL, V21, P246; Yoshida H, 2001, ADV POWDER TECHNOL, V12, P79, DOI 10.1163/156855201744976; Yoshida H, 2012, POWDER TECHNOL, V219, P29, DOI 10.1016/j.powtec.2011.12.002; Yoshida H, 2003, ADV POWDER TECHNOL, V14, P17, DOI 10.1163/156855203762469876; Yoshida H, 2009, ADV POWDER TECHNOL, V20, P145, DOI 10.1016/j.apt.2008.05.002; Yoshida H, 2013, POWDER TECHNOL, V237, P303, DOI 10.1016/j.powtec.2012.12.011	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	MAR	2015	26	2					650	656		10.1016/j.apt.2015.01.017		7	Engineering, Chemical	Engineering	CF6VU	WOS:000352695400043		
J	Han, CG; Zhu, CY; Saito, G; Akiyama, T				Han, Cheng-Gong; Zhu, Chunyu; Saito, Genki; Akiyama, Tomohiro			Glycine/sucrose-based solution combustion synthesis of high-purity LiMn2O4 with improved yield as cathode materials for lithium-ion batteries	ADVANCED POWDER TECHNOLOGY			English	Article						LiMn2O4; Cathode material; Solution combustion synthesis; Nanoparticles	ELECTROCHEMICAL PERFORMANCE; SPINEL LIMN2O4; ELEVATED-TEMPERATURE; COPRECIPITATION; STORAGE	Single-phase, high-purity nanosized LiMn2O4 powders, which are employed as cathode materials for lithium-ion batteries, were produced by solution combustion synthesis using glycine, sucrose, and nitrate, followed by calcination. Phase structure and morphology of the powders were characterized by X-ray diffraction and scanning electron microscopy. The electrochemical performance was measured by galvanostatic charge-discharge cycling in a voltage range of 3.2-4.4 V. The analysis of yield, morphology, and electrochemical performance mainly focused on the influence of different glycine/sucrose ratios. Compared to the sample obtained using 100% glycine, the yields of powders obtained by adding sucrose to the fuel were remarkably improved, from around 50% to over 90%. The highest discharge capacity at 1 C was obtained for the sample with 2% added sucrose, which retained a capacity of 116.6 mAh/g after 80 cycles. (C) 2015 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Han, Cheng-Gong; Zhu, Chunyu; Saito, Genki; Akiyama, Tomohiro] Hokkaido Univ, Ctr Adv Res Energy & Mat, Sapporo, Hokkaido 0628628, Japan	Akiyama, T (reprint author), Hokkaido Univ, Ctr Adv Res Energy & Mat, Sapporo, Hokkaido 0628628, Japan.	takiyama@eng.hokudai.ac.jp			Japan Society for Promotion of Science (JSPS); Japan Science and Technology Agency (JST)	The authors would like to thank the partially financial support by the Japan Society for Promotion of Science (JSPS) and Japan Science and Technology Agency (JST).	Hosono E, 2009, NANO LETT, V9, P1045, DOI 10.1021/nl803394v; CHICK LA, 1990, MATER LETT, V10, P6, DOI 10.1016/0167-577X(90)90003-5; Thirunakaran R, 2013, J ALLOY COMPD, V556, P266, DOI 10.1016/j.jallcom.2012.12.053; Ianos R, 2012, J AM CERAM SOC, V95, P2236, DOI 10.1111/j.1551-2916.2012.05159.x; Lazarraga MG, 2004, J MATER CHEM, V14, P1640, DOI 10.1039/b314157h; Chan HW, 2003, J POWER SOURCES, V115, P110, DOI 10.1016/S0378-7753(02)00616-X; TARASCON JM, 1991, J ELECTROCHEM SOC, V138, P2859, DOI 10.1149/1.2085330; Lee MJ, 2014, NANO LETT, V14, P993, DOI 10.1021/nl404430e; Kakuda T, 2007, J POWER SOURCES, V167, P499, DOI 10.1016/j.jpowsour.2007.01.035; Zhu CY, 2013, INT J HYDROGEN ENERG, V38, P13238, DOI 10.1016/j.ijhydene.2013.07.113; Ju BW, 2014, J SOLID STATE ELECTR, V18, P115, DOI 10.1007/s10008-013-2241-x; Tahmasebi K, 2008, MATER CHEM PHYS, V109, P156, DOI 10.1016/j.matchemphys.2007.11.009; Hayner CM, 2012, ANNU REV CHEM BIOMOL, V3, P445, DOI 10.1146/annurev-chembioeng-062011-081024; Patil KC, 1997, CURR OPIN SOLID ST M, V2, P158, DOI 10.1016/S1359-0286(97)80060-5; Zhu CY, 2014, ADV POWDER TECHNOL, V25, P342, DOI 10.1016/j.apt.2013.05.015; Waller GH, 2014, J POWER SOURCES, V251, P411, DOI 10.1016/j.jpowsour.2013.11.081; Mukasyan AS, 2007, P COMBUST INST, V31, P1789, DOI 10.1016/j.proci.2006.07.052; Ding YL, 2011, J PHYS CHEM C, V115, P9821, DOI 10.1021/jp201669x; Maier J, 2005, NAT MATER, V4, P805, DOI 10.1038/nmat1513; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Chen CL, 2013, THIN SOLID FILMS, V544, P182, DOI 10.1016/j.tsf.2013.03.127; Fey GTK, 2004, MATER CHEM PHYS, V87, P275, DOI 10.1016/j.matchemphys.2004.05.009; Guo DL, 2013, J SOLID STATE ELECTR, V17, P2849, DOI 10.1007/s10008-013-2199-8; Kiani MA, 2011, INT J ELECTROCHEM SC, V6, P2581; Lee KM, 2001, J MATER SCI LETT, V20, P1309, DOI 10.1023/A:1010942316136; Liu XM, 2010, J POWER SOURCES, V195, P4290, DOI 10.1016/j.jpowsour.2010.01.068; Makhlouf M.T., 2013, J NANOPARTICLES, V2013, P1; Pitchai R, 2011, J MATER CHEM, V21, P11040, DOI 10.1039/c1jm10857c; Ragupathy P, 2010, MATER CHEM PHYS, V124, P870, DOI 10.1016/j.matchemphys.2010.08.014; Stiaszny B, 2014, J POWER SOURCES, V251, P439, DOI 10.1016/j.jpowsour.2013.11.080; Xiao ZL, 2014, J ALLOY COMPD, V592, P226, DOI 10.1016/j.jallcom.2014.01.008; Zhang H, 2014, J SOLID STATE ELECTR, V18, P569, DOI 10.1007/s10008-013-2293-y	32	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	MAR	2015	26	2					665	671		10.1016/j.apt.2015.01.019		7	Engineering, Chemical	Engineering	CF6VU	WOS:000352695400045		
J	Motomiya, Y; Higashimoto, Y; Uji, Y; Suenaga, G; Ando, Y				Motomiya, Yoshihiro; Higashimoto, Yuichiro; Uji, Yoshinori; Suenaga, Genki; Ando, Yukio			C-terminal unfolding of an amyloidogenic beta(2)-microglobulin fragment: Delta N6 beta(2)-microglobulin	AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS			English	Article						Amyloidogenicity; capillary electrophoresis; dialysis-related amyloidosis; enzyme-linked immunosorbent assay; hemodialysis; monoclonal antibody 92-99; surface plasmon resonance	IN-VITRO; BETA-2-MICROGLOBULIN; HEMODIALYSIS; AFFINITY; KINETICS; FIBRILS; STATES	Objectives: A beta(2)-microglobulin (beta(2)m) fragment that lacks the first six amino acids, i.e., Delta N6 beta(2)-microglobulin (Delta N6 beta(2)m), is an endogenous, proteolytically derived, amyloidogenic fragment of beta(2)m, the precursor protein in A beta M-2 amyloidosis (dialysis-related amyloidosis). As reports suggest the importance of C-terminal unfolding for the amyloidogenicity of beta(2)m, in this study we aimed to investigate conformational characteristics of Delta N6 beta(2)m related to amyloidogenicity. We also measured the concentration of an amyloidogenic intermediate of beta(2)m with C-terminal unfolding (beta(2)m92-99) in serum samples from 10 patients undergoing hemodialysis (HD). Methods: We utilized capillary electrophoretic analysis, surface plasmon resonance and enzyme-linked immunosorbent assay. Results and conclusions: We confirmed the normal core structure of Delta N6 beta(2)m with a commercial monoclonal anti-beta(2)m antibody. In addition, using the specific monoclonal antibody for the C-terminal peptide, i.e. mAb 92-99, we confirmed unfolding in the C-terminal region of Delta N6 beta(2)m. On the basis of these findings, we established an ELISA to measure beta(2)m92-99 using Delta N6 beta(2)m as a standard molecule in circulation. However, we did not detect beta(2)m92-99 in serum from 10 HD patients, despite the absence of uremic inhibitors in the serum.	[Motomiya, Yoshihiro] Suiyukai Clin, Kashihara, Nara 6340007, Japan; [Higashimoto, Yuichiro] Kurume Univ, Sch Med, Dept Chem, Kurume, Fukuoka 830, Japan; [Uji, Yoshinori] Int Univ Hlth & Welf, Sch Hlth Sci Fukuoka, Dept Med Technol & Sci, Okawa, Fukuoka, Japan; [Suenaga, Genki; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Honjo, Kumamoto, Japan	Motomiya, Y (reprint author), Suiyukai Clin, 676-1 Kuzumoto Cho, Kashihara, Nara 6340007, Japan.	motomiya@silver.ocn.ne.jp			Health Labour Sciences Research KAKENHI [11103528]	The authors report no conflicts of interest. This work was supported by Health Labour Sciences Research KAKENHI Grant 11103528.	Campbell CT, 2007, BIOMATERIALS, V28, P2380, DOI 10.1016/j.biomaterials.2007.01.047; Heegaard NHH, 2000, J CHROMATOGR A, V894, P319, DOI 10.1016/S0021-9673(00)00579-3; Esposito G, 2000, PROTEIN SCI, V9, P831; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Heegaard NHH, 2009, AMYLOID, V16, P151, DOI 10.1080/13506120903151775; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; Rennella E, 2013, J MOL BIOL, V425, P2722, DOI 10.1016/j.jmb.2013.04.028; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Carson M, 2007, ACTA CRYSTALLOGR D, V63, P295, DOI 10.1107/S0907444906052024; GEJYO F, 1986, KIDNEY INT, V30, P385, DOI 10.1038/ki.1986.196; Giorgetti S, 2005, PROTEIN SCI, V14, P696, DOI 10.1110/ps.041194005; Guntert P, 1997, J MOL BIOL, V273, P28398; Lakey JH, 1998, CURR OPIN STRUC BIOL, V8, P119, DOI 10.1016/S0959-440X(98)80019-5; LINKE RP, 1989, KIDNEY INT, V36, P675, DOI 10.1038/ki.1989.245; LINKE RP, 1987, BIOL CHEM H-S, V368, P137, DOI 10.1515/bchm3.1987.368.1.137; Motomiya Y, 2005, KIDNEY INT, V67, P314, DOI 10.1111/j.1523-1755.2005.00084.x; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Stoppini M, 2005, BBA-PROTEINS PROTEOM, V1753, P23, DOI 10.1016/j.bbapap.2005.07.019; Stoppini M, 1997, EUR J BIOCHEM, V249, P1; Stoppini M, 2000, KIDNEY INT, V57, P349, DOI 10.1046/j.1523-1755.2000.00851.x; Uji Y, 2009, NEPHRON CLIN PRACT, V111, pC173, DOI 10.1159/000199457	23	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1350-6129	1744-2818		AMYLOID	Amyloid-J. Protein Fold. Disord.	MAR	2015	22	1					54	60		10.3109/13506129.2014.994057		7	Biochemistry & Molecular Biology; Medicine, General & Internal; Medicine, Research & Experimental	Biochemistry & Molecular Biology; General & Internal Medicine; Research & Experimental Medicine	CF6AC	WOS:000352637800008		
J	Tasaki, M; Ueda, M; Matsumoto, K; Kawaji, T; Misumi, Y; Eiki, D; Suenaga, G; Obayashi, K; Yamashita, T; Tanihara, H; Ando, Y				Tasaki, Masayoshi; Ueda, Mitsuharu; Matsumoto, Koki; Kawaji, Takahiro; Misumi, Yohei; Eiki, Daisuke; Suenaga, Genki; Obayashi, Konen; Yamashita, Taro; Tanihara, Hidenobu; Ando, Yukio			Clinico-histopathological and biochemical analyses of corneal amyloidosis in gelatinous drop-like corneal dystrophy	AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS			English	Letter							LACTOFERRIN; TISSUES; GENE		[Tasaki, Masayoshi; Ueda, Mitsuharu; Misumi, Yohei; Suenaga, Genki; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto 8600811, Japan; [Tasaki, Masayoshi] Kumamoto Univ, Grad Sch Med Sci, Dept Immunol & Hematol, Kumamoto 8600811, Japan; [Matsumoto, Koki] Kumamoto Shinto Gen Hosp, Dept Ophthalmol, Kumamoto, Japan; [Kawaji, Takahiro; Eiki, Daisuke; Tanihara, Hidenobu] Kumamoto Univ, Grad Sch Med Sci, Dept Ophthalmol, Kumamoto 8600811, Japan; [Obayashi, Konen] Kumamoto Univ, Grad Sch Hlth Sci, Dept Morphol & Physiol Sci, Kumamoto 8600811, Japan; [Yamashita, Taro] Kumamoto Univ Hosp, Dept Neurol, Diagnost Unit Amyloidosis, Kumamoto, Japan	Ueda, M (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, 1-1-1 Honjo, Kumamoto 8600811, Japan.	mitt@rb3.so-net.ne.jp					Ando Y, 2002, LAB INVEST, V82, P757, DOI 10.1097/01.LAB.0000017170.26718.89; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Tsujikawa M, 1999, NAT GENET, V21, P420; Araki-Sasaki K, 2013, OPHTHALMOLOGY, V120, P1166, DOI 10.1016/j.ophtha.2012.11.047; Rodriguez FJ, 2008, LAB INVEST, V88, P1024, DOI 10.1038/labinvest.2008.72; Fujiki K, 1986, 7 INT C HUM GEN, P248; GILLETTE TE, 1980, AM J OPHTHALMOL, V90, P30; GOREVIC PD, 1991, NEW ENGL J MED, V325, P1780, DOI 10.1056/NEJM199112193252505; Nakatsukasa M, 2010, AM J PATHOL, V177, P1344, DOI 10.2353/ajpath.2010.100149; Stix B, 2005, INVEST OPHTH VIS SCI, V46, P1133, DOI 10.1167/iovs.04-1319	10	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1350-6129	1744-2818		AMYLOID	Amyloid-J. Protein Fold. Disord.	MAR	2015	22	1					67	69		10.3109/13506129.2014.983222		3	Biochemistry & Molecular Biology; Medicine, General & Internal; Medicine, Research & Experimental	Biochemistry & Molecular Biology; General & Internal Medicine; Research & Experimental Medicine	CF6AC	WOS:000352637800010		
J	Yagi, H; Amiya, E; Shintani, Y; Nitta, D; Numakura, S; Hosoya, Y; Watanabe, M; Fukayama, M; Komuro, I				Yagi, Hiroki; Amiya, Eisuke; Shintani, Yukako; Nitta, Daisuke; Numakura, Satoe; Hosoya, Yumiko; Watanabe, Masafumi; Fukayama, Masashi; Komuro, Issei			A representative case of hereditary transthyretin amyloidosis complicated by intramyocardial hemorrhage	AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS			English	Letter							POLYNEUROPATHY		[Yagi, Hiroki; Amiya, Eisuke; Nitta, Daisuke; Hosoya, Yumiko; Watanabe, Masafumi; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Shintani, Yukako; Numakura, Satoe; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1138655, Japan	Amiya, E (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	amiyae-tky@umin.ac.jp					Sucker C, 2006, AM J KIDNEY DIS, V47, P947, DOI 10.1053/j.ajkd.200603.036; Dungu JN, 2012, HEART, V98, P1546, DOI 10.1136/heartjnl-2012-301924; GARCIADORADO D, 1990, AM J PATHOL, V137, P301; HOSHINO Y, 1993, INTERNAL MED, V32, P879, DOI 10.2169/internalmedicine.32.879; Nakanishi N, 2009, AMYLOID, V16, P221, DOI 10.3109/13506120903421751; Revesz T, 2002, BRAIN PATHOL, V12, P343; Sakashita N, 2001, PATHOL INT, V51, P476, DOI 10.1046/j.1440-1827.2001.01228.x; Toyama K, 2009, INTERNAL MED, V48, P821, DOI 10.2169/internalmedicine.48.1846	8	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1350-6129	1744-2818		AMYLOID	Amyloid-J. Protein Fold. Disord.	MAR	2015	22	1					70	72		10.3109/13506129.2014.987865		3	Biochemistry & Molecular Biology; Medicine, General & Internal; Medicine, Research & Experimental	Biochemistry & Molecular Biology; General & Internal Medicine; Research & Experimental Medicine	CF6AC	WOS:000352637800011		
J	Yoneshiro, T; Saito, M				Yoneshiro, Takeshi; Saito, Masayuki			Activation and recruitment of brown adipose tissue as anti-obesity regimens in humans	ANNALS OF MEDICINE			English	Article						Brown adipose tissue; beige/brite adipocyte; energy expenditure; humans; obesity	DIET-INDUCED THERMOGENESIS; BODY-MASS INDEX; ADULT HUMANS; COLD-EXPOSURE; ADAPTIVE THERMOGENESIS; ENERGY-EXPENDITURE; WHITE FAT; NONSHIVERING THERMOGENESIS; TRIGLYCERIDE CLEARANCE; ADRENERGIC-STIMULATION	Brown adipose tissue (BAT) is the site of sympathetically activated adaptive thermogenesis during cold exposure and after hyperphagia, thereby controlling whole-body energy expenditure (EE) and body fat. BAT thermogenesis is primarily dependent on the energy-dissipating activity of uncoupling protein 1 (UCP1). There are two types of UCP1-expressing adipocyte, classical brown and beige/brite adipocytes. Recent radionuclide studies have demonstrated the existence of metabolically active BAT composed of mainly beige/brite adipocytes in adult humans. Human BAT is activated by acute cold exposure, being positively correlated to cold-induced increases in EE. The inverse relationship between the BAT activity and body fatness suggests that BAT, because of its energy-dissipating activity, is protective against body fat accumulation. In fact, either repeated cold exposure or daily ingestion of some food ingredients acting on transient receptor potential channels recruited BAT in association with increased EE and decreased body fat. Moreover, possible contribution of BAT to glucose tolerance has been suggested. In addition to the sympathetic nervous system, some endocrine factors also have potential for activation/recruitment of BAT. Thus, BAT is a promising therapeutic target for combating human obesity and related metabolic disorders.	[Yoneshiro, Takeshi] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan; [Saito, Masayuki] Tenshi Coll, Sch Nursing & Nutr, Dept Nutr, Sapporo, Hokkaido, Japan	Saito, M (reprint author), Tenshi Coll, Sch Nursing & Nutr, Dept Nutr, Sapporo, Hokkaido, Japan.	saito@tenshi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22590227]; Special Research Grant from Tenshi College	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (22590227), and a Special Research Grant from Tenshi College.	Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Orava J, 2013, OBESITY, V21, P2279, DOI 10.1002/oby.20456; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Yoneshiro T, 2013, CURR OPIN CLIN NUTR, V16, P625, DOI 10.1097/MCO.0b013e3283653ee1; Sellayah D, 2014, ENDOCRINOLOGY, V155, P485, DOI 10.1210/en.2013-1629; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Vijgen GHEJ, 2012, J CLIN ENDOCR METAB, V97, pE1229, DOI 10.1210/jc.2012-1289; Dong M, 2013, CELL METAB, V18, P118, DOI 10.1016/j.cmet.2013.06.003; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Gasparetti AL, 2003, J PHYSIOL-LONDON, V552, P149, DOI 10.1113/jphysiol.2003.050369; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Guerra C, 1998, J CLIN INVEST, V102, P1724, DOI 10.1172/JCI4532; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Zhu Z, 2014, PHYSIOL BEHAV, V125, P21, DOI 10.1016/j.physbeh.2013.11.008; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Saito M, 2013, CURR OPIN LIPIDOL, V24, P71, DOI 10.1097/MOL.0b013e32835a4f40; Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Bianco AC, 2013, LANCET DIABETES ENDO, V1, P250, DOI 10.1016/S2213-8587(13)70069-X; Snitker S, 2009, AM J CLIN NUTR, V89, P45, DOI 10.3945/ajcn.2008.26561; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001; Geerling JJ, 2014, DIABETES, V63, P880, DOI 10.2337/db13-0194; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Iglesias P, 2012, EUR J ENDOCRINOL, V167, P301, DOI 10.1530/EJE-12-0357; Gilsanz V, 2012, J PEDIATR-US, V160, P604, DOI 10.1016/j.jpeds.2011.09.035; Florez-Duquet M, 1998, PHYSIOL REV, V78, P339; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Cohade C, 2003, J NUCL MED, V44, P170; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; COUSIN B, 1992, J CELL SCI, V103, P931; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Lee P, 2010, AM J PHYSIOL-ENDOC M, V299, pE601, DOI 10.1152/ajpendo.00298.2010; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Lee P, 2013, ENDOCR REV, V34, P413, DOI 10.1210/er.2012-1081; Nagai N, 2003, J CLIN ENDOCR METAB, V88, P5661, DOI 10.1210/jc.2003-030672; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Burysek L, 1997, FEBS LETT, V411, P83, DOI 10.1016/S0014-5793(97)00671-6; Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; SILVA JE, 1983, NATURE, V305, P712, DOI 10.1038/305712a0; St-Onge MP, 2010, NUTRITION, V26, P152, DOI 10.1016/j.nut.2009.07.004; Lowell BB, 2000, NATURE, V404, P652; Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213; Bishnoi M, 2013, PHARMACOL REP, V65, P751; Chainani-Wu N, 2010, AM J CARDIOL, V105, P1570, DOI 10.1016/j.amjcard.2010.01.016; Cohade C, 2003, J NUCL MED, V44, P1267; Collins S, 2014, NAT REV ENDOCRINOL, V10, P157, DOI 10.1038/nrendo.2013.234; Hee Park K, 2013, J CLIN ENDOCR METAB, V98, P4899; Jacene HA, 2011, MOL IMAGING BIOL, V13, P1278, DOI 10.1007/s11307-010-0379-9; Lee P, 2011, ENDOCRINOLOGY, V152, P3597, DOI 10.1210/en.2011-1349; Marken L Van, 2009, NEW ENGL J MED, V360, P1500, DOI DOI 10.1056/NEJM0A0808718); Matsushita M, 2013, INT J OBES LOND; Minotti AJ, 2004, CLIN NUCL MED, V29, P5, DOI 10.1097/01.rlu.0000102761.90104.c6; Moro C, 2013, AM J PHYSIOL-HEART C, V304, pH358, DOI 10.1152/ajpheart.00704.2012; Novelle MG, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/746281; Okamatsu-Ogura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084229; Okamatsu-Ogura Y, 2011, EXP BIOL MED, V236, P1274, DOI 10.1258/ebm.2011.011143; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Ricquier Daniel, 2011, Front Endocrinol (Lausanne), V2, P85, DOI 10.3389/fendo.2011.00085; Saito M, 2011, OBESITY, V19, pS79; Shabalina IG, 2013, PLOS ONE, V8; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; VALLERAND AL, 1987, AM J PHYSIOL, V253, pE179; Villarroya J, 2013, AM J PHYSIOL-ENDOC M, V305, pE567, DOI 10.1152/ajpendo.00250.2013; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001; Yoneshiro T, 2013, INT J OBESITY, V37, P993, DOI 10.1038/ijo.2012.161; Zhang QY, 2013, WIEN KLIN WOCHENSCHR, V125, P687, DOI 10.1007/s00508-013-0431-2	107	1	1	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0785-3890	1365-2060		ANN MED	Ann. Med.	MAR	2015	47	2					133	141		10.3109/07853890.2014.911595		9	Medicine, General & Internal	General & Internal Medicine	CF9TP	WOS:000352910000009		
J	Okonogi, N; Shirai, K; Oike, T; Murata, K; Noda, SE; Suzuki, Y; Nakano, T				Okonogi, Noriyuki; Shirai, Katsuyuki; Oike, Takahiro; Murata, Kazutoshi; Noda, Shin-Ei; Suzuki, Yoshiyuki; Nakano, Takashi			Topics in Chemotherapy, Molecular-targeted Therapy, and Immunotherapy for Newly-diagnosed Glioblastoma Multiforme	ANTICANCER RESEARCH			English	Review						Glioblastoma multiforme(GBM); chemotherapy; molecular-targeted therapy; immunotherapy; review	GROWTH-FACTOR RECEPTOR; BEVACIZUMAB PLUS TEMOZOLOMIDE; MALIGNANT GLIOMA PATIENTS; ADJUVANT TEMOZOLOMIDE; RADIATION-THERAPY; CANCER-IMMUNOTHERAPY; PEPTIDE VACCINATION; CLINICAL-TRIAL; PHASE-II; CELLS	Glioblastoma multiforme(GBM) is the most common primary brain tumor in adults, and it is associated with poor survival. The standard therapy for newly-diagnosed GBM is radiotherapy with concurrent temozolomide following maximal surgical resection. To improve the outcome of these patients, combinations of the standard therapy plus molecular-targeted agents have been tested in clinical trials. However, the addition of gefitinib to the standard therapy did not appear to improve clinical outcome, and the standard therapy plus bevacizumab showed no improvement in overall survival, although a 4-month improvement in progression-free survival (PFS) was observed. Phase II data have indicated the potential efficacy of talampanel combined with the standard therapy for patients with newly-diagnosed GBM, and these findings are awaiting validation in phase III trials. In addition, phase II trials have demonstrated that adjuvant immunotherapy is effective and tolerable for treatment of patients with GBM. In this article, we discuss topics in chemotherapy, molecular-targeted therapy, and immunotherapy for patients with newly-diagnosed GBM.	[Okonogi, Noriyuki; Shirai, Katsuyuki; Oike, Takahiro; Murata, Kazutoshi; Noda, Shin-Ei; Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gumma 3718511, Japan; [Suzuki, Yoshiyuki] Fukushima Med Univ, Sch Med, Dept Radiat Oncol, Fukushima, Japan	Shirai, K (reprint author), Gunma Univ, Grad Sch Med, Dept Radiat Oncol, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	kshirai@gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan for Scientific Research in Innovative Areas; Japan Society for the Promotion of Science for Young Scientists	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan for Scientific Research in Innovative Areas and from the Japan Society for the Promotion of Science for Young Scientists.	Zeng J, 2013, INT J RADIAT ONCOL, V86, P343, DOI 10.1016/j.ijrobp.2012.12.025; Phuphanich S, 2013, CANCER IMMUNOL IMMUN, V62, P125, DOI 10.1007/s00262-012-1319-0; Chinot OL, 2011, ADV THER, V28, P334, DOI 10.1007/s12325-011-0007-3; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Affronti ML, 2009, CANCER, V115, P3501, DOI 10.1002/cncr.24398; Chang CN, 2011, J CLIN NEUROSCI, V18, P1048, DOI 10.1016/j.jocn.2010.11.034; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Oka Y, 2002, CURR CANCER DRUG TAR, V2, P45, DOI 10.2174/1568009023334088; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Jackson CM, 2014, CLIN CANCER RES, V20, P3651, DOI 10.1158/1078-0432.CCR-13-2057; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ostermann S, 2004, CLIN CANCER RES, V10, P3728, DOI 10.1158/1078-0432.CCR-03-0807; Chakravarti A, 2013, INT J RADIAT ONCOL, V85, P1206, DOI 10.1016/j.ijrobp.2012.10.008; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554; BARBA D, 1989, J NEUROSURG, V70, P175, DOI 10.3171/jns.1989.70.2.0175; Hirose Y, 2001, CANCER RES, V61, P1957; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Izumoto S, 2008, J NEUROSURG, V108, P963, DOI 10.3171/JNS/2008/108/5/0963; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Brock CS, 1998, CANCER RES, V58, P4363; Sankhla SK, 1996, J NEURO-ONCOL, V27, P133; Ardon H, 2012, CANCER IMMUNOL IMMUN, V61, P2033, DOI 10.1007/s00262-012-1261-1; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Pardridge WM, 1998, J NEUROCHEM, V70, P1781; Zhang GB, 2012, J CLIN NEUROSCI, V19, P1636, DOI 10.1016/j.jocn.2011.12.028; Scott CB, 1998, INT J RADIAT ONCOL, V40, P51, DOI 10.1016/S0360-3016(97)00485-9; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Bock HC, 2010, NEUROSURG REV, V33, P441, DOI 10.1007/s10143-010-0280-7; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Brada M, 1999, BRIT J CANCER, V81, P1022, DOI 10.1038/sj.bjc.6690802; Chakravarti A, 2004, INT J RADIAT ONCOL, V58, P927, DOI 10.1016/j.ijrobp.2003.09.092; De Groot JF, 2008, J NEURO-ONCOL, V88, P121, DOI 10.1007/s11060-008-9552-2; GOLDMAN CK, 1993, MOL BIOL CELL, V4, P121; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; Howes JF, 2007, NEUROTHERAPEUTICS, V4, P126, DOI 10.1016/j.nurt.2006.11.001; HUMPHREY PA, 1988, CANCER RES, V48, P2231; Lesniak MS, 2011, J CLIN ONCOL, V29, P3105, DOI 10.1200/JCO.2011.34.9019; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Melguizo C, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-250; Oka Y, 2000, J IMMUNOL, V164, P1873; Okonogi N, 2014, J NEUROL NEUROPHYSIO, V5, P4; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Shah Abhidha, 2010, J Craniovertebr Junction Spine, V1, P126, DOI 10.4103/0974-8237.77678; STENNING SP, 1987, BRIT J CANCER, V56, P89, DOI 10.1038/bjc.1987.161; Afra D, 2002, LANCET, V359, P1011	54	4	4	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1229	1235				7	Oncology	Oncology	CF3QF	WOS:000352462900001		
J	Katsuhara, A; Fujiki, F; Aoyama, N; Tanii, S; Morimoto, S; Oka, Y; Tsuboi, A; Nakajima, H; Kondo, K; Tatsumi, N; Nakata, J; Nakae, Y; Takashima, S; Nishida, S; Hosen, N; Sogo, S; Oji, Y; Sugiyama, H				Katsuhara, Akiko; Fujiki, Fumihiro; Aoyama, Nao; Tanii, Satoe; Morimoto, Soyoko; Oka, Yoshihiro; Tsuboi, Akihiro; Nakajima, Hiroko; Kondo, Kenta; Tatsumi, Naoya; Nakata, Jun; Nakae, Yoshiki; Takashima, Satoshi; Nishida, Sumiyuki; Hosen, Naoki; Sogo, Shinji; Oji, Yusuke; Sugiyama, Haruo			Transduction of a Novel HLA-DRB1*04:05-restricted, WT1-specific TCR Gene into Human CD4(+) T Cells Confers Killing Activity Against Human Leukemia Cells	ANTICANCER RESEARCH			English	Article						Wilms' tumor gene(WT1); HLA-DRB1*04:05; HLA class II; helper peptide; TCR gene therapy	MINIMAL RESIDUAL DISEASE; WILMS-TUMOR GENE; HELPER PEPTIDE; WT1; INDUCTION; IDENTIFICATION; LYMPHOCYTES; VACCINATION; EXPRESSION; EPITOPE	Background/Aim: Wilms' tumor gene 1 (WT1) product is a pan-tumor-associated antigen. We previously identified WT1 protein-derived promiscuous helper peptide, WT1 (332). Therefore, isolation and characterization of the WT1 (332)-specific T-cell receptors (TCRs) are useful to develop broadly applicable TCR gene-based adoptive immunotherapy. Materials and Methods: A novel HLA-DRB1*04:05-restricted WT1 (332)-specific TCR gene was cloned and transduced into human CD4(+) T-cells by using a lentiviral vector. Results: The WT1(332)-specific TCR-transduced CD4(+) T-cells showed strong proliferation and Th1-cytokine production in an HLA-DRB1*04:05-restricted, WT1 (332)-specific manner. Furthermore, the WT1 (332)-specific TCR-transduced CD4(+) Teens could lyse HLA-DRB1*04:05-positive, WT1-expressing leukemia cells in vitro. Conclusion: The novel TCR gene cloned here should be a promising tool to develop adoptive immunotherapy of WT1 (332)-specific TCR-transduced CD4(+) T-cells for the treatment of WT1-expressing cancer, such as leukemia.	[Katsuhara, Akiko; Aoyama, Nao; Tanii, Satoe; Kondo, Kenta; Tatsumi, Naoya; Sugiyama, Haruo] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Suita, Osaka 5650871, Japan; [Fujiki, Fumihiro; Morimoto, Soyoko; Oka, Yoshihiro; Nakajima, Hiroko] Osaka Univ, Grad Sch Med, Dept Canc Immunol, Osaka, Japan; [Tsuboi, Akihiro; Nakata, Jun] Osaka Univ, Grad Sch Med, Dept Canc Immunotherapy, Osaka, Japan; [Oka, Yoshihiro; Nakae, Yoshiki; Takashima, Satoshi; Nishida, Sumiyuki] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Osaka, Japan; [Sogo, Shinji] Otsuka Pharmaceut Co Ltd, Microbiol Res Inst, Tokushima 77101, Japan; [Hosen, Naoki; Oji, Yusuke] Osaka Univ, Grad Sch Med, Dept Canc Stem Cell Biol, Osaka, Japan; [Oka, Yoshihiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Dept Immunopathol, Osaka, Japan	Sugiyama, H (reprint author), Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	sugiyama@sahs.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [WAKATE B-24700991]; Ministry of Education, Science, Sports, Culture and Technology [Kiban C-26430162]; Ministry of Health, Labor and Welfare of Japan	The Authors gratefully acknowledge Dr. Hiroyuki Miyoshi (RIKEN BioResource Center, Tsukuba, Japan) for providing the lentivirus vector (CSII-EF-MCS-IRES2-Venus) and its packaging plasmids (pCAG-HIVgp and pCMV-VSV-G-RSV-Rev). This study was partially supported by the Japan Society for the Promotion of Science (JSPS) through grants for Grant-in-Aid for Young Scientists (WAKATE B-24700991) and Scientific Research (Kiban C-26430162) from the Ministry of Education, Science, Sports, Culture and Technology and the Ministry of Health, Labor and Welfare of Japan.	Anguille S, 2013, LEUKEMIA, V27, P748, DOI 10.1038/leu.2012.248; Hidalgo LG, 2008, AM J TRANSPLANT, V8, P627, DOI 10.1111/j.1600-6143.2007.02128.x; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; INOUE K, 1994, BLOOD, V84, P3071; Fujiki F, 2007, J IMMUNOTHER, V30, P282, DOI 10.1097/01.cji.0000211337.91513.94; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Sugiyama H, 2010, JPN J CLIN ONCOL, V40, P377, DOI 10.1093/jjco/hyp194; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Brown DM, 2010, CELL IMMUNOL, V262, P89, DOI 10.1016/j.cellimm.2010.02.008; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Chapuis A.G, 2013, SCI TRANSL MED, V5; Fujiki F, 2010, ANTICANCER RES, V30, P2247; Fujiki F, 2008, MICROBIOL IMMUNOL, V52, P591, DOI 10.1111/j.1348-0421.2008.00080.x; FURUKAWA T, 1994, LEUKEMIA, V8, P171; Inoue K, 1996, BLOOD, V88, P2267; Saito Y, 2010, SCI TRANSL MED, V2, p17ra9, DOI DOI 10.1126/SCITRANSLMED.3000349; Stevanovic S, 2012, LEUKEMIA, V26, P312, DOI 10.1038/leu.2011.222; Tachino S, 2013, CANCER IMMUNOL IMMUN, V62, P801, DOI 10.1007/s00262-012-1385-3; Tsuboi A, 2012, LEUKEMIA, V26, P1410, DOI 10.1038/leu.2011.343	22	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1251	1261				11	Oncology	Oncology	CF3QF	WOS:000352462900004		
J	Hoshino, I; Maruyama, T; Fujito, H; Tamura, Y; Suganami, A; Hayashi, H; Toyota, T; Akutsu, Y; Murakami, K; Isozaki, Y; Akanuma, N; Takeshita, N; Toyozumi, T; Komatsu, A; Matsubara, H				Hoshino, Isamu; Maruyama, Tetsuro; Fujito, Hiromichi; Tamura, Yutaka; Suganami, Akiko; Hayashi, Hideki; Toyota, Taro; Akutsu, Yasunori; Murakami, Kentaro; Isozaki, Yuka; Akanuma, Naoki; Takeshita, Nobuyoshi; Toyozumi, Takeshi; Komatsu, Aki; Matsubara, Hisahiro			Detection of Peritoneal Dissemination with Near-infrared Fluorescence Laparoscopic Imaging Using a Liposomal Formulation of a Synthesized Indocyanine Green Liposomal Derivative	ANTICANCER RESEARCH			English	Article						Staging laparoscopy; near-infrared fluorescence imaging; indocyanin green; liposome; dissemination	ENDOTHELIAL GROWTH-FACTOR; ADVANCED GASTRIC-CANCER; STAGING LAPAROSCOPY; DIAGNOSTIC LAPAROSCOPY; BREAST-CANCER; LYMPH-NODES; NANOPARTICLES; ACCURACY; SURGERY; IDENTIFICATION	Background/Aim: Although conventional staging laparoscopy (SL) has improved the diagnostic accuracy of peritoneal dissemination, novel technology is needed to increase the sensitivity of SL. We herein describe a new imaging method employing near-infrared (NIR)fluorescence imaging using a liposomal synthesized indocyanine green (ICG) liposomal derivative, LP-ICG-C18. Methods and Results: LP-ICG-C18 is a NIR-photoactivating probe in which an ICG fluorophore is covalently conjugated with a phospholipid moiety. Nude mice were intraperitoneally injected with gastric cancer cells. Twelve days later, the mice were given intravenous injections of LP-ICG-C18 at a dose of 0.15 mg/kg. A NIR imaging system was used to identify the disseminated tumors. The disseminated nodules in mice were detected without any difficulties. Disseminated tumor nodules were collected from mice with or without injections of liposomal formulation and were transferred into the swine peritoneal cavity. The nodules in the swine peritoneal cavity were clearly and promptly defined by the NIR imaging system. Conclusion: NIR-fluorescing liposomal probes can effectively target peritoneal disseminated tumors and can be easily detected by a NIR imaging system. These results warrant future clinical trials of our imaging system and may contribute to a more precise diagnosis and therapeutic approach for gastric cancer patients.	[Hoshino, Isamu; Maruyama, Tetsuro; Akutsu, Yasunori; Murakami, Kentaro; Isozaki, Yuka; Akanuma, Naoki; Takeshita, Nobuyoshi; Toyozumi, Takeshi; Komatsu, Aki; Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba 2608670, Japan; [Tamura, Yutaka; Suganami, Akiko] Chiba Univ, Grad Sch Med, Dept Bioinformat, Chiba 2608670, Japan; [Fujito, Hiromichi; Hayashi, Hideki] Chiba Univ, Ctr Frontier Med Engn, Chiba 2608670, Japan; [Toyota, Taro] Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Chiba 2608670, Japan	Hoshino, I (reprint author), Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chuo Ku, Inohana 1-8-1, Chiba 2608670, Japan.	i_hosino@chiba-u.jp					Alander JT, 2012, INT J BIOMED IMAGING, V2012, DOI DOI 10.1155/2012/940585; Gotoh K, 2009, J SURG ONCOL, V100, P75, DOI 10.1002/jso.21272; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Nakagawa S, 2007, GASTRIC CANCER, V10, P29, DOI 10.1007/s10120-006-0406-3; Lee YT, 2005, GUT, V54, P1541, DOI 10.1136/gut.2004.055772; Engel E, 2008, INVEST OPHTH VIS SCI, V49, P1777, DOI 10.1167/iovs.07-0911; Ogawa M, 2009, CANCER RES, V69, P1268, DOI 10.1158/0008-5472.CAN-08-3116; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; van der Vorst JR, 2012, ANN SURG ONCOL, V19, P4104, DOI 10.1245/s10434-012-2466-4; Ankersmit M, 2011, COLORECTAL DIS, V13, P70, DOI 10.1111/j.1463-1318.2011.02787.x; Cahill RA, 2011, COLORECTAL DIS, V13, P12, DOI 10.1111/j.1463-1318.2011.02772.x; Yano M, 2000, WORLD J SURG, V24, P1130; Tagaya N, 2008, AM J SURG, V195, P850, DOI 10.1016/j.amjsurg.2007.02.032; Ishizawa T, 2009, CANCER, V115, P2491, DOI 10.1002/cncr.24291; Ashitate Y, 2012, J SURG RES, V176, P7, DOI 10.1016/j.jss.2011.06.027; Uchiyama K, 2010, WORLD J SURG, V34, P2953, DOI 10.1007/s00268-010-0764-1; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Wilczewska AZ, 2012, PHARMACOL REP, V64, P1020; Shenoi MM, 2011, NANOMEDICINE-UK, V6, P545, DOI [10.2217/nnm.10.153, 10.2217/NNM.10.153]; Muntean V, 2009, J GASTROINTEST LIVER, V18, P189; Monsky WL, 1999, CANCER RES, V59, P4129; van Scheltinga AGTT, 2011, J NUCL MED, V52, P1778, DOI 10.2967/jnumed.111.092833; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Puri A, 2009, CRIT REV THER DRUG, V26, P523; Leake PA, 2012, GASTRIC CANCER, V15, pS38, DOI 10.1007/s10120-011-0047-z; Miyoshi N, 2009, SURG ENDOSC, V23, P347, DOI 10.1007/s00464-008-9938-4; Wang J, 2012, CURR DRUG METAB, V13, P447; Arnold JC, 1999, Z GASTROENTEROL, V37, P483; BJORNSSON OG, 1982, EXPERIENTIA, V38, P1441; Blackshaw Guy R J C, 2003, Gastric Cancer, V6, P225, DOI 10.1007/s10120-003-0257-0; Can Mehmet Fatih, 2011, World J Gastrointest Surg, V3, P131, DOI 10.4240/wjgs.v3.i9.131; FLOWER RW, 1973, INVEST OPHTH VISUAL, V12, P881; Makino A, 2009, BIOMATERIALS, V30, P5156, DOI 10.1016/j.biomaterials.2009.05.046; Mery E, 2011, GYNECOL ONCOL, V122, P155, DOI 10.1016/j.ygyno.2011.02.035; Roberts WW, 1997, SURG ENDOSC-ULTRAS, V11, P1221, DOI 10.1007/s004649900575; Shussman N, 2011, J LAPAROENDOSC ADV S, V21, P797, DOI 10.1089/lap.2010.0474; Suganami A, 2012, BIOORG MED CHEM LETT, V22, P7481, DOI 10.1016/j.bmcl.2012.10.044; Toyota T, 2014, BIOORGAN MED CHEM, V22, P721, DOI 10.1016/j.bmc.2013.12.026; Toyota T FH, BIOORG MED CHEM; Yano M, 2000, WORLD J SURG, V24, P1135; YOSHIDA M, 2012, J GASTROENTEROL H S3, P29	41	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1353	1359				7	Oncology	Oncology	CF3QF	WOS:000352462900017		
J	Inoue, T; Sho, M; Yasuda, S; Nishiwada, S; Nakamura, S; Ueda, T; Nishigori, N; Kawasaki, K; Obara, S; Nakamoto, T; Koyama, F; Fujii, H; Nakajima, Y				Inoue, Takashi; Sho, Masayuki; Yasuda, Satoshi; Nishiwada, Satoshi; Nakamura, Shinji; Ueda, Takeshi; Nishigori, Naoto; Kawasaki, Keijiro; Obara, Shinsaku; Nakamoto, Takayuki; Koyama, Fumikazu; Fujii, Hisao; Nakajima, Yoshiyuki			HVEM Expression Contributes to Tumor Progression and Prognosis in Human Colorectal Cancer	ANTICANCER RESEARCH			English	Article						Colorectal cancer; HVEM; prognosis; surgery; tumor immunity	HERPESVIRUS ENTRY MEDIATOR; SQUAMOUS-CELL CARCINOMA; HUMAN PANCREATIC-CANCER; T-CELLS; CLINICAL-SIGNIFICANCE; IMMUNE REGULATION; IN-VIVO; RECEPTOR; BLOCKADE; IMMUNOTHERAPY	Background: Herpesvirus entry mediator (HVEM) has been recently suggested to play certain roles in cancer biology. We examined HVEM expression in human colorectal cancer (CRC) to reveal its clinical importance. Materials and Methods: Immunohistochemical staining was carried-out in normal epithelium, benign and malignant lesions. Results: While intense HVEM expression was not observed in normal epithelium and hyperplastic polyps, 24% of adenoma and more than half of CRCs had high HVEM expression. In 234 CRCs, HVEM expression was significantly associated with tumor status and pathological stage. Patients with high HVEM expression had a significantly poorer prognosis than those with low expression. Importantly, HVEM status had an independent prognostic value in CRC. Furthermore, HVEM status was inversely corrected with the presence of minor-infiltrating T-cells. Conclusion: HVEM may play a critical role in tumor progression and immune evasion, and may also he a novel prognostic marker and potential therapeutic target in human CRC.	[Inoue, Takashi; Sho, Masayuki; Yasuda, Satoshi; Nishiwada, Satoshi; Nakamura, Shinji; Ueda, Takeshi; Nishigori, Naoto; Kawasaki, Keijiro; Obara, Shinsaku; Nakamoto, Takayuki; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan; [Koyama, Fumikazu; Fujii, Hisao] Nara Med Univ, Dept Endoscopy & Ultrasound, Kashihara, Nara 6348522, Japan	Sho, M (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	m-sho@naramed-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Daiwa Securities Health Foundation; Japanese Society of Gastroenterology; Takeda Science Foundation; Nakayama Cancer Research Institute	This work was supported by the following grants: Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Research Grant from Daiwa Securities Health Foundation: Research Grant from The Japanese Society of Gastroenterology: a research grant from Takeda Science Foundation; and Research Grant from Nakayama Cancer Research Institute (M. Sho).	Steinberg MW, 2011, IMMUNOL REV, V244, P169, DOI 10.1111/j.1600-065X.2011.01064.x; Pasero C, 2013, IMMUNOL LETT, V151, P71, DOI 10.1016/j.imlet.2013.01.008; Sakoda Y, 2011, BLOOD, V117, P2506, DOI 10.1182/blood-2010-08-301325; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Yasuda S, 2013, CLIN EXP IMMUNOL, V172, P500, DOI 10.1111/cei.12069; Hotta K, 2011, BRIT J CANCER, V105, P1191, DOI 10.1038/bjc.2011.368; Migita K, 2014, CANCER-AM CANCER SOC, V120, P808, DOI 10.1002/cncr.28491; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Enomoto K, 2012, CLIN EXP IMMUNOL, V168, P186, DOI 10.1111/j.1365-2249.2012.04565.x; Yamato I, 2009, BRIT J CANCER, V101, P1709, DOI 10.1038/sj.bjc.6605375; del Rio ML, 2010, J LEUKOCYTE BIOL, V87, P223, DOI 10.1189/jlb.0809590; Pasero C, 2012, CURR OPIN PHARMACOL, V12, P478, DOI 10.1016/j.coph.2012.03.001; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Lasaro MO, 2011, MOL THER, V19, P1727, DOI 10.1038/mt.2011.88; M'Hidi H, 2009, AM J CLIN PATHOL, V132, P589, DOI 10.1309/AJCPPHKGYYGGL39C; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; Ropponen KM, 1997, J PATHOL, V182, P318, DOI 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Van Cutsem E, 2013, EUR J CANCER, V49, P2476, DOI 10.1016/j.ejca.2013.03.026; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Steinberg MW, 2008, J EXP MED, V205, P1463, DOI 10.1084/jem.20071160; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Sarrias MR, 2000, MOL IMMUNOL, V37, P665, DOI 10.1016/S0161-5890(00)00089-4; Sobin LH, 2010, UICC TNM CLASSIFICAT, V7th	35	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1361	1367				7	Oncology	Oncology	CF3QF	WOS:000352462900018		
J	Schmeel, LC; Schmeel, FC; Kim, Y; Blaum-Feder, S; Endo, T; Schmidt-Wolf, IGH				Schmeel, Leonard Christopher; Schmeel, Frederic Carsten; Kim, Young; Blaum-Feder, Sabine; Endo, Tomoyuki; Schmidt-Wolf, Ingo G. H.			Flunarizine Exhibits In Vitro Efficacy Against Lymphoma and Multiple Myeloma Cells	ANTICANCER RESEARCH			English	Article						Flunarizine; multiple myeloma; lymphoma; cancer therapy; WNT; pathway	WNT/BETA-CATENIN PATHWAY; CALCIUM-ANTAGONIST FLUNARIZINE; ETHACRYNIC-ACID; VIVO EFFICACY; WNT INHIBITORS; LEUKEMIA CELLS; MELANOMA-CELLS; BETA-CATENIN; BONE-MARROW; CANCER	Background/Aim: Novel agents such as lenalidomide and bortezomib have significantly improved today's therapy of multiple myeloma. Despite recent innovations, new therapeutic options are needed. The Wingless-related integration site (WNT) pathway is aberrantly activated in lymphoma and myeloma and therefore renders WNT signaling molecules attractive for the development of targeted therapies. Flunarizine was used in this study as it has chemical features similar to those of other known WNT inhibitors and already proven proapoptotic properties in leukemia cells. Materials and Methods: The antitumor apoptotic effect of flunarizine at doses ranging from 0.1-200 mu M was investigated on three human lymphoma cell lines, one in urine and four human myeloma cell lines by 3'3-Dihexyloxacarbocyanine iodide and propidium iodide staining in flow cytometry. Results: Flunarizine induced significant apoptotic activity in all tested myeloma and lymphoma cell lines in a dose-dependent manner. Conclusion: Our results reveal a significant selective induction of apoptosis by flunarizine and suggest an in vivo effect against lymphoma and myeloma.	[Schmeel, Leonard Christopher; Schmeel, Frederic Carsten; Kim, Young; Blaum-Feder, Sabine; Schmidt-Wolf, Ingo G. H.] Univ Hosp Bonn, CIO, Dept Internal Med 3, D-53105 Bonn, Germany; [Schmeel, Frederic Carsten] Univ Hosp Bonn, Dept Radiol, D-53105 Bonn, Germany; [Endo, Tomoyuki] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido, Japan	Schmidt-Wolf, IGH (reprint author), Univ Hosp Bonn, CIO, Sigmund Freud Str 25, D-53105 Bonn, Germany.	Ingo.Schmidt-Wolf@ukb.uni-bonn.de					Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Ashihara E, 2009, CLIN CANCER RES, V15, P2731, DOI 10.1158/1078-0432.CCR-08-1350; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Moreau P, 2006, BLOOD, V107, P397, DOI 10.1182/blood-2005-06-2573; Kim Y, 2011, IN VIVO, V25, P99; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Wall I, 2014, ANTICANCER RES, V34, P5375; Schmidt M, 2011, IN VIVO, V25, P325; Dutta-Simmons J, 2009, BLOOD, V114, P2699, DOI 10.1182/blood-2008-12-194290; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Kim Y, 2012, LEUKEMIA RES, V36, P598, DOI 10.1016/j.leukres.2012.01.025; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Rosinol L, 2008, BLOOD, V112, P3591, DOI 10.1182/blood-2008-02-141598; Kim Y, 2011, IN VIVO, V25, P887; Kim Y, 2011, ANTICANCER RES, V31, P725; Fowler JA, 2012, CANCER RES, V72, P2183, DOI 10.1158/0008-5472.CAN-11-2067; Schmidt M, 2009, BRIT J HAEMATOL, V144, P796, DOI 10.1111/j.1365-2141.2008.07503.x; Qiang YW, 2003, ONCOGENE, V22, P1536, DOI 10.1038/sj.onc.1206239; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Bringhen S, 2006, EXPERT OPIN INV DRUG, V15, P1565, DOI 10.1517/13543784.15.12.1565; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; MICKISCH GH, 1990, CANCER RES, V50, P3670; Abdul M, 2002, ANTICANCER RES, V22, P1727; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Koller CM, 2013, ANTICANCER RES, V33, P2435; Polakis P, 2000, GENE DEV, V14, P1837; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Schmeel LC, 2013, ANTICANCER RES, V33, P4719; BELLELLI A, 1987, ONCOLOGY, V44, P17; CASTELLINO SM, 1995, BRIT J CANCER, V71, P1181, DOI 10.1038/bjc.1995.230; Conrad DM, 2010, APOPTOSIS, V15, P597, DOI 10.1007/s10495-010-0454-3; Fink-Puches R, 1993, Exp Dermatol, V2, P17, DOI 10.1111/j.1600-0625.1993.tb00194.x; HOLMES B, 1984, DRUGS, V27, P6, DOI 10.2165/00003495-198427010-00002; Kocemba KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030359; Lu DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008294; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Schmeel FC, 2014, HEMATOL ONCOL, V32, P197, DOI 10.1002/hon.2122; Schmeel LC., 2014, ANTICANCER RES, V34, P835; SEZZI ML, 1984, ANTICANCER RES, V4, P229; SILVESTRINI R, 1993, INT J CANCER, V55, P636, DOI 10.1002/ijc.2910550420; Von Schulz-Hausmann SA, 2014, ANTICANCER RES, V34, P4101	43	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1369	1376				8	Oncology	Oncology	CF3QF	WOS:000352462900019		
J	Iguchi, T; Uchi, R; Nambara, S; Saito, T; Komatsu, H; Hirata, H; Ueda, M; Sakimura, S; Takano, Y; Kurashige, J; Shinden, Y; Eguchi, H; Sugimachi, K; Maehara, Y; Mimori, K				Iguchi, Tomohiro; Uchi, Ryutaro; Nambara, Sho; Saito, Tomoko; Komatsu, Hisateru; Hirata, Hidenari; Ueda, Masami; Sakimura, Shotaro; Takano, Yuki; Kurashige, Jyunji; Shinden, Yoshiaki; Eguchi, Hidetoshi; Sugimachi, Keishi; Maehara, Yoshihiko; Mimori, Koshi			A Long Noncoding RNA, IncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer	ANTICANCER RESEARCH			English	Article						Long noncoding RNA; TGF-beta; colorectal cancer; progression; prognosis	POOR-PROGNOSIS; CELL-CYCLE; METASTASIS; PROMOTES; EMT	Background/Aim: A long noncoding RNA (IncRNA) activated by transforming growth factor (TGF)-beta (IncRNA-ATB) was recently described to promote the invasion-metastasis cascade in hepatocellular carcinoma. The aim of the present study was to clarify the clinicopathological role and prognostic relevance of IncRNA-ATB in colorectal cancer (CRC). Materials and Methods: lncRNA-ATB expression was evaluated by real-time reverse transcription polymerase chain reaction in 124 patients with CRC. Patients were divided into two groups based on the median IncRNA-ATB expression. Results: High IncRNA-ATB expression was significantly associated with greater tumor size, depth of tumor invasion, lymphatic invasion, vascular invasion, and lymph node metastasis. Patients of the high-IncRNA-ATB expression group had significantly poorer outcomes than those of the low-expression group. Additionally, levels of IncRNA-ATB expression were significantly higher in patients with hematogenous meta-stases. Conclusion: IncRNA-ATB may be involved in the progression of CRC and be a novel indicator of poor prognosis in patients with CRC.	[Iguchi, Tomohiro; Uchi, Ryutaro; Nambara, Sho; Saito, Tomoko; Komatsu, Hisateru; Hirata, Hidenari; Ueda, Masami; Sakimura, Shotaro; Takano, Yuki; Kurashige, Jyunji; Shinden, Yoshiaki; Eguchi, Hidetoshi; Sugimachi, Keishi; Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita 8740838, Japan; [Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Mimori, K (reprint author), Kyushu Univ, Beppu Hosp, Dept Surg, 4546 Tsurumihara, Beppu, Oita 8740838, Japan.	kmimori@beppu.kyushu-u.ac.jp					Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Jou J, 2010, J CLIN INVEST, V120, P1031, DOI 10.1172/JCI42615; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Shi DB, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0031-7; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Matouk IJ, 2014, BBA-MOL CELL RES, V1843, P1414, DOI 10.1016/j.bbamcr.2014.03.023; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Jonkers I, 2008, MOL CELL BIOL, V28, P5583, DOI 10.1128/MCB.02269-07; Maier Harald J, 2010, Cancers (Basel), V2, P2058, DOI 10.3390/cancers2042058; Takahashi Y, 2014, BRIT J CANCER, V110, P164, DOI 10.1038/bjc.2013.698	24	4	4	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1385	1388				4	Oncology	Oncology	CF3QF	WOS:000352462900021		
J	Yoneyama, K; Ishibashi, O; Kawase, R; Kurose, K; Takeshita, T				Yoneyama, Koichi; Ishibashi, Osamu; Kawase, Rieko; Kurose, Keisuke; Takeshita, Toshiyuki			miR-200a, miR-200b and miR-429 Are Onco-miRs that Target the PTEN Gene in Endometrioid Endometrial Carcinoma	ANTICANCER RESEARCH			English	Article						Endometrioid endometrial cancer; microRNA; PTEN	CANCER; MICRORNAS; EXPRESSION; MIRNAS	Endometrioid endometrial carcinoma (EEC) is a common malignancy of the female genital tract. However, no adequate biomarker is currently available for predicting the prognosis of this cancer. Recent studies have revealed dysregulated expression of several microRNAs (miRNAs) in various cancer tissues, and therefore, these cancer-associated miRNAs (also called onco-miRs) could be promising prognostic biomarkers of cancer progression or metastasis. In this study, in order to identify onco-miRs and their possible targets involved in EEC, we performed microarray-based integrative analyses of miRNA and mRNA expression in specimens excised from EEC lesions and adjacent normal endometrial tissues. Using integrated statistical analyses, we identified miR-200a, miR-200b and miR-429 as highly up-regulated onco-miRs in EECs. Conversely, we detected expression of a tumor-suppressor gene, phosphatase and tensin homolog (PTEN), which was predicted in silico using a miRNA-targeting mRNA prediction algorithm, as a target of the three miRNAs and which was down-regulated in EECs. Furthermore, these miRNAs were validated to target PTEN experimentally using luciferase assays and real-time polymerase chain reaction. These results suggest that the occurrence of EEC is, at least in part, mediated by miRNA-induced suppression of PTEN expression.	[Yoneyama, Koichi; Kawase, Rieko; Kurose, Keisuke; Takeshita, Toshiyuki] Main Hosp, Nippon Med Sch, Dept Obstet & Gynecol, Tokyo 1138603, Japan; [Ishibashi, Osamu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Biol Macromol, Sakai, Osaka 591, Japan	Yoneyama, K (reprint author), Main Hosp, Nippon Med Sch, Dept Obstet & Gynecol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	kyone@nms.ac.jp; ishibashi@biochem.osakafu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	The Authors would like to thank Aya Horikawa for providing technical assistance. This work was supported in part by Grants-in-Aid and the "Research Core" Project for Private University: Matching Fund Subsidy from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Amant F, 2006, Int J Gynecol Cancer, V16 Suppl 2, P527, DOI 10.1111/j.1525-1438.2006.00688.x; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Garcia-Dios DA, 2013, GYNECOL ONCOL, V128, P327, DOI 10.1016/j.ygyno.2012.11.037; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Park YA, 2012, GYNECOL ONCOL, V124, P125, DOI 10.1016/j.ygyno.2011.09.026; Shen J, 2013, CANCER LETT, V329, P125, DOI 10.1016/j.canlet.2012.11.001; Arora V, 2012, BEST PRACT RES CL OB, V26, P311, DOI 10.1016/j.bpobgyn.2011.12.007; Lee JW, 2011, GYNECOL ONCOL, V120, P56, DOI 10.1016/j.ygyno.2010.09.022; Matias-Guiu X, 2013, HISTOPATHOLOGY, V62, P111, DOI 10.1111/his.12053; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Ryan AJ, 2005, CELL TISSUE RES, V322, P53, DOI 10.1007/s00441-005-1109-5; Lee H, 2012, MODERN PATHOL, V25, P1508, DOI 10.1038/modpathol.2012.111; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Castaneda CA, 2011, EXPERT REV ANTICANC, V11, P1265, DOI [10.1586/era.11.40, 10.1586/ERA.11.40]; Krell Jonathan, 2013, Front Biosci (Elite Ed), V5, P204; Merritt Melissa A, 2010, Cancer Biomark, V9, P287, DOI 10.3233/CBM-2011-0167; Snowdon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022828	18	2	2	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1401	1410				10	Oncology	Oncology	CF3QF	WOS:000352462900023		
J	Nakamura, K; Yamashita, K; Sawaki, H; Waraya, M; Katoh, H; Nakayama, N; Kawamata, H; Nishimiya, H; Ema, A; Narimatsu, H; Watanabe, M				Nakamura, Kazunori; Yamashita, Keishi; Sawaki, Hiromichi; Waraya, Mina; Katoh, Hiroshi; Nakayama, Nobukazu; Kawamata, Hiroshi; Nishimiya, Hiroshi; Ema, Akira; Narimatsu, Hisashi; Watanabe, Masahiko			Aberrant Methylation of GCNT2 Is Tightly Related to Lymph Node Metastasis of Primary CRC	ANTICANCER RESEARCH			English	Article						GCNT2; glycogene; epigenetics; colorectal cancer; lymph node metastasis	N-ACETYLGALACTOSAMINYLTRANSFERASE 6; INDEPENDENT PROGNOSTIC-FACTOR; SQUAMOUS-CELL CARCINOMA; ADULT I-PHENOTYPE; PROMOTER METHYLATION; EXPRESSION; CANCER; BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; PROLIFERATION; GLYCOSYLATION	Background: Glycoprotein expression profile is dramatically altered in human cancers; however. specific glycogenes have not been fully identified. Materials and Methods: A comprehensive real-time polymerase chain reaction (PCR) system for glycogenes (CRPS-G) identified several outstanding glyco genes. GCNT2 was of particular interest after GCNT2 expression and epigenetics were rigorously investigated in primary colorectal cancer (CRC). Results: The highlights of this work can be summarized as follows: (i) Expression of GCNT2 was remarkably suppressed. (ii) Silenced expression of GCNT2 was reactivated by combined demethylating agents. (iii) Promoter DNA methylation of GCNT2 was silenced in CRC cell lines and tissues. Hypomethylation of GCNT2 variant 2 is tightly associated with lymph node metastasis in primary CRC. (iv) GCNT2 methylation level in the normal tissues also showed a close association with that in the tumor tissues and reflected lymph node metastasis. Conclusion: We identified aberrant expression of GCNT2, which can be explained by promoter DNA hypermethylation. Hypomethylation of the GCNT2 variant 2 reflected lymph node metastasis of CRC in the tumor and normal tissues.	[Nakamura, Kazunori; Yamashita, Keishi; Waraya, Mina; Katoh, Hiroshi; Nakayama, Nobukazu; Kawamata, Hiroshi; Nishimiya, Hiroshi; Ema, Akira; Watanabe, Masahiko] Kitasato Univ, Sch Medicine, Dept Surg, Sagamihara, Kanagawa 2520374, Japan; [Sawaki, Hiromichi; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Japan	Watanabe, M (reprint author), Kitasato Univ, Sch Medicine, Dept Surg, Minami Ku, 1-15-I Kitasato, Sagamihara, Kanagawa 2520374, Japan.	gekaw@med.kitasato-u.ac.jp			NEDO (New Energy and Industrial Technology Development Organization) Medical Glycomics (MG) project	The Authors would like to thank Akemi Inoue and Akira Ooki for their tremendous support. This work was supported by NEDO (New Energy and Industrial Technology Development Organization) Medical Glycomics (MG) project.	Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; Ito H, 2009, J PROTEOME RES, V8, P1358, DOI 10.1021/pr800735j; Inaba N, 2003, BLOOD, V101, P2870, DOI 10.1182/blood-2002-09-2838; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Granovsky M, 2000, NAT MED, V6, P306; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Murata K, 2000, CLIN CANCER RES, V6, P1772; Yusa A, 2010, CANCER RES, V70, P4064, DOI 10.1158/0008-5472.CAN-09-2383; Poeta ML, 2012, GENE CHROMOSOME CANC, V51, P1133, DOI 10.1002/gcc.21998; Zhang HJ, 2011, CANCER RES, V71, P4846, DOI 10.1158/0008-5472.CAN-11-0414; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Li Z, 2011, BRIT J CANCER, V104, P1882, DOI 10.1038/bjc.2011.166; Kannagi Reiji, 2007, Chang Gung Med J, V30, P189; Mimori K, 2003, ONCOGENE, V22, P3463, DOI 10.1038/sj.onc.1206378; Shen XA, 2005, REGUL PEPTIDES, V125, P17, DOI 10.1016/j.regpep.2004.07.025; Yamashita K, 2003, CANCER RES, V63, P6575; Yu LC, 2003, BLOOD, V101, P2081, DOI 10.1182/blood-2002-09-2693; Yu LC, 2001, BLOOD, V98, P3840, DOI 10.1182/blood.V98.13.3840	23	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1411	1421				11	Oncology	Oncology	CF3QF	WOS:000352462900024		
J	Hara, Y; Yamashita, T; Oishi, N; Nio, K; Hayashi, T; Nomura, Y; Yoshida, M; Hayashi, T; Hashiba, T; Asahina, Y; Kondo, M; Okada, H; Sunagozaka, H; Honda, M; Kaneko, S				Hara, Yasumasa; Yamashita, Taro; Oishi, Naoki; Nio, Kouki; Hayashi, Takehiro; Nomura, Yoshimoto; Yoshida, Mariko; Hayashi, Tomoyuki; Hashiba, Tomomi; Asahina, Yoshiro; Kondo, Mitsumasa; Okada, Hikari; Sunagozaka, Hajime; Honda, Masao; Kaneko, Shuichi			TSU-68 Ameliorates Hepatocellular Carcinoma Growth by Inhibiting Microenvironmental Platelet-derived Growth Factor Signaling	ANTICANCER RESEARCH			English	Article						Hepatocellular carcinoma; platelet-derived growth factors; TSU-68	RANDOMIZED PHASE-II; MULTICENTER TRIAL; STEM-CELLS; CANCER; SORAFENIB; COMBINATION	Background: TSU-68 is a multikinase inhibitor that targets platelet-derived growth factor receptors (PDGFRs). In the present study, we evaluated the effect of TSU-68 on the tumor-microenvironment interaction in hepatocellular carcinoma (HCC). Materials and Methods: HCC and fibroblast cell lines (HuH7, Hep3B, HuH1 and WI-38) were used to evaluate their interactions. Cancer characteristics were evaluated by spheroid formation and tumorigenicity in immunodeficient mice. Time-lapse image analysis was performed to monitor cell motility. Results: Although PDGFA was abundantly expressed, PDGFR-alpha was predominantly located in the cytoplasm and was not functional in HuH7 cells. Co-culture experiments demonstrated that HCC cells induced phosphorylation of PDGFR-alpha in WI-38 fibroblasts and that stimulated fibroblasts, in turn, boosted the spheroid formation capacity of HCC cells. TSU-68 inhibited phosphorylation of PDGFR-alpha in WI-38 cells and suppressed the growth of subcutaneously co-injected HuH7/WI-38 tumor xenografts. Conclusion: TSU-68 inhibits stromal PDGF signaling activated by cancer cells and suppresses HCC growth.	[Hara, Yasumasa; Yamashita, Taro; Oishi, Naoki; Nio, Kouki; Hayashi, Takehiro; Nomura, Yoshimoto; Yoshida, Mariko; Hayashi, Tomoyuki; Hashiba, Tomomi; Asahina, Yoshiro; Kondo, Mitsumasa; Okada, Hikari; Sunagozaka, Hajime; Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Gastroenterol, Kanazawa, Ishikawa 9208641, Japan	Yamashita, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Gastroenterol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	taroy@m-kanazawa.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23590967, 26460994]	This research was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 23590967 and No. 26460994). The Authors would like to thank Ms. Masayo Baba, Ms. Nobuko Kuroki and Ms. Ayumi Nakata for invaluable technical assistance.	Stock P, 2007, MOL CANCER THER, V6, P1932, DOI 10.1158/1535-7163.MCT-06-0720; Kanai F, 2011, CANCER CHEMOTH PHARM, V67, P315, DOI 10.1007/s00280-010-1320-2; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Cao YH, 2013, TRENDS MOL MED, V19, P460, DOI 10.1016/j.molmed.2013.05.002; Wright JH, 2014, INT J CANCER, V134, P778, DOI 10.1002/ijc.28421; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Arao T, 2013, HEPATOLOGY, V57, P1407, DOI 10.1002/hep.25956; Zeng SS, 2014, J HEPATOL, V60, P127, DOI 10.1016/j.jhep.2013.08.024; Yamashita T, 2010, CANCER RES, V70, P4687, DOI 10.1158/0008-5472.CAN-09-4210; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Horwitz E, 2014, CANCER DISCOV, V4, P730, DOI 10.1158/2159-8290.CD-13-0782; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Seok JY, 2012, HEPATOLOGY, V55, P1776, DOI 10.1002/hep.25570; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Okada H, 2012, CANCER RES, V72, P4459, DOI 10.1158/0008-5472.CAN-12-0028; Kim SB, 2014, INVEST NEW DRUG, V32, P753, DOI 10.1007/s10637-014-0093-6; Koizumi W, 2013, BRIT J CANCER, V109, P2079, DOI 10.1038/bjc.2013.555; Lee J, 2014, INVEST NEW DRUG, V32, P561, DOI 10.1007/s10637-014-0075-8; Okamoto I, 2012, J THORAC ONCOL, V7, P427, DOI 10.1097/JTO.0b013e318238154d; Yamashita T, 2011, J GASTROEN HEPATOL, V26, P960, DOI 10.1111/j.1440-1746.2011.06723.x	20	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1423	1431				9	Oncology	Oncology	CF3QF	WOS:000352462900025		
J	Nukatsuka, M; Nakagawa, F; Saito, H; Sakata, M; Uchida, J; Takechi, T				Nukatsuka, Mamoru; Nakagawa, Fumio; Saito, Hitoshi; Sakata, Minoru; Uchida, Junji; Takechi, Teiji			Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Irinotecan Hydrochloride on Human Colorectal and Gastric Cancer Xenografts	ANTICANCER RESEARCH			English	Article						TAS-102; 5-FU resistance; irinotecan hydrochloride; colorectal cancer; gastric cancer	PHASE-III TRIAL; ANTITUMOR-ACTIVITY; IN-VIVO; THYMIDINE PHOSPHORYLASE; ACQUIRED-RESISTANCE; OPEN-LABEL; CELLS; OXALIPLATIN; PLUS; DNA	TAS-102 is a novel oral nucleoside antitumor agent consisting of trifluridine and tipiracil hydrochloride at a molar ratio of 1:0.5. TAS-102 was approved in Japan in March 2014 for the treatment of patients with unresectable, advanced or recurrent colorectal cancer that is refractory to standard therapies. In the present study, enhancement of the therapeutic efficacy using a combination therapy of TAS-102 and irinotecan hydrochloride (CPT-11) was evaluated in a colorectal and gastric cancer xenograft-bearing nude mouse model. TAS-102 was orally administered twice a day from day 1 to 14, and CPT-11 was administered intravenously on days 1 and 8. The growth-inhibitory activity was evaluated based on the tumor volume and the growth-delay period, which was estimated based on the period required to reach a tumor volume that was five-times greater than the initial volume (RTV5). The tumor growth-inhibitory activity and the RTV5 of the group receiving TAS-102 with CPT-11 were significantly superior to those of both agents as monotherapy for mice with KM12C, KM12C/5-FU, DLD-1/5-FU, and SC-2 xenografts (p<0.01). No significant decrease in body weight was observed. The present pre-clinical findings indicated that the combination of TAS-102 and CPT-11 is a promising treatment option for colorectal or gastric cancer, not only for chemo-naive tumors, but also jar recurrent tumors after 5-fluorouracil (5-FU)-based chemotherapy.	[Nukatsuka, Mamoru; Takechi, Teiji] Taiho Pharmaceut Co Ltd, Translat Res Lab, Tokushima, Tokushima 7710194, Japan; [Nakagawa, Fumio; Saito, Hitoshi; Sakata, Minoru; Uchida, Junji] Taiho Pharmaceut Co Ltd, Tokushima Res Ctr, Appl Pharmacol Lab, Tokushima, Tokushima 7710194, Japan	Nukatsuka, M (reprint author), Taiho Pharmaceut Co Ltd, Translat Res Lab, 224-2 Ebisuno Hiraishi,Kawauchi Cho, Tokushima, Tokushima 7710194, Japan.	m-nukatsuka@taiho.co.jp					Huang J, 2014, CLIN COLORECTAL CANC, V13, P100, DOI 10.1016/j.clcc.2013.12.002; Jacob S, 2001, CANCER RES, V61, P6555; DEXTER DL, 1972, CANCER RES, V32, P247; MORIKAWA K, 1988, CANCER RES, V48, P6863; Emura T, 2005, INT J ONCOL, V27, P449; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Emura T, 2004, INT J ONCOL, V25, P571; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hironaka S, 2013, J CLIN ONCOL, V31, P4438, DOI 10.1200/JCO.2012.48.5805; Utsugi T, 2013, JPN J CLIN ONCOL, V43, P945, DOI 10.1093/jjco/hyt131; ARMAND JP, 1995, EUR J CANCER, V31A, P1283, DOI 10.1016/0959-8049(95)00212-2; Bauer P, 1998, STAT MED, V17, P2133, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2133::AID-SIM901>3.0.CO;2-2; Peeters M, 2014, ANN ONCOL, V25, P107, DOI 10.1093/annonc/mdt523; Murakami Y, 2000, INT J ONCOL, V17, P277; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Shelton JW, 2013, INT J RADIAT ONCOL, V86, P469, DOI 10.1016/j.ijrobp.2013.02.015; Tomicic MT, 2013, BBA-REV CANCER, V1835, P11, DOI 10.1016/j.bbcan.2012.09.002; Balin-Gauthier D, 2006, CANCER CHEMOTH PHARM, V57, P709, DOI 10.1007/s00280-005-0123-3; Yoshino T, 2012, LANCET ONCOL, V13, P993, DOI 10.1016/S1470-2045(12)70345-5; Emura T, 2004, INT J MOL MED, V13, P249; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Emura T, 2004, INT J MOL MED, V13, P545; Fukushima M, 2000, BIOCHEM PHARMACOL, V59, P1227, DOI 10.1016/S0006-2952(00)00253-7; Fukushima M, 2001, EUR J CANCER, V37, P1681, DOI 10.1016/S0959-8049(01)00174-5; INABA M, 1986, JPN J CANCER RES, V77, P190; Sobrero AF, 1995, CLIN CANCER RES, V1, P955; SOBRERO AF, 1993, J NATL CANCER I, V85, P1937, DOI 10.1093/jnci/85.23.1937; Tanaka N, 2014, ONCOL REP, V32, P2319, DOI 10.3892/or.2014.3487; TANAKA Y, 1990, CANCER RES, V50, P4528; von Weikersthal LF, 2011, EUR J CANCER, V47, P206, DOI 10.1016/j.ejca.2010.09.022; Yoshino T, 2014, ANN ONCOL         S2, V25, P105, DOI [DOI 10.1093/ANNONC/MDU193.22, 10.1093/annonc/mdu193.22]	32	3	3	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1437	1445				9	Oncology	Oncology	CF3QF	WOS:000352462900027		
J	Ide, S; Toiyama, Y; Shimura, T; Kawamura, M; Yasuda, H; Saigusa, S; Ohi, M; Tanaka, K; Mohri, Y; Kusunoki, M				Ide, Shozo; Toiyama, Yuji; Shimura, Tadanobu; Kawamura, Mikio; Yasuda, Hiromi; Saigusa, Susumu; Ohi, Masaki; Tanaka, Koji; Mohri, Yasuhiko; Kusunoki, Masato			MicroRNA-503 Promotes Tumor Progression and Acts as a Novel Biomarker for Prognosis in Oesophageal Cancer	ANTICANCER RESEARCH			English	Article						miR-503; oesophageal cancer; prognosis; biomarker	REGULATES METASTATIC FUNCTION; CELL; EXPRESSION; ANGIOGENESIS; PATHOGENESIS; CARCINOMA; GROWTH; TISSUE	Aim: This study investigated microRNA (miR)-503 expression levels and evaluated its clinical significance in patients with oesophageal cancer (EC). Materials and Methods: miR-503 expression was quantified by quantitative reverse transcription-polymerase chain reaction in 49 EC tissue samples and 12 adjacent normal tissues from 49 patients with EC. The association between miR-503 expression and clinicopathological factors, including prognostic outcomes, were assessed. Results: miR-503 was found up-regulated in EC tissues compared to adjacent normal tissues. High miR-503 expression was significantly associated with large tumor size. Kaplan-Meier analysis showed that patients with high miR-503 expression had significantly poorer disease-free and overall survival than those with lower expression levels. High miR-503 expression was identified as an independent prognostic predictor in patients with EC according to multivariate analysis. Conclusion: miR-503 expression affects tumor cell proliferation in EC. Evaluation of miR-503 expression might thus help identify patients with EC with poor prognosis and higher risk of early recurrence.	[Ide, Shozo; Toiyama, Yuji; Shimura, Tadanobu; Kawamura, Mikio; Yasuda, Hiromi; Saigusa, Susumu; Ohi, Masaki; Tanaka, Koji; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Tsu, Mie 5148507, Japan	Toiyama, Y (reprint author), Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	ytoi0725@clin.medic.mie-u.ac.jp					Fu CR, 2014, BIOCHEM BIOPH RES CO, V446, P1197, DOI 10.1016/j.bbrc.2014.03.087; Peng Y, 2014, ONCOL LETT, V7, P1233, DOI 10.3892/ol.2014.1868; Gu J, 2013, CURR PHARM DESIGN, V19, P1292; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ozata DM, 2011, ENDOCR-RELAT CANCER, V18, P643, DOI 10.1530/ERC-11-0082; Zhou J, 2011, J SURG ONCOL, V104, P278, DOI 10.1002/jso.21941; Bhatti I, 2009, J GASTROINTEST SURG, V13, P1379, DOI 10.1007/s11605-009-0887-6; Xu YY, 2013, FEBS J, V280, P3768, DOI 10.1111/febs.12365; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Lu YC, 2012, CANCER PREV RES, V5, P665, DOI 10.1158/1940-6207.CAPR-11-0358; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Caporali A, 2011, TRENDS CARDIOVAS MED, V21, P162, DOI 10.1016/j.tcm.2012.05.003; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Tombol Z, 2009, ENDOCR-RELAT CANCER, V16, P895, DOI 10.1677/ERC-09-0096; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x; Corbetta S, 2010, ENDOCR-RELAT CANCER, V17, P135, DOI 10.1677/ERC-09-0134; Yang Y, 2014, INT J CANCER, V135, P1531, DOI 10.1002/ijc.28799; Delgado M Dolore, 2006, Clin Transl Oncol, V8, P780; Japan Esophageal Society, 2009, ESOPHAGUS, V6, P71, DOI DOI 10.1007/S10388-009-0193-0]; Japanese Esophageal Society, 2009, ESOPHAGUS, V6, P1, DOI DOI 10.1007/S10388-009-0169-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P2011, DOI DOI 10.3322/CAAC.20107; Li L, 2014, J PATHOL; Zhou J, 2014, J SURG RES, V188, P129, DOI 10.1016/j.jss.2013.12.006	24	6	6	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1447	1451				5	Oncology	Oncology	CF3QF	WOS:000352462900028		
J	Iida, Y; Sunami, E; Yamashita, H; Hiyoshi, M; Ishihara, S; Yamaguchi, H; Inoue, A; Makide, K; Tsuno, NH; Aoki, J; Kitayama, J; Watanabe, T				Iida, Yuuki; Sunami, Eiji; Yamashita, Hiroharu; Hiyoshi, Masaya; Ishihara, Soichiro; Yamaguchi, Hironori; Inoue, Asuka; Makide, Kumiko; Tsuno, Nelson H.; Aoki, Junken; Kitayama, Joji; Watanabe, Toshiaki			Phosphatidylserine-specific Phospholipase A1 (PS-PLA(1)) Expression in Colorectal Cancer Correlates with Tumor Invasion and Hematogenous Metastasis	ANTICANCER RESEARCH			English	Article						Colorectal cancer; immunohistochemistry; phosphatidylserine-specific phospholipase A(1); tumor invasion; metastasis	STIMULATES CHEMOTACTIC MIGRATION; BINDS ANIONIC PHOSPHOLIPIDS; MONOCLONAL-ANTIBODY; BLOOD-VESSELS; CELLS; A(1); STATISTICS; AUTOTAXIN; MELANOMA; FAMILY	Background: The function of phosphatidylserine-specific phospholipase A1 (PS-PLA(1)), a phospholipase that acts specifically on phosphatidylserine and produces lysophosphatidylserine, a lysophospholipid mediator, has not been fully elucidated. We evaluated the role of PS-PLA(1) in oncogenesis and metastasis of colorectal cancer (CRC). Materials and Methods: Specimens from 85 patients with CRC were immunostained with a monoclonal antibody against PS-PLA(1). The correlation between PS-PLA(1) expression and the clinicopathological variables was analyzed. Results: Tumor depth and hematogenous metastasis independently positively correlated with PS-PLA(1) expression. High PS-PLA(1) expression was associated with shorter disease-free survival, although it was not an independent predictive factor. Conclusion: PS-PLA(1) expression in CRC is associated with tumor invasion and metastasis.	[Iida, Yuuki; Sunami, Eiji; Hiyoshi, Masaya; Ishihara, Soichiro; Yamaguchi, Hironori; Kitayama, Joji; Watanabe, Toshiaki] Univ Tokyo, Fac Med Sci, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138655, Japan; [Yamashita, Hiroharu] Univ Tokyo, Fac Med Sci, Dept Gastrointestinal Surg, Bunkyo Ku, Tokyo 1138655, Japan; [Tsuno, Nelson H.] Univ Tokyo, Fac Med Sci, Dept Transfus Med, Bunkyo Ku, Tokyo 1138655, Japan; [Inoue, Asuka; Makide, Kumiko; Aoki, Junken] Tohoku Univ, Lab Mol & Cellular Biochem, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 980, Japan	Iida, Y (reprint author), Univ Tokyo, Fac Med Sci, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yiida-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported, partly, by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Nakamura K, 2010, CLIN CHIM ACTA, V411, P1090, DOI 10.1016/j.cca.2010.04.006; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Aoki J, 2007, BIOCHIMIE, V89, P197, DOI 10.1016/j.biochi.2006.09.021; Hisano Y, 2012, J BIOCHEM, V152, P305, DOI 10.1093/jb/mvs090; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Huang XM, 2005, CANCER RES, V65, P4408, DOI 10.1158/0008-5472.CAN-05-0031; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; BELLINI F, 1993, FEBS LETT, V316, P1, DOI 10.1016/0014-5793(93)81724-E; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; He J, 2007, CLIN CANCER RES, V13, P5211, DOI 10.1158/1078-0432.CCR-07-0793; Hosono H, 2001, J BIOL CHEM, V276, P29664, DOI 10.1074/jbc.M104597200; Iida Y, 2014, ANTICANCER RES, V34, P5465; Lee SY, 2008, BIOCHEM BIOPH RES CO, V374, P147, DOI 10.1016/j.bbrc.2008.06.117; Lourenssen S, 1998, NEUROSCI LETT, V248, P77, DOI 10.1016/S0304-3940(98)00275-4; Qin Y, 2011, PIGM CELL MELANOMA R, V24, P207, DOI 10.1111/j.1755-148X.2010.00781.x; Sobin LH, 2010, TNM CLASSIFICATION M; Thorpe PE, 2010, THROMB RES, V125, pS134, DOI 10.1016/S0049-3848(10)70031-1; vanGroningen JJM, 1997, FEBS LETT, V404, P82, DOI 10.1016/S0014-5793(97)00098-7	20	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1459	1464				6	Oncology	Oncology	CF3QF	WOS:000352462900030		
J	Nakajima, K; Nakajima, Y; Tsujiwaki, S				Nakajima, Kenji; Nakajima, Yoshiki; Tsujiwaki, Satomi			Sulfobetaine (Dimethylsulfoniopropionate) and Glycine Betaine Show Incompatible Involvement in Crucial Ehrlich Ascites Carcinoma in Mice	ANTICANCER RESEARCH			English	Article						Dimethylsulfoniopropionate; betaine; Ehrlich ascites carcinoma; methylation reaction; activated macrophages	HOMOCYSTEINE S-METHYLTRANSFERASE; TERTIARY SULFONIUM COMPOUND; GREEN SEA ALGAE; CAUSES HYPERHOMOCYSTEINEMIA; CELL-POPULATIONS; BEARING MICE; METHYLATION; INHIBITION; CANCER; DEGRADATION	Background/Aim: The role of methylation reactions in cancer was examined using the methylating agents, sulfobetaine [dimethylsulfonioproponate (DMSP)], and glycine betaine (GB), in murine crucial Ehrlich ascites carcinoma (EAC) for up to 10 days. Results: DMSP administration in EAC-bearing mice mitigated EAC, while GB administration clearly promoted EAC. However, the immune cell profiles did not differ largely between animals receiving DMSP and those receiving GB. Moreover; DMSP and GB had merely any effects on proliferation of EAC cells in vitro. Injection of DMSP into normal mice interestingly led to macrophage accumulation in the peritoneal cavity in a dose-dependent manner at early rearing. Conclusion: These results indicate that GB promoted EAC by the methylation of cancer promotor gene, whereas DMSP ameliorated EAC by the accumulation of activated macrophages with a rapid response and long life span during cancer progression.	[Nakajima, Kenji; Tsujiwaki, Satomi] Koshien Univ, Grad Sch, Fac Nutr, Dept Nutr, Takarazuka, Hyogo, Japan; [Nakajima, Yoshiki] Okayama Univ, Fac Sci, Dept Biol, Grad Sch, Okayama 700, Japan	Nakajima, K (reprint author), 2-7-64 Suimeidai, Kawanishi, Hyogo 6660116, Japan.	fantasista999@gmail.com					Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Guerrero-Preston R, 2014, EPIGENETICS-US, V9, P1031, DOI 10.4161/epi.29025; Ibragimova I, 2014, EPIGENETICS-US, V9, P760, DOI 10.4161/epi.28078; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Cholewa JM, 2014, AMINO ACIDS, V46, P1785, DOI 10.1007/s00726-014-1748-5; Strakova J, 2011, NUTR RES, V31, P563, DOI 10.1016/j.nutres.2011.06.004; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Liu Y, 2012, J NUTR SCI VITAMINOL, V58, P69, DOI 10.3177/jnsv.58.69; Xu XR, 2009, FASEB J, V23, P4022, DOI 10.1096/fj.09-136507; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Segura JA, 2000, IMMUNOL LETT, V74, P111, DOI 10.1016/S0165-2478(00)00208-X; Ozaslan M, 2011, AFR J BIOTECHNOL, V10, P2375; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Abhishek Bhanot, 2011, International Journal of Phytomedicine, V3, P9; Chorawala MR, 2012, INT J PHARM SCI DRUG, V4, P1; Collinsova M, 2006, J NUTR, V136, P1493; Csermely P, 2014, SEMIN CANCER BIOL, V23, P1; Ehrlich P., 1905, BERL KLIN WSCHR, V42, P871; Hoffmann L, 2013, AM J PHYSIOL-GASTR L, V304, pG835, DOI 10.1152/ajpgi.00332.2012; Iida H, 1988, B TOKAI TEG FISH RES, V124, P35; MELNICOFF MJ, 1989, CELL IMMUNOL, V118, P178, DOI 10.1016/0008-8749(89)90367-5; Misra Debashish, 2004, Clin Adv Hematol Oncol, V2, P457; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Nakajima K, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P165; Nakajima k, 2002, ITE LETT, V3, P371; Nakajima K, 2009, J NUTR SCI VITAMINOL, V55, P434, DOI 10.3177/jnsv.55.434; NAKAJIMA K, 1993, NIPPON SUISAN GAKK, V59, P1389; Nakajima K, 2014, ANTICANCER IN PRESS; Nakajima K, 2011, BIOSCI BIOTECH BIOCH, V75, P808, DOI 10.1271/bbb.110083; Nakajima K, 2014, ANTICANCER RES, V34, P4045; Nakanishi Y, 2011, DEV GROWTH DIFFER, V53, P149, DOI 10.1111/j.1440-169X.2010.01224.x; Narang AS, 2009, PHARMACEUTICAL PERSPECTIVES OF CANCER THERAPEUTICS, P49, DOI 10.1007/978-1-4419-0131-6_2; National Institutes of Health Guide USA, 1996, NAT I HLTH PUBL, V80-23; Ou XP, 2007, BIOCHEM J, V401, P87, DOI 10.1042/BJ20061119; RABINOVI.M, 1973, J IMMUNOL, V110, P695; REED RH, 1983, MAR BIOL LETT, V4, P173; Zeisel SH, 2003, J NUTR, V133, P1302	39	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1475	1480				6	Oncology	Oncology	CF3QF	WOS:000352462900032		
J	Beppu, T; Hayashi, H; Okabe, H; Imai, K; Nitta, H; Masuda, T; Hashimoto, D; Chikamoto, A; Ishiko, T; Kikuchi, K; Baba, H				Beppu, Toru; Hayashi, Hiromitsu; Okabe, Hirohisa; Imai, Katsunori; Nitta, Hidetoshi; Masuda, Toshiro; Hashimoto, Daisuke; Chikamoto, Akira; Ishiko, Takatoshi; Kikuchi, Ken; Baba, Hideo			Hybrid-including Endoscopic versus Open Hepatic Resection for Patients with Hepatocellular Carcinoma Meeting the Milan Criteria: A Propensity Case-matched Analysis	ANTICANCER RESEARCH			English	Article						Endoscopic hepatectomy; hepatocellular carcinoma; Milan criteria; open hepatectomy; propensity case-matched analysis	OPEN LIVER RESECTION; LONG-TERM OUTCOMES; LAPAROSCOPIC LIVER; DONOR HEPATECTOMY; BLOOD-LOSS; METAANALYSIS; TRANSPLANTATION; EXPERIENCE; SCORE; CIRRHOSIS	Aim: To clarify the surgical outcome of patients who underwent endoscopic hepatectomy (EH) compared to those of conventional open hepatectomy (OH) for hepatocellular carcinoma (HCC). Patients and Methods: Between 1999 and 2011, 269 HCC patients meeting the Milan criteria were divided into EH (n=89) and OH groups (n=180). To equalize the background covariates. a one-to-one propensity case-matched analysis was used. Results: With propensity matching, 52 EH and 52 OH patients showed comparable preoperative clinical characteristics. The operation time (320 min, p=0.049) and the median blood loss (180 g, p<0.001) was significantly lesser with EH, while the median postoperative hospital stay (11 days, p=0.002) was significantly shorter for EH. The cumulative disease-free and overall survival rates were equivalent in both groups. Conclusion: EH for HCC patients meeting the Milan criteria is less invasive and might provide an equivalent disease-free and overall survival when compared to conventional OH.	[Beppu, Toru] Kumamoto Univ, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan; [Beppu, Toru; Hayashi, Hiromitsu; Okabe, Hirohisa; Imai, Katsunori; Nitta, Hidetoshi; Masuda, Toshiro; Hashimoto, Daisuke; Chikamoto, Akira; Ishiko, Takatoshi; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Gastroenterol Surg, Kumamoto, Japan; [Kikuchi, Ken] Kumamoto Univ, Med Qual Management Ctr, Kumamoto, Japan	Beppu, T (reprint author), Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	tbeppu@kumamoto-u.ac.jp					Mirnezami R, 2011, HPB, V13, P295, DOI 10.1111/j.1477-2574.2011.00295.x; Kaneko H, 2005, AM J SURG, V189, P190, DOI 10.1016/j.amjsurg.2004.09.010; Ikai I, 2006, J GASTROENTEROL, V41, P884, DOI 10.1007/s00535-006-1878-y; Cho JY, 2008, SURG ENDOSC, V22, P2344, DOI 10.1007/s00464-008-9966-0; HASHIZUME M, 1995, SURG ENDOSC-ULTRAS, V9, P1289; Strasberg SM, 2005, J HEPATO-BILIARY-PAN, V12, P351, DOI 10.1007/s00534-005-0999-7; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Kim H, 2014, SURG ENDOSC, V28, P950, DOI 10.1007/s00464-013-3254-3; Marubashi S, 2013, WORLD J SURG, V37, P2202, DOI 10.1007/s00268-013-2117-3; Fancellu A, 2011, J SURG RES, V171, pE33, DOI 10.1016/j.jss.2011.07.008; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Beppu T, 2012, HEPATO-GASTROENTEROL, V59, P542, DOI 10.5754/hge09737; Ikai I, 2004, CANCER, V101, P796, DOI 10.1002/cncr.20426; Nguyen KT, 2009, ANN SURG, V250, P831, DOI 10.1097/SLA.0b013e3181b0c4df; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Yoshida M, 2012, JPN J RADIOL, V30, P255, DOI 10.1007/s11604-011-0041-8; Li N, 2012, HEPATOL RES, V42, P51, DOI 10.1111/j.1872-034X.2011.00890.x; Nitta H, 2010, ANN SURG, V251, P450, DOI 10.1097/SLA.0b013e3181cf87da; Mazzaferro V, 2011, LIVER TRANSPLANT, V17, pS44, DOI 10.1002/lt.22365; Kaneko H, 1996, SURGERY, V120, P468, DOI 10.1016/S0039-6060(96)80065-1; Belli G, 2009, BRIT J SURG, V96, P1041, DOI 10.1002/bjs.6680; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Shiba H, 2013, ANTICANCER RES, V33, P705; Sasaki A, 2009, BRIT J SURG, V96, P274, DOI 10.1002/bjs.6472; Yin Z, 2013, ANN SURG ONCOL, V20, P1203, DOI 10.1245/s10434-012-2705-8; Morino M, 2003, SURG ENDOSC, V17, P1914, DOI 10.1007/s00464-003-9070-4; Buell JF, 2009, ANN SURG, V250, P825, DOI 10.1097/SLA.0b013e3181b3b2d8; Rao A, 2012, AM J SURG, V204, P222, DOI 10.1016/j.amjsurg.2011.08.013; Gigot JF, 2002, ANN SURG, V236, P90, DOI 10.1097/01.SLA.0000018658.57709.09; Chikamoto A, 2012, HEPATO-GASTROENTEROL, V59, P1213, DOI 10.5754/hge09778; Cherqui D, 2000, ANN SURG, V232, P753, DOI 10.1097/00000658-200012000-00004; Kokudo N, 2009, J GASTROENTEROL, V44, P119, DOI 10.1007/s00535-008-2244-z; Beppu T., 2008, J MICROWAVE SURG, V26, P67, DOI 10.3380/jmicrowavesurg.26.67; Chen HY, 2008, ANN SURG ONCOL, V15, P800, DOI 10.1245/s10434-007-9749-1; Furukawa H, 2010, J HEPATO-BIL-PAN SCI, V17, P533, DOI 10.1007/s00534-009-0168-5; Imai K, 2009, J SURG ONCOL, V100, P121, DOI 10.1002/jso.21302; Ishiko T, 2012, HEPATO-GASTROENTEROL, V59, P1907, DOI 10.5754/hge10088; Johnson LB, 2012, J AM COLL SURGEONS, V214, P717, DOI 10.1016/j.jamcollsurg.2011.12.044; Kobayashi S, 2013, SURG ENDOSC, V27, P610, DOI 10.1007/s00464-012-2499-6; Lee KF, 2011, WORLD J SURG, V35, P2268, DOI 10.1007/s00268-011-1212-6; Makino Y, 2000, AM J GASTROENTEROL, V95, P1294; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mizuguchi T, 2011, SURG TODAY, V41, P39, DOI 10.1007/s00595-010-4337-6; Papp A, 2003, SURG ENDOSC, V17, P1125, DOI 10.1007/s00464-002-9204-0; Rubin DB, 1997, ANN INTERN MED, V127, P757; Soyama A, 2014, SURG ENDOSC, V28, P203, DOI 10.1007/s00464-013-3159-1; Zinsmelster AR, 2008, AM J GASTROENTEROL, V103, P262, DOI 10.1111/j.1572-0241.2007.01590.x	47	2	2	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1583	1590				8	Oncology	Oncology	CF3QF	WOS:000352462900046		
J	Maolake, A; Izumi, K; Takahashi, R; Itai, S; Machioka, K; Yaegashi, H; Nohara, T; Kitagawa, Y; Kadono, Y; Konaka, H; Mizokami, A; Namiki, M				Maolake, Aerken; Izumi, Kouji; Takahashi, Rie; Itai, Shingo; Machioka, Kazuaki; Yaegashi, Hiroshi; Nohara, Takahiro; Kitagawa, Yasuhide; Kadono, Yoshifumi; Konaka, Hiroyuki; Mizokami, Atsushi; Namiki, Mikio			Efficacy of Tegafur-Uracil in Advanced Urothelial Cancer Patients after the Treatment Failure of Platinum-based Chemotherapy	ANTICANCER RESEARCH			English	Article						Urothelial carcinoma; tegafur-uracil; chemotherapy	TRANSITIONAL-CELL-CARCINOMA; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; SUPERFICIAL BLADDER-CANCER; PHASE-III TRIAL; VINFLUNINE PLUS; SUPPORTIVE CARE; LUNG-CANCER; UFT THERAPY; ORAL UFT; METHOTREXATE	Background: Platinum-based chemotherapy is the first-line treatment for advanced urinary tract urothelial cancers. However, the optimal second-line treatment is unclear. Although tegafur-uracil is sometimes used for advanced urothelial cancer patients after the treatment failure of platinum-based chemotherapy, there is little evidence regarding its use as a second-line treatment. Patients and Methods: Advanced urothelial cancer patients previously treated with platinum-based chemotherapy were retrospectively analyzed. Overall survival (OS) was compared between patients with and without tegafur-uracil treatment. Results: Thirty-one patients (27 and 4 patients with and without tegafur-uracil treatment, respectively) were analyzed. OS from the last day of the final chemotherapy course was better in patients with tegafur-uracil treatment than in those without (p<0.001, 358 and 66.5 days of the median survival time, respectively). Conclusion: Tegafur-uracil may be a candidate for the secondary treatment of advanced urothelial cancer patients after the treatment failure of platinum-based chemotherapy.	[Maolake, Aerken; Izumi, Kouji; Machioka, Kazuaki; Yaegashi, Hiroshi; Nohara, Takahiro; Kitagawa, Yasuhide; Kadono, Yoshifumi; Konaka, Hiroyuki; Mizokami, Atsushi; Namiki, Mikio] Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa 9208640, Japan; [Takahashi, Rie; Itai, Shingo] Kanazawa Univ Hosp, Dept Hosp Pharm, Kanazawa, Ishikawa, Japan	Izumi, K (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	azuizu2003@yahoo.co.jp					STERNBERG CN, 1985, J UROLOGY, V133, P403; LOEHRER PJ, 1992, J CLIN ONCOL, V10, P1066; Tsuburaya A, 2014, LANCET ONCOL, V15, P886, DOI 10.1016/S1470-2045(14)70025-7; Bellmunt J, 2013, ANN ONCOL, V24, P1466, DOI 10.1093/annonc/mdt007; Hamada C, 2009, J THORAC ONCOL, V4, P1511, DOI 10.1097/JTO.0b013e3181bbf1f2; Hamada C, 2005, J CLIN ONCOL, V23, P4999, DOI 10.1200/JCO.2005.09.017; Bellmunt J, 2009, J CLIN ONCOL, V27, P4454, DOI 10.1200/JCO.2008.20.5534; Bamias A, 2013, ANN ONCOL, V24, P1011, DOI 10.1093/annonc/mds583; Bellmunt J, 2011, ANN ONCOL, V22, P245, DOI 10.1093/annonc/mdq684; HIRAO Y, 1992, CANCER CHEMOTH PHARM, V30, pS26, DOI 10.1007/BF00686937; Izumi K, 2013, ANTICANCER RES, V33, P5501; KUBOTA Y, 1993, CANCER, V71, P1842, DOI 10.1002/1097-0142(19930301)71:5<1842::AID-CNCR2820710520>3.0.CO;2-2; UCHIBAYASHI T, 1995, INT J CLIN PHARM TH, V33, P465; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757	14	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1603	1606				4	Oncology	Oncology	CF3QF	WOS:000352462900048		
J	Watanabe, S; Hirano, S; Mine, S; Yoshida, A; Motoi, T; Ishii, S; Naka, G; Takeda, Y; Igari, T; Sugiyama, H; Kobayashi, N				Watanabe, Sho; Hirano, Satoshi; Mine, Sohtaro; Yoshida, Akihiko; Motoi, Toru; Ishii, Satoshi; Naka, Go; Takeda, Yuichiro; Igari, Toru; Sugiyama, Haruhito; Kobayashi, Nobuyuki			A Case of Endobronchial NUT Mid line Carcinoma with Intraluminal Growth	ANTICANCER RESEARCH			English	Article						Nuclear protein in testis; NUT midline carcinoma; Ewing sarcoma; endobronchial tumour; electrocautery	MIDLINE CARCINOMA; CLINICOPATHOLOGICAL FEATURES; AIRWAY-OBSTRUCTION; BET BROMODOMAINS; BRD-NUT; DIFFERENTIATION; INHIBITORS; LEUKEMIA; ADULTS; TUMOR	Background: NUT midline carcinoma (NMC) is a rare, lethal form of differentiated squamous cell carcinoma characterized by chromosomal rearrangement of the NUT gene. Its highly aggressive nature commonly leads to unresectable and metastatic lesions. Case Report: We report on a case of endobronchial NMC in a middle-aged man who was treated by bronchoscopic electrocautery followed by Ewing sarcoma-based chemotherapy with concurrent chemoradiotherapy. The patient's disease continued to be stable 31 months after diagnosis. Review: NMC is a challenging disease entity, which is difficult to diagnose and treat, and has a dismal overall survival. Most cases of NMC are widely metastatic or unresectable when diagnosed. Discussion: This is the first reported case that involves intraluminal tumour growth of NMC and demonstrates the effectiveness of early intensive local therapy aided by bronchoscopic techniques.	[Watanabe, Sho; Hirano, Satoshi; Ishii, Satoshi; Naka, Go; Takeda, Yuichiro; Sugiyama, Haruhito; Kobayashi, Nobuyuki] Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan; [Mine, Sohtaro; Igari, Toru] Natl Ctr Global Hlth & Med, Dept Pathol, Tokyo, Japan; [Yoshida, Akihiko] Natl Canc Ctr, Dept Pathol, Tokyo, Japan; [Motoi, Toru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Pathol, Tokyo, Japan	Watanabe, S (reprint author), Jikei Univ, Hosp 3, Sch Med, Dept Resp Med, 11-1 Izumihoncho 4, Komae, Tokyo, Japan.	sh.watanabe02@gmail.com					French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; Morice RC, 2001, CHEST, V119, P781, DOI 10.1378/chest.119.3.781; Ernst A, 2004, AM J RESP CRIT CARE, V169, P1278, DOI 10.1164/rccm.200210-118150; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; Karp JE, 2012, HAEMATOL-HEMATOL J, V97, P1736, DOI 10.3324/haematol.2012.062539; French CA, 2003, CANCER RES, V63, P304; Tanaka M, 2012, AM J SURG PATHOL, V36, P381, DOI 10.1097/PAS.0b013e31824230a8; KUBONISHI I, 1991, CANCER RES, V51, P3327; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; van Boxem TJ, 1998, EUR RESPIR J, V11, P169, DOI 10.1183/09031936.98.11010169; Garcia-Cuellar MP, 2014, LEUKEMIA, V28, P1427, DOI 10.1038/leu.2014.40; KEES UR, 1991, AM J PEDIAT HEMATOL, V13, P459; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; Schwartz BE, 2011, CANCER RES, V71, P2686, DOI 10.1158/0008-5472.CAN-10-3513; Haack H, 2009, AM J SURG PATHOL, V33, P984, DOI 10.1097/PAS.0b013e318198d666; Bauer DE, 2012, CLIN CANCER RES, V18, P5773, DOI 10.1158/1078-0432.CCR-12-1153; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; Mirguet O, 2013, J MED CHEM, V56, P7501, DOI 10.1021/jm401088k; Taniyama TK, 2014, CLIN LUNG CANCER, V15, P244, DOI 10.1016/j.cllc.2013.06.012; Grayson AR, 2014, ONCOGENE, V33, P1736, DOI 10.1038/onc.2013.126; Mertens F, 2007, PEDIATR BLOOD CANCER, V49, P1015, DOI 10.1002/pbc.20755; Antelo JS, 2010, ARCH BRONCONEUMOL, V46, P44, DOI 10.1016/j.arbres.2009.03.008; Beesley AH, 2014, BRIT J CANCER, V110, P1189, DOI 10.1038/bjc.2014.54; Bhadury J, 2014, P NATL ACAD SCI USA, V111, pE2721, DOI 10.1073/pnas.1406722111; French CA., 2014, CANCER DISCOV, V4, P1; Sameer AP, 2013, J THORAC ONCOL, V8, P1335; Wang RR, 2014, CANCER RES, V74, P3332, DOI 10.1158/0008-5472.CAN-13-2658	27	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1607	1612				6	Oncology	Oncology	CF3QF	WOS:000352462900049		
J	Sakamoto, K; Beppu, T; Hayashi, H; Nakagawa, S; Okabe, H; Nitta, H; Imai, K; Hashimoto, D; Chikamoto, A; Isiko, T; Kikuchi, K; Baba, H				Sakamoto, Keita; Beppu, Toru; Hayashi, Hiromitsu; Nakagawa, Shigeki; Okabe, Hirohisa; Nitta, Hidetoshi; Imai, Katsunori; Hashimoto, Daisuke; Chikamoto, Akira; Isiko, Takatoshi; Kikuchi, Ken; Baba, Hideo			Antiviral Therapy and Long-term Outcome for Hepatitis B Virus-related Hepatocellular Carcinoma after Curative Liver Resection in a Japanese Cohort	ANTICANCER RESEARCH			English	Article						Hepatitis B virus; hepatocellular carcinoma; antiviral therapy; nucleotide/nucleoside analog; propensity score-matching	E-ANTIGEN; LAMIVUDINE; CLASSIFICATION; METAANALYSIS; RECURRENCE; ENTECAVIR; INFECTION; GENOTYPES; SURVIVAL; RISK	Aim: The aim of this study was to determine whether antiviral therapy with nucleotide/nucleoside analog (NA) is beneficial for Japanese patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) who underwent initial curative liver resection. Patients and Methods: In 162 patients with positive hepatitis B surface antigen and negative anti-hepatitis C virus antibody, sixty-two patients received antiviral therapy with NA (NA group) and the remaining 100 patients did not (non-NA group). Prognostic factors for disease-free survival (DFS) and overall survival (OS) were evaluated. Moreover, to equalize the background covariates, a one-to-one propensity case-matched analysis was used. Results: NA administered were lamivudine (LAM) solely for 21 patients, LAM plus adefovir dipivoxil (ADV) for 6, LAM switched to entecavir (ETV) for 5 and ETV solely for 31. DFS did not significantly differ between the NA group and non-NA group (p=0.19). However, OS was significantly different (p=0.0063); 1-.3- and 5-year OS were 100% and 85.9%, 88.3% and 61.9% and 65.1% and 58.0%, respectively. In multivariate analysis, no antiviral therapy with NA was an independent poor prognostic factor (hazard ratio (HR)=2.72; p=0.0229). However, after propensity case-matched analysis, disease-free and overall survival were not significantly different between the two groups. Conclusion: In a Japanese cohort, antiviral therapy with NAs might provide longer survival for postoperative HBV-related HCC patients compared to patients without antiviral therapy. However, deterministic evaluation was impossible by this study alone.	[Sakamoto, Keita; Beppu, Toru; Hayashi, Hiromitsu; Nakagawa, Shigeki; Okabe, Hirohisa; Nitta, Hidetoshi; Imai, Katsunori; Hashimoto, Daisuke; Chikamoto, Akira; Isiko, Takatoshi; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Gastroenterol Surg, Kumamoto, Kumamoto 8608556, Japan; [Beppu, Toru] Kumamoto Univ, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Kumamoto 8608556, Japan; [Kikuchi, Ken] Kumamoto Univ, Grad Sch Social & Cultural Sci, Med Qual Management Ctr, Kumamoto, Kumamoto 8608556, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Life Sci, Dept Gastroenterol Surg, Chuo Ku, 1-1-1 Honjo, Kumamoto, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Yang T, 2012, EJSO-EUR J SURG ONC, V38, P683, DOI 10.1016/j.ejso.2012.04.010; Matsumoto A, 2005, HEPATOL RES, V32, P173, DOI 10.1016/j.hepres.2005.02.006; Tateishi R, 2005, CANCER, V103, P1201, DOI 10.1002/cncr.20892; Schiff ER, 2011, CLIN GASTROENTEROL H, V9, P274, DOI 10.1016/j.cgh.2010.11.040; Sun HC, 2007, J HEPATOL, V47, P684, DOI 10.1016/j.jhep.2007.06.019; Beppu T, 2012, HEPATO-GASTROENTEROL, V59, P542, DOI 10.5754/hge09737; You SL, 2004, ANN MED, V36, P215, DOI 10.1080/07853890310021580; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Liu Y, 2011, J VIRAL HEPATITIS, V18, pe29, DOI 10.1111/j.1365-2893.2010.01360.x; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Ye XG, 2013, WORLD J GASTROENTERO, V19, P6665, DOI 10.3748/wjg.v19.i39.6665; Chu CJ, 2002, HEPATOLOGY, V35, P1274, DOI 10.1053/jhep.2002.33161; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Urata Y, 2012, J HEPATO-BIL-PAN SCI, V19, P685, DOI 10.1007/s00534-011-0489-z; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Yuen MF, 2007, ANTIVIR THER, V12, P1295; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Yin JH, 2013, J CLIN ONCOL, V31, P3647, DOI 10.1200/JCO.2012.48.5896; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; [Anonymous], GEN RULES CLIN PATHO; Chen EQ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-163; Chen JH, 2000, WORLD J SURG, V24, P383; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Imai K, 2009, J SURG ONCOL, V100, P121, DOI 10.1002/jso.21302; Ke Yang, 2013, Cancer Biology Medicine, V10, P158, DOI 10.7497/j.issn.2095-3941.2013.03.006; Kubo S, 2007, HEPATOL RES, V37, P94, DOI 10.1111/j.1872-034X.2007.00013.x; Kuzuya T, 2007, J GASTROEN HEPATOL, V22, P1929, DOI 10.1111/j.1440-1746.2006.04707.x; Lok ASF, 2004, GASTROENTEROLOGY, V127, pS303, DOI 10.1053/j.gast.2004.09.045; Nakagawa S, 2014, HEPATOL RES, V44, P964, DOI 10.1111/hepr.12277; Okabe H, 2014, NUCL MED COMMUN, V35, P478, DOI 10.1097/MNM.0000000000000075; Onto E., 2001, HEPATOLOGY, V33, P218; Poon Ronnie Tung-Ping, 2004, Liver Transpl, V10, pS39, DOI 10.1002/lt.20040; Rubin DB, 1997, ANN INTERN MED, V127, P757; Wang JC, 2013, EUR REV MED PHARMACO, V17, P1162; Zhou YM, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-108	41	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1647	1655				9	Oncology	Oncology	CF3QF	WOS:000352462900055		
J	Okamoto, N; Suzuki, H; Kawahara, K; Honda, K; Miura, N; Hirashima, T; Tamiya, M; Morishita, N; Shiroyama, T; Tanaka, A; Tani, E; Hamaguchi, M; Kitani, M; Yamada, T; Kawase, I				Okamoto, Norio; Suzuki, Hidekazu; Kawahara, Kunimitsu; Honda, Kazufumi; Miura, Nami; Hirashima, Tomonori; Tamiya, Motohiro; Morishita, Naoko; Shiroyama, Takayuki; Tanaka, Ayako; Tani, Eriko; Hamaguchi, Masanari; Kitani, Masashi; Yamada, Tesshi; Kawase, Ichiro			The Alternatively Spliced Actinin-4 Variant as a Prognostic Marker for Metastasis in Small-cell Lung Cancer	ANTICANCER RESEARCH			English	Article						Small-cell lung cancer; actinin-4; transbronchial biopsy; biomarker; prognosis	GENE AMPLIFICATION; MOTILITY; EXPRESSION; CARCINOMA; TUMORS; ADENOCARCINOMA; INVASION	Background: The alternatively spliced actinin-4 variant (ACTN4va) is expressed in small-cell lung cancer (SCLC) and is thought to be a potential diagnostic marker. However, ACTN4va expression has not been examined in transbronchial biopsy specimens. Materials and Methods: We retrospectively examined the relationship between ACTN4va expression, clinical factors and survival in 104 consecutive newly-diagnosed SCLC patients. Results: Of the 104 screened cases, 83 (median age=69 years; transbronchial biopsy, 71) were included in our study. Survival was significantly different in the group with no distant metastasis (1996 vs. 422 days, respectively; p=0.000115) but was not significantly different with regard to ACTN4va expression in the group with distant metastasis (293 vs. 254 days, respectively; p=0.678). Conclusion: ACTN4va expression was identifiable in small biopsy samples. ACTN4va expression was also significantly related to distant metastasis and could stratify SCLC patients according to prognosis.	[Okamoto, Norio; Suzuki, Hidekazu; Hirashima, Tomonori; Tamiya, Motohiro; Morishita, Naoko; Shiroyama, Takayuki; Tanaka, Ayako; Tani, Eriko; Hamaguchi, Masanari; Kawase, Ichiro] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, Habikino, Osaka 5838588, Japan; [Kawahara, Kunimitsu] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Pathol, Habikino, Osaka 5838588, Japan; [Kitani, Masashi] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Clin Invest, Habikino, Osaka 5838588, Japan; [Honda, Kazufumi; Miura, Nami; Yamada, Tesshi] Natl Canc Ctr, Res Inst, Div Chemotherapy & Clin Res, Tokyo 104, Japan	Suzuki, H (reprint author), Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, 3-7-1 Habikino, Habikino, Osaka 5838588, Japan.	suzukih@opho.jp					Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Nicholson SA, 2002, AM J SURG PATHOL, V26, P1184, DOI 10.1097/01.PAS.0000022995.91977.CD; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Auperin A, 1999, NEW ENGL J MED, V341, P476, DOI 10.1056/NEJM199908123410703; Folch E, 2013, J THORAC ONCOL, V8, P1438, DOI 10.1097/JTO.0b013e3182a471a9; Noro R, 2013, ANN ONCOL, V24, P2594, DOI 10.1093/annonc/mdt293; Pio R, 2009, J THORAC ONCOL, V4, P674, DOI 10.1097/JTO.0b013e3181a520dc; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Honda K, 2004, ONCOGENE, V23, P5257, DOI 10.1038/sj.onc.1207652; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Miyanaga A, 2013, ANN ONCOL, V24, P84, DOI 10.1093/annonc/mds215; Welsch T, 2009, PANCREAS, V38, P968, DOI 10.1097/MPA.0b013e3181b28d6f; Yoshii H, 2013, ONCOL REP, V30, P1073, DOI 10.3892/or.2013.2577	18	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1663	1667				5	Oncology	Oncology	CF3QF	WOS:000352462900057		
J	Nakamura, T; Kogashiwa, Y; Nagafuji, H; Yamauchi, K; Kohno, N				Nakamura, Takehiro; Kogashiwa, Yasunao; Nagafuji, Hiroshi; Yamauchi, Koichi; Kohno, Naoyuki			Validity of Sentinel Lymph Node Biopsy by ICG Fluorescence for Early Head and Neck Cancer	ANTICANCER RESEARCH			English	Article						Oral cancer; hypopharyngeal cancer; oropharyngeal cancer; radioisotope; ICG fluorescence	INDOCYANINE GREEN FLUORESCENCE; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; BLUE-DYE; ORAL-CAVITY; MELANOMA; TRIAL; IDENTIFICATION; RADIOISOTOPE; TECHNETIUM	Aim: This study was designed to assess the validity of sentinel lymph node (SLN) biopsy using either the combination of indocyanine green (ICG) fluorescence and radioisotope (RI) or ICG-alone in SLN mapping for early head and neck cancer patients. Patients and Methods: Nineteen patients received SLN biopsy with the following method. Thirteen patients received SLN biopsy with only RI, 2 patients with only ICG and 4 patients with the combination of ICG and RI. Detection time for each method of SLAT biopsy was measured to evaluate the validity of SLN with the combination of ICG and RI. Results: A total of 41 SLNs were identified by RI or ICG. All SLNs identified by ICG could be localized intraoperatively. The number of SLNs identified by the combination of ICG and RI was greater than that of SLNs identified by RI-alone. One of the patients who underwent SLN biopsy by RI-alone was diagnosed with a metastatic lymph node one year later, then underwent neck dissection. Mean detection time for SLN biopsy with ICG or with the combination of ICG and RI tended to be shorter than that of RI-alone. Conclusion: SLN biopsy with the combination of ICG and RI enabled us to identify SLNs more easily and rapidly than by using RI alone.	[Nakamura, Takehiro; Kogashiwa, Yasunao; Nagafuji, Hiroshi; Yamauchi, Koichi; Kohno, Naoyuki] Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Mitaka, Tokyo 1818611, Japan	Kohno, N (reprint author), Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	sukohno@ks.kyorin-u.ac.jp					Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Jung SY, 2014, ANN SURG ONCOL, V21, P1254, DOI 10.1245/s10434-013-3437-0; van der Vorst JR, 2012, ANN SURG ONCOL, V19, P4104, DOI 10.1245/s10434-012-2466-4; Murawa D, 2009, BRIT J SURG, V96, P1289, DOI 10.1002/bjs.6721; Carlson GW, 2008, ANN SURG, V248, P378, DOI 10.1097/SLA.0b013e3181855718; Morrow M, 1999, SURGERY, V126, P714, DOI 10.1067/msy.2099.99951b; Fujisawa Y, 2012, J SURG ONCOL, V106, P41, DOI 10.1002/jso.23045; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; SHAH JP, 1990, CANCER, V66, P109, DOI 10.1002/1097-0142(19900701)66:1<109::AID-CNCR2820660120>3.0.CO;2-A; Miyashiro I, 2008, ANN SURG ONCOL, V15, P1640, DOI 10.1245/s10434-008-9872-7; BENSON RC, 1978, PHYS MED BIOL, V23, P159, DOI 10.1088/0031-9155/23/1/017; van den Berg NS, 2012, EUR J NUCL MED MOL I, V39, P1128, DOI 10.1007/s00259-012-2129-5; Brouwer OR, 2012, J NUCL MED, V53, P1034, DOI 10.2967/jnumed.112.103127; Tajima Y, 2010, ANN SURG ONCOL, V17, P1787, DOI 10.1245/s10434-010-0944-0; Tafra L, 2001, ANN SURG, V233, P51, DOI 10.1097/00000658-200101000-00009; Yamauchi K, 2011, ANN SURG ONCOL, V18, P2042, DOI 10.1245/s10434-010-1499-9; Cochran AJ, 2000, LANGENBECK ARCH SURG, V385, P252, DOI 10.1007/s004230000143; Cox CE, 2001, J AM COLL SURGEONS, V193, P593, DOI 10.1016/S1072-7515(01)01086-9; DECROIX Y, 1981, CANCER, V47, P503, DOI 10.1002/1097-0142(19810201)47:3<503::AID-CNCR2820470313>3.0.CO;2-1; DiTroia J F, 1972, Otolaryngol Clin North Am, V5, P333; Handa Takemi, 2010, Gen Thorac Cardiovasc Surg, V58, P68, DOI 10.1007/s11748-009-0536-8; Kell MR, 2004, BRIT MED J, V328, P1330, DOI 10.1136/bmj.328.7452.1330; Kohno N, 2003, ORL J OTO-RHINO-LARY, V65, P66, DOI 10.1159/000068655; LEE JG, 1972, LARYNGOSCOPE, V82, P1273, DOI 10.1288/00005537-197207000-00017; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Riber-Hansen R, 2009, CANCER, V115, P2177, DOI 10.1002/cncr.24268; Sanidas EE, 2003, AM J SURG, V185, P202, DOI 10.1016/S0002-9610(02)01367-3; Wilhelm AJ, 1999, EUR J NUCL MED, V26, pS36, DOI 10.1007/PL00014793	28	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1669	1674				6	Oncology	Oncology	CF3QF	WOS:000352462900058		
J	Yonesaka, K; Satoh, T; Ueda, S; Yoshida, T; Takeda, M; Shimizu, T; Okamoto, I; Nishio, K; Tamura, T; Nakagawa, K				Yonesaka, Kimio; Satoh, Taroh; Ueda, Shinya; Yoshida, Takeshi; Takeda, Masayuki; Shimizu, Toshio; Okamoto, Isamu; Nishio, Kazuto; Tamura, Takao; Nakagawa, Kazuhiko			Circulating Hepatocyte Growth Factor Is Correlated with Resistance to Cetuximab in Metastatic Colorectal Cancer	ANTICANCER RESEARCH			English	Article						Hepatocyte growth factor; amphiregulin; transforming growth factor-alpha; epidermal growth factor receptor; cetuximab; colorectal cancer	KINASE INHIBITORS; FACTOR RECEPTOR; LUNG ADENOCARCINOMA; ERBB RECEPTORS; EXPRESSION; GEFITINIB; MUTATION; AMPHIREGULIN; CHEMOTHERAPY; PANITUMUMAB	Background/Aim: The epidermal growth factor family (EGF) has been suggested to influence the sensitivity to anti-epidermal growth factor receptor therapy. We examined the correlation between circulating levels of the epidermal growth factors amphiregulin and transforming growth factor-alpha (TGF-alpha) and the MET ligand hepatocyte growth factor and sensitivity to the anti-epidermal growth factor receptor antibody in colorectal cancer (CRC) patients. Materials and Methods: Plasma levels of each ligand were measured by enzyme-linked immunosorbent assay in 51 patients with wild-type KRAS CRC. Results: Patients with high hepatocyte growth factor (HGF) levels had a significantly lower disease control rate (DCR) and shorter median progression-free survival (PFS) and overall survival (OS) than those with low expression levels. Amphiregulin was correlated with objective response rate (ORR) but not with PFS or OS. Cetuximab response and survival were not associated with TGF-alpha. Conclusion: Circulating HGF may help identify CRC patients most likely to benefit from anti-epidermal growth factor receptor antibody therapy.	[Yonesaka, Kimio; Ueda, Shinya; Yoshida, Takeshi; Takeda, Masayuki; Shimizu, Toshio; Tamura, Takao; Nakagawa, Kazuhiko] Kinki Univ, Sch Med, Dept Med Oncol, Osaka, Osaka 5898511, Japan; [Satoh, Taroh] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Osaka, Japan; [Okamoto, Isamu] Kyushu Univ, Ctr Clin & Translat Res, Fukuoka 812, Japan; [Nishio, Kazuto] Kinki Univ, Sch Med, Genome Biol, Osaka, Osaka 5898511, Japan	Yonesaka, K (reprint author), Kinki Univ, Sch Med, Dept Med Oncol, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.	yonesaka@sakai.med.kindai.ac.jp					Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957; de Alava E, 2007, J CLIN ONCOL, V25, P2656, DOI 10.1200/JCO.2006.08.6850; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Kasahara K, 2010, CLIN CANCER RES, V16, P4616, DOI 10.1158/1078-0432.CCR-10-0383; Liska D, 2011, CLIN CANCER RES, V17, P472, DOI 10.1158/1078-0432.CCR-10-0568; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Takahashi N, 2014, BRIT J CANCER, V110, P2716, DOI 10.1038/bjc.2014.230; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Van Cutsem E, 2014, CLIN CANCER RES, V20, P4240, DOI 10.1158/1078-0432.CCR-13-2752; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Toiyama Y, 2009, INT J CANCER, V125, P1657, DOI 10.1002/ijc.24554; Jacobs B, 2007, J CLIN ONCOL, V27, P5068; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442	27	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1683	1689				7	Oncology	Oncology	CF3QF	WOS:000352462900060		
J	Yamashita, Y; Yoshida, Y; Kurihara, T; Tsujita, E; Takeishi, K; Ishida, T; Ikeda, T; Furukawa, Y; Shirabe, K; Maehara, Y				Yamashita, Yo-ichi; Yoshida, Yoshihiro; Kurihara, Takeshi; Tsujita, Eiji; Takeishi, Kazuki; Ishida, Teruyoshi; Ikeda, Tetsuo; Furukawa, Yoshinari; Shirabe, Ken; Maehara, Yoshihiko			Surgical Loupes at 5.0x Magnification and the VIO Soft-coagulation System Can Prevent Postoperative Pancreatic Fistula in Duct-to-Mucosa Pancreaticojejunostomy	ANTICANCER RESEARCH			English	Article						Surgical loups; soft coagulation; pancreaticojejunostomy; postoperative pancreatic fistula	PROSPECTIVE RANDOMIZED-TRIAL; INTERNATIONAL STUDY-GROUP; GLUE SEALANT DECREASE; FIBRIN GLUE; WHIPPLE PROCEDURE; CLINICAL-TRIAL; PANCREATICODUODENECTOMY; RECONSTRUCTION; COMPLICATIONS; RESECTION	Background/Aim: Postoperative pancreatic fistula (POPE) remains a major complication after pancreaticoduodenectomy (PD). In this study, we examined whether our new method using surgical loupes at 5.0x magnification and the VIO soft coagulation system (SC) for duct-to-mucosa pancreaticojejunostomy (PJ) can prevent POPE Patients and Methods: A retrospective cohort study was performed in 81 consecutive patients who underwent PD and duct-to-mucosa PJ for periampullary tumors by a single surgeon during a recent 5-year period from 2008 to 2012. These patients were divided into two groups according to the nature of the Pi; the conventional group (n=46) and the 5.0x loupes+SC group (n=35). Short-term surgical results including POPF were compared and an independent risk factor for POPE was identified using the stepwise logistic regression analysis in our series. Results: The rate of Grade B/C POPF was significantly decreased in the 5.0x loupes+SC group (2.9%) compared to that of the conventional group (9.9%, p=0.04). The absence of 5.0x loupes+SC for PJ was identified as the independent risk factor for Grade B/C POPF (odds ratio. 5.23; p-value, 0.03). Conclusion: 5.0x surgical loupes+SC for duct-to-mucosa PJ could be used as a novel technique for preventing POPF after PD.	[Yamashita, Yo-ichi; Yoshida, Yoshihiro; Kurihara, Takeshi; Takeishi, Kazuki; Ikeda, Tetsuo; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Yamashita, Yo-ichi; Tsujita, Eiji; Ishida, Teruyoshi] Hiroshima Red Cross Hosp, Dept Surg, Hiroshima, Japan; [Furukawa, Yoshinari] Hiroshima Red Cross Hosp, Dept Gastroenterol, Hiroshima, Japan; [Furukawa, Yoshinari] Atom Bomb Survivors Hosp, Hiroshima, Japan	Yamashita, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamashi@surg2.med.kyushu-u.ac.jp					Lillemoe KD, 2004, J GASTROINTEST SURG, V8, P766, DOI 10.1016/j.gassur.2004.06.011; [Anonymous], 2001, ANN SURG, DOI DOI 10.1097/00000658-200110000-00008]; Neoptolemos JP, 1997, BRIT J SURG, V84, P1370; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Tsai S, 2010, J GASTROINTEST SURG, V14, P1143, DOI 10.1007/s11605-010-1201-3; Motoi F, 2012, BRIT J SURG, V99, P524, DOI 10.1002/bjs.8654; Berger AC, 2009, J AM COLL SURGEONS, V208, P738, DOI 10.1016/j.jamcollsurg.2008.12.031; Nagakawa Y, 2008, J HEPATO-BILIARY-PAN, V15, P359, DOI 10.1007/s00534-008-1329-7; Watson K, 1944, BRIT J SURG, V31, P368, DOI 10.1002/bjs.18003112406; Kawai M, 2011, J HEPATO-BIL-PAN SCI, V18, P601, DOI 10.1007/s00534-011-0373-x; Wada K, 2006, SURGERY, V139, P735, DOI 10.1016/j.surg.2005.11.001; Poon RTP, 2002, AM J SURG, V183, P42, DOI 10.1016/S0002-9610(01)00829-7; Yeo CJ, 2002, ANN SURG, V236, P355, DOI 10.1097/01.SLA.0000027272.08464.0B; Hosotani R, 2002, WORLD J SURG, V26, P99; Bassi C, 2003, SURGERY, V134, P766, DOI 10.1016/S0039-6060(03)00345-3; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Yeo CJ, 2000, ANN SURG, V232, P419, DOI 10.1097/00000658-200009000-00014; Xiong JJ, 2012, BRIT J SURG, V99, P1050, DOI 10.1002/bjs.8788; TRAVERSO LW, 1978, SURG GYNECOL OBSTET, V146, P959; Whipple AO, 1935, ANN SURG, V102, P763, DOI 10.1097/00000658-193510000-00023; Pratt WB, 2009, BRIT J SURG, V96, P641, DOI 10.1002/bjs.6614; Williams TK, 2009, J AM COLL SURGEONS, V208, P210, DOI 10.1016/j.jamcollsurg.2008.10.019; Ikegami T, 2011, SURG TODAY, V41, P1224, DOI 10.1007/s00595-010-4433-7; WHIPPLE AO, 1945, ANN SURG, V121, P847, DOI 10.1097/00000658-194506000-00008; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Mckay A, 2006, BRIT J SURG, V93, P929, DOI 10.1002/bjs.5407; Hayashibe A, 2007, J SURG ONCOL, V95, P106, DOI 10.1002/jso.20608; Fernandez-del Castillo C, 2012, SURGERY, V152, pS56, DOI 10.1016/j.surg.2012.05.022; Hashimoto Y, 2010, J AM COLL SURGEONS, V211, P510, DOI 10.1016/j.jamcollsurg.2010.06.018; Li PC, 2012, TRANSPL P, V44, P448, DOI 10.1016/j.transproceed.2012.01.059; Traverso LW, 2004, J GASTROINTEST SURG, V8, P772; Ohwada S, 2002, ARCH SURG-CHICAGO, V137, P1289, DOI 10.1001/archsurg.137.11.1289; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004; Yeo CJ, 2002, ANN SURG, V236, P366	35	0	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1691	1696				6	Oncology	Oncology	CF3QF	WOS:000352462900061		
J	Watanabe, N; Niho, S; Kirita, K; Umemura, S; Matsumoto, S; Yoh, K; Ohmatsu, H; Goto, K				Watanabe, Naohiro; Niho, Seiji; Kirita, Keisuke; Umemura, Shigeki; Matsumoto, Shingo; Yoh, Kiyotaka; Ohmatsu, Hironobu; Goto, Koichi			Vinorelbine and Cisplatin in Patients with Advanced Non-small Cell Lung Cancer with Interstitial Pneumonia	ANTICANCER RESEARCH			English	Article						Acute exacerbation; cisplatin; interstitial pneumonia; non-small cell lung cancer; vinorelbine	IDIOPATHIC PULMONARY-FIBROSIS; ACUTE EXACERBATION; WEEKLY PACLITAXEL; RISK-FACTORS; DISEASE; EFFICACY; CHEMOTHERAPY; COMBINATION; CARBOPLATIN; SAFETY	Aim: The aim of the present study was to investigate the efficacy and tolerability of vinorelbine and cisplatin for the treatment of patients with advanced (stage IIIB, IV or relapse) non-small cell lung cancer (NSCLC) with interstitial pneumonia (IP). Patients and Methods: A total of 67 patients treated with vinorelbine and cisplatin as a first-line chemotherapy between January 2002 and December 2013 were retrospectively reviewed. Results: The overall response rate was 34.3% [95% confidence interval (CI)=22.9%-45.7%). The median progression-free survival, median overall survival, and I-year survival rates were 3.7 months (95% CI=3.1-4.3 months), 7.4 months (95% CI=5.4-9.4 months), and 22.4% (95% CI=12.4%-32.4%), respectively. The incidence of acute exacerbation of IP following first-line chemotherapy was 10.4%. Conclusion: The combination of vinorelbine and cisplatin is a feasible treatment option for advanced NSCLC patients with IP, after careful consideration of the potential risks and benefits on an individual basis.	[Watanabe, Naohiro; Niho, Seiji; Kirita, Keisuke; Umemura, Shigeki; Matsumoto, Shingo; Yoh, Kiyotaka; Ohmatsu, Hironobu; Goto, Koichi] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba 2778577, Japan	Niho, S (reprint author), Natl Canc Ctr Hosp East, Dept Thorac Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	siniho@east.ncc.go.jp			Ministry for Health, Labour and Welfare, Japan	This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry for Health, Labour and Welfare, Japan.	Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Okuda K, 2012, ANTICANCER RES, V32, P5475; Minegishi Y, 2009, INTERNAL MED, V48, P665, DOI 10.2169/internalmedicine.48.1650; Park J, 2001, EUR RESPIR J, V17, P1216, DOI 10.1183/09031936.01.99055301; LECHEVALIER T, 1994, J CLIN ONCOL, V12, P360; Kondoh Y, 2010, SARCOIDOSIS VASC DIF, V27, P103; Kenmotsu H, 2011, J THORAC ONCOL, V6, P1242, DOI 10.1097/JTO.0b013e318216ee6b; TURNERWARWICK M, 1980, THORAX, V35, P496, DOI 10.1136/thx.35.7.496; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5; Minegishi Y, 2011, LUNG CANCER, V71, P70, DOI 10.1016/j.lungcan.2010.04.014; Le Jeune I, 2007, RESP MED, V101, P2534, DOI 10.1016/j.rmed.2007.07.012; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Harris JM, 2010, THORAX, V65, P70, DOI 10.1136/thx.2009.121962; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Isobe K, 2010, RESPIROLOGY, V15, P88, DOI 10.1111/j.1440-1843.2009.01666.x; Watanabe N, 2013, RESPIRATION, V85, P326, DOI 10.1159/000342046; Choi MK, 2014, CANCER CHEMOTH PHARM, V73, P1217, DOI 10.1007/s00280-014-2458-0; Niho S, 2006, JPN J CLIN ONCOL, V36, P269, DOI 10.1093/jjco/hyl021; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shukuya T, 2010, ANTICANCER RES, V30, P4357; Sobin L, 2009, INT UNION CANC TNM C; Travis WD, 1999, HISTOLOGICAL TYPING	27	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1697	1701				5	Oncology	Oncology	CF3QF	WOS:000352462900062		
J	Ide, H; Yamagishi, S; Lu, Y; Sakamaki, K; Nakajima, A; Horiuchi, A; Kitamura, K; Hisasue, S; Muto, S; Yamaguchi, R; Horie, S				Ide, Hisamitsu; Yamagishi, Sho-ichi; Lu, Yan; Sakamaki, Kentaro; Nakajima, Akiko; Horiuchi, Akira; Kitamura, Kosuke; Hisasue, Schin-ichi; Muto, Satoru; Yamaguchi, Raizo; Horie, Shigeo			Circulating Pigment Epithelium-derived Factor (PEDF) Is Associated with Pathological Grade of Prostate Cancer	ANTICANCER RESEARCH			English	Article						Prostate cancer; PEDF; Gleason score	CELLS; DIFFERENTIATION; OVEREXPRESSION; ANGIOGENESIS	Background/Aim: Pigment epithelium-derived factor (PEDF) plays a protective role against oxidative stress. Levels of circulating PEDF have not been examined in patients with prostate cancer. We examined whether PEDF can be used to predict the clinical features of prostate cancer prior to therapy. Materials and Methods: Two hundred patients with an abnormal serum level of prostate-specific antigen (PSA) who underwent biopsy between 2008 and 2011 were identified for retrospective analysis. We determined the relationship of the PEDF level to clinical parameters of prostate cancer. We measured levels of PEDF and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in all 200 patients, 100 of whom had histologically-confirmed prostate cancer at the outset. We also investigated the PEDF expression in prostate cancer tissues by immunohistochemistry. Results: The PEDF level was significantly higher in patients with prostate cancer than in those without. Statistical analysis confirmed that PEDF was significant, positively associated with pathological grading (Gleason score). However, PEDF expression was only detected in few prostate cancer cells by immunohistochemistry. Levels of the oxidative marker, 8-OHdG, in patients with prostate cancer are higher than in those without cancer. Conclusion: Preoperative PEDF measurement in patients with prostate cancer may provide clinically relevant information regarding the pathological grade of tumor.	[Ide, Hisamitsu; Lu, Yan; Nakajima, Akiko; Horiuchi, Akira; Kitamura, Kosuke; Muto, Satoru; Yamaguchi, Raizo] Teikyo Univ, Sch Med, Dept Urol, Tokyo 1738605, Japan; [Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet, Vasc Complicat, Kurume, Fukuoka 830, Japan; [Sakamaki, Kentaro] Yokohama City Univ, Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Hisasue, Schin-ichi; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan	Ide, H (reprint author), Teikyo Univ, Sch Med, Dept Urol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	ihisamit@med.teikyo-u.ac.jp					Feng CC, 2011, INT UROL NEPHROL, V43, P383, DOI 10.1007/s11255-010-9834-4; Becerra SP, 2013, NAT REV CANCER, V13, P258, DOI 10.1038/nrc3484; Yamagishi S, 2011, CURR PHARM BIOTECHNO, V12, P362, DOI 10.2174/138920111794480534; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Becerra SP, 2004, EXP EYE RES, V78, P223, DOI 10.1016/j.exer.2003.10.013; Hirsch J, 2011, CYTOKINE, V55, P202, DOI 10.1016/j.cyto.2011.04.010; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Konson A, 2011, J BIOL CHEM, V286, P3540, DOI 10.1074/jbc.M110.151548; Halin S, 2010, NEOPLASIA, V12, P336, DOI 10.1593/neo.92046; BECERRA SP, 1993, J BIOL CHEM, V268, P23148; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; Manalo KB, 2011, EXPERT OPIN THER PAT, V21, P121, DOI 10.1517/13543776.2011.545347; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Halin S, 2004, CANCER RES, V64, P5664, DOI 10.1158/0008-5472.CAN-04-0835; Ho TC, 2009, AM J PHYSIOL-CELL PH, V296, pC273, DOI 10.1152/ajpcell.00432.2008; Nelius T, 2013, PROSTATE, V73, P549, DOI 10.1002/pros.22595; Qingyi Zhu, 2009, Cancer Invest, V27, P794, DOI 10.1080/07357900802175617; Ren JG, 2005, MED HYPOTHESES, V64, P74, DOI 10.1016/j.mehy.2004.05.016; Semkova I, 2006, FASEB J, V20, P1689, DOI 10.1096/fj.05-5653fje; Wang FF, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-56; Zheng Donghang, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P123; Zolochevska O, 2012, STEM CELLS DEV, V21, P1112, DOI 10.1089/scd.2011.0247	23	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1703	1708				6	Oncology	Oncology	CF3QF	WOS:000352462900063		
J	Makino, T; Mizokami, A; Namiki, M				Makino, Tomoyuki; Mizokami, Atsushi; Namiki, Mikio			Clinical Outcomes of Patients with Localized and Locally Advanced Prostate Cancer Undergoing High-dose-rate Brachytherapy with External-beam Radiotherapy at our Institute	ANTICANCER RESEARCH			English	Article						Prostate cancer; high-dose-rate brachytherapy	QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; RADIATION-THERAPY; ANDROGEN DEPRIVATION; BIOCHEMICAL FAILURE; HORMONAL-THERAPY; FOLLOW-UP; CARCINOMA; SURVIVAL; COMBINATION	Aim: To report the clinical outcomes of localized and locally advanced prostate cancer patients undergoing high-dose-rate brachytherapy (HDR-BT) with external-beam radiotherapy (HDR-BT+EBRT) at the Kanazawa University Hospital. Patients and Methods: From 1999 until 2012, we examined 327 patients with Tlc-T3bN0M0 prostate cancer that underwent HDR-BT+EBRT and were followed-up for >= 1 year. Before 2005, treatment consisted of HDR-BT at 18 Gy/3 fractions and EBRT to the prostate at 44 Gy/22 fractions, whereas after 2006, treatment consisted of HDR-BT at 19 Gy/2 fractions and EBRT to the prostate at 46 Gy/23 fractions. Results: Median age was 68 years (range=45-84 years), median follow-up duration was 57 months (range=12-148 months), and median prostate-specific antigen (PSA) level at diagnosis was 9.2 ng/ml (range=2.6-458.6 ng/ml). The patients' clinical stages were Tlc:82, T2a:112, T2b:70, T2c:5, T3a:29, T3b:29, and their Gleason score was <= 6:120, 7:108, >= 8:99, respectively. The 5-year overall survival, and biochemical recurrence-free survival (bRFS) was 97.5% and 95.3%, respectively. Recurrence was reported in 20 cases (6.1%), and 11 patients died during follow-up, but only 1 patient died of prostate cancer. The 5-year recurrence-free survival bRFS for the patients in low-risk, intermediate-risk, and high-risk groups according to the D'Amico risk classification criteria were 100%, 95.6%, and 90.7%, respectively. Regarding adverse events genitourinary toxicity was major, and thus, 8.8% patients had urethral stricture and 4.3% patients were classified as grade 3. Conclusion: HDR-BT+EBRT is considered a suitable treatment modality for localized and locally advanced prostate cancer, including high-risk cases. However, genitourinary toxicity is observed frequently, and therefore, it may be necessary to modify the therapeutic planning of the HDR-BT+EBRT modality.	[Makino, Tomoyuki; Mizokami, Atsushi; Namiki, Mikio] Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa, Japan	Makino, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa, Japan.	mackeeen511@gmail.com					Hanks GE, 2003, J CLIN ONCOL, V21, P3972, DOI 10.1200/JCO.2003.11.023; Deutsch I, 2010, BRACHYTHERAPY, V9, P313, DOI 10.1016/j.brachy.2010.02.196; Frank SJ, 2007, J UROLOGY, V177, P2151, DOI 10.1016/j.juro.2007.01.134; Akaza H, 2006, BJU INT, V98, P573, DOI 10.1111/j.1464-410X.2006.06349.x; Sullivan L, 2009, RADIOTHER ONCOL, V91, P232, DOI 10.1016/j.radonc.2008.11.013; Demanes DJ, 2005, INT J RADIAT ONCOL, V61, P1306, DOI 10.1016/j.ijrobp.2004.08.014; Potters L, 2005, J UROLOGY, V173, P1562, DOI 10.1097/01.ju.0000154633.73092.8e; Joly F, 2006, J UROLOGY, V176, P2443, DOI 10.1016/j.juro.2006.07.151; Stone NN, 2009, INT J RADIAT ONCOL, V73, P341, DOI 10.1016/j.ijrobp.2008.04.038; Mate TP, 1998, INT J RADIAT ONCOL, V41, P525, DOI 10.1016/S0360-3016(98)00097-2; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2001, J UROLOGY, V166, P2185, DOI 10.1016/S0022-5347(05)65531-0; Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7; Morton G, 2011, RADIOTHER ONCOL, V100, P463, DOI 10.1016/j.radonc.2011.08.022; Blasko JC, 2000, RADIOTHER ONCOL, V57, P273, DOI 10.1016/S0167-8140(00)00288-7; Borghede G, 1997, RADIOTHER ONCOL, V44, P245, DOI 10.1016/S0167-8140(97)00122-9; Curran MJ, 2000, J ENDOUROL, V14, P351, DOI 10.1089/end.2000.14.351; Dubbelman YD, 2006, EUR UROL, V50, P711, DOI 10.1016/j.eururo.2006.06.009; Forsythe K, 2012, INT J RADIAT ONCOL, V83, P645, DOI 10.1016/j.ijrobp.2011.07.033; Ishiyama H, 2014, J RADIAT RES, V55, P509, DOI 10.1093/jrr/rrt128; Kumar Ravi J, 2005, Curr Urol Rep, V6, P217, DOI 10.1007/s11934-005-0010-9; Martinez A, 2003, J UROLOGY, V169, P974, DOI 10.1097/01.ju.0000052720.62999.a9; Nohara T, 2010, JPN J CLIN ONCOL, V40, P677, DOI 10.1093/jjco/hyq016; Thompson CA, 2003, ONCOLOGIST, V8, P474, DOI 10.1634/theoncologist.8-5-474	25	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1723	1728				6	Oncology	Oncology	CF3QF	WOS:000352462900066		
J	Tanaka, K; Tomita, H; Osada, S; Watanabe, H; Imai, H; Sasaki, Y; Goshima, S; Kondo, H; Kanematsu, M; Hara, A; Yoshida, K				Tanaka, Kaori; Tomita, Hiroyuki; Osada, Shinji; Watanabe, Haruo; Imai, Hisashi; Sasaki, Yoshiyuki; Goshima, Satoshi; Kondo, Hiroshi; Kanematsu, Masayuki; Hara, Akira; Yoshida, Kazuhiro			Significance of Histopathological Evaluation of Pancreatic Fibrosis to Predict Postoperative Course After Pancreatic Surgery	ANTICANCER RESEARCH			English	Article						Pancreatic fibrosis; pancreatic stellate cells; apparent diffusion coefficient; pancreas texture	FISTULA; PANCREATICODUODENECTOMY; REMNANT; CANCER	Background/Aim: Pancreatic stellate cells (PSC) play a critical role in pancreatic fibrosis and the apparent diffusion coefficient (ADC) value based on the diffusion-weighted image (DWI) from magnetic resonance imaging (MRI) may he a predictor of tissue fibrosis. This study aimed to evaluate the pancreas texture from both histopathological and radiological viewpoints and to investigate the effect of pancreas texture on occurrence of postoperative pancreatic fistula (PF). Patients and Methods: We divided 40 patients into soft-pancreas group and hard-pancreas group, according to the histopathological evaluation of pancreatic fibrosis. We compared ADC values and occurrences of PF between the two groups. Results: Histopathological measurement lengths of interlobular and intralobular fibrosis increased significantly with the progression of fibrosis grade and PSC stage, while PSC stage correlated significantly with fibrosis grade (r=0.868, p<0.001). PF was detected in 14 out of 40 patients, including grade A in 7 patients and grade B/C in 7 patients. but there were no operative deaths. Pancreas texture (soft/hard), determined based on the combination of fibrosis grade and PSC stage, was 16/10 (no PF) and 14/0 (grade A/B/C PF) and the difference in the incidence was significant (p=0.022). Though ADC value was significantly lower in the hard-compared to the soft-pancreas group (1.48 +/- 0.42 vs. 1.73 +/- 0.27x10(-3) mm(2)/sec; p=0.033), there was no significant difference in ADC value between no PF versus grade A/B/C PF group. Conclusion: Histopathological evaluation of pancreas texture correlated negatively with ADC values and is critical to predict the occurrence of PF.	[Tanaka, Kaori; Imai, Hisashi; Sasaki, Yoshiyuki; Yoshida, Kazuhiro] Gifu Univ, Grad Sch Med, Dept Surg Oncol, Gifu 5011194, Japan; [Tomita, Hiroyuki; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu 5011194, Japan; [Osada, Shinji] Gifu Univ, Grad Sch Med, Dept Multidisciplinary Therapy Hepatobiliary Panc, Gifu 5011194, Japan; [Goshima, Satoshi; Kondo, Hiroshi; Kanematsu, Masayuki] Gifu Univ, Grad Sch Med, Dept Radiol, Gifu 5011194, Japan; [Watanabe, Haruo] Gifu Cent Hosp, Dept Radiol, Gifu, Japan	Osada, S (reprint author), Gifu Univ, Grad Sch Med, Dept Multidisciplinary Therapy Hepatobiliary Panc, 1-1 Yanagido, Gifu 5011194, Japan.	sting@gifu-u.ac.jp			Pancreas Research Foundation of Japan	The Authors would like to thank Kyoko Takahashi and Ayako Suga for their valuable technical assistance and all members of the Department of Tumor Pathology for helpful comments and discussion. Hiroyuki Tomita is supported by the Pancreas Research Foundation of Japan.	Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801; Muraoka N, 2008, J MAGN RESON IMAGING, V27, P1302, DOI 10.1002/jmri.21340; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Belyaev O, 2011, PANCREATOLOGY, V11, P516, DOI 10.1159/000332587; Okano K, 2013, SURG TODAY, V43, P141, DOI 10.1007/s00595-012-0235-4; Yoshikawa T, 2006, AM J ROENTGENOL, V187, P1521, DOI 10.2214/AJR.05.0778; Wellner UF, 2010, HPB, V12, P696, DOI 10.1111/j.1477-2574.2010.00239.x; Noji T, 2012, PANCREAS, V41, P916, DOI 10.1097/MPA.0b013e31823e7705; Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; Apte MV, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00344; DeOliveira ML, 2006, ANN SURG, V244, P931, DOI 10.1097/01.sla.0000246856.03918.9a; Erkan M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00389; Hayano K, 2013, J HEPATO-BIL-PAN SCI, V20, P243, DOI 10.1007/s00534-011-0491-5; Kato H, 2013, EUR J RADIOL, V82, P28; Kawai M, 2009, WORLD J SURG, V33, P2670, DOI 10.1007/s00268-009-0220-2; Kim Z, 2009, HPB, V11, P215, DOI 10.1111/j.1477-2574.2009.00011.x; Murakami Y, 2008, J GASTROINTEST SURG, V12, P51, DOI 10.1007/s11605-007-0340-7; Osada S, 2009, HEPATO-GASTROENTEROL, V56, P619; Osada S, 2011, SURG SCI, V2, P45; Pereira Fernando Leal, 2012, Rev Col Bras Cir, V39, P41, DOI 10.1590/S0100-69912012000100009; Tajima Y, 2010, J SURG RES, V158, P61, DOI 10.1016/j.jss.2008.07.033; Tajima Y, 2010, J HEPATO-BIL-PAN SCI, V17, P831, DOI 10.1007/s00534-010-0277-1; Watanabe H, 2014, RADIOLOGY, V270, P791, DOI 10.1148/radiol.13131194	24	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1749	1756				8	Oncology	Oncology	CF3QF	WOS:000352462900070		
J	Ishikawa, H; Hashimoto, T; Moriwaki, T; Hyodo, I; Hisakura, K; Terashima, H; Ohkohchi, N; Ohno, T; Makishima, H; Mizumoto, M; Ohnishi, K; Okumura, T; Sakurai, H				Ishikawa, Hitoshi; Hashimoto, Takayuki; Moriwaki, Toshikazu; Hyodo, Ichinosuke; Hisakura, Katsuji; Terashima, Hideo; Ohkohchi, Nobuhiro; Ohno, Toshiki; Makishima, Hirokazu; Mizumoto, Masashi; Ohnishi, Kayoko; Okumura, Toshiyuki; Sakurai, Hideyuki			Proton Beam Therapy Combined with Concurrent Chemotherapy for Esophageal Cancer	ANTICANCER RESEARCH			English	Article						Proton beam therapy; esophageal cancer; concurrent chemoradiotherapy; survival; late toxicity	SQUAMOUS-CELL CARCINOMA; TERM-FOLLOW-UP; RADIATION-THERAPY; DEFINITIVE CHEMORADIOTHERAPY; PHASE-II; CHEMORADIATION; TRIAL; IRRADIATION; EFFUSION; SURGERY	Background/Aim: The aim of the present study was to evaluate the outcomes of proton beam therapy (PBT) concurrently combined with chemotherapy consisting of cisplatin and 5-fluorouracil for esophageal cancer. Patients and Methods: Forty consecutive patients (stage I in 16 patients, II in 9 and III in 15) treated between 2008 and 2012 were evaluated. A total dose of 60 Gray equivalents (GyE) in 30 fractions was delivered, and an additional boost of 4-10 GyE was given when residual tumors were suspected. The median follow-up time was 24 months (range=7-66 months). Results: No cardio-pulmonary toxicities of grade 3 or higher were observed. Recurrences were observed in 16 patients, and the 2-year rates of disease-specific survival and locoregional control were 77% and 66%, respectively. Conclusion: Irrespective of the small sample size and short follow-up time of the study, proton beam therapy combined with chemotherapy seems to be feasible for esophageal cancer.	[Ishikawa, Hitoshi; Hashimoto, Takayuki; Ohno, Toshiki; Makishima, Hirokazu; Mizumoto, Masashi; Ohnishi, Kayoko; Okumura, Toshiyuki; Sakurai, Hideyuki] Univ Tsukuba, Fac Med, Dept Radiat Oncol, Tsukuba, Ibaraki 3058575, Japan; [Moriwaki, Toshikazu; Hyodo, Ichinosuke] Univ Tsukuba, Fac Med, Dept Gastroenterol, Tsukuba, Ibaraki 3058575, Japan; [Hisakura, Katsuji; Terashima, Hideo; Ohkohchi, Nobuhiro] Univ Tsukuba, Fac Med, Dept Gastroenterol & Hepatobiliary Surg, Tsukuba, Ibaraki 3058575, Japan	Ishikawa, H (reprint author), Univ Tsukuba, Fac Med, Dept Radiat Oncol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	hishikawa@pmrc.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24591832]	This work was supported by Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (24591832) of Japan.	Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Nishimura Y, 2012, JPN J CLIN ONCOL, V42, P807, DOI 10.1093/jjco/hys112; Wei X, 2008, INT J RADIAT ONCOL, V70, P707, DOI 10.1016/j.ijrobp.2007.10.056; Ishikawa H, 2010, INT J RADIAT ONCOL, V76, P452, DOI 10.1016/j.ijrobp.2009.02.029; Lin SH, 2012, INT J RADIAT ONCOL, V83, pE345, DOI 10.1016/j.ijrobp.2012.01.003; Mizumoto M, 2010, STRAHLENTHER ONKOL, V186, P482, DOI 10.1007/s00066-010-2079-4; Hironaka S, 2003, INT J RADIAT ONCOL, V57, P425, DOI 10.1016/S0360-3016(03)00585-6; Shirai K, 2011, INT J RADIAT ONCOL, V80, P1002, DOI 10.1016/j.ijrobp.2010.03.046; Zhao KL, 2010, INT J RADIAT ONCOL, V76, P446, DOI 10.1016/j.ijrobp.2009.02.078; Oshiro Y, 2013, EXPERT REV MED DEVIC, V10, P239, DOI [10.1586/erd.12.81, 10.1586/ERD.12.81]; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Kato K, 2011, INT J RADIAT ONCOL, V81, P684, DOI 10.1016/j.ijrobp.2010.06.033; Moskovitz AH, 2006, ANN THORAC SURG, V82, P2031, DOI 10.1016/j.athoracsur.2006.06.053; Terasawa T, 2009, ANN INTERN MED, V151, P556, DOI 10.7326/0003-4819-151-8-200910200-00145; Gerber N, 2014, DIS ESOPHAGUS, V27, P235, DOI 10.1111/dote.12082; Morota M, 2009, INT J RADIAT ONCOL, V75, P122, DOI 10.1016/j.ijrobp.2008.10.075; Ishikawa H, 2006, J GASTROEN HEPATOL, V21, P1290, DOI 10.1111/j.1440-1746.2006.04089.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Okonogi N, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-173; RECHT A, 1995, CHEST, V107, pS233, DOI 10.1378/chest.107.6_Supplement.233S; Smith TJ, 1998, INT J RADIAT ONCOL, V42, P269, DOI 10.1016/S0360-3016(98)00232-6; Sobin LH, 2010, TNM CLASSIFICATION M, P66; Stockeld D, 2001, ACTA ONCOL, V40, P566; The National Cancer Institute, 2010, COMM TERM CRIT ADV E	25	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1757	1762				6	Oncology	Oncology	CF3QF	WOS:000352462900071		
J	Morodomi, Y; Okamoto, T; Kohno, M; Katsura, M; Takada, K; Suzuki, Y; Fujishita, T; Kitahara, H; Shimamatsu, S; Yoshida, T; Tagawa, T; Okano, S; Maehara, Y				Morodomi, Yosuke; Okamoto, Tatsuro; Kohno, Mikihiro; Katsura, Masakazu; Takada, Kazuki; Suzuki, Yuzo; Fujishita, Takatoshi; Kitahara, Hirokazu; Shimamatsu, Shinichiro; Yoshida, Tsukihisa; Tagawa, Tetsuzo; Okano, Shinji; Maehara, Yoshihiko			Associations Between Driver Gene Mutations and Cytotoxic Chemosensitivity in Patients with Non-small Cell Lung Cancer	ANTICANCER RESEARCH			English	Article						Non-small cell lung cancer; anaplastic lymphoma kinase; epidermal growth factor receptor; chemosensitivity	GROWTH-FACTOR RECEPTOR; PHASE-III; CHEMOTHERAPY; ADENOCARCINOMA; GEMCITABINE; SENSITIVITY; GEFITINIB; DOCETAXEL; EGFR	Background/Aim: Patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) gene mutations or echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase (EML4-ALK) rearrangement often have a better prognosis when they are treated with specific inhibitors than when treated with cytotoxic agents. However, the associations between gene mutations and cytotoxic chemosensitivity are still unclear. The objective of the present study was to identify which clinicopathological factors, including genetic mutations, influence chemosensitivity, determined using the succinate dehydrogenase inhibition (SDI) test in patients with NSCLC. Materials and Methods: The chemosensitivity of tumor tissues from 96 patients with NSCLC who underwent surgical resection was evaluated using the SDI test. Results: In patients with adenocarcinoma, tumors with EGFR gene mutations were significantly more sensitive to 5-fluorouracil (5-FU) than tumors without EGFR gene mutations (p<0.0149). Conclusion: Our data suggest that patients with adenocarcinoma harboring EGFR gene mutations may be susceptible to 5-FU.	[Morodomi, Yosuke; Okamoto, Tatsuro; Kohno, Mikihiro; Katsura, Masakazu; Takada, Kazuki; Suzuki, Yuzo; Fujishita, Takatoshi; Kitahara, Hirokazu; Shimamatsu, Shinichiro; Yoshida, Tsukihisa; Tagawa, Tetsuzo; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Morodomi, Yosuke; Okano, Shinji] Kyushu Univ, Dept Innovat Appl Oncol, Fukuoka 8128582, Japan	Morodomi, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yo-suke@surg2.med.kyushu-u.ac.jp					Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Kalikaki A, 2010, LUNG CANCER, V69, P110, DOI 10.1016/j.lungcan.2009.09.010; Park JH, 2012, LUNG CANCER, V77, P433, DOI 10.1016/j.lungcan.2012.03.020; Camidge DR, 2011, J THORAC ONCOL, V6, P774, DOI 10.1097/JTO.0b013e31820cf053; Oki E, 2005, INT J CANCER, V117, P376, DOI 10.1002/ijc.21170; Michalski CW, 2008, BRIT J CANCER, V99, P760, DOI 10.1038/sj.bjc.6604528; Takenaka T, 2007, INT J CANCER, V121, P895, DOI 10.1002/ijc.22738; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Sakairi Y, 2010, CLIN CANCER RES, V16, P4938, DOI 10.1158/1078-0432.CCR-10-0099; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Yoshimasu T, 2011, J THORAC ONCOL, V6, P1658, DOI 10.1097/JTO.0b013e318221f71a; Mitsudomi T, 2010, JPN J CLIN ONCOL, V40, P101, DOI 10.1093/jjco/hyp174; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Suehisa H, 2007, J CLIN ONCOL, V25, P3952, DOI 10.1200/JCO.2007.11.8646; Kondo T, 2000, Anticancer Res, V20, P2389; Mekata E, 2013, MOL CLIN ONCOLOGY, V1, P763; Naoki K, 2011, INT J CLIN ONCOL, V16, P335, DOI 10.1007/s10147-011-0187-5; Yue GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065164	21	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1791	1796				6	Oncology	Oncology	CF3QF	WOS:000352462900076		
J	Iwasa, S; Souda, H; Yamazaki, K; Takahari, D; Miyamoto, Y; Takii, Y; Ikeda, S; Hamaguchi, T; Kanemitsu, Y; Shimada, Y				Iwasa, Satoru; Souda, Hiroaki; Yamazaki, Kentaro; Takahari, Daisuke; Miyamoto, Yuji; Takii, Yasumasa; Ikeda, Satoshi; Hamaguchi, Tetsuya; Kanemitsu, Yukihide; Shimada, Yasuhiro			Safety and Efficacy of Adjuvant Therapy with Oxaliplatin, Leucovorin and 5-Fluorouracil After Mesorectal Excision with Lateral Pelvic Lymph Node Dissection for Stage III Lower Rectal Cancer	ANTICANCER RESEARCH			English	Article						Adjuvant therapy; lateral pelvic lymph node dissection; mesorectal excision; oxaliplatin; rectal cancer	RANDOMIZED PHASE-III; COLORECTAL-CANCER; PREOPERATIVE RADIOTHERAPY; CONTROLLED-TRIAL; COLON-CANCER; CHEMOTHERAPY; FLUOROURACIL; CHEMORADIOTHERAPY; MULTICENTER; METASTASIS	Background/Aim: Preoperative chemoradiotherapy followed by total mesorectal excision (TME) is the standard treatment for stage III lower rectal cancer worldwide. However, in Japan, the standard treatment is TME with lateral pelvic lymph node dissection (LPLD) followed by adjuvant chemotherapy. We examined the safety and efficacy of adjuvant therapy with oxaliplatin, leucovorin, and 5-fluorouracil (modified FOLFOX6) after TME with LPLD. Patients and Methods: This retrospective study included 33 patients who received modified FOLFOX6 after TME with LPLD for stage lower rectal cancer. Results: The overall completion rate of 12 cycles of adjuvant modified FOLFOX6 was 76%. Grade 3 or 4 neutropenia was observed in eight patients (24%). Sensory neuropathy was observed in 32 patients (97%) with 4 (12%) having a grade 3 event. The disease-free survival (DES) rate was 45% at 3 years. Conclusion: Adjuvant modified FOLFOX6 was feasible in patients with stage 111 lower rectal cancer after TME with LPLD.	[Iwasa, Satoru; Hamaguchi, Tetsuya; Kanemitsu, Yukihide; Shimada, Yasuhiro] Natl Canc Ctr, Tokyo 1040045, Japan; [Souda, Hiroaki] Chiba Canc Ctr, Chiba 2608717, Japan; [Yamazaki, Kentaro] Shizuoka Canc Ctr, Shizuoka, Japan; [Takahari, Daisuke] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan; [Miyamoto, Yuji] Kumamoto Univ, Kumamoto, Japan; [Takii, Yasumasa] Niigata Canc Ctr Hosp, Niigata, Japan; [Ikeda, Satoshi] Hiroshima Prefectural Hosp, Hiroshima, Japan	Iwasa, S (reprint author), Natl Canc Ctr, Gastrointestinal Med Oncol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	siwasa@nce.go.jp			National Cancer Center Research and Development Fund [23-A-19]	This study was supported in part by the National Cancer Center Research and Development Fund 23-A-19.	Akasu T, 2006, JPN J CLIN ONCOL, V36, P237, DOI 10.1093/jjco/hyl014; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; van Duijvendijk P, 2002, AM J GASTROENTEROL, V97, P2282, DOI 10.1016/S0002-9270(02)04138-2; Ueno M, 2005, BRIT J SURG, V92, P756, DOI 10.1002/bjs.4975; Hamaguchi T, 2011, CANCER CHEMOTH PHARM, V67, P587, DOI 10.1007/s00280-010-1358-1; Shirao K, 2004, J CLIN ONCOL, V22, P3466, DOI 10.1200/JCO.2004.05.017; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; Marijnen CAM, 2005, J CLIN ONCOL, V23, P1847, DOI 10.1200/JCO.2005.05.256; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Akiyoshi T, 2012, ANN SURG, V255, P1129, DOI 10.1097/SLA.0b013e3182565d9d; Schrag D, 2014, J CLIN ONCOL, V32, P513, DOI 10.1200/JCO.2013.51.7904; Cassidy J, 2008, J CLIN ONCOL, V26, P2006, DOI 10.1200/JCO.2007.14.9898; Matsuoka H, 2005, LANGENBECK ARCH SURG, V390, P517, DOI 10.1007/s00423-005-0577-0; Kim JC, 2007, ANN SURG, V246, P754, DOI 10.1097/SLA.0b013e318070d587; Shimada Y, 2014, EUR J CANCER, V50, P2231, DOI 10.1016/j.ejca.2014.05.025; Benson III AB, 2013, NCCN CLIN PRACTICE G; Fujita S, 2012, HEPATO-GASTROENTEROL, V59, P2494, DOI 10.5754/hge12153; Hong YS, 2014, LANCET ONCOL, V15, P1245, DOI 10.1016/S1470-2045(14)70377-8; Moriya Y, 1997, WORLD J SURG, V21, P728; National Cancer Institute, COMM TERM CRIT ADV E; Ohue M., INT CLIN ON IN PRESS, DOI [10.1007/s1014701407053, DOI 10.1007/S1014701407053]; Rodel C, 2014, STRAHLENTHER ONKOL, V190, P5; Sato H, 2011, INT J COLORECTAL DIS, V26, P881, DOI 10.1007/s00384-011-1170-3; Takahashi T, 2000, DIS COLON RECTUM, V43, pS59, DOI 10.1007/BF02237228	25	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	MAR	2015	35	3					1815	1819				5	Oncology	Oncology	CF3QF	WOS:000352462900080		
J	Sato, M; Ito, M; Suzuki, S; Sakuma, H; Takeyama, A; Oda, S; Watanabe, M; Hashimoto, K; Miyazaki, K; Kawasaki, Y; Hosoya, M				Sato, Masatoki; Ito, Masaki; Suzuki, Shigeo; Sakuma, Hiroko; Takeyama, Aya; Oda, Shinichi; Watanabe, Masahiro; Hashimoto, Koichi; Miyazaki, Kyohei; Kawasaki, Yukihiko; Hosoya, Mitsuaki			Influenza Viral Load and Peramivir Kinetics after Single Administration and Proposal of Regimens for Peramivir Administration against Resistant Variants	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY			English	Article							VIRUS-INFECTION; INTRAVENOUS PERAMIVIR; NEURAMINIDASE INHIBITORS; DRUG SUSCEPTIBILITY; ORAL OSELTAMIVIR; UNITED-STATES; CHILDREN; ZANAMIVIR; EFFICACY; MARKER	We estimated the efficacy of the current single administration of peramivir on the basis of peramivir pharmacokinetics in the upper respiratory tract (URT) and determined the predictive peramivir concentration-time curve to assess its efficacy against viruses with decreased susceptibility to neuraminidase inhibitors. Serum, nasal swab, or aspiration samples were collected from 28 patients treated with 10 mg/kg body weight peramivir. The sequential influenza viral RNA load and susceptibility after peramivir administration were measured using a quantitative real-time reverse transcription-PCR and neuraminidase inhibition assay. The peramivir concentrations in the serum and URT after a single administration at 10 mg/kg were measured, and the predictive blood and URT peramivir concentration-time curves were determined to assess various administration regimens against resistant variants. The peramivir concentration decreased to <0.1% of the maximum concentration of drug in serum (C-max) at 24 h after administration. Rapid elimination of peramivir from the URT by 48 h after administration may contribute to an increase in the influenza A viral load after day 3 but not to a decrease in the influenza B viral load, despite the absence of a decrease in the susceptibility to peramivir. A longer maintenance of a high level of peramivir in the URT is expected by divided administration rather than once-daily administration. When no clinical improvement is observed in patients with normal susceptibility influenza A and B, peramivir readministration should be considered. In severe cases caused by resistant variants, better inhibitory effectiveness and less frequent adverse events are expected by divided administration rather than once-daily administration with an increased dosage.	[Sato, Masatoki; Hashimoto, Koichi; Miyazaki, Kyohei; Kawasaki, Yukihiko; Hosoya, Mitsuaki] Fukushima Med Univ, Dept Pediat, Fukushima, Japan; [Ito, Masaki; Takeyama, Aya] Soma Gen Hosp, Dept Pediat, Soma, Japan; [Suzuki, Shigeo] Ohara Gen Hosp, Dept Pediat, Fukushima, Japan; [Sakuma, Hiroko] Hoshi Gen Hosp, Dept Pediat, Koriyama, Fukushima, Japan; [Oda, Shinichi] Iwase Hosp, Dept Pediat, Sukagawa, Japan; [Watanabe, Masahiro] South Aizu Hosp, Dept Pediat, Minami Aizu, Japan	Sato, M (reprint author), Fukushima Med Univ, Dept Pediat, Fukushima, Japan.	smasatoki@yahoo.co.jp			research promotion division of the Fukushima Medical University from Astellas Pharma Inc.; Otsuka Pharmaceutical Co., Ltd.; Shiongi Co., Ltd.; Taisho Pharmaceutical Co., Ltd.	This work was not supported by any grants. The Department of Pediatrics, Fukushima Medical University, has received research funding through the research promotion division of the Fukushima Medical University from Astellas Pharma Inc., Otsuka Pharmaceutical Co., Ltd., Shiongi Co., Ltd., and Taisho Pharmaceutical Co., Ltd.	Kohno S, 2011, ANTIMICROB AGENTS CH, V55, P2803, DOI [10.1128/AAC.01718-10, 10.1128/AAC.00360-11]; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Renaud C, 2010, TRANSPL INFECT DIS, V12, P513, DOI 10.1111/j.1399-3062.2010.00582.x; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Brown AN, 2011, ANTIMICROB AGENTS CH, V55, P1747, DOI 10.1128/AAC.01629-10; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Okomo-Adhiambo M, 2014, INFLUENZA OTHER RESP, V8, P258, DOI 10.1111/irv.12215; Whitley RJ, 2013, CLIN INFECT DIS, V56, P1197, DOI 10.1093/cid/cis1220; Storms AD, 2012, EMERG INFECT DIS, V18, P308, DOI 10.3201/eid1802.111466; Katayose M, 2011, VACCINE, V29, P1844, DOI 10.1016/j.vaccine.2010.12.049; Sleeman K, 2013, EMERG INFECT DIS, V19, P1521, DOI 10.3201/eid1909.130724; Bautista E, 2010, NEW ENGL J MED, V362, P1708; Drusano GL, 2001, ANTIMICROB AGENTS CH, V45, P2115, DOI 10.1128/AAC.45.7.2115-2118.2001; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Hedrick JA, 2000, PEDIATR INFECT DIS J, V19, P410, DOI 10.1097/00006454-200005000-00005; KAULBACH HC, 1993, J ALLERGY CLIN IMMUN, V92, P457, DOI 10.1016/0091-6749(93)90125-Y; National Institute of Infectious Diseases, 2014, MAN DET INFL VIR; Pharmaceuticals and Medical Devices Agency, 2014, INT FORM PER; Sato M, 2005, PEDIATR INFECT DIS J, V24, P931, DOI 10.1097/01.inf.0000180976.81055.ce; Sato M, 2014, PEDIATR INFECT DIS J, V33, pE168, DOI 10.1097/INF.0000000000000266; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Sugaya N, 2012, ANTIMICROB AGENTS CH, V56, P369, DOI 10.1128/AAC.00132-11; Takashita E, 2014, EUROSURVEILLANCE, V19, P4, DOI 10.2807/1560-7917.ES2014.19.1.20666; Wenzel JJ, 2010, J CLIN MICROBIOL, V48, P3088, DOI 10.1128/JCM.00785-10	25	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0066-4804	1098-6596		ANTIMICROB AGENTS CH	Antimicrob. Agents Chemother.	MAR	2015	59	3					1648	1654		10.1128/AAC.04263-14		7	Microbiology; Pharmacology & Pharmacy	Microbiology; Pharmacology & Pharmacy	CF4VF	WOS:000352550000034		
J	Bentley, KE; Berryman, KR; Hopper, M; Hoffberg, SL; Myhre, KE; Iwao, K; Lee, JB; Glenn, TC; Mauricio, R				Bentley, Kerin E.; Berryman, Kaelyn R.; Hopper, McGee; Hoffberg, Sandra L.; Myhre, Karin E.; Iwao, Keisuke; Lee, Jared B.; Glenn, Travis C.; Mauricio, Rodney			ELEVEN MICROSATELLITES IN AN EMERGING INVADER, PHYTOLACCA AMERICANA (PHYTOLACCACEAE), FROM ITS NATIVE AND INTRODUCED RANGES	APPLICATIONS IN PLANT SCIENCES			English	Article						biological invasions; Illumina; MiSeq; Phytolacca americana; Phytolaccaceae; pokeweed	SOFTWARE	Premise of the study: To facilitate population genetic analyses, microsatellite markers were developed for pokeweed (Phytolacca americana), a large, weedy, perennial herb native to eastern North America that is emerging as a significant invasive species in China. Methods and Results: We mined 1,100,538 Illumina MiSeq reads from genomic DNA for microsatellites and identified 58 primer pairs. We screened these primers for polymorphism in two native and two invasive populations. We identified 11 loci that amplified consistently. The number of alleles per locus ranged from two to six, and observed heterozygosity ranged from 0.00 to 1.00. All loci were largely monomorphic within populations but different among populations. The primers were of very limited use in the congener P. acinosa. Conclusions: These loci will provide a valuable resource to study the population genetics and invasion history of P. americana	[Bentley, Kerin E.; Berryman, Kaelyn R.; Hopper, McGee; Hoffberg, Sandra L.; Lee, Jared B.; Mauricio, Rodney] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Myhre, Karin E.] Univ Georgia, Dept Comparat Literature, Athens, GA 30602 USA; [Iwao, Keisuke] Momoyama Gakuin Univ, Dept Sociol, Izumi Ku, Osaka 5941198, Japan; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA	Mauricio, R (reprint author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	mauricio@uga.edu			National Science Foundation Partnership for International Research and Education (PIRE) program [OISE 0730218]; National Science Foundation Graduate Research Fellowship [DGE0903734]	The authors thank M. M. Mauricio and H. A. Dahn for collecting field samples, H. Donaldson and M. Marks for assistance in screening primers, U. Bagal for help in analyzing data, and an anonymous reviewer for comments. This work was supported by the National Science Foundation Partnership for International Research and Education (PIRE) program (OISE 0730218). K.E.B. was supported by a National Science Foundation Graduate Research Fellowship (DGE0903734).	[Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Xu Haigen, 2012, NeoBiota, V15, P1; Alberto F, 2009, J HERED, V100, P394, DOI 10.1093/jhered/esn110; ARMESTO JJ, 1983, B TORREY BOT CLUB, V110, P380, DOI 10.2307/2996194; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; CAULKINS DB, 1990, B TORREY BOT CLUB, V117, P357, DOI 10.2307/2996833; Fu Jun-peng, 2012, Yingyong Shengtai Xuebao, V23, P991; Kim YO, 2005, J CHEM ECOL, V31, P1175, DOI 10.1007/s10886-005-4255-z; Li ZY, 2002, INVASIVE ALIEN SPECI; MCDONNELL MJ, 1984, AM J BOT, V71, P895, DOI 10.2307/2443660; Zhai Shu-Qiang, 2010, Chinese Journal of Plant Ecology, V34, P1236, DOI 10.3773/j.issn.1005-264x.2010.10.013	14	1	1	BOTANICAL SOC AMER INC	ST LOUIS	PO BOX 299, ST LOUIS, MO 63166-0299 USA	2168-0450			APPL PLANT SCI	Appl. Plant Sci.	MAR	2015	3	3							1500002	10.3732/apps.1500002		3	Plant Sciences	Plant Sciences	CG1SD	WOS:000353053300007		
J	Kameoka, S; Higashi, H; Setoguchi, H				Kameoka, Shinichiro; Higashi, Hiroyuki; Setoguchi, Hiroaki			DEVELOPMENT OF POLYMORPHIC MICROSATELLITE LOCI IN THE PERENNIAL HERB HEPATICA NOBILIS VAR. JAPONICA (RANUNCULACEAE)	APPLICATIONS IN PLANT SCIENCES			English	Article						gene flow; genetic diversity; Hepatica nobilis var. japonica; microsatellite; population structure; Ranunculaceae	MARKERS	Premise of the study: Microsatellite markers were developed and characterized in the vulnerable plant Hepatica nobilis var. japonica (Ranunculaceae) to investigate its genetic diversity, population structure, and gene flow. Methods and Results: Fourteen microsatellite markers were developed. The number of alleles per locus ranged from one to 12, and the expected heterozygosity per locus ranged from 0.043 to 0.855. Eleven markers were successfully amplified in the cultivar 'Mego' from Japan. Conclusions: These microsatellite markers can be used to investigate the genetic diversity, population structure, and gene fl ow of H. nobilis var. japonica	[Kameoka, Shinichiro; Higashi, Hiroyuki; Setoguchi, Hiroaki] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Kameoka, S (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto 6068501, Japan.	kameoka.shinichiro.42n@st.kyoto-u.ac.jp			Environment Research and Technology Development Fund of the Ministry of the Environment of Japan [4-1403]	This study was supported by the Environment Research and Technology Development Fund of the Ministry of the Environment of Japan (4-1403).	[Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Goudet J, 1995, J HERED, V86, P485; Lian CL, 2006, J PLANT RES, V119, P415, DOI 10.1007/s10265-006-0274-2; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Lian C, 2002, MOL ECOL NOTES, V2, P211, DOI 10.1046/j.1471-8278.2002.00213.x; Doyle JJ, 1990, FOCUS, V12, P13; SETOGUCHI H, 1995, J PLANT RES, V108, P87, DOI 10.1007/BF02344310; Takayama K, 2011, TAXON, V60, P1442	9	0	0	BOTANICAL SOC AMER INC	ST LOUIS	PO BOX 299, ST LOUIS, MO 63166-0299 USA	2168-0450			APPL PLANT SCI	Appl. Plant Sci.	MAR	2015	3	3							1400114	10.3732/apps.1400114		3	Plant Sciences	Plant Sciences	CG1SD	WOS:000353053300003		
J	Liao, KP; Hu, CH; Sueyoshi, M				Liao, Kangping; Hu, Changhong; Sueyoshi, Makoto			Free surface flow impacting on an elastic structure: Experiment versus numerical simulation	APPLIED OCEAN RESEARCH			English	Article						Fluid-structure interaction; Dam-break; Free surface flow; Elastic structure; Coupled FDM-FEM	FLUID-STRUCTURE INTERACTION; MODEL; SPH	The purpose of this study is to investigate the phenomenon of free surface flow impacting on elastic structures, which is a research topic of great interest in ship and ocean engineering. A series of quasi two-dimensional experiments on dam-break with an elastic plate are conducted. The main features of free surface flow impacting on elastic structures including large impacting force, structural vibration, violent free surface flow, are investigated. The coupled FDM-FEM method developed by the authors is applied for numerical simulation of such dam-break problem. Extensive analysis and discussion based on the comparisons between experimental data and numerical results are made and presented in this paper. (C) 2015 Elsevier Ltd. All rights reserved.	[Liao, Kangping] Harbin Engn Univ, Coll Ship Bldg Engn, Harbin 150001, Peoples R China; [Liao, Kangping; Hu, Changhong; Sueyoshi, Makoto] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	Liao, KP (reprint author), Kyushu Univ, Appl Mech Res Inst, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	liao@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015; Sueyoshi, Makoto/G-6653-2015	Sueyoshi, Makoto/0000-0002-8231-522X	 [24360358]	The authors thank Prof. Masashi Kashiwagi of Osaka University and Prof. Xian Chen of Yamaguchi University for their valuable discussions, comments and supports. The authors are also grateful to Mr. Makoto Yasunaga for his kindly support in the experiment. This research is partially supported by Grants-in Aid for Scientific Research (B), MEXT (No. 24360358).	Sriram V, 2012, J COMPUT PHYS, V231, P7650, DOI 10.1016/j.jcp.2012.07.003; Liao KP, 2013, J MAR SCI TECH-JAPAN, V18, P1, DOI 10.1007/s00773-012-0191-0; Yang Q, 2012, OCEAN ENG, V55, P136, DOI 10.1016/j.oceaneng.2012.06.031; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Walhorn E, 2005, COMPUT STRUCT, V83, P2100, DOI 10.1016/j.compstruc.2005.03.010; Tian FB, 2014, J COMPUT PHYS, V258, P451, DOI 10.1016/j.jcp.2013.10.047; Antoci C, 2007, COMPUT STRUCT, V85, P879, DOI 10.1016/j.compstruc.2007.01.002; TAKEWAKI H, 1987, J COMPUT PHYS, V70, P355, DOI 10.1016/0021-9991(87)90187-2; PESKIN CS, 1972, J COMPUT PHYS, V10, P252, DOI 10.1016/0021-9991(72)90065-4; Degroote J, 2010, COMPUT METHOD APPL M, V199, P2085, DOI 10.1016/j.cma.2010.02.019; Hu C., 2006, SHIP TECHNOLOGY RES, V53, P74; Idelsohn SR, 2008, COMPUT MECH, V43, P125, DOI 10.1007/s00466-008-0245-7; Kassiotis C, 2010, EUR J MECH B-FLUID, V29, P510, DOI 10.1016/j.euromechflu.2010.07.003; Kimmoun O, 2009, P 19 INT OFFSH POL E, P308; Sotiropoulos F, 2013, PROG AEROSP SCI, V66, P1; Xiao F., 2011, J COMPUT PHYS, V230, P7089	16	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-1187	1879-1549		APPL OCEAN RES	Appl. Ocean Res.	MAR	2015	50						192	208		10.1016/j.apor.2015.02.002		17	Engineering, Ocean; Oceanography	Engineering; Oceanography	CG1AA	WOS:000353004200015		
J	Kawaguchi, Y; Kondo, E; Takeda, R; Akita, K; Yasuda, K; Amis, AA				Kawaguchi, Yasuyuki; Kondo, Eiji; Takeda, Ryo; Akita, Keiichi; Yasuda, Kazunori; Amis, Andrew A.			The Role of Fibers in the Femoral Attachment of the Anterior Cruciate Ligament in Resisting Tibial Displacement	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Article							IN-SITU FORCES; ANATOMIC DOUBLE-BUNDLE; TUNNEL PLACEMENT; HUMAN KNEE; PATELLAR TENDON; SINGLE-BUNDLE; RECONSTRUCTION; LOADS; LOCATION; ROTATION	Purpose: The purpose was to clarify the load-bearing functions of the fibers of the femoral anterior cruciate ligament (ACL) attachment in resisting tibial anterior drawer and rotation. Methods: A sequential cutting study was performed on 8 freshfrozen human knees. The femoral attachment of the ACL was divided into a central area that had dense fibers inserting directly into the femur and anterior and posterior fan-like extension areas. The ACL fibers were cut sequentially from the bone: the posterior fan-like area in 2 stages, the central dense area in 4 stages, and then the anterior fan-like area in 2 stages. Each knee was mounted in a robotic joint testing system that applied tibial anteroposterior 6-mm translations and 10 degrees or 15 degrees of internal rotation at 0 degrees to 90 degrees of flexion. The reduction of restraining force or moment was measured after each cut. Results: The central area resisted 82% to 90% of the anterior drawer force; the anterior fan-like area, 2% to 3%; and the posterior fan-like area, 11% to 15%. Among the 4 central areas, most load was carried close to the roof of the intercondylar notch: the anteromedial bundle resisted 66% to 84% of the force and the posterolateral bundle resisted 16% to 9% from 0 degrees to 90 degrees of flexion. There was no clear pattern for tibial internal rotation, with the load shared among the posterodistal and central areas near extension and mostly the central areas in flexion. Conclusions: Under the experimental conditions described, 66% to 84% of the resistance to tibial anterior drawer arose from the ACL fibers at the central-proximal area of the femoral attachment, corresponding to the anteromedial bundle; the fan-like extension fibers contributed very little. This work did not supportmoving a single-bundle ACL graft to the sidewall of the notch or attempting to cover the whole attachment area if the intention was to mimic how the natural ACL resists tibial displacements.	[Kawaguchi, Yasuyuki; Takeda, Ryo; Amis, Andrew A.] Univ London Imperial Coll Sci Technol & Med, Dept Mech Engn, London SW7 2AZ, England; [Amis, Andrew A.] Univ London Imperial Coll Sci Technol & Med, Sch Med, Charing Cross Hosp, Musculoskeletal Surg Grp, London SW7 2AZ, England; [Kawaguchi, Yasuyuki; Kondo, Eiji; Yasuda, Kazunori] Hokkaido Univ, Grad Sch Med, Dept Sports Med & Joint Surg, Sapporo, Hokkaido, Japan; [Akita, Keiichi] Tokyo Med & Dent Univ, Grad Sch, Unit Clin Anat, Tokyo, Japan	Amis, AA (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mech Engn, South Kensington Campus, London SW7 2AZ, England.	a.amis@imperial.ac.uk	Kondo, Eiji/G-2004-2012		Wellcome Trust [088844/Z/09/Z]; Engineering and Physical Sciences Research Council; Hokkaido University Graduate School of Medicine	Supported in part by the Wellcome Trust (088844/Z/09/Z; A.A.A.) and the Engineering and Physical Sciences Research Council, and by a grant for clinical research from Hokkaido University Graduate School of Medicine. The authors report that they have no conflicts of interest in the authorship and publication of this article.	Amis A, 1995, KNEE, V2, P5, DOI 10.1016/0968-0160(95)00003-8; Lee MC, 2007, ARTHROSCOPY, V23, P771, DOI 10.1016/j.arthro.2007.04.016; NOYES FR, 1976, J BONE JOINT SURG AM, V58, P1074; Woo SLY, 2002, J BONE JOINT SURG AM, V84A, P907; Mochizuki T, 2006, ARTHROSCOPY, V22, P356, DOI 10.1016/j.arthro.2005.09.020; Hara K, 2009, AM J SPORT MED, V37, P2386, DOI 10.1177/0363546509340404; Sakane M, 1997, J ORTHOPAED RES, V15, P285, DOI 10.1002/jor.1100150219; van Eck CF, 2010, ARTHROSCOPY, V26, P258, DOI 10.1016/j.arthro.2009.07.027; BUTLER DL, 1980, J BONE JOINT SURG AM, V62, P259; Kondo E, 2011, AM J SPORT MED, V39, P279, DOI 10.1177/0363546510392350; Lie DTT, 2007, CLIN ORTHOP RELAT R, P203, DOI 10.1097/BLO.0b013e3180314b01; Sasaki N, 2012, ARTHROSCOPY, V28, P1135, DOI 10.1016/j.arthro.2011.12.021; Edwards A, 2008, KNEE SURG SPORT TR A, V16, P29, DOI 10.1007/s00167-007-0410-0; Petersen W, 1999, ANAT EMBRYOL, V200, P325, DOI 10.1007/s004290050283; Yagi M, 2002, AM J SPORT MED, V30, P660; Yasuda K, 2004, ARTHROSCOPY, V20, P1015, DOI 10.1016/j.arthro.2004.08.010; Mochizuki T, 2014, KNEE SURG SPORT TR A, V22, P336, DOI 10.1007/s00167-013-2404-4; Forsythe B, 2010, J BONE JOINT SURG AM, V92A, P1418, DOI 10.2106/JBJS.I.00654; HEFZY MS, 1989, AM J SPORT MED, V17, P208, DOI 10.1177/036354658901700210; AMIS AA, 1991, J BONE JOINT SURG BR, V73, P260; Piefer JW, 2012, ARTHROSCOPY, V28, P872, DOI 10.1016/j.arthro.2011.11.026; Gabriel MT, 2004, J ORTHOPAED RES, V22, P85, DOI 10.1016/S0736-0266(03)00133-5; Rudy TW, 1996, J BIOMECH, V29, P1357, DOI 10.1016/0021-9290(96)00056-5; Shino K, 2008, ARTHROSCOPY, V24, P1178, DOI 10.1016/j.arthro.2008.06.010; Bernard M, 1997, Am J Knee Surg, V10, P14; BUTLER DL, 1992, J BIOMECH, V25, P511, DOI 10.1016/0021-9290(92)90091-E; Georgoalis AD, 2007, CLIN ORTHOP RELAT R, P89, DOI 10.1097/BLO.0b013e31802b4a0a; GIRGIS FG, 1975, CLIN ORTHOP RELAT R, P216; Iwahashi T, 2010, ARTHROSCOPY, V26, pS13, DOI 10.1016/j.arthro.2010.01.023; MOMMERSTEEG TJA, 1994, J ORTHOPAED RES, V12, P238, DOI 10.1002/jor.1100120213; Pinczewski LA, 2008, J BONE JOINT SURG BR, V90B, P172, DOI 10.1302/0301-620X.90B2.20104; Ristanis S, 2009, J BONE JOINT SURG AM, V91A, P2151, DOI 10.2106/JBJS.H.00940; Sidles JA, 1988, J ORTHOP RES, V6, P583; WOO SLY, 1991, AM J SPORT MED, V19, P217, DOI 10.1177/036354659101900303; Zavras TD, 1998, J BIOMECH, V31, P387, DOI 10.1016/S0021-9290(98)00019-0	35	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063	1526-3231		ARTHROSCOPY	Arthroscopy	MAR	2015	31	3					435	444		10.1016/j.arthro.2014.08.033		10	Orthopedics; Surgery	Orthopedics; Surgery	CF0JX	WOS:000352231100012		
J	Miyazaki, R; Kotani, K; Tsuzaki, K; Sakane, N; Yonei, Y; Ishii, K				Miyazaki, Ryo; Kotani, Kazuhiko; Tsuzaki, Kokoro; Sakane, Naoki; Yonei, Yoshikazu; Ishii, Kojiro			Effects of a Year-Long Pedometer-Based Walking Program on Cardiovascular Disease Risk Factors in Active Older People	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						walking; elderly; blood pressure; high-density lipoprotein cholesterol; step count	DENSITY-LIPOPROTEIN CHOLESTEROL; ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; SEASONAL-VARIATION; LIFE EXPECTANCY; LIPID-LEVELS; ADULTS; EXERCISE; HEALTH	We assessed the relationship between the number of daily steps and changes in cardiovascular disease (CVD) risk factors in a year-long pedometer-based walking program for physically active older people. A total of 36 physically active older people (68.3 +/- 5.8 years) completed this 59-week program. The CVD risk parameters were measured at baseline and at weeks 21 and 59. The mean number of steps increased by week 21 and was maintained at week 59 (approximately 10 000 steps, increase in 1500 steps from the baseline; P < .05). Following a significant reduction in body mass index at week 21, systolic blood pressure levels were significantly reduced, and high-density lipoprotein cholesterol levels were significantly increased at week 59 (P < .05). In summary, even active older people can achieve further protection against CVD risks by minor, but sustained, physical activity using pedometers for a period of more than 1 year.	[Miyazaki, Ryo; Yonei, Yoshikazu; Ishii, Kojiro] Doshisha Univ, Kyoto 6100321, Japan; [Kotani, Kazuhiko; Tsuzaki, Kokoro; Sakane, Naoki] Natl Hosp Org Kyoto Med Ctr, Kyoto, Japan	Miyazaki, R (reprint author), Doshisha Univ, Grad Sch Life & Med Sci, 1-3 Tatara Miyakodani, Kyoto 6100321, Japan.	ryoplusm@gmail.com					Inoue S, 2012, J PHYS ACT HEALTH, V9, P1117; Bonora E, 2002, DIABETES CARE, V25, P1135, DOI 10.2337/diacare.25.7.1135; Houmard JA, 2004, J APPL PHYSIOL, V96, P101, DOI 10.1152/japplphysiol.00707.2003; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Yates T, 2009, DIABETES CARE, V32, P1404, DOI 10.2337/dc09-0130; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Fitzsimons CF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-206; Xue QL, 2012, AM J EPIDEMIOL, V176, P534, DOI 10.1093/aje/kws125; Chen LJ, 2012, ASIA-PAC J PUBLIC HE, V24, P795, DOI 10.1177/1010539511404397; Opdenacker J, 2008, PREV MED, V46, P518, DOI 10.1016/j.ypmed.2008.02.017; Kodama S, 2007, ARCH INTERN MED, V167, P999, DOI 10.1001/archinte.167.10.999; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; van der Bij AK, 2002, AM J PREV MED, V22, P120, DOI 10.1016/S0749-3797(01)00413-5; Lehmann R, 2001, EUR J CLIN INVEST, V31, P37, DOI 10.1046/j.1365-2362.2001.00752.x; Aoyagi Y, 2010, EUR J APPL PHYSIOL, V109, P455, DOI 10.1007/s00421-010-1357-2; Asikainen TM, 2004, SPORTS MED, V34, P753, DOI 10.2165/00007256-200434110-00004; Ball K, 2005, J SCI MED SPORT, V8, P134, DOI 10.1016/S1440-2440(05)80004-0; Bunout D, 2003, NUTRITION, V19, P310, DOI 10.1016/S0899-9007(02)01016-X; Coombes JS, 2015, ASIA-PAC J PUBLIC HE, V27, pNP600; Davern PJ, 2009, HYPERTENSION, V54, P852, DOI 10.1161/HYPERTENSIONAHA.109.136069; Diehr P, 2010, J GERONTOL A-BIOL, V65, P982, DOI 10.1093/gerona/glq070; Franceschini G, 2001, AM J CARDIOL, V88, p9N; Kamezaki F, 2010, J ATHEROSCLER THROMB, V17, P638; KING AC, 1995, CIRCULATION, V91, P2596; Koba S, 2011, J ATHEROSCLER THROMB, V18, P833; Ministry of Health Labour and Welfare, RES 2008 NAT HLTH NU; Miyatake N, 2002, DIABETES RES CLIN PR, V58, P101, DOI 10.1016/S0168-8227(02)00129-8; Miyazaki R, 2010, ANTIAGING MED, V7, P143; Ohta M, 2005, HYPERTENS RES, V28, P779, DOI 10.1291/hypres.28.779; SEIP RL, 1993, ARTERIOSCLER THROMB, V13, P1359; Silcott NA, 2011, MED SCI SPORT EXER, V43, P1791, DOI 10.1249/MSS.0b013e318212888c; Sugiura H, 2002, BMC WOMENS HLTH, V2, P3, DOI 10.1186/1472-6874-2-3; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-80; World Health Organization, GLOB STRAT DIET PHYS	36	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					155	163		10.1177/1010539513506603		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200261		
J	Aikawa, T; Pavadhgul, P; Chongsuwat, R; Sawasdivorn, S; Boonshuyar, C				Aikawa, Tomomi; Pavadhgul, Patcharanee; Chongsuwat, Rewadee; Sawasdivorn, Siraporn; Boonshuyar, Chaweewon			Maternal Return to Paid Work and Breastfeeding Practices in Bangkok, Thailand	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						breastfeeding practices; working mother; Bangkok	WOMEN; EMPLOYMENT	This study explored the association between mothers' work-related factors and breastfeeding practices in Bangkok, Thailand. Data were collected from 84 working mothers with a child aged 6 to 24 months who visited the breastfeeding mobile clinic at a nursery goods exhibition. Thai interviewers collected data using a structured questionnaire. Analysis of the data showed that exclusive breastfeeding for 3 months was 78.6%, and for 6 months it was 38.1%. Mothers who returned to work 3 months or more after giving birth exclusively breastfed more than the mothers who returned to work in less than 3 months (crude odds ratio [OR] = 4.26, 95% confidence interval [CI] = 1.39-13.05; adjusted OR = 4.15, 95% CI = 1.15-14.95). Moreover, mothers who worked at self-employed or family-owned businesses and some mothers working at private companies showed tendencies of returning to work in less than 3 months. Results suggest that longer maternity leave would help extend the duration of exclusive breastfeeding. In addition, the improvement of a breastfeeding supportive environment in the workplace would be valuable and may be an effective means to improve breastfeeding practices and infant health.	[Aikawa, Tomomi] JICA, Nagasaki, Japan; [Pavadhgul, Patcharanee; Chongsuwat, Rewadee; Boonshuyar, Chaweewon] Mahidol Univ, Bangkok 10700, Thailand; [Sawasdivorn, Siraporn] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand	Aikawa, T (reprint author), JICA, Tanzania Off, 3rdFloor,Barclays House,1008-1 Ohio St,POB 9450, Dar Es Salaam, Tanzania.	tomopuugorou@yahoo.co.jp					Lindberg LD, 1996, J MARRIAGE FAM, V58, P239, DOI 10.2307/353392; Roe B, 1999, DEMOGRAPHY, V36, P157, DOI 10.2307/2648105; COHEN R, 1995, AM J HEALTH PROMOT, V10, P148; Kimbro RT, 2006, MATERN CHILD HLTH J, V10, P19, DOI 10.1007/s10995-005-0058-7; Barona-Vilar C, 2009, MIDWIFERY, V25, P187, DOI 10.1016/j.midw.2007.01.013; Bureau of Health Promotion Department of Health Ministry of Public Health, 2005, 2005 DEP HLTH MIN PU; Chen YC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-160; Department of Health Ministry of Public Health., 2006, EV 9 NAT HLTH PLAN; Galtry J, 2003, SOC SCI MED, V57, P167, DOI 10.1016/S0277-9536(02)00372-6; International Labor Organization, 2000, MAT PROT CONV; Knodel J, 1992, ASIA PAC POPUL J, V5, P135; Kramer M. S., 2002, OPTIMAL DURATION EXC; Li Y, 1999, PEDIATR INT, V41, P648, DOI 10.1046/j.1442-200x.1999.01149.x; MORSE JM, 1989, CAN J PUBLIC HEALTH, V80, P182; National Statistical Office, 2006, REP LAB FORC SURV; Statistical Forecasting Bureau National Statistical Office, KEY FIND 2009 REPR H; Tangcharoensathen V, 2007, DETERMINANTS CLIN PR; Thailand National Statistical Office & UNICEF, 2006, THAIL MULT IND CLUST; The World Alliance for Breastfeeding Action, 2006, STAT MAT PROT COUNTR; World Health Organization, 2003, GLOB START INF YOUNG; Yimyam S, 1999, J Hum Lact, V15, P225, DOI 10.1177/089033449901500313; Yimyam S, 1999, SOC SCI MED, V49, P957, DOI 10.1016/S0277-9536(99)00190-2	22	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP1253	NP1262		10.1177/1010539511419647		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200119		
J	Aizawa, F; Kishi, M; Aizawa, Y; Hirata, S; Ishii, T; Yonemitsu, M				Aizawa, Fumie; Kishi, Mitsuo; Aizawa, Yuzuru; Hirata, Soichiro; Ishii, Takuo; Yonemitsu, Masami			Targeting Individual Empowerment to Raise Leaders for Local Oral Health Promotion in Japan	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						oral health promotion; community leaders; rural	DENTAL-HEALTH; LIFE; PARTICIPATION; PEOPLE; COHORT	The purpose of this study was to evaluate the characteristics of human resources for health promotion advocacy in a rural community. A 16-item questionnaire was sent to 1000 residents of a rural Japanese town. Items concerned demographics, participation in organizational activities, awareness of volunteer activities, and willingness to participate in community-based oral health activities. Responses were measured on a 5-point scale. The response rate was 57.4%. To reveal potential factors from the distribution of responses, a principal component analysis was performed, and 4 components were extracted. The components were interpreted as "Municipality initiative," "Personal initiative," "Worth volunteering," and "Internal health locus of control (HLC)," respectively. The results of multiple regression analysis using the above components stratified by gender and age-group revealed that potential leaders in oral health activities in Japan are presently participating in social activities of their own accord and highly value volunteer activity. Target groups are senior males and middle-aged females.	[Aizawa, Fumie; Kishi, Mitsuo; Aizawa, Yuzuru; Yonemitsu, Masami] Iwate Med Univ, Sch Dent, Morioka, Iwate 0208505, Japan; [Hirata, Soichiro; Ishii, Takuo] Tokyo Dent Coll, Tokyo, Japan	Aizawa, F (reprint author), Iwate Med Univ, Sch Dent, Dept Dev Oral Hlth Sci, Div Oral Hlth, 1-3-27 Chuo Dori, Morioka, Iwate 0208505, Japan.	faizawa@iwate-med.ac.jp			Health and Labour Science Research Grant [H13-Health-018]; Iwate Medical University	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article:; The study was supported in part by a Health and Labour Science Research Grant (H13-Health-018) and a Grant-in-Aid from an Iwate Medical University Open Research Project (2007-2011).	Kelishadi R, 2011, ASIA-PAC J PUBLIC HE, V23, P518, DOI 10.1177/1010539509348241; Casey MM, 2001, AM J PREV MED, V21, P182, DOI 10.1016/S0749-3797(01)00349-X; ZIMMERMAN MA, 1988, AM J COMMUN PSYCHOL, V16, P725, DOI 10.1007/BF00930023; Tay JB, 2004, J EPIDEMIOL COMMUN H, V58, P904, DOI 10.1136/jech.2002.006643; ROTTER JB, 1990, AM PSYCHOL, V45, P489, DOI 10.1037//0003-066X.45.4.489; Hamalainen P, 2003, EUR J ORAL SCI, V111, P291, DOI 10.1034/j.1600-0722.2003.00055.x; Thorstensson H, 2009, COMMUNITY DENT ORAL, V37, P325, DOI 10.1111/j.1600-0528.2009.00467.x; Chen ZN, 2002, BUSINESS ADM, V52, P59; Chonko L. B., 1997, J MARKETING THEORY P, V5, P93; Christensen C, 2005, BALLETTANZ, P13; Garcia A., 2006, FAM COMMUNITY HLTH S, V29, P205; Green L. W., 2005, HLTH PROMOTION PLANN; Hamann S L, 1990, Asia Pac J Public Health, V4, P39; Heumann LF, 2001, EMPOWERING FRAIL ELD, P25; Iwate Prefecture Statistics Bureau, 2004, IW STAT YB 2003; KENT GG, 1984, J AM DENT ASSOC, V109, P67; Kitamura T, 2008, J EPIDEMIOL, V19, P237; LABONTE R, 1994, HEALTH EDUC QUART, V21, P253, DOI 10.1177/109019819402100209; Mei-Chih L, 2007, PUBLIC HLTH NURS, V24, P274; Ministry of Health Labour and Welfare, 2007, NAT OR HLTH SURV; OLSEN CB, 1986, COMMUNITY DENT ORAL, V14, P302, DOI 10.1111/j.1600-0528.1986.tb01077.x; Redwood D, 2009, AM J HEALTH PROMOT, V23, P388, DOI 10.4278/ajhp.071211130; Riesel C., 1994, HEALTH PROMOT INT, V9, P39; Wallerstein N, 1992, Am J Health Promot, V6, P197; Wolfe GR, 1996, COMMUNITY DENT ORAL, V24, P37, DOI 10.1111/j.1600-0528.1996.tb00810.x; ZIMMERMAN MA, 1990, J RES PERS, V24, P71, DOI 10.1016/0092-6566(90)90007-S	26	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP2305	NP2315		10.1177/1010539511428669		11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200214		
J	Bayarsaikhan, D; Nakamura, K				Bayarsaikhan, Dorjsuren; Nakamura, Keiko			Health Promotion Financing With Mongolia's Social Health Insurance	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						health promotion; Mongolia; social health insurance		Health promotion is receiving more attention in Mongolia. A survey is undertaken to examine health promotion in terms of health-related information, education, counseling, screening, preventive and medical checkups. Almost all (97.5%) of the subjects feel that access to reliable and systematically organized health-related information is important. About 60% of the subjects expressed that the amount of currently available information is inadequate. There are several factors that limit the implementation of public health programs. These include inadequate focus on promoting health at individual level, lack of funds, and limited incentives to promote health. This article examined social health insurance as an option to address these issues. Three hypothetical benefits package options expanded to health promotion were developed and simulated by a computerized tool. The simulations show that all 3 options are financially sustainable at the existing level of contribution if Mongolia will gain near universal health insurance coverage and improve revenue collection practices.	[Bayarsaikhan, Dorjsuren] WHO Reg Off Western Pacific, Manila, Philippines; [Bayarsaikhan, Dorjsuren; Nakamura, Keiko] Tokyo Med & Dent Univ, Grad Sch, Int Hlth & Med, Tokyo, Japan	Bayarsaikhan, D (reprint author), World Hlth Org Western Pacific Reg Off, Box 2932,United Nations Ave 1000, Manila, Philippines.	bayarsaikhand@wpro.who.int					Jackson SF, 2006, HEALTH PROMOT INT, V21, P75, DOI 10.1093/heapro/dal054; [Anonymous], 2003, INT HLTH PROM PRACT; Zarcadoolas C, 2005, HEALTH PROMOT INT, V20, P195, DOI 10.1093/heapro/dah609; [Anonymous], 2003, HLTH PROM FIN OPP W; [Anonymous], 2005, MED SMART YOUTH EAT, P61; [Anonymous], 2007, TECHN COMM MED CAR S; [Anonymous], 2005, MONG NAT HLTH ACC; [Anonymous], 2007, COUNTR HLTH INF PROF; [Anonymous], 2006, PROF INT COORD COMM; [Anonymous], 2007, 3 JOINT OECD RCHSP A; [Anonymous], 2004, ANN HLTH REP MONG; [Anonymous], 2005, SIMINS HLTH INS SIM; [Anonymous], 2003, MAKING CHOICES HLTH; [Anonymous], 2007, WEBS DAT STAT COUNTR; [Anonymous], 2004, REP INT CONS SOC INS; [Anonymous], 2004, M EC GAIN PROM HLTH; [Anonymous], 2007, ANN HLTH REP MONG; Bayarsaikhan D, 2007, 4 WHO; Bayarsaikhan D, 2004, INT SOC SECUR REV, V58, P27; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Ron A, 1990, HLTH INSURANCE DEV C; World Health Organization, 2002, WORLD HLTH REP RED R	22	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP887	NP896		10.1177/1010539509332449		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200087		
J	Hashimoto, N; Fujisawa, D; Giasuddin, NA; Kenchaiah, BK; Narmandakh, A; Dugerragchaa, K; Tamrakar, SM; Adhikari, SR; Sartorius, N				Hashimoto, Naoki; Fujisawa, Daisuke; Giasuddin, Noor Ahmed; Kenchaiah, Basanth Kumar; Narmandakh, Altanzul; Dugerragchaa, Khongorzul; Tamrakar, Sharad Man; Adhikari, Shailendra Raj; Sartorius, Norman			Pathways to Mental Health Care in Bangladesh, India, Japan, Mongolia, and Nepal	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						Bangladesh; help seeking; India; Japan; Mongolia; Nepal; pathway; psychiatry	PSYCHIATRIC-CARE; SEEKING BEHAVIOR; SYSTEM; ACCESS	Introduction: As mental health systems are still developing in many Asian countries, knowledge of the pathways to mental health care (MHC) in this region would be very important. Aims: To clarify the pathways to MHC in 5 Asian countries. Method: A total of 50 new subjects attending each institution were interviewed. Pathway diagrams, the patterns and duration of care seeking, and the previous treatment were compared. Results: Four major pathways were direct access, referrals from private practitioners, referrals from general hospitals, and referrals from native or religious healers. General practitioners did not play a pivotal role in any of the areas, whereas native or religious healers had an important place in all areas except for Yokohama, Japan. Family members had a significant impact on the decision to seek MHC. Conclusions: Studies of pathways to MHC in Asian countries are feasible and can provide data of interest in the organization of care.	[Hashimoto, Naoki] Hokkaido Univ, Sapporo, Hokkaido 0608638, Japan; [Hashimoto, Naoki; Fujisawa, Daisuke] JYPO, Tokyo, Japan; [Fujisawa, Daisuke] Natl Canc Ctr East, Kashiwa, Chiba, Japan; [Giasuddin, Noor Ahmed] Mental Hosp, Pabna, Bangladesh; [Giasuddin, Noor Ahmed; Kenchaiah, Basanth Kumar; Tamrakar, Sharad Man; Adhikari, Shailendra Raj] Assoc Young Psychiatrists & Trainees Mumbai, South Asian Assoc Reg Cooperat, Bombay, Maharashtra, India; [Kenchaiah, Basanth Kumar] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Narmandakh, Altanzul; Dugerragchaa, Khongorzul] Mongolian Natl Mental Hlth Ctr, Ulaanbaatar, Mongol Peo Rep; [Tamrakar, Sharad Man] Norv Int Hosp, Kathmandu, Nepal; [Adhikari, Shailendra Raj] Kathmandu Med Coll Teaching Hosp, Kathmandu, Nepal; [Sartorius, Norman] Assoc Improvement Mental Hlth Programs, Geneva, Switzerland	Hashimoto, N (reprint author), Hokkaido Univ, Sch Med, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	hashinao@vega.ocn.ne.jp			Pfizer Health Research; Christian Medical College, Vellore, India [22X257]	The study in Yokohama was part of a domestic collaborative study in Japan that was supported by a grant from Pfizer Health Research. The study in Vellore was funded by an intramural grant from the fluid research fund (22X257) of the Christian Medical College, Vellore, India. The studies in the other 3 areas were performed on a volunteer basis and were not supported by any grants.	ABIODUN OA, 1995, PSYCHIATR SERV, V46, P823; Amaddeo F, 2001, SOC PSYCH PSYCH EPID, V36, P500, DOI 10.1007/s001270170015; Gater R, 2005, BRIT J PSYCHIAT, V186, P529, DOI 10.1192/bjp.186.6.529; GATER R, 1991, PSYCHOL MED, V21, P761; Linden M, 2003, SOC PSYCH PSYCH EPID, V38, P690, DOI 10.1007/s00127-003-0684-6; GATER R, 1991, BRIT J PSYCHIAT, V159, P90, DOI 10.1192/bjp.159.1.90; Steel Z, 2006, AUST NZ J PSYCHIAT, V40, P347, DOI 10.1080/j.1440-1614.2006.01801.x; BALESTRIERI M, 1994, PSYCHOL MED, V24, P641; Chadda RK, 2001, INT J SOC PSYCHIATR, V47, P71, DOI 10.1177/002076400104700406; Chong SA, 2005, INT J SOC PSYCHIATR, V51, P55, DOI 10.1177/0020764005053278; Deva M P, 1999, Asia Pac J Public Health, V11, P57; Fujisawa Daisuke, 2008, Int J Ment Health Syst, V2, P14, DOI 10.1186/1752-4458-2-14; Harrison J, 1997, J PUBLIC HEALTH MED, V19, P69; KILIC C, 1994, SOC PSYCH PSYCH EPID, V29, P131; Kurihara T, 2006, PSYCHIAT CLIN NEUROS, V60, P204, DOI 10.1111/j.1440-1819.2006.01487.x; Lee Albert, 2003, Asia Pac J Public Health, V15, P62; MOODLEY P, 1991, SOC PSYCH PSYCH EPID, V26, P47, DOI 10.1007/BF00783581; Nicholas J, 2010, PERSPECT PUBLIC HEAL, V130, P86, DOI 10.1177/1757913908101797; Pawlowski T, 2004, EUR PSYCHIAT, V19, P168, DOI 10.1016/j.eurpsy.2003.09.009; REELER AP, 1992, CENT AFR J MED, V38, P1; RHI BY, 1995, INT J SOC PSYCHIATR, V41, P190, DOI 10.1177/002076409504100304; VAZQUEZBARQUERO JL, 1993, ACTA PSYCHIAT SCAND, V88, P229, DOI 10.1111/j.1600-0447.1993.tb03447.x; World Health Organization, 1992, ICD 10 CLASS MENT BE	23	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP1847	NP1857		10.1177/1010539510379395		11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200173		
J	Higuchi, M; Okumura, J; Aoyama, A; Suryawati, S; Porter, J				Higuchi, Michiyo; Okumura, Junko; Aoyama, Atsuko; Suryawati, Sri; Porter, John			Use of Medicines and Adherence to Standard Treatment Guidelines in Rural Community Health Centers, Timor-Leste	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						essential medicines; health care delivery; primary health care; standard treatment guidelines; Timor-Leste	DEVELOPING-COUNTRIES; UNCOMPLICATED MALARIA; CLINICAL GUIDELINES; CARE; IMPLEMENTATION; KNOWLEDGE; QUALITY; IMPROVE; STRATEGIES; PREDICTORS	The use of medicines and nurses'/midwives' adherence to standard treatment guidelines (STGs) were examined in Timor-Leste during the early stage of the nation's new health system development. A cross-sectional study was conducted as the quantitative element of mixed methods research. Retrospective samples from patient registration books and prospective observations were obtained in 20 randomly selected rural community health centers. The medicines use indicators, in particular the level of injection use, in Timor-Leste did not suggest overprescription. Prescribers with clinical nurse training prescribed significantly fewer antibiotics than those without such training (P < .01). The adjusted odds ratio of prescribing adherence for clinical nurse training, after accounting for confounders and prescriber clustering, was 6.6 (P < .01). STGs for nonphysician health professionals at the primary health care level have potential value in basic health care delivery, including appropriate use of medicines, in resource-limited communities when strategically developed and introduced.	[Higuchi, Michiyo; Porter, John] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Higuchi, Michiyo; Aoyama, Atsuko] Nagoya Univ, Sch Med, Nagoya, Aichi 4668550, Japan; [Okumura, Junko] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Suryawati, Sri] Gadjah Mada Univ, Sch Med, Yogyakarta, Indonesia	Higuchi, M (reprint author), Nagoya Univ, Sch Med, Dept Publ Hlth & Hlth Syst, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	m.m.higuchi@med.nagoya-u.ac.jp			Takagi Fund for Citizen Science; Dr Gordon Smith Travelling Scholarship; Toyota Foundation	The author(s) disclosed the receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Takagi Fund for Citizen Science, the Dr Gordon Smith Travelling Scholarship, and the Toyota Foundation.	Agyepong IA, 2002, SOC SCI MED, V55, P2215, DOI 10.1016/S0277-9536(01)00366-5; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Siddiqi K, 2005, INT J QUAL HEALTH C, V17, P447, DOI 10.1093/intqhc/mzi051; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253; Laing RO, 2001, HEALTH POLICY PLANN, V16, P13, DOI 10.1093/heapol/16.1.13; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1; Osterholt DM, 2006, TROP MED INT HEALTH, V11, P1147, DOI 10.1111/j.1365-3156.2006.01666.x; Boonstra E, 2003, QUAL SAF HEALTH CARE, V12, P168, DOI 10.1136/qhc.12.3.168; Chalker J, 1995, HEALTH POLICY PLANN, V10, P423, DOI 10.1093/heapol/10.4.423; Chan YM, 1999, J ADV NURS, V30, P431; Flores S, 2006, FAM MED, V38, P511; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Groom A, 1998, WHODAP9814; Higuchi M., 2008, IMPROVING USE MED CO; Higuchi M, 2012, HEALTH POLICY PLANN, V27, P396, DOI 10.1093/heapol/czr051; Holloway KA, 2001, TROP MED INT HEALTH, V6, P151, DOI 10.1046/j.1365-3156.2001.00695.x; International Network for the Rational Use of Drugs World Health Organization, 1993, WHODAP931 INT NETW R; Lu CY, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-75; Miles K, 2006, INT NURS REV, V53, P290, DOI 10.1111/j.1466-7657.2006.00491.x; Ministry of Health Timor-Leste, 2002, E TIM HLTH POL FRAM; Ministry of Health Timor-Leste, 2004, ESS MED LIST E TIM C; Ponnusankar S, 2004, PATIENT EDUC COUNS, V54, P55, DOI 10.1016/s0738-3991(03)00193-9; Quick JD, 2003, HEALTH POLICY PLANN, V18, P1, DOI 10.1093/heapol/18.1.1; Soltani A, 2004, Evid Based Ment Health, V7, P64; Stark R, 1999, NURS ETHICS, V6, P273, DOI 10.1177/096973309900600402; Thomas LH, 1998, QUAL HEALTH CARE, V7, P183; Wiedenmayer KA, 2004, MANAGING PHARM INT H, P141; World Health Organisation, 2009, MED US PRIM CAR DEV; World Health Organization, 2002, WHOEDM20023	31	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP2498	NP2511		10.1177/1010539512444306		14	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200232		
J	Hirayama, F; Lee, AH				Hirayama, Fumi; Lee, Andy H.			Association Between Childhood Asthma and Chronic Obstructive Pulmonary Disease in Later Life	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						case-control studies; lung function; retrospective recall; risk factors; smoking	ADULTS	Persistent chronic inflammation and impaired lung growth due to asthma in childhood may have long-term impact on pulmonary function and increase susceptibility to chronic obstructive pulmonary disease (COPD) in later life. To investigate whether childhood asthma is associated with adult lung function and the risk of developing COPD among Japanese older adults, a case-control study was conducted in central Japan. A total of 300 patients with COPD aged 50 to 75 years were referred by respiratory physicians, while 400 controls were recruited from the community. All participants underwent spirometric measurements of lung function. Information on childhood asthma, demographic characteristics, and lifestyle characteristics was obtained by face-to-face interview using a structured questionnaire. The prevalence of childhood asthma was higher (P = .015) among the cases (6.3%) than among the control group (2.4%). Childhood asthma was significantly associated with the risk of COPD (adjusted odds ratio 3.32, 95% confidence interval 1.05-10.45). Participants with childhood asthma had lower (P = .010) forced expiratory volume in 1 second (mean 1.63 L, standard deviation [SD] 0.64 L) than those without (mean 2.04 L, SD 0.75 L). However, the adjusted lung function difference did not attain statistical significance after controlling for confounding variables such as age and cumulative smoking exposure. The epidemiological evidence suggested a positive association between childhood asthma and COPD in later life. Further study of the effect of adequate childhood asthma treatment on future risk of COPD should be undertaken.	[Hirayama, Fumi] Kyushu Univ, Fukuoka 812, Japan; [Lee, Andy H.] Curtin Univ, Perth, WA 6845, Australia	Lee, AH (reprint author), Curtin Univ, Sch Publ Hlth, GPO Box U 1987, Perth, WA 6845, Australia.	andy.lee@curtin.edu.au					Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Silva GE, 2004, CHEST, V126, P59, DOI 10.1378/chest.126.1.59; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Strunk RC, 2006, J ALLERGY CLIN IMMUN, V118, P1040, DOI 10.1016/j.jaci.2006.07.053; de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC; Bakke P S, 2003, Monaldi Arch Chest Dis, V59, P103; Braman S. S., 2006, CHEST, V130, p4S; Editorial, 2009, LANCET, V374, P663; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hirayama Fumi, 2008, Expert Rev Respir Med, V2, P645, DOI 10.1586/17476348.2.5.645; Liang WB, 2015, ASIA-PAC J PUBLIC HE, V27, pNP248, DOI 10.1177/1010539512439229; O'Brien Cousins S, 2002, PHYS OCCUP THER GERI, V20, P51; Shirtcliffe P, 2012, INTERN MED J, V42, P83, DOI 10.1111/j.1445-5994.2010.02238.x; Svanes C, 2008, INDOOR AIR, V18, P84, DOI 10.1111/j.1600-0668.2008.00523.x; The Japanese Respiratory Society, 2004, DIAGN GUID DIAGN TRE, P6; Van Sickle D, 2010, ASIA-PAC J PUBLIC HE, V22, p229S, DOI 10.1177/1010539510373129; WHO, CHRON OBSTR PULM DIS	17	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP1273	NP1279		10.1177/1010539512458953		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200121		
J	Kakehi, E; Kotani, K; Ishikawa, S; Gotoh, T; Kayaba, K; Nakamura, Y; Kajii, E				Kakehi, Eiichi; Kotani, Kazuhiko; Ishikawa, Shizukiyo; Gotoh, Tadao; Kayaba, Kazunori; Nakamura, Yosikazu; Kajii, Eiji			Serum Non-High-Density Lipoprotein Cholesterol Levels and the Incidence of Ischemic Stroke in a Japanese Population: The Jichi Medical School Cohort Study	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						ischemic stroke; ischemic stroke subtypes; non-high-density lipoprotein cholesterol; population-based survey	CORONARY-HEART-DISEASE; NON-HDL CHOLESTEROL; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CEREBRAL INFARCTION; VASCULAR-DISEASE; INCIDENCE RATES; LIPID-LEVELS; SUBTYPES; WOMEN	The predictive value of serum non-high-density lipoprotein cholesterol (non-HDL-C) levels for the incidence of ischemic stroke and its subtypes has not yet been established. The present cohort study investigated their relationships in a Japanese population. The first incidence of ischemic stroke and its subtypes was documented as the primary outcome. A total of 249 ischemic stroke patients (men/women = 145/104) were identified during a follow-up period of 10.7 years among 10 760 community-dwelling subjects (men/women = 4212/6548). Cox proportional hazard model analyses revealed that when compared with the lowest tertile of non-HDL-C, multivariate-adjusted hazard ratios for the highest tertile were 0.55 (95% confidence interval = 0.32-0.95, P =.03) on ischemic stroke and 0.29 (95% confidence interval = 0.08-1.05, P =.06) on cardioembolic infarction in women. Men did not show such significant relationships. Low serum non-HDL-C levels may be a predictive marker associated with an increase in the incidence of ischemic stroke and possibly of cardioembolic infarction in Japanese women.	[Kakehi, Eiichi; Kotani, Kazuhiko; Ishikawa, Shizukiyo; Nakamura, Yosikazu; Kajii, Eiji] Jichi Med Univ, Shimotuke City, Tochigi, Japan; [Gotoh, Tadao] Wara Natl Hlth Insurance Clin, Gifu, Japan; [Kayaba, Kazunori] Saitama Prefectural Univ, Saitama, Japan	Ishikawa, S (reprint author), Jichi Med Univ, Ctr Community Med, 3311-1 Yakushiji, Shimotuke City, Tochigi, Japan.	i-shizu@jichi.ac.jp			Foundation for the Development of the Community, Tochigi, Japan; Japan Health and Research Institute, Tokyo, Japan	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the Foundation for the Development of the Community, Tochigi, Japan, and the Japan Health and Research Institute, Tokyo, Japan.	Segrest JP, 2001, J LIPID RES, V42, P1346; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONHA.104.532499; Woo D, 1999, STROKE, V30, P2517; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; Holme I, 2009, J INTERN MED, V265, P275, DOI 10.1111/j.1365-2796.2008.02016.x; Tanizaki Y, 2000, STROKE, V31, P2616; Arsenault BJ, 2009, J AM COLL CARDIOL, V55, P35, DOI 10.1016/j.jacc.2009.07.057; Noda H, 2010, J ATHEROSCLER THROMB, V17, P30; Tanabe N, 2010, CIRC J, V74, P1346, DOI 10.1253/circj.CJ-09-0861; Okamura T, 2009, ATHEROSCLEROSIS, V203, P587, DOI 10.1016/j.atherosclerosis.2008.07.020; Liu J, 2006, AM J CARDIOL, V98, P1363, DOI 10.1016/j.amjcard.2006.06.032; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ohira T, 2006, STROKE, V37, P2493, DOI 10.1161/01.STR.0000239694.19359.88; Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413; [Anonymous], 1990, STROKE, V21, P637; Bang OY, 2008, NEUROLOGY, V70, P841, DOI 10.1212/01.wnl.0000294323.48661.a9; Petty GW, 1999, STROKE, V30, P2513; Kurth T, 2007, NEUROLOGY, V68, P556, DOI 10.1212/01.wnl.0000254472.41810.0d; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993; Kubo M, 2006, NEUROLOGY, V66, P1539, DOI 10.1212/01.wnl.0000216132.95207.b4; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Schneider AT, 2004, STROKE, V35, P1552, DOI 10.1161/01.STR.0000129335.28301.f5; Kawamoto R, 2005, J ATHEROSCLER THROMB, V12, P143; Everett BM, 2006, J AM COLL CARDIOL, V48, P2235, DOI 10.1016/j.jacc.2006.09.030; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ishikawa Shizukiyo, 2002, J Epidemiol, V12, P408; Leys D, 2002, J NEUROL, V249, P507, DOI 10.1007/s004150200057; Lu WQ, 2003, DIABETES CARE, V26, P16, DOI 10.2337/diacare.26.1.16; Packard Chris J, 2004, J Atheroscler Thromb, V11, P6; Shepherd J, 2001, CURR OPIN LIPIDOL, V12, P601, DOI 10.1097/00041433-200112000-00002; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; World Bank Institute, PUBL HLTH INS JAP; Xydakis AM, 2003, CURR OPIN CARDIOL, V18, P503, DOI 10.1097/00001573-200311000-00012	33	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP535	NP543		10.1177/1010539513475649		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200052		
J	Kaneda, Y; Ishikawa, S; Sadakane, A; Gotoh, T; Kayaba, K; Yasuda, Y; Kajii, E				Kaneda, Yuji; Ishikawa, Shizukiyo; Sadakane, Atsuko; Gotoh, Tadao; Kayaba, Kazunori; Yasuda, Yoshikazu; Kajii, Eiji			Insulin Resistance and Risk of Cerebral Infarction in a Japanese General Population: The Jichi Medical School Cohort Study	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						cerebral infarction; insulin resistance; homeostasis model assessment for insulin resistance; cohort study; Japan	HOMEOSTASIS MODEL ASSESSMENT; C-REACTIVE PROTEIN; ISCHEMIC-STROKE; PLASMINOGEN-ACTIVATOR; GLUCOSE-TOLERANCE; FIBRINOGEN; SENSITIVITY; HYPERINSULINEMIA; ATHEROSCLEROSIS; ROTTERDAM	The aim of the study was to investigate the relation between insulin resistance and risk of cerebral infarction in a Japanese general population. The subjects were 2610 men and women without past history of stroke or myocardial infarction and who were under treatment for diabetes. Subjects were divided into quartiles by the homeostasis model assessment of insulin resistance (HOMA-IR), and Cox's proportional hazard model was used to calculate hazard ratios (HRs) for cerebral infarction. In men, the multivariate-adjusted HRs were 2.51 (95% confidence interval [CI] = 0.98-6.42) in quartile 1 (Q1), 1.43 (95% CI = 0.54-3.82) in Q2, and 2.13 (95% CI = 0.82-5.51) in Q4, using Q3 as the reference. In women, the multivariate-adjusted HRs were 2.12 (95% CI = 0.72-6.31) in Q1, 2.96 (95% CI = 1.06-8.26) in Q3, and 2.31 (95% CI = 0.80-6.69) in Q4, using Q2 as the reference. The association between risk of cerebral infarction and HOMA-IR was not dose dependent.	[Kaneda, Yuji; Ishikawa, Shizukiyo; Sadakane, Atsuko; Yasuda, Yoshikazu; Kajii, Eiji] Jichi Med Univ, Shimotsuke, Tochigi 3290498, Japan; [Gotoh, Tadao] Wara Natl Hlth Insurance Clin, Gifu, Japan; [Kayaba, Kazunori] Saitama Prefectural Univ, Saitama, Japan	Kaneda, Y (reprint author), Jichi Med Univ, Dept Surg, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	ykaneda819@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Foundation for the Development of the Community, Tochigi, Japan	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by grants from the Foundation for the Development of the Community, Tochigi, Japan.	Adachi H, 2001, DIABETES RES CLIN PR, V51, P215, DOI 10.1016/S0168-8227(00)00236-9; Cohen A, 1997, CIRCULATION, V96, P3838; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Hollander M, 2003, STROKE, V34, P2367, DOI 10.1161/01.STR.0000091393.32060.0E; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Byberg L, 1998, ARTERIOSCL THROM VAS, V18, P258; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; MOLLER DE, 1991, NEW ENGL J MED, V325, P938; Nakamura K, 2010, DIABETOLOGIA, V53, P1894, DOI 10.1007/s00125-010-1803-z; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Wieberdink RG, 2012, AM J EPIDEMIOL, V176, P699, DOI 10.1093/aje/kws149; Kario K, 2001, J AM COLL CARDIOL, V37, P871, DOI 10.1016/S0735-1097(00)01172-4; Rundek T, 2010, ARCH NEUROL-CHICAGO, V67, P1195, DOI 10.1001/archneurol.2010.235; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Festa A, 1999, ARTERIOSCL THROM VAS, V19, P562; Bravata DM, 2005, NEUROEPIDEMIOLOGY, V25, P69, DOI 10.1159/000086286; Ishikawa Shizukiyo, 2002, J Epidemiol, V12, P408; Ishikawa S, 2007, CIRC J, V71, P26, DOI 10.1253/circj.71.26; Iyigun I, 2002, J INT MED RES, V30, P591; Kain K, 2002, THROMB HAEMOSTASIS, V88, P950; Kernan WN, 2002, NEUROLOGY, V59, P809; Mennen LI, 1999, THROMB HAEMOSTASIS, V82, P1106; Park Hyun-Young, 2008, J Stroke Cerebrovasc Dis, V17, P401, DOI 10.1016/j.jstrokecerebrovasdis.2008.06.004; Parry DJ, 2006, BRIT J SURG, V93, P315, DOI 10.1002/bjs.5270; Rudnicka AR, 2006, J THROMB HAEMOST, V4, P2405, DOI 10.1111/j.1538-7836.2006.02221.x; Shinozaki K, 1996, STROKE, V27, P37; Zunker P, 1999, NEUROL RES, V21, P727	27	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP572	NP579		10.1177/1010539513480233		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200056		
J	Kita, F; Hinotsu, S; Yorifuji, T; Urushihara, H; Shimakawa, T; Kishida, K; Wakazono, Y; Yamauchi, E; Sasaki, H; Nakahata, T; Kawakami, K				Kita, Fumiyo; Hinotsu, Shiro; Yorifuji, Tohru; Urushihara, Hisashi; Shimakawa, Tetsuro; Kishida, Kenji; Wakazono, Yoshihiro; Yamauchi, Eiko; Sasaki, Hiroshi; Nakahata, Tatsutoshi; Kawakami, Koji			Domperidone With ORT in the Treatment of Pediatric Acute Gastroenteritis in Japan: A Multicenter, Randomized Controlled Trial	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						antiemetics; children; gastroenteritis; oral rehydration treatment; randomized clinical study	ORAL ONDANSETRON; ANTIEMETIC USE; CHILDREN; METOCLOPRAMIDE; SUPPOSITORIES; DEHYDRATION; DIARRHEA; NAUSEA	Domperidone is an antiemetic that is often prescribed for children with acute gastroenteritis in Japan. In this study, the authors assessed the efficacy of domperidone prescription in combination with oral rehydration treatment (ORT) in the treatment of vomiting during acute gastroenteritis in children during the early period. They performed a prospective multicenter randomized trial in Japan. Patients received either ORT or ORT and domperidone prescription. The primary outcome was the proportion of patients who had vomiting during the first 2 hours after randomization. A total of 56 children were eligible; 24 received ORT alone, and 32 received ORT and prescribed domperidone suppository. Results showed that 27.3% of children in the ORT group vomited as compared with 20.7% of children in the ORT and domperidone group (P = .41). In this study, it appears that domperidone in combination with ORT in the treatment of acute gastroenteritis does not reduce vomiting in the early period.	[Kita, Fumiyo; Hinotsu, Shiro; Urushihara, Hisashi; Nakahata, Tatsutoshi; Kawakami, Koji] Kyoto Univ, Kyoto 6068501, Japan; [Yorifuji, Tohru; Nakahata, Tatsutoshi] Kyoto Univ Hosp, Kyoto 606, Japan; [Shimakawa, Tetsuro] Rakuwakai Otowa Hosp, Kyoto, Japan; [Kishida, Kenji] Takeda Gen Hosp, Kyoto, Japan; [Wakazono, Yoshihiro] Kyoto Katsura Hosp, Kyoto, Japan; [Yamauchi, Eiko] Yamauchi Clin, Kyoto, Japan; [Sasaki, Hiroshi] Sasaki Pediat Clin, Kyoto, Japan	Kawakami, K (reprint author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Sakyo Ku, Kyoto 6068501, Japan.	kawakami.koji.4e@kyoto-u.ac.jp			Inamori Foundation, Kyoto, Japan	The author(s) disclosed receipt of the following financial support for the research and/or authorship of this article: the Inamori Foundation (2009), Kyoto, Japan, supported this work.	Albano F, 2006, J PEDIATR GASTR NUTR, V43, P402, DOI 10.1097/01.mpg.0000232571.56397.0d; Alhashimi D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005506.pub3; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Parashar UD, 2003, EMERG INFECT DIS, V9, P565; Cubeddu LX, 1997, ALIMENT PHARM THERAP, V11, P185, DOI 10.1046/j.1365-2036.1997.97269000.x; DHONDT F, 1978, CURR THER RES CLIN E, V24, P912; Freedman SB, 2006, NEW ENGL J MED, V354, P1698, DOI 10.1056/NEJMoa055119; Infectious Disease Surveillance Center (IDSC) Japan, JAP INF DIS WEEKL RE; Jafri S, 2001, GOODMAN GILMANS PHAR, P1029; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Kita F, 2010, J CLIN PHARM THER, V35, P87, DOI 10.1111/j.1365-2710.2009.01074.x; Konno M., 2006, TODAYS THERAPY PEDIA, P336; Kwon KT, 2002, CLIN PEDIATR, V41, P641, DOI 10.1177/000992280204100902; Li STT, 2003, ARCH PEDIAT ADOL MED, V157, P475, DOI 10.1001/archpedi.157.5.475; MacDonald SE, 2007, ASIA-PAC J PUBLIC HE, V19, P34, DOI 10.1177/10105395070190010701; MADEJ TH, 1986, BRIT J ANAESTH, V58, P884, DOI 10.1093/bja/58.8.884; Pahwa S, 2010, J HEALTH POPUL NUTR, V28, P553; Patterson D, 1999, AM J GASTROENTEROL, V94, P1230; Pfeil N, 2008, J PEDIATR, V153, P659, DOI 10.1016/j.jpeds.2008.07.050; Ramsook C, 2002, ANN EMERG MED, V39, P397, DOI 10.1067/mem.2002.122706; Reid SR, 1996, ANN EMERG MED, V28, P318, DOI 10.1016/S0196-0644(96)70032-X; Sastry N, 2011, POPUL RES POLICY REV, V30, P81, DOI 10.1007/s11113-010-9179-9; Sawant Prabha, 2004, J Assoc Physicians India, V52, P626; VANEYGEN M, 1979, POSTGRAD MED J, V55, P36; WalkerSmith JA, 1997, J PEDIATR GASTR NUTR, V24, P619, DOI 10.1097/00005176-199705000-00024; World Health Organization, 2005, TREATM DIARRH MAN PH; Yadav H, 2000, Asia Pac J Public Health, V12, P1; Yashiro K, 1981, JPN J PEDIAT, V34, P1137	28	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP174	NP183		10.1177/1010539511425701		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200016		
J	Liu, Y; Zhang, Y; Arai, A; Obayashi, Y; Tamashiro, H				Liu, Yan; Zhang, Ying; Arai, Asuna; Obayashi, Yoshihide; Tamashiro, Hiko			Gender-Based Seasonality of Suicide in Japan, 2005-2012	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						The Great East Japan Earthquake; Japan; seasonality; suicide; population health; public health	SEX DIFFERENCE; POPULATION; EARTHQUAKE; TAIWAN; MEDIA; PREVENTION; EXPERIENCE; CLIMATE; RATES; WOMEN	This study aimed to explore the gender-based seasonal patterns of suicide in Japan between 2005 and 2012. With data from Japanese official reports, we carried out Prais-Winsten regression and Wilcoxon signed-rank test analysis with Stata 12.0 and SPSS 14.0. The suicide number was significantly higher in March, April, May, June, July, and October for both genders. The suicide number in men was markedly higher than that in women in every month. The suicide number in 2010 was lower than that in 2009 for men, while that in 2011 was higher than that in 2010 for women. The findings displayed that the nationwide television and publicity intervention campaigns might have positive effects on decreasing suicide of men while women suffered a post-earthquake increase. In terms of interventions, we should not only square up the seasonal patterns but also the gender differences in vulnerability.	[Liu, Yan; Arai, Asuna; Obayashi, Yoshihide; Tamashiro, Hiko] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Zhang, Ying] Univ Sydney, Sydney, NSW 2006, Australia	Tamashiro, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Global Hlth & Epidemiol, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.	tamashiro@med.hokudai.ac.jp			China Scholarship Council; Hokkaido University	This study was supported by the China Scholarship Council and Hokkaido University.	Ajdacic-Gross V, 2007, AM J EPIDEMIOL, V165, P561, DOI 10.1093/aje/kwk034; Ajdacic-Gross V, 2010, SOC SCI MED, V71, P657, DOI 10.1016/j.socscimed.2010.05.030; Preti A, 1998, PSYCHIAT RES, V81, P219, DOI 10.1016/S0165-1781(98)00099-7; Woo JM, 2012, INT J ENV RES PUB HE, V9, P531, DOI 10.3390/ijerph9020531; Christodoulou C, 2012, ACTA PSYCHIAT SCAND, V125, P127, DOI 10.1111/j.1600-0447.2011.01750.x; Sisask M, 2012, INT J ENV RES PUB HE, V9, P123, DOI 10.3390/ijerph9010123; KEVAN SM, 1980, SOC SCI MED-MED GEOG, V14, P369, DOI 10.1016/0160-8002(80)90005-2; Lee HC, 2006, J AFFECT DISORDERS, V92, P221, DOI 10.1016/j.jad.2006.01.026; Bando DH, 2009, REV BRAS PSIQUIATR, V31, P101, DOI 10.1590/S1516-44462009000200004; Bauer M, 2009, J AFFECT DISORDERS, V116, P152, DOI 10.1016/j.jad.2008.11.013; Blasco-Fontecilla H, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000785; Cabinet Office Government of Japan, 2011, WHIT PAP SUIC PREV P; Chou FHC, 2007, PSYCHIAT CLIN NEUROS, V61, P370, DOI 10.1111/j.1440-1819.2007.01688.x; De Vriese SR, 2004, PROSTAGLANDINS LEUKO, V71, P3; Fushimi M, 2013, COMMUNITY MENT HLT J, V49, P236, DOI 10.1007/s10597-012-9542-x; Ho TP, 1997, ACTA PSYCHIAT SCAND, V95, P26, DOI 10.1111/j.1600-0447.1997.tb00369.x; Hyodo K, 2010, TOHOKU J EXP MED, V220, P149, DOI 10.1620/tjem.220.149; Krug EG, 1999, NEW ENGL J MED, V340, P148, DOI 10.1056/NEJM199901143400213; McCurry J, 2008, LANCET, V371, P2071, DOI 10.1016/S0140-6736(08)60900-9; MEARES R, 1981, BRIT J PSYCHIAT, V138, P321, DOI 10.1192/bjp.138.4.321; MICCIOLO R, 1989, PSYCHOL MED, V19, P199; Milić Caslav, 2011, Med Pregl, V64, P202; Motohashi Y, 2012, LANCET, V379, P1282, DOI 10.1016/S0140-6736(11)61130-6; Nader IW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017413; National Police Agency of Japan, 2012, EM DIS COUNT HEADQ 2; NAYHA S, 1983, ACTA PSYCHIAT SCAND, V67, P32, DOI 10.1111/j.1600-0447.1983.tb00328.x; Niederkrotenthaler T, 2010, BRIT J PSYCHIAT, V197, P234, DOI 10.1192/bjp.bp.109.074633; Nishio A, 2009, PSYCHIAT CLIN NEUROS, V63, P247, DOI 10.1111/j.1440-1819.2009.01942.x; Reutfors J, 2009, J AFFECT DISORDERS, V119, P59, DOI 10.1016/j.jad.2009.02.020; Rihmer Z, 1998, PSYCHIAT RES, V81, P233, DOI 10.1016/S0165-1781(98)00106-1; Ruuhela R, 2009, INT J BIOMETEOROL, V53, P167, DOI 10.1007/s00484-008-0200-5; Sato T, 2001, BRIT J PSYCHIAT, V178, P183; Tsai JF, 2010, SUICIDE LIFE-THREAT, V40, P81, DOI 10.1521/suli.2010.40.1.81; Yip PSF, 2000, BRIT J PSYCHIAT, V177, P366, DOI 10.1192/bjp.177.4.366	34	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP1999	NP2007		10.1177/1010539513491420		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200187		
J	Mizumoto, K; Takahashi, T; Kinoshita, Y; Higuchi, M; Bachroen, C; Da Silva, V				Mizumoto, Kaori; Takahashi, Toru; Kinoshita, Yuri; Higuchi, Michiyo; Bachroen, Cholis; Da Silva, Valente			A Qualitative Study of Risk Factors Related to Child Malnutrition in Aileu District, Timor-Leste	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						child malnutrition; diarrhea; breast-feeding; sanitary environment; Timor-Leste	INTESTINAL MICROBIOTA; EXOCRINE PANCREAS; FED INFANTS; HEALTH; DIARRHEA; ILLNESS	Improvement in child nutritional status is one of the major health priorities in Timor-Leste. A qualitative study was conducted in Aileu District, adjacent to the capital of Timor-Leste, Dili, in September 2010 to determine the possible risk factors associated with the high prevalence of child malnutrition. In-depth interviews were conducted to 32 guardians of children aged younger than 5 years. It was observed that early termination of exclusive breast-feeding and a short lactation period along with an unsanitary living environment were associated with the nutritional status of children in the study area. Although previous surveys have reported poor food security conditions in the country, no statements from the subjects supported this contention. The identified possible risk factors for child malnutrition were closely linked to each other and were mostly modifiable.	[Mizumoto, Kaori; Takahashi, Toru] Fukuoka Womens Univ, Fac Human Environm Sci, Fukuoka 8138529, Japan; [Kinoshita, Yuri] Shizuoka Eiwa Gakuin Univ Jr Coll, Dept Food Sci, Shizuoka, Japan; [Higuchi, Michiyo] Nagoya Univ, Sch Med, Nagoya, Aichi 466, Japan	Mizumoto, K (reprint author), Fukuoka Womens Univ, Fac Human Environm Sci, Higashi Ku, 1-1-1 Kasumigaoka, Fukuoka 8138529, Japan.	mizumoto@fwu.ac.jp			Fukuoka Women's University Research Funds	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Fukuoka Women's University Research Funds.	Amarri S, 2006, J PEDIATR GASTR NUTR, V42, P488, DOI 10.1097/01.mpg.0000221907.14523.6d; LEBENTHAL E, 1980, PEDIATRICS, V66, P556; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; SULLIVAN PB, 1992, J PEDIATR GASTR NUTR, V14, P208, DOI 10.1097/00005176-199202000-00016; [Anonymous], 2008, SIT ASS AN CHILDR WO; Inoue R, 2005, J GEN APPL MICROBIOL, V51, P257, DOI 10.2323/jgam.51.257; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Baclig P V, 1990, Asia Pac J Public Health, V4, P59; Bernard HR., 2000, SOCIAL RES METHODS; Bogue D. J., 1993, READINGS POPULATION; Conger JA, 1998, LEADERSHIP QUART, V9, P107, DOI 10.1016/S1048-9843(98)90044-3; Creswell J, 2007, DESIGNING CONDUCTING; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Glaser B., 1967, DISCOVERY GROUNDED T; Goldman N, 2000, TROP MED INT HEALTH, V5, P145, DOI 10.1046/j.1365-3156.2000.00527.x; Green LW, 1999, HLTH PROMOTION PLANN; Guest G, 2006, FIELD METHOD, V2, P161; Keusch GT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P371; Martins N, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-13; Ministry of Finance, 2010, POP HOUS CENS 2010; Ministry of Health, 2008, STRENGTH COMM AR HLT; Ministry of Health, 2004, NAT NUTR STRAT; Ministry of Health National Statistics Office University of Newcastle Australian National University ACIL Australia Pty Ltd, 2003, TIM LEST 2003 DEM HL; National Directorate of Water and Sanitation Services Ministry of Health, 2007, SURV LIV STAND 2007; National Statistics Directorate, 2007, TIM LEST SURV LIV ST; National Statistics Directorate Ministry of Finance ICF Macro, 2010, TIM LEST DEM HLTH SU; Oddy Wendy H, 2002, Expert Rev Pharmacoecon Outcomes Res, V2, P161, DOI 10.1586/14737167.2.2.161; Oddy Wendy H, 2002, Breastfeed Rev, V10, P5; Parrett AM, 2000, P NUTR SOC, V59, p64A; Patton M. Q., 2001, QUALITATIVE RES EVAL; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; United Nations, 2011, MILL DEV GOALS REP 2; United Nations Children's Fund, E AS PAC; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; World Food Programme, 2005, FOOD INS VULN AN TIM; World Health Organisation (WHO), 2009, POP BAS PREV STRAT C; World Health Organization, 1978, PRIM HLTH CAR REP IN; Yoder PS, 1996, SOC SCI MED, V43, P429, DOI 10.1016/0277-9536(95)00408-4; ZOPPI G, 1972, PEDIATR RES, V6, P880, DOI 10.1203/00006450-197212000-00005	40	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP1398	NP1408		10.1177/1010539513486175		11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200133		
J	Omori, T; Kawagoe, M; Moriyama, M; Yasuda, T; Ito, Y; Hyakuta, T; Nagatsuka, K; Matsumoto, M				Omori, Toyonori; Kawagoe, Masahiro; Moriyama, Michiko; Yasuda, Takeshi; Ito, Yasuhiro; Hyakuta, Takeshi; Nagatsuka, Kazuyuki; Matsumoto, Masayasu			Multifactorial Analysis of Factors Affecting Recurrence of Stroke in Japan	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						ischemic stroke; mRS; stroke recurrence; risk factors; NIHSS	TRANSIENT ISCHEMIC ATTACK; LONG-TERM RISK; NORTHERN MANHATTAN; COMMUNITY STROKE; EVER STROKE; EDUCATION; SUBTYPES; IMPACT	Data on factors affecting stroke recurrence are relatively limited. The authors examined potential factors affecting stroke recurrence, retrospectively. The study participants were 1087 patients who were admitted to stroke centers suffering from first-ever ischemic stroke and returned questionnaires with usable information after discharge. The authors analyzed the association between clinical parameters of the patients and their prognosis. Recurrence rate of during an average of 2 years after discharge was 21.3%, and there were differences among stroke subtypes. It was found that the disability level of the patients after discharge correlated well with the level at discharge (r(s) = 0.66). Multivariate logistic regression analysis of the data shows that modified Rankin Scale score, National Institute of Health Stroke Scale score, gender, age, and family history had statistically significant impacts on stroke recurrence, and the impact was different depending on subtypes. These findings suggest that aggressive and persistent health education for poststroke patients and management of risk factors are essential to reduce stroke recurrence.	[Omori, Toyonori] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Kawagoe, Masahiro] Natl Inst Populat & Social Secur Res, Tokyo, Japan; [Moriyama, Michiko; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Hlth Sci, Hiroshima, Japan; [Yasuda, Takeshi; Ito, Yasuhiro] Toyota Mem Hosp, Toyota, Japan; [Hyakuta, Takeshi] Japanese Red Cross Hiroshima Coll Nursing, Hiroshima, Japan; [Nagatsuka, Kazuyuki] Natl Cardiovasc Res Ctr, Osaka, Japan	Omori, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	t-omori@med.nagoya-cu.ac.jp			Ministry of Health, Labour and Welfare of Japan [21171401]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare (21171401) of Japan,	Aekplakorn W, 2011, ASIA-PAC J PUBLIC HE, V23, P792, DOI 10.1177/1010539511424482; Xu GL, 2007, CEREBROVASC DIS, V23, P117, DOI 10.1159/000097047; BROTT T, 1989, STROKE, V20, P864; Toyoda K, 2007, CEREBROVASC DIS, V24, P289, DOI 10.1159/000105682; SUZUKI K, 1987, STROKE, V18, P402; Lin HJ, 2011, NEUROLOGY, V76, P438, DOI 10.1212/WNL.0b013e31820a0cd8; VANSWIETEN JC, 1988, STROKE, V19, P604; BURN J, 1994, STROKE, V25, P333; Hankey GJ, 1998, STROKE, V29, P2491; Coull AJ, 2004, BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Dhamoon MS, 2010, NEUROLOGY, V75, P328, DOI 10.1212/WNL.0b013e3181ea9f03; Mohan KM, 2009, J NEUROL NEUROSUR PS, V80, P1012, DOI 10.1136/jnnp.2008.170456; Dhamoon MS, 2006, NEUROLOGY, V66, P641, DOI 10.1212/01.wnl.0000201253.93811.f6; Petty GW, 2000, STROKE, V31, P1062; Friday G, 2002, STROKE, V33, P2652, DOI 10.1161/01.STR.0000033929.62136.6F; Hata J, 2005, J NEUROL NEUROSUR PS, V76, P368, DOI 10.1136/jnnp.2004.038166; Hirayama Takehisa, 2010, J Multidiscip Healthc, V3, P97; Hoshino H, 2004, JPN J STROKE, V20, P349; Hsu HC, 2011, ASIA-PAC J PUBLIC HE, V23, P458, DOI 10.1177/1010539511412575; Lai SL, 2002, EUR NEUROL, V60, P2114; LAI SM, 1994, STROKE, V25, P958; Wolf PA, 1999, STROKE, V30, P1991; Yokota C, 2004, CEREBROVASC DIS, V18, P111, DOI 10.1159/000079258	23	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP333	NP340		10.1177/1010539512441821		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200032		
J	Onishi, K; Otani, S; Yoshida, A; Mu, HS; Kurozawa, Y				Onishi, Kazunari; Otani, Shinji; Yoshida, Atsushi; Mu, Haosheng; Kurozawa, Youichi			Adverse Health Effects of Asian Dust Particles and Heavy Metals in Japan	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						aerosol; Asian dust; epidemiological study; health survey; Kosa; soil chemistry; suspended particulate matter	STORM EVENTS; DAILY MORTALITY; SAND DUST; TAIWAN; TAIPEI; SYMPTOMS; VISITS; ASTHMA; AIRWAY; IMPACT	Asian dust events are now considered an environmental problem rather than a natural seasonal phenomenon. In this study, we evaluated the associations between daily adverse health effects and Asian dust events in Yonago, Japan. Participants included 54 healthy volunteers, who were distributed survey sheets on nasal, ocular, respiratory, and skin effects in February 2009. Moreover, we collected meteorological and air pollutant (nitric oxide, sulfur dioxide, suspended particulate matter) data and determined pollen and metallic element concentrations in total suspended particulates. Both soil-derived metals (Fe, Ca, Al) and contaminating metals (Pb, Cr, Mn, Ni, Zn) were significantly increased on Asian dust days. Multiple regression analyses showed that the score of the skin effect was significantly associated with the levels of suspended particulate matter and Ni. The results show that increased air pollutants on Asian dust days may have skin effects.	[Onishi, Kazunari; Otani, Shinji; Mu, Haosheng; Kurozawa, Youichi] Tottori Univ, Yonago, Tottori 6838503, Japan; [Yoshida, Atsushi] Tottori Prefectural Inst Publ Hlth & Environm Sci, Yonago, Tottori, Japan	Onishi, K (reprint author), Tottori Univ, Fac Med, Div Hlth Adm & Promot, 86 Nishi Cho, Yonago, Tottori 6838503, Japan.	issey@med.tottori-u.ac.jp			Global Center of Excellence Program of the Japanese Ministry of Education, Culture, Sports, Science and Technology	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article:; This study was supported by the Global Center of Excellence Program of the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Zhuang GS, 2001, CHINESE SCI BULL, V46, P895, DOI 10.1007/BF02900460; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; Kwon HJ, 2002, ENVIRON RES, V90, P1, DOI 10.1006/enrs.2002.4377; Chao HJ, 2012, INT J BIOMETEOROL, V56, P211, DOI 10.1007/s00484-011-0413-x; Yang CY, 2005, INHAL TOXICOL, V17, P817, DOI 10.1080/08958370500241254; Chang CC, 2006, J TOXICOL ENV HEAL A, V69, P229, DOI 10.1080/15287390500227415; Ichinose T, 2006, J TOXICOL ENV HEAL A, V69, P1571, DOI 10.1080/15287390500470833; Chen YS, 2004, ENVIRON RES, V95, P151, DOI 10.1016/j.envres.2003.08.008; Yoo Y, 2008, J KOREAN MED SCI, V23, P66, DOI 10.3346/jkms.2008.23.1.66; Thyssen JP, 2009, BRIT J DERMATOL, V161, P1124, DOI 10.1111/j.1365-2133.2009.09325.x; Hiyoshi K, 2005, ENVIRON RES, V99, P361, DOI 10.1016/j.envres.2005.03.008; Choi H, 2011, TOXICOL LETT, V200, P92, DOI 10.1016/j.toxlet.2010.10.019; Kumar K S, 2000, Asia Pac J Public Health, V12, P58; NISHIKAWA M, 1991, SCI TOTAL ENVIRON, V107, P13, DOI 10.1016/0048-9697(91)90247-C; Otani S, 2011, ARCH ENVIRON OCCUP H, V66, P43, DOI 10.1080/19338244.2010.506499; Park K, 2010, ENVIRON MONIT ASSESS, V160, P289, DOI 10.1007/s10661-008-0695-6; Spickett JT, 2011, ASIA-PAC J PUBLIC HE, V23, p37S, DOI 10.1177/1010539511398114; Var F, 2000, ATMOS ENVIRON, V34, P2755, DOI 10.1016/S1352-2310(99)00353-2; Yang CY, 2006, J TOXICOL ENV HEAL A, V69, P1673, DOI 10.1080/15287390600630096	20	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP1719	NP1726		10.1177/1010539511428667		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200160		
J	Rahman, M; Islam, MT; Mostofa, MG; Reza, MS				Rahman, Mosiur; Islam, Mohammad Touhidul; Mostofa, Md Golam; Reza, Md Shahin			Men's Role in Women's Antenatal Health Status: Evidence From Rural Rajshahi, Bangladesh	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						men's role; antenatal care; knowledge about maternal complications; Rajshahi	DETERMINANTS; SERVICES; CARE; MALNUTRITION; HUSBANDS	This study aimed to extend notions of men's role in women's antenatal care (ANC) status in rural Rajshahi, Bangladesh. The analyses were based on response of 480 men aged 15 to 54 years, living with at least 1 child younger than 3 years. Only 27% men accompanied their wives for ANC. Men's perception of actual roles for ANC services was low: 63% approved of women undergoing checkups; 33% discussed their wives' pregnancy with health professionals. Only 18% scored highly on the overall index of knowledge. From multivariate analysis, it was found that the number of men accompanying their wives for ANC was higher among those respondents who were married for the first time in the age-group 25 to 34 years and aged 35 years or more, had their last child at age-group 20 to 24 years or 25 to 34 years, had completed primary or secondary and higher education, and had mass media facilities.	[Rahman, Mosiur; Mostofa, Md Golam; Reza, Md Shahin] Rajshahi Univ, Rajshahi 6205, Bangladesh; [Rahman, Mosiur; Islam, Mohammad Touhidul] Tokyo Med & Dent Univ, Tokyo, Japan	Rahman, M (reprint author), Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh.	swaponru_2000@yahoo.com					Aminul HM, 2009, ASIA-PAC J PUBLIC HE, V21, P104; Choudhury KK, 2000, J HEALTH POPUL NUTR, V18, P123; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Chakraborty N, 2003, HEALTH PROMOT INT, V18, P327, DOI 10.1093/heapro/dag414; Rahman M, 2011, HEALTH SOC CARE COMM, V19, P138, DOI 10.1111/j.1365-2524.2010.00953.x; Ashraf A, 1999, MALE INVOLVEMENT REP; Bangladesh Bureau of Statistics, 2003, BANGL POP CENS 2001; Bhalerao V R, 1984, J Postgrad Med, V30, P10; Bloom SS, 2000, J BIOSOC SCI, V32, P237, DOI 10.1017/S0021932000002376; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Dharmalingam N, 2000, THESIS U WAIKATO HAM; Greene ME, INVOLVING MEN REPROD; Hossain AHMK, 2010, ASIA-PAC J PUBLIC HE, V22, P395, DOI 10.1177/1010539510366177; Huntington D, 1995, EXPLORATORY STUDY PS; Islam MN, 2008, INTRO RES METHODS; Milton AH, 2010, ASIA-PAC J PUBLIC HE, V22, P110, DOI 10.1177/1010539509350913; Ministry of Health and Family Welfare, 2003, HSDWP0203 MIN HLTH F; National Institute of Population Research and Training (NIPORT), 2004, BANGL DEM HLTH SURV; Nuraini S, 2005, ASIA-PAC J PUBLIC HE, V17, P3; Odimegwu Clifford, 2005, Afr J Reprod Health, V9, P59; Onyango Monica A, 2010, Afr J Reprod Health, V14, P32; Rahman Mosiur, 2009, World Health Popul, V11, P5; Rahman M, 2008, Tanzan J Health Res, V10, P246; Ronald GH, 2007, THESIS NETHERLANDS I; Saha Kalyan B, 2007, Rural Remote Health, V7, P605; Saleem S, 2005, REPROD HLTH, V2, P2, DOI DOI 10.1186/1742-4755-2-8; Tuloro T, 2006, ETHIOP J HEALTH DEV, V20, P152; United Nations, 1994, PROGR ACT AD INT C P; United Nations Fund for Children, 1998, STAT WORLDS CHILDR F, P131; White V, 2003, SYNERGY PROJECT MEN; WONG EL, 1987, SOC SCI MED, V24, P927, DOI 10.1016/0277-9536(87)90286-3; World Health Organization, 2003, MAT MORT 2000 EST DE; World Health Organization, 1994, WHOFHEMSM9411	33	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP1182	NP1192		10.1177/1010539512437603		11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200113		
J	Samrith, W; Rahman, M; Harun-Or-Rashid, M; Sakamoto, J				Samrith, Wannak; Rahman, Mahbubur; Harun-Or-Rashid, Md.; Sakamoto, Junichi			Trends and Barriers to HIV Testing Among Tuberculosis Patients in Prey Kabas Operational District, Takeo Province, Cambodia	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						Cambodia; HIV; operational district; referral; tuberculosis	ANTIRETROVIRAL THERAPY; SOUTH-INDIA; EPIDEMIOLOGY; PREDICTORS; VIETNAM	Data for this study were obtained from 2375 tuberculosis (TB) patients registered during 20072009 and 43 health providers to examine the trend of TB patient referral for HIV (human immunodeficiency virus) testing and to investigate provider-associated barriers to the referral in Prey Kabas operational district, Takeo province, Cambodia. Referral rate for HIV testing was 4.4% (30/684) in 2007, 15.4% (116/751) in 2008, and 30.1% (283/940) in 2009, with a significant upward trend over the period of time (P =.009). The main barriers perceived by health providers were poor knowledge about TB/HIV, lack of communication skills, absence of any target plan for TB patient referral for HIV testing, and fear associated with informing positive test results to the TB patients and the associated stigma. Strategies to raise awareness about HIV/AIDS/TB among TB patients and their providers may improve the current state of low referral and its barriers in Cambodia.	[Samrith, Wannak; Harun-Or-Rashid, Md.; Sakamoto, Junichi] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Samrith, Wannak] Minist Hlth, Takhmao Town, Cambodia; [Rahman, Mahbubur] Univ Texas Med Branch, Galveston, TX 77555 USA	Harun-Or-Rashid, M (reprint author), Nagoya Univ, Grad Sch Med, Young Leaders Program Healthcare Adm, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	mh_rashid67@yahoo.com			nonprofit organization Epidemiological & Clinical Research Information Network (ECRIN)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported in part by the nonprofit organization Epidemiological & Clinical Research Information Network (ECRIN).	Mugisha B, 2006, INT J TUBERC LUNG D, V10, P761; Quy HT, 2006, INT J TUBERC LUNG D, V10, P45; Yi SY, 2009, AIDS CARE, V21, P529, DOI 10.1080/09540120802270268; Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Stein JA, 2000, AIDS CARE, V12, P343, DOI 10.1080/09540120050043007; Ayenew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009702; Cain KR, 2007, INT J TUBERC LUNG D, V11, P1008; Eang MT, 2007, B WORLD HEALTH ORGAN, V85, P382; Fletcher G., 2001, OR PRES 2 ANN S TB H, P1; Getahun H, 2004, INTERIM POLICY COLLA; Lee K, 2005, AIDS CARE, V17, P141, DOI 10.1080/09540120512331325644; Mahendradhata Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-385; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Ministry of Health, 2003, HIV SENT SURV HSS CA; Ministry of Health, 2006, NAT HLTH STRAT PLAN; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; National Center for Tuberculosis and Leprosy Control, 2007, NAT HIV SER SURV TB; National Center for Tuberculosis and Leprosy Control (CENAT), 2005, TB HIV ACT 4 PIL PRO; National Tuberculosis Program, 2009, MIN HLTH REP 2009; Nguyen LTN, 2010, ASIA-PAC J PUBLIC HE, V22, P451, DOI 10.1177/1010539510371869; Njozing NB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-129; Scano F, 2009, WHO POLICY TB INFECT; Thomas BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008389; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522; Vijay S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007899; Viney K, 2011, ASIA-PAC J PUBLIC HE, V23, P86, DOI 10.1177/1010539510390671; WHO, 2007, GUID PROV IN HIV TES; World Health Organization, 2009, GLOB TUB CONTR EP ST	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP789	NP797		10.1177/1010539512445190		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200077		
J	Sugawara, N; Yasui-Furukori, N; Umeda, T; Tsuchimine, S; Kaneda, A; Tsuruga, K; Iwane, K; Okubo, N; Takahashi, I; Kaneko, S				Sugawara, Norio; Yasui-Furukori, Norio; Umeda, Takashi; Tsuchimine, Shoko; Kaneda, Ayako; Tsuruga, Koji; Iwane, Kaori; Okubo, Noriyuki; Takahashi, Ippei; Kaneko, Sunao			Relationship Between Dietary Patterns and Cognitive Function in a Community-Dwelling Population in Japan	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						cross-sectional studies; dietary patterns; Japanese; Mini-Mental State Examination	ALZHEIMERS-DISEASE; HISTORY QUESTIONNAIRES; OLDER-PEOPLE; DEMENTIA; ASSOCIATION; IMPAIRMENT; ADULTS; PREVENTION; MORTALITY; RISK	The purpose of this study was to clarify the association between dietary patterns and cognitive function in a community-dwelling population in Japan. A total of 388 volunteers (60 years and older) who participated in the Iwaki Health Promotion Project 2011 were recruited. Diet was assessed with a validated, self-administered brief-type diet history questionnaire. Dietary patterns were extracted from 52 predefined food groups by principal component analysis. The Mini-Mental State Examination was also used to measure global cognitive status. Three dietary patterns were identified as follows: "Healthy," "Noodle," and "Alcohol and accompaniment." Compared with the low tertile of the "Alcohol and accompaniment" pattern, only the middle tertile was independently related to an increased risk of poor cognitive function. In conclusions, present study failed to substantiate dose-dependent associations between dietary patterns and the risk of poor cognitive function. Further studies with longitudinal observations are warranted.	[Sugawara, Norio; Yasui-Furukori, Norio; Umeda, Takashi; Tsuchimine, Shoko; Kaneda, Ayako; Tsuruga, Koji; Iwane, Kaori; Okubo, Noriyuki; Takahashi, Ippei; Kaneko, Sunao] Hirosaki Univ, Sch Med, Hirosaki, Aomori 0368562, Japan	Sugawara, N (reprint author), Hirosaki Univ, Sch Med, Dept Neuropsychiat, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	nsuga3@yahoo.co.jp			Hirosaki Research Institute for the Neurosciences	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for this study was provided by the Hirosaki Research Institute for the Neurosciences.	Akbaraly TN, 2009, DEMENT GERIATR COGN, V27, P147, DOI 10.1159/000199235; Gu Y, 2011, CURR ALZHEIMER RES, V8, P510; Joshi YB, 2012, BIOFACTORS, V38, P90, DOI 10.1002/biof.195; Torres SJ, 2012, NUTRIENTS, V4, P1542, DOI 10.3390/nu4111542; Tangney CC, 2011, AM J CLIN NUTR, V93, P601, DOI 10.3945/ajcn.110.007369; Dickens AP, 2011, CNS DRUGS, V25, P629, DOI 10.2165/11593080-000000000-00000; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Samieri C, 2008, J AM DIET ASSOC, V108, P1461, DOI 10.1016/j.jada.2008.06.437; LIU IY, 1990, AM J EPIDEMIOL, V132, P136; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Holsinger T, 2007, JAMA-J AM MED ASSOC, V297, P2391, DOI 10.1001/jama.297.21.2391; Lin YS, 2005, ANN EPIDEMIOL, V15, P590, DOI 10.1016/j.annepidem.2004.10.010; [Anonymous], 2005, SCI TECHN AG STAND T; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI [10.2188/jeaJE20110075, 10.2188/jea.JE20110075]; Solfrizzi V, 2010, AGEING RES REV, V9, P184, DOI 10.1016/j.arr.2009.07.005; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Charreire H, 2011, BRIT J NUTR, V105, P902, DOI 10.1017/S000711451000440X; Coley N, 2008, EPIDEMIOL REV, V30, P35, DOI 10.1093/epirev/mxn010; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gill TM, 1995, J GERONTOL, V50, P235; GRAY GE, 1989, J AM DIET ASSOC, V89, P1795; Gustaw-Rothenberg K, 2009, INT J ENV RES PUB HE, V6, P1335, DOI 10.3390/ijerph6041335; Harrison FE, 2012, J ALZHEIMERS DIS, V29, P711, DOI 10.3233/JAD-2012-111853; Health and Welfare Statistics Association, 2005, J HLTH WELFARE STAT, V49, P34; Raman G, 2007, J NUTR, V137, P1789; ROSENBERG IH, 1992, AM J CLIN NUTR, V55, P1237; Venables WN, 2009, INTRO R NOTES R PROG; Wada-Isoe Kenji, 2012, Dement Geriatr Cogn Dis Extra, V2, P190, DOI 10.1159/000338244; WEILER PG, 1991, AM J PUBLIC HEALTH, V81, P1153, DOI 10.2105/AJPH.81.9.1153	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP2651	NP2660		10.1177/1010539513490194		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200245		
J	Sugiyama, T; Inoue, S; Cerin, E; Shimomitsu, T; Owen, N				Sugiyama, Takemi; Inoue, Shigeru; Cerin, Ester; Shimomitsu, Teruichi; Owen, Neville			Walkable Area Within Which Destinations Matter: Differences Between Australian and Japanese Cities	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						environment; international comparison; neighborhood; proximity; walking	PERCEIVED NEIGHBORHOOD ENVIRONMENT; PHYSICAL-ACTIVITY QUESTIONNAIRE; ACTIVITY BEHAVIORS; BUILT ENVIRONMENT; WALKING; ADULTS; ATTRIBUTES; PROXIMITY; VALIDITY; MIX	Adults' walking for transport is important for health benefits and can be associated with availability of destinations such as shops and services within a walking distance of 10 to 15 minutes from home. However, relevant evidence is mostly from Western countries. This study examined associations of destinations with walking for transport in Australian and Japanese cities. Data were collected from Adelaide, Australia (n = 2508), and 4 Japanese cities (n = 1285). Logistic regressions examined associations of self-reported walking for transport with the number of destination types within walk-distance categories. Walking was significantly associated with the number of destination types within a 10-minute walk from home for Australia and with the number of destination types within a 6- to 20-minute walk for Japan. Further research is needed on why walking by residents of Japanese cities can be influenced by more distant local destinations than in Australia to inform physical activity-related environmental and policy initiatives.	[Sugiyama, Takemi; Owen, Neville] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Inoue, Shigeru; Shimomitsu, Teruichi] Tokyo Med Univ, Tokyo 1608402, Japan; [Cerin, Ester] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	Sugiyama, T (reprint author), Baker IDI Heart & Diabet Inst, Behav Epidemiol, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	takemi.sugiyama@bakeridi.edu.au	Cerin, Ester/L-1271-2015	Cerin, Ester/0000-0002-7599-165X	University of Queensland; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council of Australia (NHMRC) [569940]; NHMRC [1003960]; Japan Ministry of Health, Labour, and Welfare [H19-008, H20-001]; Japan Ministry of Education, Culture, Sports, Science, and Technology [17590556]	The collaboration between Sugiyama and Inoue was supported by a travel grant from the University of Queensland. Sugiyama and Owen are supported in part by the Victorian Government's Operational Infrastructure Support Program and a Program Grant #569940 from the National Health and Medical Research Council of Australia (NHMRC). Owen is supported by a Senior Principal Fellowship #1003960 from NHMRC. The Japanese study was supported by Grant-in-aid from the Japan Ministry of Health, Labour, and Welfare (#H19-008, #H20-001) and from the Japan Ministry of Education, Culture, Sports, Science, and Technology (#17590556).	Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI [10.1249/MSS.0b013e31817c67a4, 10.1249/MSS.0b013e31817e67a4]; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Sugiyama T, 2012, MED SCI SPORT EXER, V44, P1275, DOI 10.1249/MSS.0b013e318247d286; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Shigematsu R, 2009, MED SCI SPORT EXER, V41, P314, DOI 10.1249/MSS.0b013e318185496c; Inoue S, 2010, J EPIDEMIOL, V20, P277, DOI 10.2188/jea.JE20090120; Gebel K, 2011, HEALTH PLACE, V17, P519, DOI 10.1016/j.healthplace.2010.12.008; McCormack GR, 2008, ENVIRON BEHAV, V40, P401, DOI 10.1177/0013916507300560; Handy S, 2006, J AM PLANN ASSOC, V72, P55, DOI 10.1080/01944360608976724; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Giles-Corti B, 2006, PREV MED, V42, P455, DOI 10.1016/j.ypmed.2006.01.019; Rodriguez DA, 2009, AM J PREV MED, V37, P397, DOI 10.1016/j.amepre.2009.07.008; Cerin E, 2007, HEALTH PLACE, V13, P713, DOI 10.1016/j.healthplace.2006.11.002; Leslie E, 2007, HEALTH PLACE, V13, P111, DOI 10.1016/j.healthplace.2005.11.001; Binns C, 2011, ASIA-PAC J PUBLIC HE, V23, P441, DOI 10.1177/1010539511417491; De Bourdeaudhuij I, 2005, PUBLIC HEALTH NUTR, V8, P886, DOI 10.1079/PHN2005735; Griffiths SM, 2010, ASIA PAC J PUBLIC S, V22, p110S; Kenworthy J, 2002, WORLD TRANSPORT POLI, V8, P5; McCormack GR, 2008, PREV MED, V46, P33, DOI 10.1016/j.ypmed.2007.01.013; Sallis JF, 2008, PREV MED, V46, P6, DOI 10.1016/j.ypmed.2007.03.003	20	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP2757	NP2763		10.1177/1010539512466911		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200255		
J	Tanihata, T; Kanda, H; Osaki, Y; Ohida, T; Minowa, M; Wada, K; Suzuki, K; Hayashi, K				Tanihata, Takeo; Kanda, Hideyuki; Osaki, Yoneatsu; Ohida, Takashi; Minowa, Masumi; Wada, Kiyoshi; Suzuki, Kenji; Hayashi, Kenji			Unhealthy Lifestyle, Poor Mental Health, and Its Correlation Among Adolescents: A Nationwide Cross-Sectional Survey	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						adolescent; junior high school; senior high school; poor mental health; lifestyle behavior; depression; epidemiological study; nationwide; smoking; alcohol use	ADULT MEXICAN-AMERICANS; ALCOHOL DEPENDENCE; SELECT POPULATION; SLEEP DURATION; DRUG-ABUSE; BEHAVIOR; SMOKING; ASSOCIATION; PREVENTION; DEPRESSION	Objectives. The objective was to study the relationship between mental health and lifestyles of adolescents using samples representative of Japanese adolescents nationwide. Method. The survey was conducted between December 2004 and January 2005 among students enrolled in randomly selected junior and senior high schools. Self-administered questionnaires addressed lifestyles, sleeping habits, and mental health status. Of 103 650 questionnaires collected, 85 158 were analyzed. Results. Population characteristics associated with poor mental health were being female, being a senior high school student, skipping breakfast, not participating in extracurricular activities, not consulting parents about personal matters, parental smoking, students' smoking or alcohol use, poor subjective sleep assessment, and short or long sleeping duration. Conclusion. Smoking and anxiety disorders are associated with an elevation in acculturative stress in adolescents. Prepossessing adolescents are in subclinical depression. Results suggest that lifestyles approaches in preventions that target students can be effective in reaching high-risk populations.	[Tanihata, Takeo; Hayashi, Kenji] Natl Inst Publ Hlth, Wako, Saitama 3510197, Japan; [Kanda, Hideyuki] Fukushima Med Univ, Fukushima, Japan; [Osaki, Yoneatsu] Tottori Univ, Tottori 680, Japan; [Ohida, Takashi] Nihon Univ, Tokyo, Japan; [Minowa, Masumi] Seitoku Univ, Matsudo, Chiba, Japan; [Wada, Kiyoshi] Natl Inst Mental Hlth, Kodaira, Tokyo, Japan; [Suzuki, Kenji] Suzuki Med Off, Hyama Cho, Kanagawa, Japan	Tanihata, T (reprint author), Natl Inst Publ Hlth, Minami 2-3-6, Wako, Saitama 3510197, Japan.	takeost@niph.go.jp			Ministry of Health and Welfare Health Science Research Fund in Japan	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article:; This study was supported by a grant for a Special Research Project in 2004 from the Ministry of Health and Welfare Health Science Research Fund in Japan.	Achenbach TM, 1983, MANUAL CHILD BEHAV C; Kaneita Y, 2006, J CLIN PSYCHIAT, V67, P196; Miller KE, 2009, SOCIOL SPORT J, V26, P335; GOLDBERG DP, 1976, BRIT J PSYCHIAT, V129, P61, DOI 10.1192/bjp.129.1.61; Hallfors DD, 2004, AM J PREV MED, V27, P224, DOI 10.1016/j.amepre.2004.06.001; Patel SR, 2006, SLEEP, V29, P881; Steptoe A, 2006, ARCH INTERN MED, V166, P1689, DOI 10.1001/archinte.166.16.1689; Ehlers CL, 2009, J ADDICT MED, V3, P227, DOI 10.1097/ADM.0b013e3181ab6db7; Ehlers CL, 2010, J STUD ALCOHOL DRUGS, V71, P879; Verdurmen J, 2005, J STUD ALCOHOL, V66, P605; Stanton CA, 2007, ADDICTION, V102, P1831, DOI 10.1111/j.1360-0443.2007.01974.x; Smith AP, 2005, BRIT J NUTR, V93, pS1, DOI 10.1079/BJN20041351; Kaneita Y, 2007, J CLIN PSYCHIAT, V68, P1426; Avenevoli S, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1360-0443.98.s1.2.x; Brener Nancy D., 2004, Morbidity and Mortality Weekly Report, V53, P1; Cochran W.G., 1977, SAMPLING TECHNIQUES; Cohen S, 1997, MEASURING STRESS GUI, P80; Conry MC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-692; Irwin M, 2000, ALCOHOL CLIN EXP RES, V24, P1376, DOI 10.1111/j.1530-0277.2000.tb02106.x; JOHNSON CA, 1990, J CONSULT CLIN PSYCH, V58, P447, DOI 10.1037//0022-006X.58.4.447; Kwok SYCL, 2010, SUICIDE LIFE-THREAT, V40, P224, DOI 10.1521/suli.2010.40.3.224; Marinoni A, 1997, EUR J EPIDEMIOL, V13, P779; Meier M, 2010, PUBLIC HEALTH NUTR, V13, P2068, DOI 10.1017/S1368980010000947; MOSKOWITZ JM, 1988, J STUD ALCOHOL, V49, P299; Osaki Y, 2006, TOB CONTROL, V15, P172, DOI 10.1136/tc.2005.013060; PENTZ MA, 1989, JAMA-J AM MED ASSOC, V261, P3259, DOI 10.1001/jama.261.22.3259; Qidwai W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012914; RADOVANOVIC Z, 1983, PSYCHOL MED, V13, P205	28	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP1557	NP1565		10.1177/1010539512452753		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200147		
J	Tsuboi, S; Yoshida, H; Ae, R; Kojo, T; Nakamura, Y; Kitamura, K				Tsuboi, Satoshi; Yoshida, Honami; Ae, Ryusuke; Kojo, Takao; Nakamura, Yosikazu; Kitamura, Kunio			Selection Bias of Internet Panel Surveys: A Comparison With a Paper-Based Survey and National Governmental Statistics in Japan	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						descriptive studies; epidemiology; Internet; Internet panel survey; selection bias	RESEARCH TOOL; WEB; HEALTH; PARTICIPATION; EPIDEMIOLOGY; PROBABILITY; BEHAVIORS; MODE; MAIL	Purpose. To investigate the selection bias of an Internet panel survey organized by a commercial company. Methods. A descriptive study was conducted. The authors compared the characteristics of the Internet panel survey with a national paper-based survey and with national governmental statistics in Japan. Results. The participants in the Internet panel survey were composed of more women, were older, and resided in large cities. Regardless of age and sex, the prevalence of highly educated people in the Internet panel survey was higher than in the paper-based survey and the national statistics. In men, the prevalence of heavy drinkers among the 30- to 49-year-old population and of habitual smokers among the 20- to 49-year-old population in the Internet panel survey was lower than what was found in the national statistics. Conclusions. The estimated characteristics of commercial Internet panel surveys were quite different from the national statistical data. In a commercial Internet panel survey, selection bias should not be underestimated.	[Tsuboi, Satoshi; Kojo, Takao; Nakamura, Yosikazu] Jichi Med Univ, Shimotsuke, Tochigi 3290498, Japan; [Yoshida, Honami] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Yoshida, Honami] Natl Inst Publ Hlth, Wako, Saitama 3510197, Japan; [Ae, Ryusuke] Hamasaka Publ Hosp, Mikata, Japan; [Kitamura, Kunio] Family Planninng Res Ctr Clin, Shinjuku Ku, Fukushima, Japan	Tsuboi, S (reprint author), Jichi Med Univ, Dept Publ Hlth, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	tsuboi@jichi.ac.jp			Ministry of Helath Labour and Welfare, Japan	The author(s) declared the receipt of the following financial support for the research, authorship, and/or publication of this article: Financial support was provided by the Ministry of Helath Labour and Welfare, Japan.	Adams J, 2008, EUR J PUBLIC HEALTH, V18, P335, DOI 10.1093/eurpub/ckm100; Aizawa F, 2015, ASIA-PAC J PUBLIC HE, V27; Greenlaw C, 2009, EVALUATION REV, V33, P464, DOI 10.1177/0193841X09340214; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Whitehead LC, 2007, SOC SCI MED, V65, P782, DOI 10.1016/j.socscimed.2007.03.005; Akl EA, 2005, J CLIN EPIDEMIOL, V58, P425, DOI 10.1016/j.jclinepi.2004.10.006; Spijkerman R, 2009, ADDICTION, V104, P1641, DOI 10.1111/j.1360-0443.2009.02642.x; McCabe SE, 2002, J STUD ALCOHOL, V63, P755; Ekman A, 2007, EUR J EPIDEMIOL, V22, P285, DOI 10.1007/s10654-007-9119-0; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; van Gelder MMHJ, 2010, AM J EPIDEMIOL, V172, P1292, DOI 10.1093/aje/kwq291; Evans AR, 2007, SEX TRANSM INFECT, V83, P200, DOI 10.1136/sti.2006.023283; Chin CY, 2009, ASIA-PAC J PUBLIC HE, V21, P410, DOI 10.1177/1010539509343973; Miller PG, 2010, ADDICTION, V105, P1557, DOI 10.1111/j.1360-0443.2010.02992.x; Klovning A, 2009, J CLIN EPIDEMIOL, V62, P1068, DOI 10.1016/j.jclinepi.2008.10.015; Schleyer TKL, 2000, J AM MED INFORM ASSN, V7, P416; Beck KH, 2009, J SAFETY RES, V40, P377, DOI 10.1016/j.jsr.2009.07.007; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Lenert L, 2002, ANN BEHAV MED, V24, P251, DOI 10.1207/S15324796ABM2404_01; Miller PG, 2010, SUBST USE MISUSE, V45, P437, DOI 10.3109/10826080903452470; Ministry of Health Labour and Welfare, NAT HLTH NUTR SURV; Ministry of Internal Affairs and Communications, SCH BAS SURV DES STA; Ministry of Internal Affairs and Communications Statistics Bureau, POP CENS; Schonlau M, 2004, J MED INTERNET RES, V6, P10; Wilson JJ, 2006, CANCER J, V12, P475, DOI 10.1097/00130404-200611000-00007	25	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP2390	NP2399		10.1177/1010539512450610		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200222		
J	Tsuboi, S; Yoshida, H; Ae, R; Kojo, T; Nakamura, Y; Kitamura, K				Tsuboi, Satoshi; Yoshida, Honami; Ae, Ryusuke; Kojo, Takao; Nakamura, Yosikazu; Kitamura, Kunio			Prevalence and Demographic Distribution of Adult Survivors of Child Abuse in Japan	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						child abuse; adult survivors; demographic characteristics; descriptive epidemiology; Japan	POSTTRAUMATIC-STRESS-DISORDER; HOUSEHOLD DYSFUNCTION; SEXUAL-ABUSE; NEGLECT; RISK; ASSOCIATION; ADVERSITIES; WOMEN	A cross-sectional study was conducted with a national epidemiological survey to investigate the prevalence and demographic distribution of adult survivors of child abuse in Japan. A self-administered questionnaire was used to measure the history of child abuse and the demographic characteristics. The participants reported the following 4 types of child abuse: physical abuse (3%), sexual abuse (0.6%), neglect (0.8%), and psychological abuse (4%). Significant unequal distribution of child abuse was found to be associated with sex, living region, marital status, job status, and educational status. We determined the prevalence of adult survivors of child abuse in Japan and found that their demographic characteristics were unequally distributed. Policy makers and public health providers should take these demographic disparities into account in considering effective public health interventions for survivors of child abuse.	[Tsuboi, Satoshi; Kojo, Takao; Nakamura, Yosikazu] Jichi Med Univ, Shimotsuke, Tochigi 3290498, Japan; [Yoshida, Honami] Natl Inst Publ Hlth, Saitama, Japan; [Ae, Ryusuke] Hamasaka Publ Hosp, Hamasaka, Hyogo, Japan; [Kitamura, Kunio] Family Planning Res Ctr Clin, Tokyo, Japan	Tsuboi, S (reprint author), Jichi Med Univ, Dept Publ Hlth, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	tsuboi@jichi.ac.jp			Ministry of Helath Labour and Welfare, Japan	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Financial support was provided by the Ministry of Helath Labour and Welfare, Japan.	Testa M, 2011, CHILD ABUSE NEGLECT, V35, P363, DOI 10.1016/j.chiabu.2011.01.010; Wilson HW, 2009, J YOUTH ADOLESCENCE, V38, P340, DOI 10.1007/s10964-008-9331-6; Draucker CB, 2011, J CHILD SEX ABUS, V20, P435, DOI 10.1080/10538712.2011.588188; Gupta J, 2008, CAN MED ASSOC J, V179, P535, DOI 10.1503/cmaj.071655; Carpenter LL, 2010, NEUROPSYCHOPHARMACOL, V35, P2617, DOI 10.1038/npp.2010.159; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; Dong MX, 2004, CHILD ABUSE NEGLECT, V28, P771, DOI 10.1016/j.chiabu.2004.01.008; Bynum L., 2010, Morbidity and Mortality Weekly Report, V59, P1609; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Cloitre M, 2010, AM J PSYCHIAT, V167, P915, DOI 10.1176/appi.ajp.2010.09081247; Roy A, 2011, J AFFECT DISORDERS, V133, P591, DOI 10.1016/j.jad.2011.05.006; Rich-Edwards JW, 2010, AM J PREV MED, V39, P529, DOI 10.1016/j.amepre.2010.09.007; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; McLaughlin KA, 2010, PSYCHOL MED, V40, P847, DOI 10.1017/S0033291709991115; Nikulina V, 2011, AM J COMMUN PSYCHOL, V48, P309, DOI 10.1007/s10464-010-9385-y; Dillon DG, 2009, BIOL PSYCHIAT, V66, P206, DOI 10.1016/j.biopsych.2009.02.019; Pace TWW, 2012, BRAIN BEHAV IMMUN, V26, P13, DOI 10.1016/j.bbi.2011.07.232; Steil R, 2011, J TRAUMA STRESS, V24, P102, DOI 10.1002/jts.20617; Boden JM, 2007, CHILD ABUSE NEGLECT, V31, P1101, DOI 10.1016/j.chiabu.2007.03.022; Fujiwara T, 2011, J PSYCHIATR RES, V45, P481, DOI 10.1016/j.jpsychires.2010.08.002; Bentley T, 2009, OBESITY, V17, P1900, DOI 10.1038/oby.2009.160; Epstein RA, 2011, J NERV MENT DIS, V199, P251, DOI 10.1097/NMD.0b013e3182125b6d; Jirapramukpitak T, 2011, SOC PSYCH PSYCH EPID, V46, P825, DOI 10.1007/s00127-010-0252-9; Koenen KC, 2009, J TRAUMA STRESS, V22, P566, DOI 10.1002/jts.20478; National Statistics Center, FUK; O'Leary Patrick J, 2008, J Child Sex Abus, V17, P133, DOI 10.1080/10538710801916416; Tsuboi S, 2015, ASIA-PAC J PUBLIC HE, V27; Wilson HW, 2011, J CONSULT CLIN PSYCH, V79, P236, DOI 10.1037/a0022915; World Health Organization, PREV CHILD MALTR GUI	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP2578	NP2586		10.1177/1010539513488626		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200239		
J	Tsuda, Y; Watanabe, M; Tanimoto, Y; Hayashida, I; Kusabiraki, T; Komiyama, M; Kono, K				Tsuda, Yuko; Watanabe, Misuzu; Tanimoto, Yoshimi; Hayashida, Itsushi; Kusabiraki, Toshiyuki; Komiyama, Maki; Kono, Koichi			The Current Situation of Voluntary Vaccination and the Factors Influencing Its Coverage Among Children in Takatsuki, Japan: Focus on Hib and Pneumococcal Vaccines	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						18-month-old children; Japan; Haemophilus influenzae type b; parental awareness; pneumococcal; vaccination coverage; voluntary vaccination	IMMUNIZATION; ATTITUDES; RECALL	This study aimed to understand the current scenario of voluntary vaccination and the factors influencing its coverage among 18-month-old children of Takatsuki City, Japan. Based on 1167 parents responses, we found that voluntary vaccination coverage rates were low when compared with routine vaccination rates. The children who were not the first born of the family and who had young and poorly educated parents were less likely to receive voluntary vaccination. Japanese government-supported vaccines, such as Haemophilus influenzae type b and pneumococcal vaccine, had a higher coverage than the vaccines for which parents had to bear the entire vaccination cost. Furthermore, it was found that mass communication media and family pediatricians were effective means to disseminate voluntary vaccination-related information. We envisage that an active participation of medical professionals, easy access to vaccinations, and mass awareness programs will increase voluntary vaccination coverage in Takatsuki.	[Tsuda, Yuko; Watanabe, Misuzu; Tanimoto, Yoshimi; Hayashida, Itsushi; Kusabiraki, Toshiyuki; Komiyama, Maki; Kono, Koichi] Osaka Med Coll, Takatsuki, Osaka 5698686, Japan	Tsuda, Y (reprint author), Osaka Med Coll, Fac Med, Dept Hyg & Publ Hlth, Div Prevent & Social Med, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	nonny_b_good@hotmail.com			Daido Life Welfare foundation for research	The author(s) declared the receipt of following financial support for the research, authorship, and/or publication of this article: The authors received grant support from the Daido Life Welfare foundation for research.	VALADEZ JJ, 1992, AM J PUBLIC HEALTH, V82, P120, DOI 10.2105/AJPH.82.1.120; Haynes K, 2004, AUST NZ J PUBL HEAL, V28, P72, DOI 10.1111/j.1467-842X.2004.tb00636.x; Torun SD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-125; Heininger U, 2006, VACCINE, V24, P6351, DOI 10.1016/j.vaccine.2006.05.029; Tajiri H, 2007, J MED VIROL, V79, P922, DOI 10.1002/jmv.20916; Baba K, 2011, VACCINE, V29, P3089, DOI 10.1016/j.vaccine.2010.09.022; Black Carla L., 2011, Morbidity and Mortality Weekly Report, V60, P1157; Bolton P, 1998, PUBLIC HEALTH REP, V113, P521; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P1; Young Margaret B., 2012, Morbidity and Mortality Weekly Report, V61, P1; Coniglio MA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-305; Cross Andrea J, 2009, N Z Med J, V122, P24; Danis K, 2010, VACCINE, V28, P1861, DOI 10.1016/j.vaccine.2009.11.078; Dube E, 2009, INT J PEDIATR OTORHI, V73, P987, DOI 10.1016/j.ijporl.2009.03.022; European Centre for Disease Prevention and Control (ECDC), VACC SCHED; Hu Y, 2015, ASIA-PAC J PUBLIC HE, V27; Japan Pediatric Society, REC IMM SCHED CHILDR; Khowaja AR, 2015, ASIA-PAC J PUBLIC HE, V27; Kim YOR, 2004, J HEALTH CARE POOR U, V15, P170, DOI 10.1353/hpu.2004.0027; Kimura M, 2011, YOBOUSESSYU TEBIKI; Lung FW, 2009, ACTA PAEDIATR, V98, P834, DOI 10.1111/j.1651-2227.2008.01166.x; Murashige N, 2011, LANCET, V377, P299, DOI 10.1016/S0140-6736(11)60091-3; Quaiyum MA, 2011, ASIA-PAC J PUBLIC HE, V23, P141, DOI 10.1177/1010539509342119; Ruijs WLM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-102; Shuaib FMB, 2010, W INDIAN MED J, V59, P549; Sokal MM., 2004, CLIN PEDIAT PHILA, V43, P83; WHO, HLTH TOP IMM; World Health Organization, 2009, INTR GLOB IMM VIS ST; Yuge M, 2010, JPN J HLTH SCI RES, V14, P65	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP1409	NP1420		10.1177/1010539513487013		12	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200134		
J	Ueno, M; Zaitsu, T; Ohara, S; Wright, C; Kawaguchi, Y				Ueno, Masayuki; Zaitsu, Takashi; Ohara, Satoko; Wright, Clive; Kawaguchi, Yoko			Factors Influencing Perceived Oral Health of Japanese Middle-Aged Adults	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						clinical oral health; perceived oral health; periodontal conditions; structural equation modeling; Bayesian estimation	QUALITY-OF-LIFE; FUNCTIONAL TOOTH UNITS; MASTICATORY ABILITY; VARIABLES; MODEL	The objective of this study was to analyze the relationships between subjective oral health symptoms and clinical oral health conditions on the perceived oral health of 1799 Japanese middle-aged adults. A self-administered questionnaire together with dental examinations was administered. A structural equation modeling analysis with Bayesian estimation was used to examine the factors influencing perceived oral health as a latent variable with 4 other latent variables: subjective oral health symptoms, clinical tooth conditions, clinical periodontal conditions, and other clinical oral conditions. For perceived oral health as the endogenous variable, only subjective oral health symptoms and clinical tooth conditions showed significant relationship. Clinical periodontal conditions and other clinical oral conditions did not show significant effects on the perceived oral health.	[Ueno, Masayuki; Zaitsu, Takashi; Ohara, Satoko; Kawaguchi, Yoko] Tokyo Med & Dent Univ, Tokyo 1138549, Japan; [Wright, Clive] NSW Hlth, Ctr Oral Hlth Strategy, Westmead, NSW, Australia	Ueno, M (reprint author), Tokyo Med & Dent Univ, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	ueno.ohp@tmd.ac.jp			8020 Promotion Foundation	This research was partly supported by the 8020 Promotion Foundation.	Ueno M, 2010, CLIN ORAL INVEST, V14, P113, DOI 10.1007/s00784-009-0270-8; Afonso-Souza G, 2007, COMMUNITY DENT ORAL, V35, P393, DOI 10.1111/j.1600-0528.2006.00343.x; Baker SR, 2007, QUAL LIFE RES, V16, P297, DOI 10.1007/s11136-006-9108-x; Pattussi MP, 2010, COMMUNITY DENT ORAL, V38, P348, DOI 10.1111/j.1600-0528.2010.00542.x; Gift HC, 1998, J DENT RES, V77, P1529; Ueno M, 2008, J ORAL REHABIL, V35, P337, DOI 10.1111/j.1365-2842.2008.01847.x; Ng ST, 2011, ASIA-PAC J PUBLIC HE, V23, P470, DOI 10.1177/1010539510374751; Savolainen J, 2005, EUR J ORAL SCI, V113, P121, DOI 10.1111/j.1600-0722.2005.00201.x; Baker SR, 2009, COMMUNITY DENT ORAL, V37, P485, DOI 10.1111/j.1600-0528.2009.00495.x; Cruz GD, 2001, COMMUNITY DENT ORAL, V29, P99, DOI 10.1034/j.1600-0528.2001.290204.x; DAVIS P, 1982, INT DENT J, V32, P271; Konishi C, 2009, GERODONTOLOGY, V27, P53; Lee SY, 2003, STAT MED, V22, P3073, DOI 10.1002/sim.1544; Locker D, 2005, COMMUNITY DENT ORAL, V33, P280, DOI 10.1111/j.1600-0528.2005.00209.x; Marino R, 2008, COMMUNITY DENT ORAL, V36, P85, DOI 10.1111/j.1600-0528.2007.00378.x; Naito Mariko, 2006, J Oral Sci, V48, P1, DOI 10.2334/josnusd.48.1; Seo DC, 2009, ASIA-PAC J PUBLIC HE, V21, P421, DOI 10.1177/1010539509344112; Statistical Analysis Committee on the Survey of Dental Diseases, 2005, COMPR GUID SURV DENT; Vered Y, 2003, BMC ORAL HEALTH, V3, P3, DOI 10.1186/1472-6831-3-3; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; World Health Organization, 1997, OR HLTH SURV BAS MET	21	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	MAR	2015	27	2					NP2296	NP2304		10.1177/1010539511428352		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5GT	WOS:000352586200213		
J	Yagi, M; Koda, J; Furusho, R; Terai, T; Fujiwara, H; Watanabe, JI				Yagi, Masafumi; Koda, Jin; Furusho, Reiko; Terai, Tsuyoshi; Fujiwara, Hideaki; Watanabe, Jun-Ichi			INITIAL SPEED OF KNOTS IN THE PLASMA TAIL OF C/2013 R1( LOVEJOY)	ASTRONOMICAL JOURNAL			English	Article						comets: individual (C/2013 R1); solar wind	INTER-PLANETARY GAS; SUPRIME-CAM; DISCONNECTION EVENTS; DATA RELEASE; COMET; CATALOG	We report short-time variations in the plasma tail of C/2013 R1(Lovejoy). A series of short (2-3 minutes) exposure images with the 8.2 m Subaru telescope shows faint details of filaments and their motions over a 24 minute observing duration. We identified rapid movements of two knots in the plasma tail near the nucleus (similar to 3 x 10(5) km). Their speeds are 20 and 25 km s(-1) along the tail and 3.8 and 2.2 km s(-1) across it, respectively. These measurements set a constraint on an acceleration model of plasma tail and knots as they set the initial speed just after their formation. We also found a rapid narrowing of the tail. After correcting the motion along the tail, the narrowing speed is estimated to be similar to 8 km s(-1). These rapid motions suggest the need for high time-resolution studies of comet plasma tails with a large telescope.	[Yagi, Masafumi; Furusho, Reiko; Terai, Tsuyoshi; Watanabe, Jun-Ichi] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Koda, Jin] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Furusho, Reiko] Tsuru Univ, Tsuru, Yamanashi 4020054, Japan; [Terai, Tsuyoshi; Fujiwara, Hideaki] Subaru Telescope, Hilo, HI 96720 USA	Yagi, M (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	YAGI.Masafumi@nao.ac.jp			NSF [AST-1211680]; NASA [NNX09AF40G, NNX14AF74G]; Herschel Space Observatory; Hubble Space Telescope	This work is based on observations obtained with the Subaru Telescope. We acknowledge David Thilker, Alexandre Y. K. Bouquin, Fumiaki Nakata, and Yutaka Komiyama for their help. We thank Miriam Forman for suggestive comments. We also thank the anonymous referee for useful comments. This work has made use of SDSS DR8 database, HORIZONS ephemerides service in NASA/JPL, and the computer systems at Astronomical Data Analysis Center of NAOJ. J.K. is supported by the NSF through grant AST-1211680 and by NASA through grants NNX09AF40G, NNX14AF74G, a Herschel Space Observatory grant, and a Hubble Space Telescope grant.	Aihara H, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/2/29; Downs C, 2013, SCIENCE, V340, P1196, DOI 10.1126/science.1236550; Blanton MR, 2007, ASTRON J, V133, P734, DOI 10.1086/510127; Yagi M, 2002, ASTRON J, V123, P66, DOI 10.1086/324731; Iye M, 2004, PUBL ASTRON SOC JPN, V56, P381; Lasker BM, 2008, ASTRON J, V136, P735, DOI 10.1088/0004-6256/136/2/735; Buffington A, 2008, ASTROPHYS J, V677, P798, DOI 10.1086/529039; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833; Brandt JC, 2002, EARTH MOON PLANETS, V90, P15, DOI 10.1023/A:1021552031857; Kinoshita D, 1996, PUBL ASTRON SOC JPN, V48, pL83; Mendis DA, 2006, GEOPH MONOG SERIES, V167, P31, DOI 10.1029/167GM05; NIEDNER MB, 1981, ASTROPHYS J SUPPL S, V46, P141, DOI 10.1086/190740; NIEDNER MB, 1982, ASTROPHYS J SUPPL S, V48, P1, DOI 10.1086/190766; SAITO T, 1987, ASTRON ASTROPHYS, V187, P209; Yagi M, 2013, PUBL ASTRON SOC JPN, V65; Yagi M, 2012, PUBL ASTRON SOC PAC, V124, P1347, DOI 10.1086/668891	17	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	MAR	2015	149	3							97	10.1088/0004-6256/149/3/97		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CF1KM	WOS:000352304000008		
J	Baklanov, PV; Sorokina, EI; Blinnikov, SI				Baklanov, P. V.; Sorokina, E. I.; Blinnikov, S. I.			Hydrogenless superluminous supernova PTF12dam in the model of an explosion inside an extended envelope	ASTRONOMY LETTERS-A JOURNAL OF ASTRONOMY AND SPACE ASTROPHYSICS			English	Article						superluminous supernova; circumstellar envelope	PAIR-INSTABILITY; LUMINOUS SUPERNOVAE; 2007BI	Amodel of a supernova explosion inside a dense extended hydrogenless envelope is proposed to explain the properties of the light curve for one of the superluminous supernovae PTF12dam. It is argued in the literature that the flux of this supernova rises too fast to be explained by the explosion model due to the instability associated with the electron-positron pair production (pair-instability supernova, PISNe), but it is well described by the models with energy input by a magnetar. We show that the PTF12dam-type supernovae can be explained without a magnetar in a model with a radiative shock in a dense circumstellar envelope that does not require an excessively large explosion energy.	[Baklanov, P. V.; Sorokina, E. I.; Blinnikov, S. I.] Inst Theoret & Expt Phys, Moscow 119992, Russia; [Sorokina, E. I.; Blinnikov, S. I.] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow 119992, Russia; [Blinnikov, S. I.] Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan	Baklanov, PV (reprint author), Inst Theoret & Expt Phys, Ul Bolshaya Cheremushkinskaya 25, Moscow 119992, Russia.	baklanovp@gmail.com; sorokina@sai.msu.su; Sergei.Blinnikov@itep.ru	Baklanov, Petr/J-5668-2014	Baklanov, Petr/0000-0002-5920-1478	Russian Science Foundation [14-12-00203]	We thank K. Nomoto and R. Quimby for the useful discussions. This study was supported by a grant from the Russian Science Foundation (project no. 14-12-00203).	Baklanov PV, 2005, ASTRON LETT+, V31, P429, DOI 10.1134/1.1958107; Woosley SE, 2007, NATURE, V450, P390, DOI 10.1038/nature06333; Quimby RM, 2013, MON NOT R ASTRON SOC, V431, P912, DOI 10.1093/mnras/stt213; Gal-Yam A, 2012, SCIENCE, V337, P927, DOI 10.1126/science.1203601; Gal-Yam A, 2009, NATURE, V462, P624, DOI 10.1038/nature08579; Cooke J, 2012, NATURE, V491, P228, DOI 10.1038/nature11521; Nicholl M, 2013, NATURE, V502, P346, DOI 10.1038/nature12569; Quimby RM, 2011, NATURE, V474, P487, DOI 10.1038/nature10095; Moriya T, 2010, ASTROPHYS J LETT, V717, pL83, DOI 10.1088/2041-8205/717/2/L83; Baklanov PV, 2013, JETP LETT+, V98, P432, DOI 10.1134/S0021364013200034; Blinnikov S. I., 2010, ARXIV10094353; Chen T.-W., 2014, ARXIV14097728; Chugai NN, 2004, MON NOT R ASTRON SOC, V352, P1213, DOI 10.1111/j.1365-2966.2004.08011.x; GRASBERG EK, 1986, SOV ASTRON LETT+, V12, P68; Kozyreva A, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201423447; Moriya T. J., 2014, ARXIV14104557; Moriya TJ, 2013, MON NOT R ASTRON SOC, V430, P1402, DOI 10.1093/mnras/stt011; Nicholl M., 2014, ARXIV14051325; Quimby R. M., 2012, ATEL, V4121, P1; Sorokina E. I., 2015, UNPUB	20	1	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1063-7737	1562-6873		ASTRON LETT+	Astron. Lett.-J. Astron. Space Astrophys.	MAR	2015	41	3-4					95	103		10.1134/S1063773715040027		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CF9NY	WOS:000352893100002		
J	Shintani, H				Shintani, Hideharu			Validation Study on How to Avoid Microbial Contamination during Pharmaceutical Production	BIOCONTROL SCIENCE			English	Review						Validation study; How to avoid; Contamination; Pharmaceutical products		Every person involved in pharmaceutical product manufacturing has the responsibility to assure the quality of the product being produced. The aim of this paper is to validate quality assurance throughout the process of manufacturing pharmaceutical products. Additionally, within aseptic manufacturing, certain monitoring and information needs to be collected on a routine basis to continually assess the state of control of the complete operation. The basis for assessing the state of control is to have rigorous and defined information flow processes. Once the information is collected, quality assurance involves the ability to assess, evaluate, and make appropriate decisions to ensure the product has the required safety, identity, strength, quality, and purity. Quality assurance study is the process of bringing all of the information together, evaluating the information, making decisions, refining systems, and applying process knowledge. This process begins in the early stages of drug development when not a lot of specific process information about the process is known, but it is important to allow for development to progress, building knowledge about process. However, even in early development, sterility assurance requirements should be largely the same at all stages of development and routine commercial manufacturing.		Shintani, H (reprint author), 1-13-27 Kasuga, Tokyo 1120003, Japan.	shintani@mail.hinocatv.ne.jp					[Anonymous], 2008, EUDRALEX, V4; FDA, 2004, GUID IND STER DRUG P; Food and Drug Administration, 2008, GUID IND CGMP PHAS 1; Good Manufacturing Practices Annex 13, 2003, MANUFACTURE INVESTIG, V4; ICH, 2007, GUID IND Q8 R1 PHARM; ICH, 2006, GUID IND Q8 PHARM DE; International Organization for Standardization (ISO), 146441 ISO; Kevin L. W., 2007, ENDOTOXINS PYROGENS; Quality Assurance of Pharmaceuticals, 2007, COMP GUID REL MAT, V2	9	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	MAR	2015	20	1					1	10				10	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CF7RU	WOS:000352754800001		
J	Yoshino, K; Matsumoto, H; Iwasaki, T; Kinoshita, S; Noda, K; Oya, K; Iwamori, S				Yoshino, Kiyoshi; Matsumoto, Hiroyuki; Iwasaki, Tatsuyuki; Kinoshita, Shinobu; Noda, Kazutoshi; Oya, Kei; Iwamori, Satoru			Investigation of a Sterilization System Using Active Oxygen Species Generated by Ultraviolet Irradiation	BIOCONTROL SCIENCE			English	Article						Active oxygen species; Sterilization; Ultraviolet irradiation; Quartz crystal microbalance	LOW-TEMPERATURE STERILIZATION; CRYSTAL MICROBALANCE QCM; PLASMA; INACTIVATION; BACTERIA; FILMS	We have been investigating an advanced sterilization system that employs active oxygen species (AOS). We designed the sterilization equipment, including an evacuation system, which generates AOS from pure oxygen gas using ultraviolet irradiation, in order to study the conditions necessary for sterilization in the system's chamber. Using Geobachillus stearothermophilus spores (10(6) CFU) in a sterile bag as a biological indicator (BI) in the chamber of the AOS sterilization apparatus, we examined the viability of the BI as a function of exposure time, assessing the role of the decompression level in the sterilization performance. We found that the survival curves showed exponential reduction, and that the decompression level did not exert a significant influence on the survival curve. Subsequently, we investigated the sterilization effect as influenced by the spatial and environmental temperature variation throughout the chamber, and found that the sterilization effect varied with position, due to the varying environmental temperature in the respective areas. We confirmed that temperature is one of the most important factors influencing sterilization in the chamber, and estimated the temperature effect on the distribution of atomic oxygen concentration, using the quartz crystal microbalance (QCM) method with fluorocarbon thin film prepared by radio frequency sputtering.	[Yoshino, Kiyoshi; Matsumoto, Hiroyuki; Iwasaki, Tatsuyuki; Kinoshita, Shinobu] Iwasaki Elect Co Ltd, Dept Res & Dev, Gyoda, Saitama 3618505, Japan; [Noda, Kazutoshi] Natl Inst Adv Sci & Technol AIST, Res Inst Environm Management Technol, Tsukuba, Ibaraki 3058569, Japan; [Yoshino, Kiyoshi; Matsumoto, Hiroyuki; Oya, Kei; Iwamori, Satoru] Tokai Univ, Fac Engn, Hirastuka City, Kanagawa 2591292, Japan	Yoshino, K (reprint author), Iwasaki Elect Co Ltd, Dept Res & Dev, 1-1 Ichiriyma Chou, Gyoda, Saitama 3618505, Japan.	yoshino-kiyoshi@eye.co.jp			Japan Science and Technology Agency (JST) [AS2414101P]	This work was partially supported by a Grant-in-Aid for A-STEP (No. AS2414101P) from the Japan Science and Technology Agency (JST).	Addy T, 1989, INT KILM MEM C STER, P11; Moisan M, 2001, INT J PHARM, V226, P1, DOI 10.1016/S0378-5173(01)00752-9; Shintani Hideharu, 2007, Biocontrol Science, V12, P131; von Keudell A, 2010, PLASMA PROCESS POLYM, V7, P327, DOI 10.1002/ppap.200900121; Yoshino K, 2013, VACUUM, V93, P84, DOI 10.1016/j.vacuum.2013.01.009; Hayashi N, 2006, JPN J APPL PHYS 1, V45, P8358, DOI 10.1143/JJAP.45.8358; Cvelbar U., 2009, J APPL PHYS, V106; Gans T., 2005, PLASMA PHYS CONTROL, V47, P353; Halfmann H, 2007, J PHYS D APPL PHYS, V40, P4145, DOI 10.1088/0022-3727/40/14/008; Iwamori S, 2012, SENSOR ACTUAT B-CHEM, V171, P769, DOI 10.1016/j.snb.2012.05.070; Kobayashi T, 1997, JAPANESE J MED INSTR, V67, P303; Matsumoto H., 2010, J MAT SCI SOC JPN, V47, P42; Mozetic M, 2011, VACUUM, V85, P1080, DOI 10.1016/j.vacuum.2010.12.023; Nagatsu M, 2003, JPN J APPL PHYS 2, V42, pL856, DOI 10.1143/JJAP.42.L856; Raballand V., 2008, J PHYS D, V41; Sasaki T., 1998, METHOD STERILIZATION, P215; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Sugimitsu H, BASICS APPL OZONE, P24; Tamazawa K., 2006, JAPANESE J MED INSTR, V76, P187; Tanaka T, 2005, J VAC SCI TECHNOL A, V23, P1018, DOI 10.1116/1.1943468; Wei TC, 2005, SURF COAT TECH, V200, P2214, DOI 10.1016/j.surfcoat.2005.04.028; Yoshino K., 2012, J VAC SOC JPN, V55, P389; Yoshino K, 2012, SENSOR MATER, V24, P21; Yoshino K., 2013, JPN J APPL PHYS, V52; Yoshino Kiyoshi, 2011, Journal of the Vacuum Society of Japan, V54, DOI 10.3131/jvsj2.54.467	25	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	MAR	2015	20	1					11	18				8	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CF7RU	WOS:000352754800002		
J	Furuhata, K; Ishizaki, N; Fukuyama, M				Furuhata, Katsunori; Ishizaki, Naoto; Fukuyama, Masafumi			Antibacterial Susceptibility of Enterobacteriaceae Isolated from Raw Horsemeat Intended for Human Consumption (Basashi)	BIOCONTROL SCIENCE			English	Article						Enterobacteriaceae; Antibacterial susceptibility; R-plasmid; ESBLs; Raw horsemeat (basashi)	LACTAMASE (ESBL)-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; R-FACTORS; MEAT; PREVALENCE; STRAINS; JAPAN	Drug susceptibility testing was carried out using 14 antibiotics in order to identify trends in the antibiotic tolerance of 142 strains of Enterobacteriaceae isolated from horsemeat commercially available for raw consumption (basashi). A comparison of the sensitivity to the 14 antibiotics using the 90% MIC (minimum inhibitory concentration) values (MIC90) showed the strongest tolerance to ampicillin (ABPC) at a concentration of >128 mu g/mL, followed by that to fosfomycin (FOM) at a concentration of 128 mu g/mL. When the sensitivity to these antibiotics was examined for each individual genus of tested bacteria, Hafnia spp. exhibited relative tolerance to ceftazidime (CAZ) and ceftriaxone (CTRX) at a concentration of 4 mu g/mL and 2 mu g/mL, respectively, which was high in comparison to that observed for the other strains. Furthermore, Raoultella spp. and Serratia spp. were found to be highly resistant to tetracycline (TC) at a concentration of 128 mu g/mL and 64 mu g/mL, respectively. Of the 142 strains of test bacteria, 140 (98.6%) demonstrated resistance to ABPC, with the exception of Hafnia alvei and Klebsiella pneumonia. In addition, a total of eight strains (5.6%), seven Serratia marcescens strains and one Raoultella terrigena strain, were found to be resistant to TC. Furthermore, one strain of Citrobacter freundii exhibited resistance to nalidixic acid (NA), while another displayed resistance to ofloxacin (OFLX) (0.7% each), and one strain (0.7%) each of Enterobacter cloacae, Serratia marcescens and Citrobacter youngae demonstrated resistance to fosfomycin (FOM), streptomycin (SM) and kanamycin (KM), respectively. A single strain of C. freundii was found to be resistant to three antibiotics, ABPC, NA and OFLX. Resistance to two antibiotics was confirmed in 11 strains, including seven strains of S. marcescens and one strain of R. terrigena (a total of eight strains) resistant to ABPC and TC, and one strain each of C. youngae, S. marcescens and E. cloacae resistant to ABPC and KM, ABPC and SM, and ABPC and FOM, respectively. In addition, 128 strains were resistant to the single antibiotic of ABPC alone. Of the 140 strains demonstrating antibiotic resistance, 137 (97.9%) retained the conjugative R-plasmid transfer factor, excluding three strains of S. marcescens. All transfer factors were ABPC and retained by a high proportion of the bacterial groups, with one strain (100%) being resistant to three antibiotics, nine (81.8%) of the 11 strains being resistant to two antibiotics, and 127 (99.2%) of the 128 strains being resistant to a single antibiotic. In addition, we examined ESBL productivity in the 140 strains of bacteria demonstrating drug tolerance; however, no strains exhibited this characteristic. Therefore, further observation is required to ascertain trends in antibiotic-tolerant bacteria.	[Furuhata, Katsunori; Ishizaki, Naoto; Fukuyama, Masafumi] Azabu Univ, Sch Life & Environm Sci, Sagamihara, Kanagawa 2525201, Japan	Fukuyama, M (reprint author), Azabu Univ, Sch Life & Environm Sci, Sagamihara, Kanagawa 2525201, Japan.	fukuyama@azabu-u.ac.jp			Azabu University Research Services Division	This research was supported in part by a research project grant awarded by the Azabu University Research Services Division.	Ahmed AM, 2009, J FOOD SCI, V74, pM405, DOI 10.1111/j.1750-3841.2009.01291.x; Anjum MF, 2013, J FOOD SCI, V78, pM1892, DOI 10.1111/1750-3841.12297; Hiroi M, 2012, J FOOD PROTECT, V75, P1774, DOI 10.4315/0362-028X.JFP-11-479; Tschudin-Sutter S, 2014, INFECT CONT HOSP EP, V35, P581, DOI 10.1086/675831; Brinas L, 2005, J ANTIMICROB CHEMOTH, V56, P1107, DOI 10.1093/jac/dki370; JARLIER V, 1988, REV INFECT DIS, V10, P867; Gu WM, 2009, APPL ENVIRON MICROB, V75, P474, DOI 10.1128/AEM.02012-08; Van TTH, 2007, APPL ENVIRON MICROB, V73, P7906, DOI 10.1128/AEM.00973-07; BABCOCK GF, 1973, APPL MICROBIOL, V25, P21, DOI 10.1108/01445150510578978; BENSINK JC, 1981, AUST VET J, V57, P12, DOI 10.1111/j.1751-0813.1981.tb07077.x; Cernela N., 2013, EPIDEMIOL INFECT, V142, P84; Clinical and Laboratory Standards Institute, 2006, M7A7 CLSI; Clinical Laboratory Standards Institute, 2007, M100S17 CLSI; Fitch BR, 2005, J CLIN MICROBIOL, V43, P4221, DOI 10.1128/JCM.43.8.4221-4224.2005; Furuhata K, 2014, BIOCONTROL SCI, V19, P181, DOI 10.4265/bio.19.181; Hammad AM, 2009, J FOOD PROTECT, V72, P624; Isakbaeva E., 2005, EUROSURVEILLANCE, V10, P272; Ishizaki N., 2011, J ENV DIS, V20, P7; Jemima SA, 2008, INDIAN J MED RES, V128, P313; Jorgensen S.B., 2014, SCAND J INFECT DIS, P1; Mendonca N, 2007, ANTIMICROB AGENTS CH, V51, P1946, DOI 10.1128/AAC.01412-06; MITSUHAS.S, 1967, J BACTERIOL, V94, P1166; Shimojima Y., 2011, ANN REP TOKYO METR I, V62, P145; Tadesse D.A., 2012, EMERG INFECT DIS, DOI [10.3201/edi1805.111153, DOI 10.3201/EDI1805.111153]	24	1	1	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	MAR	2015	20	1					19	25				7	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CF7RU	WOS:000352754800003		
J	Shirai, A; Onitsuka, M; Maseda, H; Omasa, T				Shirai, Akihiro; Onitsuka, Masayoshi; Maseda, Hideaki; Omasa, Takeshi			Effect of Polyphenols on Reactive Oxygen Species Production and Cell Growth of Human Dermal Fibroblasts after Irradiation with Ultraviolet-A Light	BIOCONTROL SCIENCE			English	Article						Polyphenol; Ultraviolet-A; Reactive oxygen species; Cell proliferation	HUMAN SKIN FIBROBLASTS; OXIDATIVE STRESS; RETINAL CELLS; UVA; APOPTOSIS; RADIATION; CULTURE; DAMAGE	Ultraviolet-A (UV-A) can damage microbes by generating reactive oxygen species (ROS), singlet oxygen, superoxides, hydrogen peroxide and hydroxyl radicals. These species readily react with lipids, proteins, DNA and other constituents of cells, leading to oxidative deterioration and the eventual death of the microbe. However, the oxidative ability of these reactive species also harms the viability of mammalian cells such as fibroblasts and keratinocytes, as they cause both acute and chronic damage, photo-aging, and photo-carcinogenesis. This study describes a UV-A treatment that does not affect the viability or growth of human neonate dermal fibroblasts, as determined by examining the post-irradiation cell density after the addition of polyphenols as antioxidants. The results demonstrate the possible wide applicability of UV-A sterilization. The potency of polyphenols for attenuating UV-A-induced ROS generation in cells was tested using (+) -catechin hydrate, (-) -epigallocatechin gallate hydrate, morin hydrate, quercetin hydrate and resveratrol. The lowest concentration of polyphenols required to reduce ROS by 50% in cells upon exposure to a dose of 15 J cm(-2) was determined and defined as its IC50. Pre-treatment with morin hydrate at its IC50 allowed cells irradiated with 5.0 J cm(-2) UV-A to recover to the level of the specific growth rate of cells incubated without UV-A irradiation. However, the growth rate of cells exposed to 15 J cm(-2) UV-A irradiation was scarcely influenced by co-incubation with morin hydrate; this dose of UV-A also suppressed cell growth completely in the absence of morin hydrate, although co-incubation resulted in no decrease in cell viability. This study demonstrates the potential of polyphenols for protecting both the viability of cells and their ability to proliferate from damage caused by UV-A-irradiation.	[Shirai, Akihiro; Onitsuka, Masayoshi; Maseda, Hideaki; Omasa, Takeshi] Univ Tokushima, Inst Sci & Technol, Biosyst Engn, Dept Biol Sci & Technol, Tokushima 7708506, Japan	Shirai, A (reprint author), Univ Tokushima, Inst Sci & Technol, Biosyst Engn, Dept Biol Sci & Technol, 2-1 Minamijosanjima Cho, Tokushima 7708506, Japan.	a.shirai@tokushima-u.ac.jp			Japan Society for the Promotion of Science [23750217]	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (no. 23750217).	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Ammar Rebai Ben, 2007, Chem Biol Interact, V168, P171, DOI 10.1016/j.cbi.2007.04.002; Basly JP, 2000, LIFE SCI, V66, P769, DOI 10.1016/S0024-3205(99)00650-5; Shirai A, 2014, J PHOTOCH PHOTOBIO B, V130, P226, DOI 10.1016/j.jphotobiol.2013.11.027; Mori M, 2007, MED BIOL ENG COMPUT, V45, P1237, DOI 10.1007/s11517-007-0263-1; Hseu YC, 2012, FOOD CHEM TOXICOL, V50, P1245, DOI 10.1016/j.fct.2012.02.020; SCHARFFETTER K, 1991, ARCH DERMATOL RES, V283, P506, DOI 10.1007/BF00371923; Pourzand C, 1999, PHOTOCHEM PHOTOBIOL, V70, P380, DOI 10.1111/j.1751-1097.1999.tb08239.x; Basu-Modak S, 2003, FREE RADICAL BIO MED, V35, P910, DOI 10.1016/S0891-5849(03)00436-2; Hamamoto A, 2007, J APPL MICROBIOL, V103, P2291, DOI 10.1111/j.1365-2672.2007.03464.x; Trela BC, 1996, J AGR FOOD CHEM, V44, P1253, DOI 10.1021/jf9504576; Morita A, 1997, J EXP MED, V186, P1763, DOI 10.1084/jem.186.10.1763; Areias FM, 2001, BIOCHEM PHARMACOL, V62, P111, DOI 10.1016/S0006-2952(01)00621-9; Gadelmoula Mostafa, 2009, J Med Invest, V56, P150, DOI 10.2152/jmi.56.150; Jaszewska E, 2013, J PHOTOCH PHOTOBIO B, V126, P42, DOI 10.1016/j.jphotobiol.2013.07.001; OMASA T, 1992, BIOTECHNOL BIOENG, V39, P556, DOI 10.1002/bit.260390511; Ozgova Sarka, 2003, Biochemical Pharmacology, V66, P1127, DOI 10.1016/S0006-2952(03)00425-8; REGO AC, 1995, ARCH BIOCHEM BIOPHYS, V321, P127, DOI 10.1006/abbi.1995.1377; Shirai A., 2014, BIOCONTROL SCI, V18, P59; Venditti E, 2011, J DERMATOL SCI, V63, P55, DOI 10.1016/j.jdermsci.2011.03.008	20	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	MAR	2015	20	1					27	33				7	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CF7RU	WOS:000352754800004		
J	Matsumura, Y; Akahira-Moriya, A; Sasaki-Mori, M				Matsumura, Yoshinobu; Akahira-Moriya, Ayako; Sasaki-Mori, Miho			Bioremediation of Bisphenol-A Polluted Soil by Sphingomonas bisphenolicum AO1 and the Microbial Community Existing in the Soil	BIOCONTROL SCIENCE			English	Article						Bisphenol A; Xenobiotic pollution; Bioremediation; PCR-TTGE analysis; Sphingomonas	DIGLYCIDYL-ETHER BADGE; AROMATIC-COMPOUNDS; STRAIN AO1; EXPOSURE; BIODEGRADATION; MIGRATION; TOXICITY; GENES; METABOLISM; WILDLIFE	Bisphenol A (BPA, 2,2'-Bis(4-hydroxyphenyl)propane) is an artificial pollutant that is easily detected in soil and water environments. BPA decomposition and removal from the environment is relatively difficult due to its stability. This study evaluated the BPA decomposition and removal activities of the microbial community existing in the soil with or without Sphingomonas bisphenolicum AO1, and revealed the toxic effects of BPA towards the microbial community. The microbial community in soil was able to degrade BPA at 1.0 mg.g(-1) soil or lower, although its degradation was slow. On the other hand, BPA at more than 10 mg.g(-1) soil was not only degraded by the microbial community but also decreased its diversity, suggesting that BPA is harmful to many microorganisms. PCR-TTGE analysis and the cloned 16S rRNA gene sequence analysis indicated that Sphingomonadales, Xanthomonadales, Burkholderiales and Pseudomonadales in the microbial community might independently or cooperatively degrade BPA. On the other hand, supplementation with strain AO1 was able to significantly improve the BPA decomposition activity of the microbial community in soil even at 10 mg BPA.g(-1) soil, although BPA at 100 mg.g(-1) soil overwhelmed the BPA decomposition activity of strain AO1. Furthermore, it was also concluded that strain AO1 could not inhabit BPA purified soil after decomposition of BPA by strain AO1 and the soil microbial community, suggesting that the application of strain AO1 could be a low-burden method for the decomposition and removal of BPA from the natural environment.	[Matsumura, Yoshinobu; Akahira-Moriya, Ayako; Sasaki-Mori, Miho] Kansai Univ, Dept Life Sci & Biotechnol, Suita, Osaka 5648680, Japan; [Matsumura, Yoshinobu] Kansai Univ, Org Res & Dev Innovat Sci & Technol, Suita, Osaka 5648680, Japan	Matsumura, Y (reprint author), Kansai Univ, Dept Life Sci & Biotechnol, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	ymatsu@kansal-u.ac.jp			MEXT-Supported Programs for the Strategic Research Foundation at Private University; JSPS KAKENHI [24510108]	We thank Dr. K. Oshiman at the Sumitomo Forestry Co., Ltd., for valuable and helpful discussions. This study was supported in part by the MEXT-Supported Programs for the Strategic Research Foundation at Private University 2008-2012 and 2013-2018, and JSPS KAKENHI Grant Number 24510108.	Ammar E, 2005, WORLD J MICROB BIOT, V21, P253, DOI 10.1007/s11274-004-3625-y; Tyl RW, 2008, TOXICOL SCI, V104, P362, DOI 10.1093/toxsci/kfn084; Crain DA, 2007, REPROD TOXICOL, V24, P225, DOI 10.1016/j.reprotox.2007.05.008; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Matsumura Y, 2009, BIOCONTROL SCI, V14, P161; Gaido KW, 1997, TOXICOL APPL PHARM, V143, P205, DOI 10.1006/taap.1996.8069; Markey CM, 2001, ENVIRON HEALTH PERSP, V109, P55, DOI 10.2307/3434921; Kang JH, 2006, TOXICOLOGY, V226, P79, DOI 10.1016/j.tox.2006.06.009; Flint S, 2012, J ENVIRON MANAGE, V104, P19, DOI 10.1016/j.jenvman.2012.03.021; Muncke Jane, 2009, Sci Total Environ, V407, P4549, DOI 10.1016/j.scitotenv.2009.05.006; Mihaich EM, 2009, ECOTOX ENVIRON SAFE, V72, P1392, DOI 10.1016/j.ecoenv.2009.02.005; CHATTERJEE DK, 1987, J BACTERIOL, V169, P1993; Kang JH, 2006, TOXICOLOGY, V217, P81, DOI 10.1016/j.tox.2005.10.001; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Staples CA, 2002, HUM ECOL RISK ASSESS, V8, P1083, DOI 10.1080/1080-700291905837; Kuske CR, 1998, APPL ENVIRON MICROB, V64, P2463; Mohapatra DP, 2010, CHEMOSPHERE, V78, P923, DOI 10.1016/j.chemosphere.2009.12.053; Jones DC, 2008, BIOCHEM PHARMACOL, V76, P569, DOI 10.1016/j.bcp.2008.05.010; O'Sullivan LA, 2005, LETT APPL MICROBIOL, V41, P8, DOI 10.1111/j.1472-765X.2005.01758.x; Sasaki M, 2005, BIODEGRADATION, V16, P449, DOI 10.1007/s10532-004-5023-4; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; ALEXANDER HC, 1988, ENVIRON TOXICOL CHEM, V7, P19, DOI 10.1897/1552-8618(1988)7[19:BAAAT]2.0.CO;2; Oehlmann J, 2009, PHILOS T R SOC B, V364, P2047, DOI 10.1098/rstb.2008.0242; Munguia-Lopez EM, 2001, J AGR FOOD CHEM, V49, P3666, DOI 10.1021/jf0009044; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Staples CA, 1998, CHEMOSPHERE, V36, P2149, DOI 10.1016/S0045-6535(97)10133-3; Gutierrez T, 2013, APPL ENVIRON MICROB, V79, P205, DOI 10.1128/AEM.02833-12; Jackson CR, 1997, APPL ENVIRON MICROB, V63, P4993; Kang JH, 2002, FOOD ADDIT CONTAM, V19, P886, DOI 10.1080/02652030210147278; Sasaki M, 2008, J APPL MICROBIOL, V105, P1158, DOI 10.1111/j.1365-2672.2008.03843.x; SIMAL-GANDARA J, 1993, FOOD ADDIT CONTAM A, V10, P555; Simoneau C, 1999, FOOD ADDIT CONTAM A, V16, P457, DOI 10.1080/026520399283740; Welshons WV, 1999, TOXICOL IND HEALTH, V15, P12, DOI 10.1191/074823399678846745	33	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	MAR	2015	20	1					35	42				8	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CF7RU	WOS:000352754800005		
J	Horiuchi, I; Kawata, H; Nagao, T; Imaohji, H; Murakami, K; Kino, Y; Yamasaki, H; Koyama, AH; Fujita, Y; Goda, H; Kuwahara, T				Horiuchi, Isanori; Kawata, Hiroyuki; Nagao, Tamiko; Imaohji, Haruyuki; Murakami, Kazuya; Kino, Yasuhiro; Yamasaki, Hisashi; Koyama, A. Hajime; Fujita, Yatsuka; Goda, Hisataka; Kuwahara, Tomomi			Antimicrobial Activity and Stability of Weakly Acidified Chlorous Acid Water	BIOCONTROL SCIENCE			English	Article						Chlorous acid water; Weak acidification; Broiler carcasses; Stability in fabrics	ESCHERICHIA-COLI O157-H7; OXYCHLORO-BASED SANITIZER; SODIUM-CHLORITE; MUNG BEANS; INACTIVATION; SALMONELLA; DISINFECTANTS; HYPOCHLORITE; GLUTATHIONE; EFFICACY	The antimicrobial activity of weakly acidified chlorous acid water (WACAW) against Staphylococcus aureus, non-pathogenic Escherichia coil, enterohemorrhagic E coil (EHEC O157:H7), Candida albicans, and spore-forming Bacillus and Paenibacillus species was evaluated in vitro. The antiviral activity was also examined using feline calicivirus (FCV). Diluted WACAW (>100 ppm) effectively reduced the number of non-spore-forming bacteria (>4 log(10) CFU reductions) within 5 min. Treatment with this sanitizer at 400 ppm for 30 min achieved>5 log(10) CFU reductions in spore-forming Bacillus and Paenibacillus species while an equivalent concentration of sodium hypochlorite (NaCIO) resulted in only a 0.98 and 2.72 log(10) CFU reduction, respectively. The effect of this sanitizer against FCV was equivalent to that of NaCIO. Immersion in WACAW (400 ppm) achieved >4 and 2.26 log(10) CFU reductions in Campylobacter jejuni and EHEC, respectively, on artificially contaminated broiler carcass pieces. Finally, the antimicrobial activity of this sanitizer was shown to be maintained for at least 28 d when in contact with nonwoven fabric (100% cotton). This study showed that pH control of chlorous acid is expected to modify its antimicrobial activity and stability. WACAW is expected to have applications in various settings such as the food processing and healthcare industries.	[Horiuchi, Isanori; Nagao, Tamiko; Imaohji, Haruyuki; Murakami, Kazuya; Kino, Yasuhiro; Kuwahara, Tomomi] Kagawa Univ, Fac Med, Dept Microbiol, Kagawa 7610793, Japan; [Horiuchi, Isanori; Kawata, Hiroyuki; Fujita, Yatsuka; Goda, Hisataka] Honbu Sankei Co Ltd, Chuou Ku, Osaka, Japan; [Yamasaki, Hisashi; Koyama, A. Hajime] Wakayama Med Univ, Grad Sch Med, Div Virol, Dept Cellular & Mol Med, Wakayama 6418509, Japan; [Koyama, A. Hajime] Wakayama Shin Ai Womens Jr Coll, Wakayama 6400341, Japan	Kuwahara, T (reprint author), Kagawa Univ, Fac Med, Dept Microbiol, 1750-1 Miki, Kagawa 7610793, Japan.	tomomi@med.kagawa-u.ac.jp			Honbu Sankei Co. Ltd.	We thank Dr. Katayama (Institute of Infectious Diseases in Japan) for his kind gift of FCV strain F4 and CRFK cells. We are also thankful for the technical assistance of Mr. Tanaka. This study was performed as collaborative research with Honbu Sankei Co. Ltd. and was financially supported by funds from this company.	Beuchat LR, 2004, J FOOD PROTECT, V67, P1238; Doultree JC, 1999, J HOSP INFECT, V41, P51, DOI 10.1016/S0195-6701(99)90037-3; Kumar M, 2007, J APPL MICROBIOL, V102, P1427, DOI 10.1111/j.1365-2672.2006.03175.x; Girard M, 2010, J FOOD PROTECT, V73, P400; Allende A, 2009, FOOD CONTROL, V20, P230, DOI 10.1016/j.foodcont.2008.05.009; Duizer E, 2004, APPL ENVIRON MICROB, V70, P4538, DOI 10.1128/AEM.70.8.4538-4543.2004; WEI CI, 1985, FOOD TECHNOL-CHICAGO, V39, P107; Ingram PR, 2003, ARCH BIOCHEM BIOPHYS, V410, P121, DOI 10.1016/S0003-9861(02)00659-8; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Park GW, 2007, APPL ENVIRON MICROB, V73, P4463, DOI 10.1128/AEM.002839-06; Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016; Beuchat L.R., 1998, SURFACE DECONTAMINAT; Castillo A, 1999, J FOOD PROTECT, V62, P580; Chitnis V, 2004, AM J INFECT CONTROL, V32, P306, DOI 10.1016/j.ajic.2003.10.007; COATES D, 1988, J HOSP INFECT, V11, P60, DOI 10.1016/0195-6701(88)90040-0; Cohen S. H., 2013, INFECT CONT HOSP EP, V31, P423; Dalling J., 2004, BR J INFECT CONTROL, V5, P9, DOI 10.1177/14690446040050020301; Federal register, 1999, FED REG, V64, P49981; Gordon G., 1972, PROGR INORGANIC CHEM, V15, P15201; Hajmeer MN, 2004, MEAT SCI, V68, P277, DOI 10.1016/j.meatsci.2004.03.006; Hora R, 2007, LETT APPL MICROBIOL, V44, P188, DOI 10.1111/j.1472-765X.2006.02049.x; Ingram PR, 2004, FREE RADICAL RES, V38, P739, DOI 10.1080/10715760410001712773; Kemp GK, 2000, J FOOD PROTECT, V63, P1087; KOBAYASHI M, 1989, J FOOD HYG SOC JPN, V30, P367; Kumar M, 2006, J FOOD PROTECT, V69, P1571; Liao C. H., 2009, J FOOD SCI, V74, P159; Richardson SD, 1998, FOOD TECHNOL-CHICAGO, V52, P58; MacCannell T., 2011, GUIDELINE PREVENTION; Nthenge AK, 2007, J FOOD PROTECT, V70, P748; Richardson S. D., 1998, ENCY ENV ANAL REMEDI, V3, P1398; Young S. B., 2003, J APPL MICROBIOL, V95, P719	31	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	MAR	2015	20	1					43	51				9	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CF7RU	WOS:000352754800006		
J	Shimasaki, N; Okaue, A; Kikuno, R; Okuda, S; Abe, K				Shimasaki, Noriko; Okaue, Akira; Kikuno, Ritsuko; Okuda, Shunji; Abe, Keiko			Development of a New Technique Using Glass Beads for Dry Dispersion of Airborne Fungal Spores	BIOCONTROL SCIENCE			English	Article						Airborne fungal spores; Dry dispersion; Glass beads; Impinger		To evaluate the removal of airborne microbes by air cleaners, a technique for generating airborne fungal spores in the dry state in a test chamber (dry dispersion) become necessary. The Society of Indoor Environment Japan (SIEJ) published SIEJ Standard Method No. 20110001 (SIEJ standard), in which an aerial ultrasonic oscillator was used as the device for dry dispersion. However, a more versatile apparatus is also necessary from a practical point of view. Therefore, we developed a new device using glass beads for the dispersion. Glass beads and a fungal sheet containing spores of Wallemia sebi were set in a midget impinger, which was connected to a compressor and a compact test chamber (1 m(3)). Air was blown into the impinger from the compressor. The spores on the fungal sheet were released by impingement of the glass beads when the beads were induced to float by the air blown into the impinger, and the spores were introduced to the chamber by the airflow. This newly developed technique can be used in a compact chamber system and could be applicable as an improved method for generating airborne fungal spores in the dry state in the SIEJ standard.	[Shimasaki, Noriko; Okaue, Akira; Kikuno, Ritsuko; Okuda, Shunji] Kitasato Res Ctr Environm Sci, Minami Ku, Sagamihara, Kanagawa, Japan; [Abe, Keiko] JDC Corp, Inst Environm Biol, Aikawa, Kanagawa, Japan; [Shimasaki, Noriko] Natl Inst Infect Dis, Musashimurayama, Tokyo, Japan	Kikuno, R (reprint author), Kitasato Res Ctr Environm Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa, Japan.	shima@nih.go.jp					Abe K., 2007, INDOOR ENVIRON, V10, P163; [Anonymous], 2012, INDOOR ENV, V15, P49; Thomas RJ, 2008, APPL ENVIRON MICROB, V74, P6437, DOI 10.1128/AEM.01194-08; Gravesen S., 1994, MICROFUNGI, P154; Lin WH, 2003, AIHA J, V64, P102, DOI 10.1080/15428110308984798; NAKAMURA H, 1987, Bulletin of Tokyo Medical and Dental University, V34, P25; Nambu M., 2009, WORLD ALLERGY ORGAN, V2, P209; SALVAGGIO J, 1981, J ALLERGY CLIN IMMUN, V68, P327, DOI 10.1016/0091-6749(81)90131-7; Sudharsanam S, 2012, AFR HEALTH SCI, V12, P217, DOI 10.4314/ahs.v12i2.22; VERHOEFF AP, 1995, AM J EPIDEMIOL, V141, P103	10	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	MAR	2015	20	1					53	58				6	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CF7RU	WOS:000352754800007		
J	Nomura, H; Isshiki, Y; Sakuda, K; Sakuma, K; Kondo, S				Nomura, Harue; Isshiki, Yasunori; Sakuda, Keisuke; Sakuma, Katsuya; Kondo, Seiichi			Effects of Oakmoss and its Components on Acanthamoeba castellanii ATCC 30234 and the Uptake of Legionella pneumophila JCM 7571 (ATCC 33152) into A. castellanii	BIOCONTROL SCIENCE			English	Article						Oakmoss; Acanthamoeba castellanii; Legionella pneumophila; Amoebicidal activity; Uptake	FREE-LIVING AMEBAS; DOMESTIC TAP WATER; BIOCIDE SUSCEPTIBILITY; ANTIBACTERIAL ACTIVITY; INCREASING IMPORTANCE; INTRACELLULAR GROWTH; IDENTIFICATION; PATHOGENICITY; DISINFECTION; RESISTANCE	Acanthamoeba castellanii, a ubiquitous organism in water environments, is pathogenic toward humans and also is a host for bacteria of the genus Legionella, a causative agent of legionellosis. Oakmoss, a natural fragrance ingredient, and its components are antibacterial agents specifically against the genus Legionella. In the present study, oakmoss and its components were investigated for their amoebicidal activity against A. castellanii ATCC 30234 and the inhibitory effect on the uptake of L. pneumophila JCM 7571 (ATCC 33152) into A. castellanii. The oakmoss and its components 3-hydroxy-5-methylphenyl 2,4-dihydroxy-6-methylbenzoate (5), and 6,8-dihydroxy-3-penty1-1H-isochromen-1-one (12) exhibited high amoebicidal activity (IC50 values; 10.5 +/- 2.3, 16.3 +/- 4.0 and 17.5 +/- 2.8 mu g/mL, respectively) after 48 h of treatment, which were equivalent to that of the reference compound, chlorhexidine gluconate. Pretreatment of L. pneumophila with sub-minimal inhibitory concentration of oakmoss, compound 5, 3-hydroxy-5-methylphenyl 2-hydroxy-4-methoxy-6-methylbenzoate (10) and 8(2,4-dihydroxy-6-pentylphenoxy) -6-hydroxy-3-penty1-1H-isochromen-1-one (14) obviously reduced the uptake of L. pneumophila into A. castellanii (p < 0.05). The inhibitory effect of compound 5 on the uptake of L. pneumophila was almost equivalent to that of ampicillin used as a reference. Thus, the oakmoss and its components were considered to be good candidates for disinfectants against not only genus Legionella but also A. castellanii.	[Nomura, Harue; Isshiki, Yasunori; Kondo, Seiichi] Josai Univ, Sch Pharmaceut Sci, Dept Microbiol, Sakado, Saitama 3500295, Japan; [Sakuda, Keisuke; Sakuma, Katsuya] Ogawa & Co Ltd, Fragrance R&D Dept, Urayasu, Chiba 2790032, Japan	Kondo, S (reprint author), Josai Univ, Sch Pharmaceut Sci, Dept Microbiol, Sakado, Saitama 3500295, Japan.	kondo@josai.ac.jp					MOFFAT JF, 1992, INFECT IMMUN, V60, P296; Martin-Navarro CM, 2008, J MED MICROBIOL, V57, P1399, DOI 10.1099/jmm.0.2008/003459-0; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; KNIREL YA, 1994, EUR J BIOCHEM, V221, P239, DOI 10.1111/j.1432-1033.1994.tb18734.x; Turner NA, 2000, J ANTIMICROB CHEMOTH, V46, P27, DOI 10.1093/jac/46.1.27; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Ettinger MR, 2003, PARASITOL RES, V89, P6, DOI 10.1007/s00436-002-0707-3; Khunkitti W, 1998, J INFECTION, V36, P43, DOI 10.1016/S0163-4453(98)93054-7; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Dupuy M, 2011, WATER RES, V45, P1087, DOI 10.1016/j.watres.2010.10.025; Szenasi Z, 1998, J MED MICROBIOL, V47, P5; BARKER J, 1992, APPL ENVIRON MICROB, V58, P2420; Bandyopadhyay P, 2004, INFECT IMMUN, V72, P4541, DOI 10.1128/IAI.72.8.4541-4551.2004; Garduno RA, 2002, INFECT IMMUN, V70, P6273, DOI 10.1128/IAI.70.11.6273-6283.2002; Thomas V, 2004, J APPL MICROBIOL, V97, P950, DOI 10.1111/j.1365-2672.2004.02391.x; Hsu BM, 2009, WATER RES, V43, P2817, DOI 10.1016/j.watres.2009.04.002; GULIG PA, 1993, INFECT IMMUN, V61, P504; Edagawa A, 2009, PARASITOL RES, V105, P1109, DOI 10.1007/s00436-009-1528-4; Nomura H, 2012, BIOL PHARM BULL, V35, P1560; Garcia MT, 2007, ENVIRON MICROBIOL, V9, P1267, DOI 10.1111/j.1462-2920.2007.01245.x; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Kim BR, 2002, WATER RES, V36, P4433, DOI 10.1016/S0043-1354(02)00188-4; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kilvington S, 2004, INVEST OPHTH VIS SCI, V45, P165, DOI 10.1167/iovs.03-0559; BARKER J, 1995, ANTIMICROB AGENTS CH, V39, P2684; Borazjani RN, 2000, APPL ENVIRON MICROB, V66, P1057, DOI 10.1128/AEM.66.3.1057-1061.2000; Clinical and Laboratory Standards Institute, 2000, M7A5 CLIN LAB STAND; Cooper IR, 2010, J HOSP INFECT, V74, P152, DOI 10.1016/j.jhin.2009.07.005; Gianinazzi C, 2009, EXP PARASITOL, V121, P180, DOI 10.1016/j.exppara.2008.11.001; Gomes AT, 2006, Z NATURFORSCH C, V61, P653; Gomes AT, 2003, BRAZ J MICROBIOL, V34, P194, DOI 10.1590/S1517-83822003000300002; Huang SW, 2010, ACTA TROP, V115, P282, DOI 10.1016/j.actatropica.2010.04.012; Jeong HJ, 2007, EXP PARASITOL, V117, P357, DOI 10.1016/j.exppara.2007.05.003; Luck PC, 1998, ANTIMICROB AGENTS CH, V42, P2870; McBride J, 2005, J CLIN MICROBIOL, V43, P629, DOI 10.1016/JCM.43.2.629-634.2005; Nomura H, 2013, BIOL PHARM BULL, V36, P833; Sasaki M., 2003, MIYAGI PREFECTURAL I, V21, P56; Takeda Y., 2008, J JPN COSMET SCI SOC, V32, P95; Winiecka-Krusnell J, 2001, RES MICROBIOL, V152, P613, DOI 10.1016/S0923-2508(01)01240-2; WRIGHT JB, 1991, J APPL BACTERIOL, V71, P531, DOI 10.1111/j.1365-2672.1991.tb03828.x	40	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	MAR	2015	20	1					59	65				7	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CF7RU	WOS:000352754800008		
J	Okuno, T; Tani, K; Yamaguchi, N; Nasu, M				Okuno, Toshihiro; Tani, Katsuji; Yamaguchi, Nobuyasu; Nasu, Masao			Expression of gyrB and 16S Ribosomal RNA Genes as Indicators of Growth and Physiological Activities of Legionella pneumophila	BIOCONTROL SCIENCE			English	Article						Legionella pneumophila; Growth activity; Physiological activity; Gene expression	WATER; DNA; PCR; TRANSCRIPTION; REPLICATION; SYSTEM	To determine whether the DNA gyrase (gyrB) and 16S ribosomal RNA (16S rRNA) genes can be used as indicators of the biological activities of Legionella pneumophila, the expression levels were estimated. The ratio of mRNA/DNA in gyrB was 0.7 in mid log phase and decreased drastically after the log phase. For 16S rRNA, the ratio was highest in mid log phase (7.0 x 10(3)), and the value that was about 10% of that in the log phase was maintained for six days. The rRNA may be vital in the resting or active but nonculturable cells that are not growing but physiologically active. The expression levels of gyrB mRNA and 16S rRNA can be used as indicators of the growth activity and the physiological activity of L. pneumophila, respectively. Therefore, by measurement of these indicators, we can evaluate the activities of Legionella cells in various environments.	[Okuno, Toshihiro; Tani, Katsuji; Yamaguchi, Nobuyasu; Nasu, Masao] Osaka Univ, Grad Sch Pharmaceut Sci, Environm Sci & Microbiol, Suita, Osaka 5650871, Japan; [Tani, Katsuji] Osaka Ohtani Univ, Fac Pharm, Environm Sci & Microbiolgy, Tondabaya, Osaka 5848540, Japan	Tani, K (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Environm Sci & Microbiol, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	tanika@osaka-ohtani.ac.jp					Wellinghausen N, 2001, APPL ENVIRON MICROB, V67, P3985, DOI 10.1128/AEM.67.9.3985-3993.2001; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; STAHL DA, 1988, APPL ENVIRON MICROB, V54, P1079; Ingle CA, 1996, P NATL ACAD SCI USA, V93, P12926, DOI 10.1073/pnas.93.23.12926; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Sexton JA, 2004, J BACTERIOL, V186, P3814, DOI 10.1128/JB.186.12.3814-3825.2004; Murga R, 2001, MICROBIOL-SGM, V147, P3121; BEJ AK, 1991, APPL ENVIRON MICROB, V57, P597; WRIGHT JB, 1989, INFECT CONT HOSP EP, V10, P408; Coutard F, 2005, J APPL MICROBIOL, V98, P951, DOI 10.1111/j.1365-2672.2005.02534.x; TSAI YL, 1991, APPL ENVIRON MICROB, V57, P1070; FUHRMAN JA, 1980, APPL ENVIRON MICROB, V39, P1085; Nogva HK, 2003, BIOTECHNIQUES, V34, P804; Guerrieri E, 2005, FEMS MICROBIOL LETT, V252, P113, DOI 10.1016/j.femsle.2005.08.040; Koide M, 2001, J Infect Chemother, V7, P224, DOI 10.1007/s101560170017; Roy CR, 1997, INFECT IMMUN, V65, P571; Roberts RC, 1997, J BACTERIOL, V179, P2319; Steinert M, 1997, APPL ENVIRON MICROB, V63, P2047; Tani K., 2012, J ENV BIOTECHOL, V12, P33; Turetgen I, 2005, ENVIRON MONIT ASSESS, V100, P53, DOI 10.1007/s10661-005-7058-3	20	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	MAR	2015	20	1					67	70				4	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CF7RU	WOS:000352754800009		
J	Inoue, H; Takama, T; Yoshizaki, M; Agata, K				Inoue, Hiroaki; Takama, Tomoko; Yoshizaki, Miwa; Agata, Kunio			Detection of Legionella Species in Environmental Water by the Quantitative PCR Method in Combination with Ethidium Monoazide Treatment	BIOCONTROL SCIENCE			English	Article						Bath; Cooling tower; Ethidium monoazide (EMA); Legionella; Quantitative polymerase chain reaction (qPCR)	CELLS; QUANTIFICATION; PNEUMOPHILA; CULTURE	We detected Legionella species in 111 bath water samples and 95 cooling tower water samples by using a combination of conventional plate culture, quantitative polymerase chain reaction (qPCR) and qPCR combined with ethidium monoazide treatment (EMA-qPCR) methods. In the case of bath water samples, Legionella spp. were detected in 30 samples by plate culture, in 85 samples by qPCR, and in 49 samples by EMA-qPCR. Of 81 samples determined to be Legionella-negative by plate culture, 56 and 23 samples were positive by qPCR and EMA-qPCR, respectively. Therefore, EMA treatment decreased the number of Legionella-positive bath water samples detected by qPCR. In contrast, EMA treatment had no effect on cooling tower water samples. We therefore expect that EMA-qPCR is a useful method for the rapid detection of viable Legionella spp. from bath water samples.	[Inoue, Hiroaki; Takama, Tomoko; Agata, Kunio] Aquas Corp, Tsukuba Res Labs, Tsukuba, Ibaraki 3002646, Japan; [Yoshizaki, Miwa] Takara Bio Inc, SCM Ctr, Otsu, Shiga 5202193, Japan	Inoue, H (reprint author), Aquas Corp, Tsukuba Res Labs, 4-4 Midorigahara, Tsukuba, Ibaraki 3002646, Japan.	h_inoue0417@aquas.co.jp			Health and Labor Science Research [H25-kenki-009]	We thank Ms. Asako Morishita in our laboratory for her excellent assistance in the molecular biological experiments. This work was partially supported by the Health and Labor Science Research Grants (H25-kenki-009).	Qin T, 2012, WORLD J MICROB BIOT, V28, P1881, DOI 10.1007/s11274-011-0986-x; Chang B, 2009, APPL ENVIRON MICROB, V75, P147, DOI 10.1128/AEM.00604-08; Ng DLK, 1997, LETT APPL MICROBIOL, V24, P214, DOI 10.1046/j.1472-765X.1997.00382.x; Chen NT, 2010, J APPL MICROBIOL, V109, P623, DOI 10.1111/j.1365-2672.2010.04678.x; Nogva HK, 2003, BIOTECHNIQUES, V34, P804; Chang B, 2010, JPN J INFECT DIS, V63, P119; Delgado-Viscogliosi P, 2009, APPL ENVIRON MICROB, V75, P3502, DOI 10.1128/AEM.02878-08; Furuhata Katsunori, 2005, Biocontrol Science, V10, P117; Inoue Hiroaki, 2004, Biocontrol Science, V9, P43; Inoue H., 2004, BOKIN BOBAI, V32, P481; International Organization for Standardization, 1998, ISO11731; Vogel JP, 1999, CURR OPIN MICROBIOL, V2, P30, DOI 10.1016/S1369-5274(99)80005-8	12	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	MAR	2015	20	1					71	74				4	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CF7RU	WOS:000352754800010		
J	Choai, YK; Matsui, S				Choai, Yuki; Matsui, Shigeyuki			Estimation of Treatment Effects in All-Comers Randomized Clinical Trials with a Predictive Marker	BIOMETRICS			English	Article						All-comers designs; Predictive markers; Randomized clinical trials; Truncated normal distribution; Unbiased estimation	CELL LUNG-CANCER; BIOMARKER; ERLOTINIB; PHASE-3; DESIGNS	Recent advances in genomics and biotechnologies have accelerated the development of molecularly targeted treatments and accompanying markers to predict treatment responsiveness. However, it is common at the initiation of a definitive phase III clinical trial that there is no compelling biological basis or early trial data for a candidate marker regarding its capability in predicting treatment effects. In this case, it is reasonable to include all patients as eligible for randomization, but to plan for prospective subgroup analysis based on the marker. One analysis plan in such all-comers designs is the so-called fallback approach that first tests for overall treatment efficacy and then proceeds to testing in a biomarker-positive subgroup if the first test is not significant. In this approach, owing to the adaptive nature of the analysis and a correlation between the two tests, a bias will arise in estimating the treatment effect in the biomarker-positive subgroup after a non-significant first overall test. In this article, we formulate the bias function and show a difficulty in obtaining unbiased estimators for a whole range of an associated parameter. To address this issue, we propose bias-corrected estimation methods, including those based on an approximation of the bias function under a bounded range of the parameter using polynomials. We also provide an interval estimation method based on a bivariate doubly truncated normal distribution. Simulation experiments demonstrated a success in bias reduction. Application to a phase III trial for lung cancer is provided.	[Choai, Yuki] Grad Univ Adv Studies, Dept Stat Sci, Tachikawa, Tokyo 1908562, Japan; [Matsui, Shigeyuki] Nagoya Univ, Grad Sch Med, Dept Biostat, Showa Ku, Nagoya, Aichi 4668550, Japan	Choai, YK (reprint author), Grad Univ Adv Studies, Dept Stat Sci, 10-3 Midori Cho, Tachikawa, Tokyo 1908562, Japan.	choai@ism.ac.jp					Gregorc V, 2014, LANCET ONCOL, V15, P713, DOI 10.1016/S1470-2045(14)70162-7; Simon R, 2008, CLIN CANCER RES, V14, P5984, DOI 10.1158/1078-0432.CCR-07-4531; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Maitournam A, 2005, STAT MED, V24, P329, DOI 10.1002/sim.1975; COHEN AC, 1950, ANN MATH STAT, V21, P557, DOI 10.1214/aoms/1177729751; Hoering A, 2008, CLIN CANCER RES, V14, P4358, DOI 10.1158/1078-0432.CCR-08-0288; Song Y, 2007, STAT MED, V26, P3535, DOI 10.1002/sim.2825; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Simon R, 2006, PHARMACOGENOMICS J, V6, P166, DOI 10.1038/sj.tpj.6500349; Mandrekar SJ, 2009, J CLIN ONCOL, V27, P4027, DOI 10.1200/JCO.2009.22.3701; SELLKE T, 1983, BIOMETRIKA, V70, P315; Buyse M, 2011, EXPERT REV MOL DIAGN, V11, P171, DOI [10.1586/erm.10.120, 10.1586/ERM.10.120]; Wang SJ, 2007, PHARM STAT, V6, P227, DOI 10.1002/pst.300; Freidlin B, 2013, J CLIN ONCOL, V31, P3158, DOI 10.1200/JCO.2012.48.3826; Jennison C, 1999, GROUP SEQUENTIAL MET; Matsui S, 2014, CLIN CANCER RES, V20, P2820, DOI 10.1158/1078-0432.CCR-13-2698; Raj D, 1953, SANKHYA, V12, P277; Simon R, 2012, STAT MED, V31, P3031, DOI 10.1002/sim.5401; Spiessens B, 2010, CONTEMP CLIN TRIALS, V31, P647, DOI 10.1016/j.cct.2010.08.011; WEILER H, 1959, AUST J STAT, V1, P73	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-341X	1541-0420		BIOMETRICS	Biometrics	MAR	2015	71	1					25	32		10.1111/biom.12253		8	Biology; Mathematical & Computational Biology; Statistics & Probability	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology; Mathematics	CF5GO	WOS:000352585700004		
J	Hao, J; Liu, S; Chen, Y; Li, YX; Kitanaka, S; Li, HR				Hao, Jie; Liu, Shun; Chen, Yan; Li, Yongxia; Kitanaka, Susumu; Li, Heran			COUMARINS FROM THE TWIGS OF Juglans regia AND THEIR NITRIC OXIDE INHIBITORY ACTIVITIES	CHEMISTRY OF NATURAL COMPOUNDS			English	Article						Juglans regia; juglanslactone; coumarin; inhibitory activity on NO production	ROOTS	In our investigation of in vitro anti-allergic screening of medicinal herbal extracts, the chloroform extract of the twigs of Juglans regia L. was observed to show inhibitory activity on nitric oxide (NO) production in a lipopolysaccharide (LPS) and recombinant mouse interferon-gamma activated murine macrophage-like cell line RAW 264.7. Fractionation of the active extract led to the isolation of one new coumarin, juglanslactone (1), with four known compounds, isoscopoletin (2), osthol (3), psoralene (4), and ayapanin (5). The structures and configurations were elucidated by spectroscopic methods.	[Hao, Jie; Liu, Shun; Chen, Yan; Li, Yongxia; Li, Heran] Soochow Univ, Coll Pharmaceut Sci, Suzhou 215123, Peoples R China; [Kitanaka, Susumu] Nihon Univ, Coll Pharm, Funabashi, Chiba 2748555, Japan	Hao, J (reprint author), Soochow Univ, Coll Pharmaceut Sci, 199 Ren Rd,Suzhou Ind Pk, Suzhou 215123, Peoples R China.	heranli@suda.edu.cn			PAPD (Priority Academic Program Development of Jiangsu Higher Education Institutions); Ministry of Education, Culture, Sports, Science, and Technology	The authors gratefully acknowledge financial support from PAPD (a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions). This work was supported by a Special Research Grant-in-Aid for the Promotion and Mutual Aid Corporation for Private Schools of Japan to Nihon University, and by a grant from the Ministry of Education, Culture, Sports, Science, and Technology to promote multidisciplinary research projects.	Adfa M, 2010, J CHEM ECOL, V36, P720, DOI 10.1007/s10886-010-9807-1; GUPTA SR, 1972, PHYTOCHEMISTRY, V11, P2634, DOI 10.1016/S0031-9422(00)88569-6; Jerezano A, 2011, HELV CHIM ACTA, V94, P185, DOI 10.1002/hlca.201000306; Ngadjui BT, 1998, PHYTOCHEMISTRY, V48, P733, DOI 10.1016/S0031-9422(98)00017-X; Basile A, 2009, MOLECULES, V14, P939, DOI 10.3390/molecules14030939; BINDER RG, 1989, PHYTOCHEMISTRY, V28, P2799, DOI 10.1016/S0031-9422(00)98092-0; Kim HK, 1999, BIOCHEM PHARMACOL, V58, P759, DOI 10.1016/S0006-2952(99)00160-4; Carvalho M, 2010, FOOD CHEM TOXICOL, V48, P441, DOI 10.1016/j.fct.2009.10.043; Guo JM, 2005, FOOD CHEM, V91, P287, DOI 10.1016/j.foodchem.2004.04.029; Zhu Y, 2010, FOOD CHEM, V118, P228, DOI 10.1016/j.foodchem.2009.04.112; Canales-Martinez M, 2005, PHARM BIOL, V43, P305, DOI 10.1080/13880200590951685; Lei T., 2010, CHINA MED HERALD, V23; Thanh PN, 2004, ARCH PHARM RES, V27, P1211, DOI 10.1007/BF02975883; Tseng HY, 2005, BIOORG MED CHEM LETT, V15, P2027, DOI 10.1016/j.bmcl.2005.02.063; Wang S. L., 1995, J PHARM PRACT, V13, P40; Wang ZQ, 2012, PEST MANAG SCI, V68, P1041, DOI 10.1002/ps.3265	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-3130	1573-8388		CHEM NAT COMPD+	Chem. Nat. Compd.	MAR	2015	51	2					236	238		10.1007/s10600-015-1251-6		3	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CF6BQ	WOS:000352641900006		
J	Sekii, Y; Han, J; Isoda, H; Bouaziz, M; Dhouib, A; Sayadi, S; Shigemori, H				Sekii, Yukiko; Han, Junkyu; Isoda, Hiroko; Bouaziz, Mohamed; Dhouib, Abdelhafidh; Sayadi, Sami; Shigemori, Hideyuki			Two Isorhamnetin Glycosides from Arthrocnemum glaucum that Inhibit Adipogenesis in 3T3-L1 Adipocytes	CHEMISTRY OF NATURAL COMPOUNDS			English	Article							STRUCTURAL-CHARACTERIZATION; FLAVONOID GLYCOSIDES; THYMELAEA-HIRSUTA; MELANOMA-CELLS; EXTRACT; ACID		[Sekii, Yukiko; Han, Junkyu; Isoda, Hiroko; Shigemori, Hideyuki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Han, Junkyu; Isoda, Hiroko] Univ Tsukuba, Alliance Res North Africa, Tsukuba, Ibaraki 3058572, Japan; [Bouaziz, Mohamed; Dhouib, Abdelhafidh; Sayadi, Sami] Univ Sfax, Sfax Biotechnol Ctr, Lab Environm Bioproc, Sfax, Tunisia	Sekii, Y (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	shigemori.hideyuk.fn@u.tsukuba.ac.jp			JST-JICA Science and Technology Research Partnership for Sustainable Development (SATREPS)	This work was partially supported by the JST-JICA Science and Technology Research Partnership for Sustainable Development (SATREPS) and grant-in-aids for the Ministry of Education, Science, Sports, and Culture of Japan.	KASAI R, 1979, TETRAHEDRON, V35, P1427, DOI 10.1016/0040-4020(79)85038-3; Miyamae Y, 2009, J NAT PROD, V72, P938, DOI 10.1021/np800808h; MARKHAM KR, 1978, TETRAHEDRON, V34, P1389, DOI 10.1016/0040-4020(78)88336-7; Kerhoas L, 2006, J AGR FOOD CHEM, V54, P6603, DOI 10.1021/jf061043n; Wang MF, 1999, J AGR FOOD CHEM, V47, P4880, DOI 10.1021/jf990608v; Babael H, 2008, TURK J BIOL, V32, P203; Dawidar A. M., 1974, EGYPT J CHEM, V17, P869; Du XM, 2000, PHYTOCHEMISTRY, V53, P997, DOI 10.1016/S0031-9422(00)00027-3; FUKUNAGA T, 1988, CHEM PHARM BULL, V36, P1185; Kawano M, 2007, EXP DERMATOL, V16, P977, DOI 10.1111/j.1600-0625.2007.00618.x; KHALIL AT, 1992, PHYTOCHEMISTRY, V31, P1023; Martin-Cordero C, 2000, J NAT PROD, V63, P248, DOI 10.1021/np990105j; PUVANESARAJAH V, 1991, CARBOHYD RES, V218, P211, DOI 10.1016/0008-6215(91)84099-Z; RIZK A M, 1986, Fitoterapia, V57, P3; SANDBERG F, 1967, ACTA PHARM SUEC, V4, P51; Shinmoto H, 2005, J JPN SOC FOOD SCI, V52, P535; Tundis R, 2008, Z NATURFORSCH C, V63, P347	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-3130	1573-8388		CHEM NAT COMPD+	Chem. Nat. Compd.	MAR	2015	51	2					338	340		10.1007/s10600-015-1276-x		3	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CF6BQ	WOS:000352641900031		
J	Giang, PM; Nhan, TTT; Chinh, TTT; Son, PT; Matsunami, K				Phan Minh Giang; Tran Thi Thanh Nhan; Truong Thi To Chinh; Phan Tong Son; Matsunami, Katsuyoshi			Phytochemical Constituents of Artemisia dubia var. longeracemosa Forma tonkinensis	CHEMISTRY OF NATURAL COMPOUNDS			English	Article									[Phan Minh Giang; Tran Thi Thanh Nhan; Truong Thi To Chinh; Phan Tong Son] Vietnam Natl Univ, VNU Univ Sci, Fac Chem, Hanoi, Vietnam; [Matsunami, Katsuyoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Minami Ku, Hiroshima 7348553, Japan	Giang, PM (reprint author), Vietnam Natl Univ, VNU Univ Sci, Fac Chem, 19 Le Thanh Tong St, Hanoi, Vietnam.	phanminhgiang@yahoo.com			Vietnam National Foundation for Science and Technology Development (NAFOSTED) [104.01-2012.10]	This research is funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 104.01-2012.10.	Akihisa T, 1997, ANAL STEROLS; Tan RX, 1998, PLANTA MED, V64, P295, DOI 10.1055/s-2006-957438; Huang ZS, 2010, PLANTA MED, V76, P1710, DOI 10.1055/s-0030-1249957; Ansari SH, 2000, INDIAN J CHEM B, V39, P287; Ashraf M, 2010, J MED PLANTS RES, V4, P112; Hayat M. Q., 2009, ETHNOBOT RES APPL, V7, P147; Lee HJ, 2010, J KOREAN SOC APPL BI, V53, P826, DOI 10.3839/jksabc.2010.125; Levy G. C., 1976, TOPICS CARBON 13 NMR, V2; Masahiro T., 1990, HETEROCYCLES, V31, P1431; Pretsch E., 2009, STRUCTURE DETERMINAT; Qi SH, 2004, CHEM PHARM BULL, V52, P986, DOI 10.1248/cpb.52.986; Yu CC, 2003, B KOR CHEM SOC, V24, P1229	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-3130	1573-8388		CHEM NAT COMPD+	Chem. Nat. Compd.	MAR	2015	51	2					378	380		10.1007/s10600-015-1290-z		3	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CF6BQ	WOS:000352641900045		
J	Tosun, A; Nagashima, F; Asakawa, Y				Tosun, A.; Nagashima, F.; Asakawa, Y.			Terpenoid and Steroid Components of Selected Liverworts	CHEMISTRY OF NATURAL COMPOUNDS			English	Article							NEW-ZEALAND; PINGUISANE; SESQUITERPENOIDS; CONSTITUENTS; JAPANESE		[Tosun, A.] Ankara Univ, Fac Pharm, Dept Pharmacognosy, TR-06100 Ankara, Turkey; [Nagashima, F.; Asakawa, Y.] Tokushima Bunri Univ, Fac Pharmaceut Sci, Yamashiro, Tokushima 7708514, Japan	Tosun, A (reprint author), Ankara Univ, Fac Pharm, Dept Pharmacognosy, TR-06100 Ankara, Turkey.	pharmacogalev@gmail.com			TUBITAK (Scientific and Technical Research Council of the Turkish Republic); Tokushima Bunri University	The authors wish to thank TUBITAK (Scientific and Technical Research Council of the Turkish Republic) and Tokushima Bunri University for support of this study. In particular, we would like to thank Dr. Hasan Kirmizibekmez (Yeditepe University, Faculty of Parmacy, Deparment of Pharmacognosy) and Dr. Liva Harinantenaina (Virginia Polytechnic Institute and State University, Department of Chemistry, USA) for their kind support and discussion on the structural elucidation of the compounds.	Asakawa Y, 2001, PHYTOCHEMISTRY, V56, P297, DOI 10.1016/S0031-9422(00)00454-4; Asakawa Y, 2003, PHYTOCHEMISTRY, V62, P439, DOI 10.1016/S0031-9422(02)00542-3; Asakawa Y., 1995, PROGR CHEM ORGANIC N, V65; Braun NA, 2007, ARKIVOC, P273; Buchanan MS, 1996, PHYTOCHEMISTRY, V43, P1249, DOI 10.1016/S0031-9422(96)00513-4; Bungert M, 1998, PHYTOCHEMISTRY, V49, P1079, DOI 10.1016/S0031-9422(98)00073-9; Crandall-Stotler BJ, 2005, TAXON, V54, P299; Hai F., 2009, ZHONGGUO HAIYANG YAO, V28, P23; Hashimoto T, 2000, PHYTOCHEMISTRY, V53, P593, DOI 10.1016/S0031-9422(99)00451-3; Huang Weihua, 2009, Zhongguo Zhong Yao Za Zhi, V34, P712; Kontiza I, 2006, STEROIDS, V71, P177, DOI 10.1016/j.steroids.2005.09.004; Nagashima F, 1996, PHYTOCHEMISTRY, V42, P1361, DOI 10.1016/0031-9422(96)00105-7; Tazaki H, 1998, PHYTOCHEMISTRY, V48, P851, DOI 10.1016/S0031-9422(97)00983-7; Toyota M, 1997, PHYTOCHEMISTRY, V44, P293, DOI 10.1016/S0031-9422(96)00479-7; Weyerstahl P, 1999, FLAVOUR FRAG J, V14, P121, DOI 10.1002/(SICI)1099-1026(199903/04)14:2<121::AID-FFJ790>3.0.CO;2-K	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-3130	1573-8388		CHEM NAT COMPD+	Chem. Nat. Compd.	MAR	2015	51	2					387	391		10.1007/s10600-015-1294-8		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CF6BQ	WOS:000352641900049		
J	Lai, YT; Sato, M; Ohta, S; Akamatsu, K; Nakao, S; Sakai, Y; Ito, T				Lai, Yao-Tong; Sato, Mayu; Ohta, Seiichi; Akamatsu, Kazuki; Nakao, Shin-ichi; Sakai, Yasuyuki; Ito, Taichi			Preparation of uniform-sized hemoglobin-albumin microspheres as oxygen carriers by Shirasu porous glass membrane emulsification technique	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						Oxygen carriers; Hemoglobin; Albumin; Shirasu porous glass membrane; Membrane emulsification	LIPOSOME-ENCAPSULATED HEMOGLOBIN; HUMAN SERUM-ALBUMIN; BOVINE HEMOGLOBIN; BLOOD SUBSTITUTES; IN-VITRO; PARTICLES; MICROCAPSULES; EFFICIENCY; CONJUGATE; STABILITY	We have developed a new type of artificial oxygen carrier composed of bovine hemoglobin (bHb) and bovine serum albumin (BSA) prepared by Shirasu porous glass (SPG) membrane emulsification technique. The resultant emulsion droplets containing 10 wt% bHb and 5-20 wt% BSA were subsequently crosslinked by glutaraldehyde to form the microspheres. Due to the uniform pore structure of SPG membranes, the average diameters of bHb(10)-BSA(m) microspheres were successfully controlled at around 5 mu m with a coefficient of variation of around 10%. In addition, the biocompatibility of the carriers depended on their oxyhemoglobin percentage regardless of their same size. Finally, the P-50 values of these microspheres ranged from 8.08 to 11.60 mmHg, which showed a high oxygen affinity and an oxygen delivery function. (C) 2015 Elsevier B.V. All rights reserved.	[Lai, Yao-Tong; Sato, Mayu; Ito, Taichi] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Ohta, Seiichi; Ito, Taichi] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan; [Akamatsu, Kazuki; Nakao, Shin-ichi] Kogakuin Univ, Dept Environm & Energy Chem, Hachioji, Tokyo 1920015, Japan; [Sakai, Yasuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Ito, T (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	taichi@m.u-tokyo.ac.jp		Ohta, Seiichi/0000-0002-4775-8199	Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT); Interchange Association, Japan (IAJ)	The authors thank Center for NanoBio Integration (CNBI), the University of Tokyo, for the use of the confocal microscope and Sakamoto Yakuhin Kogyo Co., Japan, for their kind supply of TGCR. We also thank the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) and Interchange Association, Japan (IAJ) for their financial support.	Akamatsu K, 2010, LANGMUIR, V26, P14854, DOI 10.1021/la101967u; Agashe H, 2010, COLLOID SURFACE B, V75, P573, DOI 10.1016/j.colsurfb.2009.09.038; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Jia Y, 2012, ADV FUNCT MATER, V22, P1446, DOI 10.1002/adfm.201102737; Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106; SNYDER SR, 1987, P NATL ACAD SCI USA, V84, P7280, DOI 10.1073/pnas.84.20.7280; Nakashima T, 2000, ADV DRUG DELIVER REV, V45, P47, DOI 10.1016/S0169-409X(00)00099-5; Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; Qi F, 2013, COLLOID SURFACE B, V112, P492, DOI 10.1016/j.colsurfb.2013.08.048; Meng FT, 2004, COLLOID SURFACE B, V33, P177, DOI 10.1016/j.colsurfb.2003.10.003; Chen K, 2012, BIOMACROMOLECULES, V13, P2748, DOI 10.1021/bm3007242; Liu R, 2006, COLLOID SURFACE B, V51, P30, DOI 10.1016/j.colsurfb.2006.05.014; Tomita D, 2013, BIOMACROMOLECULES, V14, P1816, DOI 10.1021/bm400204y; Tsuchida E, 2009, BIOCONJUGATE CHEM, V20, P1419, DOI 10.1021/bc800431d; Kukizaki M, 2007, COLLOID SURFACE A, V293, P87, DOI 10.1016/j.colsurfa.2006.07.011; CEDRATI N, 1994, ARTIF CELL BLOOD SUB, V22, P867, DOI 10.3109/10731199409117923; Centis V, 2008, COLLOID SURFACE B, V65, P239, DOI 10.1016/j.colsurfb.2008.04.009; Chauvierre C, 2010, BIOMATERIALS, V31, P6069, DOI 10.1016/j.biomaterials.2010.04.039; Dessy A, 2011, EUR J PHARM SCI, V43, P57, DOI 10.1016/j.ejps.2011.03.010; Eike JH, 2004, BIOTECHNOL PROGR, V20, P1225, DOI 10.1021/bp049974b; Gao W, 2011, BIOMATERIALS, V32, P9425, DOI 10.1016/j.biomaterials.2011.08.046; Iacob B, 2011, ARTIF CELL BLOOD SUB, V39, P293, DOI 10.3109/10731199.2011.563362; KIOSSEOGLOU V, 1994, FOOD HYDROCOLLOID, V8, P27; Lu XL, 2005, ARTIF CELL BLOOD SUB, V33, P83, DOI 10.1081/BIO-200055841; Montagne K, 2011, J BIOSCI BIOENG, V112, P485, DOI 10.1016/j.jbiosc.2011.07.004; Naruto H, 2007, J BIOSCI BIOENG, V104, P343, DOI 10.1263/jbb.104.343; Oser B. L., 1965, HAWKS PHYSL CHEM; Sakai Y, 2010, BIOCHEM ENG J, V48, P348, DOI 10.1016/j.bej.2009.10.010; Titles A. W., 2001, BIOTECHNOL BIOENG, V73, P379; Vladisavljevic GT, 2005, ADV COLLOID INTERFAC, V113, P1, DOI 10.1016/j.cis.2004.10.002; Xiong Y, 2013, ACS NANO, V7, P7454, DOI 10.1021/nn402073n; Xiong Y, 2012, BIOMACROMOLECULES, V13, P3292, DOI 10.1021/bm301085x; YABUKI A, 1990, TRANSFUSION, V30, P516, DOI 10.1046/j.1537-2995.1990.30690333482.x; Zhao J, 2007, BIOMATERIALS, V28, P1414, DOI 10.1016/j.biomaterials.2006.10.012	36	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765	1873-4367		COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	MAR 1	2015	127						1	7		10.1016/j.colsurfb.2015.01.018		7	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	CG0YY	WOS:000353001400001		
J	Yoshikawa, C; Qiu, J; Huang, CF; Shimizu, Y; Suzuki, J; van den Bosch, E				Yoshikawa, Chiaki; Qiu, Jun; Huang, Chih-Feng; Shimizu, Yoshihisa; Suzuki, Junji; van den Bosch, Edith			Non-biofouling property of well-defined concentrated polymer brushes	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						Concentrated polymer brush; Living radical polymerization; Protein; Cell; Non-biofouling	SURFACE INTERACTION FORCES; PROTEIN ADSORPTION; METHACRYLATE) BRUSHES; SERUM-ALBUMIN; CHAIN-LENGTH; ANGIOGENESIS; DENSITY; ELLIPSOMETRY; SUSPENSIONS; MICROSCOPY	The non-biofouling properties of polymer brushes of poly(2-hydroxyethyl methacrylate) (PHEMA), poly(2-hydroxyethyl acrylate) (PHEA), and poly(poly(ethylene glycol) methyl ether methacrylate) (PPEGMA) were comprehensively studied by varying graft densities (i.e., semi-dilute and concentrated regimes) and the thicknesses at the dry state of 2 and 10 nm. Semi-dilute polymer brushes (SDPBs) were prepared by grafting-to method and concentrated polymer brushes (CPBs) were prepared by surface-initiated atom transfer radical polymerization (SI-ATRP). The adsorptions of proteins with different sizes were investigated on the brushes by quartz crystal microbalance (QCM) from a view point of size-exclusion effect specific to the CPBs. We confirmed that due to the size exclusion effect, the CPBs of all the three much suppressed proteins adsorption and human umbilical vein endothelial cell (HUVEC) adhesion compared with the corresponding SDPBs. In order to investigate what type of proteins adsorbed on the brushes to trigger cell adhesion, we identified adsorbed proteins from fetal bovine serum on the brushes using a high-performance liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Proteins were only detected on the SDPBs. Interestingly, the number and type of identified proteins were different on the SDPBs, indicating that chemical composition of the SDPBs affects protein adsorption, hence the cell adhesion. The adsorption mechanism on the SDPBs could be due to the combination of protein-polymer interaction and physical inclusion, whereas CPBs exhibit size exclusion effect combined with neutral hydrophilic nature of polymer, thereby, that provides excellent non-biofouling property. (C) 2015 Elsevier B.V. All rights reserved.	[Yoshikawa, Chiaki; Huang, Chih-Feng; Shimizu, Yoshihisa; Suzuki, Junji] Natl Inst Mat Sci, WPI Res Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Qiu, Jun] DSM Ahead TS, NL-6167 RD Geleen, Netherlands; [Huang, Chih-Feng] Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan; [van den Bosch, Edith] DSM Biomed, NL-6167 RD Geleen, Netherlands	Yoshikawa, C (reprint author), Natl Inst Mat Sci, WPI Res Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan.	YOSHIKAWA.Chiaki@nims.go.jp; edith.bosch-van-den@dsm.com	Huang, Chih-Feng/C-2297-2012	Huang, Chih-Feng/0000-0002-8062-8708	DSM, The Netherlands; JST-CREST; Nano-Integration Foundry (NIMS) in "Nanotechnology Platform Project"	This research was supported by DSM, The Netherlands, and partially supported by JST-CREST and Nano-Integration Foundry (NIMS) in "Nanotechnology Platform Project" operated by MEXT, Japan. CY thanks Mrs. Fumi Wakui for help with SDS-PAGE experiments.	Nomura A, 2011, MACROMOLECULES, V44, P5013, DOI 10.1021/ma200340d; GOLANDER CG, 1988, J COLLOID INTERF SCI, V121, P240, DOI 10.1016/0021-9797(88)90428-6; Ohno K, 2006, MACROMOLECULES, V39, P1245, DOI 10.1021/ma0521708; [Anonymous], 1995, COLLOID SURFACE B, DOI 10.1016/0927-7765(94)01139-V; Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a; Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u; Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1; SUTTIPRASIT P, 1992, J COLLOID INTERF SCI, V154, P316, DOI 10.1016/0021-9797(92)90146-D; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Ohno K, 2007, MACROMOLECULES, V40, P9143, DOI 10.1021/ma071770z; CARTER DC, 1990, SCIENCE, V249, P302, DOI 10.1126/science.2374930; KOHN EC, 1995, P NATL ACAD SCI USA, V92, P1307, DOI 10.1073/pnas.92.5.1307; Edmondson S, 2004, CHEM SOC REV, V33, P14, DOI 10.1039/b210143m; Lai BFL, 2010, BIOMATERIALS, V31, P6710, DOI 10.1016/j.biomaterials.2010.05.052; Yoshikawa C, 2006, MACROMOLECULES, V39, P2284, DOI 10.1021/ma0520242; Asolphi U., 1997, POLYMER, V38, P1513; BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406; Dolatshahi-Pirouz A, 2009, LANGMUIR, V25, P2971, DOI 10.1021/la803142u; He H., 2003, POLYM PREPR JPN SOC, V52, P2961; Liy J. H. -Y., 1999, MACROMOLECULES, V32, P8611; Sharp JS, 2002, BIOCHEMISTRY-US, V41, P15810, DOI 10.1021/bi020525z; Taraboletti G, 2004, EUR J CANCER, V40, P881, DOI 10.1016/j.ejca.2004.01.002; Tsujii Y, 2006, ADV POLYM SCI, V197, P1, DOI 10.1007/12_063; Tsujii Y., 2009, J PHYS C SER, P184; Yamamoto S, 2000, MACROMOLECULES, V33, P5602, DOI 10.1021/ma991733a; Yamamoto S, 2000, MACROMOLECULES, V33, P5608, DOI 10.1021/ma991988o; Yoshikawa C, 2007, J POLYM SCI POL CHEM, V45, P4795, DOI 10.1002/pola.22224; Yoshikawa C, 2012, MATER LETT, V83, P140, DOI 10.1016/j.matlet.2012.05.123; Yoshikawa C, 2010, CHEM LETT, V39, P142, DOI 10.1246/cl.2010.142	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765	1873-4367		COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	MAR 1	2015	127						213	220		10.1016/j.colsurfb.2015.01.026		8	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	CG0YY	WOS:000353001400028		
J	Anzai, R; Murakami, Y				Anzai, Ryosuke; Murakami, Yoshihiko			Poly(epsilon-caprolactone) (PCL)-polymeric micelle hybrid sheets for the incorporation and release of hydrophilic proteins	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						Sheet; Polymeric micelle; Protein; Sustained release; Fractal analysis	ANHYDROUS ISOOCTANE; FRACTAL DIMENSION; POLYMERIC MICELLE; SUSTAINED-RELEASE; GROWTH-FACTOR; PLA RESEARCH; HYDROGEL; COMPLEX; SURFACE; PEG	Sheets have several advantages over conventional gel- or particle-type drug carriers. Sheets have several notable attributes: sheets' size and shape are easily adjustable, sheets are highly accessible in surgery, and sheets have a large contact area relative to drug-targeting sites. However, it is difficult to incorporate hydrophilic proteins into hydrophobic sheets and to release the proteins over the long term in a sustained manner. In the present study, we show that "poly(epsilon-caprolactone) (PCL)-polymeric micelle hybrid sheets" can be used for the incorporation and release of hydrophilic proteins. Polymeric micelles (i.e., spaces that can incorporate hydrophilic compounds) are, in this study, uniformly dispersed in hydrophobic and biocompatible biomaterial sheet. We have clarified that the composition of block copolymer, methoxy-terminated poly(ethylene glycol)-block-poly(epsilon-caprolactone) (CH3O-PEG-b-PCL), can affect two variables: the stability of w/o emulsion and the release properties of the resulting sheets, by means of visual qualitative observations, newly developed quantitative analyses (advanced fractal analysis, advanced FD) based on deviation of the fractal dimension (FD), and release experiments. We clarified that the release behavior of BSA was affected by the composition of the block copolymers and the resulting emulsion. The results obtained in this paper show that the hydrophobic sheets in which polymeric micelles providing hydrophilic spaces were dispersed could be an effective platform for incorporating and releasing hydrophilic proteins. (C) 2015 Elsevier B.V. All rights reserved.	[Anzai, Ryosuke; Murakami, Yoshihiko] Tokyo Univ Agr & Technol, Dept Organ & Polymer Mat Chem, Fac Engn, Koganei, Tokyo 1848588, Japan	Murakami, Y (reprint author), Tokyo Univ Agr & Technol, Dept Organ & Polymer Mat Chem, Fac Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	muray@cc.tuat.ac.jp	Murakami, Yoshihiko/C-9485-2013		Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [22700490]	This study was funded, in part, by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (grant number: 22700490).	Gautam S, 2013, MAT SCI ENG C-MATER, V33, P1228, DOI 10.1016/j.msec.2012.12.015; Sutter M, 2007, J CONTROL RELEASE, V119, P301, DOI 10.1016/j.jconrel.2007.03.003; BROWN GL, 1988, ANN SURG, V208, P788, DOI 10.1097/00000658-198812000-00019; Fujie T, 2009, ADV FUNCT MATER, V19, P2560, DOI 10.1002/adfm.200900103; Mallwitz F, 2005, ADV MATER, V17, P1296, DOI 10.1002/adma.200401123; Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028; Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006; Eck W, 2005, ADV MATER, V17, P2583, DOI 10.1002/adma.200500900; Kopecek J, 2012, ANGEW CHEM INT EDIT, V51, P7396, DOI 10.1002/anie.201201040; Tanaka M, 2008, POWDER TECHNOL, V186, P1, DOI 10.1016/j.powtec.2007.10.030; Bisoi AK, 2001, PATTERN RECOGN LETT, V22, P631, DOI 10.1016/S0167-8655(00)00132-X; Murakami Y, 2008, COLLOID SURFACE B, V65, P186, DOI 10.1016/j.colsurfb.2008.04.005; Tang HP, 2012, POWDER TECHNOL, V217, P383, DOI 10.1016/j.powtec.2011.10.053; Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092; Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031; Murakami Y, 2005, BIOMACROMOLECULES, V6, P2927, DOI 10.1021/bm0504330; Pang XA, 2010, BIOTECHNOL J, V5, P1125, DOI 10.1002/biot.201000135; Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001; Zhang JT, 2010, ACTA BIOMATER, V6, P3890, DOI 10.1016/j.actbio.2010.05.009; Kanakubo Y, 2010, COLLOID SURFACE B, V78, P85, DOI 10.1016/j.colsurfb.2010.02.017; Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002; Takami T, 2014, LANGMUIR, V30, P3329, DOI 10.1021/la500324j; Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008; Singh S, 2007, J NANOSCI NANOTECHNO, V7, P2596, DOI 10.1166/jnn.2007.909; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Murakami Y, 2007, J BIOMED MATER RES A, V80A, P421, DOI 10.1002/jbm.a.30911; Ghasemi-Mobarakeh L, 2010, MAT SCI ENG C-MATER, V30, P1129, DOI 10.1016/j.msec.2010.06.004; Griffin W. C., 1954, J SOC COSMET CHEM, V5, P249; Ito T, 2013, MAT SCI ENG C-MATER, V33, P3697, DOI 10.1016/j.msec.2013.04.056; Lin NM, 2014, APPL SURF SCI, V311, P330, DOI 10.1016/j.apsusc.2014.05.062; Maeda M, 2001, J CONTROL RELEASE, V77, P261, DOI 10.1016/S0168-3659(01)00512-0; McCarthy DW, 1996, J INVEST DERMATOL, V106, P49, DOI 10.1111/1523-1747.ep12327214; Moroishi H, 2013, COLLOID SURFACE B, V102, P597, DOI 10.1016/j.colsurfb.2012.08.050; Murakami Y, 2003, J MOL CATAL B-ENZYM, V22, P79, DOI 10.1016/S1381-1177(03)00009-2; Murakami Y., 2009, J BIOMED MAT RES B, V916, P102; Murakami Y, 2005, MACROMOLECULES, V38, P1535, DOI 10.1021/ma047803h; Murakami Y, 1999, J BIOSCI BIOENG, V88, P441, DOI 10.1016/S1389-1723(99)80224-2; Murakami Y, 1998, SEIBUTSU-KOGAKU KAIS, V76, P238; Murakami Y, 1999, BIOTECHNOL TECH, V13, P545, DOI 10.1023/A:1008987431361; Murakami Y, 2001, BIOTECHNOL LETT, V23, P125, DOI 10.1023/A:1010345318275; Okamura Y, 2008, COLLOID SURFACE A, V318, P184, DOI 10.1016/j.colsurfa.2007.12.049; Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7; Takami T, 2011, COLLOID SURFACE B, V87, P433, DOI 10.1016/j.colsurfb.2011.06.004; Uchida Y, 2013, J POLYM SCI POL PHYS, V51, P124, DOI 10.1002/polb.23187; Vinigradov S.V., 2002, ADV DRUG DELIV REV, V54, P135; Zhang Q, 2002, J BIOMED MATER RES, V60, P502, DOI 10.1002/jbm.1294	46	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765	1873-4367		COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	MAR 1	2015	127						292	299		10.1016/j.colsurfb.2015.01.028		8	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	CG0YY	WOS:000353001400037		
J	Suga, K; Kuwata, Y; Takashima, K; Chikasue, R				Suga, K.; Kuwata, Y.; Takashima, K.; Chikasue, R.			A D3Q27 multiple-relaxation-time lattice Boltzmann method for turbulent flows	COMPUTERS & MATHEMATICS WITH APPLICATIONS			English	Article						D3Q27; Lattice Boltzmann equation; Multiple-relaxation-time; Turbulent flow	LARGE-EDDY SIMULATION; GALILEAN INVARIANCE; ROTATIONAL INVARIANCE; MODELS; ISOTROPY; CHANNEL; SQUARE; MRT	A three-dimensional twenty-seven (D3Q27) discrete velocity multiple-relaxation-time lattice Boltzmann method is developed. The proposed scheme is validated in fully developed turbulent channel, pipe and porous medium flows through direct and large eddy simulations. The direct numerical simulation of the turbulent channel flow confirms that the present scheme is as reliable as the spectrum method for simulating turbulence. Through the large eddy simulations of the pipe and porous medium flows, the present scheme shows its satisfactory accuracy for simulating turbulent flows bounded by circular walls that is failed by the three-dimensional nineteen (D3Q19) model. (C) 2015 Elsevier Ltd. All rights reserved.	[Suga, K.; Kuwata, Y.; Takashima, K.; Chikasue, R.] Osaka Prefecture Univ, Dept Mech Engn, Sakai, Osaka 5998531, Japan	Suga, K (reprint author), Osaka Prefecture Univ, Dept Mech Engn, Sakai, Osaka 5998531, Japan.	suga@me.osakafu-u.ac.jp			JSPS Japan [24360073]	The technical support by Dr. M. Kaneda is appreciated. A part of this study was financially supported by the research grant (No. 24360073) of the JSPS Japan.	Geller S, 2013, COMPUT MATH APPL, V65, P1956, DOI 10.1016/j.camwa.2013.04.013; Holdych DJ, 2004, J COMPUT PHYS, V193, P595, DOI 10.1016/j.jcp.2003.08.012; Qian YH, 1998, EUROPHYS LETT, V42, P359, DOI 10.1209/epl/i1998-00255-3; Frohlich J, 2005, J FLUID MECH, V526, P19, DOI 10.1017/S0022112004002812; KIM J, 1987, J FLUID MECH, V177, P133, DOI 10.1017/S0022112087000892; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; d'Humieres D, 2002, PHILOS T ROY SOC A, V360, P437, DOI 10.1098/rsta.2001.0955; Lallemand P, 2000, PHYS REV E, V61, P6546, DOI 10.1103/PhysRevE.61.6546; Nicoud F, 1999, FLOW TURBUL COMBUST, V62, P183, DOI 10.1023/A:1009995426001; Kang SK, 2013, J COMPUT PHYS, V232, P100, DOI 10.1016/j.jcp.2012.07.023; Aidun CK, 2010, ANNU REV FLUID MECH, V42, P439, DOI 10.1146/annurev-fluid-121108-145519; Premnath KN, 2009, PHYSICA A, V388, P2640, DOI 10.1016/j.physa.2009.02.041; BHATNAGAR PL, 1954, PHYS REV, V94, P511, DOI 10.1103/PhysRev.94.511; Eggels JGM, 1996, INT J HEAT FLUID FL, V17, P307, DOI 10.1016/0142-727X(96)00044-6; Dong YH, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2842381; Yu H, 2006, COMPUT FLUIDS, V35, P957, DOI 10.1016/j.compfluid.2005.04.009; Inagaki M, 2010, INT J ENGINE RES, V11, P229, DOI 10.1243/14680874JER546; Augier A, 2014, COMPUT MATH APPL, V67, P239, DOI 10.1016/j.camwa.2013.06.009; Bardina J., 1983, TF10 STANF U DEP MEC; Chen HD, 2011, PHILOS T R SOC A, V369, P2176, DOI 10.1098/rsta.2010.0376; d'Humieres D, 1992, PROGR ASTRONAUTICS A, V159, P450; Dellar PJ, 2014, J COMPUT PHYS, V259, P270, DOI 10.1016/j.jcp.2013.11.021; Djenidi L, 2006, J FLUID MECH, V552, P13, DOI 10.1017/S002211200600869X; Dubois F, 2011, COMPUT MATH APPL, V61, P3404, DOI 10.1016/j.camwa.2011.01.011; Dybbs A., 1984, NATO ASI SER, V82, P199; Ginzburg I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066614; Guo Z., 2002, PHYS REV E, V65; Kuwata Y, 2015, J COMPUT PHYS, V280, P563, DOI 10.1016/j.jcp.2014.10.002; lida T., 2014, J PHYS C SER, V530; Mayer G, 2006, MATH COMPUT SIMULAT, V72, P173, DOI 10.1016/j.matcom.2006.05.011; Nie XB, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/34005; Pan C., 2006, COMPUT FLUIDS, V35, P957; Premnath KN, 2011, J STAT PHYS, V143, P747, DOI 10.1007/s10955-011-0208-9; Sagaut P, 2010, COMPUT MATH APPL, V59, P2194, DOI 10.1016/j.camwa.2009.08.051; Silva G, 2014, J COMPUT PHYS, V269, P259, DOI 10.1016/j.jcp.2014.03.027; Suga K, 2013, FLUID DYN RES, V45, DOI 10.1088/0169-5983/45/3/034501; Unger F., 1993, FULLY DEV TURBULENT; Yu D., 2005, J COMPUT PHYS, V209, P599; Yu DZ, 2006, J FLUID MECH, V566, P117, DOI 10.1017/S0022112006001832	39	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0898-1221	1873-7668		COMPUT MATH APPL	Comput. Math. Appl.	MAR	2015	69	6					518	529		10.1016/j.camwa.2015.01.010		12	Mathematics, Applied	Mathematics	CF7QP	WOS:000352751700007		
J	Kitamura, T; Sakuma, S; Shimosato, M; Higashino, H; Masaoka, Y; Kataoka, M; Yamashita, S; Hiwatari, K; Kumagai, H; Morimoto, N; Koike, S; Tobita, E; Hoffman, RM; Gore, JC; Pham, W				Kitamura, Tokio; Sakuma, Shinji; Shimosato, Moe; Higashino, Haruki; Masaoka, Yoshie; Kataoka, Makoto; Yamashita, Shinji; Hiwatari, Ken-ichiro; Kumagai, Hironori; Morimoto, Naoki; Koike, Seiji; Tobita, Etsuo; Hoffman, Robert M.; Gore, John C.; Pham, Wellington			Specificity of lectin-immobilized fluorescent nanospheres for colorectal tumors in a mouse model which better resembles the clinical disease	CONTRAST MEDIA & MOLECULAR IMAGING			English	Article						imaging; optical imaging; contrast agent; fluorescent probes; fluorescent nanospheres; colonoscopy; colorectal cancer; biorecognition; molecular recognition	SURFACE POLY(N-VINYLACETAMIDE) CHAINS; CANCER; PEANUT; BIORECOGNITION; NANOPARTICLES; COPOLYMERS; MANAGEMENT; DELIVERY; ANTIGEN; MUCIN	We have been investigating an imaging agent that enables real-time and accurate diagnosis of early colorectal cancer at the intestinal mucosa by colonoscopy. The imaging agent is peanut agglutinin-immobilized polystyrene nanospheres with surface poly(N-vinylacetamide) chains encapsulating coumarin 6. Intracolonically-administered lectin-immobilized fluorescent nanospheres detect tumor-derived changes through molecular recognition of lectin for the terminal sugar of cancer-specific antigens on the mucosal surface. The focus of the present study was to evaluate imaging abilities of the nanospheres in animal models that reflect clinical environments. We previously developed an orthotopic mouse model with human colorectal tumors growing on the mucosa of the descending colon to better resemble the clinical disease. The entire colon of the mice in the exposed abdomen was monitored in real time with an in vivo imaging apparatus. Fluorescence from the nanospheres was observed along the entire descending colon after intracolonical administration from the anus. When the luminal side of the colon was washed with phosphate-buffered saline, most of the nanospheres were flushed. However, fluorescence persisted in areas where cancer cells were implanted. Histological evaluation demonstrated that tumors were present in the mucosal epithelia where the nanospheres fluoresced. In contrast, no fluorescence was observed when control mice, without tumors were tested. The lectin-immobilized fluorescent nanospheres were tumor-specific and remained bound to tumors even after vigorous washing. The nanospheres nonspecifically bound to normal mucosa were easily removed through mild washing. These results indicate that the nanospheres combined with colonoscopy, will be a clinically-valuable diagnostic tool for early-stage primary colon carcinoma. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Kitamura, Tokio; Sakuma, Shinji; Shimosato, Moe; Higashino, Haruki; Masaoka, Yoshie; Kataoka, Makoto; Yamashita, Shinji; Morimoto, Naoki] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan; [Hiwatari, Ken-ichiro; Kumagai, Hironori; Morimoto, Naoki; Koike, Seiji; Tobita, Etsuo] ADEKA Co, Life Sci Mat Lab, Arakawa Ku, Tokyo 1168553, Japan; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, La Jolla, CA 92103 USA; [Gore, John C.; Pham, Wellington] Vanderbilt Univ, Inst Imaging Sci, Med Ctr, S Nashville, TN 37232 USA	Sakuma, S (reprint author), Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	sakuma@pharm.setsunan.ac.jp; wellington.pham@Vanderbilt.Edu			Japan Society for the Promotion of Science; National Science Foundation under the Japan-US cooperative Science Program; Science Research Promotion Fund from The Promotion and Mutual Aid Corporation for Private Schools of Japan; Japanese Foundation for Research and Promotion of Endoscopy; National Cancer Institute [R01 CA160700]; Vanderbilt Ingram Cancer Center	This work was financially supported in part by a Grant-in-Aid from The Japan Society for the Promotion of Science and National Science Foundation under the Japan-US cooperative Science Program (2009-2010) (for S.S.), The Science Research Promotion Fund from The Promotion and Mutual Aid Corporation for Private Schools of Japan (2011-2012) (for S.S.), The Japanese Foundation for Research and Promotion of Endoscopy (2013) (for S.S.), The National Cancer Institute R01 CA160700 (for W.P.) and Vanderbilt Ingram Cancer Center (for W.P.). The authors thank Showa Denko Co. for the donation of NVA monomers.	Kumagai H, 2013, INT J CANCER, V132, P2107, DOI 10.1002/ijc.27903; Sakuma S, 2011, EUR J PHARM BIOPHARM, V79, P537, DOI 10.1016/j.ejpb.2011.06.001; Schneider F, 2001, CANCER RES, V61, P4605; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Hiwatari K, 2008, EUR J PHARM BIOPHARM, V70, P453, DOI 10.1016/j.ejpb.2008.04.027; Kudo S, 2000, WORLD J SURG, V24, P1081; Tytherleigh MG, 2008, BRIT J SURG, V95, P409, DOI 10.1002/bjs.6127; Sakuma S, 2009, J CONTROL RELEASE, V134, P2, DOI 10.1016/j.jconrel.2008.10.017; Mayer R, 1999, DIS COLON RECTUM, V42, P343, DOI 10.1007/BF02236351; Sakuma S, 2001, ADV DRUG DELIVER REV, V47, P21, DOI 10.1016/S0169-409X(00)00119-8; Sakuma S, 2010, EUR J PHARM BIOPHARM, V74, P451, DOI 10.1016/j.ejpb.2010.01.001; Zamai M, 2003, MOL CANCER THER, V2, P29; Sakuma S, 2001, J CONTROL RELEASE, V75, P365, DOI 10.1016/S0168-3659(01)00405-9; Sakuma S, 2011, EUR J PHARM SCI, V42, P340, DOI 10.1016/j.ejps.2010.12.011; Fukuzawa M, 2010, WORLD J GASTROENTERO, V16, P1727, DOI 10.3748/wjg.v16.i14.1727; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; LOTAN R, 1975, J BIOL CHEM, V250, P8518; CAMPBELL BJ, 1995, J CLIN INVEST, V95, P571, DOI 10.1172/JCI117700; Young PE, 2013, J CANCER, V4, P217, DOI 10.7150/jca.5829; BOLAND CR, 1988, J HISTOCHEM CYTOCHEM, V36, P1305; Amoh Y, 2005, CANCER RES, V65, P5352, DOI 10.1158/0008-5472.CAN-05-0821; Moss A, 2011, GASTROENTEROLOGY, V140, P1909, DOI 10.1053/j.gastro.2011.02.062; Sakuma S, 1999, INT J PHARM, V177, P161, DOI 10.1016/S0378-5173(98)00346-9; BOLAND CR, 1982, GASTROENTEROLOGY, V82, P664; Sakuma Shinji, 2011, Curr Drug Discov Technol, V8, P367; Wroblewski S, 2001, J CONTROL RELEASE, V74, P283, DOI 10.1016/S0168-3659(01)00338-8	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1555-4309	1555-4317		CONTRAST MEDIA MOL I	Contrast Media Mol. Imaging	MAR-APR	2015	10	2					135	143		10.1002/cmmi.1609		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CG1XC	WOS:000353067800005		
J	Kim, H; Sim, SG				Kim, Hyunchul; Sim, Seung-Gyu			Price discrimination and sequential contracting in monopolistic input markets	ECONOMICS LETTERS			English	Article						Monopolistic input market; Price discrimination; Sequential contracting	INTERMEDIATE GOOD MARKETS; WELFARE	This paper examines the welfare implication of banning price discrimination in the intermediate goods market in which a monopolistic supplier contracts with asymmetric downstream retailers. We demonstrate that the supplier has a strong incentive to manipulate the interdependent demand structure through sequential contracting whether price discrimination is banned or not, and allowing price discrimination improves social welfare and consumer surplus when sequential contracting is implemented by the supplier. (C) 2015 Elsevier B.V. All rights reserved.	[Kim, Hyunchul] Sungkyunkwan Univ, Seoul 110745, South Korea; [Sim, Seung-Gyu] Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan	Sim, SG (reprint author), Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hchkim@skku.edu; sgsim@e.u-tokyo.ac.jp					Rey P, 2004, RAND J ECON, V35, P728, DOI 10.2307/1593770; MCAFEE RP, 1994, AM ECON REV, V84, P210; DEGRABA P, 1990, AM ECON REV, V80, P1246; Dertwinkel-Kalt M, 2015, ECON LETT, V126, P181, DOI 10.1016/j.econlet.2014.12.011; Dertwinkel-Kalt M., 2013, 99 DICE; Herweg F, 2012, J ECON MANAGE STRAT, V21, P773, DOI 10.1111/j.1530-9134.2012.00344.x; KATZ ML, 1987, AM ECON REV, V77, P154; O'Brien DP, 2014, RAND J ECON, V45, P92, DOI 10.1111/1756-2171.12043; Yoshida Y, 2000, AM ECON REV, V90, P240, DOI 10.1257/aer.90.1.240	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	MAR	2015	128						39	42		10.1016/j.econlet.2015.01.011		4	Economics	Business & Economics	CF7PQ	WOS:000352749200010		
J	Deng, H; Hosoya, K; Imanishi, Y; Endo, K; Yamamura, K				Deng, Hui; Hosoya, Kenji; Imanishi, Yusuke; Endo, Katsuyoshi; Yamamura, Kazuya			Electro-chemical mechanical polishing of single-crystal SiC using CeO2 slurry	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Electro-chemical mechanical polishing; SiC; Scratch; Roughness; Subsurface-damaged layer	SILICON-CARBIDE; THERMAL-OXIDATION	Electro-chemical mechanical polishing (ECMP), which combines anodic oxidation and soft abrasive polishing, was applied to single-crystal SiC. Ceria (CeO2) slurry was used as an electrolyte for anodic oxidation as well as a polishing medium to remove the oxide layer. As a result of anodic oxidation, the surface hardness decreased from 34.5 GPa to 1.9 GPa, which made it possible to polish the oxidized SiC surface using a very soft abrasive such as CeO2. It was found that the material removal rate (MRR) of ECMP for a diamond-abrasive-polished surface was 3.62 mu m/h. ECMP using CeO2 slurry was conducted for 30 min on a diamond-abrasive-polished surface. All the scratches were completely removed and a smooth surface with a root mean square (RMS) roughness of 0.23 nm was obtained. (C) 2015 Elsevier B.V. All rights reserved.	[Deng, Hui; Hosoya, Kenji; Imanishi, Yusuke; Endo, Katsuyoshi; Yamamura, Kazuya] Osaka Univ, Grad Sch Engn, Res Ctr Ultra Precis Sci & Technol, Suita, Osaka 5650871, Japan	Yamamura, K (reprint author), Osaka Univ, Grad Sch Engn, Res Ctr Ultra Precis Sci & Technol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	yamamura@upst.eng.osaka-u.ac.jp			MEXT, Japan [25630026]; Adaptable and Seamless Technology Transfer Program through Target-driven RD; JST;  [25-581 2013]	This work was partially supported by a Grant-in-Aid for Challenging Exploratory Research (25630026) from the MEXT, Japan; a research grant from the Adaptable and Seamless Technology Transfer Program through Target-driven R & D; JST; and a Grant-in-Aid for JSPS research fellow (25-581 2013).	Arima K, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2739084; Song Y, 2004, J APPL PHYS, V95, P4953, DOI 10.1063/1.1690097; Li CH, 2004, J ELECTRON MATER, V33, P481, DOI 10.1007/s11664-004-0207-6; Zhou L, 1997, J ELECTROCHEM SOC, V144, pL161, DOI 10.1149/1.1837711; Deng H, 2014, INT J ADV MANUF TECH, V72, P1, DOI 10.1007/s00170-012-4430-7; Lee HS, 2010, CIRP ANN-MANUF TECHN, V59, P333, DOI 10.1016/j.cirp.2010.03.114; KIKUCHI M, 1992, J AM CERAM SOC, V75, P189, DOI 10.1111/j.1151-2916.1992.tb05463.x; Yamamura K, 2011, CIRP ANN-MANUF TECHN, V60, P571, DOI 10.1016/j.cirp.2011.03.072; DEAL BE, 1965, J APPL PHYS, V36, P3770, DOI 10.1063/1.1713945; Ballarin N, 2014, ELECTROCHEM COMMUN, V40, P17, DOI 10.1016/j.elecom.2013.12.018; Deng H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868487; Deng H, 2013, CIRP ANN-MANUF TECHN, V62, P575, DOI 10.1016/j.cirp.2013.03.028; Hoshino T, 2001, J NON-CRYST SOLIDS, V283, P129, DOI 10.1016/S0022-3093(01)00364-7; Lee H.S, 2009, ANN CIRP, V58, P485; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Yamamura Kazuya, 2014, Advanced Materials Research, V1017, DOI 10.4028/www.scientific.net/AMR.1017.509; Yamamura K., 2013, Japanese patent application, Patent No. [2013-060147, 2013060147]	17	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	MAR	2015	52						5	8		10.1016/j.elecom.2015.01.002		4	Electrochemistry	Electrochemistry	CF8ZJ	WOS:000352850700003		
J	Yoshii, K; Oshino, Y; Tachikawa, N; Toshima, K; Katayama, Y				Yoshii, Kazuki; Oshino, Yosuke; Tachikawa, Naoki; Toshima, Kazunobu; Katayama, Yasushi			Electrodeposition of palladium from palladium(II) acetylacetonate in an amide-type ionic liquid	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Palladium; Acetylacetonate complex; Ionic liquid; Electrodeposition; Metal nanoparticles	ELECTROCHEMICAL PREPARATION; SPUTTER-DEPOSITION; PD NANOPARTICLES; COMPLEXES; CHLORIDE; SPECTROSCOPY; NICKEL(II); SOLVATION; OXIDATION; BEHAVIOR	The electrodeposition of palladium from palladium(II) acetylacetonate (Pd(acac)(2)) was investigated in an ionic liquid, 1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)amide at room temperature. Potentiostatic cathodic reduction was conducted using a glassy carbon electrode at -2.0 V vs. Ag/Ag(I). Metallic palladium was deposited on the electrode and palladium nanoparticles were observed with dispersed state in the ionic liquid. The mean particle size of the obtained palladium nanoparticles was 2.8 +/- 0.6 nm. (C) 2015 Elsevier B.V. All rights reserved.	[Yoshii, Kazuki; Oshino, Yosuke; Tachikawa, Naoki; Toshima, Kazunobu; Katayama, Yasushi] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Katayama, Y (reprint author), Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Hiyoshi 3-14-1, Yokohama, Kanagawa 2238522, Japan.	katayama@applc.keio.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities	Part of this study was financially supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016.	Mazumder V, 2009, J AM CHEM SOC, V131, P4588, DOI 10.1021/ja9004915; Hirano M, 2013, PHYS CHEM CHEM PHYS, V15, P7286, DOI 10.1039/c3cp50816a; Hsiu SI, 2006, ELECTROCHIM ACTA, V51, P2607, DOI 10.1016/j.electacta.2005.07.042; Dupont J, 2010, CHEM SOC REV, V39, P1780, DOI 10.1039/b822551f; RICHERT SA, 1989, INORG CHEM, V28, P2471, DOI 10.1021/ic00311a044; Venkatesan R, 2011, J MATER CHEM, V21, P3030, DOI 10.1039/c0jm03557b; Katayama Y, 2008, T I MET FINISH, V86, P205, DOI 10.1179/174591908X327563; LEWIS FD, 1993, INORG CHEM, V32, P1251, DOI 10.1021/ic00059a037; Bando Y, 2007, ELECTROCHIM ACTA, V53, P87, DOI 10.1016/j.electacta.2007.02.074; LEWIS FD, 1995, INORG CHEM, V34, P3173, DOI 10.1021/ic00116a007; Cassol CC, 2005, J AM CHEM SOC, V127, P3298, DOI 10.1021/ja0430043; DELONG HC, 1994, J ELECTROCHEM SOC, V141, P1000, DOI 10.1149/1.2054831; Endres F., 2008, ELECTRODEPOSITION IO; Fukui R, 2011, J ELECTROCHEM SOC, V158, pD567, DOI 10.1149/1.3610202; Katayama Y, 2013, ELECTROCHEMISTRY, V81, P532, DOI 10.5796/electrochemistry.81.532; Katayama Y, 2014, J ELECTROCHEM SOC, V161, pD87, DOI 10.1149/2.010403jes; Katayama Y, 2013, J ELECTROCHEM SOC, V160, pD423, DOI 10.1149/2.008310jes; Mushrif SH, 2008, CHEM PHYS LETT, V465, P63, DOI 10.1016/j.cplett.2008.09.038; NAWI MA, 1981, INORG CHEM, V20, P1974, DOI 10.1021/ic50221a006; Nunes P, 2014, J MOL STRUCT, V1060, P142, DOI 10.1016/j.molstruc.2013.12.025; Nunes P, 2014, INORG CHIM ACTA, V409, P465, DOI 10.1016/j.ica.2013.09.040; Oda Y, 2010, CHEM LETT, V39, P1069, DOI 10.1246/cl.2010.1069; Ohno H., 2011, ELECTROCHEMICAL ASPE; RICHERT SA, 1988, INORG CHEM, V27, P1814, DOI 10.1021/ic00283a027; SUN IW, 1989, J ELECTROANAL CHEM, V274, P325, DOI 10.1016/0022-0728(89)87056-1; Zhu YL, 2011, ELECTROCHEM SOLID ST, V14, pD110, DOI 10.1149/2.010112esl	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	MAR	2015	52						21	24		10.1016/j.elecom.2015.01.003		4	Electrochemistry	Electrochemistry	CF8ZJ	WOS:000352850700007		
J	Ma, WJ; Yu, P; Ohsaka, T; Mao, LQ				Ma, Wenjie; Yu, Ping; Ohsaka, Takeo; Mao, Lanqun			An efficient electrocatalyst for oxygen reduction reaction derived from a Co-porphyrin-based covalent organic framework	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Electrocatalysis; Oxygen reduction reaction; Covalent organic frameworks; Non-platinum electrocatalysts; Pyrolysis	HIGH-PERFORMANCE ELECTROCATALYSTS; MEMBRANE FUEL-CELLS; COBALT NANOPARTICLES; ALKALINE; CATALYST; NITROGEN; HYDROGEN; POLYMER; COMPOSITE; GRAPHENE	A novel efficient electrocatalyst for oxygen reduction reaction (ORR) was synthesized by pyrolysis of a cobalt-based covalent organic framework, which shows electrocatalytic performance comparable with the commercial Pt/C for ORR via an almost four-electron pathway in alkaline media without methanol-crossover effect. This work not only provides a possible insight into the ORR at the M/N/C catalysts, but also paves a new route to the development of novel precious metal-free ORR electrocatalysts with high activities for ORR. (C) 2015 Elsevier B.V. All rights reserved.	[Ma, Wenjie; Yu, Ping; Mao, Lanqun] Chinese Acad Sci, Inst Chem, Beijing Natl Lab Mol Sci, Key Lab Analyt Chem Living Biosyst, Beijing 100190, Peoples R China; [Ohsaka, Takeo] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Mao, LQ (reprint author), Chinese Acad Sci, Inst Chem, Beijing Natl Lab Mol Sci, Key Lab Analyt Chem Living Biosyst, Beijing 100190, Peoples R China.	lqmao@iccas.ac.cn			National Natural Science Foundation of China [21435007, 21321003, 21210007]; Chinese Academy of Sciences [Y2290B12B1]	We acknowledge financial support from the National Natural Science Foundation of China (21435007, 21321003, 21210007) and the Chinese Academy of Sciences (Y2290B12B1).	Wu G, 2013, ACCOUNTS CHEM RES, V46, P1878, DOI 10.1021/ar400011z; Jaouen F, 2011, ENERG ENVIRON SCI, V4, P114, DOI 10.1039/c0ee00011f; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Wang YJ, 2013, CHEM SOC REV, V42, P5768, DOI 10.1039/c3cs60053j; Xiang ZH, 2014, ANGEW CHEM INT EDIT, V53, P2433, DOI 10.1002/anie.201308896; Fang QR, 2014, ANGEW CHEM INT EDIT, V53, P2878, DOI 10.1002/anie.201310500; Wan S, 2011, CHEM MATER, V23, P4094, DOI 10.1021/cm201140r; Ding XS, 2012, CHEM COMMUN, V48, P8952, DOI 10.1039/c2cc33929c; Doonan CJ, 2010, NAT CHEM, V2, P235, DOI [10.1038/nchem.548, 10.1038/NCHEM.548]; Bashyam R, 2006, NATURE, V443, P63, DOI 10.1038/nature05118; Feng X, 2012, CHEM SOC REV, V41, P6010, DOI 10.1039/c2cs35157a; Zhao Y, 2012, J AM CHEM SOC, V134, P19528, DOI 10.1021/ja3085934; Ding SY, 2013, CHEM SOC REV, V42, P548, DOI 10.1039/c2cs35072f; Furukawa H, 2009, J AM CHEM SOC, V131, P8875, DOI 10.1021/ja9015765; Olson TS, 2010, J PHYS CHEM C, V114, P5049, DOI 10.1021/jp910572g; Wu JB, 2013, ACCOUNTS CHEM RES, V46, P1848, DOI 10.1021/ar300359w; Ding SY, 2011, J AM CHEM SOC, V133, P19816, DOI 10.1021/ja206846p; Wu ZS, 2014, ADV MATER, V26, P1450, DOI 10.1002/adma.201304147; Nagai A, 2013, ANGEW CHEM INT EDIT, V52, P3770, DOI 10.1002/anie.201300256; Guo SJ, 2013, ANGEW CHEM INT EDIT, V52, P8526, DOI 10.1002/anie.201207186; Wu G, 2011, SCIENCE, V332, P443, DOI 10.1126/science.1200832; Colson JW, 2011, SCIENCE, V332, P228, DOI 10.1126/science.1202747; Guo SJ, 2012, ANGEW CHEM INT EDIT, V51, P11770, DOI 10.1002/anie.201206152; Lin L, 2014, J AM CHEM SOC, V136, P11027, DOI 10.1021/ja504696r; BETTELHEIM A, 1987, INORG CHEM, V26, P1009, DOI 10.1021/ic00254a011; Chen X, 2013, J AM CHEM SOC, V135, P546, DOI 10.1021/ja3100319; Liang HW, 2013, J AM CHEM SOC, V135, P16002, DOI 10.1021/ja407552k; Pachfule P, 2014, CHEM COMMUN, V50, P3169, DOI 10.1039/c3cc49176e; Zhao D, 2014, ADV MATER, V26, P1093, DOI 10.1002/adma.201304238; Meng WJ, 2011, ANGEW CHEM INT EDIT, V50, P3479, DOI 10.1002/anie.201100193; Oh H, 2013, ANGEW CHEM INT EDIT, V52, P13219, DOI 10.1002/anie.201307443; Chang YQ, 2013, ADV MATER, V25, P4794, DOI 10.1002/adma.201301002; Dogru M, 2013, ANGEW CHEM INT EDIT, V52, P2920, DOI 10.1002/anie.201208514; Wang DW, 2014, ENERG ENVIRON SCI, V7, P576, DOI 10.1039/c3ee43463j; Stegbauer L, 2014, CHEM SCI, V5, P2789, DOI 10.1039/c4sc00016a; O'Shea VAD, 2009, CHEM MATER, V21, P5637, DOI 10.1021/cm900845h; DING XS, 2011, ANGEW CHEM INT EDIT, V50, P1289; Lu AH, 2005, CHEM COMMUN, P98, DOI 10.1039/b414146f; Mao LQ, 2003, CHEM COMMUN, P2818, DOI 10.1039/b308301b; Moulder J. F., 1992, HDB XRAY PHOTOELECTR; Proietti E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1427; Wang J. J., 2014, NAT COMMUN, V5, P5, DOI DOI 10.1038/NCOMMS5735; Yang ZY, 2014, J MATER CHEM A, V2, P2623, DOI 10.1039/c3ta13788k	43	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	MAR	2015	52						53	57		10.1016/j.elecom.2015.01.021		5	Electrochemistry	Electrochemistry	CF8ZJ	WOS:000352850700015		
J	Zhanikeev, M				Zhanikeev, Marat			How variable bitrate video formats can help P2P streaming boost its reliability and scale	ELECTRONIC COMMERCE RESEARCH			English	Article						Variable video coding; Variable bitrate; Scalable video; Layered video; VBR; SVC; P2P live streaming; Substream method	TRACES; SVC	P2P streaming is attractive for content providers because it removes the main load of provider's servers. However, just like the conventional streaming, P2P streaming fails to scale. Additionally, P2P streaming suffers from low reliability because network and host performance vary drastically across peers. This paper extends the well-known substream P2P streaming method and proves that variable bitrate formats-the emerging topic in multimedia research can help solve both the scale and reliability problems. The paper analyzes and compares performance among several P2P methods in simulation but also presents a more formal model and optimization framework. The commercial value of this research is in the fact that the proposed P2P delivery model finally allows video content providers to run services globally without procuring local facilities in several countries. The paper also relates to application of the proposal in electronic commerce-distinct from commercial use-by discussing the relevant usecases.	Kyushu Inst Technol, Comp Sci & Syst Engn, Iizuka, Fukuoka 8208502, Japan	Zhanikeev, M (reprint author), Kyushu Inst Technol, Comp Sci & Syst Engn, Kawazu 680-4, Iizuka, Fukuoka 8208502, Japan.	maratishe@gmail.com					Liu ZY, 2009, IEEE T MULTIMEDIA, V11, P1340, DOI 10.1109/TMM.2009.2030656; Wu CA, 2009, IEEE INFOCOM SER, P2731, DOI 10.1109/INFCOM.2009.5062221; [Anonymous], 2012, 230091 ISOIEC; Sila I, 2013, ELECTRON COMMER RES, V13, P199, DOI 10.1007/s10660-013-9110-7; Dai M, 2009, IEEE T MULTIMEDIA, V11, P1010, DOI 10.1109/TMM.2009.2021802; Schwarz H, 2007, IEEE T CIRC SYST VID, V17, P1103, DOI 10.1109/TCSVT.2007.905532; [Anonymous], 2012, H264 ITUT; Baccichet P, 2007, PACKET VIDEO 2007, P173, DOI [10.1109/PACKET.2007.4397039, DOI 10.1109/PACKET.2007.4397039]; Buyya R., 2008, LECT NOTES ELECT ENG, V9; Capovilla N., 2010, 2 INT C ADV MULT MME, P1, DOI 10.1109/MMEDIA.2010.17; Chen C.-M., 2005, 19 IEEE INT C ADV IN, V1, P441; Eugster P, 2009, ELECTRON COMMER RES, V9, P245, DOI 10.1007/s10660-009-9042-4; Fidler M, 2007, CONSUM COMM NETWORK, P880, DOI 10.1109/CCNC.2007.178; Gurler CG, 2012, IEEE IMAGE PROC, P2253, DOI 10.1109/ICIP.2012.6467344; Kusching R., 2010, I ACM SIGMM C MULT S, P157; Lederer S., 2012, MMSYS 12, P89, DOI DOI 10.1145/2155555.2155570; Lee TC, 2008, LECT NOTES COMPUT SC, V5274, P104, DOI 10.1007/978-3-540-87359-4_10; Lee Y., 2003, 9 INT C PAR DISTR SY, P391; Li B., 2008, IEEE INFOCOM, P1031; Li Z, 2008, 5 INT ICST C HET NET; Lian S., 2010, SPRINGER J ELECT COM, V11, P91; Lian SG, 2011, ELECTRON COMMER RES, V11, P75, DOI 10.1007/s10660-010-9066-9; Mushtaq M, 2008, CONSUM COMM NETWORK, P447, DOI 10.1109/ccnc08.2007.106; Noh J.-H., 2009, P 5 INT ICST MOB MUL, P1; Park K, 2010, IEEE INT C COMM ICC, P1; Seeling P, 2004, IEEE COMMUN SURV TUT, V6, P58, DOI 10.1109/COMST.2004.5342293; Sivasubramanian S, 2007, IEEE INTERNET COMPUT, V11, P60, DOI 10.1109/MIC.2007.3; Walkowiak K., 2005, NETWORKING, V3462; Xylomenos G, 2012, FUT NETW MOB SUMM BE, P1; Zghaibeh M., 2007, J ELECT COMMERCE RES, V7, P381; Zhang M, 2007, IEEE J SEL AREA COMM, V25, P1678, DOI 10.1109/JSAC.2007.071207; Zhanikeev M., 2014, IEICE T COMMUN, VE97-B, P450; Zhanikeev M, 2014, IEICE COMMUNICATIONS, V2, P167; Zhanikeev M, 2014, MULTISOURCE STREAM A	34	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1389-5753	1572-9362		ELECTRON COMMER RES	Electron. Commer. Res.	MAR	2015	15	1			SI		25	47		10.1007/s10660-015-9175-6		23	Business; Management	Business & Economics	CF3JB	WOS:000352443600003		
J	Kakiuchi, T; Uematsu, Y; Hatano, Y; Nakajima, M; Nakamura, Y; Taniguchi, T				Kakiuchi, Toshifumi; Uematsu, Yoshihiko; Hatano, Yuji; Nakajima, Masaki; Nakamura, Yuki; Taniguchi, Tomonori			Effect of hydrogen on fatigue crack propagation behavior of wrought magnesium alloy AZ61 in NaCl solution under controlled cathodic potentials	ENGINEERING FRACTURE MECHANICS			English	Article						Fatigue crack propagation; Magnesium alloys; Hydrogen charge; Hydrogen embrittlement; Environmental effect	AZ31	Fatigue crack propagation (FCP) tests were performed in NaCl solution under controlled cathodic potentials to achieve the hydrogen charged condition where anodic dissolution does not occur so much to understand the effect of hydrogen on FCP behavior of wrought magnesium alloy AZ61. FCP rates were accelerated under the hydrogen charged conditions compared with dry air. A grazing incidence X-ray diffraction (GIXRD) and a thermal desorption spectrometry (TDS) analysis revealed that FCP rates have no relation to hydrogen compounds formed near the crack surface. This indicates the acceleration could be mainly attributed to hydrogen diffusion and hydrogen embrittlement is dominant in the FCP behavior of AZ61. (C) 2015 Elsevier Ltd. All rights reserved.	[Kakiuchi, Toshifumi; Uematsu, Yoshihiko] Gifu Univ, Dept Mech Engn, Gifu 5011193, Japan; [Hatano, Yuji] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan; [Nakajima, Masaki; Nakamura, Yuki] Toyota Natl Coll Technol, Toyota, Aichi 4718525, Japan; [Taniguchi, Tomonori] Gifu Univ, Grad Sch, Course Mech & Syst Engn, Gifu 5011193, Japan	Kakiuchi, T (reprint author), Gifu Univ, Dept Mech Engn, 1-1 Yanagido, Gifu 5011193, Japan.	kakiuchi@gifu-u.ac.jp; yuematsu@gifu-u.ac.jp; hatano@ctg.u-toyama.ac.jp; nakajima@toyota-ct.ac.jp; nakamura@toyota-ct.ac.jp; r3122029@gmail.co.jp					BOGDANOVIC B, 1995, INT J HYDROGEN ENERG, V20, P811, DOI 10.1016/0360-3199(95)00012-3; Uematsu Y, 2012, MAT SCI ENG A-STRUCT, V531, P171, DOI 10.1016/j.msea.2011.10.052; LIAW PK, 1984, SCRIPTA METALL MATER, V18, P821, DOI 10.1016/0036-9748(84)90402-2; [Anonymous], E64781 ASTM; Kobayashi Y, 1997, MAT SCI ENG A-STRUCT, V234, P220, DOI 10.1016/S0921-5093(97)00202-5; Pook L. P., 1973, Engineering Fracture Mechanics, V5, DOI 10.1016/0013-7944(73)90058-1; Pourbaix M., 1966, ATLAS ELECTROCHEMICA; Rozali S, 2011, MAT SCI ENG A-STRUCT, V528, P2509, DOI 10.1016/j.msea.2010.12.048; Rozali S, 2009, J SOLID MECH MAT ENG, V3, P1274; Tokaji K, 2009, INT J FATIGUE, V31, P1137, DOI 10.1016/j.ijfatigue.2008.12.012; Tokaji K, 2004, INT J FATIGUE, V26, P1217, DOI 10.1016/j.ijfatigue.2004.03.015; Uematsu Y, 2014, INT J FATIGUE, V59, P234, DOI 10.1016/j.ijfatigue.2013.08.014; Wu W, 2012, MAT SCI ENG A-STRUCT, V556, P278, DOI 10.1016/j.msea.2012.06.088; Zeng RC, 2009, MAT SCI ENG A-STRUCT, V509, P1, DOI 10.1016/j.msea.2009.01.013	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-7944	1873-7315		ENG FRACT MECH	Eng. Fract. Mech.	MAR	2015	137						88	96		10.1016/j.engfracmech.2015.03.032		9	Mechanics	Mechanics	CG0OV	WOS:000352966800009		
J	Murata, N; Soga, Y; Iida, O; Yamauchi, Y; Hirano, K; Kawasaki, D; Fujihara, M; Tomoi, Y				Murata, N.; Soga, Y.; Iida, O.; Yamauchi, Y.; Hirano, K.; Kawasaki, D.; Fujihara, M.; Tomoi, Y.			Complex Relationship of Body Mass Index with Mortality in Patients with Critical Limb Ischemia Undergoing Endovascular Treatment	EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY			English	Article						Body mass index; Ischemia/MO; Peripheral arterial disease; Endovascular procedures	PERIPHERAL ARTERIAL-DISEASE; AMERICAN-HEART-ASSOCIATION; OBESITY PARADOX; CARDIORESPIRATORY FITNESS; BYPASS-SURGERY; CORONARY; FAILURE; OUTCOMES; THERAPY; UPDATE	Objective: To investigate the relationship between body mass index (BMI) and long-term outcomes of patients with CLI after endovascular treatment (EVT). Design: Retrospective multicenter study. Subjects: 1088 consecutive patients (1306 limbs, mean age 72 +/- 10 years) with CLI who underwent EVT for isolated infrapopliteal artery lesions were evaluated. These subjects were identified in the J-BEAT III registry. Methods: The patients were divided into groups based on BMI <18.5 kg/m(2) (underweight, n = 188; 219 limbs), 18.5 to 24.9 kg/m(2) (normal weight, n = 718; 868 limbs), and >25.0 kg/m(2) (overweight/obese, n = 182; 219 limbs). The endpoints were overall survival and freedom from major adverse limb events (MALE). Results: The median follow up period was 1.5 years (range: 1 month-8.7 years). The 3 year overall survival rates were 33.3%, 61.2%, and 69.8% in underweight, normal, and overweight/obese patients, respectively. The survival rate was significantly lower in underweight patients and significantly higher in overweight/obese patients compared with patients of normal weight (both p < .0001). The 3 year rates of freedom from MALE did not differ significantly among the three groups (36.4%, 45.4%, and 52.3%, respectively, p = .32). Age, BMI <18.5 kg/m(2), heart failure, aortic valve stenosis, renal failure, triglyceride levels, serum albumin <3.0 g/dL, anticoagulant treatment, non-ambulatory status, and Rutherford 6 classification all were significantly associated with overall survival. Conclusions: BMI has a complex correlation with mortality in patients with CLI after EVT for isolated infrapopliteal artery lesions. Underweight patients with CLI have an extremely poor prognosis. Such patients have many other factors associated with mortality, but low BMI was identified as an independent predictor of a poor prognosis in patients with CLI. Similarly, normal weight patients had a small but significant increase in mortality compared with overweight/obese patients. (C) 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.	[Murata, N.; Soga, Y.; Tomoi, Y.] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka 8028555, Japan; [Iida, O.] Kansai Rosai Hosp, Cardiovasc Ctr, Amagasaki, Hyogo, Japan; [Yamauchi, Y.] Kikuna Mem Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Hirano, K.] Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Kawasaki, D.] Hyogo Coll Med, Dept Cardiol, Nishinomiya, Hyogo, Japan; [Fujihara, M.] Kishiwada Tokusyukai Hosp, Cardiovasc Ctr, Osaka, Japan	Murata, N (reprint author), Kokura Mem Hosp, Dept Cardiol, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka 8028555, Japan.	metallion2@yahoo.co.jp					Lavie CJ, 2003, AM J CARDIOL, V91, P891, DOI 10.1016/S0002-9149(03)00031-6; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Davenport DL, 2009, J VASC SURG, V49, P140, DOI 10.1016/j.jvs.2008.08.052; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Soga Y, 2013, CIRC J, V77, P2102, DOI 10.1253/circj.CJ-13-0020; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Galal W, 2008, CHEST, V134, P925, DOI 10.1378/chest.08-0418; McAuley PA, 2012, MAYO CLIN PROC, V87, P443, DOI 10.1016/j.mayocp.2012.01.013; Soderstrom MI, 2010, ANN SURG, V252, P765, DOI 10.1097/SLA.0b013e3181fc3c73; Kumakura H, 2010, J VASC SURG, V52, P110, DOI 10.1016/j.jvs.2010.02.008; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Lavie CJ, 2013, MAYO CLIN PROC, V88, P251, DOI 10.1016/j.mayocp.2012.11.020; Barba R, 2009, EUR J CARDIOV PREV R, V16, P457, DOI 10.1097/HJR.0b013e32832b1818; Kalbaugh CA, 2006, AM SURGEON, V72, P707; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; lida O, 2013, CIRC-CARDIOVASC INTE, V6, P68; lida O, 2012, EUR J VASC ENDOVASC, V43, P313; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024	21	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1078-5884	1532-2165		EUR J VASC ENDOVASC	Eur. J. Vasc. Endovasc. Surg.	MAR	2015	49	3					297	305		10.1016/j.ejvs.2014.10.014		9	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CF1UD	WOS:000352332500015		
J	Shimada, Y; Tomita, M; Yoshida, T; Fukuyama, T; Katoh, Y; Ohnuma-Koyama, A; Takahashi, N; Soma, K; Kojima, S; Ohtsuka, R; Takeda, M; Kuwahara, M; Harada, T				Shimada, Yuko; Tomita, Mariko; Yoshida, Toshinori; Fukuyama, Tomoki; Katoh, Yoshitaka; Ohnuma-Koyama, Aya; Takahashi, Naofumi; Soma, Katsumi; Kojima, Sayuri; Ohtsuka, Ryoichi; Takeda, Makio; Kuwahara, Maki; Harada, Takanori			Inhibition of lipopolysaccharide-induced liver injury in rats treated with a hepatic drug-metabolizing enzyme inducer p,p '-DDT	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article						p,p '-DDT; Lipopolysaccharide; Hepatocellular hypertrophy; Steatosis; Hepatocellular necrosis; Inflammation; Apoptosis	13-WEEK INHALATION TOXICITY; NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE; IN-VIVO; DOWN-REGULATION; HEME OXYGENASE; ENDOTOXIN; MICE; INDUCTION; CYTOCHROME-P450	Hepatocellular hypertrophy in association with drug-metabolizing enzyme induction is considered to be an adaptive change associated with drug metabolism. To improve our understanding of liver hypertrophy, we determined the effect of a single ip injection of either lipopolysaccharide (LPS) or vehicle in male F344 rats with hepatocellular hypertrophy induced by oral delivery of p,p'-DDT for 2 weeks. The rats were sacrificed 3 h or 24h after LPS or vehicle injection. LPS induced a focal hepatocellular necrosis in rats fed the control diet. When rats pre-treated with p,p'-DDT were injected with LPS, necrotic foci surrounded by ballooned hepatocytes were observed in the liver. The change was consistent with reduced LPSmediated increases in plasma hepatic biomarkers, neutrophil influx, and apoptosis, and also associated with hepatic mRNA levels of TNF-alpha, CYPs, and NOS2. By contrast, when combined with p,p'-DDT and LPS, faint hepatocellular fatty change was extended, together with a synergistic increase in total blood cholesterol. These results suggest that hepatocytes exposed to p,p'-DDT are protected from the cell-lethal toxic effects of an exogenous stimulus, resulting in cell ballooning rather than necrosis in association with reduced inflammation and apoptosis, but compromised by an adverse effect on lipid metabolism. (C) 2014 Elsevier GmbH. All rights reserved.	[Shimada, Yuko; Tomita, Mariko; Yoshida, Toshinori; Fukuyama, Tomoki; Katoh, Yoshitaka; Ohnuma-Koyama, Aya; Takahashi, Naofumi; Soma, Katsumi; Kojima, Sayuri; Ohtsuka, Ryoichi; Takeda, Makio; Kuwahara, Maki; Harada, Takanori] Inst Environm Toxicol, Joso, Ibaraki 3030043, Japan	Yoshida, T (reprint author), Tokyo Univ Agr & Technol, Pathol Lab, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	yoshida7@cc.tuat.ac.jp	Yoshida, Toshinori/B-7255-2015				Adewole SO, 2007, AFR J TRADIT COMPLEM, V4, P397; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Crespo E, 1999, FASEB J, V13, P1537; Tukov FF, 2007, TOXICOL SCI, V100, P267, DOI 10.1093/toxsci/kfm209; Aiso S, 2005, J OCCUP HEALTH, V47, P249, DOI 10.1539/joh.47.249; Vickers AEM, 2009, TOXICOL PATHOL, V37, P78, DOI 10.1177/0192623308329285; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Hall AP, 2012, TOXICOL PATHOL, V40, P971, DOI 10.1177/0192623312448935; Mohutsky MA, 2010, TOXICOL PATHOL, V38, P799, DOI 10.1177/0192623310375099; Al-Ali SY, 2005, HISTOL HISTOPATHOL, V20, P1131; Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Barton CC, 2000, TOXICOL SCI, V55, P444, DOI 10.1093/toxsci/55.2.444; Botts S, 2010, TOXICOL PATHOL, V38, P796, DOI 10.1177/0192623310374330; Cattley R. C., 2002, HDB TOXICOLOGIC PATH, V2, P187, DOI 10.1016/B978-012330215-1/50032-6; Feingold KR, 1996, J LIPID RES, V37, P223; FEINGOLD KR, 1993, J LIPID RES, V34, P2147; Furuichi M, 2009, BIOMED RES-TOKYO, V30, P235; Greaves P, 2012, HISTOPATHOLOGY OF PRECLINICAL TOXICITY STUDIES: INTERPRETATION AND RELEVANCE IN DRUG SAFETY EVALUATION, 4TH EDITION, P433, DOI 10.1016/B978-0-444-53856-7.00009-9; Harada T, 2003, TOXICOL PATHOL, V31, P87, DOI 10.1080/01926230390173941; HEWETT JA, 1993, AM J PHYSIOL, V265, pG1011; Jaeschke H, 1996, SHOCK, V6, P351, DOI 10.1097/00024382-199611000-00009; Kitaichi K, 1999, ANTIMICROB AGENTS CH, V43, P2697; Kiyosawa N, 2004, ARCH TOXICOL, V78, P435, DOI 10.1007/s00204-004-0565-0; Kobayashi Y, 2000, XENOBIOTICA, V30, P683; Kojima S, 2009, J TOXICOL SCI, V34, P527; Li J, 2002, TOXICOLOGY, V176, P91, DOI 10.1016/S0300-483X(02)00143-9; Lynch DW, 2003, TOXICOL SCI, V72, P347, DOI 10.1093/toxsci/kfg033; Maronpot RR, 2010, TOXICOL PATHOL, V38, P776, DOI 10.1177/0192623310373778; Memon RA, 2001, J BIOL CHEM, V276, P30118, DOI 10.1074/jbc.M102516200; Nayak NC, 1996, VIRCHOWS ARCH, V428, P353; Ohnuma A, 2010, EXP TOXICOL PATHOL, V62, P643, DOI 10.1016/j.etp.2009.08.007; RAIFORD DS, 1994, TOXICOL APPL PHARM, V129, P36, DOI 10.1006/taap.1994.1226; Reed James R, 2011, Drug Metab Lett, V5, P6; REYNOLDS ES, 1984, ENVIRON HEALTH PERSP, V57, P313, DOI 10.2307/3429933; Senoh H, 2003, J OCCUP HEALTH, V45, P365, DOI 10.1539/joh.45.365; Sewer MB, 1998, MOL PHARMACOL, V54, P273; Sewer MB, 1998, J PHARMACOL EXP THER, V287, P352; Sneed RA, 1997, TOXICOL APPL PHARM, V144, P77, DOI 10.1006/taap.1997.8115; The Japanese association for laboratory animal science (JALAS), 1987, EXP ANIM, V36, P285; Wallace AD, 2008, MOL BIOCH TOXICOLOGY, P671, DOI 10.1002/9780470285251.ch28; WATANABE M, 1983, Journal of Toxicological Sciences, V8, P243; WHO/IPCS, 2004, IPCS OECD KEY GEN TE; Yamazaki K, 2005, IND HEALTH, V43, P597, DOI 10.2486/indhealth.43.597; Yuan Guang-Jin, 2006, Hepatobiliary Pancreat Dis Int, V5, P262	45	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	MAR	2015	67	3					245	251		10.1016/j.etp.2014.12.004		7	Pathology; Toxicology	Pathology; Toxicology	CF9XQ	WOS:000352921500003		
J	Tsukamoto, H; Mizoshita, T; Katano, T; Hayashi, N; Ozeki, K; Ebi, M; Shimura, T; Mori, Y; Tanida, S; Kataoka, H; Tsukamoto, T; Tatematsu, M; Joh, T				Tsukamoto, Hironobu; Mizoshita, Tsutomu; Katano, Takahito; Hayashi, Noriyuki; Ozeki, Keiji; Ebi, Masahide; Shimura, Takaya; Mori, Yoshinori; Tanida, Satoshi; Kataoka, Hiromi; Tsukamoto, Tetsuya; Tatematsu, Masae; Joh, Takashi			Preventive effect of rebamipide on N-methyl-N '-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article						N-methyl-N '-nitro-N-nitrosoguanidine; Rebamipide; Gastric cancer; Rat; Chemoprevention	HELICOBACTER-PYLORI INFECTION; MONGOLIAN GERBILS; GLANDULAR STOMACH; MUCOSAL INJURY; PHENOTYPIC-EXPRESSION; CANCER CELLS; ULCER; RISK; N-METHYL-N'-NITRO-N-NITROSOGUANIDINE; MECHANISMS	Chemoprevention strategies against gastric cancer (GC) need to be explored in light of the fact that stomach cancer still occurs in the absence of Helicobacter pylori (HP) infection and following HP eradication. We evaluated the effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced carcinogenesis in SD rats. Thirty-nine male rats were divided into four groups based on whether or not they were treated with rebamipide and/or MNNG: Control, Rebamipide, Control-M, and Rebamipide-M groups. From 8 weeks of age, rats in the Control-M and Rebamipide-M groups received MNNG in drinking water for 30 weeks. The Rebamipide and Rebamipide-M groups were administered 5 mg/kg/day of rebamipide. At 50 weeks, cancerous lesions were not observed in either the Control or Rebamipide groups. Nine rats in the Control-M group had developed GC, while four rats in the Rebamipide-M group had developed GC. The incidence of cancer in the Rebamipide-M group was significantly less than in the Control-M group (p< 0.05), with a trend toward a lower incidence of invasive carcinoma in the Rebamipide-M group. Carcinomatous invasion into the muscularis propria was not observed in the Rebamipide-M group. In conclusion, the present study demonstrates that rebamipide suppresses. MNNG-induced carcinogenesis and may also inhibit progression of cancer in rats. (C) 2015 Elsevier GmbH. All rights reserved.	[Tsukamoto, Hironobu; Mizoshita, Tsutomu; Katano, Takahito; Hayashi, Noriyuki; Ozeki, Keiji; Ebi, Masahide; Shimura, Takaya; Mori, Yoshinori; Tanida, Satoshi; Kataoka, Hiromi; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Tsukamoto, Tetsuya] Fujita Hlth Univ, Sch Med, Dept Diagnost Pathol, Toyoake, Aichi 4701192, Japan; [Tatematsu, Masae] Japan Ind Safety & Hlth Assoc, Japan Bioassay Res Ctr, Hadano, Kanagawa 2570015, Japan	Mizoshita, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	tmizoshi@med.nagoya-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) [23590921]	This work was supported by a Grant-in Aid for Scientific Research C (KAKENHI no. 23590921) from the Japan Society for the Promotion of Science (JSPS) to T.M.	Kang DW, 2013, ONCOGENE, V32, P3531, DOI 10.1038/onc.2012.358; Tanigawa T, 2007, DIGEST DIS SCI, V52, P240, DOI 10.1007/s10620-006-9226-x; OGINO K, 1992, EUR J PHARMACOL, V212, P9, DOI 10.1016/0014-2999(92)90065-C; Yamamichi N, 2012, BIOCHEM BIOPH RES CO, V424, P124, DOI 10.1016/j.bbrc.2012.06.087; Mizoshita T, 2003, J CANCER RES CLIN, V129, P727, DOI 10.1007/s00432-003-0499-6; Kang DW, 2010, EXP MOL MED, V42, P555, DOI 10.3858/emm.2010.42.8.056; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Tarnawski A, 2005, BIOCHEM BIOPH RES CO, V334, P207, DOI 10.1016/j.bbrc.2005.05.204; Brenner H, 2004, AM J EPIDEMIOL, V159, P252, DOI 10.1093/aje/kwh039; Herrera V, 2009, CLIN MICROBIOL INFEC, V15, P971, DOI 10.1111/j.1469-0691.2009.03031.x; Tatematsu M, 2005, HELICOBACTER, V10, P97, DOI 10.1111/j.1523-5378.2005.00305.x; Arakawa T, 2005, DIGEST DIS SCI, V50, pS3, DOI 10.1007/s10620-005-2800-9; YOSHIKAWA T, 1993, ARZNEIMITTEL-FORSCH, V43-1, P363; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Arakawa T, 1998, DIGEST DIS SCI, V43, p5S; ARAKAWA T, 1995, DIGEST DIS SCI, V40, P2469, DOI 10.1007/BF02063257; FORMAN D, 1991, BRIT MED J, V302, P1302; Higuchi K, 2003, ALIMENT PHARM THERAP, V18, P1, DOI 10.1046/j.1365-2036.18.s1.18.x; Hirata Y, 2009, ONCOL REP, V21, P107, DOI 10.3892/or_00000196; Li L, 2012, ASIAN PAC J CANCER P, V13, P2069, DOI 10.7314/APJCP.2012.13.5.2069; Mizoshita T, 2006, CANCER SCI, V97, P38, DOI 10.1111/j.1349-7006.2006.00135.x; Naito Y, 2007, J CLIN BIOCHEM NUTR, V41, P202, DOI 10.3164/jcbn.2007029; Naito Y, 2008, J CLIN BIOCHEM NUTR, V43, P34, DOI 10.3164/jcbn.2008041; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Sasaki M, 2007, J ANTIMICROB CHEMOTH, V60, P1060, DOI 10.1093/jac/dkm329; SUGIMURA T, 1970, CANCER RES, V30, P455; Sun TT, 2011, EXPERT REV ANTICANC, V11, P1509, DOI [10.1586/era.11.124, 10.1586/ERA.11.124]; Suzuki H, 1998, DIGEST DIS SCI, V43, p181S; TATEMATSU M, 1984, GANN, V75, P957; TATEMATSU M, 1988, CARCINOGENESIS, V9, P495, DOI 10.1093/carcin/9.3.495; Tsukamoto H, 2011, ASIAN PAC J CANCER P, V12, P1049; Tsukamoto T, 2007, TOXICOL PATHOL, V35, P636, DOI 10.1080/01926230701420632; Watanabe T, 2002, DIGEST DIS SCI, V47, P1582, DOI 10.1023/A:1015879421739; Watanabe T, 2005, DIGEST DIS SCI, V50, pS63, DOI 10.1007/s10620-005-2808-1; Yamane T, 1998, DIGEST DIS SCI, V43, p207S	35	1	1	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	MAR	2015	67	3					271	277		10.1016/j.etp.2015.01.003		7	Pathology; Toxicology	Pathology; Toxicology	CF9XQ	WOS:000352921500006		
J	Murakami, T; Segawa, T; Bodington, D; Dial, R; Takeuchi, N; Kohshima, S; Hongoh, Y				Murakami, Takumi; Segawa, Takahiro; Bodington, Dylan; Dial, Roman; Takeuchi, Nozomu; Kohshima, Shiro; Hongoh, Yuichi			Census of bacterial microbiota associated with the glacier ice worm Mesenchytraeus solifugus	FEMS MICROBIOLOGY ECOLOGY			English	Article						glacier ecology; enchytraeid; symbiosis; 16S rRNA; gut bacteria	16S RIBOSOMAL-RNA; OLIGONUCLEOTIDE PROBES; TERRESTRIAL ISOPOD; EARTHWORM GUT; SEQUENCE DATA; TERMITE GUT; OLIGOCHAETA; COMMUNITIES; MOLLICUTES; DIVERSITY	The glacier ice worm, Mesenchytraeus solifugus, is a unique annelid, inhabiting only snow and ice in North American glaciers. Here, we analyzed the taxonomic composition of bacteria associated with M. solifugus based on the 16S rRNA gene. We analyzed four fixed-on-site and 10 starved ice worm individuals, along with glacier surface samples. In total, 1341 clones of 16S rRNA genes were analyzed for the ice worm samples, from which 65 bacterial phylotypes (99.0% cut-off) were identified. Of these, 35 phylotypes were closely related to sequences obtained from their habitat glacier and/or other components of cryosphere; whereas three dominant phylotypes were affiliated with animal-associated lineages of the class Mollicutes. Among the three, phylotype Ms-13 shared less than 89% similarity with database sequences and was closest to a gut symbiont of a terrestrial earthworm. Using fluorescence in situ hybridization, Ms-13 was located on the gut wall surface of the ice worms. We propose a novel genus and species, 'Candidatus Vermiplasma glacialis', for this bacterium. Our results raise the possibility that the ice worm has exploited indigenous glacier bacteria, while several symbiotic bacterial lineages have maintained their association with the ice worm during the course of adaptive evolution to the permanently cold environment.	[Murakami, Takumi; Bodington, Dylan; Hongoh, Yuichi] Tokyo Inst Technol, Dept Biol Sci, Tokyo 1528550, Japan; [Segawa, Takahiro] Natl Inst Polar Res, Tokyo 1908518, Japan; [Segawa, Takahiro] Transdisciplinary Res Integrat Ctr, Tokyo 1908518, Japan; [Dial, Roman] Alaska Pacific Univ, Dept Environm Sci, Anchorage, AK 99508 USA; [Takeuchi, Nozomu] Chiba Univ, Dept Earth Sci, Chiba 2638522, Japan; [Kohshima, Shiro] Kyoto Univ, Wildlife Res Ctr, Kyoto 6068203, Japan	Murakami, T (reprint author), Tokyo Inst Technol, Dept Biol Sci, Meguro Ku, 2-12-1-W3-48 Ookayama, Tokyo 1528550, Japan.	tmurakami@bio.titech.ac.jp			Japan Society for Promotion of Science [22241005, 26241020]; NEXT program	This study was financially supported by the Grant-in-Aid for Scientific Research from the Japan Society for Promotion of Science to S.K (22241005 and 26241020) and Y.H. (23117003) and the NEXT program to Y.H.	Segawa T, 2010, MICROBES ENVIRON, V25, P171, DOI 10.1264/jsme2.ME10119; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Depkat-Jakob PS, 2013, FEMS MICROBIOL ECOL, V83, P375, DOI 10.1111/j.1574-6941.2012.01476.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Wang YJ, 2004, APPL ENVIRON MICROB, V70, P6166, DOI 10.1128/AEM.70.10.6166-6172.2004; Daims H, 1999, SYST APPL MICROBIOL, V22, P434; Noda S, 2003, APPL ENVIRON MICROB, V69, P625, DOI 10.1128/AEM.69.1.625-633.2003; Wust PK, 2011, ISME J, V5, P92, DOI 10.1038/ismej.2010.99; Singleton DR, 2003, SOIL BIOL BIOCHEM, V35, P1547, DOI 10.1016/S0038-0717(03)00244-X; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; KARSTEN GR, 1995, APPL ENVIRON MICROB, V61, P1039; Loy A, 2008, ENVIRON MICROBIOL, V10, P2894, DOI 10.1111/j.1462-2920.2008.01706.x; Cameron KA, 2012, FEMS MICROBIOL ECOL, V82, P254, DOI 10.1111/j.1574-6941.2011.01277.x; Drake HL, 2007, ANNU REV MICROBIOL, V61, P169, DOI 10.1146/annurev.micro.61.080706.093139; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Martin P, 2008, HYDROBIOLOGIA, V595, P117, DOI 10.1007/s10750-007-9009-1; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Wang YJ, 2007, FEMS MICROBIOL ECOL, V61, P141, DOI 10.1111/j.1574-6941.2007.00329.x; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Takeuchi N, 2001, ARCT ANTARCT ALP RES, V33, P115, DOI 10.2307/1552211; Lutz S, 2014, FEMS MICROBIOL ECOL, V89, P402, DOI 10.1111/1574-6941.12351; Kostanjsek R, 2007, APPL ENVIRON MICROB, V73, P5566, DOI 10.1128/AEM.02468-06; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Thakuria D, 2010, ISME J, V4, P357, DOI 10.1038/ismej.2009.124; Fraune S, 2008, ENVIRON MICROBIOL, V10, P2497, DOI 10.1111/j.1462-2920.2008.01672.x; Takeuchi N, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027819; Curry JP, 2006, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Anesio AM, 2009, GLOBAL CHANGE BIOL, V15, P955, DOI 10.1111/j.1365-2486.2008.01758.x; Anesio AM, 2012, TRENDS ECOL EVOL, V27, P219, DOI 10.1016/j.tree.2011.09.012; Kojima H, 2009, SYST APPL MICROBIOL, V32, P429, DOI 10.1016/j.syapm.2009.06.003; Satola B, 2013, APPL MICROBIOL BIOT, V97, P541, DOI 10.1007/s00253-012-4585-z; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Hongoh Y, 2007, APPL ENVIRON MICROB, V73, P6270, DOI 10.1128/AEM.00750-07; Shain DH, 2001, CAN J ZOOL, V79, P1813, DOI 10.1139/cjz-79-10-1813; Choudhari S, 2013, GENOME ANNOUNCEMENTS, V21, DOI [10.1128/genomeA.00099-13, DOI 10.1128/GENOMEA.00099-13]; Dial CR, 2012, MOL PHYLOGENET EVOL, V63, P577, DOI 10.1016/j.ympev.2012.01.008; EDWARDS CA, 1988, AGR ECOSYST ENVIRON, V24, P235, DOI 10.1016/0167-8809(88)90069-2; Farrell AH, 2004, J MOL EVOL, V59, P666, DOI 10.1007/s00239-004-2658-z; Goodman D, 1971, 39 OH STAT U RES FDN; Hartzell PL, 2005, CAN J ZOOL, V83, P1206, DOI 10.1139/Z05-116; Marotta R, 2009, INT J EVOL BIOL, V2009; Napolitano MJ, 2004, COMP BIOCHEM PHYS A, V137, P227, DOI 10.1016/j.cbpb.2003.10.005; Napolitano MJ, 2004, P ROY SOC B-BIOL SCI, V271, pS273, DOI 10.1098/rsbl.2004.0180; Nechitaylo TY, 2009, ENVIRON MICROBIOL, V11, P1016, DOI 10.1111/j.1462-2920.2008.01837.x; Shain DH, 2000, J MORPHOL, V246, P192, DOI 10.1002/1097-4687(200012)246:3<192::AID-JMOR3>3.0.CO;2-B; Tartaglia LJ, 2008, GENE, V423, P135, DOI 10.1016/j.gene.2008.07.025; Torii T, 2012, LOW TEMP SCI, V70, P93	52	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0168-6496	1574-6941		FEMS MICROBIOL ECOL	FEMS Microbiol. Ecol.	MAR	2015	91	3								10.1093/femsec/fiv003		10	Microbiology	Microbiology	CF8BZ	WOS:000352781700002		
J	Osuka, Y; Yabushita, N; Kim, M; Seino, S; Nemoto, M; Jung, S; Okubo, Y; Figueroa, R; Tanaka, K				Osuka, Yosuke; Yabushita, Noriko; Kim, Miji; Seino, Satoshi; Nemoto, Miyuki; Jung, Songee; Okubo, Yoshiro; Figueroa, Rafael; Tanaka, Kiyoji			Association between habitual light-intensity physical activity and lower-extremity performance: A cross-sectional study of community-dwelling older Japanese adults	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						lower-extremity performance; objectively measured light-intensity physical activity; older adults	LIFE-STYLE INTERVENTIONS; ELDERS PILOT; HEALTH; MOBILITY; ACCELEROMETER; INDEPENDENCE; DISABILITY; MORTALITY; NAKANOJO; WOMEN	Aim: Habitual moderate vigorous-intensity physical activity (MVPA) positively affects lower-extremity performance. It is unclear whether habitual light-intensity physical activity (LPA), such as leisurely walking, has similar effects on lower-extremity performance. The aim of the present study was to identify the associations between habitual LPA and lower-extremity performance in older adults. Methods: This cross-sectional study included 802 community-dwelling Japanese older adults, 187 men and 615 women, aged 60-96 years. A uniaxial accelerometer measured physical activity intensity for over 10 h/day continuously for 7 days. Lower-extremity performance was assessed by repeated chair stands (RCS), single-leg stance (SLS) and Timed Up & Go (TUG). Multiple regression analysis was used to identify whether LPA was associated with lower-extremity performance, independent of potential confounders. Results: The multiple regression analysis showed that longer LPA was significantly associated with better performance of RCS and TUG. In the results of stratified analyses, LPA was significantly associated with RCS in participants aged >= 75 years and in those with at least one medical condition or joint pain. LPA was also associated with TUG in participants aged >= 75 years, in those with at least one medical condition or joint pain and in those with low MVPA (<13.9 min/day). Conclusions: These results suggest that habitual LPA is a useful lifestyle indicator of better performance in lower-extremity strength and gait with dynamic balance. Maintaining a higher level of LPA could be a recommended approach for preserving lower-extremity performance, especially among physically frail older adults.	[Osuka, Yosuke; Jung, Songee; Okubo, Yoshiro; Figueroa, Rafael] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Yabushita, Noriko; Nemoto, Miyuki; Tanaka, Kiyoji] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki 3058577, Japan; [Kim, Miji] Tokyo Metropolitan Geriatr Hosp, Res Team Promot Independence Elderly, Tokyo 173, Japan; [Seino, Satoshi] Tokyo Metropolitan Geriatr Hosp, Res Team Social Participat & Community Hlth, Tokyo 173, Japan; [Seino, Satoshi] Inst Gerontol, Tokyo, Japan; [Osuka, Yosuke; Seino, Satoshi; Nemoto, Miyuki; Okubo, Yoshiro] Japan Soc Promot Sci, Tokyo, Japan	Osuka, Y (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	osuka@stat.taiiku.tsukuba.ac.jp			Japan Society for the Promotion of Science	We are grateful to the participants and our staff members. This study was supported by the Japan Society for the Promotion of Science, Research Grant for Fellow of the Japan Society for the Promotion of Science in 2013-2014: "Recommended physical activity level to maintain better physical fitness in older adults"	Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Wanderley FAC, 2011, QUAL LIFE RES, V20, P1371, DOI 10.1007/s11136-011-9875-x; Gerdhem P, 2008, EUR J APPL PHYSIOL, V102, P173, DOI 10.1007/s00421-007-0571-z; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Brach JS, 2004, J AM GERIATR SOC, V52, P502, DOI 10.1111/j.1532-5415.2004.52154.x; Rejeski WJ, 2009, J GERONTOL A-BIOL, V64, P462, DOI 10.1093/gerona/gln041; Gando Y, 2010, HYPERTENSION, V56, P540, DOI 10.1161/HYPERTENSIONAHA.110.156331; Murphy SL, 2009, PREV MED, V48, P108, DOI 10.1016/j.ypmed.2008.12.001; Newman AB, 2008, J GERONTOL A-BIOL, V63, P603; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Davison KK, 2002, J AM GERIATR SOC, V50, P1802, DOI 10.1046/j.1532-5415.2002.50508.x; Arnardottir NY, 2013, AGE AGEING, V42, P222, DOI 10.1093/ageing/afs160; Park H, 2007, OSTEOPOROSIS INT, V18, P285, DOI 10.1007/s00198-006-0237-4; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Park H, 2010, EUR J APPL PHYSIOL, V109, P953, DOI 10.1007/s00421-010-1424-8; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Aoyagi Y, 2009, GERONTOLOGY, V55, P523, DOI 10.1159/000236326; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; GURALNIK JM, 1994, J GERONTOL, V49, pM85; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Morie M, 2010, J AM GERIATR SOC, V58, P1727, DOI 10.1111/j.1532-5415.2010.03012.x; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Hubscher M, 2010, GAIT POSTURE, V32, P383, DOI 10.1016/j.gaitpost.2010.06.018; Buchman AS, 2007, J AM GERIATR SOC, V55, P1618, DOI 10.1111/j.1532-5415.2007.01359.x; Brach JS, 2003, ARCH INTERN MED, V163, P2565, DOI 10.1001/archinte.163.21.2565; Chale-Rush A, 2010, J AM GERIATR SOC, V58, P1918, DOI 10.1111/j.1532-5415.2010.03008.x; Aoyagi Y, 2010, EUR J APPL PHYSIOL, V109, P455, DOI 10.1007/s00421-010-1357-2; Ayabe M, 2013, J SPORT SCI, V31, P1805, DOI 10.1080/02640414.2013.803589; BARANOWSKI T, 1988, RES Q EXERCISE SPORT, V59, P314; Cooper R, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4467; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; McMurdo MET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031878; MULLER E A, 1970, Archives of Physical Medicine and Rehabilitation, V51, P449; Onder G, 2006, PAIN, V121, P53, DOI 10.1016/j.pain.2005.12.003; Osuka Y, 2012, JPN J PHYS FIT SPORT, V61, P327; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; RIKLI R, 1986, J GERONTOL, V41, P645; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Yasunaga A, 2007, J AGING PHYS ACTIV, V15, P398	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	MAR	2015	15	3					268	275		10.1111/ggi.12268		8	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AB	WOS:000352565000004		
J	Umegaki, H; Kawamura, T; Umemura, T; Kawano, N				Umegaki, Hiroyuki; Kawamura, Takahiko; Umemura, Toshitaka; Kawano, Naoko			Factors associated with cognitive decline in older adults with type 2 diabetes mellitus during a 6-year observation	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						blood pressure; hemoglobin A1c; high-density lipoprotein cholesterol; insulin; renin-angiotensin system blockers	HIGH-DENSITY-LIPOPROTEIN; SMALL-VESSEL DISEASE; MINI-MENTAL-STATE; BLOOD-PRESSURE; ALZHEIMERS-DISEASE; INFLAMMATORY MARKERS; GLUCOSE CONTROL; ELDERLY-PEOPLE; CHOLESTEROL; DEMENTIA	Aims: Type 2 diabetes mellitus (T2DM) is a risk for cognitive decline in older adults. The current study was carried out to determine the factors associated with cognitive decline. Methods: The older T2DM patients (aged >= 65 years, mean age 79.2 +/- 5.1 years) were observed for 6 years, and the mean values in clinical indicators of participants with and without cognitive decline over a 6-year period were compared. Then, multiple logistic analysis was carried out to determine the factors associated with cognitive decline. Separate analyses were also carried out for each of five cognitive assessments (Mini-Mental State Examination, word immediate and delayed recall, Stroop test, digit symbol substitution). Results: In the composite of several cognitive assessments, higher age and a lower level of high-density lipoprotein cholesterol were associated with cognitive decline in older T2DM patients. Lower systolic blood pressure was associated with a decline in delayed word list recall. Higher plasma insulin level was associated with a decline in the Stroop test performance. Conclusion: Lower high-density lipoprotein cholesterol was significantly associated with general cognitive decline in older T2DM patients during our 6-year observation. Several other factors were also associated with cognitive assessments of various cognitive domains.	[Umegaki, Hiroyuki; Kawano, Naoko] Nagoya Univ, Grad Sch Med, Dept Community Healthcare & Geriatr, Nagoya, Aichi 4668550, Japan; [Kawano, Naoko] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4668550, Japan; [Kawamura, Takahiko] Chubu Rosai Hosp, Dept Diabet & Endocrine Internal Med, Nagoya, Aichi, Japan; [Kawamura, Takahiko] Chubu Rosai Hosp, Ctr Prevent Med, Nagoya, Aichi, Japan; [Umemura, Toshitaka] Chubu Rosai Hosp, Dept Neurol, Nagoya, Aichi, Japan	Umegaki, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Community Healthcare & Geriatr, Showa Ku, 65 Tsuruma, Nagoya, Aichi 4668550, Japan.	umegaki@med.nagoya-u.ac.jp					American Diabetes Association, 2012, DIABETES CARE S1, V35, pS11, DOI DOI 10.2337/DC12-S011; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Crisby M, 2010, CURR ALZHEIMER RES, V7, P534; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Marioni RE, 2010, DIABETES, V59, P710, DOI 10.2337/db09-1163; Sacco RL, 2001, JAMA-J AM MED ASSOC, V285, P2729, DOI 10.1001/jama.285.21.2729; Umegaki H, 2012, ADV EXP MED BIOL, V724, P258, DOI 10.1007/978-1-4614-0653-2_19; HANNUKSELA M, 1992, J LIPID RES, V33, P737; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351; Umemura T, 2011, J NEUROL NEUROSUR PS, V82, P1186, DOI 10.1136/jnnp.2010.217380; Bruehl H, 2010, J CLIN EXP NEUROPSYC, V32, P487, DOI 10.1080/13803390903224928; Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Schuur M, 2010, EUR J EPIDEMIOL, V25, P561, DOI 10.1007/s10654-010-9476-y; Yaffe K, 2012, ARCH NEUROL-CHICAGO, V69, P1170, DOI 10.1001/archneurol.2012.1117; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/0096-3445.121.1.15; Umegaki H, 2013, GERIATR GERONTOL INT, V13, P28, DOI 10.1111/j.1447-0594.2012.00922.x; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; Sarwar N, 2010, LANCET, V375, P2215; Umegaki H, 2012, GERIATR GERONTOL INT, V12, P103, DOI 10.1111/j.1447-0594.2011.00817.x; Yaffe K, 2011, NEUROLOGY, V77, P1351, DOI 10.1212/WNL.0b013e3182315a56; Birjmohun RS, 2005, J AM COLL CARDIOL, V45, P185, DOI 10.1016/j.jacc.2004.10.031; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Szewieczek J, 2011, J NUTR HEALTH AGING, V15, P618; Guo ZC, 1997, AM J EPIDEMIOL, V145, P1106; Cockerill GW, 2001, CIRCULATION, V103, P108; Wolf H, 2004, ANN NEUROL, V56, P745, DOI 10.1002/ana.20289; Singh-Manoux A, 2008, ARTERIOSCL THROM VAS, V28, P1556, DOI 10.1161/ATVBAHA.108.163998; Paterno R, 2004, CEREBROVASC DIS, V17, P204, DOI 10.1159/000075792; MOHS RC, 1983, PSYCHOPHARMACOL BULL, V19, P448; Araki A, 2002, GERIATR GERONTOL INT, V2, P206, DOI 10.1046/j.1444-1586.2002.00047.x; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; de Bresser J, 2010, DEMENT GERIATR COGN, V30, P381, DOI 10.1159/000321354; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glaser N, 2012, DIABETES, V61, P1831, DOI 10.2337/db11-1286; Imamine R, 2011, DIABETES RES CLIN PR, V94, P91, DOI 10.1016/j.diabres.2011.06.014; Kehoe PG, 2012, J ALZHEIMERS DIS, V30, pS251, DOI 10.3233/JAD-2012-111376; Koudinov AR, 1998, CLIN CHIM ACTA, V270, P75, DOI 10.1016/S0009-8981(97)00207-6; Maeda K, 2003, PREV MED, V37, P283, DOI 10.1016/S0091-7435(03)00110-5; Nilsson SE, 2007, AGING CLIN EXP RES, V19, P41; Olesen OF, 2000, BIOCHEM BIOPH RES CO, V270, P62, DOI 10.1006/bbrc.2000.2372; Shinagawa F, 1990, JAPANESE MANUAL WECH, P115; Spate-Douglas T, 1999, ARCH PHYS MED REHAB, V80, P691, DOI 10.1016/S0003-9993(99)90174-0; Suh DC, 2010, J DIABETES COMPLICAT, V24, P382, DOI 10.1016/j.jdiacomp.2009.07.001; Umegaki H, 2008, AGE AGEING, V37, P458, DOI 10.1093/ageing/afn051; Wilsgaard E., 2004, ANN EPIDEMIOL, V14, P265; Yesavage JA, 1986, CLIN MEMORY ASSESSME, P213; Zuliani G, 2010, J GERONTOL A-BIOL, V65, P559, DOI 10.1093/gerona/glq026	49	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	MAR	2015	15	3					302	310		10.1111/ggi.12273		9	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AB	WOS:000352565000009		
J	Ishibashi, F; Sunohara, M; Kawagoe, S				Ishibashi, Fumiaki; Sunohara, Mitsuhiro; Kawagoe, Shohei			Performance of severity scores for home care-based patients suffering from pneumonia	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						home care-based patients; nursing and health care-associated pneumonia; pneumonia severity index; A-DROP score; CURB-65 score	COMMUNITY-ACQUIRED PNEUMONIA; HOSPITAL ADMISSION; GUIDELINES; MANAGEMENT; OUTCOMES; ADULTS; RISK	Aim: The Pneumonia Severity Index (PSI) is used to determine the prognosis of community-acquired pneumonia (CAP). The concept of nursing-and healthcare-associated pneumonia (NHCAP) has recently been established in Japan. The present study aims to examine whether the PSI can predict the prognosis of home care-based patients diagnosed with NHCAP. Methods: We retrospectively sampled 97 home care-based patients diagnosed with pneumonia in 2011 at Aozora Clinic in Kamihongo. Each case was scored using the PSI, the A-DROP and the CURB-65, and the severity of each case was evaluated. We also modified the PSI to obtain the score on the site of the home visits by omitting the scores related to the radiographic and laboratory findings. We call this new score the modified PSI for home care-based patients (PSI-HC). We assessed how well each score predicted mortality. Results: The correlation efficiency of the PSI and the PSI-HC before categorization was 0.89. All the four scores well predicted the mortality, with the area under the curve of the receiver operating characteristic curves of the PSI, the PSI-HC, the A-DROP and the CURB-65 being 0.859, 0.856, 0.778, and 0.806, respectively. These scores also predicted the hospitalization rate, but more than two-thirds of high-scoring patients received therapy at home contrary to the recommendations of guidelines. Conclusions: All four scores for CAP well predicted the prognosis of pneumonia of the home care-based patients, which was categorized in NHCAP. The decision of hospitalization was made not only by considering the severity of the pneumonia.	[Ishibashi, Fumiaki; Sunohara, Mitsuhiro; Kawagoe, Shohei] Aozora Clin, Chiba, Japan; [Ishibashi, Fumiaki] Tokyo Metropolitan Bokutoh Hosp, Dept Internal Med, Tokyo, Japan; [Sunohara, Mitsuhiro] Tokyo Univ Hosp, Dept Resp Med, Tokyo 1138655, Japan	Sunohara, M (reprint author), Tokyo Univ Hosp, Dept Resp Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sunohara-tky@umin.ac.jp					[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Seki M, 2011, J INFECT CHEMOTHER, V17, P363, DOI 10.1007/s10156-010-0127-8; Venditti M, 2009, ANN INTERN MED, V150, P19; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; Carratala J, 2007, ARCH INTERN MED, V167, P1393, DOI 10.1001/archinte.167.13.1393; Ishida T, 2012, INTERNAL MED, V51, P2537, DOI 10.2169/internalmedicine.51.7987; Falcone M, 2011, INTERN EMERG MED, V6, P431, DOI 10.1007/s11739-011-0521-y; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Sager MA, 1996, J AM GERIATR SOC, V44, P251; Shindo Y, 2009, CHEST, V135, P633, DOI 10.1378/chest.08-1357; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; DAMON LE, 1982, AM FAM PHYSICIAN, V26, P144; Kohno Shigeru, 2013, Respir Investig, V51, P103, DOI 10.1016/j.resinv.2012.11.001; The Japanese Respiratory Society, 2007, GUID MAN COMM ACQ PN	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	MAR	2015	15	3					311	317		10.1111/ggi.12274		7	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AB	WOS:000352565000010		
J	Kawasaki, A; Matsushima, M; Miura, Y; Watanabe, T; Tominaga, T; Nagata, T; Hirayama, Y; Moriya, A; Nomura, K				Kawasaki, Ayako; Matsushima, Masato; Miura, Yasuhiko; Watanabe, Takamasa; Tominaga, Tomokazu; Nagata, Takuya; Hirayama, Yoko; Moriya, Akinari; Nomura, Kouji			Recognition of and intent to use gastrostomy or ventilator treatments in older patients with advanced dementia: Differences between laypeople and healthcare professionals in Japan	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						advance directives; end-of-life care; gastrostomy; ventilator; withholding treatment	LIFE; END	Aim: We compared differences between laypeople and healthcare professionals in the recognition of and intent to use gastrostomy and ventilator treatments in older patients with dementia. Methods: Between November 2011 and January 2012, a questionnaire survey was carried out. People who underwent a general health check-up at Nomura Hospital Preventive Medical Center were recruited as the laypeople group. Physicians and nurses working in Mitaka, Tokyo, Japan, were recruited as the healthcare professional group. We assessed the recognition rate of ventilator and gastrostomy treatments. Then we provided two scenarios for participants to determine whether these methods represented life-sustaining treatments that will simply delay an inevitable death. Intentions were compared between cases with and without advance directives. Results: Approximately 60% of laypeople did not know what gastrostomy is. Healthcare professionals were more likely to recognize a ventilator as a life-sustaining treatment; in contrast, there were no significant differences in judgments regarding gastrostomy. Both groups were more likely to have intent to use a gastrostomy and a ventilator for family members than themselves. Furthermore, healthcare professionals were more likely to want to use these items for patients than their family members. Advance directive for withholding life-sustaining treatment reduced the intention to use these treatments. Conclusion: It is necessary to increase our understanding regarding knowledge of end-of-life care options of both laypeople and healthcare professionals.	[Kawasaki, Ayako; Matsushima, Masato; Watanabe, Takamasa; Tominaga, Tomokazu; Nagata, Takuya; Hirayama, Yoko; Moriya, Akinari] Jikei Univ, Sch Med, Res Ctr Med Sci, Div Clin Epidemiol, Tokyo, Japan; [Kawasaki, Ayako; Miura, Yasuhiko; Nomura, Kouji] Nomura Hosp, Tokyo, Japan	Kawasaki, A (reprint author), Nomura Hosp, 8-3-6 Shimorennjaku, Mitaka, Tokyo 1818503, Japan.	a_kwsk@nomurahp.or.jp			Jikei University School of Medicine; Postgraduate Medical School research grant	Many thanks to the questionnaire participants and the Mitaka Medical Association for their cooperation. This work was supported by a fiscal year 2012 Jikei University School of Medicine and Postgraduate Medical School research grant.	Aita K, 2007, BMC GERIATR, V7, P1; All Japan Hospital Association, 2011, THE SURVEILLANCE STU; Triplett P, 2008, J AGING HEALTH, V20, P583, DOI 10.1177/0898264308317822; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Bito S, 2007, BIOETHICS, V21, P251, DOI 10.1111/j.1467-8519.2007.00551.x; Bosshard G, 2005, ARCH INTERN MED, V165, P401, DOI 10.1001/archinte.165.4.401; Aw D, 2012, QJM-INT J MED, V105, P225, DOI 10.1093/qjmed/hcr209; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Asai A, 2012, HOSP HOME CARE, V20, P42; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; Kosaka Y, 2003, GERIATR GERONTOL INT, V3, P172, DOI 10.1046/j.1444-1586.2003.00080.x; Kuzuhara S., 2012, RES REP SUZUKA UNIV, V19, P15; Minooka M., 2008, BIOETH STUDY NETW, V7, P76; Miyata Hiroaki, 2007, Nihon Koshu Eisei Zasshi, V54, P254; Okamura S., 2010, HOSPITALS, V69, P298; Richter J, 2001, J MED ETHICS, V27, P186, DOI 10.1136/jme.27.3.186; StataCorp, 2009, STATA STATISTICAL SO; Suzuki Y, 2008, ENDOSCOPIA DIGESTIVA, V20, P30; The Ministry of Health Labour and Welfare of Japan, 2012, NATIONWIDE SURVEY OF	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	MAR	2015	15	3					318	325		10.1111/ggi.12276		8	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AB	WOS:000352565000011		
J	Yuki, A; Ando, F; Otsuka, R; Shimokata, H				Yuki, Atsumu; Ando, Fujiko; Otsuka, Rei; Shimokata, Hiroshi			Low free testosterone is associated with loss of appendicular muscle mass in Japanese community-dwelling women	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						aging; dual-energy X-ray absorptiometry; epidemiology; longitudinal study; sarcopenia	LEAN BODY-MASS; SERUM TESTOSTERONE; POSTMENOPAUSAL WOMEN; OLDER MEN; PHYSICAL-DISABILITY; ELDERLY-MEN; SARCOPENIA; ANDROGENS; MENOPAUSE; STRENGTH	Aim: Sarcopenia accelerates frailty syndrome, and adversely affects activities of daily living and quality of life. The aim of the present study was to assess longitudinal relationships between baseline androgen and muscle mass changes in Japanese women. Methods: Data were collected from 539 community-dwelling, Japanese women aged 40-79 years at baseline who participated in both baseline and follow-up examinations of a longitudinal study of aging (mean duration 8.3 years). Appendicular skeletal muscle mass was measured with dual-energy X-ray absorptiometry at baseline and follow-up examinations. The cut-off point for sarcopenia was a skeletal muscle index (appendicular skeletal muscle mass/height(2)) <5.46 kg/m(2). Participants with sarcopenia at baseline were excluded. Thus, 430 women were included. Total testosterone, free testosterone and dehydroepiandrosterone-sulphate were measured by radioimmunoassay at baseline. The androgens were categorized into three groups by serum levels. Multiple logistic regression models were fit to determine the associations between androgens and sarcopenia while controlling for baseline age, body mass index, leisure-time physical activity, nutritional intakes (total energy, total protein, vitamin D), serum C-reactive protein levels, medical histories (heart disease, osteoporosis, rheumatoid arthritis), menopause and smoking habit. Results: The fully adjusted odds ratio of sarcopenia for the low-free testosterone group (<0.7 pg/mL) compared with the high-free testosterone group (>= 1.2 pg/mL) was 3.59 (95% confidence interval 1.25-10.34). Sarcopenia was not significantly related to total testosterone or dehydroepiandrosterone-sulphate. Conclusion: A low-free testosterone level appears to be a significant predictor of the risk for loss of appendicular muscle in Japanese women.	[Yuki, Atsumu] Kochi Univ, Fac Educ, Kochi, Kochi 7808520, Japan; [Ando, Fujiko] Aichi Shukutoku Univ, Fac Hlth & Med Sci, Nagakute, Aichi, Japan; [Otsuka, Rei] Natl Ctr Geriatr & Gerontol, Sect NILS LSA, Obu, Japan; [Shimokata, Hiroshi] Nagoya Univ Arts & Sci, Grad Sch Nutr Sci, Nisshin, Japan	Yuki, A (reprint author), Kochi Univ, Fac Educ, 2-5-1 Akebono, Kochi, Kochi 7808520, Japan.	ats.yuki.73@gmail.com			Japan Society for the Promotion of Science KAKENHI [24700775, 24249044]; National Center for Geriatrics and Gerontology, Japan [23-33]	This work was supported by the Japan Society for the Promotion of Science KAKENHI (24700775, 24249044) and the Research Funding for Longevity Sciences (23-33) from the National Center for Geriatrics and Gerontology, Japan.	Mauras N, 1998, J CLIN ENDOCR METAB, V83, P1886, DOI 10.1210/jc.83.6.1886; Laughlin GA, 2010, J CLIN ENDOCR METAB, V95, P740, DOI 10.1210/jc.2009-1693; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Santoro N, 2005, J CLIN ENDOCR METAB, V90, P4836, DOI 10.1210/jc.2004-2063; van Geel TACM, 2009, EUR J ENDOCRINOL, V160, P681, DOI 10.1530/EJE-08-0702; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755; Haring R, 2012, J CLIN ENDOCR METAB, V97, P408, DOI 10.1210/jc.2011-2134; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Burger HG, 2000, J CLIN ENDOCR METAB, V85, P2832, DOI 10.1210/jc.85.8.2832; Roth GS, 2002, SCIENCE, V297, P811, DOI 10.1126/science.1071851; Voznesensky M, 2009, AGE AGEING, V38, P401, DOI 10.1093/ageing/afp015; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629; LeBlanc ES, 2011, J CLIN ENDOCR METAB, V96, P3855, DOI 10.1210/jc.2011-0312; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; Emmelot-Vonk MH, 2008, JAMA-J AM MED ASSOC, V299, P39, DOI 10.1001/jama.2007.51; Baumgartner RN, 1999, MECH AGEING DEV, V107, P123, DOI 10.1016/S0047-6374(98)00130-4; Fogle RH, 2007, J CLIN ENDOCR METAB, V92, P3040, DOI 10.1210/jc.2007-0581; Ding EL, 2007, DIABETOLOGIA, V50, P2076, DOI 10.1007/s00125-007-0785-y; Cappola AR, 2009, J GERONTOL A-BIOL, V64, P243, DOI 10.1093/gerona/gln026; Demling RH, 2000, J CRIT CARE, V15, P12, DOI 10.1053/jcrc.2000.0150012; Gower BA, 2000, J CLIN ENDOCR METAB, V85, P4476, DOI 10.1210/jc.85.12.4476; Haren MT, 2007, MATURITAS, V57, P347, DOI 10.1016/j.maturitas.2007.03.003; Imai T, 2009, J INTEGR STUD DIET H, V20, P203; Iwamoto T, 2009, INT J UROL, V16, P168, DOI 10.1111/j.1442-2042.2008.02203.x; Kozakai R, 2012, J PHYS FITNESS SPORT, V1, P167; Miyakoshi N, 2013, J BONE MINER METAB, V31, P556, DOI 10.1007/s00774-013-0443-z; Morley JE, 2003, J GERONTOL A-BIOL, V58, P409; Roy TA, 2002, AM J PHYSIOL-ENDOC M, V283, pE284, DOI 10.1152/ajpendo.00334.2001; Shimokata H, 2000, J Epidemiol, V10, pS1; Yasui Toshiyuki, 2012, J Med Invest, V59, P12; Yuki A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01818	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	MAR	2015	15	3					326	333		10.1111/ggi.12278		8	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AB	WOS:000352565000012		
J	Takahashi, J; Shibata, T; Sasaki, M; Kudo, M; Yanezawa, H; Obara, S; Kudo, K; Ito, K; Yamashita, F; Terayama, Y				Takahashi, Junko; Shibata, Toshihide; Sasaki, Makoto; Kudo, Masako; Yanezawa, Hisashi; Obara, Satoko; Kudo, Kohsuke; Ito, Kenji; Yamashita, Fumio; Terayama, Yasuo			Detection of changes in the locus coeruleus in patients with mild cognitive impairment and Alzheimer's disease: High-resolution fast spin-echo T1-weighted imaging	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						Alzheimer's disease; locus coeruleus; magnetic resonance imaging; mild cognitive impairment; neuromelanin	NORADRENERGIC NERVOUS-SYSTEM; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; CERULEUS; BRAIN; MRI; DIAGNOSIS; DEMENTIA; DYSFUNCTION; PATHOLOGY	Aim: Neuronal degeneration in the locus coeruleus occurs in the early phase of Alzheimer's disease, similar to mild cognitive impairment. The locus coeruleus produces norepinephrine, a deficiency of which causes both memory disturbance and psychological symptoms. Thus, we evaluated signal alterations in the locus coeruleus of patients with Alzheimer's disease and mild cognitive impairment using a high-resolution fast spin-echo T1-weighted imaging. Methods: A total of 22 patients with Alzheimer's disease, 47 patients with mild cognitive impairment and 26 healthy controls were prospectively examined by high-resolution fast spin-echo T1-weighted imaging at 3 Tesla. Signal intensities in the locus coeruleus were manually measured and expressed relative to those in the adjacent white matter structures as contrast ratios. Results: Locus coeruleus contrast ratios were significantly reduced in patient groups with Alzheimer's disease, mild cognitive impairment that converted to Alzheimer's disease and mild cognitive impairment that did not convert to Alzheimer's disease (1.80-16.09% [median, 9.30%], 3.45-14.84% [median 6.87%] and 3.01-19.19% [median 7.72%], respectively) compared with the healthy control group (6.24-20.94% [median 14.35%]; P < 0.0001). The sensitivity and specificity for discriminating these diseases were 85.0% and 69.2%, respectively, which suggests that this measurement can be carried out reliably. There was no significant difference in the locus coeruleus contrast ratios among the Alzheimer's disease, mild cognitive impairment-converted and mild cognitive impairment-non-converted groups. Conclusions: High-resolution fast spin-echo T1-weighted imaging can show signal attenuation in the locus coeruleus of patients with Alzheimer's disease or with mild cognitive impairment whose pathology may or may not eventually convert to Alzheimer's disease.	[Takahashi, Junko; Shibata, Toshihide; Kudo, Masako; Yanezawa, Hisashi; Obara, Satoko; Terayama, Yasuo] Iwate Med Univ, Dept Neurol & Gerontol, Sch Med, Morioka, Iwate 020, Japan; [Sasaki, Makoto; Ito, Kenji; Yamashita, Fumio] Iwate Med Univ, Inst Biomed Sci, Div Ultrahigh Field MRI, Morioka, Iwate 020, Japan; [Kudo, Kohsuke] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido 060, Japan	Takahashi, J (reprint author), Iwate Med Univ, Dept Neurol & Gerontol, 19-1 Uchimaru, Morioka, Iwate 020, Japan.	jtakahas@iwate-med.ac.jp			Ministry of Education, Culture, Sport, Science and Technology of Japan	Our deepest appreciation goes to the late Dr Satoshi Takahashi, who made an inspirational effort in leading our study during his short life. This work was partly supported by a Grant-in-Aid for Strategic Medical Science Research from the Ministry of Education, Culture, Sport, Science and Technology of Japan.	BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; McMillan PJ, 2011, BRAIN RES, V1373, P240, DOI 10.1016/j.brainres.2010.12.015; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Jellinger KA, 2003, ACTA NEUROPATHOL, V106, P191, DOI 10.1007/s00401-003-0725-y; Keren NI, 2009, NEUROIMAGE, V47, P1261, DOI 10.1016/j.neuroimage.2009.06.012; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; Braak H, 2011, ACTA NEUROPATHOL, V121, P589, DOI 10.1007/s00401-011-0825-z; Enochs WS, 1997, RADIOLOGY, V204, P417; Petersen RC, 2001, NEUROLOGY, V56, P1133; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awml12; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Grudzien A, 2007, NEUROBIOL AGING, V28, P327, DOI 10.1016/j.neurobiolaging.2006.02.007; Del Tredici K, 2013, J NEUROL NEUROSUR PS, V84, P774, DOI 10.1136/jnnp-2011-301817; Bosboom JLW, 2004, J NEURAL TRANSM, V111, P1303, DOI 10.1007/s00702-004-0168-1; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Sasaki M, 2006, NEUROREPORT, V17, P1215, DOI 10.1097/01.wnr.0000227984.84927.a7; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Thal DR, 2002, NEUROLOGY, V58, P1791; Braak H, 2006, J NEUROL SCI, V248, P255, DOI 10.1016/j.jns.2006.05.011; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Szot P, 2012, EPILEPSIA, V53, P61, DOI 10.1111/j.1528-1167.2012.03476.x; Huglund M, 2006, NEUROPATHOLOGY, V26, P528; Kaneda T, 2013, HIGH SIGNAL INTENSIT; Karen NI, 2009, NEUROIMAGE, V47, P1261; MCKHANN G, 1984, NEUROLOGY, V34, P939; Saito Y, 2007, NEUROPATHOLOGY, V27, P578, DOI 10.1111/j.1440-1789.2007.00806.x; Saka E, 2007, ARCH GERONTOL GERIAT, V44, P141, DOI 10.1016/j.archeger.2006.04.006; Shibata Eri, 2006, Magn Reson Med Sci, V5, P197, DOI 10.2463/mrms.5.197; Shibata E, 2008, BIOL PSYCHIAT, V64, P401, DOI [10.1016/j.biopsych.2008.03.021, 10.1016/j.biopsych.2008.03.02]; Shibata E, 2007, NEUROREPORT, V18, P415, DOI 10.1097/WNR.0b013e328058674a; TOSK JM, 1992, MAGNET RESON MED, V26, P40, DOI 10.1002/mrm.1910260105; Yoshiura T, 2011, EUR RADIOL, V21, P419, DOI 10.1007/s00330-010-1939-8	35	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	MAR	2015	15	3					334	340		10.1111/ggi.12280		7	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AB	WOS:000352565000013		
J	Sakurai, H; Hanyu, H; Terayama, H; Fukuda, K; Iwamoto, T; Konno, S; Harada, N; Suzuki, Y; Nagata, M				Sakurai, Hirofumi; Hanyu, Haruo; Terayama, Hideyuki; Fukuda, Kaori; Iwamoto, Toshihiko; Konno, Sachie; Harada, Nanako; Suzuki, Yutaka; Nagata, Mie			Factors associated with the burden of caregivers of patients with dementia	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Letter									[Sakurai, Hirofumi; Hanyu, Haruo; Terayama, Hideyuki; Fukuda, Kaori; Iwamoto, Toshihiko] Tokyo Med Univ, Dept Geriatr Med, Tokyo 1608402, Japan; [Sakurai, Hirofumi; Harada, Nanako; Suzuki, Yutaka; Nagata, Mie] Tokyo Med Univ Hosp, Comprehens Counseling & Support Ctr, Tokyo, Japan; [Konno, Sachie] Tokyo Med Univ Hosp, Dept Nursing, Tokyo, Japan	Sakurai, H (reprint author), Tokyo Med Univ, Dept Geriatr Med, Tokyo 1608402, Japan.						Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Arai Yumiko, 1997, Psychiatry and Clinical Neurosciences, V51, P281, DOI 10.1111/j.1440-1819.1997.tb03199.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Imai Y, 2011, JPN J GERIATR PSYCHI, V22, P1155; Kawano Y, 2009, J GERIATR PSYCHIAT, V20, P1149; Sugiura Keiko, 2007, Nihon Ronen Igakkai Zasshi, V44, P717, DOI 10.3143/geriatrics.44.717; Tanji H, 2005, GERIATR GERONTOL INT, V5, P94, DOI 10.1111/j.1447-0594.2005.00274.x	8	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	MAR	2015	15	3					384	385		10.1111/ggi.12350		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AB	WOS:000352565000021		
J	Mariko, A; Matsuda, H; Takahashi, M; Fujii, M; Sasaki, H				Mariko, Atsushi; Matsuda, Hiroyasu; Takahashi, Maki; Fujii, Masahiko; Sasaki, Hidetada			Touch on the acupoint of Shinchuu of Alzheimer's disease patients	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Letter							PSYCHOLOGICAL SYMPTOMS; DEMENTIA PATIENTS; STATE; CARE		[Mariko, Atsushi; Matsuda, Hiroyasu; Takahashi, Maki; Fujii, Masahiko; Sasaki, Hidetada] Sendai Tomozawa Hosp, Sendai, Miyagi, Japan	Mariko, A (reprint author), Sendai Tomozawa Hosp, Sendai, Miyagi, Japan.						American Psychiatric Association, 1994, DIAGN STAT MAN MENT; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308; Butler P, 2012, TOHOKU J EXP MED, V227, P203; China Academy of Traditional Chinese Medicine, 1990, LOC AC; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujii M, 2014, GERIATR GERONTOL INT, V14, P508, DOI 10.1111/ggi.12127; Ishizuka S, 2012, GERIATR GERONTOL INT, V12, P2, DOI 10.1111/j.1447-0594.2011.00718.x; Kudoh H, 2009, GERIATR GERONTOL INT, V9, P399, DOI 10.1111/j.1447-0594.2009.00545.x; Mahoney FL, 1969, MD STATE MED J, V14, P61; Matsuda H, 2012, GERIATR GERONTOL INT, V12, P568, DOI 10.1111/j.1447-0594.2011.00802.x; Satoh S, 2013, GERIATR GERONTOL INT, V13, P515, DOI 10.1111/ggi.12010; Woods DL, 2005, ALTERN THER HEALTH M, V11, P66	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	MAR	2015	15	3					385	386		10.1111/ggi.12351		3	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AB	WOS:000352565000022		
J	Kosaka, Y; Ohrui, T; Ohtawara, A; Ishizuka, S; Azumi, M; Fujii, M; Sasaki, H				Kosaka, Youichi; Ohrui, Takashi; Ohtawara, Akira; Ishizuka, Satoshi; Azumi, Masako; Fujii, Masahiko; Sasaki, Hidetada			Lactobacillus bifidus and pathogenic Escherichia coli in geriatric patients	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Letter									[Kosaka, Youichi; Ohrui, Takashi; Ohtawara, Akira; Ishizuka, Satoshi; Azumi, Masako; Fujii, Masahiko; Sasaki, Hidetada] Sendai Tomizawa Hosp, Sendai, Miyagi, Japan	Kosaka, Y (reprint author), Sendai Tomizawa Hosp, Sendai, Miyagi, Japan.						Amdekar S, 2010, WEBMED CENTRAL MICRO, V1, P1; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Arribas B, 2009, BRIT J NUTR, V101, P51, DOI 10.1017/S0007114508986876; Mogadhamm MZ, 2006, PAK J BIOL SCI, V9, P2112; Takahashi M, 2012, GERIATR GERONTOL INT, V12, P570, DOI 10.1111/j.1447-0594.2011.00829.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	MAR	2015	15	3					387	388		10.1111/ggi.12362		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AB	WOS:000352565000023		
J	Kobayashi, D; Otsubo, T; Imanaka, Y				Kobayashi, Daisuke; Otsubo, Tetsuya; Imanaka, Yuichi			The effect of centralization of health care services on travel time and its equality	HEALTH POLICY			English	Article						Health care access; Travel time; Regional variations; Gini coefficient	UNITED-STATES; CANCER CARE; ACCESS; HOSPITALS	Objectives: To analyze the regional variations in travel time between patient residences and medical facilities for the treatment of ischemic heart disease and breast cancer, and to simulate the effects of health care services centralization on travel time and equality of access. Methods: We used medical insurance claims data for inpatients and outpatients for the two target diseases that had been filed between September 2008 and May 2009 in Kyoto Prefecture, Japan. Using a geographical information system, patient travel times were calculated based on the driving distance between patient residences and hospitals via highways and toll roads. Locations of residences and hospital locations were identified using postal codes. We then conducted a simulation analysis of centralization of health care services to designated regional core hospitals. The simulated changes in potential spatial access to care were examined. Results: Inequalities in access to care were examined using Gini coefficients, which ranged from 0.4109 to 0.4574. Simulations of health care services centralization showed reduced travel time for most patients and overall improvements in equality of access, except in breast cancer outpatients. Conclusion: Our findings may contribute to the decision-making process in policies aimed at improving the potential spatial access to health care services. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kobayashi, Daisuke; Otsubo, Tetsuya; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Kyoto 6068501, Japan	Imanaka, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	kobayashi-d@umin.ac.jp; otsubo-kyoto@umin.ac.jp; imanaka-y@umin.net			Ministry of Health, Labour and Welfare [H22-SEISAKU-IPPAN-028]; Japan Society for the Promotion of Science [25253033]	This study was funded by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare (H22-SEISAKU-IPPAN-028) and the Japan Society for the Promotion of Science ((A)25253033).	Nallamothu BK, 2006, CIRCULATION, V113, P1189, DOI 10.1161/CIRCULATIONAHA.105.596346; Boscoe FP, 2012, PROF GEOGR, V64, P188, DOI 10.1080/00330124.2011.583586; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Church J, 1998, INT J HEALTH SERV, V28, P467, DOI 10.2190/UFPT-7XPW-794C-VJ52; Tracy R, 2013, HEALTH SERV RES, V48, P1719, DOI 10.1111/1475-6773.12050; Hanlon N, 2005, CAN GEOGR-GEOGR CAN, V49, P1, DOI 10.1111/j.0008-3658.2005.00077.x; Baird G, 2008, RURAL REMOTE HEALTH, V8; Gooiker G A, 2010, Eur J Surg Oncol, V36 Suppl 1, pS27, DOI 10.1016/j.ejso.2010.06.024; Hattori Masakazu, 2010, Nihon Koshu Eisei Zasshi, V57, P263; Japan Post Service Co. Ltd, POST COD DAT DOWNL; KHAN AA, 1992, SOCIO ECON PLAN SCI, V26, P275, DOI 10.1016/0038-0121(92)90004-O; Kobayashi D, 2011, P 31 JOINT C MED INF, V31, P470; Kunisawa S, 2014, J STROKE CEREBROVASC, V23, P724; Kyoto Prefectural Government, KYOT HLTH CAR YOR NE; Kyoto Prefectural Government, KYOT PREF HLTH CAR P; Kyoto Prefectural Government, KYOT PREF INF REL CA; Kyoto Prefecture Medical System Research Council, 2010, KYOT PREF MED SYST R; Matsumoto M, 2013, RURAL REMOTE HEALTH, V13; Ministry of Health Labour and Welfare, 2005, INV REP COMM PROM CA; Ministry of Health Labour and Welfare, 2010, SURV ACT NUMB REQ DO; Ministry of Health Labour and Welfare Japan, 2013, SERV GUID; Ministry of Health Labour and Welfare Japan, 2012, ABR LIF TABL JAP 201; Ministry of land Infrastructure Transport and Tourism, 2006, BLOCK LEV LOC REF DO; Schuurman Nadine, 2006, Int J Health Geogr, V5, P43, DOI 10.1186/1476-072X-5-43; Yamada Y, 2009, J JAPAN SOC HEALTHCA, V46, P167	25	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8510	1872-6054		HEALTH POLICY	Health Policy	MAR	2015	119	3					298	306		10.1016/j.healthpol.2014.11.008		9	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	CF0PC	WOS:000352245700007		
J	Maarisit, W; Yano, K; Miyazato, T; Roy, PK; Taira, J; Ued, K				Maarisit, Wilmar; Yano, Kentaro; Miyazato, Tomofumi; Roy, Prodip K.; Taira, Junsei; Ued, Katsuhiro			STRUCTURES AND BIOACTIVITIES OF XENICANES FROM AN OKINAWAN SOFT CORAL XENIA sp.	HETEROCYCLES			English	Article						Soft Coral; Xenia sp.; Diterpenoid; NMR; Spectroscopy; Bioactivity	MARINE NATURAL-PRODUCTS; A-D; DITERPENOIDS	Three new xenicane diterpenoids 1-3 were isolated from a soft coral Xenia sp. together with the known xenicanes 4-7. Their structures were determined by spectroscopic methods and the structure of 1 was further confirmed by single X-ray diffraction analysis. Metabolites 1-7 showed weak cytotoxicity against HCT 116 cells and a dose dependent, anti-inflammatory effect in LPS/IFN-gamma-stimulated inflammatory RAW 264.7 macrophage cells.	[Maarisit, Wilmar; Yano, Kentaro; Miyazato, Tomofumi; Roy, Prodip K.; Ued, Katsuhiro] Univ Ryukyus, Dept Chem Biol & Marine Sci, Okinawa 9030213, Japan; [Taira, Junsei] Okinawa Natl Coll Technol, Dept Bioresources Engn, Nagoya, Okinawa 9052192, Japan	Ued, K (reprint author), Univ Ryukyus, Dept Chem Biol & Marine Sci, Okinawa 9030213, Japan.	kueda@sci.u-ryukyu.ac.jp					Fattorusso E, 2008, TETRAHEDRON, V64, P3141, DOI 10.1016/j.tet.2008.01.120; Taira J, 2009, FOOD CHEM, V115, P1221, DOI 10.1016/j.foodchem.2009.01.030; Iwagawa T, 1996, HETEROCYCLES, V43, P1271; Blunt JW, 2013, NAT PROD REP, V30, P237, DOI 10.1039/c2np20112g; VANDERAH DJ, 1977, J AM CHEM SOC, V99, P5780, DOI 10.1021/ja00459a040; Bishara A, 2006, TETRAHEDRON, V62, P12092, DOI 10.1016/j.tet.2006.09.050; Iwagawa T, 1996, TETRAHEDRON, V52, P13121, DOI 10.1016/0040-4020(96)00774-0; Faulkner DJ, 2002, NAT PROD REP, V19, P1, DOI 10.1039/b009029h; IWAGAWA T, 1995, TETRAHEDRON, V51, P11111, DOI 10.1016/0040-4020(95)00684-Z; KASHMAN Y, 1978, TETRAHEDRON LETT, P4833	10	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	MAR 1	2015	91	3					505	514		10.3987/COM-14-13149		10	Chemistry, Organic	Chemistry	CF6OR	WOS:000352676500002		
J	Moriya, A; Ohki, T; Hayai, A; Ueno, Y				Moriya, Ayako; Ohki, Tokimitsu; Hayai, Aya; Ueno, Yoshihito			DEVELOPMENT OF A PROBE CONTAINING NOVEL FLUORESCENT TRICYCLIC-NUCLEOSIDE ANALOGS FOR DETECTING SINGLE NUCLEOTIDE POLYMORPHISMS	HETEROCYCLES			English	Article						DNA; RNA; SNPs; Fluorescence; Tricyclic Base	ALLELIC VARIANT; ADENINE; BASES	Here we report the synthesis of nucleoside analogs containing several aryl groups at the 6-position of the fluorescent tricyclic base, 8-amino-3-(2,3-dihydroxypropyl)imidazo[4',5':5,6]pyrido[2,3-d]pyrimidine (1), to expand the fluorescence color range of single nucleotide polymorphism (SNP)-detecting probes. The identity of the RNA target bases could be determined using probes containing an analog with a phenyl group at the 6-position of 1.	[Moriya, Ayako; Hayai, Aya; Ueno, Yoshihito] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan; [Ohki, Tokimitsu] Gifu Univ, Fac Engn, Gifu 5011193, Japan; [Ueno, Yoshihito] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan	Ueno, Y (reprint author), Gifu Univ, Fac Appl Biol Sci, 1-1 Yanagido, Gifu 5011193, Japan.	uenoy@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24659045]; C19 Kiyomi Yoshizaki research grant	This research was partially supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-Aid for Exploratory Research, 24659045) and by a C19 Kiyomi Yoshizaki research grant.	Krueger AT, 2008, J AM CHEM SOC, V130, P3989, DOI 10.1021/ja0782347; SullivanKlose TH, 1996, PHARMACOGENETICS, V6, P341, DOI 10.1097/00008571-199608000-00007; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Furukawa K, 2012, BIOORGAN MED CHEM, V20, P16, DOI 10.1016/j.bmc.2011.11.045; Harris PA, 1996, J HETEROCYCLIC CHEM, V33, P319; Harrori M., 2012, BIOORG MED CHEM LETT, V22, P253; Kohler O, 2003, CHEM COMMUN, P2938, DOI 10.1039/b308299g; MARUMOTO R, 1975, CHEM PHARM BULL, V23, P759; Okamoto A, 2003, J AM CHEM SOC, V125, P4972, DOI 10.1021/ja034090u; RETTIE AE, 1994, PHARMACOGENETICS, V4, P39, DOI 10.1097/00008571-199402000-00005; SATO Y, 1989, CHEM PHARM BULL, V37, P1604; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457	13	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	MAR 1	2015	91	3					515	525		10.3987/COM-14-13152		11	Chemistry, Organic	Chemistry	CF6OR	WOS:000352676500003		
J	Kobayashi, K; Shigemura, Y; Ezaki, K				Kobayashi, Kazuhiro; Shigemura, Yuuho; Ezaki, Kosuke			SYNTHESIS OF N-SUBSTITUTED (Z)-3-ARYLBENZO[c]THIOPHEN-1(3H)-IMINES BY THE REACTION OF 1-[ARYL(METHOXY)METHYL]-2-LITHIOBENZENES WITH ISOTHIOCYANATES FOLLOWED BY ACID-MEDIATED CYCLIZATION	HETEROCYCLES			English	Article						Benzo[c]thiophen-1(3H)-imine; Benzo[c]thiophen-1(3H)-one; O-[Aryl(methoxy)methyl]phenyl lithium; Aryl Isothiocyanate; Thioamide	LAWESSONS REAGENT; DERIVATIVES; IODINE	A simple procedure for the preparation of N-substituted (Z)-3-arylbenzo[c]thiophen-1(3H)-imines has been developed. Thus, bromine/lithium exchange between 1-[aryl(methoxy)methyl]-2-bromobenzenes and butyllithium, followed by reaction of the resulting 1-[aryl(methoxy)methyl]-2-lithiobenzenes with aliphatic and aromatic isothiocyanates, yields the corresponding N-substituted 2-[aryl(methoxy)methyl]benzothioamides. These were treated with concentrated hydrobromic acid to give the desired products.	[Kobayashi, Kazuhiro; Shigemura, Yuuho; Ezaki, Kosuke] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Div Appl Chem, Tottori 6808552, Japan	Kobayashi, K (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Div Appl Chem, 4-101 Koyama Minami, Tottori 6808552, Japan.	kkoba@chem.tottori-u.ac.jp					Kobayashi K, 2013, HELV CHIM ACTA, V96, P1894, DOI 10.1002/hlca.201300112; Luo YM, 2003, J AM CHEM SOC, V125, P12720, DOI 10.1021/ja037500n; Coric I, 2013, ANGEW CHEM INT EDIT, V52, P3490, DOI 10.1002/anie.201209983; BAUER VJ, 1976, J MED CHEM, V19, P1315, DOI 10.1021/jm00233a012; CANONNE P, 1988, TETRAHEDRON, V44, P2903; Ding QP, 2012, SYNTHESIS-STUTTGART, V44, P920, DOI 10.1055/s-0031-1289722; Jung DI, 2013, ASIAN J CHEM, V25, P5325; Kobayashi K, 2011, TETRAHEDRON, V67, P9680, DOI 10.1016/j.tet.2011.10.045; Kobayashi K, 2008, HETEROCYCLES, V75, P3025; Kobayashi K, 2007, B CHEM SOC JPN, V80, P763, DOI 10.1246/bcsj.80.763; Kobayashi K, 2008, HETEROCYCLES, V75, P2555; Kobayashi K, 2011, HETEROCYCLES, V83, P99, DOI 10.3987/COM-10-12071; Kobayashi K, 2013, HELV CHIM ACTA, V96, P239; Matsumoto S, 2014, TETRAHEDRON LETT, V55, P1082, DOI 10.1016/j.tetlet.2013.12.094; Moorthy JN, 2007, J ORG CHEM, V72, P9786, DOI 10.1021/jo7017872; Nishio T, 1999, TETRAHEDRON, V55, P5017, DOI 10.1016/S0040-4020(99)00200-8; Shkoor MG, 2014, HETEROCYCLES, V88, P1603, DOI 10.3987/COM-13-S(S)112	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	MAR 1	2015	91	3					526	536		10.3987/COM-14-13154		11	Chemistry, Organic	Chemistry	CF6OR	WOS:000352676500004		
J	Choshi, T; Hironaka, M; Goto, M; Shhnizu, K; Kurata, Y; Nishiyama, T; Hatae, N; Hibino, S				Choshi, Tominari; Hironaka, Miharu; Goto, Miki; Shhnizu, Kaori; Kurata, Yuhki; Nishiyama, Takashi; Hatae, Noriyuki; Hibino, Satoshi			NOVEL TOTAL SYNTHESIS OF THE 2-AZAANTHRAQUINONE ALKALOID SCORPINONE USING A TANDEM OXIDATION AND AZAELECTROCYCLIC REACTION	HETEROCYCLES			English	Article						2-Azaanthraquinone Alkaloid; Scorpinone; Total Synthesis; Tandem Reaction; Azaelectrocyclic Reaction	THERMAL ELECTROCYCLIC REACTIONS; SOLANI D2 PURPLE; NECTRIA-HAEMATOCOCCA; AMOROSIA-LITTORALIS; FUNGAL METABOLITES; BOSTRYCOIDIN; AZAANTHRAQUINONE; DERIVATIVES; 6-PI-ELECTRON; TMC-120B	A new tandem oxidation and electrocyclic reaction of a 1-aza 6 pi-electron system derived from a known 3-hydroxynaphthalene derivative was developed for the synthesis of 2-azaanthraquinones. Total synthesis of scorpinone (1a) was achieved in seven steps using this new tandem reaction. In addition, the positional isomer, 7,9-dimethoxy-4-methylbenzo[g]isoquinoline-5,10-dione (1b) was also synthesized in the same way.	[Choshi, Tominari; Hironaka, Miharu; Goto, Miki; Shhnizu, Kaori; Kurata, Yuhki; Nishiyama, Takashi; Hibino, Satoshi] Fukuyama Univ, Fac Pharmaceut Sci, Fukuyama, Hiroshima 7290292, Japan; [Hatae, Noriyuki] Hokkaido Univ, Sch Pharmaceut Sci Hlth Sci, Ishikari, Hokkaido 0610293, Japan	Choshi, T (reprint author), Fukuyama Univ, Fac Pharmaceut Sci, Fukuyama, Hiroshima 7290292, Japan.	choshi@fupharm.fukuyama-u.ac.jp; hibino@fupharm.fukuyama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15590033, 22590010, 24590040]	This work was supported in part by Grant-in Aid for Scientific Research (C) (No. 15590033 for T.C., No.22590010 for N.H., and No. 24590040 for S.H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Kohno K, 2009, TETRAHEDRON LETT, V50, P590, DOI 10.1016/j.tetlet.2008.11.076; Choshi T, 2009, HETEROCYCLES, V77, P85, DOI 10.3987/REV-08-SR(F)2; Miljkovic A, 2001, J NAT PROD, V64, P1251, DOI 10.1021/np000625a; Awakawa T, 2012, BIOORG MED CHEM LETT, V22, P4338, DOI 10.1016/j.bmcl.2012.05.005; Nok AJ, 2002, CELL BIOCHEM FUNCT, V20, P205, DOI 10.1002/cbf.948; Tagawa S, 2013, HETEROCYCLES, V87, P357, DOI 10.3987/COM-12-12630; Kesteleyn B, 2000, J ORG CHEM, V65, P640, DOI 10.1021/jo990676g; PARISOT D, 1989, J ANTIBIOT, V42, P1189; Kumemura T, 2005, HETEROCYCLES, V66, P87; Hayashi K, 2012, TETRAHEDRON, V68, P4274, DOI 10.1016/j.tet.2012.03.055; Hieda Y, 2013, EUR J ORG CHEM, V2013, P7391, DOI 10.1002/ejoc.201301059; Yang ZJ, 2013, PHYTOCHEM LETT, V6, P257, DOI 10.1016/j.phytol.2013.02.003; WATANABE M, 1987, TETRAHEDRON, V43, P5281, DOI 10.1016/S0040-4020(01)87704-8; Mantle PG, 2006, MYCOL RES, V110, P1371, DOI 10.1016/j.mycres.2006.09.013; Ishihara Y, 2011, TETRAHEDRON, V67, P1320, DOI 10.1016/j.tet.2010.11.066; ARSENAUL.GP, 1965, TETRAHEDRON LETT, P4033; ARSENAUL.GP, 1968, TETRAHEDRON, V24, P4745, DOI 10.1016/S0040-4020(01)98671-5; BAILES RH, 1947, J AM CHEM SOC, V69, P1886, DOI 10.1021/ja01200a013; CAJORI FA, 1954, J BIOL CHEM, V208, P107; CAMERON DW, 1982, AUST J CHEM, V35, P1451; Cameron D. W., 1982, AUST J CHEM, V35, P1349; CAMERON DW, 1980, TETRAHEDRON LETT, V21, P5089, DOI 10.1016/S0040-4039(00)71142-7; Choshi T, 2012, HETEROCYCLES, V84, P587, DOI 10.3987/COM-11-S(P)27; Choshi T, 2011, HETEROCYCLES, V83, P1205, DOI 10.3987/REV-10-691; Choshi T, 2001, YAKUGAKU ZASSHI, V121, P487, DOI 10.1248/yakushi.121.487; Choshi T, 2008, TETRAHEDRON LETT, V49, P3725, DOI 10.1016/j.tetlet.2008.04.033; Claessens S, 2007, SYNLETT, P741, DOI 10.1055/s-2007-970778; Claessens S, 2007, SYNLETT, P829, DOI 10.1055/s-2007-973888; Deshpande VH, 1996, INDIAN J CHEM B, V35, P965; Grafe D., 1991, PHARMAZIE, V46, P297; Grafe U., 1990, BIOL MET, V3, P39, DOI 10.1007/BF01141176; HAMILTON MA, 1953, ANTIBIOT CHEMOTHER, V3, P853; HIBINO S, 1995, ADV NITROG HETERCYC, V1, P205; Hong H., 1998, ANTIVIAL CHEM CHEMOT, V9, P46; KAWASAKI T, 1994, J INDIAN CHEM SOC, V71, P443; Kesteleyn B, 1999, TETRAHEDRON, V55, P2091, DOI 10.1016/S0040-4020(98)01220-4; Krapcho AP, 1999, HETEROCYCLES, V51, P737; Kumemura T, 2005, CHEM PHARM BULL, V53, P393, DOI 10.1248/cpb.53.393; KUROBANE I, 1980, J ANTIBIOT, V33, P1376; Kuwabara N, 2004, TETRAHEDRON, V60, P2943, DOI 10.1016/j.tet.2004.02.010; Moriyasu Y, 2001, PHYTOCHEMISTRY, V58, P239, DOI 10.1016/S0031-9422(01)00167-4; Nuguyen V. T., 2005, TETRAHEDRON, V61, P2295; Ohgaki E., 1990, J CHEM SOC P1, P3109; Okunade AL, 1999, PLANTA MED, V65, P447, DOI 10.1055/s-2006-960807; Omura K, 2008, CHEM PHARM BULL, V56, P237, DOI 10.1248/cpb.56.237; PARISOT D, 1990, PHYTOCHEMISTRY, V29, P3364, DOI 10.1016/0031-9422(90)80219-7; Piettre A, 2002, ORG LETT, V4, P3139, DOI 10.1021/ol026454d; Schuffler A, 2009, Z NATURFORSCH C, V64, P25; Tagawa S, 2013, EUR J ORG CHEM, P1805, DOI 10.1002/ejoc.201201652; Tazaki Y, 2014, HETEROCYCLES, V89, P427, DOI 10.3987/COM-13-12906; VANDORT HM, 1967, RECL TRAV CHIM PAY-B, V86, P520; Van Wagoner RM, 2008, J NAT PROD, V71, P426, DOI 10.1021/np070614i; Werner W, 1997, TETRAHEDRON, V53, P109, DOI 10.1016/S0040-4020(96)00956-8; Wijeratne EMK, 2010, J NAT PROD, V73, P1156, DOI 10.1021/np900684v; Yamamoto Y, 2002, PHYTOCHEMISTRY, V60, P741, DOI 10.1016/S0031-9422(02)00128-0	55	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	MAR 1	2015	91	3					537	549		10.3987/COM-14-13155		13	Chemistry, Organic	Chemistry	CF6OR	WOS:000352676500005		
J	Hamamoto, H; Umemoto, H; Umemoto, M; Ohta, C; Fujita, E; Nakamura, A; Maegawa, T; Miki, Y				Hamamoto, Hiromi; Umemoto, Hideaki; Umemoto, Misako; Ohta, Chiaki; Fujita, Emi; Nakamura, Akira; Maegawa, Tomohiro; Miki, Yasuyoshi			DECARBOXYLATIVE HALOGENATION OF INDOLECARBOXYLIC ACIDS USING HYPERVALENT IODINE(III) REAGENT AND ITS APPLICATION TO THE SYNTHESIS OF POLYBROMOINDOLES	HETEROCYCLES			English	Article						Indole; Hypervalent Iodine; Marine Natural Product; Halogenation Reaction; Decarboxylation Reaction	UNSATURATED CARBOXYLIC-ACIDS; FRIEDEL-CRAFTS REACTION; INDOLE-2,3-DICARBOXYLIC ANHYDRIDE; HUNSDIECKER REACTION; ORGANOHYPERVALENT IODINE; IODOSOBENZENE DIACETATE; ORGANOBROMINE COMPOUNDS; LAURENCIA-BRONGNIARTII; POLYVALENT IODINE; RIVULARIA-FIRMA	Hypervalent iodine mediated decarboxylative halogenation of indoledicarboxylic acid derivatives was studied. The treatment of 1-methylindole-2,3-dicarboxylic acid with phenyliodine diacetate (PIDA) in the presence of lithium bromide gave 1-methyl-3,3-bromooxindole. However, the reaction of 1-(phenylsulfonyl)indole-2,3-dicarboxylic acid with PIDA in the presence of lithium bromide afforded 2,3-dibromo-1-(phenylsulfonyl)indole. In a similar manner, the 2,3-dichloro- and 2,3-diiodoindole derivatives could be obtained by the reaction of the indole-2,3-dicarboxylic acids with PIDA in the presence of lithium chloride and iodide. This method was optimized to the synthesis of polybromoindole alkaloids.	[Hamamoto, Hiromi; Umemoto, Hideaki; Umemoto, Misako; Ohta, Chiaki; Fujita, Emi; Nakamura, Akira; Maegawa, Tomohiro; Miki, Yasuyoshi] Kinki Univ, Sch Pharmaceut Sci, Higashiosaka, Osaka 5778502, Japan; [Hamamoto, Hiromi] Meijo Univ, Fac Agr, Tempaku Ku, Nagoya, Aichi 4688502, Japan	Hamamoto, H (reprint author), Kinki Univ, Sch Pharmaceut Sci, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	hamam@meijo-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25460027]; Kinki University Research Grant Project; Research Institute of Meijo University; "High-Tech Research Center Project" for Private Universities	This work was partially supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) (25460027), Kinki University Research Grant Project, the Research Institute of Meijo University, and also in part "High-Tech Research Center Project" for Private Universities and matching fund subsidy.	ALVAREZ M, 1991, HETEROCYCLES, V32, P1391; Zhdankin VV, 2002, CHEM REV, V102, P2523, DOI 10.1021/cr010003+; Vairappan CS, 2004, PLANTA MED, V70, P1087, DOI 10.1055/s-2004-832653; Brown M, 2013, SYNLETT, V24, P424, DOI 10.1055/s-0032-1318103; Varvoglis A, 1997, TETRAHEDRON, V53, P1179, DOI 10.1016/S0040-4020(96)00970-2; Ezquerra J, 1996, J ORG CHEM, V61, P5804, DOI 10.1021/jo952119+; Liu YB, 2001, TETRAHEDRON LETT, V42, P2949, DOI 10.1016/S0040-4039(01)00332-X; Miki Y, 2007, TETRAHEDRON LETT, V48, P9093, DOI 10.1016/j.tetlet.2007.10.130; KOCHI JK, 1965, J AM CHEM SOC, V87, P2500, DOI 10.1021/ja01089a041; Dohi T, 2005, ANGEW CHEM INT EDIT, V44, P6193, DOI 10.1002/anie.200501688; CONCEPCION JI, 1986, J ORG CHEM, V51, P402, DOI 10.1021/jo00353a026; Moriarty RM, 2005, J ORG CHEM, V70, P2893, DOI 10.1021/jo050117b; Miki Y, 2012, TETRAHEDRON LETT, V53, P1924, DOI 10.1016/j.tetlet.2012.01.132; Gribble GW, 1999, CHEM SOC REV, V28, P335, DOI 10.1039/a900201d; Gribble GJ, 2000, ENVIRON SCI POLLUT R, V7, P37, DOI 10.1065/espr199910.002; MORICONI EJ, 1964, J ORG CHEM, V29, P3577, DOI 10.1021/jo01035a033; SINGH R, 1988, SYNTHETIC COMMUN, V18, P1327, DOI 10.1080/00397918808078799; Das JP, 2002, ORG LETT, V4, P3055, DOI 10.1021/ol0262901; JOHNSON RG, 1956, CHEM REV, V56, P219, DOI 10.1021/cr50008a002; Wirth T, 2005, ANGEW CHEM INT EDIT, V44, P3656, DOI 10.1002/anie.200500115; Suarez-Castillo OR, 2006, J NAT PROD, V69, P1596, DOI 10.1021/np060406a; BARTON DHR, 1985, TETRAHEDRON, V41, P3901, DOI 10.1016/S0040-4020(01)97173-X; Hunsdiecker H, 1942, BER DTSCH CHEM GES, V75, P291, DOI 10.1002/cber.19420750309; NORTON RS, 1982, J AM CHEM SOC, V104, P3628, DOI 10.1021/ja00377a014; Zhdankin VV, 2008, CHEM REV, V108, P5299, DOI 10.1021/cr800332c; GRAVEN A, 1994, J ORG CHEM, V59, P3543, DOI 10.1021/jo00092a009; BAIOCCHI L, 1988, J HETEROCYCLIC CHEM, V25, P1905; BARTON DHR, 1965, J CHEM SOC, P2438, DOI 10.1039/jr9650002438; Borodin B., 1861, LIEBIGS ANN, V119, P121; Braddock DC, 2004, SYNLETT, P461, DOI 10.1055/s-2004-815410; BRENNAN MR, 1978, TETRAHEDRON LETT, P1637; Cambie R. C., 1981, J CHEM SOC PERK T, V1, P2608; Camps P, 2000, TETRAHEDRON, V56, P2703, DOI 10.1016/S0040-4020(00)00169-1; CARTER GT, 1978, TETRAHEDRON LETT, P4479; CASON J, 1972, J ORG CHEM, V37, P669, DOI 10.1021/jo00969a031; CONWAY SC, 1992, HETEROCYCLES, V34, P2095; CRISTOL SJ, 1961, J ORG CHEM, V26, P280, DOI 10.1021/jo01060a628; Dohi T, 2009, CHEM COMMUN, P2073, DOI 10.1039/b821747e; Gribble GW, 1998, ACCOUNTS CHEM RES, V31, P141, DOI 10.1021/ar9701777; Hamamoto H, 2010, SYNLETT, P2593, DOI 10.1055/s-0030-1258585; Hamamoto H, 2011, SYNLETT, P1563, DOI 10.1055/s-0030-1260791; Hantzsch A, 1921, BER DTSCH CHEM GES, V54, P1221, DOI 10.1002/cber.19210540610; HODDER AR, 1991, J NAT PROD, V54, P1661, DOI 10.1021/np50078a028; JANDA M, 1981, COLLECT CZECH CHEM C, V46, P3278; KELLIE AE, 1956, J CHEM SOC, P3809, DOI 10.1039/jr9560003809; Koo BS, 2002, SYNTHETIC COMMUN, V32, P2275, DOI 10.1081/SCC-120005997; Maruya KA, 2003, CHEMOSPHERE, V52, P409, DOI 10.1016/S0045-6535(03)00196-6; MCKILLIP A, 1969, J ORG CHEM, V34, P1172, DOI 10.1021/jo01256a104; Miki Y, 1998, HETEROCYCLES, V48, P1593; Miki Y, 2006, TETRAHEDRON LETT, V47, P5215, DOI 10.1016/j.tetlet.2006.04.157; Miki Y, 1996, TETRAHEDRON LETT, V37, P7753, DOI 10.1016/0040-4039(96)01768-6; Miki Y, 2005, HETEROCYCLES, V65, P2693; Miki Y, 1999, TETRAHEDRON LETT, V40, P4347, DOI 10.1016/S0040-4039(99)00687-5; Miki Y, 1997, HETEROCYCLES, V45, P1143; MIKI Y, 1993, SYNLETT, P333; Miki Y, 2006, HETEROCYCLES, V68, P1893; Miki Y, 2004, SYNLETT, P2206, DOI 10.1055/s-2004-831317; Minatti A, 2003, SYNLETT, P140; Putey A, 2007, SYNLETT, P419, DOI 10.1055/s-2007-967953; SAULNIER MG, 1982, J ORG CHEM, V47, P757, DOI 10.1021/jo00344a001; Sheldon R. A., 1972, ORG REACTIONS, V19, P279; Sinha J, 2001, CHEM COMMUN, P1916, DOI 10.1039/b104540g; Telvekar VN, 2005, SYNLETT, P2495, DOI 10.1055/s-2005-917077; Togo H, 2001, SYNLETT, P565; Umimoto H, 2009, HETEROCYCLES, V78, P2845, DOI 10.3987/COM-09-11802; Uyanik M, 2009, CHEM COMMUN, P2086, DOI 10.1039/b823399c; Wilson CV, 1957, ORG REACTIONS, V9, P332; Wirth T., 2003, TOP CURR CHEM, V224	68	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	MAR 1	2015	91	3					561	572		10.3987/COM-14-13162		12	Chemistry, Organic	Chemistry	CF6OR	WOS:000352676500007		
J	Ohnishi, K; Sakurai, H; Kobayashi, K; Makabe, H; Teruya, K; Akaji, K; Hattori, Y				Ohnishi, Kouji; Sakurai, Haruka; Kobayashi, Kazuya; Makabe, Hidefumi; Teruya, Kenta; Akaji, Kenichi; Hattori, Yasunao			SYNTHESES OF A PYRROLIDINE ANALOG OF A TETRAHYDROFURAN CONTAINING ACETOGENIN, cis-SOLAMIN	HETEROCYCLES			English	Article						Pyrrolidine; Natural Product; Stereoselective Synthesis	MITOCHONDRIAL COMPLEX-I; ANNONACEOUS ACETOGENINS; INHIBITORY-ACTION	Practical synthesis of a pyrrolidine analog of a mono-THE acetogenin as a proto-type analog to evaluate the effect of a heteroatom in the mono-THF ring of acetogenins was achieved using Pd(II)-catalyzed diastereo-selective cyclization. Ligand-less PdCl2 catalyzed cyclization yielded the desired pyrrolidine derivative as a single major product having the desired relative configurations. Coupling of the pyrrolidine fragment with a known gamma-lactone-containing fragment via a Sonogashira cross-coupling reaction yielded the desired aza-cis-solamin analog.	[Ohnishi, Kouji; Sakurai, Haruka; Kobayashi, Kazuya; Akaji, Kenichi; Hattori, Yasunao] Kyoto Pharmaceut Univ, Dept Med Chem, Yamashina Ku, Kyoto 6078412, Japan; [Makabe, Hidefumi] Shinshu Univ, Grad Sch Agr Sci Funct Foods, Nagano 3994598, Japan; [Teruya, Kenta] Kyoto Prefectural Univ Med, Dept Med, Sakyo Ku, Kyoto 6060823, Japan	Hattori, Y (reprint author), Kyoto Pharmaceut Univ, Dept Med Chem, Yamashina Ku, Kyoto 6078412, Japan.	hattori@mb.kyoto-phu.ac.jp					Liaw CC, 2010, PLANTA MED, V76, P1390, DOI 10.1055/s-0030-1250006; Shi JF, 2014, EUR J MED CHEM, V71, P219, DOI 10.1016/j.ejmech.2013.11.012; Hattori Y, 2008, ORG LETT, V10, P717, DOI [10.1021/ol702902w, 10.1021/ol70902w]; Hattori Y, 2011, J SYN ORG CHEM JPN, V69, P159; Masuya T, 2014, BIOCHEMISTRY-US, V53, P2307, DOI 10.1021/bi500205x; Makabe H, 2003, ORG LETT, V5, P27, DOI 10.1021/ol0201916; Liu YH, 2014, EUR J MED CHEM, V78, P248, DOI 10.1016/j.ejmech.2014.03.062; Bachan K. A., 2013, BIOORGAN MED CHEM, V21, P6554; Kojima N, 2014, EUR J MED CHEM, V86, P684, DOI 10.1016/j.ejmech.2014.09.026; Konno H, 2012, BIOSCI BIOTECH BIOCH, V76, P1257, DOI 10.1271/bbb.120176; Konno H, 1999, SYNTHESIS-STUTTGART, P1135; Lemen GS, 2010, ORG LETT, V12, P2322, DOI 10.1021/ol1006828; Makabe H, 2004, TETRAHEDRON LETT, V45, P973, DOI 10.1016/j.tetlet.2003.11.109; MAKABE H, 1993, BIOSCI BIOTECH BIOCH, V57, P1028; Makabe H, 2007, BIOSCI BIOTECH BIOCH, V71, P2367, DOI 10.1271/bbb.70202; Wang M, 2005, TETRAHEDRON LETT, V46, P5309, DOI 10.1016/j.tetlet.2005.06.050	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	MAR 1	2015	91	3					573	582		10.3987/COM-14-13163		10	Chemistry, Organic	Chemistry	CF6OR	WOS:000352676500008		
J	Sakata, R; Soeta, T; Ukaji, Y				Sakata, Ryo; Soeta, Takahiro; Ukaji, Yutaka			ONE-CARBON HOMOLOGATION OF PYRROLE CARBOXALDEHYDE VIA WITTIG REACTION AND MILD HYDROLYSIS OF VINYL ETHER-TOWARD THE SYNTHESIS OF A STERICALLY LOCKED PHYTOCHROME CHROMOPHORE	HETEROCYCLES			English	Article						Sterically Locked Tetrapyrrole Chromophore; One Carbon Homologation; Mild Hydrolysis; Vinyl Ether; Oxalyl Chloride	PHYCOCYANOBILIN DERIVATIVES; BILIVERDIN DERIVATIVES; BILIN CHROMOPHORES; OXIDATION; ANALOGS; RING; CYANOBACTERIOCHROMES; PHOTOCONVERSION; CHLOROFORM; CHEMISTRY	Mild hydrolysis of vinyl ether derived from a pyrrole carboxaldehyde corresponding to the B,C-ring component of phytochromobilin chromophore was achieved by treatment with oxalyl chloride in chloroform in the presence of water and ethanol to afford a one-carbon homologated aldehyde. This aldehyde was applied to the synthesis of the sterically locked 15E-anti CD-ring component of the chromophore. Furthermore, the aldehyde could be converted to the intermediate for the sterically locked 5Z-anti AB-ring component.	[Sakata, Ryo; Soeta, Takahiro; Ukaji, Yutaka] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Chem, Kanazawa, Ishikawa 9201192, Japan	Ukaji, Y (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Chem, Kanazawa, Ishikawa 9201192, Japan.	ukaji@staff.kanazawa-u.ac.jp			Mitani Foundation for Research and Development; Japan Society for the Promotion of Science	The present work was financially supported in part by the Mitani Foundation for Research and Development and a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science.	Gemma S, 2011, J MED CHEM, V54, P5949, DOI 10.1021/jm200686d; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; [Anonymous], 2004, A AM CHEM SOC; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P3576, DOI 10.1021/bi300171s; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; Zhuang XH, 2013, J PHYS CHEM B, V117, P15976, DOI 10.1021/jp408799b; HENDRICKSON JB, 1977, J AM CHEM SOC, V99, P5439, DOI 10.1021/ja00458a035; Ermolat'ev DS, 2010, ANGEW CHEM INT EDIT, V49, P9465, DOI 10.1002/anie.201004256; Burgie ES, 2014, J BIOL CHEM, V289, P24573, DOI 10.1074/jbc.M114.571661; Carey F. A., 2007, ADVANCED ORGANIC CHE, P1165; Chen LY, 2009, CHEM LETT, V38, P602, DOI 10.1246/cl.2009.602; Chen LY, 2011, CHEM LETT, V40, P632, DOI 10.1246/cl.2011.632; Clover AM, 1923, J AM CHEM SOC, V45, P3133, DOI 10.1021/ja01665a048; DEMOPOULOS VJ, 1988, J HETEROCYCLIC CHEM, V25, P635; Gentile G, 2007, BIOORG MED CHEM LETT, V17, P5218, DOI 10.1016/j.bmcl.2007.06.077; Hammam MAS, 2006, B CHEM SOC JPN, V79, P1561, DOI 10.1246/bcsj.79.1561; Inomata K, 2012, HETEROCYCLES, V85, P2879, DOI 10.3987/REV-12-750; Inomata K, 2008, B CHEM SOC JPN, V81, P25, DOI 10.1246/bcsj.81.25; Inomata K, 2009, BIOCHEMISTRY-US, V48, P2817, DOI 10.1021/bi802334u; Iwamoto R, 2010, CHEM LETT, V39, P176, DOI 10.1246/cl.2010.176; KEMPF DJ, 1990, J ORG CHEM, V55, P1390, DOI 10.1021/jo00291a060; Khawn H, 2008, CHEM LETT, V37, P198, DOI 10.1246/cl.2008.198; KOSARYCH Z, 1980, TETRAHEDRON LETT, V21, P3959, DOI 10.1016/S0040-4039(00)92843-0; Kuwahara Y, 2012, ORG LETT, V14, P3376, DOI 10.1021/ol301356r; Mizutani T, 2004, J PORPHYR PHTHALOCYA, V8, P226; Nishiyama K, 2010, B CHEM SOC JPN, V83, P1309, DOI 10.1246/bcsj.20100168; Sakata R, 2011, HETEROCYCLES, V82, P1157, DOI 10.3987/COM-10-S(E)110; Takahashi K, 2012, HETEROCYCLES, V86, P1031, DOI 10.3987/COM-12-S(N)126; Tanaka Y, 2015, HETEROCYCLES, V90, P883, DOI 10.3987/COM-14-S(K)97; TSUKAHARA Y, 1984, B CHEM SOC JPN, V57, P3013, DOI 10.1246/bcsj.57.3013; Williams JD, 2004, J MED CHEM, V47, P5753, DOI 10.1021/jm0400146; Yang R, 2012, PLANT CELL, V24, P1936, DOI 10.1105/tpc.111.094656; Yang Y, 2012, J AM CHEM SOC, V134, P1408, DOI 10.1021/ja209413d	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	MAR 1	2015	91	3					593	603		10.3987/COM-14-13157		11	Chemistry, Organic	Chemistry	CF6OR	WOS:000352676500010		
J	Nakata, K; Fujieda, M; Miki, H; Fukushima, W; Ohfuji, S; Maeda, A; Kase, T; Hirota, Y				Nakata, Keiko; Fujieda, Megumi; Miki, Hitoshi; Fukushima, Wakaba; Ohfuji, Satoko; Maeda, Akiko; Kase, Tetsuo; Hirota, Yoshio			Detection of influenza vaccine effectiveness among nursery school children: Lesson from a season with cocirculating respiratory syncytial virus	HUMAN VACCINES & IMMUNOTHERAPEUTICS			English	Article						case classification; influenza-like illness (ILI); influenza vaccine effectiveness; observation period; outcome misclassification; RSV infection	LABORATORY-CONFIRMED INFLUENZA; ATTENDING DAY-CARE; YOUNG-CHILDREN; INFECTIONS; AGE; EFFICACY; IMPACT; JAPAN; TIME	In the winter influenza epidemic season, patients with respiratory illnesses including respiratory syncytial virus (RSV) infections increase among young children. Therefore, we evaluated the effectiveness of influenza vaccine against influenza-like illness (ILI) using a technique to identify outbreaks of RSV infection and to distinguish those patients from ILI patients. The study subjects were 101 children aged 12 to 84 months attending nursery school. We classified the cases into 6 levels based on the definitions of ILI for outcomes. We established observation periods according to information obtained from regional surveillance and rapid diagnostic tests among children. Multivariate odds ratios (ORs) for each case classification were obtained using a logistic regression model for each observation period. For the entire observation period, ORs for cases with fever plus respiratory symptoms were reduced marginally significantly. For the local influenza epidemic period, only the OR for the most serious cases was significantly decreased (0.20 [95%CI: 0.04-0.94]). During the influenza outbreak among the nursery school children, multivariate ORs for fever plus respiratory symptoms decreased significantly ( 38.0 degrees C plus one symptoms: 0.23 [0.06-0.91), 38.0 degrees C plus 2 symptoms: 0.21 [0.05-0.85], 39.0 degrees C plus one symptoms: 0.18 [0.04-0.93] and 39.0 degrees C plus 2 symptoms: 0.16 [0.03-0.87]). These results suggest that confining observation to the peak influenza epidemic period and adoption of a strict case classification system can minimize outcome misclassification when evaluating the effectiveness of influenza vaccine against ILI, even if influenza and RSV cocirculate in the same season.	[Nakata, Keiko; Miki, Hitoshi; Fukushima, Wakaba; Ohfuji, Satoko; Maeda, Akiko; Hirota, Yoshio] Osaka Univ, Dept Publ Hlth, Grad Sch Med, Osaka, Japan; [Nakata, Keiko; Kase, Tetsuo] Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Osaka 537, Japan; [Fujieda, Megumi] Kurume Univ, Sch Med, Dept Neuropsychiat, Fukuoka, Japan	Nakata, K (reprint author), Osaka Univ, Dept Publ Hlth, Grad Sch Med, Osaka, Japan.	knakata@iph.pref.osaka.jp			Ministry of Health, Labor and Welfare of Japan [H17-SHIKO-010]	This study was supported by a research grant for emerging and re-emerging infectious diseases from the Ministry of Health, Labor and Welfare of Japan (Grant H17-SHIKO-010).	Monto AS, 2004, PEDIATR INFECT DIS J, V23, pS58, DOI 10.1097/01.inf.0000108193.91607.34; Manzoli L, 2012, HUM VACC IMMUNOTHER, V8, P851, DOI 10.4161/hv.19917; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Vesikari T, 2006, PEDIATRICS, V118, P2298, DOI 10.1542/peds.2006-0725; Staat MA, 2011, VACCINE, V29, P9005, DOI 10.1016/j.vaccine.2011.09.037; Kaneko M, 2002, J INFECTION, V44, P240, DOI 10.1053/jinf.2002.0981; Karadag-Oncel E, 2014, J MED VIROL, V86, P865, DOI 10.1002/jmv.23747; ANDERSON LJ, 1990, J INFECT DIS, V161, P640; Allison MA, 2006, J PEDIATR-US, V149, P755, DOI 10.1016/j.jpeds.2006.06.036; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Eisenberg KW, 2008, PEDIATRICS, V122, P911, DOI 10.1542/peds.2007-3304; Mizuta K, 2013, JPN J INFECT DIS, V66, P140; Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9; AYMARD M, 1994, RESPIRATION, V61, P24; de-Paris F, 2012, J VIROL METHODS, V186, P189, DOI 10.1016/j.jviromet.2012.07.008; Fu CX, 2013, INFLUENZA OTHER RESP, V7, P1168, DOI 10.1111/irv.12157; Fujieda M, 2006, VACCINE, V24, P957, DOI 10.1016/j.vaccine.2005.08.083; HARRINGTON RD, 1992, J INFECT DIS, V165, P987; Hirota Y, 1997, VACCINE, V15, P962, DOI 10.1016/S0264-410X(96)00302-7; Hirota Y, 1994, Kansenshogaku Zasshi, V68, P1293; Hurwitz ES, 2000, J INFECT DIS, V182, P1218, DOI 10.1086/315820; Kohno Hidehisa, 2012, Nihon Ronen Igakkai Zasshi, V49, P608; Ochiai H, 2009, VACCINE, V27, P7031, DOI 10.1016/j.vaccine.2009.09.067; Ozasa K, 2008, VACCINE, V26, P6462, DOI 10.1016/j.vaccine.2008.06.039; Shen SX, 2013, VACCINE, V31, P2974, DOI 10.1016/j.vaccine.2013.05.011; Shuler CM, 2007, PEDIATRICS, V119, pE587, DOI 10.1542/peds.2006-1878; Sugaya N, 2000, J MED VIROL, V60, P102, DOI 10.1002/(SICI)1096-9071(200001)60:1<102::AID-JMV17>3.0.CO;2-D; Zimmerman RK, 2014, INFLUENZA OTHER RESP, V8, P397, DOI 10.1111/irv.12247	28	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2164-5515	2164-554X		HUM VACC IMMUNOTHER	Human Vaccines Immunother.	MAR	2015	11	3					545	552		10.1080/21645515.2015.1011982		8	Biotechnology & Applied Microbiology; Immunology	Biotechnology & Applied Microbiology; Immunology	CF5SA	WOS:000352616100013		
J	Iho, S; Maeyama, J; Suzuki, F				Iho, Sumiko; Maeyama, Jun-ichi; Suzuki, Fumiko			CpG oligodeoxynucleotides as mucosal adjuvants	HUMAN VACCINES & IMMUNOTHERAPEUTICS			English	Editorial Material						CpG; IgG1; IgG2a; c; mucosal adjuvant; palindrome; phosphodiester; pDC; phylaxis; secretory IgA; Th1	PLASMACYTOID DENDRITIC CELLS; TOXIN B-SUBUNIT; CHOLERA-TOXIN; OLIGONUCLEOTIDE SEQUENCES; DNA; RESPONSES; ACTIVATION; INDUCTION; VACCINE; MOTIFS	Bacterial DNA comprising palindromic sequences and containing unmethylated CpG is recognized by toll-like receptor 9 of plasmacytoid dendritic cells (pDCs) and induces the production of interferon- and chemokines, leading to the activation of a Th1 immune response. Therefore, synthetic equivalents of bacterial DNA (CpG oligodeoxynucleotides) have been developed for clinical applications. They are usually phosphorothioated for in vivo use; this approach also leads to adverse effects as reported in mouse models.Mucosal vaccines that induce both mucosal and systemic immunity received substantial attention in recent years. For their development, phosphodiester-linked oligodeoxynucleotides, including the sequence of a palindromic CpG DNA may be advantageous as adjuvants because their target pDCs are present right there, in the mucosa of the vaccination site. In addition, the probability of adverse effects is believed to be low. Here, we review the discovery of such CpG oligodeoxynucleotides and their possible use as mucosal adjuvants.	[Iho, Sumiko] Univ Fukui, Fac Med Sci, Host Def Lab, Fukui 910, Japan; [Maeyama, Jun-ichi] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Musashimurayama, Tokyo, Japan; [Suzuki, Fumiko] Univ Fukui, Dept Forens Med & Human Genet, Fac Med Sci, Fukui 910, Japan	Iho, S (reprint author), Univ Fukui, Fac Med Sci, Host Def Lab, Fukui 910, Japan.	ihosumik@u-fukui.ac.jp					KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Tokunaga T, 1999, JPN J INFECT DIS, V52, P1; YAMAMOTO S, 1992, J IMMUNOL, V148, P4072; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Hanagata N, 2012, INT J NANOMED, V7, P2181, DOI 10.2147/IJN.S30197; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Storni T, 2004, J IMMUNOL, V172, P1777; de Vries IJM, 2011, MOL IMMUNOL, V48, P810, DOI 10.1016/j.molimm.2010.12.022; TOKUNAGA T, 1984, J NATL CANCER I, V72, P955; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Samulowitz U, 2010, OLIGONUCLEOTIDES, V20, P93, DOI 10.1089/oli.2009.0210; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; Verthelyi D, 2001, J IMMUNOL, V166, P2372; Hartmann G, 2000, J IMMUNOL, V164, P944; ELSON CO, 1984, J IMMUNOL, V132, P2736; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; Isaka M, 1999, VACCINE, V18, P743, DOI 10.1016/S0264-410X(99)00258-3; Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; CLEMENTS JD, 1988, VACCINE, V6, P269, DOI 10.1016/0264-410X(88)90223-X; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; KURAMOTO E, 1992, JPN J CANCER RES, V83, P1128; LYCKE N, 1986, IMMUNOLOGY, V59, P301; Maeyama J, 2009, VACCINE, V27, P1166, DOI 10.1016/j.vaccine.2008.12.025; Maeyama J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088846; Maeyama J, 2001, MICROBIOL IMMUNOL, V45, P111; Maeyama JI, 2011, MUCOSAL ADJUVANTS BC, P177; Osawa Y, 2006, J IMMUNOL, V177, P4841; Taniguchi K, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-25; YAMAMOTO S, 1992, MICROBIOL IMMUNOL, V36, P983; YAMAMOTO T, 1994, ANTISENSE RES DEV, V4, P119	33	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2164-5515	2164-554X		HUM VACC IMMUNOTHER	Human Vaccines Immunother.	MAR	2015	11	3					755	760		10.1080/21645515.2014.1004033		6	Biotechnology & Applied Microbiology; Immunology	Biotechnology & Applied Microbiology; Immunology	CF5SA	WOS:000352616100038		
J	Majedi, AH; Nakamura, Y; Oliver, WD; Pagano, S; Foley, C				Majedi, A. Hamed; Nakamura, Yasunobu; Oliver, William D.; Pagano, Sergio; Foley, Cathy			Introduction to the Issue on Superconducting Quantum Electronics and Photonics	IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS			English	Editorial Material									[Majedi, A. Hamed] Univ Waterloo, Waterloo Inst Nanotechnol, Dept Elect & Comp Engn, Waterloo, ON N2L 3G1, Canada; [Nakamura, Yasunobu] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan; [Nakamura, Yasunobu] RIKEN, Ctr Emergent Matter Sci, Saitama 3510198, Japan; [Oliver, William D.] MIT Lincoln Lab, Lexington, MA 02420 USA; [Pagano, Sergio] Univ Salerno, Dept Phys, I-84084 Fisciano, SA, Italy; [Foley, Cathy] Commonwealth Sci & Ind Res Org CSIRO, Mat Sci & Engn, Clayton, Vic 3169, Australia	Majedi, AH (reprint author), Univ Waterloo, Waterloo Inst Nanotechnol, Dept Elect & Comp Engn, Waterloo, ON N2L 3G1, Canada.	ahmajedi@uwaterloo.ca; nakamura@ynl.t.u-tokyo.ac.jp; oliver@ll.mit.edu; spagano@unisa.it; Cathy.Foley@csiro.au						0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1077-260X	1558-4542		IEEE J SEL TOP QUANT	IEEE J. Sel. Top. Quantum Electron.	MAR-APR	2015	21	2							0200403	10.1109/JSTQE.2015.2409054		3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CF7KE	WOS:000352734300001		
J	Chen, WH; Paik, I; Hung, PCK				Chen, Wuhui; Paik, Incheon; Hung, Patrick C. K.			Constructing a Global Social Service Network for Better Quality of Web Service Discovery	IEEE TRANSACTIONS ON SERVICES COMPUTING			English	Article						Global social service network; linked data principles; linked social service; link-as-you-go	EVOLVING NETWORKS	Web services have had a tremendous impact on the Web for supporting a distributed service-based economy on a global scale. However, despite the outstanding progress, their uptake on a Web scale has been significantly less than initially anticipated. The isolation of services and the lack of social relationships among related services have been identified as reasons for the poor uptake. In this paper, we propose connecting the isolated service islands into a global social service network to enhance the services' sociability on a global scale. First, we propose linked social service-specific principles based on linked data principles for publishing services on the open Web as linked social services. Then, we suggest a new framework for constructing the global social service network following linked social service-specific principles based on complex network theories. Next, an approach is proposed to enable the exploitation of the global social service network, providing Linked Social Services as a Service. Finally, experimental results show that our approach can solve the quality of service discovery problem, improving both the service discovering time and the success rate by exploring service-to-service based on the global social service network.	[Chen, Wuhui; Paik, Incheon] Univ Aizu, Sch Comp Sci & Engn, Fukushima, Japan; [Hung, Patrick C. K.] UOIT, Business & Informat Technol, Oshawa, ON, Canada	Chen, WH (reprint author), Univ Aizu, Sch Comp Sci & Engn, Fukushima, Japan.	chenwuhui21@gmail.com; paikic@u-aizu.ac.jp; patrick.hung@uoit.ca					Al-Masri E., 2008, P 17 INT C WORLD WID, P795, DOI DOI 10.1145/1367497.1367605; Tan W, 2010, COMPUTER, V43, P54; Maamar Z, 2011, IEEE INTERNET COMPUT, V15, P48, DOI 10.1109/MIC.2011.27; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Wang FY, 2007, IEEE INTELL SYST, V22, P79, DOI 10.1109/MIS.2007.41; [Anonymous], 2009, INT J SEMANT WEB INF; Lecue F, 2011, IEEE T KNOWL DATA EN, V23, P942, DOI 10.1109/TKDE.2010.237; Pedrinaci C, 2010, J UNIVERS COMPUT SCI, V16, P1694; Maamar Z, 2011, IEEE INTERNET COMPUT, V15, P90, DOI 10.1109/MIC.2011.49; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Bianconi G, 2001, PHYS REV LETT, V86, P5632, DOI 10.1103/PhysRevLett.86.5632; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Aquin M., 2008, INTELLIGENT SYSTEMS, V23, P20; Auer S., 2008, P 6 IEEE INT SEM WEB, V4825, P722; Bizer C., 2008, P 17 INT WORLD WID W; Broekstra J, 2003, SPINNING THE SEMANTIC WEB, P197; Brogi A, 2008, ACM T INTERNET TECHN, V8, DOI 10.1145/1391949.1391953; Chen W., 2012, INF SYST FRONTIERS, V15, P613; Davies J., 2009, BT TECHNOL J, V26; DePaoli F., 2008, P IEEE INT C WEB SER, P393; Gu ZF, 2010, IEEE T SERV COMPUT, V3, P279, DOI 10.1109/TSC.2010.22; Hadley M., 2009, MEMBER SUBMISSION; Han Y., 2012, P AAAI, P39; Jiang W., 2012, P 19 INT C WEB SERV, P218; Klusch M., 2006, P 5 INT JOINT C AUT, P915, DOI DOI 10.1145/1160633.1160796; Nature K.S., 1999, NATURE, V401, P398; Paik I., 2013, INT J BUS PROCESS IN, V6, P97; Petrie C, 2009, IEEE INTERNET COMPUT, V13, P93, DOI 10.1109/MIC.2009.135; Pilioura T, 2009, ACM T WEB, V3, DOI 10.1145/1541822.1541826; Tan W., 2011, P IEEE INT C SERV CO, P632; Taylor I.J., 2007, WORKFLOWS E SCI SCI, P428; Zhang J., 2011, P IEEE INT C SERV CO, P48	32	0	1	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1939-1374			IEEE T SERV COMPUT	IEEE Trans. Serv. Comput.	MAR-APR	2015	8	2					284	298		10.1109/TSC.2013.20		15	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CF8ES	WOS:000352789300010		
J	Mizokawa, A				Mizokawa, Ai			Theory of Mind and Sensitivity to Teacher and Peer Criticism Among Japanese Children	INFANT AND CHILD DEVELOPMENT			English	Article						sensitivity to criticism; social cognition; motivation; emotion; social interaction	INDIVIDUAL-DIFFERENCES; YOUNG-CHILDREN; DISPLAY RULES; FALSE-BELIEF; PRESCHOOLERS; BEHAVIOR; HELPLESSNESS; ASSOCIATIONS; DISTINCTION; ACHIEVEMENT	This study investigated sensitivity to teacher and peer criticism among 89 Japanese 6-year-olds and examined the connection between sensitivity to criticism and first-order and second-order theory of mind separately. Participants completed a common test battery that included tasks assessing sensitivity to criticism (teacher or peer condition), the Picture Vocabulary TestRevised, and theory of mind tasks. The results showed that the children with better understanding of second-order mental states rated their ability negatively after teacher criticism, but they were motivated to keep trying. This phenomenon was found under only the teacher condition, and peer criticism did not significantly affect children's response, irrespective of theory-of-mind level. Cognitive and social factors that may have contributed to the children's responses to criticism are discussed. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Mizokawa, Ai] Meiji Gakuin Univ, Tokyo 1088636, Japan	Mizokawa, A (reprint author), Meiji Gakuin Univ, Fac Psychol, Minato Ku, I-2-37 Shirokanedai, Tokyo 1088636, Japan.	aimizokawa@gmail.com			 [11J10622]	This work was supported by Grant-in-Aid for JSPS Fellows (No. 11J10622). The author thanks Toshihiko Endo and Serena Lecce for their valuable comments on an earlier version of this paper.	Talwar V, 2008, CHILD DEV, V79, P866, DOI 10.1111/j.1467-8624.2008.01164.x; DWECK CS, 1976, DEV PSYCHOL, V12, P147, DOI 10.1037/0012-1649.12.2.147; Caputi M, 2012, DEV PSYCHOL, V48, P257, DOI 10.1037/a0025402; Watson AC, 1999, DEV PSYCHOL, V35, P386, DOI 10.1037//0012-1649.35.2.386; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; NEWMAN RS, 1990, J EDUC PSYCHOL, V82, P92, DOI 10.1037/0022-0663.82.1.92; Pasquini ES, 2007, DEV PSYCHOL, V43, P1216, DOI 10.1037/0012-1649.43.5.1216; Corriveau K, 2009, DEVELOPMENTAL SCI, V12, P188, DOI 10.1111/j.1467-7687.2008.00763.x; Kamins ML, 1999, DEV PSYCHOL, V35, P835, DOI 10.1037/0012-1649.35.3.835; Dunn J, 1999, SOC DEV, V8, P201, DOI 10.1111/1467-9507.00091; Bornstein MH, 2004, CHILD DEV, V75, P221, DOI 10.1111/j.1467-8624.2004.00665.x; Banerjee R, 1999, BRIT J DEV PSYCHOL, V17, P111, DOI 10.1348/026151099165186; Denham SA, 2003, CHILD DEV, V74, P238, DOI 10.1111/1467-8624.00533; Hughes C, 2000, J CHILD PSYCHOL PSYC, V41, P483, DOI 10.1017/S0021963099005533; FLAVELL JH, 1983, COGNITIVE PSYCHOL, V15, P95, DOI 10.1016/0010-0285(83)90005-1; Hughes C, 1998, DEV PSYCHOL, V34, P1026, DOI 10.1037/0012-1649.34.5.1026; BENNETT M, 1990, EUR J SOC PSYCHOL, V20, P455, DOI 10.1002/ejsp.2420200507; Koenig MA, 2004, PSYCHOL SCI, V15, P694, DOI 10.1111/j.0956-7976.2004.00742.x; HARRIS PL, 1986, CHILD DEV, V57, P895, DOI 10.1111/j.1467-8624.1986.tb00253.x; GNEPP J, 1986, DEV PSYCHOL, V22, P103, DOI 10.1037/0012-1649.22.1.103; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Ng FFY, 2007, DEV PSYCHOL, V43, P1239, DOI 10.1037/0012-1649.43.5.1239; Hughes C, 2004, SOC DEV, V13, P590, DOI 10.1111/j.1467-9507.2004.00285.x; SULLIVAN K, 1994, DEV PSYCHOL, V30, P395, DOI 10.1037//0012-1649.30.3.395; Hughes C, 2005, CHILD DEV, V76, P356, DOI 10.1111/j.1467-8624.2005.00850_a.x; Cassidy KW, 2003, SOC DEV, V12, P198, DOI 10.1111/1467-9507.00229; SMILEY PA, 1994, CHILD DEV, V65, P1723, DOI 10.1111/j.1467-8624.1994.tb00845.x; Koenig MA, 2005, CHILD DEV, V76, P1261, DOI 10.1111/j.1467-8624.2005.00849.x; Iyengar SS, 1999, J PERS SOC PSYCHOL, V76, P349, DOI 10.1037/0022-3514.76.3.349; Astington J. W., 2003, INDIVIDUAL DIFFERENC, P13; ASTINGTON JW, 1995, COGNITION EMOTION, V9, P151, DOI 10.1080/02699939508409006; Banerjee R, 2000, BRIT J DEV PSYCHOL, V18, P499, DOI 10.1348/026151000165823; Banerjee R, 2002, MERRILL PALMER QUART, V48, P378, DOI 10.1353/mpq.2002.0015; Capage L., 2001, EARLY EDUC DEV, V12, P613, DOI [10.1207=s15566935eed1204_7, DOI 10.1207/S15566935EED1204_7]; CHANDLER TA, 1981, J CROSS CULT PSYCHOL, V12, P207, DOI 10.1177/0022022181122006; Cutting AL, 2002, J CHILD PSYCHOL PSYC, V43, P849, DOI 10.1111/1469-7610.t01-1-00047; DUNN J, 1995, COGNITION EMOTION, V9, P187, DOI 10.1080/02699939508409008; FLAVELL JH, 1987, DEV PSYCHOL, V23, P816, DOI 10.1037//0012-1649.23.6.816; Harris P. L, 1989, COGNITION EMOTION, V3, P379, DOI DOI 10.1080/02699938908412713; Hayashis A., 2011, THESIS ARIZONA STATE; Heyman GD, 2009, BRIT J DEV PSYCHOL, V27, P875, DOI 10.1348/026151008X390870; HEYMAN GD, 1992, CHILD DEV, V63, P401, DOI 10.1111/j.1467-8624.1992.tb01636.x; HOLLOWAY SD, 1988, REV EDUC RES, V58, P327, DOI 10.3102/00346543058003327; Lecce S, 2014, EUR J DEV PSYCHOL, V11, P305, DOI 10.1080/17405629.2013.821944; Lecce S, 2011, J EXP CHILD PSYCHOL, V110, P313, DOI 10.1016/j.jecp.2011.04.011; Maguire MC, 1997, INT J BEHAV DEV, V21, P669; Miyahara A, 2004, INTERCULTURAL COMMUN, P279; Mizokawa A, 2011, BRIT J DEV PSYCHOL, V29, P489, DOI 10.1348/026151010X519964; Mizokawa A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00807; PERNER J., 1991, UNDERSTANDING REPRES; Rubin K.H., 1998, HDB CHILD PSYCHOL, V3, P619; SAARNI C, 1990, NEBR SYM MOTIV, V36, P115; Saarni C, 1999, DEV EMOTIONAL COMPET; Stolk A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072667; Takeuchi S, 2001, INT J INTERCULT REL, V25, P315, DOI 10.1016/S0147-1767(01)00006-2; Tobin J., 2009, PRESCHOOL 3 CULTURES; Uenos K., 2008, PVT R MANUAL; Watling D, 2007, INFANT CHILD DEV, V16, P227, DOI 10.1002/icd.450	58	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-7219			INFANT CHILD DEV	Infant Child Dev.	MAR-APR	2015	24	2					189	205		10.1002/icd.1877		17	Psychology, Developmental	Psychology	CF4DK	WOS:000352498600005		
J	Fujimoto, S; Rinoshika, A				Fujimoto, S.; Rinoshika, A.			Wavelet multi-resolution analysis on turbulent wakes of asymmetric bluff body	INTERNATIONAL JOURNAL OF MECHANICAL SCIENCES			English	Article						Multi-scale structure; Orthogonal wavelet transform; PIV; Turbulent wake; Vortex	CIRCULAR-CYLINDERS; BODIES	This paper focuses on the multi-scale wake structures of a new asymmetric side mirror of a race car, which can generate the aerodynamic downforce. The turbulent wake generated by symmetric bluff bodies of triangle and semi-cylinder and an asymmetric bluff body (called CT-cylinder) were experimentally investigated and were compared. Firstly, the instantaneous velocity and voracity were quantitatively measured by high-speed Ply at a Reynolds number of 14,440 in the circulating water channel. Then a one- and two-dimensional wavelet multi-resolution techniques were used to analyze the instantaneous velocity and voracity in order to decompose turbulent structures into a number of subsets based on their central frequencies. It is found that the CT-cylinder wake generates the asymmetric flow structures and separation region that is smaller than that of the triangle wake. The contribution to vorticity concentration comes from the large-scale structure of CT-cylinder wake in the (x, y)-plane, and the intermediate-scale structure of the CT-cylinder wake dominates the flow structure in the (x, z)-plane. There is no evident difference among the three wakes in the relatively small-scale structures. The large-scale structures of three wakes exhibit the main contributions to the Reynolds shear stress, accounting for almost 82-92%. However, the small-scale structures make less contribution to Reynolds shear stresses. The phase-averaging and spectral analyses indicate that the CT-cylinder wake generates the relatively smaller vortices and smaller separation region and the CT-cylinder wake exhibits lower fluctuation in the shear layer. (C) 2014 Elsevier Ltd. All rights reserved.	[Fujimoto, S.; Rinoshika, A.] Yamagata Univ, Dept Mech Syst Engn, Yonezawa, Yamagata 9928510, Japan	Rinoshika, A (reprint author), Yamagata Univ, Dept Mech Syst Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.				Japanese Society for the Promotion of Science [23560186]	The second author (AR) wishes to acknowledge support given to him by Grant-in-Aid for Scientific Research (C) (No. 23560186) from the Japanese Society for the Promotion of Science.	WEI T, 1986, J FLUID MECH, V169, P513, DOI 10.1017/S0022112086000733; Scarano F, 2009, EXP FLUIDS, V47, P69, DOI 10.1007/s00348-009-0629-2; Tanaka T, 2007, EXP FLUIDS, V42, P893, DOI 10.1007/s00348-007-0298-y; Ozgoren M, 2006, FLOW MEAS INSTRUM, V17, P225, DOI 10.1016/j.flowmeasinst.2005.11.005; PERRY AE, 1982, J FLUID MECH, V116, P77, DOI 10.1017/S0022112082000378; Adrian RJ, 2000, EXP FLUIDS, V29, P275, DOI 10.1007/s003489900087; Schneider K, 2010, ANNU REV FLUID MECH, V42, P473, DOI 10.1146/annurev-fluid-121108-145637; MENEVEAU C, 1991, J FLUID MECH, V232, P469, DOI 10.1017/S0022112091003786; Katz J, 2006, ANNU REV FLUID MECH, V38, P27, DOI 10.1146/annurev.fluid.38.050304.092016; Hussain AKMF, 1987, J FLUID MECH, V108, P193; Lin JC, 1996, PHYS FLUIDS, V8, P555, DOI 10.1063/1.868808; Milliken WF, 1995, RACE CAR VEHICLE DYN; Mouri H, 1999, J FLUID MECH, V389, P229, DOI 10.1017/S0022112099004942; Rinoshika Akira, 2010, Journal of Flow Visualization and Image Processing, V17, DOI 10.1615/JFlowVisImageProc.v17.i1.30; Rinoshika A, 2005, J FLUID MECH, V524, P229, DOI 10.1017/S0022112004002319; Rinoshika A, LECT NOTES MECH ENG, P77; Rinoshika A, 2011, EXP THERM FLUID SCI, V35, P1231, DOI 10.1016/j.expthermflusci.2011.04.010; Rinoshika A, 2005, PHYS REV E, V71, P1; Rinoshika A, 2010, EXP THERM FLUID SCI, V34, P1389, DOI 10.1016/j.expthermflusci.2010.06.013; Rinoshika A, 2007, INT J HEAT FLUID FL, V28, P948, DOI 10.1016/j.ijheatfluidflow.2006.12.001; Rinoshika A, 2013, INT J WAVELETS MULTI, V11, P1; Rinoshika A, 2009, PHYS REV E, V79, P1; SAARENRINNE P, 2000, EXP FLUIDS, V29, P300; Taylor ZJ, 2011, J FLUID STRUCT, V27, P250, DOI 10.1016/j.jfluidstructs.2010.10.004; Vetel J, 2010, EXP FLUIDS, V48, P441, DOI 10.1007/s00348-009-0749-8; YAMADA M, 1991, PROG THEOR PHYS, V86, P799, DOI 10.1143/PTP.86.799; Zhou T, 2006, PHYS REV E, V73, P1; ZHOU Y, 1994, J FLUID MECH, V275, P59, DOI 10.1017/S0022112094002284	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7403	1879-2162		INT J MECH SCI	Int. J. Mech. Sci.	MAR	2015	92						121	132		10.1016/j.ijmecsci.2014.12.007		12	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CF7OB	WOS:000352745100012		
J	Yuan, WY; Tomita, M				Yuan, Wen-Ye; Tomita, Motonori			Thinopyrum ponticum Chromatin-Integrated Wheat Genome Shows Salt-Tolerance at Germination Stage	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article							TRITICUM-AESTIVUM; INTROGRESSION; CHROMOSOME; SALINITY; LINES	A wild wheatgrass, Thinopyrum ponticum (2n = 10x = 70), which exhibits substantially higher levels of salt tolerance than cultivated wheat, was employed to transfer its salt tolerance to common wheat by means of wide hybridization. A highly salt-tolerant wheat line S148 (2n = 42) was obtained from the BC3F2 progenies between Triticum aestivum (2n = 42) and Th. ponticum. In the cross of S148 x salt-sensitive wheat variety Chinese Spring, the BC4F2 seeds at germination stage segregated into a ratio of 3 salt tolerant to 1 salt sensitive, indicating that the salt tolerance was conferred by a dominant gene block. Genomic in situ hybridization analysis revealed that S148 had a single pair of Th. ponticum-T. aestivum translocated chromosomes bearing the salt-tolerance. This is an initial step of molecular breeding for salt-tolerant wheat.	[Tomita, Motonori] Shizuoka Univ, Res Inst Green Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan; [Yuan, Wen-Ye; Tomita, Motonori] Tottori Univ, Mol Genet Lab, Fac Agr, Tottori 6808553, Japan	Tomita, M (reprint author), Shizuoka Univ, Res Inst Green Sci & Technol, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	omtomit@ipc.shizuoka.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	The authors thank Prof. Sun Shan-Cheng, Shanxi Academy of Agricultural Sciences, Taiyuan, China, for providing TAe68 and the derivatives. This research was supported in part by a scholarship to Wen-Ye Yuan from the Ministry of Education, Science, Sports and Culture of Japan.	AKHTAR J, 1994, PLANT SOIL, V166, P47, DOI 10.1007/BF02185480; Chen SY, 2004, PLANT SCI, V167, P773, DOI [10.1016/j.plantsci.2004.05.010, 10.1016/j.plantsci.2004.05.032]; Colmer TD, 2005, AUST J EXP AGR, V45, P1425, DOI 10.1071/EA04162; Wang MC, 2008, PROTEOMICS, V8, P1470, DOI 10.1002/pmic.200700569; Wang J, 2005, PLANTA, V221, P277, DOI 10.1007/s00425-004-1443-y; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Brasileiro-Vidal AC, 2005, GENET MOL BIOL, V28, P308, DOI 10.1590/S1415-47572005000200022; DEWEY DOUGLAS R., 1960, AGRON JOUR, V52, P631; Fedak G, 1999, GENOME, V42, P584, DOI 10.1139/gen-42-4-584; Ghassemi F., 1995, SALINIZATION LAND WA, P562; GILL BS, 1991, GENOME, V34, P830; King IP, 1997, PLANT BREEDING, V116, P127, DOI 10.1111/j.1439-0523.1997.tb02166.x; McGuire GE, 1981, CROP SCI, V21, P702, DOI DOI 10.2135/CROPSCI1981.0011183X002100050018X; Mott IW, 2007, PLANT SCI, V173, P327, DOI 10.1016/j.plantsei.2007.06.005; Mujeeb-Kazi A, 2002, TASK VEG SC, V37, P69; Mullan DJ, 2009, THEOR APPL GENET, V119, P1313, DOI 10.1007/s00122-009-1136-9; Pienaar R. V., 1990, BIOTECHNOLOGY AGR FO, P167; SHALABY EE, 1993, J AGRON CROP SCI, V171, P298, DOI 10.1111/j.1439-037X.1993.tb00144.x; Tomita M, 2008, DNA RES, V15, P49, DOI 10.1093/dnares/dsm029; Wang RRC, 2003, INT J PLANT SCI, V164, P25, DOI 10.1086/344556	20	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2015	16	3					4512	4517		10.3390/ijms16034512		6	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CG0KM	WOS:000352955500010		
J	Matsubara, K; Higaki, T; Matsubara, Y; Nawa, A				Matsubara, Keiichi; Higaki, Takashi; Matsubara, Yuko; Nawa, Akihiro			Nitric Oxide and Reactive Oxygen Species in the Pathogenesis of Preeclampsia	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							PREGNANCY-INDUCED HYPERTENSION; MESSENGER-RNA EXPRESSION; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; XANTHINE-OXIDASE; SMOOTH-MUSCLE; PEROXYNITRITE FORMATION; GLUTATHIONE-PEROXIDASE	Preeclampsia (PE) is characterized by disturbed extravillous trophoblast migration toward uterine spiral arteries leading to increased uteroplacental vascular resistance and by vascular dysfunction resulting in reduced systemic vasodilatory properties. Its pathogenesis is mediated by an altered bioavailability of nitric oxide (NO) and tissue damage caused by increased levels of reactive oxygen species (ROS). Furthermore, superoxide (O-2(-)) rapidly inactivates NO and forms peroxynitrite (ONOO-). It is known that ONOO- accumulates in the placental tissues and injures the placental function in PE. In addition, ROS could stimulate platelet adhesion and aggregation leading to intravascular coagulopathy. ROS-induced coagulopathy causes placental infarction and impairs the uteroplacental blood flow in PE. The disorders could lead to the reduction of oxygen and nutrients required for normal fetal development resulting in fetal growth restriction. On the other hand, several antioxidants scavenge ROS and protect tissues against oxidative damage. Placental antioxidants including catalase, superoxide dismutase (SOD), and glutathione peroxidase (GPx) protect the vasculature from ROS and maintain the vascular function. However, placental ischemia in PE decreases the antioxidant activity resulting in further elevated oxidative stress, which leads to the appearance of the pathological conditions of PE including hypertension and proteinuria. Oxidative stress is defined as an imbalance between ROS and antioxidant activity. This review provides new insights about roles of oxidative stress in the pathophysiology of PE.	[Matsubara, Keiichi; Matsubara, Yuko; Nawa, Akihiro] Ehime Univ, Sch Med, Dept Obstet & Gynecol, Matsuyama, Ehime 7910295, Japan; [Higaki, Takashi] Ehime Univ, Sch Med, Dept Pediat, Matsuyama, Ehime 7910295, Japan	Matsubara, K (reprint author), Ehime Univ, Sch Med, Dept Obstet & Gynecol, Matsuyama, Ehime 7910295, Japan.	keiichi@m.ehime-u.ac.jp; higaki@m.ehime-u.ac.jp; takeyu@m.ehime-u.ac.jp; nawa2011@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [18591803]	This work was supported by the Grant-in-Aid for Japan Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (18591803).	Abe E, 2008, GYNECOL OBSTET INVES, V66, P27, DOI 10.1159/000114253; Ademuyiwa O, 2007, ACTA OBSTET GYN SCAN, V86, P1175, DOI 10.1080/00016340701515357; Aires RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073562; Wang YP, 1996, J SOC GYNECOL INVEST, V3, P179, DOI 10.1016/1071-5576(96)00015-9; Kone BC, 1997, AM J PHYSIOL-RENAL, V272, pF561; Thiemermann C, 1997, GEN PHARMACOL, V29, P159, DOI 10.1016/S0306-3623(96)00410-7; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Vanhoutte PM, 2009, ARTERIOSCL THROM VAS, V29, P1156, DOI 10.1161/ATVBAHA.109.190215; KNOWLES RG, 1994, BIOCHEM J, V298, P249; Tschudi MR, 1996, HYPERTENSION, V27, P32; Mitchell BM, 2007, AM J HYPERTENS, V20, P1297, DOI 10.1016/j.amjhyper.2007.08.007; Molvarec A, 2009, CELL STRESS CHAPERON, V14, P151, DOI 10.1007/s12192-008-0067-8; Kerr S, 1999, HYPERTENSION, V33, P1353; Cockell AP, 1997, HYPERTENSION, V30, P247; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Rosta K, 2009, EUR J OBSTET GYN R B, V142, P134, DOI 10.1016/j.ejogrb.2008.10.014; Staff AC, 1999, AM J OBSTET GYNECOL, V180, P587, DOI 10.1016/S0002-9378(99)70259-0; Many A, 2000, AM J PATHOL, V156, P321, DOI 10.1016/S0002-9440(10)64733-5; Beetsch JW, 1998, BRAIN RES, V786, P89, DOI 10.1016/S0006-8993(97)01407-8; Sladek SM, 1997, AM J PHYSIOL-REG I, V272, pR441; Miyazaki H, 1999, CIRCULATION, V99, P1141; Gielis JF, 2011, FREE RADICAL BIO MED, V50, P765, DOI 10.1016/j.freeradbiomed.2010.12.018; Matsubara K, 2010, J OBSTET GYNAECOL RE, V36, P239, DOI 10.1111/j.1447-0756.2009.01128.x; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Chekir C, 2006, PLACENTA, V27, P225, DOI 10.1016/j.placenta.2005.02.016; Kalinowski L, 2002, HYPERTENSION, V40, P521, DOI 10.1161/01.HYP.0000034745.98129.EC; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Abe E, 2003, HYPERTENS PREGNANCY, V22, P31, DOI 10.1081/PRG-120016793; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; Ying ZK, 2009, TOXICOL SCI, V111, P80, DOI 10.1093/toxsci/kfp004; Guzik TJ, 2006, ARTERIOSCL THROM VAS, V26, P333, DOI 10.1161/01.ATV.0000196651.64776.51; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; HAYASHI T, 1995, BIOCHEM BIOPH RES CO, V214, P847, DOI 10.1006/bbrc.1995.2364; Kirk EA, 2000, ARTERIOSCL THROM VAS, V20, P1529; Harrington K, 1997, ULTRASOUND OBST GYN, V9, P94, DOI 10.1046/j.1469-0705.1997.09020094.x; Ungvari Z, 2004, AM J PATHOL, V165, P219, DOI 10.1016/S0002-9440(10)63290-7; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Wang Y, 2001, PLACENTA, V22, P206, DOI 10.1053/plac.2000.0608; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200; JENDRYCZKO A, 1989, ZBL GYNAKOL, V111, P1121; Aris A., 2009, PLACENTA, V324, P324; BAKER PN, 1995, HYPERTENSION, V26, P244; BUHIMSCHI I, 1995, AM J OBSTET GYNECOL, V172, P1577, DOI 10.1016/0002-9378(95)90500-6; Cannon PJ, 1998, CARDIOVASC RES, V38, P6, DOI 10.1016/S0008-6363(98)00022-4; Carey RM, 2000, ACTA PHYSIOL SCAND, V168, P65; Cianchetti S, 2008, ATHEROSCLEROSIS, V198, P22, DOI 10.1016/j.atherosclerosis.2007.09.013; Corte E D, 1972, Biochem J, V126, P739; DAVENPECK KL, 1994, GASTROENTEROLOGY, V107, P1050; Diedrich F, 2001, AM J OBSTET GYNECOL, V185, P166, DOI 10.1067/mob.2001.115281; Dordevic NZ, 2008, REPROD TOXICOL, V25, P213, DOI 10.1016/j.reprotox.2007.11.001; Farrow KN, 2008, AM J PHYSIOL-LUNG C, V295, pL979, DOI 10.1152/ajplung.90238.2008; GAUTHIER TW, 1995, ARTERIOSCL THROM VAS, V15, P1652; Goth L., 2008, DIABETES CARE, V24, pe93, DOI DOI 10.2337/DC08-1607; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269; GREER IA, 1989, BRIT J OBSTET GYNAEC, V96, P978, DOI 10.1111/j.1471-0528.1989.tb03358.x; Group NHBPEPW National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy Am, 1990, J OBSTET GYNECOL, V163, P1691; Gurovich AN, 2014, VASC MED, V19, P251, DOI 10.1177/1358863X14537546; Haque SK, 2010, HYPERTENS PREGNANCY, V29, P69, DOI 10.3109/10641950902849868; Hubel CA, 1997, FREE RADICAL BIO MED, V23, P597, DOI 10.1016/S0891-5849(97)00010-5; Kakui K, 2003, ENDOCR J, V50, P535, DOI 10.1507/endocrj.50.535; Kilbourn R G, 1997, Dis Mon, V43, P277; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Lee JB, 1998, J AM CHEM SOC, V120, P6053, DOI 10.1021/ja9801036; Lee VM, 2003, HYPERTENSION, V41, P925, DOI 10.1161/01.HYP.0000062021.68464.9D; Lee VM, 2003, J HYPERTENS, V21, P395, DOI 10.1097/01.hjh.0000052416.12292.7d; Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001; Madazli R, 2002, J Obstet Gynaecol, V22, P477; Matsubara K, 2003, J OBSTET GYNAECOL RE, V29, P422, DOI 10.1111/j.1341-8076.2003.00141.x; Mutlu-Turkoglu U, 1998, GYNECOL OBSTET INVES, V46, P37; Myatt L, 1997, PLACENTA, V18, P261, DOI 10.1016/S0143-4004(97)80060-4; Nevzati Edin, 2015, Acta Neurochir Suppl, V120, P141, DOI 10.1007/978-3-319-04981-6_24; Nowicki PT, 2001, CIRC RES, V89, P114, DOI 10.1161/hh1401.094367; Olson S, 2004, AM J PHYSIOL-LUNG C, V287, pL559, DOI 10.1152/ajplung.00312.2003; Patetsios P, 2001, AM J CARDIOL, V88, P188, DOI 10.1016/S0002-9149(01)01621-6; QUINN MT, 1995, J LEUKOCYTE BIOL, V57, P415; Roberts J. M., 2009, PLACENTA, V30, P1; Roberts JM, 1999, LANCET, V354, P788; Roggensack AM, 1999, HYPERTENSION, V33, P83; Song JH, 2003, EXP MOL MED, V35, P67; Szarka András, 2010, BMC Immunol, V11, P59, DOI 10.1186/1471-2172-11-59; Takeda-Matsubara Y, 2003, AM J HYPERTENS, V16, P993, DOI 10.1016/j.amjhyper.2003.07.020; Ullrich V, 2000, BIOCHEM BIOPH RES CO, V278, P1, DOI 10.1006/bbrc.2000.3733; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; WALSH SW, 1993, AM J OBSTET GYNECOL, V169, P1456	94	4	4	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2015	16	3					4600	4614		10.3390/ijms16034600		15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CG0KM	WOS:000352955500014		
J	Kanda, T; Yokosuka, O; Omata, M				Kanda, Tatsuo; Yokosuka, Osamu; Omata, Masao			Faldaprevir for the Treatment of Hepatitis C	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							GENOTYPE 1 INFECTION; CHRONIC HCV INFECTION; TREATMENT-NAIVE PATIENTS; NS3 PROTEASE INHIBITOR; VIRUS-INFECTION; BI 201335; RIBAVIRIN; TELAPREVIR; PEGINTERFERON; DELEOBUVIR	The current treatments for chronic hepatitis C virus (HCV) genotype 1 infection are combinations of direct-acting antivirals, and faldaprevir is one of the new generation of HCV NS3/4A protease inhibitors. At the end of 2013, the US Food and Drug Administration (FDA) approved the HCV NS3/4A protease inhibitor simeprevir and the HCV NS5B polymerase inhibitor sofosbuvir. Simeprevir or sofosbuvir in combination with pegylated interferon and ribavirin are available for clinical use. Faldaprevir, another HCV NS3/4A protease inhibitor that also has fewer adverse events than telaprevir or boceprevir, is under development. Of interest, faldaprevir in combination with pegylated interferon and ribavirin, and interferon-free treatment with faldaprevir in combination with deleobuvir plus ribavirin provides high sustained virological response rates for HCV genotype 1 infection. The aim of this article is to review these data concerning faldaprevir. Faldaprevir in combination with pegylated interferon and ribavirin treatment appears to be associated with fewer adverse events than telaprevir or boceprevir in combination with pegylated interferon and ribavirin, and may be one of the therapeutic options for treatment-naive patients with HCV genotype 1. The interferon-free combination of faldaprevir and deleobuvir with ribavirin was effective for HCV genotype 1 infection and may hold promise for interferon-ineligible and interferon-intolerant patients.	[Kanda, Tatsuo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Chiba 2608670, Japan; [Omata, Masao] Yamanashi Hosp Cent & Kita Org, Kofu, Yamanashi 4008506, Japan; [Omata, Masao] Univ Tokyo, Bunkyo Ku, Tokyo 1138655, Japan	Kanda, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	kandat-cib@umin.ac.jp; yokosukao@faculty.chiba-u.jp; momata-tky@umin.ac.jp			Chugai Pharmaceutical; MSD; Tanabe-Mitsubishi; Ajinomoto; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Pharmaceutical Companies; Bayer; Daiichi-Sankyo; Mitsubishi Tanabe Pharma; Boehringer Ingelheim; Gilead Sciences	Tatsuo Kanda reports receiving lecture fees from Chugai Pharmaceutical, MSD, Tanabe-Mitsubishi, Ajinomoto, Bristol-Myers Squibb, GlaxoSmithKline and Janssen Pharmaceutical Companies. Osamu Yokosuka reports receiving grant support from Chugai Pharmaceutical, Bayer, MSD, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, Bristol-Myers Squibb, Boehringer Ingelheim and Gilead Sciences. Masao Omata reports receiving grant support from Boehringer Ingelheim and Gilead Sciences.	De Francesco R, 1999, J HEPATOL, V31, P47, DOI 10.1016/S0168-8278(99)80374-2; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; White PW, 2010, ANTIMICROB AGENTS CH, V54, P4611, DOI 10.1128/AAC.00787-10; Sulkowski MS, 2013, HEPATOLOGY, V57, P2143, DOI 10.1002/hep.26276; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Omata M, 2012, HEPATOL INT, V6, P409, DOI 10.1007/s12072-012-9342-y; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Zeuzem S, 2015, LIVER INT, V35, P417, DOI 10.1111/liv.12693; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Wu S, 2013, WORLD J GASTROENTERO, V19, P8940, DOI 10.3748/wjg.v19.i47.8940; Atoom AM, 2014, VIROLOGY, V462, P377, DOI 10.1016/j.virol.2014.04.018; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Zeuzem S, 2011, GASTROENTEROLOGY, V141, P2047, DOI 10.1053/j.gastro.2011.08.051; Ferenci P, 2015, J HEPATOL, V62, P1246, DOI 10.1016/j.jhep.2014.12.024; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; European Association for Study of Liver, 2014, J HEPATOL, V60, P392, DOI DOI 10.1016/J.JHEP.2013.11.003; Hirotsu Y., 2015, HEPATOL INT IN PRESS; Kanda Tatsuo, 2013, Clin Transl Med, V2, P9, DOI 10.1186/2001-1326-2-9; Kanda T., 2013, WORLD J IMMUNOL, V3, P54, DOI [10.5411/wji.v3.i3.54, DOI 10.5411/WJI.V3.I3.54]; Kanda T, 2013, CHINESE MED J-PEKING, V126, P4568, DOI 10.3760/cma.j.issn.0366-6999.20131127; Kanda Tatsuo, 2014, J Clin Transl Hepatol, V2, P1, DOI 10.14218/JCTH.2013.00025; Lagace L, 2012, ANTIMICROB AGENTS CH, V56, P569, DOI 10.1128/AAC.05166-11; Nishiguchi S., 2013, LIVER INT, V34, P78, DOI [10.1111/liv.1225423944720, DOI 10.1111/LIV.1225423944720]; Ray R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002772; Sabo JP, 2015, J CLIN PHARMACOL, V55, P467, DOI 10.1002/jcph.436; Sulkowski MS, 2013, HEPATOLOGY, V57, P2155, DOI 10.1002/hep.26386; Vanwolleghem T, 2007, GASTROENTEROLOGY, V133, P1144, DOI 10.1053/j.gastro.2007.07.007; Zeuzem S, 2015, ANTIMICROB AGENTS CH, V59, P1282, DOI 10.1128/AAC.04383-14; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	38	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2015	16	3					4985	4996		10.3390/ijms16034985		12	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CG0KM	WOS:000352955500037		
J	Ueda, N				Ueda, Norishi			Ceramide-Induced Apoptosis in Renal Tubular Cells: A Role of Mitochondria and Sphingosine-1-Phoshate	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							ISCHEMIA-REPERFUSION INJURY; EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; DARBY CANINE KIDNEY; ENDOPLASMIC-RETICULUM CA2+; BCL-2 FAMILY PROTEINS; FACTOR-KAPPA-B; EPITHELIAL-CELLS; OXIDATIVE STRESS; MESANGIAL CELLS	Ceramide is synthesized upon stimuli, and induces apoptosis in renal tubular cells (RTCs). Sphingosine-1 phosphate (S1P) functions as a survival factor. Thus, the balance of ceramide/S1P determines ceramide-induced apoptosis. Mitochondria play a key role for ceramide-induced apoptosis by altered mitochondrial outer membrane permeability (MOMP). Ceramide enhances oligomerization of pro-apoptotic Bcl-2 family proteins, ceramide channel, and reduces anti-apoptotic Bcl-2 proteins in the MOM. This process alters MOMP, resulting in generation of reactive oxygen species (ROS), cytochrome C release into the cytosol, caspase activation, and apoptosis. Ceramide regulates apoptosis through mitogen-activated protein kinases (MAPKs)-dependent and -independent pathways. Conversely, MAPKs alter ceramide generation by regulating the enzymes involving ceramide metabolism, affecting ceramide-induced apoptosis. Crosstalk between Bcl-2 family proteins, ROS, and many signaling pathways regulates ceramide-induced apoptosis. Growth factors rescue ceramide-induced apoptosis by regulating the enzymes involving ceramide metabolism, S1P, and signaling pathways including MAPKs. This article reviews evidence supporting a role of ceramide for apoptosis and discusses a role of mitochondria, including MOMP, Bcl-2 family proteins, ROS, and signaling pathways, and crosstalk between these factors in the regulation of ceramide-induced apoptosis of RTCs. A balancing role between ceramide and S1P and the strategy for preventing ceramide-induced apoptosis by growth factors are also discussed.	Publ Cent Hosp Matto Ishikawa, Dept Pediat, Haku San, Ishikawa 9248588, Japan	Ueda, N (reprint author), Publ Cent Hosp Matto Ishikawa, Dept Pediat, 3-8 Kuramitsu, Haku San, Ishikawa 9248588, Japan.	nueda@mattohp.com			Aichi Kidney Foundation	This work was supported by the Aichi Kidney Foundation. The author is grateful to Hideyuki Iwayama (Department of Medicine, The University of Chicago, Chicago, IL, USA), Professors Sameh Abul-Ezz and Sudhir V. Shah (Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA) for their critical reading of the manuscript and helpful suggestions. I also thank Cindy Reid (Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA) for her editorial assistance in the revision of the manuscript, and Satoshi Yoshida (Division of Health Information Management, Public Central Hospital of Mattoh Ishikawa, Ishikawa, Japan) for his help in preparation of graphics.	Basnakian AG, 2005, AM J PHYSIOL-RENAL, V288, pF308, DOI 10.1152/ajprenal.00204.2004; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Park SW, 2012, J AM SOC NEPHROL, V23, P266, DOI 10.1681/ASN.2011050503; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Morales MC, 2007, FREE RADICAL RES, V41, P591, DOI 10.1080/10715760701218558; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Ruggiero C, 2014, AM J PHYSIOL-RENAL, V306, pF896, DOI 10.1152/ajprenal.00484.2013; Chatterjee M, 2001, MOL CELL BIOCHEM, V219, P21, DOI 10.1023/A:1011083818452; Srivastava S, 2007, FREE RADICAL RES, V41, P38, DOI 10.1080/10715760600943900; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Novgorodov SA, 2011, J BIOL CHEM, V286, P25352, DOI 10.1074/jbc.M110.214866; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Saito M, 2000, NAT CELL BIOL, V2, P553; Itoh Y, 2006, KIDNEY INT, V69, P288, DOI 10.1038/sj.ki.5000057; Suzuki J, 2011, NEUROSCIENCE, V176, P188, DOI 10.1016/j.neuroscience.2010.11.035; Lee WK, 2007, AM J PHYSIOL-CELL PH, V293, pC839, DOI 10.1152/ajpcell.00197.2007; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Flowers M, 2012, BREAST CANCER RES TR, V133, P447, DOI 10.1007/s10549-011-1768-8; El-Shewy HM, 2011, MOL ENDOCRINOL, V25, P2144, DOI 10.1210/me.2011-0101; Li X, 2012, CELL PHYSIOL BIOCHEM, V30, P815, DOI 10.1159/000341460; Fischer H, 2007, CELL MICROBIOL, V9, P1239, DOI 10.1111/j.1462-5822.2006.00867.x; Roucou X, 2002, BIOCHEM J, V363, P547, DOI 10.1042/0264-6021:3630547; Sun Y, 2008, J LEUKOCYTE BIOL, V83, P1512, DOI 10.1189/jlb.0108076; Yogi A, 2011, HYPERTENSION, V57, P809, DOI 10.1161/HYPERTENSIONAHA.110.162719; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Kim HJ, 2008, CANCER LETT, V260, P88, DOI 10.1016/j.canlet.2007.10.030; Idkowiak-Baldys J, 2010, BIOCHEM J, V427, P265, DOI 10.1042/BJ20091589; GHOSH P, 1987, J BIOL CHEM, V262, P12550; Seefelder W, 2003, TOXICOL APPL PHARM, V192, P146, DOI 10.1016/S0041-008X(03)00262-X; Sridevi P, 2009, BBA-MOL CELL RES, V1793, P1218, DOI 10.1016/j.bbamcr.2009.04.006; Sharma N, 2004, CHEM-BIOL INTERACT, V151, P33, DOI 10.1016/j.cbi.2004.10.003; Koch A, 2013, CELL PHYSIOL BIOCHEM, V31, P745, DOI 10.1159/000350093; Esposti MD, 1999, J BIOL CHEM, V274, P29831, DOI 10.1074/jbc.274.42.29831; Amarante-Mendes GP, 1998, BLOOD, V91, P1700; Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; Schwarz M, 2007, APOPTOSIS, V12, P869, DOI 10.1007/s10495-007-0748-2; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Chandran S, 2012, BIOCHEM J, V442, P391, DOI 10.1042/BJ20111461; Sawada M, 2000, ONCOGENE, V19, P3508, DOI 10.1038/sj.onc.1203699; He Q, 2012, MOL BIOL CELL, V23, P3156, DOI 10.1091/mbc.E12-02-0079; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719; Wang GH, 2009, J LIPID RES, V50, P2103, DOI 10.1194/jlr.M900097-JLR200; Ledeen RW, 2008, J LIPID RES, V49, P1176, DOI 10.1194/jlr.R800009-JLR200; Gault CR, 2012, J BIOL CHEM, V287, P31794, DOI 10.1074/jbc.M112.385765; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Thevenod F, 2013, ARCH TOXICOL, V87, P1743, DOI 10.1007/s00204-013-1110-9; Asakuma J, 2003, CANCER RES, V63, P1365; Bourbon NA, 2000, J BIOL CHEM, V275, P35617, DOI 10.1074/jbc.M007346200; Ebel P, 2013, J BIOL CHEM, V288, P21433, DOI 10.1074/jbc.M113.479907; Hedlund M, 1998, MOL MICROBIOL, V29, P1297, DOI 10.1046/j.1365-2958.1998.01017.x; Kurinna SM, 2004, CANCER RES, V64, P7852, DOI 10.1158/0008-5472.CAN-04-1552; Elrick MJ, 2006, BIOPHYS J, V91, P1749, DOI 10.1529/biophysj.106.088443; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; D'Errico I, 2011, CELL CYCLE, V10, P2937, DOI 10.4161/cc.10.17.16791; Perera MN, 2012, BIOCHEM J, V445, P81, DOI 10.1042/BJ20112103; Logue SE, 2013, APOPTOSIS, V18, P537, DOI 10.1007/s10495-013-0818-6; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Kizhakkayil J, 2012, FREE RADICAL BIO MED, V52, P1854, DOI 10.1016/j.freeradbiomed.2012.02.026; Olivera A, 1999, FASEB J, V13, P1593; Auge N, 2002, ARTERIOSCL THROM VAS, V22, P1990, DOI 10.1161/01.ATV.0000043453.21629.3B; Willaime S, 2001, EUR J NEUROSCI, V13, P2037, DOI 10.1046/j.0953-816x.2001.01581.x; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Wu CC, 2013, ANTIOXID REDOX SIGN, V19, P546, DOI 10.1089/ars.2012.4905; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Maceyka M, 2007, CIRC RES, V100, P7, DOI 10.1161/01.RES.0000255895.19868.a3; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Ishibashi Y, 2013, BBA-MOL CELL BIOL L, V1831, P1475, DOI 10.1016/j.bbalip.2013.06.001; Bektas M, 2005, ONCOGENE, V24, P178, DOI 10.1038/sj.onc.1208019; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Hofmann LP, 2008, BIOL CHEM, V389, P1399, DOI 10.1515/BC.2008.160; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Choudhury GG, 2001, BIOCHEM BIOPH RES CO, V286, P1183, DOI 10.1006/bbrc.2001.5483; Sacket SJ, 2009, ACTA PHARMACOL SIN, V30, P1454, DOI 10.1038/aps.2009.136; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Krishna S, 2011, BIOCHEM J, V435, P545, DOI 10.1042/BJ20101996; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Willaime-Morawek S, 2003, NEUROSCIENCE, V119, P387, DOI 10.1016/S0306-4522(02)00996-X; Stiban J, 2006, APOPTOSIS, V11, P773, DOI 10.1007/s10495-006-5882-8; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Beverly LJ, 2013, BIOCHEM J, V452, P111, DOI 10.1042/BJ20130147; Cho SG, 2010, AM J PHYSIOL-RENAL, V299, pF199, DOI 10.1152/ajprenal.00716.2009; Nicotera P, 2004, ONCOGENE, V23, P2757, DOI 10.1038/sj.onc.1207559; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Sridevi P, 2010, EXP CELL RES, V316, P78, DOI 10.1016/j.yexcr.2009.09.027; Lee WK, 2008, BIOCHEM PHARMACOL, V76, P1323, DOI 10.1016/j.bcp.2008.07.004; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Yacoub A, 2010, CANCER RES, V70, P1120, DOI 10.1158/0008-5472.CAN-09-4043; Bajwa A, 2010, J AM SOC NEPHROL, V21, P955, DOI 10.1681/ASN.2009060662; Aschrafi A, 2003, BBA-MOL CELL BIOL L, V1634, P30, DOI 10.1016/j.bbalip.2003.08.004; Babiychuk EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023706; Bakar AM, 2012, INT J MOL SCI, V13, P977, DOI 10.3390/ijms13010977; Betito S, 2006, BIOCHEM BIOPH RES CO, V340, P1273, DOI 10.1016/j.bbrc.2005.12.138; Bizzozero L, 2014, CELL DEATH DIFFER, V21, P507, DOI 10.1038/cdd.2013.173; Bourbon NA, 2001, AM J PHYSIOL-CELL PH, V280, pC1403; Burlaka I, 2013, J AM SOC NEPHROL, V24, P1413, DOI 10.1681/ASN.2012101044; Cabral LMP, 2007, J BIOL CHEM, V282, P24599, DOI 10.1074/jbc.M701669200; Camandola S, 2005, J BIOL CHEM, V280, P22287, DOI 10.1074/jbc.M410923200; Cao LC, 2004, KIDNEY INT, V66, P1890, DOI 10.1111/j.1523-1755.2004.00963.x; Cao LC, 2000, KIDNEY INT, V57, P2403, DOI 10.1046/j.1523-1755.2000.00099.x; Charruyer A, 2007, BIOCHEM J, V405, P77, DOI 10.1042/BJ20061528; Chatterjee S, 2007, EXP BIOL MED, V232, P1140, DOI 10.3181/0609-RM-245; Cinq-Frais C, 2013, BBA-MOL CELL BIOL L, V1831, P1344, DOI 10.1016/j.bbalip.2013.04.014; Dagher PC, 2004, KIDNEY INT, V66, P506, DOI 10.1111/j.1523-1755.2004.761_7.x; Dahdouh F, 2014, ARCH TOXICOL, V88, P881, DOI 10.1007/s00204-014-1194-x; Darios F, 2005, J NEUROSCI, V25, P4159, DOI 10.1523/JNEUROSCI.0060-05.2005; Darios F, 2003, J NEUROCHEM, V84, P643, DOI 10.1046/j.0022-3042.2003.01590.x; Donato NJ, 2004, EXP CELL RES, V294, P523, DOI 10.1016/j.yexer.2003.11.021; Dremina ES, 2004, BIOCHEM J, V383, P361, DOI 10.1042/BJ20040187; El-Shewy HM, 2012, MOL ENDOCRINOL, V26, P833, DOI 10.1210/me.2011-1261; Facchinetti MM, 2003, BIOL NEONATE, V84, P243, DOI 10.1159/000072308; Falluel-Morel A, 2004, J NEUROCHEM, V91, P1231, DOI 10.1111/j.1471-4159.2004.02810.x; Fatatis A, 1999, FASEB J, V13, P1291; Fiebig AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-213; Franzen R, 2002, FEBS LETT, V532, P441, DOI 10.1016/S0014-5793(02)03727-4; Franzen R, 2001, J BIOL CHEM, V276, P35382, DOI 10.1074/jbc.M102153200; Gao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044543; Gibson SB, 2004, VITAM HORM, V67, P207; Grammatikos G, 2007, ANTIOXID REDOX SIGN, V9, P1449, DOI 10.1089/ars.2007.1673; He QR, 2002, PHARMACOL TOXICOL, V90, P268, DOI 10.1034/j.1600-0773.2002.900507.x; Henke N, 2011, CELL CALCIUM, V50, P251, DOI 10.1016/j.ceca.2011.05.005; Heringdorf DM, 1999, FEBS LETT, V461, P217; Herrmann JL, 1997, EXP CELL RES, V234, P442, DOI 10.1006/excr.1997.3653; Hsin YH, 2006, APOPTOSIS, V11, P2167, DOI 10.1007/s10495-006-0289-0; Huwiler A, 2004, BBA-MOL CELL BIOL L, V1636, P159, DOI 10.1016/j.bbalip.2003.08.010; Huwiler A, 1999, J BIOL CHEM, V274, P7190, DOI 10.1074/jbc.274.11.7190; Ichi I, 2009, TOXICOLOGY, V261, P33, DOI 10.1016/j.tox.2009.04.040; Ishizawa S, 2014, CLIN EXP NEPHROL, V18, P844, DOI 10.1007/s10157-014-0933-x; IWATA M, 1995, P NATL ACAD SCI USA, V92, P8970, DOI 10.1073/pnas.92.19.8970; Iwayama H, 2013, MOL CELL BIOCHEM, V379, P37, DOI 10.1007/s11010-013-1624-8; Iwayama Hideyuki, 2011, Nephron Extra, V1, P178, DOI 10.1159/000333014; Jin S, 2008, ARTERIOSCL THROM VAS, V28, P2056, DOI 10.1161/ATVBAHA.108.172478; Jo SK, 2008, KIDNEY INT, V73, P1220, DOI 10.1038/ki.2008.34; Johnstone ED, 2005, PLACENTA, V26, P548, DOI 10.1016/j.placenta.2004.08.012; Kim M, 2007, AM J PHYSIOL-RENAL, V293, pF1827, DOI 10.1152/ajprenal.00290.2007; Kim M, 2011, ANESTHESIOLOGY, V114, P363, DOI 10.1097/ALN.0b013e3182070c3a; Kim M, 2010, AM J NEPHROL, V31, P353, DOI 10.1159/000298339; Kirby RJ, 2009, AM J PHYSIOL-RENAL, V296, pF634, DOI 10.1152/ajprenal.90232.2008; Kirkland RA, 2010, J NEUROSCI, V30, P16114, DOI 10.1523/JNEUROSCI.2862-10.2010; Kobrinsky E, 1999, AM J PHYSIOL-CELL PH, V277, pC665; KOK JW, 1989, P NATL ACAD SCI USA, V86, P9896, DOI 10.1073/pnas.86.24.9896; Kumagai K, 2014, J BIOL CHEM, V289, P10748, DOI 10.1074/jbc.M113.528380; Lan T, 2011, MOL ENDOCRINOL, V25, P2094, DOI 10.1210/me.2011-0095; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Lee HT, 2012, AM J PHYSIOL-RENAL, V303, pF1216, DOI 10.1152/ajprenal.00220.2012; Li T, 2012, TOXICOL SCI, V128, P147, DOI 10.1093/toxsci/kfs141; Lochhead KM, 1998, KIDNEY INT, V54, P373, DOI 10.1046/j.1523-1755.1998.00022.x; Malik RK, 2000, PEDIATR NEPHROL, V15, P188; Malik RK, 2001, AM J PHYSIOL-RENAL, V281, pF56; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Manna SK, 2000, J INTERF CYTOK RES, V20, P725, DOI 10.1089/10799900050116435; Martinez-Abundis E, 2009, FEBS J, V276, P5579, DOI 10.1111/j.1742-4658.2009.07239.x; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Miller C, 2000, TOXICOL APPL PHARM, V162, P132, DOI 10.1006/taap.1999.8835; Mimeault M, 2003, INT J CANCER, V106, P116, DOI 10.1002/ijc.11171; Mitsutake S, 2001, J BIOL CHEM, V276, P26249, DOI 10.1074/jbc.M102233200; Monaco G, 2012, BIOCHEM BIOPH RES CO, V428, P31, DOI 10.1016/j.bbrc.2012.10.002; Nieto FL, 2008, J BIOL CHEM, V283, P25682, DOI 10.1074/jbc.M804437200; Niimura Y, 2010, GLYCOBIOLOGY, V20, P710, DOI 10.1093/glycob/cwq018; Oh HL, 2006, NEUROTOXICOLOGY, V27, P31, DOI 10.1016/j.neuro.2005.05.008; Park MA, 2009, MOL CANCER THER, V8, P1280, DOI 10.1158/1535-7163.MCT-09-0073; Park SW, 2012, KIDNEY INT, V82, P878, DOI 10.1038/ki.2012.224; Park SW, 2012, AM J PHYSIOL-RENAL, V303, pF721, DOI 10.1152/ajprenal.00157.2012; Park SW, 2011, KIDNEY INT, V80, P1315, DOI 10.1038/ki.2011.281; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Pautz A, 2002, KIDNEY INT, V61, P790, DOI 10.1046/j.1523-1755.2002.00222.x; Pfeilschifter J, 1998, KIDNEY INT, V54, pS34; Phillips DC, 2002, ARCH BIOCHEM BIOPHYS, V407, P15, DOI 10.1016/S0003-9861(02)00496-4; Pyszko J, 2014, MOL NEUROBIOL, V50, P38, DOI 10.1007/s12035-013-8622-4; Qiu LH, 2006, ONCOL REP, V16, P907; Ravid T, 2003, AM J PHYSIOL-LUNG C, V284, pL1082, DOI 10.1152/ajplung.00172.2002; Rutherford C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.455; Sawai H, 2004, BIOCHEM BIOPH RES CO, V319, P46, DOI 10.1016/j.bbrc.2004.04.152; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Serlachius E, 1997, KIDNEY INT, V52, P901, DOI 10.1038/ki.1997.411; Sheng G, 2007, AM J PHYSIOL-GASTR L, V293, pG599, DOI 10.1152/ajpgi.00182.2007; Subathra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023644; ter Braak M, 2009, BBA-MOL CELL BIOL L, V1791, P357, DOI 10.1016/j.bbalip.2009.01.019; Tomassini B, 2002, BIOCHIMIE, V84, P123, DOI 10.1016/S0300-9084(02)01377-9; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; Tsao CC, 2007, CELL CYCLE, V6, P2377; Ueda N, 1998, KIDNEY INT, V54, P399, DOI 10.1046/j.1523-1755.1998.00008.x; Ueda N, 2001, J AM SOC NEPHROL, V12, P2384; Ueda Y, 2013, FASEB J, V27, P3284, DOI 10.1096/fj.12-226548; Wang MR, 2012, EXP DIABETES RES, DOI 10.1155/2012/647914; Wang SX, 2013, AM J PHYSIOL-RENAL, V305, pF1085, DOI 10.1152/ajprenal.00399.2013; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Yabu T, 2015, CELL DEATH DIFFER, V22, P258, DOI 10.1038/cdd.2014.128; Yang DP, 2013, AM J NEPHROL, V37, P264, DOI 10.1159/000348526; Zager RA, 1998, KIDNEY INT, V53, P573, DOI 10.1046/j.1523-1755.1998.00772.x; Zager RA, 1998, J AM SOC NEPHROL, V9, P1670; Zager RA, 1997, KIDNEY INT, V52, P60, DOI 10.1038/ki.1997.304; Zhao S, 2002, EXP CELL RES, V279, P354, DOI 10.1006/excr.2002.5622; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006	226	0	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2015	16	3					5076	5124		10.3390/ijms16035076		49	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CG0KM	WOS:000352955500043		
J	Fujita, Y; Kuwano, K; Ochiya, T				Fujita, Yu; Kuwano, Kazuyoshi; Ochiya, Takahiro			Development of Small RNA Delivery Systems for Lung Cancer Therapy	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							SMALL INTERFERING RNA; RESPIRATORY SYNCYTIAL VIRUS; DOUBLE-STRANDED-RNA; IN-VIVO; SIRNA DELIVERY; MEDIATED DELIVERY; TUMOR-GROWTH; FUTURE-PROSPECTS; MAMMALIAN-CELLS; DOWN-REGULATION	RNA interference (RNAi) has emerged as a powerful tool for studying target identification and holds promise for the development of therapeutic gene silencing. Recent advances in RNAi delivery and target selection provide remarkable opportunities for translational medical research. The induction of RNAi relies on small silencing RNAs, which affect specific messenger RNA (mRNA) degradation. Two types of small RNA molecules, small interfering RNAs (siRNAs) and microRNAs (miRNAs), have a central function in RNAi technology. The success of RNAi-based therapeutic delivery may be dependent upon uncovering a delivery route, sophisticated delivery carriers, and nucleic acid modifications. Lung cancer is still the leading cause of cancer death worldwide, for which novel therapeutic strategies are critically needed. Recently, we have reported a novel platform (PnkRNA (TM) and nkRNA((R))) to promote naked RNAi approaches through inhalation without delivery vehicles in lung cancer xenograft models. We suggest that a new class of RNAi therapeutic agent and local drug delivery system could also offer a promising RNAi-based strategy for clinical applications in cancer therapy. In this article, we show recent strategies for an RNAi delivery system and suggest the possible clinical usefulness of RNAi-based therapeutics for lung cancer treatment.	[Fujita, Yu; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo 1040045, Japan; [Fujita, Yu; Kuwano, Kazuyoshi] Jikei Univ, Sch Med, Dept Internal Med, Div Resp Dis, Tokyo 1058461, Japan	Ochiya, T (reprint author), Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo 1040045, Japan.	yufujit2@ncc.go.jp; kkuwano@jikei.ac.jp; tochiya@ncc.go.jp		Fujita, Yu/0000-0002-8916-7303	Foundation for Promotion of Cancer Research (Japan); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio)	We thank Tadaaki Ohgi for his excellent support of drawing the Figure 1. This work was supported, in part, by a grant-in-aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control of Japan including Awardee of Research Resident Fellowship from the Foundation for Promotion of Cancer Research (Japan); the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio).	Dong AQ, 2007, CELL BIOL INT, V31, P500, DOI 10.1016/j.cellbi.2006.11.017; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Honma K, 2008, NAT MED, V14, P939, DOI 10.1038/nm.1858; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Hong SH, 2012, INT J NANOMED, V7, P2293, DOI 10.2147/IJN.S29152; Wu Y, 2011, MOL PHARMACEUT, V8, P1381, DOI 10.1021/mp2002076; Yu HJ, 2013, BIOMATERIALS, V34, P2738, DOI 10.1016/j.biomaterials.2012.12.042; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759; Conde J, 2013, BIOMATERIALS, V34, P7744, DOI 10.1016/j.biomaterials.2013.06.041; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Fehring V, 2014, MOL THER, V22, P811, DOI 10.1038/mt.2013.291; Han JF, 2014, SMALL, V10, P524, DOI 10.1002/smll.201301992; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Li J, 2012, J CONTROL RELEASE, V158, P108, DOI 10.1016/j.jconrel.2011.10.020; Bouchie A, 2012, NAT BIOTECHNOL, V30, P1154, DOI 10.1038/nbt1212-1154; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Das J, 2014, TOXICOL LETT, V225, P454, DOI 10.1016/j.toxlet.2014.01.009; Wang CM, 2011, BIOCHEM BIOPH RES CO, V410, P537, DOI 10.1016/j.bbrc.2011.06.019; Thomas M, 2007, ADV DRUG DELIVER REV, V59, P124, DOI 10.1016/j.addr.2007.03.003; Cortez MA, 2014, MOL THER, V22, P1494, DOI 10.1038/mt.2014.79; Whitmore M, 1999, GENE THER, V6, P1867, DOI 10.1038/sj.gt.3301026; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Tian HW, 2012, J BIOMED NANOTECHNOL, V8, P633, DOI 10.1166/jbn.2012.1419; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Ahn CH, 2004, J CONTROL RELEASE, V97, P567, DOI 10.1016/j.jconrel.2004.04.002; Taratula O, 2011, J DRUG TARGET, V19, P900, DOI 10.3109/1061186X.2011.622404; Gu XQ, 2013, INT J MED SCI, V10, P870, DOI 10.7150/ijms.5727; Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Chiou GY, 2012, J CONTROL RELEASE, V159, P240, DOI 10.1016/j.jconrel.2012.01.014; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Bonnet ME, 2013, J CONTROL RELEASE, V170, P183, DOI 10.1016/j.jconrel.2013.05.015; Dehousse V, 2010, BIOMATERIALS, V31, P1839, DOI 10.1016/j.biomaterials.2009.11.028; Jiang HL, 2011, INT J PHARMACEUT, V420, P256, DOI 10.1016/j.ijpharm.2011.08.045; Yang Y, 2012, MOL THER, V20, P609, DOI 10.1038/mt.2011.270; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; He XY, 2010, J CANCER RES CLIN, V136, P1023, DOI 10.1007/s00432-009-0747-5; Okuda T, 2013, BIOL PHARM BULL, V36, P1183; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Shim G, 2013, MOL THER, V21, P816, DOI 10.1038/mt.2013.10; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Zhang Y, 2013, MOL THER, V21, P1559, DOI 10.1038/mt.2013.120; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Bramson JL, 2000, CANCER GENE THER, V7, P353, DOI 10.1038/sj.cgt.7700143; Burchard J, 2009, RNA, V15, P308, DOI 10.1261/rna.1326809; Check E, 2005, NAT MED, V11, P243, DOI 10.1038/nm0305-243; De Veer MJ, 2005, IMMUNOL CELL BIOL, V83, P224, DOI 10.1111/j.1440-1711.2005.01337.x; Fernandez CA, 2009, MOL PHARMACEUT, V6, P1277, DOI 10.1021/mp900033j; Fortunato O., 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/75697525580438, DOI 10.1155/2014/75697525580438]; Fujita Yu, 2013, Pharmaceuticals (Basel), V6, P223, DOI 10.3390/ph6020223; Fujita Y, 2015, ONCOTARGET, V6, P3335; Fujita Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03325; Hama S, 2012, CANCER GENE THER, V19, P553, DOI 10.1038/cgt.2012.31; Hamasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042655; Hong SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077121; Kedinger V, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-338; Li YJ, 2012, ONCOL REP, V27, P129, DOI 10.3892/or.2011.1466; Lian YX, 2012, GENE, V511, P169, DOI 10.1016/j.gene.2012.09.079; Liu Y, 2012, J CANCER RES CLIN, V138, P1329, DOI 10.1007/s00432-012-1206-2; Mainelis G., 2013, J AEROSOL MED PULM D, V26, P345, DOI DOI 10.1089/JAMP.2011-0966; Merkel OM, 2014, ADV DRUG DELIVER REV, V75, P112, DOI 10.1016/j.addr.2014.05.018; Misso G, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.47; Turrisi AT, 2002, EUR J CANCER, V38, P279, DOI 10.1016/S0959-8049(01)00364-1; Wang XM, 2012, ASIAN PAC J CANCER P, V13, P1043, DOI 10.7314/APJCP.2012.13.3.1043; Wu Y, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.14; Xia L, 2013, BIOMED RES INT, DOI 10.1155/2013/957913	86	7	7	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2015	16	3					5254	5270		10.3390/ijms16035254		17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CG0KM	WOS:000352955500051		
J	Takahashi, K; Shiraishi, N; Ishiko-Uzuka, R; Anada, T; Suzuki, O; Masumoto, H; Sasaki, K				Takahashi, Kenta; Shiraishi, Naru; Ishiko-Uzuka, Risa; Anada, Takahisa; Suzuki, Osamu; Masumoto, Hiroshi; Sasaki, Keiichi			Biomechanical Evaluation of Ti-Nb-Sn Alloy Implants with a Low Young's Modulus	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article							CALCIUM-PHOSPHATE; BONE INTEGRATION; IN-VIVO; TITANIUM; COMPLICATIONS; INTERFACES	Dental implants are widely used and are a predictable treatment in various edentulous cases. Occlusal overload may be causally related to implant bone loss and a loss of integration. Stress concentrations may be diminished using a mechanobiologically integrated implant with bone tissue. The purpose of this study was to investigate the biomechanical behavior, biocompatibility and bioactivity of a Ti-Nb-Sn alloy as a dental implant material. It was compared with cpTi. Cell proliferation and alkaline phosphatase (ALP) activity were quantified. To assess the degree of osseointegration, a push-in test was carried out. Cell proliferation and ALP activity in the cells grown on prepared surfaces were similar for the Ti-Nb-Sn alloy and for cpTi in all the experiments. A comparison between the Ti-Nb-Sn alloy implant and the cpTi implant revealed that no significant difference was apparent for the push-in test values. These results suggest that implants fabricated using Ti-Nb-Sn have a similar biological potential as cpTi and are capable of excellent osseointegration.	[Takahashi, Kenta; Shiraishi, Naru; Ishiko-Uzuka, Risa; Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Shiraishi, Naru] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Community Oral Hlth Sci,Aoba Ku, Sendai, Miyagi 9808573, Japan; [Anada, Takahisa; Suzuki, Osamu] Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Masumoto, Hiroshi] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Shiraishi, N (reprint author), Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808577, Japan.	kenta@dent.tohoku.ac.jp; nshiraishi@dent.tohoku.ac.jp; uzuka@dent.tohoku.ac.jp; anada@m.tohoku.ac.jp; suzuki-o@m.tohoku.ac.jp; hiromasu@fris.tohoku.ac.jp; keii@dent.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25861822]	This work was supported by a Grant-in-Aid for scientific research (No. 25861822) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors are grateful to Hanada, Shuji (Institute for Materials Research, Tohoku University) for providing Ti-Nb-Sn alloy as test samples in this study.	Ogawa T, 2000, J DENT RES, V79, P1857; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x; Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008; Duyck J, 2001, CLIN ORAL IMPLAN RES, V12, P207, DOI 10.1034/j.1600-0501.2001.012003207.x; Heitz-Mayfield LJA, 2014, INT J ORAL MAX IMPL, V29, P346, DOI 10.11607/jomi.2013.g5; Takeuchi M, 2005, J PHYS CHEM B, V109, P7387, DOI 10.1021/jp040630d; Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070; Wazen RM, 2013, ACTA BIOMATER, V9, P6663, DOI 10.1016/j.actbio.2013.01.014; Ogawa T, 2008, J DENT RES, V87, P751; Skerry TM, 2008, ARCH BIOCHEM BIOPHYS, V473, P117, DOI 10.1016/j.abb.2008.02.028; Brett PM, 2004, BONE, V35, P124, DOI 10.1016/j.bone.2004.03.009; Isidor F, 2006, CLIN ORAL IMPLAN RES, V17, P8, DOI 10.1111/j.1600-0501.2006.01360.x; Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032; Hanada S., 2005, INT C SERIES, V1284, P239, DOI 10.1016/j.ics.2005.06.084; Hori N, 2009, J DENT RES, V88, P663, DOI 10.1177/0022034509339567; Kelly D. J., 2006, ANNU REV BIOMED ENG, V8, P455, DOI [10.1146/annurev.bioeng.8.061505.09572116834564, DOI 10.1146/ANNUREV.BIOENG.8.061505.095721]; Niinomi M., 2011, International Journal of Biomaterials, DOI 10.1155/2011/836587; Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25; Salvi GE, 2014, INT J ORAL MAX IMPL, V29, P292, DOI 10.11607/jomi.2014suppl.g5.1; Seong WJ, 2013, CLIN IMPLANT DENT R, V15, P460, DOI 10.1111/j.1708-8208.2011.00357.x; Shigemitsu R, 2013, ODONTOLOGY, V101, P222, DOI 10.1007/s10266-012-0077-y; Shiraishi N, 2012, MATER TRANS, V53, P1343, DOI [10.2320/matertrans.M2012075, 10.2320/matertrans.M2012078]; Tamai M, 2007, J ARTIF ORGANS, V10, P22, DOI 10.1007/s10047-006-0363-y; Zheng T. F., 2006, MAT SCI ENG A-STRUCT, V438-440, P891, DOI [10.1016/j.msea.2006.01.131, DOI 10.1016/J.MSEA.2006.01.131]	24	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2015	16	3					5779	5788		10.3390/ijms16035779		10	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CG0KQ	WOS:000352955900004		
J	Kitamura, A; Nagata, K; Kinjo, M				Kitamura, Akira; Nagata, Kazuhiro; Kinjo, Masataka			Conformational Analysis of Misfolded Protein Aggregation by FRET and Live-Cell Imaging Techniques	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; RESONANCE ENERGY-TRANSFER; CROSS-CORRELATION SPECTROSCOPY; FLUORESCENCE CORRELATION SPECTROSCOPY; UBIQUITIN PROTEASOME SYSTEM; NEURODEGENERATIVE DISEASES; LIVING CELLS; CASPASE-3 ACTIVATION; PROTEOTOXIC STRESS; MUTANT SOD1	Cellular homeostasis is maintained by several types of protein machinery, including molecular chaperones and proteolysis systems. Dysregulation of the proteome disrupts homeostasis in cells, tissues, and the organism as a whole, and has been hypothesized to cause neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and Huntington's disease (HD). A hallmark of neurodegenerative disorders is formation of ubiquitin-positive inclusion bodies in neurons, suggesting that the aggregation process of misfolded proteins changes during disease progression. Hence, high-throughput determination of soluble oligomers during the aggregation process, as well as the conformation of sequestered proteins in inclusion bodies, is essential for elucidation of physiological regulation mechanism and drug discovery in this field. To elucidate the interaction, accumulation, and conformation of aggregation-prone proteins, in situ spectroscopic imaging techniques, such as Forster/fluorescence resonance energy transfer (FRET), fluorescence correlation spectroscopy (FCS), and bimolecular fluorescence complementation (BiFC) have been employed. Here, we summarize recent reports in which these techniques were applied to the analysis of aggregation-prone proteins (in particular their dimerization, interactions, and conformational changes), and describe several fluorescent indicators used for real-time observation of physiological states related to proteostasis.	[Kitamura, Akira; Kinjo, Masataka] Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido 0010021, Japan; [Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 6038555, Japan	Kitamura, A (reprint author), Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido 0010021, Japan.	akita@sci.hokudai.ac.jp; nagata@cc.kyoto-su.ac.jp; kinjo@sci.hokudai.ac.jp			Japan Society for Promotion of Science (JSPS) [26440090]; Japan Science and Technology Agency (JST); JSPS [24227009]; JST	Akira Kitamura was supported by a Japan Society for Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) (26440090), and by a grant for Development of Systems and Technologies for Advanced Measurement and Analysis from the Japan Science and Technology Agency (JST). Kazuhiro Nagata was supported by a JSPS Grant-in-Aid for Scientific Research (S) (24227009), and by a grant to create revolutionary technological seeds for science and technology innovation (CREST) from JST.	Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Zhai SY, 2013, SCIENCE, V342, P1107, DOI 10.1126/science.1245622; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Latonen L, 2011, BIOESSAYS, V33, P386, DOI 10.1002/bies.201100008; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Nagai T, 2004, BIOCHEM BIOPH RES CO, V319, P72, DOI 10.1016/j.bbrc.2004.04.147; Luo KQ, 2001, BIOCHEM BIOPH RES CO, V283, P1054, DOI 10.1006/bbrc.2001.4896; Munishkina LA, 2007, BBA-BIOMEMBRANES, V1768, P1862, DOI 10.1016/j.bbamem.2007.03.015; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; Ong DST, 2010, NAT CHEM BIOL, V6, P424, DOI 10.1038/nchembio.368; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Wu C, 2009, J MOL BIOL, V394, P627, DOI 10.1016/j.jmb.2009.09.056; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Vukojevic V, 2010, P NATL ACAD SCI USA, V107, P4093, DOI 10.1073/pnas.0914612107; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Bartoszewska M, 2012, J BIOL CHEM, V287, P27380, DOI 10.1074/jbc.M112.381566; Whitaker M, 2010, METHOD CELL BIOL, V99, P153, DOI [10.1016/B978-0-12-374841-6.00006-2, 10.1016/S0091-679X(10)99006-7]; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Ganesan S, 2008, CELL DEATH DIFFER, V15, P312, DOI 10.1038/sj.cdd.4402262; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472; Shibata Y, 2014, CURR BIOL, V24, pR463, DOI 10.1016/j.cub.2014.03.033; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI [10.1016/j.tcb.2009.12.003, 10.1016/i.tcb.2009.12.003]; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/nmeth.1317, 10.1038/NMETH.1317]; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Erard M, 2013, MOL BIOSYST, V9, P258, DOI 10.1039/c2mb25303h; Weisberg SJ, 2012, P NATL ACAD SCI USA, V109, P15811, DOI 10.1073/pnas.1205829109; Tashiro E, 2013, J BIOL CHEM, V288, P19958, DOI 10.1074/jbc.M113.477984; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; van Oosten-Hawle P, 2014, GENE DEV, V28, P1533, DOI 10.1101/gad.241125.114; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Inagi R, 2014, NAT REV NEPHROL, V10, P369, DOI 10.1038/nrneph.2014.67; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Kerppola TK, 2006, NAT METHODS, V3, P969, DOI 10.1038/nmeth1206-969; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Avezov E, 2015, BMC BIOL, V13, DOI 10.1186/s12915-014-0112-2; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/nmeth.1697, 10.1038/NMETH.1697]; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Kim J, 2014, J BIOL CHEM, V289, P15094, DOI 10.1074/jbc.M113.542613; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kitamura A, 2010, FEBS J, V277, P1369, DOI 10.1111/j.1742-4658.2010.07570.x; Kitamura A, 2014, GENES CELLS, V19, P209, DOI 10.1111/gtc.12125; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Mardones P, 2015, TRENDS CELL BIOL, V25, P1, DOI 10.1016/j.tcb.2014.08.001; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Miyawaki A, 2012, CURR OPIN STRUC BIOL, V22, P679, DOI 10.1016/j.sbi.2012.09.002; Ohta S, 2013, BIOCHEM BIOPH RES CO, V442, P28, DOI 10.1016/j.bbrc.2013.10.147; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169; Rothlein C, 2014, J BIOL CHEM, V289, P26817, DOI 10.1074/jbc.M114.581991; Sadaie W, 2014, MOL CELL BIOL, V34, P3272, DOI 10.1128/MCB.00087-14; Saito K, 2004, BIOCHEM BIOPH RES CO, V324, P849, DOI 10.1016/j.bbrc.2004.09.126; Simoes-Pires C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-7; Sugiura K, 2015, BIOCHEM BIOPH RES CO, V457, P242, DOI 10.1016/j.bbrc.2014.12.095; The Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Tiwari M, 2013, BIOCHEM BIOPH RES CO, V436, P430, DOI 10.1016/j.bbrc.2013.05.121; Tsunoda S, 2014, ELIFE, V3, DOI 10.7554/eLife.03421; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Watkins JL, 2013, ACTA CRYSTALLOGR D, V69, P767, DOI 10.1107/S0907444913001546; Wright GSA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2750; Yano T, 2010, MOL CELL BIOL, V30, P3758, DOI 10.1128/MCB.00121-10; Zempell H, 2014, TRENDS NEUROSCI, V37, P721, DOI 10.1016/j.tins.2014.08.004; Zheng C, 2014, NEURODEGENER DIS, V14, P161, DOI 10.1159/000367694	93	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2015	16	3					6076	6092		10.3390/ijms16036076		17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CG0KQ	WOS:000352955900019		
J	Shimizu, M; Shirakami, Y; Sakai, H; Kubota, M; Kochi, T; Ideta, T; Miyazaki, T; Moriwaki, H				Shimizu, Masahito; Shirakami, Yohei; Sakai, Hiroyasu; Kubota, Masaya; Kochi, Takahiro; Ideta, Takayasu; Miyazaki, Tsuneyuki; Moriwaki, Hisataka			Chemopreventive Potential of Green Tea Catechins in Hepatocellular Carcinoma	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							FATTY LIVER-DISEASE; GROWTH-FACTOR RECEPTOR; CHAIN AMINO-ACIDS; COLON-CANCER CELLS; (-)-EPIGALLOCATECHIN GALLATE SUPPRESSES; DIABETIC C57BL/KSJ-DB/DB MICE; PRENEOPLASTIC LESIONS; EPIGALLOCATECHIN GALLATE; POLYPHENON-E; INDUCED PROLIFERATION	Hepatocellular carcinoma (HCC), which is a common malignancy worldwide, usually develops in a cirrhotic liver due to hepatitis virus infection. Metabolic syndrome, which is frequently complicated by obesity and diabetes mellitus, is also a critical risk factor for liver carcinogenesis. Green tea catechins (GTCs) may possess potent anticancer and chemopreventive properties for a number of different malignancies, including liver cancer. Antioxidant and anti-inflammatory activities are key mechanisms through which GTCs prevent the development of neoplasms, and they also exert cancer chemopreventive effects by modulating several signaling transduction and metabolic pathways. Furthermore, GTCs are considered to be useful for the prevention of obesity- and metabolic syndrome-related carcinogenesis by improving metabolic disorders. Several interventional trials in humans have shown that GTCs may ameliorate metabolic abnormalities and prevent the development of precancerous lesions. The purpose of this article is to review the key mechanisms by which GTCs exert chemopreventive effects in liver carcinogenesis, focusing especially on their ability to inhibit receptor tyrosine kinases and improve metabolic abnormalities. We also review the evidence for GTCs acting to prevent metabolic syndrome-associated liver carcinogenesis.	[Shimizu, Masahito; Shirakami, Yohei; Sakai, Hiroyasu; Kubota, Masaya; Kochi, Takahiro; Ideta, Takayasu; Miyazaki, Tsuneyuki; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Med Gastroenterol, Gifu 5011194, Japan	Shimizu, M (reprint author), Gifu Univ, Grad Sch Med, Dept Med Gastroenterol, 1-1 Yanagido, Gifu 5011194, Japan.	shimim-gif@umin.ac.jp; shirakamiyy@yahoo.co.jp; sakaih03@gifu-u.ac.jp; kubota-gif@umin.ac.jp; kottii924@yahoo.co.jp; taka.mailbox.789@gmail.com; tsunemiyazaking@yahoo.co.jp; hmori@gifu-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [25460988]; Ministry of Health, Labor and Welfare of Japan; Takeda Science Foundation	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (No. 25460988), Grant-in-Aid for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan, and the Takeda Science Foundation.	Adachi S, 2008, CARCINOGENESIS, V29, P1986, DOI 10.1093/carcin/bgn128; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Kumada T, 1997, HEPATOLOGY, V25, P87, DOI 10.1002/hep.510250116; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; Li N, 1999, P SOC EXP BIOL MED, V220, P218, DOI 10.1046/j.1525-1373.1999.d01-37.x; Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135; Okita K, 2015, J GASTROENTEROL, V50, P667, DOI 10.1007/s00535-014-0996-1; Scharf JG, 2003, HORM METAB RES, V35, P685; Iwasa J, 2010, CANCER SCI, V101, P460, DOI 10.1111/j.1349-7006.2009.01402.x; Shimizu M, 2012, CURR CANCER DRUG TAR, V12, P1119; Ninomiya S, 2011, CANCER PREV RES, V4, P2092, DOI 10.1158/1940-6207.CAPR-11-0340; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Koda M, 2000, CANCER, V88, P529; Masterjohn C, 2012, NUTR REV, V70, P41, DOI 10.1111/j.1753-4887.2011.00440.x; Adachi S, 2007, CANCER RES, V67, P6493, DOI 10.1158/0008-5472.CAN-07-0411; Shimizu M, 2013, SEMIN IMMUNOPATHOL, V35, P191, DOI 10.1007/s00281-012-0336-6; Jimenez-Saenz M, 2006, J HEPATOL, V44, P616, DOI 10.1016/j.jhep.2005.11.041; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Tovar V, 2010, J HEPATOL, V52, P550, DOI 10.1016/j.jhep.2010.01.015; Shimizu M, 2005, CLIN CANCER RES, V11, P2735, DOI 10.1158/1078-0432.CCR-04-2014; Luo HT, 2006, CARCINOGENESIS, V27, P262, DOI 10.1093/carcin/bgi147; Larsson SC, 2007, BRIT J CANCER, V97, P1005; Chow HHS, 2003, CLIN CANCER RES, V9, P3312; Kuo PL, 2003, J BIOMED SCI, V10, P219, DOI 10.1159/000068711; Scharf JG, 2001, J CLIN PATHOL-MOL PA, V54, P138; Shimizu M, 2008, CANCER EPIDEM BIOMAR, V17, P3020, DOI 10.1158/1055-9965.EPI-08-0528; Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8; Suganuma M, 1999, CANCER RES, V59, P44; Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013; Clark J, 2006, MOL NUTR FOOD RES, V50, P144, DOI 10.1002/mnfr.200500135; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; IMAI K, 1995, BRIT MED J, V310, P693; Darvesh AS, 2013, NUTR CANCER, V65, P329, DOI 10.1080/01635581.2013.767367; McLarty J, 2009, CANCER PREV RES, V2, P673, DOI 10.1158/1940-6207.CAPR-08-0167; Shirakami Y, 2009, CANCER SCI, V100, P1957, DOI 10.1111/j.1349-7006.2009.01241.x; Yasuda Y, 2009, CHEM-BIOL INTERACT, V182, P159, DOI 10.1016/j.cbi.2009.07.015; Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53; Nishikawa T, 2006, J HEPATOL, V44, P1074, DOI 10.1016/j.jhep.2005.11.045; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Frezza EE, 2006, GUT, V55, P285, DOI 10.1136/gut.2005.073163; Moriwaki H, 2008, HEPATOL RES, V38, pS102, DOI 10.1111/j.1872-034X.2008.00434.x; Sakata R, 2004, J HEPATOL, V40, P52, DOI 10.1016/S0168-8278(03)00477-X; Parikh S, 2007, AM J MED, V120, P194, DOI 10.1016/j.amjmed.2006.11.020; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Sakata R, 2013, INT J MOL MED, V32, P989, DOI 10.3892/ijmm.2013.1503; Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7; Fujiki H, 2002, CANCER LETT, V188, P9, DOI 10.1016/S0304-3835(02)00379-8; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Lin SC, 2006, CANCER LETT, V236, P80, DOI 10.1016/j.canlet.2005.05.003; Shirakami Y, 2012, CURR DRUG TARGETS, V13, P1842; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Jin X, 2008, LIVER INT, V28, P990, DOI 10.1111/j.1478-3231.2008.01776.x; Kubota M, 2012, NUTR CANCER, V64, P72, DOI 10.1080/01635581.2012.630554; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Shimizu M, 2008, CANCER LETT, V262, P10, DOI 10.1016/j.canlet.2007.11.026; Shimizu M, 2011, CANCER PREV RES, V4, P396, DOI 10.1158/1940-6207.CAPR-10-0331; Berasain C, 2014, J GASTROENTEROL, V49, P9, DOI 10.1007/s00535-013-0907-x; Brick DJ, 2010, EUR J ENDOCRINOL, V163, P185, DOI 10.1530/EJE-10-0365; Enguita-Germán Mónica, 2014, World J Hepatol, V6, P716, DOI 10.4254/wjh.v6.i10.716; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Hirose M, 1997, CANCER LETT, V112, P141, DOI 10.1016/S0304-3835(96)04560-0; Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143; Imai K, 2010, HEPATOL RES, V40, P376, DOI 10.1111/j.1872-034X.2009.00616.x; Kochi T, 2014, CANCER LETT, V342, P60, DOI 10.1016/j.canlet.2013.08.031; NISHIDA H, 1994, JPN J CANCER RES, V85, P221; Okita K, 2015, J GASTROENTEROL, V50, P191, DOI 10.1007/s00535-014-0956-9; Shimizu M, 2009, CANCER SCI, V100, P369, DOI 10.1111/j.1349-7006.2008.01045.x; Shimizu M, 2012, INT J MOL SCI, V13, P579, DOI 10.3390/ijms13010579; Shimizu M, 2014, MOL NUTR FOOD RES, V58, P124, DOI 10.1002/mnfr.201300538; Shimizu M, 2011, CANCER PREV RES, V4, P128, DOI 10.1158/1940-6207.CAPR-10-0163; Shimizu M, 2008, CANCER PREV RES, V1, P298, DOI 10.1158/1940-6207.CAPR-08-0045; Shimizu M, 2009, CLIN CANCER RES, V15, P3068, DOI 10.1158/1078-0432.CCR-08-2093; Shimizu M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-281; Shirakami Y, 2014, WORLD J GASTROENTERO, V20, P8939, DOI 10.3748/wjg.v20.i27.8939; Sumi T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-690; Tamura K, 1997, JPN J CANCER RES, V88, P356; Terakura D, 2012, CARCINOGENESIS, V33, P2499, DOI 10.1093/carcin/bgs303; Teschke R, 2014, EXPERT OPIN DRUG MET, V10, P1663, DOI 10.1517/17425255.2014.971011; Tornesello ML, 2013, GENOMICS, V102, P74, DOI 10.1016/j.ygeno.2013.04.001; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Watanabe N, 2011, J CLIN BIOCHEM NUTR, V49, P153, DOI 10.3164/jcbn.10-149	86	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2015	16	3					6124	6139		10.3390/ijms16036124		16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CG0KQ	WOS:000352955900022		
J	Kaneto, H; Matsuoka, T				Kaneto, Hideaki; Matsuoka, Taka-aki			Role of Pancreatic Transcription Factors in Maintenance of Mature beta-Cell Function	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							INSULIN GENE-TRANSCRIPTION; TYPE-2 DIABETES-MELLITUS; OXIDATIVE STRESS; GLUCOSE TOXICITY; ISLET CELLS; HOMEOBOX FACTOR; HIT-T15 CELLS; FACTOR PDX-1; FACTOR-I; MEDIATED SUPPRESSION	A variety of pancreatic transcription factors including PDX-1 and MafA play crucial roles in the pancreas and function for the maintenance of mature beta-cell function. However, when beta-cells are chronically exposed to hyperglycemia, expression and/or activities of such transcription factors are reduced, which leads to deterioration of beta-cell function. These phenomena are well known as beta-cell glucose toxicity in practical medicine as well as in the islet biology research area. Here we describe the possible mechanism for beta-cell glucose toxicity found in type 2 diabetes. It is likely that reduced expression levels of PDX-1 and MafA lead to suppression of insulin biosynthesis and secretion. In addition, expression levels of incretin receptors (GLP-1 and GIP receptors) in beta-cells are decreased, which likely contributes to the impaired incretin effects found in diabetes. Taken together, down-regulation of insulin gene transcription factors and incretin receptors explains, at least in part, the molecular mechanism for beta-cell glucose toxicity.	[Kaneto, Hideaki] Kawasaki Med Univ, Dept Diabet Endocrinol & Metab, Kurashiki, Okayama 7010192, Japan; [Matsuoka, Taka-aki] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan	Kaneto, H (reprint author), Kawasaki Med Univ, Dept Diabet Endocrinol & Metab, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	kaneto@med.kawasaki-m.ac.jp; matsuoka@endmet.med.osaka-u.ac.jp					Moran A, 1997, J CLIN INVEST, V99, P534, DOI 10.1172/JCI119190; Sussel L, 1998, DEVELOPMENT, V125, P2213; Miyatsuka T, 2003, BIOCHEM BIOPH RES CO, V310, P1017, DOI 10.1016/j.bbrc.2003.09.108; Pedersen JK, 2005, DEV BIOL, V288, P487, DOI 10.1016/j.ydbio.2005.10.001; Fujitani Y, 1999, MOL CELL BIOL, V19, P8281; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Kaneto H, 2005, J MOL MED-JMM, V83, P429, DOI 10.1007/s00109-005-0640-x; Apelqvist A, 1999, NATURE, V400, P877; Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2; OHLSSON H, 1993, EMBO J, V12, P4251; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Smith SB, 1999, MOL CELL BIOL, V19, P8272; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JC130706; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; GUZ Y, 1995, DEVELOPMENT, V121, P11; Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Li H, 1999, NAT GENET, V23, P67; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Taniguchi H, 2003, GENE THER, V10, P15, DOI 10.1038/sj.gt.3301846; Kawashima S, 2011, BIOCHEM BIOPH RES CO, V404, P534, DOI 10.1016/j.bbrc.2010.12.021; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Kojima H, 2002, DIABETES, V51, P1398, DOI 10.2337/diabetes.51.5.1398; Matsuoka T, 1997, J CLIN INVEST, V99, P144, DOI 10.1172/JCI119126; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Stoffers DA, 1999, ENDOCRINOLOGY, V140, P5374, DOI 10.1210/en.140.11.5374; Offield MF, 1996, DEVELOPMENT, V122, P983; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Harrison KA, 1999, NAT GENET, V23, P71; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Takamoto I, 2014, DIABETOLOGIA, V57, P542, DOI 10.1007/s00125-013-3131-6; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kaneto H, 2005, DIABETES, V54, P1009, DOI 10.2337/diabetes.54.4.1009; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Melloul D, 2004, ANN NY ACAD SCI, V1014, P28, DOI 10.1196/annals.1294.003; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; NOSE K, 1991, EUR J BIOCHEM, V201, P99, DOI 10.1111/j.1432-1033.1991.tb16261.x; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Dutta S, 1998, NATURE, V392, P560, DOI 10.1038/33311; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Noguchi H, 2003, DIABETES, V52, P1732, DOI 10.2337/diabetes.52.7.1732; Gorogawa S, 2002, DIABETES RES CLIN PR, V57, P1, DOI 10.1016/S0168-8227(02)00005-0; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Kaneto H, 2001, J BIOL CHEM, V276, P31099, DOI 10.1074/jbc.M104115200; Clocquet AR, 2000, DIABETES, V49, P1856, DOI 10.2337/diabetes.49.11.1856; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Kaneto H, 1996, BIOCHEM J, V320, P855; Noguchi H, 2005, DIABETES, V54, P2859, DOI 10.2337/diabetes.54.10.2859; Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478; Sander M, 2000, DEVELOPMENT, V127, P5533; Poitout V, 1996, J CLIN INVEST, V97, P1041, DOI 10.1172/JCI118496; Stoffers DA, 1997, NAT GENET, V17, P138; Yoshida S, 2002, DIABETES, V51, P2505, DOI 10.2337/diabetes.51.8.2505; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Villareal DT, 2010, DIABETES, V59, P479, DOI 10.2337/db09-1169; Brissova M., 2002, J BIOL CHEM, p[277, 1125], DOI 10.1074/jbc.M111272200; Cao LZ, 2004, DIABETES, V53, P3168, DOI 10.2337/diabetes.53.12.3168; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804; Dominguez-Bendala J, 2005, DIABETES, V54, P720, DOI 10.2337/diabetes.54.3.720; GERMAN MS, 1994, MOL CELL BIOL, V14, P4067; Heller RS, 2001, DIABETES, V50, P1553, DOI 10.2337/diabetes.50.7.1553; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; HENDERSON E, 1994, MOL CELL BIOL, V14, P655; Imai J, 2005, BIOCHEM BIOPH RES CO, V326, P402, DOI 10.1016/j.bbrc.2004.11.047; INAGAKI N, 1992, P NATL ACAD SCI USA, V89, P1045, DOI 10.1073/pnas.89.3.1045; Jonsson J., 1993, NATURE, V37, P606; Kajimoto Y, 1999, DIABETOLOGIA, V42, P1417, DOI 10.1007/s001250051313; Kaneto H, 1997, J BIOL CHEM, V272, P29137, DOI 10.1074/jbc.272.46.29137; Kang ZF, 2013, DIABETOLOGIA, V56, P423, DOI 10.1007/s00125-012-2776-x; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; LEONARD J, 1993, MOL ENDOCRINOL, V7, P1275, DOI 10.1210/me.7.10.1275; Macfarlane WM, 1999, J CLIN INVEST, V104, pR33, DOI 10.1172/JCI7449; MILLER CP, 1994, EMBO J, V13, P1145; Mitchell RK, 2015, HUM MOL GENET, V24, P1390, DOI 10.1093/hmg/ddu553; Naya F. J., 1997, GENE DEV, V11, P323, DOI [10.1101/gad.11.18.2323, DOI 10.1101/GAD.11.18.2323]; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; SHARMA A, 1994, MOL CELL BIOL, V14, P871; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1468, DOI 10.1210/me.9.11.1468; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Watada H, 2004, ENDOCR J, V51, P255, DOI 10.1507/endocrj.51.255; Weng J, 2001, DIABETOLOGIA, V44, P249, DOI 10.1007/s001250051608	116	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2015	16	3					6281	6297		10.3390/ijms16036281		17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CG0KQ	WOS:000352955900031		
J	Terasaka, N; Iwane, Y; Geiermann, AS; Goto, Y; Suga, H				Terasaka, Naohiro; Iwane, Yoshihiko; Geiermann, Anna-Skrollan; Goto, Yuki; Suga, Hiroaki			Recent Developments of Engineered Translational Machineries for the Incorporation of Non-Canonical Amino Acids into Polypeptides	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							PEPTIDE-BOND FORMATION; 23S RIBOSOMAL-RNA; ELONGATION-FACTOR TU; GENETIC-CODE EXPANSION; INITIATOR TRANSFER-RNA; IN-VITRO SELECTION; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; MACROCYCLIC PEPTIDES; STRUCTURAL BASIS	Genetic code expansion and reprogramming methodologies allow us to incorporate non-canonical amino acids (ncAAs) bearing various functional groups, such as fluorescent groups, bioorthogonal functional groups, and post-translational modifications, into a desired position or multiple positions in polypeptides both in vitro and in vivo. In order to efficiently incorporate a wide range of ncAAs, several methodologies have been developed, such as orthogonal aminoacyl-tRNA-synthetase (AARS)-tRNA pairs, aminoacylation ribozymes, frame-shift suppression of quadruplet codons, and engineered ribosomes. More recently, it has been reported that an engineered translation system specifically utilizes an artificially built genetic code and functions orthogonally to naturally occurring counterpart. In this review we summarize recent advances in the field of ribosomal polypeptide synthesis containing ncAAs.	[Terasaka, Naohiro; Iwane, Yoshihiko; Geiermann, Anna-Skrollan; Goto, Yuki; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Suga, Hiroaki] Univ Tokyo, Core Res Evolut Sci & Technol, Japan Sci & Technol Agcy, Bunkyo Ku, Tokyo 1130033, Japan	Suga, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	n_terasaka@chem.s.u-tokyo.ac.jp; iwane@chem.s.u-tokyo.ac.jp; geiermann@chem.s.u-tokyo.ac.jp; y-goto@chem.s.u-tokyo.ac.jp; hsuga@chem.s.u-tokyo.ac.jp			Japan Science and Technology Agency (JST); Life Science Research Fund of Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) [24-8188, 26-9576, 25-03730]; Core Research for Evolutional Science and Technology (CREST) of Molecular Technology and Platform for Drug Discovery, Informatics, and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported by the Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST) of Molecular Technology and Platform for Drug Discovery, Informatics, and Structural Life Science from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and the Life Science Research Fund of Takeda Science Foundation to Hiroaki Suga, Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Fellows to Naohiro Terasaka (24-8188), Yoshihiko Iwane (26-9576) and Anna-Skrollan Geiermann (25-03730).	Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004; ZINONI F, 1987, P NATL ACAD SCI USA, V84, P3156, DOI 10.1073/pnas.84.10.3156; Goto Y, 2009, J AM CHEM SOC, V131, P5040, DOI 10.1021/ja900597d; Ibba M, 2000, TRENDS BIOCHEM SCI, V25, P311, DOI 10.1016/S0968-0004(00)01600-5; Ieong KW, 2012, J AM CHEM SOC, V134, P17955, DOI 10.1021/ja3063524; Niwa N, 2009, BIOORG MED CHEM LETT, V19, P3892, DOI 10.1016/j.bmcl.2009.03.114; Buechter DD, 2003, J BIOL CHEM, V278, P645, DOI 10.1074/jbc.M209364200; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Ivanova NN, 2014, SCIENCE, V344, P909, DOI 10.1126/science.1250691; Dedkova LM, 2012, BIOCHEMISTRY-US, V51, P401, DOI 10.1021/bi2016124; Saito H, 2001, EMBO J, V20, P1797, DOI 10.1093/emboj/20.7.1797; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lodder M, 2005, METHODS, V36, P245, DOI 10.1016/j.ymeth.2005.04.002; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Kawakami T, 2013, J AM CHEM SOC, V135, P12297, DOI 10.1021/ja405044k; Mukai T, 2011, BIOCHEM BIOPH RES CO, V411, P757, DOI 10.1016/j.bbrc.2011.07.020; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Kawakami T, 2009, NAT CHEM BIOL, V5, P888, DOI 10.1038/nchembio.259; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Xiao H, 2008, NATURE, V454, P358, DOI 10.1038/nature07033; Kawakami T, 2008, J AM CHEM SOC, V130, P16861, DOI 10.1021/ja806998v; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Yamagishi Y, 2011, CHEM BIOL, V18, P1562, DOI 10.1016/j.chembiol.2011.09.013; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Aldag C, 2013, ANGEW CHEM INT EDIT, V52, P1441, DOI 10.1002/anie.201207567; KOZAK M, 1983, MICROBIOL REV, V47, P1; Zhou XL, 2011, NUCLEIC ACIDS RES, V39, P8857, DOI 10.1093/nar/gkr595; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Ishizawa T, 2013, J AM CHEM SOC, V135, P5433, DOI 10.1021/ja312579u; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Lee S, 2013, ANGEW CHEM INT EDIT, V52, P5771, DOI 10.1002/anie.201300531; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Spurio R, 2000, J BIOL CHEM, V275, P2447, DOI 10.1074/jbc.275.4.2447; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Dedkova LM, 2003, J AM CHEM SOC, V125, P6616, DOI 10.1021/ja035141q; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; Terasaka N, 2014, NAT CHEM BIOL, V10, P555, DOI [10.1038/nchembio.1549, 10.1038/NCHEMBIO.1549]; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Ieong KW, 2014, RNA, V20, P632, DOI 10.1261/rna.042234.113; Fujino T, 2013, J AM CHEM SOC, V135, P1830, DOI 10.1021/ja309570x; Hipolito CJ, 2012, CURR OPIN CHEM BIOL, V16, P196, DOI 10.1016/j.cbpa.2012.02.014; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; Wan W, 2010, ANGEW CHEM INT EDIT, V49, P3211, DOI 10.1002/anie.201000465; RYDEN SM, 1984, MOL GEN GENET, V193, P38, DOI 10.1007/BF00327411; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; MACINO G, 1979, P NATL ACAD SCI USA, V76, P3784, DOI 10.1073/pnas.76.8.3784; Goto Y, 2008, ACS CHEM BIOL, V3, P120, DOI [10.1021/cb700233t, 10.1021/c6700233t]; Murakami H, 2003, CHEM BIOL, V10, P1077, DOI 10.1016/j.chembiol.2003.10.010; Kawakami T, 2008, CHEM BIOL, V15, P32, DOI 10.1016/j.chembiol.2007.12.008; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Forster AC, 2003, P NATL ACAD SCI USA, V100, P6353, DOI 10.1073/pnas.1132122100; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Magliery TJ, 2001, J MOL BIOL, V307, P755, DOI 10.1006/jmbi.2001.4518; Morimoto J, 2012, ANGEW CHEM INT EDIT, V51, P3423, DOI 10.1002/anie.201108118; Hohsaka T, 1996, J AM CHEM SOC, V118, P9778, DOI 10.1021/ja9614225; Maini R, 2013, BIOORGAN MED CHEM, V21, P1088, DOI 10.1016/j.bmc.2013.01.002; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; HECHT SM, 1978, J BIOL CHEM, V253, P4517; CAVARELLI J, 1993, FASEB J, V7, P79; CHATTAPADHYAY R, 1990, BIOCHEMISTRY-US, V29, P4263, DOI 10.1021/bi00470a001; Chen XH, 2014, ACS CHEM BIOL, V9, P1956, DOI 10.1021/cb500453a; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; FAHNESTO.S, 1971, SCIENCE, V173, P340, DOI 10.1126/science.173.3994.340; Forster AC, 2001, ANAL BIOCHEM, V297, P60, DOI 10.1006/abio.2001.5329; Gaston MA, 2011, CURR OPIN MICROBIOL, V14, P342, DOI 10.1016/j.mib.2011.04.001; Goto Y, 2008, RNA, V14, P1390, DOI 10.1261/rna.1020708; Goto Y, 2013, ACS CHEM BIOL, V8, P2630, DOI 10.1021/cb400549p; Green R, 1998, SCIENCE, V280, P286, DOI 10.1126/science.280.5361.286; HANSEN PK, 1986, BIOCHIMIE, V68, P697, DOI 10.1016/S0300-9084(86)80163-8; Hipolito CJ, 2014, CURR OPIN STRUC BIOL, V26, P24, DOI 10.1016/j.sbi.2014.03.001; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; LIU MS, 1994, P NATL ACAD SCI USA, V91, P10389, DOI 10.1073/pnas.91.22.10389; Mamaev S, 2004, ANAL BIOCHEM, V326, P25, DOI 10.1016/j.ab.2003.11.002; Merryman C, 2004, CHEM BIOL, V11, P575, DOI 10.1016/j.chembiol.2004.03.009; Muranaka N, 2007, CHEMBIOCHEM, V8, P1650, DOI 10.1002/cbic.200700249; O'Donoghue P, 2012, FEBS LETT, V586, P3931, DOI 10.1016/j.febslet.2012.09.033; Ohshiro Y, 2011, CHEMBIOCHEM, V12, P1183, DOI 10.1002/cbic.201100104; Ohta A, 2007, CHEM BIOL, V14, P1315, DOI 10.1016/j.chembiol.2007.10.015; Olejnik J, 2005, METHODS, V36, P252, DOI 10.1016/j.ymeth.2005.04.003; RAJBHANDARY UL, 1994, J BACTERIOL, V176, P547; Rasmussen L.C., 2009, ELS, DOI [10.1002/9780470015902.a0000543.pub2, DOI 10.1002/9780470015902.A0000543.PUB2]; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sando S, 2005, J AM CHEM SOC, V127, P7998, DOI 10.1021/ja0502977; SCHULMAN LH, 1977, BIOCHEMISTRY-US, V16, P4256, DOI 10.1021/bi00638a020; Steinfeld JB, 2014, ACS CHEM BIOL, V9, P1104, DOI 10.1021/cb5000532; Suga H, 2011, PHILOS T R SOC B, V366, P2959, DOI 10.1098/rstb.2011.0137; Terasaka N, 2014, CHEM LETT, V43, P11, DOI 10.1246/cl.130910; Thyer R, 2013, J AM CHEM SOC, V135, P2, DOI 10.1021/ja3069177; Uno M, 1996, BIOCHIMIE, V78, P935, DOI 10.1016/S0300-9084(97)86715-6; VARSHNEY U, 1990, P NATL ACAD SCI USA, V87, P1586, DOI 10.1073/pnas.87.4.1586; Wang WJ, 2014, ACS CHEM BIOL, V9, P2165, DOI 10.1021/cb500351s	102	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2015	16	3					6513	6531		10.3390/ijms16036513		19	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CG0KQ	WOS:000352955900044		
J	Matsunaga, S; Kishi, T; Iwata, N				Matsunaga, Shinji; Kishi, Taro; Iwata, Nakao			Combination Therapy with Cholinesterase Inhibitors and Memantine for Alzheimer's Disease: A Systematic Review and Meta-Analysis	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Article						Alzheimer's disease; memantine; cholinesterase inhibitors; systematic review; meta-analysis	PLACEBO-CONTROLLED TRIAL; ALLOSTERIC MODULATORS; CLINICAL-TRIALS; DOUBLE-BLIND; DEMENTIA; MODERATE; EFFICACY; TOLERABILITY; RIVASTIGMINE; INVENTORY	Background: We performed an updated meta-analysis of randomized controlled trials of combination therapy with cholinesterase inhibitors and memantine in patients with Alzheimer's disease. Methods: We reviewed cognitive function, activities of daily living, behavioral disturbance, global assessment, discontinuation rate, and individual side effects. Results: Seven studies (total n = 2182) were identified. Combination therapy significantly affected behavioral disturbance scores (standardized mean difference = -0.13), activity of daily living scores (standardized mean difference = -0.10), and global assessment scores (standardized mean difference = -0.15). In addition, cognitive function scores (standardized mean difference = -0.13, P=.06) exhibited favorable trends with combination therapy. The effects of combination therapy were more significant in the moderate-to-severe Alzheimer's disease subgroup in terms of all efficacy outcome scores. The discontinuation rate was similar in both groups, and there were no significant differences in individual side effects. Conclusions: Combination therapy was beneficial for the treatment of moderate-to-severe Alzheimer's disease in terms of cognition, behavioral disturbances, activities of daily living, and global assessment was well tolerated.	[Matsunaga, Shinji; Kishi, Taro; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan	Matsunaga, S (reprint author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan.	shinjim@fujita-hu.ac.jp					Ametamey SM, 2002, NUCL MED BIOL, V29, P227, DOI 10.1016/S0969-8051(01)00293-1; Porsteinsson AP, 2008, CURR ALZHEIMER RES, V5, P83, DOI 10.2174/156720508783884576; Pimlott SL, 2004, NEUROPSYCHOPHARMACOL, V29, P108, DOI 10.1038/sj.npp.1300302; Kishi T, 2013, J PSYCHIATR RES, V47, P1143, DOI 10.1016/j.jpsychires.2013.04.013; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Bucks RS, 1996, AGE AGEING, V25, P113, DOI 10.1093/ageing/25.2.113; Grossberg GT, 2013, CNS DRUGS, V27, P469, DOI 10.1007/s40263-013-0077-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; MORRIS JC, 1993, NEUROLOGY, V43, P2412; Hager K, 2014, NEUROPSYCH DIS TREAT, V10, P391, DOI 10.2147/NDT.S57909; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Jackson A, 2009, NEUROPSYCHOPHARMACOL, V34, P257, DOI 10.1038/npp.2008.50; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308; Pandya A, 2011, BIOCHEM PHARMACOL, V82, P952, DOI 10.1016/j.bcp.2011.04.020; Dysken MW, 2014, JAMA-J AM MED ASSOC, V311, P33, DOI 10.1001/jama.2013.282834; Boada M, 2013, DEMENT GERIATR COGN, V35, P23, DOI 10.1159/000345989; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; PANISSET M, 1994, ARCH NEUROL-CHICAGO, V51, P41; Danysz W, 2003, INT J GERIATR PSYCH, V18, pS23, DOI 10.1002/gps.938; Asada Takashi, 2012, Rinsho Shinkeigaku, V52, P962; Berman K, 2012, AM J GERIAT PSYCHIAT, V20, P104, DOI 10.1097/JGP.0b013e31822001a6; Choi SH, 2011, CURR MED RES OPIN, V27, P1375, DOI 10.1185/03007995.2011.582484; Creţu Oana, 2008, Rev Med Chir Soc Med Nat Iasi, V112, P641; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; International AsD, 2009, WORLD ALZH REP 2009; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535; Molloy DW, 1997, INT PSYCHOGERIATR S, V9, P143; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; Muayqil Taim, 2012, Dement Geriatr Cogn Dis Extra, V2, P546, DOI 10.1159/000343479; Olin JT, 1996, J GERIATR PSYCH NEUR, V9, P176	36	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1461-1457	1469-5111		INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	MAR	2015	18	5								10.1093/ijnp/pyu115		11	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CF4RI	WOS:000352538100018		
J	Tsutsui-Kimura, I; Yoshida, T; Ohmura, Y; Izumi, T; Yoshioka, M				Tsutsui-Kimura, Iku; Yoshida, Takayuki; Ohmura, Yu; Izumi, Takeshi; Yoshioka, Mitsuhiro			Milnacipran Remediates Impulsive Deficits in Rats with Lesions of the Ventromedial Prefrontal Cortex	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Article						inhibitory control; infralimbic cortex; spinogenesis; impulsive behavior; BDNF	REACTION-TIME-TASK; VOXEL-BASED MORPHOMETRY; NUCLEUS-ACCUMBENS CORE; NEUROTROPHIC FACTOR; FUNCTIONAL NEUROCHEMISTRY; HYPERACTIVITY DISORDER; REUPTAKE INHIBITORS; RESPONSE-INHIBITION; RECEPTOR ANTAGONISM; BIPOLAR DISORDER	Background: Deficits in impulse control are often observed in psychiatric disorders in which abnormalities of the prefrontal cortex are observed, including attention-deficit/hyperactivity disorder and bipolar disorder. We recently found that milnacipran, a serotonin/noradrenaline reuptake inhibitor, could suppress impulsive action in normal rats. However, whether milnacipran could suppress elevated impulsive action in rats with lesions of the ventromedial prefrontal cortex, which is functionally comparable with the human prefrontal cortex, remains unknown. Methods: Selective lesions of the ventromedial prefrontal cortex were made using quinolinic acid in rats previously trained on a 3-choice serial reaction time task. Sham rats received phosphate buffered saline. Following a period of recovery, milnacipran ( 0 or 10 mg/kg/d x 14 days) was orally administered 60 minutes prior to testing on the 3-choice task. After 7 days of drug cessation, Western blotting, immunohistochemistry, electrophysiological analysis, and morphological analysis were conducted. Results: Lesions of the ventromedial prefrontal cortex induced impulsive deficits, and repeated milnacipran ameliorated the impulsive deficit both during the dosing period and after the cessation of the drug. Repeated milnacipran remediated the protein levels of mature brain-derived neurotrophic factor and postsynaptic density-95, dendritic spine density, and excitatory currents in the few surviving neurons in the ventromedial prefrontal cortex of ventromedial prefrontal cortex-lesioned rats. Conclusions: The findings of this study suggest that milnacipran treatment could be a novel strategy for the treatment of psychiatric disorders that are associated with a lack of impulse control.	[Tsutsui-Kimura, Iku; Yoshida, Takayuki; Ohmura, Yu; Izumi, Takeshi; Yoshioka, Mitsuhiro] Hokkaido Univ, Grad Sch Med, Dept Neuropharmacol, Sapporo, Hokkaido 0608638, Japan; [Tsutsui-Kimura, Iku] Japan Soc Promot Sci, Tokyo, Japan; [Tsutsui-Kimura, Iku] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan	Ohmura, Y (reprint author), Hokkaido Univ, Grad Sch Med, Dept Neuropharmacol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	gwd0701@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [234134, 24791192, 12023490, 26118701, 26120701, 25713043, 24591674, 20390309]	This work was supported by Grant-in-Aid for JSPS Fellows 234134 (I. TK.); Grant-in-Aid for Young Scientists 24791192 (T.Y.); Grant-in-Aid for Scientific Research on Innovative Areas 12023490, 26118701, 26120701 (Y.O.); Grant-in-Aid for Young Scientists (A) 25713043 (Y.O.); Grant-in-Aid for Scientific Research 24591674 (T.I.); Grant-in-Aid for Scientific Research 20390309 (M.Y.); and Strategic Research Program for Brain Sciences (Integrated Research on Neuropsychiatric Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alme Maria Nordheim, 2007, Neural Plast, V2007, P26496, DOI 10.1155/2007/26496; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Potvin S, 2003, ENCEPHALE, V29, P193; Blondeau C, 2007, BIOL PSYCHIAT, V61, P1340, DOI 10.1016/j.biopsych.2006.06.030; Joel D, 2005, EUR J NEUROSCI, V21, P2252, DOI 10.1111/j.1460-9568.2005.04042.x; Perroud N, 2011, J AFFECT DISORDERS, V134, P112, DOI [10.1016/j.jad.2011.05.048, 10.1016/j.jad.201105.048]; Robinson ESJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1028, DOI 10.1038/sj.npp.1301487; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Maalouf FT, 2011, J AFFECT DISORDERS, V133, P625, DOI 10.1016/j.jad.2011.04.041; Antonini A, 2011, MOVEMENT DISORD, V26, P464, DOI 10.1002/mds.23501; Diergaarde L, 2008, BIOL PSYCHIAT, V63, P301, DOI 10.1016/j.biopsych.2007.07.011; Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003; Nugent AC, 2006, NEUROIMAGE, V30, P485, DOI 10.1016/j.neuroimage.2005.09.029; Nakata H, 2007, FEBS LETT, V581, P2047, DOI 10.1016/j.febslet.2007.04.041; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; McGirr A, 2008, PSYCHOL MED, V38, P407, DOI 10.1017/S0033291707001419; Mukai H, 2011, CEREB CORTEX, V21, P2704, DOI 10.1093/cercor/bhr059; COLE BJ, 1987, PSYCHOPHARMACOLOGY, V91, P458, DOI 10.1007/BF00216011; Marek GJ, 1998, BIOL PSYCHIAT, V44, P1118, DOI 10.1016/S0006-3223(98)00036-5; Milstein JA, 2010, J PSYCHOPHARMACOL, V24, P309, DOI 10.1177/0269881108098146; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Tsutsui-Kimura I, 2013, PSYCHOPHARMACOLOGY, V225, P495, DOI 10.1007/s00213-012-2835-5; Molteni R, 2009, NEUROPSYCHOPHARMACOL, V34, P1523, DOI 10.1038/npp.2008.208; Larsen MH, 2010, J PSYCHIATR RES, V44, P808, DOI 10.1016/j.jpsychires.2010.01.005; Enticott PG, 2008, PSYCHIAT RES, V157, P251, DOI 10.1016/j.psychres.2007.04.007; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Licznerski P, 2013, NEUROSCIENCE, V251, P33, DOI 10.1016/j.neuroscience.2012.09.057; Baarendse PJJ, 2012, PSYCHOPHARMACOLOGY, V219, P313, DOI 10.1007/s00213-011-2576-x; Fernando ABP, 2012, PSYCHOPHARMACOLOGY, V219, P341, DOI 10.1007/s00213-011-2408-z; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Economidou D, 2012, NEUROPSYCHOPHARMACOL, V37, P2057, DOI 10.1038/npp.2012.53; Pezze MA, 2009, PSYCHOPHARMACOLOGY, V202, P307, DOI 10.1007/s00213-008-1384-4; Murphy ER, 2012, PSYCHOPHARMACOLOGY, V219, P401, DOI 10.1007/s00213-011-2572-1; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Paterson NE, 2011, NEUROSCI RES, V69, P41, DOI 10.1016/j.neures.2010.10.001; Tsutsui-Kimura I, 2009, BEHAV PHARMACOL, V20, P474, DOI 10.1097/FBP.0b013e3283305e65; Dalley JW, 2008, PHARMACOL BIOCHEM BE, V90, P250, DOI 10.1016/j.pbb.2007.12.021; Jourdi H, 2009, J NEUROSCI, V29, P8688, DOI 10.1523/JNEUROSCI.6078-08.2009; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Murphy ER, 2005, PSYCHOPHARMACOLOGY, V179, P99, DOI 10.1007/s00213-004-2068-3; Sharma A, 2014, ANN PHARMACOTHER, V48, P209, DOI 10.1177/1060028013510699; Abela AR, 2013, CEREB CORTEX, V23, P1396, DOI 10.1093/cercor/bhs121; Pattij T, 2007, PSYCHOPHARMACOLOGY, V191, P587, DOI 10.1007/s00213-006-0533-x; Besson M, 2010, NEUROPSYCHOPHARMACOL, V35, P560, DOI 10.1038/npp.2009.162; Corruble E, 2003, PROG NEURO-PSYCHOPH, V27, P829, DOI 10.1016/S0278-5846(03)00115-5; Daruna J.H., 1993, IMPULSIVE CLIENT THE, P23, DOI 10.1037/10500-002; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P422, DOI 10.1007/PL00005487; Grider MH, 2005, J NEUROSCI RES, V82, P404, DOI 10.1002/jnr.20635; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hof PR, 2004, INTRO CELLULAR MOL M, P1; Humpston CS, 2013, J PSYCHOPHARMACOL, V27, P213, DOI 10.1177/0269881112466182; Kates WR, 2002, PSYCHIAT RES-NEUROIM, V116, P63, DOI 10.1016/S0925-4927(02)00066-5; KITA H, 1981, BRAIN RES, V213, P1, DOI 10.1016/0006-8993(81)91244-0; Kron M, 2008, J PHYSIOL-LONDON, V586, P2331, DOI 10.1113/jphysiol.2007.148916; Mannari C, 2008, CELL MOL NEUROBIOL, V28, P457, DOI 10.1007/s10571-007-9254-x; Moreno M, 2013, PSYCHOPHARMACOLOGY, V228, P19, DOI 10.1007/s00213-013-3010-3; Murphy ER, 2008, EUR J NEUROSCI, V28, P353, DOI 10.1111/j.1460-9568.2008.06309.x; Ohmura Y, 2009, BEHAV BRAIN RES, V198, P429, DOI 10.1016/j.bbr.2008.11.025; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1107/s00213-002-1154-7; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Sasaki A, 1994, CLIN REPORT, V28, P3649; Sasaki A, 1994, CLIN REPORT, V28, P3671; Shikanai H, 2012, J NEUROSCI, V32, P14415, DOI 10.1523/JNEUROSCI.5929-11.2012; Song N, 2012, INT J NEUROPSYCHOPH, V16, P803; Thome Johannes, 2002, Expert Rev Neurother, V2, P347, DOI 10.1586/14737175.2.3.347	69	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1461-1457	1469-5111		INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	MAR	2015	18	5								10.1093/ijnp/pyu083		14	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CF4RI	WOS:000352538100007		
J	Yamanouchi, Y; Sukegawa, T; Inagaki, A; Inada, T; Yoshio, T; Yoshimura, R; Iwata, N				Yamanouchi, Yoshio; Sukegawa, Tsuruhei; Inagaki, Ataru; Inada, Toshiya; Yoshio, Takashi; Yoshimura, Reiji; Iwata, Nakao			Evaluation of the Individual Safe Correction of Antipsychotic Agent Polypharmacy in Japanese Patients with Chronic Schizophrenia: Validation of Safe Corrections for Antipsychotic Polypharmacy and the High-Dose Method	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Article						psychopharmacology; clinical trial; schizophrenia; polypharmacy; antipsychotics	INPATIENTS; CLOZAPINE	Background: Polypharmacy for schizophrenia treatment is not justified by the available clinical evidence. We evaluated a treatment reduction approach that reduces the dose and number of antipsychotic medications simultaneously prescribed to patients. Methods: In a randomized open study of the Safe Correction of Antipsychotic Polypharmacy and High-Dose Prescriptions program funded by the Japanese Ministry of Health, Labour, and Welfare, we evaluated a drug reduction method consisting of a dose reduction intervention performed on 163 patients with schizophrenia for twelve or 24 weeks. One antipsychotic medication was removed each week from each patient's treatment regimen by reducing the dose by 0 to 50 chlorpromazine equivalents. Data on health-related indices of quality of life, clinical symptoms, and risk of side effects were analyzed using a two-way repeated-measures mixed linear model. Results: Despite a 23% reduction in antipsychotic dose, no differences in outcomes were observed between the dose reduction and observation groups (effect size = 0.001 - 0.085, P = .24-.97), despite high statistical power (1-beta = 0.48-0.97). The findings are limited by the nonuniformity of the participants' treatment history, duration, and dose reduction amount. Dose reduction protocol patients exhibited no difference in psychotic symptoms or adverse events compared with the observation group. Conclusions: Importantly, the low dropout rate in our study (6.9% of participants withdrew because of patient factors and 23.8% for all secondary reasons) indicates that our "slowly" method is well tolerated. We hope that this approach will result in therapeutic improvements.	[Yamanouchi, Yoshio] Natl Ctr Neurol & Psychiat, Dept Social Psychiat, Natl Inst Mental Hlth, Kodaira, Tokyo 1878553, Japan; [Sukegawa, Tsuruhei] Natl Hosp Org, Tottori Med Ctr, Tottori, Japan; [Inagaki, Ataru] Aoyama Gakuin Univ, Sch Int Polit Econ & Commun, Tokyo, Japan; [Inada, Toshiya] Seiwa Hosp, Inst Neuropsychiat, Tokyo, Japan; [Yoshio, Takashi] Toho Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Funabashi, Chiba 274, Japan; [Yoshimura, Reiji] Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan; [Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan	Yamanouchi, Y (reprint author), Natl Ctr Neurol & Psychiat, Dept Social Psychiat, Natl Inst Mental Hlth, 4-1 Ogawahigashicho, Kodaira, Tokyo 1878553, Japan.	yamanouchi@ncnp.go.jp					American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Fleischhacker WW, 2014, INT J NEUROPSYCHOPH, V17, P1083, DOI 10.1017/S1461145712000399; Kang M, 2008, J ATHL TRAINING, V43, P215, DOI 10.4085/1062-6050-43.2.215; Essock SM, 2011, AM J PSYCHIAT, V168, P702, DOI 10.1176/appi.ajp.2011.10060908; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538; Xiang YT, 2012, PHARMACOPSYCHIATRY, V45, P7, DOI 10.1055/s-0031-1286345; Atkinson M, 1997, AM J PSYCHIAT, V154, P99; Barnes TRE, 2011, CNS DRUGS, V25, P383, DOI 10.2165/11587810-000000000-00000; Collell CU, 2009, SCHIZOPHR B, V35, P443; First MB, 1997, STRUCTURED CLIN INTE; Goh Yen-Li, 2011, Perm J, V15, P52; Guy W., 2000, PSYCHIAT MEASURES; Inada T, 2009, DIEPSS 2 GENERATION; Inagaki A, 2008, BLONANSERIN JPN J CL, V5, P887; Ito H, 2012, OPEN J PSYCHIAT, V2, P340; Lingjaerede O, 1987, ACTA PSYCHIAT SCAND, V334, P11; MANCHANDA R, 1986, ACTA PSYCHIAT SCAND, V74, P563, DOI 10.1111/j.1600-0447.1986.tb06285.x; Miodownik C, 2006, J CLIN PSYCHIAT, V67, P1204; Mizumoto A, 2010, LET KANSAI CHAPTER C, P47; Murasugi K, 2004, ATTEMPT CORRECT ANTI, P67; Okumura Y, 2013, JPN J CLIN PSYCHOPHA, V16, P1201; Samaha AN, 2013, PROG NEUROPSYCHOPHAR, V52, P9; Sukegawa T, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-103; Suzuki T, 2004, INT J NEUROPSYCHOPH, V7, P133, DOI 10.1017/S1461145703004012; Takekawa Y, 1994, SEISHINIGAKU, V36, P389; Tani H, 2012, SCHIZOPHR RES, V143, P215; Thompson A, 2008, PSYCHOL MED, V38, P705, DOI 10.1017/S003329170700147X; Yoshio T, 2012, HUM PSYCHOPHARM CLIN, V27, P70, DOI 10.1002/hup.1272	29	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1461-1457	1469-5111		INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	MAR	2015	18	5								10.1093/ijnp/pyu016		8	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CF4RI	WOS:000352538100001		
J	El Khoudary, SR; Shin, C; Masaki, K; Miura, K; Budoff, M; Edmundowicz, D; Kadowaki, S; Barinas-Mitchell, E; El-Saed, A; Fujiyoshi, A; Evans, RW; Hisamatsu, T; Ohkubo, T; Willcox, BJ; Kuller, LH; Ueshima, H; Sekikawa, A				El Khoudary, S. R.; Shin, C.; Masaki, K.; Miura, K.; Budoff, M.; Edmundowicz, D.; Kadowaki, S.; Barinas-Mitchell, E.; El-Saed, A.; Fujiyoshi, A.; Evans, R. W.; Hisamatsu, T.; Ohkubo, T.; Willcox, B. J.; Kuller, L. H.; Ueshima, H.; Sekikawa, A.		ERA JUMP Electron-Beam Tomography	Ectopic cardiovascular fat in middle-aged men: effects of race/ethnicity, overall and central adiposity. The ERA JUMP study	INTERNATIONAL JOURNAL OF OBESITY			English	Article							VISCERAL ABDOMINAL FAT; DISEASE RISK-FACTORS; PERICARDIAL FAT; JAPANESE MEN; METABOLIC SYNDROME; EPICARDIAL FAT; WHITE MEN; TISSUE; CALCIFICATION; OBESITY	BACKGROUND/OBJECTIVES: Higher volumes of ectopic cardiovascular fat (ECF) are associated with greater risk of coronary heart disease (CHD). Identifying factors that are associated with ECF volumes may lead to new preventive efforts to reduce risk of CHD. Significant racial/ethnic differences exist for overall and central adiposity measures, which are known to be associated with ECF volumes. Whether racial/ethnic differences also exist for ECF volumes and their associations with these adiposity measures remain unclear. SUBJECTS/METHODS: Body mass index (BMI), computerized tomography-measured ECF volumes (epicardial, pericardial and their summation) and visceral adipose tissue (VAT) were examined in a community-based sample of 1199 middle-aged men (24.2% Caucasians, 7.0% African-Americans, 23.6% Japanese-Americans, 22.0% Japanese, 23.2% Koreans). RESULTS: Significant racial/ethnic differences existed in ECF volumes and their relationships with BMI and VAT. ECF volumes were the highest among Japanese-Americans and the lowest among African-Americans. The associations of BMI and VAT with ECF differed by racial/ethnic groups. Compared with Caucasians, for each 1-unit increase in BMI, African-Americans had lower, whereas Koreans had higher increases in ECF volumes (P-values < 0.05 for both). Meanwhile, compared with Caucasians, for each 1-unit increase in log-transformed VAT, African-Americans, Japanese-Americans and Japanese had similar increases, whereas Koreans had a lower increase in ECF volumes (P-value < 0.05). CONCLUSIONS: Racial/ethnic groups differed in their propensity to accumulate ECF at increasing level of overall and central adiposity. Future studies should evaluate whether reducing central adiposity or overall weight will decrease ECF volumes more in certain racial/ethnic groups. Evaluating these questions might help in designing race-specific prevention strategy of CHD risk associated with higher ECF.	[El Khoudary, S. R.; Barinas-Mitchell, E.; El-Saed, A.; Evans, R. W.; Kuller, L. H.; Sekikawa, A.] Univ Pittsburgh, Dept Epidemiol, Epidemiol Data Ctr, Pittsburgh, PA 15213 USA; [Shin, C.] Korea Univ, Dept Internal Med, Ansan, South Korea; [Masaki, K.; Willcox, B. J.] Univ Hawaii, Geriatr Med, Geri Med Residency PD, Honolulu, HI 96822 USA; [Miura, K.; Kadowaki, S.; Fujiyoshi, A.; Hisamatsu, T.; Ueshima, H.] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga, Japan; [Budoff, M.] Los Angeles Biomed Res Inst, Torrance, CA USA; [Edmundowicz, D.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19122 USA; [Ohkubo, T.] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan	El Khoudary, SR (reprint author), Univ Pittsburgh, Dept Epidemiol, Epidemiol Data Ctr, Keystone Bldg,1st Floor,Room 5,3520 Fifth Ave, Pittsburgh, PA 15213 USA.	elkhoudarys@edc.pitt.edu			National Institutes of Health, Bethesda, MD, USA [HL068200, HL071561]; Japanese Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan) [B 16790335, A 13307016, 17209023, 21249043, A 25253046, B 23390174]; Korea Center for Disease Control and Prevention [2004-E71001-00, 205-E71001-00]	This work was supported by grants HL068200 and HL071561 from the National Institutes of Health, Bethesda, MD, USA, Korea Center for Disease Control and Prevention (Government budget code: 2004-E71001-00, 205-E71001-00) and grants B 16790335, A 13307016, 17209023, 21249043, A 25253046 and B 23390174 from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan).	Abbott RD, 2007, AM J EPIDEMIOL, V166, P1280, DOI 10.1093/aje/kwm201; Rabkin SW, 2007, OBES REV, V8, P253, DOI 10.1111/j.1467-789X.2006.00293.x; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Iacobellis G, 2005, CYTOKINE, V29, P251, DOI 10.1016/j.cyto.2004.11.002; Hoffman DJ, 2005, OBES RES, V13, P66, DOI 10.1038/oby.2005.9; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Stanforth PR, 2004, INT J OBESITY, V28, P925, DOI 10.1038/sj.ijo.0802563; Shen W, 2004, AM J CLIN NUTR, V80, P271; Hill JO, 1999, AM J CLIN NUTR, V69, P381; Lee S, 2004, J APPL PHYSIOL, V97, P948, DOI 10.1152/japplphysiol.01200.2003; KAGAN A, 1974, J CHRON DIS, V27, P345, DOI 10.1016/0021-9681(74)90014-9; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Liu JK, 2010, DIABETES CARE, V33, P1635, DOI 10.2337/dc10-0245; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Gao YJ, 2006, CARDIOVASC RES, V71, P363, DOI 10.1016/j.cardiores.2006.03.013; Ravussin E, 2002, ANN NY ACAD SCI, V967, P363; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ding JZ, 2008, OBESITY, V16, P1914, DOI 10.1038/oby.2008.278; Lionetti L, 2009, NUTR METAB CARDIOVAS, V19, P146, DOI 10.1016/j.numecd.2008.10.010; Sekikawa A, 2012, ATHEROSCLEROSIS, V222, P473, DOI 10.1016/j.atherosclerosis.2012.03.027; Azuma K, 2009, METABOLISM, V58, P1200, DOI 10.1016/j.metabol.2009.03.021; Lehman SJ, 2010, ATHEROSCLEROSIS, V210, P656, DOI 10.1016/j.atherosclerosis.2010.01.007; El-Saed A, 2008, ATHEROSCLEROSIS, V196, P913, DOI 10.1016/j.atherosclerosis.2007.02.009; Ferrannini E, 2008, EUR HEART J SUPPL, V10, pB4, DOI 10.1093/eurheartj/sum042; Fujiyoshi A, 2013, EUR HEART J-CARD IMG, V14, P921, DOI 10.1093/ehjci/jet080; Salami SS, 2013, ETHNIC DIS, V23, P281; Willens HJ, 2008, ETHNIC DIS, V18, P311	29	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0307-0565	1476-5497		INT J OBESITY	Int. J. Obes.	MAR	2015	39	3					488	494		10.1038/ijo.2014.154		7	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CF3AD	WOS:000352418700015		
J	Borel, AL; Nazare, JA; Smith, J; Aschner, P; Barter, P; Van Gaal, L; Tan, CE; Wittchen, HU; Matsuzawa, Y; Kadowaki, T; Ross, R; Brulle-Wohlhueter, C; Almeras, N; Haffner, SM; Balkau, B; Despres, JP				Borel, A-L; Nazare, J-A; Smith, J.; Aschner, P.; Barter, P.; Van Gaal, L.; Tan, C. Eng; Wittchen, H-U; Matsuzawa, Y.; Kadowaki, T.; Ross, R.; Brulle-Wohlhueter, C.; Almeras, N.; Haffner, S. M.; Balkau, B.; Despres, J-P		INSPIRE ME IAA Investigators	Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance	INTERNATIONAL JOURNAL OF OBESITY			English	Article							MACROVESICULAR HEPATIC STEATOSIS; INSULIN-RESISTANCE; RISK-FACTOR; INTRAABDOMINAL ADIPOSITY; CARDIOMETABOLIC RISK; SENSITIVITY; SECRETION; OBESITY; CT; SPECTROSCOPY	OBJECTIVES: To examine the specific distribution of liver fat content, visceral and subcutaneous adiposity in normal glucose tolerance (NGT/NGT), isolated impaired fasting glucose (iIFG), isolated impaired glucose tolerance (iIGT) and combined conditions (IFG+IGT), as well as with newly diagnosed type 2 diabetes (nT2D). DESIGN: Multicenter, international observational study: cross-sectional analysis. SUBJECTS: Two thousand five hundred and fifteen patients (50.0% women, 54.5% non-Caucasian) without previously known diabetes were recruited from 29 countries. Abdominal fat distribution was measured by computed tomography (CT). Liver fat was estimated using the CT-liver mean attenuation. RESULTS: Compared with NGT/NGT patients, increased visceral adiposity was found in iIFG, iIGT, IFG+IGT and nT2D; estimated liver fat progressively increased across these conditions. A one-s.d. increase in visceral adiposity was associated with an increased risk of having iIFG (men: odds ratio (OR) 1.41 (95% confidence interval (CI) 1.15-1.74), women: OR 1.62 (1.29-2.04)), iIGT (men: OR 1.59 (1.15-2.01), women: OR 1.30 (0.96-1.76)), IFG+IGT (men: OR 1.64 (1.27-2.13), women: OR 1.83 (1.36-2.48)) and nT2D (men: OR 1.80 (1.35-2.42), women: OR 1.73 (1.25-2.41)). A one-s.d. increase in estimated liver fat was associated with iIGT (men: OR 1.46 (1.12-1.90), women: OR 1.81 (1.41-2.35)), IFG+IGT (men: OR 1.42 (1.14-1.77), women: OR 1.74 (1.35-2.26)) and nT2D (men: OR 1.77 (1.40-2.27), women: OR 2.38 (1.81-3.18)). Subcutaneous abdominal adipose tissue showed an inverse relationship with nT2D in women (OR 0.63 (0.45-0.88)). CONCLUSIONS: Liver fat was associated with iIGT but not with iIFG, whereas visceral adiposity was associated with both. Liver fat and visceral adiposity were associated with nT2D, whereas subcutaneous adiposity showed an inverse relationship with nT2D in women.	[Borel, A-L; Nazare, J-A; Smith, J.; Almeras, N.; Despres, J-P] Ctr Rech Inst Univ Pneumol & Cardiol Quebec, Quebec City, PQ, Canada; [Borel, A-L] Grenoble Alpes Univ, INSERM, HP2 Lab, U1042, Grenoble, France; [Borel, A-L] Univ Hosp Grenoble, Dept Endocrinol, Grenoble, France; [Nazare, J-A] CENS, CarMeN Lab, Pierre Benite, France; [Aschner, P.] Javeriana Univ, San Ignacio Univ Hosp, Sch Med, Bogota, Colombia; [Barter, P.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Van Gaal, L.] Univ Antwerp Hosp, Dept Endocrinol Diabetol Metab & Clin Nutr, Edegem, Belgium; [Tan, C. Eng] SingapRe, Gleneagles Med Ctr, Singapore, Singapore; [Wittchen, H-U] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-01062 Dresden, Germany; [Wittchen, H-U] Tech Univ Dresden, Ctr Clin Epidemiol & Longitudinal Studies CELOS, D-01062 Dresden, Germany; [Matsuzawa, Y.] Sumitomo Hosp, Dept Endocrinol & Metab, Osaka, Japan; [Kadowaki, T.] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Ross, R.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Brulle-Wohlhueter, C.] Sanofi, Paris, France; [Haffner, S. M.] Baylor Coll Med, San Antonio, TX USA; [Balkau, B.] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, UMRS Epidemiol Diabet Obes & Chron Kidney Dis Ove, Villejuif, France; [Balkau, B.] Univ Paris 11, Paris, France	Despres, JP (reprint author), Ctr Rech Inst Univ Pneumol & Cardiol Quebec, Quebec City, PQ, Canada.	jean-pierre.despres@criucpq.ulaval.ca			Agiradom (Meylan, France); Rhone-Alpes region (France); CIHR (Canadian Institute of Health Research); SANOFI	Dr Borel is a postdoctoral fellow supported by a fellowship from Agiradom (Meylan, France) and from the Rhone-Alpes region (France). Dr Nazare is a postdoctoral fellow supported by a fellowship from the CIHR (Canadian Institute of Health Research). The INSPIRE ME IAA was supported by SANOFI.	Borel AL, 2012, OBESITY, V20, P1223, DOI 10.1038/oby.2011.396; Despres JP, 2009, ARTERIOSCL THROM VAS, V29, P416, DOI 10.1161/ATVBAHA.108.176362; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI 10.1172/JCI200421047; Smith JD, 2012, J CLIN ENDOCR METAB, V97, P1517, DOI 10.1210/jc.2011-2550; Kantartzis K, 2010, DIABETOLOGIA, V53, P882, DOI 10.1007/s00125-010-1663-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; van der Zijl NJ, 2011, J CLIN ENDOCR METAB, V96, P459, DOI 10.1210/jc.2010-1722; Hwang JH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1663, DOI 10.1152/ajpendo.00590.2006; van Werven JR, 2010, RADIOLOGY, V256, P159, DOI 10.1148/radiol.10091790; Sung KC, 2012, DIABETES CARE, V35, P717, DOI 10.2337/dc11-1853; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Park BJ, 2008, J GASTROEN HEPATOL, V23, P900, DOI 10.1111/j.1440-1746.2007.05212.x; Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200; Borel AL, 2012, METABOLISM, V61, P262, DOI 10.1016/j.metabol.2011.06.024; Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Sung KC, 2013, J CLIN ENDOCR METAB, V98, P3637, DOI 10.1210/jc.2013-1519; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Faerch K, 2009, DIABETES CARE, V32, P439, DOI [10.2337/dc08-1195, 10.2337/dc-08-1195]; Ducluzeau PH, 2010, CLIN RADIOL, V65, P695, DOI 10.1016/j.crad.2010.03.013; FERLAND M, 1989, BRIT J NUTR, V61, P139, DOI 10.1079/BJN19890104; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Hanefeld M, 2003, DIABETES CARE, V26, P868, DOI 10.2337/diacare.26.3.868; Lee SW, 2007, RADIOLOGY, V244, P479, DOI 10.1148/radiol.2442061177; PIEKARSKI J, 1980, RADIOLOGY, V137, P727; Tripathy D, 2000, DIABETES, V49, P975, DOI 10.2337/diabetes.49.6.975; VANDERKOOY K, 1993, INT J OBESITY, V17, P187; Wareham N J, 1995, Diabet Med, V12, P931	35	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0307-0565	1476-5497		INT J OBESITY	Int. J. Obes.	MAR	2015	39	3					495	501		10.1038/ijo.2014.163		7	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CF3AD	WOS:000352418700016		
J	Hirata, Y; Kato, T; Choi, J				Hirata, Yuki; Kato, Takahisa; Choi, Junho			DLC coating on a trench-shaped target by bipolar PBII	INTERNATIONAL JOURNAL OF REFRACTORY METALS & HARD MATERIALS			English	Article						DLC film; Bipolar PBII; Trench-shaped target; Ion sheath; PIC-MCC method; DSMC method	DIAMOND-LIKE CARBON; BOLTZMANN-EQUATION; VELOCITY CORRELATION; ION-IMPLANTATION; SIMULATION; CELL; DISCHARGES; MODEL	Bipolar-type plasma based ion implantation (bipolar PBII) and deposition is a promising coating technique, especially for the complex-shaped target surface. In this study, diamond-like carbon (DLC) films were prepared by a bipolar PBII technique to a trench-shaped target (20 mm pitch and 10 mm depth), and the uniformity, structural and mechanical properties of DLC films coated on the top, inside wall and bottom surfaces of the trench were evaluated by surface profilometer, Raman spectroscopy and nanoindentation hardness tests. Moreover, plasma simulation was conducted to reveal the DLC coating mechanism for finding the optimum coating conditions. Particle-In-Cell with Monte Carlo Collision (PIC-MCC) method and Direct Simulation Monte Carlo (DSMC) method were used for computing the plasma behavior. As a result, thickness uniformity of DLC films was improved with decreasing negative pulse voltage. On the other hand, the thickness of DLC films on the inside wall of the trench was much smaller than those of the top and bottom surfaces of the trench. This is because the conformal ion sheath cannot be formed around the inside wall, which in turn leads to the decrease of incidence ion flux to the inside wall, and the idea has been verified through the simulation of plasma behavior. From the Raman measurements of DLC coatings on the inside wall, it is observed that the Raman G-peak position shifts to a higher wave number and the Full Width at Half Maximum of G-peak (FWHM(G)) decreases to a smaller value compared to those of the films on the top and bottom surfaces. These indicate that the structure of DLC coatings on the inside wall surface has changed compared to those on top and bottom surfaces, i.e., graphitized, which results in the reduction of hardness. (C) 2014 Elsevier Ltd. All rights reserved.	[Hirata, Yuki; Kato, Takahisa; Choi, Junho] Univ Tokyo, Bunkyo Ku, Tokyo 1138656, Japan	Hirata, Y (reprint author), Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	hirata@sstl.info			JSPS KAKENHI [23360072]	This work was supported by JSPS KAKENHI (23360072).	Anders A, 2004, SURF COAT TECH, V183, P301, DOI 10.1016/j.surfcoat.2003.09.049; BIRDSALL CK, 1991, IEEE T PLASMA SCI, V19, P65, DOI 10.1109/27.106800; NANBU K, 1980, J PHYS SOC JPN, V49, P2042, DOI 10.1143/JPSJ.49.2042; VAHEDI V, 1995, COMPUT PHYS COMMUN, V87, P179, DOI 10.1016/0010-4655(94)00171-W; Choi J, 2011, DIAM RELAT MATER, V20, P845, DOI 10.1016/j.diamond.2011.04.003; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Miyagawa S, 2002, SURF COAT TECH, V156, P322, DOI 10.1016/S0257-8972(02)00101-9; Piscanec S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.185503; BOEUF JP, 1982, J PHYS D APPL PHYS, V15, P2169, DOI 10.1088/0022-3727/15/11/012; Eastwood J, 1981, COMPUTER SIMULATION; Langdon A.B., 1985, PLASMA PHYS VIA COMP; LIN SL, 1977, J CHEM PHYS, V66, P435, DOI 10.1063/1.433988; NANBU K, 1980, J PHYS SOC JPN, V49, P2050, DOI 10.1143/JPSJ.49.2050; NANBU K, 1982, J PHYS SOC JPN, V51, P1763, DOI 10.1143/JPSJ.51.1763; NANBU K, 1982, J PHYS SOC JPN, V51, P59, DOI 10.1143/JPSJ.51.59; NANBU K, 1981, J PHYS SOC JPN, V50, P2829, DOI 10.1143/JPSJ.50.2829; NANBU K, 1983, J PHYS SOC JPN, V52, P3382, DOI 10.1143/JPSJ.52.3382; Paulus M, 1999, J APPL PHYS, V85, P761, DOI 10.1063/1.369157; ROBERTSON J, 1992, SURF COAT TECH, V50, P185, DOI 10.1016/0257-8972(92)90001-Q; Vahedi V, 1993, PLASMA SOURCES SCI T, V2, P261, DOI 10.1088/0963-0252/2/4/006; Wei Q, 2008, J PHYS D, V41, P1	21	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-4368			INT J REFRACT MET H	Int. J. Refract. Met. Hard Mat.	MAR	2015	49				SI		392	399		10.1016/j.ijrmhm.2014.08.005		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CF6LB	WOS:000352667100050		
J	Saito, M; Sugimoto, I; Sasaki, E				Saito, Masamichi; Sugimoto, Ichiro; Sasaki, Eiichi			Experimental study on noise reduction effect of installing concrete deck on existing steel girders	INTERNATIONAL JOURNAL OF STEEL STRUCTURES			English	Article						steel railway bridge; concrete deck; structure-borne noise reduction; impact hammer test; response acceleration	PERFORMANCE; BRIDGES	There are a number of existing steel railway bridges which has problems regarding structure-borne noise under train passage. Authors have proposed a performance improvement method of existing steel railway bridges by installing concrete deck. By this method, the vibration of the girder and the structure-borne noise are expected to be reduced. Generally, it is known that concrete deck can reduce the vibration and the noise. However, the noise reduction effect has not been clarified. In this study, impact hammer tests were carried out to figure out the reduction effect of the concrete deck on the vibration and the noise. Through the test, it was found that the response acceleration of the steel girder web was reduced by installing the concrete deck, as a result of reducing the propagation of on-girder vibration into the steel girder.	[Saito, Masamichi; Sugimoto, Ichiro] Railway Tech Res Inst, Struct Technol Div, Kokubunji, Tokyo 1858540, Japan; [Sasaki, Eiichi] Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, Tokyo 1528552, Japan	Saito, M (reprint author), Railway Tech Res Inst, Struct Technol Div, 2-8-38 Hikari Cho, Kokubunji, Tokyo 1858540, Japan.	msaito@rtri.or.jp			Japanese Ministry of Land, Infrastructure, Transport and Tourism	We are deeply grateful to Mr. Yokokawa and Mr. Okayama at Abe Nikko Kogyo Co., Ltd., for their assistance in the loading tests of composite girders. We are also gratefully appreciate that the loading tests of composite girders were financially supported by the Japanese Ministry of Land, Infrastructure, Transport and Tourism.	Hansaka M., 1998, Journal of the Acoustical Society of Japan (E), V19; Hansaka M., 2004, Quarterly Report of RTRI, V45, DOI 10.2219/rtriqr.45.210; Hansaka M., 2013, P DYN DES C; Hansaka M., 2003, LECT RAILWAY NOISE, V4, P1; Lin WW, 2013, J CONSTR STEEL RES, V85, P130, DOI 10.1016/j.jcsr.2013.03.002; Saito M, 2013, INT J STEEL STRUCT, V13, P473, DOI 10.1007/s13296-013-3007-0; Saito M., 2013, J JAPAN SOC CIVIL EN, V69, P335; Thompson D, 2009, RAILWAY NOISE AND VIBRATION: MECHANISMS, MODELLING AND MEANS OF CONTROL, P1; Zenda Y., 1996, Q REPORT RTRI RAILWA, V37, P197	9	0	0	KOREAN SOC STEEL CONSTRUCTION-KSSC	SEOUL	106-18 MUNJUNG-DONG, SONGPA-KU, SEOUL, 138-200, SOUTH KOREA	1598-2351	2093-6311		INT J STEEL STRUCT	Int. J. Steel Struct.	MAR	2015	15	1					205	212		10.1007/s13296-015-3015-3		8	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CF8DZ	WOS:000352787200018		
J	Khurram, N; Sasaki, E; Katsuchi, H; Yamada, H				Khurram, Nauman; Sasaki, Eiichi; Katsuchi, Hiroshi; Yamada, Hitoshi			Experimental and numerical evaluation of bearing capacity of steel plate girder affected by end panel corrosion (vol 14, pg 659, 2014)	INTERNATIONAL JOURNAL OF STEEL STRUCTURES			English	Correction									[Khurram, Nauman] Univ Engn & Technol Lahore, Dept Civil Engn, Lahore 54890, Pakistan; [Sasaki, Eiichi] Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, Tokyo 1528552, Japan; [Katsuchi, Hiroshi; Yamada, Hitoshi] Yokohama Natl Univ, Dept Civil Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Khurram, N (reprint author), Univ Engn & Technol Lahore, Dept Civil Engn, Lahore 54890, Pakistan.	engr.nkch@gmail.com					Khurram N, 2014, INT J STEEL STRUCT, V14, P659, DOI 10.1007/s13296-014-3023-8	1	0	0	KOREAN SOC STEEL CONSTRUCTION-KSSC	SEOUL	106-18 MUNJUNG-DONG, SONGPA-KU, SEOUL, 138-200, SOUTH KOREA	1598-2351	2093-6311		INT J STEEL STRUCT	Int. J. Steel Struct.	MAR	2015	15	1					245	245		10.1007/s13296-015-3018-0		1	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CF8DZ	WOS:000352787200021		
J	Arai, H; Imamura, H				Arai, Hiroko; Imamura, Hiroshi			Control of domain wall thickness by spatial modulation of uniaxial anisotropy and exchange stiffness parameters	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article								The effect of spatial modulation of the uniaxial anisotropy (K) and exchange stiffness (A) parameters on the domain wall thickness was theoretically studied. We derived the Euler-Lagrange equation and the Landau-Lifshitz-Gilbert equation considering the modulation of K and A, and showed that the modulation of A gives rise to an additional term consisting of the first derivatives of A and the magnetization unit vector. Owing to this term, the modulation of A is more effective to modify the domain wall thickness than K. The condition for domain wall pinning by controlling its thickness through the modulation of K and A was also obtained. (C) 2015 The Japan Society of Applied Physics	[Arai, Hiroko] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Arai, Hiroko; Imamura, Hiroshi] Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan	Arai, H (reprint author), JST, PRESTO, Kawaguchi, Saitama 3320012, Japan.	h-imamura@aist.go.jp			JSPS KAKENHI [23226001, 25790011]; JST, PRESTO	We would like to thank T. Yorozu, H. Maehara, and H. Tomita for valuable discussions. This work was partially supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (S) 23226001, JSPS KAKENHI Grant-in-Aid for Young Scientists (B) 25790011, and JST, PRESTO.	Tseng AA, 2005, SMALL, V1, P924, DOI 10.1002/smIl.200500113; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Chang LJ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4770306; Koyama T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.101303; GAUNT P, 1983, PHILOS MAG B, V48, P261, DOI 10.1080/13642818308228288; Breitkreutz S, 2014, J APPL PHYS, V115, DOI 10.1063/1.4864737; Thomas L, 2007, SCIENCE, V315, P1553, DOI 10.1126/science.1137662; Arai H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4745777; Bisig A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238314; Braun HB, 1997, PHYS REV B, V56, P8129, DOI 10.1103/PhysRevB.56.8129; Brown W. F., 1978, MICROMAGNETICS; CHEN XH, 1990, J APPL PHYS, V67, P2540, DOI 10.1063/1.345509; Doi M, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/9/092001; Franchin M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.054447; Franken JH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.037205; Hayashi M, 2008, SCIENCE, V320, P209, DOI 10.1126/science.1154587; Hubert A., 1998, MAGNETIC DOMAINS, P1, DOI 10.1007/978-3-540-85054-0_1; Kim SD, 2007, J APPL PHYS, V101, DOI 10.1063/1.2711166; Klaui M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2042542; Lepadatu S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.060402; Noh SJ, 2012, J APPL PHYS, V111, DOI 10.1063/1.3677340; Ono T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.061301; Urbanek M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/14/145304; Yorozu T, 1998, J APPL PHYS, V84, P3278, DOI 10.1063/1.368483	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030307	10.7567/JJAP.54.030307		4	Physics, Applied	Physics	CF8FT	WOS:000352792200030		
J	Cai, P; Okajima, T				Cai, PingGen; Okajima, Takaharu			Precision of cell-to-cell variation in power-law rheology characterized by atomic force microscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SINGLE CELLS; LIVING CELLS; MECHANICS; DYNAMICS; ELASTICITY; CANCER; CYTOSKELETON; FIBROBLASTS; TISSUE	The mechanical properties of compliant single cells are significantly associated with various cell functions. It is thus crucially important in the identification and sorting of cells to characterize not only the complex moduli that exhibit power-law rheology but also the cell-to-cell variation at the single cell level. Atomic force microscopy (AFM) can be used to measure cellular mechanical properties and to quantify cell-to-cell variation. However, less is known about how precisely and routinely the cell-to-cell variation is obtained when the complex moduli vary substantially in different cell samples. Here, we investigate the storage modulus G' for single cells measured at controlled positions by AFM. We find that the spatial dependence of the frequency-dependent component of the cell-to-cell variation is preserved even if the spatial heterogeneity of G' is changed with the cell sample. The invariance of the frequency-dependent cell-to-cell variation indicates the robustness of AFM for the mechanical diagnosis of single cells. (C) 2015 The Japan Society of Applied Physics	[Cai, PingGen; Okajima, Takaharu] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan	Cai, P (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan.	okajima@ist.hokudai.ac.jp			Educational Commission of Zhejiang Province of China [25286081, 26106701, 26103501, Y201329791]	We thank B. Fabry, K. J. Van Vliet, and J. M. Maloney for helpful and informative discussions, and Y. Mizutani and M. Tsuchiya for cell sample preparation and AFM data analysis. This work was supported by Grants-in-Aid for Scientific Research (B) (25286081), and Scientific Research on Innovative Areas "Bio-assembler" (26106701) and "Fluctuation and Structure" (26103501), and from the Educational Commission of Zhejiang Province of China (Y201329791).	Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Bursac P, 2007, BIOCHEM BIOPH RES CO, V355, P324, DOI 10.1016/j.bbrc.2007.01.191; Hoffman BD, 2009, ANNU REV BIOMED ENG, V11, P259, DOI 10.1146/annurev.bioeng.10.061807.160511; Hiratsuka S, 2009, ULTRAMICROSCOPY, V109, P937, DOI 10.1016/j.ultramic.2009.03.008; Kollmannsberger P, 2011, ANNU REV MATER RES, V41, P75, DOI 10.1146/annurev-matsci-062910-100351; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; Alcaraz J, 2003, BIOPHYS J, V84, P2071; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Lekka M, 2012, ARCH BIOCHEM BIOPHYS, V518, P151, DOI 10.1016/j.abb.2011.12.013; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Trepat X, 2008, SOFT MATTER, V4, P1750, DOI 10.1039/b804866e; Chowdhury F, 2008, BIOPHYS J, V95, P5719, DOI 10.1529/biophysj.108.139832; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Cai P, 2013, BIOPHYS J, V105, P1093, DOI 10.1016/j.bpj.2013.07.035; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; FREDBERG JJ, 1989, J APPL PHYSIOL, V67, P2408; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103; RADMACHER M, 1992, SCIENCE, V257, P1900, DOI 10.1126/science.1411505; Laudadio RE, 2005, AM J PHYSIOL-CELL PH, V289, pC1388, DOI 10.1152/ajpcell.00060.2005; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Balland M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021911; Fabry B., 2003, PHYS REV E, V68, P41914, DOI DOI 10.1103/PhysRevE.68.041914; Kollmannsberger P, 2009, SOFT MATTER, V5, P1771, DOI 10.1039/b820228a; Landau L. D., 1986, THEORY ELASTICITY; Maloney J. M., ARXIV11040702V2; Maloney JD, 2010, ILLUSTRATIVE HANDBOOK OF GENERAL SURGERY, P99, DOI 10.1007/978-1-84882-089-0_14; Miyaoka A, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08LB16; Mizutani Y, 2008, JPN J APPL PHYS, V47, P6177, DOI 10.1143/JJAP.47.6177; Puig-de-Morales M, 2004, AM J PHYSIOL-CELL PH, V287, pC643, DOI 10.1152/ajpcell.00070.2004; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; Takahashi R, 2014, ADV ROBOTICS, V28, P449, DOI 10.1080/01691864.2013.876933	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							037001	10.7567/JJAP.54.037001		5	Physics, Applied	Physics	CF8FT	WOS:000352792200068		
J	Fujino, M; Hidenori, T; Suga, T				Fujino, Masahisa; Hidenori, Terasaka; Suga, Tadatomo			Fabrication of carbon nanotube bump interconnects for flexible multilayer substrates	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CLASSIFIED CATALYST NANOPARTICLES; AG ION IRRADIATION; ELECTRICAL-PROPERTIES; TECHNOLOGIES; CU	Bump-shaped vertically aligned carbon nanotubes were fabricated as bump interconnect structures on flexible substrates for flexible multilayer substrates. These structures were bonded and transferred by the surface activated bonding method. In this paper, the fabrication process and mechanical properties of these structures are reported. (C) 2015 The Japan Society of Applied Physics	[Fujino, Masahisa; Hidenori, Terasaka; Suga, Tadatomo] Univ Tokyo, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan	Fujino, M (reprint author), Univ Tokyo, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan.	fujino.masahisa@su.t.u-tokyo.ac.jp	Suga, Tadatomo/F-9925-2010	Suga, Tadatomo/0000-0002-1029-0326			Wang XG, 2010, J ALLOY COMPD, V508, P463, DOI 10.1016/j.jallcom.2010.08.094; Wei BQ, 2003, APPL PHYS LETT, V83, P3581, DOI 10.1063/1.1622781; Yung KP, 2009, DIAM RELAT MATER, V18, P1109, DOI 10.1016/j.diamond.2009.02.022; Oppermann H, 2012, MICROELECTRON RELIAB, V52, P356, DOI 10.1016/j.microrel.2011.06.027; Howlader MMR, 2010, MATER LETT, V64, P445, DOI 10.1016/j.matlet.2009.11.044; Zhao CC, 2009, CORROS SCI, V51, P2120, DOI 10.1016/j.corsci.2009.05.043; Liu LF, 2009, NANO LETT, V9, P4352, DOI 10.1021/nl902619q; Higurashi E, 2009, IEEE J SEL TOP QUANT, V15, P1500, DOI 10.1109/JSTQE.2009.2020812; Yokoyama D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2824390; Fu YF, 2012, MATER LETT, V72, P78, DOI 10.1016/j.matlet.2011.12.026; Awano Y, 2006, IEICE T ELECTRON, VE89C, P1499, DOI 10.1093/ietele/e89-c.11.1499; Awano Y, 2006, PHYS STATUS SOLIDI A, V203, P3611, DOI 10.1002/pssa.200622415; Fujino M., 2012, 12 IEEE NANO, P1; Fujino M., 2012, P 3 IEEE INT WORKSH, P159; Horibe M, 2004, JPN J APPL PHYS 1, V43, P6499, DOI 10.1143/JJAP.43.6499; Jiang H., 2007, P 57 ECTC, P463; Jin HJ, 2007, ADV ENG MATER, V9, P849, DOI 10.1002/adem.200700177; Johnson RD, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/6/065703; Kondo D, 2006, CHEM PHYS LETT, V422, P481, DOI 10.1016/j.cplett.2006.03.017; Kondo D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/43/435601; Mathew S, 2007, CARBON, V45, P2659, DOI 10.1016/j.carbon.2007.08.001; Mathew S, 2007, NUCL INSTRUM METH B, V264, P36, DOI 10.1016/j.nimb.2007.08.003; Nihei M, 2005, JPN J APPL PHYS 1, V44, P1626, DOI 10.1143/JJAP.44.1626; Pugh DV, 2003, J MATER RES, V18, P216, DOI 10.1557/JMR.2003.0030; Rodriguez-Manzo JA, 2009, P NATL ACAD SCI USA, V106, P4591, DOI 10.1073/pnas.0900960106; Soga I., 2008, P 58 EL COMP TECHN C, P1390; Takigawa R, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.112201; Warner JH, 2009, ACS NANO, V3, P1557, DOI 10.1021/nn900362a	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030205	10.7567/JJAP.54.030205		4	Physics, Applied	Physics	CF8FT	WOS:000352792200008		
J	Fujita, S				Fujita, Shizuo			Wide-bandgap semiconductor materials: For their full bloom	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Review							FIELD-EFFECT TRANSISTORS; LIGHT-EMITTING-DIODES; VAPOR-PHASE EPITAXY; BASAL-PLANE DISLOCATION; MOLECULAR-BEAM EPITAXY; BETA-GA2O3 SINGLE-CRYSTALS; BULK GAN CRYSTALS; NA FLUX METHOD; LASER-DIODES; ELECTRICAL-PROPERTIES	Wide-bandgap semiconductors are expected to be applied to solid-state lighting and power devices, supporting a future energy-saving society. While GaN-based white LEDs have rapidly become widespread in the lighting industry, SiC- and GaN-based power devices have not yet achieved their popular use, like GaN-based white LEDs for lighting, despite having reached the practical phase. What are the issues to be addressed for such power devices? In addition, other wide-bandgap semiconductors such as diamond and oxides are attracting focusing interest due to their promising functions especially for power-device applications. There, however, should be many unknown phenomena and problems in their defect, surface, and interface properties, which must be addressed to fully exploit their functions. In this review, issues of wide-bandgap semiconductors to be addressed in their basic properties are examined toward their "full bloom". (C) 2015 The Japan Society of Applied Physics	Kyoto Univ, Photon & Elect Sci & Engn Ctr, Kyoto 6158520, Japan	Fujita, S (reprint author), Kyoto Univ, Photon & Elect Sci & Engn Ctr, Kyoto 6158520, Japan.	fujitasz@kuee.kyoto-u.ac.jp					Amano H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.050001; Amano H., 2012, 6 WID BANDG SEM WORK; Taniyasu Y, 2006, NATURE, V441, P325, DOI 10.1038/nature04760; Fukuda K, 2004, APPL PHYS LETT, V84, P2088, DOI 10.1063/1.1682680; Uemoto Y, 2007, IEEE T ELECTRON DEV, V54, P3393, DOI 10.1109/TED.2007.908601; Sharma YK, 2013, IEEE ELECTR DEVICE L, V34, P175, DOI 10.1109/LED.2012.2232900; NAKAMURA S, 1992, JPN J APPL PHYS 2, V31, pL1457; NAKAMURA S, 1991, JPN J APPL PHYS 2, V30, pL1705; Sumakeris JJ, 2006, MATER SCI FORUM, V527-529, P141; Mishra UK, 2002, P IEEE, V90, P1022, DOI 10.1109/JPROC.2002.1021567; Funaki T, 2012, IEICE ELECTRON EXPR, V9, P1835, DOI 10.1587/elex.9.1835; Hirayama H, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.031002; Hashimoto T, 2007, NAT MATER, V6, P568, DOI 10.1038/nmat1955; Oto T, 2010, NAT PHOTONICS, V4, P767, DOI [10.1038/nphoton.2010.220, 10.1038/NPHOTON.2010.220]; Pengelly RS, 2012, IEEE T MICROW THEORY, V60, P1764, DOI 10.1109/TMTT.2012.2187535; Iwasaki T, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.091301; Lipkin LA, 2002, MATER SCI FORUM, V389-3, P985; Storasta L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2472530; JEON H, 1991, APPL PHYS LETT, V59, P3619, DOI 10.1063/1.105625; Lelis A, 2011, ECS TRANSACTIONS, V41, P203, DOI 10.1149/1.3631498; Schorner R, 1999, IEEE ELECTR DEVICE L, V20, P241, DOI 10.1109/55.761027; Tawara T, 2004, MATER SCI FORUM, V457-460, P565; Dwilinski R, 2011, PHYS STATUS SOLIDI A, V208, P1489, DOI 10.1002/pssa.201001196; Narukawa Y, 2002, JPN J APPL PHYS 2, V41, pL371, DOI 10.1143/JJAP.41.L371; IVANOV PA, 1992, SEMICOND SCI TECH, V7, P863, DOI 10.1088/0268-1242/7/7/001; Porowski S, 1996, J CRYST GROWTH, V166, P583, DOI 10.1016/0022-0248(96)00116-9; Nakamura S, 1996, JPN J APPL PHYS 2, V35, pL74, DOI 10.1143/JJAP.35.L74; Araghchini M, 2013, IEEE T POWER ELECTR, V28, P4182, DOI 10.1109/TPEL.2013.2237791; Krames MR, 2007, J DISP TECHNOL, V3, P160, DOI 10.1109/JDT.2007.895339; Oshima T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.011605; Ueda N, 1997, APPL PHYS LETT, V70, P3561, DOI 10.1063/1.119233; Suzuki N, 2013, J CRYST GROWTH, V364, P30, DOI 10.1016/j.jcrysgro.2012.11.065; Kaneta A, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4737883; Ikeda N, 2010, P IEEE, V98, P1151, DOI 10.1109/JPROC.2009.2034397; Akasaka S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.080215; Porowski S, 1997, J CRYST GROWTH, V178, P174, DOI 10.1016/S0022-0248(97)00072-9; Akasaki I, 2006, JPN J APPL PHYS 1, V45, P9001, DOI 10.1143/JJAP.45.9001; Kimoto T, 2008, PHYS STATUS SOLIDI B, V245, P1327, DOI 10.1002/pssb.200844076; Trew RJ, 2002, P IEEE, V90, P1032, DOI 10.1109/JPROC.2002.1021568; Nakamura S, 1998, JPN J APPL PHYS 2, V37, pL309, DOI 10.1143/JJAP.37.L309; Skowronski M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2159578; Fujito K, 2009, J CRYST GROWTH, V311, P3011, DOI 10.1016/j.jcrysgro.2009.01.046; Ozgur U, 2010, P IEEE, V98, P1255, DOI 10.1109/JPROC.2010.2044550; DAVIS RF, 1991, P IEEE, V79, P677, DOI 10.1109/5.90132; Kaneta A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125317; Higashiwaki M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821858; Aida H, 2008, JPN J APPL PHYS, V47, P8506, DOI 10.1143/JJAP.47.8506; Katayama K, 1998, APPL PHYS LETT, V73, P102, DOI 10.1063/1.121781; Matsunami H, 1997, MAT SCI ENG R, V20, P125, DOI 10.1016/S0927-796X(97)00005-3; Simin G, 2001, APPL PHYS LETT, V79, P2651, DOI 10.1063/1.1412282; Miyazawa T, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3517487; Johnson MAL, 1996, J ELECTRON MATER, V25, P855, DOI 10.1007/BF02666649; White ME, 2008, J VAC SCI TECHNOL A, V26, P1300, DOI 10.1116/1.2966423; GEIS MW, 1991, P IEEE, V79, P669, DOI 10.1109/5.90131; Shinohara D, 2008, JPN J APPL PHYS, V47, P7311, DOI 10.1143/JJAP.47.73111; Hirayama H, 2009, PHYS STATUS SOLIDI A, V206, P1176, DOI 10.1002/pssa.200880961; Yamaguchi K, 2004, SOLID STATE COMMUN, V131, P739, DOI 10.1016/j.ssc.2004.07.030; Ha S, 2002, J CRYST GROWTH, V244, P257, DOI 10.1016/S0022-0248(02)01706-2; Sasaki K, 2014, J CRYST GROWTH, V392, P30, DOI 10.1016/j.jcrysgro.2014.02.002; Binari SC, 2001, IEEE T ELECTRON DEV, V48, P465, DOI 10.1109/16.906437; Shimamura K, 2005, JPN J APPL PHYS 2, V44, pL7, DOI 10.1143/JJAP.44.L7; Hiyoshi T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.041101; Hayashi T, 2012, J APPL PHYS, V112, DOI 10.1063/1.4748315; Hoshino Y, 2012, PHYS STATUS SOLIDI A, V209, P1761, DOI 10.1002/pssa.201200053; Selvaraj SL, 2009, IEEE ELECTR DEVICE L, V30, P587, DOI 10.1109/LED.2009.2018288; Mukai T, 1999, JPN J APPL PHYS 1, V38, P3976, DOI 10.1143/JJAP.38.3976; Danno K, 2004, JPN J APPL PHYS 2, V43, pL969, DOI 10.1143/JJAP.43.L969; Kambayashi H, 2010, SOLID STATE ELECTRON, V54, P660, DOI 10.1016/j.sse.2010.01.001; HAASE MA, 1991, APPL PHYS LETT, V59, P1272, DOI 10.1063/1.105472; Ohno T, 2004, J CRYST GROWTH, V271, P1, DOI 10.1016/j.jcrysgro.2004.04.044; Vetury R, 2001, IEEE T ELECTRON DEV, V48, P560, DOI 10.1109/16.906451; Narukawa Y, 1997, APPL PHYS LETT, V70, P981, DOI 10.1063/1.118455; Fujita S, 2014, J CRYST GROWTH, V401, P588, DOI 10.1016/j.jcrysgro.2014.02.032; Hwang JI, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.071003; Hayashi T, 2011, J APPL PHYS, V109, DOI 10.1063/1.3583657; BHATNAGAR M, 1993, IEEE T ELECTRON DEV, V40, P645, DOI 10.1109/16.199372; Yano H, 1999, IEEE ELECTR DEVICE L, V20, P611, DOI 10.1109/55.806101; Kimoto T, 2005, JPN J APPL PHYS 1, V44, P1213, DOI 10.1143/JJAP.44.1213; Oka T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.021002; Segawa Y, 1997, PHYS STATUS SOLIDI B, V202, P669, DOI 10.1002/1521-3951(199708)202:2<669::AID-PSSB669>3.0.CO;2-T; AMANO H, 1989, JPN J APPL PHYS 2, V28, pL2112; Millan J, 2014, IEEE T POWER ELECTR, V29, P2155, DOI 10.1109/TPEL.2013.2268900; Delaney KT, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3133359; Ekimov EA, 2004, NATURE, V428, P542, DOI 10.1038/nature02449; Orita M, 2000, APPL PHYS LETT, V77, P4166, DOI 10.1063/1.1330559; Piprek J, 2010, PHYS STATUS SOLIDI A, V207, P2217, DOI 10.1002/pssa.201026149; Saks NS, 2000, APPL PHYS LETT, V76, P2250, DOI 10.1063/1.126311; Albrecht JD, 1999, J APPL PHYS, V86, P6864, DOI 10.1063/1.371764; Mizutani T, 2003, IEEE T ELECTRON DEV, V50, P2015, DOI 10.1109/TED.2003.816549; Kumagai Y, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.055504; Kasai J, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.082102; AMANO H, 1986, APPL PHYS LETT, V48, P353, DOI 10.1063/1.96549; Niwa H, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.064001; MORKOC H, 1994, J APPL PHYS, V76, P1363; Ichikawa S, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.101301; Buttay C, 2011, MATER SCI ENG B-ADV, V176, P283, DOI 10.1016/j.mseb.2010.10.003; Okayama T, 2008, SOLID STATE ELECTRON, V52, P164, DOI 10.1016/j.sse.2007.07.031; Higashiwaki M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3674287; Shen YC, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2785135; Kato H, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.055502; Klein PB, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2170144; Banal RG, 2010, PHYS STATUS SOLIDI C, V7, DOI 10.1002/pssc.200983609; Bano E, 2000, SOLID STATE ELECTRON, V44, P63, DOI 10.1016/S0038-1101(99)00202-6; Chanthaphan A, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4794942; Chow T. P., 2014, ECS Transactions, V60, DOI 10.1149/06001.1039ecst; DasGupta S, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3611029; Fasol G., 1997, BLUE LASER DIODE GAN; Freedsman JJ, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.041003; Fujita Shizuo, 2009, Oyo Buturi, V78; FUJITA S, 1989, J CRYST GROWTH, V94, P102, DOI 10.1016/0022-0248(89)90608-8; Hayashi T., 2013, THESIS KYOTOU U KYOT, P17; Hirayama Hideki, 2011, Oyo Buturi, V80; Hirayama H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.051101; Ikeda N., 2008, FURUKAWA ELECT REV, V122, P20; Inoue K., 2010, SEI TECH REV, V177, P97; ITOH S, 1993, JPN J APPL PHYS 2, V32, pL1530; ITOH S, 1994, JPN J APPL PHYS 2, V33, pL639, DOI 10.1143/JJAP.33.L639; Iwakami S, 2007, JPN J APPL PHYS 2, V46, pL587, DOI 10.1143/JJAP.46.L587; Kamimura T, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4876920; Kaneko K, 2013, J APPL PHYS, V113, DOI 10.1063/1.4807651; Kaneko K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.075501; Kaneko K., 2014, 32 INT C PHYS SEM SE; Kaneta A, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.102102; Kasu M, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.110209; Kato H, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3005639; Kawakami Y., 2012, 6 WID BANDG SEM WORK; KAWARADA H, 1994, APPL PHYS LETT, V65, P1563, DOI 10.1063/1.112915; Kikuchi RH, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4891166; Kimoto T., 2011, 13 NITR SEM APPL WOR; Kimoto T, 1999, MAT SCI ENG B-SOLID, V61-2, P349, DOI 10.1016/S0921-5107(98)00532-7; Kimoto T., 2012, 6 WID BANDG SEM WORK; Kozuka Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4748306; Kozuka Y, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205411; Kuroda N., 1987, 19 C SOL STAT DEV MA, P227; Lelis A, 2013, ECS TRANSACTIONS, V58, P87, DOI 10.1149/05804.0087ecst; Li JQ, 2012, J CRYST GROWTH, V353, P63, DOI 10.1016/j.jcrysgro.2012.05.014; Lochner Z, 2013, PHYS STATUS SOLIDI A, V210, P1768, DOI 10.1002/pssa.201329013; Maeda M., 2013, SEISAN GIJUTSU, V65, P75; Maeda N., 2011, 12 NITR SEM APPL WOR; Makino T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.085312; Matsunami H., 2006, NIHON KESSHO SEICHO, V33, P12; Matsuoka T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.100200; MITSUHASHI H, 1985, JPN J APPL PHYS 2, V24, pL864, DOI 10.1143/JJAP.24.L864; Mori Y, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000911; Mori Y., 2010, PHYS STATUS SOLIDI A, V207, P1269; Mori Y, 2012, J CRYST GROWTH, V350, P72, DOI 10.1016/j.jcrysgro.2011.12.026; Nagashima T, 2012, J CRYST GROWTH, V350, P75, DOI 10.1016/j.jcrysgro.2011.12.027; Nakahara Ken, 2011, Oyo Buturi, V80; Nakamura S, 1999, SEMICOND SCI TECH, V14, pR27, DOI 10.1088/0268-1242/14/6/201; NAKAMURA S, 1995, JPN J APPL PHYS 2, V34, pL1332; NAKAMURA S, 1994, APPL PHYS LETT, V64, P1687, DOI 10.1063/1.111832; Nakamura T., 2011, 13 NITR SEM APPL WOR; Nakayama K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.04DF04; Nanishi Y, 2014, NAT PHOTONICS, V8, P884; Narukawa Y, 2007, JPN J APPL PHYS 2, V46, pL963, DOI 10.1143/JJAP.46.L963; Niki Shigeru, 2008, Oyo Buturi, V77; Nomura T, 2012, J CRYST GROWTH, V350, P69, DOI 10.1016/j.jcrysgro.2011.12.025; Ohira S, 2007, PHYS STATUS SOLIDI C, V4, P2306, DOI 10.1002/pssc.200674877; Ohira S, 2006, THIN SOLID FILMS, V496, P53, DOI 10.1016/j.tsf.2005.08.230; Ohno Y., 2002, ED2001187 IEICE; Ohno Y., 2012, 81 WORKSH MAT, P17; Ohta K., 2012, OYO BUTURI, V81, P493; Ohtani Noboru, 2013, Oyo Buturi, V82; Okamoto M, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.041302; Okumura H, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.095501; Okuno T, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000619; Oshima T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.070202; Oshima T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.120207; Oshima T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.051101; Oshima T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011202; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Pryde J. R., 2014, P 14 INTERSOCIETY C, P31; Saito W, 2007, IEEE ELECTR DEVICE L, V28, P676, DOI 10.1109/LED.2007.901665; SASAKI A, 1980, JPN J APPL PHYS, V19, P1695, DOI 10.1143/JJAP.19.1695; Sasaki K, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.086502; Sasaki K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.035502; Sato S, 2014, JPN J APPL PHYS, V53, P4, DOI 10.7567/JJAP.53.08LA01; Seki M., 2014, JPN J APPL PHYS, V53; Senzaki J, 2013, MATER SCI FORUM, V740-742, P621, DOI 10.4028/www.scientific.net/MSF.740-742.621; Shen XA, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3554428; Shibahara K., 1987, NIHON KESSHO SEICHO, V13, P226; SHIBAHARA K, 1987, JPN J APPL PHYS 2, V26, pL1815; Shikata Shinichi, 2013, Oyo Buturi, V82; SHIOMI H, 1989, JPN J APPL PHYS 2, V28, pL2153; Song HZ, 2012, CRYST GROWTH DES, V12, P1703, DOI 10.1021/cg300077g; Suzuki N, 2007, PHYS STATUS SOLIDI C, V4, P2310, DOI 10.1002/pssc.200674884; Takasu H., 2013, OYO BUTURI, V82, P227; TAKEDA Y, 1981, JPN J APPL PHYS, V20, P189; Uchida K, 2012, AIP ADV, V2, DOI 10.1063/1.4769082; Ueda T., 2013, KEC JOHO, V224, P35; Ueno K, 1999, MAT SCI ENG B-SOLID, V61-2, P472, DOI 10.1016/S0921-5107(98)00558-3; Umeda T, 2013, ECS TRANSACTIONS, V58, P55, DOI 10.1149/05807.0055ecst; Umeda T., 2013, ECS T, V50, P305; Umezawa H, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FP06; Usui A, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JB02; Usui A, 2002, PHYS STATUS SOLIDI A, V194, P572, DOI 10.1002/1521-396X(200212)194:2<572::AID-PSSA572>3.0.CO;2-B; Villora E. G., 2004, J CRYST GROWTH, V270, P420; Villora E. G., 2006, NIHON KESSHO SEICHO, V33, P147; Wuerfl J, 2011, MICROELECTRON RELIAB, V51, P1710, DOI 10.1016/j.microrel.2011.07.017; Yamane H, 1997, CHEM MATER, V9, P413, DOI 10.1021/cm960494s; Yano H, 2001, APPL PHYS LETT, V78, P374, DOI 10.1063/1.1340861; Yano H, 2011, MATER SCI FORUM, V679-680, P603, DOI 10.4028/www.scientific.net/MSF.679-680.603; Yano H, 2000, MATER SCI FORUM, V338-3, P1109; Yasukawa Electric Corporation, 2012, Press Release, Patent No. 342857; Yoshida T, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000953; Yoshikawa A, 2004, J CRYST GROWTH, V260, P67, DOI 10.1016/j.jcrysgro.2003.08.031; Yoshikawa T., 2012, 80 WORKSH MAT, P29; Yoshizumi Y., 2011, SEI TECH REV, V179, P48	208	4	4	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030101	10.7567/JJAP.54.030101		12	Physics, Applied	Physics	CF8FT	WOS:000352792200001		
J	Fukano, H; Kushida, Y; Taue, S				Fukano, Hideki; Kushida, Yohei; Taue, Shuji			Sensitivity improvement of optical-fiber temperature sensor with solid cladding material based on multimode interference	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MODAL INTERFEROMETER; LOOP MIRROR; STRAIN; TRANSMISSION; GRATINGS	We have developed a simple, high-sensitivity optical-fiber temperature sensor based on multimode interference (MMI). The fabricated MMI structure comprises three segmented fibers: a single-mode fiber (SMF); a large-core multimode fiber (MMF), whose outer surface is coated with a temperature-sensitive material; and another SMF. Fluoroacrylate and silicone rubber are tested as temperature-sensitive cladding materials. The silicone rubber coating exhibits a large shift in interference wavelength with temperature, producing a very fine temperature resolution as low as 0.01 degrees C. (C) 2015 The Japan Society of Applied Physics	[Fukano, Hideki; Kushida, Yohei; Taue, Shuji] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Fukano, H (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	fukano@okayama-u.ac.jp	FUKANO, Hideki/B-2600-2011				Frazao O, 2006, IEEE PHOTONIC TECH L, V18, P2407, DOI 10.1109/LPT.2006.886139; Ng MN, 2002, OPT COMMUN, V208, P321, DOI 10.1016/S0030-4018(02)01597-3; Sim LC, 2005, THERMOCHIM ACTA, V430, P155, DOI 10.1016/j.tca.2004.12.024; NIETOVESPERINAS M, 1990, OPT LETT, V15, P1261, DOI 10.1364/OL.15.001261; Zhu JJ, 2010, IEEE SENS J, V10, P1415, DOI 10.1109/JSEN.2010.2042592; BEEVERS RB, 1964, J POLYM SCI PART A, V2, P5257, DOI 10.1002/pol.1964.100021221; Wang Q, 2008, J LIGHTWAVE TECHNOL, V26, P512, DOI 10.1109/JLT.2007.915205; Antonio-Lopez JE, 2010, OPT LETT, V35, P324, DOI 10.1364/OL.35.000324; Lu P, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3115029; Kersey AD, 1997, J LIGHTWAVE TECHNOL, V15, P1442, DOI 10.1109/50.618377; Choi HY, 2008, OPT LETT, V33, P2455, DOI 10.1364/OL.33.002455; Geng YF, 2011, IEEE SENS J, V11, P2891, DOI 10.1109/JSEN.2011.2146769; Kim YJ, 2002, OPT LETT, V27, P1297, DOI 10.1364/OL.27.001297; Silva S, 2012, APPL OPTICS, V51, P3236, DOI 10.1364/AO.51.003236; Born M., 1970, PRINCIPLES OPTICS, P47; Choi DI, 2004, J APPL POLYM SCI, V93, P2082, DOI 10.1002/app.20680; Fukano H, 2012, IEICE ELECTRON EXPR, V9, P302, DOI 10.1587/elex.9.302; Fukano H, 2013, IEICE ELECTRON EXPR, V10, DOI 10.1587/elex.10.20130812; Jung Y, 2006, MEAS SCI TECHNOL, V17, P1129, DOI 10.1088/0957-0233/17/5/S32; Kim MJ, 2008, IEEE PHOTONIC TECH L, V20, P1290, DOI 10.1109/LPT.2008.926889; Shu W., 2002, J LIGHTWAVE TECHNOL, V20, P255; Sun GY, 2007, IEEE PHOTONIC TECH L, V19, P2027, DOI 10.1109/LPT.2007.908775; Taue S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.04DG14; Web, 2001, [No title captured], Patent No. 6222972; Yuan LB, 2000, SENSOR ACTUAT A-PHYS, V86, P2, DOI 10.1016/S0924-4247(00)00357-5	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							032502	10.7567/JJAP.54.032502		5	Physics, Applied	Physics	CF8FT	WOS:000352792200043		
J	Furusawa, K; Ishikawa, Y; Ikeda, H; Fujito, K; Chichibu, SF				Furusawa, Kentaro; Ishikawa, Yoichi; Ikeda, Hirotaka; Fujito, Kenji; Chichibu, Shigefusa F.			Local excitation and emission dynamics of an isolated single basal-plane stacking-fault in GaN studied by spatio-time-resolved cathodoluminescence	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							VAPOR-PHASE EPITAXY; GALLIUM NITRIDE; QUANTUM-WELLS; COLLECTION; REDUCTION; EXCITONS; NONPOLAR; HVPE	Local excitation and emission dynamics of an isolated "Type-I-1" basal-plane stacking-fault (BSF) in very low dislocation density GaN were studied using spatio-time-resolved cathodoluminescence. The low temperature lifetime of the BSF emission was quantified to be 640 ps. The carrier diffusion length was estimated by observing the temporal delay of the BSF peak relative to the free-exciton signal as a function of distance from the BSF. The results indicate that the near-band-edge emission leads to subsequent optical excitation of the BSF that increases the apparent diffusion length. Limiting the observation volume can improve the spatial resolution. (C) 2015 The Japan Society of Applied Physics	[Furusawa, Kentaro; Ishikawa, Yoichi; Chichibu, Shigefusa F.] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Ikeda, Hirotaka; Fujito, Kenji] Mitsubishi Chem Corp, Gallium Nitride Dept, Ushi Ku, Ibaraki 3001295, Japan	Furusawa, K (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan.	chichibulab@yahoo.co.jp			NEDO programs by METI; MEXT [23656206]; Asahi Glass Foundation, Japan; AOARD/AFOSR Grants	The authors would like to thank Dr. K. Hazu and M. Tashiro for their help in the experiments. This work was supported in part by NEDO programs by METI, Grant-in-Aid for Scientific Research No. 23656206 from MEXT, The Asahi Glass Foundation, Japan, and AOARD/AFOSR Grants monitored by Dr. G. Jessen.	Liu R, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1852085; Mei J, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2193352; EVERHART TE, 1971, J APPL PHYS, V42, P5837, DOI 10.1063/1.1660019; KLEIN CA, 1968, J APPL PHYS, V39, P2029, DOI 10.1063/1.1656484; Chichibu S, 1996, APPL PHYS LETT, V69, P4188, DOI 10.1063/1.116981; Corfdir P, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3142396; Corfdir P, 2009, J APPL PHYS, V105, DOI 10.1063/1.3075596; Speck JS, 2009, MRS BULL, V34, P304, DOI 10.1557/mrs2009.91; Fujito K, 2009, J CRYST GROWTH, V311, P3011, DOI 10.1016/j.jcrysgro.2009.01.046; Haskell BA, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866225; Fujito K, 2008, PHYS STATUS SOLIDI A, V205, P1056, DOI 10.1002/pssa.200778709; Takeuchi T, 1997, JPN J APPL PHYS 2, V36, pL382, DOI 10.1143/JJAP.36.L382; Stampfl C, 1998, PHYS REV B, V57, P15052; Rebane YT, 1997, PHYS STATUS SOLIDI A, V164, P141, DOI 10.1002/1521-396X(199711)164:1<141::AID-PSSA141>3.0.CO;2-G; Chichibu SF, 2013, J APPL PHYS, V113, DOI 10.1063/1.4807906; Chichibu SF, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4823826; Chichibu SF, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2998580; DONOLATO C, 1981, PHYS STATUS SOLIDI A, V65, P649, DOI 10.1002/pssa.2210650231; Furusawa K, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4817297; Harima H, 2002, J PHYS-CONDENS MAT, V14, pR967, DOI 10.1088/0953-8984/14/38/201; Ino N, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3040310; Ishikawa Y, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4767357; Kagaya M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.111002; Kaneta A, 2001, JPN J APPL PHYS 1, V40, P110, DOI 10.1143/JJAP.40.110; Merano M, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2008975; Motoki K, 2007, J CRYST GROWTH, V305, P377, DOI 10.1016/j.jcrysgro.2007.03.038; Onuma T, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3701368; Yoshida T, 2008, PHYS STATUS SOLIDI A, V205, P1053, DOI 10.1002/pssa.200778431	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030303	10.7567/JJAP.54.030303		4	Physics, Applied	Physics	CF8FT	WOS:000352792200026		
J	He, R; Fujino, M; Yamauchi, A; Suga, T				He, Ran; Fujino, Masahisa; Yamauchi, Akira; Suga, Tadatomo			Novel hydrophilic SiO2 wafer bonding using combined surface-activated bonding technique	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SILICON-ON-INSULATOR; LOW-TEMPERATURE; MEDIUM-VACUUM; PLASMA ACTIVATION; THERMAL OXIDE; MODEL; LAYER	Low-temperature hydrophilic SiO2-SiO2 wafer bonding has been performed in vacuum by a new combined surface-activated bonding (SAB) technique. In this technique, wafers are irradiated by ion beam bombardment and simultaneously deposited with silicon by in situ silicon sputter deposition, and then terminated with Si-OH groups by water vapor exposure prior to bonding in vacuum. A surface energy of more than 1 J/m(2) was achieved by 200 degrees C postbonding annealing. A void-free oxide intermediate layer with a thickness of about 15 nm was observed at the bonding interface by transmission electron microscopy (TEM). The increased bonding energy can be attributed to the greater number of Si-OH formed through hydroxylation of the silicon deposited on the SiO2 surfaces. (C) 2015 The Japan Society of Applied Physics	[He, Ran; Fujino, Masahisa; Suga, Tadatomo] Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Yamauchi, Akira] Bondtech Co Ltd, Kyoto 611003, Japan	He, R (reprint author), Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan.	he.ran@su.t.u-tokyo.ac.jp; suga@pe.t.u-tokyo.ac.jp	Suga, Tadatomo/F-9925-2010	Suga, Tadatomo/0000-0002-1029-0326			LASKY JB, 1986, APPL PHYS LETT, V48, P78, DOI 10.1063/1.96768; Tong QY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2240232; Tong QY, 1999, ADV MATER, V11, P1409, DOI 10.1002/(SICI)1521-4095(199912)11:17<1409::AID-ADMA1409>3.0.CO;2-W; MASZARA WP, 1988, J APPL PHYS, V64, P4943, DOI 10.1063/1.342443; Christiansen SH, 2006, P IEEE, V94, P2060, DOI 10.1109/JPROC.2006.886026; Tong QY, 1996, J ELECTROCHEM SOC, V143, P1773, DOI 10.1149/1.1836715; Fournel F, 2012, J APPL PHYS, V111, DOI 10.1063/1.4716030; Moriceau H, 2012, MICROELECTRON RELIAB, V52, P331, DOI 10.1016/j.microrel.2011.08.004; Masteika V, 2014, ECS J SOLID STATE SC, V3, pQ42, DOI 10.1149/2.007403jss; ARMISTEA.CG, 1969, J PHYS CHEM-US, V73, P3947, DOI 10.1021/j100845a065; Chong GY, 2011, J ELECTROCHEM SOC, V158, pH137, DOI 10.1149/1.3507291; Dragoi V., 2006, ECS T, V3, P147, DOI 10.1149/1.2357064; MITANI K, 1992, APPL PHYS A-MATER, V54, P543, DOI 10.1007/BF00324337; Plach T, 2013, J APPL PHYS, V113, DOI 10.1063/1.4794319; Rauer C, 2013, ECS J SOLID STATE SC, V2, pQ147, DOI 10.1149/2.004309jss; Sabbione C, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752258; Shigetou A., 2010, IEEE 60 EL COMP TECH, P872; Shigetou A., 2011, IEEE 61 EL COMP TECH, P32; Suni T, 2002, J ELECTROCHEM SOC, V149, pG348, DOI 10.1149/1.1477209; Takagi H., 2008, ECS T, V16, P531, DOI 10.1149/1.2982908; Tan CM, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2185467; Tan CS, 2011, J ELECTROCHEM SOC, V158, pH1107, DOI 10.1149/2.005111jes; Tan CS, 2005, ELECTROCHEM SOLID ST, V8, pG1, DOI 10.1149/1.1825292; Tan CS, 2003, APPL PHYS LETT, V82, P2649, DOI 10.1063/1.1569657; Tan CS, 2005, ELECTROCHEM SOLID ST, V8, pG362, DOI 10.1149/1.2119549; Vincent S, 2010, J APPL PHYS, V107, DOI 10.1063/1.3357389; Wang CX, 2012, MICROELECTRON RELIAB, V52, P347, DOI 10.1016/j.microrel.2011.09.005; Wiemer M, 2012, HDB WAFER BONDING, P101; Yu WB, 2005, J MICROMECH MICROENG, V15, P1001, DOI 10.1088/0960-1317/15/5/015; Yu WB, 2005, IEEE T ADV PACKAGING, V28, P650, DOI 10.1109/TADVP.2005.858306	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030218	10.7567/JJAP.54.030218		5	Physics, Applied	Physics	CF8FT	WOS:000352792200021		
J	Higurashi, E; Okumura, K; Nakasuji, K; Suga, T				Higurashi, Eiji; Okumura, Ken; Nakasuji, Kaori; Suga, Tadatomo			Surface activated bonding of GaAs and SiC wafers at room temperature for improved heat dissipation in high-power semiconductor lasers	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FINITE-ELEMENT-ANALYSIS; THERMAL MANAGEMENT; SILICON	Thermal management of high-power semiconductor lasers is of great importance since the output power and beam quality are affected by the temperature rise of the gain region. Thermal simulations of a vertical-external-cavity surface-emitting laser by a finite-element method showed that the solder layer between the semiconductor thin film consisting of the gain region and a heat sink has a strong influence on the thermal resistance and direct bonding is preferred to achieve effective heat dissipation. To realize thin-film semiconductor lasers directly bonded on a high-thermal-conductivity substrate, surface-activated bonding using an argon fast atom beam was applied to the bonding of gallium arsenide (GaAs) and silicon carbide (SiC) wafers. The GaAs/SiC structure was demonstrated in the wafer scale (2 in. in diameter) at room temperature. The cross-sectional transmission electron microscopy observations showed that void-free bonding interfaces were achieved. (C) 2015 The Japan Society of Applied Physics	[Higurashi, Eiji; Okumura, Ken; Nakasuji, Kaori; Suga, Tadatomo] Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan	Higurashi, E (reprint author), Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan.	eiji@su.t.u-tokyo.ac.jp	Suga, Tadatomo/F-9925-2010	Suga, Tadatomo/0000-0002-1029-0326	Japan Society for the Promotion of Science (JSPS) [25289085]	Part of this study was supported by a Grant-in-Aid for Scientific Research (B) (25289085) from the Japan Society for the Promotion of Science (JSPS).	Howlader MMR, 2001, J VAC SCI TECHNOL B, V19, P2114, DOI 10.1116/1.1414115; Hastie JE, 2003, IEEE PHOTONIC TECH L, V15, P894, DOI 10.1109/LPT.2003.813446; Kuznetsov M, 1997, IEEE PHOTONIC TECH L, V9, P1063, DOI 10.1109/68.605500; Takagi H, 1996, APPL PHYS LETT, V68, P2222, DOI 10.1063/1.115865; Liau ZL, 2000, APPL PHYS LETT, V77, P651, DOI 10.1063/1.127074; Chung TR, 1997, APPL SURF SCI, V117, P808; Chung TR, 1997, NUCL INSTRUM METH B, V121, P203, DOI 10.1016/S0168-583X(96)00546-0; Giet S, 2008, P SOC PHOTO-OPT INS, V6871, P87115, DOI 10.1117/12.761616; Higurashi E, 2012, ECS TRANSACTIONS, V50, P351, DOI 10.1149/05007.0351ecst; Higurashi E, 2007, P SOC PHOTO-OPT INS, V6717, pL7170, DOI 10.1117/12.754402; Kemp AJ, 2005, IEEE J QUANTUM ELECT, V41, P148, DOI 10.1109/JQE.2004.839706; Kemp AJ, 2008, IEEE J QUANTUM ELECT, V44, P125, DOI [10.1109/JQE.2007.911673, 10.1109/.JQE.2007.911673]; Liang J., 2014, P 4 IEEE INT WORKSH, P53; Liang J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873113; Mu F., 2014, P 4 IEEE INT WORKSH, P55; Nishida S., 2014, P 4 IEEE INT WORKSH, P54; Nishida S, 2014, MATER SCI FORUM, V778-780, P718, DOI 10.4028/www.scientific.net/MSF.778-780.718; Sandusky JV, 1996, IEEE PHOTONIC TECH L, V8, P313, DOI 10.1109/68.481101; Yagi K., 2014, P 4 IEEE INT WORKSH, P56; Zhang F., 2011, P 2011 INT C EL PACK, P95	20	0	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030207	10.7567/JJAP.54.030207		4	Physics, Applied	Physics	CF8FT	WOS:000352792200010		
J	Higurashi, E; Sasaki, Y; Kurayama, R; Suga, T; Doi, Y; Sawayama, Y; Hosako, I				Higurashi, Eiji; Sasaki, Yuta; Kurayama, Ryuji; Suga, Tadatomo; Doi, Yasuo; Sawayama, Yoshihiro; Hosako, Iwao			Room-temperature direct bonding of germanium wafers by surface-activated bonding method	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							IMPURITY-BAND DETECTORS; SILICON-WAFERS; GE; ADSORPTION; INSULATOR; FIELD; H2O	This paper reports the mechanical and electrical characteristics of Ge/Ge interfaces prepared by room-temperature surface-activated bonding (SAB). Bonded Ge/Ge wafer pairs with high bonding strength equivalent to that of the bulk material were achieved without any heat treatment. It was found that the bonding of Ge wafers was not sensitive to the background vacuum pressure in a wafer-bonding chamber compared with the bonding of Si wafers. The current-voltage characteristics and microstructures of bonded interfaces formed by SAB and low-temperature plasma activation bonding (PAB) were compared. It was demonstrated that junctions with very low resistivity can be obtained by SAB at room temperature. (C) 2015 The Japan Society of Applied Physics	[Higurashi, Eiji; Sasaki, Yuta; Kurayama, Ryuji; Suga, Tadatomo] Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Doi, Yasuo; Sawayama, Yoshihiro] Univ Tokyo, Coll Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Hosako, Iwao] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan	Higurashi, E (reprint author), Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan.	eiji@su.t.u-tokyo.ac.jp	Suga, Tadatomo/F-9925-2010	Suga, Tadatomo/0000-0002-1029-0326	Japan Society for the Promotion of Science (JSPS) [22360025]	Part of this study was supported by a Grant-in-Aid for Scientific Research (B) (22360025) from the Japan Society for the Promotion of Science (JSPS).	JACCODINE RJ, 1963, J ELECTROCHEM SOC, V110, P524, DOI 10.1149/1.2425806; MASZARA WP, 1988, J APPL PHYS, V64, P4943, DOI 10.1063/1.342443; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Takagi H, 1998, JPN J APPL PHYS 1, V37, P4197, DOI 10.1143/JJAP.37.4197; Vanhellemont J, 2007, J ELECTROCHEM SOC, V154, pH572, DOI 10.1149/1.2732221; Beeman JW, 2007, INFRARED PHYS TECHN, V51, P60, DOI 10.1016/j.infrared.2006.12.001; Takagi H, 1996, APPL PHYS LETT, V68, P2222, DOI 10.1063/1.115865; Bandaru J, 2002, INFRARED PHYS TECHN, V43, P353, DOI 10.1016/S1350-4495(02)00178-0; Bandaru Jordana, 2002, Proceedings of the SPIE - The International Society for Optical Engineering, V4486, DOI 10.1117/12.455106; Cho JH, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.113306; Haegel NM, 2003, J APPL PHYS, V93, P1305, DOI 10.1063/1.1529072; HUFFMAN JE, 1993, J CRYST GROWTH, V129, P525, DOI 10.1016/0022-0248(93)90486-G; ICHIKAWA T, 1978, JPN J APPL PHYS, V17, P1675, DOI 10.1143/JJAP.17.1675; Jung SJ, 2005, J PHYS CHEM B, V109, P24445, DOI 10.1021/jp054415o; Kanbe H, 2006, JPN J APPL PHYS 2, V45, pL644, DOI 10.1143/JJAP.45.L644; Kaneda H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.066503; Kim MJ, 2003, J ELECTRON MATER, V32, P849, DOI 10.1007/s11664-003-0199-7; KUHR HJ, 1987, SURF SCI, V189, P420, DOI 10.1016/S0039-6028(87)80462-4; Kurayama R., 2010, P 2 INT IEEE WORKSH, P451; Kurayama R., 2009, 70 AUT M, P1297; Petroff MD, 1986, United States Patent, Patent No. 4568960; REEVES GK, 1980, SOLID STATE ELECTRON, V23, P487, DOI 10.1016/0038-1101(80)90086-6; Sawayama Y., 2010, 35 INT C INFR MILL T; SUGA T, 1992, ACTA METALL MATER, V40, pS133, DOI 10.1016/0956-7151(92)90272-G; Tong QY, 2000, J ELECTRON MATER, V29, P928, DOI 10.1007/s11664-000-0183-4; Wada T., 2010, 35 INT C INFR MILL T; Watanabe K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.015701; WATSON DM, 1993, J APPL PHYS, V74, P4199, DOI 10.1063/1.354424; WU IC, 1991, APPL PHYS LETT, V58, P1431, DOI 10.1063/1.105189; Yu DS, 2006, J VAC SCI TECHNOL A, V24, P690, DOI 10.1116/1.2167978	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030213	10.7567/JJAP.54.030213		7	Physics, Applied	Physics	CF8FT	WOS:000352792200016		
J	Howlader, MMR; Deen, MJ; Suga, T				Howlader, Matiar M. R.; Deen, M. Jamal; Suga, Tadatomo			Nanobonding: A key technology for emerging applications in health and environmental sciences	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							BEAM SURFACE ACTIVATION; LEVEL TRANSIENT SPECTROSCOPY; FORMIC-ACID PRETREATMENT; FIELD-EFFECT TRANSISTORS; ROOM-TEMPERATURE; BONDING STRENGTH; DEEP-LEVEL; BUMPLESS INTERCONNECT; RAMAN SPECTROMETER; COPPER ELECTRODES	In this paper, surface-activation-based nanobonding technology and its applications are described. This bonding technology allows for the integration of electronic, photonic, fluidic and mechanical components into small form-factor systems for emerging sensing and imaging applications in health and environmental sciences. Here, we describe four different nanobonding techniques that have been used for the integration of various substrates-silicon, gallium arsenide, glass, and gold. We use these substrates to create electronic (silicon), photonic (silicon and gallium arsenide), microelectromechanical (glass and silicon), and fluidic (silicon and glass) components for biosensing and bioimaging systems being developed. Our nanobonding technologies provide void-free, strong, and nanometer scale bonding at room temperature or at low temperatures (<200 degrees C), and do not require chemicals, adhesives, or high external pressure. The interfaces of the nanobonded materials in ultra-high vacuum and in air correspond to covalent bonds, and hydrogen or hydroxyl bonds, respectively. (C) 2015 The Japan Society of Applied Physics	[Howlader, Matiar M. R.; Deen, M. Jamal] McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON L8S 4K1, Canada; [Deen, M. Jamal] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Kowloon, Hong Kong, Peoples R China; [Suga, Tadatomo] Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan	Howlader, MMR (reprint author), McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON L8S 4K1, Canada.	mrhowlader@ece.mcmaster.ca; jamal@mcmaster.ca; suga@pe.t.u-tokyo.ac.jp	Suga, Tadatomo/F-9925-2010	Suga, Tadatomo/0000-0002-1029-0326	Natural Science and Engineering Research Council of Canada; Canada Foundation for Innovation; Ontario Research Fund for Research Excellence Funding Grant; FedDev of Southern Ontario grant; Canada Research Chair program	This research is supported by Discovery Grants from the Natural Science and Engineering Research Council of Canada, an infrastructure grant from the Canada Foundation for Innovation, an Ontario Research Fund for Research Excellence Funding Grant, a FedDev of Southern Ontario grant and the Canada Research Chair program.	Alam AU, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/035010; Howlader MMR, 2001, J VAC SCI TECHNOL B, V19, P2114, DOI 10.1116/1.1414115; Shinwari MW, 2010, SENSORS-BASEL, V10, P1679, DOI 10.3390/s100301679; Howlader MMR, 2006, SENSOR ACTUAT A-PHYS, V127, P31, DOI 10.1016/j.sna.2005.11.003; El-Desouki M, 2009, SENSORS-BASEL, V9, P430, DOI 10.3390/s90100430; Tanaka N, 2009, IEEE T ADV PACKAGING, V32, P746, DOI 10.1109/TADVP.2009.2027420; Takagi H, 2001, J MICROMECH MICROENG, V11, P348, DOI 10.1088/0960-1317/11/4/311; El-Desouki MM, 2011, IEEE SENS J, V11, P1078, DOI 10.1109/JSEN.2010.2058846; Howlader MMR, 2011, IEEE J SEL TOP QUANT, V17, P689, DOI 10.1109/JSTQE.2010.2080261; Howlader MMR, 2007, IEEE T ADV PACKAGING, V30, P598, DOI 10.1109/TADVP.2007.906394; Deen MJ, 2006, J MATER SCI-MATER EL, V17, P549, DOI 10.1007/s10854-006-0001-8; Shinwari MW, 2007, MICROELECTRON RELIAB, V47, P2025, DOI 10.1016/j.microrel.2006.10.003; Campos FD, 2013, IEEE SENS J, V13, P1554, DOI 10.1109/JSEN.2012.2235827; [Anonymous], 2010, MOR THAN MOOR WHIT P; Howlader M, 2005, J MATER SCI, V40, P3177, DOI 10.1007/s10853-005-2681-5; Howlader MMR, 2009, J ELECTROCHEM SOC, V156, pH846, DOI 10.1149/1.3223985; Li ZY, 2012, APPL OPTICS, V51, P6855, DOI 10.1364/AO.51.006855; Kim TH, 2003, J VAC SCI TECHNOL A, V21, P449, DOI 10.1116/1.1537716; Zhang F, 2010, ECS TRANSACTIONS, V33, P329, DOI 10.1149/1.3483522; Shigetou A, 2006, IEEE T ADV PACKAGING, V29, P218, DOI 10.1109/TADVP.2006.873138; Wang TD, 2004, CLIN GASTROENTEROL H, V2, P744, DOI 10.1053/S1542-3565(04)00345-3; Li ZY, 2014, OPT EXPRESS, V22, P18736, DOI 10.1364/OE.22.018736; Palubiak D, 2011, IEEE SENS J, V11, P2401, DOI 10.1109/JSEN.2011.2123090; Knowles KM, 2006, INT MATER REV, V51, P273, DOI [10.1179/174328006X102501, 10.1179/174328006X202501]; Zhang XX, 2005, J MICROELECTROMECH S, V14, P368, DOI 10.1109/JMEMS.2004.839027; Howlader MMR, 2002, J APPL PHYS, V91, P3062, DOI 10.1063/1.1430883; Kondou R, 2012, MICROELECTRON RELIAB, V52, P342, DOI 10.1016/j.microrel.2010.12.006; Qin YH, 2014, SENSOR ACTUAT B-CHEM, V202, P758, DOI 10.1016/j.snb.2014.05.063; Shinwari MW, 2010, ADV FUNCT MATER, V20, P1865, DOI 10.1002/adfm.200902066; Cheng YT, 2000, J MICROELECTROMECH S, V9, P3, DOI 10.1109/84.825770; Takagi H, 1999, JPN J APPL PHYS 1, V38, P1589, DOI 10.1143/JJAP.38.1589; Masteika V, 2014, ECS J SOLID STATE SC, V3, pQ42, DOI 10.1149/2.007403jss; Asgaran S, 2007, IEEE T CIRCUITS-I, V54, P544, DOI 10.1109/TCSI.2006.887622; Byun KY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3360201; Choa SH, 2009, MICROSYST TECHNOL, V15, P677, DOI 10.1007/s00542-009-0788-3; Deen M., 2012, SILICON PHOTONICS FU; Deen M. J., 2012, SILICON BASED MILLIM; Deen M. J., 2002, CMOS RF MODELLING CH; Deen MJ, 2005, IEE P-CIRC DEV SYST, V152, P509, DOI 10.1049/ip-cds:20045069; Deen MJ, 2006, J APPL PHYS, V100, DOI 10.1063/1.2355542; Deen MJ, 2005, P IEEE, V93, P1312, DOI 10.1109/JPROC.2005.850300; Dragoi V, 2008, MICROSYST TECHNOL, V14, P509, DOI 10.1007/s00542-007-0437-7; El-Desouki MM, 2011, IEEE SENS J, V11, P1375, DOI 10.1109/JSEN.2010.2089447; El-Desouki MM, 2013, SENSORS-BASEL, V13, P9878, DOI 10.3390/s130809878; Essig S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4807905; Essig S, 2013, ECS J SOLID STATE SC, V2, pQ178, DOI 10.1149/2.031309jss; Faramarzpour N, 2007, IEEE T ELECTRON DEV, V54, P3229, DOI 10.1109/TED.2007.908594; Fournel F., 2006, ECS T, V3-6, P139, DOI 10.1149/1.2357063; He R., 2014, ECS SMEQ JOINT INT M; Howlader M. R., 2006, ECS T, V3, P191, DOI 10.1149/1.2357070; Howlader MMR, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2229262; Howlader MMR, 2010, J MICROELECTROMECH S, V19, P840, DOI 10.1109/JMEMS.2010.2049731; Howlader MMR, 2010, VACUUM, V84, P1334, DOI 10.1016/j.vacuum.2010.02.014; Howlader MMR, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/2/025009; Howlader MMR, 2012, MICROELECTRON RELIAB, V52, P361, DOI 10.1016/j.microrel.2011.08.018; Howlader MMR, 2010, MATER LETT, V64, P1532, DOI 10.1016/j.matlet.2010.04.012; Howlader MMR, 2010, TALANTA, V82, P508, DOI 10.1016/j.talanta.2010.05.001; Howlader MMR, 2010, J MICRO-NANOLITH MEM, V9, DOI 10.1117/1.3500747; Howlader MMR, 2006, IEEE T ADV PACKAGING, V29, P448, DOI 10.1109/TADVP.2006.875070; Howlader MMR, 2011, J MICROELECTROMECH S, V20, P17, DOI 10.1109/JMEMS.2010.2090502; Howlader MMR, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/6/065012; Howlader MMR, 2011, J VAC SCI TECHNOL A, V29, DOI 10.1116/1.3549114; Howlader MMR, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/31/315301; Howlader MMR, 2010, THIN SOLID FILMS, V519, P804, DOI 10.1016/j.tsf.2010.08.144; Howlader MMR, 2010, ELECTROCHEM SOLID ST, V13, pH61, DOI 10.1149/1.3272957; Howlader MMR, 2014, AIP CONF PROC, V1590, P244, DOI 10.1063/1.4870225; Huang ZR, 2007, IEEE T COMPON PACK T, V30, P708, DOI 10.1109/TCAPT.2007.901757; Jeung W. K., 2008, DTIP MEMS MOEMS, V2008, P201; Kfouri M, 2008, IEEE J SEL TOP QUANT, V14, P226, DOI 10.1109/JSTQE.2007.911765; Kibria MG, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/13/134011; Kolev P., 1999, ADV IMAG ELECT PHYS, V109, P1, DOI 10.1016/S1076-5670(08)70196-4; Kolev P, 1998, J ELECTROCHEM SOC, V145, P3258, DOI 10.1149/1.1838795; Kolev PV, 1998, REV SCI INSTRUM, V69, P2464, DOI 10.1063/1.1148975; Kolev PV, 1998, J APPL PHYS, V83, P820, DOI 10.1063/1.366763; Kono G., 2014, INT C EL PACK, P720; Lai SI, 2004, MATER CHEM PHYS, V83, P265, DOI 10.1016/j.matchemphys.2003.09.024; Schjolberg-Henriksen K, 2008, SENSOR ACTUAT A-PHYS, V142, P413, DOI 10.1016/j.sna.2007.02.020; Shigetou A, 2012, J ELECTRON MATER, V41, P2274, DOI 10.1007/s11664-012-2091-9; Shigetou A, 2008, IEEE T ADV PACKAGING, V31, P473, DOI 10.1109/TADVP.2008.920644; Shinwari MW, 2012, SENSOR ACTUAT B-CHEM, V171, P463, DOI 10.1016/j.snb.2012.05.012; Shinwari MW, 2010, NANOSCALE RES LETT, V5, P494, DOI 10.1007/s11671-009-9522-4; Shinwari MW, 2011, SENSOR ACTUAT B-CHEM, V160, P441, DOI 10.1016/j.snb.2011.08.006; Song S.-D., 2008, ECS T, V16, P287, DOI 10.1149/1.2982880; Takagi H, 1999, JPN J APPL PHYS 2, V38, pL1559, DOI 10.1143/JJAP.38.L1559; Tummala RR, 2006, IEEE SPECTRUM, V43, P44, DOI 10.1109/MSPEC.2006.1638044; van Helvoort ATJ, 2003, J ELECTROCHEM SOC, V150, pG624, DOI 10.1149/1.1604116; Wang Q, 2002, ELEC COMP C, P915; Wang RCC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3593148; Wang YH, 2005, MATER TRANS, V46, P2431, DOI 10.2320/matertrans.46.2431; Yang WH, 2012, ECS TRANSACTIONS, V50, P133, DOI 10.1149/05007.0133ecst; Yang WH, 2013, ECS J SOLID STATE SC, V2, pP271, DOI 10.1149/2.010306jss; Yu T, 2011, ECS TRANSACTIONS, V35, P3, DOI 10.1149/1.3568842; Yuan Y, 2009, OPT LETT, V34, P1132	93	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030201	10.7567/JJAP.54.030201		10	Physics, Applied	Physics	CF8FT	WOS:000352792200004		
J	Ichimura, M; Kawai, S				Ichimura, Masaya; Kawai, Shoichi			Band alignment at the CdS/FeS2 interface based on the first-principles calculation	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PYRITE FES2; THIN-FILMS; HETEROJUNCTION	FeS2 is potentially well-suited for the absorber layer of a thin-film solar cell. Since it usually has p-type conductivity, a pn heterojunction cell can be fabricated by combining it with an n-type material. In this work, the band alignment in the heterostructure based on FeS2 is investigated on the basis of the first-principles calculation. CdS, the most popular buffer-layer material for thin-film solar cells, is selected as the partner in the heterostructure. The results indicate that there is a large conduction band offset (0.65 eV) at the interface, which will hinder the flow of photogenerated electrons from FeS2 to CdS. Thus an n-type material with the conduction band minimum positioned lower than that of CdS will be preferable as the partner in the heterostructure. (C) 2015 The Japan Society of Applied Physics	[Ichimura, Masaya] Nagoya Inst Technol, Dept Engn Phys Elect & Mech, Nagoya, Aichi 4668555, Japan; [Kawai, Shoichi] DENSO Corp, Res Labs, Nisshin, Aichi 4700111, Japan	Ichimura, M (reprint author), Nagoya Inst Technol, Dept Engn Phys Elect & Mech, Nagoya, Aichi 4668555, Japan.						Schmid D, 1996, SOL ENERG MAT SOL C, V41-2, P281, DOI 10.1016/0927-0248(95)00107-7; Wang DY, 2012, ADV MATER, V24, P3415, DOI 10.1002/adma.201200753; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; KRAUT EA, 1980, PHYS REV LETT, V44, P1620, DOI 10.1103/PhysRevLett.44.1620; Nakamura S, 2001, SOL ENERG MAT SOL C, V65, P79, DOI 10.1016/S0927-0248(00)00080-5; Wadia C, 2009, ENVIRON SCI TECHNOL, V43, P2072, DOI 10.1021/es8019534; Altermatt PP, 2002, SOL ENERG MAT SOL C, V71, P181, DOI 10.1016/S0927-0248(01)00053-8; NELSON AJ, 1993, APPL PHYS LETT, V62, P2557, DOI 10.1063/1.109295; ENNAOUI A, 1986, SOL ENERG MATER, V14, P461, DOI 10.1016/0165-1633(86)90030-4; Kawai S, 2014, APL MATER, V2, DOI 10.1063/1.4869035; Meng L, 1999, MATER LETT, V38, P103, DOI 10.1016/S0167-577X(98)00140-2; NELSON AJ, 1995, J APPL PHYS, V78, P5701, DOI 10.1063/1.359629; WEI SH, 1993, APPL PHYS LETT, V63, P2549, DOI 10.1063/1.110429	13	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							038002	10.7567/JJAP.54.038002		3	Physics, Applied	Physics	CF8FT	WOS:000352792200070		
J	Ito, Y; Fukushima, T; Kino, H; Lee, KW; Choki, K; Tanaka, T; Koyanagi, M				Ito, Yuka; Fukushima, Takafumi; Kino, Hisashi; Lee, Kang-Wook; Choki, Koji; Tanaka, Tetsu; Koyanagi, Mitsumasa			Vertical-cavity surface-emitting laser chip bonding by surface-tension-driven self-assembly for optoelectronic heterogeneous integration	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MULTICHIP-MODULE; ALIGNMENT; TECHNOLOGY; SILICON; SUBSTRATE; DEVICES; DIODES; FORCES; VCSEL	Twelve-channel vertical-cavity surface-emitting laser (12-ch VCSEL) chips are heterogeneously self-assembled on Si and glass wafers using water surface tension as a driving force. The VCSEL chips have a high length-to-width aspect ratio, that is, 3 mm long and 0.35 mm wide. The VCSEL chips are precisely self-assembled with alignment accuracies within 2 mu m even when they are manually placed on liquid droplets provided on the host substrate. After the self-assembly of the VCSEL chips and the subsequent thermal compression, the chips successfully emit 850 nm light and exhibit no degradation of their current-voltage (I-V) characteristics. (C) 2015 The Japan Society of Applied Physics	[Ito, Yuka; Tanaka, Tetsu] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Ito, Yuka; Choki, Koji] Sumitomo Bakelite Co Ltd, Utsunomiya, Tochigi 3213231, Japan; [Fukushima, Takafumi; Lee, Kang-Wook; Koyanagi, Mitsumasa] Tohoku Univ, New Ind Creat Hatchery Ctr NICHe, Sendai, Miyagi 9808579, Japan; [Kino, Hisashi; Tanaka, Tetsu] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 9808579, Japan	Ito, Y (reprint author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan.	link@lbc.mech.tohoku.ac.jp					LIN W, 1995, IEEE T COMPON PACK B, V18, P543, DOI 10.1109/96.404114; Jokerst NM, 2003, IEEE J SEL TOP QUANT, V9, P350, DOI 10.1109/JSTQE.2003.813307; Higurashi E, 2007, IEEE PHOTONIC TECH L, V19, P1994, DOI 10.1109/LPT.2007.908642; Fukushima T, 2011, MICROMACHINES-BASEL, V2, P49, DOI 10.3390/mi2010049; Lee BG, 2012, J LIGHTWAVE TECHNOL, V30, P886, DOI 10.1109/JLT.2012.2183853; Lee KW, 2011, IEEE T ELECTRON DEV, V58, P748, DOI 10.1109/TED.2010.2099870; Iga K, 2013, P IEEE, V101, P2229, DOI 10.1109/JPROC.2013.2275016; Fukushima T, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3328098; TU JK, 1995, ELECTRON LETT, V31, P1448, DOI 10.1049/el:19950989; Srinivasan U, 2002, IEEE J SEL TOP QUANT, V8, P4, DOI 10.1109/2944.991393; YEH HJJ, 1994, IEEE PHOTONIC TECH L, V6, P706, DOI 10.1109/68.300169; Fukushima T, 2012, IEEE T ELECTRON DEV, V59, P2956, DOI 10.1109/TED.2012.2212709; Jacobs HO, 2002, SCIENCE, V296, P323, DOI 10.1126/science.1069153; Routa I, 2014, J MICROELECTROMECH S, V23, P819, DOI 10.1109/JMEMS.2013.2293602; Higurashi E, 2009, IEEE J SEL TOP QUANT, V15, P1500, DOI 10.1109/JSTQE.2009.2020812; Xiao J, 2011, J LIGHTWAVE TECHNOL, V29, P1578, DOI 10.1109/JLT.2011.2134072; Arase H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.036501; Baba T., 2011, DENSHI JOHO TSUSHIN, V94, P1037; Broesch DJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866459; Fujiwara M, 2008, JPN J APPL PHYS, V47, P2936, DOI 10.1143/JJAP.47.29361; Fukushima T, 2008, INT EL DEVICES MEET, P499; Fukushima T, 2011, IEEE T COMP PACK MAN, V1, P1873, DOI 10.1109/TCPMT.2011.2160266; Fukushima T., 2005, IEDM, P348, DOI 10.1109/IEDM.2005.1609347; Fukushima T., 2012, IEDM, P789, DOI DOI 10.1109/IEDM.2012.6479157; Ito Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CB09; Jatlaoui MM, 2012, INT J MICROW WIREL T, V4, P109, DOI 10.1017/S1759078711000961; Kosaka H, 1998, IEEE T COMPON PACK B, V21, P471, DOI 10.1109/96.730430; Koyanagi M., 1998, IEEE Micro, V18, DOI 10.1109/40.710867; Koyanagi M., 1989, P 8 S FUT EL DEV, P50; Lee K. W., 2009, IEDM, P531; Lee KW, 2010, J MICROELECTROMECH S, V19, P1284, DOI 10.1109/JMEMS.2010.2082497; Lee SJ, 2010, IEEE T BIOMED CIRC S, V4, P426, DOI 10.1109/TBCAS.2010.2079330; Lin C, 2009, MICROFLUID NANOFLUID, V6, P63, DOI 10.1007/s10404-008-0294-4; Liu Y, 2002, IEEE T ADV PACKAGING, V25, P43; Nakano J, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.116501; Roelkens G, 2005, J LIGHTWAVE TECHNOL, V23, P3827, DOI 10.1109/JLT.2005.856231; Sasaki JI, 2001, IEEE T ADV PACKAGING, V24, P569, DOI 10.1109/6040.982846; Sato K, 2007, INT J PRECIS ENG MAN, V8, P75; Sekikawa M, 2008, INT EL DEVICES MEET, P935; Tojo T, 2005, JPN J APPL PHYS 1, V44, P2568, DOI 10.1143/JJAP.44.2568; Tung BT, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CB08	41	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030206	10.7567/JJAP.54.030206		6	Physics, Applied	Physics	CF8FT	WOS:000352792200009		
J	Kashiwagi, K; Kasuya, Y; Kojima, S; Kurokawa, T				Kashiwagi, Ken; Kasuya, Yosuke; Kojima, Shuto; Kurokawa, Takashi			Synchronous scanning of reference mirror and objective lens for high-resolution full-field interferometry	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ULTRAHIGH-RESOLUTION; SUPERCONTINUUM GENERATION; FIBER LASER; ALL-FIBER; CONTINUUM; COMPACT; BAND	We realized a long-scanning-range and high-resolution interferometry in a time-domain full-field microscopic scheme by adopting a simple configuration. A reference mirror was synchronously scanned with an objective lens, which was installed in a common path, to prevent lateral resolution degradation due to defocus at the mirror. High axial resolution was obtained using a broadband supercontinuum (SC) generated by a 1.55 mu m pump. The SC was generated by propagating a femtosecond pulse at 1.55 mu m through a highly nonlinear dispersion shifted fiber with a small dispersion slope. We designed and constructed an interferometer carefully to utilize the entire bandwidth. The broad bandwidth of the interferometer achieved an axial resolution of 2.50 mu m in air. The synchronous scanning maintained a lateral resolution longer than 1 mm. The system successfully yielded a cross-sectional image of two layers of scotch tape along the 400-mu m-depth and 90-nm-step surface profiles. (C) 2015 The Japan Society of Applied Physics	[Kashiwagi, Ken; Kasuya, Yosuke; Kojima, Shuto; Kurokawa, Takashi] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Elect & Elect Engn, Koganei, Tokyo 1848588, Japan	Kashiwagi, K (reprint author), Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Elect & Elect Engn, Koganei, Tokyo 1848588, Japan.	kkash@cc.tuat.ac.jp	Kashiwagi, Ken/E-6711-2013	Kashiwagi, Ken/0000-0002-7993-0555			Dubois A, 2004, APPL OPTICS, V43, P2874, DOI 10.1364/AO.43.002874; Vabre L, 2002, OPT LETT, V27, P530, DOI 10.1364/OL.27.000530; Ohmi M, 2003, OPT REV, V10, P478, DOI 10.1007/s10043-003-0478-9; Hirano M, 2009, IEEE J SEL TOP QUANT, V15, P103, DOI 10.1109/JSTQE.2008.2010241; Povazay B, 2002, OPT LETT, V27, P1800, DOI 10.1364/OL.27.001800; Reolon D, 2006, OPT EXPRESS, V14, P128, DOI 10.1364/OPEX.14.000128; Choi S, 2012, OPT EXPRESS, V20, P27820, DOI 10.1364/OE.20.027820; Gale DM, 1996, APPL OPTICS, V35, P131, DOI 10.1364/AO.35.000131; Huber R, 2006, OPT EXPRESS, V14, P3225, DOI 10.1364/OE.14.003225; Chinn SR, 1997, OPT LETT, V22, P340, DOI 10.1364/OL.22.000340; Hori T, 2004, OPT EXPRESS, V12, P317, DOI 10.1364/OPEX.12.000317; Hartl I, 2001, OPT LETT, V26, P608, DOI 10.1364/OL.26.000608; Nakaji H, 2008, J NEUROSCI METH, V174, P82, DOI 10.1016/j.jneumeth.2008.07.004; Nishizawa N, 2004, OPT LETT, V29, P2846, DOI 10.1364/OL.29.002846; Yun SH, 2003, OPT EXPRESS, V11, P2953, DOI 10.1364/OE.11.002953; Bizheva K, 2003, OPT LETT, V28, P707, DOI 10.1364/OL.28.000707; Choi S, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.106601; Ishida S, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.052501; Kashiwagi K, 2013, OPT EXPRESS, V21, P3001, DOI 10.1364/OE.21.003001; Kasuya Y., 2011, P INT QUANT EL C C L, P533; Ohta T, 2008, APPL OPTICS, V47, P2503, DOI 10.1364/AO.47.002503; Stumpf MC, 2008, OPT EXPRESS, V16, P10572, DOI 10.1364/OE.16.010572	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							032501	10.7567/JJAP.54.032501		5	Physics, Applied	Physics	CF8FT	WOS:000352792200042		
J	Komuro, Y; Kawana, D; Hirayama, T; Ohomori, K; Kozawa, T				Komuro, Yoshitaka; Kawana, Daisuke; Hirayama, Taku; Ohomori, Katsumi; Kozawa, Takahiro			Modeling and simulation of acid generation in anion-bound chemically amplified resists used for extreme ultraviolet lithography	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTRON-BEAM RESIST; TRIARYLSULFONIUM SALTS; PULSE-RADIOLYSIS; EUV RESIST; POLYMER; AMPLIFICATION; EFFICIENCY; DIFFUSION	Extreme ultraviolet (EUV) lithography is the most promising candidate technique for the high-volume production of semiconductor devices with half-pitches of sub-10 nm. An anion-bound polymer, in which the anion part of onium salts is polymerized, has attracted much attention from the viewpoint of the control of acid diffusion. In this study, we modeled the acid generation processes in the anion-bound chemically amplified resists upon exposure to EUV radiation and developed a Monte Carlo simulation code. Using the developed simulation code, the dependence of the quantum efficiency of acid generation on the concentration of acid generator units was calculated. The calculated quantum efficiencies well agreed with the experimental values with a fitting error of less than 10%. The thermalization distance was considered to be approximately 3 nm. The blur of proton distribution intrinsic to the reaction mechanisms of anion-bound chemically amplified resists was roughly estimated to be 4.5-6.5nm. (C) 2015 The Japan Society of Applied Physics	[Komuro, Yoshitaka; Kozawa, Takahiro] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Komuro, Yoshitaka; Kawana, Daisuke; Hirayama, Taku; Ohomori, Katsumi] Tokyo Ohka Kogyo Co Ltd, Samukawa, Kanagawa 2530114, Japan	Komuro, Y (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	kozawa@sanken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25246036]	We thank Central Glass Co., Ltd. for synthesizing the ABP. This work was supported in part by a Grant-in-Aid for Scientific Research (No. 25246036) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Allen RD, 2009, J PHOTOPOLYM SCI TEC, V22, P25, DOI 10.2494/photopolymer.22.25; Fukuyama T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.065004; Kozawa T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.106501; KOZAWA T, 1992, JPN J APPL PHYS 1, V31, P4301, DOI 10.1143/JJAP.31.4301; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; KINOSHITA H, 1989, J VAC SCI TECHNOL B, V7, P1648, DOI 10.1116/1.584507; DEKTAR JL, 1990, J AM CHEM SOC, V112, P6004, DOI 10.1021/ja00172a015; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.030209; Itani T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.010002; TANUMA S, 1994, SURF INTERFACE ANAL, V21, P165, DOI 10.1002/sia.740210302; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.030001; Kozawa T, 2007, J VAC SCI TECHNOL B, V25, P2481, DOI 10.1116/1.2794063; ITO H, 1983, POLYM ENG SCI, V23, P1012, DOI 10.1002/pen.760231807; BARTCZAK WM, 1987, J CHEM PHYS, V87, P5222, DOI 10.1063/1.453690; Kozawa T, 2006, J VAC SCI TECHNOL B, V24, P3055, DOI 10.1116/1.2366656; Cameron JF, 2001, P SOC PHOTO-OPT INS, V4345, P106, DOI 10.1117/12.436838; Dean KR, 2006, PROC SPIE, V6153, pU576, DOI 10.1117/12.657163; de Vera P, 2011, J APPL PHYS, V109, DOI 10.1063/1.3581120; Enomoto S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.06GC03; Komuro Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.116503; Komuro Y, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.014001; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.016504; Kozawa T, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.074301; Kozawa T, 2007, J PHOTOPOLYM SCI TEC, V20, P577, DOI 10.2494/photopolymer.20.577; MCKEAN DR, 1991, J POLYM SCI POL CHEM, V29, P309, DOI 10.1002/pola.1991.080290303; Natsuda K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FC05; Oizumi H, 2010, P SOC PHOTO-OPT INS, V7636, DOI 10.1117/12.846269; Okamoto K, 2006, CHEM PHYS LETT, V426, P306, DOI 10.1016/j.cplett.2006.05.115; Okamoto K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.096701; Okamoto K, 2007, RADIAT PHYS CHEM, V76, P818, DOI 10.1016/j.radphyschem.2006.06.001; Okudaira KK, 1998, J APPL PHYS, V83, P4292, DOI 10.1063/1.367188; Pollentier I, 2010, J PHOTOPOLYM SCI TEC, V23, P605, DOI 10.2494/photopolymer.23.605; Saeki A, 2002, JPN J APPL PHYS 1, V41, P4213, DOI 10.1143/JJAP.41.4213; Tarutani S, 2011, J PHOTOPOLYM SCI TEC, V24, P185, DOI 10.2494/photopolymer.24.185; Thackeray JW, 2011, J PHOTOPOLYM SCI TEC, V24, P179, DOI 10.2494/photopolymer.24.179; Tsubaki H, 2009, PROC SPIE, V7273, DOI 10.1117/12.814067; Utsumi Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FC07; Van Steenwinckel D, 2005, P SOC PHOTO-OPT INS, V5753, P269, DOI 10.1117/12.598677; Vogt BD, 2006, PROC SPIE, V6153, pU498, DOI 10.1117/12.656464; Wallraff GM, 2002, P SOC PHOTO-OPT INS, V4690, P160, DOI 10.1117/12.474215; Yoshizawa S., 2002, J VAC SCI TECHNOL B, V20, P1342	41	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							036506	10.7567/JJAP.54.036506		7	Physics, Applied	Physics	CF8FT	WOS:000352792200066		
J	Koyama, S; Hagiwara, N; Shohji, I				Koyama, Shinji; Hagiwara, Naoki; Shohji, Ikuo			Cu/Cu direct bonding by metal salt generation bonding technique with organic acid and persistence of reformed layer	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							STATE BONDED INTERFACE; SURFACE MODIFICATION; COPPER; TEMPERATURE; CU; STRENGTH; FILMS; BUMP; REDUCTION; FORMATE	In this study, the effect of the metal salt generation bonding technique on the strength of a direct-bonded copper-copper interface was investigated. Copper surfaces were modified by boiling in several types of organic acids, and direct bonding was performed at a bonding temperature of 423-673K under a load of 588N (for a bonding time of 0.9 ks). As a result of the surface modification, bonded joints were obtained at bonding temperatures of 150K (after treatment with formic acid) and 100 K (after citric acid treatment) lower than that required for the unmodified surfaces. In addition, the duration of the modification effects was investigated by exposing the modified surface to an air atmosphere furnace kept at 323 K. The bonding strength of the citric acid-modified surface remained unchanged even after 168 h, whereas that of the surface modified with formic acid decreased within 6 h. (C) 2015 The Japan Society of Applied Physics	[Koyama, Shinji; Hagiwara, Naoki; Shohji, Ikuo] Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gunma 3768515, Japan	Koyama, S (reprint author), Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gunma 3768515, Japan.	koyama@gunma-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26820124]	This study was supported by a Grant-in-Aid for Scientific Research (C) (26820124) from the Japan Society for the Promotion of Science (JSPS).	Koyama S, 2010, MATER TRANS, V51, P1759, DOI 10.2320/matertrans.MJ201019; Cooper DR, 2014, J MATER PROCESS TECH, V214, P2576, DOI 10.1016/j.jmatprotec.2014.04.018; Siow KS, 2012, J ALLOY COMPD, V514, P6, DOI 10.1016/j.jallcom.2011.10.092; Higurashi E, 2007, IEEE PHOTONIC TECH L, V19, P1994, DOI 10.1109/LPT.2007.908642; Shigetou A, 2005, J MATER SCI, V40, P3149, DOI 10.1007/s10853-005-2677-1; Chuang CL, 2006, MICROELECTRON RELIAB, V46, P449, DOI 10.1016/j.microrel.2005.01.010; Kind C, 2012, J MATER CHEM, V22, P987, DOI 10.1039/c1jm12779a; Wang Q, 2003, MICROELECTRON RELIAB, V43, P751, DOI 10.1016/S0026-2714(03)00039-8; Xu H, 2011, MICROELECTRON ENG, V88, P3155, DOI 10.1016/j.mee.2011.06.018; Mehr VY, 2014, MATER DESIGN, V53, P174, DOI 10.1016/j.matdes.2013.06.028; Lu Q, 2013, APPL SURF SCI, V268, P368, DOI 10.1016/j.apsusc.2012.12.102; Mohamed MA, 2004, THERMOCHIM ACTA, V411, P13, DOI 10.1016/j.tca.2003.07.003; Dohle R, 2011, MICROELECTRON RELIAB, V51, P97, DOI 10.1016/j.microrel.2010.08.001; Eskhult J, 2008, ELECTROCHIM ACTA, V53, P2188, DOI 10.1016/j.electacta.2007.09.032; Hurley BL, 2004, J ELECTROCHEM SOC, V151, pB252, DOI 10.1149/1.1687428; Imamura T., 2008, IEEJ T SENSORS MICRO, V128, P266, DOI 10.1541/ieejsmas.128.266; Koyama S, 2009, J JPN I MET, V73, P809, DOI 10.2320/jinstmet.73.809; Koyama S, 2013, MATER TRANS, V54, P1975, DOI 10.2320/matertrans.M2013101; Lee JY, 2005, J ELECTRON MATER, V34, P96, DOI 10.1007/s11664-005-0185-3; Lopez-Delgado A, 2001, J MATER SCI, V36, P5203, DOI 10.1023/A:1012497912875; Poulston S, 1998, SURF SCI, V402, P599, DOI 10.1016/S0039-6028(98)00006-5; Shah A, 2011, MICROELECTRON RELIAB, V51, P67, DOI 10.1016/j.microrel.2010.06.002; Tajima S, 2011, THIN SOLID FILMS, V519, P6773, DOI 10.1016/j.tsf.2011.01.219; Tanida K, 2003, JPN J APPL PHYS 1, V42, P2198, DOI 10.1143/JJAP.42.2198; Wang FL, 2009, SENSOR ACTUAT A-PHYS, V149, P100, DOI 10.1016/j.sna.2008.11.006; Watanabe N, 2003, JPN J APPL PHYS 1, V42, P2193, DOI 10.1143/JJAP.42.2193; Woo K, 2011, ACS APPL MATER INTER, V3, P2377, DOI 10.1021/am2002907; Xu H, 2011, MICROELECTRON RELIAB, V51, P113, DOI 10.1016/j.microrel.2010.03.016; Yang WH, 2013, ECS J SOLID STATE SC, V2, pP271, DOI 10.1149/2.010306jss	29	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030216	10.7567/JJAP.54.030216		4	Physics, Applied	Physics	CF8FT	WOS:000352792200019		
J	Kozawa, T; Santillan, JJ; Itani, T				Kozawa, Takahiro; Santillan, Julius Joseph; Itani, Toshiro			Feasibility study of sub-10-nm-half-pitch fabrication by chemically amplified resist processes of extreme ultraviolet lithography: II. Stochastic effects	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ACID DISTRIBUTION; AMPLIFICATION; DIFFUSION; DESIGN	Line edge roughness (LER) rapidly increases in the sub-10-nm-half-pitch region of resist processes used for the fabrication of semiconductor devices. Sub-10-nm fabrication with high throughput is a challenging task. In this study, the stochastic effects (LER and stochastic defect generation) of chemically amplified resist processes in the sub-10-nm-half-pitch node were investigated, assuming the use of extreme ultraviolet (EUV) lithography. The latent images were calculated by a Monte Carlo method on the basis of the sensitization and reaction mechanisms of chemically amplified EUV resists. 7-nm-half-pitch fabrication by chemically amplified resist processes is considered to be feasible. However, significant improvement in the efficiencies of the conversion processes from optical images to resist images is required. (C) 2015 The Japan Society of Applied Physics	[Kozawa, Takahiro] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Santillan, Julius Joseph; Itani, Toshiro] EUVL Infrastruct Dev Ctr Inc EIDEC, Tsukuba, Ibaraki 3058569, Japan	Kozawa, T (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	kozawa@sanken.osaka-u.ac.jp	Itani, Toshiro/E-4510-2014		New Energy and Industrial Technology Development Organization (NEDO)	This work was partially supported by the New Energy and Industrial Technology Development Organization (NEDO).	Yamamoto H, 2005, JPN J APPL PHYS 1, V44, P5836, DOI 10.1143/JJAP.44.5836; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.066504; SCHLEGEL L, 1991, J VAC SCI TECHNOL B, V9, P278, DOI 10.1116/1.585607; Hirose R, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.027004; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.126501; Natsuda K, 2007, JPN J APPL PHYS 1, V46, P7285, DOI 10.1143/JJAP.46.7285; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076503; NAKAMURA J, 1991, JPN J APPL PHYS 1, V30, P2619, DOI 10.1143/JJAP.30.2619; Kozawa T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.026502; Fukuyama T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.065004; Kozawa T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.106501; KINOSHITA H, 1989, J VAC SCI TECHNOL B, V7, P1648, DOI 10.1116/1.584507; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.116505; Yamamoto H, 2004, JPN J APPL PHYS 2, V43, pL848, DOI 10.1143/JJAP.43.L848; Kozawa T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.036501; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.030209; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076505; Itani T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.010002; Natsuda K, 2006, JPN J APPL PHYS 2, V45, pL1256, DOI 10.1143/JJAP.45.L1256; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.030001; Kozawa T, 2007, J VAC SCI TECHNOL B, V25, P2481, DOI 10.1116/1.2794063; ITO H, 1983, POLYM ENG SCI, V23, P1012, DOI 10.1002/pen.760231807; Constantoudis V, 2010, PROC SPIE, V7639, DOI 10.1117/12.849300; Cummings K, 2014, PROC SPIE, V9048, DOI 10.1117/12.2046380; Gao WM, 2012, PROC SPIE, V8322, DOI 10.1117/12.917804; Kozawa T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.086504; Kozawa T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.076502; Mack CA, 2011, PROC SPIE, V7972, DOI 10.1117/12.879831; Matsuzawa NN, 1999, JPN J APPL PHYS 1, V38, P7109, DOI 10.1143/JJAP.38.7109; Sakai K, 2014, J PHOTOPOLYM SCI TEC, V27, P639; Setten E., 2014, EUV S; Tarutani S, 2014, J PHOTOPOLYM SCI TEC, V27, P645; Yen A., 2014, EUV S	33	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							036507	10.7567/JJAP.54.036507		7	Physics, Applied	Physics	CF8FT	WOS:000352792200067		
J	Kumai, Y; Nakano, H				Kumai, Yoko; Nakano, Hideyuki			Characteristics of layered polysilane and its application to lithium ion battery anodes	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							RECHARGEABLE BATTERIES; COMPOSITE ANODE; HIGH-CAPACITY; SILICON; SI; SI6H6	Although layered polysilane (LPS) has a graphitelike structure and a higher electric capacity than Si powder, LPS shows poor cycling performance. Therefore, to improve its cyclability, the synthesis of composite materials of LPS and carbon was attempted. Carbon-coated LPS (C-LPS) was prepared by pulsed laser deposition (PLD), and a silicon-carbon (Si-C) composite consisting of silicon plates coated onto carbon particles was obtained by reacting LPS with sucrose. The cycling performance characteristics of the C-LPS and Si-C composite electrodes were better than that of the LPS electrode. On galvanostatic discharge-charge curves, although the Si-C composite showed no plateau at 0.3 V on the first discharge, the LPS and C-LPS electrodes showed a 0.3 V plateau that was due to the dissociation of the Si-H bonds of LPS, which led to a high initial irreversible capacity. (C) 2015 The Japan Society of Applied Physics	[Kumai, Yoko; Nakano, Hideyuki] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan	Kumai, Y (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	kumai@mosk.tytlabs.co.jp					Maranchi JP, 2003, ELECTROCHEM SOLID ST, V6, pA198, DOI 10.1149/1.1596918; DAHN JR, 1993, PHYS REV B, V48, P17872, DOI 10.1103/PhysRevB.48.17872; WILSON AM, 1995, J ELECTROCHEM SOC, V142, P326, DOI 10.1149/1.2043994; Chew SY, 2007, ELECTROCHEM COMMUN, V9, P941, DOI 10.1016/j.elecom.2006.11.028; Wu XD, 2003, ELECTROCHEM COMMUN, V5, P935, DOI 10.1016/j.elecom.2003.09.001; Yoshio M, 2002, J ELECTROCHEM SOC, V149, pA1598, DOI 10.1149/1.1518988; Ryu JH, 2004, ELECTROCHEM SOLID ST, V7, pA306, DOI 10.1149/1.1792242; Zhang XW, 2004, J POWER SOURCES, V125, P206, DOI 10.1016/j.jpowsour.2003.07.019; Li H, 1999, ELECTROCHEM SOLID ST, V2, P547, DOI 10.1149/1.1390899; Guo ZP, 2005, J ELECTROCHEM SOC, V152, pA2211, DOI 10.1149/1.2051847; Hatchard TD, 2004, J ELECTROCHEM SOC, V151, pA838, DOI 10.1149/1.1739217; Kumai Y, 2011, J MATER CHEM, V21, P11941, DOI 10.1039/c1jm10532a; Kumai Y, 2011, J POWER SOURCES, V196, P1503, DOI 10.1016/j.jpowsour.2010.08.040; Obrovac MN, 2004, ELECTROCHEM SOLID ST, V7, pA93, DOI 10.1149/1.1652421	14	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							035201	10.7567/JJAP.54.035201		4	Physics, Applied	Physics	CF8FT	WOS:000352792200057		
J	Lee, SD; Ito, Y; Kaneko, K; Fujita, S				Lee, Sam-Dong; Ito, Yoshito; Kaneko, Kentaro; Fujita, Shizuo			Enhanced thermal stability of alpha gallium oxide films supported by aluminum doping	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; GA2O3 THIN-FILM; GROWTH; BETA-GA2O3; TEMPERATURE	In order to enhance the thermal stability of corundum-structured gallium oxide (alpha-Ga2O3), which is attractive for use in wide-band-gap heterostructure devices and amenable to band gap and function engineering but suffers from phase transformation in high-temperature growth (>500 degrees C) and treatments (>550 degrees C), we attempted aluminum (Al) doping. The thermal stability of the films was enhanced by increasing the Al doping concentration, and under the best doping conditions where the Al concentration was negligible compared with the basic chemical composition of Ga2O3, the growth and successive thermal treatment temperatures were increased to as high as 650 and 750 degrees C, respectively, without the marked appearance of the beta-gallia phase. Under the doping conditions above, the inclusion of Al was not negligible at the growth temperature of 800 degrees C and the film composition was expressed as an alloy of alpha-(Al0.2Ga0.8)(2)O-3, but this film remained as the a-phase at annealing temperatures up to 900 degrees C. Enhanced thermal stability widens the device process windows, contributing to the formation of various high-performance devices. (C) 2015 The Japan Society of Applied Physics	[Lee, Sam-Dong; Ito, Yoshito] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan; [Kaneko, Kentaro; Fujita, Shizuo] Kyoto Univ, Photon & Elect Sci & Engn Ctr, Kyoto 6158520, Japan	Lee, SD (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan.	lee.samdong.73r@st.kyoto-u.ac.jp; fujitasz@kuee.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25286050]	This work was supported in part by a Grant-in-Aid for Scientific Research (Grant Number 25286050) from the Japan Society for the Promotion of Science (JSPS).	He HY, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195123; Higashiwaki M, 2014, PHYS STATUS SOLIDI A, V211, P21, DOI 10.1002/pssa.201330197; ROY R, 1952, J AM CHEM SOC, V74, P719, DOI 10.1021/ja01123a039; Kaneko K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.020201; Higashiwaki M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821858; Nishinaka H, 2007, JPN J APPL PHYS 1, V46, P6811, DOI 10.1143/JJAP.46.6811; Shinohara D, 2008, JPN J APPL PHYS, V47, P7311, DOI 10.1143/JJAP.47.73111; Ogita M, 2001, APPL SURF SCI, V175, P721, DOI 10.1016/S0169-4332(01)00080-0; Fujita S, 2014, J CRYST GROWTH, V401, P588, DOI 10.1016/j.jcrysgro.2014.02.032; Lee SD, 2013, PHYS STATUS SOLIDI C, V10, P1592, DOI 10.1002/pssc.201300259; Kawaharamura T, 2008, JPN J APPL PHYS, V47, P4669, DOI 10.1143/JJAP.47.4669; Orita M, 2000, APPL PHYS LETT, V77, P4166, DOI 10.1063/1.1330559; Higashiwaki M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3674287; Oshima T, 2007, JPN J APPL PHYS 1, V46, P7217, DOI 10.1143/JJAP.46.7217; EHRENREICH H, 1985, APPL PHYS LETT, V46, P668, DOI 10.1063/1.95523; Ito H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.100207; Kaneko K, 2013, J APPL PHYS, V113, DOI 10.1063/1.4807651; Kaneko K, 2010, PHYS STATUS SOLIDI C, V7, DOI 10.1002/pssc.200983896; Oda M., 2014, INT C SOL STAT DEV M; Oda M., 2013, MAT RES SOC FALL M; Sasaki K, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.086502; Sasaki K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.035502; Suzuki N, 2007, PHYS STATUS SOLIDI C, V4, P2310, DOI 10.1002/pssc.200674884; TIPPINS HH, 1965, PHYS REV, V140, pA316, DOI 10.1103/PhysRev.140.A316	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030301	10.7567/JJAP.54.030301		4	Physics, Applied	Physics	CF8FT	WOS:000352792200024		
J	Liang, JB; Chai, L; Nishida, S; Morimoto, M; Shigekawa, N				Liang, Jianbo; Chai, Li; Nishida, Shota; Morimoto, Masashi; Shigekawa, Naoteru			Investigation on the interface resistance of Si/GaAs heterojunctions fabricated by surface-activated bonding	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TANDEM SOLAR-CELLS; ROOM-TEMPERATURE; GAAS; SILICON; WAFERS; EFFICIENCY; JUNCTION; SI; STRENGTH	The electrical properties of p-GaAs/n(+)-Si, p(+)-Si/n-GaAs, p(+)-GaAs/n+-Si, p(+)-Si/n(+)-GaAs, n(+)-Si/n(+)-GaAs, and p(+)-Si/p(+)-GaAs junctions fabricated by surface-activated bonding (SAB) were investigated. An amorphous layer with a thickness of 3 nm was found across the bonding interface without annealing. The current-voltage (I-V) characteristics of p(+)-GaAs/n(+)-Si, p(+)-Si/n(+)-GaAs, n(+)-Si/n(+)-GaAs, and p(+)-Si/p(+)-GaAs junctions showed excellent linearity. The interface resistance of n(+)-Si/n(+)-GaAs junctions was found to be 0.112 Omega.cm(2), which is the smallest value observed in all the samples. The resistance decreased with increasing annealing temperature and decreased to 0.074 Omega.cm(2) after the junction annealing at 400 degrees C. These results demonstrate that n(+)-Si/n(+)-GaAs junctions are suitable for the connection of subcells in the fabrication of tandem solar cells. (C) 2015 The Japan Society of Applied Physics	[Liang, Jianbo; Chai, Li; Nishida, Shota; Morimoto, Masashi; Shigekawa, Naoteru] Osaka City Univ, Dept Elect Engn, Osaka 5588585, Japan	Liang, JB (reprint author), Osaka City Univ, Dept Elect Engn, Osaka 5588585, Japan.	liang@elec.eng.osaka-cu.ac.jp; shigekawa@elec.eng.osaka-cu.ac.jp			"Creative research for clean energy generation using solar energy" project in Core Research for Evolutional Science and Technology (CREST) programs of the Japan Science and Technology Agency (JST)	This work was supported by the "Creative research for clean energy generation using solar energy" project in Core Research for Evolutional Science and Technology (CREST) programs of the Japan Science and Technology Agency (JST).	BERTNESS KA, 1994, APPL PHYS LETT, V65, P989, DOI 10.1063/1.112171; Howlader MMR, 2001, J VAC SCI TECHNOL B, V19, P2114, DOI 10.1116/1.1414115; Derendorf K, 2013, IEEE J PHOTOVOLT, V3, P1423, DOI 10.1109/JPHOTOV.2013.2273097; SUGIURA H, 1988, JPN J APPL PHYS 1, V27, P269, DOI 10.1143/JJAP.27.269; FANG SF, 1990, J APPL PHYS, V68, pR31, DOI 10.1063/1.346284; Takamoto T, 2005, PROG PHOTOVOLTAICS, V13, P495, DOI 10.1002/pip.642; Takamoto T, 1997, JPN J APPL PHYS 1, V36, P6215, DOI 10.1143/JJAP.36.6215; Umeno M, 1998, SOL ENERG MAT SOL C, V50, P203, DOI 10.1016/S0927-0248(96)00149-3; Nishioka K, 2006, SOL ENERG MAT SOL C, V90, P1308, DOI 10.1016/j.solmat.2005.08.003; Yang VK, 2003, J APPL PHYS, V93, P3859, DOI 10.1063/1.1558963; King RR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734507; Howlader MMR, 2002, J APPL PHYS, V91, P3062, DOI 10.1063/1.1430883; OLSON JM, 1990, APPL PHYS LETT, V56, P623, DOI 10.1063/1.102717; Takagi H, 1999, JPN J APPL PHYS 1, V38, P1589, DOI 10.1143/JJAP.38.1589; ASHOK S, 1984, APPL PHYS LETT, V45, P431, DOI 10.1063/1.95247; ASHOK S, 1985, JPN J APPL PHYS 2, V24, pL533, DOI 10.1143/JJAP.24.L533; BENGTSSON S, 1989, J APPL PHYS, V66, P1231, DOI 10.1063/1.343469; BENGTSSON S, 1992, J APPL PHYS, V72, P124, DOI 10.1063/1.352172; Essig S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4807905; Essig S, 2013, ECS J SOLID STATE SC, V2, pQ178, DOI 10.1149/2.031309jss; GUERET P, 1989, APPL PHYS LETT, V55, P1735; Howlader MMR, 2010, THIN SOLID FILMS, V519, P804, DOI 10.1016/j.tsf.2010.08.144; Howlader MMR, 2010, ELECTROCHEM SOLID ST, V13, pH61, DOI 10.1149/1.3272957; Jackson MJ, 2011, ARTFORUM INT, V49, P110; KURTZ SR, 1990, J APPL PHYS, V68, P1890, DOI 10.1063/1.347177; Liang J, 2013, J APPL PHYS, V114, DOI 10.1063/1.4829676; Liang J, 2013, ELECTRON LETT, V49, P830, DOI 10.1049/el.2013.1553; Liang J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873113; Liang JB, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.021801; Morimoto M, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.030212; Shi F, 2002, J APPL PHYS, V92, P7544, DOI 10.1063/1.1522484; Shigekawa N, 2014, PHYS STATUS SOLIDI C, V11, P644, DOI 10.1002/pssc.201300413; Shigekawa N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04ER05; Shigekawa N., 2012, P 3 INT IEEE WORKSH, P109; Yu T., ECS T, V35, P3	35	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030211	10.7567/JJAP.54.030211		5	Physics, Applied	Physics	CF8FT	WOS:000352792200014		
J	Matsumoto, K; Zhang, XX; Kishikawa, J; Shimomura, K				Matsumoto, Keiichi; Zhang, Xinxin; Kishikawa, Junya; Shimomura, Kazuhiko			Current-injected light emission of epitaxially grown InAs/InP quantum dots on directly bonded InP/Si substrate	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SELECTIVE MOVPE GROWTH; SILICON PHOTONICS; GAINAS/INP MQW; AREA GROWTH; WAVE-GUIDE; SI; OPERATION; DEVICES; LASERS; GAAS	Current-injected light emission was confirmed for metal organic vapor phase epitaxy (MOVPE) grown (Ga)InAs/InP quantum dots (QDs) on directly bonded InP/Si substrate. The InP/Si substrate was prepared by directly bonding of InP thin film and a Si substrate using a wet-etching and annealing process. A p-i-n LED structure including Stranski-Krastanov (Ga) InAs/InP QDs was grown by MOVPE on an InP/Si substrate. No debonding between Si substrate and InP layer was observed, even after MOVPE growth and operation of the device under continuous wave conditions at RT. The photoluminescence, current/voltage, and electroluminescence characteristics of the device grown on the InP/Si substrate were compared with reference grown on an InP substrate. (C) 2015 The Japan Society of Applied Physics	[Matsumoto, Keiichi; Zhang, Xinxin; Kishikawa, Junya; Shimomura, Kazuhiko] Sophia Univ, Dept Engn & Appl Sci, Chiyoda Ku, Tokyo 1028554, Japan	Matsumoto, K (reprint author), Sophia Univ, Dept Engn & Appl Sci, Chiyoda Ku, Tokyo 1028554, Japan.	kshimom@sophia.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT-Supported Program for the Strategic Research Foundation at Private Universities	The authors would like to thank Professor T. Nakaoka for his help of observing by Nomarski microscope. This work supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Akaishi M, 2008, IEEE J SEL TOP QUANT, V14, P1197, DOI 10.1109/JSTQE.2008.917625; Jalali B, 2006, J LIGHTWAVE TECHNOL, V24, P4600, DOI 10.1109/JLT.2006.885782; SHIMBO M, 1986, J APPL PHYS, V60, P2987, DOI 10.1063/1.337750; Talneau A, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807890; Tong QY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2240232; Fang AW, 2008, IEEE PHOTONIC TECH L, V20, P1667, DOI 10.1109/LPT.2008.2003382; Ejeckam FE, 1995, APPL PHYS LETT, V67, P3936, DOI 10.1063/1.114410; Christiansen SH, 2006, P IEEE, V94, P2060, DOI 10.1109/JPROC.2006.886026; Liang D, 2011, APPL PHYS A-MATER, V103, P213, DOI 10.1007/s00339-010-5999-z; Arakawa Y, 2013, IEEE COMMUN MAG, V51, P72, DOI 10.1109/MCOM.2013.6476868; Miller DAB, 2000, P IEEE, V88, P728, DOI 10.1109/5.867687; Esser RH, 2003, J ELECTROCHEM SOC, V150, pG228, DOI 10.1149/1.1545469; Gosele U, 1998, ANNU REV MATER SCI, V28, P215, DOI 10.1146/annurev.matsci.28.1.215; KATO T, 1992, ELECTRON LETT, V28, P153, DOI 10.1049/el:19920095; Kawakita Y, 2004, ELECTRON LETT, V40, P900, DOI 10.1049/el:20040571; Kawashima F, 2011, J CRYST GROWTH, V318, P1109, DOI 10.1016/j.jcrysgro.2010.10.061; Kihara T, 2000, J CRYST GROWTH, V221, P196, DOI 10.1016/S0022-0248(00)00685-0; LO YH, 1993, APPL PHYS LETT, V62, P1038, DOI 10.1063/1.108787; Matsumoto K, 2013, PHYS STATUS SOLIDI C, V10, P1357, DOI 10.1002/pssc.201300227; Matsumoto K, 2013, J CRYST GROWTH, V370, P133, DOI 10.1016/j.jcrysgro.2012.09.063; Matsumoto K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.116502; MITANI K, 1992, APPL PHYS A-MATER, V54, P543, DOI 10.1007/BF00324337; Okumura T, 2007, JPN J APPL PHYS 2, V46, pL1206, DOI 10.1143/JJAP.46.L1206; Plach T, 2013, J APPL PHYS, V113, DOI 10.1063/1.4794319; RAZEGHI M, 1988, APPL PHYS LETT, V53, P2389, DOI 10.1063/1.100239; Sudo S, 2000, J CRYST GROWTH, V221, P189, DOI 10.1016/S0022-0248(00)00684-9; UJIIE Y, 1989, JPN J APPL PHYS 2, V28, pL337, DOI 10.1143/JJAP.28.L337; Wada H, 1998, JPN J APPL PHYS 1, V37, P1383, DOI 10.1143/JJAP.37.1383; WADA H, 1994, JPN J APPL PHYS 1, V33, P4878, DOI 10.1143/JJAP.33.4878; Yoshikawa S, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.092103	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030208	10.7567/JJAP.54.030208		5	Physics, Applied	Physics	CF8FT	WOS:000352792200011		
J	Mieda, E; Maeda, T; Miyata, N; Yasuda, T; Kurashima, Y; Maeda, A; Takagi, H; Aoki, T; Yamamoto, T; Ichikawa, O; Osada, T; Hata, M; Ogawa, A; Kikuchi, T; Kunii, Y				Mieda, Eiko; Maeda, Tatsuro; Miyata, Noriyuki; Yasuda, Tetsuji; Kurashima, Yuichi; Maeda, Atsuhiko; Takagi, Hideki; Aoki, Takeshi; Yamamoto, Taketsugu; Ichikawa, Osamu; Osada, Takenori; Hata, Masahiko; Ogawa, Arito; Kikuchi, Toshiyuki; Kunii, Yasuo			Wafer-scale layer transfer of GaAs and Ge onto Si wafers using patterned epitaxial lift-off	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							BEAM SURFACE ACTIVATION; ROOM-TEMPERATURE; SILICON-WAFERS; INTERFACE CURRENT; BONDING STRENGTH; TECHNOLOGY; GROWTH; FILMS	We have developed a wafer-scale layer-transfer technique for transferring GaAs and Ge onto Si wafers of up to 300 mm in diameter. Lattice-matched GaAs or Ge layers were epitaxially grown on GaAs wafers using an AlAs release layer, which can subsequently be transferred onto a Si handle wafer via direct wafer bonding and patterned epitaxial lift-off (ELO). The crystal properties of the transferred GaAs layers were characterized by X-ray diffraction (XRD), photoluminescence, and the quality of the transferred Ge layers was characterized using Raman spectroscopy. We find that, after bonding and the wet ELO processes, the quality of the transferred GaAs and Ge layers remained the same compared to that of the as-grown epitaxial layers. Furthermore, we realized Ge-on-insulator and GaAs-on-insulator wafers by wafer-scale pattern ELO technique. (C) 2015 The Japan Society of Applied Physics	[Mieda, Eiko; Maeda, Tatsuro; Miyata, Noriyuki; Yasuda, Tetsuji; Kurashima, Yuichi; Maeda, Atsuhiko; Takagi, Hideki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Aoki, Takeshi; Yamamoto, Taketsugu; Ichikawa, Osamu; Osada, Takenori; Hata, Masahiko] Sumitomo Chem Co Ltd, Tsukuba, Ibaraki 3003294, Japan; [Ogawa, Arito; Kikuchi, Toshiyuki; Kunii, Yasuo] Hitachi Kokusai Elect Inc, Toyama 9392393, Japan	Mieda, E (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan.	eiko-mieda@aist.go.jp					Howlader MMR, 2001, J VAC SCI TECHNOL B, V19, P2114, DOI 10.1116/1.1414115; Yokoyama M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3374447; Schermer JJ, 2000, APPL PHYS LETT, V76, P2131, DOI 10.1063/1.126276; KONAGAI M, 1978, J CRYST GROWTH, V45, P277, DOI 10.1016/0022-0248(78)90449-9; Takagi S, 2008, IEEE T ELECTRON DEV, V55, P21, DOI 10.1109/TED.2007.911034; YABLONOVITCH E, 1987, APPL PHYS LETT, V51, P2222, DOI 10.1063/1.98946; Voncken MMAJ, 2002, MAT SCI ENG B-SOLID, V95, P242, DOI 10.1016/S0921-5107(02)00240-4; Schermer JJ, 2005, PHYS STATUS SOLIDI A, V202, P501, DOI 10.1002/pssa.200460410; MASZARA WP, 1988, J APPL PHYS, V64, P4943, DOI 10.1063/1.342443; George SM, 1996, J PHYS CHEM-US, V100, P13121, DOI 10.1021/jp9536763; PAVESI L, 1994, J APPL PHYS, V75, P4779, DOI 10.1063/1.355769; HIGASHI GS, 1989, APPL PHYS LETT, V55, P1963, DOI 10.1063/1.102337; Howlader MMR, 2002, J APPL PHYS, V91, P3062, DOI 10.1063/1.1430883; Puurunen RL, 2005, J APPL PHYS, V97, DOI 10.1063/1.1940727; Takagi H, 1996, APPL PHYS LETT, V68, P2222, DOI 10.1063/1.115865; PARKER JH, 1967, PHYS REV, V155, P712, DOI 10.1103/PhysRev.155.712; Takagi H, 1999, JPN J APPL PHYS 1, V38, P1589, DOI 10.1143/JJAP.38.1589; Chung T, 1998, JPN J APPL PHYS 1, V37, P1405, DOI 10.1143/JJAP.37.1405; Czornomaz L., 2012, IEDM, P517; Hill R. J. W., 2010, IEDM, P130; Horng RH, 2012, IEEE T ELECTRON DEV, V59, P666, DOI 10.1109/TED.2011.2177986; Horng R.-H., 2013, INT J PHOTOENERGY, V2013, P1; Ilegems M., 1985, TECHNOLOGY PHYSICS M, P83; Liang JB, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.021801; Maeda J, 1997, JPN J APPL PHYS 1, V36, P1554, DOI 10.1143/JJAP.36.1554; Maeda T, 2013, MICROELECTRON ENG, V109, P133, DOI 10.1016/j.mee.2013.03.069; Maeda T., 2011, SOL STAT DEV MAT, P1442; Onishi Y, 2002, JPN J APPL PHYS 2, V41, pL669, DOI 10.1143/JJAP.41.L669; Takagi H, 2006, J CRYST GROWTH, V292, P429, DOI 10.1016/j.jcrysgro.2006.04.049; Takagi H, 1999, APPL PHYS LETT, V74, P2387, DOI 10.1063/1.123860; WILLIAMS EW, 1992, SEMICONDUCT SEMIMET, V8, P321; Zahler JM, 2002, THIN SOLID FILMS, V403, P558, DOI 10.1016/S0040-6090(01)01570-X	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							036505	10.7567/JJAP.54.036505		5	Physics, Applied	Physics	CF8FT	WOS:000352792200065		
J	Mori, T; Fukuda, K; Miyata, N; Morita, Y; Migita, S; Mizubayashi, W; Masahara, M; Yasuda, T; Ota, H				Mori, Takahiro; Fukuda, Koichi; Miyata, Noriyuki; Morita, Yukinori; Migita, Shinji; Mizubayashi, Wataru; Masahara, Meishoku; Yasuda, Tetsuji; Ota, Hiroyuki			Study of gate leakage current paths in p-channel tunnel field-effect transistor by current separation measurement and device simulation	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							DIELECTRICS; LOGIC	Scaling the gate dielectric is a key to improving the steep switching characteristics of tunnel field-effect transistors (TFETs). The effect of the gate leakage current caused by this scaling has not fully been investigated until now. In this work, gate leakage current paths in a p-channel TFET are experimentally investigated by designing three types of measurement setup for separating the current paths. Our measurements reveal that the socalled gate-edge leakage current that directly flows from the gate into the source adversely affects the subthreshold characteristics of the source current. We also report that the areal leakage current tunneling from the gate to the channel causes the OFF current to increase. A device simulation is performed to separate the contribution of electron gate tunneling from that of hole gate tunneling and to understand the mechanism underlying these tunnelings, which reveals that electron tunneling occurring in the nanometer-scale source-gate overlap determines the gate leakage. Structural engineering around the source-channel overlap plays an important role in achieving high-performance TFETs.	[Mori, Takahiro; Fukuda, Koichi; Miyata, Noriyuki; Morita, Yukinori; Migita, Shinji; Mizubayashi, Wataru; Masahara, Meishoku; Yasuda, Tetsuji; Ota, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst NeRI, Tsukuba, Ibaraki 3058562, Japan	Mori, T (reprint author), Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst NeRI, Tsukuba, Ibaraki 3058562, Japan.	mori-takahiro@aist.go.jp	Mori, Takahiro/D-2038-2014		Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP), Japan	This research was supported by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program) initiated by the Council for Science and Technology Policy (CSTP), Japan.	Ribes G, 2005, IEEE T DEVICE MAT RE, V5, P5, DOI 10.1109/TDMR.2005.845236; Boucart K, 2007, IEEE T ELECTRON DEV, V54, P1725, DOI 10.1109/TED.2007.899389; Verhulst AS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2757593; Takagi S, 2013, SOLID STATE ELECTRON, V88, P2, DOI 10.1016/j.sse.2013.04.020; Kingon AI, 2000, NATURE, V406, P1032, DOI 10.1038/35023243; Seabaugh AC, 2010, P IEEE, V98, P2095, DOI 10.1109/JPROC.2010.2070470; Gandhi R, 2011, IEEE ELECTR DEVICE L, V32, P437, DOI 10.1109/LED.2011.2106757; Salahuddin S, 2008, NANO LETT, V8, P405, DOI 10.1021/nl071804g; Choi WY, 2007, IEEE ELECTR DEVICE L, V28, P743, DOI 10.1109/LED.2007.901273; Appenzeller J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.196805; Choi CH, 2001, IEEE T ELECTRON DEV, V48, P2823; Chan T. Y., 1987, IEDM, P718; Dewey G., 2011, IEDM; Fukuda K., 2012, INT WORKSH SIM SEM P, P284; Gopalakrishnan K, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P289, DOI 10.1109/IEDM.2002.1175835; Hall S., 2007, J TELECOM INFORM TEC, V2, P33; Huang Q., 2011, IEDM; Jeon K, 2010, S VLSI TECH, P121, DOI 10.1109/VLSIT.2010.5556195; Kim S. H., 2009, S VLSI, P179; Krishnamohan T., 2008, IEDM, P1; Mayer F., 2008, IEDM, P1; Mizubayashi W, 2005, MICROELECTRON RELIAB, V45, P1041, DOI 10.1016/j.microrel.2004.12.016; Mori T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.024201; Mori T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.06GF14; Sze S. M., 1981, PHYSICS SEMICONDUCTO, P446; Tan TT, 2009, APPL PHYS A-MATER, V97, P475, DOI 10.1007/s00339-009-5245-8; Toriumi A, 2005, MICROELECTRON ENG, V80, P190, DOI 10.1016/j.mee.2005.04.067; Toyoda S, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2035894	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							034202	10.7567/JJAP.54.034202		8	Physics, Applied	Physics	CF8FT	WOS:000352792200051		
J	Morimoto, M; Liang, JB; Nishida, S; Shigekawa, N				Morimoto, Masashi; Liang, Jianbo; Nishida, Shota; Shigekawa, Naoteru			Effects of annealing on electrical properties of Si/Si junctions by surface-activated bonding	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ROOM-TEMPERATURE; SILICON; INTERFACE; SI; SEMICONDUCTORS; DEVICES; WAFERS; ENERGY; GAAS; INP	Effects of annealing on surface-activated bonding (SAB)-based Si/Si junctions were investigated by transmission electron microscopy (TEM) observations and current-voltage (I-V) measurements. We observed an amorphous-like layer at the bonding interface, which was recrystallized by annealing. We extracted the potential barrier heights at Si/Si interfaces annealed at different temperatures from the results of I-V measurements at various ambient temperatures. For p-Si/p-Si junctions, the barrier height increased as the annealing temperature increased from 200 to 400 degrees C and decreased from 400 to 1000 degrees C. For n-Si/n-Si junctions, the barrier height increased as the annealing temperature increased from 200 to 600 degrees C and decreased from 600 to 1000 degrees C. By using the charge neutral level (CNL) model, we estimated the energy of CNL, ECNL, and the density of interface states, D-it, at each annealing temperature. Dit decreased as the annealing temperature increased from 400 to 1000 degrees C. ECNL showed values larger than the reported ones. (C) 2015 The Japan Society of Applied Physics	[Morimoto, Masashi; Liang, Jianbo; Nishida, Shota; Shigekawa, Naoteru] Osaka City Univ, Grad Sch Engn, Osaka 5588585, Japan	Morimoto, M (reprint author), Osaka City Univ, Grad Sch Engn, Osaka 5588585, Japan.	shigekawa@elec.eng.osaka-cu.ac.jp			"Creative research for clean energy generation using solar energy" project under CREST programs of JST	This work was supported by the "Creative research for clean energy generation using solar energy" project under CREST programs of JST.	ABE T, 1990, JPN J APPL PHYS 2, V29, pL2311; Robertson J, 2006, J APPL PHYS, V100, DOI 10.1063/1.2213170; Moutanabbir O, 2010, ANNU REV MATER RES, V40, P469, DOI 10.1146/annurev-matsci-070909-104448; Takagi H, 1999, JPN J APPL PHYS 1, V38, P1589, DOI 10.1143/JJAP.38.1589; ASHOK S, 1984, APPL PHYS LETT, V45, P431, DOI 10.1063/1.95247; ASHOK S, 1985, JPN J APPL PHYS 2, V24, pL533, DOI 10.1143/JJAP.24.L533; BENGTSSON S, 1989, J APPL PHYS, V66, P1231, DOI 10.1063/1.343469; BENGTSSON S, 1992, J APPL PHYS, V72, P124, DOI 10.1063/1.352172; Essig S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4807905; Hobart KD, 1998, APPL PHYS LETT, V72, P1095, DOI 10.1063/1.120975; Howlader MMR, 2010, J MICRO-NANOLITH MEM, V9, DOI 10.1117/1.3500747; Howlader MMR, 2010, THIN SOLID FILMS, V519, P804, DOI 10.1016/j.tsf.2010.08.144; Jackson MJ, 2011, ARTFORUM INT, V49, P110; Liang J, 2013, J APPL PHYS, V114, DOI 10.1063/1.4829676; Liang J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873113; Liang JB, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.021801; SEAGER CH, 1982, APPL PHYS LETT, V40, P471, DOI 10.1063/1.93138; Shigekawa N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04ER05; SINGH R, 1983, APPL PHYS LETT, V43, P502, DOI 10.1063/1.94367; Tanabe K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00349; Wada H, 1998, JPN J APPL PHYS 1, V37, P1383, DOI 10.1143/JJAP.37.1383; WADA H, 1993, APPL PHYS LETT, V62, P738, DOI 10.1063/1.108855; Yu LS, 2003, APPL PHYS LETT, V82, P916, DOI 10.1063/1.1544063; Zhou YC, 1998, APPL PHYS LETT, V73, P2337, DOI 10.1063/1.122454	24	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030212	10.7567/JJAP.54.030212		5	Physics, Applied	Physics	CF8FT	WOS:000352792200015		
J	Murase, K; Banura, N; Mimura, A; Nishimoto, K				Murase, Kenya; Banura, Natsuo; Mimura, Atsushi; Nishimoto, Kohei			Simple and practical method for correcting the inhomogeneous sensitivity of a receiving coil in magnetic particle imaging	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article								Magnetic particle imaging is a novel method of imaging the spatial distribution of magnetic nanoparticles. When considering the practical application of magnetic particle imaging, it is important to correct the inhomogeneous sensitivity of the receiving coil together with the feedthrough interference. In this study, we developed a simple and practical method for these corrections in which projection data are multiplied by correction factors obtained by fitting projection data acquired in a blank scan to a sixth-degree polynomial. Phantom experiments suggest that our method can be simply and easily implemented to realize the above corrections. (C) 2015 The Japan Society of Applied Physics	[Murase, Kenya; Banura, Natsuo; Mimura, Atsushi; Nishimoto, Kohei] Osaka Univ, Grad Sch Med, Fac Hlth Sci, Dept Med Phys & Engn,Div Med Technol & Sci, Suita, Osaka 5650871, Japan	Murase, K (reprint author), Osaka Univ, Grad Sch Med, Fac Hlth Sci, Dept Med Phys & Engn,Div Med Technol & Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	murase@sahs.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25282131]	This work was supported by a Grant-in-Aid for Scientific Research (B) (Grant No. 25282131) from the Japan Society for the Promotion of Science (JSPS).	SHEPP LA, 1974, IEEE T NUCL SCI, VNS21, P21; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Graeser M, 2013, MED PHYS, V40, DOI 10.1118/1.4794482; Lai SM, 2012, J MATER CHEM, V22, P15160, DOI 10.1039/c2jm32086j; Murase Kenya, 2011, Radiol Phys Technol, V4, P194, DOI 10.1007/s12194-011-0123-4; Murase Kenya, 2013, Radiol Phys Technol, V6, P399, DOI 10.1007/s12194-013-0213-6; Murase K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.067001; Murase K, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4885146; Shepp L. A., 1982, IEEE T MED IMAGING, V1, P113	9	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							038001	10.7567/JJAP.54.038001		3	Physics, Applied	Physics	CF8FT	WOS:000352792200069		
J	Murata, M; Chantana, J; Ashida, N; Hironiwa, D; Minemoto, T				Murata, Masashi; Chantana, Jakapan; Ashida, Naoki; Hironiwa, Daisuke; Minemoto, Takashi			Influence of conduction band minimum difference between transparent conductive oxide and absorber on photovoltaic performance of thin-film solar cell	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL BATH DEPOSITION; BUFFER LAYERS; OFFSET	Difference of conduction band minimum (E-C) between transparent conductive oxide (TCO) and absorber, named Delta EC-TA, in thin-film solar cell is investigated for high cell performance using device simulator. According to the simulation, the optimized Delta EC-TA value is different, depending on the carrier density in buffer layer, ND-B. With Delta EC-TA above 0.6 eV for both N(D-B)s of 1.0 x 10(13) and 1.0 x 10(18) cm(-3), the spike is formed at the TCO/buffer interface, thus decreasing cell performances, especially short-circuit current density owing to impeding photo-generated carriers to TCO. On the other hand, with Delta E(C-TA)s below -0.2 and -0.4 eV for N(D-B)s of 1.0 x 10(13) and 1.0 x 10(18) cm(-3), the solar cells demonstrate double diode characteristics, thereby decreasing cell efficiency. Eventually, the optimized Delta EC-TA values for high cell performance are proposed to be in the ranges from -0.2 to 0.6 eV and from -0.4 to 0.6 eV for N(D-B)s of 1.0 x 10(13) and 1.0 x 10(18) cm(-3), respectively.	[Murata, Masashi; Chantana, Jakapan; Ashida, Naoki; Hironiwa, Daisuke; Minemoto, Takashi] Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan	Murata, M (reprint author), Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan.	jakapan@fc.ritsumei.ac.jp	Minemoto, Takashi/F-9342-2011; Chantana, Jakapan/O-5110-2015	Chantana, Jakapan/0000-0002-5711-4979			Schmid D, 1996, SOL ENERG MAT SOL C, V41-2, P281, DOI 10.1016/0927-0248(95)00107-7; Reddy KTR, 2006, SOL ENERG MAT SOL C, V90, P3041, DOI 10.1016/j.solmat.2006.06.012; Minemoto T, 2001, SOL ENERG MAT SOL C, V67, P83, DOI 10.1016/S0927-0248(00)00266-X; Chantana J, 2014, SOL ENERG MAT SOL C, V130, P567, DOI 10.1016/j.solmat.2014.08.012; Chirila A, 2011, NAT MATER, V10, P857, DOI [10.1038/nmat3122, 10.1038/NMAT3122]; Burgelman M, 2000, THIN SOLID FILMS, V361, P527, DOI 10.1016/S0040-6090(99)00825-1; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Minami T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.044101; Nakada T, 2003, THIN SOLID FILMS, V431, P242, DOI 10.1016/S0040-6090(03)00265-7; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Katagiri H, 2009, THIN SOLID FILMS, V517, P2455, DOI 10.1016/j.tsf.2008.11.002; Chantana J, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW03; Chen SY, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.125201; Chirila A, 2013, NAT MATER, V12, P1107, DOI [10.1038/nmat3789, 10.1038/NMAT3789]; Gloeckler M., 2005, THESIS COLORADO STAT; Hashimoto Y, 1998, SOL ENERG MAT SOL C, V50, P71, DOI 10.1016/S0927-0248(97)00124-4; Ichiboshi A, 2006, SOL ENERG MAT SOL C, V90, P3130, DOI 10.1016/j.solmat.2006.06.032; Ikuno T, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804603; Kramm B, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3685719; Matsunaga K, 2009, SOL ENERG MAT SOL C, V93, P1134, DOI 10.1016/j.solmat.2009.02.015; Nakada T, 2002, JPN J APPL PHYS 2, V41, pL165, DOI 10.1143/JJAP.41.L165; Nakada T, 1998, JPN J APPL PHYS 2, V37, pL499, DOI 10.1143/JJAP.37.L499	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							032301	10.7567/JJAP.54.032301		5	Physics, Applied	Physics	CF8FT	WOS:000352792200041		
J	Muroo, K				Muroo, Kazuyuki			Electromagnetic interaction of atoms with an evanescent light field in attenuated total reflection spectroscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							OPTICALLY DENSE VAPOR; WAVE SPECTROSCOPY; LINE	The electromagnetic interaction of atoms with an evanescent light field is investigated with photon energy density and photon energy flux density using the Fresnel-Maxwell equations. The theory provides expressions of absorption signal intensities in attenuated total reflection spectroscopy for the p- and s-polarizations of the incident light, and relates them to the Goos-Hanchen shift. For an electric dipole interaction, the energy stored in the electric field of an evanescent light governs the absorption process, and hence the photon energy density and the photon energy flux density should be estimated from the energy stored in the electric field. The violation of equality between the portions of the energy stored respectively in the electric and magnetic fields yields the difference of the absorption signal intensity and its dependence on the incident angle between the s- and p-polarizations. (C) 2015 The Japan Society of Applied Physics	Tokyo Univ Agr & Technol, Fac Technol, Dept Appl Phys, Koganei, Tokyo 1848588, Japan	Muroo, K (reprint author), Tokyo Univ Agr & Technol, Fac Technol, Dept Appl Phys, Koganei, Tokyo 1848588, Japan.	muroo@cc.tuat.ac.jp					Matsudo T, 1998, OPT COMMUN, V145, P64, DOI 10.1016/S0030-4018(97)00420-3; RENARD RH, 1964, J OPT SOC AM, V54, P1190, DOI 10.1364/JOSA.54.001190; Failache H, 1999, PHYS REV LETT, V83, P5467, DOI 10.1103/PhysRevLett.83.5467; HOROWITZ BR, 1971, J OPT SOC AM, V61, P586, DOI 10.1364/JOSA.61.000586; Bordo VG, 2001, PHYS REV LETT, V86, P1490, DOI 10.1103/PhysRevLett.86.1490; GorrisNeveux M, 1997, OPT COMMUN, V134, P85, DOI 10.1016/S0030-4018(96)00559-7; Guo J, 1996, PHYS REV A, V53, P1130, DOI 10.1103/PhysRevA.53.1130; Kiersnowski K, 1998, PHYS REV A, V57, pR4079, DOI 10.1103/PhysRevA.57.R4079; Kondo R, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.062504; MAHAN AI, 1978, APPL OPTICS, V17, P509, DOI 10.1364/AO.17.000509; SIMONEAU P, 1986, OPT COMMUN, V59, P103, DOI 10.1016/0030-4018(86)90458-X; Tojo S, 2003, J PHYS SOC JPN, V72, P1069, DOI 10.1143/JPSJ.72.1069; Zhao KF, 2001, J OPT SOC AM B, V18, P1904, DOI 10.1364/JOSAB.18.001904	13	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							032001	10.7567/JJAP.54.032001		6	Physics, Applied	Physics	CF8FT	WOS:000352792200039		
J	Nagase, M; Takahashi, T; Shimizu, M				Nagase, Masanori; Takahashi, Tokio; Shimizu, Mitsuaki			Investigating the bistability characteristics of GaN/AlN resonant tunneling diodes for ultrafast nonvolatile memory	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MOLECULAR-BEAM EPITAXY; LEAKAGE CURRENT MECHANISMS; DOUBLE-BARRIER DIODES; GAN FILMS; PHOTOLUMINESCENCE; INSTABILITIES; SPECTROSCOPY	The bistability characteristics of GaN/AlN resonant tunneling diodes (RTDs) grown on a sapphire substrate by metalorganic vapor phase epitaxy (MOVPE) were investigated to better understand their physical origin and explore their use in nonvolatile memories. The bistability current-voltage (I-V) characteristics of GaN/AlN RTDs, which were due to intersubband transitions and electron accumulation in the quantum well, were clearly observed over a wide temperature range between 50 and 300 K. However, the I-V characteristics sometimes degraded at temperatures above 250 K. Complex staircase structures were observed in the voltage region showing a negative differential resistance in the I-V curve, and the forward current increased or decreased rapidly as the forward-bias voltage increased. Repeated measurements of the I-V characteristics over the wide temperature range between 50 and 300K revealed that the bistability characteristics of GaN/AlN RTDs degraded owing to the leakage of electrons accumulating in the quantum well through a deep level in the AlN barrier associated with crystal defects such as dislocations and impurities. Therefore, reduction in crystal defect and impurity densities in the AlN barrier, and a careful design that considers deep levels are important for realizing realize ultrafast nonvolatile memories based on the bistability characteristics of GaN/AlN RTDs. (C) 2015 The Japan Society of Applied Physics	[Nagase, Masanori] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Takahashi, Tokio; Shimizu, Mitsuaki] Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr, Tsukuba, Ibaraki 3058568, Japan	Nagase, M (reprint author), Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058568, Japan.	m-nagase@aist.go.jp			IBEC Innovation Platform, AIST of Japan	The authors thank Dr. T. Tokizaki of the National Institute of Advanced Industrial Science and Technology (AIST), Professor M. Suhara of Tokyo Metropolitan University, and Associate Professor M. Watanabe of the Tokyo Institute of Technology for fruitful discussions. This work was conducted at the Nano-Processing Facility, supported by the IBEC Innovation Platform, AIST of Japan.	Akinaga H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.100001; Kikuchi A, 2002, APPL PHYS LETT, V81, P1729, DOI 10.1063/1.1501157; Ando K, 2006, SCIENCE, V312, P1883, DOI 10.1126/science.1125461; Bayram C, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3484280; Bayram C, 2012, PROC SPIE, V8268, DOI 10.1117/12.913740; Foxon CT, 2003, PHYS STATUS SOLIDI C, V0, P2389, DOI 10.1002/pssc.200303376; Kanaya H, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.124101; Zhang H, 2006, J APPL PHYS, V99, DOI 10.1063/1.2159547; Asada M, 2008, JPN J APPL PHYS, V47, P4375, DOI [10.1143/JJAP.47.4375, 10.1143/JJAP.47.43751]; Denda J, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.044103; Li D, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729819; Miller EJ, 2004, APPL PHYS LETT, V84, P535, DOI 10.1063/1.1644029; Boucherit M, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3659468; Golka S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199445; Yoshikawa M, 1999, J APPL PHYS, V86, P4400, DOI 10.1063/1.371377; Setter N, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336999; Nagase M, 2014, IEEE T ELECTRON DEV, V61, P1321, DOI 10.1109/TED.2014.2310473; TSU R, 1973, APPL PHYS LETT, V22, P562, DOI 10.1063/1.1654509; Feiginov M, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3667191; Belyaev AE, 2004, PHYSICA E, V21, P752, DOI 10.1016/j.physe.2003.11.119; Denda J, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CJ07; GOLDMAN VJ, 1987, PHYS REV LETT, V58, P1256, DOI 10.1103/PhysRevLett.58.1256; Iliopoulos E, 1998, APPL PHYS LETT, V73, P375, DOI 10.1063/1.121839; Leconte S, 2008, PHYS STATUS SOLIDI C, V5, P431, DOI 10.1002/pssc.200777463; Lee ML, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2803067; Li J, 2002, APPL PHYS LETT, V81, P3365, DOI 10.1063/1.1518558; Iizuka N, 2000, APPL PHYS LETT, V77, P648, DOI 10.1063/1.127073; MENDEZ EE, 1986, PHYS REV B, V33, P2893, DOI 10.1103/PhysRevB.33.2893; Nagase M., 2014, INT S COMP SEM, pP37; Nagase M, 2001, JPN J APPL PHYS 1, V40, P3018, DOI 10.1143/JJAP.40.3018; Nagase M., 2013, SOL STAT DEV MAT; OHNISHI H, 1986, APPL PHYS LETT, V49, P1248, DOI 10.1063/1.97428; Ooyama K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.101001; PAYLING CA, 1988, SURF SCI, V196, P404, DOI 10.1016/0039-6028(88)90718-2; Razzhuvalov AN, 2008, SEMICONDUCTORS+, V42, P580, DOI 10.1134/S1063782608050163; Sacconi F, 2002, PHYS STATUS SOLIDI A, V190, P295, DOI 10.1002/1521-396X(200203)190:1<295::AID-PSSA295>3.0.CO;2-A; Tsen KT, 1997, APPL PHYS LETT, V71, P1852, DOI 10.1063/1.119420; TSUCHIYA M, 1991, JPN J APPL PHYS 1, V30, P1164, DOI 10.1143/JJAP.30.1164; WEIL T, 1987, APPL PHYS LETT, V50, P1281, DOI 10.1063/1.97884; Yuasa Shinji, 2009, Synthesiology (English Edition), V2	40	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							034201	10.7567/JJAP.54.034201		8	Physics, Applied	Physics	CF8FT	WOS:000352792200050		
J	Nakano, H; Sakai, T				Nakano, Hiroki; Sakai, Toru			Instability of a ferrimagnetic state of a frustrated S=1/2 Heisenberg antiferromagnet in two dimensions	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							T-J; MAGNETIZATION PROCESS; KAGOME LATTICE; SPIN CHAINS; QUANTUM; MODELS; EXCITATIONS; HUBBARD; SQUARE	To clarify the instability of the ferrimagnetism which is the fundamental magnetism of ferrite, numerical-diagonalization study is carried out for the two-dimensional S = 1/2 Heisenberg antiferromagnet with frustration. We find that the ferrimagnetic ground state has the spontaneous magnetization in small frustration; due to a frustrating interaction above a specific strength, the spontaneous magnetization discontinuously vanishes so that the ferrimagnetic state appears only under some magnetic fields. We also find that, when the interaction is increased further, the ferrimagnetism disappears even under magnetic field. (C) 2015 The Japan Society of Applied Physics	[Nakano, Hiroki; Sakai, Toru] Univ Hyogo, Grad Sch Mat Sci, Kamigori, Hyogo 6781297, Japan; [Sakai, Toru] Japan Atom Energy Agcy, SPring 8, Sayo, Hyogo 6795148, Japan	Nakano, H (reprint author), Univ Hyogo, Grad Sch Mat Sci, Kamigori, Hyogo 6781297, Japan.	hnakano@sci.u-hyogo.ac.jp			JSPS KAKENHI [23340109, 24540348]; Strategic Programs for Innovative Research; Ministry of Education, Culture, Sports, Science and Technology of Japan; Computational Materials Science Initiative, Japan	This work was partly supported by JSPS KAKENHI Grant Numbers 23340109 and 24540348. Nonhybrid thread-parallel calculations in numerical diagonalizations were based on TITPACK version 2 coded by H. Nishimori. Part of calculations in this study were carried out as an activity of a cooperative study in Center for Cooperative Work on Computational Science, University of Hyogo. Some of the computations were also performed using facilities of the Department of Simulation Science, National Institute for Fusion Science; Center for Computational Materials Science, Institute for Materials Research, Tohoku University; Supercomputer Center, Institute for Solid State Physics, The University of Tokyo; and Supercomputing Division, Information Technology Center, The University of Tokyo. This work was partly supported by the Strategic Programs for Innovative Research; the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the Computational Materials Science Initiative, Japan. We also would like to express our sincere thanks to the staff of the Center for Computational Materials Science of the Institute for Materials Research, Tohoku University, for their continuous support of the SR16000 supercomputing facilities.	Waldtmann C, 1998, EUR PHYS J B, V2, P501, DOI 10.1007/s100510050274; Kohno M, 1997, PHYS REV B, V56, P3212, DOI 10.1103/PhysRevB.56.3212; Sakai T, 1999, PHYS REV B, V60, P7295, DOI 10.1103/PhysRevB.60.7295; Nakano H, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.053702; Shimokawa T, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.043703; MARSHALL W, 1955, PROC R SOC LON SER-A, V232, P48, DOI 10.1098/rspa.1955.0200; Rousochatzakis I, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.104415; LIN HQ, 1990, PHYS REV B, V42, P6561, DOI 10.1103/PhysRevB.42.6561; Schulenburg J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.167207; LANCZOS C, 1950, J RES NAT BUR STAND, V45, P255, DOI 10.6028/jres.045.026; Nakano H, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.053707; Lecheminant P, 1997, PHYS REV B, V56, P2521, DOI 10.1103/PhysRevB.56.2521; LIEB E, 1962, J MATH PHYS, V3, P749, DOI 10.1063/1.1724276; Isoda M, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.084710; Shimokawa T, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.084710; OGATA M, 1991, PHYS REV LETT, V66, P2388, DOI 10.1103/PhysRevLett.66.2388; MOREO A, 1990, PHYS REV B, V42, P4786, DOI 10.1103/PhysRevB.42.4786; Nakano H, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.033709; WHITE SR, 1993, PHYS REV B, V48, P3844, DOI 10.1103/PhysRevB.48.3844; Hida K, 2001, J PHYS SOC JPN, V70, P3673, DOI 10.1143/JPSJ.70.3673; Nakano H, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.053704; Nakano H, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.084709; BLANCO AM, 1989, J PHYS D APPL PHYS, V22, P210, DOI 10.1088/0022-3727/22/1/031; DAGOTTO E, 1992, PHYS REV B, V45, P10741, DOI 10.1103/PhysRevB.45.10741; HEINDL R, 1978, J MAGN MAGN MATER, V7, P26, DOI 10.1016/0304-8853(78)90142-7; Hosokoshi Y, 2001, J AM CHEM SOC, V123, P7921, DOI 10.1021/ja015711r; Hosokoshi Y, 2003, SYNTHETIC MET, V133, P527, DOI 10.1016/S0379-6779(02)00425-3; ICHINOSE N, 1966, JPN J APPL PHYS, V5, P1140, DOI 10.1143/JJAP.5.1140; ICHINOSE N, 1966, JPN J APPL PHYS, V5, P461, DOI 10.1143/JJAP.5.461; MIYASHITA S, 1988, J PHYS SOC JPN, V57, P1934, DOI 10.1143/JPSJ.57.1934; Nakano H, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.043715; Nakano H, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.014003; Nakano H, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.034705; Nakano H, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.104710; PARKINSON JB, 1985, PHYS REV B, V32, P4703, DOI 10.1103/PhysRevB.32.4703; Sakai T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.100405; Shimokawa T, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.125003; Sindzingre P, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/27009; TODO S, 2001, PHYS REV LETT, V87; Tsunetsugu H, 1998, J PHYS SOC JPN, V67, P1864, DOI 10.1143/JPSJ.67.1864	40	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030305	10.7567/JJAP.54.030305		4	Physics, Applied	Physics	CF8FT	WOS:000352792200028		
J	Nishida, S; Liang, JB; Hayashi, T; Arai, M; Shigekawa, N				Nishida, Shota; Liang, Jianbo; Hayashi, Tomohiro; Arai, Manabu; Shigekawa, Naoteru			Correlation between the electrical properties of p-Si/n-4H-SiC junctions and concentrations of acceptors in Si	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; BEAM SURFACE ACTIVATION; ROOM-TEMPERATURE; HETEROJUNCTIONS; INP	We fabricated p(+)-, p-, and p(-)-Si/ n-4H-SiC junctions by surface activated bonding (SAB). We investigated their electrical properties by measuring their current-voltage (I-V) characteristics at raised ambient temperatures, capacitance-voltage (C-V) characteristics at various frequencies, and capacitance-frequency (C-f) characteristics at room temperature. The activation energy of their reverse-bias current and the flat-band voltage in their C-V characteristics, which were estimated to be 0.97-1.01 eV and 0.83-0.84V, respectively, were insensitive to the concentrations of acceptors in Si substrates. The relaxation times estimated from the C-f characteristics were 0.8 and 1.5 mu s for the p-Si/ n-4H-SiC and p%-Si/ n-4H-SiC junctions, respectively. The results are explained by a scheme wherein Fermi level pinning occurs at the Si/ 4H-SiC interfaces fabricated by SAB. (C) 2015 The Japan Society of Applied Physics	[Nishida, Shota; Liang, Jianbo; Hayashi, Tomohiro; Shigekawa, Naoteru] Osaka City Univ, Grad Sch Engn, Osaka 5588585, Japan; [Arai, Manabu] New Japan Radio Co Ltd, Chuo Ku, Tokyo 1038456, Japan	Nishida, S (reprint author), Osaka City Univ, Grad Sch Engn, Osaka 5588585, Japan.	shigekawa@elec.eng.osaka-cu.ac.jp			"Creative research for clean energy generation using solar energy" project in Core Research for Evolutional Science and Technology (CREST) programs of the Japan Science and Technology Agency (JST)	Part of this work was supported by the "Creative research for clean energy generation using solar energy" project in Core Research for Evolutional Science and Technology (CREST) programs of the Japan Science and Technology Agency (JST).	YIH PH, 1994, IEEE T ELECTRON DEV, V41, P281, DOI 10.1109/16.275210; KROEMER H, 1982, P IEEE, V70, P13, DOI 10.1109/PROC.1982.12226; Nazarov AN, 2001, J APPL PHYS, V89, P4422, DOI 10.1063/1.1355698; DONNELLY JP, 1967, IEEE T ELECTRON DEV, VED14, P63, DOI 10.1109/T-ED.1967.15900; Takagi H, 1998, JPN J APPL PHYS 1, V37, P4197, DOI 10.1143/JJAP.37.4197; Howlader MMR, 2002, J APPL PHYS, V91, P3062, DOI 10.1063/1.1430883; MORKOC H, 1994, J APPL PHYS, V76, P1363; Takagi H, 1999, JPN J APPL PHYS 1, V38, P1589, DOI 10.1143/JJAP.38.1589; Essig S, 2013, ECS J SOLID STATE SC, V2, pQ178, DOI 10.1149/2.031309jss; Guy OJ, 2009, MATER SCI FORUM, V615-617, P443; Hayashi T, 2006, MATER SCI FORUM, V527-529, P1453; Howlader MMR, 2004, J ELECTROCHEM SOC, V151, pG461, DOI 10.1149/1.1758723; Jennings MR, 2008, ELECTROCHEM SOLID ST, V11, pH306, DOI 10.1149/1.2976158; Konovalov I, 1998, PROG PHOTOVOLTAICS, V6, P151; Liang J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873113; Liang JB, 2013, PHYS STATUS SOLIDI C, V10, P1644, DOI 10.1002/pssc.201300235; Nishida S, 2014, MATER SCI FORUM, V778-780, P718, DOI 10.4028/www.scientific.net/MSF.778-780.718; Perez-Tomas A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3099018; Perez-Tomas A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2752148; Shigekawa N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04ER05; Shigekawa N., 2012, P 3 INT IEEE WORKSH, P109; Shinohara H, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2991449; Wada H, 1998, JPN J APPL PHYS 1, V37, P1383, DOI 10.1143/JJAP.37.1383; Wu KH, 1997, JPN J APPL PHYS 1, V36, P5151, DOI 10.1143/JJAP.36.5151; Yoshimoto M., 2013, ECS T, V50, P61	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							030210	10.7567/JJAP.54.030210		4	Physics, Applied	Physics	CF8FT	WOS:000352792200013		
J	Ryong-Sok, O; Takamura, M; Furukawa, K; Nagase, M; Hibino, H				Ryong-Sok, O.; Takamura, Makoto; Furukawa, Kazuaki; Nagase, Masao; Hibino, Hiroki			Effects of UV light intensity on electrochemical wet etching of SiC for the fabrication of suspended graphene	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							EPITAXIAL GRAPHENE; RAMAN-SPECTROSCOPY; RESONATORS; SCATTERING; SILICON	We report on the effects of UV light intensity on the photo assisted electrochemical wet etching of SiC(0001) underneath an epitaxially grown graphene for the fabrication of suspended structures. The maximum etching rate of SiC(0001) was 2.5 mu m/h under UV light irradiation in 1 wt% KOH at a constant current of 0.5 mA/cm(2). The successful formation of suspended structures depended on the etching rate of SiC. In the Raman spectra of the suspended structures, we did not observe a significant increase in the intensity of the D peak, which originates from defects in graphene sheets. This is most likely explained by the high quality of the single-crystalline graphene epitaxially grown on SiC. (C) 2015 The Japan Society of Applied Physics	[Ryong-Sok, O.; Takamura, Makoto; Furukawa, Kazuaki; Hibino, Hiroki] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Ryong-Sok, O.; Nagase, Masao] Univ Tokushima, Grad Sch Adv Technol & Sci, Tokushima 7708506, Japan	Ryong-Sok, O (reprint author), NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan.	oryonsoku@ee.tokushima-u.ac.jp	Furukawa, Kazuaki/D-1743-2010; Takamura, Makoto/C-4352-2013	Takamura, Makoto/0000-0002-9454-6754			Shivaraman S, 2009, NANO LETT, V9, P3100, DOI 10.1021/nl900479g; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Dong XC, 2009, SMALL, V5, P1422, DOI 10.1002/smll.200801711; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Bolotin KI, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096802; Lee DS, 2008, NANO LETT, V8, P4320, DOI 10.1021/nl802156w; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/nmat2382, 10.1038/NMAT2382]; Singh V, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/16/165204; Zhao SC, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/35/355703; Bunch JS, 2007, SCIENCE, V315, P490, DOI 10.1126/science.1136836; Huh S, 2011, ACS NANO, V5, P9799, DOI 10.1021/nn204156n; Gunes F, 2011, NANO, V6, P409, DOI 10.1142/S1793292011002780; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Chen CY, 2009, NAT NANOTECHNOL, V4, P861, DOI [10.1038/nnano.2009.267, 10.1038/NNANO.2009.267]; Shioya H, 2014, NANO LETT, V14, P1158, DOI 10.1021/nl403679f; Mohiuddin TMG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205433; Berciaud S, 2009, NANO LETT, V9, P346, DOI 10.1021/nl8031444; Yu QK, 2011, NAT MATER, V10, P443, DOI [10.1038/nmat3010, 10.1038/NMAT3010]; Ferralis N, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.156801; Chien FSS, 1999, APPL PHYS LETT, V75, P2429, DOI 10.1063/1.125037; Hibino H, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/37/374005; Imamura G, 2014, J PHYS CHEM C, V118, P11842, DOI 10.1021/jp503802d; Imamura G, 2013, CHEM PHYS LETT, V587, P56, DOI 10.1016/j.cplett.2013.09.065; Ryong-Sok O, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FD06; Kato M, 2003, JPN J APPL PHYS 1, V42, P4233, DOI 10.1143/JJAP.42.4233; Kunc J, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4830374; Shivaraman S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195425; Takamura M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CH01; Zhang EX, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4753817	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							036502	10.7567/JJAP.54.036502		5	Physics, Applied	Physics	CF8FT	WOS:000352792200062		
J	Sasaki, A; Kataoka, Y; Aoki, K; Saito, S; Kobayashi, K; Ito, T; Kakushima, K; Iwai, H				Sasaki, Akito; Kataoka, Yoshinori; Aoki, Katsuaki; Saito, Syuichi; Kobayashi, Kumpei; Ito, Takahiro; Kakushima, Kuniyuki; Iwai, Hiroshi			Power generation characteristics of Schottky-type solar cells fabricated using barium silicide	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MOLECULAR-BEAM EPITAXY; DOPED BASI2 FILMS; POLYCRYSTALLINE BASI2; ELECTRICAL-PROPERTIES; OPTICAL-PROPERTIES; CONDUCTION TYPE; SI/FE RATIOS; BETA-FESI2; SI(111); TEMPERATURE	We studied a novel method of increasing the efficiency of solar cells using BaSi2 as a semiconductor. BaSi2 could be deposited by RF magnetron sputtering using a polycrystalline BaSi2 target, followed by annealing at 500 degrees C for 30 min in N-2 ambient. Furthermore, Schottky-type solar cells using BaSi2 were fabricated. The crucial point is that Al-Nd was used to form the Schottky junction between the BaSi2 film and the Al-Nd electrode. Additionally, Si3N4 (3-5 nm) was used as an oxidation prevention layer. Under irradiation at 90 K, resulting in a short-circuit current density (J(sc)) of 3.19 mA/cm(2), an open-circuit voltage (V-oc) of 0.76 V, and a fill factor (FF) of 0.28 were obtained. (C) 2015 The Japan Society of Applied Physics	[Sasaki, Akito; Kataoka, Yoshinori; Aoki, Katsuaki; Saito, Syuichi; Kobayashi, Kumpei] Toshiba Mat Co Ltd, Yokohama, Kanagawa 2358522, Japan; [Ito, Takahiro] Geomatec Co Ltd, Ota, Tokyo 1460093, Japan; [Kakushima, Kuniyuki; Iwai, Hiroshi] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 2268502, Japan; [Iwai, Hiroshi] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268502, Japan	Sasaki, A (reprint author), Toshiba Mat Co Ltd, Yokohama, Kanagawa 2358522, Japan.	akito.sasaki@toshiba.co.jp					Latiff NAA, 2013, PHYS STATUS SOLIDI C, V10, P1759, DOI 10.1002/pssc.201300333; Takeishi M, 2011, PHYSCS PROC, V11, P27, DOI 10.1016/j.phpro.2011.01.030; Yoneyama T, 2013, THIN SOLID FILMS, V534, P116, DOI 10.1016/j.tsf.2013.02.003; Suemasu T, 2006, JPN J APPL PHYS 2, V45, pL519, DOI [10.1143/JJAP.45.L519, 10.1143/JJAP.45.L5191]; Toh K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.068001; MORRIS RG, 1958, PHYS REV, V109, P1909, DOI 10.1103/PhysRev.109.1909; Imai Y, 2001, THIN SOLID FILMS, V381, P176, DOI 10.1016/S0040-6090(00)01740-5; Baba M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.098003; Saito T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.021301; Du WJ, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3703585; Inomata Y, 2004, JPN J APPL PHYS 2, V43, pL478, DOI 10.1143/JJAP.43.L478; Morita K, 2006, THIN SOLID FILMS, V508, P363, DOI 10.1016/j.tsf.2005.07.344; Morita K, 2006, JPN J APPL PHYS 2, V45, pL390, DOI 10.1143/JJAP.45.L390; Khan MA, 2011, PHYSCS PROC, V11, P11, DOI 10.1016/j.phpro.2011.01.026; Matsumoto Y, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.021101; Hara KO, 2012, J APPL PHYS, V112, DOI 10.1063/1.4759246; BIRKHOLZ U, 1968, PHYS STATUS SOLIDI, V27, P413, DOI 10.1002/pssb.19680270141; Baba M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824335; Borisenko V. E., 2000, SEMICONDUCTING SILIC, P21; Gotoh K, 2007, THIN SOLID FILMS, V515, P8263, DOI 10.1016/j.tsf.2007.02.066; Khan MA, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4796142; Khan MA, 2012, THIN SOLID FILMS, V522, P95, DOI 10.1016/j.tsf.2012.09.005; Kobayashi M, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.051403; Migas DB, 2007, PHYS STATUS SOLIDI B, V244, P2611, DOI 10.1002/pssb.200642556; MIKI T, 1994, J APPL PHYS, V75, P1693, DOI 10.1063/1.356356; Murakami Y, 2004, THIN SOLID FILMS, V461, P198, DOI 10.1016/j.tsf.2004.02.071; Seki N, 2003, MAT SCI SEMICON PROC, V6, P307, DOI 10.1016/j.mssp.2003.07.018; Takakura K, 2000, JPN J APPL PHYS 2, V39, pL789, DOI 10.1143/JJAP.39.L789; Terai Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4731246; Tsukada D, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.051601; Yang ZY, 2011, PHYSCS PROC, V11, P118, DOI 10.1016/j.phpro.2011.01.018; Zhao FJ, 2009, SCI CHINA SER G, V52, P580, DOI 10.1007/s11433-009-0086-1	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							031202	10.7567/JJAP.54.031202		4	Physics, Applied	Physics	CF8FT	WOS:000352792200035		
J	Satoh, Y; Hanawa, H; Nakajima, A; Horio, K				Satoh, Yoshiki; Hanawa, Hideyuki; Nakajima, Atsushi; Horio, Kazushige			Analysis of high-k passivation-layer effects on buffer-related breakdown and current collapse in AlGaN/GaN HEMTs	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTRON-MOBILITY TRANSISTORS; GATE-LAG PHENOMENA; FIELD-PLATE; 2-DIMENSIONAL ANALYSIS; CURRENT TRANSIENTS; RECESSED-GATE; GAAS-MESFETS; IMPACT-IONIZATION; SURFACE-STATE; VOLTAGE	We analyze breakdown characteristics and current collapse in AlGaN/GaN HEMTs, with the passivation layer's relative permittivity er as a parameter. It is shown that the off-state breakdown voltage is considerably enhanced by introducing a high-k passivation layer because the electric field at the drain edge of the gate is weakened and the buffer leakage current is reduced. The breakdown voltage in the high-epsilon(r) region increases when the gate voltage is changed from -8 to -10V, because the buffer leakage current is reduced. It is also shown that drain lag and current collapse in AlGaN/GaN HEMTs could be reduced by introducing a high-k thick passivation layer, because the electric field at the drain edge of the gate is reduced, leading to less electron injection into the buffer layer and weaker buffer trapping effects. (C) 2015 The Japan Society of Applied Physics	[Satoh, Yoshiki; Hanawa, Hideyuki; Nakajima, Atsushi; Horio, Kazushige] Shibaura Inst Technol, Fac Syst Engn, Saitama 3378570, Japan	Satoh, Y (reprint author), Shibaura Inst Technol, Fac Syst Engn, Saitama 3378570, Japan.						Bahat-Treidel E, 2010, IEEE T ELECTRON DEV, V57, P1208, DOI 10.1109/TED.2010.2045705; Hao Y, 2011, IEEE ELECTR DEVICE L, V32, P626, DOI 10.1109/LED.2011.2118736; HORIO K, 1994, IEEE T ELECTRON DEV, V41, P2256, DOI 10.1109/16.337436; Meneghesso G, 2004, IEEE T ELECTRON DEV, V51, P1554, DOI 10.1109/TED.2004.835025; Onodera H, 2012, SEMICOND SCI TECH, V27, DOI 10.1088/0268-1242/27/8/085016; Brannick A, 2009, IEEE ELECTR DEVICE L, V30, P436, DOI 10.1109/LED.2009.2016680; Uren MJ, 2006, IEEE T ELECTRON DEV, V53, P395, DOI 10.1109/TED.2005.862702; Ikeda N, 2010, P IEEE, V98, P1151, DOI 10.1109/JPROC.2009.2034397; Horio K, 2009, SEMICOND SCI TECH, V24, DOI 10.1088/0268-1242/24/8/085022; Okamoto Y, 2004, IEEE T MICROW THEORY, V52, P2536, DOI 10.1109/TMTT.2004.837159; Wu YF, 2004, IEEE ELECTR DEVICE L, V25, P117, DOI 10.1109/LED.2003.822667; Horio K, 2008, JPN J APPL PHYS, V47, P3428, DOI 10.1143/JJAP.47.3428; Meneghesso G, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.100211; Bulutay C, 2002, SEMICOND SCI TECH, V17, pL59, DOI 10.1088/0268-1242/17/10/102; Karmalkar S, 2001, IEEE T ELECTRON DEV, V48, P1515, DOI 10.1109/16.936500; Mishra UK, 2008, P IEEE, V96, P287, DOI 10.1109/JPROC.2007.911060; Luo Q, 2012, NANOSCI NANOTECH LET, V4, P936, DOI 10.1166/nnl.2012.1406; Hanawa H, 2014, IEEE T ELECTRON DEV, V61, P769, DOI 10.1109/TED.2014.2298194; Hanawa H, 2014, PHYS STATUS SOLIDI A, V211, P784, DOI 10.1002/pssa.201300403; Horio K, 2011, IEEE T ELECTRON DEV, V58, P698, DOI 10.1109/TED.2010.2094621; Horio K, 2005, J APPL PHYS, V98, DOI 10.1063/1.2141653; Horio K, 2000, IEEE T ELECTRON DEV, V47, P617, DOI 10.1109/16.824738; Horio K, 2011, J APPL PHYS, V109, DOI 10.1063/1.3596561; Mitani Y, 2003, IEEE T ELECTRON DEV, V50, P285, DOI 10.1109/TED.2003.809039; Wakabayashi A, 2002, IEEE T ELECTRON DEV, V49, P37, DOI 10.1109/16.974746	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							031002	10.7567/JJAP.54.031002		5	Physics, Applied	Physics	CF8FT	WOS:000352792200032		
J	Shigeta, M; Kamiya, K; Uejima, M; Okada, S				Shigeta, Masahiro; Kamiya, Katsumasa; Uejima, Mitsugu; Okada, Susumu			Dispersion of carbon nanotubes in organic solvent by commercial polymers with ethylene chains: Experimental and theoretical studies	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FIELD-EFFECT TRANSISTORS; ELECTRON-GAS; SINGLE; WATER; SOLUBILIZATION; MICROTUBULES; CONDUCTORS; COMPOSITE	We demonstrate the possible candidate dispersion agents that can uniformly disperse carbon nanotubes (CNTs) into organic solvent, from among commercially available polymers. We find that CNTs were well dispersed into dimethylacetamide with the use of polystyrene, poly(vinyl chloride), and poly(vinyl pyrrolidone) as dispersion agents. Theoretical calculations revealed that the dispersibility of these polymers arises from the moderate strength and preferential directionality of the interactions between the CNTs and the polymers. (C) 2015 The Japan Society of Applied Physics	[Shigeta, Masahiro; Okada, Susumu] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Shigeta, Masahiro; Uejima, Mitsugu] Technol Res Assoc Single Wall Carbon Nanotubes TA, Tsukuba, Ibaraki 3058565, Japan; [Kamiya, Katsumasa] Kanagawa Inst Technol, Ctr Basic Educ & Integrated Learning, Atsugi, Kanagawa 2430292, Japan	Shigeta, M (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan.	msigeta@gmail.com	Okada, Susumu/D-7461-2012		New Energy and Industrial Technology Development Organization (NEDO) of Japan [P10024]; CREST from the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) of Japan (No. P10024), CREST from the Japan Science and Technology Agency, and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. A part of the calculations were performed on NEC SX-9 at the Cybermedia center at Osaka University and on NEC SX-9 at the Institute of Solid State Physics, The University of Tokyo. The TEM image of SWCNTs (Fig. 1) was supplied by AIST.	Shigeta M, 2006, CHEM PHYS LETT, V418, P115, DOI 10.1016/j.cplett.2005.10.088; Hasan T, 2007, J PHYS CHEM C, V111, P12594, DOI 10.1021/jp0723012; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Islam MF, 2003, NANO LETT, V3, P269, DOI 10.1021/nl025924u; [Anonymous], 1983, TOKYO AB INITIO PROG; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Nish A, 2007, NAT NANOTECHNOL, V2, P640, DOI 10.1038/nnano.2007.290; Nosho Y, 2006, NANOTECHNOLOGY, V17, P3412, DOI 10.1088/0957-4484/17/14/011; Giordani S, 2006, J PHYS CHEM B, V110, P15708, DOI 10.1021/jp0626216; SAITO R, 1992, APPL PHYS LETT, V60, P2204, DOI 10.1063/1.107080; Bekyarova E, 2007, J PHYS CHEM C, V111, P17865, DOI 10.1021/jp071329a; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Tans SJ, 1998, NATURE, V393, P49; Konabe S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.227401; Yamauchi J, 1996, PHYS REV B, V54, P5586, DOI 10.1103/PhysRevB.54.5586; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Kato H, 2009, CARBON, V47, P3434, DOI 10.1016/j.carbon.2009.08.006; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j; Liu K, 2010, ACS NANO, V4, P5827, DOI 10.1021/nn1017318; Chang TE, 2006, POLYMER, V47, P7740, DOI 10.1016/j.polymer.2006.09.013; Dresselhaus M. S., 1996, SCI FULLERENES CARBO; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Konabe S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4798274; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Nakashima N, 2003, CHEM LETT, V32, P456, DOI 10.1246/cl.2003.456; Nakashima N, 2002, CHEM LETT, P638, DOI 10.1246/cl.2002.638; Nosho Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1865343	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							035101	10.7567/JJAP.54.035101		4	Physics, Applied	Physics	CF8FT	WOS:000352792200054		
J	Shiino, T; Furuya, R; Soma, T; Watanabe, Y; Sakai, T; Jiang, L; Maezawa, H; Yamakura, T; Sakai, N; Yamamoto, S				Shiino, Tatsuya; Furuya, Ryuta; Soma, Tatsuya; Watanabe, Yoshimasa; Sakai, Takeshi; Jiang, Ling; Maezawa, Hiroyuki; Yamakura, Tetsuya; Sakai, Nami; Yamamoto, Satoshi			Low-noise 1.5 THz waveguide-type hot-electron bolometer mixers using relatively thick NbTiN superconducting film	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							HETERODYNE RECEIVER; TERAHERTZ MIXER; BANDWIDTH; PERFORMANCE; TELESCOPE; GHZ	We have developed waveguide-type low-noise superconducting hot-electron bolometer (HEB) mixers for astronomical observations in the 1.3-1.5 THz region by using a relatively thick NbTiN superconducting film (10.8 nm). We have achieved a receiver noise temperature of 490K (DSB: double side band) at 1.475 THz. This noise temperature corresponds to seven times the quantum noise. According to gain bandwidth measurements, the contribution of diffusion cooling is found to be responsible for such a good noise performance. (C) 2015 The Japan Society of Applied Physics	[Shiino, Tatsuya; Furuya, Ryuta; Soma, Tatsuya; Watanabe, Yoshimasa; Sakai, Nami; Yamamoto, Satoshi] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Shiino, Tatsuya; Furuya, Ryuta; Soma, Tatsuya; Watanabe, Yoshimasa; Sakai, Nami; Yamamoto, Satoshi] Univ Tokyo, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan; [Sakai, Takeshi] Univ Electrocommun, Chofu, Tokyo 1828585, Japan; [Jiang, Ling] Nanjing Forestry Univ, Coll Informat Sci & Technol, Nanjing 210037, Jiangsu, Peoples R China; [Maezawa, Hiroyuki] Osaka Prefecture Univ, Sakai, Osaka 5998531, Japan; [Yamakura, Tetsuya] Univ Tsukuba, Grad Sch Pure & Appl Sci, Inst Phys, Tsukuba, Ibaraki 3058577, Japan	Shiino, T (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.	shiino@taurus.phys.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21224002]	This study was supported by a Grant-in-Aid for Scientific Research (No. 21224002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21224002).	PROBER DE, 1993, APPL PHYS LETT, V62, P2119, DOI 10.1063/1.109445; Wiedner MC, 2006, ASTRON ASTROPHYS, V454, pL33, DOI 10.1051/0004-6361:20065341; Cherednichenko S, 2002, PHYSICA C, V372, P427, DOI 10.1016/S0921-4534(02)00715-3; Semenov AD, 2001, PHYSICA C, V351, P349, DOI 10.1016/S0921-4534(00)01637-3; Tretyakov I, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3544050; Semenov AD, 2000, J APPL PHYS, V88, P6758, DOI 10.1063/1.1323531; Meledin D, 2009, IEEE T MICROW THEORY, V57, P89, DOI 10.1109/TMTT.2008.2008946; Semenov A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.054510; Cherednichenko S, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2890099; Cherednichenko S., 1997, P 8 INT S SPAC TER T, P245; Cherednichenko S., 2000, P 11 INT S SPAC THZ, P228; De Graauw T, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014698; Ekstrom H, 1997, APPL PHYS LETT, V70, P3296, DOI 10.1063/1.119143; Fiegle K, 1997, IEEE T APPL SUPERCON, V7, P3552, DOI 10.1109/77.622165; Finkel M., 2003, P 14 INT S SPAC TER, P276; Gershenzon E. M., 1990, Superconductivity: Physics, Chemistry, Technology, V3; Gundlach KH, 2000, SUPERCOND SCI TECH, V13, pR171, DOI 10.1088/0953-2048/13/12/202; Hajenius M, 2004, SUPERCOND SCI TECH, V17, pS224, DOI 10.1088/0953-2048/17/5/026; Jiang L, 2009, IEEE T APPL SUPERCON, V19, P301, DOI 10.1109/TASC.2009.2019071; Jiang L, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/4/045025; Karasik BS, 1996, APPL PHYS LETT, V68, P853, DOI 10.1063/1.116555; Loudkov D, 2005, IEEE T APPL SUPERCON, V15, P476, DOI 10.1109/TASC.2005.849881; Miki S, 2001, IEEE T APPL SUPERCON, V11, P175, DOI 10.1109/77.919313; Satou N, 2008, PUBL ASTRON SOC JPN, V60, P1199; Schoelkopf RJ, 1997, IEEE T APPL SUPERCON, V7, P3576, DOI 10.1109/77.622173; Tong C.-Y. E., 2003, IEEE MTTS DIGEST, V2, P751	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							033101	10.7567/JJAP.54.033101		5	Physics, Applied	Physics	CF8FT	WOS:000352792200048		
J	Shimazu, Y; Murata, K; Toda, S				Shimazu, Yoshihiro; Murata, Kotaro; Toda, Shunichi			Anomalous hysteresis below 1 K in the transfer characteristics of MoS2 field effect transistors	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TRANSITION-METAL DICHALCOGENIDES; SINGLE-LAYER MOS2; MONOLAYER MOS2; MECHANISM; TRANSPORT; GRAPHENE	Recent studies on single- and multilayer molybdenum disulfide (MoS2) devices have revealed their promising characteristics as semiconductor devices. Understanding the transport properties at metal/MoS2 interfaces may be crucial for their implementation. In this study, we measured the electrical characteristics of field effect transistors (FETs) with a MoS2 channel from room temperature to 30 mK. A high on/off ratio (up to 10(7) at 1 K) was observed at all temperatures. Below 1 K, we observed for the first time an anomalously large hysteresis in the transfer characteristics of the MoS2 FET. We hypothesize that this hysteresis results from the slow injection of electrons via quantum tunneling through the Schottky barrier at the contacts. The size of the hysteresis increased with increase in the scan rate of the gate voltage, which is consistent with the possibility of slow injection of electrons. (C) 2015 The Japan Society of Applied Physics	[Shimazu, Yoshihiro; Murata, Kotaro; Toda, Shunichi] Yokohama Natl Univ, Dept Phys, Yokohama, Kanagawa 2408501, Japan	Shimazu, Y (reprint author), Yokohama Natl Univ, Dept Phys, Yokohama, Kanagawa 2408501, Japan.	yshimazu@ynu.ac.jp			JSPS [24651132]	The authors thank M. Tanaka for valuable discussions and K. Osada for the measurement of AFM profiles. This work was supported by JSPS KAKENHI Grant Number 24651132.	Kim W, 2003, NANO LETT, V3, P193, DOI 10.1021/nl0259232; Lopez-Sanchez O, 2013, NAT NANOTECHNOL, V8, P497, DOI [10.1038/nnano.2013.100, 10.1038/NNANO.2013.100]; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Popov I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.156802; Fang H, 2013, NANO LETT, V13, P1991, DOI 10.1021/nl400044m; Perera MM, 2013, ACS NANO, V7, P4449, DOI 10.1021/nn401053g; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Gong C, 2014, NANO LETT, V14, P1714, DOI 10.1021/nl403465v; Taniguchi K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4740268; Wang HM, 2010, ACS NANO, V4, P7221, DOI 10.1021/nn101950n; Cho K, 2013, ACS NANO, V7, P7751, DOI 10.1021/nn402348r; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Yoon Y, 2011, NANO LETT, V11, P3768, DOI 10.1021/nl2018178; Das S, 2013, NANO LETT, V13, P100, DOI 10.1021/nl303583v; Liu H, 2014, ACS NANO, V8, P1031, DOI 10.1021/nn405916t; MARTINIS JM, 1987, PHYS REV B, V35, P4682, DOI 10.1103/PhysRevB.35.4682; Late DJ, 2012, ACS NANO, V6, P5635, DOI 10.1021/nn301572c; Park W, 2014, ACS NANO, V8, P4961, DOI 10.1021/nn501019g; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Roy K, 2013, NAT NANOTECHNOL, V8, P826, DOI [10.1038/nnano.2013.206, 10.1038/NNANO.2013.206]; Kuc A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245213; Chen JR, 2013, NANO LETT, V13, P3106, DOI 10.1021/nl4010157; TANAKA M, 1978, J PHYS SOC JPN, V45, P1899, DOI 10.1143/JPSJ.45.1899; Pu J, 2012, NANO LETT, V12, P4013, DOI 10.1021/nl301335q; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Ganatra R, 2014, ACS NANO, V8, P4074, DOI 10.1021/nn405938z; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; Radisavljevic B, 2011, ACS NANO, V5, P9934, DOI 10.1021/nn203715c; Esmaeili-Rad MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02345; Fontana M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01634; KAM KK, 1982, J PHYS CHEM-US, V86, P463, DOI 10.1021/j100393a010; Lee YG, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3588033; Ong HG, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/28/285301; Sze S. M., 2002, SEMICONDUCTOR DEVICE; Tanaka M., 2013, 19 INT VAC C	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	MAR	2015	54	3							031201	10.7567/JJAP.54.031201		4	Physics, Applied	Physics	CF8FT	WOS:000352792200034		
